Citrus Sinensis ID: 040557

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------
Protein Sequence
MQSSTTSCDRGLLAALFFFLGVLSVSVILIILIIILWKFNKAKELVRLALRTTKEGVSKDFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVRPAYLERRRKRDETLSWDTISEPFPSLTQSESPALPHQQPSN
Secondary Structure (PSIPRED)
ccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccHHHHHHHHccccccccccccccccccEEEcccccEEEEEEcccccccHHHHHHHHHHHHHHHccccccccEEccccccccEEEEEEEcccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccEEcccccccccccccccccccccccccccccccccEEEcEEEEEcccccHHHHcccccccccccccHHHHHHHHHccccccccccccccccHHHHHHHHHHccccccccccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHcccccccccccccEEEccccccccccccccccccccEEEEcccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccHHHHEHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccEcHHHHHHHHccccHHccccccccccEEccEcccccEEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHEEEEccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHcccccEccccccHHHEEEcHHHcEEEccccccccccccccEEEccEEEcHHHccHHHHHHccccHHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHccccHHHcccccccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHcccccccccccccEEEEccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mqssttscDRGLLAALFFFLGVLSVSVILIILIIILWKFNKAKELVRLALRTtkegvskdffngnlrtisyFDFQTLKKatknfhpgnllgrggfgpvyrgkladgTLVAVKKLCVdksqqgeseFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIygesdkflnWSTRFQIILGIARGLqylhedshtrivhrdikasnvlldekfqskigdfglarffpedqayLSTNfagtlgytapeyairgelsekadiySFGVLVLEIIScrkntdltlpsemqyLPEYAWKLYERGRilelvdprmrkegiverdALQVINVAFIClqphgnqrppmSEIVAMLTCkvesgipvrpaYLERRRkrdetlswdtisepfpsltqsespalphqqpsn
Flexible Loop (DISEMBL)
mqssttscDRGLLAALFFFLGVLSVSVILIILIIILWKFNKAKELVRLALrttkegvskdffngnlRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCrkntdltlpseMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKvesgipvrpaylerrrkrdetlswdtisepfpsltqsespalphqqpsn
Low Complexity Region (SEG)
MQSSTTSCDRgllaalffflgvlsvsviliiliiilWKFNKAKELVRLALRTTKEGVSKDFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVRPAYLERRRKRDETLSWDTISEPFPSLTQSESPALPHQQPSN
Disordered region (IsUnstruct)
*******CDRGLLAALFFFLGVLSVSVILIILIIILWKFNKAKELVRLALRTTKEGVSKDFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGN****MSEIVAMLTCKVESGIPVRPAYL*************************************
Disordered Region (DISOPRED)
****************FFFLGVLSVSVILIILIIILWKFN**************************RTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLC******G**EFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVRPAY**************************************
Disordered Region (DISEMBL)
********DRGLLAALFFFLGVLSVSVILIILIIILWKFNKAKELVRLALRTTKEGVSKDFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVRPAYLERRRKRDETLSWDTISEPF******************
Disordered Region (DISPRO)
***********LLAALFFFLGVLSVSVILIILIIILWKFNKAKE**********************RTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVRPAYLERRR*********************************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSiiHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MQSSTTSCDRGLLAALFFFLGVLSVSVILIILIIILWKFNKAKELVRLALRTTKEGVSKDFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVRPAYLERRRKRDETLSWDTISEPFPSLTQSESPALPHQQPSN
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	407	2.2.26 [Sep-21-2011]
C0LGH3	1033	Probable LRR receptor-lik	yes	no	0.754	0.297	0.511	3e-89
C0LGH2	1032	Probable LRR receptor-lik	no	no	0.754	0.297	0.495	4e-87
C0LGG9	1035	Probable LRR receptor-lik	no	no	0.724	0.285	0.491	5e-83
C0LGG8	1038	Probable LRR receptor-lik	no	no	0.761	0.298	0.478	5e-83
C0LGN2	1020	Probable leucine-rich rep	no	no	0.783	0.312	0.468	7e-80
C0LGE0	1014	Probable LRR receptor-lik	no	no	0.796	0.319	0.448	3e-79
O64784	821	G-type lectin S-receptor-	no	no	0.918	0.455	0.414	8e-79
C0LGG7	953	Probable LRR receptor-lik	no	no	0.872	0.372	0.442	8e-79
O81906	849	G-type lectin S-receptor-	no	no	0.850	0.407	0.443	2e-78
O64781	831	G-type lectin S-receptor-	no	no	0.867	0.424	0.425	1e-75

>sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2

 Score =  328 bits (842), Expect = 3e-89,   Method: Compositional matrix adjust.
 Identities = 159/311 (51%), Positives = 220/311 (70%), Gaps = 4/311 (1%)

Query: 72  FDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVR 131
           F +  LK AT++F P N LG GGFGPVY+GKL DG  VAVK L V  S+QG+ +F++E+ 
Sbjct: 681 FTYSELKSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVG-SRQGKGQFVAEIV 739

Query: 132 MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIA 191
            I+++QH+NLV+L GCC +G  RLLVYEY+ N SLD  ++GE    L+WSTR++I LG+A
Sbjct: 740 AISAVQHRNLVKLYGCCYEGEHRLLVYEYLPNGSLDQALFGEKTLHLDWSTRYEICLGVA 799

Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY 251
           RGL YLHE++  RIVHRD+KASN+LLD K   K+ DFGLA+ + + + ++ST  AGT+GY
Sbjct: 800 RGLVYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHISTRVAGTIGY 859

Query: 252 TAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILE 311
            APEYA+RG L+EK D+Y+FGV+ LE++S R N+D  L  E +YL E+AW L+E+GR +E
Sbjct: 860 LAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEDEKRYLLEWAWNLHEKGREVE 919

Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE-SGIPVRPAYL 370
           L+D ++ +  + E    ++I +A +C Q     RPPMS +VAML+  VE S +  +P YL
Sbjct: 920 LIDHQLTEFNMEE--GKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEVSDVTSKPGYL 977

Query: 371 ERRRKRDETLS 381
              R  D T S
Sbjct: 978 TDWRFDDTTAS 988

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2

 Score =  322 bits (824), Expect = 4e-87,   Method: Compositional matrix adjust.
 Identities = 154/311 (49%), Positives = 218/311 (70%), Gaps = 4/311 (1%)

Query: 72  FDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVR 131
           F +  LK AT++F P N LG GGFGPVY+G L DG +VAVK L V  S+QG+ +F++E+ 
Sbjct: 682 FTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSV-GSRQGKGQFVAEIV 740

Query: 132 MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIA 191
            I+S+ H+NLV+L GCC +G  R+LVYEY+ N SLD  ++G+    L+WSTR++I LG+A
Sbjct: 741 AISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKTLHLDWSTRYEICLGVA 800

Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY 251
           RGL YLHE++  RIVHRD+KASN+LLD +   +I DFGLA+ + + + ++ST  AGT+GY
Sbjct: 801 RGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIGY 860

Query: 252 TAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILE 311
            APEYA+RG L+EK D+Y+FGV+ LE++S R N+D  L  E +YL E+AW L+E+ R +E
Sbjct: 861 LAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEKSRDIE 920

Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESG-IPVRPAYL 370
           L+D ++    + E  A ++I +A +C Q     RPPMS +VAML+  VE G +  +P Y+
Sbjct: 921 LIDDKLTDFNMEE--AKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEIGDVTSKPGYV 978

Query: 371 ERRRKRDETLS 381
              R  D T S
Sbjct: 979 SDWRFDDTTGS 989

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2

 Score =  308 bits (789), Expect = 5e-83,   Method: Compositional matrix adjust.
 Identities = 149/303 (49%), Positives = 215/303 (70%), Gaps = 8/303 (2%)

Query: 72  FDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVR 131
           F  + +K+AT NF P N +G GGFGPVY+G LADG  +AVK+L   KS+QG  EF++E+ 
Sbjct: 655 FTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLS-SKSKQGNREFVTEIG 713

Query: 132 MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDK--FLNWSTRFQIILG 189
           MI+++QH NLV+L GCC +G + LLVYEY++N SL   ++G   +   L+WSTR ++ +G
Sbjct: 714 MISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKVCIG 773

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
           IA+GL YLHE+S  +IVHRDIKA+NVLLD    +KI DFGLA+   E+  ++ST  AGT+
Sbjct: 774 IAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIAGTI 833

Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRI 309
           GY APEYA+RG L++KAD+YSFGV+ LEI+S + NT+     E  YL ++A+ L E+G +
Sbjct: 834 GYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLDWAYVLQEQGSL 893

Query: 310 LELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVRPAY 369
           LELVDP +      +++A++++N+A +C  P    RPPMS +V+ML  K++    V+P  
Sbjct: 894 LELVDPDL-GTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSMLQGKIK----VQPPL 948

Query: 370 LER 372
           ++R
Sbjct: 949 VKR 951

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1

 Score =  308 bits (789), Expect = 5e-83,   Method: Compositional matrix adjust.
 Identities = 157/328 (47%), Positives = 223/328 (67%), Gaps = 18/328 (5%)

Query: 72  FDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVR 131
           F  + +K+AT NF P N +G GGFGPVY+G LADG  +AVK+L   KS+QG  EF++E+ 
Sbjct: 657 FTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLS-SKSKQGNREFVTEIG 715

Query: 132 MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDK--FLNWSTRFQIILG 189
           MI+++QH NLV+L GCC +G + LLVYEY++N SL   ++G   +   L+WSTR +I +G
Sbjct: 716 MISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKICIG 775

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
           IA+GL YLHE+S  +IVHRDIKA+NVLLD    +KI DFGLA+   ++  ++ST  AGT+
Sbjct: 776 IAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLNDDENTHISTRIAGTI 835

Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRI 309
           GY APEYA+RG L++KAD+YSFGV+ LEI+S + NT+     E  YL ++A+ L E+G +
Sbjct: 836 GYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGSL 895

Query: 310 LELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVRPAY 369
           LELVDP +      +++A++++N+A +C  P    RPPMS +V+ML    E  I V+P  
Sbjct: 896 LELVDPDL-GTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSML----EGKIKVQPPL 950

Query: 370 LER----------RRKRDETLSWDTISE 387
           ++R          R K  E LS D+ S+
Sbjct: 951 VKREADPSGSAAMRFKALELLSQDSESQ 978

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1

 Score =  298 bits (762), Expect = 7e-80,   Method: Compositional matrix adjust.
 Identities = 157/335 (46%), Positives = 222/335 (66%), Gaps = 16/335 (4%)

Query: 25  VSVILIILII--ILWKFNKAKELVRLALRTTKEGVSKDFFNGNLRTISYFDFQTLKKATK 82
            S + ++L+I  ILW         R  LR  K  + KDF N + + IS F  + +K AT 
Sbjct: 621 ASTVFLVLLIGGILW--------WRGCLRP-KSQMEKDFKNLDFQ-ISSFSLRQIKVATD 670

Query: 83  NFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           NF P N +G GGFGPV++G + DGT++AVK+L   KS+QG  EFL+E+ MI+++QH +LV
Sbjct: 671 NFDPANKIGEGGFGPVHKGIMTDGTVIAVKQLSA-KSKQGNREFLNEIAMISALQHPHLV 729

Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYG--ESDKFLNWSTRFQIILGIARGLQYLHED 200
           +L GCC +G Q LLVYEY++N SL   ++G  E+   LNW  R +I +GIARGL YLHE+
Sbjct: 730 KLYGCCVEGDQLLLVYEYLENNSLARALFGPQETQIPLNWPMRQKICVGIARGLAYLHEE 789

Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
           S  +IVHRDIKA+NVLLD++   KI DFGLA+   E+  ++ST  AGT GY APEYA+RG
Sbjct: 790 SRLKIVHRDIKATNVLLDKELNPKISDFGLAKLDEEENTHISTRVAGTYGYMAPEYAMRG 849

Query: 261 ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE 320
            L++KAD+YSFGV+ LEI+  + NT     ++  YL ++   L E+  +LE+VDPR+  +
Sbjct: 850 HLTDKADVYSFGVVALEIVHGKSNTSSRSKADTFYLLDWVHVLREQNTLLEVVDPRLGTD 909

Query: 321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
              +++AL +I +  +C  P    RP MS +V+ML
Sbjct: 910 -YNKQEALMMIQIGMLCTSPAPGDRPSMSTVVSML 943

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1

 Score =  295 bits (756), Expect = 3e-79,   Method: Compositional matrix adjust.
 Identities = 153/341 (44%), Positives = 226/341 (66%), Gaps = 17/341 (4%)

Query: 22  VLSVSVILIILIIILWKFNKAKELVRLALRTTKEGVSKDFFNGNLRTISYFDFQTLKKAT 81
           V + +++L I++ + WK            R  K  + K+    +L+T   F  + +K AT
Sbjct: 628 VAAATLLLFIIVGVFWK-----------KRRDKNDIDKELRGLDLQT-GTFTLRQIKAAT 675

Query: 82  KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
            NF     +G GGFG VY+G+L++G L+AVK+L   KS+QG  EF++E+ MI+++QH NL
Sbjct: 676 DNFDVTRKIGEGGFGSVYKGELSEGKLIAVKQLSA-KSRQGNREFVNEIGMISALQHPNL 734

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYG--ESDKF-LNWSTRFQIILGIARGLQYLH 198
           V+L GCC +G+Q +LVYEY++N  L   ++G  ES +  L+WSTR +I LGIA+GL +LH
Sbjct: 735 VKLYGCCVEGNQLILVYEYLENNCLSRALFGKDESSRLKLDWSTRKKIFLGIAKGLTFLH 794

Query: 199 EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI 258
           E+S  +IVHRDIKASNVLLD+   +KI DFGLA+   +   ++ST  AGT+GY APEYA+
Sbjct: 795 EESRIKIVHRDIKASNVLLDKDLNAKISDFGLAKLNDDGNTHISTRIAGTIGYMAPEYAM 854

Query: 259 RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR 318
           RG L+EKAD+YSFGV+ LEI+S + NT+     +  YL ++A+ L ERG +LELVDP + 
Sbjct: 855 RGYLTEKADVYSFGVVALEIVSGKSNTNFRPTEDFVYLLDWAYVLQERGSLLELVDPTLA 914

Query: 319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV 359
            +   E +A+ ++NVA +C       RP MS++V+++  K 
Sbjct: 915 SD-YSEEEAMLMLNVALMCTNASPTLRPTMSQVVSLIEGKT 954

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64784|Y1136_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61360 OS=Arabidopsis thaliana GN=At1g61360 PE=2 SV=1

 Score =  294 bits (753), Expect = 8e-79,   Method: Compositional matrix adjust.
 Identities = 157/379 (41%), Positives = 234/379 (61%), Gaps = 5/379 (1%)

Query: 23  LSVSVILIILIIILWKFNKAKELVRLALRTTKEGVSK-DFFNGNLRTISYFDFQTLKKAT 81
           LSV +IL+++    W++   +    L  +   EG  K D  + ++  +++F+   L+ AT
Sbjct: 436 LSVCLILVLVACGCWRYRVKQNGSSLVSKDNVEGAWKSDLQSQDVSGLNFFEIHDLQTAT 495

Query: 82  KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
            NF   N LG+GGFG VY+GKL DG  +AVK+L    S QG  EF++E+++I+ +QH+NL
Sbjct: 496 NNFSVLNKLGQGGFGTVYKGKLQDGKEIAVKRL-TSSSVQGTEEFMNEIKLISKLQHRNL 554

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF-LNWSTRFQIILGIARGLQYLHED 200
           +RLLGCC DG ++LLVYEYM N+SLD+ I+    K  ++W+TRF II GIARGL YLH D
Sbjct: 555 LRLLGCCIDGEEKLLVYEYMVNKSLDIFIFDLKKKLEIDWATRFNIIQGIARGLLYLHRD 614

Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST-NFAGTLGYTAPEYAIR 259
           S  R+VHRD+K SN+LLDEK   KI DFGLAR F  +Q   ST +  GTLGY +PEYA  
Sbjct: 615 SFLRVVHRDLKVSNILLDEKMNPKISDFGLARLFHGNQHQDSTGSVVGTLGYMSPEYAWT 674

Query: 260 GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLY-ERGRILELVDPRMR 318
           G  SEK+DIYSFGVL+LEII+ ++ +  +   + + L  YAW  + E G +  L      
Sbjct: 675 GTFSEKSDIYSFGVLMLEIITGKEISSFSYGKDNKNLLSYAWDSWSENGGVNLLDQDLDD 734

Query: 319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVRPAYLERRRKRDE 378
            + +   +A + +++  +C+Q     RP + ++++MLT   +   P +P ++      D 
Sbjct: 735 SDSVNSVEAGRCVHIGLLCVQHQAIDRPNIKQVMSMLTSTTDLPKPTQPMFVLETSDEDS 794

Query: 379 TLSWDTISEPFPSLTQSES 397
           +LS    S    S+ +++S
Sbjct: 795 SLSHSQRSNDLSSVDENKS 813

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2

 Score =  294 bits (752), Expect = 8e-79,   Method: Compositional matrix adjust.
 Identities = 161/364 (44%), Positives = 229/364 (62%), Gaps = 9/364 (2%)

Query: 21  GVLSVSVILIILIIILWKFNKAKELVRLALRTTKEGVSKDFFNGNLRTISYFDFQTLKKA 80
           G L   V+++ + I+   F     L +     +K  + KDF +  L  I+ F  + +K A
Sbjct: 565 GTLHTLVVILSIFIVFLVFGT---LWKKGYLRSKSQMEKDFKSLEL-MIASFSLRQIKIA 620

Query: 81  TKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           T NF   N +G GGFGPVY+GKL DGT++AVK+L    S+QG  EFL+E+ MI+++ H N
Sbjct: 621 TNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTG-SKQGNREFLNEIGMISALHHPN 679

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYG--ESDKFLNWSTRFQIILGIARGLQYLH 198
           LV+L GCC +G Q LLVYE+++N SL   ++G  E+   L+W TR +I +G+ARGL YLH
Sbjct: 680 LVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRKICIGVARGLAYLH 739

Query: 199 EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI 258
           E+S  +IVHRDIKA+NVLLD++   KI DFGLA+   ED  ++ST  AGT GY APEYA+
Sbjct: 740 EESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRIAGTFGYMAPEYAM 799

Query: 259 RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR 318
           RG L++KAD+YSFG++ LEI+  R N      +   YL ++   L E+  +LELVDPR+ 
Sbjct: 800 RGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLREKNNLLELVDPRLG 859

Query: 319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGI-PVRPAYLERRRKRD 377
            E   E +A+ +I +A +C      +RP MSE+V ML  K    +  +  A + R  KR 
Sbjct: 860 SEYNRE-EAMTMIQIAIMCTSSEPCERPSMSEVVKMLEGKKMVEVEKLEEASVHRETKRL 918

Query: 378 ETLS 381
           E ++
Sbjct: 919 ENMN 922

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  293 bits (749), Expect = 2e-78,   Method: Compositional matrix adjust.
 Identities = 168/379 (44%), Positives = 227/379 (59%), Gaps = 33/379 (8%)

Query: 25  VSVILI-ILIIILWKFNKAKEL-------------VRLALRTTKEGVSKDFFNG------ 64
           V VILI I  ++LW+F + K++             V   L  +KE  S   F+G      
Sbjct: 447 VGVILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKSKETTSA--FSGSVDIMI 504

Query: 65  -----NLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKS 119
                N   +  F    +  AT +F   N LGRGGFGPVY+G L DG  +AVK+L   KS
Sbjct: 505 EGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLS-GKS 563

Query: 120 QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDK-FL 178
            QG  EF +E+ +I  +QH+NLVRLLGCC +G +++LVYEYM N+SLD  ++ E+ +  +
Sbjct: 564 GQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALI 623

Query: 179 NWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ 238
           +W  RF II GIARGL YLH DS  RI+HRD+K SNVLLD +   KI DFG+AR F  +Q
Sbjct: 624 DWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQ 683

Query: 239 AYLST-NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLP 297
              +T    GT GY +PEYA+ G  S K+D+YSFGVL+LEI+S ++NT L   SE   L 
Sbjct: 684 NEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLR-SSEHGSLI 742

Query: 298 EYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC 357
            YAW LY  GR  ELVDP++R     +R+AL+ I+VA +C+Q    +RP M+ ++ ML  
Sbjct: 743 GYAWYLYTHGRSEELVDPKIRVT-CSKREALRCIHVAMLCVQDSAAERPNMASVLLMLES 801

Query: 358 KVES-GIPVRPAYLERRRK 375
              +   P +P +   RR 
Sbjct: 802 DTATLAAPRQPTFTSTRRN 820

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64781|Y1639_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61390 OS=Arabidopsis thaliana GN=At1g61390 PE=2 SV=1

 Score =  283 bits (725), Expect = 1e-75,   Method: Compositional matrix adjust.
 Identities = 153/360 (42%), Positives = 221/360 (61%), Gaps = 7/360 (1%)

Query: 23  LSVSVILIILIIILWKF-NKAKELVRLALRTTKEGVSKDFFNGNLRTISYFDFQTLKKAT 81
           LS+ VIL+      W++  K  E   + + ++++  +KD    ++  ++ FD  T++ AT
Sbjct: 458 LSIFVILVFAAYKSWRYRTKQNEPNPMFIHSSQDAWAKDMEPQDVSGVNLFDMHTIRTAT 517

Query: 82  KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
            NF   N LG+GGFGPVY+GKL DG  +AVK+L    S QG  EF++E+R+I+ +QHKNL
Sbjct: 518 NNFSSSNKLGQGGFGPVYKGKLVDGKEIAVKRLS-SSSGQGTDEFMNEIRLISKLQHKNL 576

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF-LNWSTRFQIILGIARGLQYLHED 200
           VRLLGCC  G ++LL+YEY+ N+SLD+ ++  + KF ++W  RF II G+ARGL YLH D
Sbjct: 577 VRLLGCCIKGEEKLLIYEYLVNKSLDVFLFDSTLKFEIDWQKRFNIIQGVARGLLYLHRD 636

Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST-NFAGTLGYTAPEYAIR 259
           S  R++HRD+K SN+LLDEK   KI DFGLAR     Q   +T    GTLGY APEYA  
Sbjct: 637 SRLRVIHRDLKVSNILLDEKMIPKISDFGLARMSQGTQYQDNTRRVVGTLGYMAPEYAWT 696

Query: 260 GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK 319
           G  SEK+DIYSFGVL+LEII   K +  +   E + L  YAW+ +   + ++L+D  +  
Sbjct: 697 GVFSEKSDIYSFGVLLLEIIIGEKISRFS--EEGKTLLAYAWESWCETKGVDLLDQAL-A 753

Query: 320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVRPAYLERRRKRDET 379
           +     +  + + +  +C+Q     RP   E+++MLT   E   P +P +    R  D T
Sbjct: 754 DSSHPAEVGRCVQIGLLCVQHQPADRPNTLELMSMLTTISELPSPKQPTFTVHSRDDDST 813

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	407
255573543	415	serine-threonine protein kinase, plant-t	0.916	0.898	0.778	1e-167
297735414	454	unnamed protein product [Vitis vinifera]	0.921	0.825	0.731	1e-159
356558343	458	PREDICTED: LOW QUALITY PROTEIN: probable	0.928	0.825	0.716	1e-158
359485102	456	PREDICTED: probable LRR receptor-like se	0.921	0.822	0.727	1e-157
356532704	412	PREDICTED: probable LRR receptor-like se	0.923	0.912	0.705	1e-156
356564802	408	PREDICTED: probable LRR receptor-like se	0.936	0.933	0.713	1e-156
224087168	317	predicted protein [Populus trichocarpa]	0.776	0.996	0.823	1e-155
147861521	449	hypothetical protein VITISV_001563 [Viti	0.862	0.781	0.740	1e-154
357479449	463	Cysteine-rich receptor-like protein kina	0.941	0.827	0.704	1e-154
224142637	298	predicted protein [Populus trichocarpa]	0.729	0.996	0.842	1e-149

>gi|255573543|ref|XP_002527696.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223532927|gb|EEF34695.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  595 bits (1534), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 292/375 (77%), Positives = 328/375 (87%), Gaps = 2/375 (0%)

Query: 16  LFFFLGVLSVSVILIILIIILWKFNKAKELVRLALRTTKEGVSKDFFNGNLRTISYFDFQ 75
           LFFFLG + + +IL+ILI+++WK+ K  E+++   R   +  S DF++GNLRTISY+DFQ
Sbjct: 26  LFFFLGGVVLLIILLILIVVIWKY-KPAEVMKFLRRNKSQKASADFWSGNLRTISYYDFQ 84

Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITS 135
           TLKKATKNFHP NLLGRGGFGPVYRGKLADG LVAVK L ++KS QGESEFLSEVRMITS
Sbjct: 85  TLKKATKNFHPSNLLGRGGFGPVYRGKLADGRLVAVKMLSLEKSHQGESEFLSEVRMITS 144

Query: 136 IQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQ 195
           IQHKN+VRLLGCCSDGSQRLLVYEYMKNRSLD ++YG SD+FL+W+TRFQIILGIARGLQ
Sbjct: 145 IQHKNMVRLLGCCSDGSQRLLVYEYMKNRSLDNIVYGNSDQFLDWNTRFQIILGIARGLQ 204

Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE 255
           YLHEDSH RIVHRDIKASN+LLD+KFQ KIGDFGLARFFPEDQAYLST FAGTLGYTAPE
Sbjct: 205 YLHEDSHLRIVHRDIKASNILLDDKFQPKIGDFGLARFFPEDQAYLSTTFAGTLGYTAPE 264

Query: 256 YAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP 315
           YAIRGELSEKADIYSFGVLVLEIISCR+NTDLTLPSE QYLPEYAWKLYER   +ELVDP
Sbjct: 265 YAIRGELSEKADIYSFGVLVLEIISCRRNTDLTLPSEKQYLPEYAWKLYERSSTIELVDP 324

Query: 316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESG-IPVRPAYLERRR 374
           RMR+ G+ E+D LQ I+VA  CLQ     RPPMSEIVAMLTCKVE G  PV+PA+L+RR 
Sbjct: 325 RMRERGLAEKDVLQAIHVALFCLQSRAKLRPPMSEIVAMLTCKVEMGATPVKPAFLDRRP 384

Query: 375 KRDETLSWDTISEPF 389
           K++  LSWDTISE F
Sbjct: 385 KKEHNLSWDTISEVF 399

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297735414|emb|CBI17854.3| unnamed protein product [Vitis vinifera]

 Score =  568 bits (1465), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 281/384 (73%), Positives = 326/384 (84%), Gaps = 9/384 (2%)

Query: 15  ALFFFLGVLSVSVILIILIIILWKFNKAKELVRLALRTTKEGVSKDFFNGNLRTISYFDF 74
           ALFFFL    V +I +ILI++ WKF    EL +L   T +   +KDF +GNLRT+  FDF
Sbjct: 17  ALFFFLVAAVVLLIFLILILVSWKFKNLAELKKLVTETKRLQEAKDFCSGNLRTVGQFDF 76

Query: 75  QTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMIT 134
           ++LKKATKNFHP NLLGRGGFGPVYRGKL DG LVAVKKL +DKSQQGE+EFL+EV+MIT
Sbjct: 77  RSLKKATKNFHPSNLLGRGGFGPVYRGKLRDGKLVAVKKLSLDKSQQGEAEFLAEVKMIT 136

Query: 135 SIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           SIQHKNLVRLLGCCSDG QRLLVYEYMKNRSLDL+IY  +D+FLNW+TRFQIILGIARGL
Sbjct: 137 SIQHKNLVRLLGCCSDGPQRLLVYEYMKNRSLDLIIYERNDQFLNWNTRFQIILGIARGL 196

Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           QYLHEDSH RIVHRDIKASN+LLD++FQ +IGDFGLARFFPED+AYLST FAGTLGYTAP
Sbjct: 197 QYLHEDSHLRIVHRDIKASNILLDDRFQPRIGDFGLARFFPEDEAYLSTAFAGTLGYTAP 256

Query: 255 EYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD 314
           EYAIRGELSEKADIYSFGVLVLEII CRKNTDLTL SEMQYLPEYAWKLYE+ R+++LVD
Sbjct: 257 EYAIRGELSEKADIYSFGVLVLEIIGCRKNTDLTLSSEMQYLPEYAWKLYEKSRVIDLVD 316

Query: 315 PRMRKEGIVE------RDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES-GIPVRP 367
           PR++++G VE         LQVI+VA  CLQP+ N RPPMSE+VA+LTC+ +  G P++P
Sbjct: 317 PRIQEDGFVENHVLQVNHVLQVIHVALFCLQPYANLRPPMSEVVAVLTCRADMVGTPMKP 376

Query: 368 AYLERRRKRDETLSWDTISEPFPS 391
           A+L+  RK+D+ +S DTISE FPS
Sbjct: 377 AFLD--RKQDKNISSDTISEAFPS 398

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356558343|ref|XP_003547466.1| PREDICTED: LOW QUALITY PROTEIN: probable LRR receptor-like serine/threonine-protein kinase At1g56140-like [Glycine max]

 Score =  565 bits (1455), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 273/381 (71%), Positives = 318/381 (83%), Gaps = 3/381 (0%)

Query: 14  AALFFFLGVLSVSVILIILIIILWK-FNKAKELVRLALRTTKEGVSKDFFNGNLRTISYF 72
           ++LF+ LG L V  I++I + ++WK   +  + + +A +  K   S +FF+GNLRTIS F
Sbjct: 70  SSLFYILGGLVVLAIVLIFLYVVWKRIKRPAQTMTVAKKREKRKASXEFFSGNLRTISCF 129

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRM 132
           D+QTLKKAT+NFHP NLLG GGFGPVY+GKL DG LVAVKKL ++KSQQGE EFL EVR 
Sbjct: 130 DYQTLKKATENFHPDNLLGSGGFGPVYQGKLVDGRLVAVKKLALNKSQQGEKEFLVEVRT 189

Query: 133 ITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR 192
           ITSIQHKNLVRLLGCC DG QRLLVYEYMKNRSLDL I+G SD+FLNWSTRFQIILG+AR
Sbjct: 190 ITSIQHKNLVRLLGCCVDGPQRLLVYEYMKNRSLDLFIHGNSDQFLNWSTRFQIILGVAR 249

Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
           GLQYLHEDSH RIVHRDIKASN+LLD+KF  +IGDFGLARFFPEDQAYLST FAGTLGYT
Sbjct: 250 GLQYLHEDSHQRIVHRDIKASNILLDDKFHPRIGDFGLARFFPEDQAYLSTQFAGTLGYT 309

Query: 253 APEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL 312
           APEYAIRGELSEKADIYSFGVLVLEII CRKNT+ TLPSEMQYLPEYAWKLYE  RIL++
Sbjct: 310 APEYAIRGELSEKADIYSFGVLVLEIICCRKNTEHTLPSEMQYLPEYAWKLYENARILDI 369

Query: 313 VDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES-GIPVRPAYLE 371
           VDP++R+ G VE+D +Q  +VAF+CLQPH + RPPMSEIVA+LT K+E    P+RPA+L+
Sbjct: 370 VDPKLREHGFVEKDVMQANHVAFLCLQPHAHLRPPMSEIVALLTFKIEMVTTPMRPAFLD 429

Query: 372 RR-RKRDETLSWDTISEPFPS 391
           RR RK DE    + +S+ F S
Sbjct: 430 RRPRKGDENHPLEALSQGFTS 450

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485102|ref|XP_002268362.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56140-like [Vitis vinifera]

 Score =  562 bits (1448), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 281/386 (72%), Positives = 324/386 (83%), Gaps = 11/386 (2%)

Query: 15  ALFFFLGVLSVSVILIILIIILWKFNKAKELVRLALRTTKEGVSKDFFNGNLRTISYFDF 74
           ALFFFL    V +I +ILI++ WKF    EL +L   T +   +KDF +GNLRT+  FDF
Sbjct: 17  ALFFFLVAAVVLLIFLILILVSWKFKNLAELKKLVTETKRLQEAKDFCSGNLRTVGQFDF 76

Query: 75  QTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMIT 134
           ++LKKATKNFHP NLLGRGGFGPVYRGKL DG LVAVKKL +DKSQQGE+EFL+EV+MIT
Sbjct: 77  RSLKKATKNFHPSNLLGRGGFGPVYRGKLRDGKLVAVKKLSLDKSQQGEAEFLAEVKMIT 136

Query: 135 SIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESD--KFLNWSTRFQIILGIAR 192
           SIQHKNLVRLLGCCSDG QRLLVYEYMKNRSLDL+IYG      FLNW+TRFQIILGIAR
Sbjct: 137 SIQHKNLVRLLGCCSDGPQRLLVYEYMKNRSLDLIIYGSDGIPGFLNWNTRFQIILGIAR 196

Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
           GLQYLHEDSH RIVHRDIKASN+LLD++FQ +IGDFGLARFFPED+AYLST FAGTLGYT
Sbjct: 197 GLQYLHEDSHLRIVHRDIKASNILLDDRFQPRIGDFGLARFFPEDEAYLSTAFAGTLGYT 256

Query: 253 APEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL 312
           APEYAIRGELSEKADIYSFGVLVLEII CRKNTDLTL SEMQYLPEYAWKLYE+ R+++L
Sbjct: 257 APEYAIRGELSEKADIYSFGVLVLEIIGCRKNTDLTLSSEMQYLPEYAWKLYEKSRVIDL 316

Query: 313 VDPRMRKEGIVE------RDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES-GIPV 365
           VDPR++++G VE         LQVI+VA  CLQP+ N RPPMSE+VA+LTC+ +  G P+
Sbjct: 317 VDPRIQEDGFVENHVLQVNHVLQVIHVALFCLQPYANLRPPMSEVVAVLTCRADMVGTPM 376

Query: 366 RPAYLERRRKRDETLSWDTISEPFPS 391
           +PA+L+  RK+D+ +S DTISE FPS
Sbjct: 377 KPAFLD--RKQDKNISSDTISEAFPS 400

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356532704|ref|XP_003534911.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56140-like [Glycine max]

 Score =  558 bits (1438), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 268/380 (70%), Positives = 319/380 (83%), Gaps = 4/380 (1%)

Query: 15  ALFFFLG-VLSVSVILIILIIILWKFNKAKELVRLALRTTKEGVSKDFFNGNLRTISYFD 73
           +LF+ LG ++ ++++LI L ++  +  +  + + +A    ++G SK+FF+GNLRTIS FD
Sbjct: 26  SLFYILGGIVVLAIVLIFLYVVRKRIKRPAQTMTVA-TNEQQGRSKEFFSGNLRTISCFD 84

Query: 74  FQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMI 133
           +QTLKKAT+NFHP NLLG GGFGPVY+GKL D  LVAVKKL ++KSQQGE EFL EVR I
Sbjct: 85  YQTLKKATRNFHPDNLLGSGGFGPVYQGKLVDERLVAVKKLALNKSQQGEKEFLVEVRTI 144

Query: 134 TSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARG 193
           TSIQHKNLVRLLGCC DG QRLLVYEYMKNRSLDL I+G SD+FLNWSTRFQIILG+ARG
Sbjct: 145 TSIQHKNLVRLLGCCLDGPQRLLVYEYMKNRSLDLFIHGNSDQFLNWSTRFQIILGVARG 204

Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           LQYLHEDSH RIVHRDIKASN+LLD+KF  +IGDFGLARFFPEDQAYLST FAGTLGYTA
Sbjct: 205 LQYLHEDSHPRIVHRDIKASNILLDDKFHPRIGDFGLARFFPEDQAYLSTQFAGTLGYTA 264

Query: 254 PEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           PEYAIRGELSEKADIYSFGVLVLEII CRKNT+ TLPSEMQYLPEYAWKLYE  RIL++V
Sbjct: 265 PEYAIRGELSEKADIYSFGVLVLEIICCRKNTEHTLPSEMQYLPEYAWKLYENARILDIV 324

Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES-GIPVRPAYLER 372
           DP++R+ G VE+D +Q I+VAF+CLQPH + RPPMSEIVA+LT K+E    P+RPA+L++
Sbjct: 325 DPKLRQHGFVEKDVMQAIHVAFLCLQPHAHLRPPMSEIVALLTFKIEMVTTPMRPAFLDQ 384

Query: 373 RRKRD-ETLSWDTISEPFPS 391
           R + D E    + +S+ F S
Sbjct: 385 RPREDGENHPLEALSQGFTS 404

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356564802|ref|XP_003550637.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56140-like [Glycine max]

 Score =  556 bits (1432), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 274/384 (71%), Positives = 325/384 (84%), Gaps = 3/384 (0%)

Query: 15  ALFFFLGVLSVSVILIILIIILWK-FNKAKELVRLALRTTKEGVSKDFFNGNLRTISYFD 73
            +FFFLG + V VIL+IL+ I W+   +  +++   + T+++    +F +GNLRTISYFD
Sbjct: 22  GVFFFLGGIVVLVILLILVFIFWRRIKRPAKVMENTVLTSQQHGPMEFISGNLRTISYFD 81

Query: 74  FQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMI 133
           F+TL++ATKNFHP NLLG GGFGPVY+GKLADG L+AVK L +DKSQQGE EFL+EVRMI
Sbjct: 82  FRTLRRATKNFHPRNLLGSGGFGPVYQGKLADGRLIAVKTLSLDKSQQGEKEFLAEVRMI 141

Query: 134 TSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARG 193
           TSIQHKNLVRL+GCC+DG QR+LVYEYMKNRSLDL+IYG+SD+FLNWSTRFQIILG+ARG
Sbjct: 142 TSIQHKNLVRLIGCCTDGPQRILVYEYMKNRSLDLIIYGKSDQFLNWSTRFQIILGVARG 201

Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           LQYLHEDSH RIVHRDIKASN+LLDEKFQ +IGDFGLARFFPEDQAYLST FAGTLGYTA
Sbjct: 202 LQYLHEDSHLRIVHRDIKASNILLDEKFQPRIGDFGLARFFPEDQAYLSTQFAGTLGYTA 261

Query: 254 PEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           PEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTL SE QYLPEYAWKLYE+  ++E+V
Sbjct: 262 PEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLASEKQYLPEYAWKLYEKSMLMEIV 321

Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES-GIPVRPAYLER 372
           DP+++++GI E+D +Q  +VA +CLQPH + RP MSEIVAMLT KVE    P+RP +++R
Sbjct: 322 DPKLQEQGIEEKDVMQAFHVALLCLQPHADLRPAMSEIVAMLTFKVEMVTAPMRPIFVDR 381

Query: 373 RR-KRDETLSWDTISEPFPSLTQS 395
           RR   DE  SW+TI E F +   S
Sbjct: 382 RRVMDDEHHSWETIYEAFTTAVAS 405

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224087168|ref|XP_002308093.1| predicted protein [Populus trichocarpa] gi|222854069|gb|EEE91616.1| predicted protein [Populus trichocarpa]

 Score =  553 bits (1425), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 261/317 (82%), Positives = 291/317 (91%), Gaps = 1/317 (0%)

Query: 63  NGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQG 122
           +GNL+TI+YFDFQTLKKATK+FHP NLLGRGGFGPVYRGKL DG LVAVKKL +DKSQQG
Sbjct: 1   SGNLQTINYFDFQTLKKATKDFHPANLLGRGGFGPVYRGKLHDGRLVAVKKLSLDKSQQG 60

Query: 123 ESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWST 182
           ESEFLSEV+MITSIQ KNLVRLLGCCSDG QRLLVYEYMKNRSLDL+++G SDKFL+W+T
Sbjct: 61  ESEFLSEVKMITSIQQKNLVRLLGCCSDGPQRLLVYEYMKNRSLDLIVHGNSDKFLDWNT 120

Query: 183 RFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS 242
           RFQIILGIARGLQYLHEDSH RIVHRDIKASN+LLD+KFQ +I DFGLARFFPEDQAYLS
Sbjct: 121 RFQIILGIARGLQYLHEDSHLRIVHRDIKASNILLDDKFQPRISDFGLARFFPEDQAYLS 180

Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWK 302
           T FAGTLGYTAPEYAI+GELSEKADIYSFGVLVLEIIS RKNTDL+LPSEMQYLPEYAWK
Sbjct: 181 TAFAGTLGYTAPEYAIKGELSEKADIYSFGVLVLEIISSRKNTDLSLPSEMQYLPEYAWK 240

Query: 303 LYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES- 361
           LYER R+++LVDP++ + GIVE+D LQVI+VAF+CLQP  N RPPMS IVA LTCKVE  
Sbjct: 241 LYERSRVMDLVDPKLLEHGIVEKDVLQVIHVAFLCLQPLANLRPPMSRIVAQLTCKVEMV 300

Query: 362 GIPVRPAYLERRRKRDE 378
           G P+RP +L+R RK+D+
Sbjct: 301 GTPMRPVFLQRSRKKDD 317

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147861521|emb|CAN83581.1| hypothetical protein VITISV_001563 [Vitis vinifera]

 Score =  552 bits (1422), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 268/362 (74%), Positives = 308/362 (85%), Gaps = 11/362 (3%)

Query: 37  WKFNKAKELVRLALRTTKEGVSKDFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFG 96
           W   K  E  RL      E  +KDF +GNLRT+  FDF++LKKATKNFHP NLLGRGGFG
Sbjct: 36  WAKKKIDETSRLIFIFVAE--AKDFCSGNLRTVGQFDFRSLKKATKNFHPSNLLGRGGFG 93

Query: 97  PVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL 156
           PVY+GKL DG LVAVKKL +DKSQQGE+EFL+EV+MITSIQHKNLVRLLGCCSDG QRLL
Sbjct: 94  PVYQGKLRDGKLVAVKKLSLDKSQQGEAEFLAEVKMITSIQHKNLVRLLGCCSDGPQRLL 153

Query: 157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVL 216
           VYEYMKNRSLDL+IY  +D+FLNW+TRFQIILGIARGLQYLHEDSH RIVHRDIKASN+L
Sbjct: 154 VYEYMKNRSLDLIIYERNDQFLNWNTRFQIILGIARGLQYLHEDSHLRIVHRDIKASNIL 213

Query: 217 LDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVL 276
           LD++FQ +IGDFGLARFFPED+AYLST FAGTLGYTAPEYAIRGELSEKADIYSFGVLVL
Sbjct: 214 LDDRFQPRIGDFGLARFFPEDEAYLSTAFAGTLGYTAPEYAIRGELSEKADIYSFGVLVL 273

Query: 277 EIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVE------RDALQV 330
           EII CRKNTDLTL SEMQYLPEYAWKLYE+ R+++LVDPR++++G VE         LQV
Sbjct: 274 EIIGCRKNTDLTLSSEMQYLPEYAWKLYEKSRVIDLVDPRIQEDGFVENHVLQVNHVLQV 333

Query: 331 INVAFICLQPHGNQRPPMSEIVAMLTCKVES-GIPVRPAYLERRRKRDETLSWDTISEPF 389
           I+VA  CLQP+ N RPPMSE+VA+LTC+ +  G P++PA+L+  RK+D+ +S DTISE F
Sbjct: 334 IHVALFCLQPYANLRPPMSEVVAVLTCRADMVGTPMKPAFLD--RKQDKNISSDTISEAF 391

Query: 390 PS 391
           PS
Sbjct: 392 PS 393

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357479449|ref|XP_003610010.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355511065|gb|AES92207.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula]

 Score =  551 bits (1419), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 279/396 (70%), Positives = 326/396 (82%), Gaps = 13/396 (3%)

Query: 14  AALFFFLGVLSVSVILIILIIILWK-----FNKAKELVRLAL-----RTTKEGVSKDFFN 63
            AL+FFLGV+ V VIL+I++ + WK       K +EL          +T K+G   +F +
Sbjct: 67  GALYFFLGVIVVLVILLIILFVFWKRFRRGSGKTEELPEETAPPPPSQTQKQGF-MEFIS 125

Query: 64  GNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGE 123
           GNLRTISYFDFQTL+KATKNFH   LLG GGFGPVY+GKLADG LVA KKL +DKS QGE
Sbjct: 126 GNLRTISYFDFQTLRKATKNFHRRYLLGSGGFGPVYQGKLADGRLVACKKLSLDKSHQGE 185

Query: 124 SEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR 183
            EFL+EVRMITSIQHKNLVRLLGCCSDG QR+LVYEYMKNRSLD  I+G+SD+FLNWSTR
Sbjct: 186 REFLAEVRMITSIQHKNLVRLLGCCSDGPQRILVYEYMKNRSLDFFIHGKSDEFLNWSTR 245

Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST 243
           FQIILG+ARGLQYLHEDSH RIVHRDIKASN+LLDEKFQ +IGDFGLARFFPEDQAYLST
Sbjct: 246 FQIILGVARGLQYLHEDSHVRIVHRDIKASNILLDEKFQPRIGDFGLARFFPEDQAYLST 305

Query: 244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKL 303
            FAGTLGYTAPEYAIRGELSEKADIYSFGVL+LEIISCRKNTDLTLPS+MQYLPEYAWKL
Sbjct: 306 QFAGTLGYTAPEYAIRGELSEKADIYSFGVLLLEIISCRKNTDLTLPSDMQYLPEYAWKL 365

Query: 304 YERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES-G 362
           YE+  ++EL+DP++ ++G VE+D +Q  +VAF+CLQPH + RP MS+IVA+LT K++   
Sbjct: 366 YEKSMVMELIDPKLIEKGYVEKDVMQAFHVAFLCLQPHPDLRPAMSQIVALLTFKIDMVT 425

Query: 363 IPVRPAYLERRR-KRDETLSWDTISEPFPSLTQSES 397
            P+RPA+L+RRR   DE  SW+ ISE   +   S+S
Sbjct: 426 TPMRPAFLDRRRVMDDENHSWEVISEVLQTPAASDS 461

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224142637|ref|XP_002324661.1| predicted protein [Populus trichocarpa] gi|222866095|gb|EEF03226.1| predicted protein [Populus trichocarpa]

 Score =  533 bits (1372), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 251/298 (84%), Positives = 275/298 (92%), Gaps = 1/298 (0%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRM 132
           DFQTLKKAT NFHPGNLLGRGGFGPVYRGKL+DG +VAVKKL +DKSQQGESEFLSEV+M
Sbjct: 1   DFQTLKKATNNFHPGNLLGRGGFGPVYRGKLSDGRMVAVKKLSLDKSQQGESEFLSEVKM 60

Query: 133 ITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR 192
           ITSIQHKNLVRLLGCCSDG QRLLVYEYMKNRSLDL++YG  DKFL+W TRFQIILGIAR
Sbjct: 61  ITSIQHKNLVRLLGCCSDGPQRLLVYEYMKNRSLDLIVYGNGDKFLDWETRFQIILGIAR 120

Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
           GLQYLHEDSH RIVHRDIKASN+LLD KFQ +I DFGLARFFPEDQAYLST FAGTLGYT
Sbjct: 121 GLQYLHEDSHLRIVHRDIKASNILLDVKFQPRISDFGLARFFPEDQAYLSTTFAGTLGYT 180

Query: 253 APEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL 312
           APEYAIRGELSEKADIYSFGVLVLEIISCRKNTDL LPSEMQYLPEYAWKLYER  +++L
Sbjct: 181 APEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLRLPSEMQYLPEYAWKLYERSSVIDL 240

Query: 313 VDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES-GIPVRPAY 369
           VDP++R++G +E+D LQVI+VAF+CLQP  N RPPMS+IVA+LTCKVE  G P+RPA+
Sbjct: 241 VDPKLREDGFMEKDVLQVIHVAFLCLQPLANLRPPMSKIVALLTCKVEMVGTPMRPAF 298

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	407
TAIR|locus:2205250	1032	AT1G56130 [Arabidopsis thalian	0.749	0.295	0.495	4.7e-80
TAIR|locus:2203718	1035	AT1G53440 [Arabidopsis thalian	0.788	0.310	0.479	3.4e-77
TAIR|locus:2205260	1047	AT1G56120 [Arabidopsis thalian	0.727	0.282	0.483	3.1e-76
TAIR|locus:2009630	953	AT1G53420 [Arabidopsis thalian	0.842	0.359	0.450	1.7e-73
TAIR|locus:2019317	969	AT1G29730 [Arabidopsis thalian	0.837	0.351	0.466	4.6e-73
TAIR|locus:2197649	821	AT1G61360 [Arabidopsis thalian	0.884	0.438	0.416	2e-72
TAIR|locus:2095334	393	AT3G09010 [Arabidopsis thalian	0.724	0.750	0.468	8.6e-72
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.754	0.361	0.485	1.1e-71
TAIR|locus:2017923	390	AT1G16670 [Arabidopsis thalian	0.700	0.730	0.474	6.1e-71
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.769	0.467	0.465	9.9e-71

TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)]

 Score = 804 (288.1 bits), Expect = 4.7e-80, P = 4.7e-80
 Identities = 153/309 (49%), Positives = 217/309 (70%)

Query:    72 FDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVR 131
             F +  LK AT++F P N LG GGFGPVY+G L DG +VAVK L V  S+QG+ +F++E+ 
Sbjct:   682 FTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVG-SRQGKGQFVAEIV 740

Query:   132 MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIA 191
              I+S+ H+NLV+L GCC +G  R+LVYEY+ N SLD  ++G+    L+WSTR++I LG+A
Sbjct:   741 AISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKTLHLDWSTRYEICLGVA 800

Query:   192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY 251
             RGL YLHE++  RIVHRD+KASN+LLD +   +I DFGLA+ + + + ++ST  AGT+GY
Sbjct:   801 RGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIGY 860

Query:   252 TAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILE 311
              APEYA+RG L+EK D+Y+FGV+ LE++S R N+D  L  E +YL E+AW L+E+ R +E
Sbjct:   861 LAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEKSRDIE 920

Query:   312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESG-IPVRPAYL 370
             L+D ++    + E  A ++I +A +C Q     RPPMS +VAML+  VE G +  +P Y+
Sbjct:   921 LIDDKLTDFNMEE--AKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEIGDVTSKPGYV 978

Query:   371 ERRRKRDET 379
                R  D T
Sbjct:   979 SDWRFDDTT 987

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=ISS

TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)]

 Score = 777 (278.6 bits), Expect = 3.4e-77, P = 3.4e-77
 Identities = 161/336 (47%), Positives = 231/336 (68%)

Query:    45 LVRLALRTT-----KEGVSKDFFNG-NLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPV 98
             LV + LR T     KE    +   G +L+T S F  + +K+AT NF P N +G GGFGPV
Sbjct:   623 LVLVILRLTGYLGGKEVDENEELRGLDLQTGS-FTLKQIKRATNNFDPENKIGEGGFGPV 681

Query:    99 YRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY 158
             Y+G LADG  +AVK+L   KS+QG  EF++E+ MI+++QH NLV+L GCC +G + LLVY
Sbjct:   682 YKGVLADGMTIAVKQLS-SKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVY 740

Query:   159 EYMKNRSLDLLIYG-ESDKF-LNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVL 216
             EY++N SL   ++G E  +  L+WSTR ++ +GIA+GL YLHE+S  +IVHRDIKA+NVL
Sbjct:   741 EYLENNSLARALFGTEKQRLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVL 800

Query:   217 LDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVL 276
             LD    +KI DFGLA+   E+  ++ST  AGT+GY APEYA+RG L++KAD+YSFGV+ L
Sbjct:   801 LDLSLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCL 860

Query:   277 EIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFI 336
             EI+S + NT+     E  YL ++A+ L E+G +LELVDP +      +++A++++N+A +
Sbjct:   861 EIVSGKSNTNYRPKEEFIYLLDWAYVLQEQGSLLELVDPDLGTS-FSKKEAMRMLNIALL 919

Query:   337 CLQPHGNQRPPMSEIVAMLTCKVESGIPVRPAYLER 372
             C  P    RPPMS +V+ML  K++    V+P  ++R
Sbjct:   920 CTNPSPTLRPPMSSVVSMLQGKIK----VQPPLVKR 951

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)]

 Score = 768 (275.4 bits), Expect = 3.1e-76, P = 3.1e-76
 Identities = 145/300 (48%), Positives = 209/300 (69%)

Query:    72 FDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVR 131
             F +  LK AT++F   N LG GGFG VY+G L DG  VAVK+L +  S+QG+ +F++E+ 
Sbjct:   698 FTYSELKNATQDFDLSNKLGEGGFGAVYKGNLNDGREVAVKQLSIG-SRQGKGQFVAEII 756

Query:   132 MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIA 191
              I+S+ H+NLV+L GCC +G  RLLVYEY+ N SLD  ++G+    L+WSTR++I LG+A
Sbjct:   757 AISSVLHRNLVKLYGCCFEGDHRLLVYEYLPNGSLDQALFGDKSLHLDWSTRYEICLGVA 816

Query:   192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY 251
             RGL YLHE++  RI+HRD+KASN+LLD +   K+ DFGLA+ + + + ++ST  AGT+GY
Sbjct:   817 RGLVYLHEEASVRIIHRDVKASNILLDSELVPKVSDFGLAKLYDDKKTHISTRVAGTIGY 876

Query:   252 TAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILE 311
              APEYA+RG L+EK D+Y+FGV+ LE++S RKN+D  L    +YL E+AW L+E+ R +E
Sbjct:   877 LAPEYAMRGHLTEKTDVYAFGVVALELVSGRKNSDENLEEGKKYLLEWAWNLHEKNRDVE 936

Query:   312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE-SGIPVRPAYL 370
             L+D  + +  + E    ++I +A +C Q     RPPMS +VAML+   E +    +P YL
Sbjct:   937 LIDDELSEYNMEE--VKRMIGIALLCTQSSYALRPPMSRVVAMLSGDAEVNDATSKPGYL 994

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)]

 Score = 742 (266.3 bits), Expect = 1.7e-73, P = 1.7e-73
 Identities = 158/351 (45%), Positives = 226/351 (64%)

Query:    53 TKEGVSKDFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVK 112
             +K  + KDF +  L  I+ F  + +K AT NF   N +G GGFGPVY+GKL DGT++AVK
Sbjct:   594 SKSQMEKDFKSLELM-IASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVK 652

Query:   113 KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYG 172
             +L    S+QG  EFL+E+ MI+++ H NLV+L GCC +G Q LLVYE+++N SL   ++G
Sbjct:   653 QLSTG-SKQGNREFLNEIGMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFG 711

Query:   173 --ESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGL 230
               E+   L+W TR +I +G+ARGL YLHE+S  +IVHRDIKA+NVLLD++   KI DFGL
Sbjct:   712 PQETQLRLDWPTRRKICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGL 771

Query:   231 ARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLP 290
             A+   ED  ++ST  AGT GY APEYA+RG L++KAD+YSFG++ LEI+  R N      
Sbjct:   772 AKLDEEDSTHISTRIAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSK 831

Query:   291 SEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSE 350
             +   YL ++   L E+  +LELVDPR+  E   E +A+ +I +A +C      +RP MSE
Sbjct:   832 NNTFYLIDWVEVLREKNNLLELVDPRLGSEYNRE-EAMTMIQIAIMCTSSEPCERPSMSE 890

Query:   351 IVAMLTCKVESGIP-VRPAYLERRRKRDETLSWDTISEPFPSLTQSESPAL 400
             +V ML  K    +  +  A + R  KR E ++  T+ + +  + Q  S ++
Sbjct:   891 VVKMLEGKKMVEVEKLEEASVHRETKRLENMN--TMKKYYEMIGQEISTSM 939

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)]

 Score = 738 (264.8 bits), Expect = 4.6e-73, P = 4.6e-73
 Identities = 165/354 (46%), Positives = 227/354 (64%)

Query:    54 KEGVSKDFFNG-NLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVK 112
             K+ +SK    G +LRT S F  + LK AT +F P N +G GGFG VY+G+L DGTL+AVK
Sbjct:   612 KKKISK--LKGPDLRTGS-FSLRQLKVATNDFDPLNKIGEGGFGSVYKGRLPDGTLIAVK 668

Query:   113 KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIY 171
             KL   KS QG  EF++E+ MI  +QH NLV+L GCC + +Q LLVYEY++N  L D L  
Sbjct:   669 KLS-SKSHQGNKEFVNEIGMIACLQHPNLVKLYGCCVEKNQLLLVYEYLENNCLSDALFA 727

Query:   172 GESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLA 231
             G S   L W TR +I LGIARGL +LHEDS  +I+HRDIK +NVLLD+   SKI DFGLA
Sbjct:   728 GRSCLKLEWGTRHKICLGIARGLAFLHEDSAVKIIHRDIKGTNVLLDKDLNSKISDFGLA 787

Query:   232 RFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPS 291
             R   ++Q++++T  AGT+GY APEYA+RG L+EKAD+YSFGV+ +EI+S + N   T   
Sbjct:   788 RLHEDNQSHITTRVAGTIGYMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKSNAKYTPDD 847

Query:   292 EMQY-LPEYAWKLYERGRILELVDPRMRKEGIVE-RDALQVINVAFICLQPHGNQRPPMS 349
             E    L ++A+ L ++G I E++DPR+  EG+ +  +A ++I V+ +C       RP MS
Sbjct:   848 ECCVGLLDWAFVLQKKGDIAEILDPRL--EGMFDVMEAERMIKVSLLCANKSSTLRPNMS 905

Query:   350 EIVAMLT--CKVESGIPVRPAYLERRRKRDETLSWDTISEPFPSLTQSESPALP 401
             ++V ML    ++E  I     Y +    +  +LS D I    PS ++S     P
Sbjct:   906 QVVKMLEGETEIEQIISDPGVYSDNLHFKPSSLSSDYILS-IPSSSESAYDLYP 958

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)]

 Score = 732 (262.7 bits), Expect = 2.0e-72, P = 2.0e-72
 Identities = 152/365 (41%), Positives = 225/365 (61%)

Query:    37 WKFNKAKELVRLALRTTKEGVSK-DFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGF 95
             W++   +    L  +   EG  K D  + ++  +++F+   L+ AT NF   N LG+GGF
Sbjct:   450 WRYRVKQNGSSLVSKDNVEGAWKSDLQSQDVSGLNFFEIHDLQTATNNFSVLNKLGQGGF 509

Query:    96 GPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRL 155
             G VY+GKL DG  +AVK+L    S QG  EF++E+++I+ +QH+NL+RLLGCC DG ++L
Sbjct:   510 GTVYKGKLQDGKEIAVKRL-TSSSVQGTEEFMNEIKLISKLQHRNLLRLLGCCIDGEEKL 568

Query:   156 LVYEYMKNRSLDLLIYGESDKF-LNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASN 214
             LVYEYM N+SLD+ I+    K  ++W+TRF II GIARGL YLH DS  R+VHRD+K SN
Sbjct:   569 LVYEYMVNKSLDIFIFDLKKKLEIDWATRFNIIQGIARGLLYLHRDSFLRVVHRDLKVSN 628

Query:   215 VLLDEKFQSKIGDFGLARFFPEDQAYLST-NFAGTLGYTAPEYAIRGELSEKADIYSFGV 273
             +LLDEK   KI DFGLAR F  +Q   ST +  GTLGY +PEYA  G  SEK+DIYSFGV
Sbjct:   629 ILLDEKMNPKISDFGLARLFHGNQHQDSTGSVVGTLGYMSPEYAWTGTFSEKSDIYSFGV 688

Query:   274 LVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVER-DALQVIN 332
             L+LEII+ ++ +  +   + + L  YAW  +     + L+D  +     V   +A + ++
Sbjct:   689 LMLEIITGKEISSFSYGKDNKNLLSYAWDSWSENGGVNLLDQDLDDSDSVNSVEAGRCVH 748

Query:   333 VAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVRPAYLERRRKRDETLSWDTISEPFPSL 392
             +  +C+Q     RP + ++++MLT   +   P +P ++      D +LS    S    S+
Sbjct:   749 IGLLCVQHQAIDRPNIKQVMSMLTSTTDLPKPTQPMFVLETSDEDSSLSHSQRSNDLSSV 808

Query:   393 TQSES 397
              +++S
Sbjct:   809 DENKS 813

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

TAIR|locus:2095334 AT3G09010 [Arabidopsis thaliana (taxid:3702)]

 Score = 726 (260.6 bits), Expect = 8.6e-72, P = 8.6e-72
 Identities = 142/303 (46%), Positives = 200/303 (66%)

Query:    58 SKDFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVD 117
             +++    N+R  SY    +L+ AT +FHP N +G GG+G V++G L DGT VAVK L  +
Sbjct:    23 AEEICTNNVRVFSY---NSLRSATDSFHPTNRIGGGGYGVVFKGVLRDGTQVAVKSLSAE 79

Query:   118 KSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF 177
              S+QG  EFL+E+ +I++I H NLV+L+GCC +G+ R+LVYEY++N SL  ++ G   ++
Sbjct:    80 -SKQGTREFLTEINLISNIHHPNLVKLIGCCIEGNNRILVYEYLENNSLASVLLGSRSRY 138

Query:   178 --LNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP 235
               L+WS R  I +G A GL +LHE+    +VHRDIKASN+LLD  F  KIGDFGLA+ FP
Sbjct:   139 VPLDWSKRAAICVGTASGLAFLHEEVEPHVVHRDIKASNILLDSNFSPKIGDFGLAKLFP 198

Query:   236 EDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQY 295
             ++  ++ST  AGT+GY APEYA+ G+L++KAD+YSFG+LVLE+IS   +T      E   
Sbjct:   199 DNVTHVSTRVAGTVGYLAPEYALLGQLTKKADVYSFGILVLEVISGNSSTRAAFGDEYMV 258

Query:   296 LPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
             L E+ WKL E  R+LE VDP + K      +  + I VA  C Q    +RP M +++ ML
Sbjct:   259 LVEWVWKLREERRLLECVDPELTK--FPADEVTRFIKVALFCTQAAAQKRPNMKQVMEML 316

Query:   356 TCK 358
               K
Sbjct:   317 RRK 319

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 725 (260.3 bits), Expect = 1.1e-71, P = 1.1e-71
 Identities = 152/313 (48%), Positives = 202/313 (64%)

Query:    65 NLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGES 124
             N   +  F    +  AT +F   N LGRGGFGPVY+G L DG  +AVK+L   KS QG  
Sbjct:   510 NTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLS-GKSGQGVD 568

Query:   125 EFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFL-NWSTR 183
             EF +E+ +I  +QH+NLVRLLGCC +G +++LVYEYM N+SLD  ++ E+ + L +W  R
Sbjct:   569 EFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLR 628

Query:   184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST 243
             F II GIARGL YLH DS  RI+HRD+K SNVLLD +   KI DFG+AR F  +Q   +T
Sbjct:   629 FSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANT 688

Query:   244 -NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWK 302
                 GT GY +PEYA+ G  S K+D+YSFGVL+LEI+S ++NT L   SE   L  YAW 
Sbjct:   689 VRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLR-SSEHGSLIGYAWY 747

Query:   303 LYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES- 361
             LY  GR  ELVDP++R     +R+AL+ I+VA +C+Q    +RP M+ ++ ML     + 
Sbjct:   748 LYTHGRSEELVDPKIRVT-CSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATL 806

Query:   362 GIPVRPAYLERRR 374
               P +P +   RR
Sbjct:   807 AAPRQPTFTSTRR 819

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2017923 AT1G16670 [Arabidopsis thaliana (taxid:3702)]

 Score = 718 (257.8 bits), Expect = 6.1e-71, P = 6.1e-71
 Identities = 139/293 (47%), Positives = 200/293 (68%)

Query:    69 ISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLS 128
             +  + ++ +++AT +F   N +G GGFG VY+G L DG L A+K L  + S+QG  EFL+
Sbjct:    26 VKIYKYREIRQATDDFSAENKIGEGGFGSVYKGCLKDGKLAAIKVLSAE-SRQGVKEFLT 84

Query:   129 EVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLD--LLI--YGESDKFLNWSTRF 184
             E+ +I+ IQH+NLV+L GCC +G+ R+LVY +++N SLD  LL   Y  S    +WS+R 
Sbjct:    85 EINVISEIQHENLVKLYGCCVEGNHRILVYNFLENNSLDKTLLAGGYTRSGIQFDWSSRA 144

Query:   185 QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN 244
              I +G+A+GL +LHE+    I+HRDIKASN+LLD+    KI DFGLAR  P +  ++ST 
Sbjct:   145 NICVGVAKGLAFLHEEVRPHIIHRDIKASNILLDKYLSPKISDFGLARLMPPNMTHVSTR 204

Query:   245 FAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLY 304
              AGT+GY APEYA+RG+L+ KADIYSFGVL++EI+S R N +  LP+E QYL E AW+LY
Sbjct:   205 VAGTIGYLAPEYAVRGQLTRKADIYSFGVLLMEIVSGRSNKNTRLPTEYQYLLERAWELY 264

Query:   305 ERGRILELVDPRMRKEGIVE-RDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
             ER  +++LVD  +   G+ +  +A + + +  +C Q     RP MS +V +LT
Sbjct:   265 ERNELVDLVDSGLN--GVFDAEEACRYLKIGLLCTQDSPKLRPSMSTVVRLLT 315

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 716 (257.1 bits), Expect = 9.9e-71, P = 9.9e-71
 Identities = 148/318 (46%), Positives = 207/318 (65%)

Query:    73 DFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRM 132
             D++T++ AT +F   N +G+GGFG VY+G L+DGT VAVK+L    S QGE EF +EV +
Sbjct:   337 DYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLS-KSSGQGEVEFKNEVVL 395

Query:   133 ITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF-LNWSTRFQIILGIA 191
             +  +QH+NLVRLLG C DG +R+LVYEY+ N+SLD  ++  + K  L+W+ R++II G+A
Sbjct:   396 VAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVA 455

Query:   192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN-FAGTLG 250
             RG+ YLH+DS   I+HRD+KASN+LLD     KI DFG+AR F  DQ   +T+   GT G
Sbjct:   456 RGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVGTYG 515

Query:   251 YTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRIL 310
             Y +PEYA+ G+ S K+D+YSFGVLVLEIIS +KN+          L  YAW L+  GR L
Sbjct:   516 YMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYAWGLWSNGRPL 575

Query:   311 ELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK-VESGIPVRPAY 369
             ELVDP +  E     + ++ +++  +C+Q    +RP +S IV MLT   V   +P +P  
Sbjct:   576 ELVDPAI-VENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNTVTLPVPRQPGL 634

Query:   370 LERRRKRDETLSWDTISE 387
               + R   + L  DT S+
Sbjct:   635 FFQSRIGKDPLDTDTTSK 652

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	407
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-57
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-56
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-52
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-52
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-52
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-47
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-46
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-43
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	9e-35
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-34
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-33
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-32
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-32
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-31
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-31
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-30
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-30
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-30
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-30
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-29
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-28
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-28
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-28
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-28
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-27
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-27
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-27
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-27
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-27
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-27
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-27
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-27
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	9e-27
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-26
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-26
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-26
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-26
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-25
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-25
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-25
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-25
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-25
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-25
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-25
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-25
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-25
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-25
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-25
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	8e-25
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-24
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-24
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-24
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-24
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-24
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-24
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	9e-24
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-23
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-23
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-23
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-23
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-23
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	8e-23
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	9e-23
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-22
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-22
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-22
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-22
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-22
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-22
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-22
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-22
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-22
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-22
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-22
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-21
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-21
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-21
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	6e-21
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-21
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-20
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-20
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-20
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-20
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-20
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-20
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-20
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-20
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-20
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-20
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	9e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-19
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-19
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-19
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-19
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-19
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-19
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-19
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-19
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-19
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-19
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-19
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-19
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-19
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-19
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-19
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-19
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	7e-19
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	9e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-18
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-18
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-18
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-18
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-18
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-18
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-18
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-18
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-18
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-18
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-17
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-17
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-17
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-17
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-17
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-17
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-16
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-16
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-16
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-16
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-16
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-15
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	9e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	9e-15
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-14
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-14
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-14
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-14
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-14
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-14
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-14
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-14
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-14
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	8e-14
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-13
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	8e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-12
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-12
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-12
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-12
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-12
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	7e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-11
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-11
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-11
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	7e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	9e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	9e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-10
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	6e-10
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	9e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-09
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	8e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	9e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	7e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	6e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.001
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.001
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.002

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  186 bits (476), Expect = 7e-57
 Identities = 90/274 (32%), Positives = 125/274 (45%), Gaps = 24/274 (8%)

Query: 87  GNLLGRGGFGPVYRGKLADG-----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
           G  LG G FG VY+G L          VAVK L  D S+Q   EFL E R++  + H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
           V+LLG C++    ++V EYM    L   +     K L+ S      L IARG++YL   S
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--S 121

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
               +HRD+ A N L+ E    KI DFGL+R   +D  Y        + + APE    G+
Sbjct: 122 K-NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180

Query: 262 LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEG 321
            + K+D++SFGVL+ EI         TL  E    P       E   +LE +    R   
Sbjct: 181 FTSKSDVWSFGVLLWEI--------FTLGEE----PYPGMSNAE---VLEYLKKGYRLP- 224

Query: 322 IVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
                  ++  +   C       RP  SE+V +L
Sbjct: 225 KPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  185 bits (472), Expect = 3e-56
 Identities = 89/274 (32%), Positives = 128/274 (46%), Gaps = 25/274 (9%)

Query: 87  GNLLGRGGFGPVYRGKL-----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
           G  LG G FG VY+GKL          VAVK L  D S+Q   EFL E R++  + H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
           V+LLG C++     +V EYM+   L   +  ++   L+ S      L IARG++YL   S
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLE--S 120

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
               +HRD+ A N L+ E    KI DFGL+R   +D  Y        + + APE    G+
Sbjct: 121 K-NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 262 LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEG 321
            + K+D++SFGVL+ EI         TL  +    P       E   +LE +    R   
Sbjct: 180 FTSKSDVWSFGVLLWEI--------FTLGEQ----PYPGMSNEE---VLEYLKNGYRLP- 223

Query: 322 IVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
                  ++ ++   C       RP  SE+V +L
Sbjct: 224 QPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  174 bits (444), Expect = 1e-52
 Identities = 74/198 (37%), Positives = 108/198 (54%), Gaps = 10/198 (5%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG GGFG VY  +    G  VA+K +  + S     E L E+ ++  + H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 149 SDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVH 207
            D +   LV EY +  SL DLL   E++  L+     +I+L I  GL+YLH      I+H
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 208 RDIKASNVLLDEKFQS-KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI-RGELSEK 265
           RD+K  N+LLD      K+ DFGL++    D++ L T   GT  Y APE  + +G  SEK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSEK 174

Query: 266 ADIYSFGVLVLEIISCRK 283
           +DI+S GV++ E+   + 
Sbjct: 175 SDIWSLGVILYELPELKD 192

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  174 bits (443), Expect = 5e-52
 Identities = 92/293 (31%), Positives = 124/293 (42%), Gaps = 62/293 (21%)

Query: 87  GNLLGRGGFGPVYRGKL-----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
           G  LG G FG VY+G L        T VAVK L    S++   EFL E  ++  + H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
           VRLLG C+ G    +V EYM    L   +    +K L      Q+ L IA+G++YL   S
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQIAKGMEYLE--S 120

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG---YTAPEYAI 258
               VHRD+ A N L+ E    KI DFGL+R   ED  Y      G      + APE   
Sbjct: 121 K-NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKWMAPESLK 177

Query: 259 RGELSEKADIYSFGVLVLEIISC-------RKNTDLTLPSEMQYL--------PEYAWK- 302
            G+ + K+D++SFGVL+ EI +          N ++     ++ L        PE     
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV-----LELLEDGYRLPRPENCPDE 232

Query: 303 LYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
           LYE           M +                 C       RP  SE+V  L
Sbjct: 233 LYE----------LMLQ-----------------CWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  174 bits (443), Expect = 6e-52
 Identities = 74/209 (35%), Positives = 103/209 (49%), Gaps = 23/209 (11%)

Query: 88  NLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
             LG G FG VY+GKL       T VAVK L  D S++   +FL E R++  + H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 144 LLGCCSDGSQRLLVYEYMKNRSLD-------LLIYGESDKFLNWSTRFQIILGIARGLQY 196
           LLG C++     LV EYM+   L         +        L+        + IA+G++Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG-----Y 251
           L      + VHRD+ A N L+ E    KI DFGL+R   +D  Y       T G     +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPIRW 173

Query: 252 TAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            APE    G  + K+D++SFGVL+ EI +
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  162 bits (412), Expect = 2e-47
 Identities = 79/272 (29%), Positives = 123/272 (45%), Gaps = 22/272 (8%)

Query: 84  FHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           +     LG G FG VY  +    G LVA+K +   K ++     L E++++  ++H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
           RL     D  +  LV EY +   L  L+  +  +      RF  +  I   L+YLH  S 
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLK-KRGRLSEDEARF-YLRQILSALEYLH--SK 116

Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
             IVHRD+K  N+LLDE    K+ DFGLAR     +    T F GT  Y APE  +    
Sbjct: 117 -GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAPEVLLGKGY 173

Query: 263 SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGI 322
            +  DI+S GV++ E+++ +       P + Q L     +L++  +I +   P    E  
Sbjct: 174 GKAVDIWSLGVILYELLTGK----PPFPGDDQLL-----ELFK--KIGKPKPPFPPPEWD 222

Query: 323 VERDALQVINVAFICLQPHGNQRPPMSEIVAM 354
           +  +A  +I      L     +R    E +  
Sbjct: 223 ISPEAKDLIR---KLLVKDPEKRLTAEEALQH 251

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  159 bits (404), Expect = 3e-46
 Identities = 70/201 (34%), Positives = 103/201 (51%), Gaps = 11/201 (5%)

Query: 84  FHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQ-QGESEFLSEVRMITSIQHKNL 141
           +     LG G FG VY+ K    G +VAVK L     + + +     E+R++  + H N+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
           VRL+    D     LV EY +   L   +       L+     +I L I RGL+YLH + 
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLHSN- 117

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
              I+HRD+K  N+LLDE    KI DFGLA+   +  + L+T F GT  Y APE  + G 
Sbjct: 118 --GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPE-VLLGG 173

Query: 262 L--SEKADIYSFGVLVLEIIS 280
                K D++S GV++ E+++
Sbjct: 174 NGYGPKVDVWSLGVILYELLT 194

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  150 bits (381), Expect = 8e-43
 Identities = 75/210 (35%), Positives = 106/210 (50%), Gaps = 24/210 (11%)

Query: 83  NFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQHKN 140
            +  G LLGRG FG VY     D G L+AVK + +    + E E L  E+R+++S+QH N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 141 LVRLLGCCSD--GSQRLLVYEYMKNRSLDLLI--YG---ESD--KFLNWSTRFQIILGIA 191
           +VR  G   D   +   +  EY+   SL  L+  +G   E    K+    TR QI+    
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY----TR-QIL---- 111

Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN-FAGTLG 250
            GL YLH +    IVHRDIK +N+L+D     K+ DFG A+   + +    T    GT  
Sbjct: 112 EGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY 168

Query: 251 YTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           + APE     E    ADI+S G  V+E+ +
Sbjct: 169 WMAPEVIRGEEYGRAADIWSLGCTVIEMAT 198

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  129 bits (325), Expect = 9e-35
 Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 5/199 (2%)

Query: 82  KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
           + F     LG G FG V+ G   +   VA+K L  D     + +F  EV+ +  ++HK+L
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD-DLLKQQDFQKEVQALKRLRHKHL 64

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
           + L   CS G    ++ E M+  SL   +     + L  ++   +   +A G+ YL E  
Sbjct: 65  ISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ- 123

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
               +HRD+ A N+L+ E    K+ DFGLAR   ED  YLS++      +TAPE A  G 
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGLARLIKED-VYLSSDKKIPYKWTAPEAASHGT 180

Query: 262 LSEKADIYSFGVLVLEIIS 280
            S K+D++SFG+L+ E+ +
Sbjct: 181 FSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  126 bits (320), Expect = 4e-34
 Identities = 55/201 (27%), Positives = 98/201 (48%), Gaps = 20/201 (9%)

Query: 84  FHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           F     +G+GGFG VY+ +    G  VA+K + ++  ++ + + ++E++++   +H N+V
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEK-KEKIINEIQILKKCKHPNIV 60

Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ------IILGIARGLQY 196
           +  G      +  +V E+    SL        D   + +          +   + +GL+Y
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSL-------KDLLKSTNQTLTESQIAYVCKELLKGLEY 113

Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEY 256
           LH +    I+HRDIKA+N+LL    + K+ DFGL+    + +A       GT  + APE 
Sbjct: 114 LHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEV 168

Query: 257 AIRGELSEKADIYSFGVLVLE 277
                   KADI+S G+  +E
Sbjct: 169 INGKPYDYKADIWSLGITAIE 189

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  124 bits (313), Expect = 4e-33
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 12/204 (5%)

Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCV-DKSQQGESEFLSEVRMITSIQHKN 140
           N+  G+L+GRG FG VY+G  L  G  VA+K++ +    ++     + E+ ++ +++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF-LNWSTRFQIILGIARGLQYLHE 199
           +V+ +G         ++ EY +N SL   I  +   F  +    +  +  + +GL YLHE
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSL-RQIIKKFGPFPESLVAVY--VYQVLQGLAYLHE 117

Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
                ++HRDIKA+N+L  +    K+ DFG+A    +       +  GT  + APE  I 
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-DDASVVGTPYWMAPE-VIE 172

Query: 260 GE-LSEKADIYSFGVLVLEIISCR 282
               S  +DI+S G  V+E+++  
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  123 bits (310), Expect = 1e-32
 Identities = 72/197 (36%), Positives = 100/197 (50%), Gaps = 17/197 (8%)

Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGE---SEFLSEVRMITSIQHKNLVRLLG 146
           LG G FG V+ G     T VAVK L     + G      FL E +++  ++H  LV+L  
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTL-----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68

Query: 147 CCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
            CS+     +V EYM   SL D L  GE  K L       +   IA G+ YL        
Sbjct: 69  VCSEEEPIYIVTEYMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLES---RNY 124

Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ--AYLSTNFAGTLGYTAPEYAIRGELS 263
           +HRD+ A N+L+ E    KI DFGLAR   +D+  A     F   + +TAPE A  G  +
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAANYGRFT 182

Query: 264 EKADIYSFGVLVLEIIS 280
            K+D++SFG+L+ EI++
Sbjct: 183 IKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  122 bits (308), Expect = 2e-32
 Identities = 71/201 (35%), Positives = 104/201 (51%), Gaps = 14/201 (6%)

Query: 82  KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKL-CVDKSQQGESEFLSEVRMITSIQHKN 140
           K    G  +G+G FG V  G    G  VAVK L     + Q    FL+E  ++T+++H N
Sbjct: 6   KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ---AFLAEASVMTTLRHPN 61

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
           LV+LLG    G+   +V EYM   SL   +       +  + +    L +  G++YL E 
Sbjct: 62  LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121

Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR- 259
                VHRD+ A NVL+ E   +K+ DFGLA+     Q   S      + +TAPE A+R 
Sbjct: 122 ---NFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP--VKWTAPE-ALRE 173

Query: 260 GELSEKADIYSFGVLVLEIIS 280
            + S K+D++SFG+L+ EI S
Sbjct: 174 KKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  120 bits (303), Expect = 1e-31
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 22/201 (10%)

Query: 88  NLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEF-LSEVRMITSIQHKNLVRLL 145
             +G+G FG VY  +  +DG L  +K++ +    + E E  L+EV+++  + H N+++  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLI--------YGESDKFLNWSTRFQIILGIARGLQYL 197
               +  +  +V EY     L   I            ++ L+W    Q+ L     L+YL
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV--QLCLA----LKYL 119

Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYA 257
           H     +I+HRDIK  N+ L      K+GDFG+++          T   GT  Y +PE  
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-VVGTPYYLSPE-L 174

Query: 258 IRGE-LSEKADIYSFGVLVLE 277
            + +  + K+DI+S G ++ E
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYE 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  120 bits (303), Expect = 2e-31
 Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 14/207 (6%)

Query: 88  NLLGRGGFGPVYRGK---LADGT--LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
             LG G FG V   +   L D T   VAVK L     +Q  S+F  E+ ++ ++ H+N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 143 RLLGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
           +  G C     R   L+ EY+ + SL   +    D+ +N          I +G+ YL   
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-INLKRLLLFSSQICKGMDYLGS- 127

Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YTAPEYAI 258
              R +HRD+ A N+L++ +   KI DFGLA+  PED+ Y      G     + APE   
Sbjct: 128 --QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185

Query: 259 RGELSEKADIYSFGVLVLEIIS-CRKN 284
             + S  +D++SFGV + E+ +    +
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  117 bits (296), Expect = 1e-30
 Identities = 65/193 (33%), Positives = 101/193 (52%), Gaps = 9/193 (4%)

Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+ G   + T VAVK L          +FL+E +++  ++H  L++L   C+
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD--PKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 +V E MK  SL   + G + + L       +   +A G+ YL   ++   +HRD
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY---IHRD 128

Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPED--QAYLSTNFAGTLGYTAPEYAIRGELSEKAD 267
           + A NVL+ E    K+ DFGLAR   ED  +A     F   + +TAPE A+    S K+D
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFP--IKWTAPEAALYNRFSIKSD 186

Query: 268 IYSFGVLVLEIIS 280
           ++SFG+L+ EI++
Sbjct: 187 VWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  117 bits (296), Expect = 2e-30
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 29/209 (13%)

Query: 87  GNLLGRGGFGPVYRG---------KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ 137
             +LG G FG VY+G         K+     VA+K L  + S +   E L E  ++ S+ 
Sbjct: 12  IKVLGSGAFGTVYKGVWIPEGEKVKIP----VAIKVLREETSPKANKEILDEAYVMASVD 67

Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDK-----FLNWSTRFQIILGIAR 192
           H ++VRLLG C   SQ  L+ + M    L   +    D       LNW  +      IA+
Sbjct: 68  HPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAK 120

Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ-AYLSTNFAGTLGY 251
           G+ YL E    R+VHRD+ A NVL+      KI DFGLA+    D+  Y +      + +
Sbjct: 121 GMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177

Query: 252 TAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            A E  +    + K+D++S+GV V E+++
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  120 bits (300), Expect = 2e-30
 Identities = 84/338 (24%), Positives = 132/338 (39%), Gaps = 28/338 (8%)

Query: 83  NFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESE--FLSEVRMITSIQH-K 139
           ++     LG G FG VY  +  D  LVA+K L      + +    FL E++++ S+ H  
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 140 NLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLH 198
           N+V+L     D     LV EY+   SL DLL        L+ S    I+  I   L+YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 199 EDSHTRIVHRDIKASNVLLDEK-FQSKIGDFGLARFFPEDQ-----AYLSTNFAGTLGYT 252
                 I+HRDIK  N+LLD      K+ DFGLA+  P+         L +   GT GY 
Sbjct: 119 S---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 253 APEYAIRGEL---SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRI 309
           APE  +   L   S  +DI+S G+ + E+++         P E +       +  +    
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL------PPFEGEKNSSATSQTLKIILE 229

Query: 310 LEL-VDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVRPA 368
           L              E  +    ++    L      R   S  ++     + + + ++ +
Sbjct: 230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHD---LLAHLKLKES 286

Query: 369 YLERRRKRDETLSWDTISEPFPSLTQSESPALPHQQPS 406
            L    K D++        P      S   +L      
Sbjct: 287 DLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSD 324

Length = 384

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  117 bits (296), Expect = 2e-30
 Identities = 67/216 (31%), Positives = 106/216 (49%), Gaps = 34/216 (15%)

Query: 90  LGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG G FG V+ G+        D  LVAVK L    S     +F  E  ++T+ QH+N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 144 LLGCCSDGSQRLLVYEYMKNRSLD-----------LLIYGESDKF-LNWSTRFQIILGIA 191
             G C++G   ++V+EYM++  L+            L   +S    L  S   QI + IA
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY 251
            G+ YL   +    VHRD+   N L+      KIGDFG++R       Y +T++    G+
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-----DVY-TTDYYRVGGH 183

Query: 252 T-------APEYAIRGELSEKADIYSFGVLVLEIIS 280
           T        PE  +  + + ++D++SFGV++ EI +
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  115 bits (289), Expect = 1e-29
 Identities = 62/194 (31%), Positives = 93/194 (47%), Gaps = 6/194 (3%)

Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+ GK      VA+K +   +    E +F+ E +++  + H NLV+L G C+
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMI--REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 +V EYM N  L L    E    L       +   +   ++YL  +     +HRD
Sbjct: 70  KQRPIFIVTEYMANGCL-LNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125

Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           + A N L+ E    K+ DFGLAR+  +DQ   S      + +  PE       S K+D++
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVW 185

Query: 270 SFGVLVLEIISCRK 283
           SFGVL+ E+ S  K
Sbjct: 186 SFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  112 bits (283), Expect = 1e-28
 Identities = 69/211 (32%), Positives = 106/211 (50%), Gaps = 26/211 (12%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVR 131
           D + +K           LG+G  G VY+ +    G + A+KK+ VD  ++   + L E++
Sbjct: 2   DLERVKV----------LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELK 51

Query: 132 MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIA 191
            + S +   +V+  G      +  +V EYM   SL  L+     K         ++  IA
Sbjct: 52  TLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLK----KVGKIPE--PVLAYIA 105

Query: 192 R----GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG 247
           R    GL YLH   H  I+HRDIK SN+L++ K + KI DFG+++         +T F G
Sbjct: 106 RQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT-FVG 162

Query: 248 TLGYTAPEYAIRGEL-SEKADIYSFGVLVLE 277
           T+ Y +PE  I+GE  S  ADI+S G+ +LE
Sbjct: 163 TVTYMSPE-RIQGESYSYAADIWSLGLTLLE 192

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  111 bits (279), Expect = 2e-28
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 11/196 (5%)

Query: 89  LLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
            +G+G FG VY+G L   T VAVK          + +FL E  ++    H N+V+L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
                  +V E +   SL   +  + ++ L      Q+ L  A G++YL   +    +HR
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKN---CIHR 117

Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT----LGYTAPEYAIRGELSE 264
           D+ A N L+ E    KI DFG++R   E++  + T   G     + +TAPE    G  + 
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174

Query: 265 KADIYSFGVLVLEIIS 280
           ++D++S+G+L+ E  S
Sbjct: 175 ESDVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  111 bits (279), Expect = 4e-28
 Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 16/211 (7%)

Query: 83  NFHPGNLLGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI 136
           N      LGRG FG V+  K          TLV VK L   K +  +SEF  E+ M   +
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLD--LLIYGESDKF-----LNWSTRFQIILG 189
            HKN+VRLLG C +     ++ EY     L   L      D+      L+   +  +   
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
           IA G+ +L   S+ R VHRD+ A N L+  + + K+    L++     + Y   N    L
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182

Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + APE     + S K+D++SFGVL+ E+ +
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  110 bits (277), Expect = 6e-28
 Identities = 69/202 (34%), Positives = 100/202 (49%), Gaps = 21/202 (10%)

Query: 87  GNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD----KSQQGESEFLSEVRMITSIQHKNL 141
           G LLG G FG VY G  L DG   AVK++ +       Q+   +   E+ +++ +QH N+
Sbjct: 5   GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF----LNWSTRFQIILGIARGLQYL 197
           V+ LG   +     +  E +   SL  L   +   F    +   TR QI+LG    L+YL
Sbjct: 65  VQYLGTEREEDNLYIFLELVPGGSLAKL-LKKYGSFPEPVIRLYTR-QILLG----LEYL 118

Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYA 257
           H+      VHRDIK +N+L+D     K+ DFG+A+   E     S  F G+  + APE  
Sbjct: 119 HDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVI 173

Query: 258 IR-GELSEKADIYSFGVLVLEI 278
            + G     ADI+S G  VLE+
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEM 195

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 2e-27
 Identities = 61/198 (30%), Positives = 106/198 (53%), Gaps = 9/198 (4%)

Query: 88  NLLGRGGFGPVYRGKLA----DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
            ++G G FG V RG+L         VA+K L    S +   +FL+E  ++    H N++R
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
           L G  +     +++ EYM+N SLD  +  E+D          ++ GIA G++YL E ++ 
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLR-ENDGKFTVGQLVGMLRGIASGMKYLSEMNY- 127

Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE-DQAYLSTNFAGTLGYTAPEYAIRGEL 262
             VHRD+ A N+L++     K+ DFGL+R   + +  Y +      + +TAPE     + 
Sbjct: 128 --VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185

Query: 263 SEKADIYSFGVLVLEIIS 280
           +  +D++SFG+++ E++S
Sbjct: 186 TSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  109 bits (274), Expect = 2e-27
 Identities = 81/275 (29%), Positives = 130/275 (47%), Gaps = 17/275 (6%)

Query: 90  LGRGGFGPV--YRGKLA-DGT--LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG G FG V  Y    A DGT  +VAVK L  +  QQ  S +  E+ ++ ++ H+N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 145 LGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            GCCS+   +   L+ EY+   S  L  Y    K LN +        I  G+ YLH    
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGS--LRDYLPKHK-LNLAQLLLFAQQICEGMAYLHSQ-- 126

Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY--LSTNFAGTLGYTAPEYAIRG 260
              +HRD+ A NVLLD     KIGDFGLA+  PE   Y  +  +    + + A E     
Sbjct: 127 -HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN 185

Query: 261 ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE 320
           + S  +D++SFGV + E+++   ++  + P + + +           R++EL++  MR  
Sbjct: 186 KFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLP 244

Query: 321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
              +    +V  +   C +     RP    ++ +L
Sbjct: 245 -CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  108 bits (272), Expect = 3e-27
 Identities = 76/275 (27%), Positives = 117/275 (42%), Gaps = 29/275 (10%)

Query: 89  LLGRGGFGPVYRG--KLADGTL--VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
            LG G FG V RG    + G +  VAVK L  DK      +FL E  ++ S+ H+NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTR 204
            G        ++V E     SL   +  ++      ST     + IA G++YL      R
Sbjct: 62  YGVVLTHPL-MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KR 117

Query: 205 IVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL--GYTAPEYAIRGEL 262
            +HRD+ A N+LL    + KIGDFGL R  P+++ +        +   + APE       
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177

Query: 263 SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGI 322
           S  +D++ FGV + E+ +                 E  W      +IL+ +D     E +
Sbjct: 178 SHASDVWMFGVTLWEMFT---------------YGEEPWAGLSGSQILKKIDK--EGERL 220

Query: 323 VERDA--LQVINVAFICLQPHGNQRPPMSEIVAML 355
              +A    + NV   C   +   RP  + +   L
Sbjct: 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  108 bits (270), Expect = 4e-27
 Identities = 60/191 (31%), Positives = 103/191 (53%), Gaps = 6/191 (3%)

Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           +G G FG V+ G   +   VA+K   + +    E +F+ E +++  + H  LV+L G C+
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKT--IREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           + S   LV+E+M++  L   +  +  KF +  T   + L +  G+ YL   +   ++HRD
Sbjct: 70  ERSPICLVFEFMEHGCLSDYLRAQRGKF-SQETLLGMCLDVCEGMAYLESSN---VIHRD 125

Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           + A N L+ E    K+ DFG+ RF  +DQ   ST     + +++PE     + S K+D++
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185

Query: 270 SFGVLVLEIIS 280
           SFGVL+ E+ S
Sbjct: 186 SFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  108 bits (271), Expect = 4e-27
 Identities = 63/210 (30%), Positives = 113/210 (53%), Gaps = 21/210 (10%)

Query: 85  HPGNL-----LGRGGFGPVYRGKLA----DGTLVAVKKLCVDKSQQGESEFLSEVRMITS 135
           HP ++     +G G FG V+RG L         VA+K L    +++   +FLSE  ++  
Sbjct: 3   HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQ 62

Query: 136 IQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII---LGIAR 192
             H N++RL G  +     +++ EYM+N +LD  +     +F    + +Q++    GIA 
Sbjct: 63  FSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEF----SSYQLVGMLRGIAA 118

Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG-- 250
           G++YL + ++   VHRD+ A N+L++   + K+ DFGL+R   +D     T   G +   
Sbjct: 119 GMKYLSDMNY---VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR 175

Query: 251 YTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           +TAPE     + +  +D++SFG+++ E++S
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 6e-27
 Identities = 65/201 (32%), Positives = 91/201 (45%), Gaps = 20/201 (9%)

Query: 90  LGRGGFGPV----YRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V    Y  K      VAVK L  +    G+ EFL E  ++  + H  +VRL+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESD----KFLNWSTRFQIILGIARGLQYLHEDS 201
           G C  G   +LV E      L   +    +         + +      +A G+ YL    
Sbjct: 63  GVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES-- 113

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIR 259
               VHRD+ A NVLL  + Q+KI DFG++R       Y     AG   L + APE    
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172

Query: 260 GELSEKADIYSFGVLVLEIIS 280
           G+ S K+D++S+GV + E  S
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  107 bits (270), Expect = 7e-27
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 9/197 (4%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQHKNLVRLLGC 147
           +G+G FG V + +  +DG ++  K++      + E + L SEV ++  ++H N+VR    
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67

Query: 148 CSDGSQRLL--VYEYMKNRSLDLLI--YGESDKFLNWSTRFQIILGIARGLQYLH--EDS 201
             D S + L  V EY +   L  LI    +  K++     ++I+  +   L   H   D 
Sbjct: 68  IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
              ++HRD+K +N+ LD     K+GDFGLA+    D ++  T + GT  Y +PE      
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YVGTPYYMSPEQLNHMS 186

Query: 262 LSEKADIYSFGVLVLEI 278
             EK+DI+S G L+ E+
Sbjct: 187 YDEKSDIWSLGCLIYEL 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  108 bits (270), Expect = 7e-27
 Identities = 74/215 (34%), Positives = 106/215 (49%), Gaps = 29/215 (13%)

Query: 88  NLLGRGGFGPVYRGK----LADGT---LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           N LG G FG VY G     L  G+    VAVK L    + Q + EFL E  ++++  H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDK-------FLNWSTRFQIILGIARG 193
           +V+LLG C     + ++ E M+    DLL Y    +        L       I L +A+G
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGG--DLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQS-----KIGDFGLAR-FFPEDQAYLSTNFAG 247
             YL +      +HRD+ A N L+ EK        KIGDFGLAR  +  D  Y      G
Sbjct: 119 CVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD--YYRKEGEG 173

Query: 248 TLG--YTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            L   + APE  + G+ + ++D++SFGVL+ EI++
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  107 bits (269), Expect = 9e-27
 Identities = 61/205 (29%), Positives = 110/205 (53%), Gaps = 22/205 (10%)

Query: 89  LLGRGGFGPVYRGKLA----DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           ++G G FG V RG+L         VA+K L    +++   +FLSE  ++    H N++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII---LGIARGLQYLHEDS 201
            G  +     +++ E+M+N +LD  +     +F    T  Q++    GIA G++YL E +
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQF----TVIQLVGMLRGIAAGMKYLSEMN 126

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG------YTAPE 255
           +   VHRD+ A N+L++     K+ DFGL+RF  +D +     +  +LG      +TAPE
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS--DPTYTSSLGGKIPIRWTAPE 181

Query: 256 YAIRGELSEKADIYSFGVLVLEIIS 280
                + +  +D++S+G+++ E++S
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 2e-26
 Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 38/210 (18%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEF----LSEVRMITSIQHKNLVRL 144
           +G G +G VY+ +    G LVA+KK+   + +  +  F    + E++++  ++H N+VRL
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRHPNIVRL 63

Query: 145 LG-CCSDGSQRL-LVYEYMKNRSLDL--LIYGESDKFLNWSTRFQI---ILGIARGLQYL 197
                S G   + +V+EYM +   DL  L+     KF    T  QI   +  +  GLQYL
Sbjct: 64  KEIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKF----TESQIKCYMKQLLEGLQYL 116

Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE-- 255
           H      I+HRDIK SN+L++     K+ DFGLAR + +  +   TN   TL Y  PE  
Sbjct: 117 H---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173

Query: 256 -----YAIRGELSEKADIYSFGVLVLEIIS 280
                Y        + D++S G ++ E+  
Sbjct: 174 LGATRY------GPEVDMWSVGCILAELFL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  106 bits (268), Expect = 2e-26
 Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 20/197 (10%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G  G VY+    A G  VA+KK+ + K  Q +   ++E+ ++   +H N+V      
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRK--QNKELIINEILIMKDCKHPNIVDYYDSY 84

Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
             G +  +V EYM   SL  +I  ++   +N      +   + +GL+YLH      ++HR
Sbjct: 85  LVGDELWVVMEYMDGGSLTDIIT-QNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHR 140

Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN------FAGTLGYTAPEYAIRGEL 262
           DIK+ N+LL +    K+ DFG A       A L+          GT  + APE   R + 
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFA-------AQLTKEKSKRNSVVGTPYWMAPEVIKRKDY 193

Query: 263 SEKADIYSFGVLVLEII 279
             K DI+S G++ +E+ 
Sbjct: 194 GPKVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  105 bits (265), Expect = 5e-26
 Identities = 69/217 (31%), Positives = 105/217 (48%), Gaps = 45/217 (20%)

Query: 84  FHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNL 141
           +     LG G +G VY+ +    G +VA+KK+ +D  ++G  S  L E+ ++  ++H N+
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR-----------FQIILGI 190
           V+LL       +  LV+EY     +DL       K+L+               +Q++   
Sbjct: 61  VKLLDVIHTERKLYLVFEYC---DMDL------KKYLDKRPGPLSPNLIKSIMYQLL--- 108

Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
            RGL Y H  SH RI+HRD+K  N+L++     K+ DFGLAR F    + Y  T+   TL
Sbjct: 109 -RGLAYCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVTL 162

Query: 250 GYTAPE-------YAIRGELSEKADIYSFGVLVLEII 279
            Y APE       Y      S   DI+S G +  E+I
Sbjct: 163 WYRAPEILLGSKHY------STAVDIWSVGCIFAEMI 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  104 bits (262), Expect = 6e-26
 Identities = 81/285 (28%), Positives = 136/285 (47%), Gaps = 37/285 (12%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCV-DKSQQGESEFLSEV 130
           DF+ LKK          LG+G +G VY+ K L+D    A+K++ +   SQ+   + ++E+
Sbjct: 1   DFKVLKK----------LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEI 50

Query: 131 RMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLI--YGESDKFLNWSTRFQIIL 188
           R++ S+ H N++       DG++  +V EY     L   I    +  K +     ++I +
Sbjct: 51  RILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI 110

Query: 189 GIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT 248
            + RGLQ LHE    +I+HRD+K++N+LL      KIGD G+++   ++ A       GT
Sbjct: 111 QLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GT 164

Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGR 308
             Y APE       S K+DI+S G L+ E+ +         P E + + +  +K+ +RG+
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT------FAPPFEARSMQDLRYKV-QRGK 217

Query: 309 ILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVA 353
                 P      I    +  + N     LQ     RP   +I+A
Sbjct: 218 Y-----PP-----IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  104 bits (262), Expect = 8e-26
 Identities = 63/192 (32%), Positives = 99/192 (51%), Gaps = 8/192 (4%)

Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+ G     T VA+K L   +       FL+E  ++  +QH  LVRL    +
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSL--KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 ++ EYM+N SL   +       L  +    +   IA G+ ++   ++   +HRD
Sbjct: 72  Q-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHRD 127

Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADI 268
           ++A+N+L+ E    KI DFGLAR   ED  Y +   A   + +TAPE    G  + K+D+
Sbjct: 128 LRAANILVSETLCCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186

Query: 269 YSFGVLVLEIIS 280
           +SFG+L+ EI++
Sbjct: 187 WSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  104 bits (262), Expect = 1e-25
 Identities = 71/229 (31%), Positives = 100/229 (43%), Gaps = 25/229 (10%)

Query: 80  ATKNFHPGNLLGRGGFGPVY----RGKLADGT--LVAVKKLCVDKSQQGESEFLSEVRMI 133
              +      LG G FG VY    RG+  D     VAVK L    S+Q ES+FL E  ++
Sbjct: 4   PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63

Query: 134 TSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDK-----FLNWSTRFQIIL 188
           +   H+N+VRL+G   +   R ++ E M    L   +     +      L          
Sbjct: 64  SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123

Query: 189 GIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNF 245
            +A+G +YL E+     +HRDI A N LL  K      KI DFG+AR       Y     
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180

Query: 246 AG-TLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-------CRKNTD 286
           A   + +  PE  + G  + K D++SFGVL+ EI S        R N +
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 1e-25
 Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 32/213 (15%)

Query: 90  LGRGGFGPVYRGKLAD------GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG+G FG VY G           T VA+K +  + S +   EFL+E  ++      ++VR
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 144 LLGCCSDGSQRLLVYEYMK--------------NRSLDLLIYGESDKFLNWSTRFQIILG 189
           LLG  S G   L+V E M                 +   L      KF+  +        
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE------ 127

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
           IA G+ YL      + VHRD+ A N ++ E    KIGDFG+ R   E   Y      G L
Sbjct: 128 IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG-KGLL 183

Query: 250 G--YTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
              + APE    G  + K+D++SFGV++ E+ +
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  104 bits (261), Expect = 2e-25
 Identities = 58/197 (29%), Positives = 101/197 (51%), Gaps = 10/197 (5%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G  G V++ K    G  VA+KK+ + + + G  ++ L E++ + + QH  +V+LL  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVH 207
              GS  +LV EYM    L  ++  E         +   +  + +G+ Y+H +    I+H
Sbjct: 68  FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVK-SYMRMLLKGVAYMHAN---GIMH 122

Query: 208 RDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE--YAIRGELSEK 265
           RD+K +N+L+      KI DFGLAR F E++  L ++   T  Y APE  Y  R +    
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR-KYDPG 181

Query: 266 ADIYSFGVLVLEIISCR 282
            D+++ G +  E+++  
Sbjct: 182 VDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  103 bits (260), Expect = 2e-25
 Identities = 59/193 (30%), Positives = 102/193 (52%), Gaps = 10/193 (5%)

Query: 89  LLGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
            +G+G FG VY+        +VA+K + +++++    +   E++ ++  +   + +  G 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 148 CSDGSQRLLVYEYMKNRS-LDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
              GS+  ++ EY    S LDLL  G+ D+       F I+  +  GL+YLHE+     +
Sbjct: 68  FLKGSKLWIIMEYCGGGSCLDLLKPGKLDET---YIAF-ILREVLLGLEYLHEE---GKI 120

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKA 266
           HRDIKA+N+LL E+   K+ DFG++       +  +T F GT  + APE   +    EKA
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPFWMAPEVIKQSGYDEKA 179

Query: 267 DIYSFGVLVLEII 279
           DI+S G+  +E+ 
Sbjct: 180 DIWSLGITAIELA 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  104 bits (260), Expect = 2e-25
 Identities = 86/298 (28%), Positives = 134/298 (44%), Gaps = 48/298 (16%)

Query: 83  NFHPGNLLGRGGFGPVYRGK------LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI 136
           N   G  LG G FG V +         A  T VAVK L  + S     + LSE  ++  +
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLI---------YGESDKFLNWSTRFQ-- 185
            H ++++L G CS     LL+ EY K  SL   +         Y  SD   N S      
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 186 ---IILG--------IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF 234
              + +G        I+RG+QYL E    ++VHRD+ A NVL+ E  + KI DFGL+R  
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177

Query: 235 PEDQAYLSTNFAGT-LGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEM 293
            E+ +Y+  +     + + A E       + ++D++SFGVL+ EI++   N    +    
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--- 234

Query: 294 QYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEI 351
              PE  + L + G  +E      R E   E    ++ N+   C +   ++RP  ++I
Sbjct: 235 ---PERLFNLLKTGYRME------RPENCSE----EMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  103 bits (257), Expect = 4e-25
 Identities = 66/192 (34%), Positives = 103/192 (53%), Gaps = 8/192 (4%)

Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG+G FG V+ G     T VA+K L           FL E +++  ++H+ LV+L    S
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           +     +V EYM   SL   + GE  K+L       +   IA G+ Y+   ++   VHRD
Sbjct: 72  E-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRD 127

Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADI 268
           ++A+N+L+ E    K+ DFGLAR   ED  Y +   A   + +TAPE A+ G  + K+D+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 269 YSFGVLVLEIIS 280
           +SFG+L+ E+ +
Sbjct: 187 WSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  102 bits (257), Expect = 4e-25
 Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 9/196 (4%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G    VY    L +   VA+K++ ++K Q    E   EV+ ++   H N+V+     
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 149 SDGSQRLLVYEYMKNRS-LDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVH 207
             G +  LV  Y+   S LD++        L+ +    ++  + +GL+YLH +     +H
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IH 125

Query: 208 RDIKASNVLLDEKFQSKIGDFGLARFFPED---QAYLSTNFAGTLGYTAPE-YAIRGELS 263
           RDIKA N+LL E    KI DFG++    +       +   F GT  + APE         
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185

Query: 264 EKADIYSFGVLVLEII 279
            KADI+SFG+  +E+ 
Sbjct: 186 FKADIWSFGITAIELA 201

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  103 bits (258), Expect = 5e-25
 Identities = 55/226 (24%), Positives = 90/226 (39%), Gaps = 32/226 (14%)

Query: 82  KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQ----QGESEFLSEVRMITSI 136
            +F  G ++G G F  V   K        A+K L  DK Q    +       E  ++T +
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL--DKRQLIKEKKVKYVKIEKEVLTRL 58

Query: 137 -QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQ 195
             H  +++L     D      V EY  N   +LL Y      L+          I   L+
Sbjct: 59  NGHPGIIKLYYTFQDEENLYFVLEYAPNG--ELLQYIRKYGSLDEKCTRFYAAEILLALE 116

Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST------------ 243
           YLH      I+HRD+K  N+LLD+    KI DFG A+    + +  S             
Sbjct: 117 YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 244 -------NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCR 282
                  +F GT  Y +PE        + +D+++ G ++ ++++ +
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  102 bits (255), Expect = 5e-25
 Identities = 65/197 (32%), Positives = 100/197 (50%), Gaps = 17/197 (8%)

Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+ G   + T VAVK L           FL E  ++ ++QH  LVRL    +
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTL--KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 150 DGSQRLLVYEYMKNRSL-DLLIYGESD-----KFLNWSTRFQIILGIARGLQYLHEDSHT 203
                 ++ EYM   SL D L   E       K +++S +      IA G+ Y+   ++ 
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIERKNY- 124

Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELS 263
             +HRD++A+NVL+ E    KI DFGLAR   +++          + +TAPE    G  +
Sbjct: 125 --IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182

Query: 264 EKADIYSFGVLVLEIIS 280
            K+D++SFG+L+ EI++
Sbjct: 183 IKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  102 bits (255), Expect = 7e-25
 Identities = 65/196 (33%), Positives = 100/196 (51%), Gaps = 14/196 (7%)

Query: 88  NLLGRGGFGPVYRG--KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           + LG G +G VY G  K    T VAVK L  D  +    EFL E  ++  I+H NLV+LL
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLT-VAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLL 68

Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G C+      ++ E+M   +L   +   + + +N      +   I+  ++YL + +    
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 125

Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT---LGYTAPEYAIRGEL 262
           +HRD+ A N L+ E    K+ DFGL+R    D     T  AG    + +TAPE     + 
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKF 182

Query: 263 SEKADIYSFGVLVLEI 278
           S K+D+++FGVL+ EI
Sbjct: 183 SIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  101 bits (254), Expect = 8e-25
 Identities = 67/196 (34%), Positives = 100/196 (51%), Gaps = 16/196 (8%)

Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           G ++G G FG V +G+   G  VAVK +  D + Q    FL E  ++T + HKNLVRLLG
Sbjct: 11  GEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLG 66

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
                   + V E M   +L   +       ++     Q  L +A G++YL      ++V
Sbjct: 67  VILHNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLV 122

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPE--DQAYLSTNFAGTLGYTAPEYAIRGELSE 264
           HRD+ A N+L+ E   +K+ DFGLAR      D + L         +TAPE     + S 
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSS 176

Query: 265 KADIYSFGVLVLEIIS 280
           K+D++S+GVL+ E+ S
Sbjct: 177 KSDVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  102 bits (256), Expect = 8e-25
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)

Query: 90  LGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG G FG VY+G+L         T VA+K L  +   + + EF  E  +++ +QH N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 144 LLGCCSDGSQRLLVYEYMKNRSL-DLLI-------------YGESDKFLNWSTRFQIILG 189
           LLG C+      +++EY+ +  L + L+                    L+ S    I + 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR-FFPEDQAYLSTNFAGT 248
           IA G++YL   S    VHRD+ A N L+ E    KI DFGL+R  +  D   + +     
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           + +  PE  + G+ + ++DI+SFGV++ EI S
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  101 bits (254), Expect = 1e-24
 Identities = 74/281 (26%), Positives = 130/281 (46%), Gaps = 42/281 (14%)

Query: 89  LLGRGGFGPVYRGKLA----DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           ++G G FG V  G+L         VA+K L    +++   +FLSE  ++    H N++ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII---LGIARGLQYLHEDS 201
            G  +     ++V EYM+N SLD  +     +F    T  Q++    GIA G++YL +  
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQF----TVIQLVGMLRGIASGMKYLSDMG 126

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED--QAYLSTNFAGTLGYTAPEYAIR 259
           +   VHRD+ A N+L++     K+ DFGL+R   +D   AY +      + +TAPE    
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183

Query: 260 GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL-----VD 314
            + +  +D++S+G+++ E++S              Y     W++  +  I  +     + 
Sbjct: 184 RKFTSASDVWSYGIVMWEVMS--------------YGERPYWEMSNQDVIKAIEEGYRLP 229

Query: 315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
             M     + +  L        C Q   N+RP   +IV++L
Sbjct: 230 APMDCPAALHQLMLD-------CWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score =  101 bits (252), Expect = 1e-24
 Identities = 69/194 (35%), Positives = 102/194 (52%), Gaps = 8/194 (4%)

Query: 90  LGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +GRG FG V+ G+L AD T VAVK          +++FL E R++    H N+VRL+G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +      +V E ++       +  E  + L      Q++   A G++YL E  H   +HR
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYL-ESKHC--IHR 118

Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL--GYTAPEYAIRGELSEKA 266
           D+ A N L+ EK   KI DFG++R   ED  Y ST     +   +TAPE    G  S ++
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSES 177

Query: 267 DIYSFGVLVLEIIS 280
           D++SFG+L+ E  S
Sbjct: 178 DVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  101 bits (252), Expect = 2e-24
 Identities = 69/210 (32%), Positives = 110/210 (52%), Gaps = 23/210 (10%)

Query: 87  GNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLS-------EVRMITSIQ 137
           G L+G G FG VY G  A  G L+AVK++ +   S   +    S       E+ ++  +Q
Sbjct: 5   GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLI--YGESDKFLNWSTRFQIILGIARGLQ 195
           H+N+V+ LG   D     +  EY+   S+  L+  YG  ++ L  +   QI+    +GL 
Sbjct: 65  HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLN 120

Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN-----FAGTLG 250
           YLH   +  I+HRDIK +N+L+D K   KI DFG+++    +     TN       G++ 
Sbjct: 121 YLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177

Query: 251 YTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           + APE   +   + KADI+S G LV+E+++
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLT 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  100 bits (251), Expect = 4e-24
 Identities = 67/221 (30%), Positives = 101/221 (45%), Gaps = 35/221 (15%)

Query: 87  GNLLGRGGFGPVYRG------KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHK 139
           G  LG G FG V +          + + VAVK L  D +++  S+ +SE+ M+  I +HK
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 76

Query: 140 NLVRLLGCCSDGSQRLLVYEY-----------------MKNRSLDLLIYGESDKFLNW-S 181
           N++ LLG C+      +V EY                       D     E+    +  S
Sbjct: 77  NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136

Query: 182 TRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL 241
             +Q+    ARG+++L   +  + +HRD+ A NVL+ E    KI DFGLAR       Y 
Sbjct: 137 FAYQV----ARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR 189

Query: 242 STNFAGTLGY--TAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            T   G L     APE       + ++D++SFGVL+ EI +
Sbjct: 190 KTT-NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 99.8 bits (249), Expect = 6e-24
 Identities = 70/211 (33%), Positives = 112/211 (53%), Gaps = 25/211 (11%)

Query: 89  LLGRGGFGPVYRGK---LADGT--LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
            LG+G FG V   +   L D T  +VAVKKL    ++    +F  E+ ++ S+QH N+V+
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLR-DFEREIEILKSLQHDNIVK 69

Query: 144 LLGCC-SDGSQRL-LVYEYMKNRSL-DLLIYG----ESDKFLNWSTRFQIILGIARGLQY 196
             G C S G + L LV EY+   SL D L       +  K L ++++      I +G++Y
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ------ICKGMEY 123

Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAP 254
           L      R VHRD+   N+L++ + + KIGDFGL +  P+D+ Y      G   + + AP
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAP 180

Query: 255 EYAIRGELSEKADIYSFGVLVLEIIS-CRKN 284
           E     + S  +D++SFGV++ E+ +   K+
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFTYSDKS 211

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 99.1 bits (248), Expect = 8e-24
 Identities = 62/200 (31%), Positives = 96/200 (48%), Gaps = 21/200 (10%)

Query: 90  LGRGGFGPVY--RGKLADGTLVAVKKL----CVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG+G FG V   R K   G L A+K L     + + +   +  L+E  +++ I H  +V+
Sbjct: 1   LGKGSFGKVLLVR-KKDTGKLYAMKVLKKKKIIKRKEVEHT--LTERNILSRINHPFIVK 57

Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
           L        +  LV EY     L   +  E  +F     RF   +I+L     L+YLH  
Sbjct: 58  LHYAFQTEEKLYLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVLA----LEYLHS- 111

Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               I++RD+K  N+LLD     K+ DFGLA+    + +  +T F GT  Y APE  +  
Sbjct: 112 --LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGK 168

Query: 261 ELSEKADIYSFGVLVLEIIS 280
              +  D +S GVL+ E+++
Sbjct: 169 GYGKAVDWWSLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 98.9 bits (246), Expect = 8e-24
 Identities = 69/195 (35%), Positives = 103/195 (52%), Gaps = 10/195 (5%)

Query: 89  LLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LLG+G FG V++G L D T VAVK    D  Q+ + +FLSE R++    H N+V+L+G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 149 SDGSQRLLVYEYMKNRS-LDLLIYGESDK-FLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
              +QR  +Y  M+     D L +    K  L      +  L  A G+ YL   +    +
Sbjct: 62  ---TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CI 115

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT-LGYTAPEYAIRGELSEK 265
           HRD+ A N L+ E    KI DFG++R   +D  Y S+      + +TAPE    G  S +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174

Query: 266 ADIYSFGVLVLEIIS 280
           +D++S+G+L+ E  S
Sbjct: 175 SDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 98.9 bits (247), Expect = 9e-24
 Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 11/192 (5%)

Query: 89  LLGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
            LG G +G VY+      G +VA+K + V++  Q   E + E+ ++       +V+  G 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ---EIIKEISILKQCDSPYIVKYYGS 66

Query: 148 CSDGSQRLLVYEYMKNRS-LDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
               +   +V EY    S  D++    ++K L       I+    +GL+YLH     + +
Sbjct: 67  YFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHS---NKKI 121

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKA 266
           HRDIKA N+LL+E+ Q+K+ DFG++    +  A  +T   GT  + APE       + KA
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYNNKA 180

Query: 267 DIYSFGVLVLEI 278
           DI+S G+  +E+
Sbjct: 181 DIWSLGITAIEM 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 67/206 (32%), Positives = 106/206 (51%), Gaps = 18/206 (8%)

Query: 84  FHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEF-LSEV---RMITSIQH 138
           +     +G G +G VY+ + L  G  VA+KK+ V  S++G     L E+   + + S +H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 139 KNLVRLLGCCSDGSQR------LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR 192
            N+VRLL  C  G +        LV+E++ ++ L   +       L   T   ++  + R
Sbjct: 61  PNIVRLLDVC-HGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLR 118

Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
           G+ +LH  SH RIVHRD+K  N+L+    Q KI DFGLAR +  + A   T+   TL Y 
Sbjct: 119 GVDFLH--SH-RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--TSVVVTLWYR 173

Query: 253 APEYAIRGELSEKADIYSFGVLVLEI 278
           APE  ++   +   D++S G +  E+
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 98.2 bits (244), Expect = 3e-23
 Identities = 79/287 (27%), Positives = 131/287 (45%), Gaps = 41/287 (14%)

Query: 90  LGRGGFGPVYRGK------LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG G FG V+  +        D  LVAVK L  D +     +F  E  ++T++QH+++V+
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 144 LLGCCSDGSQRLLVYEYMKNRSLD-----------LLIYG---ESDKFLNWSTRFQIILG 189
             G C DG   ++V+EYMK+  L+           +L+ G   ++   L  S    I   
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR-FFPEDQAYLSTNFAGT 248
           IA G+ YL   +    VHRD+   N L+      KIGDFG++R  +  D   +  +    
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188

Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGR 308
           + +  PE  +  + + ++D++SFGV++ EI +  K          Q       +   +GR
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ------PWFQLSNTEVIECITQGR 242

Query: 309 ILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
           +LE   PR+  +        +V ++   C Q    QR  + EI  +L
Sbjct: 243 VLE--RPRVCPK--------EVYDIMLGCWQREPQQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 97.9 bits (244), Expect = 4e-23
 Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 16/207 (7%)

Query: 87  GNLLGRGGFGPVYRGKLADGTL-----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
            +LL  G FG ++ G L D        V VK +    S+   +  L E  ++  + H+N+
Sbjct: 11  SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70

Query: 142 VRLLGCCS-DGSQRLLVYEYMKNRSLDLLI----YGESDKFLNWSTRFQIILG--IARGL 194
           + +L  C  DG    ++Y YM   +L L +     GE++     ST+  + +   IA G+
Sbjct: 71  LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130

Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR-FFPEDQAYLSTNFAGTLGYTA 253
            YLH+     ++H+DI A N ++DE+ Q KI D  L+R  FP D   L  N    + + A
Sbjct: 131 SYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMA 187

Query: 254 PEYAIRGELSEKADIYSFGVLVLEIIS 280
            E  +  E S  +D++SFGVL+ E+++
Sbjct: 188 LESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 97.4 bits (242), Expect = 5e-23
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 24/211 (11%)

Query: 90  LGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG G FG V+  +        D  LVAVK L  + S+    +F  E  ++T +QH+++VR
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTVLQHQHIVR 71

Query: 144 LLGCCSDGSQRLLVYEYMKNRSLD--LLIYGESDKFLN-----------WSTRFQIILGI 190
             G C++G   L+V+EYM++  L+  L  +G   K L                  I   I
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR-FFPEDQAYLSTNFAGTL 249
           A G+ YL   +    VHRD+   N L+ +    KIGDFG++R  +  D   +       +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            +  PE  +  + + ++DI+SFGV++ EI +
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 97.0 bits (242), Expect = 5e-23
 Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 15/206 (7%)

Query: 87  GNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQHKNLVRL 144
           GN +G G FG VY    L  G L+AVK++ +  +     + +  E++++  ++H NLV+ 
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 145 LGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
            G      +  +  EY    +L +LL +G   + L+        L +  GL YLH     
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH--- 118

Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG---YTAPEYAIRG 260
            IVHRDIK +N+ LD     K+GDFG A     +   +        G   Y APE    G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178

Query: 261 ELSEK---ADIYSFGVLVLEIISCRK 283
           +       ADI+S G +VLE+ + ++
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 96.8 bits (241), Expect = 7e-23
 Identities = 70/204 (34%), Positives = 106/204 (51%), Gaps = 18/204 (8%)

Query: 88  NLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
            ++G+G FG VY G L D        AVK L      +   +FL E  ++    H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 144 LLGCC--SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--IARGLQYLHE 199
           LLG C  S+GS  L+V  YMK+  L   I  E+    N + +  I  G  +A+G++YL  
Sbjct: 61  LLGICLPSEGSP-LVVLPYMKHGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLAS 116

Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT---LGYTAPEY 256
               + VHRD+ A N +LDE F  K+ DFGLAR   + + Y   N  G    + + A E 
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173

Query: 257 AIRGELSEKADIYSFGVLVLEIIS 280
               + + K+D++SFGVL+ E+++
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 96.5 bits (240), Expect = 8e-23
 Identities = 74/264 (28%), Positives = 125/264 (47%), Gaps = 22/264 (8%)

Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V  GK      VA+K   + +    E EF+ E +++  + H+ LV+L G C+
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKM--IKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 +V EYM N  L L    E  K    S   ++   +  G+ YL  +S  + +HRD
Sbjct: 70  KQRPIYIVTEYMSNGCL-LNYLREHGKRFQPSQLLEMCKDVCEGMAYL--ESK-QFIHRD 125

Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           + A N L+D++   K+ DFGL+R+  +D+   S      + ++ PE  +  + S K+D++
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVW 185

Query: 270 SFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQ 329
           +FGVL+ E+ S  K     +P E     E   K+ +  R   L  P +  E        +
Sbjct: 186 AFGVLMWEVYSLGK-----MPYERFNNSETVEKVSQGLR---LYRPHLASE--------K 229

Query: 330 VINVAFICLQPHGNQRPPMSEIVA 353
           V  + + C      +RP   ++++
Sbjct: 230 VYAIMYSCWHEKAEERPTFQQLLS 253

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 96.9 bits (242), Expect = 9e-23
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 32/213 (15%)

Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEF----LSEVRMITSIQ 137
            +  G  LG G +  VY+ +    G +VA+KK+ + + ++ +       L E++++  ++
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 138 HKNLVRLLGCCSDGSQRLLVYEYM--------KNRSLDLLIYGESD-KFLNWSTRFQIIL 188
           H N++ LL      S   LV+E+M        K++S+   +   +D K          +L
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTPADIK--------SYML 109

Query: 189 GIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT 248
              RGL+YLH +    I+HRD+K +N+L+      K+ DFGLAR F      ++     T
Sbjct: 110 MTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-T 165

Query: 249 LGYTAPE--YAIRGELSEKADIYSFGVLVLEII 279
             Y APE  +  R       D++S G +  E++
Sbjct: 166 RWYRAPELLFGAR-HYGVGVDMWSVGCIFAELL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 96.2 bits (239), Expect = 1e-22
 Identities = 65/193 (33%), Positives = 102/193 (52%), Gaps = 10/193 (5%)

Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+ G     T VAVK L           FL E +++  ++H  LV+L    S
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTL--KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 150 DGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +     +V EYM   SL D L  GE  + L       +   +A G+ Y+   ++   +HR
Sbjct: 72  E-EPIYIVTEYMSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERMNY---IHR 126

Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKAD 267
           D++++N+L+ +    KI DFGLAR   ED  Y +   A   + +TAPE A+ G  + K+D
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 268 IYSFGVLVLEIIS 280
           ++SFG+L+ E+++
Sbjct: 186 VWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 95.8 bits (239), Expect = 1e-22
 Identities = 69/235 (29%), Positives = 102/235 (43%), Gaps = 17/235 (7%)

Query: 88  NLLGRGGFGPVYRGKLADGTLV-----AVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
            ++G+G FG V   +  D   +       K+ CV+K        L+E R++  + H  LV
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEK--GSVRNVLNERRILQELNHPFLV 63

Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            L     D     LV + +    L   +  +  KF     +F  I  I   L+YLH    
Sbjct: 64  NLWYSFQDEENMYLVVDLLLGGDLRYHL-SQKVKFSEEQVKF-WICEIVLALEYLHSK-- 119

Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
             I+HRDIK  N+LLDE+    I DF +A     D   L+T+ +GT GY APE   R   
Sbjct: 120 -GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGY 176

Query: 263 SEKADIYSFGVLVLEIISCR---KNTDLTLPSEMQYLPEYAWKLYERGRILELVD 314
           S   D +S GV   E +  +   +    T+  +++   E A  LY      E +D
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAID 231

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 96.4 bits (240), Expect = 1e-22
 Identities = 59/199 (29%), Positives = 106/199 (53%), Gaps = 16/199 (8%)

Query: 89  LLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQH---KNLVRL 144
           L+GRG +G VYRGK +  G +VA+K + +D      S+   EV +++ ++     N+ + 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGE--SDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            G    G +  ++ EY +  S+  L+     ++K+++   R  ++      L+Y+H+   
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLV-----ALKYIHKVG- 121

Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-E 261
             ++HRDIKA+N+L+      K+ DFG+A    ++ +  ST F GT  + APE    G  
Sbjct: 122 --VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVITEGKY 178

Query: 262 LSEKADIYSFGVLVLEIIS 280
              KADI+S G+ + E+ +
Sbjct: 179 YDTKADIWSLGITIYEMAT 197

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 95.5 bits (238), Expect = 2e-22
 Identities = 59/195 (30%), Positives = 97/195 (49%), Gaps = 9/195 (4%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G  G V +      G ++AVK + ++ ++  + + L E+ ++       +V   G  
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
            +     +  EYM   SLD  I  E    +      +I + + +GL YLHE     I+HR
Sbjct: 69  YNNGDISICMEYMDGGSLDK-ILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHR 125

Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE-LSEKAD 267
           D+K SN+L++ + Q K+ DFG++       A     F GT  Y APE  I+G   S K+D
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVSGQLVNSLA---KTFVGTSSYMAPE-RIQGNDYSVKSD 181

Query: 268 IYSFGVLVLEIISCR 282
           I+S G+ ++E+ + R
Sbjct: 182 IWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 96.1 bits (239), Expect = 2e-22
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 30/218 (13%)

Query: 90  LGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           +G+G FG V++ +          T+VAVK L  + S   +++F  E  ++    H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 144 LLGCCSDGSQRLLVYEYMK--------------------NRSLDLLIYGESDKFLNWSTR 183
           LLG C+ G    L++EYM                     + +      G +   L+ + +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR-FFPEDQAYLS 242
             I   +A G+ YL E    + VHRD+   N L+ E    KI DFGL+R  +  D    S
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            N A  + +  PE       + ++D++++GV++ EI S
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 95.7 bits (238), Expect = 2e-22
 Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 19/210 (9%)

Query: 87  GNLLGRGGFGPVYRGKLA--DGTL--VAVKKLCVDKSQQGE-SEFLSEVRMITSIQHKNL 141
           G +LG G FG V  G+L+  DG+   VAVK + +D     E  EFLSE   +    H N+
Sbjct: 4   GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63

Query: 142 VRLLGCCSDGSQR------LLVYEYMKNRSL-DLLIY---GESDKFLNWSTRFQIILGIA 191
           ++L+G C + S        +++  +MK+  L   L+Y   G   + L   T  + ++ IA
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123

Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT-LG 250
            G++YL   S+   +HRD+ A N +L E     + DFGL++       Y     A   + 
Sbjct: 124 LGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180

Query: 251 YTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           + A E       + K+D+++FGV + EI +
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 95.5 bits (238), Expect = 2e-22
 Identities = 58/196 (29%), Positives = 98/196 (50%), Gaps = 9/196 (4%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G +G VY+ +    G +VA+KK+ +    +G     L E++++  + H N+++LL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVH 207
                   LV+E+M      L+   +  + L  S     +  + +GL + H  SH  I+H
Sbjct: 67  FRHKGDLYLVFEFMDTDLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCH--SH-GILH 121

Query: 208 RDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR-GELSEKA 266
           RD+K  N+L++ +   K+ DFGLAR F        T++  T  Y APE  +     S   
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPY-THYVVTRWYRAPELLLGDKGYSTPV 180

Query: 267 DIYSFGVLVLEIISCR 282
           DI+S G +  E++S R
Sbjct: 181 DIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 94.8 bits (236), Expect = 4e-22
 Identities = 63/200 (31%), Positives = 95/200 (47%), Gaps = 15/200 (7%)

Query: 90  LGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G  G V + +L   G + A+K +  D +   + + L E+ +  S +   +V+  G  
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68

Query: 149 SDGSQRLL--VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIA----RGLQYLHEDSH 202
            D S   +    EY +  SLD  IY +  K        +++  IA    +GL YLH    
Sbjct: 69  LDESSSSIGIAMEYCEGGSLDS-IYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHS--- 123

Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
            +I+HRDIK SN+LL  K Q K+ DFG++       A     F GT  Y APE       
Sbjct: 124 RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA---GTFTGTSFYMAPERIQGKPY 180

Query: 263 SEKADIYSFGVLVLEIISCR 282
           S  +D++S G+ +LE+   R
Sbjct: 181 SITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 94.7 bits (235), Expect = 5e-22
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 22/209 (10%)

Query: 90  LGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG G FG V+  +        D  LVAVK L  D S     +F  E  ++T++QH+++V+
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTL-KDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 144 LLGCCSDGSQRLLVYEYMKNRSLD-----------LLIYGESDKFLNWSTRFQIILGIAR 192
             G C +G   ++V+EYMK+  L+           L+  G     L  S    I   IA 
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR-FFPEDQAYLSTNFAGTLGY 251
           G+ YL   +    VHRD+   N L+ E    KIGDFG++R  +  D   +  +    + +
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188

Query: 252 TAPEYAIRGELSEKADIYSFGVLVLEIIS 280
             PE  +  + + ++D++S GV++ EI +
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 94.0 bits (233), Expect = 6e-22
 Identities = 65/193 (33%), Positives = 103/193 (53%), Gaps = 10/193 (5%)

Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG+G FG V+ G     T VA+K L           FL E +++  ++H  LV L    S
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 150 DGSQRLLVYEYM-KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +     +V E+M K   LD L  G+  K+L       +   IA G+ Y+   ++   +HR
Sbjct: 72  E-EPIYIVTEFMGKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERMNY---IHR 126

Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKAD 267
           D++A+N+L+ +    KI DFGLAR   ED  Y +   A   + +TAPE A+ G  + K+D
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 268 IYSFGVLVLEIIS 280
           ++SFG+L+ E+++
Sbjct: 186 VWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 94.9 bits (236), Expect = 6e-22
 Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 21/211 (9%)

Query: 83  NFHPGNLLGRGGFGPVYR------GKLADGTLVAVKKLCVDKSQQGESE---FLSEVRMI 133
           N   G  LG G FG V         K      VAVK L   K     SE    +SE++++
Sbjct: 36  NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKML---KPTAHSSEREALMSELKIM 92

Query: 134 TSI-QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIY--GESDKFLNWSTRFQIILGI 190
           + +  H+N+V LLG C+ G   L++ EY      DLL +   + + FL           +
Sbjct: 93  SHLGNHENIVNLLGACTIGGPILVITEYC--CYGDLLNFLRRKRESFLTLEDLLSFSYQV 150

Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TL 249
           A+G+ +L   +    +HRD+ A NVLL      KI DFGLAR    D  Y+    A   +
Sbjct: 151 AKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV 207

Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + APE       + ++D++S+G+L+ EI S
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 93.7 bits (233), Expect = 6e-22
 Identities = 56/192 (29%), Positives = 98/192 (51%), Gaps = 6/192 (3%)

Query: 88  NLLGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGE-SEFLSEVRMITSIQHKNLVRLL 145
           N +G+G FG V++  + AD  + A+K++ + K  + E  E + E R++  +    ++R  
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65

Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
               D  +  +V EY +N  L  L+  +  + L     ++  + I  GL +LH     +I
Sbjct: 66  ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KI 122

Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEK 265
           +HRDIK+ N+ LD     KIGD G+A+    D    +    GT  Y +PE       +EK
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFANTIVGTPYYLSPELCEDKPYNEK 181

Query: 266 ADIYSFGVLVLE 277
           +D+++ GV++ E
Sbjct: 182 SDVWALGVVLYE 193

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 93.8 bits (233), Expect = 7e-22
 Identities = 55/191 (28%), Positives = 97/191 (50%), Gaps = 6/191 (3%)

Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+ GK      VA+K   +++    E +F+ E +++  + H  LV+L G C+
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKA--INEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 +V E+M+N  L L    +    L+      +   +  G++YL  +S    +HRD
Sbjct: 70  QQKPLYIVTEFMENGCL-LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRD 125

Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           + A N L+      K+ DFG+ R+  +D+   S+     + ++ PE     + S K+D++
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVW 185

Query: 270 SFGVLVLEIIS 280
           SFGVL+ E+ +
Sbjct: 186 SFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 92.9 bits (231), Expect = 1e-21
 Identities = 67/211 (31%), Positives = 107/211 (50%), Gaps = 24/211 (11%)

Query: 83  NFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLS----EVRMITSIQ 137
           N+  G LLG+G FG VY     D G  +AVK++  D       + ++    E++++ ++Q
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRFQIILGIARGLQ 195
           H+ +V+  GC  D     +  EYM   S+   L  YG   + +      QI+     G++
Sbjct: 63  HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVE 118

Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST-----NFAGTLG 250
           YLH +    IVHRDIK +N+L D     K+GDFG ++     Q   S+     +  GT  
Sbjct: 119 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL---QTICSSGTGMKSVTGTPY 172

Query: 251 YTAPEYAIRGE-LSEKADIYSFGVLVLEIIS 280
           + +PE  I GE    KAD++S G  V+E+++
Sbjct: 173 WMSPE-VISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 92.7 bits (230), Expect = 2e-21
 Identities = 64/194 (32%), Positives = 96/194 (49%), Gaps = 16/194 (8%)

Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGC-C 148
           +G+G FG V  G    G  VAVK +  D + Q    FL+E  ++T ++H NLV+LLG   
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69

Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
            +     +V EYM   SL   +       L      +  L +   ++YL  ++    VHR
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126

Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFP--EDQAYLSTNFAGTLGYTAPEYAIRGELSEKA 266
           D+ A NVL+ E   +K+ DFGL +     +D   L         +TAPE     + S K+
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKS 180

Query: 267 DIYSFGVLVLEIIS 280
           D++SFG+L+ EI S
Sbjct: 181 DVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 92.6 bits (230), Expect = 2e-21
 Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 21/209 (10%)

Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESE-----FLSEVRMITSI 136
            +  G  LG G F   Y+ + +  GTL+AVK++   ++   E E        E+R++  +
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLI--YGESDKFLNWSTRFQIILGIARGL 194
            H +++R+LG   + S   L  E+M   S+  L+  YG    F   +        + RGL
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG---AFKE-AVIINYTEQLLRGL 116

Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQS-KIGDFGLARFFPED---QAYLSTNFAGTLG 250
            YLHE+   +I+HRD+K +N+L+D   Q  +I DFG A                  GT+ 
Sbjct: 117 SYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173

Query: 251 YTAPEYAIRGE-LSEKADIYSFGVLVLEI 278
           + APE  +RGE      D++S G +++E+
Sbjct: 174 FMAPE-VLRGEQYGRSCDVWSVGCVIIEM 201

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 92.8 bits (231), Expect = 3e-21
 Identities = 59/194 (30%), Positives = 99/194 (51%), Gaps = 26/194 (13%)

Query: 107 TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL 166
            LVAVK L  D S     +FL EV++++ +   N+ RLLG C+      ++ EYM+N  L
Sbjct: 47  VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106

Query: 167 DLLIY---------GESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL 217
           +  +            + K L++ST   +   IA G++YL        VHRD+   N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLV 163

Query: 218 DEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG-------YTAPEYAIRGELSEKADIYS 270
            + +  KI DFG++R       Y S+++    G       + A E  + G+ + K+D+++
Sbjct: 164 GKNYTIKIADFGMSR-----NLY-SSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWA 217

Query: 271 FGVLVLEIIS-CRK 283
           FGV + EI++ CR+
Sbjct: 218 FGVTLWEILTLCRE 231

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 91.6 bits (227), Expect = 4e-21
 Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 20/198 (10%)

Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+       T VAVK +           FL+E  ++ ++QH  LV+L    +
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTM--KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 150 DGSQRLLVYEYMKNRSL-DLLIYGESD-----KFLNWSTRFQIILGIARGLQYLHEDSHT 203
                 ++ E+M   SL D L   E       K +++S +      IA G+ ++ + ++ 
Sbjct: 72  K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQRNY- 123

Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGEL 262
             +HRD++A+N+L+      KI DFGLAR   ED  Y +   A   + +TAPE    G  
Sbjct: 124 --IHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSF 180

Query: 263 SEKADIYSFGVLVLEIIS 280
           + K+D++SFG+L++EI++
Sbjct: 181 TIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 91.8 bits (228), Expect = 5e-21
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 26/214 (12%)

Query: 87  GNLLGRGGFGPVYRGKLAD-GTLVAVKKLCV--------DKSQQGESEFL-SEVRMITSI 136
           G L+G+G +G VY       G ++AVK++ +        D  Q+   + L SE+  +  +
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLI--YGESDKFLNWSTRFQIILGIARGL 194
            H N+V+ LG  +      +  EY+   S+   +  YG  ++ L      Q++     GL
Sbjct: 66  DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL----EGL 121

Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS---TNFAGTLGY 251
            YLH      I+HRD+KA N+L+D     KI DFG+++    D  Y +    +  G++ +
Sbjct: 122 AYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDNDQNMSMQGSVFW 176

Query: 252 TAPE--YAIRGELSEKADIYSFGVLVLEIISCRK 283
            APE  ++     S K DI+S G +VLE+ + R+
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 91.4 bits (227), Expect = 6e-21
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 28/204 (13%)

Query: 89  LLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +LG+G +G VY  + L+    +A+K++    S+  +     E+ + + ++H+N+V+ LG 
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP-LHEEIALHSYLKHRNIVQYLGS 73

Query: 148 CSDGSQRLLVYEYMKNRSLDLLI------YGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
            S+     +  E +   SL  L+        ++++ + + T+ QI+     GL+YLH++ 
Sbjct: 74  DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QIL----EGLKYLHDN- 127

Query: 202 HTRIVHRDIKASNVLLDE-KFQSKIGDFG----LARFFPEDQAYLSTNFAGTLGYTAPEY 256
             +IVHRDIK  NVL++      KI DFG    LA   P      +  F GTL Y APE 
Sbjct: 128 --QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-----CTETFTGTLQYMAPEV 180

Query: 257 AIRGE--LSEKADIYSFGVLVLEI 278
             +G       ADI+S G  ++E+
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEM 204

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 94.5 bits (235), Expect = 8e-21
 Identities = 64/270 (23%), Positives = 132/270 (48%), Gaps = 19/270 (7%)

Query: 88  NLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           N++ RG  G  Y+GK + +G    VK+  ++      S  ++++     +QH N+V+L+G
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKE--INDVNSIPSSEIADMG---KLQHPNIVKLIG 750

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
            C       L++EY++ ++L  ++       L+W  R +I +GIA+ L++LH      +V
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVV 805

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKA 266
             ++    +++D K +  +    L      D     ++      Y APE     +++EK+
Sbjct: 806 VGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISS-----AYVAPETRETKDITEKS 859

Query: 267 DIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIV-ER 325
           DIY FG++++E+++ +   D         + E+A   Y    +   +DP +R +  V + 
Sbjct: 860 DIYGFGLILIELLTGKSPADAEFGVH-GSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQN 918

Query: 326 DALQVINVAFICLQPHGNQRPPMSEIVAML 355
           + ++V+N+A  C       RP  ++++  L
Sbjct: 919 EIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 91.3 bits (227), Expect = 1e-20
 Identities = 68/211 (32%), Positives = 106/211 (50%), Gaps = 27/211 (12%)

Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGES-EFLSEVRMITSIQHK 139
             F   N +G G +G VYR +    G +VA+KK+ +D  + G     L E+ ++ +++H 
Sbjct: 7   TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66

Query: 140 NLVRLLGCCSDGSQRL----LVYEYMKNRSLDLLIYGESDKFLNWSTRFQ------IILG 189
           N+V L        + L    LV EY + + L  L+        N  T F       ++L 
Sbjct: 67  NIVELKEVVV--GKHLDSIFLVMEYCE-QDLASLLD-------NMPTPFSESQVKCLMLQ 116

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
           + RGLQYLHE+    I+HRD+K SN+LL +K   KI DFGLAR +      ++     TL
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TL 172

Query: 250 GYTAPEYAIRGELSEKA-DIYSFGVLVLEII 279
            Y APE  +       A D+++ G ++ E++
Sbjct: 173 WYRAPELLLGCTTYTTAIDMWAVGCILAELL 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 90.2 bits (224), Expect = 2e-20
 Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 15/197 (7%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKL----CVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           +G+G F  VY+   L DG +VA+KK+     +D   + +   L E+ ++  + H N+++ 
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDC--LKEIDLLKQLDHPNVIKY 67

Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLI--YGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
           L    + ++  +V E      L  +I  + +  + +   T ++  + +   L+++H    
Sbjct: 68  LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS--- 124

Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE- 261
            RI+HRDIK +NV +      K+GD GL RFF   +   + +  GT  Y +PE  I    
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPE-RIHENG 182

Query: 262 LSEKADIYSFGVLVLEI 278
            + K+DI+S G L+ E+
Sbjct: 183 YNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 90.4 bits (224), Expect = 2e-20
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 21/205 (10%)

Query: 87  GNLLGRGGFGPVYRGK-LADGTL----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
             LLG G FG V++G  + +G      VA+K +     +Q   E    +  + S+ H  +
Sbjct: 12  LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYI 71

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESD-----KFLNWSTRFQIILGIARGLQY 196
           VRLLG C  G+   LV +     SL   +    D     + LNW  +      IA+G+ Y
Sbjct: 72  VRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYY 124

Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR-FFPEDQAYLSTNFAGTLGYTAPE 255
           L E    R+VHR++ A N+LL      +I DFG+A   +P+D+ Y  +     + + A E
Sbjct: 125 LEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181

Query: 256 YAIRGELSEKADIYSFGVLVLEIIS 280
             + G  + ++D++S+GV V E++S
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 90.5 bits (224), Expect = 2e-20
 Identities = 61/191 (31%), Positives = 104/191 (54%), Gaps = 10/191 (5%)

Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G+G FG V++G       +VA+K + +++++    +   E+ +++      + +  G  
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 149 SDGSQRLLVYEYMKNRS-LDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVH 207
             G++  ++ EY+   S LDLL  G  D+F   +T  + IL   +GL YLH +   + +H
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLRAGPFDEF-QIATMLKEIL---KGLDYLHSE---KKIH 124

Query: 208 RDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKAD 267
           RDIKA+NVLL E+   K+ DFG+A    + Q   +T F GT  + APE   +     KAD
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIQQSAYDSKAD 183

Query: 268 IYSFGVLVLEI 278
           I+S G+  +E+
Sbjct: 184 IWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 90.5 bits (225), Expect = 2e-20
 Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 33/177 (18%)

Query: 80  ATKNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEF----LSEVRMIT 134
             +++     LG G FG VY+  ++  G +VA+KK+ +   + G   F    L E++++ 
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILK 62

Query: 135 SIQHKNLVRLLGCC---SDGSQRLLVYEYMKNRSLDLLIYGESDKFL-----NWSTRFQ- 185
            ++H N+V L+       D S+R     YM      +  Y + D  L     N S +   
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYM------VTPYMDHD--LSGLLENPSVKLTE 114

Query: 186 -----IILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED 237
                 +L +  G+ YLHE+    I+HRDIKA+N+L+D +   KI DFGLAR +   
Sbjct: 115 SQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGP 168

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 89.8 bits (223), Expect = 3e-20
 Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 18/208 (8%)

Query: 88  NLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNLVRLL 145
             +G G +G VY+ +  D G LVA+KK+ +D  ++G     + E++++  + H+N+V L 
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72

Query: 146 GCCSDGSQRL----------LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQ 195
              +D    L          LV+EYM +  + LL  G      +       +  +  GL 
Sbjct: 73  EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH--FSEDHIKSFMKQLLEGLN 130

Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE 255
           Y H+      +HRDIK SN+LL+ K Q K+ DFGLAR +  +++   TN   TL Y  PE
Sbjct: 131 YCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPE 187

Query: 256 YAIRGELSEKA-DIYSFGVLVLEIISCR 282
             +  E    A D++S G ++ E+ + +
Sbjct: 188 LLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 89.9 bits (223), Expect = 3e-20
 Identities = 65/195 (33%), Positives = 92/195 (47%), Gaps = 16/195 (8%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGE--SEFLSEVRMITSIQHKNLVRLLG 146
           +G G FG VY  + +    +VA+KK+     Q  E   + + EVR +  ++H N +   G
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
           C        LV EY    + D+L   +  K L       I  G  +GL YLH  SH RI 
Sbjct: 83  CYLREHTAWLVMEYCLGSASDILEVHK--KPLQEVEIAAICHGALQGLAYLH--SHERI- 137

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI---RGELS 263
           HRDIKA N+LL E    K+ DFG A       +     F GT  + APE  +    G+  
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPANS-----FVGTPYWMAPEVILAMDEGQYD 192

Query: 264 EKADIYSFGVLVLEI 278
            K D++S G+  +E+
Sbjct: 193 GKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 90.0 bits (223), Expect = 3e-20
 Identities = 74/268 (27%), Positives = 126/268 (47%), Gaps = 31/268 (11%)

Query: 108 LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLD 167
           LVAVK L  D ++   ++FL EV++++ ++  N++RLLG C D     ++ EYM+N  L+
Sbjct: 48  LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107

Query: 168 ------LLIYGESDKF-----------LNWSTRFQIILGIARGLQYLHEDSHTRIVHRDI 210
                  L   E +             +++S+   + L IA G++YL   S    VHRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDL 164

Query: 211 KASNVLLDEKFQSKIGDFGLAR-FFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
              N L+ E    KI DFG++R  +  D   +       + + A E  + G+ +  +D++
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224

Query: 270 SFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDAL 328
           +FGV + EI+  C++     L  E Q +        ++GR + L  P    +G+ E    
Sbjct: 225 AFGVTLWEILMLCKEQPYGELTDE-QVIENAGEFFRDQGRQVYLFRPPPCPQGLYE---- 279

Query: 329 QVINVAFICLQPHGNQRPPMSEIVAMLT 356
               +   C      +RP  S+I A LT
Sbjct: 280 ----LMLQCWSRDCRERPSFSDIHAFLT 303

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 88.8 bits (220), Expect = 4e-20
 Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 19/204 (9%)

Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESE-----FLSEVRMITSIQHKNL 141
           G +LG+G +G VY G    G L+AVK++ +D S    +E        EV ++ S++H N+
Sbjct: 5   GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLI--YGESDKFLNWSTRFQIILGIARGLQYLHE 199
           V+ LG C D +   +  E++   S+  ++  +G   + +      QI+ G+A    YLH 
Sbjct: 65  VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLHN 120

Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS-----TNFAGTLGYTAP 254
           +    +VHRDIK +NV+L      K+ DFG AR       + +      +  GT  + AP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177

Query: 255 EYAIRGELSEKADIYSFGVLVLEI 278
           E         K+DI+S G  V E+
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEM 201

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 88.9 bits (221), Expect = 5e-20
 Identities = 67/206 (32%), Positives = 107/206 (51%), Gaps = 34/206 (16%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G +G VY+ +    G +VA+KK+ ++   +G  S  + E+ ++  + H N+VRLL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGES-----------DKFLNWSTRFQIILGIARGLQY 196
               ++  LV+E++    LDL  Y +S             +L     +Q++ GIA    Y
Sbjct: 67  VHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYL-----YQLLQGIA----Y 114

Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF--PEDQAYLSTNFAGTLGYTAP 254
            H  SH R++HRD+K  N+L+D +   K+ DFGLAR F  P  + Y  T+   TL Y AP
Sbjct: 115 CH--SH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RTY--THEVVTLWYRAP 168

Query: 255 EYAIRGEL-SEKADIYSFGVLVLEII 279
           E  +     S   DI+S G +  E++
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMV 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 88.6 bits (220), Expect = 5e-20
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 23/206 (11%)

Query: 86  PGNLLGRGGFGPVYRG----KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
            G  +G G FG VY+G       +   VAVK      S     +FL E  ++    H ++
Sbjct: 10  LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFL----NWSTRFQIIL---GIARGL 194
           V+L+G  ++    ++         ++L   GE   +L           +IL    ++  L
Sbjct: 70  VKLIGVITENPVWIV---------MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTAL 120

Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            YL      R VHRDI A NVL+      K+GDFGL+R+  ++  Y ++     + + AP
Sbjct: 121 AYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAP 177

Query: 255 EYAIRGELSEKADIYSFGVLVLEIIS 280
           E       +  +D++ FGV + EI+ 
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 88.5 bits (219), Expect = 9e-20
 Identities = 87/282 (30%), Positives = 124/282 (43%), Gaps = 36/282 (12%)

Query: 90  LGRGGFGPVYRGKLAD------GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG+G FG VY G   D       T VAVK +    S +   EFL+E  ++      ++VR
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--------FQIILGIARGLQ 195
           LLG  S G   L+V E M +  L   +     +  N   R         Q+   IA G+ 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL--GYTA 253
           YL+     + VHRD+ A N ++   F  KIGDFG+ R   E   Y      G L   + A
Sbjct: 134 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG-KGLLPVRWMA 189

Query: 254 PEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           PE    G  +  +D++SFGV++ EI S  +     L +E Q L     K    G  L+  
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-QVL-----KFVMDGGYLD-- 241

Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
               + +   ER    V ++  +C Q +   RP   EIV +L
Sbjct: 242 ----QPDNCPER----VTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 72/287 (25%), Positives = 119/287 (41%), Gaps = 30/287 (10%)

Query: 89  LLGRGGFGPVYRGK-LADGTLVAVKK-LCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           ++G G +G V + +  A G +VA+KK    +  +  +   L EV+++  ++H+N+V L  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
                 +  LV+EY++   L+LL    S   L        I  + + + Y H  SH  I+
Sbjct: 68  AFRRKGRLYLVFEYVERTLLELL--EASPGGLPPDAVRSYIWQLLQAIAYCH--SH-NII 122

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKA 266
           HRDIK  N+L+ E    K+ DFG AR      A   T++  T  Y APE  +      K 
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKP 182

Query: 267 -DIYSFGVLVLEIISCR---------------KNTDLTLPSEMQYLPEYAWKLYERGRIL 310
            D+++ G ++ E++                  +     LP   Q L   +   +      
Sbjct: 183 VDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL-FSSNPRFAGVAFP 241

Query: 311 ELVDP---RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAM 354
           E   P     R  G V   AL  +     CL+    +R    E++  
Sbjct: 242 EPSQPESLERRYPGKVSSPALDFLKA---CLRMDPKERLTCDELLQH 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 87.6 bits (217), Expect = 1e-19
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 8/196 (4%)

Query: 90  LGRGGFGPVYRGKLAD-GTLVAVKKLCVD--KSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           LG+GGFG V   ++   G + A KKL     K ++GE   L+E +++  +  + +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
                    LV   M    L   IY   +     +        I  GL++LH+    RIV
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIV 117

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKA 266
           +RD+K  NVLLD+    +I D GLA      +       AGT GY APE           
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEVYDFSV 175

Query: 267 DIYSFGVLVLEIISCR 282
           D ++ G  + E+I+ R
Sbjct: 176 DWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 25/205 (12%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G +G VY+G+    G +VA+KK+ ++  ++G  S  + E+ ++  +QH N+V L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGES-------DKFLNWSTRFQIILGIARGLQYLHED 200
               S+  L++E++   S+DL  Y +S       D  L  S  +QI+ GI     + H  
Sbjct: 68  LMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL----FCHS- 119

Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF--PEDQAYLSTNFAGTLGYTAPEYAI 258
              R++HRD+K  N+L+D K   K+ DFGLAR F  P  + Y  T+   TL Y APE  +
Sbjct: 120 --RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVY--THEVVTLWYRAPEVLL 174

Query: 259 RGEL-SEKADIYSFGVLVLEIISCR 282
                S   DI+S G +  E+ + +
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 66/201 (32%), Positives = 109/201 (54%), Gaps = 27/201 (13%)

Query: 93  GGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEF----LSEVRMITSIQHKNLVRL--- 144
           G +G VYR +    G +VA+KKL ++K ++G   F    L E+ ++  +QH N+V +   
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQHPNIVTVKEV 72

Query: 145 -LGCCSDGSQRLLVYEYMKNRSLDL--LIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
            +G  S+  +  +V EY+++   DL  L+      FL  S    ++L +  G+ +LH++ 
Sbjct: 73  VVG--SNLDKIYMVMEYVEH---DLKSLMETMKQPFLQ-SEVKCLMLQLLSGVAHLHDNW 126

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED-QAYLSTNFAGTLGYTAPEYAI-R 259
              I+HRD+K SN+LL+ +   KI DFGLAR +    + Y  T    TL Y APE  +  
Sbjct: 127 ---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVVTLWYRAPELLLGA 181

Query: 260 GELSEKADIYSFGVLVLEIIS 280
            E S   D++S G +  E+++
Sbjct: 182 KEYSTAIDMWSVGCIFAELLT 202

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 87.8 bits (217), Expect = 2e-19
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 27/218 (12%)

Query: 87  GNLLGRGGFGPVY--------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V         + K  +   VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 20  GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 79

Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGE--------------SDKFLNWSTR 183
           HKN++ LLG C+      ++ EY    +L   +                  D+ + +   
Sbjct: 80  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139

Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
                 +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR       Y  +
Sbjct: 140 VSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196

Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           TN    + + APE       + ++D++SFGVL+ EI +
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 86.7 bits (215), Expect = 2e-19
 Identities = 62/276 (22%), Positives = 126/276 (45%), Gaps = 25/276 (9%)

Query: 83  NFHPGNLLGRGGFGP--VYRGKLADGTLVAVKKLCV-DKSQQGESEFLSEVRMITSIQHK 139
           ++ P  +LG+G FG   +YR +  D +LV  K++ +   S++   + L+E+ +++ +QH 
Sbjct: 1   HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59

Query: 140 NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
           N++       D +  L+  EY    +L   I  +  +          +  I   + Y+H+
Sbjct: 60  NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119

Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
                I+HRDIK  N+ L +    K+GDFG+++    + +   T   GT  Y +PE    
Sbjct: 120 AG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQG 175

Query: 260 GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK 319
            + + K+DI++ G ++ E+++ ++  D T P  +        K+ +              
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL------VVKIVQGNY----------- 218

Query: 320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
             +V   + ++I++    LQ    +RP   E++   
Sbjct: 219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 87.8 bits (217), Expect = 2e-19
 Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 21/203 (10%)

Query: 89  LLGRGGFGPVYRGK-LADGTLV----AVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           +LG G FG VY+G  + +G  V    A+K L      +   EF+ E  ++ S+ H +LVR
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDK-----FLNWSTRFQIILGIARGLQYLH 198
           LLG C   + +L V + M +  L   ++   D       LNW  +      IA+G+ YL 
Sbjct: 74  LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLE 126

Query: 199 EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA-YLSTNFAGTLGYTAPEYA 257
           E    R+VHRD+ A NVL+      KI DFGLAR    D+  Y +      + + A E  
Sbjct: 127 E---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183

Query: 258 IRGELSEKADIYSFGVLVLEIIS 280
              + + ++D++S+GV + E+++
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 87.0 bits (215), Expect = 2e-19
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 18/207 (8%)

Query: 87  GNLLGRGGFGPVYRGKLA--DGTL-VAVKKLCVDKSQQGESE-FLSEVRMITSIQHKNLV 142
           G  LG G FG V  G+L   D  L VAVK + +    + E E FLSE   +    H N++
Sbjct: 4   GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63

Query: 143 RLLGCCSDGSQR------LLVYEYMKNRSL-DLLIY---GESDKFLNWSTRFQIILGIAR 192
           RL+G C    +       +++  +MK+  L   L+Y   G+  ++L      + +  IA 
Sbjct: 64  RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123

Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT-LGY 251
           G++YL   S    +HRD+ A N +L+E     + DFGL++       Y     A   + +
Sbjct: 124 GMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180

Query: 252 TAPEYAIRGELSEKADIYSFGVLVLEI 278
            A E       + K+D++SFGV + EI
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 86.8 bits (215), Expect = 3e-19
 Identities = 63/201 (31%), Positives = 109/201 (54%), Gaps = 18/201 (8%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +  VY+G+    G +VA+K++ +D  +   S  + E+ ++  ++H+N+VRL    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 149 SDGSQRLLVYEYMKN---RSLDLLIYGES---DKFLNWSTRFQIILGIARGLQYLHEDSH 202
              ++ +LV+EYM     + +D   +G     D     S  +Q++ GIA    + HE+  
Sbjct: 68  HTENKLMLVFEYMDKDLKKYMD--THGVRGALDPNTVKSFTYQLLKGIA----FCHEN-- 119

Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
            R++HRD+K  N+L++++ + K+ DFGLAR F       S N   TL Y AP+  +    
Sbjct: 120 -RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS-NEVVTLWYRAPDVLLGSRT 177

Query: 263 -SEKADIYSFGVLVLEIISCR 282
            S   DI+S G ++ E+I+ R
Sbjct: 178 YSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 87.4 bits (216), Expect = 3e-19
 Identities = 70/218 (32%), Positives = 110/218 (50%), Gaps = 27/218 (12%)

Query: 87  GNLLGRGGFGPVY--------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V         + K    T VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 23  GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82

Query: 138 HKNLVRLLGCCS-DGSQRLLV--------YEYMKNRSLDLLIYGES-----DKFLNWSTR 183
           HKN++ LLG C+ DG   ++V         EY++ R    + Y  +     ++ L++   
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
                 +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR       Y  +
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199

Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           TN    + + APE       + ++D++SFGVL+ EI +
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 87.5 bits (216), Expect = 3e-19
 Identities = 66/195 (33%), Positives = 94/195 (48%), Gaps = 16/195 (8%)

Query: 90  LGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGE--SEFLSEVRMITSIQHKNLVRLLG 146
           +G G FG VY  +      +VA+KK+     Q  E   + + EV+ +  I+H N +   G
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
           C        LV EY    + DLL   +  K L       I  G  +GL YLH  SH  ++
Sbjct: 93  CYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH--SHN-MI 147

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI---RGELS 263
           HRDIKA N+LL E  Q K+ DFG A       A  + +F GT  + APE  +    G+  
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFGSASI-----ASPANSFVGTPYWMAPEVILAMDEGQYD 202

Query: 264 EKADIYSFGVLVLEI 278
            K D++S G+  +E+
Sbjct: 203 GKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 87.0 bits (215), Expect = 3e-19
 Identities = 64/253 (25%), Positives = 115/253 (45%), Gaps = 31/253 (12%)

Query: 90  LGRGGFGPVYRGKLADG----------------TLVAVKKLCVDKSQQGESEFLSEVRMI 133
           LG G FG V+  + A+G                 LVAVK L  D ++   ++FL E++++
Sbjct: 13  LGEGQFGEVHLCE-AEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 134 TSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLL-----IYGESDKFLN-----WSTR 183
           + +++ N++RLLG C       ++ EYM+N  L+       I        N      +  
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131

Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR-FFPEDQAYLS 242
             + + IA G++YL   +    VHRD+   N L+   +  KI DFG++R  +  D   + 
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188

Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWK 302
                 + + A E  + G+ +  +D+++FGV + E+ +  K    +L S+ Q +      
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEF 248

Query: 303 LYERGRILELVDP 315
              +GR + L   
Sbjct: 249 FRNQGRQIYLSQT 261

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 86.3 bits (214), Expect = 4e-19
 Identities = 52/195 (26%), Positives = 96/195 (49%), Gaps = 12/195 (6%)

Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG VY+ +  +  L A  K+   +S++   +F+ E+ +++  +H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
             ++  ++ E+    +LD ++  E ++ L       +   +   L +LH     +++HRD
Sbjct: 73  YENKLWILIEFCDGGALDSIML-ELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRD 128

Query: 210 IKASNVLLDEKFQSKIGDFGL-ARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSE---- 264
           +KA N+LL      K+ DFG+ A+     Q   +  F GT  + APE        +    
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNPYD 186

Query: 265 -KADIYSFGVLVLEI 278
            KADI+S G+ ++E+
Sbjct: 187 YKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (212), Expect = 4e-19
 Identities = 71/213 (33%), Positives = 111/213 (52%), Gaps = 26/213 (12%)

Query: 83  NFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLS----EVRMITSIQ 137
           N+  G LLGRG FG VY    AD G  +AVK++  D   Q  S+ ++    E++++ +++
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 138 HKNLVRLLGCCSDGSQRLL--VYEYMKNRSL--DLLIYGE-SDKFLNWSTRFQIILGIAR 192
           H  +V+  GC  D  ++ L    EYM   S+   L  YG  ++      TR QI+    +
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR-QIL----Q 117

Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS----TNFAGT 248
           G+ YLH +    IVHRDIK +N+L D     K+GDFG ++        +S     +  GT
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI--QTICMSGTGIKSVTGT 172

Query: 249 LGYTAPEYAIRGE-LSEKADIYSFGVLVLEIIS 280
             + +PE  I GE    KAD++S    V+E+++
Sbjct: 173 PYWMSPE-VISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 86.3 bits (213), Expect = 5e-19
 Identities = 62/191 (32%), Positives = 101/191 (52%), Gaps = 10/191 (5%)

Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G+G FG VY+G       +VA+K + +++++    +   E+ +++      + R  G  
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 149 SDGSQRLLVYEYMKNRS-LDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVH 207
             G++  ++ EY+   S LDLL  G     L  +    I+  I +GL YLH +   R +H
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLHSE---RKIH 124

Query: 208 RDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKAD 267
           RDIKA+NVLL E+   K+ DFG+A    + Q   +T F GT  + APE   +     KAD
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSAYDFKAD 183

Query: 268 IYSFGVLVLEI 278
           I+S G+  +E+
Sbjct: 184 IWSLGITAIEL 194

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 86.6 bits (214), Expect = 5e-19
 Identities = 63/195 (32%), Positives = 95/195 (48%), Gaps = 16/195 (8%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGE--SEFLSEVRMITSIQHKNLVRLLG 146
           +G G FG VY  + + +  +VA+KK+     Q  E   + + EVR +  ++H N ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
           C        LV EY    + DLL   +  K L       +  G  +GL YLH  SH  ++
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH--SHN-MI 137

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI---RGELS 263
           HRD+KA N+LL E    K+GDFG A          +  F GT  + APE  +    G+  
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANXFVGTPYWMAPEVILAMDEGQYD 192

Query: 264 EKADIYSFGVLVLEI 278
            K D++S G+  +E+
Sbjct: 193 GKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 86.0 bits (213), Expect = 5e-19
 Identities = 65/208 (31%), Positives = 109/208 (52%), Gaps = 18/208 (8%)

Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKN 140
           NF     +G G +G VY+ +    G +VA+KK+ +D   +G  S  + E+ ++  + H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 141 LVRLLGCCSDGSQRLLVYEYMKN---RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYL 197
           +V+LL      ++  LV+E++     + +D          L  S  FQ++ G+A    + 
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----FC 116

Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF--PEDQAYLSTNFAGTLGYTAPE 255
           H  SH R++HRD+K  N+L++ +   K+ DFGLAR F  P  + Y  T+   TL Y APE
Sbjct: 117 H--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTY--THEVVTLWYRAPE 170

Query: 256 YAIRGEL-SEKADIYSFGVLVLEIISCR 282
             +  +  S   DI+S G +  E+++ R
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 86.2 bits (213), Expect = 7e-19
 Identities = 66/195 (33%), Positives = 94/195 (48%), Gaps = 16/195 (8%)

Query: 90  LGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGE--SEFLSEVRMITSIQHKNLVRLLG 146
           +G G FG VY    +    +VAVKK+     Q  E   + + EV+ +  ++H N +   G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
           C        LV EY    + DLL   +  K L       I  G  +GL YLH  SH  I 
Sbjct: 89  CYLKEHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH--SHNMI- 143

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI---RGELS 263
           HRDIKA N+LL E  Q K+ DFG A      ++  + +F GT  + APE  +    G+  
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSA-----SKSSPANSFVGTPYWMAPEVILAMDEGQYD 198

Query: 264 EKADIYSFGVLVLEI 278
            K D++S G+  +E+
Sbjct: 199 GKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 86.6 bits (214), Expect = 7e-19
 Identities = 71/218 (32%), Positives = 109/218 (50%), Gaps = 27/218 (12%)

Query: 87  GNLLGRGGFGPVY--------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V         + K      VAVK L  D + +  S+ +SE+ M+  I +
Sbjct: 17  GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76

Query: 138 HKNLVRLLGCCS-DGSQRLLV--------YEYMKNRSLDLLIYG-ESDKFLNWSTRFQII 187
           HKN++ LLG C+ DG   +LV         EY++ R    + Y  ++ K       F+ +
Sbjct: 77  HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136

Query: 188 LG----IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
           +     +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR       Y  +
Sbjct: 137 VSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193

Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           TN    + + APE       + ++D++SFGVL+ EI +
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 85.4 bits (211), Expect = 9e-19
 Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 24/212 (11%)

Query: 90  LGRGGFGPVYRGKL-----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG   FG +Y+G L         LVA+K L    + Q   EF  E  ++  + H N+V L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 145 LGCCSDGSQRLLVYEYMKNRSL-DLLIY--------------GESDKFLNWSTRFQIILG 189
           LG  +      +++EY+    L + LI               G     L+      I + 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR-FFPEDQAYLSTNFAGT 248
           IA G++YL   SH   VH+D+ A N+L+ E+   KI D GL+R  +  D   +       
Sbjct: 133 IAAGMEYL--SSHF-FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           + +  PE  + G+ S  +DI+SFGV++ EI S
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 1e-18
 Identities = 66/204 (32%), Positives = 96/204 (47%), Gaps = 34/204 (16%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGE--SEFLSEVRMITSIQHKNLVRLLG 146
           +G G +G VY+ + +A G LVA+K   V K + G+       E+ M+   +H N+V   G
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIK---VIKLEPGDDFEIIQQEISMLKECRHPNIVAYFG 67

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR----GLQYLHEDSH 202
                 +  +V EY    SL   IY  +   L+     QI   + R    GL YLHE   
Sbjct: 68  SYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSEL---QIAY-VCRETLKGLAYLHE--- 119

Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA------GTLGYTAPEY 256
           T  +HRDIK +N+LL E    K+ DFG++       A L+   A      GT  + APE 
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVS-------AQLTATIAKRKSFIGTPYWMAPEV 172

Query: 257 A---IRGELSEKADIYSFGVLVLE 277
           A    +G    K DI++ G+  +E
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 84.5 bits (209), Expect = 1e-18
 Identities = 78/281 (27%), Positives = 135/281 (48%), Gaps = 34/281 (12%)

Query: 89  LLGRGGFGPVY--RGKLADGTLVAVKKLCV-------DKSQQGES--EFLSEVRMIT-SI 136
            LG G FG VY  R K     L+A+K++ V       DK ++ +S  + +SEV +I   +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N+VR      +  +  +V + ++   L        +K   ++    + I + +   L
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +YLH++   RIVHRD+  +N++L E  +  I DFGLA+   + ++ L T+  GT+ Y+ P
Sbjct: 127 RYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKL-TSVVGTILYSCP 182

Query: 255 EYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD 314
           E        EKAD+++FG ++ ++ +      L  P     +   A K+ E      + +
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLATKIVE-----AVYE 231

Query: 315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
           P    EG+   D   VI     CL P    RP + ++ AM+
Sbjct: 232 P--LPEGMYSEDVTDVITS---CLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 84.6 bits (209), Expect = 1e-18
 Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 20/202 (9%)

Query: 89  LLGRGGFGPVYRGKLA----DGTLVAVKKL---CVDKSQQGESEFLSEVRMITSIQHKNL 141
           +LG G FG + RG L         VA+  L   C DK ++G   FL+E   +    H N+
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG---FLAEALTLGQFDHSNI 68

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
           VRL G  + G+  ++V EYM N +LD  +     + L       ++ G+A G++YL E  
Sbjct: 69  VRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ-LVAGQLMGMLPGLASGMKYLSEMG 127

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA---YLSTNFAGTLGYTAPEYAI 258
           +   VH+ + A  VL++     KI  F   R   ED++   Y + +    + + APE   
Sbjct: 128 Y---VHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181

Query: 259 RGELSEKADIYSFGVLVLEIIS 280
               S  +D++SFG+++ E++S
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 67/206 (32%), Positives = 99/206 (48%), Gaps = 22/206 (10%)

Query: 90  LGRGGFGPVYRGKLADG-------TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           LG+G FG VY G +A G       T VA+K +    S +   EFL+E  ++      ++V
Sbjct: 14  LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 143 RLLGCCSDGSQRLLVYEYMKN-------RSLDLLIYGESDKFL-NWSTRFQIILGIARGL 194
           RLLG  S G   L++ E M         RSL   +     +   +     Q+   IA G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YT 252
            YL+ +   + VHRD+ A N ++ E F  KIGDFG+ R   E   Y      G L   + 
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG-KGLLPVRWM 188

Query: 253 APEYAIRGELSEKADIYSFGVLVLEI 278
           +PE    G  +  +D++SFGV++ EI
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 61/197 (30%), Positives = 99/197 (50%), Gaps = 12/197 (6%)

Query: 90  LGRGGFGPVYRG---KLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V +G          VAVK L  D +    + E L E  ++  + +  +VR++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G C +    +LV E  +   L+  +  + +K +      +++  ++ G++YL E   T  
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFL--QKNKHVTEKNITELVHQVSMGMKYLEE---TNF 116

Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRGELS 263
           VHRD+ A NVLL  +  +KI DFGL++    D+ Y      G   + + APE     + S
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 264 EKADIYSFGVLVLEIIS 280
            K+D++SFGVL+ E  S
Sbjct: 177 SKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 65/223 (29%), Positives = 111/223 (49%), Gaps = 25/223 (11%)

Query: 82  KNFHPGNLLGRGGFGPVYRGK--LADGTLVAVKKLCVDKSQQGES-EFLSEV---RMITS 135
           + +     +G G +G V++ +     G  VA+K++ V   ++G     + EV   R + +
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60

Query: 136 IQHKNLVRLLGCCS----DGSQRL-LVYEYMKNRSLDLLIYGES--DKFLNWSTRFQIIL 188
            +H N+VRL   C+    D   +L LV+E++     DL  Y +   +  +   T   ++ 
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVPTETIKDMMF 117

Query: 189 GIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT 248
            + RGL +LH  SH R+VHRD+K  N+L+    Q K+ DFGLAR +    A   T+   T
Sbjct: 118 QLLRGLDFLH--SH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVT 172

Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIIS----CRKNTDL 287
           L Y APE  ++   +   D++S G +  E+       R ++D+
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 215

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 83.9 bits (207), Expect = 5e-18
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 27/211 (12%)

Query: 84  FHPGNLLGRGGFGPVYRGK-LADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +LG G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 139 KNLVRLLGCCSDGSQRLL--------VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L+        + +Y++    ++     S   LNW  +      I
Sbjct: 69  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------I 118

Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL E    R+VHRD+ A NVL+      KI DFGLA+    +++ Y +      +
Sbjct: 119 AKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI 175

Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 83.4 bits (206), Expect = 5e-18
 Identities = 63/259 (24%), Positives = 121/259 (46%), Gaps = 21/259 (8%)

Query: 108 LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLD 167
           LVAVK L  D ++   ++FL E+++++ ++  N++RLL  C       ++ EYM+N  L+
Sbjct: 48  LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 168 LLI---------YGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD 218
             +                +++ST   +   IA G++YL   S    VHRD+   N L+ 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVG 164

Query: 219 EKFQSKIGDFGLAR-FFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLE 277
           + +  KI DFG++R  +  D   +       + + + E  + G+ +  +D+++FGV + E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224

Query: 278 IISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFIC 337
           I++  K    +  S+ Q +        ++GR + L  P +  +         +  +   C
Sbjct: 225 ILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPD--------SLYKLMLSC 276

Query: 338 LQPHGNQRPPMSEIVAMLT 356
            + +  +RP   EI A L 
Sbjct: 277 WRRNAKERPSFQEIHATLL 295

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 82.7 bits (204), Expect = 5e-18
 Identities = 57/196 (29%), Positives = 101/196 (51%), Gaps = 10/196 (5%)

Query: 90  LGRGGFGPVYRG--KLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           LG G FG V +G  K+    + VA+K L  +  +    E + E  ++  + +  +VR++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
            C +    +LV E      L+  + G+ D+ +  S   +++  ++ G++YL   +    V
Sbjct: 63  VC-EAEALMLVMEMASGGPLNKFLSGKKDE-ITVSNVVELMHQVSMGMKYLEGKN---FV 117

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRGELSE 264
           HRD+ A NVLL  +  +KI DFGL++    D +Y     AG   L + APE     + S 
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177

Query: 265 KADIYSFGVLVLEIIS 280
           ++D++S+G+ + E  S
Sbjct: 178 RSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 83.1 bits (205), Expect = 6e-18
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 21/203 (10%)

Query: 89  LLGRGGFGPVYRGKLA-DG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           +LG G FG VY+G    DG      VA+K L  + S +   E L E  ++  +    + R
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDK-----FLNWSTRFQIILGIARGLQYLH 198
           LLG C   + +L V + M    L   +    D+      LNW  +      IA+G+ YL 
Sbjct: 74  LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLE 126

Query: 199 EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA-YLSTNFAGTLGYTAPEYA 257
           E    R+VHRD+ A NVL+      KI DFGLAR    D+  Y +      + + A E  
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183

Query: 258 IRGELSEKADIYSFGVLVLEIIS 280
           +    + ++D++S+GV V E+++
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 63/199 (31%), Positives = 107/199 (53%), Gaps = 17/199 (8%)

Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKK-LCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           L+G G +G V + K  + G +VA+KK L  +  +  +   + E+RM+  ++H+NLV L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKF---LNWSTRFQIILGIARGLQYLHEDSHT 203
                 +  LV+E++ +  LD L     +K+   L+ S   + +  I RG+++ H  SH 
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDL-----EKYPNGLDESRVRKYLFQILRGIEFCH--SHN 120

Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE-DQAYLSTNFAGTLGYTAPEYAIRGEL 262
            I+HRDIK  N+L+ +    K+ DFG AR      + Y  T++  T  Y APE  +    
Sbjct: 121 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAPELLVGDTK 177

Query: 263 SEKA-DIYSFGVLVLEIIS 280
             +A DI++ G LV E+++
Sbjct: 178 YGRAVDIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 82.3 bits (203), Expect = 1e-17
 Identities = 66/219 (30%), Positives = 107/219 (48%), Gaps = 29/219 (13%)

Query: 87  GNLLGRGGFGPVYRGKLADG---------TLVAVKKLCVDKSQQGESEFLSEVRMITSI- 136
           G  LG G FG V R + A G           VAVK L  + + +  ++ +SE+ ++  I 
Sbjct: 17  GKPLGEGCFGQVVRAE-AYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG 75

Query: 137 QHKNLVRLLGCCS-DGSQRLLV--------YEYMKNR-----SLDLLIYGESDKFLNWST 182
           +HKN++ LLG C+ +G   ++V         E+++ R          I    ++ L++  
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 183 RFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS 242
                  +ARG++YL      R +HRD+ A NVL+ E    KI DFGLAR   +   Y  
Sbjct: 136 LVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192

Query: 243 T-NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           T N    + + APE       + ++D++SFG+L+ EI +
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 15/201 (7%)

Query: 90  LGRGGFGPVY------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG G FG V        G    G  VAVK L  +      ++   E+ ++ ++ H+N+V+
Sbjct: 12  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 144 LLGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
             G C++       L+ E++ + SL   +    +K +N   + +  + I +G+ YL    
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYLGSRQ 129

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST--NFAGTLGYTAPEYAIR 259
           +   VHRD+ A NVL++ + Q KIGDFGL +    D+ Y +   +    + + APE  I+
Sbjct: 130 Y---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186

Query: 260 GELSEKADIYSFGVLVLEIIS 280
            +    +D++SFGV + E+++
Sbjct: 187 SKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 25/207 (12%)

Query: 90  LGRGGFGPVYRGKLADGTLVA---VKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           +G G FG V  G+   G   A   VK+L    +   +  FL EV+    + H N+++ LG
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 147 CCSDGSQRLLVYEY-----MKN--RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
            C +    LLV E+     +KN  RS   ++   + K        ++   +A GL +LH+
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK----DVLQRMACEVASGLLWLHQ 118

Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLA-RFFPEDQAYLSTNFAGTLGYTAPEYA- 257
                 +H D+   N  L      KIGD+GLA   +PED        A  L + APE   
Sbjct: 119 AD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175

Query: 258 IRG------ELSEKADIYSFGVLVLEI 278
           IRG      + ++K++I+S GV + E+
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 77/269 (28%), Positives = 126/269 (46%), Gaps = 43/269 (15%)

Query: 90  LGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G +G V++ K  +   +VA+K++ +D   +G  S  L E+ ++  ++HKN+VRL   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 148 CSDGSQRLLVYEYMKNRSLDLLIY-----GESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
                +  LV+EY      DL  Y     G+ D  +  S  FQ++    +GL + H  SH
Sbjct: 68  LHSDKKLTLVFEYCDQ---DLKKYFDSCNGDIDPEIVKSFMFQLL----KGLAFCH--SH 118

Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
             ++HRD+K  N+L+++  + K+ DFGLAR F       S     TL Y  P+     +L
Sbjct: 119 -NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKL 176

Query: 263 -SEKADIYSFGVLVLEIISCRK----NTD-----------LTLPSEMQY-----LPEY-A 300
            S   D++S G +  E+ +  +      D           L  P+E  +     LP+Y  
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236

Query: 301 WKLYERGRILELVDPRMRKEGIVERDALQ 329
           + +Y     L  V P++   G   RD LQ
Sbjct: 237 YPMYPATTSLVNVVPKLNSTG---RDLLQ 262

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 81.4 bits (202), Expect = 2e-17
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 27/205 (13%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKL---------CVDKSQQGESEFLSEVRMITSIQ-H 138
           LG G FG VY  +    G LVA+KK+         C++         L EV+ +  +  H
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN---------LREVKSLRKLNEH 57

Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLH 198
            N+V+L     +  +   V+EYM+  +L  L+     K  + S    II  I +GL ++H
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 199 EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI 258
                   HRD+K  N+L+      KI DFGLAR       Y  T++  T  Y APE  +
Sbjct: 117 ---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY--TDYVSTRWYRAPEILL 171

Query: 259 R-GELSEKADIYSFGVLVLEIISCR 282
           R    S   DI++ G ++ E+ + R
Sbjct: 172 RSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 80.9 bits (199), Expect = 2e-17
 Identities = 69/213 (32%), Positives = 107/213 (50%), Gaps = 26/213 (12%)

Query: 83  NFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLS----EVRMITSIQ 137
           N+  G LLG+G FG VY     D G  +A K++  D      S+ +S    E++++ ++Q
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 138 HKNLVRLLGCCSDGSQRLLV--YEYMKNRSL--DLLIYGESDKFLNWSTRFQIILGIARG 193
           H+ +V+  GC  D +++ L    EYM   S+   L  YG     L  S   +    I  G
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA----LTESVTRKYTRQILEG 118

Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST-----NFAGT 248
           + YLH +    IVHRDIK +N+L D     K+GDFG ++     Q    +     +  GT
Sbjct: 119 MSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL---QTICMSGTGIRSVTGT 172

Query: 249 LGYTAPEYAIRGE-LSEKADIYSFGVLVLEIIS 280
             + +PE  I GE    KAD++S G  V+E+++
Sbjct: 173 PYWMSPE-VISGEGYGRKADVWSLGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 81.1 bits (201), Expect = 3e-17
 Identities = 72/223 (32%), Positives = 99/223 (44%), Gaps = 48/223 (21%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQ---QGESE-FL 127
           DF+ +K           LG G FG V   +    G   A+K L   K++     + E  L
Sbjct: 2   DFEFIK----------TLGTGSFGRVMLVRHKGSGKYYALKIL--SKAKIVKLKQVEHVL 49

Query: 128 SEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGE-------SDKFLNW 180
           +E R++ SI+H  LV L G   D S   LV EY        +  GE       S +F   
Sbjct: 50  NEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY--------VPGGELFSHLRKSGRFPEP 101

Query: 181 STRF---QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED 237
             RF   Q++L     L+YLH      IV+RD+K  N+LLD     KI DFG A+     
Sbjct: 102 VARFYAAQVVLA----LEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154

Query: 238 QAYLSTNFAGTLGYTAPEYAIRGELSEKA-DIYSFGVLVLEII 279
              L     GT  Y APE  I  +   KA D ++ G+L+ E++
Sbjct: 155 TYTLC----GTPEYLAPE-IILSKGYGKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 80.8 bits (199), Expect = 3e-17
 Identities = 67/279 (24%), Positives = 126/279 (45%), Gaps = 27/279 (9%)

Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHK 139
           NF     +GRG F  VYR   L DG  VA+KK+ +      +  ++ + E+ ++  + H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 140 NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLI--YGESDKFLNWSTRFQIILGIARGLQYL 197
           N+++      + ++  +V E      L  +I  + +  + +   T ++  + +   L+++
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYA 257
           H     R++HRDIK +NV +      K+GD GL RFF   +   + +  GT  Y +PE  
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPERI 178

Query: 258 IRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWK--LYERGRILELVDP 315
                + K+DI+S G L+ E+ + +              P Y  K  LY   + +E  D 
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQS-------------PFYGDKMNLYSLCKKIEQCDY 225

Query: 316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAM 354
                     +  Q++N   +C+ P   +RP ++ +  +
Sbjct: 226 PPLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 81.5 bits (201), Expect = 4e-17
 Identities = 47/155 (30%), Positives = 80/155 (51%), Gaps = 9/155 (5%)

Query: 127 LSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIY-GESDKFLNWSTRFQ 185
           L E  ++ ++ H +++R+      G+   +V  +  +   DL  Y  +  + L       
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS---DLYTYLTKRSRPLPIDQALI 161

Query: 186 IILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF 245
           I   I  GL+YLH     RI+HRD+K  N+ +++  Q  IGD G A+F     A+L    
Sbjct: 162 IEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--L 216

Query: 246 AGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           AGT+   APE   R + + KADI+S G+++ E+++
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 80.4 bits (198), Expect = 5e-17
 Identities = 63/200 (31%), Positives = 93/200 (46%), Gaps = 8/200 (4%)

Query: 84  FHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVD--KSQQGESEFLSEVRMITSIQHKN 140
           F    +LG+GGFG V   ++ A G + A KKL     K ++GES  L+E +++  +  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
           +V L           LV   M    L   IY   +              I  GL+ LH++
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121

Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
              RIV+RD+K  N+LLD+    +I D GLA   PE Q        GT+GY APE     
Sbjct: 122 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR--VGTVGYMAPEVVKNE 176

Query: 261 ELSEKADIYSFGVLVLEIIS 280
             +   D ++ G L+ E+I+
Sbjct: 177 RYTFSPDWWALGCLLYEMIA 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 80.1 bits (197), Expect = 6e-17
 Identities = 60/193 (31%), Positives = 103/193 (53%), Gaps = 14/193 (7%)

Query: 90  LGRGGFGPVYRGKLADGT--LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G+G FG V++G + + T  +VA+K + +++++    +   E+ +++      + +  G 
Sbjct: 12  IGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 148 CSDGSQRLLVYEYMKNRS-LDLLIYGESDKFLNWSTRFQIIL-GIARGLQYLHEDSHTRI 205
               ++  ++ EY+   S LDLL  G  D+     T+   IL  I +GL YLH +   + 
Sbjct: 71  YLKDTKLWIIMEYLGGGSALDLLEPGPLDE-----TQIATILREILKGLDYLHSE---KK 122

Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEK 265
           +HRDIKA+NVLL E  + K+ DFG+A    + Q      F GT  + APE   +     K
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIKQSAYDSK 181

Query: 266 ADIYSFGVLVLEI 278
           ADI+S G+  +E+
Sbjct: 182 ADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 79.5 bits (196), Expect = 6e-17
 Identities = 69/273 (25%), Positives = 126/273 (46%), Gaps = 27/273 (9%)

Query: 89  LLGRGGFGPVY--RGKLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLL 145
           ++GRG FG V+  R K AD  LV +K++ V++ ++       +E +++  + H N++   
Sbjct: 7   VVGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65

Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
               +    ++V EY    +L   I    +  L+  T     + I   L ++H      I
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---I 122

Query: 206 VHRDIKASNVLLDE-KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSE 264
           +HRD+K  N+LLD+ K   KIGDFG+++         +    GT  Y +PE       ++
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK--AYTVVGTPCYISPELCEGKPYNQ 180

Query: 265 KADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVE 324
           K+DI++ G ++ E+ S ++        E   LP    K+   G    + D   R    + 
Sbjct: 181 KSDIWALGCVLYELASLKR------AFEAANLPALVLKIM-SGTFAPISD---RYSPDLR 230

Query: 325 RDALQVINVAFICLQPHGNQRPPMSEIVAMLTC 357
           +  L ++N+         ++RP +S+I+A   C
Sbjct: 231 QLILSMLNL-------DPSKRPQLSQIMAQPIC 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 79.7 bits (196), Expect = 6e-17
 Identities = 70/214 (32%), Positives = 109/214 (50%), Gaps = 24/214 (11%)

Query: 83  NFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLS----EVRMITSIQ 137
           N+  G LLG+G FG VY    AD G  +AVK++  D      S+ ++    E++++ ++ 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 138 HKNLVRLLGCCSDGSQRLL--VYEYMKNRSL--DLLIYGESDKFLNWSTRFQIILGIARG 193
           H+ +V+  GC  D  +R L    E+M   S+   L  YG   + +      QI+     G
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EG 118

Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS----TNFAGTL 249
           + YLH +    IVHRDIK +N+L D     K+GDFG ++        LS     +  GT 
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL--QTICLSGTGMKSVTGTP 173

Query: 250 GYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
            + +PE  I GE    KADI+S G  V+E+++ +
Sbjct: 174 YWMSPE-VISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 78.8 bits (194), Expect = 1e-16
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 19/205 (9%)

Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEF-LSEVRMITSIQHKN 140
            +     +G G FG +Y  K  +D     +K++ + K    E E    EV ++  ++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 141 LVRLLGCCSDGSQRLLVYEY------MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           +V       +  +  +V EY      MK  +    +    D+ L+W       + I+ GL
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGL 114

Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQ-SKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           +++H+    +I+HRDIK+ N+ L +    +K+GDFG+AR    D   L+    GT  Y +
Sbjct: 115 KHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLS 170

Query: 254 PEYAIRGELSEKADIYSFGVLVLEI 278
           PE       + K DI+S G ++ E+
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 79.5 bits (196), Expect = 1e-16
 Identities = 63/203 (31%), Positives = 107/203 (52%), Gaps = 21/203 (10%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G +G VY+ +       +A+KK+ +++  +G  S  + E+ ++  +QH N+VRL   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII----LGIARGLQYLHEDSHT 203
                +  LV+EY     LDL +    D   +++   ++I      I RG+ Y H  SH 
Sbjct: 70  VHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH--SH- 121

Query: 204 RIVHRDIKASNVLLDEKFQS-KIGDFGLARFF--PEDQAYLSTNFAGTLGYTAPEYAIRG 260
           R++HRD+K  N+L+D +  + K+ DFGLAR F  P  + +  T+   TL Y APE  +  
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-RTF--THEVVTLWYRAPEILLGS 178

Query: 261 -ELSEKADIYSFGVLVLEIISCR 282
              S   DI+S G +  E+++ +
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 77.8 bits (191), Expect = 4e-16
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 26/213 (12%)

Query: 90  LGRGGFGPVYRGKLADGT------LVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNLV 142
           LG   FG VY+G L           VA+K L  DK++     EF  E  M + +QH N+V
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 143 RLLGCCSDGSQRLLVYEYMKNRSL-DLLIY-------GESD------KFLNWSTRFQIIL 188
            LLG  +      +++ Y  +  L + L+        G +D        L  +    I+ 
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 189 GIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR-FFPEDQAYLSTNFAG 247
            IA G+++L   SH  +VH+D+   NVL+ +K   KI D GL R  +  D   L  N   
Sbjct: 132 QIAAGMEFL--SSH-HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188

Query: 248 TLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + + +PE  + G+ S  +DI+S+GV++ E+ S
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 24/209 (11%)

Query: 84  FHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMIT------SI 136
           + P   +G G +G VY+ +    G  VA+K + V  ++ G    LS VR +       + 
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLP--LSTVREVALLKRLEAF 59

Query: 137 QHKNLVRLLGCCSDG-----SQRLLVYEYMKNRSLDLLIYGES--DKFLNWSTRFQIILG 189
            H N+VRL+  C+       ++  LV+E++     DL  Y +      L   T   ++  
Sbjct: 60  DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ---DLRTYLDKVPPPGLPAETIKDLMRQ 116

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
             RGL +LH +    IVHRD+K  N+L+    Q K+ DFGLAR +    A   T    TL
Sbjct: 117 FLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL--TPVVVTL 171

Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEI 278
            Y APE  ++   +   D++S G +  E+
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 77.4 bits (190), Expect = 6e-16
 Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 12/195 (6%)

Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG VY+ K  +   +A  K+   KS++   +++ E+ ++ +  H  +V+LLG   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
              +  ++ E+    ++D ++  E D+ L       I   +   LQYLH     +I+HRD
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIML-ELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRD 135

Query: 210 IKASNVLLDEKFQSKIGDFGL-ARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSE---- 264
           +KA NVLL      K+ DFG+ A+     Q   S  F GT  + APE  +   + +    
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMCETMKDTPYD 193

Query: 265 -KADIYSFGVLVLEI 278
            KADI+S G+ ++E+
Sbjct: 194 YKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 76.9 bits (190), Expect = 7e-16
 Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 31/221 (14%)

Query: 77  LKKATKNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITS 135
           L   T  F    ++G G +G VY+ +    G LVA+K + + + +  E E   E  ++  
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE--EEEIKEEYNILRK 58

Query: 136 I-QHKNLVRLLGC------CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ--- 185
              H N+    G         +  Q  LV E     S+  L+            R +   
Sbjct: 59  YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV----KGLRKKGKRLKEEW 114

Query: 186 ---IILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS 242
              I+    RGL YLHE+   +++HRDIK  N+LL +  + K+ DFG++          +
Sbjct: 115 IAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN 171

Query: 243 TNFAGTLGYTAPEYAIRGELS------EKADIYSFGVLVLE 277
           T F GT  + APE  I  +         ++D++S G+  +E
Sbjct: 172 T-FIGTPYWMAPE-VIACDEQPDASYDARSDVWSLGITAIE 210

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 76.8 bits (189), Expect = 7e-16
 Identities = 66/202 (32%), Positives = 96/202 (47%), Gaps = 17/202 (8%)

Query: 90  LGRGGFGPVYRGKL-ADGTLVAVKKLCVD--KSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           LG+GGFG V   ++ A G L A KKL     K ++G    + E R++  +  + +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYG---ESDKFLNWSTRF---QIILGIARGLQYLHED 200
                +   LV   M    L   IY    E+  F      F   QII G    L++LH+ 
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG----LEHLHQR 116

Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
              RI++RD+K  NVLLD     +I D GLA    + Q+  +  +AGT G+ APE     
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGE 172

Query: 261 ELSEKADIYSFGVLVLEIISCR 282
           E     D ++ GV + E+I+ R
Sbjct: 173 EYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 59/194 (30%), Positives = 91/194 (46%), Gaps = 8/194 (4%)

Query: 89  LLGRGGFGPVYRGKL-ADGTLVAVKKLCVD--KSQQGESEFLSEVRMITSIQHKNLVRLL 145
           +LG+GGFG V   ++ A G + A KKL     K ++GE+  L+E R++  +  + +V L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66

Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
                     LV   M    L   IY   +   +          +  GL+ L  +   RI
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RI 123

Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEK 265
           V+RD+K  N+LLD++   +I D GLA   PE +        GT+GY APE     + +  
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR--VGTVGYMAPEVINNEKYTFS 181

Query: 266 ADIYSFGVLVLEII 279
            D +  G L+ E+I
Sbjct: 182 PDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 76.4 bits (189), Expect = 2e-15
 Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 34/211 (16%)

Query: 88  NLLGRGGFGPVYRGK-LADGTLVAVKKLC-VDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
             +G G +G V        G  VA+KK+  V          L E++++  ++H+N++ LL
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65

Query: 146 GCCSDGSQR-----LLVYEYMKNRSLDL--LIYGESDKFLNWSTRFQ-IILGIARGLQYL 197
                 S        +V E M     DL  +I   S + L      Q  +  I RGL+YL
Sbjct: 66  DILRPPSPEDFNDVYIVTELM---ETDLHKVIK--SPQPLT-DDHIQYFLYQILRGLKYL 119

Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPE 255
           H  +   ++HRD+K SN+L++     KI DFGLAR    D+      T +  T  Y APE
Sbjct: 120 HSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE 176

Query: 256 -------YAIRGELSEKADIYSFGVLVLEII 279
                  Y      ++  DI+S G +  E++
Sbjct: 177 LLLSSSRY------TKAIDIWSVGCIFAELL 201

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 25/212 (11%)

Query: 88  NLLGRGGFGPVYRGKLADGTL---VAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVR 143
           +++G G FG V + ++    L    A+K++    S+    +F  E+ ++  +  H N++ 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 144 LLGCCSDGSQRLLVYEYM----------KNRSLD----LLIYGESDKFLNWSTRFQIILG 189
           LLG C       L  EY           K+R L+      I   +   L+          
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-T 248
           +ARG+ YL   S  + +HRD+ A N+L+ E + +KI DFGL+R     + Y+        
Sbjct: 133 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 186

Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           + + A E       +  +D++S+GVL+ EI+S
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 25/212 (11%)

Query: 88  NLLGRGGFGPVYRGKLADGTL---VAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVR 143
           +++G G FG V + ++    L    A+K++    S+    +F  E+ ++  +  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 144 LLGCCSDGSQRLLVYEYM----------KNRSL--DLLIYGESDKFLNWSTR--FQIILG 189
           LLG C       L  EY           K+R L  D      +      S++        
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-T 248
           +ARG+ YL +    + +HRD+ A N+L+ E + +KI DFGL+R     + Y+        
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174

Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           + + A E       +  +D++S+GVL+ EI+S
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 53/181 (29%), Positives = 96/181 (53%), Gaps = 22/181 (12%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGES-EFLSEVRMITSIQHKNLVRLLGC 147
           +G+G FG V++ +      +VA+KK+ ++  ++G     L E++++  ++H+N+V L+  
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 148 CS--------DGSQRLLVYEYMKNRSLDL--LIYGESDKFLNWSTRFQIILGIARGLQYL 197
           C               LV+E+ ++   DL  L+  ++ KF   S   +++  +  GL Y+
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFCEH---DLAGLLSNKNVKF-TLSEIKKVMKMLLNGLYYI 135

Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP---EDQAYLSTNFAGTLGYTAP 254
           H +   +I+HRD+KA+N+L+ +    K+ DFGLAR F      +    TN   TL Y  P
Sbjct: 136 HRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192

Query: 255 E 255
           E
Sbjct: 193 E 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 25/212 (11%)

Query: 88  NLLGRGGFGPVYRGKLA-DGTLV--AVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVR 143
           +++G G FG V R  +  DG  +  A+K L    S+    +F  E+ ++  +  H N++ 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 144 LLGCCSDGSQRLLVYEYM----------KNRSL--DLLIYGESDKFLNWSTR--FQIILG 189
           LLG C +     +  EY           K+R L  D     E       +++   Q    
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-T 248
           +A G+QYL   S  + +HRD+ A NVL+ E   SKI DFGL+R    ++ Y+        
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181

Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           + + A E       + K+D++SFGVL+ EI+S
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 64/204 (31%), Positives = 92/204 (45%), Gaps = 25/204 (12%)

Query: 90  LGRGGFGPV----YRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRM---ITSIQHKNLV 142
           LGRG FG V    Y+       + A+KK  +    + ES  + E R+     S +H  LV
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVES-LMCEKRIFETANSERHPFLV 65

Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QIILGIARGLQYLHE 199
            L  C         V EY      DL+++  +D F      F    ++LG    LQYLHE
Sbjct: 66  NLFACFQTEDHVCFVMEYAAGG--DLMMHIHTDVFSEPRAVFYAACVVLG----LQYLHE 119

Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST--NFAGTLGYTAPEYA 257
           +   +IV+RD+K  N+LLD +   KI DFGL +   E   +      F GT  + APE  
Sbjct: 120 N---KIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEFLAPEVL 173

Query: 258 IRGELSEKADIYSFGVLVLEIISC 281
                +   D +  GVL+ E++  
Sbjct: 174 TETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 54/196 (27%), Positives = 85/196 (43%), Gaps = 16/196 (8%)

Query: 90  LGRGGFGPVYRGKLA-DGTLVAVKKL----CVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG GGFG V   K+       A+K +     V+  QQ      SE  ++    H  +V+L
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ--EHIFSEKEILEECNHPFIVKL 58

Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTR 204
                D     ++ EY     L  ++  +   F  ++ RF  I  +    +YLH      
Sbjct: 59  YRTFKDKKYIYMLMEYCLGGELWTILR-DRGLFDEYTARF-YIACVVLAFEYLHNRG--- 113

Query: 205 IVHRDIKASNVLLDEKFQSKIGDFGLAR-FFPEDQAYLSTNFAGTLGYTAPEYAIRGELS 263
           I++RD+K  N+LLD     K+ DFG A+      + +    F GT  Y APE  +     
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW---TFCGTPEYVAPEIILNKGYD 170

Query: 264 EKADIYSFGVLVLEII 279
              D +S G+L+ E++
Sbjct: 171 FSVDYWSLGILLYELL 186

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 74.7 bits (183), Expect = 4e-15
 Identities = 67/275 (24%), Positives = 126/275 (45%), Gaps = 29/275 (10%)

Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHK 139
           NF     +GRG F  VYR   L D   VA+KK+ + +    +   + + E+ ++  + H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 140 NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLI--YGESDKFLNWSTRFQIILGIARGLQYL 197
           N+++ L    + ++  +V E      L  +I  + +  + +   T ++  + +   ++++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYA 257
           H     R++HRDIK +NV +      K+GD GL RFF   +   + +  GT  Y +PE  
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPERI 178

Query: 258 IRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWK--LYERGRILELVD- 314
                + K+DI+S G L+ E+ + +              P Y  K  L+   + +E  D 
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQS-------------PFYGDKMNLFSLCQKIEQCDY 225

Query: 315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMS 349
           P +  E   E+    +  +  +C+ P  +QRP + 
Sbjct: 226 PPLPTEHYSEK----LRELVSMCIYPDPDQRPDIG 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 75.2 bits (185), Expect = 5e-15
 Identities = 60/198 (30%), Positives = 95/198 (47%), Gaps = 18/198 (9%)

Query: 87  GNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
            N +G G  G VY+      G L A+K +  +       +   E+ ++  + H N+V+  
Sbjct: 79  VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCH 138

Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
                  +  ++ E+M   SL+       ++FL    R QI+ GIA    YLH      I
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIA-DEQFLADVAR-QILSGIA----YLHR---RHI 189

Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEK 265
           VHRDIK SN+L++     KI DFG++R   +     +++  GT+ Y +PE  I  +L+  
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS-VGTIAYMSPE-RINTDLNHG 247

Query: 266 A------DIYSFGVLVLE 277
           A      DI+S GV +LE
Sbjct: 248 AYDGYAGDIWSLGVSILE 265

Length = 353

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 73.9 bits (182), Expect = 8e-15
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 27/203 (13%)

Query: 90  LGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESE--------FLSEVRMITSIQHKN 140
           +G G +G V++ +  + G +VA+KK         ESE         L E+RM+  ++H N
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFV-------ESEDDPVIKKIALREIRMLKQLKHPN 61

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
           LV L+       +  LV+EY  +  L+ L   ++ + +      +II    + + + H  
Sbjct: 62  LVNLIEVFRRKRKLHLVFEYCDHTVLNEL--EKNPRGVPEHLIKKIIWQTLQAVNFCH-- 117

Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPEYAIR 259
            H  I HRD+K  N+L+ ++ Q K+ DFG AR        Y  T++  T  Y APE  + 
Sbjct: 118 KHNCI-HRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAPELLV- 173

Query: 260 GELSEKA--DIYSFGVLVLEIIS 280
           G+       D+++ G +  E+++
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 74.4 bits (183), Expect = 9e-15
 Identities = 63/199 (31%), Positives = 93/199 (46%), Gaps = 18/199 (9%)

Query: 89  LLGRGGFGPVYRGKLADGT----LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           +LG+G FG V   +L        + A+KK  V +    E   +    +  + +H  L  L
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QIILGIARGLQYLHEDS 201
                       V EY+    L   I   S +F     RF   +II G    LQ+LH+  
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDLMFHIQ-SSGRFDEARARFYAAEIICG----LQFLHKKG 116

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
              I++RD+K  NVLLD+    KI DFG+ +     +   ST F GT  Y APE  ++G+
Sbjct: 117 ---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPE-ILKGQ 171

Query: 262 L-SEKADIYSFGVLVLEII 279
             +E  D +SFGVL+ E++
Sbjct: 172 KYNESVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 74.0 bits (181), Expect = 9e-15
 Identities = 52/191 (27%), Positives = 99/191 (51%), Gaps = 9/191 (4%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G+G  G V+    +A G  VA+K++ + K  + E   ++E+ ++  +++ N+V  L   
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL-IINEILVMKELKNPNIVNFLDSF 85

Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
             G +  +V EY+   SL  ++   ++  ++ +    +     + L++LH +   +++HR
Sbjct: 86  LVGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLHAN---QVIHR 139

Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           DIK+ NVLL      K+ DFG       +Q+  ST   GT  + APE   R     K DI
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDI 198

Query: 269 YSFGVLVLEII 279
           +S G++ +E++
Sbjct: 199 WSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 54/192 (28%), Positives = 97/192 (50%), Gaps = 12/192 (6%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G  G V + K +  GT++A K + +        + L E++++   +   +V   G  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKF--LNWSTRFQIILGIARGLQYLHEDSHTRIV 206
            + +   +  E+M   SLD        K   +      +I + +  GL YL+ + H RI+
Sbjct: 73  LNENNICMCMEFMDCGSLD----RIYKKGGPIPVEILGKIAVAVVEGLTYLY-NVH-RIM 126

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKA 266
           HRDIK SN+L++ + Q K+ DFG++    E    ++  F GT  Y +PE    G+ + K+
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVS---GELINSIADTFVGTSTYMSPERIQGGKYTVKS 183

Query: 267 DIYSFGVLVLEI 278
           D++S G+ ++E+
Sbjct: 184 DVWSLGISIIEL 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 73.0 bits (179), Expect = 2e-14
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 21/205 (10%)

Query: 90  LGRGGFGPVYRGKLADG---TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           +G G FG V  G++  G     V VK+L V  S Q + +FL E +   S+QH NL++ LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFL-----NWSTRFQIILGIARGLQYLHEDS 201
            C++ +  LLV E+      DL  Y  S +       + +T  ++   IA GL +LH+++
Sbjct: 63  QCTEVTPYLLVMEFCPLG--DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARF-FPEDQAYLSTNFAGTLGYTAPEYA--I 258
               +H D+   N LL      KIGD+GL+   + ED           L + APE    +
Sbjct: 121 F---IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177

Query: 259 RGEL-----SEKADIYSFGVLVLEI 278
            G L     +++++++S GV + E+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 23/215 (10%)

Query: 84  FHPGNLLGRGGFGPVYRG--KLADGTL--VAVKKLCVDKSQQGE-SEFLSEVRMITSIQH 138
           F  G +LG+G FG V     K  DG+   VAVK L  D     +  EFL E   +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 139 KNLVRLLGCC--SDGSQRL----LVYEYMKNRSLDLLIY----GESDKFLNWSTRFQIIL 188
            N+++L+G    S    RL    ++  +MK+  L   +     GE    L   T  + ++
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 189 GIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR-FFPEDQAYLSTNFAG 247
            IA G++YL   S    +HRD+ A N +L+E     + DFGL++  +  D  Y     A 
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD--YYRQGCAS 175

Query: 248 TL--GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            L   + A E       +  +D+++FGV + EI++
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 55/196 (28%), Positives = 98/196 (50%), Gaps = 12/196 (6%)

Query: 90  LGRGGFGPVY----RGKLADGTLVAVKKLCVDKSQQGES-EFLSEVRMITSIQHKNLVRL 144
           LG+G FG VY    +  +A+  L  +K++ V +    E+ +   E ++++ + H  +V+ 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLI--YGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
                +     ++ EY + R LD  +     + K L+ +   +  + +  G+ Y+H+   
Sbjct: 68  HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ--- 124

Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
            RI+HRD+KA N+ L      KIGDFG++R        L+T F GT  Y +PE       
Sbjct: 125 RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPEALKHQGY 182

Query: 263 SEKADIYSFGVLVLEI 278
             K+DI+S G ++ E+
Sbjct: 183 DSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 6/155 (3%)

Query: 128 SEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII 187
           +E  ++ +I H ++++L G  +      L+    K    DL  Y  + + +       I 
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT---DLYCYLAAKRNIAICDILAIE 188

Query: 188 LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG 247
             + R +QYLHE+   RI+HRDIKA N+ ++      +GDFG A F  +  A     +AG
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAG 245

Query: 248 TLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCR 282
           T+   APE   R       DI+S G+++ E+ +C 
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 67/208 (32%), Positives = 102/208 (49%), Gaps = 35/208 (16%)

Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKS----QQGESEFLSEVRMITSIQHKNLVR 143
           ++GRGGFG VY  + AD G + A+K  C+DK     +QGE+  L+E R++ S+       
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK--CLDKKRIKMKQGETLALNE-RIMLSLVSTGDCP 57

Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYG-------ESDKFLNWSTRF---QIILGIARG 193
            + C S          ++    LDL+  G       +   F     RF   +IILG+   
Sbjct: 58  FIVCMSYAFHTPDKLSFI----LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGL--- 110

Query: 194 LQYLHEDSHTR-IVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
                E  H R +V+RD+K +N+LLDE    +I D GLA  F + + + S    GT GY 
Sbjct: 111 -----EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162

Query: 253 APEYAIRG-ELSEKADIYSFGVLVLEII 279
           APE   +G      AD +S G ++ +++
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 58/196 (29%), Positives = 87/196 (44%), Gaps = 8/196 (4%)

Query: 90  LGRGGFGPVYRGKLAD-GTLVAVKKLCVD--KSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           LG+GGFG V   ++ + G + A KKL     K + GE   L E  ++  +    +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
                +   LV   M    L   IY   ++ L           I  G+ +LH      IV
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIV 117

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKA 266
           +RD+K  NVLLD++   ++ D GLA    + +    T  AGT GY APE       S   
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSYPV 175

Query: 267 DIYSFGVLVLEIISCR 282
           D ++ G  + E+++ R
Sbjct: 176 DWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 8/199 (4%)

Query: 84  FHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVD--KSQQGESEFLSEVRMITSIQHKN 140
           F    +LG+GGFG V   ++ A G + A K+L     K ++GES  L+E +++  +  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
           +V L           LV   M    L   IY   +              I  GL+ LH +
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
           +    V+RD+K  N+LLD+    +I D GLA   PE +        GT+GY APE     
Sbjct: 122 N---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SIRGRVGTVGYMAPEVLNNQ 176

Query: 261 ELSEKADIYSFGVLVLEII 279
             +   D +  G L+ E+I
Sbjct: 177 RYTLSPDYWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 53/197 (26%), Positives = 101/197 (51%), Gaps = 16/197 (8%)

Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG VY+ +  +  ++A  K+   KS++   +++ E+ ++ S  H N+V+LL    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
             +   ++ E+    ++D ++  E ++ L       +       L YLHE+   +I+HRD
Sbjct: 73  YENNLWILIEFCAGGAVDAVML-ELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRD 128

Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPEYAIRGELSE--- 264
           +KA N+L       K+ DFG++    ++   +    +F GT  + APE  +  E S+   
Sbjct: 129 LKAGNILFTLDGDIKLADFGVS---AKNTRTIQRRDSFIGTPYWMAPE-VVMCETSKDRP 184

Query: 265 ---KADIYSFGVLVLEI 278
              KAD++S G+ ++E+
Sbjct: 185 YDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 29/213 (13%)

Query: 91  GRGGFGPVYRGKL---ADGTLVAVKKLCVDKSQQ-GESEFLSEVRMIT---SIQHKNLVR 143
           GRG +G VY+ K     DG   A+KK   DK Q  G S   S  R I     ++H+N+V 
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGIS--QSACREIALLRELKHENVVS 66

Query: 144 LLGCCSDGSQRL--LVYEYMKNRSLDLLIYGESDK--FLNWSTRFQIILGIARGLQYLHE 199
           L+    + + +   L+++Y ++    ++ +    K   +  S    ++  I  G+ YLH 
Sbjct: 67  LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126

Query: 200 DSHTRIVHRDIKASNVLL----DEKFQSKIGDFGLARFFPEDQAYLSTNFAG-----TLG 250
           +    ++HRD+K +N+L+     E+   KIGD GLAR F    A L           T+ 
Sbjct: 127 N---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF---NAPLKPLADLDPVVVTIW 180

Query: 251 YTAPEYAIRGELSEKA-DIYSFGVLVLEIISCR 282
           Y APE  +      KA DI++ G +  E+++  
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 12/197 (6%)

Query: 90  LGRGGFGPVYRG--KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           LG G +  V++G  KL +  LVA+K++ ++  +      + EV ++  ++H N+V L   
Sbjct: 14  LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIIL-GIARGLQYLHEDSHTRIV 206
                   LV+EY+     DL  Y +    +      +I L  I RGL Y H     +++
Sbjct: 73  VHTDKSLTLVFEYLDK---DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVL 126

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI-RGELSEK 265
           HRD+K  N+L++E+ + K+ DFGLAR         S N   TL Y  P+  +   E S +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS-NEVVTLWYRPPDVLLGSSEYSTQ 185

Query: 266 ADIYSFGVLVLEIISCR 282
            D++  G +  E+ S R
Sbjct: 186 IDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 19/225 (8%)

Query: 67  RTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESE 125
           R++   D   L+     F    ++G G +G VY+G+ +  G L A+K   +D ++  E E
Sbjct: 1   RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIK--VMDVTEDEEEE 58

Query: 126 FLSEVRMITSI-QHKNLVRLLGCCSDGS------QRLLVYEYMKNRSLDLLIYGESDKFL 178
              E+ M+     H+N+    G     S      Q  LV E+    S+  L+       L
Sbjct: 59  IKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNAL 118

Query: 179 NWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ 238
                  I   I RGL +LH  +H +++HRDIK  NVLL E  + K+ DFG++       
Sbjct: 119 KEDWIAYICREILRGLAHLH--AH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 175

Query: 239 AYLSTNFAGTLGYTAPEYAIRGELSE-----KADIYSFGVLVLEI 278
              +T F GT  + APE     E  +     ++DI+S G+  +E+
Sbjct: 176 GRRNT-FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 72.2 bits (177), Expect = 4e-14
 Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 21/197 (10%)

Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQHKNLVRLLGC 147
           +G+G  G VY    +A G  VA+K++  +  QQ + E + +E+ ++   +H N+V  L  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQM--NLQQQPKKELIINEILVMRENKHPNIVNYLDS 84

Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR----GLQYLHEDSHT 203
              G +  +V EY+   SL       +D           I  + R     L++LH +   
Sbjct: 85  YLVGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLHSN--- 134

Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGL-ARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
           +++HRDIK+ N+LL      K+ DFG  A+  PE Q+  ST   GT  + APE   R   
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRST-MVGTPYWMAPEVVTRKAY 192

Query: 263 SEKADIYSFGVLVLEII 279
             K DI+S G++ +E++
Sbjct: 193 GPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 71.8 bits (176), Expect = 4e-14
 Identities = 60/194 (30%), Positives = 90/194 (46%), Gaps = 8/194 (4%)

Query: 89  LLGRGGFGPVYRGKL-ADGTLVAVKKLCVD--KSQQGESEFLSEVRMITSIQHKNLVRLL 145
           +LG+GGFG V   ++ A G + A KKL     K ++GE+  L+E +++  +  + +V L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66

Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
                     LV   M    L   IY   +   +          I  GL+ LH +   RI
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RI 123

Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEK 265
           V+RD+K  N+LLD+    +I D GLA   PE +        GT+GY APE       +  
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--TIRGRVGTVGYMAPEVVKNERYTFS 181

Query: 266 ADIYSFGVLVLEII 279
            D +  G L+ E+I
Sbjct: 182 PDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 49/175 (28%), Positives = 89/175 (50%), Gaps = 10/175 (5%)

Query: 106 GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRS 165
           G  VAVKK+ + K Q+ E  F +EV ++   QH N+V +      G +  +V E+++  +
Sbjct: 44  GRQVAVKKMDLRKQQRRELLF-NEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102

Query: 166 L-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSK 224
           L D++ +      +N      + L + + L +LH      ++HRDIK+ ++LL    + K
Sbjct: 103 LTDIVTHTR----MNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVK 155

Query: 225 IGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
           + DFG      ++      +  GT  + APE   R     + DI+S G++V+E++
Sbjct: 156 LSDFGFCAQVSKEVPR-RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 19/200 (9%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSE--VRMITSIQHKNLVRLLG 146
           LGRG +G V + + +  GT++AVK++    + Q +   L +  + M +       V   G
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSV-DCPYTVTFYG 67

Query: 147 CCSDGSQRLLVYEYMKNRSLDLL---IYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
                    +  E M   SLD     +Y +    +      +I + I + L+YLH     
Sbjct: 68  ALFREGDVWICMEVMDT-SLDKFYKKVY-DKGLTIPEDILGKIAVSIVKALEYLHSKLS- 124

Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELS 263
            ++HRD+K SNVL++   Q K+ DFG++ +  +  A   T  AG   Y APE  I  EL+
Sbjct: 125 -VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA--KTIDAGCKPYMAPE-RINPELN 180

Query: 264 E-----KADIYSFGVLVLEI 278
           +     K+D++S G+ ++E+
Sbjct: 181 QKGYDVKSDVWSLGITMIEL 200

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 72.5 bits (178), Expect = 4e-14
 Identities = 58/231 (25%), Positives = 101/231 (43%), Gaps = 35/231 (15%)

Query: 79  KATKNFHP-GNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEF---------- 126
             ++ +   G  LG G +G V +      G +VA+KK+ + +     ++           
Sbjct: 5   SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH 64

Query: 127 ---LSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR 183
              L E++++  I+H+N++ L+    +G    LV + M +   DL    +    L  S  
Sbjct: 65  FTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS---DLKKVVDRKIRLTESQV 121

Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF--------P 235
             I+L I  GL  LH+      +HRD+  +N+ ++ K   KI DFGLAR +         
Sbjct: 122 KCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178

Query: 236 EDQAYLS-----TNFAGTLGYTAPEYAIRGELSEKA-DIYSFGVLVLEIIS 280
                +      T+   TL Y APE  +  E    A D++S G +  E+++
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229

Length = 335

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 71.2 bits (174), Expect = 4e-14
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 7/196 (3%)

Query: 89  LLGRGGFGP--VYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           ++G G FG   + +   +D    A+K++ + KS     +   E  ++  ++H N+V    
Sbjct: 7   VVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
                    +V EY     L   I  +  K     T  Q  + +  G+Q++HE    R++
Sbjct: 66  SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVL 122

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKA 266
           HRDIK+ N+ L +  + K+GDFG AR      AY  T + GT  Y  PE       + K+
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT-YVGTPYYVPPEIWENMPYNNKS 181

Query: 267 DIYSFGVLVLEIISCR 282
           DI+S G ++ E+ + +
Sbjct: 182 DIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 71.4 bits (175), Expect = 5e-14
 Identities = 57/224 (25%), Positives = 89/224 (39%), Gaps = 25/224 (11%)

Query: 92  RGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQH-----KNLVRLL 145
           +G FG VY   K + G   A+K L   KS       ++ V+   +I         + +L 
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVL--KKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
                     LV EY+       LI        +W+   Q I  +  G++ LH+     I
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAEVVLGVEDLHQRG---I 118

Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEK 265
           +HRDIK  N+L+D+    K+ DFGL+R         +  F GT  Y APE  +     + 
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAPETILGVGDDKM 173

Query: 266 ADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRI 309
           +D +S G ++ E +          P      P+  +      RI
Sbjct: 174 SDWWSLGCVIFEFL-------FGYPPFHAETPDAVFDNILSRRI 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 71.6 bits (175), Expect = 5e-14
 Identities = 64/205 (31%), Positives = 101/205 (49%), Gaps = 29/205 (14%)

Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKS----QQGESEFLSEVRMITSIQHKNLVR 143
           ++GRGGFG VY  + AD G + A+K  C+DK     +QGE+  L+E R++ S+       
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK--CLDKKRIKMKQGETLALNE-RIMLSLVSTGDCP 57

Query: 144 LLGCCSDG----SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QIILGIARGLQY 196
            + C +       +   + + M    L   +  +   F     RF   +IILG+      
Sbjct: 58  FIVCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFSEKEMRFYATEIILGL------ 110

Query: 197 LHEDSHTR-IVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE 255
             E  H R +V+RD+K +N+LLDE    +I D GLA  F + + + S    GT GY APE
Sbjct: 111 --EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPE 165

Query: 256 YAIRG-ELSEKADIYSFGVLVLEII 279
              +G      AD +S G ++ +++
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 72.0 bits (177), Expect = 6e-14
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 26/220 (11%)

Query: 72  FDFQTLKKATKNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLC-VDKSQQGESEFLSE 129
           FD  +  K  +N      +G G +G V        G  VA+KK+             L E
Sbjct: 1   FDVGSRYKPIEN------IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRE 54

Query: 130 VRMITSIQHKNLVRLLGCC----SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF- 184
           ++++   +H N++ +        +D     +V + M++  L  +I+ +          F 
Sbjct: 55  LKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFL 113

Query: 185 -QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF---FPEDQAY 240
            Q++    RGL+Y+H      ++HRD+K SN+L++E  + +IGDFG+AR     P +  Y
Sbjct: 114 YQLL----RGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY 166

Query: 241 LSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEII 279
             T +  T  Y APE  +   E +   D++S G +  E++
Sbjct: 167 FMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 71.2 bits (174), Expect = 8e-14
 Identities = 57/196 (29%), Positives = 98/196 (50%), Gaps = 10/196 (5%)

Query: 90  LGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +  V++G+      LVA+K++ ++  +      + EV ++ +++H N+V L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIIL-GIARGLQYLHEDSHTRIVH 207
                  LV+EY+ +   DL  Y ++   L      +I +  + RGL Y H     +I+H
Sbjct: 73  HTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILH 126

Query: 208 RDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI-RGELSEKA 266
           RD+K  N+L++EK + K+ DFGLAR         S N   TL Y  P+  +   E S   
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS-NEVVTLWYRPPDVLLGSTEYSTPI 185

Query: 267 DIYSFGVLVLEIISCR 282
           D++  G ++ E+ + R
Sbjct: 186 DMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 16/199 (8%)

Query: 90  LGRGGFGPVYRG--KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           LG G +  VY+G  KL D  LVA+K++ ++  +      + EV ++  ++H N+V L   
Sbjct: 14  LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 148 CSDGSQRLLVYEYMKNRSLDLLIY-GESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
                   LV+EY+     DL  Y  +    +N       +  + RGL Y H     +++
Sbjct: 73  IHTEKSLTLVFEYLDK---DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVL 126

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARF--FPEDQAYLSTNFAGTLGYTAPEYAI-RGELS 263
           HRD+K  N+L++E+ + K+ DFGLAR    P  + Y  +N   TL Y  P+  +   + S
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPT-KTY--SNEVVTLWYRPPDILLGSTDYS 183

Query: 264 EKADIYSFGVLVLEIISCR 282
            + D++  G +  E+ + R
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 70.5 bits (172), Expect = 1e-13
 Identities = 53/192 (27%), Positives = 97/192 (50%), Gaps = 11/192 (5%)

Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQHKNLVRLLGC 147
           +G+G  G VY    +A G  VA+K++  +  QQ + E + +E+ ++   ++ N+V  L  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVH 207
              G +  +V EY+   SL  ++   ++  ++      +     + L +LH +   +++H
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFLHSN---QVIH 138

Query: 208 RDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKAD 267
           RDIK+ N+LL      K+ DFG       +Q+  ST   GT  + APE   R     K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVD 197

Query: 268 IYSFGVLVLEII 279
           I+S G++ +E++
Sbjct: 198 IWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 19/203 (9%)

Query: 89  LLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLG 146
           L+G G +G VY+G+ +  G L A+K   +D +   E E   E+ M+     H+N+    G
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIK--VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70

Query: 147 CCSDGS------QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
                +      Q  LV E+    S+  LI       L       I   I RGL +LH+ 
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130

Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
              +++HRDIK  NVLL E  + K+ DFG++          +T F GT  + APE     
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVIACD 186

Query: 261 ELSE-----KADIYSFGVLVLEI 278
           E  +     K+D++S G+  +E+
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 11/192 (5%)

Query: 90  LGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G  G V    + + G LVAVKK+ + K Q+ E  F +EV ++   QH+N+V +    
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 86

Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
             G +  +V E+++  +L  ++   +   +N      + L + + L  LH      ++HR
Sbjct: 87  LVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLKALSVLHAQG---VIHR 140

Query: 209 DIKASNVLLDEKFQSKIGDFGL-ARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKAD 267
           DIK+ ++LL    + K+ DFG  A+   E     S    GT  + APE   R     + D
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYGPEVD 198

Query: 268 IYSFGVLVLEII 279
           I+S G++V+E++
Sbjct: 199 IWSLGIMVIEMV 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 69.8 bits (170), Expect = 2e-13
 Identities = 53/193 (27%), Positives = 98/193 (50%), Gaps = 13/193 (6%)

Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQHKNLVRLLGC 147
           +G+G  G VY    +A G  VA++++  +  QQ + E + +E+ ++   ++ N+V  L  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVH 207
              G +  +V EY+   SL  ++   ++  ++      +     + L++LH +   +++H
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139

Query: 208 RDIKASNVLLDEKFQSKIGDFGL-ARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKA 266
           RDIK+ N+LL      K+ DFG  A+  PE      +   GT  + APE   R     K 
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKV 197

Query: 267 DIYSFGVLVLEII 279
           DI+S G++ +E+I
Sbjct: 198 DIWSLGIMAIEMI 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 69.2 bits (169), Expect = 3e-13
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 33/209 (15%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQHKNLVR---- 143
           +G+G +G V   +   DG    +KKL +  + + E +    E ++++ ++H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 144 ----------LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARG 193
                     ++G C  G     +Y  +K +   LL     ++ + W       + IA  
Sbjct: 68  WEGEDGLLYIVMGFCEGGD----LYHKLKEQKGKLLP---ENQVVEW------FVQIAMA 114

Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           LQYLHE     I+HRD+K  NV L      K+GD G+AR   E+Q  +++   GT  Y +
Sbjct: 115 LQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLIGTPYYMS 170

Query: 254 PEYAIRGELSEKADIYSFGVLVLEIISCR 282
           PE       + K+D+++ G  V E+ + +
Sbjct: 171 PELFSNKPYNYKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 68.8 bits (169), Expect = 3e-13
 Identities = 55/206 (26%), Positives = 89/206 (43%), Gaps = 25/206 (12%)

Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKL-CVDKSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           + +G +G V+   K + G + A+K +   D  ++ + + +   R I S      V  L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 148 CSDGSQRL-LVYEYMKNRSLDLLI--YGESDKFLNWSTRF---QIILGIARGLQYLHEDS 201
              G + L LV EY+    L  L+   G  D+      R    +I+L     L+YLH + 
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDED---VARIYIAEIVLA----LEYLHSNG 113

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARF-------FPEDQAYLSTNFAGTLGYTAP 254
              I+HRD+K  N+L+D     K+ DFGL++           D         GT  Y AP
Sbjct: 114 ---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170

Query: 255 EYAIRGELSEKADIYSFGVLVLEIIS 280
           E  +    S+  D +S G ++ E + 
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 69.1 bits (169), Expect = 4e-13
 Identities = 68/227 (29%), Positives = 106/227 (46%), Gaps = 34/227 (14%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKN-LVRLLG 146
           +G G +G VY+ +    G LVA+KK  ++  ++G     L E+ ++  +     +VRLL 
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 147 C----CSDGSQRL-LVYEYMKNRSLDLLIYGES---------DKFLNWSTRFQIILGIAR 192
                  +G   L LV+EY+     DL  + +S               S  +Q++ G+A 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYL---DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA- 124

Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFP-EDQAYLSTNFAGTLG 250
              + H   H  ++HRD+K  N+L+D +K   KI D GL R F    ++Y  T+   TL 
Sbjct: 125 ---HCH--KHG-VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVTLW 176

Query: 251 YTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYL 296
           Y APE  +     S   DI+S G +  E+   RK       SE+Q L
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMS--RKQPLFPGDSELQQL 221

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 28/210 (13%)

Query: 88  NLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           + +G G +G V        G  VA+KK+   + Q      L E++++   +H+N++ +L 
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILD 70

Query: 147 CCSDGSQRLLVYEYMKNRSL-------DL--LIYGE--SDKFLNWSTRFQIILGIARGLQ 195
                  R   +E   +  +       DL  LI  +  S+  + +   +QI+    RGL+
Sbjct: 71  I-----IRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFL-YQIL----RGLK 120

Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF--PEDQAYLSTNFAGTLGYTA 253
           Y+H      ++HRD+K SN+LL+     KI DFGLAR      D     T +  T  Y A
Sbjct: 121 YIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177

Query: 254 PEYAIRGELSEKA-DIYSFGVLVLEIISCR 282
           PE  +  +   KA DI+S G ++ E++S R
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 68.4 bits (167), Expect = 5e-13
 Identities = 50/195 (25%), Positives = 96/195 (49%), Gaps = 15/195 (7%)

Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G  G VY+   L    ++AVK + +D + + + + +SE+ ++       ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGE-SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVH 207
              ++  +  E+M   SLD  +Y +  +  L      +I + + +GL YL      +I+H
Sbjct: 69  FVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWS---LKILH 118

Query: 208 RDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKAD 267
           RD+K SN+L++ + Q K+ DFG++         ++  + GT  Y APE     +    +D
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGEQYGIHSD 175

Query: 268 IYSFGVLVLEIISCR 282
           ++S G+  +E+   R
Sbjct: 176 VWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 68.1 bits (166), Expect = 8e-13
 Identities = 50/178 (28%), Positives = 93/178 (52%), Gaps = 16/178 (8%)

Query: 106 GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRS 165
           G  VAVKK+ + K Q+ E  F +EV ++    H+N+V +      G +  +V E+++  +
Sbjct: 47  GKQVAVKKMDLRKQQRRELLF-NEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105

Query: 166 LDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKI 225
           L  ++   +   +N      + L + R L YLH      ++HRDIK+ ++LL    + K+
Sbjct: 106 LTDIV---THTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKL 159

Query: 226 GDFG----LARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
            DFG    +++  P+ ++ + T +     + APE   R     + DI+S G++V+E+I
Sbjct: 160 SDFGFCAQVSKEVPKRKSLVGTPY-----WMAPEVISRLPYGTEVDIWSLGIMVIEMI 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 68.3 bits (167), Expect = 8e-13
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 17/211 (8%)

Query: 74  FQTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESE-FLSEVR 131
           F T+ + T  +     +G G FG V   +    G  VA+KK+    S    ++    E++
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61

Query: 132 MITSIQHKNLVRLLGC-CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
           ++  ++H+N++ L     S       V E +      LL     +K       +QI+   
Sbjct: 62  LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQIL--- 118

Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
            RGL+Y+H      +VHRD+K SN+L++E    KI DFGLAR   P+   Y+ST +    
Sbjct: 119 -RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY---- 170

Query: 250 GYTAPEYAIRGE-LSEKADIYSFGVLVLEII 279
            Y APE  +  +    + DI+S G +  E++
Sbjct: 171 -YRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 19/202 (9%)

Query: 89  LLGRGGFGPVYRGKLADGT-------LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
           +LG+GG+G V++ +   G        +  +KK  + ++Q+  +   +E  ++ +++H  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QIILGIARGLQYLH 198
           V L+     G +  L+ EY+    L + +  E   F+  +  F   +I L     L++LH
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGELFMHLEREG-IFMEDTACFYLSEISLA----LEHLH 117

Query: 199 EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI 258
                 I++RD+K  N+LLD +   K+ DFGL +    +     T F GT+ Y APE  +
Sbjct: 118 ---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTIEYMAPEILM 173

Query: 259 RGELSEKADIYSFGVLVLEIIS 280
           R    +  D +S G L+ ++++
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLT 195

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 30/228 (13%)

Query: 70  SYFDFQTLKKATKNFHPGNLLGRGGFGPVYR-GKLADGTLVAVKKLCVDKSQQGESEFLS 128
           S    ++L   T  +     +G+G +G VY+     DG+L AVK L  D     + E  +
Sbjct: 10  SMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL--DPISDVDEEIEA 67

Query: 129 EVRMITSI-QHKNLVRLLGCC--SD---GSQRLLVYEYMKNRSLDLLIYGESDKFLNWST 182
           E  ++ S+  H N+V+  G    +D   G Q  LV E     S+  L+ G     L    
Sbjct: 68  EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG----LLICGQ 123

Query: 183 RFQ------IILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE 236
           R        I+ G   GLQ+LH +   RI+HRD+K +N+LL  +   K+ DFG++     
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180

Query: 237 DQAYLSTNFAGTLGYTAPEYAIRGE------LSEKADIYSFGVLVLEI 278
            +   +T+  GT  + APE  I  E         + D++S G+  +E+
Sbjct: 181 TRLRRNTS-VGTPFWMAPE-VIACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 28/208 (13%)

Query: 88  NLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLS-----EVRMITSIQHKNL 141
           + +G G +G V        G  VA+KKL    S+  +S   +     E+R++  + H+N+
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKL----SRPFQSAIHAKRTYRELRLLKHMDHENV 76

Query: 142 VRLLGC------CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQ 195
           + LL          D     LV   M     DL    +  K  +   +F ++  I RGL+
Sbjct: 77  IGLLDVFTPASSLEDFQDVYLVTHLM---GADLNNIVKCQKLSDDHIQF-LVYQILRGLK 132

Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE 255
           Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y APE
Sbjct: 133 YIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPE 185

Query: 256 YAI-RGELSEKADIYSFGVLVLEIISCR 282
             +     ++  DI+S G ++ E+++ +
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 29/206 (14%)

Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKK--LCVDKSQQGESEFLSEVRMITSIQH-KNLVRL 144
            +GRG FG V +      GT++AVK+    VD+ +Q     L ++ ++        +V+ 
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQ--KRLLMDLDVVMRSSDCPYIVKF 68

Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLL---IYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
            G         +  E M + SLD     +Y      +      +I +   + L YL E+ 
Sbjct: 69  YGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE------ 255
              I+HRD+K SN+LLD     K+ DFG++    +  A   T  AG   Y APE      
Sbjct: 128 K--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPSA 183

Query: 256 ---YAIRGELSEKADIYSFGVLVLEI 278
              Y +R      +D++S G+ + E+
Sbjct: 184 RDGYDVR------SDVWSLGITLYEV 203

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 64/206 (31%), Positives = 88/206 (42%), Gaps = 32/206 (15%)

Query: 89  LLGRGGFGPV----YRGKLADGTLVAVKKLCVD--------KSQQGESEFLSEVRMITSI 136
           +LG+G FG V     +G      L AVK L  D        +    E   L+        
Sbjct: 2   VLGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAG----- 53

Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QIILGIARG 193
           +H  L +L  C     +   V EY+    L   I   S +F     RF   +I+LG    
Sbjct: 54  KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ-RSGRFDEPRARFYAAEIVLG---- 108

Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           LQ+LHE     I++RD+K  NVLLD +   KI DFG+ +         ST F GT  Y A
Sbjct: 109 LQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST-FCGTPDYIA 164

Query: 254 PEYAIRGELSEKADIYSFGVLVLEII 279
           PE           D ++ GVL+ E++
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEML 190

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 14/195 (7%)

Query: 90  LGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +  VY+GK   +G LVA+K + + + +      + E  ++  ++H N+V L    
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72

Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKF---LNWSTRFQIILGIARGLQYLHEDSHTRI 205
                  LV+EY+     DL  Y   DK    L+       +  + RGL Y+H+     I
Sbjct: 73  HTKETLTLVFEYVHT---DLCQY--MDKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYI 124

Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI-RGELSE 264
           +HRD+K  N+L+ +  + K+ DFGLAR      ++  +N   TL Y  P+  +   E S 
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183

Query: 265 KADIYSFGVLVLEII 279
             D++  G + +E+I
Sbjct: 184 CLDMWGVGCIFVEMI 198

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 35/216 (16%)

Query: 90  LGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G  G V+    +D    VAVKK+ +   Q  +   L E+++I  + H N+V++    
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHA-LREIKIIRRLDHDNIVKVYEVL 71

Query: 149 SDGSQRL--------------LVYEYMKNRSLDLLIYGESDKFLNWSTR---FQIILGIA 191
                 L              +V EYM+    DL    E         R   +Q++    
Sbjct: 72  GPSGSDLTEDVGSLTELNSVYIVQEYMET---DLANVLEQGPLSEEHARLFMYQLL---- 124

Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPED---QAYLSTNFAG 247
           RGL+Y+H      ++HRD+K +NV ++ E    KIGDFGLAR        + YLS     
Sbjct: 125 RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV- 180

Query: 248 TLGYTAPEYAIRGELSEKA-DIYSFGVLVLEIISCR 282
           T  Y +P   +      KA D+++ G +  E+++ +
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 68.4 bits (167), Expect = 2e-12
 Identities = 82/315 (26%), Positives = 140/315 (44%), Gaps = 63/315 (20%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPV-YRGKLADGTLVAVKKLCVDKSQQGESEFL---S 128
           D  T K+  K +    +LG G  G V    +++DG   AVK   VD     E++     +
Sbjct: 23  DEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVK--VVDMEGMSEADKNRAQA 80

Query: 129 EVRMITSIQHKNLVRLLGCCSDGSQR-----------LLVYEY---------MKNRSLDL 168
           EV  + +    ++V+   C  D +++            LV +Y         +K+R+   
Sbjct: 81  EVCCLLNCDFFSIVK---CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTN 137

Query: 169 LIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDF 228
             + E +  L +    Q++L +       H      ++HRDIK++N+LL      K+GDF
Sbjct: 138 RTFREHEAGLLF---IQVLLAV-------HHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187

Query: 229 GLARFFPEDQAYLSTN----FAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKN 284
           G ++ +    A +S +    F GT  Y APE   R   S+KAD++S GVL+ E+++ ++ 
Sbjct: 188 GFSKMY---AATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR- 243

Query: 285 TDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQ 344
                P + + + E   K    GR   L  P +  E       +Q I  A +   P   +
Sbjct: 244 -----PFDGENMEEVMHKTLA-GRYDPL-PPSISPE-------MQEIVTALLSSDPK--R 287

Query: 345 RPPMSEIVAMLTCKV 359
           RP  S+++ M  CK+
Sbjct: 288 RPSSSKLLNMPICKL 302

Length = 496

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 15/208 (7%)

Query: 83  NFHPGNLLGRGGFGPVY----RGKLADGTLVAVK---KLCVDKSQQGESEFLSEVRMITS 135
           NF    +LG G +G V+     G    G L A+K   K  + +  +      +E +++ +
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 136 IQHKN-LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           ++    LV L       ++  L+ +Y+    L   +Y + + F     R   I  I   L
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-QREHFTESEVRV-YIAEIVLAL 118

Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            +LH+     I++RDIK  N+LLD +    + DFGL++ F  ++   + +F GT+ Y AP
Sbjct: 119 DHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175

Query: 255 EYAIRGEL--SEKADIYSFGVLVLEIIS 280
           E    G     +  D +S GVL  E+++
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLT 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 16/207 (7%)

Query: 90  LGRGGFGPVYRGKLADGTLVA---VKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           +G G FG V   ++   T VA   VK+L  + S + ++EFL +      +QH N+++ LG
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF--QIILGIARGLQYLHEDSHTR 204
            C +    LLV+EY +   L   +  E     N       ++   IA G+ ++H+ +   
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--- 119

Query: 205 IVHRDIKASNVLLDEKFQSKIGDFGLARF-FPEDQAYLSTNFAGTLGYTAPEYA------ 257
            +H D+   N  L      K+GD+G+    + ED      +    L + APE        
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179

Query: 258 -IRGELSEKADIYSFGVLVLEIISCRK 283
            I  E ++ +++++ GV + E+     
Sbjct: 180 LITAEQTKPSNVWALGVTLWELFENAA 206

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 63/197 (31%), Positives = 93/197 (47%), Gaps = 12/197 (6%)

Query: 89  LLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGE--SEFLSEVRMIT-SIQHKNLVRL 144
           +LG+G FG V   +L   G L AVK L  D   Q +     ++E R+++ +  H  L +L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 145 LGCCSDGSQRLL-VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
             CC     RL  V E++    L   I  +S +F     RF     I   L +LH+    
Sbjct: 62  Y-CCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFDEARARFYAA-EITSALMFLHDKG-- 116

Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELS 263
            I++RD+K  NVLLD +   K+ DFG+ +    +    ST F GT  Y APE        
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEILQEMLYG 174

Query: 264 EKADIYSFGVLVLEIIS 280
              D ++ GVL+ E++ 
Sbjct: 175 PSVDWWAMGVLLYEMLC 191

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 66.4 bits (163), Expect = 4e-12
 Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 33/211 (15%)

Query: 90  LGRGGFGPVYRGKLAD---GTLVAVKKL------CVDKSQQGESE--FLSEVRMITSIQH 138
           LG+G +G V+  K  D     +VA+KK+        D +Q+   E  FL E+       H
Sbjct: 15  LGKGAYGIVW--KAIDRRTKEVVALKKIFDAFRNATD-AQRTFREIMFLQELG-----DH 66

Query: 139 KNLVRLLGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
            N+V+LL      + +   LV+EYM+    DL     ++   +   R+ I+  + + L+Y
Sbjct: 67  PNIVKLLNVIKAENDKDIYLVFEYMET---DLHAVIRANILEDVHKRY-IMYQLLKALKY 122

Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS----TNFAGTLGYT 252
           +H      ++HRD+K SN+LL+   + K+ DFGLAR   E +        T++  T  Y 
Sbjct: 123 IHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR 179

Query: 253 APEYAIRGELSEKA-DIYSFGVLVLEIISCR 282
           APE  +      K  D++S G ++ E++  +
Sbjct: 180 APEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 27/204 (13%)

Query: 90  LGRGGFGPVYRGKLAD-GTLVAVKKLC-VDKSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +GRG +G V   K ++    VA+KK+     ++      L E++++  + H+N++ +   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 148 CSDGSQR-----LLVYEYMKN------RSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
                +       +VYE M        RS   L       FL     +Q++    RGL+Y
Sbjct: 73  MPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFL-----YQLL----RGLKY 123

Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEY 256
           +H      ++HRD+K SN+LL+     KI DFGLAR   E   ++ T +  T  Y APE 
Sbjct: 124 IHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM-TEYVVTRWYRAPEL 179

Query: 257 AIR-GELSEKADIYSFGVLVLEII 279
            +   E +   D++S G +  E++
Sbjct: 180 LLNCSEYTTAIDVWSVGCIFAELL 203

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 65.8 bits (160), Expect = 6e-12
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 18/199 (9%)

Query: 89  LLGRGGFGPVYRGKL-ADGTLVAVKKLCVD---KSQQGESEFLSEVRMITSIQHKNLVRL 144
           +LG+G FG V+  +L       A+K L  D        E   + +  +  + +H  L  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGES-DKF-LNWSTRF--QIILGIARGLQYLHED 200
                       V EY+     DL+ + +S  KF L  +T +  +II G    LQ+LH  
Sbjct: 62  YCTFQTKENLFFVMEYLNGG--DLMFHIQSCHKFDLPRATFYAAEIICG----LQFLHSK 115

Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               IV+RD+K  N+LLD     KI DFG+ +      A   T F GT  Y APE  +  
Sbjct: 116 G---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQ 171

Query: 261 ELSEKADIYSFGVLVLEII 279
           + +   D +SFGVL+ E++
Sbjct: 172 KYNTSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 66.4 bits (162), Expect = 7e-12
 Identities = 45/173 (26%), Positives = 73/173 (42%), Gaps = 17/173 (9%)

Query: 112 KKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIY 171
           +K  + K+  G      E+ ++ +I H+ ++ L+      S   +V   M     DL  Y
Sbjct: 119 RKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTY 175

Query: 172 GESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLA 231
            +    L       I   +   L YLH      I+HRD+K  N+ LDE   + +GDFG A
Sbjct: 176 VDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232

Query: 232 ------RFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEI 278
                    P+   +     +GTL   +PE         K DI+S G+++ E+
Sbjct: 233 CKLDAHPDTPQCYGW-----SGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 65.6 bits (160), Expect = 7e-12
 Identities = 35/91 (38%), Positives = 55/91 (60%), Gaps = 4/91 (4%)

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
           +A  L +LH      I++RD+K  N+LLDE+   K+ DFGL++    D    + +F GT+
Sbjct: 107 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTV 162

Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            Y APE   R   ++ AD +SFGVL+ E+++
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 193

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 65.5 bits (160), Expect = 7e-12
 Identities = 60/213 (28%), Positives = 90/213 (42%), Gaps = 46/213 (21%)

Query: 89  LLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRM---ITSIQH--KNLV 142
            +G G  G VY+ +    G ++AVK++     + G  E    + M   +    H    +V
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQM----RRTGNKEENKRILMDLDVVLKSHDCPYIV 77

Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLL--IYGESDKFLNWSTRFQIILG-----IARGLQ 195
           +  G     S   +  E M      LL  I G   +          ILG     I + L 
Sbjct: 78  KCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPED---------ILGKMTVAIVKALH 128

Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE 255
           YL E  H  ++HRD+K SN+LLD     K+ DFG++    + +A   T  AG   Y APE
Sbjct: 129 YLKE-KHG-VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPE 184

Query: 256 ----------YAIRGELSEKADIYSFGVLVLEI 278
                     Y IR      AD++S G+ ++E+
Sbjct: 185 RIDPPDPNPKYDIR------ADVWSLGISLVEL 211

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 49/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)

Query: 106 GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRS 165
           G  VAVK + + K Q+ E  F +EV ++   QH+N+V +      G +  ++ E+++  +
Sbjct: 46  GRQVAVKMMDLRKQQRRELLF-NEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104

Query: 166 LDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKI 225
           L  ++   S   LN      +   + + L YLH      ++HRDIK+ ++LL    + K+
Sbjct: 105 LTDIV---SQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKL 158

Query: 226 GDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
            DFG      +D      +  GT  + APE   R     + DI+S G++V+E++
Sbjct: 159 SDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 61/232 (26%), Positives = 93/232 (40%), Gaps = 50/232 (21%)

Query: 89  LLGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQG--ESEFLSEVRMITSIQHKNLVRLL 145
           L+G+GG G VY          VA+KK+  D S+    +  FL E ++   + H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ------------------II 187
             CSDG     VY  M        I G + K L  S   +                  I 
Sbjct: 69  SICSDGD---PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119

Query: 188 LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP---EDQAYLSTN 244
             I   ++Y+H      ++HRD+K  N+LL    +  I D+G A F     ED   +  +
Sbjct: 120 HKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176

Query: 245 --------------FAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCR 282
                           GT  Y APE  +    SE  DIY+ GV++ ++++  
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLS 228

Length = 932

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 21/199 (10%)

Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEF----LSEVRMITSIQHKNLVR 143
           ++G G +G V + +  +   +VA+KK    K  +   E     L E++M+ +++ +N+V 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKF---KDSEENEEVKETTLRELKMLRTLKQENIVE 64

Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLL----IYGESDKFLNWSTRFQIILGIARGLQYLHE 199
           L        +  LV+EY++   L+LL         +K  ++   +Q+I    + + + H+
Sbjct: 65  LKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYI--YQLI----KAIHWCHK 118

Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
           +    IVHRDIK  N+L+      K+ DFG AR   E      T +  T  Y +PE  + 
Sbjct: 119 ND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG 175

Query: 260 GELSEKADIYSFGVLVLEI 278
               +  D++S G ++ E+
Sbjct: 176 APYGKAVDMWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 64/216 (29%), Positives = 94/216 (43%), Gaps = 33/216 (15%)

Query: 78  KKATKNFHPGNLLGRGGFGPVYRGKLADGTL--VAVKKL--CVDKSQQGESEFLSEVRMI 133
           K   ++F+    LG G FG V      +     VA+K+        Q+      SE +++
Sbjct: 26  KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKIL 85

Query: 134 TSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF--------- 184
             I H   V L G   D S   LV E+        +I GE   FL  + RF         
Sbjct: 86  NYINHPFCVNLYGSFKDESYLYLVLEF--------VIGGEFFTFLRRNKRFPNDVGCFYA 137

Query: 185 -QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST 243
            QI+L I   LQ L+      IV+RD+K  N+LLD+    K+ DFG A+   + + Y   
Sbjct: 138 AQIVL-IFEYLQSLN------IVYRDLKPENLLLDKDGFIKMTDFGFAKVV-DTRTY--- 186

Query: 244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
              GT  Y APE  +     + AD ++ G+ + EI+
Sbjct: 187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 18/201 (8%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGE-SEFLSEVRMITSIQHKNLVRLLGC 147
           +G G FG     K   DG    +K++ + K    E  E   EV ++++++H N+V+    
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67

Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGE------SDKFLNWSTRFQIILGIARGLQYLHEDS 201
             +     +V +Y +   L   I  +       D+ L+W    QI L     L+++H+  
Sbjct: 68  FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV--QICLA----LKHVHD-- 119

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
             +I+HRDIK+ N+ L +    K+GDFG+AR        L+    GT  Y +PE      
Sbjct: 120 -RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL-NSTVELARTCIGTPYYLSPEICENRP 177

Query: 262 LSEKADIYSFGVLVLEIISCR 282
            + K+DI++ G ++ E+ + +
Sbjct: 178 YNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 16/149 (10%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +  VY+G+    G LVA+K++ ++  +      + E  ++  ++H N+V L    
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72

Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGES-DKFLNWST----RFQIILGIARGLQYLHEDSHT 203
                  LV+EY+     DL  Y +     L+        FQ++    RGL Y H     
Sbjct: 73  HTKKTLTLVFEYLDT---DLKQYMDDCGGGLSMHNVRLFLFQLL----RGLAYCH---QR 122

Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLAR 232
           R++HRD+K  N+L+ E+ + K+ DFGLAR
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 4/92 (4%)

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-T 248
           +ARG+++L   +  + +HRD+ A N+LL E    KI DFGLAR   +D  Y+    A   
Sbjct: 182 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           L + APE       + ++D++SFGVL+ EI S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 54/181 (29%), Positives = 88/181 (48%), Gaps = 17/181 (9%)

Query: 106 GTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLLGCCS------DGSQRLLVY 158
           G  VAVKKL    ++Q        E+ ++  + HKN++ LL   +      +     LV 
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105

Query: 159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD 218
           E M + +L  +I+ E D        +Q++ GI    ++LH      I+HRD+K SN+++ 
Sbjct: 106 ELM-DANLCQVIHMELDHERMSYLLYQMLCGI----KHLHSAG---IIHRDLKPSNIVVK 157

Query: 219 EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEI 278
                KI DFGLAR    +  ++ T +  T  Y APE  +     E  DI+S G ++ E+
Sbjct: 158 SDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215

Query: 279 I 279
           +
Sbjct: 216 V 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 66/294 (22%), Positives = 118/294 (40%), Gaps = 64/294 (21%)

Query: 90  LGRGGFGPVYRGKL---ADGTL------VAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           LG+G F  +Y+G L   +D  +      V+V    +    +    F     +++ + HK+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 141 LVRLLG-CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
           LV+L G C  D +   +V EY+K   LD+ ++ E +  ++   +  +   +A  L YL +
Sbjct: 63  LVKLYGVCVRDENI--MVEEYVKFGPLDVFLHREKNN-VSLHWKLDVAKQLASALHYLED 119

Query: 200 DSHTRIVHRDIKASNVLL-----DEKFQ--SKIGDFG-----LARFFPEDQAYLSTNFAG 247
               ++VH ++   N+L+     +E +    K+ D G     L+R    ++         
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-------- 168

Query: 248 TLGYTAPEYAIRG---ELSEKADIYSFGVLVLEIISCRKNTDLT--LPSEMQYLPEYAWK 302
              + APE  IR     L+  AD +SFG  +LEI        L+    SE +       +
Sbjct: 169 --PWIAPEC-IRNGQASLTIAADKWSFGTTLLEIC-SNGEEPLSTLSSSEKE-------R 217

Query: 303 LYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
            Y+    L               D  ++ N+   C      +RP    I+  L 
Sbjct: 218 FYQDQHRLP------------MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 17/207 (8%)

Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 20  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76

Query: 140 NLVRLLGCCSDGS---QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
           N++ LL   +      +   VY        DL    +  K  +   +F +I  I RGL+Y
Sbjct: 77  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKY 135

Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEY 256
           +H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y APE 
Sbjct: 136 IHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEI 188

Query: 257 AIRG-ELSEKADIYSFGVLVLEIISCR 282
            +     ++  DI+S G ++ E+++ R
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 49/198 (24%), Positives = 97/198 (48%), Gaps = 8/198 (4%)

Query: 82  KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLC-VDKSQQGESEFLSEVRMITSIQHKN 140
            +F   + LG G  G V + +     L+  +KL  ++      ++ + E++++       
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
           +V   G      +  +  E+M   SLD ++  +  K +      ++ + + RGL YL E 
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAYLREK 122

Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
              +I+HRD+K SN+L++ + + K+ DFG++    +  A    +F GT  Y +PE     
Sbjct: 123 H--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGT 177

Query: 261 ELSEKADIYSFGVLVLEI 278
             S ++DI+S G+ ++E+
Sbjct: 178 HYSVQSDIWSMGLSLVEL 195

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 26/213 (12%)

Query: 84  FHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLC-VDKSQQGESEFLSEVRMITSIQHKNL 141
             P   +G G FG V+      DG  VA+KK+  V ++         E++M+   +H N+
Sbjct: 2   VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV 61

Query: 142 VRLLGCCS----DGSQRLLVYEYMKNRSLDLLIYGE----SDK---FLNWSTRFQIILGI 190
           +  L        D  + + V   +    L  +I       SD    FL     +QI+   
Sbjct: 62  LSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFL-----YQIL--- 113

Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
            RGL+YLH      I+HRDIK  N+L++     KI DFGLAR    D++   T    T  
Sbjct: 114 -RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY 169

Query: 251 YTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           Y APE  +     +   DI+S G +  E++  R
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 67/213 (31%), Positives = 92/213 (43%), Gaps = 25/213 (11%)

Query: 82  KNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQGESE---FLSEVRMITSI 136
           K+F   +L+GRG FG V   R K A G + A+K +   KS     E   F  E R I SI
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREK-ATGDIYAMKVM--KKSVLLAQETVSFFEEERDILSI 57

Query: 137 QHKN-LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QIILGIAR 192
            +   + +L     D     LV EY     L  L+    D+F     +F   +++L I  
Sbjct: 58  SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAI-- 115

Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
               +H+  +   VHRDIK  NVL+D     K+ DFG A     ++   S    GT  Y 
Sbjct: 116 --HSVHQMGY---VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYI 170

Query: 253 APEYAIRGELSEKA------DIYSFGVLVLEII 279
           APE         K       D +S GV+  E+I
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 53/185 (28%), Positives = 88/185 (47%), Gaps = 25/185 (13%)

Query: 109 VAVKKLCVDKSQQGE--SEFLSEVRMITSIQHKNLVRLL--GCCSDGSQRLL-VYEYMKN 163
           VA+K L  D  ++    + F  E  +   + H N+V LL  G    G   L  V+EY+  
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG--LLFAVFEYVPG 63

Query: 164 RSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL---DE 219
           R+L ++L    +D  L      +++L +   L   H      IVHRD+K  N+++     
Sbjct: 64  RTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGV 117

Query: 220 KFQSKIGDFGLARFFP------EDQAYLSTNFAGTLGYTAPEYAIRGE-LSEKADIYSFG 272
           +  +K+ DFG+    P            +T   GT  Y APE  +RGE ++  +D+Y++G
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPNSDLYAWG 176

Query: 273 VLVLE 277
           ++ LE
Sbjct: 177 LIFLE 181

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 46/207 (22%), Positives = 84/207 (40%), Gaps = 24/207 (11%)

Query: 89  LLGR----GGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQHKNLVR 143
           L+G+         + + K    TLVAVKK+ +D   + + + L  E+     +QH N++ 
Sbjct: 5   LIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
            +      S+  +V   M   S + L+     + L       I+  +   L Y+H     
Sbjct: 64  YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SK 120

Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLAR-FFPEDQAY-----LSTNFAGTLGYTAPEY- 256
             +HR +KAS++LL    +  +     +       +          +    L + +PE  
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180

Query: 257 --AIRGELSEKADIYSFGVLVLEIISC 281
              ++G  +EK+DIYS G     I +C
Sbjct: 181 QQNLQG-YNEKSDIYSVG-----ITAC 201

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 56/195 (28%), Positives = 89/195 (45%), Gaps = 14/195 (7%)

Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +  VY+G    +G LVA+K + +   +      + E  ++  ++H N+V L    
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72

Query: 149 SDGSQRLLVYEYMKNRSLDLLIY-GESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVH 207
                   V+EYM     DL  Y  +    L+       +  + RGL Y+H      I+H
Sbjct: 73  HTKETLTFVFEYMHT---DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILH 126

Query: 208 RDIKASNVLLDEKFQSKIGDFGLARF--FPEDQAYLSTNFAGTLGYTAPEYAIRG-ELSE 264
           RD+K  N+L+    + K+ DFGLAR    P  Q Y S     TL Y  P+  +   + S 
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPS-QTYSSE--VVTLWYRPPDVLLGATDYSS 183

Query: 265 KADIYSFGVLVLEII 279
             DI+  G + +E++
Sbjct: 184 ALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 60/236 (25%), Positives = 94/236 (39%), Gaps = 50/236 (21%)

Query: 82  KNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKS---QQGESEFLSEVRMI-TS 135
            +F    ++GRG FG V+  R K   G + A+K L   KS   ++ +   +   R I   
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDK-DTGQVYAMKVL--RKSDMIKRNQIAHVRAERDILAD 57

Query: 136 IQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRF---QIILGIA 191
                +V+L     D     LV EYM    L +LLI    D F   + RF   +++L + 
Sbjct: 58  ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLI--RKDVFPEETARFYIAELVLALD 115

Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLA--------RFFPEDQAYLST 243
                +H+      +HRDIK  N+L+D     K+ DFGL         R +  + ++   
Sbjct: 116 ----SVHKLGF---IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168

Query: 244 NFA--------------------GTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
                                  GT  Y APE         + D +S GV++ E++
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 51/169 (30%), Positives = 80/169 (47%), Gaps = 23/169 (13%)

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-T 248
           +ARG+++L   +  + +HRD+ A N+LL E    KI DFGLAR   +D  Y+    A   
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYE--R 306
           L + APE       + ++D++SFGVL+ EI S   +     P  +Q   E+  +L +  R
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS---PYPG-VQINEEFCQRLKDGTR 295

Query: 307 GRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
            R  E   P + +             +   C Q    +RP  S +V +L
Sbjct: 296 MRAPENATPEIYR-------------IMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 62.7 bits (153), Expect = 5e-11
 Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 35/207 (16%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKL---CVDKSQQGESEFLSEVRMITSIQ-HKNLVRL 144
           +G G F  V + +    G   A+K +        Q      L E++ +  +  H N++RL
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN---LREIQALRRLSPHPNILRL 63

Query: 145 LGCCSD---GSQRLL-------VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           +    D   G   L+       +YE +K R   L    E  +  ++   +Q++    + L
Sbjct: 64  IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPL---PEK-RVKSY--MYQLL----KSL 113

Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            ++H      I HRDIK  N+L+ +    K+ DFG  R       Y  T +  T  Y AP
Sbjct: 114 DHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPY--TEYISTRWYRAP 167

Query: 255 EYAIR-GELSEKADIYSFGVLVLEIIS 280
           E  +  G    K DI++ G +  EI+S
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 62.5 bits (152), Expect = 6e-11
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 34/217 (15%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDK--SQQGESEFLSE 129
           D + +K           +G G FG V+  +        A+K + + +    + E    +E
Sbjct: 2   DLERIK----------TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNE 51

Query: 130 VRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG 189
            R++  + H  ++RL    ++  QR L   YM    ++ +  GE   +L  S RF    G
Sbjct: 52  KRVLKEVSHPFIIRLF--WTEHDQRFL---YM---LMEYVPGGELFSYLRNSGRFSNSTG 103

Query: 190 ------IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST 243
                 I   L+YLH      IV+RD+K  N+LLD++   K+ DFG A+    D+ +   
Sbjct: 104 LFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTW--- 156

Query: 244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
              GT  Y APE       ++  D ++ G+L+ E++ 
Sbjct: 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLV 193

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 62.9 bits (153), Expect = 6e-11
 Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 16/199 (8%)

Query: 89  LLGRGGFGPVYRGKLADGT--LVAVKKLCVDKSQQGESE--FLSEVRMITSIQHKNLVRL 144
           +LG+G FG V   +L  GT  + A+K L  D   Q +     ++E R++        +  
Sbjct: 2   VLGKGSFGKVMLAEL-KGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 145 LGCCSDGSQRLL-VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
           L CC     RL  V EY+    L   I   S KF    +RF     +   L +LH     
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQ-RSRKFDEPRSRFYAA-EVTLALMFLHRHG-- 116

Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA--YLSTNFAGTLGYTAPEYAIRGE 261
            +++RD+K  N+LLD +   K+ DFG+ +   E       +T F GT  Y APE     E
Sbjct: 117 -VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEILQELE 172

Query: 262 LSEKADIYSFGVLVLEIIS 280
                D ++ GVL+ E+++
Sbjct: 173 YGPSVDWWALGVLMYEMMA 191

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 77/277 (27%), Positives = 121/277 (43%), Gaps = 44/277 (15%)

Query: 83  NFHPGNLLGRGGFGPVYRGKLADG----TLVAVKKL----CVDKSQ-----QGESEFLSE 129
           NF    +LG G +G V+  +   G     L A+K L     V K++     + E   L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 130 VRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QI 186
           VR     Q   LV L       ++  L+ +Y+    +   +Y + D F     RF   +I
Sbjct: 61  VR-----QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-QRDNFSEDEVRFYSGEI 114

Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA 246
           IL     L++LH+     IV+RDIK  N+LLD +    + DFGL++ F  ++   + +F 
Sbjct: 115 ILA----LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC 167

Query: 247 GTLGYTAPEYAIRGEL--SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLY 304
           GT+ Y APE  IRG+    +  D +S G+L+ E+++    +  TL  E     E +    
Sbjct: 168 GTIEYMAPE-IIRGKGGHGKAVDWWSLGILIFELLT--GASPFTLEGERNTQSEVS---- 220

Query: 305 ERGRILELVDPRMRKEGIVERDALQVINVAFICLQPH 341
              RIL+   P     G   +D L       +   P 
Sbjct: 221 --RRILKCDPPFPSFIGPEAQDLLH----KLLRKDPK 251

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 61.6 bits (149), Expect = 9e-11
 Identities = 57/195 (29%), Positives = 88/195 (45%), Gaps = 15/195 (7%)

Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGE--SEFLSEVRMITSIQHKNLVRLLG 146
           +G G +G VY+   L  G L AVK   + K + G+  S    E+ M+   +H N+V   G
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVK---IIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
                 +  +  EY    SL   IY  +         + +     +GL YLH       +
Sbjct: 74  SYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAY-VCRETLQGLAYLHSKGK---M 128

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI---RGELS 263
           HRDIK +N+LL +    K+ DFG+A       A    +F GT  + APE A     G  +
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAK-RKSFIGTPYWMAPEVAAVEKNGGYN 187

Query: 264 EKADIYSFGVLVLEI 278
           +  DI++ G+  +E+
Sbjct: 188 QLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 62.3 bits (151), Expect = 9e-11
 Identities = 72/249 (28%), Positives = 108/249 (43%), Gaps = 22/249 (8%)

Query: 89  LLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESE--FLSEVRMITSIQHKNLVRLL 145
           +LG+G FG V   +L   G   AVK L  D     +     + E R++        +  L
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61

Query: 146 GCCSDGSQRLL-VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTR 204
            C     + L  V E++    L   I  +  +F  +   F     I  GLQ+LH      
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHIQ-DKGRFDLYRATFYAA-EIVCGLQFLHSKG--- 116

Query: 205 IVHRDIKASNVLLDEKFQSKIGDFGLAR--FFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
           I++RD+K  NV+LD     KI DFG+ +   F +++A   + F GT  Y APE     + 
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA---STFCGTPDYIAPEILQGLKY 173

Query: 263 SEKADIYSFGVLVLEIISCRK-----NTDLTLPSEMQYLPEYA-WKLYERGRILELVDPR 316
           +   D +SFGVL+ E++  +      + D    S     P Y  W   E   ILE +  R
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFER 233

Query: 317 --MRKEGIV 323
              R+ G+V
Sbjct: 234 DPTRRLGVV 242

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 64/198 (32%), Positives = 91/198 (45%), Gaps = 11/198 (5%)

Query: 89  LLGRGGFGPV--YRGKLADGTLVAVK--KLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LLG+G FG V   R K A G   A+K  K  V  ++   +  L+E R++ + +H  L  L
Sbjct: 2   LLGKGTFGKVILVREK-ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTR 204
                   +   V EY+    L   +  E   F    TRF     I   L YLH     +
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRER-VFSEDRTRFYGA-EIVSALDYLHSG---K 115

Query: 205 IVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSE 264
           IV+RD+K  N++LD+    KI DFGL +    D A + T F GT  Y APE     +   
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDYGR 174

Query: 265 KADIYSFGVLVLEIISCR 282
             D +  GV++ E++  R
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 61.4 bits (149), Expect = 1e-10
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 33/211 (15%)

Query: 90  LGRGGFGPVYRGK---LADG-----TLVAVKKLCVDKSQQGESE-FLSEVRMITSIQHKN 140
           LG+G F  +++G    + D      T V +K L  DKS +  SE F     M++ + HK+
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVL--DKSHRNYSESFFEAASMMSQLSHKH 60

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
           LV   G C  G + ++V EY+K  SLD  +    +  +N S + ++   +A  L +L + 
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNL-INISWKLEVAKQLAWALHFLEDK 119

Query: 201 SHTRIVHRDIKASNVLL----DEKFQS----KIGDFGLA-RFFPEDQAYLSTNFAGTLGY 251
               + H ++ A NVLL    D K  +    K+ D G++    P++           + +
Sbjct: 120 G---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI------LLERIPW 170

Query: 252 TAPEYAIRG--ELSEKADIYSFGVLVLEIIS 280
             PE  I     LS  AD +SFG  + EI S
Sbjct: 171 VPPE-CIENPQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 66/219 (30%), Positives = 103/219 (47%), Gaps = 37/219 (16%)

Query: 83  NFHPGNLLGRGGFGPVYRGKLADG----TLVAVKKL----CVDKSQ-----QGESEFLSE 129
           NF    +LG G +G V+  +   G     L A+K L     V K++     + E + L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 130 VRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF----- 184
           +R     Q   LV L       ++  L+ +Y+          GE    L+   RF     
Sbjct: 61  IR-----QSPFLVTLHYAFQTDTKLHLILDYING--------GELFTHLSQRERFKEQEV 107

Query: 185 QIILG-IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST 243
           QI  G I   L++LH+     I++RDIK  N+LLD      + DFGL++ F ED+   + 
Sbjct: 108 QIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY 164

Query: 244 NFAGTLGYTAPEYAIRGELS-EKA-DIYSFGVLVLEIIS 280
           +F GT+ Y AP+    G+   +KA D +S GVL+ E+++
Sbjct: 165 SFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 4/92 (4%)

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-T 248
           +A+G+++L   +  + +HRD+ A N+LL E    KI DFGLAR   +D  Y+    A   
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           L + APE       + ++D++SFGVL+ EI S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 29/205 (14%)

Query: 89  LLGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLS-----EVRMITSIQHKNLV 142
            +G G +G V        G  VA+KKL     +  +SE  +     E+ ++  +QH+N++
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKLS----RPFQSEIFAKRAYRELTLLKHMQHENVI 77

Query: 143 RLL-----GCCSDGSQRL-LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
            LL         D  Q   LV  YM+     ++ +  S+  + +     ++  +  GL+Y
Sbjct: 78  GLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY-----LVYQMLCGLKY 132

Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEY 256
           +H      I+HRD+K  N+ ++E  + KI DFGLAR    +     T +  T  Y APE 
Sbjct: 133 IHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TGYVVTRWYRAPEV 185

Query: 257 AIRG-ELSEKADIYSFGVLVLEIIS 280
            +     ++  DI+S G ++ E+++
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLT 210

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 38/213 (17%)

Query: 83  NFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQ----QGESEFLSEVRMITSIQ 137
           +F  G  LG G FG V   K    G   A+K  C+ K +    +       E  ++  + 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIK--CLKKREILKMKQVQHVAQEKSILMELS 76

Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGE-------SDKFLNWSTRF---QII 187
           H  +V ++    D ++   + E+        ++ GE       + +F N   +F   +++
Sbjct: 77  HPFIVNMMCSFQDENRVYFLLEF--------VVGGELFTHLRKAGRFPNDVAKFYHAELV 128

Query: 188 LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG 247
           L      +YLH      I++RD+K  N+LLD K   K+ DFG A+  P+    L     G
Sbjct: 129 LA----FEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL----CG 177

Query: 248 TLGYTAPEYAIRGELSEKA-DIYSFGVLVLEII 279
           T  Y APE  I+ +   KA D ++ GVL+ E I
Sbjct: 178 TPEYLAPE-VIQSKGHGKAVDWWTMGVLLYEFI 209

Length = 329

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 45/164 (27%), Positives = 87/164 (53%), Gaps = 22/164 (13%)

Query: 128 SEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY---------MKNRSLDLLIYGESDKFL 178
           SE+  + +  H  +V+         + LL+ EY         +K R  + L + E +  L
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173

Query: 179 NWSTRFQIILGIARGLQYLHEDSHTR-IVHRDIKASNVLLDEKFQSKIGDFGLARFFPED 237
            +   +QI+L +        ++ H+R ++HRD+K++N+ L      K+GDFG ++ + + 
Sbjct: 174 LF---YQIVLAL--------DEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222

Query: 238 QAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            +  ++++F GT  Y APE   R   S+KAD++S GV++ E+++
Sbjct: 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 14/197 (7%)

Query: 89  LLGRGGFGPVYRGKL-ADGTLVAVK----KLCVDKSQQGESEFLSEVR-MITSIQHKNLV 142
           ++G+G FG V   K  +DG+  AVK    K  + K +Q  +  ++E   ++ +++H  LV
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQ--NHIMAERNVLLKNLKHPFLV 59

Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            L        +   V +Y+    L   +  E   FL    RF     +A  + YLH    
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGELFFHLQRER-CFLEPRARFYAA-EVASAIGYLHS--- 114

Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
             I++RD+K  N+LLD +    + DFGL +   E +   ST F GT  Y APE   +   
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEPY 173

Query: 263 SEKADIYSFGVLVLEII 279
               D +  G ++ E++
Sbjct: 174 DRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 60.5 bits (146), Expect = 4e-10
 Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 18/212 (8%)

Query: 89  LLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-----QHKNLVR 143
           ++GRG +  V   +L     +   K+ V K    + E +  V+    +      H  LV 
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKV-VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
           L  C    S+   V EY+     DL+ + +  + L           I+  L YLHE    
Sbjct: 61  LHSCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG-- 116

Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLAR--FFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
            I++RD+K  NVLLD +   K+ D+G+ +    P D    ++ F GT  Y APE  +RGE
Sbjct: 117 -IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPE-ILRGE 171

Query: 262 -LSEKADIYSFGVLVLEIISCRKNTDLTLPSE 292
                 D ++ GVL+ E+++ R   D+   S+
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 203

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 33/210 (15%)

Query: 90  LGRGGFGPVYRGKLA---DGTLVAVKK---------LCVDKSQQGESEFLSEVRMITSIQ 137
           LG+G +G V   + A   +   VA+KK         L   K    E + L   R      
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILA--KRALRELKLLRHFR-----G 60

Query: 138 HKNLVRLLG---CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ-IILGIARG 193
           HKN+  L             L +YE +    L  +I   S + L     FQ  I  I  G
Sbjct: 61  HKNITCLYDMDIVFPGNFNELYLYEELMEADLHQII--RSGQPLT-DAHFQSFIYQILCG 117

Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF---PEDQAYLSTNFAGTLG 250
           L+Y+H      ++HRD+K  N+L++   + KI DFGLAR F   P + A   T +  T  
Sbjct: 118 LKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174

Query: 251 YTAPEYAIRGELSEKA-DIYSFGVLVLEII 279
           Y APE  +  +   KA D++S G ++ E++
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELL 204

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 59.4 bits (144), Expect = 6e-10
 Identities = 42/191 (21%), Positives = 87/191 (45%), Gaps = 17/191 (8%)

Query: 98  VYRGKLADGTLVAVKKL-CVDKSQQGESE-FLSEVRMITSIQHKNLVRLLGCCSDGSQRL 155
           +Y+G   +   V ++      K  +   +   +E++ +  I   N++++ G   D    L
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 156 ----LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIK 211
               L+ EY     L  ++  E D  L++ T+  + +   +GL  L+   +T   ++++ 
Sbjct: 95  PRLSLILEYCTRGYLREVLDKEKD--LSFKTKLDMAIDCCKGLYNLY--KYTNKPYKNLT 150

Query: 212 ASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYA--IRGELSEKADIY 269
           + + L+ E ++ KI   GL +       + + NF   + Y + +    I  E + K DIY
Sbjct: 151 SVSFLVTENYKLKIICHGLEKIL-SSPPFKNVNF---MVYFSYKMLNDIFSEYTIKDDIY 206

Query: 270 SFGVLVLEIIS 280
           S GV++ EI +
Sbjct: 207 SLGVVLWEIFT 217

Length = 283

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 60.1 bits (146), Expect = 6e-10
 Identities = 71/282 (25%), Positives = 111/282 (39%), Gaps = 78/282 (27%)

Query: 82  KNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVR----MITSI 136
            +F    ++GRG FG V   +  D G + A+KKL   KS+  E E ++ VR    ++   
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKL--RKSEMLEKEQVAHVRAERDILAEA 58

Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQI---ILGIAR 192
            +  +V+L     D +   L+ EY+    +  LL+  + D F    TRF I   IL I  
Sbjct: 59  DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYIAETILAI-- 114

Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF------------------ 234
               +H+  +   +HRDIK  N+LLD K   K+ DFGL                      
Sbjct: 115 --DSIHKLGY---IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169

Query: 235 --------PEDQAYLSTNF-----------AGTLGYTAPEYAIRGELSEKADIYSFGVLV 275
                   P      +  +            GT  Y APE  ++   +++ D +S GV++
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229

Query: 276 LE-------------------IISCRKNTDLTLPSEMQYLPE 298
            E                   II+ ++   L  P E+   PE
Sbjct: 230 YEMLVGYPPFCSDNPQETYRKIINWKET--LQFPDEVPLSPE 269

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 60.1 bits (145), Expect = 6e-10
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 24/201 (11%)

Query: 90  LGRGGFGPV---YRGKLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLL 145
           +G G +G V   Y  +L     VAVKKL    +S         E+R++  ++H+N++ LL
Sbjct: 23  VGSGAYGSVCSAYDTRLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 146 GCCS------DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
              +      + ++  LV   M     DL    +  K  +   +F +I  + RGL+Y+H 
Sbjct: 81  DVFTPATSIENFNEVYLVTNLM---GADLNNIVKCQKLSDEHVQF-LIYQLLRGLKYIHS 136

Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
                I+HRD+K SNV ++E  + +I DFGLAR   ++     T +  T  Y APE  + 
Sbjct: 137 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEM----TGYVATRWYRAPEIMLN 189

Query: 260 G-ELSEKADIYSFGVLVLEII 279
               ++  DI+S G ++ E++
Sbjct: 190 WMHYNQTVDIWSVGCIMAELL 210

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 10/202 (4%)

Query: 83  NFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEV-RMITSIQHKN 140
           +F+   +LG+G FG V   +      L A+K L  D   Q +    + V + + ++Q K 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 141 --LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLH 198
             L +L  C     +   V EY+    L   I  +  KF      F     I+ GL +LH
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ-QVGKFKEPQAVFYAA-EISVGLFFLH 118

Query: 199 EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI 258
                 I++RD+K  NV+LD +   KI DFG+ +    D     T F GT  Y APE   
Sbjct: 119 RRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT-FCGTPDYIAPEIIA 174

Query: 259 RGELSEKADIYSFGVLVLEIIS 280
                +  D +++GVL+ E+++
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLA 196

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 60.1 bits (145), Expect = 8e-10
 Identities = 41/176 (23%), Positives = 83/176 (47%), Gaps = 23/176 (13%)

Query: 116 VDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE---YMKNRSLDLLIYG 172
           V    +   +  +E+  +  + H+N++++        + +L  E   YM  +  D  +Y 
Sbjct: 200 VKAGSRAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYS 251

Query: 173 E--------SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSK 224
                     D+ L   TR  I+  +   ++Y+H+    +++HRDIK  N+ L+   +  
Sbjct: 252 FMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIV 307

Query: 225 IGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           +GDFG A  F +++      + GT+   +PE        E  DI+S G+++L+++S
Sbjct: 308 LGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 59.0 bits (143), Expect = 9e-10
 Identities = 40/133 (30%), Positives = 71/133 (53%), Gaps = 14/133 (10%)

Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGES---DKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           SDG   + + E+M   SLD ++       +  L      +I + + RGL YL E    +I
Sbjct: 70  SDGEISICM-EHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYLREKH--KI 121

Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEK 265
           +HRD+K SN+L++ + + K+ DFG++    +  A    +F GT  Y +PE       + +
Sbjct: 122 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHYTVQ 178

Query: 266 ADIYSFGVLVLEI 278
           +DI+S G+ ++E+
Sbjct: 179 SDIWSLGLSLVEM 191

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 29/205 (14%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVK--KLCVDKSQQGESEFLSEVRMITSIQHK----NLV 142
           LG+G +G VY+      G  +A+K  +L +D+S+       +++ M   I HK     +V
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK------FNQIIMELDILHKAVSPYIV 62

Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF--LNWSTRFQIILGIARGLQYLHED 200
              G         +  EYM   SLD L Y        +      +I   + +GL++L E+
Sbjct: 63  DFYGAFFIEGAVYMCMEYMDAGSLDKL-YAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121

Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
            +  I+HRD+K +NVL++   Q K+ DFG++       A L+    G   Y APE  I+ 
Sbjct: 122 HN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL---VASLAKTNIGCQSYMAPE-RIKS 175

Query: 261 E-------LSEKADIYSFGVLVLEI 278
                    + ++D++S G+ +LE+
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEM 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 44/225 (19%)

Query: 74  FQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL----VAVKKLC-----VDKSQQGES 124
           F  LK+  +N  P   +G G  G V     A  T+    VA+KKL      V  +++   
Sbjct: 12  FTVLKR-YQNLKP---IGSGAQGIVC---AAYDTVTGQNVAIKKLSRPFQNVTHAKRAYR 64

Query: 125 EFLSEVRMITSIQHKNLVRLLGC------CSDGSQRLLVYEYMKNRSLDLLIYGESD--- 175
           E +    ++  + HKN++ LL          +     LV E M + +L  +I  + D   
Sbjct: 65  ELV----LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHER 119

Query: 176 -KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF 234
             +L     +Q++ GI    ++LH      I+HRD+K SN+++      KI DFGLAR  
Sbjct: 120 MSYL----LYQMLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-- 166

Query: 235 PEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
               +++ T +  T  Y APE  +     E  DI+S G ++ E+I
Sbjct: 167 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 63/201 (31%), Positives = 89/201 (44%), Gaps = 20/201 (9%)

Query: 89  LLGRGGFGPVYRGKLAD--GT--LVAVKKLCVDKSQQGESE--FLSEVRMITSIQHKNLV 142
           +LG+G FG V    LA+  GT  L A+K L  D   Q +     + E R++        +
Sbjct: 7   VLGKGSFGKVM---LAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFL 63

Query: 143 RLLGCCSDGSQRL-LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
             L  C     RL  V EY+    L   I     KF      F     IA GL +LH   
Sbjct: 64  TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPHAVFYAA-EIAIGLFFLHSKG 121

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLAR--FFPEDQAYLSTNFAGTLGYTAPEYAIR 259
              I++RD+K  NV+LD +   KI DFG+ +   F       +  F GT  Y APE    
Sbjct: 122 ---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAPEIIAY 175

Query: 260 GELSEKADIYSFGVLVLEIIS 280
               +  D ++FGVL+ E+++
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLA 196

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 21/198 (10%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGE--SEFLSEVRMITSIQHKNLVRLLG 146
           +G G +G VY+ + +  G L A+K   V K + GE  +    E+ M+   +H N+V   G
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIK---VIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGE---SDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
                 +  +  E+    SL  + +     S+  + + +R  +     +GL YLH     
Sbjct: 74  SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGK- 127

Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI---RG 260
             +HRDIK +N+LL +    K+ DFG++       A    +F GT  + APE A    +G
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVSAQITATIAK-RKSFIGTPYWMAPEVAAVERKG 184

Query: 261 ELSEKADIYSFGVLVLEI 278
             ++  DI++ G+  +E+
Sbjct: 185 GYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 62/201 (30%), Positives = 90/201 (44%), Gaps = 17/201 (8%)

Query: 89  LLGRGGFGPVY--RGKLADGTLVAVK--KLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LLG+G FG V   R K A G   A+K  K  V  ++   +  L+E R++ + +H  L  L
Sbjct: 2   LLGKGTFGKVILVREK-ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QIILGIARGLQYLHEDS 201
                   +   V EY     L   +  E   F     RF   +I+      L YLH   
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSA----LGYLHS-- 113

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
              +V+RD+K  N++LD+    KI DFGL +    D A + T F GT  Y APE     +
Sbjct: 114 -CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDND 171

Query: 262 LSEKADIYSFGVLVLEIISCR 282
                D +  GV++ E++  R
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 61/200 (30%), Positives = 92/200 (46%), Gaps = 14/200 (7%)

Query: 89  LLGRGGFGPVYRGK-LADGTLVAVK----KLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LLG+G FG V   K  A G   A+K    ++ V K +   +  L+E R++ + +H  L  
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--LTENRVLQNSRHPFLTA 59

Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDK-FLNWSTRFQIILGIARGLQYLHEDSH 202
           L        +   V EY      +L  +   ++ F     RF     I   L YLH  S 
Sbjct: 60  LKYSFQTHDRLCFVMEYANGG--ELFFHLSRERVFSEDRARFYGA-EIVSALDYLH--SE 114

Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
             +V+RD+K  N++LD+    KI DFGL +   +D A + T F GT  Y APE     + 
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDY 173

Query: 263 SEKADIYSFGVLVLEIISCR 282
               D +  GV++ E++  R
Sbjct: 174 GRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 62/200 (31%), Positives = 89/200 (44%), Gaps = 15/200 (7%)

Query: 89  LLGRGGFGPV--YRGKLADGTLVAVKKL----CVDKSQQGESEFLSEVRMITSIQHKNLV 142
           LLG+G FG V   R K A G   A+K L     + K +   +  ++E R++ + +H  L 
Sbjct: 2   LLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHT--VTESRVLQNTRHPFLT 58

Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            L        +   V EY     L   +  E   F     RF     I   L+YLH    
Sbjct: 59  ALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGA-EIVSALEYLHSRD- 115

Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
             +V+RDIK  N++LD+    KI DFGL +    D A + T F GT  Y APE     + 
Sbjct: 116 --VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDY 172

Query: 263 SEKADIYSFGVLVLEIISCR 282
               D +  GV++ E++  R
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 19/199 (9%)

Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK----KLCVDKSQQ----GESEFLSEVRMITSIQHKN 140
           +G+G FG VY+ +  D   + A+K    K  V K +     GE   L    +  S     
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDES---PF 57

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
           +V L       S   LV +YM    L   +  E  +F     +F I   +   L++LH+ 
Sbjct: 58  IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG-RFSEDRAKFYIA-ELVLALEHLHKY 115

Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               IV+RD+K  N+LLD      + DFGL++    D    +  F GT  Y APE  +  
Sbjct: 116 D---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNTFCGTTEYLAPEVLLDE 171

Query: 261 E-LSEKADIYSFGVLVLEI 278
           +  ++  D +S GVLV E+
Sbjct: 172 KGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 48/200 (24%), Positives = 97/200 (48%), Gaps = 14/200 (7%)

Query: 83  NFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLC-VDKSQQGESEFLSEVRMITSIQHKNL 141
           +F   + LG G  G V++       L+  +KL  ++      ++ + E++++       +
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGES---DKFLNWSTRFQIILGIARGLQYLH 198
           V   G      +  +  E+M   SLD ++       ++ L      ++ + + +GL YL 
Sbjct: 66  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLR 120

Query: 199 EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI 258
           E    +I+HRD+K SN+L++ + + K+ DFG++    +  A    +F GT  Y +PE   
Sbjct: 121 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQ 175

Query: 259 RGELSEKADIYSFGVLVLEI 278
               S ++DI+S G+ ++E+
Sbjct: 176 GTHYSVQSDIWSMGLSLVEM 195

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 28/206 (13%)

Query: 90  LGRGGFGPV-YRGKLADGTLVAVKKLCVDKSQQGESEFLS-----EVRMITSIQHKNLVR 143
           +G G +G V        G  VA+KKL     +  +SE  +     E+R++  ++H+N++ 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKL----YRPFQSELFAKRAYRELRLLKHMKHENVIG 78

Query: 144 LLGCCS------DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYL 197
           LL   +            LV  +M     DL    + +K      +F ++  + +GL+Y+
Sbjct: 79  LLDVFTPDLSLDRFHDFYLVMPFM---GTDLGKLMKHEKLSEDRIQF-LVYQMLKGLKYI 134

Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYA 257
           H      I+HRD+K  N+ ++E  + KI DFGLAR    +     T +  T  Y APE  
Sbjct: 135 HAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM----TGYVVTRWYRAPEVI 187

Query: 258 IRG-ELSEKADIYSFGVLVLEIISCR 282
           +     ++  DI+S G ++ E+++ +
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 35/114 (30%), Positives = 58/114 (50%), Gaps = 4/114 (3%)

Query: 172 GESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLA 231
            E    L+     +    +A+G+ +L   +    +HRD+ A NVLL +   +KI DFGLA
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLA 259

Query: 232 RFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKN 284
           R    D  Y +  N    + + APE       + ++D++S+G+L+ EI S  K+
Sbjct: 260 RDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 28/207 (13%)

Query: 90  LGRGGFGPVYR-GKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-HKNLVRLLGC 147
           +G+G +G V++     +G+  AVK L  D     + E  +E  ++ ++  H N+V+  G 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKIL--DPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83

Query: 148 -----CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ------IILGIARGLQY 196
                  +G Q  LV E     S+  L+ G    FL    R +      I+     GLQ+
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKG----FLKRGERMEEPIIAYILHEALMGLQH 139

Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEY 256
           LH +   + +HRD+K +N+LL  +   K+ DFG++      +   +T+  GT  + APE 
Sbjct: 140 LHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPFWMAPEV 195

Query: 257 -AIRGEL----SEKADIYSFGVLVLEI 278
            A   +L      + D++S G+  +E+
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 21/168 (12%)

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAG 247
           +A G+++L   +    VHRD+ A NVL+ E    KI DFGLAR    D  Y+S  + F  
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL- 303

Query: 248 TLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERG 307
            L + APE       +  +D++SFG+L+ EI +        LP   Q+     +   +RG
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF-----YNAIKRG 358

Query: 308 RILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
                   RM K      +  +++     C +     RP  S++V ++
Sbjct: 359 Y-------RMAKPAHASDEIYEIMQK---CWEEKFEIRPDFSQLVHLV 396

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 51/161 (31%), Positives = 79/161 (49%), Gaps = 20/161 (12%)

Query: 134 TSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFL-NWSTRF---QIILG 189
           T+  H  LV L  C    S+   V E++     DL+ + +  + L     RF   +I L 
Sbjct: 51  TASNHPFLVGLHSCFQTESRLFFVIEFV--SGGDLMFHMQRQRKLPEEHARFYSAEISLA 108

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR--FFPEDQAYLSTNFAG 247
               L +LHE     I++RD+K  NVLLD +   K+ D+G+ +    P D    ++ F G
Sbjct: 109 ----LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---TTSTFCG 158

Query: 248 TLGYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCRKNTDL 287
           T  Y APE  +RGE      D ++ GVL+ E+++ R   D+
Sbjct: 159 TPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 57.0 bits (137), Expect = 5e-09
 Identities = 48/150 (32%), Positives = 72/150 (48%), Gaps = 12/150 (8%)

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
           LV L  C    S+  LV EY+     DL+ + +  + L           I   L +LHE 
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGG--DLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115

Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR--FFPEDQAYLSTNFAGTLGYTAPEYAI 258
               I++RD+K  NVLLD     K+ D+G+ +    P D    ++ F GT  Y APE  +
Sbjct: 116 G---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT---TSTFCGTPNYIAPE-IL 168

Query: 259 RGE-LSEKADIYSFGVLVLEIISCRKNTDL 287
           RGE      D ++ GVL+ E+++ R   D+
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 57.0 bits (137), Expect = 6e-09
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)

Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 14  TVLKRYQNLKP---IGSGAQGIVCAA--YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 68

Query: 132 MITSIQHKNLVRLLGCCS------DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ 185
           ++  + HKN++ LL   +      +     LV E M + +L  +I  E D        +Q
Sbjct: 69  LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQ 127

Query: 186 IILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF 245
           ++ GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T +
Sbjct: 128 MLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPY 178

Query: 246 AGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
             T  Y APE  +     E  DI+S G ++ E++
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 56.6 bits (136), Expect = 8e-09
 Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 6/93 (6%)

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAG 247
           +ARG+++L   +    VHRD+ A NVLL +    KI DFGLAR    D  Y+S  + F  
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL- 301

Query: 248 TLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + + APE       +  +D++S+G+L+ EI S
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 58/196 (29%), Positives = 88/196 (44%), Gaps = 12/196 (6%)

Query: 89  LLGRGGFGPVYRGK-LADGTLVAVK---KLCVDKSQQGESEFLSEVR-MITSIQHKNLVR 143
           ++G+G FG V   +  A+    AVK   K  + K ++ E   +SE   ++ +++H  LV 
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKE-EKHIMSERNVLLKNVKHPFLVG 60

Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
           L        +   V +Y+    L   +  E   FL    RF     IA  L YLH     
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAA-EIASALGYLHS---L 115

Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELS 263
            IV+RD+K  N+LLD +    + DFGL +   E     ST F GT  Y APE   +    
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLHKQPYD 174

Query: 264 EKADIYSFGVLVLEII 279
              D +  G ++ E++
Sbjct: 175 RTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 59/219 (26%), Positives = 91/219 (41%), Gaps = 23/219 (10%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKS-QQGESEFLSE 129
               L+   ++F    ++GRG FG V   R K +   + A+K L   +  ++ +S F  E
Sbjct: 34  KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHK-SSKQVYAMKLLSKFEMIKRSDSAFFWE 92

Query: 130 VRMITSIQHKN---LVRLLGCCSDGSQRLLVYEYMKNRSLDLLI--YGESDKFLNWSTRF 184
            R I +  H N   +V+L     D     +V EYM    L  L+  Y   +K   W  RF
Sbjct: 93  ERDIMA--HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK---W-ARF 146

Query: 185 QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN 244
                +   L  +H       +HRD+K  N+LLD+    K+ DFG       +       
Sbjct: 147 -YTAEVVLALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT 202

Query: 245 FAGTLGYTAPEY----AIRGELSEKADIYSFGVLVLEII 279
             GT  Y +PE        G    + D +S GV + E++
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 50/177 (28%), Positives = 86/177 (48%), Gaps = 15/177 (8%)

Query: 109 VAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLLGCCS-----DGSQRLLVYEYMK 162
           VA+KKL    ++Q        E+ ++  + HKN++ LL   +     +  Q + +   + 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111

Query: 163 NRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ 222
           + +L  +I  E D        +Q++ GI    ++LH      I+HRD+K SN+++     
Sbjct: 112 DANLCQVIQMELDHERMSYLLYQMLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCT 164

Query: 223 SKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
            KI DFGLAR      +++ T +  T  Y APE  +     E  DI+S G ++ E+I
Sbjct: 165 LKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 26/213 (12%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKL---CVDKSQQGESEFLS 128
           DFQ L +          +G+GG+G V+  K  D G +VA+K++    + K  +     L+
Sbjct: 2   DFQILTQ----------VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE-VRHVLT 50

Query: 129 EVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIIL 188
           E  ++T+ + + LV+LL    D     L  EY+       L+            RF +  
Sbjct: 51  ERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFYMAE 109

Query: 189 GIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT 248
                +  LHE      +HRD+K  N L+D     K+ DFGL++         + +  G+
Sbjct: 110 MFE-AVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGS 161

Query: 249 LGYTAPEYAIRGE-LSEKADIYSFGVLVLEIIS 280
             Y APE  +RG+      D +S G ++ E + 
Sbjct: 162 PDYMAPE-VLRGKGYDFTVDYWSLGCMLYEFLC 193

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 4/91 (4%)

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
           IA GL +LH      I++RD+K  NV+LD +   KI DFG+ +    D     T F GT 
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT-FCGTP 165

Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            Y APE        +  D ++FGVL+ E+++
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 58/197 (29%), Positives = 86/197 (43%), Gaps = 14/197 (7%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVK----KLCVDKSQQGESEFLSEVR-MITSIQHKNLVR 143
           +G+G FG V   K  ADG   AVK    K  + K +Q     ++E   ++ +++H  LV 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQ--KHIMAERNVLLKNVKHPFLVG 60

Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
           L        +   V +Y+    L   +  E   F     RF     IA  L YLH     
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRER-SFPEPRARFYAA-EIASALGYLHS---L 115

Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELS 263
            I++RD+K  N+LLD +    + DFGL +   E     ST F GT  Y APE   +    
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPEVLRKQPYD 174

Query: 264 EKADIYSFGVLVLEIIS 280
              D +  G ++ E++ 
Sbjct: 175 RTVDWWCLGAVLYEMLY 191

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 54.7 bits (131), Expect = 4e-08
 Identities = 57/229 (24%), Positives = 99/229 (43%), Gaps = 52/229 (22%)

Query: 78  KKATKNFHPGNLLGRGGFGPVYRGKLADGT-LVAVKKLCVDKSQQGESEFLSEVRMITSI 136
           +   K++  GN++G G FG VY     D +  VA+KK+  D   +       E+ ++ ++
Sbjct: 62  RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR-----ELLIMKNL 116

Query: 137 QHKNLVRL-----LGCCSDGSQRLL-----------VYEYMK-----NRSLDLLIYGESD 175
            H N++ L       C     + +            V++YMK     N +L L +     
Sbjct: 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV---- 172

Query: 176 KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS-KIGDFGLARFF 234
           K  ++         + R L Y+H      I HRD+K  N+L+D    + K+ DFG A+  
Sbjct: 173 KLYSYQ--------LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221

Query: 235 PEDQ---AYLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEII 279
              Q   +Y+ + F     Y APE  +     +   D++S G ++ E+I
Sbjct: 222 LAGQRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMI 265

Length = 440

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 31/212 (14%)

Query: 89  LLGRGGFGPVYRGK-LADGTLVAVKKLC-VDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           ++G+G +G V        G  VA+KK+  V +     +  L E++++  ++H ++V +  
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 147 CCSDGSQR-----LLVYEYMKNRSLDLLIYGESDK-------FLNWSTRFQIILGIARGL 194
                S+R      +V+E M++  L  +I    D        FL     +Q++    R L
Sbjct: 67  IMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFL-----YQLL----RAL 116

Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR--FFPEDQAYLSTNFAGTLGYT 252
           +Y+H  +   + HRD+K  N+L +   + KI DFGLAR  F     A   T++  T  Y 
Sbjct: 117 KYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173

Query: 253 APEY--AIRGELSEKADIYSFGVLVLEIISCR 282
           APE   +   + +   DI+S G +  E+++ +
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 54.9 bits (132), Expect = 5e-08
 Identities = 51/159 (32%), Positives = 74/159 (46%), Gaps = 38/159 (23%)

Query: 92  RGGFGPVYRG-KLADGTLVAVKKL----CVDKS--QQGESE----FLSE----VRMITSI 136
           RG FG VY G K  +  L AVK +     ++K+   Q ++E     LS+    V +  S+
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73

Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKN---RSLDLLIYGESDKFLNWSTRFQIILGIARG 193
           Q  N V             LV EY+     +SL L IYG  D+        + I  +A  
Sbjct: 74  QSANNV------------YLVMEYLIGGDVKSL-LHIYGYFDE----EMAVKYISEVALA 116

Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR 232
           L YLH      I+HRD+K  N+L+  +   K+ DFGL++
Sbjct: 117 LDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 24/214 (11%)

Query: 85  HPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLS---EVRMITSIQHKNL 141
           + G  +GRG +G VY+ K  DG     +K    K  +G    +S   E+ ++  ++H N+
Sbjct: 4   YEGCKVGRGTYGHVYKAKRKDGK---DEKEYALKQIEGTGISMSACREIALLRELKHPNV 60

Query: 142 VRLLGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKF------LNWSTRFQIILGIARG 193
           + L       S R   L+++Y ++    ++ +  + K       L  S    ++  I  G
Sbjct: 61  IALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120

Query: 194 LQYLHEDSHTRIVHRDIKASNVLL----DEKFQSKIGDFGLARFFPEDQAYLS--TNFAG 247
           + YLH +    ++HRD+K +N+L+     E+ + KI D G AR F      L+       
Sbjct: 121 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177

Query: 248 TLGYTAPEYAIRGELSEKA-DIYSFGVLVLEIIS 280
           T  Y APE  +      KA DI++ G +  E+++
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 18/199 (9%)

Query: 89  LLGRGGFGPVYRGKLA-DGTLVAVK----KLCVDKSQQGESEFLSEVR-MITSIQHKNLV 142
           ++G+G FG V   K   DG   AVK    K+ +++ +Q     ++E   ++ +++H  LV
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQ--KHIMAERNVLLKNVKHPFLV 59

Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            L        +   V +++    L   +  E   F     RF     IA  L YLH    
Sbjct: 60  GLHYSFQTTEKLYFVLDFVNGGELFFHLQRER-SFPEPRARFYAA-EIASALGYLHS--- 114

Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE--DQAYLSTNFAGTLGYTAPEYAIRG 260
             IV+RD+K  N+LLD +    + DFGL +   E   Q+  +T F GT  Y APE   + 
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEVIRKQ 171

Query: 261 ELSEKADIYSFGVLVLEII 279
                 D +  G ++ E++
Sbjct: 172 PYDNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 52.8 bits (126), Expect = 1e-07
 Identities = 52/214 (24%), Positives = 97/214 (45%), Gaps = 24/214 (11%)

Query: 85  HPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLS---EVRMITSIQHKNL 141
           + G  +GRG +G VY+ K  DG      +    K  +G    +S   E+ ++  ++H N+
Sbjct: 4   YEGCKVGRGTYGHVYKAKRKDGK---DDRDYALKQIEGTGISMSACREIALLRELKHPNV 60

Query: 142 VRLLGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRF------QIILGIARG 193
           + L       + R   L+++Y ++    ++ +  + K      +        ++  I  G
Sbjct: 61  ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120

Query: 194 LQYLHEDSHTRIVHRDIKASNVLL----DEKFQSKIGDFGLARFFPEDQAYLS--TNFAG 247
           + YLH +    ++HRD+K +N+L+     E+ + KI D G AR F      L+       
Sbjct: 121 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177

Query: 248 TLGYTAPEYAIRGELSEKA-DIYSFGVLVLEIIS 280
           T  Y APE  +      KA DI++ G +  E+++
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 56/218 (25%), Positives = 90/218 (41%), Gaps = 28/218 (12%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESE---FLSE 129
           DF+ LK          ++GRG FG V   KL +   V   K+         +E   F  E
Sbjct: 2   DFEILK----------VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 51

Query: 130 VRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QI 186
             ++ +  ++ +  L     D +   LV +Y     L  L+    D+      RF   ++
Sbjct: 52  RDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEM 111

Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA 246
           ++ I   +  LH       VHRDIK  N+L+D     ++ DFG      ED    S+   
Sbjct: 112 VIAI-DSVHQLH------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV 164

Query: 247 GTLGYTAPEYAI-----RGELSEKADIYSFGVLVLEII 279
           GT  Y +PE        +G+   + D +S GV + E++
Sbjct: 165 GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 51.8 bits (125), Expect = 2e-07
 Identities = 45/175 (25%), Positives = 79/175 (45%), Gaps = 24/175 (13%)

Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQY 196
           + N ++L    +     +L+ +Y+K+  L DLL   + +  L+ +   +II  +   L  
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL---KKEGKLSEAEVKKIIRQLVEALND 124

Query: 197 LHEDSHTRIVHRDIKASNVLLDE-KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE 255
           LH   H  I+H DIK  NVL D  K +  + D+GL +          + + GTL Y +PE
Sbjct: 125 LH--KHN-IIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIGT---PSCYDGTLDYFSPE 176

Query: 256 YAIRGEL-SEKADIYSFGVLVLEIISCR------KNTDLTLPSEMQYLPEYAWKL 303
             I+G       D ++ GVL  E+++ +      ++ +L     +        KL
Sbjct: 177 -KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD-LESLLKR--QQKKL 227

Length = 267

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 4/92 (4%)

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LSTNFAGT 248
           +A+G+ +L   +    +HRD+ A N+LL     +KI DFGLAR    D  Y +  N    
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279

Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           + + APE       + ++D++S+G+L+ EI S
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 17/212 (8%)

Query: 77  LKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLC--VDKSQQGESEFLSEVRMIT 134
           L+   +++    ++GRG FG V   +      V   KL    +  ++ +S F  E R I 
Sbjct: 38  LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97

Query: 135 SIQHKNLVRLLGCC-SDGSQRLLVYEYMKNRSLDLLI--YGESDKFLNWSTRFQIILGIA 191
           +  +   V  L C   D     +V EYM    L  L+  Y   +K+  + T  +++L   
Sbjct: 98  AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTA-EVVLA-- 154

Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY 251
             L  +H      ++HRD+K  N+LLD+    K+ DFG      E          GT  Y
Sbjct: 155 --LDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDY 209

Query: 252 TAPEYAIR----GELSEKADIYSFGVLVLEII 279
            +PE        G    + D +S GV + E++
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.2 bits (120), Expect = 8e-07
 Identities = 51/178 (28%), Positives = 78/178 (43%), Gaps = 24/178 (13%)

Query: 83  NFHPGNLLGRGGFGPV-YRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN- 140
           +FH   ++G+G FG V    K   G + A+K L   KS+  + + L+ V+    +  ++ 
Sbjct: 2   DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLL--KSEMFKKDQLAHVKAERDVLAESD 59

Query: 141 ---LVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRF---QIILGIARG 193
              +V L     D     L+ E++    L  +LI  + D F    TRF   + +L I   
Sbjct: 60  SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI--KYDTFSEDVTRFYMAECVLAI--- 114

Query: 194 LQYLHEDSHTR-IVHRDIKASNVLLDEKFQSKIGDFGLARFF--PEDQAYLSTNFAGT 248
                E  H    +HRDIK  N+L+D     K+ DFGL+  F    D AY      G 
Sbjct: 115 -----EAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGK 167

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 50.0 bits (119), Expect = 9e-07
 Identities = 61/240 (25%), Positives = 101/240 (42%), Gaps = 21/240 (8%)

Query: 49  ALRTTKEGVSKDFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL 108
           ALR  K     +F N    TI+    + L+   +++    ++GRG FG V   +      
Sbjct: 14  ALRKNKN--IDNFLNRYKDTIN--KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK 69

Query: 109 VAVKKLC--VDKSQQGESEFLSEVRMITSIQHKN-LVRLLGCCSDGSQRLLVYEYMKNRS 165
           V   KL    +  ++ +S F  E R I +  +   +V+L     D     +V EYM    
Sbjct: 70  VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGD 129

Query: 166 LDLLI--YGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS 223
           L  L+  Y   +K+  + T  +++L     L  +H       +HRD+K  N+LLD+    
Sbjct: 130 LVNLMSNYDVPEKWARFYTA-EVVLA----LDAIHS---MGFIHRDVKPDNMLLDKSGHL 181

Query: 224 KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR----GELSEKADIYSFGVLVLEII 279
           K+ DFG      ++         GT  Y +PE        G    + D +S GV + E++
Sbjct: 182 KLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 55/215 (25%), Positives = 86/215 (40%), Gaps = 22/215 (10%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESE---FLSE 129
           DF+ +K          ++GRG FG V   K+     +   K+         +E   F  E
Sbjct: 2   DFEIIK----------VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREE 51

Query: 130 VRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG 189
             ++ +   + +  L     D +   LV +Y     L  L+    D+      RF I   
Sbjct: 52  RNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYI--- 108

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
            A  +  +H       VHRDIK  NVLLD     ++ DFG      +D    S+   GT 
Sbjct: 109 -AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP 167

Query: 250 GYTAPEY--AIR---GELSEKADIYSFGVLVLEII 279
            Y +PE   A+    G+   + D +S GV + E++
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 61/277 (22%), Positives = 95/277 (34%), Gaps = 65/277 (23%)

Query: 71  YFDFQTLKKATKNFHP---------GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQ 121
           + D   L      F P         G  LG G FG VY+  L +       K  + K+ +
Sbjct: 112 FVDMFVLAPLEGLFRPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATE 171

Query: 122 -GESEFLSEVRM-------ITSIQHKNLVRLLGCCSDGSQRLLVYEY---------MKNR 164
            G  E     R+            +  L  +        +  LV+ Y         M+++
Sbjct: 172 YGAVEIWMNERVRRACPNSCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSK 229

Query: 165 ----SLDLLIYGESDKFLNWSTRFQIILG-----IARGLQYLHEDSHTRIVHRDIKASNV 215
               +++  + G+         R   I+      I   L  LH    T IVHRD+K  N+
Sbjct: 230 EFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNI 286

Query: 216 LLDEKFQS-KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-------------- 260
           +  E   S KI D G A        Y+   F     Y APE  I                
Sbjct: 287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATA 346

Query: 261 --------ELSEKADIYSFGVLVLEII--SCRKNTDL 287
                    L ++ DIYS G++ L++   + R +++L
Sbjct: 347 LSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNL 383

Length = 566

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 59/246 (23%), Positives = 104/246 (42%), Gaps = 56/246 (22%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVR 131
           DF++LK          ++GRG FG V   +  D G + A+K L   K+   E E ++ +R
Sbjct: 2   DFESLK----------VIGRGAFGEVRLVQKKDTGHIYAMKIL--RKADMLEKEQVAHIR 49

Query: 132 ----MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII 187
               ++       +V++     D     L+ E++    +  L+  + D     +T+F I 
Sbjct: 50  AERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM-KKDTLSEEATQFYIA 108

Query: 188 LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGL---------ARFF---- 234
             +   +  +H+      +HRDIK  N+LLD K   K+ DFGL           F+    
Sbjct: 109 ETVL-AIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLT 164

Query: 235 ---PEDQAY------------------LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGV 273
              P D ++                  L+ +  GT  Y APE  ++   ++  D +S GV
Sbjct: 165 HNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224

Query: 274 LVLEII 279
           ++ E++
Sbjct: 225 IMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 4/87 (4%)

Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           L+ LH+     +++RD+K  N+LLD +    + DFGL +   +D    +T F GT  Y A
Sbjct: 106 LENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLA 161

Query: 254 PEYAIRGELSEKADIYSFGVLVLEIIS 280
           PE  +    ++  D ++ GVL+ E+++
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 34/99 (34%), Positives = 49/99 (49%), Gaps = 14/99 (14%)

Query: 187 ILGIARGL----QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS 242
           +  +AR L     Y+H +    I+HRDIK  NVL++      +GDFG A F    +   S
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFA---RGSWS 315

Query: 243 TNF----AGTLGYTAPEYAIRGELSEKADIYSFGVLVLE 277
           T F    AGT+   APE       +   DI+S G+++ E
Sbjct: 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 59/246 (23%), Positives = 98/246 (39%), Gaps = 56/246 (22%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVR 131
           DF++LK          ++GRG FG V   +  D G + A+K L   K+   E E +  +R
Sbjct: 2   DFESLK----------VIGRGAFGEVRLVQKKDTGHVYAMKIL--RKADMLEKEQVGHIR 49

Query: 132 ----MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII 187
               ++       +V++     D     L+ E++    +  L+  + D      T+F I 
Sbjct: 50  AERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM-KKDTLTEEETQFYI- 107

Query: 188 LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGL---------ARFF---- 234
              A  +  +        +HRDIK  N+LLD K   K+ DFGL           F+    
Sbjct: 108 ---AETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLN 164

Query: 235 ---PEDQAYLSTN------------------FAGTLGYTAPEYAIRGELSEKADIYSFGV 273
              P D  + + N                    GT  Y APE  ++   ++  D +S GV
Sbjct: 165 HSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224

Query: 274 LVLEII 279
           ++ E++
Sbjct: 225 IMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 39/140 (27%), Positives = 65/140 (46%), Gaps = 16/140 (11%)

Query: 90  LGRGGFGPVYRGKLAD---------GTLVAVKKL--CVDKSQQGES-EFLSEVRMITSIQ 137
           LGRG    +Y G L                +K +   +D S +  S  F     M+  + 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYL 197
           HK++V L G C    + ++V E+++   LDL ++ +SD  L    +F++   +A  L YL
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQLASALSYL 121

Query: 198 HEDSHTRIVHRDIKASNVLL 217
            ED    +VH ++   N+LL
Sbjct: 122 -EDK--DLVHGNVCTKNILL 138

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.9 bits (104), Expect = 2e-05
 Identities = 31/146 (21%), Positives = 57/146 (39%), Gaps = 15/146 (10%)

Query: 93  GGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV--RLLGCCSD 150
           G    VY     D   V +K      S++  ++   EV ++  +  K L   ++L     
Sbjct: 9   GLTNRVYLLGTKDEDYV-LKIN---PSREKGADREREVAILQLLARKGLPVPKVLASGES 64

Query: 151 GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDI 210
                L+ E+++  +LD +   E +          I   +A  L  LH+     + H D+
Sbjct: 65  DGWSYLLMEWIEGETLDEVSEEEKE---------DIAEQLAELLAKLHQLPLLVLCHGDL 115

Query: 211 KASNVLLDEKFQSKIGDFGLARFFPE 236
              N+L+D+     I D+  A + P 
Sbjct: 116 HPGNILVDDGKILGIIDWEYAGYGPP 141

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 47/189 (24%), Positives = 88/189 (46%), Gaps = 18/189 (9%)

Query: 106 GTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNR 164
           GTLV V+   ++   +   + L +EV +    +H N++      + GS   ++  +M   
Sbjct: 25  GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84

Query: 165 SLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSK 224
           S + L+     + ++ +    I+ G  RGL YLH++ +   +HR+IKAS++L+       
Sbjct: 85  SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY---IHRNIKASHILISGDGLVS 141

Query: 225 IGDFGLARFF-------PEDQAYLSTNFA-GTLGYTAPEYAIRGELSE---KADIYSFGV 273
           +   GL+  +            Y    F+   L + +PE  +R +L     K+DIYS G+
Sbjct: 142 LS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL-LRQDLYGYNVKSDIYSVGI 198

Query: 274 LVLEIISCR 282
              E+ + R
Sbjct: 199 TACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 30/85 (35%), Positives = 42/85 (49%), Gaps = 7/85 (8%)

Query: 83  NFHPGNLLGRGGFGPVYR------GKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI 136
           N   G  LG G FG V        GK  +   VAVK L            +SE+++++ +
Sbjct: 39  NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHL 98

Query: 137 -QHKNLVRLLGCCSDGSQRLLVYEY 160
            QHKN+V LLG C+ G   L++ EY
Sbjct: 99  GQHKNIVNLLGACTHGGPVLVITEY 123

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 28/218 (12%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCV-DKSQQGESE-FLSE 129
           DF+ LK          ++GRG FG V   K+ + G + A+K L   +  ++ E+  F  E
Sbjct: 2   DFEILK----------VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREE 51

Query: 130 VRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QI 186
             ++ +   + +  L     D +   LV +Y     L  L+    D+      RF   ++
Sbjct: 52  RDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEM 111

Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA 246
           +L I      +H+      VHRDIK  NVLLD+    ++ DFG       D    S    
Sbjct: 112 VLAI----DSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV 164

Query: 247 GTLGYTAPEY--AI---RGELSEKADIYSFGVLVLEII 279
           GT  Y +PE   A+   +G    + D +S GV + E++
Sbjct: 165 GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 44.4 bits (105), Expect = 6e-05
 Identities = 28/100 (28%), Positives = 46/100 (46%), Gaps = 17/100 (17%)

Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF--------------PEDQA 239
           L+YLH      IVHRD+K  N+L+      K+ DFGL++                 + + 
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
           +L     GT  Y APE  +R    +  D ++ G+++ E +
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 44.1 bits (104), Expect = 6e-05
 Identities = 56/241 (23%), Positives = 101/241 (41%), Gaps = 39/241 (16%)

Query: 126 FLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF-LNWSTRF 184
           F     +++ + H +L  + G C  GS+ ++V E++++  LD+ +  E  +  + W  + 
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120

Query: 185 QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS-------KIGDFGLARFFPED 237
            +   +A  L YL + +   +VH ++ A N+LL     +       K+ D G++      
Sbjct: 121 TVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSF----- 172

Query: 238 QAYLSTNFAGTLGYTAPEYAIRG--ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQY 295
            A         + + APE  + G   LS  AD +SFG  +LEI  C  + ++ L      
Sbjct: 173 TALSREERVERIPWIAPE-CVPGGNSLSTAADKWSFGTTLLEI--CF-DGEVPLKERT-- 226

Query: 296 LPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
            P    + YE            +K  + E    ++  +   CL     QRP    I+  L
Sbjct: 227 -PSEKERFYE------------KKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273

Query: 356 T 356
           T
Sbjct: 274 T 274

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 8/105 (7%)

Query: 87  GNLLGRGGFGPVYRG------KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHK 139
           G  LGRG FG V         K A    VAVK L    +       +SE++++  I  H 
Sbjct: 12  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 71

Query: 140 NLVRLLGCCSD-GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR 183
           N+V LLG C+  G   +++ E+ K  +L   +  +  +F+ + T+
Sbjct: 72  NVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTK 116

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 41/148 (27%), Positives = 63/148 (42%), Gaps = 16/148 (10%)

Query: 87  GNLLGRGGFGPVYR------GKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHK 139
           G  LGRG FG V +       K A    VAVK L    +       ++E++++  I  H 
Sbjct: 12  GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHL 71

Query: 140 NLVRLLGCCSDGSQRLLV-YEYMKNRSLDLLIYGESDKFL---NWSTRFQIILGIARGLQ 195
           N+V LLG C+     L+V  EY K  +L   +  + + F    N STR + +       Q
Sbjct: 72  NVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQ 131

Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQS 223
            L       +      AS+  +++K  S
Sbjct: 132 RL-----DSVSSSQSSASSGFIEDKSLS 154

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 41.5 bits (98), Expect = 5e-04
 Identities = 63/236 (26%), Positives = 101/236 (42%), Gaps = 48/236 (20%)

Query: 82  KNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGE----SEFLSEVRMITSI 136
           K+F    LLG+G  G V+  +L   G L A+K   +DK +  +       L+E  ++ ++
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALK--VLDKKEMIKRNKVKRVLTEQEILATL 58

Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWST-RF---QIILGIAR 192
            H  L  L       +   LV +Y     L  L+  +  K L+    RF   +++L    
Sbjct: 59  DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA--- 115

Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLA--------------------- 231
            L+YLH      IV+RD+K  N+LL E     + DF L+                     
Sbjct: 116 -LEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171

Query: 232 -------RFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKA-DIYSFGVLVLEII 279
                    F E+ ++ S +F GT  Y APE  I G+    A D ++ G+L+ E++
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEML 226

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 7/81 (8%)

Query: 87  GNLLGRGGFGPV-----YRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSI-QHK 139
           G  LG G FG V     Y    +D  + VAVK L            +SE+++++ +  H 
Sbjct: 40  GKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHI 99

Query: 140 NLVRLLGCCSDGSQRLLVYEY 160
           N+V LLG C+ G   L++ EY
Sbjct: 100 NIVNLLGACTVGGPTLVITEY 120

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 41.3 bits (96), Expect = 0.001
 Identities = 48/211 (22%), Positives = 94/211 (44%), Gaps = 34/211 (16%)

Query: 120 QQGESEFLSEVRMITSIQHKNLVRLLG-CCSDGSQRL-LVYEYMKNRSLDLLIYGESDKF 177
           ++ +S+ + EV ++  ++HKN+VR +    +  +Q+L ++ E+     L   I      F
Sbjct: 53  EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMF 112

Query: 178 --LNWSTRFQIILGIARGLQYLHE----DSHTRIVHRDIKASNVLLDEKFQ--------- 222
             +       I   +   L Y H      +  R++HRD+K  N+ L    +         
Sbjct: 113 GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172

Query: 223 --------SKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELS--EKADIYSFG 272
                   +KIGDFGL++    +   ++ +  GT  Y +PE  +    S  +K+D+++ G
Sbjct: 173 NNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG 230

Query: 273 VLVLEIISCRK-----NTDLTLPSEMQYLPE 298
            ++ E+ S +      N    L SE++  P+
Sbjct: 231 CIIYELCSGKTPFHKANNFSQLISELKRGPD 261

Length = 1021

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 62/261 (23%), Positives = 98/261 (37%), Gaps = 68/261 (26%)

Query: 90  LGRGGFGPVYRGKLAD-GTLVAVKKL----CVDKSQ----QGESEFLSEVRMITSIQHKN 140
           LG G FG V      D   L A+K L     ++++Q    + E + L+E        ++ 
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA------DNEW 62

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
           +V+L     D      V +Y+    +  LLI  E   F     RF I   +   ++ +H+
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEV--FPEVLARFYIA-ELTLAIESVHK 119

Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF---------------------PED- 237
                 +HRDIK  N+L+D     K+ DFGL   F                     P D 
Sbjct: 120 ---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176

Query: 238 ------------------------QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGV 273
                                   Q  L+ +  GT  Y APE  +R   ++  D +S GV
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236

Query: 274 LVLEIISCRKNTDLTLPSEMQ 294
           ++ E++  +       P+E Q
Sbjct: 237 ILFEMLVGQPPFLAPTPTETQ 257

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	407
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.85
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.83
PRK10345	210	hypothetical protein; Provisional	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.79
smart00090	237	RIO RIO-like kinase.	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.76
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.69
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.67
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.59
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.51
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.48
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.47
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.41
KOG3087	229	consensus Serine/threonine protein kinase [General	99.39
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.35
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.31
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.31
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.3
KOG1243	690	consensus Protein kinase [General function predict	99.3
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.17
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.14
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.1
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.06
COG4248	637	Uncharacterized protein with protein kinase and he	99.05
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.87
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.85
PRK09902	216	hypothetical protein; Provisional	98.83
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.81
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.69
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.6
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.6
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.59
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.57
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.52
PF01636	239	APH: Phosphotransferase enzyme family This family	98.4
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.37
PLN02876	822	acyl-CoA dehydrogenase	98.28
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.23
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.16
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.13
PRK10593	297	hypothetical protein; Provisional	98.07
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.04
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.03
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.96
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.88
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.74
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.74
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.74
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.71
PRK05231	319	homoserine kinase; Provisional	97.66
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.63
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.55
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.46
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.21
PLN02236	344	choline kinase	97.07
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.07
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.97
KOG2270	520	consensus Serine/threonine protein kinase involved	96.92
PLN02756	418	S-methyl-5-thioribose kinase	96.74
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.6
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.57
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.55
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.51
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.41
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.17
COG2334	331	Putative homoserine kinase type II (protein kinase	96.16
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.11
PRK11768	325	serine/threonine protein kinase; Provisional	95.98
PRK06148	1013	hypothetical protein; Provisional	95.93
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.88
PRK12396	409	5-methylribose kinase; Reviewed	95.51
PF01102	122	Glycophorin_A: Glycophorin A; InterPro: IPR001195	95.15
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	95.14
PTZ00384	383	choline kinase; Provisional	95.09

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-60  Score=447.50  Aligned_cols=288  Identities=48%  Similarity=0.846  Sum_probs=256.5

Q ss_pred             cccccCHHHHHHHhcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeee
Q 040557           68 TISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGC  147 (407)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~  147 (407)
                      ....|++.++..+|++|...+.||+|+||.||+|.+.+|..||||++....... ..+|.+|++++.+++|||+|+++||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence            456699999999999999999999999999999999999999999886544432 5669999999999999999999999


Q ss_pred             eecCC-eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEe
Q 040557          148 CSDGS-QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIG  226 (407)
Q Consensus       148 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~  226 (407)
                      |.+.+ +.+||||||++|+|.++++......++|..|++||.++|+||+|||....++|+|||||++|||||+++++||+
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            99988 59999999999999999987654379999999999999999999999988899999999999999999999999


Q ss_pred             cccCccccCC-CCccccccc-ccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHH
Q 040557          227 DFGLARFFPE-DQAYLSTNF-AGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLY  304 (407)
Q Consensus       227 Dfgla~~~~~-~~~~~~~~~-~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~  304 (407)
                      |||+|+..+. ....  ... .||.+|+|||++..+..++|+|||||||+|+||+||+++.+...+.....+..|.+..+
T Consensus       220 DFGLa~~~~~~~~~~--~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTSV--STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCccccce--eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            9999976654 2221  122 79999999999999999999999999999999999999998776665666889999999


Q ss_pred             HhCccccccCcccccCCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          305 ERGRILELVDPRMRKEGIVE-RDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       305 ~~~~~~~~~d~~~~~~~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .++.+.+++|+.+....... .....+..++.+|++.+|++||+|.||+++|...
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~  352 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI  352 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence            99999999999997444443 6788899999999999999999999999999543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-51  Score=383.69  Aligned_cols=256  Identities=32%  Similarity=0.513  Sum_probs=211.6

Q ss_pred             CCCCeeeccCCccEEEEEecCCcE-EEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC-eeEEEEEec
Q 040557           85 HPGNLLGRGGFGPVYRGKLADGTL-VAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS-QRLLVYEYM  161 (407)
Q Consensus        85 ~~~~~lg~G~~g~Vy~~~~~~~~~-vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~  161 (407)
                      ...+.||+|+||+||+|.+. |.. ||||++.... .......|.+|+.+|.+++|||||+++|+|.+.. ..++||||+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~-g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWR-GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhcccCCceeEEEEEeC-CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            33456999999999999996 555 9999996543 2222678999999999999999999999999887 799999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC-ceEEecccCccccCCCCcc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF-QSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~~~  240 (407)
                      ++|+|..+++......+++..+++++.|||+||.|||+.+.  ||||||||.|||++.++ ++||+|||+++...... .
T Consensus       123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~  199 (362)
T KOG0192|consen  123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T  199 (362)
T ss_pred             CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence            99999999987556679999999999999999999999863  99999999999999997 99999999998765432 2


Q ss_pred             cccccccCccccCccccc--cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          241 LSTNFAGTLGYTAPEYAI--RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~--~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                      ..+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||....+.      .........+.          
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~------~~~~~v~~~~~----------  263 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV------QVASAVVVGGL----------  263 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcCC----------
Confidence            233468999999999999  669999999999999999999999999865431      11222222221          


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                      ....+..++..+..++.+||+.||+.||++.+++..|+....
T Consensus       264 Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  264 RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence            112233366779999999999999999999999999986654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-52  Score=367.85  Aligned_cols=257  Identities=27%  Similarity=0.391  Sum_probs=215.0

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC-eeEEEEEe
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS-QRLLVYEY  160 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  160 (407)
                      +.+..+.||+|..|+||+++++ +++.+|+|.+.........+++.+|+++++.++||+||.++|+|.+.. ...++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            3445678999999999999875 689999999977777777889999999999999999999999999888 59999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccc-cCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE-DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |++|+|+.++...  +.+++....+++.++++||.|||. .+   |+||||||+|||++..|++||||||.+..+.+.  
T Consensus       160 MDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             cCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            9999999998543  559999999999999999999996 55   999999999999999999999999999987655  


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                       ...+++||..|||||.+.+..|+.++||||||+.++|+.+|+.|+....+..... .+...         .+++...  
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~-~~Ll~---------~Iv~~pp--  299 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDI-FELLC---------AIVDEPP--  299 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCH-HHHHH---------HHhcCCC--
Confidence             3457899999999999999999999999999999999999999987652221111 11111         1111111  


Q ss_pred             CCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          320 EGIVE-RDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       320 ~~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ...+. ..+.++.+++..||++||.+|||+.|+++|-+-..
T Consensus       300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~  340 (364)
T KOG0581|consen  300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK  340 (364)
T ss_pred             CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence            01222 36678999999999999999999999999987553

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.5e-51  Score=383.02  Aligned_cols=253  Identities=28%  Similarity=0.435  Sum_probs=217.1

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ..|..++.||+|||++||.++. .+|+.||+|++.+..  .....+.+.+|+++.+.|+|||||+++++|++.++.|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688899999999999999986 789999999997643  3445567899999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      |+|.+++|.+++.  .++.+++.++..++.||+.||.|||+++   |+|||||..|+||+++.++||+|||||..+..+.
T Consensus        98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            9999999999985  5677999999999999999999999998   9999999999999999999999999999887553


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                      . ...+.+|||.|+|||++....++..+||||+|||+|-|++|++||+...          +.+.+..-+..+       
T Consensus       173 E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~----------vkety~~Ik~~~-------  234 (592)
T KOG0575|consen  173 E-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT----------VKETYNKIKLNE-------  234 (592)
T ss_pred             c-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch----------HHHHHHHHHhcC-------
Confidence            2 3456899999999999999999999999999999999999999997432          111111111111       


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                       ...+.....+..+||..+|+.||.+|||+++|+.|-.+.
T Consensus       235 -Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~  273 (592)
T KOG0575|consen  235 -YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK  273 (592)
T ss_pred             -cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence             112334456788999999999999999999999998763

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-50  Score=373.03  Aligned_cols=251  Identities=32%  Similarity=0.469  Sum_probs=214.2

Q ss_pred             CCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCCh
Q 040557           87 GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL  166 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  166 (407)
                      .+.||+|.||.||.|.+.....||+|.++..  ....+.|.+|+++|++|+|+|||+++|+|..+...+||||||+.|+|
T Consensus       211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~--~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL  288 (468)
T KOG0197|consen  211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEG--SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL  288 (468)
T ss_pred             HHHhcCCccceEEEEEEcCCCcccceEEecc--ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence            4679999999999999977779999999654  34456788999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccccccc
Q 040557          167 DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA  246 (407)
Q Consensus       167 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  246 (407)
                      .+++....+..+.....+.++.|||+||+||++++   +|||||.++||||+++..+||+|||||+...++.........
T Consensus       289 l~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~k  365 (468)
T KOG0197|consen  289 LDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGK  365 (468)
T ss_pred             HHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCC
Confidence            99998767788999999999999999999999998   999999999999999999999999999977777766666666


Q ss_pred             cCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHH
Q 040557          247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVER  325 (407)
Q Consensus       247 gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  325 (407)
                      -+..|.|||.+..+.++.|||||||||+||||+| |+.|+....       ...+.+.++.|-       ++.   .+..
T Consensus       366 fPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-------n~ev~~~le~Gy-------Rlp---~P~~  428 (468)
T KOG0197|consen  366 FPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-------NEEVLELLERGY-------RLP---RPEG  428 (468)
T ss_pred             CCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-------HHHHHHHHhccC-------cCC---CCCC
Confidence            7889999999999999999999999999999999 444543322       122333344332       222   3455


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          326 DALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       326 ~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ++..+.+++..||+.+|++|||++.+...|+...
T Consensus       429 CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  429 CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence            7788999999999999999999999988887543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-50  Score=361.55  Aligned_cols=259  Identities=24%  Similarity=0.315  Sum_probs=210.8

Q ss_pred             HhcCCCCCCeeeccCCccEEEEE-ecCCcEEEEEEeccccChh------hHHHHHHHHHHHHcCCCCceeeeeeeeecCC
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQ------GESEFLSEVRMITSIQHKNLVRLLGCCSDGS  152 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  152 (407)
                      ..+.|.+.+.||+|+||.|-+|. .++|+.||||++.......      ....+.+|+++|++++|||||++.+++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            44678888999999999999997 4579999999997643221      2334679999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCC---CceEEeccc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEK---FQSKIGDFG  229 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfg  229 (407)
                      ..|+||||++||+|.+.+-.+  +.+.+..-.-++.|++.|+.|||+.|   |+||||||+|||+..+   ..+||+|||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence            999999999999999988543  44777777889999999999999999   9999999999999866   789999999


Q ss_pred             CccccCCCCcccccccccCccccCccccccCCC---CccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh
Q 040557          230 LARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL---SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER  306 (407)
Q Consensus       230 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      +|+.....  ....+.|||+.|.|||++.++..   ..++|+||+||+||-+++|.+||.......      -..+.+..
T Consensus       325 lAK~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~------sl~eQI~~  396 (475)
T KOG0615|consen  325 LAKVSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP------SLKEQILK  396 (475)
T ss_pred             hhhccccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc------cHHHHHhc
Confidence            99988743  34567899999999999987643   458899999999999999999997654331      01222333


Q ss_pred             CccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          307 GRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       307 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      |+....       ...-.....+..++|.+||..||++|||+.|+++|.|..
T Consensus       397 G~y~f~-------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~  441 (475)
T KOG0615|consen  397 GRYAFG-------PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK  441 (475)
T ss_pred             Cccccc-------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence            332210       011223567789999999999999999999999999975

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3e-49  Score=354.26  Aligned_cols=203  Identities=32%  Similarity=0.548  Sum_probs=182.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .+|...+.||.|+||+||+|++. ++..||||.+.... .....+.+..|+.+|+.++|||||++++++.+++..|+|||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            56777888999999999999864 58999999997665 55666778899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCC------CceEEecccCccc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEK------FQSKIGDFGLARF  233 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~------~~~kl~Dfgla~~  233 (407)
                      ||.||+|..+++..  +.+++.+...++.|+|.||++||+++   |+||||||.||||+..      -.+||+|||+|+.
T Consensus        90 yC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             eCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            99999999999654  46999999999999999999999999   9999999999999865      4689999999999


Q ss_pred             cCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCc
Q 040557          234 FPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPS  291 (407)
Q Consensus       234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~  291 (407)
                      +....  ...+.+|++.|||||+++..+|+.|+|+||+|++||++++|+.||+...+.
T Consensus       165 L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~  220 (429)
T KOG0595|consen  165 LQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK  220 (429)
T ss_pred             CCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence            87543  345789999999999999999999999999999999999999999865544

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.4e-49  Score=383.87  Aligned_cols=257  Identities=30%  Similarity=0.477  Sum_probs=218.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRL  155 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  155 (407)
                      .+....+.||+|+||.||+|+..      +...||||.++.....+...+|.+|+++|+.++|||||+++|.|..++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            45555678999999999999743      346799999988777778899999999999999999999999999999999


Q ss_pred             EEEEeccCCChhHHHhccC--------C----CCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCce
Q 040557          156 LVYEYMKNRSLDLLIYGES--------D----KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS  223 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~--------~----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~  223 (407)
                      +|+|||..|||.++|....        +    ..|+..+.+.||.|||.||+||-++.   +|||||..+|+||.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence            9999999999999996432        1    23889999999999999999999988   9999999999999999999


Q ss_pred             EEecccCccccCCCCccccc-ccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHH
Q 040557          224 KIGDFGLARFFPEDQAYLST-NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAW  301 (407)
Q Consensus       224 kl~Dfgla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~  301 (407)
                      ||+||||++..-..+++... +..-+.+||+||.++.++||++||||||||+|||++| |+.|+.+...       +.+-
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-------~EVI  715 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-------QEVI  715 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-------HHHH
Confidence            99999999977655555433 4556789999999999999999999999999999998 5666654332       3344


Q ss_pred             HHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          302 KLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       302 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      +.+..|++.          ..++.++..+++|+..||+.+|.+||+++||-..|...
T Consensus       716 e~i~~g~lL----------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~  762 (774)
T KOG1026|consen  716 ECIRAGQLL----------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW  762 (774)
T ss_pred             HHHHcCCcc----------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence            555656543          24566788899999999999999999999999988754

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5e-50  Score=342.37  Aligned_cols=258  Identities=25%  Similarity=0.412  Sum_probs=208.3

Q ss_pred             cCCCCCCeeeccCCccEEEEE-ecCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeee-eecCCe-eEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGC-CSDGSQ-RLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~-~~~~~~-~~lv  157 (407)
                      .+|.+.++||.|+||+||++. ..+|..+|.|.+.... +....+.+..|+.+|++|+|||||+++++ +...+. +++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            345666789999999999996 6789999999986443 44556788999999999999999999984 444444 8999


Q ss_pred             EEeccCCChhHHHhc--cCCCCCCHHHHHHHHHHHHHHhccccccC-CCceeeeccccccEEEcCCCceEEecccCcccc
Q 040557          158 YEYMKNRSLDLLIYG--ESDKFLNWSTRFQIILGIARGLQYLHEDS-HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF  234 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~  234 (407)
                      ||||.+|+|..++..  ...+.+++..+|+++.|++.||..+|+.- ...|+||||||.||+|+.+|.|||+||||++++
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999998853  33567999999999999999999999932 123999999999999999999999999999999


Q ss_pred             CCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          235 PEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       235 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      ...... ....+|||.||+||.+.+..|+.||||||+||++|||+.-++||.+..      + ....+.+..+...    
T Consensus       179 ~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~-~~L~~KI~qgd~~----  246 (375)
T KOG0591|consen  179 SSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------L-LSLCKKIEQGDYP----  246 (375)
T ss_pred             cchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------H-HHHHHHHHcCCCC----
Confidence            776654 456899999999999999999999999999999999999999998652      1 1122233333211    


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                       .+    ..+..+.++..|+..|+..||+.||+...++..+.
T Consensus       247 -~~----p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  247 -PL----PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             -CC----cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence             11    11456778999999999999999998555554443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-48  Score=343.21  Aligned_cols=253  Identities=23%  Similarity=0.316  Sum_probs=209.8

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      .++|++.++||+|+||.||+++. ++++.+|+|++++...  .........|..+|.+++||.||+++..|.+...+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            46789999999999999999975 4689999999976542  23467788999999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      +||+.||.|..++.  +...+++..+..++.+|+.||.|||+.+   |+||||||+|||||++|.++|+||||++.....
T Consensus       104 ld~~~GGeLf~hL~--~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQ--REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EeccCCccHHHHHH--hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            99999999999995  3445899999999999999999999999   999999999999999999999999999965443


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      .. .+.+++||+.|||||++.+..|+..+|.||+|+++|||++|.+||......      .+..+... ++        +
T Consensus       179 ~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~~I~~-~k--------~  242 (357)
T KOG0598|consen  179 GD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYDKILK-GK--------L  242 (357)
T ss_pred             CC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHHHHhc-Cc--------C
Confidence            32 234589999999999999999999999999999999999999999865432      22222222 22        0


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCC----CHHHHHHHhh
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRP----PMSEIVAMLT  356 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP----s~~ev~~~l~  356 (407)
                      .  ..+.-.+.+..+++...|+.||++|.    .+.+|.+|-.
T Consensus       243 ~--~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~Hpf  283 (357)
T KOG0598|consen  243 P--LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPF  283 (357)
T ss_pred             C--CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcc
Confidence            0  11222445688999999999999995    5777766644

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-47  Score=342.82  Aligned_cols=260  Identities=29%  Similarity=0.422  Sum_probs=208.8

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecC-CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC--eeEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS--QRLLV  157 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv  157 (407)
                      ..+|..++.||+|+||+||++...+ |...|||.+....... .+.+.+|+.+|.+++|||||+++|......  .+++.
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence            3567778999999999999998654 8999999986553333 567889999999999999999999855444  68999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC-CCceEEecccCccccCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE-KFQSKIGDFGLARFFPE  236 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfgla~~~~~  236 (407)
                      |||+++|+|.+++....+ .+++..+..++.||++||.|||+++   ++||||||+|||++. ++.+||+|||++.....
T Consensus        95 mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            999999999999977666 7999999999999999999999998   999999999999999 79999999999987763


Q ss_pred             --CCcccccccccCccccCccccccCC-CCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccccc
Q 040557          237 --DQAYLSTNFAGTLGYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV  313 (407)
Q Consensus       237 --~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                        ..........||+.|||||++..+. ...++|||||||++.||+||++||....     ....+.......+..    
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~~~~~ig~~~~~----  241 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAEALLLIGREDSL----  241 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHHHHHHHhccCCC----
Confidence              2222234578999999999998643 3459999999999999999999987430     001111221111111    


Q ss_pred             CcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       314 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                       |     ..+...+.+..+++..|++.||++|||++++++|......
T Consensus       242 -P-----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~  282 (313)
T KOG0198|consen  242 -P-----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN  282 (313)
T ss_pred             -C-----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence             1     2334456678899999999999999999999999865443

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-46  Score=338.23  Aligned_cols=268  Identities=23%  Similarity=0.328  Sum_probs=218.7

Q ss_pred             hcCCCCCCeeeccCCccEEEEE-ecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .+.|++.+.||.|..++||+|+ .+.++.||||++..++.......+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            3678889999999999999997 567899999999988877778899999999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC-
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ-  238 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~-  238 (407)
                      ||.+|++.+++...-...+++..+..|+.++++||.|||++|   .||||||+.||||+++|.|||+|||.+..+-... 
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            999999999998777777999999999999999999999999   9999999999999999999999999987654322 


Q ss_pred             --cccccccccCccccCcccccc--CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          239 --AYLSTNFAGTLGYTAPEYAIR--GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       239 --~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                        ......++||+.|||||+++.  ..|+.|+||||||++..||.+|..||....+...      ....++ +......-
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv------Ll~tLq-n~pp~~~t  254 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV------LLLTLQ-NDPPTLLT  254 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH------HHHHhc-CCCCCccc
Confidence              111155789999999999554  4799999999999999999999999976554321      111111 11111110


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ... ...........+.+++..||+.||++|||+++++++-.+..
T Consensus       255 ~~~-~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~  298 (516)
T KOG0582|consen  255 SGL-DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKK  298 (516)
T ss_pred             ccC-ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhh
Confidence            000 00111223457889999999999999999999998866544

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=9e-48  Score=367.73  Aligned_cols=257  Identities=26%  Similarity=0.447  Sum_probs=214.0

Q ss_pred             CCCCCeeeccCCccEEEEEec----CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           84 FHPGNLLGRGGFGPVYRGKLA----DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      ..+.++||.|.||.||+|+++    ....||||.++.........+|+.|+.+|.+.+||||++|.|+.......++|+|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            456778999999999999875    2457999999887788888899999999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      ||+||+|+.+|+.+.++ +++.+..-++.+||.||.||.+.+   +|||||..+|||++.+..+|++||||++.+.++..
T Consensus       711 yMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~  786 (996)
T KOG0196|consen  711 YMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  786 (996)
T ss_pred             hhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence            99999999999876655 899999999999999999999998   99999999999999999999999999998866553


Q ss_pred             cccc--ccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          240 YLST--NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       240 ~~~~--~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                      ...+  ...-+.+|.|||.+...++|.+||||||||++||.++ |.+|+=....      .+ +-+.++         ..
T Consensus       787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN------Qd-VIkaIe---------~g  850 (996)
T KOG0196|consen  787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN------QD-VIKAIE---------QG  850 (996)
T ss_pred             ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch------HH-HHHHHH---------hc
Confidence            3222  2334579999999999999999999999999999887 5555421111      11 111122         11


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                      .+- ..+.+++..|.+|+++|||+|-.+||++.+|+.+|...+..
T Consensus       851 yRL-PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  851 YRL-PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             cCC-CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            221 14456788899999999999999999999999999876543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2e-46  Score=323.39  Aligned_cols=268  Identities=21%  Similarity=0.322  Sum_probs=207.6

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      +.|+...++|+|+||.||+++++ +|+.||||+|..... ..-.+-.++|+++|++++|+|+|.++.+|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            34666778999999999999976 599999999976554 3344567899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      ||+..-|.++-+  ....++.....+++.|++.|+.|+|+++   ++||||||+|||++.++.+||||||+|+.+... .
T Consensus        82 ~~dhTvL~eLe~--~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-g  155 (396)
T KOG0593|consen   82 YCDHTVLHELER--YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP-G  155 (396)
T ss_pred             ecchHHHHHHHh--ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-c
Confidence            999866655542  3445899999999999999999999998   999999999999999999999999999988742 2


Q ss_pred             ccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchh--------HHHHHHHHhCcc-
Q 040557          240 YLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLP--------EYAWKLYERGRI-  309 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~-  309 (407)
                      ..-+..+.|.+|.|||.+.+ .+|...+||||+||++.||++|.+.|.+...-+.-+..        -.-.+.+..+.. 
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            23356789999999999887 78999999999999999999999988655432211110        001112222211 


Q ss_pred             c-----cccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          310 L-----ELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       310 ~-----~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      .     +.-++......++ ....-+++++..||+.||.+|++-++++.|-.
T Consensus       236 ~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~y  286 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHHPY  286 (396)
T ss_pred             eeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcChH
Confidence            1     1111111111111 23346789999999999999999999987644

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-46  Score=342.47  Aligned_cols=268  Identities=26%  Similarity=0.390  Sum_probs=214.4

Q ss_pred             HhcCCCCCCeeeccCCccEEEEE-ecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCC-CCceeeeeeeeecCC-eeEE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-HKNLVRLLGCCSDGS-QRLL  156 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~l  156 (407)
                      ..++|...++||.|.||+||+|+ ..+|..||||+++..-....+-.=++|+..|++++ ||||+++...+.+.+ .+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            34677778899999999999997 45799999999976554444444579999999998 999999999998888 9999


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      |||||+. +|.+++..+ ++.+++..+..|+.||++||+|+|.+|   +.|||+||+|||+..+..+||+|||+|+....
T Consensus        88 VfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             eHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence            9999976 899999876 778999999999999999999999999   99999999999999888999999999998876


Q ss_pred             CCcccccccccCccccCccccc-cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHH----------
Q 040557          237 DQAYLSTNFAGTLGYTAPEYAI-RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYE----------  305 (407)
Q Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------  305 (407)
                      ...+  +..+.|.+|.|||++. .+.|+.+.|+||+|||++|+.+-++.|-+...-      +.+++.++          
T Consensus       163 kpPY--TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~------Dqi~KIc~VLGtP~~~~~  234 (538)
T KOG0661|consen  163 KPPY--TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI------DQIYKICEVLGTPDKDSW  234 (538)
T ss_pred             CCCc--chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH------HHHHHHHHHhCCCccccc
Confidence            6654  5678999999999876 478899999999999999999999887654321      12222221          


Q ss_pred             -hC-ccccccCcc---ccc---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          306 -RG-RILELVDPR---MRK---EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       306 -~~-~~~~~~d~~---~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                       +| .+...+.-.   +..   .........+.++++.+|+.+||++|||+.+.++|.-+...
T Consensus       235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~  297 (538)
T KOG0661|consen  235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG  297 (538)
T ss_pred             hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence             00 111111111   111   01222366789999999999999999999999999765543

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-46  Score=348.25  Aligned_cols=253  Identities=25%  Similarity=0.398  Sum_probs=214.0

Q ss_pred             cCCCCCCeeeccCCccEEEEE-ecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      ..|....+||+|+.|.||.++ ..+++.||||++... .+...+.+.+|+.+|+..+|+|||++++.|...+.+|+||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~-~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR-KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEec-cCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            456667889999999999996 557899999999644 344556788999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      |+||+|.+.+...   .+++..+..|+.+++.||+|||.++   |+|||||.+|||++.+|.+||+|||++..+..... 
T Consensus       352 m~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-  424 (550)
T KOG0578|consen  352 MEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-  424 (550)
T ss_pred             cCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence            9999999998433   3899999999999999999999999   99999999999999999999999999998876654 


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                      .....+||+.|||||++..+.|+.|.||||||++++||+-|.+||-...+-      ...+.....|.      +.++  
T Consensus       425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl------rAlyLIa~ng~------P~lk--  490 (550)
T KOG0578|consen  425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALYLIATNGT------PKLK--  490 (550)
T ss_pred             ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH------HHHHHHhhcCC------CCcC--
Confidence            345689999999999999999999999999999999999999998754332      11222222222      2222  


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                       .++..+..+.+++.+||+.|+++||++.|+|+|--.
T Consensus       491 -~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl  526 (550)
T KOG0578|consen  491 -NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFL  526 (550)
T ss_pred             -CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence             334456779999999999999999999999998644

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-46  Score=372.82  Aligned_cols=261  Identities=31%  Similarity=0.477  Sum_probs=216.3

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecC--Cc----EEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCee
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLAD--GT----LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQR  154 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  154 (407)
                      ..+.+..+.||+|+||.||.|...+  |.    .||+|.++...+.+...+|++|..+|+.++|||||+++|+|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            3556677899999999999997643  43    49999998888888999999999999999999999999999999999


Q ss_pred             EEEEEeccCCChhHHHhccC-----CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEeccc
Q 040557          155 LLVYEYMKNRSLDLLIYGES-----DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFG  229 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  229 (407)
                      ++++|||++|+|..++...+     ...++....+.++.|||+|+.||++++   +|||||..+|+||++...|||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            99999999999999997552     356899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCccccccc-ccCccccCccccccCCCCccccEEehhHHHHHHHhc-CCCCCCCCCcccCchhHHHHHHHHhC
Q 040557          230 LARFFPEDQAYLSTNF-AGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISC-RKNTDLTLPSEMQYLPEYAWKLYERG  307 (407)
Q Consensus       230 la~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      ||+.+.....+..... .-...|||||.+..+.+|.|+|||||||++||++|. ..|+......      +........|
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~------~v~~~~~~gg  921 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF------EVLLDVLEGG  921 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH------HHHHHHHhCC
Confidence            9996665555544433 445689999999999999999999999999999995 4454322211      1111123333


Q ss_pred             ccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          308 RILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       308 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                      +        +.   .+..++..+++++.+||+.+|++||++..|++.+..+...
T Consensus       922 R--------L~---~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  922 R--------LD---PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             c--------cC---CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence            2        21   3445677899999999999999999999999988765543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=340.61  Aligned_cols=256  Identities=26%  Similarity=0.363  Sum_probs=212.4

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccC---h-hhHHHHHHHHHHHHcCC-CCceeeeeeeeecCCe
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKS---Q-QGESEFLSEVRMITSIQ-HKNLVRLLGCCSDGSQ  153 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~  153 (407)
                      ..++|.+++.||+|+||+|+.|.. .+|..||+|.+.....   . ...+.+.+|+.+++.++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            347899999999999999999974 4689999997755311   1 23456678999999998 9999999999999999


Q ss_pred             eEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCC-CceEEecccCcc
Q 040557          154 RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEK-FQSKIGDFGLAR  232 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfgla~  232 (407)
                      .++||||+.||+|.+++..  ...+.+..+..++.|++.|++|||+.+   |+||||||+|||++.+ +++||+|||++.
T Consensus        95 ~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            9999999999999999965  456889999999999999999999999   9999999999999999 999999999999


Q ss_pred             ccCCCCcccccccccCccccCccccccCC-CC-ccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccc
Q 040557          233 FFPEDQAYLSTNFAGTLGYTAPEYAIRGE-LS-EKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRIL  310 (407)
Q Consensus       233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      ... .......+.+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||+....      ...... +..+.. 
T Consensus       170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~l~~k-i~~~~~-  240 (370)
T KOG0583|consen  170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PNLYRK-IRKGEF-  240 (370)
T ss_pred             ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HHHHHH-HhcCCc-
Confidence            874 2223345689999999999999977 85 789999999999999999999986221      111221 222211 


Q ss_pred             cccCcccccCCCCHHH-HHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          311 ELVDPRMRKEGIVERD-ALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       311 ~~~d~~~~~~~~~~~~-~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                                .++... ..++..++.+|++.||.+|+|+.+|+++-|...
T Consensus       241 ----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  241 ----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             ----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                      111222 566889999999999999999999999999876

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.3e-45  Score=344.95  Aligned_cols=260  Identities=28%  Similarity=0.439  Sum_probs=205.5

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe------cCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecC-C
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDG-S  152 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~  152 (407)
                      .++|++.+.||+|+||.||+|..      .+++.||+|++...........+.+|+.++..+ +||||++++++|... .
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            36788899999999999999963      235689999987554445566789999999999 899999999988764 4


Q ss_pred             eeEEEEEeccCCChhHHHhccC----------------------------------------------------------
Q 040557          153 QRLLVYEYMKNRSLDLLIYGES----------------------------------------------------------  174 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  174 (407)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            5789999999999999886432                                                          


Q ss_pred             --CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc-ccccccCccc
Q 040557          175 --DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL-STNFAGTLGY  251 (407)
Q Consensus       175 --~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y  251 (407)
                        ...+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++......... .....++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              134788899999999999999999988   9999999999999999999999999998654332221 2234467789


Q ss_pred             cCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHH
Q 040557          252 TAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQV  330 (407)
Q Consensus       252 ~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l  330 (407)
                      +|||.+.+..++.++|||||||++|||++ |..||......      .........+...     .     .+...+..+
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~------~~~~~~~~~~~~~-----~-----~~~~~~~~l  306 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN------EEFCQRLKDGTRM-----R-----APENATPEI  306 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc------HHHHHHHhcCCCC-----C-----CCCCCCHHH
Confidence            99999999999999999999999999997 89888653221      1111222222111     0     112234568


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          331 INVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       331 ~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .+++.+||+.||++|||+.++++.|+...
T Consensus       307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         307 YRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            89999999999999999999999997543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-45  Score=337.36  Aligned_cols=266  Identities=25%  Similarity=0.393  Sum_probs=209.6

Q ss_pred             cCCCCCCeeeccCCccEEEEE-ecCCcEEEEEEeccccChh-hHHHHHHHHHHHHcCCCCceeeeeeeeecC--CeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQ-GESEFLSEVRMITSIQHKNLVRLLGCCSDG--SQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  157 (407)
                      +.|+..++||+|.||.||+|+ ..+|+.||+|++..+.... .-.-..+|+.+|++|+||||+++.+...+.  ..+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            456667789999999999997 4679999999998766333 334567999999999999999999988766  689999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      +|||+. +|.-++... .-.+++.++..++.|++.||+|||+.+   |.|||||.+|||||++|.+||+|||||+++...
T Consensus       197 FeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             Eecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            999987 777777543 334899999999999999999999999   999999999999999999999999999998877


Q ss_pred             CcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhC--------c
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERG--------R  308 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~  308 (407)
                      .....++.+-|.+|.|||.+.+ ..|+.++|+||.||||.||++|++.+.+...-+  .+ +-+.+++..-        +
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve--Ql-~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE--QL-HKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH--HH-HHHHHHhCCCChhcccccc
Confidence            7666778899999999999887 479999999999999999999999886543211  11 1111111110        1


Q ss_pred             cc--cccCc------ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          309 IL--ELVDP------RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       309 ~~--~~~d~------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      +.  ..+.+      .+..  .....+...++|+..+|..||++|.|+.+++++-.+
T Consensus       349 LP~~~~~kp~~~y~r~l~E--~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF  403 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRE--TFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF  403 (560)
T ss_pred             CCcccccCCCCcccchHHH--HhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence            11  01100      0100  011123567889999999999999999999998877

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-45  Score=340.56  Aligned_cols=258  Identities=24%  Similarity=0.311  Sum_probs=212.6

Q ss_pred             HHHhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCe
Q 040557           78 KKATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQ  153 (407)
Q Consensus        78 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  153 (407)
                      ++..++|..++.||.|+|++|++|+. ..++.||||++.+..  .+....-+..|-++|.+| .||.|++|+-.|.|...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            34457899999999999999999974 569999999986442  222334567899999999 89999999999999999


Q ss_pred             eEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          154 RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      +|+|+||++||+|.+++..  -+.+++.....++.+|+.||+|||+.|   ||||||||+|||||.++.++|+|||.|+.
T Consensus       149 LYFvLe~A~nGdll~~i~K--~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKK--YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             eEEEEEecCCCcHHHHHHH--hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence            9999999999999999954  356999999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCcc----------c--ccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHH
Q 040557          234 FPEDQAY----------L--STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAW  301 (407)
Q Consensus       234 ~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~  301 (407)
                      ++.....          .  ...++||..|.+||++..+..+..+|+|+|||+||+|+.|++||.....-    +  ...
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney----l--iFq  297 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY----L--IFQ  297 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH----H--HHH
Confidence            7532221          1  14588999999999999999999999999999999999999999754321    0  111


Q ss_pred             HHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          302 KLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       302 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      +.+.       +|..     +++..++.+.+|+.+.|..||++|+|..+|.+|.-+.
T Consensus       298 kI~~-------l~y~-----fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~  342 (604)
T KOG0592|consen  298 KIQA-------LDYE-----FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFE  342 (604)
T ss_pred             HHHH-------hccc-----CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccc
Confidence            1111       1111     2333446788999999999999999999999886543

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-46  Score=337.97  Aligned_cols=251  Identities=26%  Similarity=0.413  Sum_probs=214.8

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      ..|+..+.||+|+||.||+|.. ..++.||+|++..+......+++.+|+.+|.+++++||.+++|.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            3466668899999999999974 468999999999888888888999999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      |.||++.+.+.  .+..+++....-++.+++.|+.|||.++   .+|||||+.|||+..+|.+||+|||.+..+......
T Consensus        93 ~~gGsv~~lL~--~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   93 CGGGSVLDLLK--SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             hcCcchhhhhc--cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            99999999984  4445588888889999999999999998   999999999999999999999999999988766554


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                      . .+++||+.|||||++....|+.|+||||||++.+||++|.+|+....|....++            +.+-..|.+.  
T Consensus       168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl------------Ipk~~PP~L~--  232 (467)
T KOG0201|consen  168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL------------IPKSAPPRLD--  232 (467)
T ss_pred             c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe------------ccCCCCCccc--
Confidence            4 678999999999999988999999999999999999999999976555322111            0111112222  


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                         ......+.+++..||+.||+.||++.++++|-
T Consensus       233 ---~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~  264 (467)
T KOG0201|consen  233 ---GDFSPPFKEFVEACLDKNPEFRPSAKELLKHK  264 (467)
T ss_pred             ---cccCHHHHHHHHHHhhcCcccCcCHHHHhhhH
Confidence               23456688999999999999999999999873

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-46  Score=343.52  Aligned_cols=238  Identities=26%  Similarity=0.420  Sum_probs=199.1

Q ss_pred             CCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCCh
Q 040557           87 GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL  166 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  166 (407)
                      ++-||+|+.|.||.|++. ++.||||+++.-+        ..++.-|++|+|+||+.+.|+|.....+|||||||..|-|
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence            467999999999999995 7889999874222        2467889999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccccccc
Q 040557          167 DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA  246 (407)
Q Consensus       167 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  246 (407)
                      ...++  .+..+......+|..+||.||.|||.+.   |||||||+-||||..+..|||+|||-++...+..  ....++
T Consensus       200 ~~VLk--a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S--TkMSFa  272 (904)
T KOG4721|consen  200 YEVLK--AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS--TKMSFA  272 (904)
T ss_pred             HHHHh--ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh--hhhhhh
Confidence            99994  4556888999999999999999999998   9999999999999999999999999999776553  234688


Q ss_pred             cCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHH
Q 040557          247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERD  326 (407)
Q Consensus       247 gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  326 (407)
                      ||-.|||||++.+.+.++|+||||||||||||+||..|+..-...-      .+|.         + ......-..+..+
T Consensus       273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA------IIwG---------V-GsNsL~LpvPstc  336 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA------IIWG---------V-GSNSLHLPVPSTC  336 (904)
T ss_pred             hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe------eEEe---------c-cCCcccccCcccC
Confidence            9999999999999999999999999999999999999985322110      0111         0 0111111244556


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          327 ALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       327 ~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      +.-+.-|+++||+..|.+||++++|+.||.
T Consensus       337 P~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             chHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            667788899999999999999999999986

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-45  Score=342.91  Aligned_cols=266  Identities=26%  Similarity=0.442  Sum_probs=213.0

Q ss_pred             HHHHHHhcCCCCCCeeeccCCccEEEEEecCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCe
Q 040557           75 QTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQ  153 (407)
Q Consensus        75 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  153 (407)
                      ++++...+.+.++..||+|.||+||+|++.  ..||||++.... ..+..+.|++|+..+++-+|.||+-+.|||..+..
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            344455566778899999999999999984  359999998765 44567899999999999999999999999988877


Q ss_pred             eEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          154 RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                       .+|+-+|+|.+|..++|.... .++..+.++|+.||++||.|||.++   |||||||++||++.++++|||+||||+..
T Consensus       463 -AIiTqwCeGsSLY~hlHv~et-kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQET-KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             -eeeehhccCchhhhhccchhh-hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence             999999999999999987664 4899999999999999999999999   99999999999999999999999999975


Q ss_pred             cCCC-CcccccccccCccccCcccccc---CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcc
Q 040557          234 FPED-QAYLSTNFAGTLGYTAPEYAIR---GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRI  309 (407)
Q Consensus       234 ~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ...- .........|...|||||++..   .+|+..+||||||+|+|||+||..|+.....+..-+.       +..|- 
T Consensus       538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifm-------VGrG~-  609 (678)
T KOG0193|consen  538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFM-------VGRGY-  609 (678)
T ss_pred             eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEE-------ecccc-
Confidence            4311 1111123457789999999874   5789999999999999999999999974433221111       11111 


Q ss_pred             ccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          310 LELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       310 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                       -.  +++.  ....+++..+.+|+..||..++++||.+.+|+..|+.+..
T Consensus       610 -l~--pd~s--~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  610 -LM--PDLS--KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             -cC--ccch--hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence             11  1111  1234566789999999999999999999999998876543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=8.9e-45  Score=307.98  Aligned_cols=276  Identities=24%  Similarity=0.377  Sum_probs=213.3

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhh-HHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .+|...+.||+|.||.||+|+. .+|+.||||+++.....++ .....+|+..|+.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            3566678899999999999984 5799999999987654433 3467899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      ||+. +|+..++. +...++...+..++.++++|++|||++.   |+||||||+|+|++++|.+||+|||+|+.+.....
T Consensus        82 fm~t-dLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   82 FMPT-DLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             eccc-cHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            9976 88888864 3456899999999999999999999998   99999999999999999999999999999876554


Q ss_pred             ccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcc------ccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRI------LEL  312 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~  312 (407)
                      ... ..+-|..|.|||.+.+ ..|+..+|+||.||++.||+-|.+-|.+...-+  .+ ..+.+.+..-..      ..+
T Consensus       157 ~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid--QL-~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  157 IQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID--QL-SKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             ccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH--HH-HHHHHHcCCCCcccCcccccc
Confidence            433 2378999999998887 579999999999999999999887665433211  11 111111111100      011


Q ss_pred             cC-------cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccCCCCCCc
Q 040557          313 VD-------PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVRP  367 (407)
Q Consensus       313 ~d-------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~~~~~~p  367 (407)
                      .|       |.......-.....++++++..++..||.+|+|+.|+++|-.+.. .+.|..|
T Consensus       233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~-~P~pt~~  293 (318)
T KOG0659|consen  233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS-LPLPTPP  293 (318)
T ss_pred             ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc-CCCCCCh
Confidence            11       111111122334566799999999999999999999999988754 4444433

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-45  Score=344.92  Aligned_cols=261  Identities=30%  Similarity=0.406  Sum_probs=210.0

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEecC--C--cE-EEEEEecc--ccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLAD--G--TL-VAVKKLCV--DKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS  152 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  152 (407)
                      ..++....++||+|+||.||+|++..  +  .. ||||....  ........+|++|+++|++++|||||+++|++....
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~  234 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE  234 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            34566677999999999999998642  2  23 89999874  235677889999999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                      ++++|||+|.||+|.+++..... .++..++..++.+.|.||+|||+++   ++||||..+|+|++.++.+||+||||++
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~  310 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR  310 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence            99999999999999999965443 5999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHH-HhCccc
Q 040557          233 FFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLY-ERGRIL  310 (407)
Q Consensus       233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~  310 (407)
                      .... .........-+..|+|||.+..+.|+.++|||||||++||+++ |..|+.+....       .+...+ ..+.  
T Consensus       311 ~~~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-------~v~~kI~~~~~--  380 (474)
T KOG0194|consen  311 AGSQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-------EVKAKIVKNGY--  380 (474)
T ss_pred             CCcc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-------HHHHHHHhcCc--
Confidence            6541 1111112235679999999999999999999999999999998 77777643322       122222 2111  


Q ss_pred             cccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccCC
Q 040557          311 ELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESG  362 (407)
Q Consensus       311 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~~  362 (407)
                           ++.   .+...+..+..++.+||..+|++||||.++.+.++......
T Consensus       381 -----r~~---~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~  424 (474)
T KOG0194|consen  381 -----RMP---IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK  424 (474)
T ss_pred             -----cCC---CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence                 111   22234566888899999999999999999999998765543

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.1e-45  Score=342.58  Aligned_cols=255  Identities=24%  Similarity=0.286  Sum_probs=216.0

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      .-|++++.||+|+.|.|-.|++ .+|+.+|||.+.+..  .......+.+|+-+|+.+.|||++++++++++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4588899999999999999985 579999999997652  2233456789999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|.|.+++.  ..+.+++.++.+++.||+.|+.|||..+   |+||||||+|+|||..+++||+|||+|..-..+.
T Consensus        92 Eyv~gGELFdylv--~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   92 EYVPGGELFDYLV--RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             EecCCchhHHHHH--hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence            9999999999984  4456999999999999999999999998   9999999999999999999999999998765544


Q ss_pred             cccccccccCccccCccccccCCC-CccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      -  -.+.||.+.|.|||++++.+| ..++||||+|||||.|+||+.||+.+.       ...+...+..|..        
T Consensus       167 l--LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-------ir~LLlKV~~G~f--------  229 (786)
T KOG0588|consen  167 L--LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-------IRVLLLKVQRGVF--------  229 (786)
T ss_pred             c--ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-------HHHHHHHHHcCcc--------
Confidence            3  346799999999999999988 579999999999999999999998322       2223333444432        


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                         ..+...+.++.+|+.+|+..||++|.|+.||++|.+-....
T Consensus       230 ---~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~  270 (786)
T KOG0588|consen  230 ---EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT  270 (786)
T ss_pred             ---cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence               23445566788999999999999999999999999865544

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-45  Score=337.96  Aligned_cols=264  Identities=23%  Similarity=0.392  Sum_probs=212.9

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      .+...+.++||+|-||.|.++....+..||||.++.........+|.+|+++|.+++||||++++|+|..++.+++++||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            35567788999999999999998778999999998877777778999999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      |++|+|.+++..+....+.-....+|+.||+.||+||.+.+   ++||||.++|+|++.++++||+|||+++.+-....+
T Consensus       617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence            99999999997665444556667789999999999999988   999999999999999999999999999966554444


Q ss_pred             c-ccccccCccccCccccccCCCCccccEEehhHHHHHHHh--cCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          241 L-STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS--CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       241 ~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      . ....+-+.+|||+|.+..+++|++||||+||+++||+++  ...|+.......   ..+-.-.+...+.....+    
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~~~l----  766 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQVVL----  766 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCcceec----
Confidence            3 334567889999999999999999999999999999875  445554221110   011111111111111110    


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                         ..+.-++..+++++..||..|.++||+++++..+|..
T Consensus       767 ---~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  767 ---SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             ---cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence               1233456778999999999999999999999998864

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=4.4e-44  Score=329.92  Aligned_cols=256  Identities=25%  Similarity=0.344  Sum_probs=206.8

Q ss_pred             CCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .|+..+.||+|+||.||+|.. .+|+.||+|.+.....  ......+.+|+.++..++|+||+++.+++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            366778999999999999985 5799999999864332  2334567899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++|+|..++.......+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.++|+|||++........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence            999999998886555556899999999999999999999998   99999999999999999999999999987643322


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                        .....||..|+|||.+.+..++.++|||||||++|||++|+.||........   ............           
T Consensus       158 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~-----------  221 (285)
T cd05631         158 --VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKEDQ-----------  221 (285)
T ss_pred             --ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhccc-----------
Confidence              2345789999999999999999999999999999999999999975433211   111111111100           


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhhc
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPP-----MSEIVAMLTC  357 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~l~~  357 (407)
                      .......+..+.+|+.+||+.||++||+     ++++++|-+.
T Consensus       222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~  264 (285)
T cd05631         222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIF  264 (285)
T ss_pred             ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhh
Confidence            0112223456889999999999999997     8999998765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.9e-45  Score=340.75  Aligned_cols=249  Identities=25%  Similarity=0.375  Sum_probs=210.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      ++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+.. .......+.+|+++++.++||||+.++++|+...+.|+|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46788889999999999999754 68899999986543 44456778999999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+.| +|..++.  .++.++++.+..++.+++.||.|||+++   |.|||+||.|||++.++.+|++|||+|+.+..+..
T Consensus        82 ~a~g-~L~~il~--~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~  155 (808)
T KOG0597|consen   82 YAVG-DLFTILE--QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS  155 (808)
T ss_pred             hhhh-hHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCce
Confidence            9987 9999994  4556999999999999999999999998   99999999999999999999999999998766443


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                       ..+...|||.|||||...+.+|+..+|.||+||++||+.+|++||....-      ...+.....        |+.   
T Consensus       156 -vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si------~~Lv~~I~~--------d~v---  217 (808)
T KOG0597|consen  156 -VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI------TQLVKSILK--------DPV---  217 (808)
T ss_pred             -eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH------HHHHHHHhc--------CCC---
Confidence             44567899999999999999999999999999999999999999863211      111111111        111   


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                       ..+......+.+++...|++||..|.|..+++.|-
T Consensus       218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp  252 (808)
T KOG0597|consen  218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP  252 (808)
T ss_pred             -CCcccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence             12335567789999999999999999999999874

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-45  Score=313.63  Aligned_cols=250  Identities=25%  Similarity=0.301  Sum_probs=211.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|+..+.||.|+||.|.+++.+ +|..+|+|++.+..  ...+.+...+|..+|+.+.||.++++++.+.+.+..++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            56777889999999999999854 68999999996543  3345567889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||++||.|..+++  +.+.+++..+..++.||+.|++|||+.+   |++|||||+|||+|.+|.+||+|||.|+......
T Consensus       124 eyv~GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT  198 (355)
T KOG0616|consen  124 EYVPGGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRT  198 (355)
T ss_pred             eccCCccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCcE
Confidence            9999999999995  4456999999999999999999999998   9999999999999999999999999999876653


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                          -+.||||.|+|||.+..+.|..++|.|||||++|||+.|.+||....+.      . .++.+-.+++         
T Consensus       199 ----~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~------~-iY~KI~~~~v---------  258 (355)
T KOG0616|consen  199 ----WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI------Q-IYEKILEGKV---------  258 (355)
T ss_pred             ----EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH------H-HHHHHHhCcc---------
Confidence                4589999999999999999999999999999999999999999876552      1 2222222221         


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCC-----CCHHHHHHHhhcc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQR-----PPMSEIVAMLTCK  358 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~R-----Ps~~ev~~~l~~~  358 (407)
                        .++......+.+|+...|+.|-.+|     +...+|..|-|+.
T Consensus       259 --~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~  301 (355)
T KOG0616|consen  259 --KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFK  301 (355)
T ss_pred             --cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccc
Confidence              1334445668899999999999998     4456777777754

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.5e-43  Score=329.40  Aligned_cols=262  Identities=26%  Similarity=0.439  Sum_probs=202.4

Q ss_pred             cCCCCCCeeeccCCccEEEEEecC-----------------CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeee
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLAD-----------------GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL  144 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l  144 (407)
                      ++|++.+.||+|+||.||++.+.+                 +..||+|.+..........+|.+|++++.+++|+||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            568888999999999999997532                 346999998765555566789999999999999999999


Q ss_pred             eeeeecCCeeEEEEEeccCCChhHHHhccC-----------------CCCCCHHHHHHHHHHHHHHhccccccCCCceee
Q 040557          145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGES-----------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVH  207 (407)
Q Consensus       145 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H  207 (407)
                      ++++.+.+..++||||+++|+|.+++....                 ...+++..+.+++.|++.||.|||+.+   ++|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            999999999999999999999999885321                 134788899999999999999999998   999


Q ss_pred             eccccccEEEcCCCceEEecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHhc--CCC
Q 040557          208 RDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISC--RKN  284 (407)
Q Consensus       208 ~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg--~~p  284 (407)
                      |||||+|||+++++.+||+|||+++........ ......++..|+|||.+.++.++.++||||||+++|||+++  ..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            999999999999999999999999866443322 12234567889999999988999999999999999999975  445


Q ss_pred             CCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          285 TDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      +.......   ............... ..   .   ..+..++..+.+++.+||+.||++|||+.+|.+.|+
T Consensus       242 ~~~~~~~~---~~~~~~~~~~~~~~~-~~---~---~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTDEQ---VIENAGEFFRDQGRQ-VY---L---FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCHHH---HHHHHHHHhhhcccc-cc---c---cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            54322111   111111111111000 00   0   011123456899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7.1e-44  Score=334.30  Aligned_cols=247  Identities=24%  Similarity=0.266  Sum_probs=201.0

Q ss_pred             CeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCC
Q 040557           88 NLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNR  164 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  164 (407)
                      +.||+|+||.||+++. .+|+.||+|++....  .......+.+|++++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 468999999986432  2234456789999999999999999999999999999999999999


Q ss_pred             ChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccccc
Q 040557          165 SLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN  244 (407)
Q Consensus       165 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  244 (407)
                      +|..++..  ...+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+++....... ....
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~  154 (323)
T cd05571          81 ELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT  154 (323)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cccc
Confidence            99988853  346899999999999999999999998   99999999999999999999999999975432221 1234


Q ss_pred             cccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCH
Q 040557          245 FAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVE  324 (407)
Q Consensus       245 ~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  324 (407)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||......       ........+.      .     ..+.
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~~~~~~~~~~------~-----~~p~  216 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILMEE------I-----RFPR  216 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-------HHHHHHHcCC------C-----CCCC
Confidence            57999999999999999999999999999999999999998643211       1111111111      0     1122


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhcc
Q 040557          325 RDALQVINVAFICLQPHGNQRP-----PMSEIVAMLTCK  358 (407)
Q Consensus       325 ~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~l~~~  358 (407)
                      .....+.+++.+||+.||++||     ++.++++|-+..
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~  255 (323)
T cd05571         217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFA  255 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcC
Confidence            2345688999999999999999     899999987754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.3e-43  Score=333.22  Aligned_cols=251  Identities=22%  Similarity=0.281  Sum_probs=206.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|.+....  .......+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56788899999999999999865 58999999986432  2233457889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+.+|+|.+++..  ...+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||++.......
T Consensus        98 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  172 (329)
T PTZ00263         98 EFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT  172 (329)
T ss_pred             cCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence            99999999998854  345889999999999999999999998   9999999999999999999999999998765433


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                          ....||+.|+|||.+.+..++.++|||||||++|||++|+.||....+.       ........+...        
T Consensus       173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~~~--------  233 (329)
T PTZ00263        173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-------RIYEKILAGRLK--------  233 (329)
T ss_pred             ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-------HHHHHHhcCCcC--------
Confidence                2357999999999999999999999999999999999999998643221       111222222110        


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhhccc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPP-----MSEIVAMLTCKV  359 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~l~~~~  359 (407)
                         .+......+.+++.+||+.||++||+     +.+++.|.+...
T Consensus       234 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        234 ---FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             ---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence               11112345789999999999999997     799999987643

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.2e-43  Score=328.12  Aligned_cols=259  Identities=21%  Similarity=0.263  Sum_probs=209.5

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      ..++|++...||+|+||.||+++- .+|..+|+|++++..  ...+.+.++.|-.+|...++++||+++..|.+...+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            457899999999999999999974 469999999997654  23455678899999999999999999999999999999


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ||||++||++..+|.  ....|++..+..++.+++.|++.||+.|   ++||||||+|+|||..|.+||+||||+.-+..
T Consensus       219 iMEylPGGD~mTLL~--~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLM--RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             EEEecCCccHHHHHH--hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhh
Confidence            999999999999984  4456999999999999999999999999   99999999999999999999999999953210


Q ss_pred             -----------------------CCc-----c------------------cccccccCccccCccccccCCCCccccEEe
Q 040557          237 -----------------------DQA-----Y------------------LSTNFAGTLGYTAPEYAIRGELSEKADIYS  270 (407)
Q Consensus       237 -----------------------~~~-----~------------------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s  270 (407)
                                             +..     .                  .....+|||-|||||++.++.|+...|.||
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS  373 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS  373 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence                                   000     0                  001246999999999999999999999999


Q ss_pred             hhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCC---
Q 040557          271 FGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPP---  347 (407)
Q Consensus       271 ~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---  347 (407)
                      +|||+||||.|-+||....+.+.       ++.+...+..      +... .......+..+||.+|+. ||++|..   
T Consensus       374 LG~ImyEmLvGyPPF~s~tp~~T-------~rkI~nwr~~------l~fP-~~~~~s~eA~DLI~rll~-d~~~RLG~~G  438 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFCSETPQET-------YRKIVNWRET------LKFP-EEVDLSDEAKDLITRLLC-DPENRLGSKG  438 (550)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHH-------HHHHHHHhhh------ccCC-CcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence            99999999999999987766431       1111111100      0000 011123568899999999 9999985   


Q ss_pred             HHHHHHHhhcc
Q 040557          348 MSEIVAMLTCK  358 (407)
Q Consensus       348 ~~ev~~~l~~~  358 (407)
                      +.||-+|.++.
T Consensus       439 ~~EIK~HPfF~  449 (550)
T KOG0605|consen  439 AEEIKKHPFFK  449 (550)
T ss_pred             HHHHhcCCccc
Confidence            88999988765

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2e-43  Score=324.97  Aligned_cols=245  Identities=18%  Similarity=0.252  Sum_probs=198.2

Q ss_pred             CeeeccCCccEEEEEecCCcEEEEEEeccccCh--hhHHHHHHHHHHHHcCCCCceeeeeeeeec----CCeeEEEEEec
Q 040557           88 NLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQ--QGESEFLSEVRMITSIQHKNLVRLLGCCSD----GSQRLLVYEYM  161 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~  161 (407)
                      ..||+|++|.||+|.+ +|+.||||.+......  ...+.|.+|+.+|.+++||||++++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            5799999999999998 6899999998654321  224678899999999999999999999876    34678999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhcccccc-CCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED-SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      ++|+|.+++..  .+.+++....+++.+++.|+.|||+. +   ++||||||+||++++++.+||+|||+++......  
T Consensus       105 ~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        105 TRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            99999999964  34689999999999999999999984 5   8899999999999999999999999998654332  


Q ss_pred             cccccccCccccCcccccc--CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          241 LSTNFAGTLGYTAPEYAIR--GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                        ....|+..|+|||.+.+  ..++.++|||||||++|||++|+.||......      .........+..     ..  
T Consensus       178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~~~~~i~~~~~~-----~~--  242 (283)
T PHA02988        178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------EIYDLIINKNNS-----LK--  242 (283)
T ss_pred             --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcCCC-----CC--
Confidence              23468899999999876  68999999999999999999999999753221      111111111110     01  


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                         .+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus       243 ---~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        243 ---LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             ---CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence               1112455788999999999999999999999998753

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.9e-43  Score=332.86  Aligned_cols=257  Identities=23%  Similarity=0.278  Sum_probs=204.3

Q ss_pred             CCCCCCeeeccCCccEEEEEe----cCCcEEEEEEecccc---ChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCee
Q 040557           83 NFHPGNLLGRGGFGPVYRGKL----ADGTLVAVKKLCVDK---SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQR  154 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  154 (407)
                      +|++.+.||+|+||.||+++.    .+|+.||+|.+....   .......+.+|+.++..+ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477789999999999999875    358899999986432   223345678899999999 599999999999999999


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcccc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF  234 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~  234 (407)
                      ++||||+++|+|.+++..  ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.+
T Consensus        81 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            999999999999998854  345899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccccc
Q 040557          235 PEDQAYLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV  313 (407)
Q Consensus       235 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ............||+.|+|||.+.+. .++.++|||||||++|||++|+.||........   ..........      .
T Consensus       156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~~~~~~~~------~  226 (332)
T cd05614         156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT---QSEVSRRILK------C  226 (332)
T ss_pred             cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC---HHHHHHHHhc------C
Confidence            54433333456799999999998765 478999999999999999999999964322111   1111111111      1


Q ss_pred             CcccccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhcc
Q 040557          314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRP-----PMSEIVAMLTCK  358 (407)
Q Consensus       314 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~l~~~  358 (407)
                      ++.+     +......+.+++.+||+.||++||     ++.++++|.|..
T Consensus       227 ~~~~-----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~  271 (332)
T cd05614         227 DPPF-----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK  271 (332)
T ss_pred             CCCC-----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcC
Confidence            1111     112345678999999999999999     888999998754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=7.3e-44  Score=340.58  Aligned_cols=257  Identities=26%  Similarity=0.405  Sum_probs=204.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEe------cCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCee
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQR  154 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  154 (407)
                      ++|++++.||+|+||.||+|..      .++..||||++...........+.+|+.++..+ +||||++++++|..++..
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            5788899999999999999963      246689999986554445556788999999999 899999999999999999


Q ss_pred             EEEEEeccCCChhHHHhccC------------------------------------------------------------
Q 040557          155 LLVYEYMKNRSLDLLIYGES------------------------------------------------------------  174 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~------------------------------------------------------------  174 (407)
                      ++||||+++|+|.+++....                                                            
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            99999999999998885422                                                            


Q ss_pred             -------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          175 -------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       175 -------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                                   ...+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||++..........
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                         124788999999999999999999988   9999999999999999999999999998765433221


Q ss_pred             -ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          242 -STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       242 -~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                       .....++..|+|||.+.+..++.++|||||||++|||++ |..||......      ....+.+..+....        
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~------~~~~~~~~~~~~~~--------  337 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD------SKFYKMIKEGYRML--------  337 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch------HHHHHHHHhCccCC--------
Confidence             122345678999999999999999999999999999998 77777543211      11122222221100        


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                        .+...+.++.+++.+||+.||++|||+.+|+++|+.
T Consensus       338 --~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         338 --SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             --CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence              111124568899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2e-43  Score=325.91  Aligned_cols=270  Identities=21%  Similarity=0.316  Sum_probs=205.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++..... ......+.+|+++++.++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46888899999999999999875 588999999865432 2334577899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |++++.+..+..  ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          81 YVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             cCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            999987766543  2345899999999999999999999988   99999999999999999999999999987654333


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCc--------hhHHHHHHH-HhCccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQY--------LPEYAWKLY-ERGRIL  310 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~--------~~~~~~~~~-~~~~~~  310 (407)
                      .......|++.|+|||++.+..++.++|||||||++|||++|+.||......+...        ++....... ......
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence            22334578999999999999899999999999999999999999986543211000        000000000 000000


Q ss_pred             cccCcccccC-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          311 ELVDPRMRKE-----GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       311 ~~~d~~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ....+.....     ......+..+.+++.+||+.||++|||++++++|-+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~  286 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPA  286 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence            0000000000     001113456899999999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-44  Score=330.04  Aligned_cols=250  Identities=22%  Similarity=0.274  Sum_probs=206.3

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|... +|+.||+|++....  .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888899999999999999865 68999999985432  2234556889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|.+++..  ...+++.....++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||++.......
T Consensus        81 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  155 (291)
T cd05612          81 EYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT  155 (291)
T ss_pred             eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence            99999999999854  345899999999999999999999998   9999999999999999999999999998664332


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                          ....|++.|+|||.+.+..++.++|||||||++|||++|+.||......      . .......+..         
T Consensus       156 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~-~~~~i~~~~~---------  215 (291)
T cd05612         156 ----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------G-IYEKILAGKL---------  215 (291)
T ss_pred             ----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCCc---------
Confidence                2356899999999999989999999999999999999999998754321      1 1111221211         


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhhcc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPP-----MSEIVAMLTCK  358 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~l~~~  358 (407)
                        ..+......+.+++.+||+.||.+||+     +.++++|.|..
T Consensus       216 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~  258 (291)
T cd05612         216 --EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK  258 (291)
T ss_pred             --CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcccc
Confidence              011122456889999999999999995     99999998864

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.4e-43  Score=321.77  Aligned_cols=255  Identities=26%  Similarity=0.384  Sum_probs=205.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEec----CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA----DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ++|++.+.||+|+||.||+|.+.    .+..||+|.+...........+.+|+..+.+++||||+++++++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            56888899999999999999753    36689999987655555566789999999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.++++|||.+......
T Consensus        85 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          85 TEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999986433 45899999999999999999999988   999999999999999999999999988754333


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                      .........++..|+|||.+.+..++.++|||||||++||+++ |+.||......      . .......+...      
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~------~-~~~~~~~~~~~------  227 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ------D-VIKAVEDGFRL------  227 (266)
T ss_pred             chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------H-HHHHHHCCCCC------
Confidence            2222223345678999999999999999999999999999775 99888643221      1 11112221110      


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                          ..+...+..+.+++..||+.+|++||++++|++.|..
T Consensus       228 ----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         228 ----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence                1122345668899999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.1e-43  Score=334.30  Aligned_cols=268  Identities=22%  Similarity=0.305  Sum_probs=208.8

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|++.+.||+|+||.||+++.. +|..+|+|.+...........+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            367888899999999999999865 6889999998755444556789999999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++|+|.+++...  ..+++..+..++.|++.||.|||+.+  +++||||||+|||+++++.++|+|||++....... 
T Consensus        84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  158 (331)
T cd06649          84 HMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (331)
T ss_pred             cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence            99999999998543  45899999999999999999999853  39999999999999999999999999998654322 


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhC--c---------
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERG--R---------  308 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~---------  308 (407)
                        .....|++.|+|||.+.+..++.++|||||||++|||++|+.||......+..   .........+  .         
T Consensus       159 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE---AIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             --cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHhcccccccccCCccccCccc
Confidence              23456899999999999999999999999999999999999998643321110   0000000000  0         


Q ss_pred             -------------------cccccC---cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          309 -------------------ILELVD---PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       309 -------------------~~~~~d---~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                                         ..+..+   ..............++.+++.+||+.||++|||++++++|.+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~  305 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIK  305 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHh
Confidence                               000000   00000001112345789999999999999999999999998764

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-44  Score=322.87  Aligned_cols=251  Identities=22%  Similarity=0.353  Sum_probs=213.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      .+|++.+.||+|.||.|-+|.. ..|+.||||.++++.  +.++.-.+.+|+++|+.|+||||+.++.+|++.+...+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4677788999999999999974 679999999997765  4455667889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||..+|.|.+++.  .++.|++.+...++.||..|+.|+|.++   ++|||||.+|||||+++++||+||||+..+....
T Consensus       133 EYaS~GeLYDYiS--er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  133 EYASGGELYDYIS--ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EecCCccHHHHHH--HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            9999999999994  4566999999999999999999999998   9999999999999999999999999999887665


Q ss_pred             cccccccccCccccCccccccCCC-CccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      .  ..+++|++-|.+||++.+.+| .+.+|-|||||+||.|+.|..||++....       ..-+.+..|.        .
T Consensus       208 f--LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-------~lvrQIs~Ga--------Y  270 (668)
T KOG0611|consen  208 F--LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-------RLVRQISRGA--------Y  270 (668)
T ss_pred             H--HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-------HHHHHhhccc--------c
Confidence            4  357899999999999999988 57899999999999999999999864321       1112222221        1


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      +.    ...+.+..-||+|||..||++|.|+.+|..|-|-.
T Consensus       271 rE----P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  271 RE----PETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             cC----CCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence            11    12234577899999999999999999999998854

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.3e-43  Score=338.54  Aligned_cols=259  Identities=27%  Similarity=0.446  Sum_probs=205.6

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe------cCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCe
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQ  153 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  153 (407)
                      .++|++.+.||+|+||.||+|..      .++..||+|++...........+.+|+++++.+ +|+||++++++|.....
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            35788899999999999999873      234579999997655555566788999999999 89999999999999999


Q ss_pred             eEEEEEeccCCChhHHHhccC-----------------------------------------------------------
Q 040557          154 RLLVYEYMKNRSLDLLIYGES-----------------------------------------------------------  174 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  174 (407)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999998875321                                                           


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc-cccc
Q 040557          175 ---------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LSTN  244 (407)
Q Consensus       175 ---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~  244 (407)
                               ...+++..+.+++.|++.||.|||+.+   ++||||||+|||+++++.++|+|||+++........ ....
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                     124788899999999999999999988   999999999999999999999999999865433221 1122


Q ss_pred             cccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCC
Q 040557          245 FAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIV  323 (407)
Q Consensus       245 ~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  323 (407)
                      ..++..|+|||++.+..++.++|||||||++|||++ |+.||.......      ........+.     ...     .+
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~~~~~~~-----~~~-----~~  337 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYKMVKRGY-----QMS-----RP  337 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHHHHHccc-----Ccc-----CC
Confidence            345678999999999999999999999999999997 999986432211      1112222111     000     01


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          324 ERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       324 ~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ...+.++.+++.+||+.||++|||+.+|++.|+..
T Consensus       338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11245688999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.5e-42  Score=366.38  Aligned_cols=264  Identities=25%  Similarity=0.478  Sum_probs=212.3

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ....+...+.||+|+||.||+|.. .+|..||||++......     ...|++.+++++||||++++|+|.+....++||
T Consensus       688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            345677788999999999999986 57899999988533221     134688899999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|.++++     .++|..+.+++.|++.||+|||....++++||||||+||+++.++.+++. ||........ 
T Consensus       763 Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-  835 (968)
T PLN00113        763 EYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-  835 (968)
T ss_pred             eCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence            9999999999984     28999999999999999999996655569999999999999999888875 6665443222 


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                          ....+++.|+|||++.+..++.++|||||||++|||+||+.|++..... ......|.............+|+.+.
T Consensus       836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  910 (968)
T PLN00113        836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSIR  910 (968)
T ss_pred             ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCcccc
Confidence                2236789999999999999999999999999999999999998654332 22344555444444455556676664


Q ss_pred             cC-CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          319 KE-GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       319 ~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                      .. ........++.+++.+||+.||++||||.||++.|+....
T Consensus       911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            32 2344566788999999999999999999999999986543

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-43  Score=332.00  Aligned_cols=258  Identities=22%  Similarity=0.269  Sum_probs=207.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++.....  ......+.+|++++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888899999999999999865 589999999864421  234457889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|.+++..  ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.....  
T Consensus        81 e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          81 EYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            99999999999853  345899999999999999999999998   99999999999999999999999999986544  


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                        ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+      .............  .+...
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~~~~~--~~~~~  223 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE------TWENLKYWKETLQ--RPVYD  223 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH------HHHHHHhcccccc--CCCCC
Confidence              2234679999999999999999999999999999999999999987543221      1111111000000  01110


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .  .....+..+.+++.+||+.+|++||++.++++|.+..
T Consensus       224 ~--~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~  261 (333)
T cd05600         224 D--PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFK  261 (333)
T ss_pred             c--cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccC
Confidence            0  0012345688999999999999999999999997754

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.3e-44  Score=330.90  Aligned_cols=253  Identities=23%  Similarity=0.378  Sum_probs=215.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChh-hHHHHHHHHHHHHcCCCCceeeeeeeeecCCe-eEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQ-GESEFLSEVRMITSIQHKNLVRLLGCCSDGSQ-RLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~  158 (407)
                      ++|...+++|+|+||.++.++.+ +++.+++|.+....... ......+|+.++++++|||||.+.+.+..++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56888899999999999999754 68899999997765332 33467899999999999999999999988887 89999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      +|++||++.+.+...++..++++.+.+|+.|++.|+.|||++.   |+|||||+.|||++.++.++|+|||+|+.+....
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999998888788999999999999999999999887   9999999999999999999999999999987765


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                      .. ....+||+.||.||.+.+.+|..|+|||||||++|||++-+++|......      ..+.+.....           
T Consensus       161 ~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~------~Li~ki~~~~-----------  222 (426)
T KOG0589|consen  161 SL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS------ELILKINRGL-----------  222 (426)
T ss_pred             hh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH------HHHHHHhhcc-----------
Confidence            32 35688999999999999999999999999999999999999998754332      2222222211           


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                      -...+..+..++..++..|++.+|+.||++.+++.+.
T Consensus       223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P  259 (426)
T KOG0589|consen  223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP  259 (426)
T ss_pred             CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence            1123445677899999999999999999999999763

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.5e-44  Score=298.89  Aligned_cols=252  Identities=25%  Similarity=0.339  Sum_probs=214.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++++.||+|-||.||.|+. +++-.||+|++.++.-  ..-..++.+|+++-+.|+||||+++++++.+....||++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            6788999999999999999985 4688999999865542  233467889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||..+|++...+.......+++.....+..|+|.|+.|+|..+   ++||||||+|+|++.++..|++|||-+..-+.. 
T Consensus       102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~-  177 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSN-  177 (281)
T ss_pred             EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCCC-
Confidence            9999999999998777788999999999999999999999988   999999999999999999999999999865522 


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                        ...+.+||.-|.+||...+..++..+|+|++|++.||++.|.+||+.....+      ...+ +..   .+..     
T Consensus       178 --kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e------tYkr-I~k---~~~~-----  240 (281)
T KOG0580|consen  178 --KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE------TYKR-IRK---VDLK-----  240 (281)
T ss_pred             --CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH------HHHH-HHH---cccc-----
Confidence              3456899999999999999999999999999999999999999998544211      1111 111   1122     


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                         ++...+..+.++|.+|+..+|.+|.+..|+++|.|-
T Consensus       241 ---~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI  276 (281)
T KOG0580|consen  241 ---FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWI  276 (281)
T ss_pred             ---CCcccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence               223345568899999999999999999999999874

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-43  Score=320.14  Aligned_cols=267  Identities=26%  Similarity=0.384  Sum_probs=202.6

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHc--CCCCceeeeeeeeecCC----eeE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITS--IQHKNLVRLLGCCSDGS----QRL  155 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~  155 (407)
                      ......++||+|.||.||+|.+. ++.||||++.    .+..+.|.+|-++.+.  ++|+||++++++-..+.    .++
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecC----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            33445578999999999999994 6999999994    4455678888887775  48999999999876655    889


Q ss_pred             EEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhcccccc------CCCceeeeccccccEEEcCCCceEEeccc
Q 040557          156 LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED------SHTRIVHRDIKASNVLLDEKFQSKIGDFG  229 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  229 (407)
                      ||+||.+.|+|.+++..+   .++|....+++..+++||+|||+.      ..++|+|||||++||||.+|+++.|+|||
T Consensus       285 LVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             EEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            999999999999999544   489999999999999999999985      24679999999999999999999999999


Q ss_pred             CccccCCCCcc-cccccccCccccCccccccCC-CC-----ccccEEehhHHHHHHHhcCCCCCCCCCcccCchh-----
Q 040557          230 LARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGE-LS-----EKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLP-----  297 (407)
Q Consensus       230 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~-----~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~-----  297 (407)
                      ||..+...... ...+.+||.+|||||++.+.. +.     .+.||||+|.|||||++.-.-.+.....+.+...     
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            99988644332 233578999999999987642 22     3689999999999999977655422222222110     


Q ss_pred             -----HHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          298 -----EYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       298 -----~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                           +..+..+-..+    ..|.+............+++.+..||+.|++.|.|+.=+-+.++....
T Consensus       442 ~hPt~e~mq~~VV~kK----~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRKK----QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             CCCCHHHHHHHHHhhc----cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence                 11122221111    123332222223446678999999999999999999999888876543

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.3e-43  Score=318.01  Aligned_cols=254  Identities=27%  Similarity=0.430  Sum_probs=208.3

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      ++|++.+.||+|+||.||+|...++..||+|.+...  ....+.+.+|+.+++.++|+||+++++++.+.+..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG--TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC--chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            568888999999999999999888889999987532  234567899999999999999999999999999999999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      ++|+|.+++.......+++..+..++.|++.|++|||+.+   ++||||||+||++++++.++|+|||++..........
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA  160 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence            9999999997665667899999999999999999999988   9999999999999999999999999998765443322


Q ss_pred             ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                      .....++..|+|||.+....++.++||||||+++|+|+| |+.||......       ........+...    +     
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~~~~~~~----~-----  224 (261)
T cd05072         161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-------DVMSALQRGYRM----P-----  224 (261)
T ss_pred             cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-------HHHHHHHcCCCC----C-----
Confidence            233446778999999988899999999999999999998 88888543221       111112211100    0     


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                       .....+..+.+++.+||+.+|++||+++++++.|+.
T Consensus       225 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         225 -RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             -CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             111234568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-43  Score=342.16  Aligned_cols=267  Identities=22%  Similarity=0.301  Sum_probs=215.1

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecCC-cEEEEEEeccccChhhHHHHHHHHHHHHcCC-CCceeeeeee-ee---c---C
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLADG-TLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-HKNLVRLLGC-CS---D---G  151 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~---~---~  151 (407)
                      ..++++.+.|.+|||+.||.|....+ ..||+|++... +......+.+|+++|++|. |+|||.+++. ..   .   .
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            35667778999999999999997665 99999999755 7778889999999999996 9999999993 21   1   2


Q ss_pred             CeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCc
Q 040557          152 SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLA  231 (407)
Q Consensus       152 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla  231 (407)
                      -+++|.||||.||.|-+++..+....|++.++++|+.++++|+.+||... ++|||||||-+||||+.++..||||||.+
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence            36789999999999999997666666999999999999999999999984 78999999999999999999999999999


Q ss_pred             cccCCCC--cc------cccccccCccccCccccc---cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHH
Q 040557          232 RFFPEDQ--AY------LSTNFAGTLGYTAPEYAI---RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYA  300 (407)
Q Consensus       232 ~~~~~~~--~~------~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~  300 (407)
                      ...-...  ..      ..-...-|+.|+|||++.   +...++|+|||+|||+||-|+....||+..-.          
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------  263 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------  263 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence            7432211  10      001234689999999874   67889999999999999999999999975411          


Q ss_pred             HHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccCCCCCCchh
Q 040557          301 WKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVRPAY  369 (407)
Q Consensus       301 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~~~~~~p~~  369 (407)
                               ..+++....-. ........+.+||..||+.||++||++-+|+..+..+.....|..-.+
T Consensus       264 ---------laIlng~Y~~P-~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~  322 (738)
T KOG1989|consen  264 ---------LAILNGNYSFP-PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY  322 (738)
T ss_pred             ---------eeEEeccccCC-CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence                     12222222222 123567789999999999999999999999999987777665544444

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.9e-43  Score=328.54  Aligned_cols=247  Identities=24%  Similarity=0.279  Sum_probs=199.9

Q ss_pred             CeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCC
Q 040557           88 NLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNR  164 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  164 (407)
                      +.||+|+||.||+++. .+|..||+|.+....  .......+.+|++++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999985 468999999986432  2234456788999999999999999999999999999999999999


Q ss_pred             ChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccccc
Q 040557          165 SLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN  244 (407)
Q Consensus       165 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  244 (407)
                      +|..++..  ...+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||++........ ....
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~  154 (323)
T cd05595          81 ELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT  154 (323)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cccc
Confidence            99888753  345899999999999999999999998   99999999999999999999999999875432221 1234


Q ss_pred             cccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCH
Q 040557          245 FAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVE  324 (407)
Q Consensus       245 ~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  324 (407)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||......      . .........      ..     .+.
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~-~~~~~~~~~------~~-----~p~  216 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------R-LFELILMEE------IR-----FPR  216 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH------H-HHHHHhcCC------CC-----CCC
Confidence            57999999999999999999999999999999999999998643221      1 111111111      00     112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhcc
Q 040557          325 RDALQVINVAFICLQPHGNQRP-----PMSEIVAMLTCK  358 (407)
Q Consensus       325 ~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~l~~~  358 (407)
                      ..+..+.+++.+||+.||++||     ++.++++|-+..
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~  255 (323)
T cd05595         217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL  255 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcC
Confidence            2345688999999999999998     899999987654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=9.5e-44  Score=323.05  Aligned_cols=249  Identities=33%  Similarity=0.517  Sum_probs=196.7

Q ss_pred             CCeeeccCCccEEEEEec-----CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           87 GNLLGRGGFGPVYRGKLA-----DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      .+.||.|.||.||+|.+.     .+..|+||.+...........|.+|++.+++++||||++++|++...+..++||||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            367999999999999875     367899999965555566789999999999999999999999999888899999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc-c
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA-Y  240 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-~  240 (407)
                      ++|+|.+++.......+++..+..|+.|++.||.|||+.+   ++|+||+++||++++++.+||+|||++........ .
T Consensus        84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            9999999998775667999999999999999999999988   99999999999999999999999999987733222 2


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                      ..........|+|||.+....++.++||||||+++|||++ |+.|+.....      ...... +..+....        
T Consensus       161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~------~~~~~~-~~~~~~~~--------  225 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN------EEIIEK-LKQGQRLP--------  225 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH------HHHHHH-HHTTEETT--------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccc------cccccc-ccccccce--------
Confidence            2233457789999999999999999999999999999999 6677643211      112222 22222211        


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                        .+..++..+.+++.+||..+|++|||+.++++.|
T Consensus       226 --~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 --IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             --SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             --eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence              1222345688999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.3e-42  Score=315.02  Aligned_cols=251  Identities=25%  Similarity=0.416  Sum_probs=203.0

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      ++|++.+.||+|+||.||+|...++..+|+|.+...  ......+.+|++++++++||||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG--AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC--CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            457777899999999999999888889999987533  223457889999999999999999999999999999999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      ++|+|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||+++.........
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          82 ENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            9999999986443 35899999999999999999999988   9999999999999999999999999998664433322


Q ss_pred             ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......      ..... ...+..  ..       
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~------~~~~~-i~~~~~--~~-------  221 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY------EVVEM-ISRGFR--LY-------  221 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH-HHCCCC--CC-------
Confidence            223345678999999988889999999999999999999 88888643221      11111 111111  00       


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                       .+...+..+.+++.+||+.+|++||++.++++.|
T Consensus       222 -~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         222 -RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             -CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence             1111234688999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.4e-42  Score=319.54  Aligned_cols=256  Identities=28%  Similarity=0.449  Sum_probs=207.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEecC------CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLAD------GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRL  155 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  155 (407)
                      ++|++.+.||+|+||.||+|....      ...||+|.+...........|.+|++++..++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            457778899999999999997532      25799999875555555677899999999999999999999999999999


Q ss_pred             EEEEeccCCChhHHHhccCC--------------CCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC
Q 040557          156 LVYEYMKNRSLDLLIYGESD--------------KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF  221 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~  221 (407)
                      ++|||+++|+|.+++.....              ..+++..+..++.|++.||.|||+.+   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999999864321              45889999999999999999999998   99999999999999999


Q ss_pred             ceEEecccCccccCCCCc-ccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHH
Q 040557          222 QSKIGDFGLARFFPEDQA-YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEY  299 (407)
Q Consensus       222 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~  299 (407)
                      .++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......       .
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-------~  234 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-------E  234 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-------H
Confidence            999999999986543322 12233456888999999998899999999999999999998 98888653322       1


Q ss_pred             HHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          300 AWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       300 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      ....+..+...          ..+...+..+.+++.+||+.||.+||++.+|+++|..
T Consensus       235 ~~~~i~~~~~~----------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         235 VIEMIRSRQLL----------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHcCCcC----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            11222222111          1223345679999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.4e-43  Score=330.62  Aligned_cols=250  Identities=23%  Similarity=0.258  Sum_probs=205.0

Q ss_pred             cCCCCCCeeeccCCccEEEEEecC--CcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLAD--GTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ++|++.+.||+|+||.||+|...+  +..||+|.+....  .......+.+|++++..++||||+++++++.+.+..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            568888999999999999997543  3689999985432  223445788999999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++......
T Consensus       110 ~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            9999999999998543  45899999999999999999999998   999999999999999999999999999876432


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      .    ....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.       ........+..      . 
T Consensus       185 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i~~~~~------~-  246 (340)
T PTZ00426        185 T----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKILEGII------Y-  246 (340)
T ss_pred             c----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHHHHHhcCCC------C-
Confidence            2    2457999999999999988999999999999999999999999753321       11111221111      0 


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhcc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRP-----PMSEIVAMLTCK  358 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~l~~~  358 (407)
                          .+......+.+++.+||+.||++|+     +++++++|.|..
T Consensus       247 ----~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~  288 (340)
T PTZ00426        247 ----FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFG  288 (340)
T ss_pred             ----CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcC
Confidence                1111234578999999999999995     899999998764

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.1e-43  Score=326.38  Aligned_cols=267  Identities=22%  Similarity=0.298  Sum_probs=202.5

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|.+...........+.+|+++++.++|+||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            367888999999999999999865 6899999998654443444567899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+. ++|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||++........
T Consensus        84 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  158 (303)
T cd07869          84 YVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH  158 (303)
T ss_pred             CCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence            996 5777776533 345889999999999999999999998   99999999999999999999999999975533221


Q ss_pred             ccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh-Cccc-------
Q 040557          240 YLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER-GRIL-------  310 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~-------  310 (407)
                       ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......     .......... +...       
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  232 (303)
T cd07869         159 -TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI-----QDQLERIFLVLGTPNEDTWPGV  232 (303)
T ss_pred             -cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH-----HHHHHHHHHHhCCCChhhccch
Confidence             1234568999999998865 45789999999999999999999999753221     1111111000 0000       


Q ss_pred             ---cccCc-ccc--cCCC------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          311 ---ELVDP-RMR--KEGI------VERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       311 ---~~~d~-~~~--~~~~------~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                         ...++ ...  ....      .......+.+++.+||+.||++|||+.|+++|-++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~  292 (303)
T cd07869         233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS  292 (303)
T ss_pred             hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccc
Confidence               00000 000  0000      000124577999999999999999999999998864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.2e-43  Score=324.66  Aligned_cols=266  Identities=23%  Similarity=0.346  Sum_probs=202.2

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      ++|+..+.||.|+||.||+|... ++..||+|.+...........+.+|+++++.++|+||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56888899999999999999864 68999999986544334445678999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +.+ +|.+++... ...+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||+++....... 
T Consensus        85 ~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-  158 (288)
T cd07871          85 LDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-  158 (288)
T ss_pred             CCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence            975 888887543 335789999999999999999999998   99999999999999999999999999976543222 


Q ss_pred             cccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHH--------HHh----C
Q 040557          241 LSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKL--------YER----G  307 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~--------~~~----~  307 (407)
                      ......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+..   ......        +..    .
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL---HLIFRLLGTPTEETWPGITSNE  235 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChHHhhccccch
Confidence            1233568999999998865 56899999999999999999999998654322110   000000        000    0


Q ss_pred             ccccccCcccccCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          308 RILELVDPRMRKEG---IVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       308 ~~~~~~d~~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      .......+......   .......++.+++.+||+.||.+|||++|+++|-+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~  287 (288)
T cd07871         236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY  287 (288)
T ss_pred             hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCC
Confidence            00000111110000   00112346789999999999999999999998865

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-43  Score=329.88  Aligned_cols=256  Identities=26%  Similarity=0.409  Sum_probs=216.3

Q ss_pred             CCCCCCeeeccCCccEEEEEecC---Cc--EEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLAD---GT--LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~~---~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ..+..+.||.|.||.||+|.+.+   |+  .||||..+.+...+..+.|++|..+|+.++||||++++|+|.+ ...|+|
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv  468 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV  468 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence            34556789999999999997532   33  5899998877777778899999999999999999999999975 467999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      ||.++-|.|..++..++. .++......++.||+.||.|||+..   ++||||..+|||+....-|||+||||++.+.++
T Consensus       469 mEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             EecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            999999999999976654 4899999999999999999999998   999999999999999999999999999999998


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                      ..+..+...-+..|||||.+.-..+|.+||||.|||++||+++ |..||.+-...+                ....+.. 
T Consensus       545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------VI~~iEn-  607 (974)
T KOG4257|consen  545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------VIGHIEN-  607 (974)
T ss_pred             chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------eEEEecC-
Confidence            8887776667889999999999999999999999999999876 788886432211                1111111 


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                      -.+-..++.++..++.|+.+||..+|.+||++.++...|..+..
T Consensus       608 GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  608 GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            11123566788899999999999999999999999999886554

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.4e-42  Score=329.55  Aligned_cols=254  Identities=22%  Similarity=0.308  Sum_probs=199.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      ++|+..+.||+|+||.||+|... +|+.||||.+...........+.+|+++++.++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            44566788999999999999864 68999999986554455567789999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++|+|...      ....+..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||++..+..... 
T Consensus       154 ~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-  223 (353)
T PLN00034        154 MDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-  223 (353)
T ss_pred             CCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence            999998643      23567788899999999999999998   99999999999999999999999999987643322 


Q ss_pred             cccccccCccccCcccccc-----CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          241 LSTNFAGTLGYTAPEYAIR-----GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                      ......||..|+|||.+..     ...+.++|||||||++|||++|+.||......+.   ....... ....       
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~-~~~~-------  292 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW---ASLMCAI-CMSQ-------  292 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH---HHHHHHH-hccC-------
Confidence            1234578999999998743     2345689999999999999999999973322211   0111100 0000       


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                         ...........+.+++.+||+.||++|||+.|+++|-+...
T Consensus       293 ---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~  333 (353)
T PLN00034        293 ---PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILR  333 (353)
T ss_pred             ---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence               00111223456899999999999999999999999977543

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2e-42  Score=331.81  Aligned_cols=257  Identities=21%  Similarity=0.283  Sum_probs=200.1

Q ss_pred             CCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .|+..+.||+|+||+||+|+. .+++.||+|++....  .......+.+|++++..++|+||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            577788999999999999975 468899999986433  23345678899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++|+|.+++..  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..+.....
T Consensus        82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          82 YIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             cCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            9999999999854  345889999999999999999999998   99999999999999999999999999864321000


Q ss_pred             ----------------------------------------------ccccccccCccccCccccccCCCCccccEEehhH
Q 040557          240 ----------------------------------------------YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGV  273 (407)
Q Consensus       240 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~  273 (407)
                                                                    ......+||+.|+|||.+.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                          0012357999999999999989999999999999


Q ss_pred             HHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHH--ccCCCCCCCCCHHHH
Q 040557          274 LVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFI--CLQPHGNQRPPMSEI  351 (407)
Q Consensus       274 vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~--cl~~~p~~RPs~~ev  351 (407)
                      ++|||++|+.||....+..      ............     ....   ......++.+++.+  |+..++..||++.++
T Consensus       237 il~elltG~~Pf~~~~~~~------~~~~i~~~~~~~-----~~~~---~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTE------TQLKVINWENTL-----HIPP---QVKLSPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHH------HHHHHHcccccc-----CCCC---CCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence            9999999999997543321      111111100000     0000   01123456677776  556677779999999


Q ss_pred             HHHhhcc
Q 040557          352 VAMLTCK  358 (407)
Q Consensus       352 ~~~l~~~  358 (407)
                      ++|-++.
T Consensus       303 l~hp~f~  309 (381)
T cd05626         303 KAHPFFS  309 (381)
T ss_pred             hcCcccC
Confidence            9998764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.3e-42  Score=333.25  Aligned_cols=260  Identities=26%  Similarity=0.394  Sum_probs=207.1

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcCC-CCceeeeeeeeecCC
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-HKNLVRLLGCCSDGS  152 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  152 (407)
                      ..++|++++.||+|+||.||+|...      .+..||||++.........+.+.+|+++++++. ||||+++++++.+..
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            3478889999999999999999752      234799999975555555678999999999995 999999999999999


Q ss_pred             eeEEEEEeccCCChhHHHhccC----------------------------------------------------------
Q 040557          153 QRLLVYEYMKNRSLDLLIYGES----------------------------------------------------------  174 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  174 (407)
                      ..++||||+++|+|.++++...                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999998875421                                                          


Q ss_pred             ------------------------------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc
Q 040557          175 ------------------------------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD  218 (407)
Q Consensus       175 ------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~  218 (407)
                                                          ...+++..+..++.|++.||.|||+.+   ++||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence                                                124788889999999999999999988   99999999999999


Q ss_pred             CCCceEEecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCch
Q 040557          219 EKFQSKIGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYL  296 (407)
Q Consensus       219 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~  296 (407)
                      +++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..|+.......    
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~----  347 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS----  347 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH----
Confidence            9999999999999866443322 1223456788999999999999999999999999999997 888876432211    


Q ss_pred             hHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          297 PEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       297 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                        ........+.       ..   ..+...+..+.+++.+||+.||++||++.+|.++|...
T Consensus       348 --~~~~~~~~~~-------~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         348 --TFYNKIKSGY-------RM---AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             --HHHHHHhcCC-------CC---CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence              1111111111       00   01123456788999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=9e-43  Score=327.37  Aligned_cols=247  Identities=25%  Similarity=0.272  Sum_probs=200.4

Q ss_pred             CeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCC
Q 040557           88 NLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNR  164 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  164 (407)
                      +.||+|+||.||++.. .+|+.||+|++....  .......+.+|+++++.++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 468999999986432  2334567889999999999999999999999999999999999999


Q ss_pred             ChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccccc
Q 040557          165 SLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN  244 (407)
Q Consensus       165 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  244 (407)
                      +|..++..  ...+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++....... ....
T Consensus        81 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~  154 (328)
T cd05593          81 ELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKT  154 (328)
T ss_pred             CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-cccc
Confidence            99888753  345899999999999999999999998   99999999999999999999999999975432221 1234


Q ss_pred             cccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCH
Q 040557          245 FAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVE  324 (407)
Q Consensus       245 ~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  324 (407)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||......      .... ....+.      ..     .+.
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~-~~~~~~------~~-----~p~  216 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFE-LILMED------IK-----FPR  216 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHH-HhccCC------cc-----CCC
Confidence            57999999999999999999999999999999999999998643221      1111 111110      01     112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhcc
Q 040557          325 RDALQVINVAFICLQPHGNQRP-----PMSEIVAMLTCK  358 (407)
Q Consensus       325 ~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~l~~~  358 (407)
                      .....+.+++.+||+.||++||     ++.++++|.|..
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~  255 (328)
T cd05593         217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFT  255 (328)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcC
Confidence            2345688999999999999997     899999997753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.1e-42  Score=326.39  Aligned_cols=250  Identities=26%  Similarity=0.329  Sum_probs=198.7

Q ss_pred             CCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHH---HcCCCCceeeeeeeeecCCeeEEE
Q 040557           84 FHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMI---TSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      |++.+.||+|+||.||+|... +|+.||||.+....  .......+.+|.+++   ..++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            566789999999999999854 68999999986432  222344566676655   566899999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++|+|..++..   ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++......
T Consensus        81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            999999999888743   35899999999999999999999998   999999999999999999999999998754322


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      .. ......|++.|+|||.+.+..++.++|||||||++|||++|+.||......      ...... ..+..      . 
T Consensus       155 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~i-~~~~~------~-  219 (324)
T cd05589         155 GD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDSI-VNDEV------R-  219 (324)
T ss_pred             CC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHHH-HhCCC------C-
Confidence            21 223467999999999999999999999999999999999999998643221      111111 11110      0 


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhcc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRP-----PMSEIVAMLTCK  358 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~l~~~  358 (407)
                          .+...+..+.+++.+||+.||++||     ++.+++++.+..
T Consensus       220 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~  261 (324)
T cd05589         220 ----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFR  261 (324)
T ss_pred             ----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcC
Confidence                1122345678999999999999999     688998887653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.3e-42  Score=324.04  Aligned_cols=247  Identities=22%  Similarity=0.367  Sum_probs=199.3

Q ss_pred             CeeeccCCccEEEEEe----cCCcEEEEEEecccc---ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           88 NLLGRGGFGPVYRGKL----ADGTLVAVKKLCVDK---SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      +.||+|+||.||+++.    .+++.||+|.+....   .......+.+|+++|+.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999975    357899999986432   223345678899999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++|+|.+++..  ...+.+..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++....... 
T Consensus        82 ~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  155 (323)
T cd05584          82 LSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-  155 (323)
T ss_pred             CCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence            999999998853  345788888999999999999999998   99999999999999999999999999975433222 


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......      ...... ..+..           
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~-~~~~~-----------  217 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKI-LKGKL-----------  217 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHH-HcCCC-----------
Confidence            123457999999999999988999999999999999999999998653221      111111 11111           


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhcc
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRP-----PMSEIVAMLTCK  358 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~l~~~  358 (407)
                      ..+......+.+++.+||+.||++||     ++.+++++.+..
T Consensus       218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~  260 (323)
T cd05584         218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFR  260 (323)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcC
Confidence            01112345688999999999999999     899999987653

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=9.7e-43  Score=327.77  Aligned_cols=258  Identities=23%  Similarity=0.258  Sum_probs=206.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||++... +|+.||+|.+.....  ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888899999999999999854 689999999865432  234566889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++..+....
T Consensus        81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            999999999998644 245899999999999999999999998   9999999999999999999999999998776544


Q ss_pred             cccccccccCccccCccccc------cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAI------RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL  312 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~------~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ........||+.|+|||++.      ...++.++|||||||++|||++|+.||......      ...............
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~  230 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFLKF  230 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCccCC
Confidence            33333457899999999886      456789999999999999999999998654321      111222211111100


Q ss_pred             cCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          313 VDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       313 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                           .   .....+..+.+++..|++ +|.+|||+.+++.|-+..
T Consensus       231 -----~---~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~  267 (330)
T cd05601         231 -----P---EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFS  267 (330)
T ss_pred             -----C---CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcC
Confidence                 0   001134567889999998 999999999999987754

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-42  Score=323.76  Aligned_cols=245  Identities=20%  Similarity=0.251  Sum_probs=199.1

Q ss_pred             eeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCCh
Q 040557           90 LGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL  166 (407)
Q Consensus        90 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  166 (407)
                      ||+|+||.||+|+.. +++.||+|.+....  .......+.+|++++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999865 58899999986432  233456788999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccccccc
Q 040557          167 DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA  246 (407)
Q Consensus       167 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  246 (407)
                      .+++..  ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||+++....... ......
T Consensus        81 ~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~  154 (312)
T cd05585          81 FHHLQR--EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTFC  154 (312)
T ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-cccccc
Confidence            998854  345899999999999999999999998   99999999999999999999999999986433222 223467


Q ss_pred             cCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHH
Q 040557          247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERD  326 (407)
Q Consensus       247 gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  326 (407)
                      ||+.|+|||.+.+..++.++|||||||++|||++|+.||.....      ......... +.        .   ..+...
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~-~~--------~---~~~~~~  216 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQ-EP--------L---RFPDGF  216 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHc-CC--------C---CCCCcC
Confidence            99999999999999999999999999999999999999864321      111111111 11        0   112223


Q ss_pred             HHHHHHHHHHccCCCCCCCC---CHHHHHHHhhcc
Q 040557          327 ALQVINVAFICLQPHGNQRP---PMSEIVAMLTCK  358 (407)
Q Consensus       327 ~~~l~~l~~~cl~~~p~~RP---s~~ev~~~l~~~  358 (407)
                      ...+.+++.+||+.||++||   ++.+++.|.+..
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~  251 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFS  251 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcC
Confidence            45688999999999999997   578888887654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-42  Score=329.34  Aligned_cols=257  Identities=23%  Similarity=0.272  Sum_probs=207.6

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++....  .......+.+|++++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888899999999999999865 68999999986432  1234567889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            999999999998644  56899999999999999999999988   9999999999999999999999999998765433


Q ss_pred             ----------------------------cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCC
Q 040557          239 ----------------------------AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLP  290 (407)
Q Consensus       239 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~  290 (407)
                                                  ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                        1122345689999999999999999999999999999999999999975432


Q ss_pred             cccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHhhcc
Q 040557          291 SEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPP-MSEIVAMLTCK  358 (407)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~ev~~~l~~~  358 (407)
                      .      ..........       ...... .....+..+.+++.+|++ ||.+||+ +.++++|.+..
T Consensus       236 ~------~~~~~i~~~~-------~~~~~p-~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~  289 (350)
T cd05573         236 Q------ETYNKIINWK-------ESLRFP-PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK  289 (350)
T ss_pred             H------HHHHHHhccC-------CcccCC-CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcC
Confidence            1      1111111100       000000 000134568899999998 9999999 99999998754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-42  Score=318.46  Aligned_cols=257  Identities=25%  Similarity=0.334  Sum_probs=207.1

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      +|+..+.||+|+||.||++... +++.||+|.+.....  ......+.+|+++++.++|+||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4777889999999999999864 689999999864322  2233567889999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++|+|..++.......+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence            999999998886555556899999999999999999999998   99999999999999999999999999987643332


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                      .  ....|+..|+|||.+.+..++.++|||||||++|||++|+.||........   ............           
T Consensus       158 ~--~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~-----------  221 (285)
T cd05605         158 I--RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVERRVKEDQ-----------  221 (285)
T ss_pred             c--ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHHHhhhcc-----------
Confidence            1  234689999999999988999999999999999999999999975332110   011111111100           


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhcc
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRP-----PMSEIVAMLTCK  358 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~l~~~  358 (407)
                      .......+..+.+++.+||+.||++||     +++++++|.+..
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~  265 (285)
T cd05605         222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFR  265 (285)
T ss_pred             cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCcc
Confidence            011223455688999999999999999     899999987653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-42  Score=330.45  Aligned_cols=257  Identities=23%  Similarity=0.293  Sum_probs=203.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++....  .......+.+|++++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46888899999999999999864 68999999996432  2233456789999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|.+++..  ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++..+....
T Consensus        81 E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          81 EYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            99999999999854  345899999999999999999999998   9999999999999999999999999997543211


Q ss_pred             cc-------------------------------------cccccccCccccCccccccCCCCccccEEehhHHHHHHHhc
Q 040557          239 AY-------------------------------------LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISC  281 (407)
Q Consensus       239 ~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg  281 (407)
                      ..                                     .....+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            00                                     01124699999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHhhcc
Q 040557          282 RKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPP---MSEIVAMLTCK  358 (407)
Q Consensus       282 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~ev~~~l~~~  358 (407)
                      ..||....+.      .............     .....   ......+.+++.+|+. +|.+|++   +.++++|.+..
T Consensus       236 ~~Pf~~~~~~------~~~~~i~~~~~~~-----~~~~~---~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~  300 (364)
T cd05599         236 YPPFCSDNPQ------ETYRKIINWKETL-----QFPDE---VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFK  300 (364)
T ss_pred             CCCCCCCCHH------HHHHHHHcCCCcc-----CCCCC---CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcC
Confidence            9999754321      1111111111000     00000   0123457788898997 9999998   99999998764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.9e-43  Score=327.47  Aligned_cols=246  Identities=23%  Similarity=0.305  Sum_probs=197.8

Q ss_pred             CeeeccCCccEEEEEe----cCCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEecc
Q 040557           88 NLLGRGGFGPVYRGKL----ADGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMK  162 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  162 (407)
                      +.||+|+||.||+++.    .+|+.||+|++..... ......+.+|++++.+++|+||+++++++.+.+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999864    3588999999864332 2234567789999999999999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccc
Q 040557          163 NRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS  242 (407)
Q Consensus       163 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  242 (407)
                      +|+|.+++..  ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++........ ..
T Consensus        82 ~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~  155 (318)
T cd05582          82 GGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KA  155 (318)
T ss_pred             CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ce
Confidence            9999998853  345899999999999999999999998   99999999999999999999999999986543322 12


Q ss_pred             cccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCC
Q 040557          243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGI  322 (407)
Q Consensus       243 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  322 (407)
                      ....|++.|+|||.+.+..++.++|||||||++|||++|+.||......      ...... .....           ..
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~~~i-~~~~~-----------~~  217 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK------ETMTMI-LKAKL-----------GM  217 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH------HHHHHH-HcCCC-----------CC
Confidence            3457899999999999888999999999999999999999998643221      111111 11110           01


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhhc
Q 040557          323 VERDALQVINVAFICLQPHGNQRPP-----MSEIVAMLTC  357 (407)
Q Consensus       323 ~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~l~~  357 (407)
                      +...+..+.+++.+||+.||++||+     +.+++.+.+.
T Consensus       218 p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~  257 (318)
T cd05582         218 PQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFF  257 (318)
T ss_pred             CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCc
Confidence            1223456789999999999999999     6667776654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-42  Score=316.06  Aligned_cols=256  Identities=29%  Similarity=0.456  Sum_probs=207.0

Q ss_pred             cCCCCCCeeeccCCccEEEEEecC----CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLAD----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ++|++.+.||+|+||.||+|.+..    ...||+|.+...........|.+|+.++..++|+||+++++++...+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568888999999999999998642    4579999986555555667889999999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++++|.+++.... ..+++..+..++.|++.|+.|||+.+   ++|+||||+||++++++.++|+|||++......
T Consensus        84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          84 TEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999986543 35899999999999999999999988   999999999999999999999999999977522


Q ss_pred             C-cccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          238 Q-AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       238 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                      . ........++..|+|||.+.+..++.++||||||+++|||++ |..|+......       ........+...    +
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~----~  228 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-------DVIKAVEDGYRL----P  228 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-------HHHHHHHcCCCC----C
Confidence            2 222222345678999999998999999999999999999998 88887532211       111112211100    0


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                            .+...+..+.+++.+||+.+|++||++.+|+++|...
T Consensus       229 ------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         229 ------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  1122345688999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.3e-42  Score=320.85  Aligned_cols=263  Identities=22%  Similarity=0.350  Sum_probs=198.6

Q ss_pred             cCCCCCCeeeccCCccEEEEEec--CCcEEEEEEeccccCh-hhHHHHHHHHHHHHcC---CCCceeeeeeeee-----c
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA--DGTLVAVKKLCVDKSQ-QGESEFLSEVRMITSI---QHKNLVRLLGCCS-----D  150 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l---~h~niv~l~~~~~-----~  150 (407)
                      ++|++.+.||+|+||.||+|+..  +|+.||+|.+...... .....+.+|+.++..+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888899999999999999862  4688999998654322 2234556777777665   6999999999885     3


Q ss_pred             CCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccC
Q 040557          151 GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGL  230 (407)
Q Consensus       151 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgl  230 (407)
                      ....++||||+. ++|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999996 58988887655566899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCc--
Q 040557          231 ARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGR--  308 (407)
Q Consensus       231 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--  308 (407)
                      +.......  ......||+.|+|||.+.+..++.++|||||||++|||++|++||......+      ..........  
T Consensus       157 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~------~~~~i~~~~~~~  228 (290)
T cd07862         157 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD------QLGKILDVIGLP  228 (290)
T ss_pred             eEeccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH------HHHHHHHHhCCC
Confidence            98665432  2234568999999999988899999999999999999999999987543211      1111111000  


Q ss_pred             ----c-------ccccCccccc--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          309 ----I-------LELVDPRMRK--EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       309 ----~-------~~~~d~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                          .       ...+.+....  .......+..+.+++.+||+.||++|||+.++++|.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~  289 (290)
T cd07862         229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY  289 (290)
T ss_pred             ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCC
Confidence                0       0000000000  0001123456789999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-42  Score=329.61  Aligned_cols=257  Identities=19%  Similarity=0.273  Sum_probs=201.0

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||++.. .+|+.||+|++....  .......+.+|++++..++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            3688889999999999999975 468999999985432  2234467889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|.+++..  ...+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.++|+|||+++.+....
T Consensus        81 E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          81 EFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            99999999999853  345889999999999999999999998   9999999999999999999999999996432110


Q ss_pred             cc----------------------------------------------cccccccCccccCccccccCCCCccccEEehh
Q 040557          239 AY----------------------------------------------LSTNFAGTLGYTAPEYAIRGELSEKADIYSFG  272 (407)
Q Consensus       239 ~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G  272 (407)
                      ..                                              .....+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence            00                                              00124699999999999999999999999999


Q ss_pred             HHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCC---CCHH
Q 040557          273 VLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQR---PPMS  349 (407)
Q Consensus       273 ~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---Ps~~  349 (407)
                      |++|||++|+.||......+      ..............  +   .   .......+.+++.+|++ +|.+|   +++.
T Consensus       236 vil~elltG~~Pf~~~~~~~------~~~~i~~~~~~~~~--p---~---~~~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHE------TYRKIINWRETLYF--P---D---DIHLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHH------HHHHHHccCCccCC--C---C---CCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            99999999999996543211      11111110000000  0   0   01123467889999998 66665   6999


Q ss_pred             HHHHHhhcc
Q 040557          350 EIVAMLTCK  358 (407)
Q Consensus       350 ev~~~l~~~  358 (407)
                      +++.|.+..
T Consensus       301 ~~l~hp~~~  309 (377)
T cd05629         301 EIKSHPFFR  309 (377)
T ss_pred             HHhcCCCcC
Confidence            999998764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=316.48  Aligned_cols=267  Identities=24%  Similarity=0.314  Sum_probs=208.8

Q ss_pred             cCHHHHHHHhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccCh-------------hhHHHHHHHHHHHHcCC
Q 040557           72 FDFQTLKKATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQ-------------QGESEFLSEVRMITSIQ  137 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------~~~~~~~~e~~~l~~l~  137 (407)
                      ++..+-.+..++|++.+.||+|.||.|-+|+. .+++.||||++.+....             ...+.+.+|+.+|++++
T Consensus        87 ~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~  166 (576)
T KOG0585|consen   87 YDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH  166 (576)
T ss_pred             ecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence            34444445568899999999999999999985 46999999999654211             12357899999999999


Q ss_pred             CCceeeeeeeeecC--CeeEEEEEeccCCChhHHHhccCCCC-CCHHHHHHHHHHHHHHhccccccCCCceeeecccccc
Q 040557          138 HKNLVRLLGCCSDG--SQRLLVYEYMKNRSLDLLIYGESDKF-LNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASN  214 (407)
Q Consensus       138 h~niv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~N  214 (407)
                      |+|||+|+.+..+.  +.+|||+|||..|.+...   ...+. +++.++++++.++..||+|||.++   |+||||||+|
T Consensus       167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsN  240 (576)
T KOG0585|consen  167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSN  240 (576)
T ss_pred             CcCeeEEEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhh
Confidence            99999999999765  578999999998876433   44455 999999999999999999999999   9999999999


Q ss_pred             EEEcCCCceEEecccCccccCCCCc----ccccccccCccccCccccccCC----CCccccEEehhHHHHHHHhcCCCCC
Q 040557          215 VLLDEKFQSKIGDFGLARFFPEDQA----YLSTNFAGTLGYTAPEYAIRGE----LSEKADIYSFGVLVLEIISCRKNTD  286 (407)
Q Consensus       215 ill~~~~~~kl~Dfgla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~~~k~Dv~s~G~vl~el~tg~~p~~  286 (407)
                      +||+++|.+||+|||.+..+.....    ......+|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||.
T Consensus       241 LLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~  320 (576)
T KOG0585|consen  241 LLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF  320 (576)
T ss_pred             eEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence            9999999999999999987733211    1122368999999999887732    2568899999999999999999996


Q ss_pred             CCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          287 LTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                      .....      + ....        ++...+.-... .+....+.+||.++|++||+.|.+..+|..|.|-...
T Consensus       321 ~~~~~------~-l~~K--------Ivn~pL~fP~~-pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  321 DDFEL------E-LFDK--------IVNDPLEFPEN-PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             cchHH------H-HHHH--------HhcCcccCCCc-ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            43221      1 1111        11122221111 1345568899999999999999999999999996554

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.6e-42  Score=324.88  Aligned_cols=267  Identities=21%  Similarity=0.303  Sum_probs=206.8

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|++.+.||+|+||.||++... ++..+|+|.+...........+.+|++++..++|+||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            367889999999999999999865 6888999988655444556678999999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++|+|.+++..  ...+++.....++.|++.||.|||+.+  +++||||||+|||+++++.+||+|||++....... 
T Consensus        84 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-  158 (333)
T cd06650          84 HMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (333)
T ss_pred             cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence            9999999999854  345899999999999999999999742  29999999999999999999999999997653322 


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccc---------
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRIL---------  310 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------  310 (407)
                        .....|+..|+|||.+.+..++.++|||||||++|||++|+.||..........   ... ....+...         
T Consensus       159 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~---~~~-~~~~~~~~~~~~~~~~~  232 (333)
T cd06650         159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL---MFG-CPVEGDPAESETSPRPR  232 (333)
T ss_pred             --cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHH---Hhc-CcccCCccccccCcccC
Confidence              123568999999999998889999999999999999999999986433211000   000 00000000         


Q ss_pred             --------------------cccCcccc---cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          311 --------------------ELVDPRMR---KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       311 --------------------~~~d~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                                          ...+....   ..........++.+++.+||+.||++|||+.|+++|.+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~  303 (333)
T cd06650         233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIK  303 (333)
T ss_pred             CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHh
Confidence                                00000000   0000001234688999999999999999999999998764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.2e-42  Score=323.88  Aligned_cols=254  Identities=23%  Similarity=0.318  Sum_probs=201.7

Q ss_pred             CeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEEEEeccC
Q 040557           88 NLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVYEYMKN  163 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  163 (407)
                      +.||+|+||.||+|+.. +++.||+|.+....  .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999864 68899999996532  223345678899999888 799999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccccc
Q 040557          164 RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST  243 (407)
Q Consensus       164 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  243 (407)
                      |+|..++..  ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++....... ...
T Consensus        81 g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~~  154 (329)
T cd05588          81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TTS  154 (329)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC-ccc
Confidence            999888743  346999999999999999999999998   99999999999999999999999999975322111 223


Q ss_pred             ccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcc--cCchhHHHHHHHHhCccccccCcccccCC
Q 040557          244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSE--MQYLPEYAWKLYERGRILELVDPRMRKEG  321 (407)
Q Consensus       244 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  321 (407)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||+......  ......+.......+..      .     
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~-----  223 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------R-----  223 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------C-----
Confidence            4679999999999999999999999999999999999999996432211  11112222222222211      0     


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHHhhcc
Q 040557          322 IVERDALQVINVAFICLQPHGNQRPP------MSEIVAMLTCK  358 (407)
Q Consensus       322 ~~~~~~~~l~~l~~~cl~~~p~~RPs------~~ev~~~l~~~  358 (407)
                      .+...+..+.+++.+||+.||++||+      +.++++|-|..
T Consensus       224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~  266 (329)
T cd05588         224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR  266 (329)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCC
Confidence            11123456889999999999999997      78999988764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-42  Score=315.05  Aligned_cols=255  Identities=27%  Similarity=0.409  Sum_probs=207.1

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      .++|++.+.||+|++|.||+|...+++.||+|.+....  .....+.+|++++++++|+||+++++++...+..+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            35688889999999999999998778899999985432  2345788999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++++|.+++.......+++..+..++.|++.|+.|||+.+   ++||||||+||++++++.++|+|||++.........
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            99999999997655567899999999999999999999988   999999999999999999999999999877533222


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                      .......+..|+|||.+.+..++.++||||||+++|||++ |+.|+......       ........+...         
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~---------  223 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-------EVLQQVDQGYRM---------  223 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCCC---------
Confidence            1222233457999999998899999999999999999999 88887543211       111122211100         


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                       ..+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       224 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         224 -PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             -CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence             0112234668999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-43  Score=330.97  Aligned_cols=250  Identities=24%  Similarity=0.309  Sum_probs=207.3

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRL  155 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  155 (407)
                      ..++|...++||+|+||+|+++..+ +++.+|||.+++..  ..+..+..+.|.+++... +||.+++++.++...+++|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            3468899999999999999999864 68899999998765  345567788999998887 5999999999999999999


Q ss_pred             EEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccC
Q 040557          156 LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP  235 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~  235 (407)
                      +||||+.||++..+   .....+++..+..++..++.||.|||+++   ||+||||.+|||||.+|.+||+||||++..-
T Consensus       446 fvmey~~Ggdm~~~---~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHH---IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             EEEEecCCCcEEEE---EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccC
Confidence            99999999994444   34456999999999999999999999999   9999999999999999999999999998654


Q ss_pred             CCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          236 EDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       236 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                      .... .+++++|||.|||||++.+..|+..+|.|||||+||||+.|..||.++..++      .......+         
T Consensus       520 ~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee------~FdsI~~d---------  583 (694)
T KOG0694|consen  520 GQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE------VFDSIVND---------  583 (694)
T ss_pred             CCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHhcC---------
Confidence            2222 4567999999999999999999999999999999999999999998654322      11111111         


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPM-----SEIVAM  354 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~ev~~~  354 (407)
                         ...++...+.+.++|+.++|..+|++|..+     .+|.+|
T Consensus       584 ---~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h  624 (694)
T KOG0694|consen  584 ---EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH  624 (694)
T ss_pred             ---CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence               112444566788999999999999999976     455544

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-42  Score=310.78  Aligned_cols=273  Identities=23%  Similarity=0.352  Sum_probs=210.4

Q ss_pred             CHHHHHHHhcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcC--CCCceeeeeeeeec
Q 040557           73 DFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI--QHKNLVRLLGCCSD  150 (407)
Q Consensus        73 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~  150 (407)
                      ..--.+...++..+.+.||+|.||.||+|++. |+.||||+|.    ..++..+.+|.++....  +|+||+.+++.-..
T Consensus       202 plLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~----srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~  276 (513)
T KOG2052|consen  202 PLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFS----SRDERSWFRETEIYQTVMLRHENILGFIAADNK  276 (513)
T ss_pred             hhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEec----ccchhhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence            33345566678888999999999999999995 8999999994    34455677888888764  99999999987543


Q ss_pred             C----CeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhcccccc-----CCCceeeeccccccEEEcCCC
Q 040557          151 G----SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED-----SHTRIVHRDIKASNVLLDEKF  221 (407)
Q Consensus       151 ~----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~i~H~dlk~~Nill~~~~  221 (407)
                      +    .++|||++|.++|||.+++..   ..++....++++..+|.||++||-.     |.|.|.|||||+.|||+..++
T Consensus       277 ~~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~  353 (513)
T KOG2052|consen  277 DNGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  353 (513)
T ss_pred             CCCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence            3    367999999999999999943   4599999999999999999999974     678899999999999999999


Q ss_pred             ceEEecccCccccCCCCccc---ccccccCccccCccccccCC----C--CccccEEehhHHHHHHHhc----------C
Q 040557          222 QSKIGDFGLARFFPEDQAYL---STNFAGTLGYTAPEYAIRGE----L--SEKADIYSFGVLVLEIISC----------R  282 (407)
Q Consensus       222 ~~kl~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~----~--~~k~Dv~s~G~vl~el~tg----------~  282 (407)
                      .+.|+|+|||.....+....   ....+||.+|||||++...-    +  -..+||||||.|+||+...          +
T Consensus       354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~  433 (513)
T KOG2052|consen  354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ  433 (513)
T ss_pred             cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence            99999999998876554332   34578999999999887542    1  2468999999999999752          2


Q ss_pred             CCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          283 KNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       283 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .||..-.+.+.++      +.+.+--..+.+.|.+.......+....+.++++.||..+|.-|-|+--|.+.|....
T Consensus       434 ~Pyyd~Vp~DPs~------eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  434 LPYYDVVPSDPSF------EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             CCcccCCCCCCCH------HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            4554433332221      1111111222233444444455667788999999999999999999999988887654

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.3e-42  Score=314.79  Aligned_cols=254  Identities=28%  Similarity=0.403  Sum_probs=206.2

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      .+|+..+.||+|+||.||+|... +++.||+|.+...  ......+.+|++++..++|+||+++++++...+..+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            34667789999999999999854 5889999988532  33456788999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++++|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++.........
T Consensus        84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            99999999987655566899999999999999999999988   999999999999999999999999999876544332


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                      ......++..|+|||.+.+..++.++|||||||++|||++ |..|+......       ........+.     ..    
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~-----~~----  224 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELLEKGY-----RM----  224 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCC-----CC----
Confidence            2222334668999999998999999999999999999998 88887543211       1122222111     00    


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                       ..+...+..+.+++.+||+.+|++|||+.+++++|+.
T Consensus       225 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         225 -ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             -CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence             1112234678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-42  Score=330.40  Aligned_cols=264  Identities=21%  Similarity=0.284  Sum_probs=200.8

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      .+|++.+.||+|+||.||++.. .+++.||+|...       ...+.+|++++++++||||+++++++......++|+|+
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            5799999999999999999985 468899999642       12467899999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +. ++|..++...  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.........
T Consensus       165 ~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        165 YK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             CC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            95 6888777433  45899999999999999999999998   999999999999999999999999999754333222


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCch-hHHHHHHHHh-Cc----------
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYL-PEYAWKLYER-GR----------  308 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~-~~----------  308 (407)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.|+........... .......... +.          
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            23346799999999999999999999999999999999999988754322111100 0000000000 00          


Q ss_pred             --cccc---------cCcccccC-CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          309 --ILEL---------VDPRMRKE-GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       309 --~~~~---------~d~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                        ....         ..+..+.. ......+.++.+++.+||+.||++|||++|++++-++.
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~  380 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ  380 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhc
Confidence              0000         00000000 00112355788999999999999999999999998864

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=6.7e-42  Score=321.62  Aligned_cols=253  Identities=24%  Similarity=0.326  Sum_probs=199.9

Q ss_pred             CeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEEEEeccC
Q 040557           88 NLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVYEYMKN  163 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  163 (407)
                      +.||+|+||.||+|... +++.||+|.+....  .......+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999864 58899999986542  233445677899888877 899999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccccc
Q 040557          164 RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST  243 (407)
Q Consensus       164 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  243 (407)
                      |+|..++..  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++....... ...
T Consensus        81 ~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~  154 (329)
T cd05618          81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTS  154 (329)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-ccc
Confidence            999888743  345899999999999999999999998   99999999999999999999999999975432221 123


Q ss_pred             ccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcc--cCchhHHHHHHHHhCccccccCcccccCC
Q 040557          244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSE--MQYLPEYAWKLYERGRILELVDPRMRKEG  321 (407)
Q Consensus       244 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  321 (407)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||.......  ......+.......+..           .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-----------~  223 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-----------R  223 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-----------C
Confidence            4679999999999999999999999999999999999999996422111  11112222222222111           0


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHHhhc
Q 040557          322 IVERDALQVINVAFICLQPHGNQRPP------MSEIVAMLTC  357 (407)
Q Consensus       322 ~~~~~~~~l~~l~~~cl~~~p~~RPs------~~ev~~~l~~  357 (407)
                      .+......+.+++.+||+.||++||+      +.++++|-+.
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f  265 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF  265 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCC
Confidence            12223456789999999999999998      6899888765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.9e-42  Score=326.16  Aligned_cols=260  Identities=28%  Similarity=0.440  Sum_probs=205.1

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeec-CC
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSD-GS  152 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-~~  152 (407)
                      .++|++.+.||+|+||.||+|...      +++.||+|++...........+.+|+.++.++ +|+||++++++|.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357888999999999999999632      35789999986544445556788999999999 89999999998864 45


Q ss_pred             eeEEEEEeccCCChhHHHhccC----------------------------------------------------------
Q 040557          153 QRLLVYEYMKNRSLDLLIYGES----------------------------------------------------------  174 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  174 (407)
                      ..+++|||+++|+|.+++....                                                          
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            6789999999999998885422                                                          


Q ss_pred             -CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc-ccccccCcccc
Q 040557          175 -DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL-STNFAGTLGYT  252 (407)
Q Consensus       175 -~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~  252 (407)
                       ...+++..+.+++.|++.||.|||+.+   |+||||||+|||+++++.++|+|||++..+....... .....++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             125899999999999999999999988   9999999999999999999999999998764333222 22345677899


Q ss_pred             CccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHH
Q 040557          253 APEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVI  331 (407)
Q Consensus       253 aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~  331 (407)
                      |||++.+..++.++|||||||++|||++ |..||......+      ........+...          ..+......+.
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~----------~~~~~~~~~~~  306 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTRM----------RAPEYATPEIY  306 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCCC----------CCCccCCHHHH
Confidence            9999999999999999999999999998 988886432211      111222221110          01112345688


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          332 NVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       332 ~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      +++.+||+.+|++||++.+++++|....
T Consensus       307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         307 SIMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            9999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.7e-42  Score=313.75  Aligned_cols=256  Identities=27%  Similarity=0.433  Sum_probs=209.8

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      ...+|++.+.||.|+||.||+|...++..+|+|.+.... ......+.+|+.+++.++|+||+++++++.+....++|||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            345688889999999999999998889999999986433 3345578899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++++|.+++.......+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            999999999997666667899999999999999999999988   99999999999999999999999999987654332


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                      . .....++..|+|||.+.+..++.++||||||+++++|++ |+.|+......      .... ....+..     .   
T Consensus       160 ~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~------~~~~-~~~~~~~-----~---  223 (261)
T cd05148         160 L-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH------EVYD-QITAGYR-----M---  223 (261)
T ss_pred             c-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH------HHHH-HHHhCCc-----C---
Confidence            2 223446778999999988899999999999999999998 78888543311      1111 1111100     0   


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                        ..+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus       224 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         224 --PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence              0112334568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.3e-42  Score=311.71  Aligned_cols=252  Identities=26%  Similarity=0.422  Sum_probs=202.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      ++|++.+.||+|+||.||.|...++..+|+|.+....  .....+.+|+.++.+++||||+++++++...+..+++|||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            3567788999999999999988777789999885332  23457899999999999999999999999988999999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      .+|+|.+++..... .+++..+..++.|++.|+.|||+.+   ++|+||||+||++++++.+||+|||+++.........
T Consensus        82 ~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          82 SNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             CCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            99999999864333 5899999999999999999999998   9999999999999999999999999998665443222


Q ss_pred             ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+......      .... ....+...    .     
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~-~~~~~~~~----~-----  221 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS------ETVE-KVSQGLRL----Y-----  221 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHHH-HHhcCCCC----C-----
Confidence            223345678999999988889999999999999999999 88887543221      1111 11111110    0     


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                       .+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus       222 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 -RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence             11112456899999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.3e-42  Score=320.80  Aligned_cols=256  Identities=27%  Similarity=0.410  Sum_probs=203.8

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCc----EEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGT----LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      .+|+..+.||+|+||.||+|.+. +|.    .||+|.+..........++.+|+.+++.++|+||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46888899999999999999753 343    48999986554555667899999999999999999999999764 5679


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ++||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||+++.+..
T Consensus        86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccC
Confidence            999999999999986543 35889999999999999999999998   99999999999999999999999999987754


Q ss_pred             CCccc-ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          237 DQAYL-STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       237 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      ..... .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+......       ........+...    
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~----  230 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------EISSILEKGERL----  230 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHhCCCCC----
Confidence            33221 122334678999999999999999999999999999998 89888643221       112222221110    


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                         .   .+..+...+.+++.+||+.+|++||++.+++..+....
T Consensus       231 ---~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         231 ---P---QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             ---C---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence               0   11123456889999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.3e-42  Score=324.45  Aligned_cols=271  Identities=21%  Similarity=0.288  Sum_probs=199.1

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC-----CeeE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG-----SQRL  155 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~  155 (407)
                      +|++.+.||+|+||.||+|... +|..||||++.... .......+.+|+++++.++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4777889999999999999854 68999999986432 223345788999999999999999999987543     2479


Q ss_pred             EEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccC
Q 040557          156 LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP  235 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~  235 (407)
                      +||||+. ++|.+++..  ...+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++...
T Consensus        81 lv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELME-SDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCC-CCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            9999995 688888743  345899999999999999999999998   9999999999999999999999999998653


Q ss_pred             CCCc--ccccccccCccccCcccccc--CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCc--------hhHHHHHH
Q 040557          236 EDQA--YLSTNFAGTLGYTAPEYAIR--GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQY--------LPEYAWKL  303 (407)
Q Consensus       236 ~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~--------~~~~~~~~  303 (407)
                      ....  .......||+.|+|||.+.+  ..++.++|||||||++|||++|+.||..........        ........
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            3221  11234578999999998865  678999999999999999999999986533211000        00000000


Q ss_pred             HHhCccccccCcccccCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          304 YERGRILELVDPRMRKEGI-----VERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       304 ~~~~~~~~~~d~~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      +......+.++........     .......+.+++.+||+.||++|||++|+++|-+...
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~  295 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG  295 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence            0000000000000000000     0012345789999999999999999999999987643

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.7e-42  Score=302.82  Aligned_cols=273  Identities=27%  Similarity=0.356  Sum_probs=209.0

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhH-HHHHHHHHHHHcCCCCceeeeeeeeec--CCeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGE-SEFLSEVRMITSIQHKNLVRLLGCCSD--GSQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv  157 (407)
                      ++|+..+.|++|+||.||+|+++ +++.||+|+++.+....+. ..-++|+.+|.+++|||||.+-.+...  -+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            45777789999999999999864 6899999999876644332 245799999999999999999887654  3578999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      ||||+. +|..+++... +.+...++..+..|+++|++|||.+.   |+|||||++|+|++..|.+||+|||||+.+...
T Consensus       156 Me~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             HHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            999987 8999987655 56888899999999999999999998   999999999999999999999999999988765


Q ss_pred             CcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                      .. ..+..+-|..|.|||.+.+ ..|++..|+||+|||+.||+++++.|.+...-+  .+.. +...+.  .-.+.+-|.
T Consensus       231 ~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d--Ql~~-If~llG--tPte~iwpg  304 (419)
T KOG0663|consen  231 LK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID--QLDK-IFKLLG--TPSEAIWPG  304 (419)
T ss_pred             cc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH--HHHH-HHHHhC--CCccccCCC
Confidence            33 2356788999999999887 579999999999999999999998886543211  1111 111111  111111110


Q ss_pred             -------------------cccCCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccCCCCCCc
Q 040557          317 -------------------MRKEGIVE-RDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVRP  367 (407)
Q Consensus       317 -------------------~~~~~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~~~~~~p  367 (407)
                                         ++.. +.. .....-.+++..+|..||.+|.|++|.++|=++. +.+.|..|
T Consensus       305 ~~~lp~~k~~~f~~~pyn~lr~k-F~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~-e~P~p~~P  373 (419)
T KOG0663|consen  305 YSELPAVKKMTFSEHPYNNLRKK-FGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFR-ETPLPIDP  373 (419)
T ss_pred             ccccchhhccccCCCCchhhhhh-ccccccchhHHHHHHHHhccCccccccHHHhhcccccc-cCCCCCCh
Confidence                               1100 111 0235667889999999999999999999998764 33334333

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.5e-42  Score=325.67  Aligned_cols=247  Identities=25%  Similarity=0.279  Sum_probs=199.2

Q ss_pred             CeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCC
Q 040557           88 NLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNR  164 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  164 (407)
                      +.||+|+||.||++.. .+|+.||+|.+....  .......+.+|++++..++|+||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 468999999986432  2234456788999999999999999999999999999999999999


Q ss_pred             ChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccc-cCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccccc
Q 040557          165 SLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE-DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST  243 (407)
Q Consensus       165 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  243 (407)
                      +|..++..  ...+++..+..++.|++.||.|||+ .+   ++||||||+|||+++++.+||+|||++........ ...
T Consensus        81 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~  154 (325)
T cd05594          81 ELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMK  154 (325)
T ss_pred             cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccc
Confidence            99888743  3468999999999999999999997 56   99999999999999999999999999875432222 123


Q ss_pred             ccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCC
Q 040557          244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIV  323 (407)
Q Consensus       244 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  323 (407)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......       ........+.      ..     .+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-------~~~~~i~~~~------~~-----~p  216 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILMEE------IR-----FP  216 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-------HHHHHHhcCC------CC-----CC
Confidence            456999999999999999999999999999999999999998643221       1111111111      00     11


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhcc
Q 040557          324 ERDALQVINVAFICLQPHGNQRP-----PMSEIVAMLTCK  358 (407)
Q Consensus       324 ~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~l~~~  358 (407)
                      ......+.+++.+||+.||++|+     ++.++++|.+..
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~  256 (325)
T cd05594         217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFA  256 (325)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcC
Confidence            12345688999999999999996     999999987754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-41  Score=317.01  Aligned_cols=260  Identities=21%  Similarity=0.230  Sum_probs=201.2

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+++.. +++.||+|.+....  .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46888899999999999999864 58999999986422  2233456889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|.+++... ...+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++..+....
T Consensus        81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            999999999998542 345899999999999999999999998   9999999999999999999999999997665444


Q ss_pred             cccccccccCccccCcccccc-----CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIR-----GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV  313 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ........||+.|+|||++..     ..++.++|||||||++|||++|+.||......      .............. +
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~-~  229 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHFQ-F  229 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCccc-C
Confidence            333334569999999998863     45788999999999999999999998643221      11111111111010 0


Q ss_pred             CcccccCCCCHHHHHHHHHHHHHccCC--CCCCCCCHHHHHHHhhcc
Q 040557          314 DPRMRKEGIVERDALQVINVAFICLQP--HGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       314 d~~~~~~~~~~~~~~~l~~l~~~cl~~--~p~~RPs~~ev~~~l~~~  358 (407)
                      .+      .....+..+.+++.+|++.  ++..||++.++++|.|..
T Consensus       230 ~~------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~  270 (331)
T cd05597         230 PP------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFE  270 (331)
T ss_pred             CC------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCC
Confidence            00      0111344577788887755  334488999999998864

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=8.9e-42  Score=313.64  Aligned_cols=255  Identities=28%  Similarity=0.476  Sum_probs=206.1

Q ss_pred             cCCCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRL  155 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  155 (407)
                      ++|.+.+.||+|+||.||+|...      ++..||+|.+...........+.+|++++..++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            45777789999999999999763      347899999875555545678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhHHHhccC------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCce
Q 040557          156 LVYEYMKNRSLDLLIYGES------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS  223 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~  223 (407)
                      +||||+++++|.+++....            ...+++..+..++.|++.|+.|||+.+   ++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            9999999999999986432            245789999999999999999999998   9999999999999999999


Q ss_pred             EEecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHH
Q 040557          224 KIGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAW  301 (407)
Q Consensus       224 kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~  301 (407)
                      +|+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.......       ..
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-------~~  234 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-------VI  234 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HH
Confidence            99999999865332221 1223346788999999999999999999999999999998 998876432211       11


Q ss_pred             HHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          302 KLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       302 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      .....+....          .+...+..+.+++.+||+.||++||++.||++.|.
T Consensus       235 ~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         235 ECITQGRLLQ----------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHHHcCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            1122221110          11223456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.3e-41  Score=317.96  Aligned_cols=246  Identities=25%  Similarity=0.314  Sum_probs=194.0

Q ss_pred             CeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEEEEeccC
Q 040557           88 NLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVYEYMKN  163 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  163 (407)
                      +.||+|+||.||+|... +++.||+|.+....  .......+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999864 58899999986432  123334556677777654 899999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccccc
Q 040557          164 RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST  243 (407)
Q Consensus       164 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  243 (407)
                      |+|..++...  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++....... ....
T Consensus        81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~  154 (316)
T cd05592          81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS  154 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence            9999888543  45899999999999999999999988   9999999999999999999999999998653322 2223


Q ss_pred             ccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCC
Q 040557          244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIV  323 (407)
Q Consensus       244 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  323 (407)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||......      ..... +....      +     ..+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~------~~~~~-i~~~~------~-----~~~  216 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED------ELFDS-ILNDR------P-----HFP  216 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHcCC------C-----CCC
Confidence            467999999999999999999999999999999999999998753221      11111 11110      0     111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHH-HHHHHhhc
Q 040557          324 ERDALQVINVAFICLQPHGNQRPPMS-EIVAMLTC  357 (407)
Q Consensus       324 ~~~~~~l~~l~~~cl~~~p~~RPs~~-ev~~~l~~  357 (407)
                      ......+.+++.+||+.||++||++. +++++.+.
T Consensus       217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~  251 (316)
T cd05592         217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF  251 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCccc
Confidence            22345678999999999999999875 66666543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-42  Score=304.10  Aligned_cols=275  Identities=24%  Similarity=0.318  Sum_probs=206.5

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecc-ccChhhHHHHHHHHHHHHcCCCCceeeeeeeeec-----CC
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCV-DKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSD-----GS  152 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~  152 (407)
                      ....|...+.||+|+||.|+.+.. .+|+.||||++.. -......++-.+|+.+|+.++|+||+.+++.+..     -+
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            345566678899999999999975 4789999999852 2345556788999999999999999999998754     35


Q ss_pred             eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                      ..|+|+|+|+ .+|...++  .++.++......+++|+++||.|+|+.+   ++||||||+|+|++.+..+||+|||+|+
T Consensus       100 DvYiV~elMe-tDL~~iik--~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen  100 DVYLVFELME-TDLHQIIK--SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             eeEEehhHHh-hHHHHHHH--cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence            7899999994 48888884  3445899999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCC-CcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccC--------chhHHHHH
Q 040557          233 FFPED-QAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQ--------YLPEYAWK  302 (407)
Q Consensus       233 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~--------~~~~~~~~  302 (407)
                      ..... .....+..+.|..|.|||.+.. ..||...||||.||++.||++|++.|.+...-..-        ........
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            87543 1222356788999999998764 68999999999999999999999988654321100        00011111


Q ss_pred             HHHhCccccccCcccccCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          303 LYERGRILELVDPRMRKEG-----IVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       303 ~~~~~~~~~~~d~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                      .+........+........     .-.......++|+.+||..||.+|+|++|.++|.-...-
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~  316 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY  316 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence            1111111111110000000     111234578999999999999999999999999765443

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.8e-41  Score=311.59  Aligned_cols=256  Identities=20%  Similarity=0.321  Sum_probs=205.2

Q ss_pred             CCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           83 NFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      +|+..+.||+|+||.||+|.. .++..||+|.+...........+.+|++++.+++|+||+++++++...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            577788999999999999975 4689999999865544555667999999999999999999999999999999999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      ++++|..+.      .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......   
T Consensus        82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---  149 (279)
T cd06619          82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---  149 (279)
T ss_pred             CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence            999987552      3688889999999999999999998   9999999999999999999999999998654332   


Q ss_pred             ccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCC
Q 040557          242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEG  321 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  321 (407)
                      .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||.......................     .+.+..  
T Consensus       150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~--  222 (279)
T cd06619         150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVLPV--  222 (279)
T ss_pred             ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCCCC--
Confidence            2345789999999999999999999999999999999999999865433222111111111111110     111111  


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          322 IVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       322 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                        ......+.+++.+||+.+|++||++++++++.+...
T Consensus       223 --~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~  258 (279)
T cd06619         223 --GQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ  258 (279)
T ss_pred             --CcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence              113346889999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=9.8e-42  Score=326.64  Aligned_cols=257  Identities=22%  Similarity=0.277  Sum_probs=200.3

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      .+|++.+.||+|+||.||+|+.. +++.||+|.+....  .......+.+|+++|+.++|+||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36888899999999999999854 58999999985432  1223456889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++|+|||++..+....
T Consensus        81 E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          81 DYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            99999999999854  345889999999999999999999998   9999999999999999999999999985332000


Q ss_pred             ------------------------------------------cccccccccCccccCccccccCCCCccccEEehhHHHH
Q 040557          239 ------------------------------------------AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVL  276 (407)
Q Consensus       239 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~  276 (407)
                                                                ........||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                      00012347999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCC---CHHHHHH
Q 040557          277 EIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRP---PMSEIVA  353 (407)
Q Consensus       277 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP---s~~ev~~  353 (407)
                      ||++|+.||....+.+      ....... ... ....+.      .......+.+++.+|+ .+|++|+   ++.++++
T Consensus       236 ell~G~~Pf~~~~~~~------~~~~i~~-~~~-~~~~~~------~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         236 EMLVGQPPFLADTPAE------TQLKVIN-WET-TLHIPS------QAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             ehhhCCCCCCCCCHHH------HHHHHhc-cCc-cccCCC------CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            9999999997544321      1111111 000 000000      0112345667777766 4999999   9999999


Q ss_pred             Hhhcc
Q 040557          354 MLTCK  358 (407)
Q Consensus       354 ~l~~~  358 (407)
                      |.+..
T Consensus       301 h~~~~  305 (376)
T cd05598         301 HPFFK  305 (376)
T ss_pred             CCCcC
Confidence            98764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=7.7e-42  Score=314.67  Aligned_cols=255  Identities=26%  Similarity=0.415  Sum_probs=204.3

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-----cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      +.|++.+.||+|+||.||+|..     .++..||+|.+...........+.+|+++++.++|+||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577778999999999999974     24678999998755555555788999999999999999999999999999999


Q ss_pred             EEEeccCCChhHHHhccC---------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC
Q 040557          157 VYEYMKNRSLDLLIYGES---------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF  221 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~  221 (407)
                      ||||+++++|.+++....               ...+++.....++.|++.||.|||+.+   ++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999885322               234788999999999999999999998   99999999999999999


Q ss_pred             ceEEecccCccccCCCCc-ccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHH
Q 040557          222 QSKIGDFGLARFFPEDQA-YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEY  299 (407)
Q Consensus       222 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~  299 (407)
                      .+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||....+       ..
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-------~~  234 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------QE  234 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------HH
Confidence            999999999986643322 12233446778999999988889999999999999999998 8888754321       11


Q ss_pred             HHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          300 AWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       300 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      .......+....          .+...+..+.+++.+||+.||++||++.+|.++|.
T Consensus       235 ~~~~~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         235 VIEMVRKRQLLP----------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             HHHHHHcCCcCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence            112222211110          11223456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=9.3e-42  Score=313.14  Aligned_cols=257  Identities=27%  Similarity=0.425  Sum_probs=204.2

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCe
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQ  153 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  153 (407)
                      ..++|++.+.||+|+||.||+|...      ++..||+|.+..........++.+|+.+++.++|+||+++++++..+..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567899999999999999998753      3567999988644444455678999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhHHHhccC--------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEE
Q 040557          154 RLLVYEYMKNRSLDLLIYGES--------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKI  225 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl  225 (407)
                      .++||||+++|+|.+++....        ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            999999999999999986432        124678899999999999999999988   999999999999999999999


Q ss_pred             ecccCccccCCCCccc-ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHH
Q 040557          226 GDFGLARFFPEDQAYL-STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKL  303 (407)
Q Consensus       226 ~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~  303 (407)
                      +|||++.......... .....++..|+|||.+.+..++.++|||||||++|||++ |..|+......       .....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-------~~~~~  233 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-------QVLRF  233 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHH
Confidence            9999998654433221 122345778999999998899999999999999999999 67777543221       11111


Q ss_pred             HHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          304 YERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       304 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ...+....          .+...+..+.+++.+||+.+|++|||+.|++++|+
T Consensus       234 ~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         234 VMEGGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHcCCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            12221111          11123456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=7.5e-42  Score=326.10  Aligned_cols=258  Identities=20%  Similarity=0.210  Sum_probs=205.3

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      .++|++.+.||+|+||.||+++.. +++.||+|.+....  .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            467888899999999999999864 68899999985432  223344578899999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++|+|.+++...   .+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||++......
T Consensus       122 ~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         122 MEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999999988542   4788888999999999999999998   999999999999999999999999999876544


Q ss_pred             CcccccccccCccccCccccccC----CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccccc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRG----ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV  313 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      .........||+.|+|||.+.+.    .++.++|||||||++|||++|+.||......      ........ +...   
T Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~-~~~~---  265 (370)
T cd05596         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMD-HKNS---  265 (370)
T ss_pred             CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHc-CCCc---
Confidence            33333456799999999988653    4789999999999999999999999754321      11111111 1100   


Q ss_pred             CcccccCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHhhcc
Q 040557          314 DPRMRKEGIVERDALQVINVAFICLQPHGNQ--RPPMSEIVAMLTCK  358 (407)
Q Consensus       314 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~~l~~~  358 (407)
                       .....   ....+..+.+++.+||+.+|++  ||++.++++|.+..
T Consensus       266 -~~~~~---~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~  308 (370)
T cd05596         266 -LTFPD---DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK  308 (370)
T ss_pred             -CCCCC---cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccC
Confidence             00000   0113456889999999999988  99999999998764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.4e-41  Score=319.34  Aligned_cols=254  Identities=23%  Similarity=0.304  Sum_probs=201.4

Q ss_pred             CeeeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEEEEeccC
Q 040557           88 NLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVYEYMKN  163 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  163 (407)
                      +.||+|+||.||+|... +++.||+|++.....  ......+.+|..++.++ +|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999864 578999999965432  23345678899999888 699999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccccc
Q 040557          164 RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST  243 (407)
Q Consensus       164 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  243 (407)
                      |+|..++..  ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++........ ...
T Consensus        81 ~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~  154 (327)
T cd05617          81 GDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TTS  154 (327)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-cee
Confidence            999888743  345899999999999999999999998   99999999999999999999999999975322211 123


Q ss_pred             ccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCC
Q 040557          244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIV  323 (407)
Q Consensus       244 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  323 (407)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||........................           ..+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------~~p  223 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-----------RIP  223 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC-----------CCC
Confidence            467999999999999999999999999999999999999999754332222222333332222111           011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCC------HHHHHHHhhcc
Q 040557          324 ERDALQVINVAFICLQPHGNQRPP------MSEIVAMLTCK  358 (407)
Q Consensus       324 ~~~~~~l~~l~~~cl~~~p~~RPs------~~ev~~~l~~~  358 (407)
                      ...+..+.+++.+||+.||++||+      +.++++|-++.
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~  264 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFR  264 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCC
Confidence            123355789999999999999998      57898887653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-42  Score=311.70  Aligned_cols=251  Identities=27%  Similarity=0.407  Sum_probs=201.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      .+|++.+.||+|+||.||+|...++..+|+|.+....  .....+.+|+++++.++|+||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM   81 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence            3477788999999999999998777889999885322  23456889999999999999999999999999999999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      ++++|.+++.... ..+++..+..++.|++.|+.|||+.+   ++||||||+||++++++.+||+|||+++.........
T Consensus        82 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          82 ANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             CCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            9999999986443 35899999999999999999999998   9999999999999999999999999998665433222


Q ss_pred             ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......      . .......+.     ...    
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~-~~~~~~~~~-----~~~----  221 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS------E-VVESVSAGY-----RLY----  221 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH------H-HHHHHHcCC-----cCC----
Confidence            222234567999999999999999999999999999999 78887643221      1 111111110     000    


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                       .+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus       222 -~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         222 -RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence             1112355789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.5e-41  Score=319.65  Aligned_cols=260  Identities=20%  Similarity=0.222  Sum_probs=202.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+++.. +++.||+|.+....  .......+.+|..++..++|+||+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888899999999999999864 58899999985422  2233455788999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|..++... ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.......
T Consensus        81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            999999999998643 245899999999999999999999998   9999999999999999999999999998765544


Q ss_pred             cccccccccCccccCcccccc-----CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIR-----GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV  313 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ........||+.|+|||++.+     +.++.++|||||||++|||++|+.||......      ...........     
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~-----  225 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEE-----  225 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCC-----
Confidence            333334579999999998875     46789999999999999999999999643221      11111111110     


Q ss_pred             CcccccCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHhhcc
Q 040557          314 DPRMRKEGIVERDALQVINVAFICLQPHGNQ--RPPMSEIVAMLTCK  358 (407)
Q Consensus       314 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~~l~~~  358 (407)
                        +..........+..+.+++.+|++.++++  |++++++++|.++.
T Consensus       226 --~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~  270 (331)
T cd05624         226 --RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFE  270 (331)
T ss_pred             --cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcC
Confidence              00000011123456788999988866554  57899999987653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.6e-41  Score=322.04  Aligned_cols=260  Identities=20%  Similarity=0.222  Sum_probs=204.4

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      ..++|++.+.||+|+||.||+++.. +++.||+|.+....  .......+.+|+.+++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3467899999999999999999865 58899999985422  22334567899999999999999999999999999999


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ||||+++|+|.+++...   .+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++.....
T Consensus       121 v~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            99999999999998532   4788999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcccccccccCccccCccccccC----CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccc
Q 040557          237 DQAYLSTNFAGTLGYTAPEYAIRG----ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL  312 (407)
Q Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ..........||+.|+|||.+.+.    .++.++|||||||++|||++|+.||......      .............. 
T Consensus       195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~-  267 (370)
T cd05621         195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHKNSLN-  267 (370)
T ss_pred             CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCcccC-
Confidence            433333456799999999988754    3788999999999999999999999754321      11112111111000 


Q ss_pred             cCcccccCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHhhccc
Q 040557          313 VDPRMRKEGIVERDALQVINVAFICLQPHGNQ--RPPMSEIVAMLTCKV  359 (407)
Q Consensus       313 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~~l~~~~  359 (407)
                          ...   ....+..+.+++..|++.++.+  ||++.|+++|.|...
T Consensus       268 ----~p~---~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~  309 (370)
T cd05621         268 ----FPE---DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN  309 (370)
T ss_pred             ----CCC---cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence                000   0112445778888899865544  899999999988654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.6e-41  Score=309.76  Aligned_cols=259  Identities=23%  Similarity=0.375  Sum_probs=208.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.+....  .......+.+|+++++.++||||+++++++.+.+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57888999999999999999854 68999999875422  3344567889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhcc--CCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          159 EYMKNRSLDLLIYGE--SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       159 e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ||+++|+|..++...  ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            999999999887532  2345889999999999999999999988   99999999999999999999999999987654


Q ss_pred             CCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          237 DQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                      .... .....+++.|+|||.+.+..++.++|+||||+++|||++|+.|+.......    .... .......     .+.
T Consensus       159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~-~~~~~~~-----~~~  227 (267)
T cd08228         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLC-QKIEQCD-----YPP  227 (267)
T ss_pred             hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHH-HHHhcCC-----CCC
Confidence            3321 223568889999999988889999999999999999999999985432211    1111 1111111     011


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                          ......+..+.+++.+||+.+|++||++.+|++.+...
T Consensus       228 ----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         228 ----LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             ----CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence                11223456789999999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.9e-42  Score=314.28  Aligned_cols=266  Identities=28%  Similarity=0.410  Sum_probs=202.1

Q ss_pred             CCCCeeeccCCccEEEEEe-----cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC--CeeEEE
Q 040557           85 HPGNLLGRGGFGPVYRGKL-----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG--SQRLLV  157 (407)
Q Consensus        85 ~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  157 (407)
                      +..+.||+|+||.||.+..     .++..||+|.+...........+.+|+++++.++|+||+++++++...  ...+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            7788999999999988642     357899999986554444567788999999999999999999988653  457899


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++|+|.+++...   .+++..+..++.|++.|+.|||+.+   ++||||||+||++++++.++|+|||++......
T Consensus        87 ~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          87 MEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             ecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            9999999999998543   4899999999999999999999998   999999999999999999999999999876543


Q ss_pred             Cccc--ccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          238 QAYL--STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       238 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                      ....  .....++..|+|||.+.+..++.++||||||+++|||+||..|+......... ...............+.++.
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQMTVVRLIELLER  239 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh-hhcccccccchhhhhhhhhc
Confidence            3211  12234566799999998889999999999999999999999987543221100 00000000000011111111


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .... ..+...+..+.+++.+||+.+|++|||++++++.|+..
T Consensus       240 ~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         240 GMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             CCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            1111 11223456789999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.1e-41  Score=309.71  Aligned_cols=253  Identities=27%  Similarity=0.422  Sum_probs=206.4

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      .++|++.++||+|+||.||+|...+++.||+|.+....  .....+.+|+.++++++|+|++++++++. .+..+++|||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            46788889999999999999998889999999986433  23457889999999999999999999874 4568999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +.+++|.+++.......+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||++.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            99999999987666667899999999999999999999988   999999999999999999999999999876543332


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                      ......++..|+|||.+....++.++||||||+++|||++ |+.||......      .... .+..+...         
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~-~~~~~~~~---------  222 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP------EVIQ-NLERGYRM---------  222 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH------HHHH-HHHcCCCC---------
Confidence            2233456778999999998899999999999999999999 99888643321      1111 11111100         


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                       ......+..+.+++.+||+.+|++||+++++++.|+
T Consensus       223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  258 (260)
T cd05067         223 -PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE  258 (260)
T ss_pred             -CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence             011223456999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=9.5e-42  Score=310.13  Aligned_cols=253  Identities=26%  Similarity=0.427  Sum_probs=204.1

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      ++|++.+.||+|+||.||+|...++..+|+|.+.....  ....+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            56788899999999999999988888999999864332  3456899999999999999999999885 45678999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      ++++|.+++.......+++..+..++.|++.|+.|||+.+   ++||||+|+||++++++.++|+|||++..+.......
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence            9999999997655556899999999999999999999998   9999999999999999999999999998765433222


Q ss_pred             ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |..||......      ... .....+..     .     
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~-~~~~~~~~-----~-----  222 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------EVL-EQVERGYR-----M-----  222 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------HHH-HHHHcCCC-----C-----
Confidence            223345678999999988899999999999999999999 78887543211      111 11111100     0     


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      ..+...+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            0112234568999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-43  Score=327.71  Aligned_cols=261  Identities=27%  Similarity=0.395  Sum_probs=218.8

Q ss_pred             HHHHhcCCCCCCeeeccCCccEEEEEecC-CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeE
Q 040557           77 LKKATKNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRL  155 (407)
Q Consensus        77 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  155 (407)
                      ++....+.....+||.|.||.||.|.++. ...||||.++.+  ....++|+.|..+|+.++|||+|+++|+|.....+|
T Consensus       262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED--tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc--chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            33334556667899999999999998754 678999998644  345678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccC
Q 040557          156 LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP  235 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~  235 (407)
                      ||+|||..|+|.+++....+..++--..+.++.||+.||+||..++   +|||||..+|+|+.++..||++||||++++.
T Consensus       340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMT  416 (1157)
T ss_pred             EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhc
Confidence            9999999999999998888777888889999999999999999998   9999999999999999999999999999998


Q ss_pred             CCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          236 EDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       236 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                      .+.+.......-...|.|||-+.-+.++.|+|||+|||+|||+.|-.........      ...++.+++.+       .
T Consensus       417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------lSqVY~LLEkg-------y  483 (1157)
T KOG4278|consen  417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYGLLEKG-------Y  483 (1157)
T ss_pred             CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------HHHHHHHHhcc-------c
Confidence            8877655556667899999999999999999999999999999985432221111      12233444432       3


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      +|.   .++.|+..+++|++.||+++|.+||++.|+-+.++..
T Consensus       484 RM~---~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  484 RMD---GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             ccc---CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence            333   3456778899999999999999999999998887744

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.4e-41  Score=318.40  Aligned_cols=260  Identities=20%  Similarity=0.226  Sum_probs=201.0

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+++.. +++.+|+|.+....  .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36788899999999999999865 47889999985322  2223445788999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.......
T Consensus        81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            999999999998643 245899999999999999999999998   9999999999999999999999999997654443


Q ss_pred             cccccccccCccccCccccc-----cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAI-----RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV  313 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ........||+.|+|||++.     ...++.++|||||||++|||++|+.||......      .............   
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~---  227 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKERF---  227 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHHHHhCCCccc---
Confidence            33333457999999999886     346789999999999999999999999643221      1111211111000   


Q ss_pred             CcccccCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHhhcc
Q 040557          314 DPRMRKEGIVERDALQVINVAFICLQPHGNQ--RPPMSEIVAMLTCK  358 (407)
Q Consensus       314 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~~l~~~  358 (407)
                        ..  .......+..+.+++.+|++.++++  |+++.++++|-+..
T Consensus       228 --~~--p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~  270 (332)
T cd05623         228 --QF--PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFT  270 (332)
T ss_pred             --cC--CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcC
Confidence              00  0011123456778888888654444  78999999997653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.9e-41  Score=321.71  Aligned_cols=258  Identities=21%  Similarity=0.277  Sum_probs=198.1

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|+..+.||+|+||+||++... +++.||+|++....  .......+.+|+.++..++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888899999999999999754 58999999986432  2233456788999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|.+++..  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        81 E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          81 EFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             cCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            99999999999854  346899999999999999999999998   9999999999999999999999999997543211


Q ss_pred             c----------------------------------ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCC
Q 040557          239 A----------------------------------YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKN  284 (407)
Q Consensus       239 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p  284 (407)
                      .                                  ......+||+.|+|||.+.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            0                                  001235799999999999999999999999999999999999999


Q ss_pred             CCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccC--CCCCCCCCHHHHHHHhhcc
Q 040557          285 TDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQ--PHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~--~~p~~RPs~~ev~~~l~~~  358 (407)
                      |....+.+      ....... ....-.+.+..   .    ....+.+++.+++.  .++..||+++||++|-+..
T Consensus       236 f~~~~~~~------~~~~i~~-~~~~~~~p~~~---~----~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~  297 (363)
T cd05628         236 FCSETPQE------TYKKVMN-WKETLIFPPEV---P----ISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFE  297 (363)
T ss_pred             CCCCCHHH------HHHHHHc-CcCcccCCCcC---C----CCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCC
Confidence            97543221      1111111 10000011110   0    12345566665333  3444679999999997754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=291.42  Aligned_cols=263  Identities=27%  Similarity=0.324  Sum_probs=208.7

Q ss_pred             HHhcCCCCCCeeeccCCccEEEEE-ecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC-----C
Q 040557           79 KATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG-----S  152 (407)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  152 (407)
                      ...++|++.+.||.|||+-||.++ ..+++.||+|++.... .++.+..++|++.-++++|||+++++++...+     .
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            345789999999999999999997 5689999999986544 56778889999999999999999999987443     3


Q ss_pred             eeEEEEEeccCCChhHHHhccC--CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccC
Q 040557          153 QRLLVYEYMKNRSLDLLIYGES--DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGL  230 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgl  230 (407)
                      ..|++++|+..|+|.+.+...+  +..+++...++|+.++++||++||+.. ++++||||||.|||+.+.+.++|.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence            4899999999999999886544  457999999999999999999999985 6799999999999999999999999999


Q ss_pred             ccccCCCCcc--------cccccccCccccCcccccc---CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHH
Q 040557          231 ARFFPEDQAY--------LSTNFAGTLGYTAPEYAIR---GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEY  299 (407)
Q Consensus       231 a~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~  299 (407)
                      ++..+-.-..        ......-|..|.|||.+.-   ...++++|||||||+||+|+.|..||+......       
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-------  248 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-------  248 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC-------
Confidence            9865421110        0112345889999998753   467899999999999999999999997433211       


Q ss_pred             HHHHHHhCcccc-ccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          300 AWKLYERGRILE-LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       300 ~~~~~~~~~~~~-~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                             +.+.- +..+.+... .....+..+.+++.+|++.||.+||++.+++.++...
T Consensus       249 -------gSlaLAv~n~q~s~P-~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  249 -------GSLALAVQNAQISIP-NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             -------CeEEEeeeccccccC-CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                   11111 111222211 1112566789999999999999999999999988643

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.2e-41  Score=313.20  Aligned_cols=258  Identities=28%  Similarity=0.432  Sum_probs=206.5

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCe
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQ  153 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  153 (407)
                      .++|+..+.||+|+||.||++...      +...+|+|.+...........+.+|++++.++ +|+||+++++++...+.
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            356788899999999999999753      23679999987554555556788999999999 89999999999999999


Q ss_pred             eEEEEEeccCCChhHHHhcc--------------CCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC
Q 040557          154 RLLVYEYMKNRSLDLLIYGE--------------SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE  219 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~  219 (407)
                      .+++|||+++|+|..++...              ....+++..+.+++.|++.|+.|||+.+   ++||||||+||++++
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~  167 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTE  167 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcC
Confidence            99999999999999998642              2356899999999999999999999988   999999999999999


Q ss_pred             CCceEEecccCccccCCCCccc-ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchh
Q 040557          220 KFQSKIGDFGLARFFPEDQAYL-STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLP  297 (407)
Q Consensus       220 ~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~  297 (407)
                      ++.++|+|||+++.+....... .....++..|+|||.+.+..++.++|||||||++|||++ |..|+......      
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------  241 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE------  241 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH------
Confidence            9999999999998765433211 122335678999999988899999999999999999998 88877532211      


Q ss_pred             HHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          298 EYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       298 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                       ........+...          ..+......+.+++.+||+.||++|||+.++++.|+..
T Consensus       242 -~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         242 -ELFKLLKEGYRM----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             -HHHHHHHcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence             112222221111          01122345688999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=9.4e-42  Score=319.74  Aligned_cols=246  Identities=22%  Similarity=0.312  Sum_probs=198.5

Q ss_pred             CeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEEEEeccC
Q 040557           88 NLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVYEYMKN  163 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  163 (407)
                      +.||+|+||.||+|+.. +++.||+|.+....  .......+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999864 57899999986432  223445677899998866 799999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccccc
Q 040557          164 RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST  243 (407)
Q Consensus       164 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  243 (407)
                      |+|..++..  ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++........ ...
T Consensus        81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~  154 (321)
T cd05591          81 GDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTT  154 (321)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc-ccc
Confidence            999988853  345899999999999999999999998   99999999999999999999999999975433222 223


Q ss_pred             ccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCC
Q 040557          244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIV  323 (407)
Q Consensus       244 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  323 (407)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||......      ........ +..   .        .+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------~~~~~i~~-~~~---~--------~p  216 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------DLFESILH-DDV---L--------YP  216 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------HHHHHHHc-CCC---C--------CC
Confidence            457899999999999999999999999999999999999999754321      11111111 110   0        11


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-------CHHHHHHHhhc
Q 040557          324 ERDALQVINVAFICLQPHGNQRP-------PMSEIVAMLTC  357 (407)
Q Consensus       324 ~~~~~~l~~l~~~cl~~~p~~RP-------s~~ev~~~l~~  357 (407)
                      ......+.+++..||+.||++||       ++.++++|.+.
T Consensus       217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~  257 (321)
T cd05591         217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFF  257 (321)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCcc
Confidence            11235688999999999999999       89999998765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.2e-41  Score=308.09  Aligned_cols=253  Identities=28%  Similarity=0.440  Sum_probs=203.8

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      ++|++.+.||+|+||.||+|...++..||+|.+....  .....+.+|+++++.++|+||+++++++.. ...++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc--cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            5688899999999999999988777789999986422  234578899999999999999999998754 5679999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      ++|+|.+++.......+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++..........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~  159 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  159 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence            9999999997655556899999999999999999999988   9999999999999999999999999998765443322


Q ss_pred             ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                      .....++..|+|||...+..++.++||||||+++|||+| |..||......       ........+..     .     
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-------~~~~~~~~~~~-----~-----  222 (262)
T cd05071         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERGYR-----M-----  222 (262)
T ss_pred             ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-------HHHHHHhcCCC-----C-----
Confidence            223446778999999988899999999999999999999 77777543221       11111111100     0     


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      ......+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            1122345678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.7e-42  Score=320.44  Aligned_cols=247  Identities=23%  Similarity=0.325  Sum_probs=198.7

Q ss_pred             CeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEEEEeccC
Q 040557           88 NLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVYEYMKN  163 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  163 (407)
                      +.||+|+||.||+|+.. +++.||+|++....  .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999864 58899999986432  223445677888888876 799999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccccc
Q 040557          164 RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST  243 (407)
Q Consensus       164 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  243 (407)
                      |+|..++...  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++........ ...
T Consensus        81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~  154 (320)
T cd05590          81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTS  154 (320)
T ss_pred             chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-ccc
Confidence            9999888533  45899999999999999999999998   99999999999999999999999999875432221 123


Q ss_pred             ccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCC
Q 040557          244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIV  323 (407)
Q Consensus       244 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  323 (407)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||......      .. ...+..+..           ..+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~-~~~i~~~~~-----------~~~  216 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------DL-FEAILNDEV-----------VYP  216 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HH-HHHHhcCCC-----------CCC
Confidence            457999999999999999999999999999999999999999753321      11 111111111           011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHhhcc
Q 040557          324 ERDALQVINVAFICLQPHGNQRPPM------SEIVAMLTCK  358 (407)
Q Consensus       324 ~~~~~~l~~l~~~cl~~~p~~RPs~------~ev~~~l~~~  358 (407)
                      ......+.+++.+||+.||++||++      ++++.|-+..
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~  257 (320)
T cd05590         217 TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFK  257 (320)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcC
Confidence            1234568899999999999999998      8888887753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.3e-41  Score=307.63  Aligned_cols=248  Identities=29%  Similarity=0.400  Sum_probs=197.8

Q ss_pred             CeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCCh
Q 040557           88 NLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL  166 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  166 (407)
                      +.||+|+||.||+|... +++.||+|.+...........+.+|+++++.++|+||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36899999999999864 68999999886544455567899999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccc-ccc
Q 040557          167 DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS-TNF  245 (407)
Q Consensus       167 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~-~~~  245 (407)
                      .+++... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........... ...
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          81 LTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            9998543 345899999999999999999999988   99999999999999999999999999976543221111 111


Q ss_pred             ccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCH
Q 040557          246 AGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVE  324 (407)
Q Consensus       246 ~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  324 (407)
                      ..+..|+|||.+.++.++.++||||||+++|||++ |..|+......       ........+...          ..+.
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-------~~~~~~~~~~~~----------~~~~  219 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-------QTREAIEQGVRL----------PCPE  219 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-------HHHHHHHcCCCC----------CCcc
Confidence            23457999999999899999999999999999998 77777532211       111111111000          1122


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          325 RDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       325 ~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ..+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            23457889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.2e-41  Score=317.58  Aligned_cols=246  Identities=23%  Similarity=0.296  Sum_probs=193.9

Q ss_pred             CeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHH-HHHcCCCCceeeeeeeeecCCeeEEEEEeccC
Q 040557           88 NLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVR-MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKN  163 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  163 (407)
                      +.||+|+||.||+|... +|+.||+|++....  .......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999864 68999999986432  1222344555554 45778999999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccccc
Q 040557          164 RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST  243 (407)
Q Consensus       164 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  243 (407)
                      |+|..++..  ...+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||++........ ...
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~  154 (323)
T cd05575          81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TTS  154 (323)
T ss_pred             CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-ccc
Confidence            999988853  346899999999999999999999998   99999999999999999999999999975432221 223


Q ss_pred             ccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCC
Q 040557          244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIV  323 (407)
Q Consensus       244 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  323 (407)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||......      ...... ..+..      .+     .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i-~~~~~------~~-----~  216 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNI-LNKPL------RL-----K  216 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHH-HcCCC------CC-----C
Confidence            457999999999999999999999999999999999999998643211      111111 11110      11     1


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCH----HHHHHHhhc
Q 040557          324 ERDALQVINVAFICLQPHGNQRPPM----SEIVAMLTC  357 (407)
Q Consensus       324 ~~~~~~l~~l~~~cl~~~p~~RPs~----~ev~~~l~~  357 (407)
                      ...+..+.+++.+||+.||++||++    .+++++.+.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~  254 (323)
T cd05575         217 PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFF  254 (323)
T ss_pred             CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCc
Confidence            1224568899999999999999987    588877664

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.7e-41  Score=311.91  Aligned_cols=250  Identities=24%  Similarity=0.312  Sum_probs=199.4

Q ss_pred             eeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCCh
Q 040557           90 LGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL  166 (407)
Q Consensus        90 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  166 (407)
                      ||+|+||+||++... +|+.||+|.+.....  ......+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999754 689999999864322  22345678899999999999999999999999999999999999999


Q ss_pred             hHHHhcc--CCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccccc
Q 040557          167 DLLIYGE--SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN  244 (407)
Q Consensus       167 ~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  244 (407)
                      ..++...  ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++......... ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence            8887532  3456899999999999999999999998   999999999999999999999999999866543321 234


Q ss_pred             cccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCH
Q 040557          245 FAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVE  324 (407)
Q Consensus       245 ~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  324 (407)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||........   .......        ......   ..+.
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~--------~~~~~~---~~~~  222 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---NKELKQR--------ILNDSV---TYPD  222 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh---HHHHHHh--------hcccCC---CCcc
Confidence            5789999999999999999999999999999999999999865322110   0000000        000111   1122


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhc
Q 040557          325 RDALQVINVAFICLQPHGNQRP-----PMSEIVAMLTC  357 (407)
Q Consensus       325 ~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~l~~  357 (407)
                      ..+..+.+++.+||+.||++||     +++++++|-|.
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~  260 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF  260 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhh
Confidence            3455688999999999999999     78999988765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.5e-41  Score=305.43  Aligned_cols=248  Identities=30%  Similarity=0.415  Sum_probs=200.8

Q ss_pred             CeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCChh
Q 040557           88 NLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLD  167 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  167 (407)
                      ++||+|+||.||+|...++..+|+|.+...........+.+|+++++.++|+||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988899999999865555555567899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccccccccc
Q 040557          168 LLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG  247 (407)
Q Consensus       168 ~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g  247 (407)
                      +++.... ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++...............+
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence            9886433 45899999999999999999999988   9999999999999999999999999997654332222222344


Q ss_pred             CccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHH
Q 040557          248 TLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERD  326 (407)
Q Consensus       248 t~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  326 (407)
                      +..|+|||++.+..++.++||||||+++||+++ |..||......       ........+..       .   ..+...
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-------~~~~~~~~~~~-------~---~~~~~~  219 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-------QAREQVEKGYR-------M---SCPQKC  219 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHHcCCC-------C---CCCCCC
Confidence            667999999998899999999999999999998 88888543221       11111111110       0   011123


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          327 ALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       327 ~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      +..+.+++.+||+.+|++||++.++++.|.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            457899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.7e-41  Score=315.75  Aligned_cols=246  Identities=21%  Similarity=0.297  Sum_probs=192.5

Q ss_pred             CeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHH-HHHcCCCCceeeeeeeeecCCeeEEEEEeccC
Q 040557           88 NLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVR-MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKN  163 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  163 (407)
                      +.||+|+||.||+|+.. +|+.||+|.+....  .......+..|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999864 68899999986432  1223344555654 57788999999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccccc
Q 040557          164 RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST  243 (407)
Q Consensus       164 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  243 (407)
                      |+|..++..  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++....... ...
T Consensus        81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~  154 (321)
T cd05603          81 GELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TTS  154 (321)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-ccc
Confidence            999888753  345888899999999999999999988   99999999999999999999999999875422221 223


Q ss_pred             ccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCC
Q 040557          244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIV  323 (407)
Q Consensus       244 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  323 (407)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||.....      ........ .+.        .   ..+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~-~~~--------~---~~~  216 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDNIL-HKP--------L---QLP  216 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHHHh-cCC--------C---CCC
Confidence            45789999999999998999999999999999999999999865321      11111111 111        0   011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCH----HHHHHHhhc
Q 040557          324 ERDALQVINVAFICLQPHGNQRPPM----SEIVAMLTC  357 (407)
Q Consensus       324 ~~~~~~l~~l~~~cl~~~p~~RPs~----~ev~~~l~~  357 (407)
                      ......+.+++.+||+.||++||+.    .+++++.+.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~  254 (321)
T cd05603         217 GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFF  254 (321)
T ss_pred             CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCc
Confidence            1234568899999999999999875    477776654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.6e-41  Score=313.78  Aligned_cols=257  Identities=30%  Similarity=0.455  Sum_probs=205.3

Q ss_pred             CCCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      +|++.+.||+|+||.||+|...      ....+++|.+...........+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4677889999999999999752      2357899988655555556788999999999999999999999999999999


Q ss_pred             EEEeccCCChhHHHhccC----------------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeecccccc
Q 040557          157 VYEYMKNRSLDLLIYGES----------------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASN  214 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~N  214 (407)
                      ++||+.+|+|.+++....                      ...+++..++.++.|++.|+.|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999875321                      234789999999999999999999988   9999999999


Q ss_pred             EEEcCCCceEEecccCccccCCCCccc-ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcc
Q 040557          215 VLLDEKFQSKIGDFGLARFFPEDQAYL-STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSE  292 (407)
Q Consensus       215 ill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~  292 (407)
                      ||+++++.++|+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....+  
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--  235 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP--  235 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence            999999999999999998654333221 122345678999999988899999999999999999999 8888864322  


Q ss_pred             cCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          293 MQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                           ...+.....+..     ..     .+...+..+.+++.+||+.+|++||++.++++.|+...
T Consensus       236 -----~~~~~~~~~~~~-----~~-----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         236 -----ERLFNLLKTGYR-----ME-----RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             -----HHHHHHHhCCCC-----CC-----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence                 122222222110     00     11223456889999999999999999999999997653

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.5e-41  Score=311.73  Aligned_cols=256  Identities=29%  Similarity=0.401  Sum_probs=203.6

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCee
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQR  154 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  154 (407)
                      .++|.+.+.||+|+||.||+|.+.      .+..||+|.+...........|.+|+.+++.++|+||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            467888899999999999999864      35689999886555555567799999999999999999999999988899


Q ss_pred             EEEEEeccCCChhHHHhccCC-----CCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC---ceEEe
Q 040557          155 LLVYEYMKNRSLDLLIYGESD-----KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF---QSKIG  226 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~kl~  226 (407)
                      ++||||+++++|.+++.....     ..+++..+.+++.||+.|+.|||+.+   ++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            999999999999999865432     25899999999999999999999998   99999999999998654   59999


Q ss_pred             cccCccccCCCCccc-ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHH
Q 040557          227 DFGLARFFPEDQAYL-STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLY  304 (407)
Q Consensus       227 Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  304 (407)
                      |||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||.......       .....
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-------~~~~~  234 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-------VMEFV  234 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHH
Confidence            999998764322211 112234568999999999999999999999999999997 888876432211       11111


Q ss_pred             HhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          305 ERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       305 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ..+...          ..+...+..+.+++.+||+.+|++||++.+|+++|.
T Consensus       235 ~~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         235 TGGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HcCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            111100          011223456889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2e-41  Score=317.05  Aligned_cols=247  Identities=25%  Similarity=0.328  Sum_probs=198.9

Q ss_pred             CeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEEEEeccC
Q 040557           88 NLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVYEYMKN  163 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  163 (407)
                      +.||+|+||.||+|... +++.||+|.+....  .......+..|.+++..+ +|+||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 57899999986542  223445677899999887 799999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccccc
Q 040557          164 RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST  243 (407)
Q Consensus       164 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  243 (407)
                      |+|..++...  ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++........ ...
T Consensus        81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~  154 (318)
T cd05570          81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTS  154 (318)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-ccc
Confidence            9999887533  45899999999999999999999998   99999999999999999999999999975322221 123


Q ss_pred             ccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCC
Q 040557          244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIV  323 (407)
Q Consensus       244 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  323 (407)
                      ...|+..|+|||.+.+..++.++|||||||++|||++|+.||......      . ..........      .     .+
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~------~-~~~~i~~~~~------~-----~~  216 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED------E-LFQSILEDEV------R-----YP  216 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH------H-HHHHHHcCCC------C-----CC
Confidence            356899999999999999999999999999999999999998643211      1 1111111110      0     11


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHhhcc
Q 040557          324 ERDALQVINVAFICLQPHGNQRPPM-----SEIVAMLTCK  358 (407)
Q Consensus       324 ~~~~~~l~~l~~~cl~~~p~~RPs~-----~ev~~~l~~~  358 (407)
                      ...+..+.+++.+||+.||++||++     .+++++-+..
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~  256 (318)
T cd05570         217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR  256 (318)
T ss_pred             CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcC
Confidence            1234568899999999999999999     9999887654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.2e-41  Score=335.07  Aligned_cols=262  Identities=24%  Similarity=0.350  Sum_probs=208.3

Q ss_pred             HHHHHHhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC
Q 040557           75 QTLKKATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS  152 (407)
Q Consensus        75 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  152 (407)
                      .+.+...++|++.+.||+|+||+||+|+. .+|+.||||.+.... .......+.+|+..+..++|+|++++.+.+...+
T Consensus        25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD  104 (496)
T ss_pred             ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence            34445567999999999999999999975 479999999986543 3445567889999999999999999887764322


Q ss_pred             --------eeEEEEEeccCCChhHHHhcc--CCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCc
Q 040557          153 --------QRLLVYEYMKNRSLDLLIYGE--SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ  222 (407)
Q Consensus       153 --------~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~  222 (407)
                              ..++||||+++|+|.+++...  ....+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~  181 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL  181 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence                    367999999999999988643  2456899999999999999999999988   999999999999999999


Q ss_pred             eEEecccCccccCCCCc-ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHH
Q 040557          223 SKIGDFGLARFFPEDQA-YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAW  301 (407)
Q Consensus       223 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~  301 (407)
                      +||+|||+++.+..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....      .....
T Consensus       182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~  255 (496)
T PTZ00283        182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMH  255 (496)
T ss_pred             EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHH
Confidence            99999999987653321 122346799999999999999999999999999999999999999864321      11111


Q ss_pred             HHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          302 KLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       302 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ... .+...          ..+...+..+.+++.+||+.||++||++.+++++.+
T Consensus       256 ~~~-~~~~~----------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~  299 (496)
T PTZ00283        256 KTL-AGRYD----------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPI  299 (496)
T ss_pred             HHh-cCCCC----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHH
Confidence            111 11111          012223456889999999999999999999998754

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6e-41  Score=303.89  Aligned_cols=252  Identities=25%  Similarity=0.405  Sum_probs=207.6

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      +|+..+.||+|++|.||+|... +|+.|++|.+.... .......+.+|+++++.++|+|++++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4667789999999999999864 68999999986432 344567789999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++++|.+++.......+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            99999999997655567899999999999999999999988   999999999999999999999999999876544322


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                       .....|++.|+|||+..+..++.++||||||+++|||++|+.||......      .... ....+...          
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~-~~~~~~~~----------  219 (256)
T cd08529         158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG------ALIL-KIIRGVFP----------  219 (256)
T ss_pred             -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHH-HHHcCCCC----------
Confidence             23356889999999999999999999999999999999999998644311      1111 11111111          


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                      ......+..+.+++.+||+.+|++||++.+++++-
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~  254 (256)
T cd08529         220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNP  254 (256)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCC
Confidence            11123456789999999999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.6e-41  Score=311.42  Aligned_cols=257  Identities=26%  Similarity=0.350  Sum_probs=205.6

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .|+..+.||+|+||.||++... +++.||+|.+.....  ......+.+|+.++..++|+|++++.+.+.+.+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3667789999999999999754 689999999864332  2233567789999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++++|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            999999999886555556899999999999999999999988   99999999999999999999999999976543332


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                      .  ....|+..|+|||.+.+..++.++||||||+++|||++|+.||........   ............      ..   
T Consensus       158 ~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~---~~~~~~~~~~~~------~~---  223 (285)
T cd05630         158 I--KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK---REEVERLVKEVQ------EE---  223 (285)
T ss_pred             c--cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch---HHHHHhhhhhhh------hh---
Confidence            1  234689999999999999999999999999999999999999975332110   011111111000      00   


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhhcc
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPP-----MSEIVAMLTCK  358 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~l~~~  358 (407)
                        ........+.+++.+||+.||++|||     +.|+++|-+..
T Consensus       224 --~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~  265 (285)
T cd05630         224 --YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK  265 (285)
T ss_pred             --cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence              11223445789999999999999999     89999987753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.6e-41  Score=318.58  Aligned_cols=251  Identities=24%  Similarity=0.275  Sum_probs=199.5

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCC-CceeeeeeeeecCCeeEEEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQH-KNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  158 (407)
                      +|++.+.||+|+||.||+|... +++.||+|++....  .......+..|.+++..+.| ++|+++.+++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4777889999999999999865 57899999986432  22345677889999999965 56888999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|..++...  ..+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.++|+|||++.......
T Consensus        81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence            999999999888533  45899999999999999999999998   9999999999999999999999999987532222


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                      . ......||+.|+|||++.+..++.++|||||||++|||+||+.||......      ..... .....      ..  
T Consensus       156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~-i~~~~------~~--  219 (324)
T cd05587         156 K-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------ELFQS-IMEHN------VS--  219 (324)
T ss_pred             C-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHH-HHcCC------CC--
Confidence            1 123457999999999999999999999999999999999999999743221      11111 11111      01  


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHhhc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPPM-----SEIVAMLTC  357 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~ev~~~l~~  357 (407)
                         .+...+..+.+++.+||+.||++|++.     .++.+|.+.
T Consensus       220 ---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~  260 (324)
T cd05587         220 ---YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFF  260 (324)
T ss_pred             ---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCc
Confidence               111234567899999999999999986     788877654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.9e-41  Score=308.72  Aligned_cols=256  Identities=28%  Similarity=0.407  Sum_probs=201.2

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCc----EEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGT----LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      ++|+..+.||+|+||.||+|... +|.    .+++|.+..........++..|+..++.++|+||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            45777889999999999999863 344    4788887543334445678888999999999999999999864 45788


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ++||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++....
T Consensus        86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            999999999999986433 45899999999999999999999988   99999999999999999999999999987643


Q ss_pred             CCc-ccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          237 DQA-YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       237 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      ... .......++..|+|||.+.++.++.++||||||+++|||++ |+.|+....+.       .....+..+....  .
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~--~  232 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-------EVPDLLEKGERLA--Q  232 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCCcCC--C
Confidence            322 12233457778999999998999999999999999999998 88888643321       1122222222111  0


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      +        ..+...+.+++.+||+.||++|||+.|+++.|....
T Consensus       233 ~--------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~  269 (279)
T cd05111         233 P--------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA  269 (279)
T ss_pred             C--------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            1        112345788999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-41  Score=308.19  Aligned_cols=255  Identities=29%  Similarity=0.429  Sum_probs=205.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRL  155 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  155 (407)
                      ++|++.+.||+|+||.||+|...      .+..||+|.+...........+.+|+.++..++|+||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            57888899999999999999753      246899999865544455667899999999999999999999999999999


Q ss_pred             EEEEeccCCChhHHHhccC--------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEec
Q 040557          156 LVYEYMKNRSLDLLIYGES--------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGD  227 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~D  227 (407)
                      +||||+++|+|.+++....        ...+++..+..++.|++.|+.|||+.+   ++||||||+||++++++.++|+|
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECC
Confidence            9999999999999986432        234788999999999999999999988   99999999999999999999999


Q ss_pred             ccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHH
Q 040557          228 FGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYE  305 (407)
Q Consensus       228 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  305 (407)
                      ||+++........ ......++..|+|||.+.+..++.++|||||||++|||+| |..|+.......       ..+...
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~  235 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VLKFVI  235 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-------HHHHHh
Confidence            9999866443321 2233456789999999988889999999999999999998 888875432211       112222


Q ss_pred             hCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          306 RGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       306 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      .+....          .+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       236 ~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         236 DGGHLD----------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             cCCCCC----------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            221111          11123567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.6e-41  Score=317.01  Aligned_cols=251  Identities=24%  Similarity=0.288  Sum_probs=199.8

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      +|++.+.||+|+||.||+|... +++.||+|.+....  .......+..|..++..+ +|++|+++.+++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4777889999999999999865 57899999986432  222344567788888877 6899999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|..++...  ..+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++......
T Consensus        81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            999999999888543  45899999999999999999999998   9999999999999999999999999997543222


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                      . ......||+.|+|||.+.+..++.++|||||||++|||+||+.||......      ..... +.....         
T Consensus       156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~------~~~~~-i~~~~~---------  218 (323)
T cd05616         156 V-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQS-IMEHNV---------  218 (323)
T ss_pred             C-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH------HHHHH-HHhCCC---------
Confidence            1 123467999999999999999999999999999999999999999753321      11111 111111         


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhhc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPP-----MSEIVAMLTC  357 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~l~~  357 (407)
                        ..+......+.+++.+||+.||++|++     ..++.+|-+.
T Consensus       219 --~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~  260 (323)
T cd05616         219 --AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF  260 (323)
T ss_pred             --CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCc
Confidence              011223456889999999999999998     4788777543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.4e-41  Score=321.56  Aligned_cols=264  Identities=20%  Similarity=0.217  Sum_probs=206.2

Q ss_pred             HHHHHhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC
Q 040557           76 TLKKATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS  152 (407)
Q Consensus        76 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  152 (407)
                      .+....++|++.+.||+|+||.||+++.. +++.||+|.+....  .......+.+|..+++.++||||+++++++.++.
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            34445588999999999999999999865 58899999985422  2233456788999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                      ..++||||+++|+|..++...   .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            999999999999999988532   4788889999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcccccccccCccccCccccccC----CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCc
Q 040557          233 FFPEDQAYLSTNFAGTLGYTAPEYAIRG----ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGR  308 (407)
Q Consensus       233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      ..............||+.|+|||.+.+.    .++.++|||||||++|||++|+.||......      ...........
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~  264 (371)
T cd05622         191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKN  264 (371)
T ss_pred             EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCC
Confidence            7654433333456799999999998753    3789999999999999999999999753221      11122211111


Q ss_pred             cccccCcccccCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHhhccc
Q 040557          309 ILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQ--RPPMSEIVAMLTCKV  359 (407)
Q Consensus       309 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~~l~~~~  359 (407)
                      .....        .....+..+.+++..|++.++.+  ||++.++++|.+...
T Consensus       265 ~~~~~--------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~  309 (371)
T cd05622         265 SLTFP--------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  309 (371)
T ss_pred             cccCC--------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence            11100        01123455788999999854443  789999999987643

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.4e-41  Score=314.27  Aligned_cols=259  Identities=27%  Similarity=0.428  Sum_probs=207.5

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEe------cCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCC
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGS  152 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  152 (407)
                      ..++|...+.||+|+||.||+|..      .++..||+|.+.........+.+.+|+.+++++ +|+||+++++++...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            336788899999999999999964      135579999986554445556789999999999 7999999999999999


Q ss_pred             eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                      ..+++|||+.+|+|.+++.......+++..+..++.|++.|+.|||+.+   ++|+||||+||+++.++.++|+|||++.
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence            9999999999999999997555555899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccc
Q 040557          233 FFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRIL  310 (407)
Q Consensus       233 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      ........ ......++..|+|||.+.+..++.++|||||||++|||++ |..|+......      .........+...
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~------~~~~~~~~~~~~~  263 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD------SKFYKLIKEGYRM  263 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch------HHHHHHHHcCCcC
Confidence            66543321 1222346778999999999999999999999999999998 88887543221      1111122211100


Q ss_pred             cccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          311 ELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       311 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                             .   .+...+..+.+++.+||+.+|++|||+.++++.|..
T Consensus       264 -------~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         264 -------A---QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             -------C---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence                   0   111124568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-41  Score=306.51  Aligned_cols=254  Identities=25%  Similarity=0.378  Sum_probs=204.4

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccC----hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKS----QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      ++|...+.||+|++|.||.|.. .+++.||+|.+.....    ......+.+|++++++++|+||+++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5788999999999999999985 4689999999864322    1234568899999999999999999999999999999


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      |+||+++++|.+++...  ..+++.....++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            99999999999988543  45889999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCcccc--cccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          237 DQAYLS--TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       237 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      ......  ....++..|+|||.+.+..++.++||||||+++|||++|+.||......      ........... .    
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~-~----  225 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQPT-N----  225 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHHhccCC-C----
Confidence            222111  2345788999999999988999999999999999999999998643211      11111111100 0    


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      .     ..+......+.+++.+||+.+|++|||+.+++++.+
T Consensus       226 ~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  262 (263)
T cd06625         226 P-----QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF  262 (263)
T ss_pred             C-----CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence            0     112223456889999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.8e-41  Score=325.07  Aligned_cols=263  Identities=26%  Similarity=0.386  Sum_probs=207.1

Q ss_pred             HHHHhcCCCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcCC-CCceeeeeeeee
Q 040557           77 LKKATKNFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-HKNLVRLLGCCS  149 (407)
Q Consensus        77 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~  149 (407)
                      .+...++|.+++.||+|+||.||+|++.      .++.||+|++...........+.+|+++|.++. |+||+++++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            3344567888899999999999999853      346899999975544444557899999999997 999999999999


Q ss_pred             cCCeeEEEEEeccCCChhHHHhccC-------------------------------------------------------
Q 040557          150 DGSQRLLVYEYMKNRSLDLLIYGES-------------------------------------------------------  174 (407)
Q Consensus       150 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------  174 (407)
                      .....++||||+++|+|.++++...                                                       
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            9999999999999999999986432                                                       


Q ss_pred             -----------------------------------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccc
Q 040557          175 -----------------------------------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKAS  213 (407)
Q Consensus       175 -----------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~  213 (407)
                                                               ...+++..+..++.|++.||.|||+.+   ++||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence                                                     124677888999999999999999987   999999999


Q ss_pred             cEEEcCCCceEEecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCc
Q 040557          214 NVLLDEKFQSKIGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPS  291 (407)
Q Consensus       214 Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~  291 (407)
                      |||+++++.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            999999999999999999865432221 1223456788999999998889999999999999999998 78887543211


Q ss_pred             ccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          292 EMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                            .........+..       ..   .+......+.+++.+||+.+|++||++++|++.|+..
T Consensus       349 ------~~~~~~~~~~~~-------~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         349 ------EQFYNAIKRGYR-------MA---KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             ------HHHHHHHHcCCC-------CC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                  111122221110       00   1112345689999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2e-41  Score=323.99  Aligned_cols=268  Identities=26%  Similarity=0.320  Sum_probs=202.4

Q ss_pred             CCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC-----eeE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS-----QRL  155 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  155 (407)
                      +|++.+.||+|+||.||++.. .+|+.||+|++.... .......+.+|+++++.++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999986 478999999985432 2334567889999999999999999999998776     789


Q ss_pred             EEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccC
Q 040557          156 LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP  235 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~  235 (407)
                      +||||+. ++|..++.  ....+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++...
T Consensus        81 lv~e~~~-~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQ-SDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccc-cCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            9999997 57777764  3346899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCch---------hHH------
Q 040557          236 EDQAYLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYL---------PEY------  299 (407)
Q Consensus       236 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~---------~~~------  299 (407)
                      ...........+++.|+|||.+.+. .++.++|||||||++|||++|+.||....+......         ...      
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            4433333345688999999988774 579999999999999999999999975443211000         000      


Q ss_pred             -HHHHHHhCccccccCccccc-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          300 -AWKLYERGRILELVDPRMRK-EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       300 -~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                       ....+......   .+.... ..........+.+++.+||+.||++|||+.|+++|.+...
T Consensus       235 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  293 (372)
T cd07853         235 GARAHILRGPHK---PPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE  293 (372)
T ss_pred             HHHHHHHhCCCC---CCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence             00000000000   000000 0011112456889999999999999999999999987543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-41  Score=310.92  Aligned_cols=262  Identities=23%  Similarity=0.408  Sum_probs=201.0

Q ss_pred             cCCCCCCeeeccCCccEEEEEecC---------------CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeee
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLAD---------------GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG  146 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~  146 (407)
                      ++|++.+.||+|+||.||++...+               ...||+|.+...........|.+|++++.+++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578888999999999999987532               23589999865545555667999999999999999999999


Q ss_pred             eeecCCeeEEEEEeccCCChhHHHhccC----------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEE
Q 040557          147 CCSDGSQRLLVYEYMKNRSLDLLIYGES----------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVL  216 (407)
Q Consensus       147 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil  216 (407)
                      ++...+..++||||+.+++|.+++....          ...+++..+..++.|++.|+.|||+.+   ++|+||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            9999999999999999999999885421          123688999999999999999999998   999999999999


Q ss_pred             EcCCCceEEecccCccccCCCCccc-ccccccCccccCccccccCCCCccccEEehhHHHHHHHhc--CCCCCCCCCccc
Q 040557          217 LDEKFQSKIGDFGLARFFPEDQAYL-STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISC--RKNTDLTLPSEM  293 (407)
Q Consensus       217 l~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg--~~p~~~~~~~~~  293 (407)
                      +++++.+||+|||++.......... .....++..|+|||.+.++.++.++||||||++++||+++  ..||....... 
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~-  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence            9999999999999998654332211 1223456789999999988999999999999999999984  44554322211 


Q ss_pred             CchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          294 QYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                        ..................       ..+...+..+.+++.+||+.||++|||+++|++.|.
T Consensus       241 --~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 --VIENTGEFFRNQGRQIYL-------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             --HHHHHHHhhhhccccccC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence              000011111110000000       011113457999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1e-40  Score=309.10  Aligned_cols=263  Identities=26%  Similarity=0.432  Sum_probs=204.3

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecC-----------------CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceee
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLAD-----------------GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR  143 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~  143 (407)
                      .++|++.+.||+|+||.||+|...+                 +..||+|.+...........+.+|++++.+++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578889999999999999987542                 24589999876555566778999999999999999999


Q ss_pred             eeeeeecCCeeEEEEEeccCCChhHHHhccC---------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeecccccc
Q 040557          144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGES---------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASN  214 (407)
Q Consensus       144 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~N  214 (407)
                      +++++...+..+++|||+++++|..++....         ...+++..+..++.|++.||.|||+.+   ++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999986433         125899999999999999999999988   9999999999


Q ss_pred             EEEcCCCceEEecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh--cCCCCCCCCCc
Q 040557          215 VLLDEKFQSKIGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS--CRKNTDLTLPS  291 (407)
Q Consensus       215 ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t--g~~p~~~~~~~  291 (407)
                      |++++++.++|+|||++......... ......++..|+|||.+.+..++.++|||||||++|||++  |..|+......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            99999999999999999865433221 1223456778999999988899999999999999999998  55565432211


Q ss_pred             ccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          292 EMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      .   ........+.........       ..+...+.++.+++.+||+.||++|||+.+|++.|.
T Consensus       241 ~---~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 Q---VIENAGHFFRDDGRQIYL-------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             H---HHHHHHhccccccccccC-------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            0   000111110000000000       011123457899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.1e-41  Score=314.45  Aligned_cols=269  Identities=22%  Similarity=0.297  Sum_probs=205.6

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      ++|++.+.||+|+||.||++... +|..+|+|.+...........+.+|++++.+++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888899999999999999854 68889999886544444556788999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccc-cCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE-DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+ .+   ++|+||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  154 (308)
T cd06615          81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  154 (308)
T ss_pred             cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence            9999999998543  558999999999999999999997 45   9999999999999999999999999987653322 


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCc-----------
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGR-----------  308 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------  308 (407)
                        .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.......................           
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (308)
T cd06615         155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD  232 (308)
T ss_pred             --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence              2345788999999999888899999999999999999999999864322111000000000000000           


Q ss_pred             ------cccccCcccc---cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          309 ------ILELVDPRMR---KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       309 ------~~~~~d~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                            ..+..+....   ...........+.+++.+||+.+|++|||+.+++++.+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~  291 (308)
T cd06615         233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK  291 (308)
T ss_pred             ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence                  0000000000   0000011345688999999999999999999999998864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=7.6e-41  Score=304.22  Aligned_cols=253  Identities=27%  Similarity=0.435  Sum_probs=203.4

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      ++|.+...||+|++|.||+|...++..+|+|.+....  .....+.+|+++++.++|+|++++++++.. +..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence            4577888999999999999998777789999875332  234578899999999999999999998854 5678999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      .+|+|.+++.......+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++..........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05069          83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence            9999999997655556899999999999999999999988   9999999999999999999999999998765433222


Q ss_pred             ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                      .....++..|+|||.+.+..++.++||||||+++|||+| |+.|+......      . .......+..     .     
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~-~~~~~~~~~~-----~-----  222 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR------E-VLEQVERGYR-----M-----  222 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCC-----C-----
Confidence            223446778999999988899999999999999999999 88887643221      1 1111111110     0     


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      ..+...+..+.+++.+||+.||++||++++|++.|+.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            1122345678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=6e-41  Score=303.94  Aligned_cols=251  Identities=22%  Similarity=0.343  Sum_probs=206.4

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      +|++.+.||+|+||.||++... ++..+|+|.+.........+.+.+|+.+++.++|+||+++.+.+.+++..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4677889999999999999854 689999999865554555677889999999999999999999999999999999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      ++|+|.+++.......+++.....++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++........ .
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  156 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y  156 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence            9999999886655666899999999999999999999998   99999999999999999999999999986654322 1


Q ss_pred             ccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCC
Q 040557          242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEG  321 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  321 (407)
                      .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||......      ...... ..+...          .
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~-~~~~~~----------~  219 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLILKV-CQGSYK----------P  219 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHHHH-hcCCCC----------C
Confidence            23456889999999998888999999999999999999999998643211      111111 111111          0


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040557          322 IVERDALQVINVAFICLQPHGNQRPPMSEIVAM  354 (407)
Q Consensus       322 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  354 (407)
                      .+...+..+.+++.+||+.||++||++.+++..
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            112234568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=326.91  Aligned_cols=249  Identities=29%  Similarity=0.427  Sum_probs=208.0

Q ss_pred             CCeeeccCCccEEEEEe-cCCc----EEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           87 GNLLGRGGFGPVYRGKL-ADGT----LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      .++||+|+||+||+|.+ +.|+    +||+|++......+...++++|+-+|.+++|||+++++|+|.... ..||++|+
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m  779 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM  779 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence            57899999999999964 4444    689999987777777889999999999999999999999997766 78999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      +.|+|.++++.++ ..+-....+.|..|||+||.|||.+.   ++||||..+|||+.+-..+|+.|||+++....+....
T Consensus       780 P~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  780 PLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             ccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence            9999999998654 45888999999999999999999988   9999999999999999999999999999887655443


Q ss_pred             c-cccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          242 S-TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       242 ~-~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                      . ....-.+.|||-|.+....|+.++|||||||++||++| |..|++.....       .+.+.++.+.       ++  
T Consensus       856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-------eI~dlle~ge-------RL--  919 (1177)
T KOG1025|consen  856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-------EIPDLLEKGE-------RL--  919 (1177)
T ss_pred             cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-------HhhHHHhccc-------cC--
Confidence            3 33345678999999999999999999999999999998 66776644322       2333333332       12  


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                       ..++.+..++..++.+||..|+..||+++++...+..
T Consensus       920 -sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~  956 (1177)
T KOG1025|consen  920 -SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR  956 (1177)
T ss_pred             -CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence             2345577889999999999999999999999887764

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.9e-41  Score=325.23  Aligned_cols=256  Identities=22%  Similarity=0.269  Sum_probs=198.3

Q ss_pred             CCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .|+..+.||+|+||.||+|+. .+++.||+|.+....  .......+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            577889999999999999985 468899999986432  22344678899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC-
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ-  238 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~-  238 (407)
                      |+++|+|.+++...  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..+.... 
T Consensus        82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            99999999988543  45889999999999999999999998   9999999999999999999999999985332100 


Q ss_pred             ---------------------------------------------cccccccccCccccCccccccCCCCccccEEehhH
Q 040557          239 ---------------------------------------------AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGV  273 (407)
Q Consensus       239 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~  273 (407)
                                                                   .......+||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                         00012346899999999999999999999999999


Q ss_pred             HHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHH
Q 040557          274 LVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPP---MSE  350 (407)
Q Consensus       274 vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~e  350 (407)
                      ++|||++|+.||....+.+      .........       ...... ........+.+++.+|+ .+|++|++   +.+
T Consensus       237 il~elltG~~Pf~~~~~~~------~~~~i~~~~-------~~~~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e  301 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPLE------TQMKVINWQ-------TSLHIP-PQAKLSPEASDLIIKLC-RGPEDRLGKNGADE  301 (382)
T ss_pred             HHHHHHhCCCCCCCCCHHH------HHHHHHccC-------CCcCCC-CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence            9999999999997543221      111111100       000000 00112344667776665 49999997   999


Q ss_pred             HHHHhhcc
Q 040557          351 IVAMLTCK  358 (407)
Q Consensus       351 v~~~l~~~  358 (407)
                      +++|-+..
T Consensus       302 i~~hp~f~  309 (382)
T cd05625         302 IKAHPFFK  309 (382)
T ss_pred             HhcCCCcC
Confidence            99987653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-42  Score=323.17  Aligned_cols=246  Identities=29%  Similarity=0.426  Sum_probs=201.5

Q ss_pred             eeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCChh
Q 040557           89 LLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLD  167 (407)
Q Consensus        89 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  167 (407)
                      +||+|.||+||.|++. +...+|||.+.... ....+.+..|+.+-+.++|.|||+++|.+..++..-+.||-++||+|.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            6999999999999864 46679999986443 444567889999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCC--CHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc-CCCceEEecccCccccCCCCcccccc
Q 040557          168 LLIYGESDKFL--NWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTN  244 (407)
Q Consensus       168 ~~l~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~~  244 (407)
                      .++.. +.+++  ++.++-.+..||++||.|||++.   |+|||||-+|||++ -.|.+||+|||-++.+..-+ ..+.+
T Consensus       661 sLLrs-kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TET  735 (1226)
T KOG4279|consen  661 SLLRS-KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTET  735 (1226)
T ss_pred             HHHHh-ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC-ccccc
Confidence            99864 34456  78888999999999999999998   99999999999997 57899999999998765433 23456


Q ss_pred             cccCccccCccccccC--CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCC
Q 040557          245 FAGTLGYTAPEYAIRG--ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGI  322 (407)
Q Consensus       245 ~~gt~~y~aPE~~~~~--~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  322 (407)
                      +.||..|||||++..+  .|..++|||||||++.||.||++||.........        ++.-|-.      . .....
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--------MFkVGmy------K-vHP~i  800 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--------MFKVGMY------K-VHPPI  800 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--------hhhhcce------e-cCCCC
Confidence            8899999999999876  5889999999999999999999999643222111        1111100      0 11235


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          323 VERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       323 ~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                      +++...+...+|++|+.+||.+||++.++++-.
T Consensus       801 Peelsaeak~FilrcFepd~~~R~sA~~LL~Dp  833 (1226)
T KOG4279|consen  801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQDP  833 (1226)
T ss_pred             cHHHHHHHHHHHHHHcCCCcccCccHHHhccCc
Confidence            677788899999999999999999999998753

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.5e-41  Score=315.97  Aligned_cols=246  Identities=23%  Similarity=0.289  Sum_probs=195.0

Q ss_pred             CeeeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEEEEeccC
Q 040557           88 NLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVYEYMKN  163 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  163 (407)
                      +.||+|+||.||+|+.. +|+.||+|.+.....  ......+..|..++... +|+||+++++++.+.+..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999865 688999999864321  22344567788888765 899999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccccc
Q 040557          164 RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST  243 (407)
Q Consensus       164 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  243 (407)
                      |+|..++..  ...+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.++|+|||+++....... ...
T Consensus        81 g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~  154 (316)
T cd05620          81 GDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RAS  154 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-cee
Confidence            999988854  345899999999999999999999998   99999999999999999999999999875322111 223


Q ss_pred             ccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCC
Q 040557          244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIV  323 (407)
Q Consensus       244 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  323 (407)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||......       ........+.      +.     .+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-------~~~~~~~~~~------~~-----~~  216 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-------ELFESIRVDT------PH-----YP  216 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC------CC-----CC
Confidence            467999999999999999999999999999999999999999643221       1111111110      11     11


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCH-HHHHHHhhc
Q 040557          324 ERDALQVINVAFICLQPHGNQRPPM-SEIVAMLTC  357 (407)
Q Consensus       324 ~~~~~~l~~l~~~cl~~~p~~RPs~-~ev~~~l~~  357 (407)
                      ......+.+++.+||+.||++||++ +++++|.+.
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f  251 (316)
T cd05620         217 RWITKESKDILEKLFERDPTRRLGVVGNIRGHPFF  251 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCc
Confidence            1134467899999999999999998 477767654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.5e-41  Score=311.28  Aligned_cols=253  Identities=26%  Similarity=0.380  Sum_probs=201.3

Q ss_pred             CCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           84 FHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      |++.+.||+|+||.||+|...      ++..||+|++...........+.+|+.++..++|+||+++++++......+++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            555678999999999999753      25789999987554444456788999999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccC--------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCce
Q 040557          158 YEYMKNRSLDLLIYGES--------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS  223 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~  223 (407)
                      +||+.+++|.+++....              ...+++..+..++.|++.||.|||+.+   ++||||||.||++++++.+
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCce
Confidence            99999999999885221              234788899999999999999999988   9999999999999999999


Q ss_pred             EEecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHH
Q 040557          224 KIGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAW  301 (407)
Q Consensus       224 kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~  301 (407)
                      ||+|||+++........ ......+++.|+|||.+.++.++.++|||||||++|||++ |..|+.....       ....
T Consensus       164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~~  236 (283)
T cd05091         164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------QDVI  236 (283)
T ss_pred             EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHH
Confidence            99999999866433221 1223446789999999988899999999999999999998 7777654221       1112


Q ss_pred             HHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          302 KLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       302 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      .....+...          ..+..++..+.+++..||+.+|++||++++|++.|.
T Consensus       237 ~~i~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         237 EMIRNRQVL----------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             HHHHcCCcC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence            222222211          112234566889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.8e-41  Score=306.64  Aligned_cols=256  Identities=24%  Similarity=0.347  Sum_probs=201.9

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.++.+++|+||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e   86 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME   86 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence            35788899999999999999985 468899999985432 2334567899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++++|.+++..  ...+++..+..++.|++.|+.|||+.+   ++||||+|+||++++++.++|+|||++........
T Consensus        87 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          87 YCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            9999999998853  345899999999999999999999988   99999999999999999999999999986643221


Q ss_pred             ccccccccCccccCccccc---cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          240 YLSTNFAGTLGYTAPEYAI---RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                       ......|+..|+|||.+.   ...++.++|||||||++|||++|+.|+....+.....      . .....   ...+.
T Consensus       162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~-~~~~~---~~~~~  230 (267)
T cd06646         162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------L-MSKSN---FQPPK  230 (267)
T ss_pred             -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------e-eecCC---CCCCC
Confidence             122356889999999874   3457889999999999999999999985432211100      0 00000   00011


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ..   .....+..+.+++.+||+.+|++|||+++++++|+
T Consensus       231 ~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         231 LK---DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             Cc---cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            11   11123457889999999999999999999998863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-41  Score=304.67  Aligned_cols=255  Identities=30%  Similarity=0.452  Sum_probs=207.7

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      .++|++.+.||+|+||.||+|...++..||+|.+....  .....+.+|+.++++++|+|++++++++......+++|||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            46788899999999999999998788899999986432  3346789999999999999999999999988899999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++++|.+++.......+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++..+......
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT  159 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence            99999999997665567899999999999999999999998   999999999999999999999999999876543322


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                      ......++..|+|||.+.+..++.++||||||++++||++ |+.||......      .... ....+.       ..  
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------~~~~-~~~~~~-------~~--  223 (261)
T cd05034         160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR------EVLE-QVERGY-------RM--  223 (261)
T ss_pred             hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHH-HHHcCC-------CC--
Confidence            2223345678999999998899999999999999999999 88887543211      1111 111110       00  


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                       ..+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus       224 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         224 -PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence             0111224568899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.1e-41  Score=316.79  Aligned_cols=246  Identities=22%  Similarity=0.284  Sum_probs=191.1

Q ss_pred             CeeeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHH-HHHcCCCCceeeeeeeeecCCeeEEEEEeccC
Q 040557           88 NLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVR-MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKN  163 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  163 (407)
                      +.||+|+||.||+|+.. +++.||+|++.....  ......+..|.. +++.++|+||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999865 578899999864321  222334445544 56778999999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccccc
Q 040557          164 RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST  243 (407)
Q Consensus       164 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  243 (407)
                      |+|..++..  ...+.+.....++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++....... ...
T Consensus        81 ~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~  154 (325)
T cd05602          81 GELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTS  154 (325)
T ss_pred             CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Ccc
Confidence            999998854  345788888899999999999999998   99999999999999999999999999975432221 223


Q ss_pred             ccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCC
Q 040557          244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIV  323 (407)
Q Consensus       244 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  323 (407)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......      ........ ...        .   ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~-~~~--------~---~~  216 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILN-KPL--------Q---LK  216 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHHHHh-CCc--------C---CC
Confidence            467999999999999999999999999999999999999998643221      11111111 110        0   11


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHH----HHHHHhhc
Q 040557          324 ERDALQVINVAFICLQPHGNQRPPMS----EIVAMLTC  357 (407)
Q Consensus       324 ~~~~~~l~~l~~~cl~~~p~~RPs~~----ev~~~l~~  357 (407)
                      ...+..+.+++.+||+.||.+||++.    ++.++.+.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~  254 (325)
T cd05602         217 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFF  254 (325)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCccc
Confidence            12345678999999999999999876    55555543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.4e-41  Score=315.00  Aligned_cols=246  Identities=24%  Similarity=0.319  Sum_probs=194.9

Q ss_pred             CeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEEEEeccC
Q 040557           88 NLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVYEYMKN  163 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  163 (407)
                      +.||+|+||.||+|... +++.||+|.+....  .......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999865 57899999986542  123344566788888764 899999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccccc
Q 040557          164 RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST  243 (407)
Q Consensus       164 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  243 (407)
                      |+|..++..  ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++........ ...
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~  154 (316)
T cd05619          81 GDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTC  154 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-cee
Confidence            999998853  345899999999999999999999998   99999999999999999999999999975432221 123


Q ss_pred             ccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCC
Q 040557          244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIV  323 (407)
Q Consensus       244 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  323 (407)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||......       ........+.      +.     .+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~i~~~~------~~-----~~  216 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-------ELFQSIRMDN------PC-----YP  216 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC------CC-----CC
Confidence            457899999999999999999999999999999999999998643221       1111111111      11     11


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHH-HHHHHhhc
Q 040557          324 ERDALQVINVAFICLQPHGNQRPPMS-EIVAMLTC  357 (407)
Q Consensus       324 ~~~~~~l~~l~~~cl~~~p~~RPs~~-ev~~~l~~  357 (407)
                      ......+.+++.+||+.||++||++. ++.+|.+.
T Consensus       217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~  251 (316)
T cd05619         217 RWLTREAKDILVKLFVREPERRLGVKGDIRQHPFF  251 (316)
T ss_pred             ccCCHHHHHHHHHHhccCHhhcCCChHHHHcCccc
Confidence            12334578999999999999999997 77776553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=7.3e-41  Score=308.48  Aligned_cols=255  Identities=25%  Similarity=0.316  Sum_probs=203.4

Q ss_pred             CCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           84 FHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      |+..+.||+|+||+||+|.. .+++.||+|.+.....  ......+.+|+++++.++|+|++++.+++..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            56678899999999999986 4689999999854332  22334578899999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++++|..++.......+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++........ 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  157 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-  157 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence            99999998887655556999999999999999999999988   99999999999999999999999999976543322 


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                       .....|+..|+|||.+.+..++.++|+||||+++|||++|+.||........   ............      ..    
T Consensus       158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~~------~~----  223 (285)
T cd05632         158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLETE------EV----  223 (285)
T ss_pred             -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhccc------cc----
Confidence             1345689999999999988999999999999999999999999864322110   001111111100      00    


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhhc
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPP-----MSEIVAMLTC  357 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~l~~  357 (407)
                       ........+.+++..||+.||++||+     +.+++.+-+.
T Consensus       224 -~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~  264 (285)
T cd05632         224 -YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFF  264 (285)
T ss_pred             -cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhh
Confidence             11223445789999999999999999     7788887654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=8.1e-41  Score=309.16  Aligned_cols=257  Identities=28%  Similarity=0.473  Sum_probs=205.4

Q ss_pred             cCCCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRL  155 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  155 (407)
                      .+|.+.+.||+|+||.||+|...      ++..+++|.+.. ........+.+|++++++++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC-ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            45777789999999999999742      355689998753 23344467889999999999999999999999999999


Q ss_pred             EEEEeccCCChhHHHhccC--------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC
Q 040557          156 LVYEYMKNRSLDLLIYGES--------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF  221 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~  221 (407)
                      +||||+++++|.+++....              ...+++..+..++.|++.|+.|||+.+   ++||||||+||++++++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence            9999999999999986432              234899999999999999999999998   99999999999999999


Q ss_pred             ceEEecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHH
Q 040557          222 QSKIGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEY  299 (407)
Q Consensus       222 ~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~  299 (407)
                      .++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|||+| |+.|+.......       
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------  233 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------  233 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------
Confidence            9999999999865443221 1233456788999999999999999999999999999999 898876433211       


Q ss_pred             HHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          300 AWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       300 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .......+....          .....+..+.+++.+||+.+|++||++.+|++.|....
T Consensus       234 ~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~  283 (291)
T cd05094         234 VIECITQGRVLE----------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG  283 (291)
T ss_pred             HHHHHhCCCCCC----------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence            112222222111          11123456889999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.2e-41  Score=329.80  Aligned_cols=251  Identities=21%  Similarity=0.290  Sum_probs=202.2

Q ss_pred             CCCCCCeeeccCCccEEEEEec-C-CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-D-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      .|.+.+.||+|+||.||+|... + +..||+|.+... .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            3778889999999999999753 3 677888876433 344455678899999999999999999999999999999999


Q ss_pred             ccCCChhHHHhcc--CCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          161 MKNRSLDLLIYGE--SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       161 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      +++|+|.+++...  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            9999999887542  3446889999999999999999999988   9999999999999999999999999998765433


Q ss_pred             cc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          239 AY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       239 ~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      .. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......... +...    +  
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~-~~~~----~--  290 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLY-GKYD----P--  290 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh-CCCC----C--
Confidence            21 23345799999999999999999999999999999999999999864321      111111111 1110    0  


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAM  354 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  354 (407)
                          .+...+..+.+++.+||+.||++||++.+++.+
T Consensus       291 ----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        291 ----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             ----CCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence                111234568899999999999999999999865

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=7.6e-41  Score=307.10  Aligned_cols=245  Identities=25%  Similarity=0.324  Sum_probs=194.0

Q ss_pred             eeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCCh
Q 040557           90 LGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL  166 (407)
Q Consensus        90 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  166 (407)
                      ||+|+||.||+++.. +|+.||+|.+.....  ......+..|++++.+++||||+++.+++.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999864 589999999854321  12234556799999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccccccc
Q 040557          167 DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA  246 (407)
Q Consensus       167 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  246 (407)
                      ..++.......+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++........  .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~  155 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRA  155 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eeccC
Confidence            98887656666899999999999999999999988   99999999999999999999999999987654322  23356


Q ss_pred             cCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHH
Q 040557          247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERD  326 (407)
Q Consensus       247 gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  326 (407)
                      |+..|+|||++.+..++.++|||||||++|||++|+.||........  .........     ...+.  ..    ....
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~-----~~~~~--~~----~~~~  222 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTL-----EDEVK--FE----HQNF  222 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhh-----ccccc--cc----cccC
Confidence            89999999999998899999999999999999999999864322110  001111111     10110  00    0123


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHH
Q 040557          327 ALQVINVAFICLQPHGNQRPPMSEIV  352 (407)
Q Consensus       327 ~~~l~~l~~~cl~~~p~~RPs~~ev~  352 (407)
                      +.++.+++..||+.||++||++.|++
T Consensus       223 ~~~~~~li~~~L~~~P~~R~~~~~~~  248 (277)
T cd05607         223 TEESKDICRLFLAKKPEDRLGSREKN  248 (277)
T ss_pred             CHHHHHHHHHHhccCHhhCCCCccch
Confidence            45688999999999999999996554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.3e-40  Score=303.72  Aligned_cols=259  Identities=24%  Similarity=0.393  Sum_probs=208.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|... +|+.||+|.+....  .......+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999875 79999999885422  2334567889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhcc--CCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          159 EYMKNRSLDLLIYGE--SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       159 e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ||+++|+|..++...  ....+++..+..++.+++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999888542  2455899999999999999999999998   99999999999999999999999999986654


Q ss_pred             CCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          237 DQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                      .... .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+......    .... ......+..       
T Consensus       159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~-~~~~~~~~~-------  225 (267)
T cd08224         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSL-CKKIEKCDY-------  225 (267)
T ss_pred             CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHH-HhhhhcCCC-------
Confidence            3321 22346888999999999888999999999999999999999998543211    0111 111111111       


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                        ........+..+.+++.+||+.+|++|||+.+|+++|...
T Consensus       226 --~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         226 --PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             --CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence              0001113455788999999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.1e-41  Score=312.03  Aligned_cols=258  Identities=27%  Similarity=0.380  Sum_probs=202.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEecC-C--cEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLAD-G--TLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ++|++.+.||+|+||.||+|...+ +  ..+++|.++..........+.+|+++++++ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            568888999999999999998643 3  347888876444445566789999999999 799999999999999999999


Q ss_pred             EEeccCCChhHHHhccC--------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCce
Q 040557          158 YEYMKNRSLDLLIYGES--------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS  223 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~  223 (407)
                      +||+++|+|.+++....              ...+++..+..++.|++.|++|||+.+   ++||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999986432              135889999999999999999999988   9999999999999999999


Q ss_pred             EEecccCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHH
Q 040557          224 KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWK  302 (407)
Q Consensus       224 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~  302 (407)
                      ||+|||++.......  .......+..|+|||.+.+..++.++|||||||++|||++ |..||.......       ...
T Consensus       159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-------~~~  229 (297)
T cd05089         159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-------LYE  229 (297)
T ss_pred             EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHH
Confidence            999999986432211  1111223557999999998899999999999999999998 988886433211       111


Q ss_pred             HHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          303 LYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       303 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                      ....+.     ...     .+...+..+.+++.+||+.+|.+|||+.++++.|......
T Consensus       230 ~~~~~~-----~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~  278 (297)
T cd05089         230 KLPQGY-----RME-----KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA  278 (297)
T ss_pred             HHhcCC-----CCC-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            111110     000     1122345688999999999999999999999998765543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5.1e-41  Score=312.86  Aligned_cols=259  Identities=29%  Similarity=0.423  Sum_probs=205.8

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec--------CCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecC
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA--------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDG  151 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  151 (407)
                      .++|.+.+.||+|+||.||++...        ++..+|+|.+...........+.+|++++..+ +|+||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            367889999999999999999742        23579999987554445566788999999999 799999999999999


Q ss_pred             CeeEEEEEeccCCChhHHHhccC--------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEE
Q 040557          152 SQRLLVYEYMKNRSLDLLIYGES--------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL  217 (407)
Q Consensus       152 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill  217 (407)
                      +..++||||+++|+|.+++....              ...+++..+.+++.|++.||+|||+.+   ++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            99999999999999999996532              135889999999999999999999988   9999999999999


Q ss_pred             cCCCceEEecccCccccCCCCccc-ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCc
Q 040557          218 DEKFQSKIGDFGLARFFPEDQAYL-STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQY  295 (407)
Q Consensus       218 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~  295 (407)
                      +.++.++|+|||++.......... .....++..|+|||.+.+..++.++|||||||++|||++ |..|+.....     
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-----  248 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  248 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----
Confidence            999999999999998664322211 122234568999999998889999999999999999998 7777753221     


Q ss_pred             hhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          296 LPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                        .........+...          ..+...+..+.+++.+||+.+|++|||+.++++.|..+.
T Consensus       249 --~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         249 --EELFKLLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             --HHHHHHHHcCCCC----------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence              1122222222111          112223457889999999999999999999999997654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8.5e-41  Score=307.24  Aligned_cols=258  Identities=27%  Similarity=0.387  Sum_probs=207.6

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecC-----CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeec-CCee
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLAD-----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSD-GSQR  154 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~  154 (407)
                      .++|++.+.||+|+||.||+|...+     +..|++|.+...........+.+|+.++++++|+||+++++++.. +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678888999999999999998755     788999998655555667788999999999999999999998765 4678


Q ss_pred             EEEEEeccCCChhHHHhccCC------CCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecc
Q 040557          155 LLVYEYMKNRSLDLLIYGESD------KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDF  228 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  228 (407)
                      ++++||+.+|+|.+++.....      ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence            999999999999999865322      45899999999999999999999988   999999999999999999999999


Q ss_pred             cCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHh
Q 040557          229 GLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYER  306 (407)
Q Consensus       229 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      |+++.+...... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||....+.+       .......
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~  234 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-------MAAYLKD  234 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHc
Confidence            999866433221 1223346778999999988899999999999999999999 999886432211       1111221


Q ss_pred             CccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          307 GRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       307 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      +.       ...   .....+..+.+++.+||+.||++|||+.++++.|...
T Consensus       235 ~~-------~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         235 GY-------RLA---QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             CC-------CCC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            11       000   1112345688999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-40  Score=303.58  Aligned_cols=254  Identities=25%  Similarity=0.438  Sum_probs=200.3

Q ss_pred             CCCCCeeeccCCccEEEEEecC----CcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCe-----
Q 040557           84 FHPGNLLGRGGFGPVYRGKLAD----GTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQ-----  153 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  153 (407)
                      |++++.||+|+||.||+|....    +..||+|.+.... .......+.+|++.++.++|+||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998642    3679999986543 33445678999999999999999999998865544     


Q ss_pred             -eEEEEEeccCCChhHHHhcc----CCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecc
Q 040557          154 -RLLVYEYMKNRSLDLLIYGE----SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDF  228 (407)
Q Consensus       154 -~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  228 (407)
                       .++++||+++|+|..++...    ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             79999999999999888543    2346899999999999999999999988   999999999999999999999999


Q ss_pred             cCccccCCCCcccc-cccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHh
Q 040557          229 GLARFFPEDQAYLS-TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYER  306 (407)
Q Consensus       229 gla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      |+++.......... ....++..|+|||.+.+..++.++|||||||++|||++ |..|+......      .. ......
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~------~~-~~~~~~  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH------EI-YDYLRH  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------HH-HHHHHc
Confidence            99987654332211 12335678999999988899999999999999999999 77777542211      11 111111


Q ss_pred             CccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          307 GRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       307 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      +...          ..+...+..+.+++.+||+.||++|||+.++++.|..
T Consensus       231 ~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         231 GNRL----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             CCCC----------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            1111          1122345578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.1e-41  Score=309.97  Aligned_cols=261  Identities=26%  Similarity=0.422  Sum_probs=199.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-----cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeec--CCee
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSD--GSQR  154 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  154 (407)
                      ++|++.+.||+|+||.||++..     .++..||+|.+... .......+.+|+++++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            4677889999999999999974     35889999998533 34455678999999999999999999998743  3467


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcccc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF  234 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~  234 (407)
                      ++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++...
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            89999999999999986432 35899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCccc--ccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccC---------chhHHHHHH
Q 040557          235 PEDQAYL--STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQ---------YLPEYAWKL  303 (407)
Q Consensus       235 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~---------~~~~~~~~~  303 (407)
                      .......  .....++..|+|||.+.+..++.++||||||+++|||++|..++.........         .........
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL  238 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence            5433221  11223445699999999889999999999999999999987765322110000         000000111


Q ss_pred             HHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          304 YERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       304 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      ...+         .. .......+..+.+++.+||+.+|++|||+.+|++.|+.
T Consensus       239 ~~~~---------~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         239 LKNN---------GR-LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             HhcC---------Cc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence            1111         00 00112234568999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.4e-41  Score=312.08  Aligned_cols=255  Identities=24%  Similarity=0.391  Sum_probs=200.6

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCc--EEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGT--LVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ++|++.+.||+|+||.||+|.+. ++.  .+|+|.+...........+.+|++++.++ +|+||+++++++...+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            56788899999999999999864 454  46788775444455567888999999999 899999999999999999999


Q ss_pred             EEeccCCChhHHHhccC--------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCce
Q 040557          158 YEYMKNRSLDLLIYGES--------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS  223 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~  223 (407)
                      |||+++|+|.+++....              ...+++..+..++.|++.|++|||+.+   ++||||||+|||+++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            99999999999986432              235789999999999999999999988   9999999999999999999


Q ss_pred             EEecccCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHH
Q 040557          224 KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWK  302 (407)
Q Consensus       224 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~  302 (407)
                      +|+|||++.......  ......++..|+|||.+.+..++.++|||||||++|||+| |..||......      . ...
T Consensus       164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~-~~~  234 (303)
T cd05088         164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------E-LYE  234 (303)
T ss_pred             EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------H-HHH
Confidence            999999986432111  1111234667999999988889999999999999999998 89888543221      1 111


Q ss_pred             HHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          303 LYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       303 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ....+.       ..   ..+...+..+.+++.+||+.+|++||++.+++++|+..
T Consensus       235 ~~~~~~-------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         235 KLPQGY-------RL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             HHhcCC-------cC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111110       00   01112345688999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.2e-41  Score=308.03  Aligned_cols=263  Identities=24%  Similarity=0.409  Sum_probs=204.2

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-----cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC--Cee
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG--SQR  154 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  154 (407)
                      +.|++.+.||+|+||.||.++.     .++..||+|.+...........+.+|+++++.++|+|++++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3467788999999999999974     357889999986554455567899999999999999999999998765  568


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcccc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF  234 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~  234 (407)
                      ++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||+++..
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence            89999999999999985432 35899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcc--cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCc--------ccCchhHHHHHHH
Q 040557          235 PEDQAY--LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPS--------EMQYLPEYAWKLY  304 (407)
Q Consensus       235 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~--------~~~~~~~~~~~~~  304 (407)
                      ......  ......++..|+|||.+.+..++.++||||||+++|||+|++.|.......        .............
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL  239 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence            543321  112345677899999998889999999999999999999987664322110        0010111111111


Q ss_pred             HhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          305 ERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       305 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ..+...          ......+..+.+++.+||+.+|++|||+.++++.|+..
T Consensus       240 ~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         240 EEGKRL----------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HcCccC----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            111100          01122346799999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=9.2e-41  Score=310.73  Aligned_cols=261  Identities=28%  Similarity=0.422  Sum_probs=207.3

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe--------cCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecC
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL--------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDG  151 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  151 (407)
                      .++|++.+.||+|+||.||+|+.        .++..||+|.+...........+.+|+.++..+ +|+||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            46788889999999999999963        134579999886544455567889999999999 899999999999999


Q ss_pred             CeeEEEEEeccCCChhHHHhccC--------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEE
Q 040557          152 SQRLLVYEYMKNRSLDLLIYGES--------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL  217 (407)
Q Consensus       152 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill  217 (407)
                      ...+++|||+.+|+|.+++....              ...+++..+..++.|++.||.|||+.+   ++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence            99999999999999999986532              235788999999999999999999998   9999999999999


Q ss_pred             cCCCceEEecccCccccCCCCccc-ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCc
Q 040557          218 DEKFQSKIGDFGLARFFPEDQAYL-STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQY  295 (407)
Q Consensus       218 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~  295 (407)
                      ++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+.....     
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----  245 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-----  245 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----
Confidence            999999999999998765433221 223346678999999988889999999999999999998 6666643221     


Q ss_pred             hhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          296 LPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                        .........+...          ..+...+..+.+++.+||+.+|++|||+.++++.|..+...
T Consensus       246 --~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         246 --EELFKLLKEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             --HHHHHHHHcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence              1122222222111          01122345688999999999999999999999999765443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=8.7e-41  Score=308.47  Aligned_cols=259  Identities=29%  Similarity=0.423  Sum_probs=204.1

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCe
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQ  153 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  153 (407)
                      ..++|++.+.||+|+||.||+|...      .+..||+|.+...........+.+|+.+++.++|+||+++++++.+.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4577889999999999999999643      2458999988655444455678899999999999999999999999999


Q ss_pred             eEEEEEeccCCChhHHHhccC--------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEE
Q 040557          154 RLLVYEYMKNRSLDLLIYGES--------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKI  225 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl  225 (407)
                      .++||||+++|+|.+++....        ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            999999999999999986422        234567888999999999999999988   999999999999999999999


Q ss_pred             ecccCccccCCCCccc-ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHH
Q 040557          226 GDFGLARFFPEDQAYL-STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKL  303 (407)
Q Consensus       226 ~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~  303 (407)
                      +|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..|+......      ... ..
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~-~~  233 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVL-KF  233 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHH-HH
Confidence            9999998654332211 122345678999999999999999999999999999999 67777532211      111 11


Q ss_pred             HHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          304 YERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       304 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ...+....          .+...+..+.+++.+||+.||++|||+.++++.|...
T Consensus       234 ~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         234 VMDGGYLD----------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HHcCCCCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            11111110          1112345789999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.8e-40  Score=301.15  Aligned_cols=247  Identities=24%  Similarity=0.403  Sum_probs=196.8

Q ss_pred             eeeccCCccEEEEEec---CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCC
Q 040557           89 LLGRGGFGPVYRGKLA---DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRS  165 (407)
Q Consensus        89 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  165 (407)
                      .||+|+||.||+|.+.   ++..||+|.+.........+.+.+|+.++++++|+||+++++++.. ...++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999753   3567999998655455556779999999999999999999999864 56799999999999


Q ss_pred             hhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccc--c
Q 040557          166 LDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--T  243 (407)
Q Consensus       166 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~--~  243 (407)
                      |.+++... ...+++..+.+++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...........  .
T Consensus        81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            99988643 345899999999999999999999988   99999999999999999999999999986644332211  1


Q ss_pred             ccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCC
Q 040557          244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGI  322 (407)
Q Consensus       244 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  322 (407)
                      ...++..|+|||.+.+..++.++||||||+++||+++ |..||......       ........+...          ..
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~----------~~  219 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-------EVMSFIEQGKRL----------DC  219 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHHCCCCC----------CC
Confidence            2234578999999988889999999999999999996 99888643221       112222222111          11


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          323 VERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       323 ~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      +...+..+.+++.+||+.+|++||++.+|.+.|..
T Consensus       220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            12235678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=7.9e-41  Score=316.23  Aligned_cols=260  Identities=28%  Similarity=0.427  Sum_probs=202.5

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe------cCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecC-C
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDG-S  152 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~  152 (407)
                      .++|++.+.||+|+||.||+|..      .+++.||||++...........+.+|+.++.++ +|+||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35788999999999999999963      357889999997554455566788999999999 789999999988654 4


Q ss_pred             eeEEEEEeccCCChhHHHhccC----------------------------------------------------------
Q 040557          153 QRLLVYEYMKNRSLDLLIYGES----------------------------------------------------------  174 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  174 (407)
                      ..+++|||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999999886421                                                          


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc-ccccc
Q 040557          175 -------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL-STNFA  246 (407)
Q Consensus       175 -------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~  246 (407)
                             ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++.......... .....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   123678888999999999999999998   9999999999999999999999999998654332211 12234


Q ss_pred             cCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHH
Q 040557          247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVER  325 (407)
Q Consensus       247 gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  325 (407)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..|+......      .........+....          .+..
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~~~~----------~~~~  306 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRRLKEGTRMR----------APDY  306 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc------HHHHHHHhccCCCC----------CCCC
Confidence            5678999999999999999999999999999997 88887542211      11111122111110          0111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          326 DALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       326 ~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .+..+.+++..||+.+|++|||+.+|+++|+...
T Consensus       307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            2345889999999999999999999999997653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.2e-40  Score=307.07  Aligned_cols=262  Identities=24%  Similarity=0.413  Sum_probs=202.1

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-----------------CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeee
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-----------------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL  144 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l  144 (407)
                      ++|++.+.||+|+||.||++...                 ++..+|+|.+...........+.+|+++++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56888999999999999998532                 2446999998655455556789999999999999999999


Q ss_pred             eeeeecCCeeEEEEEeccCCChhHHHhccC---------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccE
Q 040557          145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGES---------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNV  215 (407)
Q Consensus       145 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Ni  215 (407)
                      ++++...+..+++|||+++|+|.+++....         ...+++..+..++.|++.|+.|||+.+   ++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            999999999999999999999999986432         124778899999999999999999998   99999999999


Q ss_pred             EEcCCCceEEecccCccccCCCCccc-ccccccCccccCccccccCCCCccccEEehhHHHHHHHh--cCCCCCCCCCcc
Q 040557          216 LLDEKFQSKIGDFGLARFFPEDQAYL-STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS--CRKNTDLTLPSE  292 (407)
Q Consensus       216 ll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t--g~~p~~~~~~~~  292 (407)
                      ++++++.++|+|||++..+....... .....++..|++||...++.++.++|||||||++|||++  |..|+......+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            99999999999999998654332211 122345678999999888899999999999999999998  556665332211


Q ss_pred             cCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          293 MQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      .   ................. +      .+..++..+.+++.+||+.||++||++.+|++.|.
T Consensus       242 ~---~~~~~~~~~~~~~~~~~-~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 V---IENTGEFFRDQGRQVYL-P------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             H---HHHHHHHHhhccccccC-C------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            0   00011111111000000 0      11123467889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.3e-40  Score=307.38  Aligned_cols=257  Identities=28%  Similarity=0.470  Sum_probs=204.8

Q ss_pred             cCCCCCCeeeccCCccEEEEEe------cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRL  155 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  155 (407)
                      .+|.+.+.||+|+||.||++..      .++..+|+|.+... .......+.+|++++.+++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            5678889999999999999974      23456899988533 3444567899999999999999999999999999999


Q ss_pred             EEEEeccCCChhHHHhccC-----------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceE
Q 040557          156 LVYEYMKNRSLDLLIYGES-----------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSK  224 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k  224 (407)
                      +||||+++++|.+++....           ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence            9999999999999986432           234899999999999999999999988   99999999999999999999


Q ss_pred             EecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHH
Q 040557          225 IGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWK  302 (407)
Q Consensus       225 l~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~  302 (407)
                      |+|||++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||......      . ...
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~------~-~~~  233 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------E-VIE  233 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHH
Confidence            9999999865433221 1223345778999999998899999999999999999999 88887543321      1 111


Q ss_pred             HHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          303 LYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       303 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ....+....     .     ....+..+.+++.+||+.||.+|||+.++++.|+...
T Consensus       234 ~i~~~~~~~-----~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         234 CITQGRVLQ-----R-----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             HHHcCCcCC-----C-----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            222222111     0     1112346899999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=8.8e-41  Score=304.87  Aligned_cols=259  Identities=23%  Similarity=0.403  Sum_probs=207.3

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|.. .+|+.+|||.+....  ......++.+|+.+++.++|+||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4677788999999999999985 579999999875432  2334467889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhc--cCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          159 EYMKNRSLDLLIYG--ESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       159 e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ||+++++|.+++..  .....+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998853  22456899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          237 DQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                      .... .....++..|+|||.+.+..++.++||||||+++|||++|..|+........    .. ......     ...+.
T Consensus       159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~-~~~~~~-----~~~~~  227 (267)
T cd08229         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SL-CKKIEQ-----CDYPP  227 (267)
T ss_pred             CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH----HH-hhhhhc-----CCCCC
Confidence            3321 2235688999999999888899999999999999999999999864322110    11 111111     11111


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .    .....+..+.+++.+||+.||++|||+.+|++.+...
T Consensus       228 ~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         228 L----PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             C----CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            1    1123455788999999999999999999999988643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.1e-41  Score=308.75  Aligned_cols=256  Identities=28%  Similarity=0.401  Sum_probs=201.7

Q ss_pred             HHhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecC-----
Q 040557           79 KATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDG-----  151 (407)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-----  151 (407)
                      .+.+.|+..+.||+|+||.||+|... +++.||+|.+....  .....+.+|+.++.++ +|+||+++++++...     
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            34567888889999999999999864 58899999985432  3345788999999998 799999999998653     


Q ss_pred             -CeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccC
Q 040557          152 -SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGL  230 (407)
Q Consensus       152 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgl  230 (407)
                       ...+++|||+.+++|.+++.......+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||+
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence             45789999999999999987655566899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccCccccCccccc-----cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHH
Q 040557          231 ARFFPEDQAYLSTNFAGTLGYTAPEYAI-----RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYE  305 (407)
Q Consensus       231 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  305 (407)
                      +........ ......|+..|+|||++.     +..++.++|||||||++|||++|+.|+....+..       ......
T Consensus       158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-------~~~~~~  229 (272)
T cd06637         158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-------ALFLIP  229 (272)
T ss_pred             ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-------HHHHHh
Confidence            986543222 223456899999999886     3467889999999999999999999986432211       000111


Q ss_pred             hCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          306 RGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       306 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ...     .....    ....+..+.+++.+||+.+|++|||+.+++++-|
T Consensus       230 ~~~-----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  271 (272)
T cd06637         230 RNP-----APRLK----SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF  271 (272)
T ss_pred             cCC-----CCCCC----CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCC
Confidence            110     01111    1123456889999999999999999999998754

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.6e-40  Score=303.34  Aligned_cols=256  Identities=28%  Similarity=0.453  Sum_probs=204.3

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CC---cEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DG---TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ++|+..+.||+|+||.||+|... ++   ..+|+|.+...........+.+|++++.+++|+|++++.+++.+.+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46777889999999999999864 23   379999886554455567789999999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++++|.+++.... ..+++..+..++.|++.|++|||+.+   ++|+||||+||++++++.++|+|||++......
T Consensus        85 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          85 TEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999986433 45899999999999999999999988   999999999999999999999999999866533


Q ss_pred             Cccccc--ccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          238 QAYLST--NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       238 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      ......  ....+..|+|||.+.+..++.++|||||||++|||++ |+.|+......      ... .....+.      
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~-~~i~~~~------  227 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVM-KAINDGF------  227 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHH-HHHhcCC------
Confidence            221111  1223457999999998889999999999999999998 99998543221      111 1111110      


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                         . .......+..+.+++.+||+.+|++||++.+|++.|...
T Consensus       228 ---~-~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 ---R-LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ---C-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               0 001122345688999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.6e-41  Score=314.56  Aligned_cols=247  Identities=22%  Similarity=0.283  Sum_probs=193.3

Q ss_pred             CeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHH-HHHcCCCCceeeeeeeeecCCeeEEEEEeccC
Q 040557           88 NLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVR-MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKN  163 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  163 (407)
                      +.||+|+||.||+|+. .+|+.||+|++....  .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999985 468999999986432  2223345556655 46778999999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccccc
Q 040557          164 RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST  243 (407)
Q Consensus       164 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  243 (407)
                      |+|..++..  ...+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||++........ ...
T Consensus        81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~  154 (325)
T cd05604          81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTT  154 (325)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Ccc
Confidence            999888743  346899999999999999999999998   99999999999999999999999999975432221 123


Q ss_pred             ccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCC
Q 040557          244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIV  323 (407)
Q Consensus       244 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  323 (407)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||......      ....... .+..      .+     .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~-~~~~------~~-----~  216 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNIL-HKPL------VL-----R  216 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHH-cCCc------cC-----C
Confidence            457999999999999999999999999999999999999998643221      1111111 1110      01     1


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHH----HHHHHhhcc
Q 040557          324 ERDALQVINVAFICLQPHGNQRPPMS----EIVAMLTCK  358 (407)
Q Consensus       324 ~~~~~~l~~l~~~cl~~~p~~RPs~~----ev~~~l~~~  358 (407)
                      ......+.+++.+|++.+|++||++.    ++++|.+..
T Consensus       217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~  255 (325)
T cd05604         217 PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFE  255 (325)
T ss_pred             CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcC
Confidence            11234577899999999999999874    777765543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.7e-40  Score=303.86  Aligned_cols=254  Identities=24%  Similarity=0.398  Sum_probs=197.8

Q ss_pred             CCCCCeeeccCCccEEEEEecC-Cc--EEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC------Ce
Q 040557           84 FHPGNLLGRGGFGPVYRGKLAD-GT--LVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG------SQ  153 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  153 (407)
                      |.+++.||+|+||.||+|...+ +.  .+|+|.+.... .......+.+|+++++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999998654 32  68999886542 334456788999999999999999999987432      24


Q ss_pred             eEEEEEeccCCChhHHHhcc----CCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEeccc
Q 040557          154 RLLVYEYMKNRSLDLLIYGE----SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFG  229 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  229 (407)
                      .+++|||+++|+|..++...    ....+++.....++.|++.||.|||+.+   ++||||||+|||+++++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            68999999999998887422    2345899999999999999999999988   9999999999999999999999999


Q ss_pred             CccccCCCCccc-ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhC
Q 040557          230 LARFFPEDQAYL-STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERG  307 (407)
Q Consensus       230 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      +++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....       .........+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~  230 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-------SEIYDYLRQG  230 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHcC
Confidence            998765433221 122346678999999999999999999999999999999 7777754221       1122222222


Q ss_pred             ccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          308 RILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       308 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      ....          .....+..+.+++.+||+.||++|||+.++++.|+.
T Consensus       231 ~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         231 NRLK----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             CCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            2110          111234568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.7e-40  Score=303.11  Aligned_cols=255  Identities=26%  Similarity=0.440  Sum_probs=204.3

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-C---CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-D---GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      .+|++.+.||+|+||.||+|... +   +..+|+|.+...........+.+|+.++.+++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46778899999999999999753 2   3479999986554455567889999999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++++|.+++.... ..+++..+..++.|++.|+.|||+.+   ++||||||+||++++++.++|+|||++......
T Consensus        84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999986443 45899999999999999999999998   999999999999999999999999999876543


Q ss_pred             Ccccc--cccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          238 QAYLS--TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       238 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      .....  ....++..|+|||.+.+..++.++||||||+++||+++ |..||......+       .......+..     
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~~-----  227 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-------VIKAIEEGYR-----  227 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-------HHHHHhCCCc-----
Confidence            32211  12223568999999998899999999999999999886 998886432211       1111111100     


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                        .   ......+..+.+++.+||+.+|++||++.++++.|..
T Consensus       228 --~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         228 --L---PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             --C---CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence              0   0111234568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.8e-40  Score=300.48  Aligned_cols=254  Identities=26%  Similarity=0.413  Sum_probs=205.6

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      .++|++.+.||+|+||.||+|...++..+|+|.+...  ......+.+|+++++.++|+||+++.+++.. ...+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            3678888999999999999999877888999987532  3345678899999999999999999999887 778999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++++|.+++.......+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            99999999997655566899999999999999999999988   999999999999999999999999999876543332


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                      ......++..|+|||.+....++.++|+||||+++|+++| |+.||.......       .......+...         
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~---------  222 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERGYRM---------  222 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhCCCCC---------
Confidence            2233345678999999998889999999999999999999 888876432211       11111111110         


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                       ......+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       223 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 -PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             -CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             0112234568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.2e-40  Score=300.82  Aligned_cols=252  Identities=27%  Similarity=0.388  Sum_probs=193.2

Q ss_pred             eeeccCCccEEEEEecC---CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCC
Q 040557           89 LLGRGGFGPVYRGKLAD---GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRS  165 (407)
Q Consensus        89 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  165 (407)
                      .||+|+||.||+|...+   +..+|+|.+...........+.+|+.+++.++|+||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            58999999999997543   457999988655544555678999999999999999999999999999999999999999


Q ss_pred             hhHHHhccC---CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc-
Q 040557          166 LDLLIYGES---DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL-  241 (407)
Q Consensus       166 L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~-  241 (407)
                      |.+++....   ....++..+..++.|++.|+.|||+.+   ++|+||||+||+++.++.++|+|||++.......... 
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999986432   234677888899999999999999998   9999999999999999999999999997554333221 


Q ss_pred             ccccccCccccCccccccC-------CCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCcccccc
Q 040557          242 STNFAGTLGYTAPEYAIRG-------ELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELV  313 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~-------~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      .....++..|+|||.+.+.       .++.++||||||+++|||++ |+.||......+       .......+......
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~  231 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ-------VLTYTVREQQLKLP  231 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH-------HHHHHhhcccCCCC
Confidence            1234577889999988642       35789999999999999996 998886432211       11111111111122


Q ss_pred             CcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       314 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ++.+..     .....+.+++..|| .+|++|||+++|+..|+
T Consensus       232 ~~~~~~-----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         232 KPRLKL-----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCccCC-----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            222211     12345778999999 58999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7.4e-41  Score=303.74  Aligned_cols=246  Identities=28%  Similarity=0.434  Sum_probs=196.1

Q ss_pred             eeeccCCccEEEEEe---cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCC
Q 040557           89 LLGRGGFGPVYRGKL---ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNR  164 (407)
Q Consensus        89 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  164 (407)
                      .||+|+||.||+|.+   .++..+|+|++.... .......+.+|+.+++.++|+||+++++++.. ...++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999964   357889999986443 23345678999999999999999999999854 5678999999999


Q ss_pred             ChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc--c
Q 040557          165 SLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL--S  242 (407)
Q Consensus       165 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~--~  242 (407)
                      +|.+++...  ..+++..+..++.|++.|+.|||+.+   ++||||||.||++++++.++|+|||++..........  .
T Consensus        81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            999998533  45899999999999999999999988   9999999999999999999999999998765443221  1


Q ss_pred             cccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCC
Q 040557          243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEG  321 (407)
Q Consensus       243 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  321 (407)
                      ....++..|+|||.+....++.++||||||+++|||++ |+.||......      . .......+....          
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~-~~~~i~~~~~~~----------  218 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN------E-VTQMIESGERME----------  218 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHCCCCCC----------
Confidence            22234578999999988889999999999999999998 89888643221      1 112222221110          


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          322 IVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       322 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      .+...+.++.+++.+||+.||++||++.+|.+.|..
T Consensus       219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            112234568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.2e-41  Score=315.68  Aligned_cols=271  Identities=23%  Similarity=0.358  Sum_probs=203.2

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      ++|...+.||+|+||.||+|+.. +++.||+|.+...........+.+|++++++++|+||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888899999999999999864 68889999986554444445678999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++ +|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++.........
T Consensus        86 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  160 (309)
T cd07872          86 LDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT  160 (309)
T ss_pred             CCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence            975 787777543 345889999999999999999999998   999999999999999999999999999765433221


Q ss_pred             cccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchh--------HHHHHHHHhCcccc
Q 040557          241 LSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLP--------EYAWKLYERGRILE  311 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~~  311 (407)
                       .....+++.|+|||.+.+ ..++.++|||||||++|||+||+.||......+.....        ...+..+.......
T Consensus       161 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         161 -YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             -cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence             223467899999998865 46899999999999999999999998654332110000        00000000000000


Q ss_pred             ccC-cccccC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          312 LVD-PRMRKE---GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       312 ~~d-~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ..+ +.....   ......+..+.+++.+||+.||++|||+.|+++|.+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~  290 (309)
T cd07872         240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR  290 (309)
T ss_pred             hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhh
Confidence            000 000000   00011245678999999999999999999999998764

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.9e-41  Score=302.67  Aligned_cols=249  Identities=31%  Similarity=0.466  Sum_probs=205.3

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      ++|++.+.||+|+||.||+|... |+.||+|.+.....  ...++.+|+.++..++|+||+++++++.+.+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            56788899999999999999874 88999999864432  5667899999999999999999999999999999999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      ++++|.+++.......+++..+..++.|++.|+.|||+.+   ++|+||||+||++++++.++|+|||++........  
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            9999999997665557999999999999999999999998   99999999999999999999999999987633221  


Q ss_pred             ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                        ...++..|+|||.+....++.++||||||+++|||++ |+.||......       ........+...          
T Consensus       158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~----------  218 (256)
T cd05039         158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPHVEKGYRM----------  218 (256)
T ss_pred             --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHhcCCCC----------
Confidence              2335668999999988899999999999999999997 88887543211       111122211100          


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      ..+...+..+.+++.+||+.+|++||++.+++++|..
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            0112234668899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=8.8e-41  Score=308.35  Aligned_cols=265  Identities=25%  Similarity=0.364  Sum_probs=196.4

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChh-hHHHHHHHHHHHHcC---CCCceeeeeeeeec-----CC
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQ-GESEFLSEVRMITSI---QHKNLVRLLGCCSD-----GS  152 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~  152 (407)
                      +|++.+.||+|+||.||+|... +|+.||+|.+....... ....+.+|++++..+   +|+||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778889999999999999864 68999999986543222 223455677776655   79999999998754     34


Q ss_pred             eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                      ..+++|||+.+ +|..++.......+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++.
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence            57899999975 8888886555556899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhC---cc
Q 040557          233 FFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERG---RI  309 (407)
Q Consensus       233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~  309 (407)
                      .......  .....||..|+|||.+.+..++.++|||||||++|||++|++||........  +.. ........   ..
T Consensus       157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~-~~~~~~~~~~~~~  231 (288)
T cd07863         157 IYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGK-IFDLIGLPPEDDW  231 (288)
T ss_pred             cccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHH-HHHHhCCCChhhC
Confidence            7653322  2345689999999999999999999999999999999999999864432110  000 00000000   00


Q ss_pred             -------ccccCccccc--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          310 -------LELVDPRMRK--EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       310 -------~~~~d~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                             .....+....  ..........+.+++.+||+.||++|||+.|++.|.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~  287 (288)
T cd07863         232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF  287 (288)
T ss_pred             cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence                   0000000000  0011123456789999999999999999999998765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7.6e-41  Score=313.71  Aligned_cols=251  Identities=23%  Similarity=0.298  Sum_probs=198.8

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCC-CCceeeeeeeeecCCeeEEEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQ-HKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  158 (407)
                      +|+..+.||+|+||.||+|... +|+.||+|++....  .......+..|.+++..+. |++|+++.+++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3666789999999999999854 68999999986432  2233456778999988885 577888999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|..++..  ...+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.++|+|||+++......
T Consensus        81 Ey~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          81 EYVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            99999999998853  345899999999999999999999998   9999999999999999999999999997543322


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                      . ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......      ....... .+..         
T Consensus       156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~i~-~~~~---------  218 (323)
T cd05615         156 V-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED------ELFQSIM-EHNV---------  218 (323)
T ss_pred             c-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHH-hCCC---------
Confidence            1 123456899999999999999999999999999999999999998754321      1111111 1111         


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhhc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPP-----MSEIVAMLTC  357 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~l~~  357 (407)
                        ..+...+..+.+++.+||+.+|++|++     ..++.+|-+.
T Consensus       219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f  260 (323)
T cd05615         219 --SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFF  260 (323)
T ss_pred             --CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCccc
Confidence              011223456789999999999999997     4677777554

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-40  Score=313.31  Aligned_cols=246  Identities=23%  Similarity=0.276  Sum_probs=192.1

Q ss_pred             eeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHHHcC---CCCceeeeeeeeecCCeeEEEEEeccC
Q 040557           90 LGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMITSI---QHKNLVRLLGCCSDGSQRLLVYEYMKN  163 (407)
Q Consensus        90 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  163 (407)
                      ||+|+||.||+|+.. +|+.||+|++.....  ......+..|..++...   +||||+++++++...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999864 589999999854321  12233455677776655   699999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccccc
Q 040557          164 RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST  243 (407)
Q Consensus       164 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  243 (407)
                      |+|..++..  ...+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.++|+|||++........ ...
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~  154 (330)
T cd05586          81 GELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTN  154 (330)
T ss_pred             ChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Ccc
Confidence            999988853  345899999999999999999999998   99999999999999999999999999975433222 123


Q ss_pred             ccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCC
Q 040557          244 NFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGI  322 (407)
Q Consensus       244 ~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  322 (407)
                      ...||+.|+|||.+.+. .++.++|||||||++|||++|+.||......       ........+..      .+..   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~~------~~~~---  218 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-------QMYRNIAFGKV------RFPK---  218 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-------HHHHHHHcCCC------CCCC---
Confidence            46799999999988764 5899999999999999999999998653221       11112221111      1111   


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCC----CHHHHHHHhhcc
Q 040557          323 VERDALQVINVAFICLQPHGNQRP----PMSEIVAMLTCK  358 (407)
Q Consensus       323 ~~~~~~~l~~l~~~cl~~~p~~RP----s~~ev~~~l~~~  358 (407)
                       ......+.+++.+||+.||++||    ++.++++|.+..
T Consensus       219 -~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~  257 (330)
T cd05586         219 -NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFA  257 (330)
T ss_pred             -ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcccc
Confidence             11234578999999999999998    689999887754

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1e-40  Score=307.45  Aligned_cols=260  Identities=22%  Similarity=0.335  Sum_probs=207.3

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      ++|++.+.||+|+||+||++... +|+.||+|.+...........+.+|+++++.++|+||+++++++...+.+++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            45667788999999999999854 68899999886554455567899999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccc-cCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE-DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      +++++|..++..  .+.+++.....++.+++.|+.|||+ .+   ++||||+|+||++++++.++|+|||++....... 
T Consensus        85 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          85 MDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-  158 (284)
T ss_pred             CCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence            999999988854  3458999999999999999999997 45   9999999999999999999999999987543222 


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccC-----chhHHHHHHHHhCccccccC
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQ-----YLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~d  314 (407)
                        .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||.........     .............      .
T Consensus       159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~  230 (284)
T cd06620         159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------P  230 (284)
T ss_pred             --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------C
Confidence              12356899999999998889999999999999999999999999754432110     0111111111100      0


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      +.+.    ....+..+.+++.+||+.||++|||+.|++++.+...
T Consensus       231 ~~~~----~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         231 PRLP----SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             CCCC----chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            1111    1124456889999999999999999999999977643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.7e-40  Score=306.57  Aligned_cols=256  Identities=28%  Similarity=0.454  Sum_probs=204.5

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCee
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQR  154 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  154 (407)
                      .++|+..+.||+|+||.||+|...      ++..||+|.+...........+.+|+.+++.++|+||+++++++.++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            357888899999999999999753      46789999987555555567799999999999999999999999999999


Q ss_pred             EEEEEeccCCChhHHHhccC--------------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeecccccc
Q 040557          155 LLVYEYMKNRSLDLLIYGES--------------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASN  214 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~N  214 (407)
                      +++|||+++|+|.+++....                    ...+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999986322                    124788899999999999999999988   9999999999


Q ss_pred             EEEcCCCceEEecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcc
Q 040557          215 VLLDEKFQSKIGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSE  292 (407)
Q Consensus       215 ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~  292 (407)
                      |++++++.++|+|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..|+...... 
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            99999999999999999765433221 1122335667999999998899999999999999999998 77777532211 


Q ss_pred             cCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          293 MQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                           + .......+....          .+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus       240 -----~-~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         240 -----E-VIYYVRDGNVLS----------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             -----H-HHHHHhcCCCCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence                 1 112222222110          11223456899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=9.4e-41  Score=317.89  Aligned_cols=257  Identities=21%  Similarity=0.286  Sum_probs=200.6

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|+..+.||+|+||.||++... +++.||+|.+....  .......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36778899999999999999864 68999999986432  2234457788999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|.+++..  ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++.......
T Consensus        81 E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          81 EFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             eCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            99999999999853  345899999999999999999999998   9999999999999999999999999987543211


Q ss_pred             c----------------------------------ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCC
Q 040557          239 A----------------------------------YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKN  284 (407)
Q Consensus       239 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p  284 (407)
                      .                                  ......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence            0                                  001235799999999999999999999999999999999999999


Q ss_pred             CCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHHhhcc
Q 040557          285 TDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRP---PMSEIVAMLTCK  358 (407)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP---s~~ev~~~l~~~  358 (407)
                      |....+..      ....... ......+.+..       .....+.+++.+|+. ||.+|+   ++.++++|-++.
T Consensus       236 f~~~~~~~------~~~~i~~-~~~~~~~p~~~-------~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~  297 (360)
T cd05627         236 FCSETPQE------TYRKVMN-WKETLVFPPEV-------PISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFE  297 (360)
T ss_pred             CCCCCHHH------HHHHHHc-CCCceecCCCC-------CCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCC
Confidence            97543321      1111111 00000011100       123456777777664 999998   488999997754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=8.3e-41  Score=307.36  Aligned_cols=254  Identities=28%  Similarity=0.447  Sum_probs=201.8

Q ss_pred             cCCCCCCeeeccCCccEEEEEe------cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRL  155 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  155 (407)
                      .+|+..+.||+|+||.||++..      .++..+|+|.+.. ........+.+|+++++.++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc-CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            4577788999999999999963      2466899998753 34455668999999999999999999999999999999


Q ss_pred             EEEEeccCCChhHHHhccCC-------------CCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCc
Q 040557          156 LVYEYMKNRSLDLLIYGESD-------------KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ  222 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~~-------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~  222 (407)
                      ++|||+++|+|.+++.....             ..+++..+..++.|++.|+.|||+.+   ++||||||+|||+++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence            99999999999999865331             35889999999999999999999988   999999999999999999


Q ss_pred             eEEecccCccccCCCCccc-ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHH
Q 040557          223 SKIGDFGLARFFPEDQAYL-STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYA  300 (407)
Q Consensus       223 ~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~  300 (407)
                      ++|+|||++.......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||.......      ..
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~  234 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE------AI  234 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH------HH
Confidence            9999999997654332211 122345678999999999999999999999999999998 888875322211      11


Q ss_pred             HHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          301 WKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       301 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                       .....+...          ..+...+..+.+++.+||+.||++||++.+|++.|+
T Consensus       235 -~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         235 -ECITQGREL----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -HHHHcCccC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence             111111110          011123456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.2e-41  Score=306.33  Aligned_cols=256  Identities=29%  Similarity=0.425  Sum_probs=201.0

Q ss_pred             CCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhH-HHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           84 FHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGE-SEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      |++.+.||+|+||+||+++.. +++.||+|.+......... ....+|+.++.+++|+||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            456689999999999999875 4678999999755433322 23456999999999999999999999999999999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      ++++|.+++.  ....+++..+..++.|+++||.+||+.+   ++|+||||+||++++++.++|+|||.+....... ..
T Consensus        81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~-~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENN-EN  154 (260)
T ss_dssp             TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTT-SE
T ss_pred             cccccccccc--cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-cc
Confidence            9999999996  3455899999999999999999999998   9999999999999999999999999998652222 22


Q ss_pred             ccccccCccccCccccc-cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          242 STNFAGTLGYTAPEYAI-RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                      .....++..|+|||.+. +..++.++||||+|+++|+|++|+.|+........   .........    .........  
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~---~~~~~~~~~----~~~~~~~~~--  225 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ---LEIIEKILK----RPLPSSSQQ--  225 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH---HHHHHHHHH----THHHHHTTS--
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhh---hhhhhhccc----ccccccccc--
Confidence            34567899999999988 78899999999999999999999999875411100   011111110    000000000  


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                        .......+.+++.+||+.||++|||+.+++++-|
T Consensus       226 --~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~  259 (260)
T PF00069_consen  226 --SREKSEELRDLIKKMLSKDPEQRPSAEELLKHPW  259 (260)
T ss_dssp             --HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred             --cchhHHHHHHHHHHHccCChhHCcCHHHHhcCCC
Confidence              0001267899999999999999999999998865

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.6e-40  Score=316.24  Aligned_cols=269  Identities=24%  Similarity=0.263  Sum_probs=200.3

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC-----
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS-----  152 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  152 (407)
                      ..++|++.+.||+|+||.||++... +|+.||+|.+.... .......+.+|+.+++.++|+||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999864 58999999986432 3344567889999999999999999999886443     


Q ss_pred             -eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCc
Q 040557          153 -QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLA  231 (407)
Q Consensus       153 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla  231 (407)
                       ..++||||+++ +|...+.    ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence             46999999976 5555553    23788999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCccc---------C----c---
Q 040557          232 RFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEM---------Q----Y---  295 (407)
Q Consensus       232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~---------~----~---  295 (407)
                      +......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........         .    .   
T Consensus       171 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (359)
T cd07876         171 RTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR  248 (359)
T ss_pred             cccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence            7654322  12345789999999999999999999999999999999999999975432100         0    0   


Q ss_pred             hhHHHHHHHHhCccc------cccCccc-cc-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          296 LPEYAWKLYERGRIL------ELVDPRM-RK-EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       296 ~~~~~~~~~~~~~~~------~~~d~~~-~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ...............      +...... .. ..........+.+++.+||+.||++|||+.|+++|.|..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  319 (359)
T cd07876         249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT  319 (359)
T ss_pred             HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence            000000000000000      0000000 00 000111235678999999999999999999999998754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.7e-40  Score=308.02  Aligned_cols=258  Identities=27%  Similarity=0.429  Sum_probs=204.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEec--------CCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCC
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA--------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGS  152 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  152 (407)
                      .+|.+.+.||+|+||.||+|...        .+..+|+|.+...........+.+|++++..+ +|+||+++++++.+..
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            56788899999999999999642        24579999986554555567789999999999 6999999999999999


Q ss_pred             eeEEEEEeccCCChhHHHhccC--------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGES--------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD  218 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~  218 (407)
                      ..+++|||+++|+|.+++....              ...+++..+..++.|++.||.|||+.+   ++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence            9999999999999999986432              245889999999999999999999988   99999999999999


Q ss_pred             CCCceEEecccCccccCCCCccc-ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCch
Q 040557          219 EKFQSKIGDFGLARFFPEDQAYL-STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYL  296 (407)
Q Consensus       219 ~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~  296 (407)
                      +++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....      
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~------  242 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV------  242 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH------
Confidence            99999999999998665332211 112234567999999998899999999999999999999 7777753321      


Q ss_pred             hHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          297 PEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       297 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                       .........+....          .+...+..+.+++.+||+.+|++|||+.++++.|+...
T Consensus       243 -~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         243 -EELFKLLREGHRMD----------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             -HHHHHHHHcCCCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence             11222222221110          11223456889999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.5e-40  Score=301.63  Aligned_cols=260  Identities=25%  Similarity=0.371  Sum_probs=209.2

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      ++|++.+.||.|+||.||+|... ++..+|+|++...........+.+|++.++.++|+|++++++.+...+..+++||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888999999999999999854 68899999986555444667899999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCC-CCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          161 MKNRSLDLLIYGESD-KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      +++++|.+++..... ..+++.....++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999865433 56899999999999999999999988   99999999999999999999999999987654332


Q ss_pred             c---cccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          240 Y---LSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       240 ~---~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                      .   ......|+..|+|||.+... .++.++|+||||+++|||++|+.|+.......      ...+.....      .+
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~~------~~  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQND------PP  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcCC------CC
Confidence            2   12334688999999998876 78999999999999999999999986443221      111111110      11


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ...........+..+.+++.+||+.||++||++.++++|-+
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~  266 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF  266 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCC
Confidence            11111111233466889999999999999999999998754

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=310.03  Aligned_cols=258  Identities=26%  Similarity=0.305  Sum_probs=215.4

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccCh--hhHHHHHHHHHHHHcCC-CCceeeeeeeeecCCeeE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQ--QGESEFLSEVRMITSIQ-HKNLVRLLGCCSDGSQRL  155 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~  155 (407)
                      ....|++++.||.|.||.||++... +|+.+|+|.+.+....  .....+.+|+.+|+++. ||||+.+.+.+++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            4467888899999999999999865 4999999999765433  24468899999999998 999999999999999999


Q ss_pred             EEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCC----CceEEecccCc
Q 040557          156 LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEK----FQSKIGDFGLA  231 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~----~~~kl~Dfgla  231 (407)
                      +|||++.||.|.+.+...   .+++..+..++.|++.++.|||+.+   ++||||||+|+|+...    +.++++|||++
T Consensus       113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            999999999999988655   2999999999999999999999998   9999999999999643    57999999999


Q ss_pred             cccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccc
Q 040557          232 RFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILE  311 (407)
Q Consensus       232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      .....  .......+||+.|+|||.+....|+..+||||+|+++|.|++|.+||........       ...+..+..  
T Consensus       187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~-------~~~i~~~~~--  255 (382)
T KOG0032|consen  187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI-------FLAILRGDF--  255 (382)
T ss_pred             eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH-------HHHHHcCCC--
Confidence            98877  3344678999999999999999999999999999999999999999986543221       112222222  


Q ss_pred             ccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       312 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                          ....+ .-......+-+++..|+..||.+|+|+.++++|.|-..
T Consensus       256 ----~f~~~-~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~  298 (382)
T KOG0032|consen  256 ----DFTSE-PWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKS  298 (382)
T ss_pred             ----CCCCC-CccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccC
Confidence                11111 11234567889999999999999999999999998544

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.7e-40  Score=302.07  Aligned_cols=254  Identities=27%  Similarity=0.472  Sum_probs=201.8

Q ss_pred             CCCCCCeeeccCCccEEEEEecC-C---cEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLAD-G---TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      .|++.+.||+|+||.||+|.... +   ..||+|.+...........|..|+.+++.++||||+++++++.++...++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            46778899999999999998642 3   3699999865545556678999999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|.+++... ...+++..+..++.|++.|+.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        85 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          85 EFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             ecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            999999999998644 345899999999999999999999988   9999999999999999999999999998664332


Q ss_pred             cccc--cccc--cCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCcccccc
Q 040557          239 AYLS--TNFA--GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELV  313 (407)
Q Consensus       239 ~~~~--~~~~--gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ....  ....  .+..|+|||.+.+..++.++|||||||++||+++ |..||......      . .........     
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~------~-~~~~i~~~~-----  228 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ------D-VINAIEQDY-----  228 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH------H-HHHHHHcCC-----
Confidence            2111  1111  2457999999999999999999999999999886 88888643221      1 111111110     


Q ss_pred             CcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       314 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                        ..   ..+...+..+.+++.+||+.+|++||++.+++..|+.
T Consensus       229 --~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         229 --RL---PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             --cC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence              00   0112234568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.2e-40  Score=302.18  Aligned_cols=249  Identities=29%  Similarity=0.433  Sum_probs=199.6

Q ss_pred             CeeeccCCccEEEEEecC--C--cEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccC
Q 040557           88 NLLGRGGFGPVYRGKLAD--G--TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKN  163 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  163 (407)
                      +.||+|++|.||+|.+.+  +  ..||+|.+...........+.+|++++++++|+||+++++.+.+ ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            368999999999998643  3  36999998755544556789999999999999999999999988 889999999999


Q ss_pred             CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc--c
Q 040557          164 RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY--L  241 (407)
Q Consensus       164 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--~  241 (407)
                      |+|.+++.......+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++..+......  .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999987554356899999999999999999999998   999999999999999999999999999877543221  1


Q ss_pred             ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                      .....++..|+|||.+.+..++.++|||||||++|||++ |+.|+......      ...........       ..   
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~-------~~---  220 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS------QILKKIDKEGE-------RL---  220 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhcCC-------cC---
Confidence            123457788999999998899999999999999999999 99988543221      11111111110       00   


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ..+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            011223457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.4e-40  Score=301.59  Aligned_cols=252  Identities=25%  Similarity=0.389  Sum_probs=205.2

Q ss_pred             cCCCCCCeeeccCCccEEEEEecC-CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      ++|+..+.||+|+||.||+|...+ +..+++|.+....   ....+.+|++++++++|+||+++++++......++++||
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            578888999999999999998754 8899999985332   266899999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +.+++|.+++... ...+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        80 ~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          80 CGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            9999999998543 346899999999999999999999988   99999999999999999999999999987654332 


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                      ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+....+....      . ....     ...+..   
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~------~-~~~~-----~~~~~~---  219 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI------F-MIPN-----KPPPTL---  219 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh------h-hhcc-----CCCCCC---
Confidence            122345788999999999889999999999999999999999998643222110      0 0000     000111   


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ..+......+.+++.+||+.+|++|||+.+++++-+
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~  255 (256)
T cd06612         220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPF  255 (256)
T ss_pred             CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCC
Confidence            112233456889999999999999999999998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-40  Score=298.15  Aligned_cols=249  Identities=33%  Similarity=0.493  Sum_probs=204.1

Q ss_pred             CeeeccCCccEEEEEecC----CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccC
Q 040557           88 NLLGRGGFGPVYRGKLAD----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKN  163 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  163 (407)
                      +.||+|+||.||+|....    +..|++|.+...........+.+|++.+..++|+|++++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999998653    7899999997655444567889999999999999999999999999999999999999


Q ss_pred             CChhHHHhccC-------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          164 RSLDLLIYGES-------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       164 g~L~~~l~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ++|.+++....       ...+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            99999986542       356899999999999999999999988   99999999999999999999999999987765


Q ss_pred             CCc-ccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          237 DQA-YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       237 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      ... .......++..|+|||.+....++.++||||||++++||++ |..|+......       ........+..     
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~-----  225 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-------EVLEYLRKGYR-----  225 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCC-----
Confidence            432 12234557889999999988899999999999999999999 58888654211       11222221111     


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                        .   ..+...+..+.+++.+||+.+|++|||+.+++++|+
T Consensus       226 --~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         226 --L---PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             --C---CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              0   112223567899999999999999999999999873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.6e-40  Score=305.20  Aligned_cols=255  Identities=27%  Similarity=0.401  Sum_probs=202.4

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCc----EEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGT----LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      ++|+..+.||+|+||.||+|.+ .+|.    .||+|.+...........+.+|+.++..++|+||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence            5677789999999999999974 3454    48999987555556667889999999999999999999998754 5689


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ++||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++....
T Consensus        86 ~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          86 VTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            999999999999986433 45899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCccc-ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          237 DQAYL-STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       237 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      ..... .....++..|+|||.+.+..++.++|||||||++|||++ |..|+......       ........+...    
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~----  230 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-------EIPDLLEKGERL----  230 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCCcC----
Confidence            33221 112335678999999998899999999999999999998 88887543211       111122221111    


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                            ......+..+.+++.+||+.||++||++.++++.|...
T Consensus       231 ------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~  268 (279)
T cd05109         231 ------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM  268 (279)
T ss_pred             ------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence                  01122345688999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.5e-40  Score=315.54  Aligned_cols=270  Identities=21%  Similarity=0.276  Sum_probs=207.6

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCC-C-----CceeeeeeeeecCCee
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-H-----KNLVRLLGCCSDGSQR  154 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~  154 (407)
                      -+|.+.+.||+|+||.|.++.. .+++.||||+++..  ..-..+-..|+.+|..++ |     -|+|+++++|...++.
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~--k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK--KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC--hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            3788899999999999999974 56999999999633  334445568999999886 4     4899999999999999


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCC--CceEEecccCcc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEK--FQSKIGDFGLAR  232 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~--~~~kl~Dfgla~  232 (407)
                      |||+|.+.. +|.++++.++-.+++...+..++.||+.||.+||+.+   |||+||||+||||.+.  ..+||+|||.|+
T Consensus       264 ciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  264 CIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence            999999965 9999999888888999999999999999999999998   9999999999999753  479999999999


Q ss_pred             ccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCccc--------CchhHHHHH--
Q 040557          233 FFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEM--------QYLPEYAWK--  302 (407)
Q Consensus       233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~--------~~~~~~~~~--  302 (407)
                      .....-.    ..+-+..|.|||++.+.+|+.+.|+||||||+.||++|.+.|.+....+.        ...+.+..+  
T Consensus       340 ~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  340 FESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             ccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            7665443    45677899999999999999999999999999999999877654332110        000011100  


Q ss_pred             -----HHHh-Ccccc--------------------------ccCc-ccc--cCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 040557          303 -----LYER-GRILE--------------------------LVDP-RMR--KEGIVERDALQVINVAFICLQPHGNQRPP  347 (407)
Q Consensus       303 -----~~~~-~~~~~--------------------------~~d~-~~~--~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  347 (407)
                           .+.. .....                          ..-| ...  ...........+++++.+||.+||.+|+|
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t  495 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT  495 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence                 0011 00000                          0000 000  00111134567899999999999999999


Q ss_pred             HHHHHHHhhccccC
Q 040557          348 MSEIVAMLTCKVES  361 (407)
Q Consensus       348 ~~ev~~~l~~~~~~  361 (407)
                      ..+.++|-+.....
T Consensus       496 p~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  496 PAQALNHPFLTGTS  509 (586)
T ss_pred             HHHHhcCccccccc
Confidence            99999998866433

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.2e-40  Score=306.94  Aligned_cols=255  Identities=23%  Similarity=0.361  Sum_probs=206.1

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      .+|+..+.||+|+||.||+|.. .++..||+|.+..... .....+.+|+.+++.++|+|++++++.+..+...++||||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            5788888999999999999985 4689999999864433 3346788999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++++|.+++..   ..+++..+..++.|++.|+.|||+.+   ++||||||+||+++.++.++|+|||++.........
T Consensus        99 ~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  172 (296)
T cd06654          99 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (296)
T ss_pred             cCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence            999999999853   34789999999999999999999998   999999999999999999999999998865433221


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                       .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+..      ........+ .     +..   
T Consensus       173 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~~~~~~-~-----~~~---  236 (296)
T cd06654         173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNG-T-----PEL---  236 (296)
T ss_pred             -cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHHHhcCC-C-----CCC---
Confidence             223468899999999998889999999999999999999999996543211      111111100 0     001   


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ..+......+.+++.+||+.+|++||++.+++++-+...
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~  275 (296)
T cd06654         237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (296)
T ss_pred             CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence            012223456889999999999999999999999876544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-40  Score=298.09  Aligned_cols=248  Identities=29%  Similarity=0.439  Sum_probs=198.1

Q ss_pred             CeeeccCCccEEEEEec--C--CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccC
Q 040557           88 NLLGRGGFGPVYRGKLA--D--GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKN  163 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  163 (407)
                      +.||+|+||.||+|...  +  +..+|+|.+...........+.+|+.+++.++|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999743  2  36899999876555456678999999999999999999999876 4567999999999


Q ss_pred             CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccccc
Q 040557          164 RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST  243 (407)
Q Consensus       164 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  243 (407)
                      |+|.+++....  .+++..+..++.|++.|+.|||..+   ++|+||||+||+++.++.++|+|||+++...........
T Consensus        80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            99999996443  6899999999999999999999988   999999999999999999999999999876543332211


Q ss_pred             --ccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          244 --NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       244 --~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                        ...++..|+|||.+.+..++.++||||||+++|||++ |+.||......       ........+...          
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-------~~~~~~~~~~~~----------  217 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-------EVIAMLESGERL----------  217 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHHcCCcC----------
Confidence              1223567999999998899999999999999999998 89888643221       111222222111          


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ..+...+..+.+++.+||+.+|++||++.++++.|...
T Consensus       218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            01122345688999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-40  Score=321.71  Aligned_cols=264  Identities=21%  Similarity=0.265  Sum_probs=199.2

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      .+|.+.+.||+|+||.||+|... .++.||||....       ..+.+|+++|++++|+||+++++++..++..++|||+
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            36888899999999999999865 478899996421       2356899999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +. ++|..++... ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||+++........
T Consensus       242 ~~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        242 YR-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             cC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            95 6888877543 235899999999999999999999998   999999999999999999999999999876443221


Q ss_pred             -cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCc-ccCchhHHHHHHHHhCcccc-ccC---
Q 040557          241 -LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPS-EMQYLPEYAWKLYERGRILE-LVD---  314 (407)
Q Consensus       241 -~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~d---  314 (407)
                       ......||..|+|||++.+..++.++|||||||++|||++|..++...... ........+.+.+....... .+.   
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence             123457999999999999999999999999999999999988765432211 11111112222222211100 000   


Q ss_pred             -----------------cccccCCC--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          315 -----------------PRMRKEGI--VERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       315 -----------------~~~~~~~~--~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                                       +.......  .......+.+|+.+||+.||++|||+.|+++|-++
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f  458 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF  458 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence                             00000000  00122467889999999999999999999999775

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.4e-40  Score=303.23  Aligned_cols=254  Identities=27%  Similarity=0.410  Sum_probs=202.6

Q ss_pred             CCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccC-----hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKS-----QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      +|+.++.||+|+||.||+|...+|+.+|+|.+.....     ......+.+|+++++.++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4788899999999999999888899999998864321     22345688999999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++++|.+++...  ..+++..+..++.|++.|++|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          81 MEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            9999999999998543  35789999999999999999999988   999999999999999999999999999765321


Q ss_pred             C-----cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccc
Q 040557          238 Q-----AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL  312 (407)
Q Consensus       238 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      .     ........|+..|+|||.+.+..++.++||||||+++|+|++|+.||......     ..........+.    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~----  226 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-----AAMFYIGAHRGL----  226 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH-----HHHHHhhhccCC----
Confidence            1     11122356889999999999888999999999999999999999998643211     111000000000    


Q ss_pred             cCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          313 VDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       313 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                       .+..     +......+.+++.+||+.+|++||++.+++++-+
T Consensus       227 -~~~~-----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~  264 (265)
T cd06631         227 -MPRL-----PDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF  264 (265)
T ss_pred             -CCCC-----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence             0111     1223456889999999999999999999998643

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5.4e-40  Score=297.80  Aligned_cols=253  Identities=24%  Similarity=0.426  Sum_probs=208.1

Q ss_pred             CCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           83 NFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      +|+..+.||.|+||.||.++. .+++.+++|.+.... .......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            477889999999999999974 468999999986543 344556788999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++|+|.+++.......+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            99999999997654566899999999999999999999988   99999999999999999999999999987654432 


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                      ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+......      ....... .+....         
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~-~~~~~~---------  220 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIV-QGNYTP---------  220 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-cCCCCC---------
Confidence            223456899999999998888999999999999999999999998643221      1222221 111110         


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                       .....+..+.+++.+||+.+|++||++.++++++.
T Consensus       221 -~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~  255 (256)
T cd08221         221 -VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL  255 (256)
T ss_pred             -CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence             11223456889999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.4e-41  Score=300.22  Aligned_cols=262  Identities=27%  Similarity=0.359  Sum_probs=197.2

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC-----eeE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS-----QRL  155 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  155 (407)
                      -.|...+++|.|+||.||+|... +++.||||+...+....     -+|+++|+.++|||||+++-+|....     ...
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            34566789999999999999854 57999999986544322     27999999999999999998875322     345


Q ss_pred             EEEEeccCCChhHHHhc--cCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCC-CceEEecccCcc
Q 040557          156 LVYEYMKNRSLDLLIYG--ESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEK-FQSKIGDFGLAR  232 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfgla~  232 (407)
                      +|||||+. +|.+.++.  ..+..++...+.-+..||++||.|||+.+   |+||||||.|+|+|.+ |.+||||||.|+
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcce
Confidence            89999987 88877752  23455777777889999999999999988   9999999999999955 999999999999


Q ss_pred             ccCCCCcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhC----
Q 040557          233 FFPEDQAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERG----  307 (407)
Q Consensus       233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----  307 (407)
                      .+......  ....-|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+....+  .+.... +.+..-    
T Consensus       175 ~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--QL~eIi-k~lG~Pt~e~  249 (364)
T KOG0658|consen  175 VLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--QLVEII-KVLGTPTRED  249 (364)
T ss_pred             eeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--HHHHHH-HHhCCCCHHH
Confidence            88655433  34556889999999887 589999999999999999999999887644321  111111 111100    


Q ss_pred             ------ccccccCcccccCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          308 ------RILELVDPRMRKEG----IVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       308 ------~~~~~~d~~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                            ...+.-.+.+....    .....+.+.++++.++|+.+|.+|.++.|++.|--+
T Consensus       250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fF  309 (364)
T KOG0658|consen  250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFF  309 (364)
T ss_pred             HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhh
Confidence                  00011112222211    233456789999999999999999999999987543

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-40  Score=304.26  Aligned_cols=255  Identities=25%  Similarity=0.390  Sum_probs=208.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      ++|+..+.||.|++|.||+|... +++.||+|.+...........+.+|+++++.++|+|++++.+++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            35777889999999999999864 68899999986554445556788999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++++|.+++...   .+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||+++....... 
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  153 (274)
T cd06609          81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-  153 (274)
T ss_pred             eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence            9999999998543   6899999999999999999999988   99999999999999999999999999987764422 


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                      ......++..|+|||.+.+..++.++||||||+++|||+||+.||....+..      .. .....+.     .+.+...
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~-~~~~~~~-----~~~~~~~  221 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VL-FLIPKNN-----PPSLEGN  221 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HH-HHhhhcC-----CCCCccc
Confidence            2233568889999999998889999999999999999999999986433211      11 1111111     1111110


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                          ..+..+.+++.+||+.+|++|||+++++++-+...
T Consensus       222 ----~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~  256 (274)
T cd06609         222 ----KFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK  256 (274)
T ss_pred             ----ccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcC
Confidence                13456889999999999999999999999877644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=291.77  Aligned_cols=258  Identities=25%  Similarity=0.295  Sum_probs=208.5

Q ss_pred             hcCCCCCCeeeccCCccEEEEE-ecCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      .++|++.+.||+|.|+.||+.. ..+|+.+|+|.+.... ...+.+.+.+|+++-+.|+||||+++...+......|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            3567777889999999999985 4579999999886554 3346678899999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc---CCCceEEecccCccccC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD---EKFQSKIGDFGLARFFP  235 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfgla~~~~  235 (407)
                      |+|.|++|..-+-.+  ...++..+...+.||++||.|+|.++   |+|||+||.|+++.   ....+||+|||+|..+.
T Consensus        90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            999999986544222  45788888999999999999999999   99999999999995   34568999999999887


Q ss_pred             CCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          236 EDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       236 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                      ..  .....+.|||+|||||++...+|+..+|||+.||+||-|+.|.+||.....       ..+++.+..+..    | 
T Consensus       165 ~g--~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-------~rlye~I~~g~y----d-  230 (355)
T KOG0033|consen  165 DG--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYEQIKAGAY----D-  230 (355)
T ss_pred             Cc--cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-------HHHHHHHhcccc----C-
Confidence            33  334568899999999999999999999999999999999999999975322       122222222211    1 


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                       +... ......++..+|+++||..||.+|.|+.|.+.|.|-..
T Consensus       231 -~~~~-~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  231 -YPSP-EWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             -CCCc-ccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence             1111 11223456889999999999999999999999988543

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.7e-40  Score=299.75  Aligned_cols=251  Identities=28%  Similarity=0.469  Sum_probs=201.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      .+|+..+.||+|+||.||+|...++..+|+|.+....  .....+.+|++++++++|+|++++++++......++||||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC--CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            3566778999999999999988778899999885332  23456889999999999999999999999999999999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      ++++|.+++.... ..+++..+..++.|++.|+.|||+.+   ++|+||||+||+++.++.++|+|||++..........
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          82 EHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            9999999986443 34789999999999999999999988   9999999999999999999999999998664433222


Q ss_pred             ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                      .....++..|+|||.+.++.++.++||||||+++|||++ |+.|+......      .... ....+.  ....+..   
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~-~~~~~~--~~~~~~~---  225 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS------EVVE-TINAGF--RLYKPRL---  225 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH------HHHH-HHhCCC--CCCCCCC---
Confidence            223345678999999998899999999999999999998 88887643211      1111 111110  1111111   


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                           .+..+.+++.+||+.+|++|||+.+++++|
T Consensus       226 -----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         226 -----ASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             -----CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                 235688999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=9e-43  Score=300.53  Aligned_cols=250  Identities=26%  Similarity=0.362  Sum_probs=210.7

Q ss_pred             CCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEecc
Q 040557           84 FHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMK  162 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  162 (407)
                      |.+..+||+|+||.||++.++ .|..+|+|.+..+.   +.+++.+|+.+|.+++.+++|+++|.|.....+|+|||||.
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            555678999999999999754 69999999986543   45678899999999999999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccc
Q 040557          163 NRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS  242 (407)
Q Consensus       163 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  242 (407)
                      .|+..+++.. +++.+++.++..++...+.||+|||...   -+|||||..||||+.+|.+||+|||.|..+.+.... .
T Consensus       112 AGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK-R  186 (502)
T KOG0574|consen  112 AGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK-R  186 (502)
T ss_pred             CCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHh-h
Confidence            9999999864 4567999999999999999999999987   899999999999999999999999999877654432 3


Q ss_pred             cccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCC
Q 040557          243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGI  322 (407)
Q Consensus       243 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  322 (407)
                      .++.||+.|||||++..-.|+.++||||+|+...||.-|++|+..-.+...-++            +.....|.++   .
T Consensus       187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM------------IPT~PPPTF~---K  251 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM------------IPTKPPPTFK---K  251 (502)
T ss_pred             CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe------------ccCCCCCCCC---C
Confidence            457899999999999999999999999999999999999999865433211110            0001112222   3


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          323 VERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       323 ~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ++..+.++.++++.||-+.|++|-|+.++++|--
T Consensus       252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~F  285 (502)
T KOG0574|consen  252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTF  285 (502)
T ss_pred             hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhh
Confidence            5667888999999999999999999999998853

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3e-40  Score=302.01  Aligned_cols=249  Identities=24%  Similarity=0.396  Sum_probs=195.1

Q ss_pred             CeeeccCCccEEEEEecC-Cc--EEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEEEEeccC
Q 040557           88 NLLGRGGFGPVYRGKLAD-GT--LVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVYEYMKN  163 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  163 (407)
                      +.||+|+||.||+|...+ +.  .+++|.+...........+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999998753 43  46888886444455566889999999999 899999999999999999999999999


Q ss_pred             CChhHHHhccC--------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEeccc
Q 040557          164 RSLDLLIYGES--------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFG  229 (407)
Q Consensus       164 g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  229 (407)
                      |+|.+++....              ...+++..+..++.|++.|++|||+.+   ++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999986432              134789999999999999999999988   9999999999999999999999999


Q ss_pred             CccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCc
Q 040557          230 LARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGR  308 (407)
Q Consensus       230 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      ++.......  .......+..|+|||++....++.++||||||+++|||++ |..||......      . .......+.
T Consensus       158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~-~~~~~~~~~  228 (270)
T cd05047         158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------E-LYEKLPQGY  228 (270)
T ss_pred             Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------H-HHHHHhCCC
Confidence            986322111  1111234567999999988889999999999999999997 88888543211      1 111111111


Q ss_pred             cccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          309 ILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       309 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                             ...   .+...+..+.+++.+||+.+|.+|||+.+++..|..+
T Consensus       229 -------~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         229 -------RLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             -------CCC---CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence                   000   1112345688999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.3e-40  Score=300.93  Aligned_cols=256  Identities=25%  Similarity=0.362  Sum_probs=204.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEecC----CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLAD----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ++|++.+.||+|+||.||+|...+    ...||+|...........+.+.+|+.+++.++|+||+++++++.+ ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457788999999999999997543    246899988655445566789999999999999999999999876 457899


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++|+|.+++.... ..+++..+..++.|++.|+.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          85 MELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccc
Confidence            99999999999986533 35899999999999999999999988   999999999999999999999999999876554


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                      .........++..|+|||.+....++.++||||||+++|||++ |..||......      .... ....+...      
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~-~~~~~~~~------  227 (270)
T cd05056         161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN------DVIG-RIENGERL------  227 (270)
T ss_pred             cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH------HHHH-HHHcCCcC------
Confidence            3332333345568999999988889999999999999999986 99988644321      1111 11111100      


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                          ..+...+..+.+++.+|+..+|++|||+.++++.|....
T Consensus       228 ----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         228 ----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                011223457889999999999999999999999997643

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2e-40  Score=305.61  Aligned_cols=262  Identities=23%  Similarity=0.334  Sum_probs=203.3

Q ss_pred             HHHHHHHhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeee--
Q 040557           74 FQTLKKATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCS--  149 (407)
Q Consensus        74 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~--  149 (407)
                      ++.+..+.++|++.+.||+|+||.||++... +++.+|+|.+...  ......+.+|+.++..+ +|+||+++++++.  
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI--HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc--cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            3455667789999999999999999999764 5889999987432  22335678899999999 7999999999873  


Q ss_pred             ---cCCeeEEEEEeccCCChhHHHhcc--CCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceE
Q 040557          150 ---DGSQRLLVYEYMKNRSLDLLIYGE--SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSK  224 (407)
Q Consensus       150 ---~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k  224 (407)
                         .++..++||||+++++|.+++...  ....+++..+..++.|++.|+.|||+.+   ++||||||+||++++++.++
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEE
Confidence               445789999999999999887532  3356889999999999999999999988   99999999999999999999


Q ss_pred             EecccCccccCCCCcccccccccCccccCcccccc-----CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHH
Q 040557          225 IGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR-----GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEY  299 (407)
Q Consensus       225 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~  299 (407)
                      |+|||++........ ......|++.|+|||.+..     ..++.++|||||||++|||++|+.|+.......      .
T Consensus       165 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~------~  237 (286)
T cd06638         165 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR------A  237 (286)
T ss_pred             EccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH------H
Confidence            999999986643322 2233468999999998753     457889999999999999999999986432211      0


Q ss_pred             HHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          300 AWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       300 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ... ...+..     +...   .+......+.+++.+||+.||++|||+.|++++++
T Consensus       238 ~~~-~~~~~~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~  285 (286)
T cd06638         238 LFK-IPRNPP-----PTLH---QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF  285 (286)
T ss_pred             Hhh-ccccCC-----Cccc---CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence            000 001100     1110   11112346889999999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.3e-41  Score=326.13  Aligned_cols=264  Identities=22%  Similarity=0.281  Sum_probs=194.7

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC--------
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG--------  151 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------  151 (407)
                      .++|++.+.||+|+||.||+|.. .+++.||||++....     ....+|+.+|+.++|+||+++.+++...        
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            46799999999999999999986 468899999885322     1234799999999999999998876321        


Q ss_pred             CeeEEEEEeccCCChhHHHhc--cCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC-ceEEecc
Q 040557          152 SQRLLVYEYMKNRSLDLLIYG--ESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF-QSKIGDF  228 (407)
Q Consensus       152 ~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Df  228 (407)
                      ...++||||+++ +|.+++..  .....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            246799999975 66665532  23456899999999999999999999998   99999999999999654 7999999


Q ss_pred             cCccccCCCCcccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhC
Q 040557          229 GLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERG  307 (407)
Q Consensus       229 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      |+++.+.....  .....||+.|+|||.+.+. .++.++|||||||++|||++|.+||......+.  +.... ......
T Consensus       216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~-~~~~~p  290 (440)
T PTZ00036        216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRII-QVLGTP  290 (440)
T ss_pred             ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHH-HHhCCC
Confidence            99987654332  2345789999999988764 689999999999999999999999975433211  00000 000000


Q ss_pred             ----------ccccccCccccc----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          308 ----------RILELVDPRMRK----EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       308 ----------~~~~~~d~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                                ...+.--+....    ...+...+.++.+++.+||+.||++|||+.|+++|.++.
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~  355 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD  355 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHH
Confidence                      000000000000    001112345788999999999999999999999998864

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.9e-41  Score=296.95  Aligned_cols=266  Identities=25%  Similarity=0.315  Sum_probs=201.1

Q ss_pred             CCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccCh-hhHHHHHHHHHHHHcCCCCc-eeeeeeeeecCC------ee
Q 040557           84 FHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQ-QGESEFLSEVRMITSIQHKN-LVRLLGCCSDGS------QR  154 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------~~  154 (407)
                      |...++||+|+||+||+|+. .+|+.||+|++...... ..-....+|+.+|..++|+| |+++.+++...+      ..
T Consensus        13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l   92 (323)
T KOG0594|consen   13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL   92 (323)
T ss_pred             HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence            33445699999999999984 47899999999766542 22244579999999999999 999999998777      78


Q ss_pred             EEEEEeccCCChhHHHhccCC--CCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          155 LLVYEYMKNRSLDLLIYGESD--KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                      ++|+||++. +|..++.....  ..++...+..++.|++.||+|||+++   |+||||||.|||++++|.+||+|||+|+
T Consensus        93 ~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAr  168 (323)
T KOG0594|consen   93 YLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLAR  168 (323)
T ss_pred             EEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHH
Confidence            999999965 89999875543  46788889999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCcccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcc--
Q 040557          233 FFPEDQAYLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRI--  309 (407)
Q Consensus       233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  309 (407)
                      .+.-.... .+..++|..|.|||++.+. .|+...||||+||++.||++++..|.+....+  .+ ..+.+.+..-..  
T Consensus       169 a~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~--ql-~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  169 AFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID--QL-FRIFRLLGTPNEKD  244 (323)
T ss_pred             HhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH--HH-HHHHHHcCCCCccC
Confidence            76532221 2456789999999999886 79999999999999999999988886554311  11 111111111000  


Q ss_pred             ----ccccCcc--cccCC----CCHH---HHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          310 ----LELVDPR--MRKEG----IVER---DALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       310 ----~~~~d~~--~~~~~----~~~~---~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                          ....+..  .....    ....   ...+..+++.+|++.+|.+|.|++.++.|-.+
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf  305 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYF  305 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhh
Confidence                0000100  00000    0011   11368899999999999999999999998544

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=9.4e-41  Score=310.22  Aligned_cols=271  Identities=23%  Similarity=0.352  Sum_probs=202.8

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      ++|+..+.||+|+||.||+|+.. +++.||+|.+...........+.+|+.+++.++|+||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56888899999999999999864 68899999986554444445678999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +. ++|..++... ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++.........
T Consensus        86 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (301)
T cd07873          86 LD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  160 (301)
T ss_pred             cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence            97 5888887543 345889999999999999999999998   999999999999999999999999999765432221


Q ss_pred             cccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCc--------hhHHHHHHHHhCcccc
Q 040557          241 LSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQY--------LPEYAWKLYERGRILE  311 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~~~  311 (407)
                       .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+...        .....+..........
T Consensus       161 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (301)
T cd07873         161 -YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  239 (301)
T ss_pred             -ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence             1234578899999987654 57889999999999999999999986543211000        0000000000000000


Q ss_pred             ccC-cccccC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          312 LVD-PRMRKE---GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       312 ~~d-~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ..+ +.....   ......+..+.+++.+||+.||.+|||+.|+++|-|+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~  290 (301)
T cd07873         240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH  290 (301)
T ss_pred             ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence            000 000000   00011244678999999999999999999999998864

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6.7e-40  Score=297.28  Aligned_cols=248  Identities=29%  Similarity=0.409  Sum_probs=199.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeee-cCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS-DGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~  160 (407)
                      ++|++.+.||+|+||.||++... |..+|+|.+...   .....+.+|+.++++++|+|++++++++. ..+..+++|||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            46788899999999999999874 788999988532   23457889999999999999999999764 55678999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++++|.+++.......+++..+.+++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            99999999987655556899999999999999999999988   9999999999999999999999999997554322  


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                        ....++..|+|||++.+..++.++|||||||++|||++ |+.|+.....      .... .....+..     +    
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~-~~~~~~~~-----~----  218 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVV-PRVEKGYK-----M----  218 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHH-HHHhcCCC-----C----
Confidence              12345668999999988899999999999999999998 8888753221      1111 11111110     0    


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                       ......+..+.+++.+||+.+|++|||+.++++.|..
T Consensus       219 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         219 -DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence             1112235568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.1e-40  Score=304.13  Aligned_cols=261  Identities=23%  Similarity=0.355  Sum_probs=209.7

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++|+||+++++++..+...++|||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            36788899999999999999985 479999999986433 2334568899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++++|.+++..   ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++........
T Consensus        97 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          97 YLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             ccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            9999999999843   34789999999999999999999988   99999999999999999999999999986644332


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                      . .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||....+.....      .... +..     +..  
T Consensus       171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~-~~~-----~~~--  235 (297)
T cd06656         171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIAT-NGT-----PEL--  235 (297)
T ss_pred             C-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eecc-CCC-----CCC--
Confidence            2 223468889999999999889999999999999999999999996543221100      0000 000     000  


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccCCCC
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP  364 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~~~~  364 (407)
                       ..+...+..+.+++.+||+.+|++||++.+++++-+.......+
T Consensus       236 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (297)
T cd06656         236 -QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS  279 (297)
T ss_pred             -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence             01222345578999999999999999999999998766544433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-39  Score=307.00  Aligned_cols=260  Identities=28%  Similarity=0.424  Sum_probs=205.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEec--------CCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCC
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA--------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGS  152 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  152 (407)
                      .+|++++.||+|+||.||+|...        .+..||+|.+...........+.+|++++.++ +|+||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46888899999999999999642        12368999886544455567889999999999 8999999999999999


Q ss_pred             eeEEEEEeccCCChhHHHhccC--------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGES--------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD  218 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~  218 (407)
                      ..+++|||+++|+|.+++....              ...+++..+..++.|++.||.|||+.+   ++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence            9999999999999999986432              235789999999999999999999988   99999999999999


Q ss_pred             CCCceEEecccCccccCCCCccc-ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCch
Q 040557          219 EKFQSKIGDFGLARFFPEDQAYL-STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYL  296 (407)
Q Consensus       219 ~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~  296 (407)
                      +++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+.....      
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------  242 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------  242 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH------
Confidence            99999999999998665432221 122334568999999999999999999999999999998 7777753221      


Q ss_pred             hHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          297 PEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       297 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                       .........+....          .+...+..+.+++.+||+.+|++||++.++++.|......
T Consensus       243 -~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         243 -EELFKLLKEGHRMD----------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             -HHHHHHHHcCCCCC----------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence             11112222111110          1112345688999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.1e-40  Score=334.54  Aligned_cols=259  Identities=24%  Similarity=0.345  Sum_probs=202.2

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|... +|+.||+|++....  ......++.+|+++++.++||||+++++++.+++..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57888999999999999999864 58999999986432  2334567899999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccC---------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEeccc
Q 040557          159 EYMKNRSLDLLIYGES---------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFG  229 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  229 (407)
                      ||++||+|.+++....         ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999885321         234567788999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCc-----------------ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcc
Q 040557          230 LARFFPEDQA-----------------YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSE  292 (407)
Q Consensus       230 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~  292 (407)
                      ++........                 .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986621110                 01123469999999999999999999999999999999999999986532211


Q ss_pred             cCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhcc
Q 040557          293 MQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRP-PMSEIVAMLTCK  358 (407)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~ev~~~l~~~  358 (407)
                      .      ..    ....   .++.-..  .....+..+.+++.+||+.||++|| +++++++.|...
T Consensus       239 i------~~----~~~i---~~P~~~~--p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        239 I------SY----RDVI---LSPIEVA--PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             h------hh----hhhc---cChhhcc--ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1      00    0000   0110000  0112345688999999999999996 566676666544

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.3e-40  Score=302.90  Aligned_cols=258  Identities=23%  Similarity=0.358  Sum_probs=203.4

Q ss_pred             CCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEecc
Q 040557           84 FHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMK  162 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  162 (407)
                      |++.+.||+|+||.||+|... ++..+++|.+... .......+.+|+++++.++|+|++++++++..++..++|+||++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            455678999999999999865 4778899988532 34455678899999999999999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccc
Q 040557          163 NRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS  242 (407)
Q Consensus       163 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  242 (407)
                      +++|..++... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........ ..
T Consensus        86 ~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~  160 (282)
T cd06643          86 GGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RR  160 (282)
T ss_pred             CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc-cc
Confidence            99998887543 346899999999999999999999998   99999999999999999999999999976543221 12


Q ss_pred             cccccCccccCccccc-----cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          243 TNFAGTLGYTAPEYAI-----RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       243 ~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      ....++..|+|||.+.     +..++.++|||||||++|||++|+.||....+.      ........ ...     +.+
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~-~~~-----~~~  228 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVLLKIAK-SEP-----PTL  228 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHHHHHhh-cCC-----CCC
Confidence            3356899999999874     345788999999999999999999998643211      11111111 110     111


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccCC
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESG  362 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~~  362 (407)
                      .   .+...+..+.+++.+||+.+|++||++.+++++.+......
T Consensus       229 ~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  270 (282)
T cd06643         229 A---QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN  270 (282)
T ss_pred             C---CccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence            0   11123456889999999999999999999999988765443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.3e-39  Score=295.35  Aligned_cols=252  Identities=33%  Similarity=0.539  Sum_probs=203.6

Q ss_pred             CCCCCeeeccCCccEEEEEecC-----CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           84 FHPGNLLGRGGFGPVYRGKLAD-----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      +++.+.||.|+||.||++...+     +..||+|.+...........+.+|++.+..++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3566889999999999998653     38899999965554446678999999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++++|.+++.......+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            9999999999986544433899999999999999999999998   9999999999999999999999999998776543


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      ........++..|+|||.+.+..++.++||||||+++++|++ |..|+.....      .. .......+...       
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------~~-~~~~~~~~~~~-------  223 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------EE-VLEYLKKGYRL-------  223 (258)
T ss_pred             ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------HH-HHHHHhcCCCC-------
Confidence            332222347789999999988889999999999999999998 6777654211      11 11112211111       


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                         ......+..+.+++.+||+.+|++|||+.++++.|
T Consensus       224 ---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 ---PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ---CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence               01112455788999999999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.2e-40  Score=302.96  Aligned_cols=257  Identities=23%  Similarity=0.337  Sum_probs=204.9

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      +|++.+.||+|+||.||++... +|..||+|.+...........+.+|++++.+++|+||+++++++...+..++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            5778889999999999999865 689999999865444445568899999999999999999999999999999999999


Q ss_pred             cCCChhHHHhccC-CCCCCHHHHHHHHHHHHHHhcccccc-CCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          162 KNRSLDLLIYGES-DKFLNWSTRFQIILGIARGLQYLHED-SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       162 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      ++++|..++.... ...+++..+..++.|++.||.|||+. +   ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA  158 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence            9999998886432 33689999999999999999999964 5   99999999999999999999999999976543221


Q ss_pred             ccccccccCccccCccccccC------CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRG------ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV  313 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~------~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                         ....++..|+|||.+.+.      .++.++|||||||++|||++|+.||.......   ....... ...+..    
T Consensus       159 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~-~~~~~~----  227 (286)
T cd06622         159 ---KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSA-IVDGDP----  227 (286)
T ss_pred             ---ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHH-HhhcCC----
Confidence               234578899999988554      35889999999999999999999986432211   0000000 111110    


Q ss_pred             CcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       314 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                       +     ..+......+.+++.+||+.+|++||++.+++.+.|...
T Consensus       228 -~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~  267 (286)
T cd06622         228 -P-----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK  267 (286)
T ss_pred             -C-----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhh
Confidence             1     122235567889999999999999999999999887543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.3e-40  Score=312.74  Aligned_cols=264  Identities=22%  Similarity=0.274  Sum_probs=195.8

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ...+|++.+.||+|+||.||+|... ++..||+|.....       ....|+.++.+++|+||+++++++......++||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            3467999999999999999999864 5778999975322       2346899999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      |++. ++|..++... ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||+++......
T Consensus       137 e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  211 (357)
T PHA03209        137 PHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP  211 (357)
T ss_pred             EccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence            9995 5787777543 345899999999999999999999998   9999999999999999999999999997543222


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCch----hHHHHHHHHh-Cccccc-
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYL----PEYAWKLYER-GRILEL-  312 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~-~~~~~~-  312 (407)
                      .  .....||..|+|||++.+..++.++|||||||++|||+++..++....+......    .......... +..... 
T Consensus       212 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  289 (357)
T PHA03209        212 A--FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF  289 (357)
T ss_pred             c--cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence            1  2345689999999999999999999999999999999997666543322211100    0011111110 000000 


Q ss_pred             ------------cCc-ccccCCC-------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          313 ------------VDP-RMRKEGI-------VERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       313 ------------~d~-~~~~~~~-------~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                                  ++. .......       ....+.++.+++.+||+.||++|||+.|+++|-++
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f  354 (357)
T PHA03209        290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF  354 (357)
T ss_pred             CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchh
Confidence                        000 0000000       00123345679999999999999999999999765

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.4e-40  Score=309.31  Aligned_cols=263  Identities=18%  Similarity=0.224  Sum_probs=198.7

Q ss_pred             CCCeeecc--CCccEEEEEe-cCCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           86 PGNLLGRG--GFGPVYRGKL-ADGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        86 ~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      +.++||+|  +||+||++.. .+|+.||+|++..... ......+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            34689999  6789999975 5789999999865433 333456778999999999999999999999999999999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc-
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-  240 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-  240 (407)
                      ++|+|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++++||+........... 
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            9999999986555556899999999999999999999988   999999999999999999999999876433211100 


Q ss_pred             -----cccccccCccccCcccccc--CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccccc
Q 040557          241 -----LSTNFAGTLGYTAPEYAIR--GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV  313 (407)
Q Consensus       241 -----~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                           ......++..|+|||++.+  ..++.++|||||||++|||++|+.||.......      ..... ..+.....+
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~~-~~~~~~~~~  231 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ------MLLEK-LNGTVPCLL  231 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH------HHHHH-hcCCccccc
Confidence                 0112346778999999876  468999999999999999999999986432111      00000 001111000


Q ss_pred             C-------------------ccc----------------ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          314 D-------------------PRM----------------RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       314 d-------------------~~~----------------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      +                   ...                ............+.+++.+||+.||++|||+.+++++.+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~  311 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  311 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence            0                   000                00001122345788999999999999999999999988764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.2e-40  Score=314.86  Aligned_cols=269  Identities=24%  Similarity=0.252  Sum_probs=200.8

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC------
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG------  151 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  151 (407)
                      ..++|+..+.||+|+||.||++... .++.||+|.+.... .......+.+|+.+++.++|+||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999754 58899999986433 333456788999999999999999999988543      


Q ss_pred             CeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCc
Q 040557          152 SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLA  231 (407)
Q Consensus       152 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla  231 (407)
                      ...++||||+++ ++...+.    ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCccc
Confidence            356999999976 5666553    23788999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccC---------chhH----
Q 040557          232 RFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQ---------YLPE----  298 (407)
Q Consensus       232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~---------~~~~----  298 (407)
                      +......  ......||..|+|||.+.+..++.++|||||||++|||++|+.||........-         ..+.    
T Consensus       167 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (355)
T cd07874         167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_pred             ccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            8654332  123457899999999999999999999999999999999999998654311100         0000    


Q ss_pred             ---HHHHHHHhCc-cccccCccc-----c--cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          299 ---YAWKLYERGR-ILELVDPRM-----R--KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       299 ---~~~~~~~~~~-~~~~~d~~~-----~--~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                         .......... ......+..     .  ...........+.+++.+||+.||++|||+.|+++|.|..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~  315 (355)
T cd07874         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN  315 (355)
T ss_pred             hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchh
Confidence               0000000000 000000000     0  0001111245678999999999999999999999998764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1e-39  Score=296.10  Aligned_cols=253  Identities=22%  Similarity=0.358  Sum_probs=204.7

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeec-CCeeEEEEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSD-GSQRLLVYE  159 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  159 (407)
                      +|++.+.||+|++|.||++... +++.||+|.+.... .......+.+|++++++++|+|++++.+.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4778899999999999999864 57899999986443 23445678899999999999999999988764 446789999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++++|.+++.......+++..+..++.+++.|+.+||+.+   ++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            999999999987655566899999999999999999999998   99999999999999999999999999987644322


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                       ......+++.|+|||.+.+..++.++||||||+++++|++|+.|+.....      ....... ..+...         
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~-~~~~~~---------  220 (257)
T cd08223         158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRI-IEGKLP---------  220 (257)
T ss_pred             -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHH-HhcCCC---------
Confidence             22345688999999999999999999999999999999999998864321      1111111 112111         


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                       ..+...+..+.+++.+||+.+|++||++.+++++-+
T Consensus       221 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~  256 (257)
T cd08223         221 -PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPY  256 (257)
T ss_pred             -CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence             112234457889999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.6e-40  Score=307.31  Aligned_cols=263  Identities=20%  Similarity=0.278  Sum_probs=189.1

Q ss_pred             CCeeeccCCccEEEEEec---CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeec--CCeeEEEEEec
Q 040557           87 GNLLGRGGFGPVYRGKLA---DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSD--GSQRLLVYEYM  161 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~  161 (407)
                      +++||+|+||.||+|+..   +++.||+|.+....   ....+.+|++++++++||||+++++++..  ....+++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            468999999999999854   46789999885332   22356789999999999999999998854  45678999998


Q ss_pred             cCCChhHHHhcc-------CCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEE----cCCCceEEecccC
Q 040557          162 KNRSLDLLIYGE-------SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL----DEKFQSKIGDFGL  230 (407)
Q Consensus       162 ~~g~L~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfgl  230 (407)
                      .+ +|.+++...       ....+++..+..++.|++.||.|||+.+   ++||||||+|||+    +.++.+||+|||+
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            65 777776422       1235889999999999999999999998   9999999999999    4567899999999


Q ss_pred             ccccCCCCcc--cccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCch---hHHHHHHH
Q 040557          231 ARFFPEDQAY--LSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYL---PEYAWKLY  304 (407)
Q Consensus       231 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~---~~~~~~~~  304 (407)
                      ++.+......  ......||+.|+|||++.+ ..++.++||||+||++|||++|++||...........   ........
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            9876543221  1234578999999999877 4589999999999999999999999965432211100   00011100


Q ss_pred             HhC------------cccc--ccCcccccC-----C-------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          305 ERG------------RILE--LVDPRMRKE-----G-------IVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       305 ~~~------------~~~~--~~d~~~~~~-----~-------~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ...            ...+  .........     .       ........+.+++.+||+.||++|||++|+++|-+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~  316 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY  316 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence            000            0000  000000000     0       00001235789999999999999999999998854

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=8e-40  Score=300.32  Aligned_cols=251  Identities=24%  Similarity=0.376  Sum_probs=207.1

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      .|+..+.||+|+||.||+|... ++..||+|.+...........+.+|+.+++.++|+||+++++++.+....++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4566678999999999999864 588999999875555556678899999999999999999999999999999999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      ++|+|.+++..   ..+++.....++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++........ .
T Consensus        85 ~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06640          85 GGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K  157 (277)
T ss_pred             CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-c
Confidence            99999998853   34888999999999999999999988   99999999999999999999999999986654332 1


Q ss_pred             ccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCC
Q 040557          242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEG  321 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  321 (407)
                      .....++..|+|||.+.+..++.++|+||||+++|||++|+.|+....+...      . .....+          ....
T Consensus       158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~-~~~~~~----------~~~~  220 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV------L-FLIPKN----------NPPT  220 (277)
T ss_pred             cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH------h-hhhhcC----------CCCC
Confidence            2234678899999999888899999999999999999999999865432211      0 001100          0112


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          322 IVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       322 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      .....+..+.+++.+||+.+|++||++.+++.+.+.
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  256 (277)
T cd06640         221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI  256 (277)
T ss_pred             CchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHh
Confidence            334456778999999999999999999999998764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9.3e-40  Score=296.24  Aligned_cols=253  Identities=21%  Similarity=0.357  Sum_probs=206.1

Q ss_pred             CCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           83 NFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      +|+..+.||+|+||.||++.. .+|+.||+|.+.... ......++.+|++++++++|+||+++.+++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            477789999999999999975 468999999986432 233456789999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +.+++|.+++.......+++..+.+++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++.........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence            99999999887555556899999999999999999999988   999999999999999999999999999866543221


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                       .....|++.|+|||.+.+..++.++|+||||+++++|++|+.|+.....      ......... +...          
T Consensus       158 -~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~-~~~~----------  219 (256)
T cd08218         158 -ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKIIR-GSYP----------  219 (256)
T ss_pred             -hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHhc-CCCC----------
Confidence             2234588899999999988899999999999999999999999864321      112222111 1110          


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ..+......+.+++.+||+.+|++||++.+|+++-+
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~  255 (256)
T cd08218         220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF  255 (256)
T ss_pred             CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcC
Confidence            011223456889999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=9.3e-40  Score=299.49  Aligned_cols=256  Identities=28%  Similarity=0.407  Sum_probs=203.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRL  155 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  155 (407)
                      ++|+..+.||+|+||.||+|+..      +.+.|++|.+...........+.+|++++++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56788899999999999999853      346799998854444334567999999999999999999999999989999


Q ss_pred             EEEEeccCCChhHHHhccCC-------CCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecc
Q 040557          156 LVYEYMKNRSLDLLIYGESD-------KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDF  228 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~~-------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  228 (407)
                      +||||+++|+|.+++.....       ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            99999999999999865441       25899999999999999999999998   999999999999999999999999


Q ss_pred             cCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhC
Q 040557          229 GLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERG  307 (407)
Q Consensus       229 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      |++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||......      . .......+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~------~-~~~~~~~~  234 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE------E-VLNRLQAG  234 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH------H-HHHHHHcC
Confidence            9987554333322333456778999999988889999999999999999999 66777432211      1 11112211


Q ss_pred             ccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          308 RILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       308 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      .....         .....+..+.+++.+||+.+|++||++.+++++|+
T Consensus       235 ~~~~~---------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         235 KLELP---------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CcCCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            11100         11123456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-40  Score=312.90  Aligned_cols=265  Identities=25%  Similarity=0.336  Sum_probs=200.2

Q ss_pred             HHHhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC----
Q 040557           78 KKATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG----  151 (407)
Q Consensus        78 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----  151 (407)
                      ....++|++.+.||+|+||.||+|.. .+++.||||.+.... .......+.+|+++++.++|+||+++++++...    
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            34567899999999999999999985 468899999986432 223345678999999999999999999887533    


Q ss_pred             --CeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEeccc
Q 040557          152 --SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFG  229 (407)
Q Consensus       152 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  229 (407)
                        ...++++|++ +++|..++..   ..+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence              3568999988 7789887742   35899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh-C
Q 040557          230 LARFFPEDQAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER-G  307 (407)
Q Consensus       230 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~  307 (407)
                      ++.......    ....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......      ........ +
T Consensus       164 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~  233 (343)
T cd07878         164 LARQADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID------QLKRIMEVVG  233 (343)
T ss_pred             cceecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHHHhC
Confidence            998664432    34578999999999877 578999999999999999999999986432210      00000000 0


Q ss_pred             c-------------cccccC--cccccC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          308 R-------------ILELVD--PRMRKE---GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       308 ~-------------~~~~~d--~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .             ....+.  +.....   .........+.+++.+||+.||++|||+.|+++|-+...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~  303 (343)
T cd07878         234 TPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ  303 (343)
T ss_pred             CCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence            0             000000  000000   000011234789999999999999999999999987654

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.1e-40  Score=325.74  Aligned_cols=271  Identities=20%  Similarity=0.235  Sum_probs=194.7

Q ss_pred             HHHHhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCC------CCceeeeeeeee
Q 040557           77 LKKATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ------HKNLVRLLGCCS  149 (407)
Q Consensus        77 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~  149 (407)
                      +....++|++.+.||+|+||+||+|... +++.||||++...  ......+..|+.++..++      |.+++++++++.
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV--PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc--hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            3445678999999999999999999864 5889999998532  122234456666666654      456888998886


Q ss_pred             cC-CeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhcccccc-CCCceeeeccccccEEEcCCC------
Q 040557          150 DG-SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED-SHTRIVHRDIKASNVLLDEKF------  221 (407)
Q Consensus       150 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~~~~------  221 (407)
                      .. ...++|||++ +++|.+++...  ..+++..+..++.||+.||.|||++ +   |+||||||+|||++.++      
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence            54 5788999988 67888877533  4589999999999999999999974 7   99999999999998765      


Q ss_pred             ----------ceEEecccCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCc
Q 040557          222 ----------QSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPS  291 (407)
Q Consensus       222 ----------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~  291 (407)
                                .+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~  351 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL  351 (467)
T ss_pred             cccccCCCCceEEECCCCccccCccc----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence                      4999999988643222    23467999999999999999999999999999999999999999754321


Q ss_pred             ccCch--------h-HHHH--------HHHHh-CccccccCccc----ccCC--CCHHHHHHHHHHHHHccCCCCCCCCC
Q 040557          292 EMQYL--------P-EYAW--------KLYER-GRILELVDPRM----RKEG--IVERDALQVINVAFICLQPHGNQRPP  347 (407)
Q Consensus       292 ~~~~~--------~-~~~~--------~~~~~-~~~~~~~d~~~----~~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs  347 (407)
                      +....        + .|..        ..+.. +.+....++..    ....  ........+++|+.+||+.||++|||
T Consensus       352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  431 (467)
T PTZ00284        352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN  431 (467)
T ss_pred             HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence            11000        0 0000        00000 00000000000    0000  00011346789999999999999999


Q ss_pred             HHHHHHHhhccc
Q 040557          348 MSEIVAMLTCKV  359 (407)
Q Consensus       348 ~~ev~~~l~~~~  359 (407)
                      ++|+++|-|...
T Consensus       432 a~e~L~Hp~~~~  443 (467)
T PTZ00284        432 ARQMTTHPYVLK  443 (467)
T ss_pred             HHHHhcCccccc
Confidence            999999988754

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.5e-40  Score=301.39  Aligned_cols=252  Identities=24%  Similarity=0.362  Sum_probs=190.4

Q ss_pred             eeeccCCccEEEEEecC---CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCC
Q 040557           89 LLGRGGFGPVYRGKLAD---GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRS  165 (407)
Q Consensus        89 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  165 (407)
                      .||+|+||.||+|...+   ...+|+|.+...........+.+|++.++.++|+||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997533   356888887644444556678899999999999999999999999999999999999999


Q ss_pred             hhHHHhccC---CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc-
Q 040557          166 LDLLIYGES---DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL-  241 (407)
Q Consensus       166 L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~-  241 (407)
                      |.+++....   ....++.....++.|++.|++|||+.+   ++||||||+|||+++++.+||+|||++.......... 
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999986543   233567888999999999999999998   9999999999999999999999999987543322211 


Q ss_pred             ccccccCccccCcccccc-------CCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCcccccc
Q 040557          242 STNFAGTLGYTAPEYAIR-------GELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELV  313 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~-------~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |..|+......      .........+ .....
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~-~~~~~  231 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE------QVLKQVVREQ-DIKLP  231 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhhcc-CccCC
Confidence            122345678999998643       356889999999999999999 66676533211      1111212211 11111


Q ss_pred             CcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       314 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ++..     .......+.+++..|| .||++|||+++|++.|.
T Consensus       232 ~~~~-----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         232 KPQL-----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCcc-----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            2211     1223445667888898 49999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=7.8e-40  Score=302.71  Aligned_cols=255  Identities=24%  Similarity=0.372  Sum_probs=202.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      ++|++.+.||+|+||.||+|... ++..+++|.+... .......+.+|+.+++.++|+|++++++++..++..++||||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            56888899999999999999864 5889999998543 344566788999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++++|..++.... ..+++..+..++.|++.|+.|||+.+   ++||||+|+||+++.++.++|+|||++........ 
T Consensus        91 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-  165 (292)
T cd06644          91 CPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ-  165 (292)
T ss_pred             CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence            99999988775433 45899999999999999999999988   99999999999999999999999999875433221 


Q ss_pred             cccccccCccccCccccc-----cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          241 LSTNFAGTLGYTAPEYAI-----RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                      ......++..|+|||.+.     ...++.++|||||||++|||++|+.|+....+.      ...... ....     .+
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~-~~~~-----~~  233 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKI-AKSE-----PP  233 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHH-hcCC-----Cc
Confidence            122346788999999885     345788999999999999999999998643221      111111 1110     01


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      ...   .+......+.+++.+||+.+|++||++.+++++-+.
T Consensus       234 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  272 (292)
T cd06644         234 TLS---QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFV  272 (292)
T ss_pred             cCC---CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence            111   112234568899999999999999999999998764

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.3e-40  Score=302.88  Aligned_cols=262  Identities=26%  Similarity=0.389  Sum_probs=205.6

Q ss_pred             CHHHHHHHhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeec
Q 040557           73 DFQTLKKATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSD  150 (407)
Q Consensus        73 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  150 (407)
                      +..++....+.|++.+.||+|+||.||+|.. .+++.+|+|.+...  ......+..|+.++.++ +|+||+++++++..
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC--hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            4455556678899999999999999999986 46889999988533  23445678899999998 79999999999843


Q ss_pred             ------CCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceE
Q 040557          151 ------GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSK  224 (407)
Q Consensus       151 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k  224 (407)
                            ....+++|||+++|+|.+++.......+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence                  457899999999999999987655566889999999999999999999998   99999999999999999999


Q ss_pred             EecccCccccCCCCcccccccccCccccCccccc-----cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHH
Q 040557          225 IGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI-----RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEY  299 (407)
Q Consensus       225 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~  299 (407)
                      |+|||++........ ......|+..|+|||.+.     ...++.++|||||||++|||++|+.||....+...      
T Consensus       162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~------  234 (282)
T cd06636         162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA------  234 (282)
T ss_pred             EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh------
Confidence            999999876543221 122356889999999876     34678899999999999999999999864322111      


Q ss_pred             HHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          300 AWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       300 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      .... .     ....+...    ....+..+.+++.+||+.||.+||++.|++++-|
T Consensus       235 ~~~~-~-----~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~  281 (282)
T cd06636         235 LFLI-P-----RNPPPKLK----SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF  281 (282)
T ss_pred             hhhH-h-----hCCCCCCc----ccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence            0000 0     00011111    1123457899999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.5e-40  Score=300.66  Aligned_cols=263  Identities=25%  Similarity=0.439  Sum_probs=205.1

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-----CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeec--CCee
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-----DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSD--GSQR  154 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  154 (407)
                      ..|+..+.||+|+||.||+|...     +++.+|+|.+...........|.+|+++++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35666789999999999999853     3688999998654443356789999999999999999999999877  5578


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcccc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF  234 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~  234 (407)
                      +++|||+++++|.+++.... ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++...
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            99999999999999996543 35899999999999999999999988   999999999999999999999999999877


Q ss_pred             CCCCccc--ccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccC--------chhHHHHHHH
Q 040557          235 PEDQAYL--STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQ--------YLPEYAWKLY  304 (407)
Q Consensus       235 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~--------~~~~~~~~~~  304 (407)
                      .......  .....++..|+|||.+.+..++.++||||||++++||++|+.|+.........        ..........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL  239 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence            6332211  11234556799999998889999999999999999999999887543322111        0001111111


Q ss_pred             HhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          305 ERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       305 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ..+.         .. ..+..++..+.+++.+||+.+|++|||+.||+++|..+
T Consensus       240 ~~~~---------~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         240 KEGE---------RL-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HcCC---------cC-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1110         00 01122346788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.5e-39  Score=297.06  Aligned_cols=252  Identities=22%  Similarity=0.343  Sum_probs=190.3

Q ss_pred             eeeccCCccEEEEEecCC---cEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCC
Q 040557           89 LLGRGGFGPVYRGKLADG---TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRS  165 (407)
Q Consensus        89 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  165 (407)
                      .||+|+||.||+|...++   ..+++|.+...........+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999975433   35667776544444556789999999999999999999999999999999999999999


Q ss_pred             hhHHHhccC--CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc-ccc
Q 040557          166 LDLLIYGES--DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA-YLS  242 (407)
Q Consensus       166 L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-~~~  242 (407)
                      |.+++....  ....++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++........ ...
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999986532  234677778899999999999999988   99999999999999999999999999864322211 122


Q ss_pred             cccccCccccCcccccc-------CCCCccccEEehhHHHHHHHhc-CCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          243 TNFAGTLGYTAPEYAIR-------GELSEKADIYSFGVLVLEIISC-RKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       243 ~~~~gt~~y~aPE~~~~-------~~~~~k~Dv~s~G~vl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      ....++..|+|||++..       ..++.++||||||+++|||+++ ..|+.....      .+....... +......+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~-~~~~~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIK-DQQVKLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHh-hcccccCC
Confidence            34567889999998753       2457899999999999999975 556543211      112222222 22223333


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      +.+...     ....+.+++..|| .+|++||++.+|++.|.
T Consensus       232 ~~~~~~-----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQLELP-----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CccCCC-----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            333221     2345778899999 57999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-40  Score=317.60  Aligned_cols=267  Identities=19%  Similarity=0.196  Sum_probs=201.8

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec---CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA---DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ..+|.+.+.||+|+||.||++...   .+..||+|.+...      ..+.+|+++++.++|+||+++++++......++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            357999999999999999999643   3678999987532      1345899999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      ||++. ++|.+++.  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++......
T Consensus       165 ~e~~~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        165 MPKYK-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             ehhcC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            99996 57888773  3456899999999999999999999998   999999999999999999999999999866543


Q ss_pred             Ccc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccc------
Q 040557          238 QAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRIL------  310 (407)
Q Consensus       238 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------  310 (407)
                      ... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.+........      
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            322 2234579999999999999999999999999999999999999986543321110000001100000000      


Q ss_pred             -------cccCcccccCCC------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          311 -------ELVDPRMRKEGI------VERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       311 -------~~~d~~~~~~~~------~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                             .......+....      ......++.+++.+||+.||++|||+.|++.|-++..
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~  380 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK  380 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence                   000000000000      0112346788999999999999999999999987743

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.2e-40  Score=299.08  Aligned_cols=240  Identities=26%  Similarity=0.391  Sum_probs=187.1

Q ss_pred             CeeeccCCccEEEEEecC-------------CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCee
Q 040557           88 NLLGRGGFGPVYRGKLAD-------------GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQR  154 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  154 (407)
                      +.||+|+||.||+|...+             ...|++|.+... .......+.+|+.++..++||||+++++++......
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh-hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            368999999999997532             235888887533 233445788999999999999999999999999899


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCc-------eEEec
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ-------SKIGD  227 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~-------~kl~D  227 (407)
                      ++||||+++|+|..++.... ..+++..+.+++.|++.||+|||+.+   ++||||||+|||++.++.       ++++|
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999998875433 45899999999999999999999998   999999999999987654       89999


Q ss_pred             ccCccccCCCCcccccccccCccccCccccc-cCCCCccccEEehhHHHHHHH-hcCCCCCCCCCcccCchhHHHHHHHH
Q 040557          228 FGLARFFPEDQAYLSTNFAGTLGYTAPEYAI-RGELSEKADIYSFGVLVLEII-SCRKNTDLTLPSEMQYLPEYAWKLYE  305 (407)
Q Consensus       228 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~s~G~vl~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~  305 (407)
                      ||++.......     ...++..|+|||.+. +..++.++|||||||++|||+ +|..|+......+       ......
T Consensus       156 ~g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~  223 (262)
T cd05077         156 PGIPITVLSRQ-----ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------KERFYE  223 (262)
T ss_pred             CCCCccccCcc-----cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-------HHHHHh
Confidence            99987553322     345788999999886 467899999999999999998 4777665322111       011111


Q ss_pred             hCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          306 RGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       306 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                       +..      ..     .......+.+++.+||+.||++||++.+|+++++
T Consensus       224 -~~~------~~-----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         224 -GQC------ML-----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             -cCc------cC-----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence             110      00     0112346889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.1e-40  Score=304.16  Aligned_cols=251  Identities=26%  Similarity=0.406  Sum_probs=203.7

Q ss_pred             CCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEecc
Q 040557           84 FHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMK  162 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  162 (407)
                      |+..+.||+|+||.||+|... ++..||+|.+...........+.+|+++++.++|+||+++++++..++..++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            344567999999999999754 5789999998655445556688999999999999999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccc
Q 040557          163 NRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS  242 (407)
Q Consensus       163 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  242 (407)
                      +++|.+++..   ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++........ ..
T Consensus        86 ~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~  158 (277)
T cd06642          86 GGSALDLLKP---GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR  158 (277)
T ss_pred             CCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-hh
Confidence            9999998843   35899999999999999999999988   99999999999999999999999999986654322 12


Q ss_pred             cccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCC
Q 040557          243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGI  322 (407)
Q Consensus       243 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  322 (407)
                      ....++..|+|||.+.+..++.++||||||+++|||++|+.|+....+...      .. ....+.     .+.     .
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~-~~~~~~-----~~~-----~  221 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LF-LIPKNS-----PPT-----L  221 (277)
T ss_pred             hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------Hh-hhhcCC-----CCC-----C
Confidence            234678899999999998999999999999999999999999864322210      00 111110     111     1


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          323 VERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       323 ~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ....+..+.+++.+||+.+|++||++.+++++.+..
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  257 (277)
T cd06642         222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFIT  257 (277)
T ss_pred             CcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHH
Confidence            223455688999999999999999999999987743

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.1e-40  Score=305.86  Aligned_cols=257  Identities=23%  Similarity=0.355  Sum_probs=208.0

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      .+|+..+.||.|++|.||+|.. .+|+.||+|.+.... ......+.+|+.+++.++|+|++++++++......++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            4688888999999999999975 568999999986433 33456788999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++++|..++..   ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++.........
T Consensus        98 ~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  171 (296)
T cd06655          98 LAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK  171 (296)
T ss_pred             cCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence            999999998843   34899999999999999999999998   999999999999999999999999998866543322


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                       .....++..|+|||.+.+..++.++|||||||++|+|++|+.||....+..      .... ........     ..  
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~~~~-~~~~~~~~-----~~--  236 (296)
T cd06655         172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYL-IATNGTPE-----LQ--  236 (296)
T ss_pred             -CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HHhcCCcc-----cC--
Confidence             223468889999999998889999999999999999999999986543211      1111 11111100     00  


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                       .+...+..+.+++.+||+.||++||++.+++.+-+.....
T Consensus       237 -~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         237 -NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             -CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence             1122345688999999999999999999999998875443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-40  Score=295.84  Aligned_cols=248  Identities=28%  Similarity=0.407  Sum_probs=199.5

Q ss_pred             CeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCChh
Q 040557           88 NLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLD  167 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  167 (407)
                      ++||+|+||.||++...+++.||+|.+...........+.+|++++++++|+||+++++++.+....++||||+.+++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            36999999999999976799999999865544445678999999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccc-cccc
Q 040557          168 LLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS-TNFA  246 (407)
Q Consensus       168 ~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~-~~~~  246 (407)
                      +++.... ..+++..+..++.+++.|+.|||+++   ++||||+|+||+++.++.++|+|||++........... ....
T Consensus        81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            9986433 35789999999999999999999998   99999999999999999999999999986543222111 1223


Q ss_pred             cCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHH
Q 040557          247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVER  325 (407)
Q Consensus       247 gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  325 (407)
                      ++..|+|||.+.++.++.++||||||+++|||+| |..|+.......       .......+.       ..   ..+..
T Consensus       157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-------~~~~~~~~~-------~~---~~~~~  219 (251)
T cd05041         157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERIESGY-------RM---PAPQL  219 (251)
T ss_pred             ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-------HHHHHhcCC-------CC---CCCcc
Confidence            4567999999988899999999999999999999 777775432211       111111110       00   11222


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          326 DALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       326 ~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      .+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus       220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            3457899999999999999999999999884

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.2e-39  Score=296.52  Aligned_cols=250  Identities=30%  Similarity=0.439  Sum_probs=192.5

Q ss_pred             CeeeccCCccEEEEEec----CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeee-cCCeeEEEEEecc
Q 040557           88 NLLGRGGFGPVYRGKLA----DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS-DGSQRLLVYEYMK  162 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  162 (407)
                      +.||+|+||.||+|.+.    ++..||+|.+...........+.+|+.+++.++|+||+++++++. .++..+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            36899999999999753    245799998854444455678889999999999999999999775 4556789999999


Q ss_pred             CCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc--
Q 040557          163 NRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY--  240 (407)
Q Consensus       163 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--  240 (407)
                      +|+|.+++.... ..+++..+..++.|++.|+.|||+.+   ++||||||+|||+++++.+||+|||+++........  
T Consensus        81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            999999986433 34678888999999999999999988   999999999999999999999999999865432211  


Q ss_pred             -cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCC-CCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          241 -LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKN-TDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       241 -~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                       ......++..|+|||.+.+..++.++||||||+++|||++|+.| +.....      ..... ....+..       ..
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~-~~~~~~~-------~~  222 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FDITV-YLLQGRR-------LL  222 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHH-HHhcCCC-------CC
Confidence             11233457789999999888999999999999999999996554 432111      11111 1111110       00


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                         .+...+..+.+++.+||+.+|++||++.++++.|+..
T Consensus       223 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         223 ---QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             ---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence               1111235688999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-40  Score=296.96  Aligned_cols=257  Identities=23%  Similarity=0.246  Sum_probs=210.4

Q ss_pred             cCCCCCCeeeccCCccEEEEEecC-CcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      +.|+..+.||+|.-|+||++++.+ +..+|+|++.+..  ......+...|-+||+.++||.++.+++.++.....|++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            345566789999999999999764 6899999996543  2334456778999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC--
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE--  236 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~--  236 (407)
                      |||+||+|..+++.+.++.+++..+..++.+++.||+|||-.|   ||.|||||+||||-++|.+-|+||.|+.....  
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            9999999999999888999999999999999999999999999   99999999999999999999999999853310  


Q ss_pred             -------------------------------C-C---------------------cccccccccCccccCccccccCCCC
Q 040557          237 -------------------------------D-Q---------------------AYLSTNFAGTLGYTAPEYAIRGELS  263 (407)
Q Consensus       237 -------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~  263 (407)
                                                     . .                     ...+..++||-.|+|||++.+...+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                           0 0                     0112245799999999999999999


Q ss_pred             ccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCC
Q 040557          264 EKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGN  343 (407)
Q Consensus       264 ~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~  343 (407)
                      .++|+|+|||++|||+.|..||.+....+      ...+.         +...+.-...+ ..+..+.+||++.|.+||+
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~------Tl~NI---------v~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~  377 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKE------TLRNI---------VGQPLKFPEEP-EVSSAAKDLIRKLLVKDPS  377 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCchh------hHHHH---------hcCCCcCCCCC-cchhHHHHHHHHHhccChh
Confidence            99999999999999999999998754432      11111         11122111111 3456788999999999999


Q ss_pred             CCCC----HHHHHHHhhc
Q 040557          344 QRPP----MSEIVAMLTC  357 (407)
Q Consensus       344 ~RPs----~~ev~~~l~~  357 (407)
                      +|..    +.||-+|--+
T Consensus       378 kRlg~~rGA~eIK~HpFF  395 (459)
T KOG0610|consen  378 KRLGSKRGAAEIKRHPFF  395 (459)
T ss_pred             hhhccccchHHhhcCccc
Confidence            9998    9999888543

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.8e-40  Score=301.91  Aligned_cols=239  Identities=26%  Similarity=0.384  Sum_probs=186.6

Q ss_pred             eeeccCCccEEEEEecC-------------------------CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceee
Q 040557           89 LLGRGGFGPVYRGKLAD-------------------------GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR  143 (407)
Q Consensus        89 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~  143 (407)
                      .||+|+||.||+|.+..                         ...||+|.+... .......+.+|+.+++.++|+||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS-HRDIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH-HHHHHHHHHHHHHHHhcCCCCCeee
Confidence            59999999999997421                         235889988533 2333457889999999999999999


Q ss_pred             eeeeeecCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC--
Q 040557          144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF--  221 (407)
Q Consensus       144 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~--  221 (407)
                      +++++.+....++||||+++|+|..++... ...+++..+..++.|++.||+|||+.+   ++||||||+|||++..+  
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            999999999999999999999999888543 345899999999999999999999988   99999999999997643  


Q ss_pred             -----ceEEecccCccccCCCCcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHH-hcCCCCCCCCCcccC
Q 040557          222 -----QSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEII-SCRKNTDLTLPSEMQ  294 (407)
Q Consensus       222 -----~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~-tg~~p~~~~~~~~~~  294 (407)
                           .++++|||++.......     ...++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+....+.+. 
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-  230 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-  230 (274)
T ss_pred             cCccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence                 37999999986443221     2357788999998865 56899999999999999995 68888765433211 


Q ss_pred             chhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          295 YLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                            .......       ...     +......+.+++.+||+.+|++|||+.+|++.|.
T Consensus       231 ------~~~~~~~-------~~~-----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 ------ERFYEKK-------HRL-----PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ------HHHHHhc-------cCC-----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence                  1111110       001     1112245889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7.7e-40  Score=298.28  Aligned_cols=258  Identities=25%  Similarity=0.361  Sum_probs=207.9

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      +|+..+.||.|++|.||++... +++.+|+|.+...........+.+|++++++++|+||+++++++...+..++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5667788999999999999875 689999999876555566678899999999999999999999999999999999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccc-cCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE-DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      ++++|.+++.... ..+++.....++.|++.|+.|||+ .+   ++|+||+|+||++++++.++|+|||.+........ 
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  156 (265)
T cd06605          82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-  156 (265)
T ss_pred             CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence            9999999986543 568999999999999999999999 77   99999999999999999999999999876543221 


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                        ....++..|+|||.+.+..++.++||||||+++|+|++|+.|+........ ........... ..     .+.+.  
T Consensus       157 --~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~-~~-----~~~~~--  225 (265)
T cd06605         157 --KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVN-EP-----PPRLP--  225 (265)
T ss_pred             --hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhc-CC-----CCCCC--
Confidence              125688899999999998999999999999999999999999865422111 11111111111 10     01111  


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                        .......+.+++..||..+|++|||+.+++.+-+..
T Consensus       226 --~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~  261 (265)
T cd06605         226 --SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK  261 (265)
T ss_pred             --hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhh
Confidence              111455688999999999999999999999987753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=7.4e-40  Score=312.29  Aligned_cols=269  Identities=24%  Similarity=0.249  Sum_probs=200.4

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC------
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG------  151 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  151 (407)
                      ..++|++.+.||+|+||.||++... .++.||||++.... .......+.+|+.+++.++|+||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999854 58899999986432 233456788999999999999999999987543      


Q ss_pred             CeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCc
Q 040557          152 SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLA  231 (407)
Q Consensus       152 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla  231 (407)
                      ...++||||+++ +|...+.    ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            357999999975 6666653    23788999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccC---------chhHH---
Q 040557          232 RFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQ---------YLPEY---  299 (407)
Q Consensus       232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~---------~~~~~---  299 (407)
                      +......  ......+|..|+|||.+.+..++.++|||||||++|||++|+.||......+..         ..+.+   
T Consensus       174 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (364)
T cd07875         174 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  251 (364)
T ss_pred             cccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            8654332  123457899999999999999999999999999999999999999654321100         00000   


Q ss_pred             ----HHHHHHhCc-ccc----ccCccccc---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          300 ----AWKLYERGR-ILE----LVDPRMRK---EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       300 ----~~~~~~~~~-~~~----~~d~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                          ......... ...    .+.+....   ..........+.+++.+||+.||++|||+.++++|-|..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~  322 (364)
T cd07875         252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN  322 (364)
T ss_pred             hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence                000000000 000    00000000   000111234678999999999999999999999998753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=9.5e-40  Score=298.31  Aligned_cols=257  Identities=26%  Similarity=0.367  Sum_probs=200.2

Q ss_pred             HHhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           79 KATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      .+++++.....||+|+||.||+|... ++..||+|.+... .......+.+|+.+++.++|+||+++++++..++..+++
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER-DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC-CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            34556666678999999999999854 5788999988543 334556789999999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCC--CHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC-CCceEEecccCcccc
Q 040557          158 YEYMKNRSLDLLIYGESDKFL--NWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE-KFQSKIGDFGLARFF  234 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfgla~~~  234 (407)
                      +||+++++|.+++.... ..+  ++..+..++.|++.|+.|||+.+   ++||||||+||+++. ++.++|+|||++...
T Consensus        84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          84 MEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            99999999999986432 224  78888899999999999999988   999999999999986 679999999999765


Q ss_pred             CCCCcccccccccCccccCccccccCC--CCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccc
Q 040557          235 PEDQAYLSTNFAGTLGYTAPEYAIRGE--LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL  312 (407)
Q Consensus       235 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ..... ......++..|+|||.+.+..  ++.++||||||+++|+|++|+.|+........     ..+.... ...   
T Consensus       160 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-----~~~~~~~-~~~---  229 (268)
T cd06624         160 AGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-----AMFKVGM-FKI---  229 (268)
T ss_pred             ccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-----hHhhhhh-hcc---
Confidence            43222 122345789999999987643  78999999999999999999999864221110     0000000 000   


Q ss_pred             cCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          313 VDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       313 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                       .+     ..+......+.+++.+||+.+|++|||+.+++++-|
T Consensus       230 -~~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  267 (268)
T cd06624         230 -HP-----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF  267 (268)
T ss_pred             -CC-----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCC
Confidence             01     112233456889999999999999999999998854

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=314.30  Aligned_cols=244  Identities=28%  Similarity=0.413  Sum_probs=201.7

Q ss_pred             CCCeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEecc
Q 040557           86 PGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMK  162 (407)
Q Consensus        86 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  162 (407)
                      -.+.||.|+||.||-|+. .+...||||++....  +.....+++.|++.|.+++|||++.+.|||......|||||||-
T Consensus        30 dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl  109 (948)
T KOG0577|consen   30 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL  109 (948)
T ss_pred             HHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh
Confidence            345699999999999984 578899999986543  33445689999999999999999999999999999999999996


Q ss_pred             CCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccc
Q 040557          163 NRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS  242 (407)
Q Consensus       163 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  242 (407)
                      | +-.+++...+ +++-+..+..|+.+.+.||.|||+.+   .||||||..||||++.|.|||+|||.|....+.+    
T Consensus       110 G-SAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn----  180 (948)
T KOG0577|consen  110 G-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN----  180 (948)
T ss_pred             c-cHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCchh----
Confidence            4 7788876443 56889999999999999999999998   9999999999999999999999999998776654    


Q ss_pred             cccccCccccCccccc---cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          243 TNFAGTLGYTAPEYAI---RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       243 ~~~~gt~~y~aPE~~~---~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                       .++|||.|||||++.   .+.|+-|+||||+||+-.||.-.++|.........      .+ .+..+.     .|.+. 
T Consensus       181 -sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA------LY-HIAQNe-----sPtLq-  246 (948)
T KOG0577|consen  181 -SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LY-HIAQNE-----SPTLQ-  246 (948)
T ss_pred             -cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH------HH-HHHhcC-----CCCCC-
Confidence             478999999999875   57999999999999999999999998764332110      11 111111     12232 


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                         ..+.+..+++++..||++-|.+|||..+++.|-
T Consensus       247 ---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~  279 (948)
T KOG0577|consen  247 ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR  279 (948)
T ss_pred             ---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence               345677899999999999999999999998774

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-40  Score=307.30  Aligned_cols=257  Identities=23%  Similarity=0.254  Sum_probs=206.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccCh--hhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQ--QGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|+..+.||+|++|.||+|... +++.||+|.+......  .....+.+|++++..++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36788899999999999999865 4899999998654432  24567889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+.+++|.+++.......+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            9999999999987655567999999999999999999999988   9999999999999999999999999987553221


Q ss_pred             cc----------------------------cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCC
Q 040557          239 AY----------------------------LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLP  290 (407)
Q Consensus       239 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~  290 (407)
                      ..                            ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            10                            11134678899999999998999999999999999999999999864332


Q ss_pred             cccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCC----HHHHHHHhhc
Q 040557          291 SEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPP----MSEIVAMLTC  357 (407)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs----~~ev~~~l~~  357 (407)
                      ..      .......         ...... .....+..+.+++.+||+.||++|||    +.+++.+-|.
T Consensus       238 ~~------~~~~~~~---------~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~  292 (316)
T cd05574         238 DE------TFSNILK---------KEVTFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF  292 (316)
T ss_pred             HH------HHHHHhc---------CCccCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchh
Confidence            11      1111111         111000 01114567899999999999999999    8888887554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=8.6e-40  Score=301.25  Aligned_cols=263  Identities=22%  Similarity=0.343  Sum_probs=198.9

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      +|++.+.||+|++|.||+|... ++..||+|.+..... ......+.+|+.+++.++|+||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4677889999999999999864 689999999864432 22345678999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccC-CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          161 MKNRSLDLLIYGES-DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       161 ~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      ++ ++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 58888875433 356899999999999999999999988   99999999999999999999999999986543321


Q ss_pred             ccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh-Cc---------
Q 040557          240 YLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER-GR---------  308 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~---------  308 (407)
                       ......+++.|+|||.+.+. .++.++||||||+++|||+||+.||.......      ........ +.         
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~  229 (285)
T cd07861         157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID------QLFRIFRILGTPTEDVWPGV  229 (285)
T ss_pred             -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHHHhCCCChhhhhcc
Confidence             11234578899999987654 57899999999999999999999987543211      00000000 00         


Q ss_pred             -----cccccCccccc--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          309 -----ILELVDPRMRK--EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       309 -----~~~~~d~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                           ....++.....  .......+.++.+++.+||+.||++|||+.+++.+-|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~  284 (285)
T cd07861         230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY  284 (285)
T ss_pred             hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCC
Confidence                 00000000000  0000113456789999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=9.4e-40  Score=298.43  Aligned_cols=249  Identities=31%  Similarity=0.490  Sum_probs=197.7

Q ss_pred             CeeeccCCccEEEEEecC-------CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           88 NLLGRGGFGPVYRGKLAD-------GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      +.||+|+||.||+|+..+       +..+|+|.+...........+.+|+.+++.++|+||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998642       2579999886544445567889999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccC-----CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC-----ceEEecccC
Q 040557          161 MKNRSLDLLIYGES-----DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF-----QSKIGDFGL  230 (407)
Q Consensus       161 ~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-----~~kl~Dfgl  230 (407)
                      +++++|.+++....     ...+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999986432     234789999999999999999999988   99999999999999887     899999999


Q ss_pred             ccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCc
Q 040557          231 ARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGR  308 (407)
Q Consensus       231 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      +......... ......++..|+|||.+.++.++.++||||||+++|||++ |+.||......      .. ......+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~------~~-~~~~~~~~  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ------EV-LQHVTAGG  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH------HH-HHHHhcCC
Confidence            9765433221 1122345778999999999999999999999999999998 88887533211      11 11111111


Q ss_pred             cccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          309 ILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       309 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                             ..   ......+..+.+++.+||+.+|++||++.++++.|.
T Consensus       231 -------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         231 -------RL---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             -------cc---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                   00   112234567889999999999999999999999885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.4e-40  Score=302.70  Aligned_cols=269  Identities=22%  Similarity=0.341  Sum_probs=202.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      ++|+..+.||+|+||.||+|... +|+.||+|++..... ....+.+.+|+.+++.++|+|++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46788899999999999999875 589999999864432 2234567899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++++|..+...  ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++........
T Consensus        81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          81 YCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             ccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            9999988887643  335899999999999999999999988   99999999999999999999999999987654332


Q ss_pred             ccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhH-----HH---HHHHHhCccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPE-----YA---WKLYERGRIL  310 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~-----~~---~~~~~~~~~~  310 (407)
                       ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+......     ..   ...+..+...
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07847         156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF  234 (286)
T ss_pred             -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence             1223457889999998876 567899999999999999999999986543321100000     00   0000000000


Q ss_pred             -cccCcccccCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          311 -ELVDPRMRKEG----IVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       311 -~~~d~~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                       ....+......    .....+..+.+++.+||+.+|++||++.|++.|.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~  285 (286)
T cd07847         235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY  285 (286)
T ss_pred             ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCC
Confidence             00000000000    00122456889999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-40  Score=303.13  Aligned_cols=267  Identities=22%  Similarity=0.319  Sum_probs=198.8

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      ++|+..+.||+|++|.||+|... +++.||+|.+...........+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888899999999999999865 68999999986544333334567899999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +.+ +|.+++.... ..+++.....++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||+++........
T Consensus        85 ~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  159 (291)
T cd07844          85 LDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT  159 (291)
T ss_pred             CCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence            985 8988876443 36899999999999999999999998   999999999999999999999999998754322211


Q ss_pred             cccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCc---------cc
Q 040557          241 LSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGR---------IL  310 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~  310 (407)
                       .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........  ....+.......         ..
T Consensus       160 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         160 -YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ--LHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             -ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHhcCCCChhhhhhhhhcc
Confidence             122346889999998875 46889999999999999999999998643311000  000000000000         00


Q ss_pred             cccC--------cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          311 ELVD--------PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       311 ~~~d--------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      +...        ..+............+.+++.+||+.+|++|||+.+++++.|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~  290 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY  290 (291)
T ss_pred             ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCC
Confidence            0000        000000000001256789999999999999999999998765

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.8e-40  Score=303.42  Aligned_cols=264  Identities=25%  Similarity=0.337  Sum_probs=206.3

Q ss_pred             cCHHHHHHHhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeee
Q 040557           72 FDFQTLKKATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCS  149 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  149 (407)
                      ++..++..+.++|++.+.||+|+||.||++.. .+++.+|+|.+...  ......+.+|+.++.++ +|+|++++++++.
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   89 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI--SDVDEEIEAEYNILQSLPNHPNVVKFYGMFY   89 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc--ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence            55567777889999999999999999999986 46889999988532  22345677899999998 8999999999986


Q ss_pred             cC-----CeeEEEEEeccCCChhHHHhcc--CCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCc
Q 040557          150 DG-----SQRLLVYEYMKNRSLDLLIYGE--SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ  222 (407)
Q Consensus       150 ~~-----~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~  222 (407)
                      ..     +..++||||+++|+|.+++...  ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.
T Consensus        90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~  166 (291)
T cd06639          90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG  166 (291)
T ss_pred             eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence            43     3589999999999999987532  3456899999999999999999999988   999999999999999999


Q ss_pred             eEEecccCccccCCCCcccccccccCccccCccccccC-----CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchh
Q 040557          223 SKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-----ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLP  297 (407)
Q Consensus       223 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~  297 (407)
                      ++|+|||++......... .....|+..|+|||.+...     .++.++|||||||++|||++|+.|+....+.      
T Consensus       167 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------  239 (291)
T cd06639         167 VKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------  239 (291)
T ss_pred             EEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH------
Confidence            999999999865433221 2234688899999987643     3688999999999999999999998643221      


Q ss_pred             HHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          298 EYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       298 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ..... ...+...     .+.   ........+.+++.+||+.+|++||++.++++|-+
T Consensus       240 ~~~~~-~~~~~~~-----~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~  289 (291)
T cd06639         240 KTLFK-IPRNPPP-----TLL---HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF  289 (291)
T ss_pred             HHHHH-HhcCCCC-----CCC---cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcc
Confidence            11111 1111111     111   11223456889999999999999999999998855

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.9e-40  Score=300.63  Aligned_cols=254  Identities=22%  Similarity=0.347  Sum_probs=199.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++|+||+++++.+...+..++||||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            4566677899999999999985 468899999986443 23345678999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++++|.+++..  ...+++..+..++.|++.|+.|||+.+   ++|+||||+||+++.++.++|+|||++........ 
T Consensus        88 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06645          88 CGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-  161 (267)
T ss_pred             cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence            999999998853  345899999999999999999999998   99999999999999999999999999976543221 


Q ss_pred             cccccccCccccCccccc---cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          241 LSTNFAGTLGYTAPEYAI---RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      ......|+..|+|||.+.   ...++.++|||||||++|||++|+.|+....+..      ....... ....   .+..
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~------~~~~~~~-~~~~---~~~~  231 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR------ALFLMTK-SNFQ---PPKL  231 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh------hHHhhhc-cCCC---CCcc
Confidence            123456899999999874   4568899999999999999999999885433211      0111111 1100   0111


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                      ..   ....+..+.+++.+||+.+|++|||++++++|-
T Consensus       232 ~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~  266 (267)
T cd06645         232 KD---KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHP  266 (267)
T ss_pred             cc---cCCCCHHHHHHHHHHccCCchhCcCHHHHhcCC
Confidence            10   011234578999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-39  Score=297.72  Aligned_cols=252  Identities=28%  Similarity=0.444  Sum_probs=201.7

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccCh--------hhHHHHHHHHHHHHcCCCCceeeeeeeeecCCe
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQ--------QGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQ  153 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  153 (407)
                      +|.++..||+|++|.||+|... +++.+|+|.+......        ...+.+.+|+.++++++|+||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4778899999999999999754 5889999988543221        123568899999999999999999999999999


Q ss_pred             eEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          154 RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      .+++|||+++++|..++...  ..+++..+..++.|++.|+.|||+.+   ++||||+|+||++++++.++|+|||+++.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            99999999999999998543  45889999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCcc-----cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCc
Q 040557          234 FPEDQAY-----LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGR  308 (407)
Q Consensus       234 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      .......     ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......      ........   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~---  226 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAIFKIGE---  226 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHHHHHhc---
Confidence            6532211     112345788999999999989999999999999999999999998643211      11111100   


Q ss_pred             cccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          309 ILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       309 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                         ...+.     .+...+..+.+++.+||+.||++||++.+++++-+
T Consensus       227 ---~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  266 (267)
T cd06628         227 ---NASPE-----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPF  266 (267)
T ss_pred             ---cCCCc-----CCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCC
Confidence               01111     12234566889999999999999999999998643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.6e-40  Score=304.85  Aligned_cols=269  Identities=25%  Similarity=0.392  Sum_probs=201.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccCh-hhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQ-QGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      ++|+..+.||+|+||.||+|... +++.||+|.+...... ...+.+.+|+++++.++|+||+++++++.++...++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36778899999999999999875 5899999988644322 234568899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++++|..+...  ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07846          81 FVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  155 (286)
T ss_pred             cCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence            9999999887643  234899999999999999999999988   99999999999999999999999999987644332


Q ss_pred             ccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccC--------chhHHHHHHHHhCccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQ--------YLPEYAWKLYERGRIL  310 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~  310 (407)
                       ......++..|+|||.+.+ ..++.++||||||+++|||++|++|+......+..        .+..............
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07846         156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF  234 (286)
T ss_pred             -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence             2233567889999998875 45788999999999999999999888643221100        0000000000000000


Q ss_pred             -cccCcccccC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          311 -ELVDPRMRKE----GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       311 -~~~d~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                       ....+.....    ......+..+.+++.+||+.+|++||++.+++++-+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~  285 (286)
T cd07846         235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF  285 (286)
T ss_pred             hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCC
Confidence             0000000000    001123467899999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.9e-39  Score=297.27  Aligned_cols=265  Identities=25%  Similarity=0.291  Sum_probs=206.4

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC--CeeEEEEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG--SQRLLVYE  159 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  159 (407)
                      +|+..+.||.|++|.||++... +++.+|+|.+...........+.+|+++++.++|+||+++++++.+.  +..++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            5677789999999999999874 58899999987554445567899999999999999999999988543  46899999


Q ss_pred             eccCCChhHHHhc--cCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          160 YMKNRSLDLLIYG--ESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       160 ~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |+++++|.+++..  .....+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999887653  23455889999999999999999999988   999999999999999999999999998755432


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      ..   ....++..|+|||.+.+..++.++||||||+++|+|++|+.|+......... ..... .......... +....
T Consensus       159 ~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~-~~~~~~~~~~-~~~~~  232 (287)
T cd06621         159 LA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG-PIELL-SYIVNMPNPE-LKDEP  232 (287)
T ss_pred             cc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC-hHHHH-HHHhcCCchh-hccCC
Confidence            21   2345788999999999999999999999999999999999998755321111 11111 1111111111 11111


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .   .....+..+.+++.+||+.+|++|||+.|++++-|...
T Consensus       233 ~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~  271 (287)
T cd06621         233 G---NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA  271 (287)
T ss_pred             C---CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence            0   01123567899999999999999999999999988643

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-40  Score=305.32  Aligned_cols=264  Identities=22%  Similarity=0.346  Sum_probs=204.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      ++|++.+.||+|+||.||+|... +++.||+|.+.... .......+.+|+++++.++|+||+++++++..++..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36788899999999999999865 58899999886433 23345678899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |++++.+..+..  ....+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          81 YVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             cCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            999877766653  2345899999999999999999999998   99999999999999999999999999987765543


Q ss_pred             ccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHH-------------
Q 040557          240 YLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYE-------------  305 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------------  305 (407)
                      .......++..|+|||++.+. .++.++||||||+++|+|++|+.|+......+      ..+....             
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~  229 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID------QLYLIQKCLGPLPPSHQELF  229 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHHhCCCCHHHhhhc
Confidence            233345688899999999888 88999999999999999999999886432211      1110000             


Q ss_pred             --hC-----ccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          306 --RG-----RILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       306 --~~-----~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                        ..     ...+..++.......+...+..+.+++.+||+.+|++|||+++++++-+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  287 (288)
T cd07833         230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY  287 (288)
T ss_pred             ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCC
Confidence              00     0000000000000111223567899999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4e-40  Score=303.35  Aligned_cols=266  Identities=22%  Similarity=0.300  Sum_probs=198.4

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      +|+..+.||+|+||.||+|+.. +|+.||+|.+..... ......+.+|++++++++|+||+++++++.+....++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4777889999999999999864 689999999864332 22335677899999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +.+ +|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.........
T Consensus        81 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  155 (284)
T cd07839          81 CDQ-DLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC  155 (284)
T ss_pred             CCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence            974 777776533 345899999999999999999999998   999999999999999999999999999865433221


Q ss_pred             cccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhC------cccccc
Q 040557          241 LSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERG------RILELV  313 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~  313 (407)
                       .....++..|+|||.+.+. .++.++|||||||++|||+||+.|+.........  ...........      ......
T Consensus       156 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         156 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             -cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH--HHHHHHHhCCCChHHhHHhhhcc
Confidence             1234578899999988764 4789999999999999999999886533221100  00000000000      000000


Q ss_pred             Cc----cccc----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          314 DP----RMRK----EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       314 d~----~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      +.    ....    ..........+.+++.+||+.||++|||+.++++|.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~  283 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY  283 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence            00    0000    0011123456889999999999999999999998865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=296.01  Aligned_cols=254  Identities=24%  Similarity=0.367  Sum_probs=204.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      ++|+..+.||.|+||.||+|... +++.+++|.+..... .....+.+|++++++++|+||+++++++.+....+++|||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            57888899999999999999864 578899999864432 3556788999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++++|.+++... ...+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        82 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  156 (262)
T cd06613          82 CGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-  156 (262)
T ss_pred             CCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence            9999999988643 245899999999999999999999988   99999999999999999999999999986644321 


Q ss_pred             cccccccCccccCccccccC---CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          241 LSTNFAGTLGYTAPEYAIRG---ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~---~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      ......++..|+|||.+.+.   .++.++||||||+++|||++|+.|+....+...      ... ......   ..+.+
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~------~~~-~~~~~~---~~~~~  226 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA------LFL-ISKSNF---PPPKL  226 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHhccC---CCccc
Confidence            12335688899999998776   889999999999999999999999864332110      111 111100   00111


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAM  354 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  354 (407)
                      .   .....+..+.+++.+||+.+|.+|||+.+|+.+
T Consensus       227 ~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         227 K---DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             c---chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            1   123345678999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-39  Score=297.54  Aligned_cols=255  Identities=29%  Similarity=0.424  Sum_probs=203.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCc----EEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGT----LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      .+|++.+.||+|+||.||+|... +|+    .+|+|.+...........+.+|+.++.+++|+||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            56777899999999999999854 333    5899988665555566788999999999999999999999987 78899


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ||||+++|+|.+++.... ..+++..+..++.|++.|++|||+.+   ++||||+|+||++++++.++|+|||+++....
T Consensus        86 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            999999999999986543 34899999999999999999999988   99999999999999999999999999987654


Q ss_pred             CCcccc-cccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          237 DQAYLS-TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       237 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      ...... ....++..|+|||.+....++.++||||||+++||+++ |+.|+......+       .......+...    
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~----  230 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-------IPDLLEKGERL----  230 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhCCCCC----
Confidence            332211 12224568999999988899999999999999999998 999986543211       11222221110    


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                            ..+..+...+.+++.+||..+|++||++.++++.|...
T Consensus       231 ------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         231 ------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                  01111334688999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=9.8e-40  Score=295.83  Aligned_cols=247  Identities=30%  Similarity=0.463  Sum_probs=199.4

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      ++|++.+.||+|+||.||+|.. +++.||+|.+....   ....+.+|+.++..++|+|++++++++... ..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            4578889999999999999976 68889999885332   335788999999999999999999998654 479999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      .+++|.+++.......+++..+..++.|++.|+.|||+.+   ++||||||+||+++.++.++|+|||++.......   
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            9999999997665556899999999999999999999988   9999999999999999999999999997543221   


Q ss_pred             ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                       .....+..|+|||.+.+..++.++|+||||+++|||++ |+.||......      . .......+...   +      
T Consensus       155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~-~~~~~~~~~~~---~------  217 (254)
T cd05083         155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------E-VKECVEKGYRM---E------  217 (254)
T ss_pred             -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------H-HHHHHhCCCCC---C------
Confidence             12234568999999988899999999999999999998 88887643221      1 11122221110   0      


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                       .....+..+.+++.+||+.+|++||++.++++.|..
T Consensus       218 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         218 -PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence             112234568899999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-40  Score=299.57  Aligned_cols=257  Identities=27%  Similarity=0.399  Sum_probs=202.7

Q ss_pred             HHhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCC----
Q 040557           79 KATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGS----  152 (407)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~----  152 (407)
                      ..+++|++.+.||+|++|.||+|... +++.+++|.+....  .....+.+|+++++++ +|+||+++++++....    
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            35688999999999999999999874 57899999885432  3446788999999999 7999999999996544    


Q ss_pred             --eeEEEEEeccCCChhHHHhccC--CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecc
Q 040557          153 --QRLLVYEYMKNRSLDLLIYGES--DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDF  228 (407)
Q Consensus       153 --~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  228 (407)
                        ..++||||+++++|.+++....  ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCC
Confidence              4899999999999999886433  456899999999999999999999998   999999999999999999999999


Q ss_pred             cCccccCCCCcccccccccCccccCcccccc-----CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHH
Q 040557          229 GLARFFPEDQAYLSTNFAGTLGYTAPEYAIR-----GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKL  303 (407)
Q Consensus       229 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~  303 (407)
                      |++........ ......|+..|+|||.+..     ..++.++||||||+++++|++|+.||......      ......
T Consensus       158 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~  230 (275)
T cd06608         158 GVSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM------RALFKI  230 (275)
T ss_pred             ccceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH------HHHHHh
Confidence            99976543322 1233568899999998753     34678999999999999999999998643211      111111


Q ss_pred             HHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          304 YERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       304 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                       ..+.     .+.+.   ........+.+++.+||..||++|||+.+++++-|
T Consensus       231 -~~~~-----~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~  274 (275)
T cd06608         231 -PRNP-----PPTLK---SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF  274 (275)
T ss_pred             -hccC-----CCCCC---chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence             1111     11111   12224567889999999999999999999998754

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.4e-39  Score=304.46  Aligned_cols=263  Identities=21%  Similarity=0.276  Sum_probs=188.5

Q ss_pred             CCeeeccCCccEEEEEec---CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeee--cCCeeEEEEEec
Q 040557           87 GNLLGRGGFGPVYRGKLA---DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS--DGSQRLLVYEYM  161 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~  161 (407)
                      +..||+|+||.||+|+..   ++..||+|.+....   ....+.+|+++++.++|+||+++++++.  .....++||||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            368999999999999864   45789999885332   2235778999999999999999999884  355779999998


Q ss_pred             cCCChhHHHhcc-------CCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEE----cCCCceEEecccC
Q 040557          162 KNRSLDLLIYGE-------SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL----DEKFQSKIGDFGL  230 (407)
Q Consensus       162 ~~g~L~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfgl  230 (407)
                      .+ +|.+++...       ....+++..+..++.|++.||.|||+.+   ++||||||+|||+    ++++.+||+|||+
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            75 676665321       1235889999999999999999999998   9999999999999    5667999999999


Q ss_pred             ccccCCCCcc--cccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCch---hHHHHHHH
Q 040557          231 ARFFPEDQAY--LSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYL---PEYAWKLY  304 (407)
Q Consensus       231 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~---~~~~~~~~  304 (407)
                      ++........  ......||+.|+|||.+.+ ..++.++|||||||++|||+||++||...........   ........
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF  238 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence            9876543221  1234568999999998876 4579999999999999999999999865432211100   00000000


Q ss_pred             H--------------hC-ccccccC----ccccc-------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          305 E--------------RG-RILELVD----PRMRK-------EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       305 ~--------------~~-~~~~~~d----~~~~~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      .              .. .......    .....       ..........+.+++.+||+.||.+|||+.|+++|.|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~  316 (317)
T cd07867         239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY  316 (317)
T ss_pred             HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCC
Confidence            0              00 0000000    00000       0000011245778999999999999999999998865

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-40  Score=301.32  Aligned_cols=257  Identities=22%  Similarity=0.348  Sum_probs=205.0

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|++.+.||.|+||.||+|... ++..+|+|.+... .......+.+|++++++++|+||+++++.+..+...++|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            356888889999999999999864 6899999998543 34455678899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++++|..++... ...+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        83 ~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          83 FCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             ccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            99999999988543 345899999999999999999999998   99999999999999999999999999876543322


Q ss_pred             ccccccccCccccCccccc-----cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          240 YLSTNFAGTLGYTAPEYAI-----RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                       ......+++.|+|||.+.     ...++.++||||||+++|||++|+.|+......      ..... ...+..     
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~~~-----  225 (280)
T cd06611         159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLK-ILKSEP-----  225 (280)
T ss_pred             -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHH-HhcCCC-----
Confidence             123356899999999875     345678999999999999999999998643221      11111 111110     


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      +.+.   .+...+..+.+++..||+.+|++||++.+++++-|..
T Consensus       226 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~  266 (280)
T cd06611         226 PTLD---QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVS  266 (280)
T ss_pred             CCcC---CcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhc
Confidence            1111   1122345688999999999999999999999997754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.9e-40  Score=302.41  Aligned_cols=267  Identities=25%  Similarity=0.361  Sum_probs=204.0

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      +|++.+.||.|+||.||+|... +|+.||+|++..... ......+.+|+.++++++|+|++++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778889999999999999864 689999999865442 33456788999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      + +++|.+++.... ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.........
T Consensus        81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence            9 999999886443 56899999999999999999999998   999999999999999999999999999877554322


Q ss_pred             cccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCc------ccccc
Q 040557          241 LSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGR------ILELV  313 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~  313 (407)
                      ......++..|+|||.+.+. .++.++||||+|++++||++|++++.......  .+ ...........      ..++.
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE--QL-AIVFRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH--HH-HHHHHHcCCCChHHHhhccCcc
Confidence            22345688999999988654 46899999999999999999977775432211  00 00000000000      00000


Q ss_pred             C------ccccc---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          314 D------PRMRK---EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       314 d------~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      +      +....   ..........+.+++.+||+.+|++|||++++++|.+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~  285 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF  285 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence            0      00000   00111234678999999999999999999999998653

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.3e-39  Score=295.96  Aligned_cols=253  Identities=26%  Similarity=0.433  Sum_probs=200.8

Q ss_pred             CCCCCCeeeccCCccEEEEEecC--CcEEEEEEecccc---------ChhhHHHHHHHHHHHHc-CCCCceeeeeeeeec
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLAD--GTLVAVKKLCVDK---------SQQGESEFLSEVRMITS-IQHKNLVRLLGCCSD  150 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~---------~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~  150 (407)
                      +|++.+.||+|+||.||+|....  ++.+|+|.+....         ......++.+|+.++.+ ++|+||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47778899999999999998754  7889999875321         22334567788888875 699999999999999


Q ss_pred             CCeeEEEEEeccCCChhHHHhc--cCCCCCCHHHHHHHHHHHHHHhccccc-cCCCceeeeccccccEEEcCCCceEEec
Q 040557          151 GSQRLLVYEYMKNRSLDLLIYG--ESDKFLNWSTRFQIILGIARGLQYLHE-DSHTRIVHRDIKASNVLLDEKFQSKIGD  227 (407)
Q Consensus       151 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~D  227 (407)
                      .+..+++|||+++++|.+++..  .....+++..++.++.|++.||.|||+ .+   ++|+||+|+||++++++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999988743  234568999999999999999999996 55   99999999999999999999999


Q ss_pred             ccCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhC
Q 040557          228 FGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERG  307 (407)
Q Consensus       228 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      ||++.......  ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+......      ...... ..+
T Consensus       158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~~~~-~~~  228 (269)
T cd08528         158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLATKI-VEA  228 (269)
T ss_pred             ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHHHHH-hhc
Confidence            99998765443  223456889999999999888999999999999999999999998643211      111111 111


Q ss_pred             ccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          308 RILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       308 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ...    + ..    ....+..+.+++.+||+.||++||++.|+.+++.
T Consensus       229 ~~~----~-~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         229 VYE----P-LP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             cCC----c-CC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            111    0 00    1122456889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.5e-39  Score=295.07  Aligned_cols=250  Identities=28%  Similarity=0.417  Sum_probs=203.0

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc----ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK----SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      +|+..+.||+|++|.||+|... +++.|++|.+....    .......+.+|+.+++.++|+||+++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999875 78999999985433    133456789999999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      +||+++++|.+++...  ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            9999999999998543  45889999999999999999999998   999999999999999999999999999866443


Q ss_pred             CcccccccccCccccCccccccCC-CCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                      .  ......++..|++||.+.... ++.++|+||||+++|+|++|+.||......      .............      
T Consensus       156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~------  221 (258)
T cd06632         156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRSKELP------  221 (258)
T ss_pred             c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhcccCC------
Confidence            3  123456889999999987776 899999999999999999999998643311      1111111101110      


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                          ..+......+.+++.+||+.+|++||++.+++.+-
T Consensus       222 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~  256 (258)
T cd06632         222 ----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHP  256 (258)
T ss_pred             ----CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCC
Confidence                11122345688999999999999999999999874

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-41  Score=318.10  Aligned_cols=252  Identities=29%  Similarity=0.388  Sum_probs=207.0

Q ss_pred             CCCCCCeeeccCCccEEEEEec--CCc--EEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA--DGT--LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      .....++||+|.||.|++|.+.  +|+  .||||.+..........+|++|+.+|.+|+|+|+++++|...+ ....+||
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            3445678999999999999764  344  6899999766655567899999999999999999999999987 6788999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      |+++.|+|.+.++......+-......++.|||.||.||.+++   +|||||..+|+||-..-.+||+||||.+.+....
T Consensus       190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            9999999999998766677889999999999999999999998   9999999999999999999999999999886433


Q ss_pred             c-c-cccccccCccccCccccccCCCCccccEEehhHHHHHHHhc-CCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          239 A-Y-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISC-RKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       239 ~-~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                      . + ......-...|+|||.+....++.+||||+|||++|||+|+ ..||-+-.+.                .+.+.+|.
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----------------qIL~~iD~  330 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----------------QILKNIDA  330 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------------HHHHhccc
Confidence            2 2 22344566789999999999999999999999999999985 4566543221                22333342


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                      .-+- ..+..++.++++++..||..+|.+|||+..|.+.+
T Consensus       331 ~erL-pRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  331 GERL-PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             cccC-CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            1111 23455788999999999999999999999997543

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.4e-39  Score=292.38  Aligned_cols=251  Identities=24%  Similarity=0.427  Sum_probs=204.2

Q ss_pred             CCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           83 NFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      +|+..+.||+|+||.||++.. .++..+|+|.+.... .......+.+|+++++.++|+|++++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            477788999999999999975 468899999986543 334456789999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCC-CceEEecccCccccCCCCc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEK-FQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfgla~~~~~~~~  239 (407)
                      +++++|.+++.......+++..+..++.+++.|+.|||+.+   ++|+||+|+||+++++ +.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            99999999997655666899999999999999999999988   9999999999999855 4689999999987654332


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                        .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+......      ........ +....        
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~-~~~~~--------  220 (256)
T cd08220         158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIMS-GTFAP--------  220 (256)
T ss_pred             --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHHh-cCCCC--------
Confidence              22356889999999999888999999999999999999999998643221      11111111 11110        


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                        .+...+..+.+++.+||+.+|++|||+.|++++-
T Consensus       221 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p  254 (256)
T cd08220         221 --ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP  254 (256)
T ss_pred             --CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCC
Confidence              1112345688999999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-39  Score=296.52  Aligned_cols=253  Identities=26%  Similarity=0.422  Sum_probs=204.2

Q ss_pred             CCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCC---CCceeeeeeeeecCCeeEEEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ---HKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  158 (407)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+...........+.+|+.+++.++   |+|++++++++.+....++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            466778899999999999985 5789999999865544555667889999999986   999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++++|.+++...   .+++.....++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            999999999988532   5899999999999999999999998   9999999999999999999999999998775443


Q ss_pred             cccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      .. .....|+..|+|||.+.++ .++.++||||||+++|+|++|+.||........      .. ....     ...+.+
T Consensus       156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~-~~~~-----~~~~~~  222 (277)
T cd06917         156 SK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MM-LIPK-----SKPPRL  222 (277)
T ss_pred             cc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hh-cccc-----CCCCCC
Confidence            22 2345688999999988754 568999999999999999999999864322110      00 0000     011111


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ...    ..+..+.+++.+||+.||++||++.+++.+-+..
T Consensus       223 ~~~----~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~  259 (277)
T cd06917         223 EDN----GYSKLLREFVAACLDEEPKERLSAEELLKSKWIK  259 (277)
T ss_pred             Ccc----cCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhh
Confidence            111    1345688999999999999999999999987764

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.4e-39  Score=299.14  Aligned_cols=249  Identities=26%  Similarity=0.304  Sum_probs=205.2

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||++... +++.||+|.+....  .......+.+|++++++++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46788899999999999999864 68999999986432  2234567889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++...... 
T Consensus        81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            999999999998543  56899999999999999999999988   999999999999999999999999999876544 


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                         .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||.....       .........+..      .  
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~------~--  216 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-------IQIYEKILEGKV------R--  216 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCc------c--
Confidence               2345688999999999888899999999999999999999999864331       111111111111      1  


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRP-----PMSEIVAMLTC  357 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~l~~  357 (407)
                         .+......+.+++.+||+.||.+||     +++|++++.+.
T Consensus       217 ---~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~  257 (290)
T cd05580         217 ---FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF  257 (290)
T ss_pred             ---CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccc
Confidence               1112245688999999999999999     88999988664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.3e-39  Score=295.35  Aligned_cols=257  Identities=24%  Similarity=0.355  Sum_probs=200.7

Q ss_pred             CCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccC---------hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC
Q 040557           83 NFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKS---------QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS  152 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  152 (407)
                      +|...+.||+|+||.||+|.. .+|+.+|+|.+.....         ....+.+.+|+.+++.++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            467788999999999999975 4689999998853211         112346788999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                      ..++||||+++++|.+++...  ..+++..+..++.|++.|+.|||+.+   ++||||+|+||++++++.++|+|||++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccc
Confidence            999999999999999998544  46899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCcc-cccccccCccccCccccccCC--CCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcc
Q 040557          233 FFPEDQAY-LSTNFAGTLGYTAPEYAIRGE--LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRI  309 (407)
Q Consensus       233 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ........ ......++..|+|||.+....  ++.++|+||||+++||+++|..|+......      ........ ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~-~~~  229 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLGN-KRS  229 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhhc-ccc
Confidence            65432211 123356888999999887654  789999999999999999999998532111      11111111 111


Q ss_pred             ccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          310 LELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       310 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ...++...     ....+..+.+++.+||+.+|++|||+.+|++|.+
T Consensus       230 ~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  271 (272)
T cd06629         230 APPIPPDV-----SMNLSPVALDFLNACFTINPDNRPTARELLQHPF  271 (272)
T ss_pred             CCcCCccc-----cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCC
Confidence            11111111     1123467889999999999999999999998854

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-41  Score=314.03  Aligned_cols=254  Identities=22%  Similarity=0.360  Sum_probs=203.0

Q ss_pred             CCCCCeeeccCCccEEEEEecCCcE-EEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEecc
Q 040557           84 FHPGNLLGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMK  162 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~~~~~-vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  162 (407)
                      |.+...||-|+||.||+|..++... .|.|.+. ..+....++++-|+++|+.++||+||++++.|.-.+.+|++.|||.
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe-tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE-TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhc-ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            3444569999999999998765444 4556653 4456677889999999999999999999999988999999999999


Q ss_pred             CCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccc
Q 040557          163 NRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS  242 (407)
Q Consensus       163 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  242 (407)
                      ||-.+.++... +..|++..+.-+++|++.||.|||+++   |||||||..|||++-+|.++|+|||.+...... ....
T Consensus       113 GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qkR  187 (1187)
T KOG0579|consen  113 GGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQKR  187 (1187)
T ss_pred             CchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH-Hhhh
Confidence            99998887543 456999999999999999999999998   999999999999999999999999999654322 2233


Q ss_pred             cccccCccccCcccccc-----CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          243 TNFAGTLGYTAPEYAIR-----GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       243 ~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      ..+.|||.|||||+++.     .+|+.++||||||++|.||..+.+|...-.+.      ..+.+. ....     .|.+
T Consensus       188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM------RVllKi-aKSe-----PPTL  255 (1187)
T KOG0579|consen  188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKI-AKSE-----PPTL  255 (1187)
T ss_pred             ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH------HHHHHH-hhcC-----CCcc
Confidence            46899999999998764     57999999999999999999999886543321      111111 1111     1222


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .   .+......+.+++..||..||+.||++.++++|.+.-
T Consensus       256 l---qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~  293 (1187)
T KOG0579|consen  256 L---QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ  293 (1187)
T ss_pred             c---CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence            2   2345667789999999999999999999999998743

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2e-40  Score=282.45  Aligned_cols=261  Identities=23%  Similarity=0.301  Sum_probs=209.6

Q ss_pred             HHHHhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccCh-------hhHHHHHHHHHHHHcC-CCCceeeeeee
Q 040557           77 LKKATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQ-------QGESEFLSEVRMITSI-QHKNLVRLLGC  147 (407)
Q Consensus        77 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l-~h~niv~l~~~  147 (407)
                      -+...++|...+.||.|..+.|-+... .+|+.+|+|++......       .-.+.-.+|+.+|+++ .||+|+.+.++
T Consensus        12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~   91 (411)
T KOG0599|consen   12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV   91 (411)
T ss_pred             HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence            345567788889999999999988864 46889999998643211       1234456899999998 69999999999


Q ss_pred             eecCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEec
Q 040557          148 CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGD  227 (407)
Q Consensus       148 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~D  227 (407)
                      |+.+...++|+|.|+.|.|.+++..  .-.+++....+|+.|+.+|++|||..+   |+||||||+|||+|++.+++|+|
T Consensus        92 yes~sF~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   92 YESDAFVFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             ccCcchhhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence            9999999999999999999999953  345899999999999999999999998   99999999999999999999999


Q ss_pred             ccCccccCCCCcccccccccCccccCcccccc------CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHH
Q 040557          228 FGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR------GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAW  301 (407)
Q Consensus       228 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~  301 (407)
                      ||+++.+......  ...+|||+|+|||.+..      ..|+..+|.|++||++|.|+.|.+||-..-       .-...
T Consensus       167 FGFa~~l~~GekL--relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------QmlML  237 (411)
T KOG0599|consen  167 FGFACQLEPGEKL--RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------QMLML  237 (411)
T ss_pred             cceeeccCCchhH--HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------HHHHH
Confidence            9999988766543  56899999999998864      357889999999999999999999984210       00112


Q ss_pred             HHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          302 KLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       302 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      +++.+|+..      ...+ .-.+......+++.+||+.||.+|.|.+|+++|.++.
T Consensus       238 R~ImeGkyq------F~sp-eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~  287 (411)
T KOG0599|consen  238 RMIMEGKYQ------FRSP-EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI  287 (411)
T ss_pred             HHHHhcccc------cCCc-chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence            223333211      1111 1123455678999999999999999999999998763

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.1e-39  Score=293.83  Aligned_cols=254  Identities=26%  Similarity=0.384  Sum_probs=197.3

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc----ChhhHHHHHHHHHHHHcCCCCceeeeeeeeec--CCee
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK----SQQGESEFLSEVRMITSIQHKNLVRLLGCCSD--GSQR  154 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  154 (407)
                      .+|+..+.||+|+||.||+|... ++..||+|.+....    .......+.+|+.+++.++|+||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47888999999999999999864 58999999885432    12334568899999999999999999998865  3567


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcccc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF  234 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~  234 (407)
                      ++++||+++++|.+++...  ..+++.....++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++...
T Consensus        82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            8999999999999998543  34889999999999999999999988   999999999999999999999999999865


Q ss_pred             CCCCcc--cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccc
Q 040557          235 PEDQAY--LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL  312 (407)
Q Consensus       235 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ......  ......++..|+|||.+.+..++.++|||||||++|||++|+.||......      ..........     
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~~-----  225 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQP-----  225 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcCC-----
Confidence            432111  112345888999999999888999999999999999999999998643211      1111111100     


Q ss_pred             cCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          313 VDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       313 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      ..+.     .+......+.+++ .||..+|++||+++||++|-+.
T Consensus       226 ~~~~-----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~  264 (266)
T cd06651         226 TNPQ-----LPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFA  264 (266)
T ss_pred             CCCC-----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCccc
Confidence            0111     1222334456666 6888999999999999988653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.5e-39  Score=291.41  Aligned_cols=255  Identities=27%  Similarity=0.389  Sum_probs=208.8

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      ++|++.+.||+|++|.||+|... +++.|++|++...........+.+|++.+.+++|+|++++++++......++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36788899999999999999875 59999999987654445567899999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccc-cCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE-DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      +++++|.+++...  ..+++..+..++.|+++|+.|||+ .+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            9999999998643  568999999999999999999999 88   99999999999999999999999999987654433


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                      . .....++..|+|||.+.+..++.++|+||||+++|+|++|+.|+.......   ......... ....     +.   
T Consensus       156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~-~~~~-----~~---  222 (264)
T cd06623         156 Q-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS---FFELMQAIC-DGPP-----PS---  222 (264)
T ss_pred             c-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC---HHHHHHHHh-cCCC-----CC---
Confidence            2 123467889999999999999999999999999999999999986543211   111111111 1110     11   


Q ss_pred             CCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          320 EGIVER-DALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       320 ~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                        .... .+..+.+++.+||+.+|++||++.+++++-+
T Consensus       223 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~  258 (264)
T cd06623         223 --LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF  258 (264)
T ss_pred             --CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHH
Confidence              1111 3467899999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.3e-39  Score=293.87  Aligned_cols=255  Identities=28%  Similarity=0.447  Sum_probs=203.9

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccCh-hhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQ-QGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      +|...+.||+|+||.||+|... +++.|++|.+...... .....+.+|+++++.++|+||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4778899999999999999854 6899999998655432 4567889999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++++|.+++...  ..+++..+..++.+++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++.........
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            9999999998543  45789999999999999999999998   999999999999999999999999999877544332


Q ss_pred             ccc---ccccCccccCccccccCC---CCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          241 LST---NFAGTLGYTAPEYAIRGE---LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       241 ~~~---~~~gt~~y~aPE~~~~~~---~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      ...   ...++..|+|||.+.+..   ++.++||||||+++||+++|+.||......     ....... ..+.     .
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~~-~~~~-----~  224 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFHV-GAGH-----K  224 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHHH-hcCC-----C
Confidence            211   356788999999988766   899999999999999999999998643211     0111111 1010     1


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      +.+..   .......+.+++.+||+.+|++|||+.+++.+-|
T Consensus       225 ~~~~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~  263 (264)
T cd06626         225 PPIPD---SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF  263 (264)
T ss_pred             CCCCc---ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence            11111   1112456789999999999999999999987643

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.4e-39  Score=300.05  Aligned_cols=255  Identities=28%  Similarity=0.423  Sum_probs=200.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCc----EEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGT----LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      ++|+..+.||+|+||.||+|... +|.    .||+|.+...........+.+|+.+++.++|+||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            45677789999999999999753 444    57899886554445556789999999999999999999998754 4678


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ++||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++....
T Consensus        86 v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccC
Confidence            999999999999986433 35889999999999999999999988   99999999999999999999999999987654


Q ss_pred             CCccc-ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          237 DQAYL-STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       237 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      ..... .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....       .........+...    
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~----  230 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-------REIPDLLEKGERL----  230 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHCCCCC----
Confidence            33221 122345678999999988899999999999999999997 8888754321       1112222222111    


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                         .   ........+.+++..||..+|++||++.++++.|...
T Consensus       231 ---~---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         231 ---P---QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             ---C---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               0   1111345688999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.6e-39  Score=292.03  Aligned_cols=238  Identities=26%  Similarity=0.431  Sum_probs=187.6

Q ss_pred             CeeeccCCccEEEEEecCCc-----------EEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           88 NLLGRGGFGPVYRGKLADGT-----------LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      +.||+|+||.||+|.+.+..           .+++|.+.....  ....+.+|+.+++.++|+||+++++++.. ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR--DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh--hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            36899999999999875432           578887643322  25788899999999999999999999988 77899


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC-------ceEEeccc
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF-------QSKIGDFG  229 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-------~~kl~Dfg  229 (407)
                      ||||+++|+|.+++..... .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++       .++|+|||
T Consensus        78 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            9999999999999865432 6899999999999999999999988   99999999999999887       79999999


Q ss_pred             CccccCCCCcccccccccCccccCccccccC--CCCccccEEehhHHHHHHHhc-CCCCCCCCCcccCchhHHHHHHHHh
Q 040557          230 LARFFPEDQAYLSTNFAGTLGYTAPEYAIRG--ELSEKADIYSFGVLVLEIISC-RKNTDLTLPSEMQYLPEYAWKLYER  306 (407)
Q Consensus       230 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~s~G~vl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      ++......     ....++..|+|||++.+.  .++.++||||||+++|||++| ..|+.......      . ...+..
T Consensus       154 ~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~------~-~~~~~~  221 (259)
T cd05037         154 IPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE------K-ERFYQD  221 (259)
T ss_pred             cccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh------H-HHHHhc
Confidence            99865431     224567789999998876  789999999999999999995 55554332111      0 011111


Q ss_pred             CccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          307 GRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       307 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ..       ....     .....+.+++.+||+.+|++|||+.++++.|.
T Consensus       222 ~~-------~~~~-----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         222 QH-------RLPM-----PDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             CC-------CCCC-----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            10       0000     01156889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.6e-39  Score=296.77  Aligned_cols=258  Identities=25%  Similarity=0.367  Sum_probs=199.2

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHH-HHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRM-ITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      ++|++.+.||+|+||.||+|... +|+.||+|++...........+..|+.. ++.++|+||+++++++...+..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46788899999999999999864 6999999998755444445566677765 556689999999999999999999999


Q ss_pred             eccCCChhHHHhcc--CCCCCCHHHHHHHHHHHHHHhcccccc-CCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          160 YMKNRSLDLLIYGE--SDKFLNWSTRFQIILGIARGLQYLHED-SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       160 ~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      |++ |+|..++...  ....+++..+..++.|++.||.|||++ +   ++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 5787776432  235689999999999999999999986 6   99999999999999999999999999986643


Q ss_pred             CCcccccccccCccccCcccccc----CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccc
Q 040557          237 DQAYLSTNFAGTLGYTAPEYAIR----GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL  312 (407)
Q Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ...  .....++..|+|||.+.+    ..++.++|+||||+++|||++|+.|+......     ......... +.    
T Consensus       157 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~-~~----  224 (283)
T cd06617         157 SVA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQVVE-EP----  224 (283)
T ss_pred             ccc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHHHHh-cC----
Confidence            221  123467889999998764    45688999999999999999999998532111     011111111 10    


Q ss_pred             cCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          313 VDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       313 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                       .+...    ....+..+.+++.+||+.+|++||++.+++++-+....
T Consensus       225 -~~~~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  267 (283)
T cd06617         225 -SPQLP----AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH  267 (283)
T ss_pred             -CCCCC----ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence             11111    11234568899999999999999999999998776543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7.7e-40  Score=302.64  Aligned_cols=250  Identities=24%  Similarity=0.353  Sum_probs=200.5

Q ss_pred             CCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCC
Q 040557           87 GNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRS  165 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  165 (407)
                      ...||+|+||.||++... ++..||||.+... .......+.+|+..++.++|+||+++++.+..++..++||||+++++
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~  105 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA  105 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecc-hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence            457999999999999864 6889999988533 33445678899999999999999999999999999999999999999


Q ss_pred             hhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccccccc
Q 040557          166 LDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF  245 (407)
Q Consensus       166 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~  245 (407)
                      |.+++..   ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++........ .....
T Consensus       106 L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~  178 (292)
T cd06658         106 LTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSL  178 (292)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCcee
Confidence            9998743   34899999999999999999999998   99999999999999999999999999976543322 12235


Q ss_pred             ccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHH
Q 040557          246 AGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVER  325 (407)
Q Consensus       246 ~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  325 (407)
                      .|+..|+|||.+.+..++.++||||||+++|||++|+.||....+..      .... ..     ..+.+....   ...
T Consensus       179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~-~~-----~~~~~~~~~---~~~  243 (292)
T cd06658         179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ------AMRR-IR-----DNLPPRVKD---SHK  243 (292)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HH-----hcCCCcccc---ccc
Confidence            68899999999988889999999999999999999999986432211      1111 11     011111111   112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          326 DALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       326 ~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ....+.+++.+||+.||++|||+.+++++-+...
T Consensus       244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~  277 (292)
T cd06658         244 VSSVLRGFLDLMLVREPSQRATAQELLQHPFLKL  277 (292)
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhChhhhc
Confidence            3446788999999999999999999999977654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.5e-39  Score=331.00  Aligned_cols=259  Identities=20%  Similarity=0.323  Sum_probs=201.2

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeec--CCeeE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSD--GSQRL  155 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~  155 (407)
                      ..++|++.+.||+|+||.||+|... ++..||+|.+.... .......|..|+.++..++||||+++++++.+  ...+|
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            4478999999999999999999864 57789999886443 33445678999999999999999999998854  45689


Q ss_pred             EEEEeccCCChhHHHhcc--CCCCCCHHHHHHHHHHHHHHhccccccCC----CceeeeccccccEEEcCC---------
Q 040557          156 LVYEYMKNRSLDLLIYGE--SDKFLNWSTRFQIILGIARGLQYLHEDSH----TRIVHRDIKASNVLLDEK---------  220 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~i~H~dlk~~Nill~~~---------  220 (407)
                      +||||+++|+|.+++...  ....+++..++.|+.||+.||.|||+.+.    .+|+||||||+||||+.+         
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            999999999999988642  23469999999999999999999998542    249999999999999642         


Q ss_pred             --------CceEEecccCccccCCCCcccccccccCccccCcccccc--CCCCccccEEehhHHHHHHHhcCCCCCCCCC
Q 040557          221 --------FQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR--GELSEKADIYSFGVLVLEIISCRKNTDLTLP  290 (407)
Q Consensus       221 --------~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~  290 (407)
                              +.+||+|||++..+.....  .....||+.|+|||++.+  ..++.++|||||||+||||+||+.||.....
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~  248 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN  248 (1021)
T ss_pred             cccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence                    3489999999987644322  234579999999998864  4589999999999999999999999864321


Q ss_pred             cccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          291 SEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                           ... ....+..+       +.+..    ...+..+.+|+..||+.+|.+||++.+++.+-+.
T Consensus       249 -----~~q-li~~lk~~-------p~lpi----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~i  298 (1021)
T PTZ00266        249 -----FSQ-LISELKRG-------PDLPI----KGKSKELNILIKNLLNLSAKERPSALQCLGYQII  298 (1021)
T ss_pred             -----HHH-HHHHHhcC-------CCCCc----CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHH
Confidence                 111 11111111       11110    1124568899999999999999999999976554

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.4e-39  Score=296.29  Aligned_cols=258  Identities=23%  Similarity=0.367  Sum_probs=207.2

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++|||++++++.+...+..++|+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   96 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME   96 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence            36788889999999999999975 468899999985332 3334678899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++++|.+++..   ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        97 ~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          97 YLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             cCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            9999999999853   24789999999999999999999998   99999999999999999999999999876654332


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                      . .....+++.|+|||.+.+..++.++||||||+++|++++|+.||.........      ......+.      +..  
T Consensus       171 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~------~~~~~~~~------~~~--  235 (293)
T cd06647         171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNGT------PEL--  235 (293)
T ss_pred             c-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe------eehhcCCC------CCC--
Confidence            2 23346888999999998888999999999999999999999999654322110      00000000      000  


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                       .........+.+++.+||+.+|++||++.+++.|-+.....
T Consensus       236 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         236 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence             01122345688999999999999999999999998765444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.2e-39  Score=299.57  Aligned_cols=265  Identities=22%  Similarity=0.298  Sum_probs=198.5

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      +++|.+.+.||+|+||.||+|.. .+|+.||+|.+...........+.+|+.+++.++|+||+++.+++..+...++|||
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            46788899999999999999975 46899999998654433444567899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+. +++..++... ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.......
T Consensus        84 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          84 YMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             ccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            996 5776665433 245788888999999999999999998   99999999999999999999999999976433221


Q ss_pred             ccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh-C----------
Q 040557          240 YLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER-G----------  307 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~----------  307 (407)
                      . .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||.......     +.....+.. +          
T Consensus       159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07870         159 T-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-----EQLEKIWTVLGVPTEDTWPGV  232 (291)
T ss_pred             C-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-----HHHHHHHHHcCCCChhhhhhh
Confidence            1 1234578899999988764 57889999999999999999999987543211     111111000 0          


Q ss_pred             -ccc----cccCc----ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          308 -RIL----ELVDP----RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       308 -~~~----~~~d~----~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                       ...    +....    ..............+.+++.+|++.||++|||+.|++.|-+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~  290 (291)
T cd07870         233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY  290 (291)
T ss_pred             hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCC
Confidence             000    00000    00000000011346789999999999999999999998754

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=301.18  Aligned_cols=254  Identities=27%  Similarity=0.343  Sum_probs=212.6

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      +.|+.-++||+||||.||-++. .+|+.+|.|++.+..  ....+...++|-.+|.+++.+.||.+-..|+..+.+++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            5688888999999999999874 469999999986543  3455667789999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ..|.||+|..++++..+..+++..+..++.+|+.||++||+..   ||.|||||+|||||+.|+++|+|+|||..+....
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence            9999999999999888888999999999999999999999998   9999999999999999999999999999887665


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                      ..  ...+||.+|||||++.+..|+...|.||+||+||||+.|+.||...-..       ..         .+.+|.+..
T Consensus       342 ~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK-------vk---------~eEvdrr~~  403 (591)
T KOG0986|consen  342 PI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK-------VK---------REEVDRRTL  403 (591)
T ss_pred             cc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh-------hh---------HHHHHHHHh
Confidence            43  3458999999999999999999999999999999999999998632111       11         112222221


Q ss_pred             --cCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhh
Q 040557          319 --KEGIVERDALQVINVAFICLQPHGNQRPP-----MSEIVAMLT  356 (407)
Q Consensus       319 --~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~l~  356 (407)
                        ...+++..+.+..+|....|+.||++|..     +.+|.+|.-
T Consensus       404 ~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~Hpf  448 (591)
T KOG0986|consen  404 EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPF  448 (591)
T ss_pred             cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcc
Confidence              12344556667888888899999999975     557766543

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-40  Score=304.21  Aligned_cols=255  Identities=20%  Similarity=0.330  Sum_probs=203.7

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccc-cChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ....|++.++||+||.+.||++...+...||+|++... .+.+...-|.+|+..|.++ .|.+|+++++|-..++.+|+|
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            34568889999999999999999888888999887543 3555667899999999999 599999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||=+ -+|..++.........| .+..+..|++.|+.++|+++   |||.||||.|+|+-.+ .+||+|||+|..+..+
T Consensus       439 mE~Gd-~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVkG-~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  439 MECGD-IDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVKG-RLKLIDFGIANAIQPD  512 (677)
T ss_pred             eeccc-ccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEee-eEEeeeechhcccCcc
Confidence            99864 48999997666555556 66778999999999999999   9999999999999765 9999999999988766


Q ss_pred             Ccc-cccccccCccccCccccccCC-----------CCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHH
Q 040557          238 QAY-LSTNFAGTLGYTAPEYAIRGE-----------LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYE  305 (407)
Q Consensus       238 ~~~-~~~~~~gt~~y~aPE~~~~~~-----------~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  305 (407)
                      ... .....+||..||+||.+....           .+.+|||||+||+||+|+.|++||..-        ....     
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~--------~n~~-----  579 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI--------INQI-----  579 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--------HHHH-----
Confidence            543 334678999999999886432           457999999999999999999998621        1111     


Q ss_pred             hCccccccCcccccC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          306 RGRILELVDPRMRKE--GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       306 ~~~~~~~~d~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                       .++..+.||...-+  ..+.  ...+++++..||+.||.+|||..++++|--
T Consensus       580 -aKl~aI~~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqhpF  629 (677)
T KOG0596|consen  580 -AKLHAITDPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQHPF  629 (677)
T ss_pred             -HHHHhhcCCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhcCcc
Confidence             12333444433111  1111  123899999999999999999999999853

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=6e-39  Score=294.52  Aligned_cols=251  Identities=25%  Similarity=0.394  Sum_probs=204.1

Q ss_pred             CCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEecc
Q 040557           84 FHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMK  162 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  162 (407)
                      |+..+.||+|+||.||+|.. .+++.||+|.+...........+.+|+.++..++|+||+++++++..+...++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            55678899999999999975 46889999998655444556678899999999999999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccc
Q 040557          163 NRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS  242 (407)
Q Consensus       163 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  242 (407)
                      +++|..++..   ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++........ ..
T Consensus        86 ~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~  158 (277)
T cd06641          86 GGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KR  158 (277)
T ss_pred             CCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-hh
Confidence            9999998853   34899999999999999999999988   99999999999999999999999999976644322 12


Q ss_pred             cccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCC
Q 040557          243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGI  322 (407)
Q Consensus       243 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  322 (407)
                      ....++..|+|||.+.+..++.++|+|||||++|+|++|..|+......      .... ....+..     +.     .
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~-~~~~~~~-----~~-----~  221 (277)
T cd06641         159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLF-LIPKNNP-----PT-----L  221 (277)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHH-HHhcCCC-----CC-----C
Confidence            2346788999999998888999999999999999999999998643211      1111 1111110     11     1


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          323 VERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       323 ~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ....+..+.+++.+||+.+|++||++.+++++-+..
T Consensus       222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~  257 (277)
T cd06641         222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIV  257 (277)
T ss_pred             CcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence            122345688999999999999999999999986544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.8e-39  Score=300.94  Aligned_cols=256  Identities=21%  Similarity=0.249  Sum_probs=200.1

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|+..+.||+|+||.||++... +++.||+|.+.....  ......+.+|+++++.++|+||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36788899999999999999864 578999999865432  233457889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++++|.+++...  ..+++..+..++.|++.|+.|||+.+   ++||||||+||++++++.++|+|||+++......
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            999999999998543  45899999999999999999999988   9999999999999999999999999987421110


Q ss_pred             --------------cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHH
Q 040557          239 --------------AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLY  304 (407)
Q Consensus       239 --------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~  304 (407)
                                    ........++..|+|||.+.+..++.++|+||||+++|||++|+.||......      ..... .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~-~  228 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQ-V  228 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-H
Confidence                          00111245788999999998888999999999999999999999998643221      11111 1


Q ss_pred             HhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHhhc
Q 040557          305 ERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPP---MSEIVAMLTC  357 (407)
Q Consensus       305 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~ev~~~l~~  357 (407)
                      ..+..   ..+..     ....+..+.+++.+||+.+|++||+   +.+++++.+.
T Consensus       229 ~~~~~---~~~~~-----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~  276 (305)
T cd05609         229 ISDDI---EWPEG-----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF  276 (305)
T ss_pred             Hhccc---CCCCc-----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence            11110   01111     0123456889999999999999998   5666666544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.7e-39  Score=292.16  Aligned_cols=256  Identities=25%  Similarity=0.442  Sum_probs=203.6

Q ss_pred             CCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccC-----hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKS-----QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      +|+..+.||+|++|.||+|.. .+++.||+|.+.....     ......+.+|+.+++.++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999985 5689999999864331     1234678899999999999999999999999999999


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC-ceEEecccCccccC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF-QSKIGDFGLARFFP  235 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfgla~~~~  235 (407)
                      ||||+++++|.+++..  ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++ .++|+|||++....
T Consensus        81 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          81 FVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             EEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            9999999999999854  345889999999999999999999998   99999999999998765 59999999998765


Q ss_pred             CCCcc---cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccc
Q 040557          236 EDQAY---LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL  312 (407)
Q Consensus       236 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      .....   ......++..|+|||.+.+..++.++||||+|+++++|++|..|+........   ..........      
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~------  226 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIASA------  226 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHHhcc------
Confidence            43211   11234678899999999888899999999999999999999999864322111   1111111000      


Q ss_pred             cCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          313 VDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       313 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                          ......+......+.+++.+||+.+|++||++.+++.+-+
T Consensus       227 ----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~  266 (268)
T cd06630         227 ----TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPV  266 (268)
T ss_pred             ----CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcc
Confidence                0011123345567889999999999999999999998754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=6.2e-39  Score=292.45  Aligned_cols=253  Identities=25%  Similarity=0.329  Sum_probs=198.6

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc----ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC--Cee
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK----SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG--SQR  154 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  154 (407)
                      .+|++.+.||+|+||.||.|... +|+.||+|.+....    .......+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47888999999999999999864 58999999875332    123345788999999999999999999988663  467


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcccc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF  234 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~  234 (407)
                      +++|||+++++|.+++...  ..+++....+++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            8999999999999988543  34788999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCCcc--cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccc
Q 040557          235 PEDQAY--LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL  312 (407)
Q Consensus       235 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ......  ......++..|+|||.+.+..++.++||||||+++|||++|+.||......      ..........     
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~-----  225 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQP-----  225 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH------HHHHHHhcCC-----
Confidence            422111  112345888999999998888999999999999999999999998642111      1111111000     


Q ss_pred             cCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          313 VDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       313 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                           .....+......+.+++.+|+. +|++||++++|+++.+
T Consensus       226 -----~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~  263 (265)
T cd06652         226 -----TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTF  263 (265)
T ss_pred             -----CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcc
Confidence                 0111233345567889999985 9999999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.9e-39  Score=297.57  Aligned_cols=263  Identities=24%  Similarity=0.375  Sum_probs=200.4

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      +|+..+.||.|++|.||+|+.. +|+.||||.+..... ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4778889999999999999864 689999998864432 22335788999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +. ++|..++.......+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++.........
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~  156 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  156 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence            96 68888887655667899999999999999999999988   999999999999999999999999999865433221


Q ss_pred             cccccccCccccCccccccCC-CCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh-CccccccC----
Q 040557          241 LSTNFAGTLGYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER-GRILELVD----  314 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~d----  314 (407)
                       .....++..|+|||.+.+.. ++.++||||||+++|||+||+.||.......      ...+.... +.....+.    
T Consensus       157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07860         157 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID------QLFRIFRTLGTPDEVVWPGVT  229 (284)
T ss_pred             -cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHHHhCCCChhhhhhhh
Confidence             12335688999999887644 6889999999999999999999986432211      11111100 00000000    


Q ss_pred             ---------cccccC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          315 ---------PRMRKE---GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       315 ---------~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                               +.....   .........+.+++.+||+.||++|||+.+++++-|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~  283 (284)
T cd07860         230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF  283 (284)
T ss_pred             HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCC
Confidence                     000000   000112345789999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.1e-39  Score=296.36  Aligned_cols=240  Identities=25%  Similarity=0.385  Sum_probs=187.1

Q ss_pred             CeeeccCCccEEEEEecC--------CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           88 NLLGRGGFGPVYRGKLAD--------GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      +.||+|+||.||+|....        ...+|+|.+... .....+.+.+|+.++..++|+|++++++++..+...++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch-hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            369999999999997532        234888877432 23445678899999999999999999999999899999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCc--------eEEecccCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ--------SKIGDFGLA  231 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~--------~kl~Dfgla  231 (407)
                      |+++|+|..++.... ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.        ++++|||++
T Consensus        80 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          80 YVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             cCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999999986543 35899999999999999999999998   999999999999987765        699999998


Q ss_pred             cccCCCCcccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcC-CCCCCCCCcccCchhHHHHHHHHhCcc
Q 040557          232 RFFPEDQAYLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCR-KNTDLTLPSEMQYLPEYAWKLYERGRI  309 (407)
Q Consensus       232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ......     ....++..|+|||.+.+. .++.++||||||+++|||++|. .|+....+..       ........  
T Consensus       156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-------~~~~~~~~--  221 (258)
T cd05078         156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-------KLQFYEDR--  221 (258)
T ss_pred             cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-------HHHHHHcc--
Confidence            755432     234578899999998874 5799999999999999999995 4433211110       01111110  


Q ss_pred             ccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          310 LELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       310 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                           ..     .+.....++.+++.+||+.||++|||++++++.|+
T Consensus       222 -----~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 -----HQ-----LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -----cc-----CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                 00     11112346889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5.7e-39  Score=297.81  Aligned_cols=267  Identities=24%  Similarity=0.341  Sum_probs=201.8

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccCh----hhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQ----QGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      +|+..+.||+|+||.||+|... +|+.||+|.+......    .....+..|+++++.++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4677789999999999999864 6899999998654322    2344567899999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+ +|+|..++.... ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            9999 899999986443 36899999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHH---------hC
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYE---------RG  307 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---------~~  307 (407)
                      ... .....++..|+|||.+.+ ..++.++|||||||+++||++|.++|......+.  +... .....         ..
T Consensus       156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~  231 (298)
T cd07841         156 NRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKI-FEALGTPTEENWPGVT  231 (298)
T ss_pred             Ccc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHH-HHHcCCCchhhhhhcc
Confidence            221 122356788999998865 4678999999999999999999777654332110  0000 00000         00


Q ss_pred             ccccccCcc----cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          308 RILELVDPR----MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       308 ~~~~~~d~~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .........    .............+.+++.+||+.+|++|||+.|++++-+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~  286 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS  286 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcccc
Confidence            000000000    000001122346788999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.4e-39  Score=297.79  Aligned_cols=258  Identities=23%  Similarity=0.354  Sum_probs=198.3

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCC-CCceeeeeeeeecCCeeEEEEEe
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-HKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      +|...+.||+|+||.||++... +|+.||+|.+...........+.+|+.++.++. |+||+++++++......+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            3444567999999999999854 689999999875544455667899999999995 99999999999998999999999


Q ss_pred             ccCCChhHH---HhccCCCCCCHHHHHHHHHHHHHHhcccccc-CCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          161 MKNRSLDLL---IYGESDKFLNWSTRFQIILGIARGLQYLHED-SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       161 ~~~g~L~~~---l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      +.. ++..+   +.......+++..+..++.|++.||+|||+. +   ++||||||+||++++++.++|+|||++.....
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            864 54443   3333345689999999999999999999974 6   99999999999999999999999999976543


Q ss_pred             CCcccccccccCccccCccccccC---CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccccc
Q 040557          237 DQAYLSTNFAGTLGYTAPEYAIRG---ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV  313 (407)
Q Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ....  ....|+..|+|||.+.+.   .++.++|||||||++|||++|+.||.....     .......... +.     
T Consensus       161 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~-~~-----  227 (288)
T cd06616         161 SIAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK-GD-----  227 (288)
T ss_pred             CCcc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC-CC-----
Confidence            3221  234588899999998776   689999999999999999999999864320     0011111100 00     


Q ss_pred             CcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       314 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .+.+... .....+..+.+++.+||+.+|++|||+.+|+++-+..
T Consensus       228 ~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~  271 (288)
T cd06616         228 PPILSNS-EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK  271 (288)
T ss_pred             CCcCCCc-CCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence            1111111 1122455789999999999999999999999987653

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.6e-39  Score=295.62  Aligned_cols=258  Identities=24%  Similarity=0.365  Sum_probs=207.8

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ..++|+..+.||+|++|.||+|... ++..+++|.+.....  ....+.+|++.++.++|+|++++++++...+..++++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            3466777789999999999999875 688999999864333  5567889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++++|.+++.... ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            9999999999996543 36999999999999999999999988   9999999999999999999999999987654332


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                      . ......++..|++||.+.+..++.++||||||+++|+|++|+.|+....+..      .... ........     . 
T Consensus       171 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~~-----~-  236 (286)
T cd06614         171 S-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR------ALFL-ITTKGIPP-----L-  236 (286)
T ss_pred             h-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HHhcCCCC-----C-
Confidence            2 1223457889999999988889999999999999999999999986432211      1111 11111110     0 


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                        ......+..+.+++.+||+.+|.+||++.+++++.+...
T Consensus       237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         237 --KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             --cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence              011123456889999999999999999999999876544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2e-39  Score=294.10  Aligned_cols=253  Identities=22%  Similarity=0.379  Sum_probs=203.6

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      +|+..+.||+|+||.||+|... +|..+|+|.+..... ......+.+|+++++.++|+||+++++++...+..++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4777889999999999999864 588999999865321 23445778999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC-ceEEecccCccccCCCCc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF-QSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~~  239 (407)
                      +++++|.+++.......+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++ .++|+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999987655556899999999999999999999988   99999999999999875 469999999987654332


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                      . .....|++.|+|||...+..++.++|+||||+++|||++|+.|+.....      ......... +...    +    
T Consensus       158 ~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~----~----  221 (257)
T cd08225         158 L-AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQ-GYFA----P----  221 (257)
T ss_pred             c-ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhc-ccCC----C----
Confidence            1 2234588899999999888899999999999999999999999864321      112221111 1110    0    


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                        ........+.+++.+||+.+|++|||+.+++++.|
T Consensus       222 --~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~  256 (257)
T cd08225         222 --ISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPF  256 (257)
T ss_pred             --CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCC
Confidence              11122346889999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.7e-38  Score=289.05  Aligned_cols=252  Identities=25%  Similarity=0.421  Sum_probs=203.5

Q ss_pred             CCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeec--CCeeEEEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSD--GSQRLLVY  158 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  158 (407)
                      +|++.+.||.|+||.||++.. .+|..+|+|.+.... .......+.+|+++++.++|+||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477788999999999999975 468899999986433 34445678899999999999999999997753  45679999


Q ss_pred             EeccCCChhHHHhcc--CCCCCCHHHHHHHHHHHHHHhcccc-----ccCCCceeeeccccccEEEcCCCceEEecccCc
Q 040557          159 EYMKNRSLDLLIYGE--SDKFLNWSTRFQIILGIARGLQYLH-----EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLA  231 (407)
Q Consensus       159 e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla  231 (407)
                      ||+++++|.+++...  ....+++..++.++.|++.|+.|||     +.+   ++|+||+|+||++++++.++|+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999998643  2456899999999999999999999     655   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccc
Q 040557          232 RFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILE  311 (407)
Q Consensus       232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      ......... .....+++.|+|||.+.+..++.++||||||+++++|++|+.|+......       ........+... 
T Consensus       158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~-  228 (265)
T cd08217         158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL-------QLASKIKEGKFR-  228 (265)
T ss_pred             ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-------HHHHHHhcCCCC-
Confidence            877654431 23356899999999999888999999999999999999999998754311       111122221111 


Q ss_pred             ccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       312 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                               ..+...+..+.+++.+||+.+|++||++.+|+++-
T Consensus       229 ---------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~  263 (265)
T cd08217         229 ---------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP  263 (265)
T ss_pred             ---------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCC
Confidence                     12223456789999999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.7e-40  Score=308.15  Aligned_cols=249  Identities=25%  Similarity=0.392  Sum_probs=201.2

Q ss_pred             CeeeccCCccEEEEEec-CCcEEEEEEecc---ccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCe--eEEEEEec
Q 040557           88 NLLGRGGFGPVYRGKLA-DGTLVAVKKLCV---DKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQ--RLLVYEYM  161 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~~  161 (407)
                      .+||+|+|-+||+|.+. +|..||.-.++.   .......++|..|+.+|+.|+|+||++++.++.+...  ..+|+|.+
T Consensus        46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~  125 (632)
T KOG0584|consen   46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF  125 (632)
T ss_pred             hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence            57999999999999764 577887554433   2345556899999999999999999999999877655  67899999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc-CCCceEEecccCccccCCCCcc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      ..|+|..|+...  +.++......|+.||++||.|||++ .|||+|||||-+||||+ ..|.|||+|+|||........ 
T Consensus       126 TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a-  201 (632)
T KOG0584|consen  126 TSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA-  201 (632)
T ss_pred             cCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcccc-
Confidence            999999999544  4588899999999999999999998 58899999999999998 558999999999998876554 


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                        ...+|||.|||||+.. ..|++.+||||||++++||+|+..|+.     +... +..+++.+..|.-...+..-    
T Consensus       202 --ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs-----EC~n-~AQIYKKV~SGiKP~sl~kV----  268 (632)
T KOG0584|consen  202 --KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS-----ECTN-PAQIYKKVTSGIKPAALSKV----  268 (632)
T ss_pred             --ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh-----hhCC-HHHHHHHHHcCCCHHHhhcc----
Confidence              2478999999999665 889999999999999999999998874     2222 23344445545433222111    


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                           ...++.+||.+|+.. .++|||+.|++.+--+..
T Consensus       269 -----~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~  301 (632)
T KOG0584|consen  269 -----KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE  301 (632)
T ss_pred             -----CCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence                 134588999999999 999999999998754433

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.5e-39  Score=291.56  Aligned_cols=251  Identities=24%  Similarity=0.282  Sum_probs=204.7

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      +|++.+.||.|+||.||+|... +++.||+|.+....  .......+.+|++++++++||||+++++++.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4777889999999999999865 58999999986433  22446788999999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+.+++|..++...  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~  155 (258)
T cd05578          81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL  155 (258)
T ss_pred             CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence            99999999998543  46899999999999999999999988   99999999999999999999999999987654431


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                        .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+.......    ..........           ..
T Consensus       156 --~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~-----------~~  218 (258)
T cd05578         156 --TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET-----------AD  218 (258)
T ss_pred             --ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc-----------cc
Confidence              233568889999999988889999999999999999999999987554321    1111111110           00


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCH--HHHHHHh
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPM--SEIVAML  355 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~--~ev~~~l  355 (407)
                      ...+...+..+.+++.+||+.||.+||++  .|++++-
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~  256 (258)
T cd05578         219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHP  256 (258)
T ss_pred             ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCC
Confidence            11222234678899999999999999999  7777653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.9e-38  Score=290.43  Aligned_cols=254  Identities=25%  Similarity=0.406  Sum_probs=197.2

Q ss_pred             CCCCCeeeccCCccEEEEEec----CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC------
Q 040557           84 FHPGNLLGRGGFGPVYRGKLA----DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS------  152 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  152 (407)
                      |++.+.||+|+||.||+|...    ++..||+|.+.... .....+++.+|+++++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            566789999999999999753    36889999986543 3345667889999999999999999999875432      


Q ss_pred             eeEEEEEeccCCChhHHHhccC----CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGES----DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDF  228 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  228 (407)
                      ..++++||+.+|+|..++....    ...+++....+++.|++.|++|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999988774321    224789999999999999999999988   999999999999999999999999


Q ss_pred             cCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHh
Q 040557          229 GLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYER  306 (407)
Q Consensus       229 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      |+++........ ......+++.|++||.+....++.++||||||+++|||++ |+.|+......      . .......
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~------~-~~~~~~~  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS------E-IYNYLIK  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH------H-HHHHHHc
Confidence            999866433321 1223345678999999988889999999999999999999 77777533211      1 1111111


Q ss_pred             CccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          307 GRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       307 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      +..       ..   ........+.+++.+||+.+|++||++.++++.|+.
T Consensus       231 ~~~-------~~---~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         231 GNR-------LK---QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             CCc-------CC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            110       00   111234578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=9.1e-39  Score=290.81  Aligned_cols=248  Identities=23%  Similarity=0.286  Sum_probs=201.1

Q ss_pred             eeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCCh
Q 040557           90 LGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL  166 (407)
Q Consensus        90 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  166 (407)
                      ||.|++|.||+++.. +++.||+|.+.....  ......+.+|+.+++.++|+||+++++.+.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999865 489999999865432  24456789999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccccccc
Q 040557          167 DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA  246 (407)
Q Consensus       167 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  246 (407)
                      .+++...  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.......  ......
T Consensus        81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~  153 (262)
T cd05572          81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC  153 (262)
T ss_pred             HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence            9998543  45899999999999999999999988   9999999999999999999999999998775543  122346


Q ss_pred             cCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHH
Q 040557          247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERD  326 (407)
Q Consensus       247 gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  326 (407)
                      ++..|++||.+.+..++.++|+||||+++|+|++|..|+.......    ......... +.         .....+...
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~-~~---------~~~~~~~~~  219 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDILK-GN---------GKLEFPNYI  219 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHhc-cC---------CCCCCCccc
Confidence            8899999999988889999999999999999999999987543211    111111110 00         000112222


Q ss_pred             HHHHHHHHHHccCCCCCCCCC-----HHHHHHHhhcc
Q 040557          327 ALQVINVAFICLQPHGNQRPP-----MSEIVAMLTCK  358 (407)
Q Consensus       327 ~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~l~~~  358 (407)
                      +..+.+++.+||+.+|++||+     +.|+++|-|+.
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~  256 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN  256 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhh
Confidence            567899999999999999999     89999987753

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.3e-39  Score=299.16  Aligned_cols=248  Identities=23%  Similarity=0.323  Sum_probs=199.3

Q ss_pred             CeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCCh
Q 040557           88 NLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL  166 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  166 (407)
                      ..||+|+||.||+|... +++.||+|.+.... ......+.+|+.++..++|||++++++++..++..++++||+++++|
T Consensus        27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            46999999999999864 68999999986433 23445688999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccccccc
Q 040557          167 DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA  246 (407)
Q Consensus       167 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  246 (407)
                      ..++..   ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++........ ......
T Consensus       106 ~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~  178 (297)
T cd06659         106 TDIVSQ---TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLV  178 (297)
T ss_pred             HHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccccee
Confidence            987743   34899999999999999999999998   99999999999999999999999999976544322 123356


Q ss_pred             cCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHH
Q 040557          247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERD  326 (407)
Q Consensus       247 gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  326 (407)
                      |+..|+|||.+.+..++.++||||||+++|||++|+.||....+.+      ... .......     +...   .....
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~-~~~~~~~-----~~~~---~~~~~  243 (297)
T cd06659         179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ------AMK-RLRDSPP-----PKLK---NAHKI  243 (297)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHH-HHhccCC-----CCcc---ccCCC
Confidence            8899999999998899999999999999999999999986432211      111 1111100     0000   01112


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          327 ALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       327 ~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ...+.+++.+||+.+|++||++.+++++.+..
T Consensus       244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~  275 (297)
T cd06659         244 SPVLRDFLERMLTREPQERATAQELLDHPFLL  275 (297)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhhChhhc
Confidence            34578999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.5e-38  Score=296.25  Aligned_cols=253  Identities=28%  Similarity=0.397  Sum_probs=200.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      +.|...+.||+|+||.||+|... +|+.||+|.+....  .......+.+|+++++.++|+|++++.+++.+.+..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45778889999999999999864 68999999885432  2334467889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+. |++.+++... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        95 e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~  169 (307)
T cd06607          95 EYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN  169 (307)
T ss_pred             HhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCCC
Confidence            9997 5666666432 345899999999999999999999988   9999999999999999999999999997654332


Q ss_pred             cccccccccCccccCccccc---cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          239 AYLSTNFAGTLGYTAPEYAI---RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                           ...++..|+|||.+.   ...++.++||||||+++|||+||+.|+......      ...... ..+.     .+
T Consensus       170 -----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~~~~~-~~~~-----~~  232 (307)
T cd06607         170 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHI-AQND-----SP  232 (307)
T ss_pred             -----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HHHHHH-hcCC-----CC
Confidence                 346788999999874   456889999999999999999999998543211      111111 1110     01


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                      ..    .....+..+.+++.+||+.+|++||++.+++.+.+....
T Consensus       233 ~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         233 TL----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             CC----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence            11    112345678999999999999999999999999886543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-39  Score=295.56  Aligned_cols=262  Identities=23%  Similarity=0.357  Sum_probs=199.3

Q ss_pred             CCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccCh-hhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           84 FHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQ-QGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      |+..+.||.|++|.||+|... +|..||+|++...... .....+.+|+++++.++|+|++++++++.+++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            566789999999999999854 7999999998654322 23356889999999999999999999999999999999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      + ++|.+++.......+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++......... 
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-  155 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-  155 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence            5 68999886555456899999999999999999999988   999999999999999999999999999765432211 


Q ss_pred             ccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh-Cccc---------
Q 040557          242 STNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER-GRIL---------  310 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~---------  310 (407)
                      .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||.......      ........ +...         
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID------QLFRIFRTLGTPDEDVWPGVTS  229 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHHhCCCChHHhhhhhh
Confidence            1223568899999987664 57899999999999999999999986432211      01111100 0000         


Q ss_pred             --cccC--ccccc---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          311 --ELVD--PRMRK---EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       311 --~~~d--~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                        +...  +....   .......+..+.+++.+||+.+|++|||++|++++-|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~  282 (283)
T cd07835         230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY  282 (283)
T ss_pred             chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCC
Confidence              0000  00000   0011122356889999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-39  Score=303.83  Aligned_cols=269  Identities=23%  Similarity=0.320  Sum_probs=199.4

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC-----Cee
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG-----SQR  154 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  154 (407)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|.+...........+.+|+.+++.++|+||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46789999999999999999975 468999999986433344456788999999999999999999887544     357


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcccc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF  234 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~  234 (407)
                      ++++||+.+ +|..++.   ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++...
T Consensus        84 ~lv~e~~~~-~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          84 YIVQELMET-DLYKLIK---TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             EEEehhccc-CHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeec
Confidence            999999975 7777763   235899999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCCcc--cccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhC---c
Q 040557          235 PEDQAY--LSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERG---R  308 (407)
Q Consensus       235 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~  308 (407)
                      ......  ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||........   ...........   .
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~~  233 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQED  233 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCHHH
Confidence            432221  1123568899999998755 5689999999999999999999999864321100   00000000000   0


Q ss_pred             cccccCc-------------ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          309 ILELVDP-------------RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       309 ~~~~~d~-------------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ...+.+.             ..............+.+++.+||+.+|++|||+.+++++-+...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~  297 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ  297 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccc
Confidence            0000000             00000000112456889999999999999999999999976543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.5e-38  Score=286.90  Aligned_cols=251  Identities=26%  Similarity=0.423  Sum_probs=204.4

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      .|+..+.||+|++|.||++... +++.+++|++..... .....+.+|++.++.++|+|++++++++......++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            3677789999999999999875 689999999865433 45567899999999999999999999999999999999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      ++++|.+++.... ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||.+........  
T Consensus        80 ~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          80 SGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            9999999986543 46899999999999999999999988   99999999999999999999999999987765432  


Q ss_pred             ccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCC
Q 040557          242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEG  321 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  321 (407)
                      .....++..|++||.+.+..++.++||||||+++++|++|+.|+.......      .... ........     ..   
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~~-----~~---  218 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK------ALFK-IATNGPPG-----LR---  218 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH------HHHH-HHhcCCCC-----cC---
Confidence            234568899999999988889999999999999999999999986432111      1111 11111110     00   


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          322 IVERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       322 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                      .....+..+.+++.+||+.||++|||+.+++++-
T Consensus       219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~  252 (253)
T cd05122         219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHP  252 (253)
T ss_pred             cccccCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence            0111245689999999999999999999999874

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.4e-38  Score=292.05  Aligned_cols=249  Identities=26%  Similarity=0.318  Sum_probs=198.8

Q ss_pred             eeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCCh
Q 040557           90 LGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL  166 (407)
Q Consensus        90 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  166 (407)
                      ||+|+||+||++.. .+|+.||+|.+....  .......+.+|+++++.++|+||+++.+.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999975 468999999986432  223345677899999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccccccc
Q 040557          167 DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA  246 (407)
Q Consensus       167 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  246 (407)
                      .+++.......+++..+..++.|++.|+.|||+.+   ++||||+|+||++++++.++|+|||++........  .....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~  155 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRA  155 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--ccccc
Confidence            99987655557899999999999999999999998   99999999999999999999999999986644222  22346


Q ss_pred             cCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHH
Q 040557          247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERD  326 (407)
Q Consensus       247 gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  326 (407)
                      ++..|+|||.+.+..++.++||||||+++++|++|+.||........   ..    .........       ....+...
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~----~~~~~~~~~-------~~~~~~~~  221 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE---KE----ELKRRTLEM-------AVEYPDKF  221 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc---HH----HHHhccccc-------cccCCccC
Confidence            78899999999888899999999999999999999999864432110   00    011110000       00112223


Q ss_pred             HHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhc
Q 040557          327 ALQVINVAFICLQPHGNQRP-----PMSEIVAMLTC  357 (407)
Q Consensus       327 ~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~l~~  357 (407)
                      +..+.+++.+||+.+|++||     ++.+++.|.+.
T Consensus       222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~  257 (277)
T cd05577         222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF  257 (277)
T ss_pred             CHHHHHHHHHHccCChhHccCCCcccHHHHHhChhh
Confidence            55688999999999999999     77778887665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-39  Score=295.30  Aligned_cols=252  Identities=25%  Similarity=0.323  Sum_probs=212.0

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .-|.+.+.||+|.|..|-+|++ -+|..||||++.+.+ .......+.+|++.|+.++|||||+++.+...+..+|||.|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            3455567899999999999974 479999999997554 33445678899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc-CCCceEEecccCccccCCCC
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfgla~~~~~~~  238 (407)
                      .-++|+|.+++-... ..+++....+++.||+.|+.|+|+..   ++||||||+||.+- .-|-|||.|||++..+....
T Consensus        98 LGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             ecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            999999999996543 45999999999999999999999998   99999999999875 56889999999998887665


Q ss_pred             cccccccccCccccCccccccCCCC-ccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELS-EKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~-~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      ..  ++.+|...|-|||++.+..|+ +++||||||||||-|++|+.||......+.               +.-++|-..
T Consensus       174 kL--~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDCKY  236 (864)
T KOG4717|consen  174 KL--TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDCKY  236 (864)
T ss_pred             hh--hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhcccc
Confidence            43  567999999999999999886 578999999999999999999976544432               111222222


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                         ..+.....+..+||..||+.||.+|.+.++|+.+-|.
T Consensus       237 ---tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wl  273 (864)
T KOG4717|consen  237 ---TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWL  273 (864)
T ss_pred             ---cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccc
Confidence               2455667788999999999999999999999988774

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.4e-38  Score=293.37  Aligned_cols=252  Identities=22%  Similarity=0.333  Sum_probs=202.1

Q ss_pred             CCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEecc
Q 040557           84 FHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMK  162 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  162 (407)
                      |...+.||+|++|.||++.. .+++.+++|.+... .......+.+|+.+++.++|+||+++++++...+..++++||++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc-chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            33446899999999999985 46889999988533 33345568899999999999999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccc
Q 040557          163 NRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS  242 (407)
Q Consensus       163 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  242 (407)
                      +++|.+++..   ..+++..+..++.|++.|++|||+.+   ++||||+|+||+++.++.++|+|||++......... .
T Consensus       100 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-~  172 (285)
T cd06648         100 GGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-R  172 (285)
T ss_pred             CCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-c
Confidence            9999999854   35899999999999999999999998   999999999999999999999999998765443221 2


Q ss_pred             cccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCC
Q 040557          243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGI  322 (407)
Q Consensus       243 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  322 (407)
                      ....|+..|+|||.+.+..++.++||||||+++|||++|+.||....+.      ..... .....     .+....   
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~-~~~~~-----~~~~~~---  237 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKR-IRDNL-----PPKLKN---  237 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHH-HHhcC-----CCCCcc---
Confidence            2356889999999998888999999999999999999999998643221      11111 11111     111111   


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          323 VERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       323 ~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ....+..+.+++.+||+.+|++||++.+++++-+..
T Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  273 (285)
T cd06648         238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLA  273 (285)
T ss_pred             cccCCHHHHHHHHHHcccChhhCcCHHHHccCcccc
Confidence            111345689999999999999999999999986654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=8.8e-39  Score=294.35  Aligned_cols=264  Identities=26%  Similarity=0.400  Sum_probs=201.2

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      +|+..+.||.|++|.||+|+.. +|..||+|.+...........+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4778899999999999999874 689999999875544444566788999999999999999999999999999999999


Q ss_pred             cCCChhHHHhccC-CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          162 KNRSLDLLIYGES-DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       162 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      ++ +|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++.........
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~  156 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT  156 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence            85 7888775433 345899999999999999999999988   999999999999999999999999999865433221


Q ss_pred             cccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHH----------HHHHHhCcc
Q 040557          241 LSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYA----------WKLYERGRI  309 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~----------~~~~~~~~~  309 (407)
                       .....++..|++||.+.+. .++.++||||||+++|+|++|+.||......+.  .....          ++.+..   
T Consensus       157 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~---  230 (284)
T cd07836         157 -FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ--LLKIFRIMGTPTESTWPGISQ---  230 (284)
T ss_pred             -cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhHHHHhc---
Confidence             1234578899999987664 578999999999999999999999875432210  00000          000000   


Q ss_pred             ccccCccccc------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          310 LELVDPRMRK------EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       310 ~~~~d~~~~~------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ..........      .......+..+.+++.+||+.||++||++.+++++-+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~  283 (284)
T cd07836         231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW  283 (284)
T ss_pred             CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence            0000000000      0011123456789999999999999999999998744

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-39  Score=319.01  Aligned_cols=273  Identities=18%  Similarity=0.261  Sum_probs=193.7

Q ss_pred             HHhcCCCCCCeeeccCCccEEEEEecC--CcEEEEEEe--------------cc--ccChhhHHHHHHHHHHHHcCCCCc
Q 040557           79 KATKNFHPGNLLGRGGFGPVYRGKLAD--GTLVAVKKL--------------CV--DKSQQGESEFLSEVRMITSIQHKN  140 (407)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~--------------~~--~~~~~~~~~~~~e~~~l~~l~h~n  140 (407)
                      ...++|++.+.||+|+||+||++....  +...+.|.+              ..  .........+.+|+++|.+++|+|
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            345789999999999999999986432  222222211              00  112233456889999999999999


Q ss_pred             eeeeeeeeecCCeeEEEEEeccCCChhHHHhccC---CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEE
Q 040557          141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGES---DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL  217 (407)
Q Consensus       141 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill  217 (407)
                      |+++++++...+..++|+|++. ++|..++....   ...........++.|++.||.|||+.+   |+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            9999999999999999999985 46666654322   122345667789999999999999998   9999999999999


Q ss_pred             cCCCceEEecccCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCC-CCCcccCch
Q 040557          218 DEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDL-TLPSEMQYL  296 (407)
Q Consensus       218 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~-~~~~~~~~~  296 (407)
                      +.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..++.. ........+
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            9999999999999987765444334456799999999999999999999999999999999998854332 211111111


Q ss_pred             hHHH-----------------HHHHHhCccc---cccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          297 PEYA-----------------WKLYERGRIL---ELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       297 ~~~~-----------------~~~~~~~~~~---~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ....                 +..+......   ..+...+...    .....+.+++.+||+.||++|||+.|+++|.+
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~  456 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNL----GLPADFEYPLVKMLTFDWHLRPGAAELLALPL  456 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhc----CCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence            1100                 0111000000   0000000000    11235677899999999999999999999988


Q ss_pred             ccc
Q 040557          357 CKV  359 (407)
Q Consensus       357 ~~~  359 (407)
                      +..
T Consensus       457 f~~  459 (501)
T PHA03210        457 FSA  459 (501)
T ss_pred             hhc
Confidence            643

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.3e-38  Score=291.23  Aligned_cols=264  Identities=23%  Similarity=0.305  Sum_probs=195.7

Q ss_pred             CCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCC-CCceeeeeeeeecC--CeeEEEEE
Q 040557           84 FHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-HKNLVRLLGCCSDG--SQRLLVYE  159 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  159 (407)
                      |++.+.||+|+||.||+|.. .+++.||+|.+.............+|+..+.++. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            56678899999999999985 4689999999865433333344568899999884 99999999999887  88999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |++ |+|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++. +.++|+|||++........
T Consensus        81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~  154 (282)
T cd07831          81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP  154 (282)
T ss_pred             cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence            997 47777765432 46899999999999999999999998   999999999999999 9999999999987654332


Q ss_pred             ccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccC---------chhHHHHHHHHhCcc
Q 040557          240 YLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQ---------YLPEYAWKLYERGRI  309 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~---------~~~~~~~~~~~~~~~  309 (407)
                      .  ....++..|+|||.+.. +.++.++|||||||++|||++|..||......+..         ....+ .........
T Consensus       155 ~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  231 (282)
T cd07831         155 Y--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKFRKSRH  231 (282)
T ss_pred             c--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhhccccc
Confidence            2  23457889999997654 56789999999999999999999998654321100         00000 001111110


Q ss_pred             ccccCcccccC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          310 LELVDPRMRKE---GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       310 ~~~~d~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      .....+.....   ......+..+.+++.+||+.+|++||++.+++++-|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~  281 (282)
T cd07831         232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY  281 (282)
T ss_pred             ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence            00000000000   001234577999999999999999999999998754

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.2e-38  Score=300.41  Aligned_cols=274  Identities=22%  Similarity=0.319  Sum_probs=203.3

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeec----CCee
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSD----GSQR  154 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~  154 (407)
                      ..+|++.+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.+++.++|+||+++.+++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            367888899999999999999854 699999999865432 2344567789999999999999999988753    3567


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcccc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF  234 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~  234 (407)
                      ++||||+. |+|..++..  ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++...
T Consensus        84 ~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence            99999996 588888853  345899999999999999999999988   999999999999999999999999999765


Q ss_pred             CCCCcc---cccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccC--------chhHHHHH
Q 040557          235 PEDQAY---LSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQ--------YLPEYAWK  302 (407)
Q Consensus       235 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~--------~~~~~~~~  302 (407)
                      ......   ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........        ..+.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            433221   1123468889999998765 46899999999999999999999999654321100        00000000


Q ss_pred             HHHhCccccccCcccccCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          303 LYERGRILELVDPRMRKEGI-----VERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       303 ~~~~~~~~~~~d~~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                      ......+.+..+..-.....     ....+..+.+++.+||+.+|++||++.+++.+.|....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~  300 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY  300 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence            00001111111100000001     11235678999999999999999999999999887543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.4e-38  Score=294.51  Aligned_cols=268  Identities=24%  Similarity=0.319  Sum_probs=199.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccCh-hhHHHHHHHHHHHHcCCCCceeeeeeeeecC--CeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQ-QGESEFLSEVRMITSIQHKNLVRLLGCCSDG--SQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  157 (407)
                      ++|+..+.||.|+||.||+|... +++.+|+|.+...... .....+.+|+.++.+++|+||+++.+++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46778889999999999999865 5889999998654322 2234567899999999999999999998777  889999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+.+ +|.+++.... ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        85 ~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          85 MEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             ehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            999974 8888876433 35899999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCc-h-------hHHHHHHHHh--
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQY-L-------PEYAWKLYER--  306 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~-~-------~~~~~~~~~~--  306 (407)
                      ... .....+++.|+|||.+.+. .++.++|+||||+++|||++|+.||.......... .       ....+..+..  
T Consensus       160 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         160 LKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             ccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence            211 1234578899999988764 46899999999999999999999987543211000 0       0000000000  


Q ss_pred             ----CccccccCcccccCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          307 ----GRILELVDPRMRKEGIVER-DALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       307 ----~~~~~~~d~~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                          ..........+.. ..... ....+.+++.+||+.+|++|||+.|++.+-|
T Consensus       239 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~  292 (293)
T cd07843         239 GAKKKTFTKYPYNQLRK-KFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY  292 (293)
T ss_pred             hhcccccccccchhhhc-cccccCCChHHHHHHHHHhccCccccCCHHHHhcCCC
Confidence                0000000001110 11111 2456789999999999999999999998754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-38  Score=291.24  Aligned_cols=267  Identities=25%  Similarity=0.341  Sum_probs=200.4

Q ss_pred             CCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCC-CCceeeeeeeeecCCeeEEEEEec
Q 040557           84 FHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-HKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      |++.+.||+|++|.||+|... +++.|++|++.............+|+..+++++ |+|++++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            566789999999999999875 578999999865433333445567999999998 999999999999999999999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                       +|+|.+++.......+++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||++......... 
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-  155 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCc-
Confidence             889988886655457899999999999999999999988   999999999999999999999999999866543221 


Q ss_pred             ccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccC--------ch--hHHHHHHHHhCccc
Q 040557          242 STNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQ--------YL--PEYAWKLYERGRIL  310 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~--------~~--~~~~~~~~~~~~~~  310 (407)
                       ....++..|+|||.+.+ ..++.++|+||||++++||++|+.||......+..        ..  ..|...........
T Consensus       156 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         156 -TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             -CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence             23467889999998754 56799999999999999999999888644321100        00  00000000000111


Q ss_pred             cccCccccc--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          311 ELVDPRMRK--EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       311 ~~~d~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ..+......  ..........+.+++.+||+.+|++|||++|++.+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~  282 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY  282 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCC
Confidence            000000000  0000111456889999999999999999999998754

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.5e-38  Score=292.20  Aligned_cols=247  Identities=23%  Similarity=0.307  Sum_probs=191.4

Q ss_pred             eeeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHHH---cCCCCceeeeeeeeecCCeeEEEEEecc
Q 040557           89 LLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMIT---SIQHKNLVRLLGCCSDGSQRLLVYEYMK  162 (407)
Q Consensus        89 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~  162 (407)
                      .||+|+||.||++... +++.+|+|.+.....  ......+.+|..++.   ..+|+|++.+.+++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999864 589999998864432  122233445544333   3479999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccc
Q 040557          163 NRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS  242 (407)
Q Consensus       163 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  242 (407)
                      +|+|..++..  ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++........   
T Consensus        81 ~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~---  152 (279)
T cd05633          81 GGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---  152 (279)
T ss_pred             CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---
Confidence            9999988853  345899999999999999999999998   99999999999999999999999999976543321   


Q ss_pred             cccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCC
Q 040557          243 TNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEG  321 (407)
Q Consensus       243 ~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  321 (407)
                      ....|+..|+|||.+.+ ..++.++|||||||++|||++|..||........    ........      ..+..     
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~------~~~~~-----  217 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMTL------TVNVE-----  217 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH----HHHHHHhh------cCCcC-----
Confidence            23468999999998864 5689999999999999999999999975433211    11111100      00111     


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhcc
Q 040557          322 IVERDALQVINVAFICLQPHGNQRP-----PMSEIVAMLTCK  358 (407)
Q Consensus       322 ~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~l~~~  358 (407)
                      .+...+..+.+++.+||+.||++||     ++.++++|.++.
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~  259 (279)
T cd05633         218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFK  259 (279)
T ss_pred             CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcccc
Confidence            2223456788999999999999999     699999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=8.8e-38  Score=283.11  Aligned_cols=254  Identities=29%  Similarity=0.392  Sum_probs=207.1

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecC--CeeEEEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDG--SQRLLVY  158 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  158 (407)
                      +|+..+.||+|++|.||+|... +++.|++|.+..... ......+.+|+..+++++|+||+++++.+.+.  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677789999999999999875 689999999865432 34567889999999999999999999999888  8899999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++++|.+++....  .+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            9999999999986443  6899999999999999999999988   9999999999999999999999999998776544


Q ss_pred             cc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          239 AY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       239 ~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      .. ......++..|+|||.+.+..++.++||||||+++++|++|+.|+.....     .....+........        
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~--------  222 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGSSGEP--------  222 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccccCCC--------
Confidence            21 12345688899999999888899999999999999999999999875431     11111111110000        


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                        ...+...+..+.+++.+|++.+|++||++.+++.+.+
T Consensus       223 --~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~  259 (260)
T cd06606         223 --PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPF  259 (260)
T ss_pred             --cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCC
Confidence              1122233567899999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.4e-38  Score=294.93  Aligned_cols=257  Identities=23%  Similarity=0.347  Sum_probs=198.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEecC-CcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      ++|++.+.||+|+||.||+|...+ ++.||||.+...........+..|+.++.+. .|+||+++++++.+....+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            567888999999999999998764 8999999986554444556677788877777 49999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccc-cCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE-DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      |+. +++..++... ...+++..+..++.|++.||.|||+ .+   ++||||+|+||++++++.++|+|||++..+....
T Consensus        95 ~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          95 LMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             ccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            985 4676666432 3468999999999999999999997 46   9999999999999999999999999998664433


Q ss_pred             cccccccccCccccCccccccCC----CCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGE----LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~----~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      ..  ....++..|+|||.+.+..    ++.++||||||+++|||++|+.||......     ........... .     
T Consensus       170 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-~-----  236 (296)
T cd06618         170 AK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE-P-----  236 (296)
T ss_pred             cc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC-C-----
Confidence            22  2235788999999987553    789999999999999999999998542111     11111111111 0     


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      +....   ....+..+.+++.+||+.||++||++.+++++.+...
T Consensus       237 ~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~  278 (296)
T cd06618         237 PSLPP---NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR  278 (296)
T ss_pred             CCCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence            01100   0123456899999999999999999999999987543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-38  Score=315.64  Aligned_cols=263  Identities=27%  Similarity=0.436  Sum_probs=213.5

Q ss_pred             HHHHhcCCCCCCeeeccCCccEEEEEec----C----CcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeee
Q 040557           77 LKKATKNFHPGNLLGRGGFGPVYRGKLA----D----GTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGC  147 (407)
Q Consensus        77 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~  147 (407)
                      ++...++..+.+.||+|+||.|++|...    .    ...||||.++........+.+..|+++|+.+ +|+||+.++|+
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            3444455566779999999999999642    1    4579999998777667788999999999999 79999999999


Q ss_pred             eecCCeeEEEEEeccCCChhHHHhccC------------C--CCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccc
Q 040557          148 CSDGSQRLLVYEYMKNRSLDLLIYGES------------D--KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKAS  213 (407)
Q Consensus       148 ~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~  213 (407)
                      |...+..++|+||+..|+|..++...+            .  ..++....+.++.|||.||+||++..   ++||||..+
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR  447 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR  447 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence            999999999999999999999997554            0  23889999999999999999999988   999999999


Q ss_pred             cEEEcCCCceEEecccCccccCCCCcccccccc--cCccccCccccccCCCCccccEEehhHHHHHHHhcC-CCCCCCCC
Q 040557          214 NVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA--GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCR-KNTDLTLP  290 (407)
Q Consensus       214 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~-~p~~~~~~  290 (407)
                      |||++++..+||+|||+++.......+......  -+..|||||.+....|+.|+|||||||+|||++|.. .|+.. .+
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~-~~  526 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG-IP  526 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC-CC
Confidence            999999999999999999977666655433333  345699999999999999999999999999999954 44432 11


Q ss_pred             cccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          291 SEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .     ...+.+.+..|...          ..+..+..+++++++.||+.+|++||++.++++.+...
T Consensus       527 ~-----~~~l~~~l~~G~r~----------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  527 P-----TEELLEFLKEGNRM----------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             c-----HHHHHHHHhcCCCC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            0     11223345544322          12344567789999999999999999999999999763

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.1e-38  Score=295.31  Aligned_cols=265  Identities=24%  Similarity=0.342  Sum_probs=198.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      ++|+..+.||+|++|.||+|... +|+.||+|.+..... ......+.+|++++++++|+||+++++++.+....++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999864 689999998854432 2234567899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC-CCceEEecccCccccCCCC
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE-KFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~~  238 (407)
                      |++ ++|..++.......+++..+..++.|++.||.|||+.+   ++|+||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            996 57877775444444688888999999999999999988   999999999999985 5679999999997654332


Q ss_pred             cccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh-C-ccccc---
Q 040557          239 AYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER-G-RILEL---  312 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~---  312 (407)
                      .. .....+++.|+|||.+.+ ..++.++||||||+++|+|+||+.||......+      ........ + .....   
T Consensus       158 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~  230 (294)
T PLN00009        158 RT-FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID------ELFKIFRILGTPNEETWPG  230 (294)
T ss_pred             cc-cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHHhCCCChhhccc
Confidence            11 123457889999998866 457899999999999999999999986543211      11111100 0 00000   


Q ss_pred             ----cC-----cccccC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          313 ----VD-----PRMRKE---GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       313 ----~d-----~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                          .+     +.....   ......+..+.+++.+|++.+|++||++.+++++-+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~  287 (294)
T PLN00009        231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF  287 (294)
T ss_pred             cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchH
Confidence                00     000000   0011224557899999999999999999999998664

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-38  Score=293.32  Aligned_cols=264  Identities=25%  Similarity=0.353  Sum_probs=199.7

Q ss_pred             CCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC--CeeEEEEE
Q 040557           84 FHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG--SQRLLVYE  159 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  159 (407)
                      |++.+.||.|++|.||+|... +|+.+|+|.+.... .......+.+|+++++.++|+|++++++++.+.  ...++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            556788999999999999865 58999999997553 223345688999999999999999999999887  78999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++ +|..++.... ..+++..+..++.|++.|++|||+.+   ++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            9975 8888875432 46899999999999999999999988   99999999999999999999999999987755442


Q ss_pred             ccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhC------cc---
Q 040557          240 YLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERG------RI---  309 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~---  309 (407)
                      .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+........  + ..........      ..   
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ--L-EKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH--H-HHHHHHhCCCchhhccccccc
Confidence            22234457888999997765 4678999999999999999999999865432110  0 0000000000      00   


Q ss_pred             --------ccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          310 --------LELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       310 --------~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                              .......+. ......++..+.+++.+||+.+|++||++.+++++-|
T Consensus       233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~  286 (287)
T cd07840         233 PWFENLKPKKPYKRRLR-EFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY  286 (287)
T ss_pred             hhhhhccccccchhHHH-HHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcC
Confidence                    000000000 0000112567889999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.9e-38  Score=298.47  Aligned_cols=269  Identities=24%  Similarity=0.260  Sum_probs=201.0

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC------
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG------  151 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  151 (407)
                      ..++|+..+.||+|+||.||+|... +|+.||+|.+.... .......+.+|+.++++++|+||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999854 68999999985432 233445678899999999999999999988543      


Q ss_pred             CeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCc
Q 040557          152 SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLA  231 (407)
Q Consensus       152 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla  231 (407)
                      ...++||||+.+ +|.+.+...    +++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence            356999999964 787776422    889999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCccc-C--------chhHH---
Q 040557          232 RFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEM-Q--------YLPEY---  299 (407)
Q Consensus       232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~-~--------~~~~~---  299 (407)
                      ........  .....++..|+|||.+.+..++.++|||||||++|+|++|+.||........ .        ....+   
T Consensus       166 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
T cd07850         166 RTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR  243 (353)
T ss_pred             eeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            87644322  2334678899999999999999999999999999999999999864321100 0        00000   


Q ss_pred             ----HHHHHHhCc------cccccCccccc---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          300 ----AWKLYERGR------ILELVDPRMRK---EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       300 ----~~~~~~~~~------~~~~~d~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                          .........      ..+.+......   .......+..+.+++.+||+.||++|||+.|++++-|..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~  315 (353)
T cd07850         244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN  315 (353)
T ss_pred             hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence                000000000      00011000000   000112355688999999999999999999999997654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.4e-38  Score=295.13  Aligned_cols=267  Identities=22%  Similarity=0.329  Sum_probs=195.3

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccCh-hhHHHHHHHHHHHHcCCCCceeeeeeeeecCC-------
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQ-QGESEFLSEVRMITSIQHKNLVRLLGCCSDGS-------  152 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------  152 (407)
                      ++|+..+.||+|+||.||+|... +++.||+|.+...... .....+.+|++++++++||||+++++++....       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            56888899999999999999864 6899999988643322 22345678999999999999999999986544       


Q ss_pred             -eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCc
Q 040557          153 -QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLA  231 (407)
Q Consensus       153 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla  231 (407)
                       ..++||||+.+ +|..++... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCc
Confidence             45999999965 777776533 235899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcc---cccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHH--
Q 040557          232 RFFPEDQAY---LSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYE--  305 (407)
Q Consensus       232 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--  305 (407)
                      ..+......   ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+........   .........  
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~---~~~~~~~~~~~  243 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ---LTLISQLCGSI  243 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCC
Confidence            866433221   11234578889999988664 478899999999999999999998865432110   001111000  


Q ss_pred             ------hCccccccC----cc-----cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          306 ------RGRILELVD----PR-----MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       306 ------~~~~~~~~d----~~-----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                            .....+..+    +.     .............+.+++.+||+.||++|||++++++|-|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~  309 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF  309 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCC
Confidence                  000000000    00     0000000011245678999999999999999999998865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=6.9e-38  Score=293.10  Aligned_cols=253  Identities=28%  Similarity=0.404  Sum_probs=200.4

Q ss_pred             CCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           84 FHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      |...+.||+|+||.||+|+.. ++..||+|.+....  .......+.+|+++++.++|+|++++++++.+....++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            566788999999999999854 68899999986432  223445788999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +.+ +|.+.+... ...+++..+..++.|++.|+.|||+.+   ++||||+|+||+++.++.++|+|||++......   
T Consensus       107 ~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---  178 (317)
T cd06635         107 CLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA---  178 (317)
T ss_pred             CCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence            975 777766433 345899999999999999999999988   999999999999999999999999998755432   


Q ss_pred             cccccccCccccCccccc---cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          241 LSTNFAGTLGYTAPEYAI---RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                        ....++..|+|||.+.   .+.++.++|||||||++|||++|+.|+......      .........+.      +..
T Consensus       179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~------~~~  244 (317)
T cd06635         179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNES------PTL  244 (317)
T ss_pred             --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhccC------CCC
Confidence              2346888999999874   457899999999999999999999998643211      11111111110      001


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccCC
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESG  362 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~~  362 (407)
                          ........+.+++.+||+.+|++||++.+++++++......
T Consensus       245 ----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         245 ----QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             ----CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence                11223456889999999999999999999999988765443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-38  Score=294.72  Aligned_cols=270  Identities=22%  Similarity=0.312  Sum_probs=197.4

Q ss_pred             CCCCCCeeeccCCccEEEEEec---CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC--CeeE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA---DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG--SQRL  155 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  155 (407)
                      +|++.+.||+|+||.||+|...   ++..||+|.+....  .......+.+|+.++..++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4677789999999999999864   47899999986532  122235677899999999999999999999888  7899


Q ss_pred             EEEEeccCCChhHHHhccC---CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC----CCceEEecc
Q 040557          156 LVYEYMKNRSLDLLIYGES---DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE----KFQSKIGDF  228 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~----~~~~kl~Df  228 (407)
                      +||||+++ ++.+++....   ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 5666553221   236899999999999999999999998   999999999999999    999999999


Q ss_pred             cCccccCCCCc--ccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhH---HHHH
Q 040557          229 GLARFFPEDQA--YLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPE---YAWK  302 (407)
Q Consensus       229 gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~---~~~~  302 (407)
                      |++........  .......++..|+|||.+.+ ..++.++||||||+++++|++|+.||...........+.   ....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987644322  11233567889999998776 457899999999999999999999997554332110000   0000


Q ss_pred             HHH--------------hC-ccccccC----cccccCCCCH------HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          303 LYE--------------RG-RILELVD----PRMRKEGIVE------RDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       303 ~~~--------------~~-~~~~~~d----~~~~~~~~~~------~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      .+.              .. ......+    ..........      .....+.+++.+||+.||++|||+.|+++|-+
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~  315 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY  315 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence            000              00 0000000    0000000000      12346889999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-40  Score=330.54  Aligned_cols=260  Identities=29%  Similarity=0.382  Sum_probs=209.2

Q ss_pred             HHHHhcCCCCCCeeeccCCccEEEEE-ecCCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCee
Q 040557           77 LKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQR  154 (407)
Q Consensus        77 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  154 (407)
                      +...+-+|..+..||.|.||.||.|. ..+|...|+|.+..... ......+.+|+.++..++|||+|+++|+-.+.+..
T Consensus      1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred             hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence            44556788889999999999999997 45799999998865432 33345678999999999999999999999999999


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcccc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF  234 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~  234 (407)
                      +|.||||++|+|.+.+.  .+...++.....+..|++.|+.|||++|   ||||||||.||+|+.+|.+|++|||.|..+
T Consensus      1310 ~IFMEyC~~GsLa~ll~--~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLE--HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHHHHhccCcHHHHHH--hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence            99999999999999984  3445677777788899999999999999   999999999999999999999999999987


Q ss_pred             CCCCcc---cccccccCccccCccccccC---CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCc
Q 040557          235 PEDQAY---LSTNFAGTLGYTAPEYAIRG---ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGR  308 (407)
Q Consensus       235 ~~~~~~---~~~~~~gt~~y~aPE~~~~~---~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      ......   .-....||+.|||||.+.+.   ....++||||+|||++||+||++||..... +.+.+     -++..| 
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-e~aIM-----y~V~~g- 1457 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-EWAIM-----YHVAAG- 1457 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-hhHHH-----hHHhcc-
Confidence            654311   12356799999999999764   356789999999999999999999964221 11100     111112 


Q ss_pred             cccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          309 ILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       309 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                               ..+..+......-.+++..||+.||++|.++.|++++--.
T Consensus      1458 ---------h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1458 ---------HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred             ---------CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcc
Confidence                     1223445566677899999999999999999999988543

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.2e-37  Score=282.16  Aligned_cols=253  Identities=24%  Similarity=0.408  Sum_probs=207.1

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      +|+..+.||.|+||.||++... ++..+|+|++..... ......+.+|+++++.++|+|++++.+.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4777889999999999999864 689999999865432 34556788999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccC--CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          161 MKNRSLDLLIYGES--DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       161 ~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      +++++|.+++....  ...+++..+..++.+++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999986543  467999999999999999999999998   9999999999999999999999999998765543


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                      . ......|++.|+|||...+..++.++|+||+|+++++|++|+.|+......      ...... ......        
T Consensus       158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~-~~~~~~--------  221 (258)
T cd08215         158 D-LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKI-LKGQYP--------  221 (258)
T ss_pred             c-eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHH-hcCCCC--------
Confidence            2 223456889999999998888999999999999999999999998643211      111111 111111        


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                        ..+......+.+++.+||+.+|++|||+.+++++-+
T Consensus       222 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~  257 (258)
T cd08215         222 --PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPF  257 (258)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCC
Confidence              011123456889999999999999999999998743

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-38  Score=290.90  Aligned_cols=261  Identities=25%  Similarity=0.372  Sum_probs=201.6

Q ss_pred             CCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccCh-hhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           84 FHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQ-QGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      |+..+.||.|++|.||+|... +|+.+++|.+...... .....+.+|++++++++|+||+++++++.+++..++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            456688999999999999864 6899999998654322 34567889999999999999999999999999999999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      ++ +|..++.... ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||.+........ .
T Consensus        81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-~  154 (283)
T cd05118          81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-P  154 (283)
T ss_pred             CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-c
Confidence            75 8877775433 46899999999999999999999998   99999999999999999999999999987765441 1


Q ss_pred             ccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh-Cc--------ccc
Q 040557          242 STNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER-GR--------ILE  311 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~--------~~~  311 (407)
                      .....++..|+|||.+.+. .++.++|+||||+++|+|+||+.||......+      ........ +.        ..+
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID------QLFKIFRTLGTPDPEVWPKFTS  228 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHHcCCCchHhcccchh
Confidence            2234578899999998776 78999999999999999999998886433211      00000000 00        000


Q ss_pred             --------ccC-cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          312 --------LVD-PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       312 --------~~d-~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                              ..+ ............+..+.+++.+||+.||.+||++.+++.+-|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~  282 (283)
T cd05118         229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY  282 (283)
T ss_pred             hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCC
Confidence                    000 000000112234667899999999999999999999998754

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=8e-38  Score=292.31  Aligned_cols=261  Identities=21%  Similarity=0.237  Sum_probs=196.9

Q ss_pred             CCeeeccCCccEEEEEecCCcEEEEEEeccc-cChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCC
Q 040557           87 GNLLGRGGFGPVYRGKLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRS  165 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  165 (407)
                      ++.+|.|+++.||++.. +|+.||+|++... ........+.+|+++++.++|+||+++++++.+.+..+++|||+++|+
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34455555555555554 6999999998654 244556789999999999999999999999999999999999999999


Q ss_pred             hhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc------
Q 040557          166 LDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA------  239 (407)
Q Consensus       166 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~------  239 (407)
                      |.+++.......+++.....++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||.+........      
T Consensus        86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence            999997655566899999999999999999999998   99999999999999999999999999875532211      


Q ss_pred             ccccccccCccccCcccccc--CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccccc----
Q 040557          240 YLSTNFAGTLGYTAPEYAIR--GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV----  313 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  313 (407)
                      .......++..|+|||.+..  ..++.++|||||||++|||++|+.||.......      ...... .+.....+    
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~------~~~~~~-~~~~~~~~~~~~  235 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ------MLLEKV-RGTVPCLLDKST  235 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hccCccccccCc
Confidence            01123456778999998876  358899999999999999999999987432211      000000 00000000    


Q ss_pred             ----------------Ccccc---cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          314 ----------------DPRMR---KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       314 ----------------d~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                                      ++...   ...........+.+++.+||+.||++|||++++++|.+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~  299 (314)
T cd08216         236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK  299 (314)
T ss_pred             hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHh
Confidence                            00000   0011223346788999999999999999999999987754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.1e-38  Score=318.82  Aligned_cols=257  Identities=26%  Similarity=0.419  Sum_probs=194.1

Q ss_pred             HHHhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeec------
Q 040557           78 KKATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSD------  150 (407)
Q Consensus        78 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------  150 (407)
                      .+-..+|+..+.||+||||.||+++++ ||+.||||++...........+.+|+..|++|+|||||+++..+..      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            345577888889999999999999865 8999999999876655666788999999999999999998763100      


Q ss_pred             --------------------------------------------------------------------------------
Q 040557          151 --------------------------------------------------------------------------------  150 (407)
Q Consensus       151 --------------------------------------------------------------------------------  150 (407)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -------------------------C--------CeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccc
Q 040557          151 -------------------------G--------SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYL  197 (407)
Q Consensus       151 -------------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~L  197 (407)
                                               .        ..+|+-||||+..++.++++.+.... .....++++.+|++||.|+
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHH
Confidence                                     0        23478899999988888885443211 4678899999999999999


Q ss_pred             cccCCCceeeeccccccEEEcCCCceEEecccCccccC-----------------CCCcccccccccCccccCccccccC
Q 040557          198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP-----------------EDQAYLSTNFAGTLGYTAPEYAIRG  260 (407)
Q Consensus       198 H~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~  260 (407)
                      |+.|   +|||||||.||+|+++..|||+|||+|+...                 .......+..+||.-|+|||.+.+.
T Consensus       714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            9999   9999999999999999999999999998721                 0111133467899999999998764


Q ss_pred             ---CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHc
Q 040557          261 ---ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFIC  337 (407)
Q Consensus       261 ---~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~c  337 (407)
                         .|+.|+|+||+|||++||+.   ||.....      ...+...+..+.+..-  +.     +..+....-.++|+|+
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME------Ra~iL~~LR~g~iP~~--~~-----f~~~~~~~e~slI~~L  854 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSME------RASILTNLRKGSIPEP--AD-----FFDPEHPEEASLIRWL  854 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCchHH------HHHHHHhcccCCCCCC--cc-----cccccchHHHHHHHHH
Confidence               59999999999999999985   3332110      1111222233333322  11     1112233356899999


Q ss_pred             cCCCCCCCCCHHHHHHH
Q 040557          338 LQPHGNQRPPMSEIVAM  354 (407)
Q Consensus       338 l~~~p~~RPs~~ev~~~  354 (407)
                      ++.||++|||+.|++..
T Consensus       855 l~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  855 LSHDPSKRPTATELLNS  871 (1351)
T ss_pred             hcCCCccCCCHHHHhhc
Confidence            99999999999999875

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1e-37  Score=293.42  Aligned_cols=260  Identities=22%  Similarity=0.315  Sum_probs=196.3

Q ss_pred             eeecc--CCccEEEEEe-cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCC
Q 040557           89 LLGRG--GFGPVYRGKL-ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNR  164 (407)
Q Consensus        89 ~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  164 (407)
                      .||+|  +||+||++.. .+|+.||+|.+.... .....+.+.+|+.+++.++|+||+++++++..++..++|+||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            46666  9999999986 479999999986543 3334567889999999999999999999999999999999999999


Q ss_pred             ChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc---
Q 040557          165 SLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL---  241 (407)
Q Consensus       165 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~---  241 (407)
                      +|.+++.......+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++++||+.+..........   
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence            9999987655556899999999999999999999988   9999999999999999999999998654332111100   


Q ss_pred             ---ccccccCccccCccccccC--CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh----------
Q 040557          242 ---STNFAGTLGYTAPEYAIRG--ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER----------  306 (407)
Q Consensus       242 ---~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------  306 (407)
                         .....++..|+|||++.+.  .++.++|||||||++|||++|+.||........      .......          
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~  235 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM------LLQKLKGPPYSPLDITT  235 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH------HHHHhcCCCCCCccccc
Confidence               0112345679999998764  478999999999999999999999864322110      0000000          


Q ss_pred             --------------------------CccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          307 --------------------------GRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       307 --------------------------~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                                                +......+..+.. .........+.+++.+||+.||++|||+++++++.|..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~  312 (328)
T cd08226         236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRT-PSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK  312 (328)
T ss_pred             cchhhhhhccchhhhhcccccchhccccccccccccccc-hhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHH
Confidence                                      0000001111111 11233566789999999999999999999999998753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5e-38  Score=292.00  Aligned_cols=270  Identities=24%  Similarity=0.355  Sum_probs=199.4

Q ss_pred             HHhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC----
Q 040557           79 KATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS----  152 (407)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  152 (407)
                      ...++|++.+.||+|+||.||+|... +|+.||+|.+..... ......+.+|+++++.++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34578899999999999999999875 589999999865432 223356778999999999999999999887654    


Q ss_pred             ------eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEe
Q 040557          153 ------QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIG  226 (407)
Q Consensus       153 ------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~  226 (407)
                            ..++|+||+++ ++...+... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence                  78999999986 666666433 345899999999999999999999998   9999999999999999999999


Q ss_pred             cccCccccCCCCcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHH
Q 040557          227 DFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYE  305 (407)
Q Consensus       227 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  305 (407)
                      |||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......  .+ ........
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~--~~-~~~~~~~~  235 (302)
T cd07864         159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA--QL-ELISRLCG  235 (302)
T ss_pred             cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HH-HHHHHHhC
Confidence            999998765443222223356788999998765 457899999999999999999999986432211  00 00111100


Q ss_pred             hCc-----------cccccCcccc--c--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          306 RGR-----------ILELVDPRMR--K--EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       306 ~~~-----------~~~~~d~~~~--~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ...           .....+..-.  .  .......+..+.+++.+||+.+|++|||+.+++++-+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~  301 (302)
T cd07864         236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW  301 (302)
T ss_pred             CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            000           0000000000  0  0000112456889999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-37  Score=284.62  Aligned_cols=261  Identities=26%  Similarity=0.361  Sum_probs=197.3

Q ss_pred             CCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChh-hHHHHHHHHHHHHcC---CCCceeeeeeeeecCCe-----
Q 040557           84 FHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQ-GESEFLSEVRMITSI---QHKNLVRLLGCCSDGSQ-----  153 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~-----  153 (407)
                      |++.+.||+|+||.||+|... +++.||+|.+....... ....+.+|+.++.++   +|+|++++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            556788999999999999976 48999999996443322 234566787776655   69999999999987776     


Q ss_pred             eEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          154 RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      .+++|||+.+ +|.+++.......+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence            8999999975 7888886544446899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccc---
Q 040557          234 FPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRIL---  310 (407)
Q Consensus       234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  310 (407)
                      .......  ....++..|+|||.+.+..++.++|||||||++|||++|+.|+......+      ...+........   
T Consensus       157 ~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~  228 (287)
T cd07838         157 YSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD------QLDKIFDVIGLPSEE  228 (287)
T ss_pred             ccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH------HHHHHHHHcCCCChH
Confidence            6443221  23357889999999999999999999999999999999998886543221      111111100000   


Q ss_pred             ----------cccCccccc--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          311 ----------ELVDPRMRK--EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       311 ----------~~~d~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                                .........  ..........+.+++.+||+.||++||++.+++.+-+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~  286 (287)
T cd07838         229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY  286 (287)
T ss_pred             hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcC
Confidence                      000000000  0111233467789999999999999999999998743

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=8.4e-38  Score=295.07  Aligned_cols=271  Identities=22%  Similarity=0.339  Sum_probs=199.5

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecC--Cee
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDG--SQR  154 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~  154 (407)
                      ..++|++.+.||+|+||.||+|... +|+.+|+|++.... .......+.+|+.+++++ +|+||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4567888899999999999999865 58899999885421 223345677899999999 999999999988643  468


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcccc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF  234 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~  234 (407)
                      ++||||+. ++|..++...   .+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++...
T Consensus        85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            99999997 5888887543   6889999999999999999999988   999999999999999999999999999866


Q ss_pred             CCCCcc----cccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCc--------hhHHHH
Q 040557          235 PEDQAY----LSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQY--------LPEYAW  301 (407)
Q Consensus       235 ~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~--------~~~~~~  301 (407)
                      ......    ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||..........        ......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            543321    2233568899999998765 567899999999999999999999986433221000        000000


Q ss_pred             HHHHhCccccccCccccc-----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          302 KLYERGRILELVDPRMRK-----EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       302 ~~~~~~~~~~~~d~~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      ..+........++.....     .......+..+.+++.+||+.||++|||+.+++++-+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~  298 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYV  298 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhh
Confidence            000000000011100000     00111135678999999999999999999999988543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1e-37  Score=288.89  Aligned_cols=264  Identities=23%  Similarity=0.308  Sum_probs=197.0

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccCh-hhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCe-----
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQ-QGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQ-----  153 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~-----  153 (407)
                      ++|+..+.||+|+||.||+|... +|+.||+|.+...... .....+.+|+.+++.+ +|+||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888899999999999999864 6899999988654322 2335678899999999 56999999999876655     


Q ss_pred             eEEEEEeccCCChhHHHhccC---CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC-CCceEEeccc
Q 040557          154 RLLVYEYMKNRSLDLLIYGES---DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE-KFQSKIGDFG  229 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg  229 (407)
                      .++||||+++ +|.+++....   ...+++..+..++.|++.||.|||+.+   ++||||+|+||+++. ++.++|+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 7888775432   346899999999999999999999998   999999999999998 8899999999


Q ss_pred             CccccCCCCcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh-C
Q 040557          230 LARFFPEDQAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER-G  307 (407)
Q Consensus       230 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~  307 (407)
                      ++..+...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.......      ........ +
T Consensus       157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~------~~~~~~~~~~  229 (295)
T cd07837         157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ------QLLHIFKLLG  229 (295)
T ss_pred             cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHHHhC
Confidence            99865432211 122356888999998865 467999999999999999999999886532211      11111110 0


Q ss_pred             ccccccC------------cccccC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          308 RILELVD------------PRMRKE---GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       308 ~~~~~~d------------~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ......-            +.....   .........+.+++.+||+.||.+||++.|++.|-|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~  293 (295)
T cd07837         230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY  293 (295)
T ss_pred             CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCC
Confidence            0000000            000000   001123456889999999999999999999998865

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.1e-38  Score=294.47  Aligned_cols=264  Identities=27%  Similarity=0.339  Sum_probs=200.0

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChh-hHHHHHHHHHHHHcCCCCceeeeeeeeecC--CeeEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQ-GESEFLSEVRMITSIQHKNLVRLLGCCSDG--SQRLL  156 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  156 (407)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+....... ....+.+|+.++.+++|+|++++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            367888899999999999999864 68999999986443222 233566899999999999999999998654  56899


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ||||+.+ +|.+++.... ..+++..+..++.|++.|+.|||+.+   ++||||+|+||++++++.++|+|||++.....
T Consensus        86 v~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            9999975 7888775433 45899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh---------
Q 040557          237 DQAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER---------  306 (407)
Q Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------  306 (407)
                      .... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....+..      ........         
T Consensus       161 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~------~~~~~~~~~~~~~~~~~  233 (309)
T cd07845         161 PAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE------QLDLIIQLLGTPNESIW  233 (309)
T ss_pred             ccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHhcCCCChhhc
Confidence            3221 122345788999998865 567899999999999999999999986443211      11111110         


Q ss_pred             -----CccccccCcccccCCC------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          307 -----GRILELVDPRMRKEGI------VERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       307 -----~~~~~~~d~~~~~~~~------~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                           ......+  .......      .......+.+++.+||+.||++|||+.++++|.|+.
T Consensus       234 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~  294 (309)
T cd07845         234 PGFSDLPLVGKF--TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK  294 (309)
T ss_pred             hhhhcccccccc--cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence                 0000000  0000000      011245678999999999999999999999998874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.5e-37  Score=287.17  Aligned_cols=256  Identities=23%  Similarity=0.293  Sum_probs=201.0

Q ss_pred             CCCCCCeeeccCCccEEEEEe----cCCcEEEEEEecccc---ChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCee
Q 040557           83 NFHPGNLLGRGGFGPVYRGKL----ADGTLVAVKKLCVDK---SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQR  154 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  154 (407)
                      +|++.+.||+|+||.||.+..    .+|..||+|++....   .....+.+.+|+.++.++ +|+||+++.+++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477788999999999999975    368999999986432   122345678899999999 699999999999999999


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcccc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF  234 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~  234 (407)
                      ++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||+|+|||+++++.++|+|||++...
T Consensus        81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            9999999999999998543  45889999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCcccccccccCccccCccccccC--CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccc
Q 040557          235 PEDQAYLSTNFAGTLGYTAPEYAIRG--ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL  312 (407)
Q Consensus       235 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ............|+..|+|||.+.+.  .++.++||||||+++|+|++|+.|+......  ..............     
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~-----  228 (290)
T cd05613         156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSE-----  228 (290)
T ss_pred             ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccC-----
Confidence            54433323345688999999988753  4688999999999999999999998643221  11111111111110     


Q ss_pred             cCcccccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhc
Q 040557          313 VDPRMRKEGIVERDALQVINVAFICLQPHGNQRP-----PMSEIVAMLTC  357 (407)
Q Consensus       313 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~l~~  357 (407)
                        +.     .+......+.+++.+||+.||++||     ++.+++.+-+.
T Consensus       229 --~~-----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~  271 (290)
T cd05613         229 --PP-----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFF  271 (290)
T ss_pred             --CC-----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccc
Confidence              11     1122345678999999999999997     78888887654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=7.7e-38  Score=283.43  Aligned_cols=250  Identities=28%  Similarity=0.419  Sum_probs=204.9

Q ss_pred             CCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           83 NFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      +|++.+.||.|+||.||++.. .+++.+|+|.+.... .......+.+|+++++.++|+||+++.+++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            477788999999999999975 468899999986533 334456778999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccC--CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          161 MKNRSLDLLIYGES--DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       161 ~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      +++++|..++....  ...+++..+..++.|++.||.|||+.+   ++|+||+|.||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            99999999885422  356899999999999999999999998   9999999999999999999999999998775542


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                         .....++..|++||...+..++.++|+||||+++|||++|+.|+......      . .......+...        
T Consensus       158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~--------  219 (256)
T cd08530         158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------D-LRYKVQRGKYP--------  219 (256)
T ss_pred             ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHhcCCCC--------
Confidence               22346888999999999999999999999999999999999998643321      1 11111111111        


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                        ........++.+++.+||+.+|++||++.+++++.
T Consensus       220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p  254 (256)
T cd08530         220 --PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP  254 (256)
T ss_pred             --CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence              12234556789999999999999999999999873

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=9.9e-38  Score=293.17  Aligned_cols=277  Identities=23%  Similarity=0.288  Sum_probs=204.5

Q ss_pred             HHhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeec-CCeeE
Q 040557           79 KATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSD-GSQRL  155 (407)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~  155 (407)
                      .++++|+..+.||.|+||.||+|... +|+.||+|++.... .......+.+|++++..++||||+++.+++.. ....+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            45688999999999999999999754 79999999885432 22334667899999999999999999998865 56789


Q ss_pred             EEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccC
Q 040557          156 LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP  235 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~  235 (407)
                      +++||+ +++|..++..   ..+++.....++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++....
T Consensus        87 lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          87 FVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQD  159 (328)
T ss_pred             EEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccC
Confidence            999998 5688888742   34788888899999999999999998   9999999999999999999999999997543


Q ss_pred             CCCcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccC--------ch-hHHHHHHHH
Q 040557          236 EDQAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQ--------YL-PEYAWKLYE  305 (407)
Q Consensus       236 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~--------~~-~~~~~~~~~  305 (407)
                      ...    ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........        .. .++......
T Consensus       160 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd07856         160 PQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS  235 (328)
T ss_pred             CCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            322    23457889999998766 57899999999999999999999998654321000        00 000000000


Q ss_pred             hCccccccCcccccCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccCCCCCCc
Q 040557          306 RGRILELVDPRMRKEGIV-----ERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVRP  367 (407)
Q Consensus       306 ~~~~~~~~d~~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~~~~~~p  367 (407)
                       ....+.+.........+     ...+..+.+++.+||+.+|++|||+.+++.+-+.......+..|
T Consensus       236 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~  301 (328)
T cd07856         236 -ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEP  301 (328)
T ss_pred             -hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCcccc
Confidence             00000000000000011     11245788999999999999999999999998765544443333

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2e-38  Score=299.18  Aligned_cols=266  Identities=23%  Similarity=0.331  Sum_probs=199.8

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC-----Ce
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG-----SQ  153 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  153 (407)
                      .++|.+.+.||+|+||.||+|+. .+|+.||+|.+.... .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            35788889999999999999985 468999999986432 223345677899999999999999999987644     34


Q ss_pred             eEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          154 RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      .++|+||+. ++|.+++..  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        84 ~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            799999996 688888743  345899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHH--------
Q 040557          234 FPEDQAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLY--------  304 (407)
Q Consensus       234 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------  304 (407)
                      ...... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........   ........        
T Consensus       158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~  233 (337)
T cd07858         158 TSEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ---LKLITELLGSPSEEDL  233 (337)
T ss_pred             cCCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHhCCCChHHh
Confidence            654321 2233467889999998765 4689999999999999999999999864321100   00000000        


Q ss_pred             ---HhCcccc-------ccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          305 ---ERGRILE-------LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       305 ---~~~~~~~-------~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                         .......       ..+....  ......+..+.+++.+||+.+|++|||+.++++|-+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~  295 (337)
T cd07858         234 GFIRNEKARRYIRSLPYTPRQSFA--RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA  295 (337)
T ss_pred             hhcCchhhhHHHHhcCcccccCHH--HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchh
Confidence               0000000       0000000  01112346688999999999999999999999997654

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.9e-37  Score=284.76  Aligned_cols=247  Identities=23%  Similarity=0.310  Sum_probs=191.5

Q ss_pred             eeeccCCccEEEEEec-CCcEEEEEEeccccCh--hhHHHHHHHHH---HHHcCCCCceeeeeeeeecCCeeEEEEEecc
Q 040557           89 LLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQ--QGESEFLSEVR---MITSIQHKNLVRLLGCCSDGSQRLLVYEYMK  162 (407)
Q Consensus        89 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  162 (407)
                      .||+|+||.||+|... +++.||+|.+......  .....+..|..   .+....|+||+++.+++...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 5889999998643321  22223444443   3444579999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccc
Q 040557          163 NRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS  242 (407)
Q Consensus       163 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  242 (407)
                      +|+|..++..  ...+++..+..++.|++.|+.|||+.+   ++||||||+||++++++.++|+|||++..+.....   
T Consensus        81 g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---  152 (278)
T cd05606          81 GGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---  152 (278)
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---
Confidence            9999988853  346899999999999999999999988   99999999999999999999999999976543322   


Q ss_pred             cccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCC
Q 040557          243 TNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEG  321 (407)
Q Consensus       243 ~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  321 (407)
                      ....|+..|+|||.+.++ .++.++||||||+++|||++|+.||.........    ........      .+..     
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~------~~~~-----  217 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLT------MAVE-----  217 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH----HHHHHhhc------cCCC-----
Confidence            234689999999998754 6899999999999999999999998754322111    11111100      0111     


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhcc
Q 040557          322 IVERDALQVINVAFICLQPHGNQRP-----PMSEIVAMLTCK  358 (407)
Q Consensus       322 ~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~l~~~  358 (407)
                      .+...+..+.+++.+||+.+|++||     ++.+++++.+..
T Consensus       218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~  259 (278)
T cd05606         218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFR  259 (278)
T ss_pred             CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcccc
Confidence            1112345688999999999999999     999999887753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=6.8e-38  Score=287.61  Aligned_cols=252  Identities=22%  Similarity=0.286  Sum_probs=204.6

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCC-CCceeeeeeeeecCCeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQ-HKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  157 (407)
                      ++|.+.+.||+|+||.||+|... +|..||+|.+....  .......+.+|.+++++++ |+||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888899999999999999864 69999999986432  2334567889999999998 99999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            9999999999998543  36999999999999999999999988   999999999999999999999999999876543


Q ss_pred             Cc-------------------ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhH
Q 040557          238 QA-------------------YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPE  298 (407)
Q Consensus       238 ~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~  298 (407)
                      ..                   .......++..|+|||.+.+..++.++||||||++++++++|+.|+......      .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~  229 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY------L  229 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH------H
Confidence            32                   1122345788999999998888999999999999999999999998744310      1


Q ss_pred             HHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHHhh
Q 040557          299 YAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPM----SEIVAMLT  356 (407)
Q Consensus       299 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~----~ev~~~l~  356 (407)
                      ....... .      ..     ..+...+..+.+++.+||+.+|++||++    +++++|.+
T Consensus       230 ~~~~~~~-~------~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~  279 (280)
T cd05581         230 TFQKILK-L------EY-----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF  279 (280)
T ss_pred             HHHHHHh-c------CC-----CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence            1111110 0      00     1122235568899999999999999999    89888754

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.9e-38  Score=295.82  Aligned_cols=265  Identities=23%  Similarity=0.309  Sum_probs=204.1

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC-----eeE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS-----QRL  155 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  155 (407)
                      +|++.+.||.|++|.||+|+.. +|+.||+|.+..... ......+.+|+++++.++|+||+++.+++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999865 489999999864332 344567889999999999999999999987765     789


Q ss_pred             EEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccC
Q 040557          156 LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP  235 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~  235 (407)
                      ++|||+.+ +|..++...  ..+++..+..++.|++.||.|||+.+   ++|+||||.||++++++.++|+|||++....
T Consensus        81 lv~e~~~~-~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELMET-DLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchhh-hHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            99999974 788887533  36999999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCc--ccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHH-------
Q 040557          236 EDQA--YLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYE-------  305 (407)
Q Consensus       236 ~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------  305 (407)
                      ....  .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+.      ......       
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~------~~~i~~~~~~~~~  228 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ------LNLIVEVLGTPSE  228 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH------HHHHHHhcCCCCh
Confidence            5431  112334678899999999887 889999999999999999999999865432110      000000       


Q ss_pred             -------hCccccccCc-----ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          306 -------RGRILELVDP-----RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       306 -------~~~~~~~~d~-----~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                             .......+..     ...........+..+.+++.+||+.+|++||++.+++.+.+...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  294 (330)
T cd07834         229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ  294 (330)
T ss_pred             hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence                   0000000000     00000011123456889999999999999999999999977643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.1e-37  Score=282.71  Aligned_cols=251  Identities=22%  Similarity=0.260  Sum_probs=194.4

Q ss_pred             HHHHhcCCCCCCee--eccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCC
Q 040557           77 LKKATKNFHPGNLL--GRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGS  152 (407)
Q Consensus        77 ~~~~~~~~~~~~~l--g~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  152 (407)
                      .....++|++.+.+  |+|+||.||++.. .++..+|+|.+.......      .|......+ +|+|++++++++...+
T Consensus         9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390          9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence            34445677776766  9999999999985 468889999885432211      122222222 7999999999999999


Q ss_pred             eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC-ceEEecccCc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF-QSKIGDFGLA  231 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfgla  231 (407)
                      ..++||||+++++|.+++...  ..+++..+..++.|++.|+.|||+.+   ++||||+|+||+++.++ .++|+|||++
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~  157 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC  157 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence            999999999999999998544  36899999999999999999999998   99999999999999988 9999999999


Q ss_pred             cccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccc
Q 040557          232 RFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILE  311 (407)
Q Consensus       232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      .......     ...++..|+|||.+.+..++.++||||||+++|||++|+.||......... ...+... . .     
T Consensus       158 ~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~-~-~-----  224 (267)
T PHA03390        158 KIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD-LESLLKR-Q-Q-----  224 (267)
T ss_pred             eecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh-HHHHHHh-h-c-----
Confidence            8664332     246889999999999989999999999999999999999999743322211 1111110 0 0     


Q ss_pred             ccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHhhc
Q 040557          312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPP-MSEIVAMLTC  357 (407)
Q Consensus       312 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~ev~~~l~~  357 (407)
                         ...   ......+..+.+++.+||+.+|.+||+ ++++++|-|.
T Consensus       225 ---~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~  265 (267)
T PHA03390        225 ---KKL---PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL  265 (267)
T ss_pred             ---ccC---CcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcc
Confidence               000   111234566889999999999999995 6999988764

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=301.59  Aligned_cols=263  Identities=25%  Similarity=0.347  Sum_probs=202.5

Q ss_pred             CCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC------eeE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS------QRL  155 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~  155 (407)
                      .|...+.||+|+||.||+|++ .+|+.||||.++........+...+|+++|++++|+|||++++.-+...      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            455567899999999999995 5799999999987666677788899999999999999999998865433      568


Q ss_pred             EEEEeccCCChhHHHhccC-CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc--CCC--ceEEecccC
Q 040557          156 LVYEYMKNRSLDLLIYGES-DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD--EKF--QSKIGDFGL  230 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~--~~~--~~kl~Dfgl  230 (407)
                      +|||||.+|||...+.... ..+|++...+.++.+++.||.|||+++   |+||||||.||++-  ++|  -.||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            9999999999999997544 467999999999999999999999988   99999999999994  323  469999999


Q ss_pred             ccccCCCCcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcc
Q 040557          231 ARFFPEDQAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRI  309 (407)
Q Consensus       231 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      |+.++++.  .....+||..|.+||.... +.|+..+|.|||||++|+++||..||........  ..+..+.......-
T Consensus       171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~--~~~~~~~~~tkkp~  246 (732)
T KOG4250|consen  171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKN--NKEIMWHIITKKPS  246 (732)
T ss_pred             cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccc--cchhhhhhhccCCC
Confidence            99988776  3456899999999998884 8899999999999999999999999976544321  12233333322211


Q ss_pred             cccc--Ccccc-----c------CCCCHHHHHHHHHHHHHccCCCCCCCC--CHHHHH
Q 040557          310 LELV--DPRMR-----K------EGIVERDALQVINVAFICLQPHGNQRP--PMSEIV  352 (407)
Q Consensus       310 ~~~~--d~~~~-----~------~~~~~~~~~~l~~l~~~cl~~~p~~RP--s~~ev~  352 (407)
                      ...+  ++...     .      -.........+-.++..+|..+|++|-  ...+..
T Consensus       247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~F  304 (732)
T KOG4250|consen  247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFF  304 (732)
T ss_pred             ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHH
Confidence            1111  11111     0      012223345566777778888999888  444443

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-37  Score=282.20  Aligned_cols=252  Identities=24%  Similarity=0.337  Sum_probs=198.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc----ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC--Cee
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK----SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG--SQR  154 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  154 (407)
                      .+|++.+.||+|+||.||+|.. .+++.||+|.+....    .......+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4688899999999999999986 468999999875321    223446788999999999999999999998664  457


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcccc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF  234 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~  234 (407)
                      ++++||+++++|.+++...  ..+++.....++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            8999999999999988543  34789999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCC--cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccc
Q 040557          235 PEDQ--AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL  312 (407)
Q Consensus       235 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ....  ........++..|+|||.+.+..++.++|+|||||++++|++|+.||......      ....+..... .   
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~-~---  226 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------AAIFKIATQP-T---  226 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------HHHHHHHcCC-C---
Confidence            3211  11112356889999999999888999999999999999999999998642111      1111111100 0   


Q ss_pred             cCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          313 VDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       313 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                            ....+......+.+++.+||+ +|..||+..+++.|.
T Consensus       227 ------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~  262 (264)
T cd06653         227 ------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP  262 (264)
T ss_pred             ------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence                  011233344568899999999 579999999998864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.9e-37  Score=286.19  Aligned_cols=255  Identities=23%  Similarity=0.314  Sum_probs=199.1

Q ss_pred             CCCCCCeeeccCCccEEEEEe----cCCcEEEEEEecccc---ChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCee
Q 040557           83 NFHPGNLLGRGGFGPVYRGKL----ADGTLVAVKKLCVDK---SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQR  154 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  154 (407)
                      +|++.+.||+|++|.||+++.    .+++.||||.+....   .......+.+|+.++.++ +|+||+++.+.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            367778999999999999874    357889999986432   122345688999999999 699999999999999999


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcccc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF  234 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~  234 (407)
                      ++||||+.+|+|.+++..  ...+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++..+
T Consensus        81 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            999999999999998853  345889999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCcccccccccCccccCccccccCC--CCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccc
Q 040557          235 PEDQAYLSTNFAGTLGYTAPEYAIRGE--LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL  312 (407)
Q Consensus       235 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ............|+..|+|||.+.+..  .+.++||||||+++|||++|..|+......  .............      
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~------  227 (288)
T cd05583         156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILKS------  227 (288)
T ss_pred             ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHcc------
Confidence            544333333456889999999987655  788999999999999999999998532211  0011111111110      


Q ss_pred             cCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          313 VDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       313 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                       .+.     .+......+.+++.+||+.+|++|||+.++.+.|.
T Consensus       228 -~~~-----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         228 -KPP-----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             -CCC-----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence             011     11223456789999999999999999887766654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.4e-38  Score=294.82  Aligned_cols=255  Identities=24%  Similarity=0.328  Sum_probs=210.4

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ....|.+...||+|.|+.|.+|++. +|..||+|.+.+... ......+.+|+++|..++|||||+++.+......+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            4467888999999999999999854 699999999876542 23335588999999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+.+|.+.+++....  ...+..+..++.|+..|++|||+++   |+|||||.+||||+.+.++||+|||++..+...
T Consensus       134 ~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             EEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence            99999999999996544  3566888889999999999999999   999999999999999999999999999988744


Q ss_pred             CcccccccccCccccCccccccCCC-CccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                      .  ...+.+|++.|.|||.+.+..| ++.+|+||+|++||-|+.|..||++..-.+.+.               ..+-..
T Consensus       209 ~--~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~---------------rvl~gk  271 (596)
T KOG0586|consen  209 L--MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP---------------RVLRGK  271 (596)
T ss_pred             c--cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc---------------hheeee
Confidence            3  3356899999999999999877 689999999999999999999998654332210               001111


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ++   .+.-...+.-+++++++-.+|.+|++++++.++-|...
T Consensus       272 ~r---Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~  311 (596)
T KOG0586|consen  272 YR---IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND  311 (596)
T ss_pred             ec---ccceeechhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence            11   22222345668899999999999999999999888544

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.9e-37  Score=282.10  Aligned_cols=247  Identities=24%  Similarity=0.318  Sum_probs=196.2

Q ss_pred             eeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCCh
Q 040557           90 LGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL  166 (407)
Q Consensus        90 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  166 (407)
                      ||+|+||.||++... +|+.+++|.+.....  ......+.+|++++++++|+||+++++.+..+...+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999875 499999999864332  24456788999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc-------
Q 040557          167 DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA-------  239 (407)
Q Consensus       167 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-------  239 (407)
                      .+++....  .+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........       
T Consensus        81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            99986433  6899999999999999999999988   99999999999999999999999999876543321       


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                      .......++..|+|||......++.++||||||++++||++|+.|+......      ... .....+...      ...
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~------~~~  222 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIF-QNILNGKIE------WPE  222 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHH-HHHhcCCcC------CCc
Confidence            1223356788999999998888999999999999999999999998644321      111 111111110      000


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCH---HHHHHHhhc
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPM---SEIVAMLTC  357 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~---~ev~~~l~~  357 (407)
                         ....+..+.+++.+||+.+|++|||+   .+++++-+.
T Consensus       223 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~  260 (265)
T cd05579         223 ---DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF  260 (265)
T ss_pred             ---cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccc
Confidence               00124668899999999999999999   666655443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-37  Score=277.21  Aligned_cols=249  Identities=27%  Similarity=0.465  Sum_probs=203.2

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      +|++.+.||+|++|.||++... +++.|++|.+..... ......+.+|++++++++|+|++++++++.+++..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4777899999999999999764 588999999865432 24456789999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++++|.+++...  ..+++..+..++.|++.|+.|||+.+   ++||||+|+||+++.++.++|+|||++.........
T Consensus        81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence            9999999998543  56899999999999999999999998   999999999999999999999999999877554332


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                       .....++..|+|||...+..++.++||||||+++++|++|+.|+......      ...+.... ...     +.    
T Consensus       156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~~~~~~~~-~~~-----~~----  218 (254)
T cd06627         156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM------AALFRIVQ-DDH-----PP----  218 (254)
T ss_pred             -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhc-cCC-----CC----
Confidence             23356888999999988888899999999999999999999998643211      11111111 110     11    


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAM  354 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  354 (407)
                       .+...+..+.+++.+||+.+|++|||+.+++.+
T Consensus       219 -~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         219 -LPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             -CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence             112234568899999999999999999999875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1e-37  Score=288.81  Aligned_cols=259  Identities=19%  Similarity=0.264  Sum_probs=183.0

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecC----CcEEEEEEeccccChhh-H---------HHHHHHHHHHHcCCCCceeeeee
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLAD----GTLVAVKKLCVDKSQQG-E---------SEFLSEVRMITSIQHKNLVRLLG  146 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-~---------~~~~~e~~~l~~l~h~niv~l~~  146 (407)
                      .++|++.+.||+|+||.||+|...+    +..+|+|.......... +         .....+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3678999999999999999998654    34566665432221110 0         11223344556678999999999


Q ss_pred             eeecCC----eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCc
Q 040557          147 CCSDGS----QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ  222 (407)
Q Consensus       147 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~  222 (407)
                      ++....    ..++++|++.. ++.+.+...  ...++..+..++.|++.||.|||+.+   ++||||||+|||++.++.
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence            765443    34677777643 555555322  23578888999999999999999988   999999999999999999


Q ss_pred             eEEecccCccccCCCCcc------cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCch
Q 040557          223 SKIGDFGLARFFPEDQAY------LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYL  296 (407)
Q Consensus       223 ~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~  296 (407)
                      ++|+|||+++.+......      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ..
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-~~  243 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-LI  243 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH-HH
Confidence            999999999876432211      11234699999999999999999999999999999999999999975422111 00


Q ss_pred             hHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          297 PEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       297 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                      .........     .+......    ....+..+.+++..|++.+|++||++.++++.+
T Consensus       244 ~~~~~~~~~-----~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        244 HAAKCDFIK-----RLHEGKIK----IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHhHHHHHH-----Hhhhhhhc----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            000000000     00001110    112346688999999999999999999999876

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2e-37  Score=288.80  Aligned_cols=252  Identities=27%  Similarity=0.404  Sum_probs=198.8

Q ss_pred             CCCCCeeeccCCccEEEEEec-CCcEEEEEEeccc--cChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           84 FHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVD--KSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      |+..+.||+|+||.||+|+.. ++..+|+|.+...  .......++.+|+++++.++|+|++++.+++......++||||
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   96 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence            555678999999999999864 5888999988542  2233445788999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +. |++.+++... ...+++..+..++.|++.|+.|||+.+   ++||||+|+||+++.++.++|+|||++.......  
T Consensus        97 ~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--  169 (308)
T cd06634          97 CL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN--  169 (308)
T ss_pred             cC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCcc--
Confidence            96 5777766533 345899999999999999999999988   9999999999999999999999999997654322  


Q ss_pred             cccccccCccccCccccc---cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          241 LSTNFAGTLGYTAPEYAI---RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                         ...++..|+|||.+.   ...++.++|||||||++|||++|+.|+......      ..... ...+..     +..
T Consensus       170 ---~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~-~~~~~~-----~~~  234 (308)
T cd06634         170 ---XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYH-IAQNES-----PAL  234 (308)
T ss_pred             ---cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HHHHH-HhhcCC-----CCc
Confidence               346788999999874   356788999999999999999999987542211      11111 111111     111


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                          ........+.+++.+||+.+|++||++.+++.+.+.....
T Consensus       235 ----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         235 ----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             ----CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence                1122345688999999999999999999999998876543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-37  Score=279.76  Aligned_cols=245  Identities=24%  Similarity=0.277  Sum_probs=189.3

Q ss_pred             CeeeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHH-HcCCCCceeeeeeeeecCCeeEEEEEeccC
Q 040557           88 NLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMI-TSIQHKNLVRLLGCCSDGSQRLLVYEYMKN  163 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  163 (407)
                      +.||+|+||.||+|... +|+.||+|.+.....  ......+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999864 589999999854321  12223445555544 445899999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccccc
Q 040557          164 RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST  243 (407)
Q Consensus       164 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  243 (407)
                      ++|..++...  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++......     .
T Consensus        82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----~  151 (260)
T cd05611          82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-----K  151 (260)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecccc-----c
Confidence            9999998543  45899999999999999999999988   999999999999999999999999999765432     2


Q ss_pred             ccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCC
Q 040557          244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIV  323 (407)
Q Consensus       244 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  323 (407)
                      ...++..|+|||.+.+..++.++||||||+++|||++|..||......       ........+...    .   .....
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~----~---~~~~~  217 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-------AVFDNILSRRIN----W---PEEVK  217 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcccC----C---CCccc
Confidence            346888999999998888999999999999999999999998643221       111111111111    0   00011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCH---HHHHHHhh
Q 040557          324 ERDALQVINVAFICLQPHGNQRPPM---SEIVAMLT  356 (407)
Q Consensus       324 ~~~~~~l~~l~~~cl~~~p~~RPs~---~ev~~~l~  356 (407)
                      ...+..+.+++.+||+.+|++||++   .|++.|.+
T Consensus       218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~  253 (260)
T cd05611         218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPF  253 (260)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChH
Confidence            1235668999999999999999966   56665544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-38  Score=267.99  Aligned_cols=251  Identities=22%  Similarity=0.329  Sum_probs=200.6

Q ss_pred             CCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEEEEeccC
Q 040557           86 PGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVYEYMKN  163 (407)
Q Consensus        86 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  163 (407)
                      ....||.|..|.|++.+.. .|...|||.+.........++++..++++... ++|+||+.+|+|......++-||.|..
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~  175 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST  175 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence            3456999999999999864 58999999998877888888999999988877 499999999999999999999999854


Q ss_pred             CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccccc
Q 040557          164 RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST  243 (407)
Q Consensus       164 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  243 (407)
                       .++.++.. ..+++++..+-++...+..||.||..++  +|+|||+||+|||+|+.|++||+|||++-.+-+....  +
T Consensus       176 -C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh--t  249 (391)
T KOG0983|consen  176 -CAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH--T  249 (391)
T ss_pred             -HHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc--c
Confidence             44555543 3455899999999999999999998865  5999999999999999999999999999877654433  3


Q ss_pred             ccccCccccCcccccc---CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          244 NFAGTLGYTAPEYAIR---GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       244 ~~~gt~~y~aPE~~~~---~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                      ...|-+.|||||.+.-   ..|+-++||||||+.|+||.||+.|+..-.. ++    +.....+++.      .|.+...
T Consensus       250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t-dF----e~ltkvln~e------PP~L~~~  318 (391)
T KOG0983|consen  250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT-DF----EVLTKVLNEE------PPLLPGH  318 (391)
T ss_pred             cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc-cH----HHHHHHHhcC------CCCCCcc
Confidence            4578999999998864   4789999999999999999999999875321 11    1122222211      1333322


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      .   ..+.++++++..||++|+.+||...++++|--
T Consensus       319 ~---gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~F  351 (391)
T KOG0983|consen  319 M---GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPF  351 (391)
T ss_pred             c---CcCHHHHHHHHHHhhcCcccCcchHHHhcCcc
Confidence            1   14567899999999999999999999998853

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.2e-37  Score=287.99  Aligned_cols=249  Identities=23%  Similarity=0.355  Sum_probs=199.2

Q ss_pred             CeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCCh
Q 040557           88 NLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL  166 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  166 (407)
                      ..||+|+||.||++.. .+|+.||+|.+... .......+.+|+.+++.++|+|++++++++...+..+++|||+++++|
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            4699999999999986 46899999988533 334556788999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccccccc
Q 040557          167 DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA  246 (407)
Q Consensus       167 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  246 (407)
                      .+++..   ..+++.....++.|++.|++|||+.+   ++|+||+|+||++++++.++|+|||++........ ......
T Consensus       105 ~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~  177 (292)
T cd06657         105 TDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV  177 (292)
T ss_pred             HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccc
Confidence            988743   34799999999999999999999998   99999999999999999999999999876644322 123356


Q ss_pred             cCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHH
Q 040557          247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERD  326 (407)
Q Consensus       247 gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  326 (407)
                      |+..|+|||.+.+..++.++|+||||+++|+|++|..|+.......      .. .....+     ..+...   .....
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~------~~-~~~~~~-----~~~~~~---~~~~~  242 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AM-KMIRDN-----LPPKLK---NLHKV  242 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHhh-----CCcccC---CcccC
Confidence            8899999999988889999999999999999999999986432211      11 111110     111111   11123


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          327 ALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       327 ~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      +..+.+++.+||+.+|.+||++.+++++-+...
T Consensus       243 ~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~  275 (292)
T cd06657         243 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK  275 (292)
T ss_pred             CHHHHHHHHHHHhCCcccCcCHHHHhcChHHhc
Confidence            445788999999999999999999999866543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-37  Score=293.68  Aligned_cols=260  Identities=22%  Similarity=0.341  Sum_probs=195.4

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC------C
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG------S  152 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  152 (407)
                      .++|...+.||+|+||.||+|.. .+|+.||+|++.... .......+.+|+.+++.++|+||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            47888889999999999999985 468999999986432 222345678999999999999999999998654      2


Q ss_pred             eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                      ..++|+||+.+ +|..+.    ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||+++
T Consensus        94 ~~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             eEEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            46899999964 676654    234899999999999999999999998   9999999999999999999999999997


Q ss_pred             ccCCCCcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh-----
Q 040557          233 FFPEDQAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER-----  306 (407)
Q Consensus       233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----  306 (407)
                      ......    ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......      ........     
T Consensus       166 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~------~~~~~~~~~~~~~  235 (342)
T cd07879         166 HADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD------QLTQILKVTGVPG  235 (342)
T ss_pred             CCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHhcCCCC
Confidence            653322    23467889999998876 468999999999999999999999997543211      11111110     


Q ss_pred             ---------CccccccC--cccccCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          307 ---------GRILELVD--PRMRKEGI---VERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       307 ---------~~~~~~~d--~~~~~~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                               ......+.  +.......   .......+.+++.+||+.||++||++.+++.|-+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~  301 (342)
T cd07879         236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFD  301 (342)
T ss_pred             HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchh
Confidence                     00000000  00000000   011234578999999999999999999999986654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.4e-37  Score=290.27  Aligned_cols=274  Identities=24%  Similarity=0.316  Sum_probs=203.1

Q ss_pred             CHHHHHHHhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeec
Q 040557           73 DFQTLKKATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSD  150 (407)
Q Consensus        73 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  150 (407)
                      ...++....++|++.+.||+|+||.||+|.. .+|+.||+|++.... .......+.+|++++++++|+||+++.+++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            3456677889999999999999999999975 468999999986432 22334568899999999999999999998754


Q ss_pred             C------CeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceE
Q 040557          151 G------SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSK  224 (407)
Q Consensus       151 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k  224 (407)
                      .      ...+++++++ +++|.+++..   ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence            3      3467888876 7799888743   34899999999999999999999998   99999999999999999999


Q ss_pred             EecccCccccCCCCcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHH----
Q 040557          225 IGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEY----  299 (407)
Q Consensus       225 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~----  299 (407)
                      |+|||++.......    ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........  +...    
T Consensus       161 l~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~  234 (345)
T cd07877         161 ILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLILRLV  234 (345)
T ss_pred             Eecccccccccccc----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHh
Confidence            99999998653322    23567889999998866 5688999999999999999999999854322110  0000    


Q ss_pred             ------HHHHHHhCccccccC--cccccC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          300 ------AWKLYERGRILELVD--PRMRKE---GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       300 ------~~~~~~~~~~~~~~d--~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                            ....+........+.  +.....   .........+.+++.+|++.||++||++.+++++-+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~  305 (345)
T cd07877         235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  305 (345)
T ss_pred             CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence                  000000000000000  000000   000012446789999999999999999999999987653

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.9e-36  Score=282.75  Aligned_cols=249  Identities=27%  Similarity=0.402  Sum_probs=196.0

Q ss_pred             CCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           84 FHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      |...+.||+|+||.||+|+.. +|..|++|.+....  .......+.+|+++++.++|+|++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            455577999999999999864 68899999986432  223445788999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +. |++.+++... ...+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++......   
T Consensus       103 ~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~---  174 (313)
T cd06633         103 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA---  174 (313)
T ss_pred             CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCC---
Confidence            96 5777766533 345899999999999999999999998   999999999999999999999999998643322   


Q ss_pred             cccccccCccccCccccc---cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          241 LSTNFAGTLGYTAPEYAI---RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                        ....|+..|+|||.+.   ...++.++||||||+++|||++|..|+.......      ....... ...     +..
T Consensus       175 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~-~~~-----~~~  240 (313)
T cd06633         175 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQ-NDS-----PTL  240 (313)
T ss_pred             --CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHh-cCC-----CCC
Confidence              2356888999999874   4568899999999999999999999986432211      1111111 111     111


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .    .......+.+++.+||+.+|++||++.+++.+-+..
T Consensus       241 ~----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~  277 (313)
T cd06633         241 Q----SNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVR  277 (313)
T ss_pred             C----ccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence            1    111234588999999999999999999999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-38  Score=312.10  Aligned_cols=264  Identities=24%  Similarity=0.221  Sum_probs=214.1

Q ss_pred             HHHHHhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC
Q 040557           76 TLKKATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS  152 (407)
Q Consensus        76 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  152 (407)
                      .++...++|.+.++||+|+||.|..+++. +++.||.|++.+..  ......-|..|-.+|..-+.+-|+.+...|.+..
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            34445578888999999999999999864 68999999996533  2234456888999999989999999999999999


Q ss_pred             eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                      ++|+|||||+||+|-.++....  .+++..+..++..|..||.-||+.|   +|||||||+|||||..|.+||+|||.+.
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsCl  223 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCL  223 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHH
Confidence            9999999999999999985433  6999999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCcccccccccCccccCccccc----c-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhC
Q 040557          233 FFPEDQAYLSTNFAGTLGYTAPEYAI----R-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERG  307 (407)
Q Consensus       233 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      .+..+....+...+|||-|++||++.    + +.|+...|.||+||++|||+.|..||+...      +.+.+.+.+.-.
T Consensus       224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KIm~hk  297 (1317)
T KOG0612|consen  224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKIMNHK  297 (1317)
T ss_pred             hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHHhchh
Confidence            99888877788889999999999885    2 678999999999999999999999997432      233333333321


Q ss_pred             ccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHhhccc
Q 040557          308 RILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPP---MSEIVAMLTCKV  359 (407)
Q Consensus       308 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~ev~~~l~~~~  359 (407)
                      ......        .....+.+..+||+..+. +|+.|..   +.++..|..+..
T Consensus       298 ~~l~FP--------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g  343 (1317)
T KOG0612|consen  298 ESLSFP--------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEG  343 (1317)
T ss_pred             hhcCCC--------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccC
Confidence            111111        001234567777777665 7888888   999999987643

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.1e-37  Score=290.18  Aligned_cols=268  Identities=24%  Similarity=0.296  Sum_probs=198.0

Q ss_pred             cCCC-CCCeeeccCCccEEEEEec-CCcEEEEEEeccccChh-------------hHHHHHHHHHHHHcCCCCceeeeee
Q 040557           82 KNFH-PGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQ-------------GESEFLSEVRMITSIQHKNLVRLLG  146 (407)
Q Consensus        82 ~~~~-~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------------~~~~~~~e~~~l~~l~h~niv~l~~  146 (407)
                      ++|. +.+.||+|+||.||+|... +++.||+|.+.......             ....+.+|+++++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4554 3567999999999999854 68999999985432211             0124779999999999999999999


Q ss_pred             eeecCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEe
Q 040557          147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIG  226 (407)
Q Consensus       147 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~  226 (407)
                      ++...+..++||||+. |+|.+++..  ...+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEEC
Confidence            9999999999999997 588888843  345899999999999999999999988   9999999999999999999999


Q ss_pred             cccCccccCCCC-------------cccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcc
Q 040557          227 DFGLARFFPEDQ-------------AYLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSE  292 (407)
Q Consensus       227 Dfgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~  292 (407)
                      |||++.......             ........++..|+|||.+.+. .++.++|||||||++|||++|+.||......+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999998665111             0111223467889999988764 46899999999999999999999986543211


Q ss_pred             cCchhHHHHHHHHhCcc-----------ccccCccccc--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          293 MQYLPEYAWKLYERGRI-----------LELVDPRMRK--EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       293 ~~~~~~~~~~~~~~~~~-----------~~~~d~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .   .............           ..........  ..........+.+++.+||+.+|++|||++|++.+.|..
T Consensus       242 ~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~  317 (335)
T PTZ00024        242 Q---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK  317 (335)
T ss_pred             H---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence            0   0011111000000           0000000000  000112245688999999999999999999999998874

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.5e-37  Score=289.51  Aligned_cols=272  Identities=24%  Similarity=0.321  Sum_probs=201.2

Q ss_pred             HHHHhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC--
Q 040557           77 LKKATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS--  152 (407)
Q Consensus        77 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--  152 (407)
                      +....++|+..+.||+|+||.||+|.. .+|..||||++.... .......+.+|+++++.++|+||+++++++....  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            444567899999999999999999974 478999999985432 2333456889999999999999999999886543  


Q ss_pred             ----eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecc
Q 040557          153 ----QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDF  228 (407)
Q Consensus       153 ----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  228 (407)
                          ..++||||+ +++|..++..   ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+||
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df  162 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF  162 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence                458999998 7789888743   35899999999999999999999998   999999999999999999999999


Q ss_pred             cCccccCCCCcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccC--------chhHH
Q 040557          229 GLARFFPEDQAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQ--------YLPEY  299 (407)
Q Consensus       229 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~--------~~~~~  299 (407)
                      |++.......    ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.........        .....
T Consensus       163 g~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07880         163 GLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE  238 (343)
T ss_pred             ccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            9998654322    23467889999998876 45889999999999999999999998643221000        00000


Q ss_pred             HHHHHHhCccccccC--cccccC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          300 AWKLYERGRILELVD--PRMRKE---GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       300 ~~~~~~~~~~~~~~d--~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ....+........+.  +.....   .........+.+++.+|++.||++|||+.+++.+-+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~  303 (343)
T cd07880         239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE  303 (343)
T ss_pred             HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence            000000000000000  000000   001122345889999999999999999999998877643

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4e-37  Score=287.02  Aligned_cols=268  Identities=24%  Similarity=0.337  Sum_probs=195.2

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChh-hHHHHHHHHHHHHcCCCCceeeeeeeeecC-------
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQ-GESEFLSEVRMITSIQHKNLVRLLGCCSDG-------  151 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  151 (407)
                      .++|++.+.||+|+||.||+|... +++.+|+|++....... ....+.+|+++++.++|+||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            478889999999999999999864 68999999986443222 234567899999999999999999887443       


Q ss_pred             -CeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccC
Q 040557          152 -SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGL  230 (407)
Q Consensus       152 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgl  230 (407)
                       ...++|+||+.+ ++...+... ...+++..+..++.|+++||.|||+.+   ++|+||||+||++++++.++|+|||+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence             346999999975 666666432 345899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcc----------cccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHH
Q 040557          231 ARFFPEDQAY----------LSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEY  299 (407)
Q Consensus       231 a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~  299 (407)
                      +.........          ......+++.|+|||.+.+. .++.++||||||+++|||++|++||.........   ..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~---~~  238 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL---HL  238 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH---HH
Confidence            9865432211          11234568889999987654 5789999999999999999999998654332100   00


Q ss_pred             HHHHHHh---------Ccccccc----CcccccC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          300 AWKLYER---------GRILELV----DPRMRKE--GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       300 ~~~~~~~---------~~~~~~~----d~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      .......         ..+....    .......  .........+.+++.+||+.||++|||+.+++.+-+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~  310 (311)
T cd07866         239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY  310 (311)
T ss_pred             HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCC
Confidence            0000000         0000000    0000000  000112256889999999999999999999998754

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-38  Score=272.75  Aligned_cols=250  Identities=24%  Similarity=0.284  Sum_probs=203.2

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|...++||+|.||.|.+++- .+|+.+|+|+++++.  ..+....-+.|-++|...+||.+..+...|...+.+|+||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            6788889999999999999984 479999999997653  3344455678999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||..||.|..++  .+.+.+++.....+-..|+.||.|||+.+   |+.||||.+|.|+|.+|.+||+||||++.--...
T Consensus       248 eyanGGeLf~HL--srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g  322 (516)
T KOG0690|consen  248 EYANGGELFFHL--SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG  322 (516)
T ss_pred             EEccCceEeeeh--hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccccc
Confidence            999999998887  34556888888889999999999999998   9999999999999999999999999998543222


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                      . ...+++|||.|+|||++....|...+|.|.+||++|||++|+.||.......       ...++.-+        .+ 
T Consensus       323 ~-t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k-------LFeLIl~e--------d~-  385 (516)
T KOG0690|consen  323 D-TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK-------LFELILME--------DL-  385 (516)
T ss_pred             c-eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH-------HHHHHHhh--------hc-
Confidence            2 3456899999999999999999999999999999999999999997543221       11111111        11 


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHh
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPP-----MSEIVAML  355 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~l  355 (407)
                        .++.....+...|+.-.|.+||.+|..     +.||.+|-
T Consensus       386 --kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~  425 (516)
T KOG0690|consen  386 --KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHR  425 (516)
T ss_pred             --cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhh
Confidence              133334456778888899999999963     66776653

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4.2e-37  Score=290.72  Aligned_cols=264  Identities=21%  Similarity=0.299  Sum_probs=195.8

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC---------
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG---------  151 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---------  151 (407)
                      .+|...+.||.|+||.||+|.. .+|+.||+|.+..... .....+.+|+++++.++|+||+++++++...         
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            6788889999999999999986 4689999999864433 4456788999999999999999999776543         


Q ss_pred             -----CeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc-CCCceEE
Q 040557          152 -----SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD-EKFQSKI  225 (407)
Q Consensus       152 -----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl  225 (407)
                           ...++||||++ ++|..++..   ..+++..+..++.|++.||.|||+.+   ++||||||+||+++ +++.++|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence                 35789999997 588887742   34889999999999999999999998   99999999999997 5567899


Q ss_pred             ecccCccccCCCCccc--ccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHH
Q 040557          226 GDFGLARFFPEDQAYL--STNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWK  302 (407)
Q Consensus       226 ~Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~  302 (407)
                      +|||++..........  .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....+...      ...
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~------~~~  230 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ------MQL  230 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH
Confidence            9999998654322111  122357889999997654 5678899999999999999999999965432110      000


Q ss_pred             HHHhC---------ccccccCccc----ccC-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          303 LYERG---------RILELVDPRM----RKE-----GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       303 ~~~~~---------~~~~~~d~~~----~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .....         .....+...+    ...     .........+.+++.+||+.||++|||+.+++.+-+...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence            00000         0000000000    000     001113356789999999999999999999999988753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.2e-36  Score=276.50  Aligned_cols=252  Identities=24%  Similarity=0.359  Sum_probs=196.5

Q ss_pred             CCCCCCeeeccCCccEEEEEecC-CcEEEEEEecccc----ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDK----SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      +|.+.+.||+|+||.||++.... +..+++|.++...    .......+..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47788999999999999997643 4445555553211    222334567899999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhc--cCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccC
Q 040557          158 YEYMKNRSLDLLIYG--ESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP  235 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~  235 (407)
                      |||+++++|..++..  .....+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++ +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999988853  23456899999999999999999999988   999999999999986 469999999998664


Q ss_pred             CCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          236 EDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       236 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                      .... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..|+.....      ........ .+.     .+
T Consensus       157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~-~~~-----~~  223 (260)
T cd08222         157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIV-EGP-----TP  223 (260)
T ss_pred             CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHH-cCC-----CC
Confidence            4322 12235678899999999888889999999999999999999999853211      11111111 111     01


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      .     .+...+..+.+++.+||+.+|++||++.+++++-+
T Consensus       224 ~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  259 (260)
T cd08222         224 S-----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF  259 (260)
T ss_pred             C-----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence            1     12334567899999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-37  Score=281.08  Aligned_cols=267  Identities=26%  Similarity=0.347  Sum_probs=200.1

Q ss_pred             CCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           84 FHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      |+..+.||+|++|.||+|... +++.+|+|.+.... .......+.+|+.+++.++|+|++++++++.+....++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            455678999999999999865 58999999986543 2233456788999999999999999999999999999999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      + ++|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++......... 
T Consensus        81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-  154 (282)
T cd07829          81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-  154 (282)
T ss_pred             C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc-
Confidence            7 58999986543 35899999999999999999999998   999999999999999999999999999876543321 


Q ss_pred             ccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccC-c-------hhHHHHHHHHhCccccc
Q 040557          242 STNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQ-Y-------LPEYAWKLYERGRILEL  312 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~-~-------~~~~~~~~~~~~~~~~~  312 (407)
                      .....++..|+|||.+.+. .++.++||||||+++|||++|+.||......+.. .       .....+.....-.....
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            2234467789999998776 8899999999999999999999888654321100 0       00000000000000000


Q ss_pred             cCcccccC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          313 VDPRMRKE---GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       313 ~d~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      .-+.....   .........+.+++..||+.+|++||++.+++.+-|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~  281 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY  281 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcC
Confidence            00000000   000112457899999999999999999999998765

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=266.76  Aligned_cols=290  Identities=21%  Similarity=0.239  Sum_probs=220.0

Q ss_pred             HhcCCCCC-CeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeec----CC
Q 040557           80 ATKNFHPG-NLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSD----GS  152 (407)
Q Consensus        80 ~~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~  152 (407)
                      .+++|++. ++||-|-.|.|-.+.. .+|+.+|+|++...  .    ...+|+++-... .|+|||.++++|++    ..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--~----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk  132 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--P----KARREVELHWMASGHPHIVSIIDVYENSYQGRK  132 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--H----HHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence            34566553 4799999999999865 46899999988422  1    235788877666 69999999998864    34


Q ss_pred             eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc---CCCceEEeccc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD---EKFQSKIGDFG  229 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg  229 (407)
                      .+.+|||+|+||.|...+..+....+++.++..|+.||+.|+.|||+.+   |.||||||+|+|.+   .|..+||+|||
T Consensus       133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            5679999999999999998888888999999999999999999999998   99999999999997   45679999999


Q ss_pred             CccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcc
Q 040557          230 LARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRI  309 (407)
Q Consensus       230 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      +|+.-.....  ..+-+-|+.|.|||++....|+...|+||+||++|-|++|-+||......-   ++--....+..|..
T Consensus       210 FAK~t~~~~~--L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~rI~~gqy  284 (400)
T KOG0604|consen  210 FAKETQEPGD--LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRRIRTGQY  284 (400)
T ss_pred             cccccCCCcc--ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhHhhccCc
Confidence            9986543322  234678999999999999999999999999999999999999997654311   11111111221111


Q ss_pred             ccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccCCCCCCchhhHhhccccCCCCCCcccccC
Q 040557          310 LELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVRPAYLERRRKRDETLSWDTISEPF  389 (407)
Q Consensus       310 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  389 (407)
                       +.-++      .-...+....++|+.+|..+|++|.|+.+++.|-|-.....+|..|..-..... .....|+...+..
T Consensus       285 -~FP~p------EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t~~~l~-~a~e~w~dvqeem  356 (400)
T KOG0604|consen  285 -EFPEP------EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLSTSRMLK-EAVEAWDDVQEEM  356 (400)
T ss_pred             -cCCCh------hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchhhhhcc-hhhhhhHHHHHHH
Confidence             01111      112345677899999999999999999999999998888888877654433322 2334477665544


Q ss_pred             CC
Q 040557          390 PS  391 (407)
Q Consensus       390 ~~  391 (407)
                      ++
T Consensus       357 ~~  358 (400)
T KOG0604|consen  357 TE  358 (400)
T ss_pred             HH
Confidence            43

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.1e-37  Score=289.32  Aligned_cols=263  Identities=24%  Similarity=0.346  Sum_probs=200.1

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCe----
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQ----  153 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  153 (407)
                      ..++|+..+.||+|++|.||+|+.. ++..||+|++.... .......+.+|+.+++.++|+|++++.+++.....    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4577888899999999999999864 58899999885432 22334567889999999999999999988765554    


Q ss_pred             --eEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCc
Q 040557          154 --RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLA  231 (407)
Q Consensus       154 --~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla  231 (407)
                        .++|+||+ +++|.+++..   ..+++..+..++.|++.|+.|||+.+   ++||||+|+||++++++.++|+|||++
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence              89999998 6699888853   35899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh-Cc-
Q 040557          232 RFFPEDQAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER-GR-  308 (407)
Q Consensus       232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~-  308 (407)
                      ......    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......      ........ +. 
T Consensus       166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~------~~~~i~~~~~~~  235 (343)
T cd07851         166 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID------QLKRIMNLVGTP  235 (343)
T ss_pred             cccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHHhcCCC
Confidence            866433    223467889999998765 467899999999999999999999986433211      11111000 00 


Q ss_pred             ------------cccccCc--ccccC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          309 ------------ILELVDP--RMRKE---GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       309 ------------~~~~~d~--~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                                  ....+..  .....   ......+..+.+++.+||+.+|++|||+.+|+++-+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~  303 (343)
T cd07851         236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE  303 (343)
T ss_pred             CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence                        0000000  00000   000112457889999999999999999999999977643

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.7e-36  Score=285.50  Aligned_cols=268  Identities=23%  Similarity=0.286  Sum_probs=193.8

Q ss_pred             CCCCCCeeeccCCccEEEEEec-C--CcEEEEEEecccc-ChhhHHHHHHHHHHHHcC-CCCceeeeeeeeec----CCe
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-D--GTLVAVKKLCVDK-SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSD----GSQ  153 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~  153 (407)
                      +|++.+.||+|+||.||+++.. +  +..||+|.+.... .......+.+|++++.++ +|+||+++++++..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4677789999999999999864 3  7789999985432 222345678999999999 59999999987532    245


Q ss_pred             eEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          154 RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      .++++||+. ++|..++.  ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++..
T Consensus        81 ~~~~~e~~~-~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          81 LYLYEELME-ADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             EEEEEeccc-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            788899886 58888874  3456899999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCcc---cccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccC---------chhHHH
Q 040557          234 FPEDQAY---LSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQ---------YLPEYA  300 (407)
Q Consensus       234 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~---------~~~~~~  300 (407)
                      +......   ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.........         ......
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL  234 (332)
T ss_pred             cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            6432221   1123568999999998765 46899999999999999999999998653311000         000000


Q ss_pred             HHHHHhCccccc---cC--cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          301 WKLYERGRILEL---VD--PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       301 ~~~~~~~~~~~~---~d--~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      ... ........   .+  +..............+.+++.+||+.||++|||+.+++.+-+.
T Consensus       235 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~  295 (332)
T cd07857         235 SRI-GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL  295 (332)
T ss_pred             Hhh-hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence            000 00000000   00  0000000001124568899999999999999999999988664

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-36  Score=272.69  Aligned_cols=243  Identities=27%  Similarity=0.309  Sum_probs=196.8

Q ss_pred             eeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCCh
Q 040557           90 LGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL  166 (407)
Q Consensus        90 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  166 (407)
                      ||.|+||.||++... +++.+|+|.+.....  ......+..|+.++++++|+|++++++.+..+...+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999865 589999999865432  23456788999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccccccc
Q 040557          167 DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA  246 (407)
Q Consensus       167 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  246 (407)
                      .+++...  ..+++.....++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++........ ......
T Consensus        81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~  154 (250)
T cd05123          81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTFC  154 (250)
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCCc
Confidence            9998543  35899999999999999999999988   99999999999999999999999999987654321 123456


Q ss_pred             cCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHH
Q 040557          247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERD  326 (407)
Q Consensus       247 gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  326 (407)
                      ++..|++||...+...+.++|+||||+++|+|++|+.||.....      ......... +.        .   ..+...
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-~~--------~---~~~~~~  216 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILK-DP--------L---RFPEFL  216 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhc-CC--------C---CCCCCC
Confidence            88899999999888899999999999999999999999864322      111111111 10        0   111222


Q ss_pred             HHHHHHHHHHccCCCCCCCCCH---HHHHHHhh
Q 040557          327 ALQVINVAFICLQPHGNQRPPM---SEIVAMLT  356 (407)
Q Consensus       327 ~~~l~~l~~~cl~~~p~~RPs~---~ev~~~l~  356 (407)
                      +..+.+++.+||+.||++||++   ++++.+.+
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~  249 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF  249 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCC
Confidence            4568899999999999999999   77776644

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.4e-36  Score=308.94  Aligned_cols=146  Identities=26%  Similarity=0.401  Sum_probs=130.3

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|... +++.||+|++....  .......+..|+.++..++|+||+++++++......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888899999999999999865 68999999986432  2333467889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                      ||+.+++|..++...  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999998543  45889999999999999999999988   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-37  Score=273.08  Aligned_cols=261  Identities=24%  Similarity=0.304  Sum_probs=209.9

Q ss_pred             HHHHhcCCCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeee-
Q 040557           77 LKKATKNFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS-  149 (407)
Q Consensus        77 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-  149 (407)
                      +.....+++...++-+|.||.||.|.+.      +.+.|-+|.++...++-+...++.|.-.+..+.|||+..+.+++. 
T Consensus       279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie  358 (563)
T KOG1024|consen  279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE  358 (563)
T ss_pred             hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence            4444567888888999999999999543      345678888877777777888999999999999999999999885 


Q ss_pred             cCCeeEEEEEeccCCChhHHHhccC------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCce
Q 040557          150 DGSQRLLVYEYMKNRSLDLLIYGES------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS  223 (407)
Q Consensus       150 ~~~~~~lv~e~~~~g~L~~~l~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~  223 (407)
                      +....++++.++.-|+|..++...+      .+.++......++.|++.|++|||+++   ++|.||..+|.++|+...+
T Consensus       359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqV  435 (563)
T KOG1024|consen  359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQV  435 (563)
T ss_pred             ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeE
Confidence            4567789999999999999997322      345677788889999999999999998   9999999999999999999


Q ss_pred             EEecccCccccC-CCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHH
Q 040557          224 KIGDFGLARFFP-EDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAW  301 (407)
Q Consensus       224 kl~Dfgla~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~  301 (407)
                      ||+|-.+++.+- .+......+...+..||+||.+.+..|+..+||||||++||||+| |+.|+..-.|.+       ..
T Consensus       436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-------m~  508 (563)
T KOG1024|consen  436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-------ME  508 (563)
T ss_pred             EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-------HH
Confidence            999999998653 333333334456778999999999999999999999999999998 666665433332       22


Q ss_pred             HHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          302 KLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       302 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      .++.+|.       ++.   .+.+++.++..++..||..+|++||++.|++.-|..
T Consensus       509 ~ylkdGy-------Rla---QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  509 HYLKDGY-------RLA---QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             HHHhccc-------eec---CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence            2333331       222   345678889999999999999999999999988754

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=294.98  Aligned_cols=263  Identities=26%  Similarity=0.389  Sum_probs=216.1

Q ss_pred             cCHHHHHHHhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeee
Q 040557           72 FDFQTLKKATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCS  149 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  149 (407)
                      .+++.+...++.|++.+.||+|.+|.||+++. ++|+..|+|+.....  +..+++..|.++|+.. +|||++.++|++.
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--d~deEiE~eynil~~~~~hpnv~~fyg~~~   86 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--DEEEEIELEYNMLKKYSHHPNVATFYGAFI   86 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--cccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence            45555666678899999999999999999974 578999999886544  3344566788888887 7999999999984


Q ss_pred             -----cCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceE
Q 040557          150 -----DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSK  224 (407)
Q Consensus       150 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k  224 (407)
                           .++++|||||||.+||..+++.+..+..+.|..+..|+..++.|+.+||.+.   ++|||||-.|||++.++.||
T Consensus        87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK  163 (953)
T KOG0587|consen   87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK  163 (953)
T ss_pred             EecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence                 3568999999999999999998888888999999999999999999999988   99999999999999999999


Q ss_pred             EecccCccccCCCCcccccccccCccccCccccccC-----CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHH
Q 040557          225 IGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-----ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEY  299 (407)
Q Consensus       225 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~  299 (407)
                      |+|||++..+..... ...+.+||+.|||||++...     .|+.++|+||||++..||.-|.+|+....+...-+    
T Consensus       164 LvDFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF----  238 (953)
T KOG0587|consen  164 LVDFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF----  238 (953)
T ss_pred             Eeeeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc----
Confidence            999999987754433 23457899999999998753     56789999999999999999999987554432111    


Q ss_pred             HHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          300 AWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       300 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                           .   +...-.|.+.   -+.....++.++|..||.+|-++||++.++++|-
T Consensus       239 -----~---IpRNPPPkLk---rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hp  283 (953)
T KOG0587|consen  239 -----L---IPRNPPPKLK---RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHP  283 (953)
T ss_pred             -----c---CCCCCCcccc---chhhHHHHHHHHHHHHHhhccccCcchhhhccCC
Confidence                 0   1111112222   3467788999999999999999999999999874

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-36  Score=273.11  Aligned_cols=260  Identities=27%  Similarity=0.395  Sum_probs=202.3

Q ss_pred             HhcCCCCCCeeeccCCccEEEEE-ecCCcEEEEEEeccccChhh------HHHHHHHHHHHHcCCCCceeeeeeeee-cC
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG------ESEFLSEVRMITSIQHKNLVRLLGCCS-DG  151 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~-~~  151 (407)
                      ..++|-+..+||+|||+.||+|. +...+.||||+-...+....      .+...+|.++-+.|+||.||++++++. +.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            34566677889999999999996 55688999998755443322      245678999999999999999999985 55


Q ss_pred             CeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC---CCceEEecc
Q 040557          152 SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE---KFQSKIGDF  228 (407)
Q Consensus       152 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Df  228 (407)
                      +.+|-|.|||+|.+|+.++..  .+.+++.++..|+.||+.||.||.... +||+|-||||.||||.+   .|.+||+||
T Consensus       541 dsFCTVLEYceGNDLDFYLKQ--hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQ--HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             ccceeeeeecCCCchhHHHHh--hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence            678999999999999999954  456899999999999999999999874 78999999999999964   478999999


Q ss_pred             cCccccCCCCcc------cccccccCccccCccccccC----CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhH
Q 040557          229 GLARFFPEDQAY------LSTNFAGTLGYTAPEYAIRG----ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPE  298 (407)
Q Consensus       229 gla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~  298 (407)
                      ||++.+.++...      .++...||.+|++||.+.-+    ..+.|+||||.||++|..+.|+.||......       
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-------  690 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-------  690 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-------
Confidence            999998765432      23456799999999987533    5689999999999999999999999754322       


Q ss_pred             HHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040557          299 YAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAM  354 (407)
Q Consensus       299 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  354 (407)
                        ...+..+.+...-.-.+.   ..+....+...+|++||+..-++|....++..+
T Consensus       691 --QdILqeNTIlkAtEVqFP---~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  691 --QDILQENTILKATEVQFP---PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             --HHHHhhhchhcceeccCC---CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence              223333433322222221   112234557789999999999999877776654

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-38  Score=266.38  Aligned_cols=253  Identities=24%  Similarity=0.332  Sum_probs=195.4

Q ss_pred             CCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEEEEeccCC
Q 040557           87 GNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVYEYMKNR  164 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g  164 (407)
                      ...||.|+||+|++-.+ +.|+..|||++........+.+++.|.+...+- +.||||+++|.+...+..|+-||.|.- 
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence            34699999999999875 469999999998777777788899999876655 799999999999999999999999964 


Q ss_pred             ChhHH---HhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          165 SLDLL---IYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       165 ~L~~~---l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      ||+.+   .+.-....+++.-.-.|+.....||.||...-  .|+|||+||+|||++..|.+||+|||++-.+.+.-.  
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA--  223 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA--  223 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHH--
Confidence            66543   33334456889988899999999999998754  599999999999999999999999999986654332  


Q ss_pred             ccccccCccccCcccccc--CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          242 STNFAGTLGYTAPEYAIR--GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                      .+.-.|-..|||||.+..  ..|+-+|||||||++|+|+.||+.|+..-..     .-+.+.. +..|..     |.+..
T Consensus       224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~-Vv~gdp-----p~l~~  292 (361)
T KOG1006|consen  224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQ-VVIGDP-----PILLF  292 (361)
T ss_pred             hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHH-HHcCCC-----CeecC
Confidence            234468889999999864  4589999999999999999999999763211     1111111 111211     11211


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                      ..........+..++..|+.+|-+.||+..++.++-
T Consensus       293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~  328 (361)
T KOG1006|consen  293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFP  328 (361)
T ss_pred             cccccccCHHHHHHHHHHhhcccccCcchhhhhcCc
Confidence            111223456788999999999999999999998753

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1e-36  Score=264.20  Aligned_cols=275  Identities=21%  Similarity=0.296  Sum_probs=201.0

Q ss_pred             cCCCCCCeeeccCCccEEEEEec---C--CcEEEEEEeccccChhhH-HHHHHHHHHHHcCCCCceeeeeeeeec-CCee
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA---D--GTLVAVKKLCVDKSQQGE-SEFLSEVRMITSIQHKNLVRLLGCCSD-GSQR  154 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~~~~-~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~  154 (407)
                      ..|+....||+|.||.||+|.-.   +  .+.+|+|+++..+...+. ....+|+.+++.++|+|++.+..++.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            45777889999999999999532   2  347999999766443332 345699999999999999999998876 7788


Q ss_pred             EEEEEeccCCChhHHHhcc---CCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCC----CceEEec
Q 040557          155 LLVYEYMKNRSLDLLIYGE---SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEK----FQSKIGD  227 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~----~~~kl~D  227 (407)
                      ++++||.+. +|.++++-.   ..+.++...+..|+.||+.|+.|||++=   |+||||||.|||+..+    |.|||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence            999999987 777777532   2457899999999999999999999987   9999999999999877    8999999


Q ss_pred             ccCccccCCCCcc--cccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccC---chhHHHH
Q 040557          228 FGLARFFPEDQAY--LSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQ---YLPEYAW  301 (407)
Q Consensus       228 fgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~---~~~~~~~  301 (407)
                      ||+++.+.+.-..  ....++-|..|.|||.+.+ ..||.+.||||.||++.||+|-.+.|.........   +-.+...
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            9999988754332  2345678999999999887 57899999999999999999988877543221111   1111111


Q ss_pred             HHHHh-CccccccCccc-------------ccCCCCH----H-------HHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          302 KLYER-GRILELVDPRM-------------RKEGIVE----R-------DALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       302 ~~~~~-~~~~~~~d~~~-------------~~~~~~~----~-------~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      +.++- |.-.+..-|.+             +......    .       -+...++|+..+|+.||-+|.|+++.+++.-
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y  339 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY  339 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence            11110 00000000000             0000000    0       1123778999999999999999999999987


Q ss_pred             cccc
Q 040557          357 CKVE  360 (407)
Q Consensus       357 ~~~~  360 (407)
                      +..+
T Consensus       340 F~~d  343 (438)
T KOG0666|consen  340 FTED  343 (438)
T ss_pred             cccC
Confidence            6543

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=9.7e-36  Score=266.83  Aligned_cols=226  Identities=19%  Similarity=0.125  Sum_probs=179.0

Q ss_pred             cCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCChhHHHh
Q 040557           93 GGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIY  171 (407)
Q Consensus        93 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~  171 (407)
                      |.+|.||+++. .+|+.||+|.+....      .+.+|...+....|||++++++++.+.+..+++|||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            89999999986 468999999985432      22345555555679999999999999999999999999999999885


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccccccccCccc
Q 040557          172 GESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY  251 (407)
Q Consensus       172 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y  251 (407)
                      ..  ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++++|||++.......    ....++..|
T Consensus        78 ~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y  148 (237)
T cd05576          78 KF--LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMY  148 (237)
T ss_pred             Hh--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccc
Confidence            43  35899999999999999999999988   9999999999999999999999999887654322    223467789


Q ss_pred             cCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHH
Q 040557          252 TAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVI  331 (407)
Q Consensus       252 ~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~  331 (407)
                      +|||...+..++.++||||+|+++|||++|+.++........            ..     .  .+   ..+......+.
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~~-----~--~~---~~~~~~~~~~~  206 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------TH-----T--TL---NIPEWVSEEAR  206 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------cc-----c--cc---CCcccCCHHHH
Confidence            999999888899999999999999999999987643211100            00     0  00   01122345688


Q ss_pred             HHHHHccCCCCCCCCCH-----HHHHHHh
Q 040557          332 NVAFICLQPHGNQRPPM-----SEIVAML  355 (407)
Q Consensus       332 ~l~~~cl~~~p~~RPs~-----~ev~~~l  355 (407)
                      +++.+||+.||++||++     .+++.|-
T Consensus       207 ~li~~~l~~dp~~R~~~~~~~~~~~~~h~  235 (237)
T cd05576         207 SLLQQLLQFNPTERLGAGVAGVEDIKSHP  235 (237)
T ss_pred             HHHHHHccCCHHHhcCCCccchHHHHcCC
Confidence            99999999999999996     6666553

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=262.88  Aligned_cols=267  Identities=23%  Similarity=0.299  Sum_probs=205.8

Q ss_pred             HHHHHHHhcCCCCCCeeeccCCccEEEEE-ecCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecC
Q 040557           74 FQTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDG  151 (407)
Q Consensus        74 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  151 (407)
                      |+++-+.++     +.||+|+|+.|--+. +.+|..||||++.+. ......++.+|++++.++ .|+||+.++.||++.
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            444444443     679999999999886 678999999999654 445567889999999999 599999999999999


Q ss_pred             CeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC---ceEEecc
Q 040557          152 SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF---QSKIGDF  228 (407)
Q Consensus       152 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~kl~Df  228 (407)
                      ..+|||||-|.||+|..++..  ++-+++.++.++..+|+.||.|||.+|   |.|||+||+|||-....   .+||+||
T Consensus       149 ~~FYLVfEKm~GGplLshI~~--~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf  223 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQK--RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF  223 (463)
T ss_pred             ceEEEEEecccCchHHHHHHH--hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence            999999999999999998854  445999999999999999999999999   99999999999997543   5799999


Q ss_pred             cCccccC--CCC----cccccccccCccccCccccc-----cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchh
Q 040557          229 GLARFFP--EDQ----AYLSTNFAGTLGYTAPEYAI-----RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLP  297 (407)
Q Consensus       229 gla~~~~--~~~----~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~  297 (407)
                      .|..-..  .+-    .....+-+|+..|||||+..     ...|+.+.|.||||||||-|++|.+||.+....+..+-.
T Consensus       224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr  303 (463)
T KOG0607|consen  224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR  303 (463)
T ss_pred             ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence            9885432  111    11223457888999999764     246899999999999999999999999877665443221


Q ss_pred             --------HHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          298 --------EYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       298 --------~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                              ..+..-+++|.. +..|...      ...+.+..+++...+..|+.+|.++.+++.|.|..
T Consensus       304 Ge~Cr~CQ~~LFesIQEGkY-eFPdkdW------ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~  365 (463)
T KOG0607|consen  304 GEVCRVCQNKLFESIQEGKY-EFPDKDW------AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQ  365 (463)
T ss_pred             CCccHHHHHHHHHHHhccCC-cCChhhh------HHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccc
Confidence                    112222232221 1111111      12345567788888999999999999999988753

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-36  Score=282.08  Aligned_cols=243  Identities=24%  Similarity=0.245  Sum_probs=197.3

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      +..|.....+|.|+|+.|-.+.. .+++..++|++.....     +-.+|+.++... +|+||+++.+.+.++.+.|+||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc-----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            56788888899999999988864 5688999999965421     223567666655 7999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEE-cCCCceEEecccCccccCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL-DEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill-~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |.+.++-+.+.+....   .....+..|+.+|+.|+.|||++|   ++||||||+|||+ ++.++++|+|||.++..+.+
T Consensus       396 e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            9999988777664332   222777889999999999999998   9999999999999 58999999999999987665


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                          ...-+-|..|.|||+.....||+++|+||||++||+|++|+.|+......      ..+...+..+          
T Consensus       470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~----------  529 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMP----------  529 (612)
T ss_pred             ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCC----------
Confidence                12335688999999999999999999999999999999999999765443      1122222222          


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                         .+....+....+|+.+||+.||.+||+|.++..|-|.
T Consensus       530 ---~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  530 ---KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ---ccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence               1223445678899999999999999999999999987

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-36  Score=276.43  Aligned_cols=251  Identities=25%  Similarity=0.298  Sum_probs=203.3

Q ss_pred             CCeeeccCCccEEEEEe-cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCC
Q 040557           87 GNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNR  164 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  164 (407)
                      .++||+|.||+||-|++ ++|+.||||++.+.. ....+..+.+|+.+|..++||.||.+--.|+..+..++|||-+.| 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            37899999999999975 579999999997654 344557889999999999999999999999999999999999965 


Q ss_pred             ChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCC---CceEEecccCccccCCCCccc
Q 040557          165 SLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEK---FQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       165 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      +..+.+.......+++.....+..||+.||.|||.++   |+|+||||+|||+.+.   ..+||+|||.|++++....  
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF--  722 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF--  722 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence            5545544444556898888889999999999999998   9999999999999744   4699999999999876553  


Q ss_pred             ccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCC
Q 040557          242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEG  321 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  321 (407)
                      ...++||+.|+|||++.++.|...-|+||.||++|--++|..||..+..         +...++....       |-...
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd---------IndQIQNAaF-------MyPp~  786 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED---------INDQIQNAAF-------MYPPN  786 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc---------hhHHhhcccc-------ccCCC
Confidence            3567899999999999999999999999999999999999999964321         1111111100       11111


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          322 IVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       322 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .-.+.....+++|...||..-++|-|.+.-+.|.|...
T Consensus       787 PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~  824 (888)
T KOG4236|consen  787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD  824 (888)
T ss_pred             chhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence            12234567889999999999999999999999988543

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=279.30  Aligned_cols=254  Identities=22%  Similarity=0.286  Sum_probs=211.0

Q ss_pred             CCCCCCeeeccCCccEEEEEecCCc-EEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLADGT-LVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      ++.....||-|+||.|=+++.+... .+|+|++++..  ...+++.+..|-++|..++.+.||+++--|.+....|++||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            4455567999999999999865433 48999886543  45667788999999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      -|-||.|...+.  .++.++..+...++..+++|++|||+++   |+.|||||+|.+|+.+|-+||.|||+|+.+.....
T Consensus       501 aClGGElWTiLr--dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K  575 (732)
T KOG0614|consen  501 ACLGGELWTILR--DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK  575 (732)
T ss_pred             hhcCchhhhhhh--hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence            999999999984  4556899999999999999999999999   99999999999999999999999999998876654


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                      .  -+++|||.|.|||++.++..+.++|.||||+++|||++|++||....+...       +..+-.|     +|    .
T Consensus       576 T--wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt-------Yn~ILkG-----id----~  637 (732)
T KOG0614|consen  576 T--WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT-------YNLILKG-----ID----K  637 (732)
T ss_pred             e--eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH-------HHHHHhh-----hh----h
Confidence            3  468999999999999999999999999999999999999999987655321       1111111     11    1


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhhccc
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPP-----MSEIVAMLTCKV  359 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~l~~~~  359 (407)
                      -.++........++++..+..+|.+|..     +.+|.+|-|+..
T Consensus       638 i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g  682 (732)
T KOG0614|consen  638 IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG  682 (732)
T ss_pred             hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence            1133334556788999999999999986     899999998753

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.9e-35  Score=292.40  Aligned_cols=264  Identities=23%  Similarity=0.300  Sum_probs=173.4

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-C----CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeee------e
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-D----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGC------C  148 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~  148 (407)
                      ..++|.+.+.||+|+||.||+|.+. +    +..||+|++.....   .+.+..+  .+....+.++..++..      +
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            4578999999999999999999864 4    68999998753221   1111111  1111122222222211      2


Q ss_pred             ecCCeeEEEEEeccCCChhHHHhccCCC------------------CCCHHHHHHHHHHHHHHhccccccCCCceeeecc
Q 040557          149 SDGSQRLLVYEYMKNRSLDLLIYGESDK------------------FLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDI  210 (407)
Q Consensus       149 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl  210 (407)
                      ......++||||+.+++|.+++......                  ......+..++.|++.||.|||+.+   |+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcC
Confidence            4566789999999999999888643211                  1123345678999999999999988   999999


Q ss_pred             ccccEEEcC-CCceEEecccCccccCCCCcccccccccCccccCccccccC----------------------CCCcccc
Q 040557          211 KASNVLLDE-KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG----------------------ELSEKAD  267 (407)
Q Consensus       211 k~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~k~D  267 (407)
                      ||+|||+++ ++.+||+|||+++.+............+++.|+|||.+...                      .++.++|
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            999999985 67999999999987655444444567889999999965322                      2345679


Q ss_pred             EEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcc-----ccccCcccccC-----CCCHHHHHHHHHHHHHc
Q 040557          268 IYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRI-----LELVDPRMRKE-----GIVERDALQVINVAFIC  337 (407)
Q Consensus       268 v~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~d~~~~~~-----~~~~~~~~~l~~l~~~c  337 (407)
                      ||||||+||||+++..+.+...       ..+. ..+.....     ...+.+....+     ...........+|+.+|
T Consensus       362 VwSlGviL~el~~~~~~~~~~~-------~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m  433 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNL-------IQFN-RQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSM  433 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHH-------HHHH-HHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence            9999999999999766543211       0010 01110000     00011110000     00001122355899999


Q ss_pred             cCCCCCCCCCHHHHHHHhhccc
Q 040557          338 LQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       338 l~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      |+.||++|||+.++++|-+...
T Consensus       434 L~~dP~kR~ta~e~L~Hpff~~  455 (566)
T PLN03225        434 MRFKGRQRISAKAALAHPYFDR  455 (566)
T ss_pred             ccCCcccCCCHHHHhCCcCcCC
Confidence            9999999999999999988643

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=266.45  Aligned_cols=242  Identities=25%  Similarity=0.315  Sum_probs=194.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  157 (407)
                      .+|....+||+|+||.|-+|..+ +.+.+|||+++++..  .++.+--+.|-++|+.. +-|.++.+..++..-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            46777889999999999999654 577899999976532  12233445778888777 578899999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+.||+|--++..  -..+.+..+..++.+||.||-+||+++   |+.||||.+|||||.+|.+||+|||+++.---+
T Consensus       429 MEyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             EEEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccC
Confidence            999999999777743  334788888999999999999999999   999999999999999999999999999854322


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      .. .+.+++|||.|+|||++.-.+|+..+|.|||||+||||+.|++||++....+       +...+.+...        
T Consensus       504 ~~-TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-------lF~aI~ehnv--------  567 (683)
T KOG0696|consen  504 GV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-------LFQAIMEHNV--------  567 (683)
T ss_pred             Cc-ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHHccC--------
Confidence            22 2356899999999999999999999999999999999999999998754332       2222222111        


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPP  347 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  347 (407)
                         .++...+.+...+....+.+.|.+|..
T Consensus       568 ---syPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  568 ---SYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             ---cCcccccHHHHHHHHHHhhcCCccccC
Confidence               244455667888888899999999964

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=264.28  Aligned_cols=269  Identities=20%  Similarity=0.235  Sum_probs=205.3

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCC-C-C----ceeeeeeeeecCC
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-H-K----NLVRLLGCCSDGS  152 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h-~----niv~l~~~~~~~~  152 (407)
                      .+++|.+...+|+|.||.|-+.... .+..||||+++.  -....+.-+-|+++|.++. + |    -++.+.+|+.-.+
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~--V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg  164 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN--VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG  164 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHH--HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence            3688999999999999999999743 478999999853  2233345567999999983 2 2    3678889999999


Q ss_pred             eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC-------------
Q 040557          153 QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE-------------  219 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-------------  219 (407)
                      +.|+|+|.+ |-|+.+++..++-.+++...+..++.|+++++++||+.+   ++|-||||+|||+.+             
T Consensus       165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence            999999998 558999998888888999999999999999999999998   999999999999931             


Q ss_pred             -------CCceEEecccCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcc
Q 040557          220 -------KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSE  292 (407)
Q Consensus       220 -------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~  292 (407)
                             +..++|+|||.|++-....    +..+.|..|.|||++.+-.++.+.||||+||||.||.||...|......+
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                   3468999999998765544    45678999999999999999999999999999999999998876543221


Q ss_pred             c--------Cchh-HH-----HHHHHHhCccc-----------cccCccc---ccCCCCHHHHHHHHHHHHHccCCCCCC
Q 040557          293 M--------QYLP-EY-----AWKLYERGRIL-----------ELVDPRM---RKEGIVERDALQVINVAFICLQPHGNQ  344 (407)
Q Consensus       293 ~--------~~~~-~~-----~~~~~~~~~~~-----------~~~d~~~---~~~~~~~~~~~~l~~l~~~cl~~~p~~  344 (407)
                      .        +.++ ..     ..+....+++.           ...++..   ........+..++.+|+..||..||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence            0        0001 00     11122222111           0000000   001122345678999999999999999


Q ss_pred             CCCHHHHHHHhhcc
Q 040557          345 RPPMSEIVAMLTCK  358 (407)
Q Consensus       345 RPs~~ev~~~l~~~  358 (407)
                      |+|+.|++.|-.+.
T Consensus       397 RiTl~EAL~HpFF~  410 (415)
T KOG0671|consen  397 RITLREALSHPFFA  410 (415)
T ss_pred             cccHHHHhcCHHhh
Confidence            99999999987654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.7e-34  Score=280.21  Aligned_cols=267  Identities=20%  Similarity=0.281  Sum_probs=184.2

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEe-----------------cCCcEEEEEEeccccChh-------------hHHHHHHH
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKL-----------------ADGTLVAVKKLCVDKSQQ-------------GESEFLSE  129 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~-------------~~~~~~~e  129 (407)
                      ..++|++.++||+|+||.||+|..                 .+++.||||++.......             ..+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            357899999999999999999963                 235689999986432111             11223457


Q ss_pred             HHHHHcCCCCce-----eeeeeeeec--------CCeeEEEEEeccCCChhHHHhccCC---------------------
Q 040557          130 VRMITSIQHKNL-----VRLLGCCSD--------GSQRLLVYEYMKNRSLDLLIYGESD---------------------  175 (407)
Q Consensus       130 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~---------------------  175 (407)
                      +.++.+++|.++     ++++++|..        .+..++||||+++|+|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     677777753        3467999999999999998864211                     


Q ss_pred             -CCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccccccccCccccCc
Q 040557          176 -KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP  254 (407)
Q Consensus       176 -~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aP  254 (407)
                       ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++...............+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence             23467788899999999999999988   99999999999999999999999999976544332222223458899999


Q ss_pred             cccccCC--------------------C--CccccEEehhHHHHHHHhcCC-CCCCCCCc--ccCch--hHHHHHHHHhC
Q 040557          255 EYAIRGE--------------------L--SEKADIYSFGVLVLEIISCRK-NTDLTLPS--EMQYL--PEYAWKLYERG  307 (407)
Q Consensus       255 E~~~~~~--------------------~--~~k~Dv~s~G~vl~el~tg~~-p~~~~~~~--~~~~~--~~~~~~~~~~~  307 (407)
                      |.+....                    +  ..+.||||+||++++|++|.. |+......  +....  ....|..+...
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            9875432                    1  235799999999999999875 44321100  00000  00011111111


Q ss_pred             ccccccCcccccCCCCHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHHhhcc
Q 040557          308 RILELVDPRMRKEGIVERDALQVINVAFICLQPHG---NQRPPMSEIVAMLTCK  358 (407)
Q Consensus       308 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p---~~RPs~~ev~~~l~~~  358 (407)
                      .    .+..     ..........+++.++|..+|   .+|+|+.|+++|.|+.
T Consensus       460 ~----~~~~-----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        460 K----YDFS-----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             C----CCcc-----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence            1    1111     112234567889999998765   6899999999998864

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=236.68  Aligned_cols=267  Identities=22%  Similarity=0.315  Sum_probs=198.2

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhh-HHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      +|...++||+|.||+||+|+.. +++.||+|++..+...+. -...++|+-+|+.++|.|||++++........-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            3444578999999999999854 588999999976654332 34678999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      |.. +|..+..... +-++.+....++.|+++|+.++|+++   +.|||+||.|.|++.+|++|++|||+++.+.-.-..
T Consensus        83 cdq-dlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrc  157 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             hhH-HHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence            965 7888876544 44899999999999999999999998   999999999999999999999999999987644322


Q ss_pred             cccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhC------cccccc
Q 040557          241 LSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERG------RILELV  313 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~  313 (407)
                       .+..+.|..|.+|.++.+ +-|++..|+||-||++.|+.....|......-.. .+... ...+..-      .+..+-
T Consensus       158 -ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd-qlkri-f~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRI-FRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             -eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH-HHHHH-HHHhCCCccccCCccccCC
Confidence             133467899999999887 4689999999999999999986666543322111 11111 1111100      111122


Q ss_pred             CcccccC--------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          314 DPRMRKE--------GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       314 d~~~~~~--------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      |...-..        ...+.....-.+++...+.-+|.+|.++++.+++..+
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf  286 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYF  286 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccc
Confidence            2111110        0111112234678888999999999999999988643

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2e-34  Score=258.23  Aligned_cols=241  Identities=27%  Similarity=0.356  Sum_probs=193.9

Q ss_pred             CCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCChhHHHhc
Q 040557           94 GFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYG  172 (407)
Q Consensus        94 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  172 (407)
                      +||.||+|... +|+.+|+|++...........+.+|++.+++++|+|++++++++......++++||+.+++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999876 48999999986544333267899999999999999999999999999999999999999999999854


Q ss_pred             cCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccccccccCcccc
Q 040557          173 ESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT  252 (407)
Q Consensus       173 ~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~  252 (407)
                      ..  .+++..+..++.+++.++.|||+.+   ++|+||+|+||++++++.++|+|||.+.......  ......++..|+
T Consensus        81 ~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~  153 (244)
T smart00220       81 RG--RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM  153 (244)
T ss_pred             cc--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence            33  2899999999999999999999998   9999999999999999999999999998776543  223456888999


Q ss_pred             CccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHH
Q 040557          253 APEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVIN  332 (407)
Q Consensus       253 aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~  332 (407)
                      +||...+..++.++||||||+++++|++|..|+......      .........+...        ........+..+.+
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~------~~~~~~~~~~~~~--------~~~~~~~~~~~~~~  219 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL------LELFKKIGKPKPP--------FPPPEWKISPEAKD  219 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH------HHHHHHHhccCCC--------CccccccCCHHHHH
Confidence            999998888999999999999999999999988642111      1111111111110        00000003456889


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHh
Q 040557          333 VAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       333 l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                      ++.+||..+|++||++.+++++-
T Consensus       220 ~i~~~l~~~p~~Rp~~~~~~~~~  242 (244)
T smart00220      220 LIRKLLVKDPEKRLTAEEALQHP  242 (244)
T ss_pred             HHHHHccCCchhccCHHHHhhCC
Confidence            99999999999999999999853

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.9e-37  Score=257.69  Aligned_cols=272  Identities=22%  Similarity=0.359  Sum_probs=197.2

Q ss_pred             CCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhh-HHHHHHHHHHHHcCCCCceeeeeeeeec--------CCe
Q 040557           84 FHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNLVRLLGCCSD--------GSQ  153 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~~~  153 (407)
                      |.-..+||+|.||.||+|+.. +|+.||+|++..+....+ -....+|+.+|..++|+|++.++..|..        ...
T Consensus        19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t   98 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT   98 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence            344567999999999999854 578899988755433322 2345799999999999999999998843        335


Q ss_pred             eEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          154 RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      +|+||.+|+. +|.-++.+. ...++..++.+++.++..||.|+|+..   |+|||+|+.|+|++.++.+||+|||+++.
T Consensus        99 ~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen   99 FYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             eeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccc
Confidence            7999999987 777777433 245899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcc---cccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccC--------chhHHHH
Q 040557          234 FPEDQAY---LSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQ--------YLPEYAW  301 (407)
Q Consensus       234 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~--------~~~~~~~  301 (407)
                      +......   ..++.+.|..|.+||.+.+ ..|+.+.|||.-||++.||+||.+-+........-        .....+|
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW  253 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW  253 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence            6533222   2245677999999998886 57999999999999999999999877544321100        0000111


Q ss_pred             HHHHhCccccccCcc-cccC--------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          302 KLYERGRILELVDPR-MRKE--------GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       302 ~~~~~~~~~~~~d~~-~~~~--------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                      ..+..-.+.+.+... +...        ..+..-..+.++++..++..||.+|+.+++++.|-++..+
T Consensus       254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence            111111111111000 0000        0001112367889999999999999999999999887654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=280.32  Aligned_cols=246  Identities=25%  Similarity=0.374  Sum_probs=188.5

Q ss_pred             CCCCCeeeccCCcc-EEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEEEEec
Q 040557           84 FHPGNLLGRGGFGP-VYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        84 ~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      |...+++|.|+.|+ ||+|.. +|+.||||++...    ......+|+..|+.- +|||||++++.-.+....|+..|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            34445789999986 699999 5899999998532    233456899999988 6999999999988999999999999


Q ss_pred             cCCChhHHHhcc--CCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC---C--CceEEecccCcccc
Q 040557          162 KNRSLDLLIYGE--SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE---K--FQSKIGDFGLARFF  234 (407)
Q Consensus       162 ~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~--~~~kl~Dfgla~~~  234 (407)
                      .. +|.+++...  ......-...+.+..|++.|+++||+.+   |+||||||.||||+.   +  ..++|+|||+++.+
T Consensus       586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            65 999999763  1111222345678899999999999988   999999999999975   2  57899999999988


Q ss_pred             CCCCccc--ccccccCccccCccccccCCCCccccEEehhHHHHHHHhc-CCCCCCCCCcccCchhHHHHHHHHhCcccc
Q 040557          235 PEDQAYL--STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISC-RKNTDLTLPSEMQYLPEYAWKLYERGRILE  311 (407)
Q Consensus       235 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      ..+....  ..+..||-+|+|||++....-+.++||||+||++|+.++| .+||......+.        ..+..+....
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~~~~~L~  733 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILTGNYTLV  733 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhcCcccee
Confidence            7655433  3456799999999999998888899999999999999998 788864322111        1111111010


Q ss_pred             ccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       312 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                      .    +.   ...++  ...+||.+|+.++|..||++.+|+.|.
T Consensus       734 ~----L~---~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HP  768 (903)
T KOG1027|consen  734 H----LE---PLPDC--EAKDLISRMLNPDPQLRPSATDVLNHP  768 (903)
T ss_pred             e----ec---cCchH--HHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence            0    11   11111  678999999999999999999999874

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=246.09  Aligned_cols=249  Identities=23%  Similarity=0.307  Sum_probs=198.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ++|.+..+||+|+|..|..+++. +.+.+|+|+++++-  ..++..-+..|-.+..+. +||.+|.+..+|.....+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            57899999999999999999864 67889999987643  222333445566666665 799999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      .||++||+|-.++.  ....++++.+..+...|+.||.|||+.|   |+.||||.+|+|+|..|.+||+|+|+++.--..
T Consensus       330 ieyv~ggdlmfhmq--rqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEecCcceeeehh--hhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCC
Confidence            99999999977774  4455999999999999999999999999   999999999999999999999999999854333


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCC-CcccCchhHHHHHHHHhCccccccCcc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTL-PSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                      .. .+++++|||.|+|||++.+..|...+|.|++||+++||+.|+.||+.-- .....+..++..+.+-+.++.      
T Consensus       405 gd-~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir------  477 (593)
T KOG0695|consen  405 GD-TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR------  477 (593)
T ss_pred             Cc-ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc------
Confidence            22 3457899999999999999999999999999999999999999997532 222233345555554443322      


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRPP  347 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  347 (407)
                           .+...+.....++..-|++||.+|..
T Consensus       478 -----iprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  478 -----IPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             -----ccceeehhhHHHHHHhhcCCcHHhcC
Confidence                 22223344567788899999999853

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-32  Score=252.36  Aligned_cols=269  Identities=24%  Similarity=0.290  Sum_probs=205.1

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCC-----C---Cceeeeeeeee---
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-----H---KNLVRLLGCCS---  149 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~---  149 (407)
                      .+|.+.++||.|.|++||++.+ .+.+.||+|+.+  ..+...+..+.|+++|.+++     |   .+||+|+++|.   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK--SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK--SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEe--hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            5788899999999999999974 467889999984  33444566789999999883     2   47999999985   


Q ss_pred             -cCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCC--------
Q 040557          150 -DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEK--------  220 (407)
Q Consensus       150 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~--------  220 (407)
                       .+.+.|+|+|++ |-+|..++.....+.++...+.+|+.|++.||.|||..+  +|||.||||+|||+..+        
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~  232 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDA  232 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhh
Confidence             456899999999 668888887777788999999999999999999999986  79999999999998000        


Q ss_pred             --------------------------------------------------------------------------------
Q 040557          221 --------------------------------------------------------------------------------  220 (407)
Q Consensus       221 --------------------------------------------------------------------------------  220 (407)
                                                                                                      
T Consensus       233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~  312 (590)
T KOG1290|consen  233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN  312 (590)
T ss_pred             hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence                                                                                            


Q ss_pred             ------------------------------------------------------------------------------Cc
Q 040557          221 ------------------------------------------------------------------------------FQ  222 (407)
Q Consensus       221 ------------------------------------------------------------------------------~~  222 (407)
                                                                                                    -.
T Consensus       313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~  392 (590)
T KOG1290|consen  313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR  392 (590)
T ss_pred             ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence                                                                                          02


Q ss_pred             eEEecccCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHH--
Q 040557          223 SKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYA--  300 (407)
Q Consensus       223 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~--  300 (407)
                      +||+|||-|+.+....    +.-.-|..|.|||++.+..|++.+||||++|+++||+||...|+.........-.+-+  
T Consensus       393 vKIaDlGNACW~~khF----T~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~  468 (590)
T KOG1290|consen  393 VKIADLGNACWVHKHF----TEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIAL  468 (590)
T ss_pred             EEEeeccchhhhhhhh----chhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHH
Confidence            4555666555443222    1234578999999999999999999999999999999999999876654432111111  


Q ss_pred             ---------HHHHHhCccc-cccC------------------cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 040557          301 ---------WKLYERGRIL-ELVD------------------PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIV  352 (407)
Q Consensus       301 ---------~~~~~~~~~~-~~~d------------------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~  352 (407)
                               +.+...|+-. +.++                  -.......+.+.+.++.+++.-||+.+|++|||+.+.+
T Consensus       469 i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl  548 (590)
T KOG1290|consen  469 IMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCL  548 (590)
T ss_pred             HHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHh
Confidence                     1222222111 1111                  11223457778889999999999999999999999999


Q ss_pred             HHhhccc
Q 040557          353 AMLTCKV  359 (407)
Q Consensus       353 ~~l~~~~  359 (407)
                      +|.|...
T Consensus       549 ~hPwLn~  555 (590)
T KOG1290|consen  549 KHPWLNP  555 (590)
T ss_pred             cCccccC
Confidence            9999653

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=231.00  Aligned_cols=206  Identities=26%  Similarity=0.380  Sum_probs=172.2

Q ss_pred             HHHHhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCee
Q 040557           77 LKKATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQR  154 (407)
Q Consensus        77 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  154 (407)
                      ++...+.......||+|++|.|-+.++ .+|...|+|++...-..+...+.++|+.+..+. .+|.+|.++|.+.+....
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            344445555567899999999998875 579999999998776777778889999887766 799999999999999999


Q ss_pred             EEEEEeccCCChhHHHhc--cCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          155 LLVYEYMKNRSLDLLIYG--ESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                      ++.||.|.. ||+.+-..  ..+..+++...-+|+..+..||.|||++-  .++|||+||+|||++.+|++|+||||.+-
T Consensus       121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence            999999965 77655431  34567899999999999999999999964  59999999999999999999999999998


Q ss_pred             ccCCCCcccccccccCccccCcccccc----CCCCccccEEehhHHHHHHHhcCCCCCC
Q 040557          233 FFPEDQAYLSTNFAGTLGYTAPEYAIR----GELSEKADIYSFGVLVLEIISCRKNTDL  287 (407)
Q Consensus       233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~Dv~s~G~vl~el~tg~~p~~~  287 (407)
                      .+.+.-..  +-..|-..|||||.+..    +.|+-||||||||+.+.||.+++.|++.
T Consensus       198 ~L~dSiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  198 YLVDSIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             eehhhhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            77654432  22457789999998753    4789999999999999999999999864

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-33  Score=261.75  Aligned_cols=209  Identities=24%  Similarity=0.350  Sum_probs=177.5

Q ss_pred             cCCCCCCeeeccCCccEEEEE-ecCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      .-|...+.||-|+||.|.+++ ..+...||.|.+.+..  .......++.|-.||+..+.+-||+|+..|.+.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            346667889999999999996 4457789999986543  2344556788999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC--
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE--  236 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~--  236 (407)
                      +|++||++-.+|-  +-+.+.+..+..++.++.+|+++.|..|   +|||||||+|||||.+|.+||+||||+.-+..  
T Consensus       709 dYIPGGDmMSLLI--rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH  783 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLI--RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  783 (1034)
T ss_pred             eccCCccHHHHHH--HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecc
Confidence            9999999988774  3346888999999999999999999998   99999999999999999999999999975420  


Q ss_pred             -CCc--------------------------------------ccccccccCccccCccccccCCCCccccEEehhHHHHH
Q 040557          237 -DQA--------------------------------------YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLE  277 (407)
Q Consensus       237 -~~~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~e  277 (407)
                       ..+                                      ......+||+.|+|||++....|+.-.|.||.||||||
T Consensus       784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE  863 (1034)
T ss_pred             ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence             000                                      01113579999999999999999999999999999999


Q ss_pred             HHhcCCCCCCCCCcccCc
Q 040557          278 IISCRKNTDLTLPSEMQY  295 (407)
Q Consensus       278 l~tg~~p~~~~~~~~~~~  295 (407)
                      |+.|+.||....+.+.++
T Consensus       864 m~~g~~pf~~~tp~~tq~  881 (1034)
T KOG0608|consen  864 MLVGQPPFLADTPGETQY  881 (1034)
T ss_pred             HhhCCCCccCCCCCccee
Confidence            999999999888877654

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=246.29  Aligned_cols=268  Identities=25%  Similarity=0.337  Sum_probs=196.4

Q ss_pred             CCCCCeeeccCCccEEEEEec-CCcEEEEEEeccc-cChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC-----eeEE
Q 040557           84 FHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS-----QRLL  156 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~l  156 (407)
                      .+..+.||-|+||.||.+.++ +|+.||.|++..- ......+++.+|+.+|+..+|.|++..+++..-..     +.|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            344578999999999999864 7999999987432 12334578899999999999999999988764332     4578


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ++|.|.. +|..++  -+.+.++-+.+.-+.+||++||.|||+.+   |.||||||.|.|+++|..+||+|||+++.-..
T Consensus       135 ~TELmQS-DLHKII--VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  135 LTELMQS-DLHKII--VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHHh-hhhhee--ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence            8888854 777776  34566888888889999999999999998   99999999999999999999999999998877


Q ss_pred             CCcccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHH--------HHHHHHhC
Q 040557          237 DQAYLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEY--------AWKLYERG  307 (407)
Q Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~--------~~~~~~~~  307 (407)
                      +.....+..+-|..|.|||.+++. .|+...||||.||++.||+..+..|....+-+.-.+...        .-+..-+|
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG  288 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG  288 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence            766666667788999999999874 789999999999999999988877754433211110000        00000011


Q ss_pred             ccccccCcccccC--------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          308 RILELVDPRMRKE--------GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       308 ~~~~~~d~~~~~~--------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      ....++....+..        ........+...+.+.++..||+.|.+..+.+.++..
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence            1111111111110        0111122345677888999999999999999988753

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=4.4e-31  Score=231.01  Aligned_cols=212  Identities=36%  Similarity=0.593  Sum_probs=184.3

Q ss_pred             eeccCCccEEEEEecC-CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCChhH
Q 040557           90 LGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDL  168 (407)
Q Consensus        90 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  168 (407)
                      ||+|++|.||++...+ |+.+++|.+...........+.+|++.++.+.|++++++++++......++++||+.+++|..
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999998754 899999998654433245678999999999999999999999999899999999999999999


Q ss_pred             HHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC-CCceEEecccCccccCCCCccccccccc
Q 040557          169 LIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE-KFQSKIGDFGLARFFPEDQAYLSTNFAG  247 (407)
Q Consensus       169 ~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~g  247 (407)
                      ++.... ..+++..+..++.+++.++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~  155 (215)
T cd00180          81 LLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG  155 (215)
T ss_pred             HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence            986442 35899999999999999999999998   999999999999999 89999999999987655432 1223557


Q ss_pred             CccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHH
Q 040557          248 TLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERD  326 (407)
Q Consensus       248 t~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  326 (407)
                      ...|++||..... .++.++|+|++|+++++|                                                
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------  187 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------  187 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence            8899999988877 888999999999999999                                                


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          327 ALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       327 ~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                       ..+.+++..|++.+|++||++.++++++
T Consensus       188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence             3477899999999999999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=1.2e-32  Score=229.32  Aligned_cols=271  Identities=21%  Similarity=0.337  Sum_probs=204.4

Q ss_pred             cccCHHHHHH---HhcCCCCCCeeeccCCccEEEEE-ecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCC-CCceeee
Q 040557           70 SYFDFQTLKK---ATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-HKNLVRL  144 (407)
Q Consensus        70 ~~~~~~~~~~---~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l  144 (407)
                      .+++++....   ..++|++.+++|+|.++.||.|. ..+++.++||.++..    ..+.+.+|+.+|..+. ||||+++
T Consensus        23 eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L   98 (338)
T KOG0668|consen   23 EYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKL   98 (338)
T ss_pred             hhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeeh
Confidence            4566665332   34678888999999999999997 457889999998533    3356789999999996 9999999


Q ss_pred             eeeeecCC--eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC-CC
Q 040557          145 LGCCSDGS--QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE-KF  221 (407)
Q Consensus       145 ~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~  221 (407)
                      ++...++.  .+.|++||+.+.+...+-     +.++...+...+.+++.||.|||+.|   |.|||+||.|+++|. .-
T Consensus        99 ~DiV~Dp~SktpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~r  170 (338)
T KOG0668|consen   99 LDIVKDPESKTPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELR  170 (338)
T ss_pred             hhhhcCccccCchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhc
Confidence            99987754  567999999998876664     34777788889999999999999999   999999999999994 55


Q ss_pred             ceEEecccCccccCCCCcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHH
Q 040557          222 QSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYA  300 (407)
Q Consensus       222 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~  300 (407)
                      .++|+|+|||.++.....+  ...+.+..|.-||.+.. ..|+..-|+|||||+|..|+..+.||........+ +...+
T Consensus       171 kLrlIDWGLAEFYHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ-LVkIa  247 (338)
T KOG0668|consen  171 KLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVKIA  247 (338)
T ss_pred             eeeeeecchHhhcCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH-HHHHH
Confidence            7999999999998876654  23456777889998876 45788899999999999999999999755443222 11111


Q ss_pred             --------HHHHHhCccccccCccccc---------------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          301 --------WKLYERGRILELVDPRMRK---------------EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       301 --------~~~~~~~~~~~~~d~~~~~---------------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                              ...+..-.+  .+|+....               .+...-...++++++...|..|-.+|||++|...|..+
T Consensus       248 kVLGt~el~~Yl~KY~i--~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF  325 (338)
T KOG0668|consen  248 KVLGTDELYAYLNKYQI--DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYF  325 (338)
T ss_pred             HHhChHHHHHHHHHHcc--CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchH
Confidence                    111111111  12222211               01111123678899999999999999999999998654

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-31  Score=232.67  Aligned_cols=266  Identities=25%  Similarity=0.257  Sum_probs=196.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC------Ce
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG------SQ  153 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  153 (407)
                      .+|.....+|.|+- .|..+.+ -.++.||+|+..... ......+..+|..++..++|+|+++++.++.-.      ..
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            56666778888887 5555543 358899999874332 234456778999999999999999999998543      35


Q ss_pred             eEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          154 RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      .|+|||+|.. +|...+..    .++-.++..++.|++.|+.|||+.+   |+||||||+||++..++.+||.|||+|+.
T Consensus        96 ~y~v~e~m~~-nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVILM----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             HHHHHHhhhh-HHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcc
Confidence            6999999964 88887752    3678888999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCc----------------ccCchh
Q 040557          234 FPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPS----------------EMQYLP  297 (407)
Q Consensus       234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~----------------~~~~~~  297 (407)
                      -..+  ...+..+.|..|.|||++.+..|.+.+||||.||++.||++|+--|.+...-                -.+.+.
T Consensus       168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~  245 (369)
T KOG0665|consen  168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ  245 (369)
T ss_pred             cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence            5544  4567788999999999999988999999999999999999999776532210                000011


Q ss_pred             HHHHHHHHh------CccccccCc-ccccC-CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          298 EYAWKLYER------GRILELVDP-RMRKE-GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       298 ~~~~~~~~~------~~~~~~~d~-~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ..+......      -...+.+.. ..... ......+..+.+++.+||-.||++|-+++++++|.-..
T Consensus       246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence            111111110      011111111 11110 11123455678999999999999999999999997654

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=5.3e-30  Score=227.10  Aligned_cols=200  Identities=36%  Similarity=0.513  Sum_probs=172.4

Q ss_pred             CCCCCeeeccCCccEEEEEecC-CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEecc
Q 040557           84 FHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMK  162 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  162 (407)
                      |+..+.||.|++|.||++...+ ++.+|+|.+...........+.+|++.+..++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567889999999999998764 899999998654433256788899999999999999999999999899999999999


Q ss_pred             CCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccc
Q 040557          163 NRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS  242 (407)
Q Consensus       163 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  242 (407)
                      +++|.+++...... +++.....++.+++.++.+||+.+   ++|+|+++.||+++.++.++|+|||++...........
T Consensus        81 ~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       81 GGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             CCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence            99999998644322 789999999999999999999987   99999999999999999999999999987765431122


Q ss_pred             cccccCccccCcccc-ccCCCCccccEEehhHHHHHHHhcCCCCCC
Q 040557          243 TNFAGTLGYTAPEYA-IRGELSEKADIYSFGVLVLEIISCRKNTDL  287 (407)
Q Consensus       243 ~~~~gt~~y~aPE~~-~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~  287 (407)
                      ....++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            345678899999988 667788899999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=3e-31  Score=244.27  Aligned_cols=275  Identities=19%  Similarity=0.228  Sum_probs=204.9

Q ss_pred             cCHHHHHHHhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCC------CCceeee
Q 040557           72 FDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ------HKNLVRL  144 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l  144 (407)
                      |.+.--+..-.+|.+....|+|-|++|..|... .|..||||++..  .....+.=+.|+++|.+|+      .-|++++
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn--NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl  499 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN--NEVMHKTGLKELEILKKLNDADPEDKFHCLRL  499 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec--chHHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence            444444555678888888999999999999854 478999999953  3333445578999999995      3588999


Q ss_pred             eeeeecCCeeEEEEEeccCCChhHHHhcc-CCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCC-Cc
Q 040557          145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGE-SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEK-FQ  222 (407)
Q Consensus       145 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~  222 (407)
                      +..|...+++|||+|-+. .+|.+.+..- .+-.|....+..++.|+..||..|..-+   |+|.||||.|||++++ ..
T Consensus       500 ~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~i  575 (752)
T KOG0670|consen  500 FRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNI  575 (752)
T ss_pred             HHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcce
Confidence            999999999999999874 5888888643 3456888999999999999999999877   9999999999999965 45


Q ss_pred             eEEecccCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchh-----
Q 040557          223 SKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLP-----  297 (407)
Q Consensus       223 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~-----  297 (407)
                      +||||||.|.....+..   +.+..+..|.|||++.+..|+...|+||.||+||||.||+..|.+.....+--+.     
T Consensus       576 LKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG  652 (752)
T KOG0670|consen  576 LKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG  652 (752)
T ss_pred             eeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence            79999999987765543   2344566899999999999999999999999999999999887654332111000     


Q ss_pred             HHHHHHHHhCccc---------------------------cccCc------cc-ccCCCC---HHHHHHHHHHHHHccCC
Q 040557          298 EYAWKLYERGRIL---------------------------ELVDP------RM-RKEGIV---ERDALQVINVAFICLQP  340 (407)
Q Consensus       298 ~~~~~~~~~~~~~---------------------------~~~d~------~~-~~~~~~---~~~~~~l~~l~~~cl~~  340 (407)
                      .+..+++..+.+.                           ..+.|      .+ ....++   .....++.+|+..||..
T Consensus       653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L  732 (752)
T KOG0670|consen  653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL  732 (752)
T ss_pred             CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence            0111222222111                           00111      00 001122   23356788999999999


Q ss_pred             CCCCCCCHHHHHHHh
Q 040557          341 HGNQRPPMSEIVAML  355 (407)
Q Consensus       341 ~p~~RPs~~ev~~~l  355 (407)
                      ||++|.|..+.++|.
T Consensus       733 dP~KRit~nqAL~Hp  747 (752)
T KOG0670|consen  733 DPEKRITVNQALKHP  747 (752)
T ss_pred             ChhhcCCHHHHhcCC
Confidence            999999999999885

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=251.77  Aligned_cols=254  Identities=24%  Similarity=0.329  Sum_probs=202.5

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|...+.+|+|.||.||++++ ..++..|+|.++... .....-..+|+-+++.++|+||+.++|.+...+..++.||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep-~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP-GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccC-CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            46788889999999999999985 468999999997554 3344556789999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      ||.+|+|.+.-+  ...++++.++..++...++|++|||+.+   -+|||||-.||++++.|.+|++|||.+..+...-.
T Consensus        93 ycgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~  167 (829)
T KOG0576|consen   93 YCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIA  167 (829)
T ss_pred             ecCCCcccceee--ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhh
Confidence            999999998874  4567899999999999999999999998   89999999999999999999999999976654332


Q ss_pred             ccccccccCccccCccccc---cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          240 YLSTNFAGTLGYTAPEYAI---RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                       ....+.||+.|||||+..   .+.|..++|||++|+...|+---++|.....+.       .+..++..    ...++.
T Consensus       168 -KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-------r~l~LmTk----S~~qpp  235 (829)
T KOG0576|consen  168 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-------RALFLMTK----SGFQPP  235 (829)
T ss_pred             -hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-------HHHHHhhc----cCCCCC
Confidence             234578999999999763   567999999999999999998777665433222       11111211    112222


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAM  354 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  354 (407)
                      -.+  ........+-++++.|+.++|.+||+++.++.|
T Consensus       236 ~lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  236 TLK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             ccc--CCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence            222  123345668899999999999999999988764

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-30  Score=241.52  Aligned_cols=197  Identities=25%  Similarity=0.360  Sum_probs=166.2

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccCh-------hhHHHHHHHHHHHHcCC---CCceeeeeeeeec
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQ-------QGESEFLSEVRMITSIQ---HKNLVRLLGCCSD  150 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~  150 (407)
                      ..|+..+.+|.|+||.|+.+.++ +...|+||.+.++.--       ...-.+-.|+.+|..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            45888999999999999999865 5678999998654311       11123457999999997   9999999999999


Q ss_pred             CCeeEEEEEecc-CCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEeccc
Q 040557          151 GSQRLLVYEYMK-NRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFG  229 (407)
Q Consensus       151 ~~~~~lv~e~~~-~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  229 (407)
                      ++.+||+||-.. +-+|.+++.  ....+++..+.-|+.|++.|+++||+.+   |+|||||-+||.++.+|-+||+|||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE--~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIE--FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhh--ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeecc
Confidence            999999999874 457777774  4456899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCcccccccccCccccCccccccCCC-CccccEEehhHHHHHHHhcCCCCC
Q 040557          230 LARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL-SEKADIYSFGVLVLEIISCRKNTD  286 (407)
Q Consensus       230 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~G~vl~el~tg~~p~~  286 (407)
                      .+.+......   ..++||..|.|||++.+..| ...-|||++|++||.++....|+.
T Consensus       716 saa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  716 SAAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             chhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9986654432   35789999999999999887 566799999999999988776654

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=1.1e-29  Score=229.37  Aligned_cols=270  Identities=25%  Similarity=0.349  Sum_probs=200.4

Q ss_pred             HHHHHhcCCCCCCeeeccCCccEEEEEec----CCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeec
Q 040557           76 TLKKATKNFHPGNLLGRGGFGPVYRGKLA----DGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSD  150 (407)
Q Consensus        76 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  150 (407)
                      .+....+.|...++||.|.|++||++.+.    ..+.||+|.+......   .++.+|+++|..+ .+.||+++.+++..
T Consensus        30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            34455678889999999999999999643    4678999998654433   3578999999999 69999999999999


Q ss_pred             CCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc-CCCceEEeccc
Q 040557          151 GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFG  229 (407)
Q Consensus       151 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg  229 (407)
                      ++...+|+||++.....++..     .++...+..++..++.||.++|.+|   |+||||||+|+|.+ ..+.-.|+|||
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             CCeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence            999999999999988888873     2678888999999999999999999   99999999999998 45678999999


Q ss_pred             CccccCCC-------------------------------------------CcccccccccCccccCcccccc-CCCCcc
Q 040557          230 LARFFPED-------------------------------------------QAYLSTNFAGTLGYTAPEYAIR-GELSEK  265 (407)
Q Consensus       230 la~~~~~~-------------------------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~k  265 (407)
                      +|......                                           ......+..||++|.|||++.. ...+++
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            99721100                                           0001123569999999998876 456899


Q ss_pred             ccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHH--------H-HHHhCc--ccc---------------ccC-cc--
Q 040557          266 ADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAW--------K-LYERGR--ILE---------------LVD-PR--  316 (407)
Q Consensus       266 ~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~--------~-~~~~~~--~~~---------------~~d-~~--  316 (407)
                      +||||.||+++.+++++.||.....+. ..+.+.+.        + ....|+  +.+               -++ ..  
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~-~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~  337 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDA-DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY  337 (418)
T ss_pred             cceeeccceeehhhccccccccCcccc-chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence            999999999999999999996433221 11111110        0 000111  111               000 00  


Q ss_pred             ------cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          317 ------MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       317 ------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                            .......+..+..+++++.+|+..||.+|-|+++.++|.-+
T Consensus       338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF  384 (418)
T KOG1167|consen  338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFF  384 (418)
T ss_pred             cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCC
Confidence                  11111122233468899999999999999999999998654

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.3e-29  Score=212.12  Aligned_cols=254  Identities=18%  Similarity=0.311  Sum_probs=187.0

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeee-eeecCCeeEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLG-CCSDGSQRLLV  157 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~-~~~~~~~~~lv  157 (407)
                      .+.|.+.+.||+|.||.+-++.+. ....+++|-+.  .......+|.+|..-=-.| .|.||+.-++ .|...+.++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp--~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVP--RPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccC--cchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            367888899999999999999865 57788999874  3445567889988654444 5899988765 46677788899


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc--CCCceEEecccCccccC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD--EKFQSKIGDFGLARFFP  235 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~--~~~~~kl~Dfgla~~~~  235 (407)
                      +||++.|+|...+.   ...+.+....+++.|++.|+.|+|+++   +||||||.+|||+-  +..++||+|||+.+..+
T Consensus       101 qE~aP~gdL~snv~---~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVE---AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             eccCccchhhhhcC---cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence            99999999988873   345888888999999999999999999   99999999999994  44589999999998654


Q ss_pred             CCCcccccccccCccccCccccccC-----CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccc
Q 040557          236 EDQAYLSTNFAGTLGYTAPEYAIRG-----ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRIL  310 (407)
Q Consensus       236 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      ..-..    ..-+..|.+||.....     ...+.+|||.||++++.++||+.||......+.   +.|-+..+..+...
T Consensus       175 ~tV~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~---~Y~~~~~w~~rk~~  247 (378)
T KOG1345|consen  175 TTVKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK---PYWEWEQWLKRKNP  247 (378)
T ss_pred             ceehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc---hHHHHHHHhcccCc
Confidence            33221    2345679999976543     236789999999999999999999974333332   33444445544333


Q ss_pred             cccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHhh
Q 040557          311 ELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPP---MSEIVAMLT  356 (407)
Q Consensus       311 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~ev~~~l~  356 (407)
                      .+. ...+      .....+..+..+-+..+|++|-.   .+.....+|
T Consensus       248 ~~P-~~F~------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w  289 (378)
T KOG1345|consen  248 ALP-KKFN------PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW  289 (378)
T ss_pred             cCc-hhhc------ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence            111 1111      12345677888899999999944   444444444

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=8.4e-29  Score=257.97  Aligned_cols=198  Identities=18%  Similarity=0.209  Sum_probs=140.8

Q ss_pred             CC-Cceeeeeeee-------ecCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeee
Q 040557          137 QH-KNLVRLLGCC-------SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR  208 (407)
Q Consensus       137 ~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~  208 (407)
                      +| .||.+++++|       .....++.++||+ +++|.+++... ...+++..+..++.||+.||.|||+++   |+||
T Consensus        30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---IvHr  104 (793)
T PLN00181         30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG---IVVH  104 (793)
T ss_pred             hHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence            44 5777777776       2234567788987 56999999643 345899999999999999999999998   9999


Q ss_pred             ccccccEEEcC-------------------CCceEEecccCccccCCCC---------------cccccccccCccccCc
Q 040557          209 DIKASNVLLDE-------------------KFQSKIGDFGLARFFPEDQ---------------AYLSTNFAGTLGYTAP  254 (407)
Q Consensus       209 dlk~~Nill~~-------------------~~~~kl~Dfgla~~~~~~~---------------~~~~~~~~gt~~y~aP  254 (407)
                      ||||+||||+.                   ++.+|++|||+++......               ........||+.||||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            99999999954                   4456666777665421100               0001124578899999


Q ss_pred             cccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHH
Q 040557          255 EYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVA  334 (407)
Q Consensus       255 E~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~  334 (407)
                      |++.+..++.++|||||||+||||++|..|+....        ..... ....    .+.+..      ........+++
T Consensus       185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~~-~~~~----~~~~~~------~~~~~~~~~~~  245 (793)
T PLN00181        185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMSS-LRHR----VLPPQI------LLNWPKEASFC  245 (793)
T ss_pred             hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHHH-HHHh----hcChhh------hhcCHHHHHHH
Confidence            99999999999999999999999999887653210        00111 1100    111111      01123456888


Q ss_pred             HHccCCCCCCCCCHHHHHHHhhcc
Q 040557          335 FICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       335 ~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .+||+.+|.+||++.|+++|.+..
T Consensus       246 ~~~L~~~P~~Rps~~eil~h~~~~  269 (793)
T PLN00181        246 LWLLHPEPSCRPSMSELLQSEFIN  269 (793)
T ss_pred             HHhCCCChhhCcChHHHhhchhhh
Confidence            899999999999999999987753

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=1.5e-27  Score=203.72  Aligned_cols=167  Identities=23%  Similarity=0.209  Sum_probs=126.6

Q ss_pred             CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccccc
Q 040557          164 RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST  243 (407)
Q Consensus       164 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  243 (407)
                      |+|.+++... ...+++..+..++.|++.||.|||+.+         ||+|||++.++.+++  ||++.......     
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----   63 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----   63 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-----
Confidence            6888988643 345999999999999999999999875         999999999999999  99998765432     


Q ss_pred             ccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCC
Q 040557          244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIV  323 (407)
Q Consensus       244 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  323 (407)
                       ..||+.|||||++.+..++.++|||||||++|||+||+.|+......     ............ .  .++...  ...
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-----~~~~~~~~~~~~-~--~~~~~~--~~~  132 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-----SAILEILLNGMP-A--DDPRDR--SNL  132 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-----cHHHHHHHHHhc-c--CCcccc--ccH
Confidence             25889999999999999999999999999999999999998643221     111111111100 0  001000  011


Q ss_pred             HHHHH--HHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          324 ERDAL--QVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       324 ~~~~~--~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .....  .+.+++.+||+.+|++||++.+++++++..
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            22222  589999999999999999999999998754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=4e-26  Score=212.89  Aligned_cols=169  Identities=22%  Similarity=0.258  Sum_probs=131.1

Q ss_pred             HHHHhcCCCCCCeeeccCCccEEEEEec--CCcEEEEEEecccc----ChhhHHHHHHHHHHHHcCCCCceeeeeeeeec
Q 040557           77 LKKATKNFHPGNLLGRGGFGPVYRGKLA--DGTLVAVKKLCVDK----SQQGESEFLSEVRMITSIQHKNLVRLLGCCSD  150 (407)
Q Consensus        77 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  150 (407)
                      .....++|.+.+.||+|+||.||+|.+.  ++..||||++....    .......|.+|+++|.+++|+|++..+..+  
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--   90 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--   90 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence            3445678999999999999999999764  57788999875321    223356789999999999999998533222  


Q ss_pred             CCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeecc-ccccEEEcCCCceEEeccc
Q 040557          151 GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDI-KASNVLLDEKFQSKIGDFG  229 (407)
Q Consensus       151 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl-k~~Nill~~~~~~kl~Dfg  229 (407)
                       +..++||||++|++|....   ..   .   ...++.+++.||.|||+.+   |+|||| ||+|||++.++.++|+|||
T Consensus        91 -~~~~LVmE~~~G~~L~~~~---~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHLAR---PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             -CCcEEEEEccCCCCHHHhC---cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence             4579999999999996321   11   1   1467889999999999998   999999 9999999999999999999


Q ss_pred             CccccCCCCcccc-------cccccCccccCccccccC
Q 040557          230 LARFFPEDQAYLS-------TNFAGTLGYTAPEYAIRG  260 (407)
Q Consensus       230 la~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~  260 (407)
                      +++.+........       .+..+++.|+|||.+...
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9997754332111       356788899999988643

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=3.5e-25  Score=206.95  Aligned_cols=259  Identities=20%  Similarity=0.249  Sum_probs=192.3

Q ss_pred             CCCCCCeeeccCCccEEEEEecCC--cEEEEEEeccccChhhHHHHHHHHHHHHcCC----CCceeeeeeee-ecCCeeE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLADG--TLVAVKKLCVDKSQQGESEFLSEVRMITSIQ----HKNLVRLLGCC-SDGSQRL  155 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~----h~niv~l~~~~-~~~~~~~  155 (407)
                      +|.+.+.||+|+||.||.+.....  ..+|+|........... .+..|..++..+.    ..++..+++.. ......+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            799999999999999999986543  47888877544333222 5678888888886    26888888888 4777889


Q ss_pred             EEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCC-----CceEEecccC
Q 040557          156 LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEK-----FQSKIGDFGL  230 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-----~~~kl~Dfgl  230 (407)
                      +||+.+ |.+|.++......+.++..+...++.|++.+|++||+.|   ++||||||.|+++...     ..+.|.|||+
T Consensus        98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            999988 779999886555677999999999999999999999999   9999999999999855     4699999999


Q ss_pred             cc--ccCCCCc-----cc--ccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHH
Q 040557          231 AR--FFPEDQA-----YL--STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAW  301 (407)
Q Consensus       231 a~--~~~~~~~-----~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~  301 (407)
                      ++  .+.....     ..  .....||..|.++..+.+...+.+.|+||++.++.|++.|..||........       .
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-------~  246 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-------K  246 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-------H
Confidence            98  3322211     11  1245699999999999999999999999999999999999999854332211       0


Q ss_pred             HHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          302 KLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       302 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ..+...........      .....+..+.++...+-..+..++|....+...+....
T Consensus       247 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~  298 (322)
T KOG1164|consen  247 SKFEKDPRKLLTDR------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF  298 (322)
T ss_pred             HHHHHHhhhhcccc------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence            00111111111111      01112334556666666689999999999998876543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=2e-25  Score=187.80  Aligned_cols=257  Identities=18%  Similarity=0.230  Sum_probs=194.2

Q ss_pred             hcCCCCCCeeeccCCccEEEEE-ecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCC-CCceeeeeeeeecCCeeEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-HKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ..+|.+.+.||+|+||.+|.|. ..+|..||||.-..   .....++.-|..+...++ ...|..+..+..+...-.+||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~---~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS---KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecc---cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            3678889999999999999996 67899999997532   223335667888888886 467777777888888889999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC---CCceEEecccCccccC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE---KFQSKIGDFGLARFFP  235 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfgla~~~~  235 (407)
                      +.. |.+|+++..-.. ..++..+.+-++-|++.-++|+|..+   ++||||||+|+|..-   ...+.++|||+|+.+.
T Consensus        91 dLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             ecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence            998 779998875443 34899999999999999999999999   999999999999963   3478999999998775


Q ss_pred             CCCcc------cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcc
Q 040557          236 EDQAY------LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRI  309 (407)
Q Consensus       236 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      +....      ...+..||.+|.+-....+...+.+.|+-|+|.+|.++.-|..||.+-.+.....    ..+.+.+.++
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q----KyEkI~EkK~  241 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ----KYEKISEKKM  241 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH----HHHHHHHhhc
Confidence            43322      2245679999999988888889999999999999999999999997655443221    1222222222


Q ss_pred             ccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          310 LELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       310 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                      .-.+....      ...+.++.-.+.-|-+..-++-|...-+.+.+
T Consensus       242 s~~ie~LC------~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF  281 (341)
T KOG1163|consen  242 STPIEVLC------KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF  281 (341)
T ss_pred             CCCHHHHh------CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence            21111111      11234566677778888888888877666554

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=3.3e-26  Score=195.71  Aligned_cols=247  Identities=22%  Similarity=0.331  Sum_probs=190.0

Q ss_pred             CeeeccCCccEEEEEecCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCCh
Q 040557           88 NLLGRGGFGPVYRGKLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL  166 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  166 (407)
                      .+|.....|..|+|+++ |..+++|++.... ...-..+|..|.-.|+...||||+.++|.|....++.++..||+-|+|
T Consensus       196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl  274 (448)
T KOG0195|consen  196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL  274 (448)
T ss_pred             hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence            46888899999999996 5556678775443 223335788899999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccccccc
Q 040557          167 DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA  246 (407)
Q Consensus       167 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  246 (407)
                      ...++....-..+..++.+++.++++|++|||+.. +-|.---|.+..+++|++.+++|+-- -++     .+.......
T Consensus       275 ynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarisma-d~k-----fsfqe~gr~  347 (448)
T KOG0195|consen  275 YNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMA-DTK-----FSFQEVGRA  347 (448)
T ss_pred             HHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecc-cce-----eeeeccccc
Confidence            99999888777888999999999999999999986 22334468999999999998887421 111     111222334


Q ss_pred             cCccccCccccccCCCC---ccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCC
Q 040557          247 GTLGYTAPEYAIRGELS---EKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIV  323 (407)
Q Consensus       247 gt~~y~aPE~~~~~~~~---~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  323 (407)
                      -.+.||+||.+..++-+   ..+|+|||++++|||.|...||..-.+.+.....      .-+|         ++ ...+
T Consensus       348 y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki------aleg---------lr-v~ip  411 (448)
T KOG0195|consen  348 YSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI------ALEG---------LR-VHIP  411 (448)
T ss_pred             cCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh------hhcc---------cc-ccCC
Confidence            57889999999887643   5789999999999999999999876665443211      0001         11 1234


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          324 ERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       324 ~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      +..+..+.+++.-|+..||.+||.++.|+-.|+..
T Consensus       412 pgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  412 PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            44556788899999999999999999999888653

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=2.9e-24  Score=188.67  Aligned_cols=201  Identities=21%  Similarity=0.300  Sum_probs=169.4

Q ss_pred             hcCCCCCCeeeccCCccEEEEE-ecCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      .-+|+++++||.|+||..+.|+ +-+++.||||.-...   ...-++..|.+..+.| ..++|..++.+...+.+-.||+
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEecccc---CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            3579999999999999999997 457999999965322   2334567788888877 5799999988888888888999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC-----CCceEEecccCccc
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE-----KFQSKIGDFGLARF  233 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-----~~~~kl~Dfgla~~  233 (407)
                      |.+ |.||+++..-..+ .++..++..+|.|++.-++|+|++.   +|.|||||+|+||..     ...+.++|||+|+.
T Consensus       104 dLL-GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhh-CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            998 7799999875554 4899999999999999999999998   999999999999963     34689999999998


Q ss_pred             cCCCCcc------cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCC
Q 040557          234 FPEDQAY------LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTL  289 (407)
Q Consensus       234 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~  289 (407)
                      +.+....      ......||.+||+-....+...+.+.|+-|+|-++.+++-|..||.+.-
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence            8654332      2234679999999999999999999999999999999999999997543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=2.5e-25  Score=220.80  Aligned_cols=258  Identities=23%  Similarity=0.261  Sum_probs=191.9

Q ss_pred             CCCCeeeccCCccEEEEEe-cCCcEEEEEEecc----ccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           85 HPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCV----DKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        85 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~----~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ....++|.|++|.|+.... ...+..+.|.+..    ... ......+..|+.+=..+.|+|++..+..+.+....+-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            4567899999998887753 3445455554431    111 112222566777777889999988887777666666669


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      |||++ +|..++..  ...+....+..++.|++.|+.|+|+.|   +.|||+|++|++++.++.+||+|||.+..+....
T Consensus       401 E~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             hcccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            99999 99888843  346888899999999999999999999   9999999999999999999999999998776433


Q ss_pred             c---ccccccccCccccCccccccCCCCc-cccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          239 A---YLSTNFAGTLGYTAPEYAIRGELSE-KADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       239 ~---~~~~~~~gt~~y~aPE~~~~~~~~~-k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      .   ......+|...|+|||.+.+..|+. ..||||.|+++..|++|+.||......+.++.     .....+..    .
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-----~~~~~~~~----~  545 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-----TNNYSDQR----N  545 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-----hhcccccc----c
Confidence            3   4456788999999999999999976 57999999999999999999976555443320     00000000    0


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      ............+.....++.++|+.||.+|-|+++|++.-|.
T Consensus       546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~  588 (601)
T KOG0590|consen  546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWI  588 (601)
T ss_pred             cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHh
Confidence            0011111223345567789999999999999999999988775

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=6.2e-23  Score=191.98  Aligned_cols=261  Identities=28%  Similarity=0.371  Sum_probs=198.6

Q ss_pred             CCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChh--hHHHHHHHHHHHHcCCCC-ceeeeeeeeecCCeeEEEEEe
Q 040557           84 FHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQ--GESEFLSEVRMITSIQHK-NLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  160 (407)
                      |...+.||.|+||.||++...  ..+++|.+.......  ....+.+|..+++.+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566788999999999999876  789999987655443  467899999999999888 799999999777778999999


Q ss_pred             ccCCChhHHHhccCC-CCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC-ceEEecccCccccCCCC
Q 040557          161 MKNRSLDLLIYGESD-KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF-QSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~  238 (407)
                      +.++++.+++..... ..+.......++.|++.++.|+|+.+   ++|||+||.||+++..+ .++++|||++..+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999966643322 26889999999999999999999998   99999999999999988 79999999998665443


Q ss_pred             cc-----cccccccCccccCcccccc---CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccc
Q 040557          239 AY-----LSTNFAGTLGYTAPEYAIR---GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRIL  310 (407)
Q Consensus       239 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      ..     ......|+..|++||.+.+   ..++...|+||+|++++++++|..|+......   ................
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence            22     2355789999999999987   57889999999999999999999996543321   0011111212211111


Q ss_pred             cccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040557          311 ELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAM  354 (407)
Q Consensus       311 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  354 (407)
                       ......... ........+.+++..|+..+|..|.+..+....
T Consensus       234 -~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 -SLASPLSPS-NPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             -ccccccCcc-ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence             000001000 001223467789999999999999999988775

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=1.2e-24  Score=216.72  Aligned_cols=250  Identities=22%  Similarity=0.293  Sum_probs=183.5

Q ss_pred             CCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHH--HHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRM--ITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      ++...+.||++.|=+|.+|++.+|. |+||++......-....|.++++-  ...++|||.+++.-+-......|+|-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5666788999999999999998777 999999766655555555555544  3445899999998887777778888888


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcc--ccCCCC
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR--FFPEDQ  238 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~--~~~~~~  238 (407)
                      ..+ +|.+.+  ..+.++...+...|+.|++.|+.-+|..|   |+|||||.+|||++.-..+.|+||..-+  +++.++
T Consensus       103 vkh-nLyDRl--STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  103 VKH-NLYDRL--STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             Hhh-hhhhhh--ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            866 777777  45677888899999999999999999999   9999999999999999999999998775  233222


Q ss_pred             c----ccccccccCccccCccccccC----------C-CCccccEEehhHHHHHHHhc-CCCCCCCCCcccCchhHHHHH
Q 040557          239 A----YLSTNFAGTLGYTAPEYAIRG----------E-LSEKADIYSFGVLVLEIISC-RKNTDLTLPSEMQYLPEYAWK  302 (407)
Q Consensus       239 ~----~~~~~~~gt~~y~aPE~~~~~----------~-~~~k~Dv~s~G~vl~el~tg-~~p~~~~~~~~~~~~~~~~~~  302 (407)
                      .    +...+...-.+|+|||.+...          . .+++-||||+||++.||++- +++|....          ...
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----------L~a  246 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----------LLA  246 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----------HHh
Confidence            2    122233345589999977531          1 56789999999999999885 66664211          000


Q ss_pred             HHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          303 LYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       303 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                       +..+.   ..|+...-+..   ....+.+++..|++.||++|.++++.++.-.
T Consensus       247 -Yr~~~---~~~~e~~Le~I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  247 -YRSGN---ADDPEQLLEKI---EDVSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             -HhccC---ccCHHHHHHhC---cCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence             11111   11111111111   1125789999999999999999999998744

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=2.4e-23  Score=180.82  Aligned_cols=173  Identities=13%  Similarity=0.100  Sum_probs=135.0

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChh--hHHH------HHHHHHHHHcCCCCceeeeeeeeecC
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQ--GESE------FLSEVRMITSIQHKNLVRLLGCCSDG  151 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~------~~~e~~~l~~l~h~niv~l~~~~~~~  151 (407)
                      ..++|+..+++|.|+||.||.... ++..+|+|.+.......  ....      +.+|++.+.++.|++|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            457899999999999999999766 57789999996543222  2222      57899999999999999988876533


Q ss_pred             --------CeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCce
Q 040557          152 --------SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS  223 (407)
Q Consensus       152 --------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~  223 (407)
                              ...+++|||++|.+|.++..      ++.    ....+++.++..+|+.+   ++|||++|+||+++.++ +
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence                    35789999999999988731      222    24568999999999998   99999999999999988 9


Q ss_pred             EEecccCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHh
Q 040557          224 KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS  280 (407)
Q Consensus       224 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t  280 (407)
                      +|+|||.......+....             .+.....|..++|+||||+.+..+..
T Consensus       174 ~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHHH
Confidence            999999987653322210             13445567789999999999987753

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=5.7e-23  Score=176.54  Aligned_cols=141  Identities=18%  Similarity=0.145  Sum_probs=108.3

Q ss_pred             CCeeeccCCccEEEEEecCCcEEEEEEeccccChh-h-------H-----------------HHHHHHHHHHHcCCCCce
Q 040557           87 GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQ-G-------E-----------------SEFLSEVRMITSIQHKNL  141 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~-------~-----------------~~~~~e~~~l~~l~h~ni  141 (407)
                      ...||+|+||.||+|...+|+.||||+++...... .       .                 .....|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            36799999999999998789999999996542110 0       1                 122359999999987776


Q ss_pred             eeeeeeeecCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccc-cccCCCceeeeccccccEEEcCC
Q 040557          142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYL-HEDSHTRIVHRDIKASNVLLDEK  220 (407)
Q Consensus       142 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~dlk~~Nill~~~  220 (407)
                      .....+..  ...++||||++++++.....  ....+++....+++.|++.+|.++ |+.+   ++||||||+|||+++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~~-  153 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYHD-  153 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEEC-
Confidence            43332221  22389999999887754432  234588999999999999999999 6888   999999999999984 


Q ss_pred             CceEEecccCccccC
Q 040557          221 FQSKIGDFGLARFFP  235 (407)
Q Consensus       221 ~~~kl~Dfgla~~~~  235 (407)
                      +.++|+|||+|....
T Consensus       154 ~~v~LiDFG~a~~~~  168 (190)
T cd05147         154 GKLYIIDVSQSVEHD  168 (190)
T ss_pred             CcEEEEEccccccCC
Confidence            789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=1.2e-21  Score=168.85  Aligned_cols=143  Identities=17%  Similarity=0.128  Sum_probs=111.1

Q ss_pred             CCeeeccCCccEEEEEecCCcEEEEEEeccccCh-------------------------hhHHHHHHHHHHHHcCCCCce
Q 040557           87 GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQ-------------------------QGESEFLSEVRMITSIQHKNL  141 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~e~~~l~~l~h~ni  141 (407)
                      ...||+|++|.||+|...+|+.||||++......                         .....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999999778999999998754211                         001234578999999999887


Q ss_pred             eeeeeeeecCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccc-cCCCceeeeccccccEEEcCC
Q 040557          142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE-DSHTRIVHRDIKASNVLLDEK  220 (407)
Q Consensus       142 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~  220 (407)
                      .....+...  ..++||||++++++.....  ....++.....+++.|++.++.++|+ .+   ++||||||+||+++ +
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-C
Confidence            543333322  2489999999886543321  12347788899999999999999999 88   99999999999999 7


Q ss_pred             CceEEecccCccccCCC
Q 040557          221 FQSKIGDFGLARFFPED  237 (407)
Q Consensus       221 ~~~kl~Dfgla~~~~~~  237 (407)
                      +.++|+|||++......
T Consensus       154 ~~~~liDFG~a~~~~~~  170 (190)
T cd05145         154 GKPYIIDVSQAVELDHP  170 (190)
T ss_pred             CCEEEEEcccceecCCC
Confidence            89999999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.87  E-value=8.2e-22  Score=187.29  Aligned_cols=217  Identities=26%  Similarity=0.406  Sum_probs=162.3

Q ss_pred             HHcCCCCceeeeeeeeecCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeecccc
Q 040557          133 ITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKA  212 (407)
Q Consensus       133 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~  212 (407)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+... ...+++.....+..+++.||.|||...  -..|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeecc
Confidence            35678999999999999999999999999999999999763 445899999999999999999999864  239999999


Q ss_pred             ccEEEcCCCceEEecccCccccCCCCc-ccccccccCccccCccccccC-------CCCccccEEehhHHHHHHHhcCCC
Q 040557          213 SNVLLDEKFQSKIGDFGLARFFPEDQA-YLSTNFAGTLGYTAPEYAIRG-------ELSEKADIYSFGVLVLEIISCRKN  284 (407)
Q Consensus       213 ~Nill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-------~~~~k~Dv~s~G~vl~el~tg~~p  284 (407)
                      .|.++|..+.+||+|||+......... .......-..-|.|||.+...       ..+.++||||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            999999999999999999987743111 111122234579999988763       146789999999999999999999


Q ss_pred             CCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          285 TDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      |+........  .+.+.. +.. .-...+-|.+...   .+....+..++..||..+|++||++++|-..+....
T Consensus       158 ~~~~~~~~~~--~eii~~-~~~-~~~~~~rP~i~~~---~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  158 FDLRNLVEDP--DEIILR-VKK-GGSNPFRPSIELL---NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             cccccccCCh--HHHHHH-HHh-cCCCCcCcchhhh---hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            9864433321  122222 111 1111122222211   123346889999999999999999999988876543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=3.5e-21  Score=163.82  Aligned_cols=185  Identities=17%  Similarity=0.056  Sum_probs=137.7

Q ss_pred             CCCeeeccCCccEEEEEecCCcEEEEEEeccccCh---hhHHHHHHHHHHHHcCC-CCceeeeeeeeecCCeeEEEEEec
Q 040557           86 PGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQ---QGESEFLSEVRMITSIQ-HKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        86 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      ....|++|+||+||.+.. .+..++.+.+......   .....+.+|+++|.++. |+++.+++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            457899999999998776 6788887777543321   11235789999999995 5889999886    3469999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeecc-ccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDI-KASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl-k~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      .|.+|......        . ...++.|++.++.++|+.|   |+|||| ||.|||++.++.++|+|||++.........
T Consensus        81 ~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         81 AGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             cCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            99988654311        1 1357789999999999999   999999 799999999999999999999866543321


Q ss_pred             ----c--------ccccccCccccCccccccC-CCC-ccccEEehhHHHHHHHhcCCCCCC
Q 040557          241 ----L--------STNFAGTLGYTAPEYAIRG-ELS-EKADIYSFGVLVLEIISCRKNTDL  287 (407)
Q Consensus       241 ----~--------~~~~~gt~~y~aPE~~~~~-~~~-~k~Dv~s~G~vl~el~tg~~p~~~  287 (407)
                          .        ..-...++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+.-.
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                0        1112357777788744322 222 456888999999999999977643

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=2e-21  Score=174.68  Aligned_cols=193  Identities=22%  Similarity=0.291  Sum_probs=136.1

Q ss_pred             CCCceeeeeeeeec---------------------------CCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHH
Q 040557          137 QHKNLVRLLGCCSD---------------------------GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG  189 (407)
Q Consensus       137 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~  189 (407)
                      +|||||+++++|.+                           +...|+||.-++. +|.+++..+.   .+.....-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHH
Confidence            59999999987632                           3456899988865 8999986544   455566678899


Q ss_pred             HHHHhccccccCCCceeeeccccccEEEc--CC--CceEEecccCccccCC-----CCcccccccccCccccCccccccC
Q 040557          190 IARGLQYLHEDSHTRIVHRDIKASNVLLD--EK--FQSKIGDFGLARFFPE-----DQAYLSTNFAGTLGYTAPEYAIRG  260 (407)
Q Consensus       190 i~~~l~~LH~~~~~~i~H~dlk~~Nill~--~~--~~~kl~Dfgla~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~  260 (407)
                      +++|+.|||.+|   +.|||+|++|||+.  +|  -.+.|+|||++-.-..     ......-...|...-||||+....
T Consensus       350 lLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            999999999999   99999999999994  33  3578999999853221     111111234578889999977542


Q ss_pred             C------CCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHH
Q 040557          261 E------LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVA  334 (407)
Q Consensus       261 ~------~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~  334 (407)
                      +      .-.|+|.|+.|-+.||+++...||...-....+   .   ..+++.++     |     ..++.++..+.+++
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~---~---r~Yqe~qL-----P-----alp~~vpp~~rqlV  490 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD---T---RTYQESQL-----P-----ALPSRVPPVARQLV  490 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec---h---hhhhhhhC-----C-----CCcccCChHHHHHH
Confidence            2      135899999999999999999999752111000   0   00111111     1     23344566788999


Q ss_pred             HHccCCCCCCCCCHHHHH
Q 040557          335 FICLQPHGNQRPPMSEIV  352 (407)
Q Consensus       335 ~~cl~~~p~~RPs~~ev~  352 (407)
                      ...|+.||++|++..-..
T Consensus       491 ~~lL~r~pskRvsp~iAA  508 (598)
T KOG4158|consen  491 FDLLKRDPSKRVSPNIAA  508 (598)
T ss_pred             HHHhcCCccccCCccHHH
Confidence            999999999999965443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.85  E-value=7.5e-22  Score=187.67  Aligned_cols=226  Identities=21%  Similarity=0.254  Sum_probs=177.7

Q ss_pred             eeeccCCccEEEEE----ecCCcEEEEEEeccccChhh-HHHHHHHHHHHHcCC-CCceeeeeeeeecCCeeEEEEEecc
Q 040557           89 LLGRGGFGPVYRGK----LADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQ-HKNLVRLLGCCSDGSQRLLVYEYMK  162 (407)
Q Consensus        89 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  162 (407)
                      .+|+|+||.|+.++    ...|..+|.|.+++...... ......|..++..++ ||.++++...+......+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999874    23477899998865442211 124456777888885 9999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccc
Q 040557          163 NRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS  242 (407)
Q Consensus       163 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  242 (407)
                      ||.|...+.  ....+++.........++-+++++|+.+   ++|||+|++||+++.+|.+++.|||+++..-.....  
T Consensus        81 gg~lft~l~--~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--  153 (612)
T KOG0603|consen   81 GGDLFTRLS--KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--  153 (612)
T ss_pred             cchhhhccc--cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence            999877763  3344666777778889999999999999   999999999999999999999999999876544432  


Q ss_pred             cccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCC
Q 040557          243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGI  322 (407)
Q Consensus       243 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  322 (407)
                         +||..|||||++.  .....+|.||||++++||+||..||..          +....+...            +...
T Consensus       154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~------------~~~~  206 (612)
T KOG0603|consen  154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKA------------ELEM  206 (612)
T ss_pred             ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhh------------ccCC
Confidence               8999999999888  567889999999999999999999874          111111110            1124


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCH
Q 040557          323 VERDALQVINVAFICLQPHGNQRPPM  348 (407)
Q Consensus       323 ~~~~~~~l~~l~~~cl~~~p~~RPs~  348 (407)
                      +......+.+++..++..+|.+|.-.
T Consensus       207 p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  207 PRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            45556667788889999999999865

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.83  E-value=1.2e-20  Score=168.84  Aligned_cols=232  Identities=21%  Similarity=0.244  Sum_probs=148.1

Q ss_pred             CCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCC----------Cceeeeeeee--
Q 040557           84 FHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQH----------KNLVRLLGCC--  148 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~--  148 (407)
                      +..++.||.|+++.||.+.+. +|+.+|+|.+.....  ....+.+.+|.-....+.+          -.++..++..  
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            344578999999999999875 589999999865442  2334566666654444322          1222222211  


Q ss_pred             -------ecC---C-----eeEEEEEeccCCChhHHHhc---cC--CCCCCHHHHHHHHHHHHHHhccccccCCCceeee
Q 040557          149 -------SDG---S-----QRLLVYEYMKNRSLDLLIYG---ES--DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR  208 (407)
Q Consensus       149 -------~~~---~-----~~~lv~e~~~~g~L~~~l~~---~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~  208 (407)
                             ...   .     ..+++|+-+ .++|..++..   ..  ...+....+..+..|+++.+++||+.|   ++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence                   111   1     236677777 4588776532   11  223456667788899999999999999   9999


Q ss_pred             ccccccEEEcCCCceEEecccCccccCCCCcccccccccCccccCccccccC--------CCCccccEEehhHHHHHHHh
Q 040557          209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG--------ELSEKADIYSFGVLVLEIIS  280 (407)
Q Consensus       209 dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~k~Dv~s~G~vl~el~t  280 (407)
                      ||+|+|++++.+|.+.|+||+.....+.....    ...+..|.+||.....        .++.+.|.|++|+++|.|++
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            99999999999999999999888755432221    2345779999976442        46889999999999999999


Q ss_pred             cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCC
Q 040557          281 CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQR  345 (407)
Q Consensus       281 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R  345 (407)
                      |+.||+...+......                   .+  ..+. +.+..+..||..+|+.||++|
T Consensus       246 ~~lPf~~~~~~~~~~~-------------------~f--~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPEW-------------------DF--SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSGG-------------------GG--TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCccccccc-------------------cc--hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999986543322110                   11  1133 567778899999999999988

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=1.5e-19  Score=156.71  Aligned_cols=135  Identities=15%  Similarity=0.206  Sum_probs=103.5

Q ss_pred             CCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-----CCCceeeeeeeeecCC---e-eEE
Q 040557           86 PGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-----QHKNLVRLLGCCSDGS---Q-RLL  156 (407)
Q Consensus        86 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~-~~l  156 (407)
                      ..+.||+|+||.||.  +++....+||++.... ......+.+|+.++..+     +||||++++|++.+..   . +.+
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCeEEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            357899999999996  4333334799886432 23456789999999999     5799999999998763   3 347


Q ss_pred             EEEe--ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHh-ccccccCCCceeeeccccccEEEcC----CCceEEeccc
Q 040557          157 VYEY--MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL-QYLHEDSHTRIVHRDIKASNVLLDE----KFQSKIGDFG  229 (407)
Q Consensus       157 v~e~--~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~i~H~dlk~~Nill~~----~~~~kl~Dfg  229 (407)
                      |+||  +.+|+|.+++...   .+++.  ..++.+++.++ +|||+++   |+||||||+|||++.    +..++|+||+
T Consensus        83 I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            8999  5579999999542   25555  35677888777 9999998   999999999999973    3479999944


Q ss_pred             Cc
Q 040557          230 LA  231 (407)
Q Consensus       230 la  231 (407)
                      -+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            33

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=7.6e-21  Score=177.53  Aligned_cols=175  Identities=26%  Similarity=0.371  Sum_probs=132.5

Q ss_pred             eeEEEEEeccCCChhHHHhcc-CCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGE-SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLA  231 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla  231 (407)
                      .+|+.|++|.-.+|.+|+..+ .....++.....++.|++.|++|   ++   .+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999633 34557889999999999999999   56   999999999999999999999999999


Q ss_pred             cccCCCC-----cccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHH
Q 040557          232 RFFPEDQ-----AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYE  305 (407)
Q Consensus       232 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  305 (407)
                      .......     ....+...||..||+||.+.+..|+.|+||||||++|+||++ -...++.          .-....+.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------~~t~~d~r  473 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------IATLTDIR  473 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------HHhhhhhh
Confidence            8776554     333456789999999999999999999999999999999997 2222210          00111122


Q ss_pred             hCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040557          306 RGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVA  353 (407)
Q Consensus       306 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  353 (407)
                      .+.+.    +....+      -..-+.++.+++.+.|.+||++.++..
T Consensus       474 ~g~ip----~~~~~d------~p~e~~ll~~lls~~p~~RP~~~~~~~  511 (516)
T KOG1033|consen  474 DGIIP----PEFLQD------YPEEYTLLQQLLSPSPEERPSAIEVAL  511 (516)
T ss_pred             cCCCC----hHHhhc------CcHHHHHHHHhcCCCcccCchHHHHhh
Confidence            22221    111111      122357899999999999996655543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=5e-19  Score=153.84  Aligned_cols=148  Identities=19%  Similarity=0.183  Sum_probs=113.6

Q ss_pred             HHHHHhcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccCh---------------------hhHHHHHHHHHHHH
Q 040557           76 TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQ---------------------QGESEFLSEVRMIT  134 (407)
Q Consensus        76 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~e~~~l~  134 (407)
                      ++......|.+.+.||+|+||.||++...+|+.||||++......                     .....+..|..++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            344444458888999999999999999888999999987543210                     01123567888888


Q ss_pred             cCCCCc--eeeeeeeeecCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeecccc
Q 040557          135 SIQHKN--LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKA  212 (407)
Q Consensus       135 ~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~  212 (407)
                      .+.|.+  +...++.    ...++||||+++++|......        .....++.+++.++.++|+.+   ++||||+|
T Consensus        89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p  153 (198)
T cd05144          89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHGDLSE  153 (198)
T ss_pred             HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence            887774  4444432    345899999999998765421        234578899999999999988   99999999


Q ss_pred             ccEEEcCCCceEEecccCccccCCCC
Q 040557          213 SNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       213 ~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      +||++++++.++|+|||++.......
T Consensus       154 ~Nill~~~~~~~liDfg~~~~~~~~~  179 (198)
T cd05144         154 FNILVDDDEKIYIIDWPQMVSTDHPN  179 (198)
T ss_pred             ccEEEcCCCcEEEEECCccccCCCcc
Confidence            99999999999999999997665443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=6.6e-19  Score=154.77  Aligned_cols=135  Identities=24%  Similarity=0.340  Sum_probs=112.9

Q ss_pred             CeeeccCCccEEEEEecCCcEEEEEEeccccCh-------hhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           88 NLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQ-------QGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      +.||+|++|.||+|.. +|..+++|........       .....+.+|++++..+.|+++.....++.+....+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 6788999986533211       1224678899999999999988777777677788999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      ++|++|.+++....     + .+..++.+++.++.++|+.+   ++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999885321     2 77889999999999999998   99999999999999 78999999999874

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.79  E-value=3.6e-19  Score=180.75  Aligned_cols=193  Identities=20%  Similarity=0.225  Sum_probs=154.0

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCC---CCceeeeeeeeecCCeeEE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ---HKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~l  156 (407)
                      ....|.+.+.||+|+||+||.|...+|+.||+|.-+.....+    |+=-.+++.+|+   -+-|..+..++.-.+.-+|
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence            346788888999999999999998889999999875444322    222223333333   2334444455555677789


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc-------CCCceEEeccc
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD-------EKFQSKIGDFG  229 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-------~~~~~kl~Dfg  229 (407)
                      |+||.+.|+|.+++.  ..+.++|.....++.|++..++.||..+   |||+||||+|+||.       +...++|+|||
T Consensus       772 v~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG  846 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFG  846 (974)
T ss_pred             eeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecc
Confidence            999999999999994  6667999999999999999999999998   99999999999994       34568999999


Q ss_pred             CccccC---CCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCC
Q 040557          230 LARFFP---EDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRK  283 (407)
Q Consensus       230 la~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~  283 (407)
                      -+..+.   +.  ..-...++|-.+-.+|+..+..++...|.|.|+-+++-|+.|+.
T Consensus       847 ~siDm~lfp~~--~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  847 RSIDMKLFPDG--TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cceeeeEcCCC--cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            996543   33  22345678999999999999999999999999999999999984

>smart00090 RIO RIO-like kinase

Probab=99.79  E-value=8.4e-19  Score=155.80  Aligned_cols=144  Identities=17%  Similarity=0.148  Sum_probs=111.1

Q ss_pred             CCCCCCeeeccCCccEEEEE--ecCCcEEEEEEeccccCh-----------------------hhHHHHHHHHHHHHcCC
Q 040557           83 NFHPGNLLGRGGFGPVYRGK--LADGTLVAVKKLCVDKSQ-----------------------QGESEFLSEVRMITSIQ  137 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~  137 (407)
                      -|.+.+.||+|+||.||+|.  ..+|+.||+|.+......                       .....+.+|++.+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47888999999999999998  568999999998643210                       01123568999999996


Q ss_pred             CC--ceeeeeeeeecCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccE
Q 040557          138 HK--NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNV  215 (407)
Q Consensus       138 h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Ni  215 (407)
                      +.  .+.+++++    ...++||||+++++|......  ...+.......++.|++.++.+||+.+  +++||||||+||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NI  180 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNI  180 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhE
Confidence            53  34455543    234899999999888665422  233556667889999999999999875  499999999999


Q ss_pred             EEcCCCceEEecccCccccC
Q 040557          216 LLDEKFQSKIGDFGLARFFP  235 (407)
Q Consensus       216 ll~~~~~~kl~Dfgla~~~~  235 (407)
                      +++ ++.++|+|||++....
T Consensus       181 li~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEE-CCCEEEEEChhhhccC
Confidence            999 7899999999987543

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=1.2e-18  Score=151.65  Aligned_cols=131  Identities=22%  Similarity=0.376  Sum_probs=105.9

Q ss_pred             eeeccCCccEEEEEecCCcEEEEEEeccccCh-------hhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           89 LLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQ-------QGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        89 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      .||+|+||.||+|.. +|..+++|........       ....++.+|++++..+.|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999986 5788999986533211       12356778999999998887655444555566779999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      +|++|.+++.....         .++.+++.+|.+||+.+   ++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH---------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999888743211         78999999999999998   99999999999999 78999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=1.3e-18  Score=173.61  Aligned_cols=141  Identities=18%  Similarity=0.310  Sum_probs=113.3

Q ss_pred             HHhcCCCCCCeeeccCCccEEEEEecCCcEEEEEEecccc--C-----hhhHHHHHHHHHHHHcCCCCceeeeeeeeecC
Q 040557           79 KATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDK--S-----QQGESEFLSEVRMITSIQHKNLVRLLGCCSDG  151 (407)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  151 (407)
                      .....|...+.||+|+||.||+|.+.+. .+++|+.....  .     .....++.+|++++..++|++++....++.+.
T Consensus       330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~  408 (535)
T PRK09605        330 EVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP  408 (535)
T ss_pred             ccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence            3344556778999999999999987543 44445432211  1     12235688999999999999998887777777


Q ss_pred             CeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCc
Q 040557          152 SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLA  231 (407)
Q Consensus       152 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla  231 (407)
                      ...++||||+++++|.+++.          ....++.+++.+|.+||+.+   ++||||||+|||+ +++.++|+|||++
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccc
Confidence            78899999999999998874          34678999999999999998   9999999999999 5779999999999


Q ss_pred             ccc
Q 040557          232 RFF  234 (407)
Q Consensus       232 ~~~  234 (407)
                      +..
T Consensus       475 ~~~  477 (535)
T PRK09605        475 KYS  477 (535)
T ss_pred             ccC
Confidence            753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.76  E-value=2e-19  Score=179.61  Aligned_cols=208  Identities=21%  Similarity=0.269  Sum_probs=142.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEecC-CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      .+|...+.|..|+||.||.++++. .+.+|.| +++.+      .+.+.  ++.....|.+|                  
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~------lilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN------LILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccc------hhhhc--cccccCCccee------------------
Confidence            678888999999999999998753 5677874 32211      01111  22222333333                  


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC---
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED---  237 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~---  237 (407)
                         |+=...+.+.  +.++...        +.+++|||+.+   |+|||+||+|.+|+.-|.+|++|||+++.....   
T Consensus       136 ---gDc~tllk~~--g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 ---GDCATLLKNI--GPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             ---chhhhhcccC--CCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence               3333333222  2233222        78899999998   999999999999999999999999999754211   


Q ss_pred             -----------CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh
Q 040557          238 -----------QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER  306 (407)
Q Consensus       238 -----------~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                                 .......++||+.|+|||++....|...+|+|++|+++||.+-|..||+++.+++.-      ...+.+
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf------g~visd  273 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF------GQVISD  273 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH------hhhhhh
Confidence                       111233568999999999999999999999999999999999999999987665421      111111


Q ss_pred             CccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 040557          307 GRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPP  347 (407)
Q Consensus       307 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  347 (407)
                      .         +...+..+..+.++.+++.+.|+.+|..|--
T Consensus       274 ~---------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  274 D---------IEWPEEDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             h---------ccccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence            0         0000112233456888999999999999963

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.71  E-value=6.3e-17  Score=139.35  Aligned_cols=139  Identities=20%  Similarity=0.212  Sum_probs=98.1

Q ss_pred             CCeeeccCCccEEEEEecCCcEEEEEEeccccChh-hHHH----------------------HHHHHHHHHcCCCC--ce
Q 040557           87 GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQ-GESE----------------------FLSEVRMITSIQHK--NL  141 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~----------------------~~~e~~~l~~l~h~--ni  141 (407)
                      .+.||+|+||.||+|...+|+.||||++....... ....                      ...|.+.+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999998789999999986432111 1111                      13455566655433  24


Q ss_pred             eeeeeeeecCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccc-cCCCceeeeccccccEEEcCC
Q 040557          142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE-DSHTRIVHRDIKASNVLLDEK  220 (407)
Q Consensus       142 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~  220 (407)
                      .+.+++    ...++||||++++++.........  .. .....++.+++.++.++|. .+   ++|+||||+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-C
Confidence            444443    245899999999544221110000  11 5667899999999999999 77   99999999999999 8


Q ss_pred             CceEEecccCccccCC
Q 040557          221 FQSKIGDFGLARFFPE  236 (407)
Q Consensus       221 ~~~kl~Dfgla~~~~~  236 (407)
                      +.++|+|||.+.....
T Consensus       151 ~~~~liDfg~a~~~~~  166 (187)
T cd05119         151 GKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CcEEEEECcccccccC
Confidence            8999999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=1.6e-16  Score=131.43  Aligned_cols=135  Identities=19%  Similarity=0.178  Sum_probs=113.0

Q ss_pred             CCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCC--CceeeeeeeeecCCeeEEEEEeccCC
Q 040557           87 GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQH--KNLVRLLGCCSDGSQRLLVYEYMKNR  164 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  164 (407)
                      .+.||+|.++.||++... +..+++|.......   ...+.+|...+..+.|  .++.+++++....+..+++|||++++
T Consensus         3 ~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             ceecccccccceEEEEec-CCeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            467999999999999985 47899998754332   4568899999999976  58999999888888899999999987


Q ss_pred             ChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcccc
Q 040557          165 SLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF  234 (407)
Q Consensus       165 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~  234 (407)
                      .+..+         +......++.+++.++.++|.....+++|+|++|+||++++++.++++|||.+...
T Consensus        79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            76543         55666778999999999999864445999999999999999899999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=6e-18  Score=168.41  Aligned_cols=262  Identities=22%  Similarity=0.268  Sum_probs=193.3

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec--CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCC-CCceeeeeeeeecCCeeEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA--DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQ-HKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  156 (407)
                      ...|...+.||+|+|+.|-.....  ....+|+|.+.... ..........|..+-..+. |.|++.+++...+....++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            345677778999999999888653  34556666664332 2233344445777666675 9999999999999999999


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhcccc-ccCCCceeeeccccccEEEcCCC-ceEEecccCcccc
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLH-EDSHTRIVHRDIKASNVLLDEKF-QSKIGDFGLARFF  234 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfgla~~~  234 (407)
                      .++|..++++...+........+....-..+.|+..++.|+| ..+   +.|+|+||+|.+++..+ ..+++|||+|..+
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence            999999999887773222224566667789999999999999 777   99999999999999999 9999999999987


Q ss_pred             CC--CCccccccccc-CccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccc
Q 040557          235 PE--DQAYLSTNFAG-TLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRIL  310 (407)
Q Consensus       235 ~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      ..  .........+| ++.|+|||...+. ......|+||.|+++.-+++|..|++........+.. |           
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~-~-----------  243 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS-W-----------  243 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee-e-----------
Confidence            76  22333345678 9999999998885 4467899999999999999999999866554422211 1           


Q ss_pred             cccCcccc-cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          311 ELVDPRMR-KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       311 ~~~d~~~~-~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                        .+.... .............++...++..+|+.|.+.+++...-|...
T Consensus       244 --~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  244 --KSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             --cccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence              111000 00011122344677888899999999999999987766543

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.67  E-value=6.2e-16  Score=137.70  Aligned_cols=137  Identities=18%  Similarity=0.229  Sum_probs=105.8

Q ss_pred             CCeee-ccCCccEEEEEecCCcEEEEEEecccc------------ChhhHHHHHHHHHHHHcCCCCce--eeeeeeeecC
Q 040557           87 GNLLG-RGGFGPVYRGKLADGTLVAVKKLCVDK------------SQQGESEFLSEVRMITSIQHKNL--VRLLGCCSDG  151 (407)
Q Consensus        87 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~  151 (407)
                      +..|| .||.|+||.+... +..++||.+....            .......+.+|++++..+.|+++  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35788 8999999999884 7789999885321            01233567899999999988775  6677664332


Q ss_pred             C----eeEEEEEeccC-CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEe
Q 040557          152 S----QRLLVYEYMKN-RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIG  226 (407)
Q Consensus       152 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~  226 (407)
                      .    ..++|||+++| .+|.+++..   ..++..    .+.+++.++.+||+.|   |+||||||.|||++.++.++|+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence            2    23599999997 688888743   234443    3568999999999999   9999999999999998899999


Q ss_pred             cccCcccc
Q 040557          227 DFGLARFF  234 (407)
Q Consensus       227 Dfgla~~~  234 (407)
                      |||.+...
T Consensus       185 Dfg~~~~~  192 (239)
T PRK01723        185 DFDRGELR  192 (239)
T ss_pred             ECCCcccC
Confidence            99999754

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.59  E-value=1.1e-14  Score=140.80  Aligned_cols=147  Identities=22%  Similarity=0.274  Sum_probs=101.6

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChh---------------------------------------h
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQ---------------------------------------G  122 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------------------------------------~  122 (407)
                      ..|. .+.||+|++|.||+|++.+|+.||||+.+......                                       .
T Consensus       118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~  196 (437)
T TIGR01982       118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR  196 (437)
T ss_pred             hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence            3444 36799999999999999999999999986432110                                       0


Q ss_pred             HHHHHHHHHHHHcCC----CCceeeeeeee-ecCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHH-Hhcc
Q 040557          123 ESEFLSEVRMITSIQ----HKNLVRLLGCC-SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR-GLQY  196 (407)
Q Consensus       123 ~~~~~~e~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~-~l~~  196 (407)
                      +-+|.+|.+.+.++.    |.+-+.+-..+ ...+..++||||++|++|.++....... .+   +.+++..++. .+..
T Consensus       197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~-~~---~~~ia~~~~~~~l~q  272 (437)
T TIGR01982       197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG-LD---RKALAENLARSFLNQ  272 (437)
T ss_pred             HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC-CC---HHHHHHHHHHHHHHH
Confidence            012445665555542    22223322222 2234579999999999998876432111 22   3446666655 4677


Q ss_pred             ccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       197 LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      +|..|   ++|+|++|.||++++++.++++|||++..+..
T Consensus       273 l~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       273 VLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            88887   99999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.51  E-value=1.1e-14  Score=128.81  Aligned_cols=204  Identities=20%  Similarity=0.238  Sum_probs=139.5

Q ss_pred             HHHHcCCCCceeeeeeeeecCC-----eeEEEEEeccCCChhHHHhccC--CCCCCHHHHHHHHHHHHHHhccccccCCC
Q 040557          131 RMITSIQHKNLVRLLGCCSDGS-----QRLLVYEYMKNRSLDLLIYGES--DKFLNWSTRFQIILGIARGLQYLHEDSHT  203 (407)
Q Consensus       131 ~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~  203 (407)
                      ..|-++.|.|||++..|+.+..     ...+++|||..|++..+|+...  ...+......+|+-||..||.|||+- .|
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence            3455667999999999886543     4678999999999999996433  45578888889999999999999996 58


Q ss_pred             ceeeeccccccEEEcCCCceEEecccCccccCC----CCcccccccccCccccCccccccCCCCccccEEehhHHHHHHH
Q 040557          204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE----DQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII  279 (407)
Q Consensus       204 ~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~  279 (407)
                      +++|+++..+.|++..++-+|+.-- -......    ........-.+-++|.+||.=.....+..+|||+||...+||.
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            8999999999999998888887432 1111111    0011111234678999999877777788999999999999998


Q ss_pred             hcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          280 SCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       280 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      .+..-.......   ...+.   ... +.+ ..+...+            =..++..|++..|..||+|++++.|..
T Consensus       277 ilEiq~tnseS~---~~~ee---~ia-~~i-~~len~l------------qr~~i~kcl~~eP~~rp~ar~llfHpl  333 (458)
T KOG1266|consen  277 ILEIQSTNSESK---VEVEE---NIA-NVI-IGLENGL------------QRGSITKCLEGEPNGRPDARLLLFHPL  333 (458)
T ss_pred             HheeccCCCcce---eehhh---hhh-hhe-eeccCcc------------ccCcCcccccCCCCCCcchhhhhcCce
Confidence            775432111100   00000   000 000 0000111            124677899999999999999987643

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.48  E-value=5.9e-14  Score=137.30  Aligned_cols=146  Identities=18%  Similarity=0.186  Sum_probs=95.5

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEecC-CcEEEEEEeccccCh---------------------------------hhH--
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQ---------------------------------QGE--  123 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---------------------------------~~~--  123 (407)
                      ....|+. +.||+|++|.||+|++.+ |+.||||+.......                                 +-.  
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            3456776 789999999999999887 999999999643210                                 001  


Q ss_pred             ----HHHHHHHHHHHcCC----CCceeeeeeeeec-CCeeEEEEEeccCCChhHHHhccCCC----CCCHHHHHHHHHHH
Q 040557          124 ----SEFLSEVRMITSIQ----HKNLVRLLGCCSD-GSQRLLVYEYMKNRSLDLLIYGESDK----FLNWSTRFQIILGI  190 (407)
Q Consensus       124 ----~~~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~----~l~~~~~~~i~~~i  190 (407)
                          -++.+|+..+.++.    +.+.+.+-.++.+ ....++||||++|+.+.++..-...+    .+.......++.|+
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi  276 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV  276 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence                12344444444442    3333333333322 34568999999999997753211111    13333333344444


Q ss_pred             HHHhccccccCCCceeeeccccccEEEcCCC----ceEEecccCccccCC
Q 040557          191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKF----QSKIGDFGLARFFPE  236 (407)
Q Consensus       191 ~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfgla~~~~~  236 (407)
                      .       ..|   ++|+|+||.||+++.++    .++++|||++..++.
T Consensus       277 f-------~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 F-------RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             H-------hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            3       355   99999999999999888    999999999987754

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.47  E-value=8.8e-14  Score=132.92  Aligned_cols=250  Identities=22%  Similarity=0.225  Sum_probs=178.6

Q ss_pred             cCCCCCCeeec--cCCccEEEEEe---cCCcEEEEEEeccccC-hhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCee
Q 040557           82 KNFHPGNLLGR--GGFGPVYRGKL---ADGTLVAVKKLCVDKS-QQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQR  154 (407)
Q Consensus        82 ~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  154 (407)
                      ..+.....+|.  |.+|.||.+..   .++..+|+|+-+.... .....+=++|+....++ .|+|.++....+...+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            44556678999  99999999976   3688899997432211 11222234677666666 599999988889999999


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHH----HhccccccCCCceeeeccccccEEEcCC-CceEEeccc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR----GLQYLHEDSHTRIVHRDIKASNVLLDEK-FQSKIGDFG  229 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg  229 (407)
                      ++-+|++. .+|..+.+.. ...++....+....+...    |+.++|+.+   ++|-|+||.||+...+ ...+++|||
T Consensus       194 fiqtE~~~-~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             eeeecccc-chhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence            99999985 6777776533 344677777777777777    999999988   9999999999999999 889999999


Q ss_pred             CccccCCCCccc----ccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHH
Q 040557          230 LARFFPEDQAYL----STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYE  305 (407)
Q Consensus       230 la~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  305 (407)
                      +...+.+.....    .....|...|++|| ...+-++..+|+|++|.++.+..++........-....        ..+
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke-~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~--------~~r  339 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKE-LLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS--------QLR  339 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChh-hhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc--------ccc
Confidence            999886554221    12235778899999 55667889999999999999999988765432111110        001


Q ss_pred             hCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040557          306 RGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAM  354 (407)
Q Consensus       306 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  354 (407)
                               ......++...-...+...+.++++.+|-.|++...+..+
T Consensus       340 ---------~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  340 ---------QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             ---------cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence                     0001111111122334458888999999999998888654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.41  E-value=7.1e-13  Score=112.10  Aligned_cols=130  Identities=18%  Similarity=0.107  Sum_probs=95.4

Q ss_pred             CeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCcee-eeeeeeecCCeeEEEEEeccCCCh
Q 040557           88 NLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV-RLLGCCSDGSQRLLVYEYMKNRSL  166 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L  166 (407)
                      +.|+.|.++.||++... |..|++|.......  ....+..|+.++..+.+.+++ +++.+.  ....++||||++|.++
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            56889999999999874 78899998743321  223457889998888655544 455443  2345899999999877


Q ss_pred             hHHHhccCCCCCCHHHHHHHHHHHHHHhccccccC--CCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          167 DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS--HTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       167 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      ....       .   ....++.++++++..||+.+  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            5430       0   11345678999999999986  22369999999999999 66899999998863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.39  E-value=4.9e-12  Score=103.64  Aligned_cols=144  Identities=18%  Similarity=0.230  Sum_probs=109.2

Q ss_pred             CCCeeeccCCccEEEEEecCCcEEEEEEeccccC-------hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           86 PGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKS-------QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        86 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ....+-+|+-+.|+++.+ .|+.+.||.-..+..       +-...+..+|++.|.++.--.|.-..-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            356899999999999998 488888886543321       123456789999999987656655455566666778999


Q ss_pred             EeccC-CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC---ceEEecccCccc
Q 040557          159 EYMKN-RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF---QSKIGDFGLARF  233 (407)
Q Consensus       159 e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfgla~~  233 (407)
                      ||++| .++.+++...............++..|-+.+.-||.++   ++|+||..+||+|..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 46777776554444444444788899999999999998   99999999999997544   458999999964

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.35  E-value=1.4e-11  Score=105.10  Aligned_cols=138  Identities=14%  Similarity=0.102  Sum_probs=99.5

Q ss_pred             CeeeccCCccEEEEEecC-------CcEEEEEEeccccC---------------------hhhHHHHH----HHHHHHHc
Q 040557           88 NLLGRGGFGPVYRGKLAD-------GTLVAVKKLCVDKS---------------------QQGESEFL----SEVRMITS  135 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~---------------------~~~~~~~~----~e~~~l~~  135 (407)
                      ..||.|--+.||.|...+       +..+|||..+....                     ......+.    +|.+.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997543       47999998854210                     01122233    79999998


Q ss_pred             CCC--CceeeeeeeeecCCeeEEEEEeccCCChhH-HHhccCCCCCCHHHHHHHHHHHHHHhccc-cccCCCceeeeccc
Q 040557          136 IQH--KNLVRLLGCCSDGSQRLLVYEYMKNRSLDL-LIYGESDKFLNWSTRFQIILGIARGLQYL-HEDSHTRIVHRDIK  211 (407)
Q Consensus       136 l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~dlk  211 (407)
                      +..  -++..++++    ...++||||+.++.+.. .+.   ...++......+..+++.+|..| |..+   ++|+||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk---d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK---DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh---ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence            843  456666654    45689999997654421 221   12345556677889999999998 8887   9999999


Q ss_pred             cccEEEcCCCceEEecccCccccCC
Q 040557          212 ASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       212 ~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      +.||++++ +.+.|+|||.+.....
T Consensus       153 ~~NIL~~~-~~v~iIDF~qav~~~h  176 (197)
T cd05146         153 EYNMLWHD-GKVWFIDVSQSVEPTH  176 (197)
T ss_pred             HHHEEEEC-CcEEEEECCCceeCCC
Confidence            99999974 5899999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.31  E-value=1.8e-11  Score=100.83  Aligned_cols=133  Identities=23%  Similarity=0.312  Sum_probs=101.1

Q ss_pred             CeeeccCCccEEEEEecCCcEEEEEEeccccCh-------hhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           88 NLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQ-------QGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      ..+++|+-+.+|.+.+. |..+++|.-..+...       -...+-.+|++++.++.--.|.-..-+..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            45789999999999774 555677754333211       1234567899999988655554444455577778899999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcccc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF  234 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~  234 (407)
                      ++|..|.+.+...         ...++..+-.-+.-||..+   |+|+||.++||++..+. +.++||||+...
T Consensus        81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence            9999999888533         2567778888888999998   99999999999998874 999999999743

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.31  E-value=1.5e-11  Score=108.61  Aligned_cols=143  Identities=20%  Similarity=0.240  Sum_probs=107.0

Q ss_pred             CeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCC--CceeeeeeeeecCC---eeEEEEEecc
Q 040557           88 NLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQH--KNLVRLLGCCSDGS---QRLLVYEYMK  162 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~  162 (407)
                      +.|+.|..+.||++...+|+.+++|.............+.+|.+++..+.+  .++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            468999999999998877789999987543322234567899999999865  44577777766542   5689999999


Q ss_pred             CCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccC-----------------------------------------
Q 040557          163 NRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS-----------------------------------------  201 (407)
Q Consensus       163 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----------------------------------------  201 (407)
                      |.++...+..   ..++......++.++++++..||+..                                         
T Consensus        84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            9888665421   23666677777777777777777521                                         


Q ss_pred             ------------CCceeeeccccccEEEcC--CCceEEecccCccc
Q 040557          202 ------------HTRIVHRDIKASNVLLDE--KFQSKIGDFGLARF  233 (407)
Q Consensus       202 ------------~~~i~H~dlk~~Nill~~--~~~~kl~Dfgla~~  233 (407)
                                  ...++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                        234899999999999998  66789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.30  E-value=1.6e-12  Score=124.29  Aligned_cols=265  Identities=22%  Similarity=0.240  Sum_probs=182.2

Q ss_pred             CCcccccccCHHH-HHHHhcCCCCCCeeeccCCccEEEEEe--cCCcEEEEEEeccccChh-hHHHHHHHHHHHHcC-CC
Q 040557           64 GNLRTISYFDFQT-LKKATKNFHPGNLLGRGGFGPVYRGKL--ADGTLVAVKKLCVDKSQQ-GESEFLSEVRMITSI-QH  138 (407)
Q Consensus        64 ~~~~~~~~~~~~~-~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l-~h  138 (407)
                      ...+...+|...+ ......+|.....||.|.|+.|+....  .++..|++|.+....... +...-+.|+.+...+ .|
T Consensus       246 ~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~  325 (524)
T KOG0601|consen  246 DDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSH  325 (524)
T ss_pred             cccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcc
Confidence            3334444455444 344556788889999999999999853  468899999875443222 222224566666666 58


Q ss_pred             CceeeeeeeeecCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc
Q 040557          139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD  218 (407)
Q Consensus       139 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~  218 (407)
                      .++++.+..+....+.|+--||++++++....  .....++...++++..|++.++.++|+..   ++|+|++|+||++.
T Consensus       326 ~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~  400 (524)
T KOG0601|consen  326 LPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILIS  400 (524)
T ss_pred             cccCCCCCCccccccccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeec
Confidence            88888877776667778889999999887665  22344778888999999999999999988   99999999999999


Q ss_pred             CC-CceEEecccCccccCCCCcccccccccCcccc--CccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCc
Q 040557          219 EK-FQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT--APEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQY  295 (407)
Q Consensus       219 ~~-~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~  295 (407)
                      .+ +..++.|||++..+.-..    .......+++  +++......+..+.|++|||.-+.|.++|..-......     
T Consensus       401 ~~~~~~~~~~~~~~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-----  471 (524)
T KOG0601|consen  401 NDGFFSKLGDFGCWTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-----  471 (524)
T ss_pred             cchhhhhccccccccccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc-----
Confidence            86 888999999997422111    1122334444  55555567788999999999999999998753221100     


Q ss_pred             hhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          296 LPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                         |  ..+..+..     +..      .....++..+...+..+++..||.+.++..+..+.
T Consensus       472 ---~--~~i~~~~~-----p~~------~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  472 ---S--LTIRSGDT-----PNL------PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             ---c--eeeecccc-----cCC------CchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence               0  00011110     111      11124455667779999999999999988776544

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.30  E-value=1.6e-11  Score=118.76  Aligned_cols=168  Identities=19%  Similarity=0.244  Sum_probs=125.0

Q ss_pred             EecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCChhHHHhccCCCCCCHH
Q 040557          102 KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWS  181 (407)
Q Consensus       102 ~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~  181 (407)
                      +..++.+|.|...+.... .......+-+..|+.++||||++++..+...+..|+|+|-+.  .|..++...     ...
T Consensus        33 ~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-----~~~  104 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-----GKE  104 (690)
T ss_pred             eeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----HHH
Confidence            345788888888765544 444567788899999999999999999999999999999885  455555332     244


Q ss_pred             HHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccccccccCccccCccccccCC
Q 040557          182 TRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE  261 (407)
Q Consensus       182 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  261 (407)
                      .....+.||+.||.|||..+  .++|++|.-..|++++.|.-||++|-++........ ......---.|..|+.+....
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence            55567889999999998765  499999999999999999999999988865433221 011111222456666443322


Q ss_pred             CCccccEEehhHHHHHHHhcC
Q 040557          262 LSEKADIYSFGVLVLEIISCR  282 (407)
Q Consensus       262 ~~~k~Dv~s~G~vl~el~tg~  282 (407)
                        -..|.|.|||+++|++.|.
T Consensus       182 --~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             --cchhhhhHHHHHHHHhCcc
Confidence              3469999999999999993

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.17  E-value=6.4e-10  Score=100.23  Aligned_cols=142  Identities=15%  Similarity=0.052  Sum_probs=101.5

Q ss_pred             CeeeccCCccEEEEEecCCcEEEEEEeccccChh----------hHHHHHHHHHHHHcCCC--Cceeeeeeeeec-----
Q 040557           88 NLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQ----------GESEFLSEVRMITSIQH--KNLVRLLGCCSD-----  150 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~h--~niv~l~~~~~~-----  150 (407)
                      +.+-......|+++.+ +|+.|.||+........          ....+.+|.+.+.++..  -.+..++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4555445556777766 67899999774322111          11237789998888843  333455555533     


Q ss_pred             CCeeEEEEEeccCC-ChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC-------CCc
Q 040557          151 GSQRLLVYEYMKNR-SLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE-------KFQ  222 (407)
Q Consensus       151 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-------~~~  222 (407)
                      ....++|||++++. +|.+++........+......++.+++..+.-||..|   ++|+|++++|||++.       +..
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence            23468999999886 7888874322234566777889999999999999999   999999999999975       468


Q ss_pred             eEEecccCccc
Q 040557          223 SKIGDFGLARF  233 (407)
Q Consensus       223 ~kl~Dfgla~~  233 (407)
                      +.|+||+.+..
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998863

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.14  E-value=1.2e-11  Score=124.70  Aligned_cols=251  Identities=18%  Similarity=0.192  Sum_probs=167.3

Q ss_pred             HHhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeE
Q 040557           79 KATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRL  155 (407)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  155 (407)
                      ...+.+.+.+-+-+|+++.++.+.- ..|...+.|.......  ..+.+....+-.++-...+|-++...--+......+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            3456677777888999999998753 2344444444322111  111111222222222234566665554445567889


Q ss_pred             EEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccC
Q 040557          156 LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP  235 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~  235 (407)
                      |+++|..+++|...++...  ..+..........+..+.+|||...   +.|+|++|.|.+...++..+++|||......
T Consensus       881 L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             hhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence            9999999999998886543  3455555566778889999999987   8999999999999999999999998443211


Q ss_pred             C------------------------------CCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCC
Q 040557          236 E------------------------------DQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNT  285 (407)
Q Consensus       236 ~------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~  285 (407)
                      .                              +.........||+.|.+||...+......+|.|++|++++|.++|.+||
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence            0                              0001122356899999999999999999999999999999999999999


Q ss_pred             CCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 040557          286 DLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMS  349 (407)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  349 (407)
                      ....+...       .        ..++...+.....+........+++...+..+|.+|-.+.
T Consensus      1036 na~tpq~~-------f--------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQI-------F--------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCcchhhh-------h--------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            86655321       1        1111111112222333344566777778899999998877

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.10  E-value=8.8e-10  Score=93.72  Aligned_cols=127  Identities=24%  Similarity=0.254  Sum_probs=83.1

Q ss_pred             cEEEEEecCCcEEEEEEeccccC-------------------------hhhHHHHHHHHHHHHcCCCC--ceeeeeeeee
Q 040557           97 PVYRGKLADGTLVAVKKLCVDKS-------------------------QQGESEFLSEVRMITSIQHK--NLVRLLGCCS  149 (407)
Q Consensus        97 ~Vy~~~~~~~~~vavK~~~~~~~-------------------------~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~  149 (407)
                      .||.|...+|..+|||.......                         ........+|.+.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            38999988999999998854210                         01123567899999999765  456666553 


Q ss_pred             cCCeeEEEEEecc--CCChhHHHhccCCCCCCHHHHHHHHHHHHHHhcc-ccccCCCceeeeccccccEEEcCCCceEEe
Q 040557          150 DGSQRLLVYEYMK--NRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY-LHEDSHTRIVHRDIKASNVLLDEKFQSKIG  226 (407)
Q Consensus       150 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~i~H~dlk~~Nill~~~~~~kl~  226 (407)
                         ...+||||++  |..+..+....    ++......++.+++..+.. +|..|   ++|+||.+.||+++++ .+.++
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence               3479999999  65555544322    1123335566677775555 57877   9999999999999988 99999


Q ss_pred             cccCccccC
Q 040557          227 DFGLARFFP  235 (407)
Q Consensus       227 Dfgla~~~~  235 (407)
                      |||.+....
T Consensus       149 Df~qav~~~  157 (188)
T PF01163_consen  149 DFGQAVDSS  157 (188)
T ss_dssp             -GTTEEETT
T ss_pred             ecCcceecC
Confidence            999987554

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.06  E-value=2e-09  Score=101.49  Aligned_cols=167  Identities=20%  Similarity=0.307  Sum_probs=125.2

Q ss_pred             ccEEEEE-ecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeee----cCCeeEEEEEeccC-CChhHH
Q 040557           96 GPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS----DGSQRLLVYEYMKN-RSLDLL  169 (407)
Q Consensus        96 g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-g~L~~~  169 (407)
                      .+.|++. ..||..|++|++........ .....-++.++++.|.|+|++..++.    .....++||+|+++ ++|.++
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQST-NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCc-ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            5789996 45899999999954332221 11235578889999999999988775    34578999999986 466555


Q ss_pred             Hhcc-------------CCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          170 IYGE-------------SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       170 l~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      -...             .+...++..+|.++.|+..||.++|+.|   +.-+-|.+.+|+++.+.+++|+..|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            4321             1234678999999999999999999999   99999999999999999999998888776544


Q ss_pred             CCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCC
Q 040557          237 DQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKN  284 (407)
Q Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p  284 (407)
                      +..               |-+.+   -.+-|.=.||.+++-|.||...
T Consensus       446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            431               10111   2356777899999999999653

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.05  E-value=1e-08  Score=94.53  Aligned_cols=260  Identities=15%  Similarity=0.148  Sum_probs=157.7

Q ss_pred             CCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeee------eecCC-eeEE
Q 040557           85 HPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGC------CSDGS-QRLL  156 (407)
Q Consensus        85 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~------~~~~~-~~~l  156 (407)
                      ..+..||+|+-+.+|-.--- +. .+.|+........ ..   +.+..|... .||-+..-+.|      ..+.. ..-+
T Consensus        14 ~~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~-~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAA-QA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             CCCccccCCccceeeecchh-hc-hhheeecCCCchH-HH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            45678999999999965321 12 2447664333221 11   233344444 56654331221      11222 2567


Q ss_pred             EEEeccCCC-hhHHHh----ccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCc
Q 040557          157 VYEYMKNRS-LDLLIY----GESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLA  231 (407)
Q Consensus       157 v~e~~~~g~-L~~~l~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla  231 (407)
                      +|..+.+-- +..+..    .++....+|...++.+..++.+.+.||..|   .+-+|++++|+|+.+++.+.|.|-...
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccce
Confidence            777776642 122221    123345789999999999999999999998   999999999999999999999996555


Q ss_pred             cccCCCCcccccccccCccccCccccc-----cCCCCccccEEehhHHHHHHHhc-CCCCCCCCCccc-CchhHHHHHHH
Q 040557          232 RFFPEDQAYLSTNFAGTLGYTAPEYAI-----RGELSEKADIYSFGVLVLEIISC-RKNTDLTLPSEM-QYLPEYAWKLY  304 (407)
Q Consensus       232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~G~vl~el~tg-~~p~~~~~~~~~-~~~~~~~~~~~  304 (407)
                      ....++..  ...-+|...|.+||.-.     +..-+...|.|.+|+++++++.| ++|+.+-..... ....+   ..+
T Consensus       165 qi~~ng~~--~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~I  239 (637)
T COG4248         165 QINANGTL--HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDI  239 (637)
T ss_pred             eeccCCce--EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhh
Confidence            44433322  23456889999999654     33457789999999999999988 888864321100 00000   011


Q ss_pred             HhCccccccCcccc-----cCCCCHHHHHHHHHHHHHccCC--CCCCCCCHHHHHHHhhcc
Q 040557          305 ERGRILELVDPRMR-----KEGIVERDALQVINVAFICLQP--HGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       305 ~~~~~~~~~d~~~~-----~~~~~~~~~~~l~~l~~~cl~~--~p~~RPs~~ev~~~l~~~  358 (407)
                      ..+.....-|....     ....-.-.+..+-.+..+|+..  ++.-|||++..+..|...
T Consensus       240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence            12222222221110     0111122345666778888876  466899999988776644

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.87  E-value=1.5e-08  Score=88.83  Aligned_cols=136  Identities=21%  Similarity=0.184  Sum_probs=94.1

Q ss_pred             CCCCCeeeccCCccEEEEEecCCcEEEEEEeccccC---------------------hhhHHHHHHHHHHHHcCCCC--c
Q 040557           84 FHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKS---------------------QQGESEFLSEVRMITSIQHK--N  140 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------------------~~~~~~~~~e~~~l~~l~h~--n  140 (407)
                      ..+++.||-|--+.||.|..++|..+|||.-+....                     ........+|.++|.++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            566789999999999999999999999996532210                     01123456899999988654  6


Q ss_pred             eeeeeeeeecCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCC
Q 040557          141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEK  220 (407)
Q Consensus       141 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~  220 (407)
                      +.+.+++    +...+||||++|-.|...-.    ..-+...   ++..|++-+.-+-..|   ++|+|+..-||+++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~----~~en~~~---il~~il~~~~~~~~~G---iVHGDlSefNIlV~~d  238 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLRL----DVENPDE---ILDKILEEVRKAYRRG---IVHGDLSEFNILVTED  238 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeecccC----cccCHHH---HHHHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence            6666654    45589999999966654421    1122222   3333333333333445   9999999999999999


Q ss_pred             CceEEecccCccc
Q 040557          221 FQSKIGDFGLARF  233 (407)
Q Consensus       221 ~~~kl~Dfgla~~  233 (407)
                      |.+.++||--+..
T Consensus       239 g~~~vIDwPQ~v~  251 (304)
T COG0478         239 GDIVVIDWPQAVP  251 (304)
T ss_pred             CCEEEEeCccccc
Confidence            9999999966553

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.85  E-value=1.8e-08  Score=98.32  Aligned_cols=148  Identities=17%  Similarity=0.219  Sum_probs=95.1

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChh---------------------------------------
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQ---------------------------------------  121 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------------------------------------  121 (407)
                      ...|.. +.|+.++-|.||+|++++|+.||||+.+..-...                                       
T Consensus       125 F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~  203 (517)
T COG0661         125 FSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR  203 (517)
T ss_pred             HHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence            344543 6799999999999999999999999985432110                                       


Q ss_pred             hHHHHHHHHHHHHcCC-----CCceeeeeeee-ecCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhc
Q 040557          122 GESEFLSEVRMITSIQ-----HKNLVRLLGCC-SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQ  195 (407)
Q Consensus       122 ~~~~~~~e~~~l~~l~-----h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~  195 (407)
                      .+-++.+|...+.++.     .+++ ++=..| +-.+...|+|||++|-.+.+...... ...+.........++.-  .
T Consensus       204 ~ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~--~  279 (517)
T COG0661         204 EELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFL--R  279 (517)
T ss_pred             HHhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHH--H
Confidence            0112334444444432     2332 222222 22456789999999998887753333 33554443333222222  2


Q ss_pred             cccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       196 ~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      .+-..|   +.|.|.+|.||+++.++.+.+.|||+...++.
T Consensus       280 q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         280 QLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            222234   99999999999999999999999999987754

>PRK09902 hypothetical protein; Provisional

Probab=98.83  E-value=6.5e-08  Score=82.85  Aligned_cols=139  Identities=17%  Similarity=0.132  Sum_probs=103.1

Q ss_pred             eeccCCccEEEEEecCCcEEEEEEecccc--C---hhhHHHHHHHHHHHHcCCC--Cceeeeeeeeec----CCeeEEEE
Q 040557           90 LGRGGFGPVYRGKLADGTLVAVKKLCVDK--S---QQGESEFLSEVRMITSIQH--KNLVRLLGCCSD----GSQRLLVY  158 (407)
Q Consensus        90 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~---~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~----~~~~~lv~  158 (407)
                      -|+||-+.|+...+. |..+-+|+-....  +   ......|.+|...|.++..  -.+.+++.+...    ....+||+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            467899999998774 5678899864111  1   3356789999999999853  334454422211    12357999


Q ss_pred             EeccC-CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCc--eEEecccCcc
Q 040557          159 EYMKN-RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ--SKIGDFGLAR  232 (407)
Q Consensus       159 e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~--~kl~Dfgla~  232 (407)
                      |-+.| -+|.+++....-...+...+..+..+++..+.-||+.+   +.|+|+.+.||+++.++.  ++++||--++
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            97764 47888875544445677888899999999999999999   999999999999986666  9999996665

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.81  E-value=2.6e-08  Score=86.87  Aligned_cols=107  Identities=22%  Similarity=0.243  Sum_probs=83.7

Q ss_pred             HHHHHHHHHHHHcCC--CCceeeeeeeeecCC----eeEEEEEeccCC-ChhHHHhccCCCCCCHHHHHHHHHHHHHHhc
Q 040557          123 ESEFLSEVRMITSIQ--HKNLVRLLGCCSDGS----QRLLVYEYMKNR-SLDLLIYGESDKFLNWSTRFQIILGIARGLQ  195 (407)
Q Consensus       123 ~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~  195 (407)
                      .....+|.+.+..+.  .-.+.+.+++.....    ..++|+|++++. +|.+++.....  .+......++.+++..+.
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA  132 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence            446778888888774  344456666665422    348999999884 78888854222  566677889999999999


Q ss_pred             cccccCCCceeeeccccccEEEcCCC---ceEEecccCcccc
Q 040557          196 YLHEDSHTRIVHRDIKASNVLLDEKF---QSKIGDFGLARFF  234 (407)
Q Consensus       196 ~LH~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfgla~~~  234 (407)
                      -||..|   ++|+|+++.|||++.+.   .+.++||+-++..
T Consensus       133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999   99999999999999887   8999999988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.69  E-value=5.7e-09  Score=101.82  Aligned_cols=151  Identities=19%  Similarity=0.320  Sum_probs=103.3

Q ss_pred             HHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccccc--------ccccCccccCcccccc
Q 040557          188 LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST--------NFAGTLGYTAPEYAIR  259 (407)
Q Consensus       188 ~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~--------~~~gt~~y~aPE~~~~  259 (407)
                      .+++.|+.|+|...  .+||++|.|++|.++.++..||+.|+.+........+...        -......|.|||++.+
T Consensus       106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            34559999999854  7999999999999999999999999998765442222111        1124557999999999


Q ss_pred             CCCCccccEEehhHHHHHHHhcCCC-CCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHcc
Q 040557          260 GELSEKADIYSFGVLVLEIISCRKN-TDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICL  338 (407)
Q Consensus       260 ~~~~~k~Dv~s~G~vl~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl  338 (407)
                      ...+.++|+||+|+++|.+..|+.+ +........     +...       ....+...  ..+..+.+.++.+=+.+++
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-----~~~~-------~~~~~~~~--~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-----YSFS-------RNLLNAGA--FGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcch-----hhhh-------hccccccc--ccccccCcHHHHHHHHHHh
Confidence            8889999999999999999955543 332211110     0000       00011111  1122345566777888899


Q ss_pred             CCCCCCCCCHHHHHHH
Q 040557          339 QPHGNQRPPMSEIVAM  354 (407)
Q Consensus       339 ~~~p~~RPs~~ev~~~  354 (407)
                      ..++.-||++.++...
T Consensus       250 ~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLSI  265 (700)
T ss_pred             cCCcccCcchhhhhcc
Confidence            9999999988877654

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.60  E-value=7e-07  Score=77.66  Aligned_cols=154  Identities=20%  Similarity=0.203  Sum_probs=100.5

Q ss_pred             cCHHHHHHHhcCCCCCCeee---ccCCccEEEEEecCCcEEEEEEeccccChhhH-----------------------HH
Q 040557           72 FDFQTLKKATKNFHPGNLLG---RGGFGPVYRGKLADGTLVAVKKLCVDKSQQGE-----------------------SE  125 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lg---~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~  125 (407)
                      .+.+.+.....+..+....|   .|--+.||+|...++..+|||++.........                       .-
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            55666777777777666555   56666899998888999999999644311000                       01


Q ss_pred             HHHHHHHHHcCC--CCceeeeeeeeecCCeeEEEEEeccCCCh-hHHHhccCCCCCCHHHHHHHHHHHHHHhccccc-cC
Q 040557          126 FLSEVRMITSIQ--HKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHE-DS  201 (407)
Q Consensus       126 ~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~  201 (407)
                      ..+|..-|.++.  +-.+.+.+++..    -.|||||+..... .-.|   +.-.+.......+..++++.+.-|-. .+
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~~a~  187 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYKEAG  187 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHHhcC
Confidence            235666676663  444455555443    3799999965311 1111   11122333455666777777777665 44


Q ss_pred             CCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       202 ~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                         +||+||..-|||+. ++.+.++|||-|.....
T Consensus       188 ---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h  218 (268)
T COG1718         188 ---LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             ---cccccchhhheEEE-CCeEEEEECccccccCC
Confidence               99999999999999 77999999998876543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.60  E-value=7e-09  Score=100.20  Aligned_cols=198  Identities=19%  Similarity=0.125  Sum_probs=140.2

Q ss_pred             cCHHHHHHHhcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCc-eeeeeeeeec
Q 040557           72 FDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN-LVRLLGCCSD  150 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~  150 (407)
                      |+...++..++.+....-+++|+++.++|.+-.-.+....+.+...      ....-++++|.+++||| .+..++-+..
T Consensus       232 ~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~  305 (829)
T KOG0576|consen  232 FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDG  305 (829)
T ss_pred             CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCc
Confidence            3444444445555555668999999999998543444445544211      34456889999999999 7777777777


Q ss_pred             CCeeEEEEEeccCC-ChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEeccc
Q 040557          151 GSQRLLVYEYMKNR-SLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFG  229 (407)
Q Consensus       151 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  229 (407)
                      .+..+++++++.++ +-..... .....+.......+...-+++++++|+..   -+|+|    ||+..+ +..+..||+
T Consensus       306 E~~~~i~~~i~s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~  376 (829)
T KOG0576|consen  306 EDYLWIPMRICSTGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFA  376 (829)
T ss_pred             ccccchhhhhhcCCccccccCC-hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-ccccccccc
Confidence            78889999999877 2211110 11111233333445566678899999865   58998    777766 589999999


Q ss_pred             CccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCC
Q 040557          230 LARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTD  286 (407)
Q Consensus       230 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~  286 (407)
                      ....+....  ......+++.|+|||....+.+..+.|+|+.|+-..++.-|-+|-.
T Consensus       377 v~~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  377 VPPQLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCcccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            998776554  2345779999999999999999999999999998888877776654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.59  E-value=6.9e-07  Score=78.92  Aligned_cols=138  Identities=14%  Similarity=0.141  Sum_probs=83.7

Q ss_pred             CeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCc--eeeeeeeeecCCeeEEEEEeccCCC
Q 040557           88 NLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN--LVRLLGCCSDGSQRLLVYEYMKNRS  165 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~  165 (407)
                      ..||+|..+.||+.   .|..+++|......   ......+|.+++..+..-+  +.+.+++..+.+...+|||+++|.+
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            46899999999984   24567788775322   2334678999998885433  4677888877778889999999863


Q ss_pred             -hhHH---------------------HhccCCCCCCHHHHHH-HHHH----------HHH-Hhcccccc-CCCceeeecc
Q 040557          166 -LDLL---------------------IYGESDKFLNWSTRFQ-IILG----------IAR-GLQYLHED-SHTRIVHRDI  210 (407)
Q Consensus       166 -L~~~---------------------l~~~~~~~l~~~~~~~-i~~~----------i~~-~l~~LH~~-~~~~i~H~dl  210 (407)
                       +...                     +|.............. +..+          +.. ...+|... ..+.++|+|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence             1111                     1111001111111110 0000          000 01111111 1234789999


Q ss_pred             ccccEEEcCCCceEEecccCcc
Q 040557          211 KASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       211 k~~Nill~~~~~~kl~Dfgla~  232 (407)
                      .|.||++++++ +.|+||+.+.
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcC
Confidence            99999999888 9999998876

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.57  E-value=6.3e-07  Score=77.11  Aligned_cols=138  Identities=16%  Similarity=0.171  Sum_probs=89.1

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHH---------HHHHHHHHHcCCC---Cceeeeeee
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESE---------FLSEVRMITSIQH---KNLVRLLGC  147 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~~e~~~l~~l~h---~niv~l~~~  147 (407)
                      ..++|...+++-......|.+-.. +|+.+++|....... ..+..         ..+.+..+.++..   .....++.+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~-r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENR-RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhh-hHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            346777777777777777777766 578999998754332 11111         1223333333322   222222222


Q ss_pred             ee-----cCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCc
Q 040557          148 CS-----DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ  222 (407)
Q Consensus       148 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~  222 (407)
                      ..     -....+++|||++|..|.+...      ++.    .++..+.+++.-||..|   +.|+|.+|+|++++++ .
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~  172 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-G  172 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-c
Confidence            21     2234568999999988765531      222    24556778899999999   9999999999999966 5


Q ss_pred             eEEecccCccc
Q 040557          223 SKIGDFGLARF  233 (407)
Q Consensus       223 ~kl~Dfgla~~  233 (407)
                      ++++||+..+.
T Consensus       173 i~iID~~~k~~  183 (229)
T PF06176_consen  173 IRIIDTQGKRM  183 (229)
T ss_pred             EEEEECccccc
Confidence            99999987763

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.52  E-value=7.6e-07  Score=86.87  Aligned_cols=148  Identities=16%  Similarity=0.184  Sum_probs=94.1

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChh------------------------------------hHHH
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQ------------------------------------GESE  125 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------------~~~~  125 (407)
                      ..|.. +.||..+.|.||+|++++|+.||||+.+..-...                                    .+-+
T Consensus       162 ~~f~~-~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELD  240 (538)
T KOG1235|consen  162 SEFDE-EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELD  240 (538)
T ss_pred             HhcCc-chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcc
Confidence            34442 6799999999999999999999999875432110                                    0112


Q ss_pred             HHHHHHHHHcC----CCCc------eeeeeeeeecCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhc
Q 040557          126 FLSEVRMITSI----QHKN------LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQ  195 (407)
Q Consensus       126 ~~~e~~~l~~l----~h~n------iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~  195 (407)
                      |.+|.+-..+.    .|-+      |.+++-.  -.....|+||||+|..+.+.-.-.+. .++...+..-+.+...-+-
T Consensus       241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~~qI  317 (538)
T KOG1235|consen  241 FTKEAKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYLEQI  317 (538)
T ss_pred             hHHHHHhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHHHHH
Confidence            44455443333    3444      2233222  23467899999999887666433332 2555544433333322222


Q ss_pred             cccccCCCceeeeccccccEEEcC----CCceEEecccCccccCCCC
Q 040557          196 YLHEDSHTRIVHRDIKASNVLLDE----KFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       196 ~LH~~~~~~i~H~dlk~~Nill~~----~~~~kl~Dfgla~~~~~~~  238 (407)
                      +.|  |   ++|+|=+|.||++..    ++.+.+-|||+........
T Consensus       318 f~~--G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~~  359 (538)
T KOG1235|consen  318 FKT--G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHKT  359 (538)
T ss_pred             Hhc--C---CccCCCCCCcEEEecCCCCCccEEEEcccccccccHHH
Confidence            222  3   999999999999983    6789999999998765443

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.40  E-value=5.6e-06  Score=73.49  Aligned_cols=141  Identities=20%  Similarity=0.165  Sum_probs=81.5

Q ss_pred             CeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCC--ceeeeeeeeec---CCeeEEEEEecc
Q 040557           88 NLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHK--NLVRLLGCCSD---GSQRLLVYEYMK  162 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~~  162 (407)
                      +.|+.|..+.||+....+ ..+++|.....   .....+.+|..++..+...  .+.+++.+...   ....+++|++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            468999999999999876 68999986432   4455677888888877432  35566664432   334689999999


Q ss_pred             CCChhH----------------HH---hcc--CCCCCCHHH---------HHHH------------HHHHHH-Hhccccc
Q 040557          163 NRSLDL----------------LI---YGE--SDKFLNWST---------RFQI------------ILGIAR-GLQYLHE  199 (407)
Q Consensus       163 ~g~L~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~~i~~-~l~~LH~  199 (407)
                      |..+..                .+   +..  ......+..         ....            ...+.. .+..+++
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            987766                11   111  011111110         0000            011122 2223322


Q ss_pred             ----cCCCceeeeccccccEEEc-CCCceEEecccCcc
Q 040557          200 ----DSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLAR  232 (407)
Q Consensus       200 ----~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfgla~  232 (407)
                          .....++|+|+.+.||+++ +++.+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence                1234599999999999999 66667899998775

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.37  E-value=3.7e-06  Score=75.42  Aligned_cols=138  Identities=14%  Similarity=0.089  Sum_probs=83.4

Q ss_pred             eeccCC-ccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCC-CCceeeeeeeeecCCeeEEEEEeccCCChh
Q 040557           90 LGRGGF-GPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-HKNLVRLLGCCSDGSQRLLVYEYMKNRSLD  167 (407)
Q Consensus        90 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  167 (407)
                      |..|.. ..||+.... +..+.+|......    ...+.+|++++..+. +--+.+++++....+..++|||+++|.++.
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            445555 688999764 4678888764321    234567888888773 445667888877666789999999998775


Q ss_pred             HHH-------------------hccCCC--CCC--HHHHHHH-----------------------HHHHHHHhcccc-cc
Q 040557          168 LLI-------------------YGESDK--FLN--WSTRFQI-----------------------ILGIARGLQYLH-ED  200 (407)
Q Consensus       168 ~~l-------------------~~~~~~--~l~--~~~~~~i-----------------------~~~i~~~l~~LH-~~  200 (407)
                      ...                   +.....  ...  .......                       ..++...+.... ..
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            431                   111000  111  0000000                       011111111100 11


Q ss_pred             CCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       201 ~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                      ..+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            23459999999999999998778899998775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.28  E-value=1.1e-05  Score=84.90  Aligned_cols=80  Identities=18%  Similarity=0.368  Sum_probs=57.5

Q ss_pred             CCeeeccCCccEEEEEecCC---cEEEEEEeccccChhhHHHHHHHHHHHHcCC-CCce--eeeeeeeecC---CeeEEE
Q 040557           87 GNLLGRGGFGPVYRGKLADG---TLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-HKNL--VRLLGCCSDG---SQRLLV  157 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv  157 (407)
                      .+.++.|.++.+|+....++   ..+++|+............+.+|.++|+.+. |.++  .+++.+|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            45688899999999876554   4677887643322223346789999999985 6654  7888888764   457899


Q ss_pred             EEeccCCCh
Q 040557          158 YEYMKNRSL  166 (407)
Q Consensus       158 ~e~~~~g~L  166 (407)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999988643

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.23  E-value=4.5e-06  Score=71.31  Aligned_cols=104  Identities=20%  Similarity=0.209  Sum_probs=81.4

Q ss_pred             HHHHHHHcCCC-CceeeeeeeeecCCeeEEEEEeccCCChhHHHhc-cCCCCCCHHHHHHHHHHHHHHhccccccCCCce
Q 040557          128 SEVRMITSIQH-KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYG-ESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI  205 (407)
Q Consensus       128 ~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  205 (407)
                      +|.-+|..+++ +++.+++|+|..    ++|.||...+++...... ..--..+|..+.+|+.++++.+.+|+......+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            57778888865 699999999943    778999987755321000 011236899999999999999999988654459


Q ss_pred             eeeccccccEEEcCCCceEEecccCccccC
Q 040557          206 VHRDIKASNVLLDEKFQSKIGDFGLARFFP  235 (407)
Q Consensus       206 ~H~dlk~~Nill~~~~~~kl~Dfgla~~~~  235 (407)
                      ...|++++|+-+++++++|++|...+....
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            999999999999999999999998776443

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.16  E-value=1.1e-05  Score=66.44  Aligned_cols=127  Identities=24%  Similarity=0.313  Sum_probs=85.8

Q ss_pred             CCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceee-eeeeeecCCeeEEEEEeccCCC
Q 040557           87 GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR-LLGCCSDGSQRLLVYEYMKNRS  165 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~g~  165 (407)
                      .+.|++|.+|.||+|.+. |..+|+|.-..+.   ....+..|+++|..+.-.++.+ ++.+..+    .+.|||+.|-.
T Consensus        27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds---~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~   98 (201)
T COG2112          27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRDS---PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRP   98 (201)
T ss_pred             hhhhhcccccEEEEeecc-CceEEEEEecCCc---chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcc
Confidence            467999999999999985 6689999865433   3446789999999988776644 4444332    34599999988


Q ss_pred             hhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccc-c-ccEEEcCCCceEEecccCcccc
Q 040557          166 LDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIK-A-SNVLLDEKFQSKIGDFGLARFF  234 (407)
Q Consensus       166 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk-~-~Nill~~~~~~kl~Dfgla~~~  234 (407)
                      |..+....     +-..    ...+++.-.-|-..|   |-|+.|. | .||++.+ ..+.|+||..|+..
T Consensus        99 L~~~~~~~-----~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~-~~~~iIDFd~At~k  156 (201)
T COG2112          99 LGKLEIGG-----DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVND-RDVYIIDFDSATFK  156 (201)
T ss_pred             hhhhhhcc-----cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecC-CcEEEEEccchhhc
Confidence            87775321     2222    233444433344445   8888885 3 4555554 49999999988743

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.13  E-value=2.7e-05  Score=66.41  Aligned_cols=138  Identities=24%  Similarity=0.335  Sum_probs=96.4

Q ss_pred             CcccccccCHHHHHHHhcCCCCCCeeeccCC-ccEEEEEecCCcEEEEEEeccc---cC-------h----------hhH
Q 040557           65 NLRTISYFDFQTLKKATKNFHPGNLLGRGGF-GPVYRGKLADGTLVAVKKLCVD---KS-------Q----------QGE  123 (407)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~---~~-------~----------~~~  123 (407)
                      ....+..|++.     +.+++..+.||.|.- |.||+++. +|+.+|+|.+..-   ..       .          ...
T Consensus        25 ~gPKL~~F~~h-----~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~   98 (207)
T PF13095_consen   25 PGPKLEPFTHH-----GDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYA   98 (207)
T ss_pred             CCCCcCCcCCC-----CCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhc
Confidence            34445567662     278888899999999 99999999 5889999994221   00       0          122


Q ss_pred             HHHHHHHHHHHcCC---CCce--eeeeeeeecC------------------CeeEEEEEeccCCChhHHHhccCCCCCCH
Q 040557          124 SEFLSEVRMITSIQ---HKNL--VRLLGCCSDG------------------SQRLLVYEYMKNRSLDLLIYGESDKFLNW  180 (407)
Q Consensus       124 ~~~~~e~~~l~~l~---h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~  180 (407)
                      ..|..|++...+|+   +.++  ++.+||..-.                  ..+.||.||++...           .+. 
T Consensus        99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~-  166 (207)
T PF13095_consen   99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ-  166 (207)
T ss_pred             ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc-
Confidence            46889999888874   4566  8889886211                  12357888776532           122 


Q ss_pred             HHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCc
Q 040557          181 STRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLA  231 (407)
Q Consensus       181 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla  231 (407)
                         .+-+.+|.+-+..+|..+   |+-+|+++.|..     .-+|+|||.+
T Consensus       167 ---~~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  167 ---IRDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             ---hhHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence               233456777788899988   999999999975     4489999864

>PRK10593 hypothetical protein; Provisional

Probab=98.07  E-value=4.9e-05  Score=70.18  Aligned_cols=76  Identities=8%  Similarity=0.086  Sum_probs=55.4

Q ss_pred             CCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCC---CceeeeeeeeecC---CeeEEEEEe
Q 040557           87 GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQH---KNLVRLLGCCSDG---SQRLLVYEY  160 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~---~~~~lv~e~  160 (407)
                      .+.||.|..+.||.....+++ +.+|..+ .  ......+..|.+.|+.+..   ..+.+++++|...   +..++|||+
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~-~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         19 VECISEQPYAALWALYDSQGN-PMPLMAR-S--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeecCCccceeEEEEEcCCCC-EEEEEec-c--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            357999999999999876564 6667643 2  1122467899999988842   4678888887543   568999999


Q ss_pred             ccCCCh
Q 040557          161 MKNRSL  166 (407)
Q Consensus       161 ~~~g~L  166 (407)
                      ++++++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998764

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.04  E-value=3.2e-05  Score=68.92  Aligned_cols=73  Identities=16%  Similarity=0.247  Sum_probs=44.9

Q ss_pred             CeeeccCCc-cEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCC---ceeeeeeeeecC---CeeEEEEEe
Q 040557           88 NLLGRGGFG-PVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHK---NLVRLLGCCSDG---SQRLLVYEY  160 (407)
Q Consensus        88 ~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~  160 (407)
                      +.|+.|+.. .||+.    +..+++|....   ......+.+|.+++..+...   .+.++++.....   ...+++|++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~---~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA---AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc---cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            457777776 58875    23467776432   22344678899998877421   334444443332   235889999


Q ss_pred             ccCCChh
Q 040557          161 MKNRSLD  167 (407)
Q Consensus       161 ~~~g~L~  167 (407)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9987763

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.03  E-value=0.00012  Score=62.93  Aligned_cols=129  Identities=19%  Similarity=0.273  Sum_probs=87.0

Q ss_pred             CCeeeccCCccEEEEEecCCcEEEEEEecccc---------------ChhhHHHHHHHHHHHHcCC------CCceeeee
Q 040557           87 GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDK---------------SQQGESEFLSEVRMITSIQ------HKNLVRLL  145 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~e~~~l~~l~------h~niv~l~  145 (407)
                      ...||+|+.-.||.  ++++....||+.....               ......+..+|+.-...+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            45799999999995  4455667788876544               0112345556665554444      88999999


Q ss_pred             eeeecCCeeEEEEEeccC--C----ChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC
Q 040557          146 GCCSDGSQRLLVYEYMKN--R----SLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE  219 (407)
Q Consensus       146 ~~~~~~~~~~lv~e~~~~--g----~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~  219 (407)
                      |+.+.....-+|+|.+.+  |    +|.+++..   ..++. ...+.+.+.   ..||-+++   |+.+|++|.||++..
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~~~L~~f---~~~l~~~~---Iv~~dl~~~NIv~~~  153 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-ELRQALDEF---KRYLLDHH---IVIRDLNPHNIVVQR  153 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-HHHHHHHHH---HHHHHHcC---CeecCCCcccEEEEe
Confidence            999999889999998754  2    46666632   23554 333344433   44555555   999999999999963


Q ss_pred             C---C-ceEEec
Q 040557          220 K---F-QSKIGD  227 (407)
Q Consensus       220 ~---~-~~kl~D  227 (407)
                      +   . .+.|+|
T Consensus       154 ~~~~~~~lvlID  165 (199)
T PF10707_consen  154 RDSGEFRLVLID  165 (199)
T ss_pred             cCCCceEEEEEe
Confidence            2   2 577777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.96  E-value=7.5e-05  Score=66.52  Aligned_cols=73  Identities=15%  Similarity=0.175  Sum_probs=47.1

Q ss_pred             CeeeccCCccEEEEEecC--CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCc-eeeeeeeeecCCeeEEEEEeccCC
Q 040557           88 NLLGRGGFGPVYRGKLAD--GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN-LVRLLGCCSDGSQRLLVYEYMKNR  164 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g  164 (407)
                      +.|..|-...+|+....+  ++.|++|......  .......+|+.++..+...+ ..++++.+..    .++|||++|.
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~--~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G~   77 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT--ELIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPGR   77 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCc--cceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCCC
Confidence            457778888999998764  6788899764321  11123347888888874333 3445444332    4799999987


Q ss_pred             Ch
Q 040557          165 SL  166 (407)
Q Consensus       165 ~L  166 (407)
                      ++
T Consensus        78 ~l   79 (235)
T cd05157          78 TL   79 (235)
T ss_pred             cC
Confidence            65

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.88  E-value=4.7e-05  Score=79.21  Aligned_cols=197  Identities=19%  Similarity=0.194  Sum_probs=135.0

Q ss_pred             HHHHHHHHcCCCCceeeeeeeeecCCee----EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCC
Q 040557          127 LSEVRMITSIQHKNLVRLLGCCSDGSQR----LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH  202 (407)
Q Consensus       127 ~~e~~~l~~l~h~niv~l~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~  202 (407)
                      .-|.+.+.+..|+|++.++.|.......    .+..|++..-++...+.  .-..++......+..+...|+.|+|+.. 
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q--~v~~i~~~~~r~~~~~~~~GL~~~h~~~-  306 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ--SVGSIPLETLRILHQKLLEGLAYLHSLS-  306 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh--hccccCHHHHHHHHHHHhhhHHHHHHhc-
Confidence            3456667778999999999887544322    34457777777766663  3345788888899999999999999986 


Q ss_pred             Cceeeeccccc---cEEEcCCCceEEe--cccCccccCCCCcccccccccCccccCccccccCCCCc--cccEEehhHHH
Q 040557          203 TRIVHRDIKAS---NVLLDEKFQSKIG--DFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSE--KADIYSFGVLV  275 (407)
Q Consensus       203 ~~i~H~dlk~~---Nill~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--k~Dv~s~G~vl  275 (407)
                        ..|.-+..+   +.-.+..+.+..+  ||+.+..+.......  ...-+..|.++|......++.  ..|+|++|..+
T Consensus       307 --l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  307 --LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             --cceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence              666666555   5555666677777  998888776544322  123455678888777666544  47999999999


Q ss_pred             HHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          276 LEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       276 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                      ..+..|..+......         ..         ..++..         ....+.+....|+..++++|++..+++.+.
T Consensus       383 ~~~~~~~~i~~~~~~---------~~---------~~l~~~---------~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSAV---------PV---------SLLDVL---------STSELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hhhhhcCcccccccc---------hh---------hhhccc---------cchhhhhhhhhhcchhhhhccchhhhhhch
Confidence            999988754321100         00         000000         111456778889999999999999999886


Q ss_pred             hc
Q 040557          356 TC  357 (407)
Q Consensus       356 ~~  357 (407)
                      -.
T Consensus       436 f~  437 (1351)
T KOG1035|consen  436 FL  437 (1351)
T ss_pred             hc
Confidence            43

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.74  E-value=0.0002  Score=66.25  Aligned_cols=140  Identities=15%  Similarity=0.125  Sum_probs=80.8

Q ss_pred             CeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCC--ceeeeeee------eecCCeeEEEEE
Q 040557           88 NLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHK--NLVRLLGC------CSDGSQRLLVYE  159 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~e  159 (407)
                      +.+..|....+|+.... +..+++|....    ........|++++..+.+.  .+.+++..      ....+..++|++
T Consensus        20 ~~i~~G~~n~~y~v~~~-~~~~vLr~~~~----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          20 EGISAGIENTNYFVTTD-SGRYVLTLFEK----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             ecccCccccceEEEEeC-CCcEEEEEcCC----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            45677777899998764 44688898743    2233456777777777432  24444432      123345689999


Q ss_pred             eccCCChhH----H----------HhccC----C-----CCCCHHHHH----------HHHHHHHHHhccccc----cCC
Q 040557          160 YMKNRSLDL----L----------IYGES----D-----KFLNWSTRF----------QIILGIARGLQYLHE----DSH  202 (407)
Q Consensus       160 ~~~~g~L~~----~----------l~~~~----~-----~~l~~~~~~----------~i~~~i~~~l~~LH~----~~~  202 (407)
                      |++|..+..    .          +|...    .     ....|....          .....+..++.++..    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999876522    0          11100    0     111222111          001112223333332    112


Q ss_pred             CceeeeccccccEEEcCCCceEEecccCcc
Q 040557          203 TRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       203 ~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                      ..++|+|+.|.||++++++.+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            349999999999999998777899998775

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.74  E-value=4e-05  Score=69.30  Aligned_cols=148  Identities=14%  Similarity=0.178  Sum_probs=100.1

Q ss_pred             cccCHHHHHHHhcC---CCCCCeeeccCCccEEEEEecCCcEEEEEEeccccC-------------------h--hhHHH
Q 040557           70 SYFDFQTLKKATKN---FHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKS-------------------Q--QGESE  125 (407)
Q Consensus        70 ~~~~~~~~~~~~~~---~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------------~--~~~~~  125 (407)
                      .-++|-.++...++   +..++.||-|--+.||.+...+|...++|.-.....                   .  ...-.
T Consensus        77 ~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRla  156 (465)
T KOG2268|consen   77 AGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLA  156 (465)
T ss_pred             ccchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHH
Confidence            34777777776654   678999999999999999998999999885422110                   0  01123


Q ss_pred             HHHHHHHHHcCC-C-CceeeeeeeeecCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCC
Q 040557          126 FLSEVRMITSIQ-H-KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT  203 (407)
Q Consensus       126 ~~~e~~~l~~l~-h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~  203 (407)
                      ..+|...|+.+. | --+.+.+++    +..++|||++.+-.|...-+.     .+..++..-   +..-+.-|-.+|  
T Consensus       157 a~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~---lm~~Iv~la~~G--  222 (465)
T KOG2268|consen  157 ATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV-----EDPPTLYDD---LMGLIVRLANHG--  222 (465)
T ss_pred             HHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec-----CChHHHHHH---HHHHHHHHHHcC--
Confidence            456777777773 2 233444443    456899999998877655322     233333332   333334455556  


Q ss_pred             ceeeeccccccEEEcCCCceEEecccCcc
Q 040557          204 RIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       204 ~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                       +||+|..-=||++++++.++++||--..
T Consensus       223 -lIHgDFNEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  223 -LIHGDFNEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             -ceecccchheeEEecCCCEEEeechHhh
Confidence             9999999999999999999999996544

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.74  E-value=0.00018  Score=65.08  Aligned_cols=138  Identities=14%  Similarity=0.130  Sum_probs=76.6

Q ss_pred             eeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCce-eeeeeeeecCCeeEEEEEeccCCChh
Q 040557           89 LLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL-VRLLGCCSDGSQRLLVYEYMKNRSLD  167 (407)
Q Consensus        89 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L~  167 (407)
                      .+..|-.+.+|+... +|+.+++|.......... ....+|.+++..+...++ .++++...    -++||||++|..+.
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALG-VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCccccccc-CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence            355677889998874 577888887532211110 134678888888754333 33444432    36899999987653


Q ss_pred             HH-----------------HhccC--CCCCCHHHH-HHHH------------HHHHHHhccc--cccCCCceeeeccccc
Q 040557          168 LL-----------------IYGES--DKFLNWSTR-FQII------------LGIARGLQYL--HEDSHTRIVHRDIKAS  213 (407)
Q Consensus       168 ~~-----------------l~~~~--~~~l~~~~~-~~i~------------~~i~~~l~~L--H~~~~~~i~H~dlk~~  213 (407)
                      ..                 +|...  ...++.... ..+.            ..+...+...  .......++|+|+.+.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            21                 11111  111222111 1111            1111111111  0011234899999999


Q ss_pred             cEEEcCCCceEEecccCccc
Q 040557          214 NVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       214 Nill~~~~~~kl~Dfgla~~  233 (407)
                      ||++++++ +.|+||..+..
T Consensus       157 Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cEEEeCCC-CEEEeccccCc
Confidence            99999876 78999987763

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.71  E-value=0.00036  Score=66.56  Aligned_cols=76  Identities=17%  Similarity=0.164  Sum_probs=53.7

Q ss_pred             CeeeccCCccEEEEEecCC-cEEEEEEeccc-----cC-hhhHHHHHHHHHHHHcCC---CCceeeeeeeeecCCeeEEE
Q 040557           88 NLLGRGGFGPVYRGKLADG-TLVAVKKLCVD-----KS-QQGESEFLSEVRMITSIQ---HKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~-----~~-~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv  157 (407)
                      +.||.|.+..||++...+| +.++||.-...     .. .....++..|.+.|..+.   ..++.+++.+  +....++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5689999999999998777 48999985311     11 223456777888888762   2456677766  44567899


Q ss_pred             EEeccCCC
Q 040557          158 YEYMKNRS  165 (407)
Q Consensus       158 ~e~~~~g~  165 (407)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>PRK05231 homoserine kinase; Provisional

Probab=97.66  E-value=0.0016  Score=60.93  Aligned_cols=155  Identities=11%  Similarity=0.098  Sum_probs=80.0

Q ss_pred             CHHHHHHHhcCCCC-----CCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCC--Cceeeee
Q 040557           73 DFQTLKKATKNFHP-----GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQH--KNLVRLL  145 (407)
Q Consensus        73 ~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~  145 (407)
                      +.+++......|.+     .+.++.|....+|.....+| .+++|++. ....   ..+..|..++..+..  -.+.+++
T Consensus         8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~~~~---~~l~~~~~~l~~L~~~glpvP~~i   82 (319)
T PRK05231          8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE-RLTA---EDLPFFLGLMQHLAARGVPVPAPV   82 (319)
T ss_pred             CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec-cCCh---HHhHHHHHHHHHHHHCCCCCCcce
Confidence            34444444445544     23466677789999887655 68889874 2222   222334444444421  1233333


Q ss_pred             e------eeecCCeeEEEEEeccCCChh-----------HH---HhccCC---------CCCCH-HHHHH----------
Q 040557          146 G------CCSDGSQRLLVYEYMKNRSLD-----------LL---IYGESD---------KFLNW-STRFQ----------  185 (407)
Q Consensus       146 ~------~~~~~~~~~lv~e~~~~g~L~-----------~~---l~~~~~---------~~l~~-~~~~~----------  185 (407)
                      .      +....+..++++||++|..+.           ..   +|....         ..+.| .....          
T Consensus        83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (319)
T PRK05231         83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ  162 (319)
T ss_pred             eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence            2      112345678999999987441           11   111100         01111 11110          


Q ss_pred             --HHHH-HHHHhcccccc----CCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          186 --IILG-IARGLQYLHED----SHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       186 --i~~~-i~~~l~~LH~~----~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                        ...+ +...+..+...    -..+++|+|+.+.||+++++...-|+||+.+.
T Consensus       163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence              1111 11122222211    12349999999999999977556899999886

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.63  E-value=0.00056  Score=62.94  Aligned_cols=139  Identities=17%  Similarity=0.280  Sum_probs=79.5

Q ss_pred             ccEEEEEecCCcEEEEEEecc-ccChhhHHHHHHHHHHHHcCC--CCceeeeeeeeecCC--eeEEEEEeccCCChhHHH
Q 040557           96 GPVYRGKLADGTLVAVKKLCV-DKSQQGESEFLSEVRMITSIQ--HKNLVRLLGCCSDGS--QRLLVYEYMKNRSLDLLI  170 (407)
Q Consensus        96 g~Vy~~~~~~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~--~~~lv~e~~~~g~L~~~l  170 (407)
                      -.+|..... ++.+++. ... ...........+|.++|+.+.  -.-+...+++|.++.  ..+.||+|++|..+...+
T Consensus        39 n~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~  116 (321)
T COG3173          39 NDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSAL  116 (321)
T ss_pred             cceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcC
Confidence            344544443 7778888 321 223344455667888888763  334556778887766  679999999884332111


Q ss_pred             hccC------------------------------------CCCCCHHHHHHHHH--------HHHHHhccccc-----cC
Q 040557          171 YGES------------------------------------DKFLNWSTRFQIIL--------GIARGLQYLHE-----DS  201 (407)
Q Consensus       171 ~~~~------------------------------------~~~l~~~~~~~i~~--------~i~~~l~~LH~-----~~  201 (407)
                      ....                                    ++.-.|...++.+.        ....-..+|+.     .+
T Consensus       117 ~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~  196 (321)
T COG3173         117 PPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAG  196 (321)
T ss_pred             CcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCC
Confidence            0000                                    00001111111000        01111222222     23


Q ss_pred             CCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       202 ~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      .+.++|+|+++.|++++.+..+-|.||+++..-+.
T Consensus       197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             CceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            35699999999999999998899999999986543

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.55  E-value=0.00042  Score=64.26  Aligned_cols=73  Identities=19%  Similarity=0.249  Sum_probs=46.7

Q ss_pred             eeeccCCccEEEEEecC-------CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCce-eeeeeeeecCCeeEEEEEe
Q 040557           89 LLGRGGFGPVYRGKLAD-------GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL-VRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        89 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~  160 (407)
                      .+..|-...+|+....+       ++.+++|......  .......+|.+++..+...++ .++++++.+    ..|+||
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV--ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC--cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            45667777899988654       5789999864322  222345678888887743333 345555532    358999


Q ss_pred             ccCCChh
Q 040557          161 MKNRSLD  167 (407)
Q Consensus       161 ~~~g~L~  167 (407)
                      ++|..+.
T Consensus        79 i~G~~l~   85 (302)
T cd05156          79 IPSRTLT   85 (302)
T ss_pred             eCCCcCC
Confidence            9887663

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.46  E-value=0.0046  Score=57.47  Aligned_cols=155  Identities=14%  Similarity=0.168  Sum_probs=84.2

Q ss_pred             HHHHHHHhcCCCCC-----CeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCC--ceeeeee
Q 040557           74 FQTLKKATKNFHPG-----NLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHK--NLVRLLG  146 (407)
Q Consensus        74 ~~~~~~~~~~~~~~-----~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~  146 (407)
                      .+.+......|.+.     +.++.|....+|+....+| .+++|.......   ...+..|.+++..|...  .+.+++.
T Consensus         9 ~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~---~~~i~~e~~~l~~L~~~g~pvp~~i~   84 (307)
T TIGR00938         9 DEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK---AEELPFFLALTTHLAARGLPVPKPVK   84 (307)
T ss_pred             HHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCCC---HHHHHHHHHHHHHHHHCCCCCCcccc
Confidence            34454444455442     3466677789999876555 577887643222   22344566666666322  2344443


Q ss_pred             ee------ecCCeeEEEEEeccCCChhH-----------H---HhccCCC----------CCCHHHHHH-----------
Q 040557          147 CC------SDGSQRLLVYEYMKNRSLDL-----------L---IYGESDK----------FLNWSTRFQ-----------  185 (407)
Q Consensus       147 ~~------~~~~~~~lv~e~~~~g~L~~-----------~---l~~~~~~----------~l~~~~~~~-----------  185 (407)
                      ..      ...+..++++||++|..+..           .   +|.....          .-.|.....           
T Consensus        85 t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~  164 (307)
T TIGR00938        85 SRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA  164 (307)
T ss_pred             CCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence            21      22456789999998854320           0   1111000          011111100           


Q ss_pred             -HHHHHHHHhccccc----cCCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          186 -IILGIARGLQYLHE----DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       186 -i~~~i~~~l~~LH~----~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                       ....+...++++..    .....++|+|+++.||++++++.+.|+||+.+.
T Consensus       165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence             01112233444422    112459999999999999998777899998875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.21  E-value=0.0028  Score=57.95  Aligned_cols=72  Identities=17%  Similarity=0.284  Sum_probs=46.3

Q ss_pred             CeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcC---CCCceeeeeeeeecCCeeEEEEEeccCC
Q 040557           88 NLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI---QHKNLVRLLGCCSDGSQRLLVYEYMKNR  164 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~g  164 (407)
                      +.++.|....+|+.. .+++.+.||.-.    ......|..|.+-|+.|   .-..+.+++++....+..+||+||++.+
T Consensus        23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~----~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD-TDGGSYFVKVNS----ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEE--SSSSEEEEEE-TTS-EEEEEEEE----GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             EecCCCChhheEEEE-CCCccEEEEecC----hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            468888889999888 568889999764    22334577888887777   3456778888887777789999999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02236 choline kinase

Probab=97.07  E-value=0.0044  Score=58.50  Aligned_cols=139  Identities=21%  Similarity=0.264  Sum_probs=78.7

Q ss_pred             eeeccCCccEEEEEecC-----CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCce-eeeeeeeecCCeeEEEEEecc
Q 040557           89 LLGRGGFGPVYRGKLAD-----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL-VRLLGCCSDGSQRLLVYEYMK  162 (407)
Q Consensus        89 ~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~  162 (407)
                      .|..|-.-.+|+....+     ++.|++|......  ...-.-.+|..++..+...++ .++++++..+    .|+||++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--CeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            35457777889887532     3678888774322  222223578888888754444 3556665433    5899998


Q ss_pred             CCChhHH-----------------HhccC----CCCCCHHHHHHHHHHHH-----------------HHhc----cccc-
Q 040557          163 NRSLDLL-----------------IYGES----DKFLNWSTRFQIILGIA-----------------RGLQ----YLHE-  199 (407)
Q Consensus       163 ~g~L~~~-----------------l~~~~----~~~l~~~~~~~i~~~i~-----------------~~l~----~LH~-  199 (407)
                      +.++...                 +|...    .....+....++..++.                 ..+.    .+.. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7666321                 11111    01122333333322211                 1111    1121 


Q ss_pred             cCCCceeeeccccccEEEcC-CCceEEecccCccc
Q 040557          200 DSHTRIVHRDIKASNVLLDE-KFQSKIGDFGLARF  233 (407)
Q Consensus       200 ~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfgla~~  233 (407)
                      .....++|+|+++.|||+++ ++.+.++||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            11234899999999999986 46899999987753

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.07  E-value=0.0051  Score=56.13  Aligned_cols=32  Identities=28%  Similarity=0.446  Sum_probs=26.3

Q ss_pred             CceeeeccccccEEEcCCCc-eEEecccCcccc
Q 040557          203 TRIVHRDIKASNVLLDEKFQ-SKIGDFGLARFF  234 (407)
Q Consensus       203 ~~i~H~dlk~~Nill~~~~~-~kl~Dfgla~~~  234 (407)
                      +.++|+|+++.||++++++. .-|+||+.+..-
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            34999999999999997555 469999988643

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.97  E-value=0.00011  Score=78.59  Aligned_cols=159  Identities=11%  Similarity=-0.005  Sum_probs=113.3

Q ss_pred             HHHHHHHHHcCCCCceeeeeeeee--cCCeeEEEEEeccCCChhHHHhccCC--CCCCHHHHHHHHHHHHHHhccccccC
Q 040557          126 FLSEVRMITSIQHKNLVRLLGCCS--DGSQRLLVYEYMKNRSLDLLIYGESD--KFLNWSTRFQIILGIARGLQYLHEDS  201 (407)
Q Consensus       126 ~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~  201 (407)
                      ...|...++...|+++.....-..  .....+.+++|+.+|.+...+-....  ..++.......-.+...+..-+|+..
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            345555566678888876554332  23456889999999999888865432  23333333333333355555555543


Q ss_pred             --CCceeeeccccccEEEcCCCceEEecccCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHH
Q 040557          202 --HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII  279 (407)
Q Consensus       202 --~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~  279 (407)
                        ....+|+++|+-|.++..+.++++.++|+.+...+.... .....+++.|+.|+....-.++.++|+|..|+-+|++.
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf-~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF-FGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCchHhh-hhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence              234899999999999999999999999999954443332 23456788899999888888999999999999999998


Q ss_pred             hcCCCC
Q 040557          280 SCRKNT  285 (407)
Q Consensus       280 tg~~p~  285 (407)
                      .|..++
T Consensus      1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred             cccHHH
Confidence            877654

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.92  E-value=0.0088  Score=55.50  Aligned_cols=141  Identities=19%  Similarity=0.204  Sum_probs=92.3

Q ss_pred             CCeeeccCCccEEEEEecCCcEEEEEEecccc----Ch----hhH----------------H-HHHHHHHHHHcCCCCce
Q 040557           87 GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDK----SQ----QGE----------------S-EFLSEVRMITSIQHKNL  141 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~----~~~----------------~-~~~~e~~~l~~l~h~ni  141 (407)
                      ...|..|--+.||-+...+|..+|||+++.+.    ..    .++                . -...|++-|.+++...|
T Consensus       149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            34678899999999999899999999885431    00    000                0 12357777777765443


Q ss_pred             eeeeeeeecCCeeEEEEEeccCCCh-hHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCC
Q 040557          142 VRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEK  220 (407)
Q Consensus       142 v~l~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~  220 (407)
                      .-.--+..  ....|||+|+....- .-.|   +...++...+...-.+++.-|.-|.+.+  ++||.||.--|+|+-++
T Consensus       229 P~PePIlL--k~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~LyhdG  301 (520)
T KOG2270|consen  229 PCPEPILL--KNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHDG  301 (520)
T ss_pred             CCCCceee--ecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEECC
Confidence            21111111  123789999953211 1111   2334666677777778888888777655  59999999999999765


Q ss_pred             CceEEecccCccccC
Q 040557          221 FQSKIGDFGLARFFP  235 (407)
Q Consensus       221 ~~~kl~Dfgla~~~~  235 (407)
                       .+.++|.+-+....
T Consensus       302 -~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  302 -KLYIIDVSQSVEHD  315 (520)
T ss_pred             -EEEEEEccccccCC
Confidence             89999988776543

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.74  E-value=0.038  Score=52.81  Aligned_cols=73  Identities=11%  Similarity=0.087  Sum_probs=49.2

Q ss_pred             CeeeccCCccEEEEEecCCcEEEEEEeccccC------hhhHHHHHHHHHHHHcCC---CCceeeeeeeeecCCeeEEEE
Q 040557           88 NLLGRGGFGPVYRGKLADGTLVAVKKLCVDKS------QQGESEFLSEVRMITSIQ---HKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  158 (407)
                      +.||.|....||+.... +..++||+-.....      .....+-..|.+.|..+.   ..++.+++.++.  +..+++|
T Consensus        38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM  114 (418)
T PLN02756         38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM  114 (418)
T ss_pred             EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence            56899999999998874 56789997642110      012333445566666553   357788888876  4467889


Q ss_pred             EeccC
Q 040557          159 EYMKN  163 (407)
Q Consensus       159 e~~~~  163 (407)
                      |++++
T Consensus       115 E~L~~  119 (418)
T PLN02756        115 RYLEP  119 (418)
T ss_pred             eecCC
Confidence            99977

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.60  E-value=0.0097  Score=51.31  Aligned_cols=153  Identities=16%  Similarity=0.163  Sum_probs=89.0

Q ss_pred             cCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCChhHHHhc
Q 040557           93 GGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYG  172 (407)
Q Consensus        93 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  172 (407)
                      |+.++.-+++.+- ....+|++......-...-|.++.++++++.  .|+++..-  +...+-++.|+|.....      
T Consensus        73 ~gNsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------  141 (308)
T ss_pred             CCceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence            3334444444322 2345666654333334456778888888764  46666622  34456788998854211      


Q ss_pred             cCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccccccccCcccc
Q 040557          173 ESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT  252 (407)
Q Consensus       173 ~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~  252 (407)
                           ..   .-.|..+ +.+|.-.|+.. ...+|+|-.|+|||-|..|.+||.|=+....  .           +-.|.
T Consensus       142 -----~~---~N~i~ag-i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--~-----------~V~~v  198 (308)
T PF07387_consen  142 -----NF---SNFITAG-IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--N-----------QVNMV  198 (308)
T ss_pred             -----ch---hHHHHHh-HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--h-----------eeeEE
Confidence                 11   1112221 35677788653 4699999999999999999999999665431  0           00111


Q ss_pred             CccccccCCCCccccEEehhHHHHHHHhcC
Q 040557          253 APEYAIRGELSEKADIYSFGVLVLEIISCR  282 (407)
Q Consensus       253 aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~  282 (407)
                      --|   -...|.++.+-+|=.-+++++...
T Consensus       199 N~~---Y~~lT~~aE~~~fv~s~l~~v~~~  225 (308)
T PF07387_consen  199 NIE---YESLTQEAEVKVFVKSCLKLVEKQ  225 (308)
T ss_pred             eee---ccccChHHHHHHHHHHHHHHHHHH
Confidence            111   123466777777777777776543

The function of this family is unknown.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.57  E-value=0.02  Score=53.22  Aligned_cols=30  Identities=30%  Similarity=0.372  Sum_probs=27.3

Q ss_pred             ceeeeccccccEEEcCCCceEEecccCccc
Q 040557          204 RIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       204 ~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      .++|+|+.++|+++++++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            599999999999999999999999987763

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.55  E-value=0.0077  Score=52.61  Aligned_cols=29  Identities=28%  Similarity=0.475  Sum_probs=20.7

Q ss_pred             ceeeeccccccEEE-cCCCceEEecccCcc
Q 040557          204 RIVHRDIKASNVLL-DEKFQSKIGDFGLAR  232 (407)
Q Consensus       204 ~i~H~dlk~~Nill-~~~~~~kl~Dfgla~  232 (407)
                      .++|+|+.+.||++ +.++.++++||..+.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            48999999999999 888999999998775

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.51  E-value=0.029  Score=52.12  Aligned_cols=29  Identities=24%  Similarity=0.378  Sum_probs=25.3

Q ss_pred             CceeeeccccccEEEcCCCceEEecccCcc
Q 040557          203 TRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       203 ~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            45899999999999998 578999998765

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.41  E-value=0.034  Score=52.17  Aligned_cols=73  Identities=15%  Similarity=0.089  Sum_probs=47.3

Q ss_pred             eeeccCCccEEEEEecCC-cEEEEEEeccc------cChhhHHHHHHHHHHHHcCC--CC-ceeeeeeeeecCCeeEEEE
Q 040557           89 LLGRGGFGPVYRGKLADG-TLVAVKKLCVD------KSQQGESEFLSEVRMITSIQ--HK-NLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        89 ~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~------~~~~~~~~~~~e~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~  158 (407)
                      .||-|....||++..++| +.|+||.-...      .......+..-|.+.|....  .| .+.+++.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            478899999999997654 68999975311      11233445566777776652  34 34445443  555667999


Q ss_pred             EeccC
Q 040557          159 EYMKN  163 (407)
Q Consensus       159 e~~~~  163 (407)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99855

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.17  E-value=0.034  Score=52.20  Aligned_cols=138  Identities=15%  Similarity=0.224  Sum_probs=76.2

Q ss_pred             eeeccCCccEEEEEecC----CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCce-eeeeeeeecCCeeEEEEEeccC
Q 040557           89 LLGRGGFGPVYRGKLAD----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL-VRLLGCCSDGSQRLLVYEYMKN  163 (407)
Q Consensus        89 ~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~  163 (407)
                      .|..|=...+|+....+    +..|++|.......  ..-.-.+|..++..+..-++ .++++++..+    +|.+|+++
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g   94 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA   94 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence            45446667788886543    23788887643221  22233578888888865444 3556555322    58999977


Q ss_pred             CChhHH-----------------HhccC----CCCCCHHHHHHHHHHHH-------------------------HHh-cc
Q 040557          164 RSLDLL-----------------IYGES----DKFLNWSTRFQIILGIA-------------------------RGL-QY  196 (407)
Q Consensus       164 g~L~~~-----------------l~~~~----~~~l~~~~~~~i~~~i~-------------------------~~l-~~  196 (407)
                      ..+..-                 +|...    ..+--|....++..++.                         ..+ ..
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            655210                 11111    01112333322222211                         111 11


Q ss_pred             ccccC-CCceeeeccccccEEEcC-CCceEEecccCcc
Q 040557          197 LHEDS-HTRIVHRDIKASNVLLDE-KFQSKIGDFGLAR  232 (407)
Q Consensus       197 LH~~~-~~~i~H~dlk~~Nill~~-~~~~kl~Dfgla~  232 (407)
                      +...+ ..-++|+|+.+.||++++ ++.++++||..|.
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            21111 224899999999999974 5789999998775

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.16  E-value=0.12  Score=48.28  Aligned_cols=138  Identities=23%  Similarity=0.328  Sum_probs=76.6

Q ss_pred             eeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCc------eeeeee----eeecCCeeEEEEE
Q 040557           90 LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN------LVRLLG----CCSDGSQRLLVYE  159 (407)
Q Consensus        90 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~----~~~~~~~~~lv~e  159 (407)
                      |.+ .-..+|+....+|+. ++|.....   ....++..|...|..+.-.+      +..+=|    ....+....-+++
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~---~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPG---WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCC---CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            444 557899998877776 88877543   23334556666666552111      122212    1222236778999


Q ss_pred             eccCCChhH-H--------------Hhc--cC--------CCCCCHHH---H----------HHHHHHHHHHhccccc--
Q 040557          160 YMKNRSLDL-L--------------IYG--ES--------DKFLNWST---R----------FQIILGIARGLQYLHE--  199 (407)
Q Consensus       160 ~~~~g~L~~-~--------------l~~--~~--------~~~l~~~~---~----------~~i~~~i~~~l~~LH~--  199 (407)
                      |++|..+.. .              +|.  ..        .....|..   .          .....++...+..+.+  
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999987762 1              010  00        01223331   0          0112222223332222  


Q ss_pred             --cCC---CceeeeccccccEEEcCCCc-eEEecccCcc
Q 040557          200 --DSH---TRIVHRDIKASNVLLDEKFQ-SKIGDFGLAR  232 (407)
Q Consensus       200 --~~~---~~i~H~dlk~~Nill~~~~~-~kl~Dfgla~  232 (407)
                        .-.   ..+||+|+.+.||+++.+.. +-++|||-+.
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence              111   12899999999999998875 8999998775

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.11  E-value=0.014  Score=54.05  Aligned_cols=72  Identities=18%  Similarity=0.208  Sum_probs=56.3

Q ss_pred             CeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCc
Q 040557          152 SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLA  231 (407)
Q Consensus       152 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla  231 (407)
                      ...|++|++. |+++.      ..+.-.+.+...++.+.+..+.-+..+  .+.-|||+.-.||||+ +|++.|+||-++
T Consensus       299 ~y~yl~~kdh-gt~is------~ik~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkls  368 (488)
T COG5072         299 LYLYLHFKDH-GTPIS------IIKADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLS  368 (488)
T ss_pred             eEEEEEEecC-Cceee------eeecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeee
Confidence            3456777765 44442      223457888899999988888877764  4699999999999999 889999999999


Q ss_pred             cc
Q 040557          232 RF  233 (407)
Q Consensus       232 ~~  233 (407)
                      +.
T Consensus       369 Rl  370 (488)
T COG5072         369 RL  370 (488)
T ss_pred             ec
Confidence            84

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.98  E-value=0.27  Score=46.09  Aligned_cols=93  Identities=16%  Similarity=0.126  Sum_probs=52.9

Q ss_pred             cCHHHHHHHhcCCCCC---C-eeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCC--Cceeeee
Q 040557           72 FDFQTLKKATKNFHPG---N-LLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQH--KNLVRLL  145 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~~---~-~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~  145 (407)
                      ++.+.+..+...+-+.   + ..-.+.-..||+....+|..+++|......  .....+..|.+.+..+..  -.++...
T Consensus        11 l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~--~~~~~i~~E~~~l~~L~~~gipv~~p~   88 (325)
T PRK11768         11 LTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPER--WSDAQILEEHAFALELAEAEIPVVAPL   88 (325)
T ss_pred             CChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCccc--CCHHHHHHHHHHHHHHHHCCCCCCCCc
Confidence            5566666655554331   1 122345578999988788889999874222  233455667777665532  1122211


Q ss_pred             ---e--eeecCCeeEEEEEeccCCCh
Q 040557          146 ---G--CCSDGSQRLLVYEYMKNRSL  166 (407)
Q Consensus       146 ---~--~~~~~~~~~lv~e~~~~g~L  166 (407)
                         |  ....++..+.++++++|...
T Consensus        89 ~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         89 AFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cCCCCEEEEECCEEEEEEeeeCCCCC
Confidence               1  12224567889999987643

>PRK06148 hypothetical protein; Provisional

Probab=95.93  E-value=0.1  Score=56.57  Aligned_cols=30  Identities=30%  Similarity=0.474  Sum_probs=25.4

Q ss_pred             ceeeeccccccEEEcCCC--ceE-EecccCccc
Q 040557          204 RIVHRDIKASNVLLDEKF--QSK-IGDFGLARF  233 (407)
Q Consensus       204 ~i~H~dlk~~Nill~~~~--~~k-l~Dfgla~~  233 (407)
                      .+||+|+++.||+++.+.  .+. |+|||-+..
T Consensus       204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        204 QVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             ceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            399999999999999775  454 999998863

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.88  E-value=0.08  Score=46.12  Aligned_cols=73  Identities=18%  Similarity=0.246  Sum_probs=49.6

Q ss_pred             eeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcC---CCCceeeeeeeeecCCeeEEEEEeccCCCh
Q 040557           90 LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI---QHKNLVRLLGCCSDGSQRLLVYEYMKNRSL  166 (407)
Q Consensus        90 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  166 (407)
                      +.-|.--..|.... +...+.||+-    .......|..|+.-|..+   +..++.+++.+-.+.++.|+|+||++-|.+
T Consensus        24 v~gG~inea~~v~d-g~~~~FvK~n----~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~   98 (286)
T COG3001          24 VSGGDINEAWRLRD-GTDPFFVKCN----QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL   98 (286)
T ss_pred             cCCccccceeEeec-CCcceEEEec----chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence            44444334444443 3567888853    334445677887776666   446788889888899999999999998766


Q ss_pred             h
Q 040557          167 D  167 (407)
Q Consensus       167 ~  167 (407)
                      .
T Consensus        99 d   99 (286)
T COG3001          99 D   99 (286)
T ss_pred             C
Confidence            4

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.51  E-value=0.071  Score=50.72  Aligned_cols=74  Identities=15%  Similarity=0.110  Sum_probs=49.1

Q ss_pred             CeeeccCCccEEEEEecC-CcEEEEEEeccc-----cChhhHHHHHHHHHHHHcCC--CC-ceeeeeeeeecCCeeEEEE
Q 040557           88 NLLGRGGFGPVYRGKLAD-GTLVAVKKLCVD-----KSQQGESEFLSEVRMITSIQ--HK-NLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~~e~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~  158 (407)
                      +.||-|.-..||++...+ ++.|+||.-...     .-.....+..-|.+.|+...  .| .+.+++.+  +.....+||
T Consensus        35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vM  112 (409)
T PRK12396         35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVM  112 (409)
T ss_pred             eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHH
Confidence            578999999999999743 568999975311     11234456667778877663  34 34455544  555667889


Q ss_pred             EeccC
Q 040557          159 EYMKN  163 (407)
Q Consensus       159 e~~~~  163 (407)
                      |+++.
T Consensus       113 EdL~~  117 (409)
T PRK12396        113 EDLSD  117 (409)
T ss_pred             HhCcc
Confidence            98854

>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane

Probab=95.15  E-value=0.025  Score=43.93  Aligned_cols=31  Identities=23%  Similarity=0.248  Sum_probs=18.1

Q ss_pred             chhhhHHHHHHHHHHHHHHHHHHHHHhchhH
Q 040557           13 LAALFFFLGVLSVSVILIILIIILWKFNKAK   43 (407)
Q Consensus        13 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~   43 (407)
                      .++++|++|++++++.+|++++|+.+|+++|
T Consensus        64 ~~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk   94 (122)
T PF01102_consen   64 PAIIGIIFGVMAGVIGIILLISYCIRRLRKK   94 (122)
T ss_dssp             TCHHHHHHHHHHHHHHHHHHHHHHHHHHS--
T ss_pred             cceeehhHHHHHHHHHHHHHHHHHHHHHhcc
Confidence            3567777777777666665555555544444

Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=95.14  E-value=0.0073  Score=58.07  Aligned_cols=74  Identities=28%  Similarity=0.569  Sum_probs=62.7

Q ss_pred             HHHHhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeec
Q 040557           77 LKKATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSD  150 (407)
Q Consensus        77 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  150 (407)
                      +....++|..+..+|.|+||+|+.+... ++..+|||++..........+..+|..-+..+.|++++++...+..
T Consensus        44 ~sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~  118 (516)
T KOG1033|consen   44 TSREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYE  118 (516)
T ss_pred             hhhhhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceec
Confidence            5556688999999999999999999865 4558999999887777777888999999999999999998776643

>PTZ00384 choline kinase; Provisional

Probab=95.09  E-value=0.16  Score=48.53  Aligned_cols=73  Identities=18%  Similarity=0.306  Sum_probs=43.6

Q ss_pred             eeeccCCccEEEEEecCC--cE-----EEEEEeccccChhhHHHHHHHHHHHHcCCCCce-eeeeeeeecCCeeEEEEEe
Q 040557           89 LLGRGGFGPVYRGKLADG--TL-----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL-VRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        89 ~lg~G~~g~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~  160 (407)
                      .|..|-...+|++...++  ..     |.++..  .........-.+|.+++..+...++ .++++.+..    ++++||
T Consensus        57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~--g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef  130 (383)
T PTZ00384         57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS--STYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW  130 (383)
T ss_pred             EeCCcccceEEEEEecCCCCCccccceEEEEec--cCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence            455577788999876433  22     444432  1111111223578888888865554 456666543    589999


Q ss_pred             ccCCChh
Q 040557          161 MKNRSLD  167 (407)
Q Consensus       161 ~~~g~L~  167 (407)
                      ++|.+|.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9987763

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	407
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-60
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-58
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-48
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-47
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-44
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-44
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-43
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-41
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-24
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-23
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-23
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-23
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-23
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-23
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-23
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-23
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-23
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-23
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-23
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-23
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-23
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-23
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-23
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-23
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-23
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-23
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-23
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-23
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-23
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-23
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-23
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-23
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-23
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-23
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-23
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		7e-23
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-23
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-23
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		9e-23
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-22
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-22
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-22
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-22
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-22
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-22
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-22
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-22
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-22
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-22
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-22
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-22
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-22
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-22
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-22
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-22
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-22
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-22
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-22
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-22
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-22
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-22
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-22
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-22
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-22
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		6e-22
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-22
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-22
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-22
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-22
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-21
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-21
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-21
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-21
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-21
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-21
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-21
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-21
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-21
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-21
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-21
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-21
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-21
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-20
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-20
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-20
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-20
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-20
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-20
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-20
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-20
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-20
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-20
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-20
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-20
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-20
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-20
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-20
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		8e-20
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		9e-20
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-20
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		9e-20
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-19
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-19
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-19
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-19
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-19
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-19
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-19
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-19
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-19
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-19
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-19
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-19
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-19
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-19
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		6e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		6e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-19
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-19
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-19
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		8e-19
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-19
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		9e-19
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		9e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-18
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-18
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-18
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-18
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-18
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-18
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-18
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-18
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-18
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-18
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-18
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-18
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-18
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-18
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-18
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-18
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-18
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-18
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-18
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-18
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-18
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-18
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-18
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-18
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-18
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-18
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-18
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-18
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-18
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-18
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-18
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-18
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-18
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-18
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-18
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		7e-18
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-18
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		7e-18
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		8e-18
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-18
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-17
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-17
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-17
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-17
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-17
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-17
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-17
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-17
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-17
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-17
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-17
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-17
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-17
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-17
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-17
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-17
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-17
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-17
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-17
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-17
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-17
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-17
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-17
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-17
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-17
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-17
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-17
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-17
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-17
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-17
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-17
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-17
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-17
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-17
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-17
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-17
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-17
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-17
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-17
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-17
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-17
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-17
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-17
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-17
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-17
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-17
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-17
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-17
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-17
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-17
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		6e-17
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-17
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-17
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-17
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-17
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-17
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-17
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-17
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-17
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		6e-17
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-17
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-17
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-17
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-17
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-17
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-17
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-17
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-17
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-17
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-17
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-17
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-17
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-17
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-17
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		8e-17
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		8e-17
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-17
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		8e-17
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		8e-17
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		8e-17
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-17
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-17
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-17
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-17
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		9e-17
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-17
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-16
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-16
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-16
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-16
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-16
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-16
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-16
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-16
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-16
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-16
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-16
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-16
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-16
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-16
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-16
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-16
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-16
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-16
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-16
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-16
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-16
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-16
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-16
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-16
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-16
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-16
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-16
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-16
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-16
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-16
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-16
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-16
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-16
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-16
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-16
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-16
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-16
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		7e-16
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		7e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		8e-16
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		8e-16
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-16
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		9e-16
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		9e-16
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		9e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-15
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-15
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-15
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-15
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-15
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-15
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-15
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-15
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-15
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-15
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-15
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-15
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-15
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-15
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-15
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-15
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-15
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-15
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-15
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-15
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-15
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-15
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-15
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-15
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-15
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-15
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-15
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-15
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-15
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-15
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-15
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-15
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-15
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-15
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-15
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-15
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-15
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-15
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-15
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-15
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-15
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-15
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-15
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-15
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-15
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-15
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-15
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		7e-15
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-15
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		8e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-15
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-15
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-15
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		9e-15
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		9e-15
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		9e-15
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		9e-15
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-14
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-14
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-14
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-14
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-14
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-14
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-14
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-14
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-14
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-14
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-14
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-14
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-14
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		9e-14
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		9e-14
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-13
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-13
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-13
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-13
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-13
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-13
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-13
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-13
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-13
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-13
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-13
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-13
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-13
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-13
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		8e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		8e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		8e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		8e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		8e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-13
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-13
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		9e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-12
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-12
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-12
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-12
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		6e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		7e-12
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-12
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-12
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		9e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		9e-12
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-11
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-11
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-11
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-11
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-11
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-11
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-11
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-11
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-11
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-10
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-10
3soa_A	444	Full-Length Human Camkii Length = 444		1e-10
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-10
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-10
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-10
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-10
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		6e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-10
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		6e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-10
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-10
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-10
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-10
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		8e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		9e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		9e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		9e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-10
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		9e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		9e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-10
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-09
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-09
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-09
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-09
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-09
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-09
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-09
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-09
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-09
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-09
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		5e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-09
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		8e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-09
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		9e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		9e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-08
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		6e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		7e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		7e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		7e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		7e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		7e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		8e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		8e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		8e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		8e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		8e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		8e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		8e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		8e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		9e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		9e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		9e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		9e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		9e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		9e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		9e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		9e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		9e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		7e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		7e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		8e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		8e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		9e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-06
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-06
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		3e-06
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		3e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-06
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		4e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-06
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		5e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		9e-06

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  227 bits (579), Expect = 7e-60,   Method: Compositional matrix adjust.
 Identities = 124/295 (42%), Positives = 184/295 (62%), Gaps = 5/295 (1%)
Query: 65  NLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGES 124
           +L  +  F  + L+ A+ NF   N+LGRGGFG VY+G+LADGTLVAVK+L  ++ Q GE 
Sbjct: 21  HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGEL 80
Query: 125 EFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLD--LLIYGESDKFLNWST 182
           +F +EV MI+   H+NL+RL G C   ++RLLVY YM N S+   L    ES   L+W  
Sbjct: 81  QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 140
Query: 183 RFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS 242
           R +I LG ARGL YLH+    +I+HRD+KA+N+LLDE+F++ +GDFGLA+       ++ 
Sbjct: 141 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVX 200
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLT--LPSEMQYLPEYA 300
               GT+G+ APEY   G+ SEK D++ +GV++LE+I+ ++  DL      +   L ++ 
Sbjct: 201 XAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 260
Query: 301 WKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
             L +  ++  LVD  ++     + +  Q+I VA +C Q    +RP MSE+V ML
Sbjct: 261 KGLLKEKKLEALVDVDLQG-NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  223 bits (569), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 122/295 (41%), Positives = 183/295 (62%), Gaps = 5/295 (1%)
Query: 65  NLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGES 124
           +L  +  F  + L+ A+ NF   N+LGRGGFG VY+G+LADG LVAVK+L  +++Q GE 
Sbjct: 13  HLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGEL 72
Query: 125 EFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLD--LLIYGESDKFLNWST 182
           +F +EV MI+   H+NL+RL G C   ++RLLVY YM N S+   L    ES   L+W  
Sbjct: 73  QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132
Query: 183 RFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS 242
           R +I LG ARGL YLH+    +I+HRD+KA+N+LLDE+F++ +GDFGLA+       ++ 
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVX 192
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLT--LPSEMQYLPEYA 300
               G +G+ APEY   G+ SEK D++ +GV++LE+I+ ++  DL      +   L ++ 
Sbjct: 193 XAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 301 WKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
             L +  ++  LVD  ++     + +  Q+I VA +C Q    +RP MSE+V ML
Sbjct: 253 KGLLKEKKLEALVDVDLQG-NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  190 bits (482), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 109/279 (39%), Positives = 168/279 (60%), Gaps = 8/279 (2%)
Query: 77  LKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI 136
           L++AT NF    L+G G FG VY+G L DG  VA+K+    +S QG  EF +E+  ++  
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRR-TPESSQGIEEFETEIETLSFC 92
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGES--DKFLNWSTRFQIILGIARGL 194
           +H +LV L+G C + ++ +L+Y+YM+N +L   +YG       ++W  R +I +G ARGL
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE-DQAYLSTNFAGTLGYTA 253
            YLH  +   I+HRD+K+ N+LLDE F  KI DFG+++   E DQ +L     GTLGY  
Sbjct: 153 HYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYID 209
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           PEY I+G L+EK+D+YSFGV++ E++  R     +LP EM  L E+A + +  G++ ++V
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIV 352
           DP +  + I      +  + A  CL      RP M +++
Sbjct: 270 DPNL-ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  187 bits (475), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 108/279 (38%), Positives = 167/279 (59%), Gaps = 8/279 (2%)
Query: 77  LKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI 136
           L++AT NF    L+G G FG VY+G L DG  VA+K+    +S QG  EF +E+  ++  
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRR-TPESSQGIEEFETEIETLSFC 92
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGES--DKFLNWSTRFQIILGIARGL 194
           +H +LV L+G C + ++ +L+Y+YM+N +L   +YG       ++W  R +I +G ARGL
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE-DQAYLSTNFAGTLGYTA 253
            YLH  +   I+HRD+K+ N+LLDE F  KI DFG+++   E  Q +L     GTLGY  
Sbjct: 153 HYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYID 209
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           PEY I+G L+EK+D+YSFGV++ E++  R     +LP EM  L E+A + +  G++ ++V
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIV 352
           DP +  + I      +  + A  CL      RP M +++
Sbjct: 270 DPNL-ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  175 bits (443), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 117/295 (39%), Positives = 165/295 (55%), Gaps = 19/295 (6%)
Query: 72  FDFQTLKKATKNFHP------GNLLGRGGFGPVYRGKLADGTLVAVKKLC--VD-KSQQG 122
           F F  LK  T NF        GN +G GGFG VY+G + + T VAVKKL   VD  +++ 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 123 ESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWS 181
           + +F  E++++   QH+NLV LLG  SDG    LVY YM N SL D L   +    L+W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 182 TRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE-DQAY 240
            R +I  G A G+ +LHE+ H   +HRDIK++N+LLDE F +KI DFGLAR   +  Q  
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYA 300
           + +   GT  Y APE A+RGE++ K+DIYSFGV++LEII+     D     ++  L    
Sbjct: 191 MXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLDIKE 248
Query: 301 WKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
               E   I + +D +M        +A+   +VA  CL    N+RP + ++  +L
Sbjct: 249 EIEDEEKTIEDYIDKKMNDADSTSVEAM--YSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  174 bits (441), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 117/295 (39%), Positives = 164/295 (55%), Gaps = 19/295 (6%)
Query: 72  FDFQTLKKATKNFHP------GNLLGRGGFGPVYRGKLADGTLVAVKKLC--VD-KSQQG 122
           F F  LK  T NF        GN +G GGFG VY+G + + T VAVKKL   VD  +++ 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 123 ESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWS 181
           + +F  E++++   QH+NLV LLG  SDG    LVY YM N SL D L   +    L+W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 182 TRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE-DQAY 240
            R +I  G A G+ +LHE+ H   +HRDIK++N+LLDE F +KI DFGLAR   +  Q  
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYA 300
           +     GT  Y APE A+RGE++ K+DIYSFGV++LEII+     D     ++  L    
Sbjct: 191 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLDIKE 248
Query: 301 WKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
               E   I + +D +M        +A+   +VA  CL    N+RP + ++  +L
Sbjct: 249 EIEDEEKTIEDYIDKKMNDADSTSVEAM--YSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 117/295 (39%), Positives = 164/295 (55%), Gaps = 19/295 (6%)
Query: 72  FDFQTLKKATKNFHP------GNLLGRGGFGPVYRGKLADGTLVAVKKLC--VD-KSQQG 122
           F F  LK  T NF        GN +G GGFG VY+G + + T VAVKKL   VD  +++ 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 123 ESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWS 181
           + +F  E++++   QH+NLV LLG  SDG    LVY YM N SL D L   +    L+W 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 182 TRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE-DQAY 240
            R +I  G A G+ +LHE+ H   +HRDIK++N+LLDE F +KI DFGLAR   +  Q  
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYA 300
           +     GT  Y APE A+RGE++ K+DIYSFGV++LEII+     D     ++  L    
Sbjct: 185 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLDIKE 242
Query: 301 WKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
               E   I + +D +M        +A+   +VA  CL    N+RP + ++  +L
Sbjct: 243 EIEDEEKTIEDYIDKKMNDADSTSVEAM--YSVASQCLHEKKNKRPDIKKVQQLL 295

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  164 bits (415), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 115/295 (38%), Positives = 159/295 (53%), Gaps = 19/295 (6%)
Query: 72  FDFQTLKKATKNFHP------GNLLGRGGFGPVYRGKLADGTLVAVKKLC--VD-KSQQG 122
           F F  LK  T NF        GN  G GGFG VY+G + + T VAVKKL   VD  +++ 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 64
Query: 123 ESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWS 181
           + +F  E+++    QH+NLV LLG  SDG    LVY Y  N SL D L   +    L+W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 182 TRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE-DQAY 240
            R +I  G A G+ +LHE+ H   +HRDIK++N+LLDE F +KI DFGLAR   +  Q  
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYA 300
             +   GT  Y APE A+RGE++ K+DIYSFGV++LEII+     D     ++  L    
Sbjct: 182 XXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLDIKE 239
Query: 301 WKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
               E   I + +D +         +A    +VA  CL    N+RP + ++  +L
Sbjct: 240 EIEDEEKTIEDYIDKKXNDADSTSVEA--XYSVASQCLHEKKNKRPDIKKVQQLL 292

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 142/279 (50%), Gaps = 25/279 (8%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLC-VDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G FG V+R +   G+ VAVK L   D   +  +EFL EV ++  ++H N+V  +G  
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKF-LNWSTRFQIILGIARGLQYLHEDSHTRIVH 207
           +      +V EY+   SL  L++    +  L+   R  +   +A+G+ YLH + +  IVH
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 208 RDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL-STNFAGTLGYTAPEYAIRGELS-EK 265
           RD+K+ N+L+D+K+  K+ DFGL+R   +   +L S   AGT  + APE  +R E S EK
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPE-VLRDEPSNEK 219
Query: 266 ADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVER 325
           +D+YSFGV++ E+ + ++                 W      +++  V  + ++  I   
Sbjct: 220 SDVYSFGVILWELATLQQ----------------PWGNLNPAQVVAAVGFKCKRLEIPRN 263
Query: 326 DALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
              QV  +   C      +RP  + I+ +L   ++S +P
Sbjct: 264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 144/279 (51%), Gaps = 25/279 (8%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLC-VDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G FG V+R +   G+ VAVK L   D   +  +EFL EV ++  ++H N+V  +G  
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKF-LNWSTRFQIILGIARGLQYLHEDSHTRIVH 207
           +      +V EY+   SL  L++    +  L+   R  +   +A+G+ YLH + +  IVH
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 208 RDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST-NFAGTLGYTAPEYAIRGELS-EK 265
           R++K+ N+L+D+K+  K+ DFGL+R   +   +LS+ + AGT  + APE  +R E S EK
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPE-VLRDEPSNEK 219
Query: 266 ADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVER 325
           +D+YSFGV++ E+ + ++                 W      +++  V  + ++  I   
Sbjct: 220 SDVYSFGVILWELATLQQ----------------PWGNLNPAQVVAAVGFKCKRLEIPRN 263
Query: 326 DALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
              QV  +   C      +RP  + I+ +L   ++S +P
Sbjct: 264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 102/191 (53%), Gaps = 6/191 (3%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG+G FG V+ G     T VA+K L           FL E +++  ++H+ LV+L    S
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           +     +V EYM   SL   + GE+ K+L       +   IA G+ Y+   ++   VHRD
Sbjct: 74  E-EPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRD 129
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           ++A+N+L+ E    K+ DFGLAR   +++          + +TAPE A+ G  + K+D++
Sbjct: 130 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 189
Query: 270 SFGVLVLEIIS 280
           SFG+L+ E+ +
Sbjct: 190 SFGILLTELTT 200

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 66/192 (34%), Positives = 104/192 (54%), Gaps = 8/192 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG+G FG V+ G     T VA+K L           FL E +++  ++H+ LV+L    S
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           +     +V EYM   SL   + GE+ K+L       +   IA G+ Y+   ++   VHRD
Sbjct: 77  E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRD 132
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADI 268
           ++A+N+L+ E    K+ DFGLAR   ED  Y +   A   + +TAPE A+ G  + K+D+
Sbjct: 133 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 191
Query: 269 YSFGVLVLEIIS 280
           +SFG+L+ E+ +
Sbjct: 192 WSFGILLTELTT 203

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/192 (34%), Positives = 103/192 (53%), Gaps = 8/192 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG+G FG V+ G     T VA+K L           FL E +++  I+H+ LV+L    S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           +     +V EYM   SL   + GE  K+L       +   IA G+ Y+   ++   VHRD
Sbjct: 84  E-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRD 139
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADI 268
           ++A+N+L+ E    K+ DFGLAR   ED  Y +   A   + +TAPE A+ G  + K+D+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 269 YSFGVLVLEIIS 280
           +SFG+L+ E+ +
Sbjct: 199 WSFGILLTELTT 210

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 66/192 (34%), Positives = 104/192 (54%), Gaps = 8/192 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG+G FG V+ G     T VA+K L           FL E +++  ++H+ LV+L    S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           +     +V EYM   SL   + GE+ K+L       +   IA G+ Y+   ++   VHRD
Sbjct: 81  E-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNY---VHRD 136
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADI 268
           ++A+N+L+ E    K+ DFGLAR   ED  Y +   A   + +TAPE A+ G  + K+D+
Sbjct: 137 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 269 YSFGVLVLEIIS 280
           +SFG+L+ E+ +
Sbjct: 196 WSFGILLTELTT 207

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 66/192 (34%), Positives = 104/192 (54%), Gaps = 8/192 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG+G FG V+ G     T VA+K L           FL E +++  ++H+ LV+L    S
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           +     +V EYM   SL   + GE+ K+L       +   IA G+ Y+   ++   VHRD
Sbjct: 333 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRD 388
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADI 268
           ++A+N+L+ E    K+ DFGLAR   ED  Y +   A   + +TAPE A+ G  + K+D+
Sbjct: 389 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 269 YSFGVLVLEIIS 280
           +SFG+L+ E+ +
Sbjct: 448 WSFGILLTELTT 459

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 66/192 (34%), Positives = 104/192 (54%), Gaps = 8/192 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG+G FG V+ G     T VA+K L           FL E +++  ++H+ LV+L    S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           +     +V EYM   SL   + GE+ K+L       +   IA G+ Y+   ++   VHRD
Sbjct: 250 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRD 305
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADI 268
           ++A+N+L+ E    K+ DFGLAR   ED  Y +   A   + +TAPE A+ G  + K+D+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 269 YSFGVLVLEIIS 280
           +SFG+L+ E+ +
Sbjct: 365 WSFGILLTELTT 376

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 66/192 (34%), Positives = 104/192 (54%), Gaps = 8/192 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG+G FG V+ G     T VA+K L           FL E +++  ++H+ LV+L    S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           +     +V EYM   SL   + GE+ K+L       +   IA G+ Y+   ++   VHRD
Sbjct: 250 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRD 305
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADI 268
           ++A+N+L+ E    K+ DFGLAR   ED  Y +   A   + +TAPE A+ G  + K+D+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 269 YSFGVLVLEIIS 280
           +SFG+L+ E+ +
Sbjct: 365 WSFGILLTELTT 376

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 102/191 (53%), Gaps = 6/191 (3%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG+G FG V+ G     T VA+K L           FL E +++  ++H+ LV+L    S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           +     +V EYM   SL   + GE+ K+L       +   IA G+ Y+   ++   VHRD
Sbjct: 81  E-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNY---VHRD 136
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           ++A+N+L+ E    K+ DFGLAR   +++          + +TAPE A+ G  + K+D++
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 270 SFGVLVLEIIS 280
           SFG+L+ E+ +
Sbjct: 197 SFGILLTELTT 207

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 88/342 (25%), Positives = 155/342 (45%), Gaps = 55/342 (16%)
Query: 61  FFNGNLRTI---SYFDFQTLKKATKNFHP------------GNLLGRGGFGPVYRGKLA- 104
           F NG+L+     +Y D  T +  T+  H               ++G G FG V  G+L  
Sbjct: 9   FGNGHLKLPGLRTYVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKL 68
Query: 105 ---DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM 161
                  VA+K L V  +++   +FL E  ++    H N++RL G  +     ++V EYM
Sbjct: 69  PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128
Query: 162 KNRSLDLLIYGESDKFLNWSTRFQII---LGIARGLQYLHEDSHTRIVHRDIKASNVLLD 218
           +N SLD  +     +F    T  Q++    GIA G++YL +  +   VHRD+ A N+L++
Sbjct: 129 ENGSLDSFLRKHDAQF----TVIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILIN 181
Query: 219 EKFQSKIGDFGLARFFPED--QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVL 276
                K+ DFGL+R   +D   AY +      + +T+PE     + +  +D++S+G+++ 
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 277 EIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFI 336
           E+              M Y     W++  +  +++ VD   R    ++  A  +  +   
Sbjct: 242 EV--------------MSYGERPYWEMSNQD-VIKAVDEGYRLPPPMDCPA-ALYQLMLD 285
Query: 337 CLQPHGNQRPPMSEIVAML--------TCKVESGIPVRPAYL 370
           C Q   N RP   +IV++L        + K+ +    RP+ L
Sbjct: 286 CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNL 327

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 88/342 (25%), Positives = 155/342 (45%), Gaps = 55/342 (16%)
Query: 61  FFNGNLRTI---SYFDFQTLKKATKNFHP------------GNLLGRGGFGPVYRGKLA- 104
           F NG+L+     ++ D  T +  T+  H               ++G G FG V  G+L  
Sbjct: 9   FGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKL 68
Query: 105 ---DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM 161
                  VA+K L V  +++   +FL E  ++    H N++RL G  +     ++V EYM
Sbjct: 69  PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128
Query: 162 KNRSLDLLIYGESDKFLNWSTRFQII---LGIARGLQYLHEDSHTRIVHRDIKASNVLLD 218
           +N SLD  +     +F    T  Q++    GIA G++YL +  +   VHRD+ A N+L++
Sbjct: 129 ENGSLDSFLRKHDAQF----TVIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILIN 181
Query: 219 EKFQSKIGDFGLARFFPED--QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVL 276
                K+ DFGLAR   +D   AY +      + +T+PE     + +  +D++S+G+++ 
Sbjct: 182 SNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 277 EIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFI 336
           E+              M Y     W++  +  +++ VD   R    ++  A  +  +   
Sbjct: 242 EV--------------MSYGERPYWEMSNQD-VIKAVDEGYRLPPPMDCPA-ALYQLMLD 285
Query: 337 CLQPHGNQRPPMSEIVAML--------TCKVESGIPVRPAYL 370
           C Q   N RP   +IV++L        + K+ +    RP+ L
Sbjct: 286 CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNL 327

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 66/192 (34%), Positives = 103/192 (53%), Gaps = 8/192 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG+G FG V+ G     T VA+K L           FL E +++  ++H+ LV+L    S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           +     +V EYM   SL   + GE  K+L       +   IA G+ Y+   ++   VHRD
Sbjct: 84  E-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRD 139
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADI 268
           ++A+N+L+ E    K+ DFGLAR   ED  Y +   A   + +TAPE A+ G  + K+D+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 269 YSFGVLVLEIIS 280
           +SFG+L+ E+ +
Sbjct: 199 WSFGILLTELTT 210

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 66/192 (34%), Positives = 103/192 (53%), Gaps = 8/192 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG+G FG V+ G     T VA+K L           FL E +++  ++H+ LV+L    S
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           +     +V EYM   SL   + GE  K+L       +   IA G+ Y+   ++   VHRD
Sbjct: 73  E-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRD 128
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADI 268
           ++A+N+L+ E    K+ DFGLAR   ED  Y +   A   + +TAPE A+ G  + K+D+
Sbjct: 129 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 187
Query: 269 YSFGVLVLEIIS 280
           +SFG+L+ E+ +
Sbjct: 188 WSFGILLTELTT 199

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 112/218 (51%), Gaps = 16/218 (7%)
Query: 75  QTLKKATKNFHPG-----NLLGRGGFGPVYRGKLADGT-----LVAVKKLCVDKSQQGES 124
           Q + K T   HP       ++G G FG VY+G L   +      VA+K L    +++   
Sbjct: 32  QAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV 91
Query: 125 EFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF 184
           +FL E  ++    H N++RL G  S     +++ EYM+N +LD  +  E D   +     
Sbjct: 92  DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLV 150
Query: 185 QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN 244
            ++ GIA G++YL   ++   VHRD+ A N+L++     K+ DFGL+R   +D     T 
Sbjct: 151 GMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 207
Query: 245 FAGTLG--YTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
             G +   +TAPE     + +  +D++SFG+++ E+++
Sbjct: 208 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 66/192 (34%), Positives = 104/192 (54%), Gaps = 8/192 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG+G FG V+ G     T VA+K L           FL E +++  ++H+ LV+L    S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           +     +V EYM   SL   + GE+ K+L       +   IA G+ Y+   ++   VHRD
Sbjct: 250 E-EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRD 305
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADI 268
           ++A+N+L+ E    K+ DFGLAR   ED  Y +   A   + +TAPE A+ G  + K+D+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 269 YSFGVLVLEIIS 280
           +SFG+L+ E+ +
Sbjct: 365 WSFGILLTELTT 376

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 88/342 (25%), Positives = 154/342 (45%), Gaps = 55/342 (16%)
Query: 61  FFNGNLRTI---SYFDFQTLKKATKNFHP------------GNLLGRGGFGPVYRGKLA- 104
           F NG+L+     +Y D  T +  T+  H               ++G G FG V  G+L  
Sbjct: 9   FGNGHLKLPGLRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKL 68
Query: 105 ---DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM 161
                  VA+K L V  +++   +FL E  ++    H N++RL G  +     ++V EYM
Sbjct: 69  PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128
Query: 162 KNRSLDLLIYGESDKFLNWSTRFQII---LGIARGLQYLHEDSHTRIVHRDIKASNVLLD 218
           +N SLD  +     +F    T  Q++    GIA G++YL +  +   VHRD+ A N+L++
Sbjct: 129 ENGSLDSFLRKHDAQF----TVIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILIN 181
Query: 219 EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YTAPEYAIRGELSEKADIYSFGVLVL 276
                K+ DFGL+R   +D     T   G +   +T+PE     + +  +D++S+G+++ 
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 277 EIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFI 336
           E+              M Y     W++  +  +++ VD   R    ++  A  +  +   
Sbjct: 242 EV--------------MSYGERPYWEMSNQD-VIKAVDEGYRLPPPMDCPA-ALYQLMLD 285
Query: 337 CLQPHGNQRPPMSEIVAML--------TCKVESGIPVRPAYL 370
           C Q   N RP   +IV++L        + K+ +    RP+ L
Sbjct: 286 CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNL 327

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 101/191 (52%), Gaps = 6/191 (3%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG+G FG V+ G     T VA+K L           FL E +++  ++H+ LV+L    S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           +     +V EYM   SL   + GE  K+L       +   IA G+ Y+   ++   VHRD
Sbjct: 84  E-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRD 139
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           ++A+N+L+ E    K+ DFGLAR   +++          + +TAPE A+ G  + K+D++
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 270 SFGVLVLEIIS 280
           SFG+L+ E+ +
Sbjct: 200 SFGILLTELTT 210

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 66/192 (34%), Positives = 103/192 (53%), Gaps = 8/192 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG+G FG V+ G     T VA+K L           FL E +++  ++H+ LV+L    S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           +     +V EYM   SL   + GE  K+L       +   IA G+ Y+   ++   VHRD
Sbjct: 84  E-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRD 139
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADI 268
           ++A+N+L+ E    K+ DFGLAR   ED  Y +   A   + +TAPE A+ G  + K+D+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 269 YSFGVLVLEIIS 280
           +SFG+L+ E+ +
Sbjct: 199 WSFGILLTELTT 210

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 66/192 (34%), Positives = 103/192 (53%), Gaps = 8/192 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG+G FG V+ G     T VA+K L           FL E +++  ++H+ LV+L    S
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           +     +V EYM   SL   + GE  K+L       +   IA G+ Y+   ++   VHRD
Sbjct: 75  E-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRD 130
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADI 268
           ++A+N+L+ E    K+ DFGLAR   ED  Y +   A   + +TAPE A+ G  + K+D+
Sbjct: 131 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 269 YSFGVLVLEIIS 280
           +SFG+L+ E+ +
Sbjct: 190 WSFGILLTELTT 201

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 88/342 (25%), Positives = 154/342 (45%), Gaps = 55/342 (16%)
Query: 61  FFNGNLRTI---SYFDFQTLKKATKNFHP------------GNLLGRGGFGPVYRGKLA- 104
           F NG+L+     +Y D  T +  T+  H               ++G G FG V  G+L  
Sbjct: 7   FGNGHLKLPGLRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKL 66
Query: 105 ---DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM 161
                  VA+K L V  +++   +FL E  ++    H N++RL G  +     ++V EYM
Sbjct: 67  PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 126
Query: 162 KNRSLDLLIYGESDKFLNWSTRFQII---LGIARGLQYLHEDSHTRIVHRDIKASNVLLD 218
           +N SLD  +     +F    T  Q++    GIA G++YL +  +   VHRD+ A N+L++
Sbjct: 127 ENGSLDSFLRKHDAQF----TVIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILIN 179
Query: 219 EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YTAPEYAIRGELSEKADIYSFGVLVL 276
                K+ DFGL+R   +D     T   G +   +T+PE     + +  +D++S+G+++ 
Sbjct: 180 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 239
Query: 277 EIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFI 336
           E+              M Y     W++  +  +++ VD   R    ++  A  +  +   
Sbjct: 240 EV--------------MSYGERPYWEMSNQD-VIKAVDEGYRLPPPMDCPA-ALYQLMLD 283
Query: 337 CLQPHGNQRPPMSEIVAML--------TCKVESGIPVRPAYL 370
           C Q   N RP   +IV++L        + K+ +    RP+ L
Sbjct: 284 CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNL 325

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 66/192 (34%), Positives = 103/192 (53%), Gaps = 8/192 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG+G FG V+ G     T VA+K L           FL E +++  ++H+ LV+L    S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           +     +V EYM   SL   + GE  K+L       +   IA G+ Y+   ++   VHRD
Sbjct: 84  E-EPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRD 139
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADI 268
           ++A+N+L+ E    K+ DFGLAR   ED  Y +   A   + +TAPE A+ G  + K+D+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 269 YSFGVLVLEIIS 280
           +SFG+L+ E+ +
Sbjct: 199 WSFGILLTELTT 210

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 115/205 (56%), Gaps = 22/205 (10%)
Query: 89  LLGRGGFGPVYRGKL-ADG---TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           ++G G FG V RG+L A G   + VA+K L    +++   EFLSE  ++   +H N++RL
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII---LGIARGLQYLHEDS 201
            G  ++    +++ E+M+N +LD  +     +F    T  Q++    GIA G++YL E S
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQF----TVIQLVGMLRGIASGMRYLAEMS 136
Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG------YTAPE 255
           +   VHRD+ A N+L++     K+ DFGL+RF  E+ +     +  +LG      +TAPE
Sbjct: 137 Y---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSS--DPTYTSSLGGKIPIRWTAPE 191
Query: 256 YAIRGELSEKADIYSFGVLVLEIIS 280
                + +  +D +S+G+++ E++S
Sbjct: 192 AIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 88/342 (25%), Positives = 154/342 (45%), Gaps = 55/342 (16%)
Query: 61  FFNGNLRTI---SYFDFQTLKKATKNFHP------------GNLLGRGGFGPVYRGKLA- 104
           F NG+L+     ++ D  T +  T+  H               ++G G FG V  G+L  
Sbjct: 9   FGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKL 68
Query: 105 ---DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM 161
                  VA+K L V  +++   +FL E  ++    H N++RL G  +     ++V EYM
Sbjct: 69  PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128
Query: 162 KNRSLDLLIYGESDKFLNWSTRFQII---LGIARGLQYLHEDSHTRIVHRDIKASNVLLD 218
           +N SLD  +     +F    T  Q++    GIA G++YL   S    VHRD+ A N+L++
Sbjct: 129 ENGSLDSFLRKHDAQF----TVIQLVGMLRGIASGMKYL---SDMGFVHRDLAARNILIN 181
Query: 219 EKFQSKIGDFGLARFFPED--QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVL 276
                K+ DFGL+R   +D   AY +      + +T+PE     + +  +D++S+G+++ 
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 277 EIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFI 336
           E+              M Y     W++  +  +++ VD   R    ++  A  +  +   
Sbjct: 242 EV--------------MSYGERPYWEMSNQD-VIKAVDEGYRLPPPMDCPA-ALYQLMLD 285
Query: 337 CLQPHGNQRPPMSEIVAML--------TCKVESGIPVRPAYL 370
           C Q   N RP   +IV++L        + K+ +    RP+ L
Sbjct: 286 CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNL 327

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 87/342 (25%), Positives = 155/342 (45%), Gaps = 55/342 (16%)
Query: 61  FFNGNLRTI---SYFDFQTLKKATKNFHP------------GNLLGRGGFGPVYRGKLA- 104
           F NG+L+     ++ D  T +  T+  H               ++G G FG V  G+L  
Sbjct: 9   FGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKL 68
Query: 105 ---DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM 161
                  VA+K L V  +++   +FL E  ++    H N++RL G  +     ++V EYM
Sbjct: 69  PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128
Query: 162 KNRSLDLLIYGESDKFLNWSTRFQII---LGIARGLQYLHEDSHTRIVHRDIKASNVLLD 218
           +N SLD  +     +F    T  Q++    GIA G++YL +  +   VHRD+ A N+L++
Sbjct: 129 ENGSLDSFLRKHDAQF----TVIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILIN 181
Query: 219 EKFQSKIGDFGLARFFPED--QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVL 276
                K+ DFGL+R   +D   AY +      + +T+PE     + +  +D++S+G+++ 
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 277 EIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFI 336
           E+              M Y     W++  +  +++ VD   R    ++  A  +  +   
Sbjct: 242 EV--------------MSYGERPYWEMSNQD-VIKAVDEGYRLPPPMDCPA-ALYQLMLD 285
Query: 337 CLQPHGNQRPPMSEIVAML--------TCKVESGIPVRPAYL 370
           C Q   N RP   +IV++L        + K+ +    RP+ L
Sbjct: 286 CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNL 327

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 66/192 (34%), Positives = 102/192 (53%), Gaps = 8/192 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG+G FG V+ G     T VA+K L           FL E +++  ++H+ LV+L    S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           +     +V EYM   SL   + GE  K+L       +   IA G+ Y+   ++   VHRD
Sbjct: 84  E-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRD 139
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADI 268
           + A+N+L+ E    K+ DFGLAR   ED  Y +   A   + +TAPE A+ G  + K+D+
Sbjct: 140 LAAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 269 YSFGVLVLEIIS 280
           +SFG+L+ E+ +
Sbjct: 199 WSFGILLTELTT 210

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 16/206 (7%)
Query: 84  FHPGNLLGRGGFGPVYRGKL----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHK 139
            H   ++G G  G V  G+L         VA+K L    +++   +FLSE  ++    H 
Sbjct: 51  IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHP 110
Query: 140 NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII---LGIARGLQY 196
           N++RL G  + G   ++V EYM+N SLD  +     +F    T  Q++    G+  G++Y
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQF----TIMQLVGMLRGVGAGMRY 166
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE--DQAYLSTNFAGTLGYTAP 254
           L +  +   VHRD+ A NVL+D     K+ DFGL+R   +  D AY +T     + +TAP
Sbjct: 167 LSDLGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223
Query: 255 EYAIRGELSEKADIYSFGVLVLEIIS 280
           E       S  +D++SFGV++ E+++
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 65/192 (33%), Positives = 102/192 (53%), Gaps = 8/192 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG+G FG V+ G     T VA+K L           FL E +++  ++H+ LV+L    S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           +     +V EYM    L   + GE  K+L       +   IA G+ Y+   ++   VHRD
Sbjct: 84  E-EPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRD 139
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADI 268
           ++A+N+L+ E    K+ DFGLAR   ED  Y +   A   + +TAPE A+ G  + K+D+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 269 YSFGVLVLEIIS 280
           +SFG+L+ E+ +
Sbjct: 199 WSFGILLTELTT 210

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 87/342 (25%), Positives = 153/342 (44%), Gaps = 55/342 (16%)
Query: 61  FFNGNLRTI---SYFDFQTLKKATKNFHP------------GNLLGRGGFGPVYRGKLA- 104
           F NG+L+     ++ D  T +  T+  H               ++G G FG V  G+L  
Sbjct: 9   FGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKL 68
Query: 105 ---DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM 161
                  VA+K L V  +++   +FL E  ++    H N++RL G  +     ++V EYM
Sbjct: 69  PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128
Query: 162 KNRSLDLLIYGESDKFLNWSTRFQII---LGIARGLQYLHEDSHTRIVHRDIKASNVLLD 218
           +N SLD  +     +F    T  Q++    GIA G++YL +  +   VHRD+ A N+L++
Sbjct: 129 ENGSLDSFLRKHDAQF----TVIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILIN 181
Query: 219 EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YTAPEYAIRGELSEKADIYSFGVLVL 276
                K+ DFGL R   +D     T   G +   +T+PE     + +  +D++S+G+++ 
Sbjct: 182 SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 277 EIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFI 336
           E+              M Y     W++  +  +++ VD   R    ++  A  +  +   
Sbjct: 242 EV--------------MSYGERPYWEMSNQD-VIKAVDEGYRLPPPMDCPA-ALYQLMLD 285
Query: 337 CLQPHGNQRPPMSEIVAML--------TCKVESGIPVRPAYL 370
           C Q   N RP   +IV++L        + K+ +    RP+ L
Sbjct: 286 CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNL 327

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 87/342 (25%), Positives = 155/342 (45%), Gaps = 55/342 (16%)
Query: 61  FFNGNLRTI---SYFDFQTLKKATKNFHP------------GNLLGRGGFGPVYRGKLA- 104
           F NG+L+     ++ D  T +  T+  H               ++G G FG V  G+L  
Sbjct: 9   FGNGHLKLPGLRTFVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKL 68
Query: 105 ---DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM 161
                  VA+K L V  +++   +FL E  ++    H N++RL G  +     ++V EYM
Sbjct: 69  PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128
Query: 162 KNRSLDLLIYGESDKFLNWSTRFQII---LGIARGLQYLHEDSHTRIVHRDIKASNVLLD 218
           +N SLD  +     +F    T  Q++    GIA G++YL +  +   VHRD+ A N+L++
Sbjct: 129 ENGSLDSFLRKHDAQF----TVIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILIN 181
Query: 219 EKFQSKIGDFGLARFFPED--QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVL 276
                K+ DFGL+R   +D   AY +      + +T+PE     + +  +D++S+G+++ 
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 277 EIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFI 336
           E+              M Y     W++  +  +++ VD   R    ++  A  +  +   
Sbjct: 242 EV--------------MSYGERPYWEMSNQD-VIKAVDEGYRLPPPMDCPA-ALYQLMLD 285
Query: 337 CLQPHGNQRPPMSEIVAML--------TCKVESGIPVRPAYL 370
           C Q   N RP   +IV++L        + K+ +    RP+ L
Sbjct: 286 CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNL 327

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 83/318 (26%), Positives = 147/318 (46%), Gaps = 45/318 (14%)
Query: 75  QTLKKATKNFHPGNL-----LGRGGFGPVYRGKLA----DGTLVAVKKLCVDKSQQGESE 125
           QT+ +  K     N+     +G G FG V  G+L         VA+K L V  +++   +
Sbjct: 4   QTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 63
Query: 126 FLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ 185
           FL E  ++    H N++RL G  +     ++V EYM+N SLD  +     +F    T  Q
Sbjct: 64  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF----TVIQ 119
Query: 186 II---LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED--QAY 240
           ++    GIA G++YL +  +   VHRD+ A N+L++     K+ DFGL+R   +D   AY
Sbjct: 120 LVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 176
Query: 241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYA 300
            +      + +T+PE     + +  +D++S+G+++ E+              M Y     
Sbjct: 177 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV--------------MSYGERPY 222
Query: 301 WKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML----- 355
           W++  +  +++ VD   R    ++  A  +  +   C Q   N RP   +IV++L     
Sbjct: 223 WEMSNQD-VIKAVDEGYRLPPPMDCPA-ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 280
Query: 356 ---TCKVESGIPVRPAYL 370
              + K+ +    RP+ L
Sbjct: 281 NPGSLKIITSAAARPSNL 298

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 65/192 (33%), Positives = 102/192 (53%), Gaps = 8/192 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG+G FG V+ G     T VA+K L           FL E +++  ++H+ LV+L    S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           +     +V EYM    L   + GE  K+L       +   IA G+ Y+   ++   VHRD
Sbjct: 84  E-EPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRD 139
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADI 268
           ++A+N+L+ E    K+ DFGLAR   ED  Y +   A   + +TAPE A+ G  + K+D+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 269 YSFGVLVLEIIS 280
           +SFG+L+ E+ +
Sbjct: 199 WSFGILLTELTT 210

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/318 (26%), Positives = 147/318 (46%), Gaps = 45/318 (14%)
Query: 75  QTLKKATKNFHPGNL-----LGRGGFGPVYRGKLA----DGTLVAVKKLCVDKSQQGESE 125
           QT+ +  K     N+     +G G FG V  G+L         VA+K L V  +++   +
Sbjct: 21  QTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 80
Query: 126 FLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ 185
           FL E  ++    H N++RL G  +     ++V EYM+N SLD  +     +F    T  Q
Sbjct: 81  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF----TVIQ 136
Query: 186 II---LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED--QAY 240
           ++    GIA G++YL +  +   VHRD+ A N+L++     K+ DFGL+R   +D   AY
Sbjct: 137 LVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 193
Query: 241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYA 300
            +      + +T+PE     + +  +D++S+G+++ E+              M Y     
Sbjct: 194 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV--------------MSYGERPY 239
Query: 301 WKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML----- 355
           W++  +  +++ VD   R    ++  A  +  +   C Q   N RP   +IV++L     
Sbjct: 240 WEMSNQD-VIKAVDEGYRLPPPMDCPA-ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 297
Query: 356 ---TCKVESGIPVRPAYL 370
              + K+ +    RP+ L
Sbjct: 298 NPGSLKIITSAAARPSNL 315

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 65/192 (33%), Positives = 102/192 (53%), Gaps = 8/192 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG+G FG V+ G     T VA+K L           FL E +++  ++H+ LV+L    S
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTL--KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           +     +V EYM   SL   + GE  K+L       +   IA G+ Y+   ++   VHRD
Sbjct: 251 E-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRD 306
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADI 268
           ++A+N+L+ E    K+ DFGL R   ED  Y +   A   + +TAPE A+ G  + K+D+
Sbjct: 307 LRAANILVGENLVCKVADFGLGRLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 365
Query: 269 YSFGVLVLEIIS 280
           +SFG+L+ E+ +
Sbjct: 366 WSFGILLTELTT 377

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 116/203 (57%), Gaps = 18/203 (8%)
Query: 89  LLGRGGFGPVYRGKL-ADG---TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           ++G G FG V RG+L A G   + VA+K L    +++   EFLSE  ++   +H N++RL
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII---LGIARGLQYLHEDS 201
            G  ++    +++ E+M+N +LD  +     +F    T  Q++    GIA G++YL E S
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQF----TVIQLVGMLRGIASGMRYLAEMS 138
Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA--YLSTNFAGTLG--YTAPEYA 257
           +   VHRD+ A N+L++     K+ DFGL+RF  E+ +    +++  G +   +TAPE  
Sbjct: 139 Y---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI 195
Query: 258 IRGELSEKADIYSFGVLVLEIIS 280
              + +  +D +S+G+++ E++S
Sbjct: 196 AFRKFTSASDAWSYGIVMWEVMS 218

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/192 (33%), Positives = 102/192 (53%), Gaps = 8/192 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+ G     T VAVK L   +       FL+E  ++  +QH+ LVRL    +
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 88
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 ++ EYM+N SL   +   S   L  +    +   IA G+ ++ E ++   +HRD
Sbjct: 89  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRD 144
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADI 268
           ++A+N+L+ +    KI DFGLAR   ED  Y +   A   + +TAPE    G  + K+D+
Sbjct: 145 LRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 203
Query: 269 YSFGVLVLEIIS 280
           +SFG+L+ EI++
Sbjct: 204 WSFGILLTEIVT 215

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 100/191 (52%), Gaps = 6/191 (3%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+ G     T VAVK L   +       FL+E  ++  +QH+ LVRL    +
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 87
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 ++ EYM+N SL   +   S   L  +    +   IA G+ ++ E ++   +HRD
Sbjct: 88  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRD 143
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           ++A+N+L+ +    KI DFGLAR   +++          + +TAPE    G  + K+D++
Sbjct: 144 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 203
Query: 270 SFGVLVLEIIS 280
           SFG+L+ EI++
Sbjct: 204 SFGILLTEIVT 214

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/192 (33%), Positives = 102/192 (53%), Gaps = 8/192 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+ G     T VAVK L   +       FL+E  ++  +QH+ LVRL    +
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 ++ EYM+N SL   +   S   L  +    +   IA G+ ++ E ++   +HRD
Sbjct: 85  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRD 140
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADI 268
           ++A+N+L+ +    KI DFGLAR   ED  Y +   A   + +TAPE    G  + K+D+
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 199
Query: 269 YSFGVLVLEIIS 280
           +SFG+L+ EI++
Sbjct: 200 WSFGILLTEIVT 211

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 100/191 (52%), Gaps = 6/191 (3%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+ G     T VAVK L   +       FL+E  ++  +QH+ LVRL    +
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 86
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 ++ EYM+N SL   +   S   L  +    +   IA G+ ++ E ++   +HRD
Sbjct: 87  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRD 142
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           ++A+N+L+ +    KI DFGLAR   +++          + +TAPE    G  + K+D++
Sbjct: 143 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 202
Query: 270 SFGVLVLEIIS 280
           SFG+L+ EI++
Sbjct: 203 SFGILLTEIVT 213

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/192 (33%), Positives = 102/192 (53%), Gaps = 8/192 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+ G     T VAVK L   +       FL+E  ++  +QH+ LVRL    +
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 83
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 ++ EYM+N SL   +   S   L  +    +   IA G+ ++ E ++   +HRD
Sbjct: 84  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRD 139
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADI 268
           ++A+N+L+ +    KI DFGLAR   ED  Y +   A   + +TAPE    G  + K+D+
Sbjct: 140 LRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 198
Query: 269 YSFGVLVLEIIS 280
           +SFG+L+ EI++
Sbjct: 199 WSFGILLTEIVT 210

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 100/191 (52%), Gaps = 6/191 (3%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+ G     T VAVK L   +       FL+E  ++  +QH+ LVRL    +
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 ++ EYM+N SL   +   S   L  +    +   IA G+ ++ E ++   +HRD
Sbjct: 85  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRD 140
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           ++A+N+L+ +    KI DFGLAR   +++          + +TAPE    G  + K+D++
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 200
Query: 270 SFGVLVLEIIS 280
           SFG+L+ EI++
Sbjct: 201 SFGILLTEIVT 211

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 100/191 (52%), Gaps = 6/191 (3%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+ G     T VAVK L   +       FL+E  ++  +QH+ LVRL    +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 ++ EYM+N SL   +   S   L  +    +   IA G+ ++ E ++   +HRD
Sbjct: 79  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRD 134
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           ++A+N+L+ +    KI DFGLAR   +++          + +TAPE    G  + K+D++
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 270 SFGVLVLEIIS 280
           SFG+L+ EI++
Sbjct: 195 SFGILLTEIVT 205

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 100/191 (52%), Gaps = 6/191 (3%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+ G     T VAVK L   +       FL+E  ++  +QH+ LVRL    +
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 80
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 ++ EYM+N SL   +   S   L  +    +   IA G+ ++ E ++   +HRD
Sbjct: 81  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRD 136
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           ++A+N+L+ +    KI DFGLAR   +++          + +TAPE    G  + K+D++
Sbjct: 137 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 196
Query: 270 SFGVLVLEIIS 280
           SFG+L+ EI++
Sbjct: 197 SFGILLTEIVT 207

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 100/191 (52%), Gaps = 6/191 (3%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+ G     T VAVK L   +       FL+E  ++  +QH+ LVRL    +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 ++ EYM+N SL   +   S   L  +    +   IA G+ ++ E ++   +HRD
Sbjct: 79  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRD 134
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           ++A+N+L+ +    KI DFGLAR   +++          + +TAPE    G  + K+D++
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 270 SFGVLVLEIIS 280
           SFG+L+ EI++
Sbjct: 195 SFGILLTEIVT 205

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 100/191 (52%), Gaps = 6/191 (3%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+ G     T VAVK L   +       FL+E  ++  +QH+ LVRL    +
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 79
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 ++ EYM+N SL   +   S   L  +    +   IA G+ ++ E ++   +HRD
Sbjct: 80  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRD 135
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           ++A+N+L+ +    KI DFGLAR   +++          + +TAPE    G  + K+D++
Sbjct: 136 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 195
Query: 270 SFGVLVLEIIS 280
           SFG+L+ EI++
Sbjct: 196 SFGILLTEIVT 206

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 16/206 (7%)
Query: 84  FHPGNLLGRGGFGPVYRGKL----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHK 139
            H   ++G G  G V  G+L         VA+K L    +++   +FLSE  ++    H 
Sbjct: 51  IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHP 110
Query: 140 NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII---LGIARGLQY 196
           N++RL G  + G   ++V EYM+N SLD  +     +F    T  Q++    G+  G++Y
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQF----TIMQLVGMLRGVGAGMRY 166
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YTAP 254
           L +  +   VHRD+ A NVL+D     K+ DFGL+R   +D     T   G +   +TAP
Sbjct: 167 LSDLGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAP 223
Query: 255 EYAIRGELSEKADIYSFGVLVLEIIS 280
           E       S  +D++SFGV++ E+++
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 87/342 (25%), Positives = 153/342 (44%), Gaps = 55/342 (16%)
Query: 61  FFNGNLRTI---SYFDFQTLKKATKNFHP------------GNLLGRGGFGPVYRGKLA- 104
           F NG+L+     +Y D  T +  T+  H               ++G G FG V  G+L  
Sbjct: 9   FGNGHLKLPGLRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKL 68
Query: 105 ---DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM 161
                  VA+K L V  +++   +FL E  ++    H N++RL G  +     ++V E M
Sbjct: 69  PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXM 128
Query: 162 KNRSLDLLIYGESDKFLNWSTRFQII---LGIARGLQYLHEDSHTRIVHRDIKASNVLLD 218
           +N SLD  +     +F    T  Q++    GIA G++YL +  +   VHRD+ A N+L++
Sbjct: 129 ENGSLDSFLRKHDAQF----TVIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILIN 181
Query: 219 EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YTAPEYAIRGELSEKADIYSFGVLVL 276
                K+ DFGL+R   +D     T   G +   +T+PE     + +  +D++S+G+++ 
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 277 EIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFI 336
           E+              M Y     W++  +  +++ VD   R    ++  A  +  +   
Sbjct: 242 EV--------------MSYGERPYWEMSNQD-VIKAVDEGYRLPPPMDCPA-ALYQLMLD 285
Query: 337 CLQPHGNQRPPMSEIVAML--------TCKVESGIPVRPAYL 370
           C Q   N RP   +IV++L        + K+ +    RP+ L
Sbjct: 286 CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNL 327

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/192 (33%), Positives = 102/192 (53%), Gaps = 8/192 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+ G     T VAVK L   +       FL+E  ++  +QH+ LVRL    +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 ++ EYM+N SL   +   S   L  +    +   IA G+ ++ E ++   +HRD
Sbjct: 79  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRD 134
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADI 268
           ++A+N+L+ +    KI DFGLAR   ED  Y +   A   + +TAPE    G  + K+D+
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 269 YSFGVLVLEIIS 280
           +SFG+L+ EI++
Sbjct: 194 WSFGILLTEIVT 205

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 65/192 (33%), Positives = 102/192 (53%), Gaps = 8/192 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+ G     T VAVK L   +       FL+E  ++  +QH+ LVRL    +
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 73
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 ++ EYM+N SL   +   S   L  +    +   IA G+ ++ E ++   +HRD
Sbjct: 74  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRD 129
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADI 268
           ++A+N+L+ +    KI DFGLAR   ED  Y +   A   + +TAPE    G  + K+D+
Sbjct: 130 LRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 188
Query: 269 YSFGVLVLEIIS 280
           +SFG+L+ EI++
Sbjct: 189 WSFGILLTEIVT 200

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 87/342 (25%), Positives = 152/342 (44%), Gaps = 55/342 (16%)
Query: 61  FFNGNLRTI---SYFDFQTLKKATKNFHP------------GNLLGRGGFGPVYRGKLA- 104
           F NG+L+     ++ D  T +  T+  H               ++G G FG V  G+L  
Sbjct: 9   FGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKL 68
Query: 105 ---DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM 161
                  VA+K L V  +++   +FL E  ++    H N++RL G  +     ++V E M
Sbjct: 69  PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXM 128
Query: 162 KNRSLDLLIYGESDKFLNWSTRFQII---LGIARGLQYLHEDSHTRIVHRDIKASNVLLD 218
           +N SLD  +     +F    T  Q++    GIA G++YL   S    VHRD+ A N+L++
Sbjct: 129 ENGSLDSFLRKHDAQF----TVIQLVGMLRGIASGMKYL---SDMGAVHRDLAARNILIN 181
Query: 219 EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YTAPEYAIRGELSEKADIYSFGVLVL 276
                K+ DFGL+R   +D     T   G +   +T+PE     + +  +D++S+G+++ 
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241
Query: 277 EIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFI 336
           E+              M Y     W++  +  +++ VD   R    ++  A  +  +   
Sbjct: 242 EV--------------MSYGERPYWEMSNQD-VIKAVDEGYRLPPPMDCPA-ALYQLMLD 285
Query: 337 CLQPHGNQRPPMSEIVAML--------TCKVESGIPVRPAYL 370
           C Q   N RP   +IV++L        + K+ +    RP+ L
Sbjct: 286 CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNL 327

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 24/206 (11%)
Query: 89  LLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQ---QGESEFLSEVRMITSIQHKNLVRLL 145
           ++G GGFG VYR     G  VAVK    D  +   Q       E ++   ++H N++ L 
Sbjct: 14  IIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGE---SDKFLNWSTRFQIILGIARGLQYLHEDSH 202
           G C       LV E+ +   L+ ++ G+    D  +NW+ +      IARG+ YLH+++ 
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ------IARGMNYLHDEAI 126
Query: 203 TRIVHRDIKASNVLLDEKFQS--------KIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
             I+HRD+K+SN+L+ +K ++        KI DFGLAR   E       + AG   + AP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAAGAYAWMAP 183
Query: 255 EYAIRGELSEKADIYSFGVLVLEIIS 280
           E       S+ +D++S+GVL+ E+++
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLT 209

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 90/285 (31%), Positives = 135/285 (47%), Gaps = 38/285 (13%)
Query: 85  HPGNLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           H   ++GRG FG VY G L D        AVK L         S+FL+E  ++    H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 141 LVRLLGCC--SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--IARGLQY 196
           ++ LLG C  S+GS  L+V  YMK+  L   I  E+    N + +  I  G  +A+G++Y
Sbjct: 88  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKY 143
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT---LGYTA 253
           L   +  + VHRD+ A N +LDEKF  K+ DFGLAR   + + Y   N  G    + + A
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIIS--CRKNTDLTLPSEMQYLPEYAWKLYERGRILE 311
            E     + + K+D++SFGVL+ E+++       D+       YL +        GR   
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GR--R 250
Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
           L+ P    + + E        V   C  P    RP  SE+V+ ++
Sbjct: 251 LLQPEYCPDPLYE--------VMLKCWHPKAEMRPSFSELVSRIS 287

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 90/285 (31%), Positives = 135/285 (47%), Gaps = 38/285 (13%)
Query: 85  HPGNLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           H   ++GRG FG VY G L D        AVK L         S+FL+E  ++    H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 141 LVRLLGCC--SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--IARGLQY 196
           ++ LLG C  S+GS  L+V  YMK+  L   I  E+    N + +  I  G  +A+G++Y
Sbjct: 92  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKY 147
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT---LGYTA 253
           L   +  + VHRD+ A N +LDEKF  K+ DFGLAR   + + Y   N  G    + + A
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 204
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIIS--CRKNTDLTLPSEMQYLPEYAWKLYERGRILE 311
            E     + + K+D++SFGVL+ E+++       D+       YL +        GR   
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GR--R 254
Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
           L+ P    + + E        V   C  P    RP  SE+V+ ++
Sbjct: 255 LLQPEYCPDPLYE--------VMLKCWHPKAEMRPSFSELVSRIS 291

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 90/285 (31%), Positives = 135/285 (47%), Gaps = 38/285 (13%)
Query: 85  HPGNLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           H   ++GRG FG VY G L D        AVK L         S+FL+E  ++    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 141 LVRLLGCC--SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--IARGLQY 196
           ++ LLG C  S+GS  L+V  YMK+  L   I  E+    N + +  I  G  +A+G++Y
Sbjct: 93  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKY 148
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT---LGYTA 253
           L   +  + VHRD+ A N +LDEKF  K+ DFGLAR   + + Y   N  G    + + A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIIS--CRKNTDLTLPSEMQYLPEYAWKLYERGRILE 311
            E     + + K+D++SFGVL+ E+++       D+       YL +        GR   
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GR--R 255
Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
           L+ P    + + E        V   C  P    RP  SE+V+ ++
Sbjct: 256 LLQPEYCPDPLYE--------VMLKCWHPKAEMRPSFSELVSRIS 292

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 90/285 (31%), Positives = 135/285 (47%), Gaps = 38/285 (13%)
Query: 85  HPGNLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           H   ++GRG FG VY G L D        AVK L         S+FL+E  ++    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 141 LVRLLGCC--SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--IARGLQY 196
           ++ LLG C  S+GS  L+V  YMK+  L   I  E+    N + +  I  G  +A+G++Y
Sbjct: 93  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKY 148
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT---LGYTA 253
           L   +  + VHRD+ A N +LDEKF  K+ DFGLAR   + + Y   N  G    + + A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIIS--CRKNTDLTLPSEMQYLPEYAWKLYERGRILE 311
            E     + + K+D++SFGVL+ E+++       D+       YL +        GR   
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GR--R 255
Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
           L+ P    + + E        V   C  P    RP  SE+V+ ++
Sbjct: 256 LLQPEYCPDPLYE--------VMLKCWHPKAEMRPSFSELVSRIS 292

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 90/285 (31%), Positives = 135/285 (47%), Gaps = 38/285 (13%)
Query: 85  HPGNLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           H   ++GRG FG VY G L D        AVK L         S+FL+E  ++    H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 141 LVRLLGCC--SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--IARGLQY 196
           ++ LLG C  S+GS  L+V  YMK+  L   I  E+    N + +  I  G  +A+G++Y
Sbjct: 91  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKY 146
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT---LGYTA 253
           L   +  + VHRD+ A N +LDEKF  K+ DFGLAR   + + Y   N  G    + + A
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 203
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIIS--CRKNTDLTLPSEMQYLPEYAWKLYERGRILE 311
            E     + + K+D++SFGVL+ E+++       D+       YL +        GR   
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GR--R 253
Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
           L+ P    + + E        V   C  P    RP  SE+V+ ++
Sbjct: 254 LLQPEYCPDPLYE--------VMLKCWHPKAEMRPSFSELVSRIS 290

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 90/285 (31%), Positives = 135/285 (47%), Gaps = 38/285 (13%)
Query: 85  HPGNLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           H   ++GRG FG VY G L D        AVK L         S+FL+E  ++    H N
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 141 LVRLLGCC--SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--IARGLQY 196
           ++ LLG C  S+GS  L+V  YMK+  L   I  E+    N + +  I  G  +A+G++Y
Sbjct: 112 VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKY 167
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT---LGYTA 253
           L   +  + VHRD+ A N +LDEKF  K+ DFGLAR   + + Y   N  G    + + A
Sbjct: 168 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 224
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIIS--CRKNTDLTLPSEMQYLPEYAWKLYERGRILE 311
            E     + + K+D++SFGVL+ E+++       D+       YL +        GR   
Sbjct: 225 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GR--R 274
Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
           L+ P    + + E        V   C  P    RP  SE+V+ ++
Sbjct: 275 LLQPEYCPDPLYE--------VMLKCWHPKAEMRPSFSELVSRIS 311

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 90/285 (31%), Positives = 135/285 (47%), Gaps = 38/285 (13%)
Query: 85  HPGNLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           H   ++GRG FG VY G L D        AVK L         S+FL+E  ++    H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 141 LVRLLGCC--SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--IARGLQY 196
           ++ LLG C  S+GS  L+V  YMK+  L   I  E+    N + +  I  G  +A+G++Y
Sbjct: 90  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKY 145
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT---LGYTA 253
           L   +  + VHRD+ A N +LDEKF  K+ DFGLAR   + + Y   N  G    + + A
Sbjct: 146 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 202
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIIS--CRKNTDLTLPSEMQYLPEYAWKLYERGRILE 311
            E     + + K+D++SFGVL+ E+++       D+       YL +        GR   
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GR--R 252
Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
           L+ P    + + E        V   C  P    RP  SE+V+ ++
Sbjct: 253 LLQPEYCPDPLYE--------VMLKCWHPKAEMRPSFSELVSRIS 289

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 90/285 (31%), Positives = 135/285 (47%), Gaps = 38/285 (13%)
Query: 85  HPGNLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           H   ++GRG FG VY G L D        AVK L         S+FL+E  ++    H N
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 141 LVRLLGCC--SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--IARGLQY 196
           ++ LLG C  S+GS  L+V  YMK+  L   I  E+    N + +  I  G  +A+G++Y
Sbjct: 85  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKY 140
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT---LGYTA 253
           L   +  + VHRD+ A N +LDEKF  K+ DFGLAR   + + Y   N  G    + + A
Sbjct: 141 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 197
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIIS--CRKNTDLTLPSEMQYLPEYAWKLYERGRILE 311
            E     + + K+D++SFGVL+ E+++       D+       YL +        GR   
Sbjct: 198 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GR--R 247
Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
           L+ P    + + E        V   C  P    RP  SE+V+ ++
Sbjct: 248 LLQPEYCPDPLYE--------VMLKCWHPKAEMRPSFSELVSRIS 284

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 90/285 (31%), Positives = 135/285 (47%), Gaps = 38/285 (13%)
Query: 85  HPGNLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           H   ++GRG FG VY G L D        AVK L         S+FL+E  ++    H N
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 141 LVRLLGCC--SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--IARGLQY 196
           ++ LLG C  S+GS  L+V  YMK+  L   I  E+    N + +  I  G  +A+G++Y
Sbjct: 111 VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKY 166
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT---LGYTA 253
           L   +  + VHRD+ A N +LDEKF  K+ DFGLAR   + + Y   N  G    + + A
Sbjct: 167 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 223
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIIS--CRKNTDLTLPSEMQYLPEYAWKLYERGRILE 311
            E     + + K+D++SFGVL+ E+++       D+       YL +        GR   
Sbjct: 224 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GR--R 273
Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
           L+ P    + + E        V   C  P    RP  SE+V+ ++
Sbjct: 274 LLQPEYCPDPLYE--------VMLKCWHPKAEMRPSFSELVSRIS 310

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 131/276 (47%), Gaps = 32/276 (11%)
Query: 89  LLGRGGFGPVYRGKLA----DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           ++G G FG V  G+L         VA+K L V  +++   +FL E  ++    H N++ L
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII---LGIARGLQYLHEDS 201
            G  +     ++V EYM+N SLD  +     +F    T  Q++    GI+ G++YL +  
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQF----TVIQLVGMLRGISAGMKYLSDMG 144
Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YTAPEYAIR 259
           +   VHRD+ A N+L++     K+ DFGL+R   +D     T   G +   +TAPE    
Sbjct: 145 Y---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAF 201
Query: 260 GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK 319
            + +  +D++S+G+++ E++S              Y     W++  +  +++ V+   R 
Sbjct: 202 RKFTSASDVWSYGIVMWEVVS--------------YGERPYWEMTNQD-VIKAVEEGYRL 246
Query: 320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
              ++  A  +  +   C Q   N RP   EIV ML
Sbjct: 247 PSPMDCPA-ALYQLMLDCWQKERNSRPKFDEIVNML 281

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 82/318 (25%), Positives = 146/318 (45%), Gaps = 45/318 (14%)
Query: 75  QTLKKATKNFHPGNL-----LGRGGFGPVYRGKLA----DGTLVAVKKLCVDKSQQGESE 125
           QT+ +  K     N+     +G G FG V  G+L         VA+K L V  +++   +
Sbjct: 4   QTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 63
Query: 126 FLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ 185
           FL E  ++    H N++RL G  +     ++V E M+N SLD  +     +F    T  Q
Sbjct: 64  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQF----TVIQ 119
Query: 186 II---LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED--QAY 240
           ++    GIA G++YL +  +   VHRD+ A N+L++     K+ DFGL+R   +D   AY
Sbjct: 120 LVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 176
Query: 241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYA 300
            +      + +T+PE     + +  +D++S+G+++ E+              M Y     
Sbjct: 177 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV--------------MSYGERPY 222
Query: 301 WKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML----- 355
           W++  +  +++ VD   R    ++  A  +  +   C Q   N RP   +IV++L     
Sbjct: 223 WEMSNQD-VIKAVDEGYRLPPPMDCPA-ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 280
Query: 356 ---TCKVESGIPVRPAYL 370
              + K+ +    RP+ L
Sbjct: 281 NPGSLKIITSAAARPSNL 298

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/192 (33%), Positives = 102/192 (53%), Gaps = 8/192 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+ G     T VAVK L   +       FL+E  ++  +QH+ LVRL    +
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 ++ EYM+N SL   +   S   L  +    +   IA G+ ++ E ++   +HR+
Sbjct: 75  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRN 130
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADI 268
           ++A+N+L+ +    KI DFGLAR   ED  Y +   A   + +TAPE    G  + K+D+
Sbjct: 131 LRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 189
Query: 269 YSFGVLVLEIIS 280
           +SFG+L+ EI++
Sbjct: 190 WSFGILLTEIVT 201

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 100/196 (51%), Gaps = 6/196 (3%)
Query: 87  GNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           G  +GRG FG V+ G+L AD TLVAVK          +++FL E R++    H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G C+      +V E ++       +  E  + L   T  Q++   A G++YL        
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT-LGYTAPEYAIRGELSE 264
           +HRD+ A N L+ EK   KI DFG++R   +     S       + +TAPE    G  S 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 265 KADIYSFGVLVLEIIS 280
           ++D++SFG+L+ E  S
Sbjct: 295 ESDVWSFGILLWETFS 310

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/196 (35%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+ G   + T VAVK L           FL E  ++ ++QH  LVRL    +
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTL--KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 150 DGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
                 ++ EYM   SL D L   E  K L           IA G+ Y+   ++   +HR
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNY---IHR 134
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKAD 267
           D++A+NVL+ E    KI DFGLAR   ED  Y +   A   + +TAPE    G  + K+D
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSD 193
Query: 268 IYSFGVLVLEIISCRK 283
           ++SFG+L+ EI++  K
Sbjct: 194 VWSFGILLYEIVTYGK 209

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/197 (34%), Positives = 102/197 (51%), Gaps = 8/197 (4%)
Query: 87  GNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           G  +GRG FG V+ G+L AD TLVAVK          +++FL E R++    H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G C+      +V E ++       +  E  + L   T  Q++   A G++YL        
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF--AGTLGYTAPEYAIRGELS 263
           +HRD+ A N L+ EK   KI DFG++R    D  Y ++       + +TAPE    G  S
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 264 EKADIYSFGVLVLEIIS 280
            ++D++SFG+L+ E  S
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 16/201 (7%)
Query: 89  LLGRGGFGPVYRGKLA----DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           ++G G FG V  G+L         VA+K L V  +++   +FL E  ++    H N+V L
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII---LGIARGLQYLHEDS 201
            G  + G   ++V E+M+N +LD  +     +F    T  Q++    GIA G++YL +  
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFLRKHDGQF----TVIQLVGMLRGIAAGMRYLADMG 165
Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YTAPEYAIR 259
           +   VHRD+ A N+L++     K+ DFGL+R   +D   + T   G +   +TAPE    
Sbjct: 166 Y---VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQY 222
Query: 260 GELSEKADIYSFGVLVLEIIS 280
            + +  +D++S+G+++ E++S
Sbjct: 223 RKFTSASDVWSYGIVMWEVMS 243

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 126/274 (45%), Gaps = 22/274 (8%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           +G G FG V+ G   +   VA+K   + +    E +F+ E  ++  + H  LV+L G C 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKT--IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           + +   LV+E+M++  L   +  +   F    T   + L +  G+ YL E S   ++HRD
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEAS---VIHRD 128
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           + A N L+ E    K+ DFG+ RF  +DQ   ST     + + +PE       S K+D++
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 188
Query: 270 SFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQ 329
           SFGVL+ E+ S  K     +P E +   E    +    R   L  PR+    +      Q
Sbjct: 189 SFGVLMWEVFSEGK-----IPYENRSNSEVVEDISTGFR---LYKPRLASTHV-----YQ 235
Query: 330 VINVAFICLQPHGNQRPPMSEIVAMLTCKVESGI 363
           ++N    C +     RP  S ++  L     SG+
Sbjct: 236 IMN---HCWKERPEDRPAFSRLLRQLAAIAASGL 266

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 89/285 (31%), Positives = 134/285 (47%), Gaps = 38/285 (13%)
Query: 85  HPGNLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           H   ++GRG FG VY G L D        AVK L         S+FL+E  ++    H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 141 LVRLLGCC--SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--IARGLQY 196
           ++ LLG C  S+GS  L+V  YMK+  L   I  E+    N + +  I  G  +A+G++Y
Sbjct: 92  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKY 147
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT---LGYTA 253
           L   +  + VHRD+ A N +LDEKF  K+ DFGLAR   + +     N  G    + + A
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIIS--CRKNTDLTLPSEMQYLPEYAWKLYERGRILE 311
            E     + + K+D++SFGVL+ E+++       D+       YL +        GR   
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GR--R 254
Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
           L+ P    + + E        V   C  P    RP  SE+V+ ++
Sbjct: 255 LLQPEYCPDPLYE--------VMLKCWHPKAEMRPSFSELVSRIS 291

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 126/274 (45%), Gaps = 22/274 (8%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           +G G FG V+ G   +   VA+K   + +    E +F+ E  ++  + H  LV+L G C 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKT--IKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           + +   LV+E+M++  L   +  +   F    T   + L +  G+ YL E     ++HRD
Sbjct: 93  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEAC---VIHRD 148
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           + A N L+ E    K+ DFG+ RF  +DQ   ST     + + +PE       S K+D++
Sbjct: 149 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 208
Query: 270 SFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQ 329
           SFGVL+ E+ S  K     +P E +   E    +    R   L  PR+    +      Q
Sbjct: 209 SFGVLMWEVFSEGK-----IPYENRSNSEVVEDISTGFR---LYKPRLASTHV-----YQ 255
Query: 330 VINVAFICLQPHGNQRPPMSEIVAMLTCKVESGI 363
           ++N    C +     RP  S ++  L    ESG+
Sbjct: 256 IMN---HCWKERPEDRPAFSRLLRQLAEIAESGL 286

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 126/274 (45%), Gaps = 22/274 (8%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           +G G FG V+ G   +   VA+K   + +    E +F+ E  ++  + H  LV+L G C 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKT--IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           + +   LV+E+M++  L   +  +   F    T   + L +  G+ YL E     ++HRD
Sbjct: 71  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEAC---VIHRD 126
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           + A N L+ E    K+ DFG+ RF  +DQ   ST     + + +PE       S K+D++
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186
Query: 270 SFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQ 329
           SFGVL+ E+ S  K     +P E +   E    +    R   L  PR+    +      Q
Sbjct: 187 SFGVLMWEVFSEGK-----IPYENRSNSEVVEDISTGFR---LYKPRLASTHV-----YQ 233
Query: 330 VINVAFICLQPHGNQRPPMSEIVAMLTCKVESGI 363
           ++N    C +     RP  S ++  L    ESG+
Sbjct: 234 IMN---HCWKERPEDRPAFSRLLRQLAEIAESGL 264

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 98/191 (51%), Gaps = 6/191 (3%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G  G V+ G     T VAVK L   +       FL+E  ++  +QH+ LVRL    +
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 ++ EYM+N SL   +   S   L  +    +   IA G+ ++ E ++   +HRD
Sbjct: 79  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRD 134
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           ++A+N+L+ +    KI DFGLAR   + +          + +TAPE    G  + K+D++
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 270 SFGVLVLEIIS 280
           SFG+L+ EI++
Sbjct: 195 SFGILLTEIVT 205

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 126/274 (45%), Gaps = 22/274 (8%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           +G G FG V+ G   +   VA+K   + +    E +F+ E  ++  + H  LV+L G C 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKT--IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           + +   LV+E+M++  L   +  +   F    T   + L +  G+ YL E     ++HRD
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEAC---VIHRD 128
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           + A N L+ E    K+ DFG+ RF  +DQ   ST     + + +PE       S K+D++
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 188
Query: 270 SFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQ 329
           SFGVL+ E+ S  K     +P E +   E    +    R   L  PR+    +      Q
Sbjct: 189 SFGVLMWEVFSEGK-----IPYENRSNSEVVEDISTGFR---LYKPRLASTHV-----YQ 235
Query: 330 VINVAFICLQPHGNQRPPMSEIVAMLTCKVESGI 363
           ++N    C +     RP  S ++  L    ESG+
Sbjct: 236 IMN---HCWKERPEDRPAFSRLLRQLAEIAESGL 266

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 126/274 (45%), Gaps = 22/274 (8%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           +G G FG V+ G   +   VA+K   + +    E +F+ E  ++  + H  LV+L G C 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKT--IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           + +   LV+E+M++  L   +  +   F    T   + L +  G+ YL E     ++HRD
Sbjct: 76  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEAC---VIHRD 131
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           + A N L+ E    K+ DFG+ RF  +DQ   ST     + + +PE       S K+D++
Sbjct: 132 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 191
Query: 270 SFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQ 329
           SFGVL+ E+ S  K     +P E +   E    +    R   L  PR+    +      Q
Sbjct: 192 SFGVLMWEVFSEGK-----IPYENRSNSEVVEDISTGFR---LYKPRLASTHV-----YQ 238
Query: 330 VINVAFICLQPHGNQRPPMSEIVAMLTCKVESGI 363
           ++N    C +     RP  S ++  L    ESG+
Sbjct: 239 IMN---HCWRERPEDRPAFSRLLRQLAEIAESGL 269

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 68/196 (34%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+ G   + T VAVK L           FL E  ++ ++QH  LVRL    +
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTL--KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 150 DGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
                 ++ E+M   SL D L   E  K L           IA G+ Y+   ++   +HR
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNY---IHR 133
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKAD 267
           D++A+NVL+ E    KI DFGLAR   ED  Y +   A   + +TAPE    G  + K++
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSN 192
Query: 268 IYSFGVLVLEIISCRK 283
           ++SFG+L+ EI++  K
Sbjct: 193 VWSFGILLYEIVTYGK 208

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 105/201 (52%), Gaps = 16/201 (7%)
Query: 89  LLGRGGFGPVYRGKLA----DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           ++G G FG V  G+L         VA+K L    + +   +FLSE  ++    H N++ L
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 74
Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII---LGIARGLQYLHEDS 201
            G  +     +++ EYM+N SLD  +     +F    T  Q++    GI  G++YL + S
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRF----TVIQLVGMLRGIGSGMKYLSDMS 130
Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED--QAYLSTNFAGTLGYTAPEYAIR 259
           +   VHRD+ A N+L++     K+ DFG++R   +D   AY +      + +TAPE    
Sbjct: 131 Y---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 187
Query: 260 GELSEKADIYSFGVLVLEIIS 280
            + +  +D++S+G+++ E++S
Sbjct: 188 RKFTSASDVWSYGIVMWEVMS 208

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 16/201 (7%)
Query: 89  LLGRGGFGPVYRGKLA----DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           ++G G FG V  G+L         VA+K L    + +   +FLSE  ++    H N++ L
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 80
Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII---LGIARGLQYLHEDS 201
            G  +     +++ EYM+N SLD  +     +F    T  Q++    GI  G++YL + S
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRF----TVIQLVGMLRGIGSGMKYLSDMS 136
Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YTAPEYAIR 259
           +   VHRD+ A N+L++     K+ DFG++R   +D     T   G +   +TAPE    
Sbjct: 137 Y---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 193
Query: 260 GELSEKADIYSFGVLVLEIIS 280
            + +  +D++S+G+++ E++S
Sbjct: 194 RKFTSASDVWSYGIVMWEVMS 214

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 108/205 (52%), Gaps = 22/205 (10%)
Query: 89  LLGRGGFGPVYRGKLA----DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           ++G G FG V  G L         VA+K L    +++   +FLSE  ++    H N++ L
Sbjct: 40  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 99
Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII---LGIARGLQYLHEDS 201
            G  +  +  +++ E+M+N SLD  +     +F    T  Q++    GIA G++YL + +
Sbjct: 100 EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF----TVIQLVGMLRGIAAGMKYLADMN 155
Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG------YTAPE 255
           +   VHRD+ A N+L++     K+ DFGL+RF  +D +     +   LG      +TAPE
Sbjct: 156 Y---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS--DPTYTSALGGKIPIRWTAPE 210
Query: 256 YAIRGELSEKADIYSFGVLVLEIIS 280
                + +  +D++S+G+++ E++S
Sbjct: 211 AIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 134/285 (47%), Gaps = 38/285 (13%)
Query: 85  HPGNLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           H   ++GRG FG VY G L D        AVK L         S+FL+E  ++    H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 141 LVRLLGCC--SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--IARGLQY 196
           ++ LLG C  S+GS  L+V  YMK+  L   I  E+    N + +  I  G  +A+G+++
Sbjct: 91  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKF 146
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE---DQAYLSTNFAGTLGYTA 253
           L   +  + VHRD+ A N +LDEKF  K+ DFGLAR   +   D  +  T     + + A
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 203
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIIS--CRKNTDLTLPSEMQYLPEYAWKLYERGRILE 311
            E     + + K+D++SFGVL+ E+++       D+       YL +        GR   
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GR--R 253
Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
           L+ P    + + E        V   C  P    RP  SE+V+ ++
Sbjct: 254 LLQPEYCPDPLYE--------VMLKCWHPKAEMRPSFSELVSRIS 290

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 134/285 (47%), Gaps = 38/285 (13%)
Query: 85  HPGNLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           H   ++GRG FG VY G L D        AVK L         S+FL+E  ++    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 141 LVRLLGCC--SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--IARGLQY 196
           ++ LLG C  S+GS  L+V  YMK+  L   I  E+    N + +  I  G  +A+G+++
Sbjct: 93  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKF 148
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE---DQAYLSTNFAGTLGYTA 253
           L   +  + VHRD+ A N +LDEKF  K+ DFGLAR   +   D  +  T     + + A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIIS--CRKNTDLTLPSEMQYLPEYAWKLYERGRILE 311
            E     + + K+D++SFGVL+ E+++       D+       YL +        GR   
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GR--R 255
Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
           L+ P    + + E        V   C  P    RP  SE+V+ ++
Sbjct: 256 LLQPEYCPDPLYE--------VMLKCWHPKAEMRPSFSELVSRIS 292

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 134/285 (47%), Gaps = 38/285 (13%)
Query: 85  HPGNLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           H   ++GRG FG VY G L D        AVK L         S+FL+E  ++    H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 141 LVRLLGCC--SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--IARGLQY 196
           ++ LLG C  S+GS  L+V  YMK+  L   I  E+    N + +  I  G  +A+G+++
Sbjct: 94  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKF 149
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE---DQAYLSTNFAGTLGYTA 253
           L   +  + VHRD+ A N +LDEKF  K+ DFGLAR   +   D  +  T     + + A
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMA 206
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIIS--CRKNTDLTLPSEMQYLPEYAWKLYERGRILE 311
            E     + + K+D++SFGVL+ E+++       D+       YL +        GR   
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GR--R 256
Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
           L+ P    + + E        V   C  P    RP  SE+V+ ++
Sbjct: 257 LLQPEYCPDPLYE--------VMLKCWHPKAEMRPSFSELVSRIS 293

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 134/285 (47%), Gaps = 38/285 (13%)
Query: 85  HPGNLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           H   ++GRG FG VY G L D        AVK L         S+FL+E  ++    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 141 LVRLLGCC--SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--IARGLQY 196
           ++ LLG C  S+GS  L+V  YMK+  L   I  E+    N + +  I  G  +A+G+++
Sbjct: 93  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKF 148
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE---DQAYLSTNFAGTLGYTA 253
           L   +  + VHRD+ A N +LDEKF  K+ DFGLAR   +   D  +  T     + + A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIIS--CRKNTDLTLPSEMQYLPEYAWKLYERGRILE 311
            E     + + K+D++SFGVL+ E+++       D+       YL +        GR   
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GR--R 255
Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
           L+ P    + + E        V   C  P    RP  SE+V+ ++
Sbjct: 256 LLQPEYCPDPLYE--------VMLKCWHPKAEMRPSFSELVSRIS 292

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 134/285 (47%), Gaps = 38/285 (13%)
Query: 85  HPGNLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           H   ++GRG FG VY G L D        AVK L         S+FL+E  ++    H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 141 LVRLLGCC--SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--IARGLQY 196
           ++ LLG C  S+GS  L+V  YMK+  L   I  E+    N + +  I  G  +A+G+++
Sbjct: 94  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKF 149
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE---DQAYLSTNFAGTLGYTA 253
           L   +  + VHRD+ A N +LDEKF  K+ DFGLAR   +   D  +  T     + + A
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 206
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIIS--CRKNTDLTLPSEMQYLPEYAWKLYERGRILE 311
            E     + + K+D++SFGVL+ E+++       D+       YL +        GR   
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GR--R 256
Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
           L+ P    + + E        V   C  P    RP  SE+V+ ++
Sbjct: 257 LLQPEYCPDPLYE--------VMLKCWHPKAEMRPSFSELVSRIS 293

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 134/285 (47%), Gaps = 38/285 (13%)
Query: 85  HPGNLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           H   ++GRG FG VY G L D        AVK L         S+FL+E  ++    H N
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 141 LVRLLGCC--SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--IARGLQY 196
           ++ LLG C  S+GS  L+V  YMK+  L   I  E+    N + +  I  G  +A+G+++
Sbjct: 98  VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKF 153
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE---DQAYLSTNFAGTLGYTA 253
           L   +  + VHRD+ A N +LDEKF  K+ DFGLAR   +   D  +  T     + + A
Sbjct: 154 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 210
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIIS--CRKNTDLTLPSEMQYLPEYAWKLYERGRILE 311
            E     + + K+D++SFGVL+ E+++       D+       YL +        GR   
Sbjct: 211 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GR--R 260
Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
           L+ P    + + E        V   C  P    RP  SE+V+ ++
Sbjct: 261 LLQPEYCPDPLYE--------VMLKCWHPKAEMRPSFSELVSRIS 297

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 125/274 (45%), Gaps = 22/274 (8%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           +G G FG V+ G   +   VA+K   + +    E +F+ E  ++  + H  LV+L G C 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKT--IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           + +   LV E+M++  L   +  +   F    T   + L +  G+ YL E     ++HRD
Sbjct: 74  EQAPICLVTEFMEHGCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEAC---VIHRD 129
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           + A N L+ E    K+ DFG+ RF  +DQ   ST     + + +PE       S K+D++
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 189
Query: 270 SFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQ 329
           SFGVL+ E+ S  K     +P E +   E    +    R   L  PR+    +      Q
Sbjct: 190 SFGVLMWEVFSEGK-----IPYENRSNSEVVEDISTGFR---LYKPRLASTHV-----YQ 236
Query: 330 VINVAFICLQPHGNQRPPMSEIVAMLTCKVESGI 363
           ++N    C +     RP  S ++  L    ESG+
Sbjct: 237 IMN---HCWRERPEDRPAFSRLLRQLAEIAESGL 267

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 134/287 (46%), Gaps = 41/287 (14%)
Query: 90  LGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG G FG V+  +        D  LVAVK L  D +     +F  E  ++T++QH+++V+
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLD-----------LLIYGESDKF---LNWSTRFQIILG 189
             G C DG   ++V+EYMK+  L+           +L+ G+  +    L  S    I   
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR-FFPEDQAYLSTNFAGT 248
           IA G+ YL   +    VHRD+   N L+      KIGDFG++R  +  D   +  +    
Sbjct: 142 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGR 308
           + +  PE  +  + + ++D++SFGV++ EI +  K     L S  + +     +   +GR
Sbjct: 199 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL-SNTEVI-----ECITQGR 252
Query: 309 ILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
           +LE   PR+  +        +V +V   C Q    QR  + EI  +L
Sbjct: 253 VLE--RPRVCPK--------EVYDVMLGCWQREPQQRLNIKEIYKIL 289

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 134/285 (47%), Gaps = 38/285 (13%)
Query: 85  HPGNLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           H   ++GRG FG VY G L D        AVK L         S+FL+E  ++    H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 141 LVRLLGCC--SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--IARGLQY 196
           ++ LLG C  S+GS  L+V  YMK+  L   I  E+    N + +  I  G  +A+G+++
Sbjct: 152 VLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKF 207
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE---DQAYLSTNFAGTLGYTA 253
           L   +  + VHRD+ A N +LDEKF  K+ DFGLAR   +   D  +  T     + + A
Sbjct: 208 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIIS--CRKNTDLTLPSEMQYLPEYAWKLYERGRILE 311
            E     + + K+D++SFGVL+ E+++       D+       YL +        GR   
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GR--R 314
Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
           L+ P    + + E        V   C  P    RP  SE+V+ ++
Sbjct: 315 LLQPEYCPDPLYE--------VMLKCWHPKAEMRPSFSELVSRIS 351

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 99/192 (51%), Gaps = 8/192 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+ G     T VA+K L           FL E +++  ++H  LV+L    S
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTL--KPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 150 DGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +     +V EYM   SL D L  GE  + L       +   +A G+ Y+   ++   +HR
Sbjct: 75  E-EPIYIVTEYMNKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERMNY---IHR 129
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D++++N+L+      KI DFGLAR   +++          + +TAPE A+ G  + K+D+
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 269 YSFGVLVLEIIS 280
           +SFG+L+ E+++
Sbjct: 190 WSFGILLTELVT 201

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 89  LLGRGGFGPVYRGKLA----DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           ++G G FG V  G+L         VA+K L    + +   +FLSE  ++    H N++ L
Sbjct: 36  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 95
Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII---LGIARGLQYLHEDS 201
            G  +     +++ EYM+N SLD  +     +F    T  Q++    GI  G++YL + S
Sbjct: 96  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRF----TVIQLVGMLRGIGSGMKYLSDMS 151
Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YTAPEYAIR 259
               VHRD+ A N+L++     K+ DFG++R   +D     T   G +   +TAPE    
Sbjct: 152 A---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 208
Query: 260 GELSEKADIYSFGVLVLEIIS 280
            + +  +D++S+G+++ E++S
Sbjct: 209 RKFTSASDVWSYGIVMWEVMS 229

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 90  LGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG G FG V+  +        D  LVAVK L  D S     +F  E  ++T++QH+++V+
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTL-KDASDNARKDFHREAELLTNLQHEHIVK 79
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLD-----------LLIYGESDKFLNWSTRFQIILGIAR 192
             G C +G   ++V+EYMK+  L+           L+  G     L  S    I   IA 
Sbjct: 80  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAA 139
Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR-FFPEDQAYLSTNFAGTLGY 251
           G+ YL   +    VHRD+   N L+ E    KIGDFG++R  +  D   +  +    + +
Sbjct: 140 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 196
Query: 252 TAPEYAIRGELSEKADIYSFGVLVLEIIS 280
             PE  +  + + ++D++S GV++ EI +
Sbjct: 197 MPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 107/205 (52%), Gaps = 22/205 (10%)
Query: 89  LLGRGGFGPVYRGKLA----DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           ++G G FG V  G L         VA+K L    +++   +FLSE  ++    H N++ L
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 73
Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII---LGIARGLQYLHEDS 201
            G  +  +  +++ E+M+N SLD  +     +F    T  Q++    GIA G++YL + +
Sbjct: 74  EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF----TVIQLVGMLRGIAAGMKYLADMN 129
Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG------YTAPE 255
           +   VHR + A N+L++     K+ DFGL+RF  +D +     +   LG      +TAPE
Sbjct: 130 Y---VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTS--DPTYTSALGGKIPIRWTAPE 184
Query: 256 YAIRGELSEKADIYSFGVLVLEIIS 280
                + +  +D++S+G+++ E++S
Sbjct: 185 AIQYRKFTSASDVWSYGIVMWEVMS 209

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 127/268 (47%), Gaps = 32/268 (11%)
Query: 90  LGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +G VY G     +L VAVK L  D  +    EFL E  ++  I+H NLV+LLG C
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +      ++ E+M   +L   +   + + +N      +   I+  ++YL + +    +HR
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 140
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+ A N L+ E    K+ DFGL+R    D           + +TAPE     + S K+D+
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 269 YSFGVLVLEI----ISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM-RKEGIV 323
           ++FGVL+ EI    +S     DL+             ++YE   +LE  D RM R EG  
Sbjct: 201 WAFGVLLWEIATYGMSPYPGIDLS-------------QVYE---LLE-KDYRMERPEGCP 243
Query: 324 ERDALQVINVAFICLQPHGNQRPPMSEI 351
           E+    V  +   C Q + + RP  +EI
Sbjct: 244 EK----VYELMRACWQWNPSDRPSFAEI 267

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 127/268 (47%), Gaps = 32/268 (11%)
Query: 90  LGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +G VY G     +L VAVK L  D  +    EFL E  ++  I+H NLV+LLG C
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +      ++ E+M   +L   +   + + +N      +   I+  ++YL + +    +HR
Sbjct: 80  TREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 136
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+ A N L+ E    K+ DFGL+R    D           + +TAPE     + S K+D+
Sbjct: 137 DLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 269 YSFGVLVLEI----ISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM-RKEGIV 323
           ++FGVL+ EI    +S     DL+             ++YE   +LE  D RM R EG  
Sbjct: 197 WAFGVLLWEIATYGMSPYPGIDLS-------------QVYE---LLE-KDYRMERPEGCP 239
Query: 324 ERDALQVINVAFICLQPHGNQRPPMSEI 351
           E+    V  +   C Q + + RP  +EI
Sbjct: 240 EK----VYELMRACWQWNPSDRPSFAEI 263

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 127/268 (47%), Gaps = 32/268 (11%)
Query: 90  LGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +G VY G     +L VAVK L  D  +    EFL E  ++  I+H NLV+LLG C
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +      ++ E+M   +L   +   + + +N      +   I+  ++YL + +    +HR
Sbjct: 84  TREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 140
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+ A N L+ E    K+ DFGL+R    D           + +TAPE     + S K+D+
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 269 YSFGVLVLEI----ISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM-RKEGIV 323
           ++FGVL+ EI    +S     DL+             ++YE   +LE  D RM R EG  
Sbjct: 201 WAFGVLLWEIATYGMSPYPGIDLS-------------QVYE---LLE-KDYRMERPEGCP 243
Query: 324 ERDALQVINVAFICLQPHGNQRPPMSEI 351
           E+    V  +   C Q + + RP  +EI
Sbjct: 244 EK----VYELMRACWQWNPSDRPSFAEI 267

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 130/270 (48%), Gaps = 27/270 (10%)
Query: 89  LLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           ++GRG FG V + K      VA+K++   +S+     F+ E+R ++ + H N+V+L G C
Sbjct: 16  VVGRGAFGVVCKAKW-RAKDVAIKQI---ESESERKAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYG-ESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVH 207
            +     LV EY +  SL  +++G E   +   +      L  ++G+ YLH      ++H
Sbjct: 72  LN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 129
Query: 208 RDIKASNVLLDEKFQS-KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKA 266
           RD+K  N+LL       KI DFG A    + Q ++ TN  G+  + APE       SEK 
Sbjct: 130 RDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHM-TNNKGSAAWMAPEVFEGSNYSEKC 185
Query: 267 DIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERD 326
           D++S+G+++ E+I+ RK  D       + +    W ++   R   + +     E ++ R 
Sbjct: 186 DVFSWGIILWEVITRRKPFDEIGGPAFRIM----WAVHNGTRPPLIKNLPKPIESLMTR- 240
Query: 327 ALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
                     C     +QRP M EIV ++T
Sbjct: 241 ----------CWSKDPSQRPSMEEIVKIMT 260

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 120/257 (46%), Gaps = 22/257 (8%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V  GK      VA+K   + +    E EF+ E +++ ++ H+ LV+L G C+
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIK--MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 ++ EYM N  L   +     +F       ++   +   ++YL      + +HRD
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQT-QQLLEMCKDVCEAMEYLES---KQFLHRD 145
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           + A N L++++   K+ DFGL+R+  +D+   S      + ++ PE  +  + S K+DI+
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 270 SFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQ 329
           +FGVL+ EI S  K     +P E     E A  +    + L L  P +  E        +
Sbjct: 206 AFGVLMWEIYSLGK-----MPYERFTNSETAEHI---AQGLRLYRPHLASE--------K 249
Query: 330 VINVAFICLQPHGNQRP 346
           V  + + C     ++RP
Sbjct: 250 VYTIMYSCWHEKADERP 266

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 127/268 (47%), Gaps = 32/268 (11%)
Query: 90  LGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +G VY G     +L VAVK L  D  +    EFL E  ++  I+H NLV+LLG C
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +      ++ E+M   +L   +   + + +N      +   I+  ++YL + +    +HR
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 140
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+ A N L+ E    K+ DFGL+R    D           + +TAPE     + S K+D+
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 269 YSFGVLVLEI----ISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM-RKEGIV 323
           ++FGVL+ EI    +S     DL+             ++YE   +LE  D RM R EG  
Sbjct: 201 WAFGVLLWEIATYGMSPYPGIDLS-------------QVYE---LLE-KDYRMERPEGCP 243
Query: 324 ERDALQVINVAFICLQPHGNQRPPMSEI 351
           E+    V  +   C Q + + RP  +EI
Sbjct: 244 EK----VYELMRACWQWNPSDRPSFAEI 267

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 102/206 (49%), Gaps = 9/206 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V  GK      VAVK   + +    E EF  E + +  + H  LV+  G CS
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKM--IKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESD-KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
                 +V EY+ N  L  L Y  S  K L  S   ++   +  G+ +L  +SH + +HR
Sbjct: 74  KEYPIYIVTEYISNGCL--LNYLRSHGKGLEPSQLLEMCYDVCEGMAFL--ESH-QFIHR 128
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+ A N L+D     K+ DFG+ R+  +DQ   S      + ++APE     + S K+D+
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDV 188
Query: 269 YSFGVLVLEIISCRKN-TDLTLPSEM 293
           ++FG+L+ E+ S  K   DL   SE+
Sbjct: 189 WAFGILMWEVFSLGKMPYDLYTNSEV 214

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 130/270 (48%), Gaps = 27/270 (10%)
Query: 89  LLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           ++GRG FG V + K      VA+K++   +S+     F+ E+R ++ + H N+V+L G C
Sbjct: 15  VVGRGAFGVVCKAKW-RAKDVAIKQI---ESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYG-ESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVH 207
            +     LV EY +  SL  +++G E   +   +      L  ++G+ YLH      ++H
Sbjct: 71  LN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 208 RDIKASNVLLDEKFQS-KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKA 266
           RD+K  N+LL       KI DFG A    + Q ++ TN  G+  + APE       SEK 
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHM-TNNKGSAAWMAPEVFEGSNYSEKC 184
Query: 267 DIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERD 326
           D++S+G+++ E+I+ RK  D       + +    W ++   R   + +     E ++ R 
Sbjct: 185 DVFSWGIILWEVITRRKPFDEIGGPAFRIM----WAVHNGTRPPLIKNLPKPIESLMTR- 239
Query: 327 ALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
                     C     +QRP M EIV ++T
Sbjct: 240 ----------CWSKDPSQRPSMEEIVKIMT 259

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 127/268 (47%), Gaps = 32/268 (11%)
Query: 90  LGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +G VY G     +L VAVK L  D  +    EFL E  ++  I+H NLV+LLG C
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +      ++ E+M   +L   +   + + +N      +   I+  ++YL + +    +HR
Sbjct: 83  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 139
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+ A N L+ E    K+ DFGL+R    D           + +TAPE     + S K+D+
Sbjct: 140 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 199
Query: 269 YSFGVLVLEI----ISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM-RKEGIV 323
           ++FGVL+ EI    +S     DL+             ++YE   +LE  D RM R EG  
Sbjct: 200 WAFGVLLWEIATYGMSPYPGIDLS-------------QVYE---LLE-KDYRMERPEGCP 242
Query: 324 ERDALQVINVAFICLQPHGNQRPPMSEI 351
           E+    V  +   C Q + + RP  +EI
Sbjct: 243 EK----VYELMRACWQWNPSDRPSFAEI 266

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 127/268 (47%), Gaps = 32/268 (11%)
Query: 90  LGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +G VY G     +L VAVK L  D  +    EFL E  ++  I+H NLV+LLG C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +      ++ E+M   +L   +   + + +N      +   I+  ++YL + +    +HR
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 135
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+ A N L+ E    K+ DFGL+R    D           + +TAPE     + S K+D+
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 269 YSFGVLVLEI----ISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM-RKEGIV 323
           ++FGVL+ EI    +S     DL+             ++YE   +LE  D RM R EG  
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLS-------------QVYE---LLE-KDYRMERPEGCP 238
Query: 324 ERDALQVINVAFICLQPHGNQRPPMSEI 351
           E+    V  +   C Q + + RP  +EI
Sbjct: 239 EK----VYELMRACWQWNPSDRPSFAEI 262

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 127/268 (47%), Gaps = 32/268 (11%)
Query: 90  LGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +G VY G     +L VAVK L  D  +    EFL E  ++  I+H NLV+LLG C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +      ++ E+M   +L   +   + + +N      +   I+  ++YL + +    +HR
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 135
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+ A N L+ E    K+ DFGL+R    D           + +TAPE     + S K+D+
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 269 YSFGVLVLEI----ISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM-RKEGIV 323
           ++FGVL+ EI    +S     DL+             ++YE   +LE  D RM R EG  
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLS-------------QVYE---LLE-KDYRMERPEGCP 238
Query: 324 ERDALQVINVAFICLQPHGNQRPPMSEI 351
           E+    V  +   C Q + + RP  +EI
Sbjct: 239 EK----VYELMRACWQWNPSDRPSFAEI 262

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 120/257 (46%), Gaps = 22/257 (8%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V  GK      VA+K   + +    E EF+ E +++ ++ H+ LV+L G C+
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIK--MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 ++ EYM N  L   +     +F       ++   +   ++YL      + +HRD
Sbjct: 74  KQRPIFIITEYMANGCLLNYLREMRHRFQT-QQLLEMCKDVCEAMEYLES---KQFLHRD 129
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           + A N L++++   K+ DFGL+R+  +D+   S      + ++ PE  +  + S K+DI+
Sbjct: 130 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 189
Query: 270 SFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQ 329
           +FGVL+ EI S  K     +P E     E A  +    + L L  P +  E        +
Sbjct: 190 AFGVLMWEIYSLGK-----MPYERFTNSETAEHI---AQGLRLYRPHLASE--------K 233
Query: 330 VINVAFICLQPHGNQRP 346
           V  + + C     ++RP
Sbjct: 234 VYTIMYSCWHEKADERP 250

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 120/257 (46%), Gaps = 22/257 (8%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V  GK      VA+K   + +    E EF+ E +++ ++ H+ LV+L G C+
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIK--MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 ++ EYM N  L   +     +F       ++   +   ++YL      + +HRD
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRFQT-QQLLEMCKDVCEAMEYLES---KQFLHRD 130
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           + A N L++++   K+ DFGL+R+  +D+   S      + ++ PE  +  + S K+DI+
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 270 SFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQ 329
           +FGVL+ EI S  K     +P E     E A  +    + L L  P +  E        +
Sbjct: 191 AFGVLMWEIYSLGK-----MPYERFTNSETAEHI---AQGLRLYRPHLASE--------K 234
Query: 330 VINVAFICLQPHGNQRP 346
           V  + + C     ++RP
Sbjct: 235 VYTIMYSCWHEKADERP 251

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 127/268 (47%), Gaps = 32/268 (11%)
Query: 90  LGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +G VY G     +L VAVK L  D  +    EFL E  ++  I+H NLV+LLG C
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +      ++ E+M   +L   +   + + +N      +   I+  ++YL + +    +HR
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 137
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+ A N L+ E    K+ DFGL+R    D           + +TAPE     + S K+D+
Sbjct: 138 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 269 YSFGVLVLEI----ISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM-RKEGIV 323
           ++FGVL+ EI    +S     DL+             ++YE   +LE  D RM R EG  
Sbjct: 198 WAFGVLLWEIATYGMSPYPGIDLS-------------QVYE---LLE-KDYRMERPEGCP 240
Query: 324 ERDALQVINVAFICLQPHGNQRPPMSEI 351
           E+    V  +   C Q + + RP  +EI
Sbjct: 241 EK----VYELMRACWQWNPSDRPSFAEI 264

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 127/268 (47%), Gaps = 32/268 (11%)
Query: 90  LGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +G VY G     +L VAVK L  D  +    EFL E  ++  I+H NLV+LLG C
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +      ++ E+M   +L   +   + + +N      +   I+  ++YL + +    +HR
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 137
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+ A N L+ E    K+ DFGL+R    D           + +TAPE     + S K+D+
Sbjct: 138 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 269 YSFGVLVLEI----ISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM-RKEGIV 323
           ++FGVL+ EI    +S     DL+             ++YE   +LE  D RM R EG  
Sbjct: 198 WAFGVLLWEIATYGMSPYPGIDLS-------------QVYE---LLE-KDYRMERPEGCP 240
Query: 324 ERDALQVINVAFICLQPHGNQRPPMSEI 351
           E+    V  +   C Q + + RP  +EI
Sbjct: 241 EK----VYELMRACWQWNPSDRPSFAEI 264

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 127/268 (47%), Gaps = 32/268 (11%)
Query: 90  LGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +G VY G     +L VAVK L  D  +    EFL E  ++  I+H NLV+LLG C
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +      ++ E+M   +L   +   + + +N      +   I+  ++YL + +    +HR
Sbjct: 80  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 136
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+ A N L+ E    K+ DFGL+R    D           + +TAPE     + S K+D+
Sbjct: 137 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 269 YSFGVLVLEI----ISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM-RKEGIV 323
           ++FGVL+ EI    +S     DL+             ++YE   +LE  D RM R EG  
Sbjct: 197 WAFGVLLWEIATYGMSPYPGIDLS-------------QVYE---LLE-KDYRMERPEGCP 239
Query: 324 ERDALQVINVAFICLQPHGNQRPPMSEI 351
           E+    V  +   C Q + + RP  +EI
Sbjct: 240 EK----VYELMRACWQWNPSDRPSFAEI 263

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 120/257 (46%), Gaps = 22/257 (8%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V  GK      VA+K   + +    E EF+ E +++ ++ H+ LV+L G C+
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIK--MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 ++ EYM N  L   +     +F       ++   +   ++YL      + +HRD
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQT-QQLLEMCKDVCEAMEYLES---KQFLHRD 145
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           + A N L++++   K+ DFGL+R+  +D+   S      + ++ PE  +  + S K+DI+
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 270 SFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQ 329
           +FGVL+ EI S  K     +P E     E A  +    + L L  P +  E        +
Sbjct: 206 AFGVLMWEIYSLGK-----MPYERFTNSETAEHI---AQGLRLYRPHLASE--------K 249
Query: 330 VINVAFICLQPHGNQRP 346
           V  + + C     ++RP
Sbjct: 250 VYTIMYSCWHEKADERP 266

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 120/257 (46%), Gaps = 22/257 (8%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V  GK      VA+K   + +    E EF+ E +++ ++ H+ LV+L G C+
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKM--IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 ++ EYM N  L   +     +F       ++   +   ++YL      + +HRD
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREMRHRFQT-QQLLEMCKDVCEAMEYLES---KQFLHRD 125
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           + A N L++++   K+ DFGL+R+  +D+   S      + ++ PE  +  + S K+DI+
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185
Query: 270 SFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQ 329
           +FGVL+ EI S  K     +P E     E A  +    + L L  P +  E        +
Sbjct: 186 AFGVLMWEIYSLGK-----MPYERFTNSETAEHI---AQGLRLYRPHLASE--------K 229
Query: 330 VINVAFICLQPHGNQRP 346
           V  + + C     ++RP
Sbjct: 230 VYTIMYSCWHEKADERP 246

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 127/268 (47%), Gaps = 32/268 (11%)
Query: 90  LGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +G VY G     +L VAVK L  D  +    EFL E  ++  I+H NLV+LLG C
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +      ++ E+M   +L   +   + + +N      +   I+  ++YL + +    +HR
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 140
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+ A N L+ E    K+ DFGL+R    D           + +TAPE     + S K+D+
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 269 YSFGVLVLEI----ISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM-RKEGIV 323
           ++FGVL+ EI    +S     DL+             ++YE   +LE  D RM R EG  
Sbjct: 201 WAFGVLLWEIATYGMSPYPGIDLS-------------QVYE---LLE-KDYRMERPEGCP 243
Query: 324 ERDALQVINVAFICLQPHGNQRPPMSEI 351
           E+    V  +   C Q + + RP  +EI
Sbjct: 244 EK----VYELMRACWQWNPSDRPSFAEI 267

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 127/268 (47%), Gaps = 32/268 (11%)
Query: 90  LGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +G VY G     +L VAVK L  D  +    EFL E  ++  I+H NLV+LLG C
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 91
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +      ++ E+M   +L   +   + + +N      +   I+  ++YL + +    +HR
Sbjct: 92  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 148
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+ A N L+ E    K+ DFGL+R    D           + +TAPE     + S K+D+
Sbjct: 149 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 208
Query: 269 YSFGVLVLEI----ISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM-RKEGIV 323
           ++FGVL+ EI    +S     DL+             ++YE   +LE  D RM R EG  
Sbjct: 209 WAFGVLLWEIATYGMSPYPGIDLS-------------QVYE---LLE-KDYRMERPEGCP 251
Query: 324 ERDALQVINVAFICLQPHGNQRPPMSEI 351
           E+    V  +   C Q + + RP  +EI
Sbjct: 252 EK----VYELMRACWQWNPSDRPSFAEI 275

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 127/268 (47%), Gaps = 32/268 (11%)
Query: 90  LGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +G VY G     +L VAVK L  D  +    EFL E  ++  I+H NLV+LLG C
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +      ++ E+M   +L   +   + + +N      +   I+  ++YL + +    +HR
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 137
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+ A N L+ E    K+ DFGL+R    D           + +TAPE     + S K+D+
Sbjct: 138 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 269 YSFGVLVLEI----ISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM-RKEGIV 323
           ++FGVL+ EI    +S     DL+             ++YE   +LE  D RM R EG  
Sbjct: 198 WAFGVLLWEIATYGMSPYPGIDLS-------------QVYE---LLE-KDYRMERPEGCP 240
Query: 324 ERDALQVINVAFICLQPHGNQRPPMSEI 351
           E+    V  +   C Q + + RP  +EI
Sbjct: 241 EK----VYELMRACWQWNPSDRPSFAEI 264

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 120/257 (46%), Gaps = 22/257 (8%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V  GK      VA+K   + +    E EF+ E +++ ++ H+ LV+L G C+
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIK--MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 ++ EYM N  L   +     +F       ++   +   ++YL      + +HRD
Sbjct: 81  KQRPIFIITEYMANGCLLNYLREMRHRFQT-QQLLEMCKDVCEAMEYLES---KQFLHRD 136
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           + A N L++++   K+ DFGL+R+  +D+   S      + ++ PE  +  + S K+DI+
Sbjct: 137 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 196
Query: 270 SFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQ 329
           +FGVL+ EI S  K     +P E     E A  +    + L L  P +  E        +
Sbjct: 197 AFGVLMWEIYSLGK-----MPYERFTNSETAEHI---AQGLRLYRPHLASE--------K 240
Query: 330 VINVAFICLQPHGNQRP 346
           V  + + C     ++RP
Sbjct: 241 VYTIMYSCWHEKADERP 257

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 124/264 (46%), Gaps = 24/264 (9%)
Query: 90  LGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G FG VY G     +L VAVK L  D  +    EFL E  ++  I+H NLV+LLG C
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +      ++ E+M   +L   +   + + ++      +   I+  ++YL + +    +HR
Sbjct: 77  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHR 133
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+ A N L+ E    K+ DFGL+R    D           + +TAPE     + S K+D+
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 269 YSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM-RKEGIVERDA 327
           ++FGVL+ EI +   +    +       P   ++L E+       D RM R EG  E+  
Sbjct: 194 WAFGVLLWEIATYGMSPYPGID------PSQVYELLEK-------DYRMERPEGCPEK-- 238
Query: 328 LQVINVAFICLQPHGNQRPPMSEI 351
             V  +   C Q + + RP  +EI
Sbjct: 239 --VYELMRACWQWNPSDRPSFAEI 260

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 120/257 (46%), Gaps = 22/257 (8%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V  GK      VA+K   + +    E EF+ E +++ ++ H+ LV+L G C+
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIK--MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
                 ++ EYM N  L   +     +F       ++   +   ++YL      + +HRD
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRFQT-QQLLEMCKDVCEAMEYLES---KQFLHRD 130
Query: 210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIY 269
           + A N L++++   K+ DFGL+R+  +D+   S      + ++ PE  +  + S K+DI+
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 270 SFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQ 329
           +FGVL+ EI S  K     +P E     E A  +    + L L  P +  E        +
Sbjct: 191 AFGVLMWEIYSLGK-----MPYERFTNSETAEHI---AQGLRLYRPHLASE--------K 234
Query: 330 VINVAFICLQPHGNQRP 346
           V  + + C     ++RP
Sbjct: 235 VYTIMYSCWHEKADERP 251

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 106/200 (53%), Gaps = 14/200 (7%)
Query: 90  LGRGGFGPVYRGK---LAD--GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG+G FG V   +   L D  G +VAVKKL    +++   +F  E+ ++ S+QH N+V+ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 145 LGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            G C    +R   L+ EY+   SL   +    ++ ++     Q    I +G++YL     
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYL---GT 132
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRG 260
            R +HRD+   N+L++ + + KIGDFGL +  P+D+ +      G   + + APE     
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192
Query: 261 ELSEKADIYSFGVLVLEIIS 280
           + S  +D++SFGV++ E+ +
Sbjct: 193 KFSVASDVWSFGVVLYELFT 212

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 124/264 (46%), Gaps = 24/264 (9%)
Query: 90  LGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +G VY G     +L VAVK L  D  +    EFL E  ++  I+H NLV+LLG C
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +      ++ E+M   +L   +   + + ++      +   I+  ++YL + +    +HR
Sbjct: 77  TREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHR 133
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+ A N L+ E    K+ DFGL+R    D           + +TAPE     + S K+D+
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 269 YSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM-RKEGIVERDA 327
           ++FGVL+ EI +   +    +       P   ++L E+       D RM R EG  E+  
Sbjct: 194 WAFGVLLWEIATYGMSPYPGID------PSQVYELLEK-------DYRMERPEGCPEK-- 238
Query: 328 LQVINVAFICLQPHGNQRPPMSEI 351
             V  +   C Q + + RP  +EI
Sbjct: 239 --VYELMRACWQWNPSDRPSFAEI 260

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 89  LLGRGGFGPVYRGK-LADGTLV----AVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           +LG G FG VY+G  + +G  V    A+K L      +   EF+ E  ++ S+ H +LVR
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDK-----FLNWSTRFQIILGIARGLQYLH 198
           LLG C   + +L V + M +  L   ++   D       LNW  +      IA+G+ YL 
Sbjct: 105 LLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLE 157
Query: 199 EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA-YLSTNFAGTLGYTAPEYA 257
           E    R+VHRD+ A NVL+      KI DFGLAR    D+  Y +      + + A E  
Sbjct: 158 E---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 214
Query: 258 IRGELSEKADIYSFGVLVLEIIS 280
              + + ++D++S+GV + E+++
Sbjct: 215 HYRKFTHQSDVWSYGVTIWELMT 237

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 127/268 (47%), Gaps = 32/268 (11%)
Query: 90  LGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +G VY G     +L VAVK L  D  +    EFL E  ++  I+H NLV+LLG C
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +      ++ E+M   +L   +   + + ++      +   I+  ++YL + +    +HR
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHR 140
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+ A N L+ E    K+ DFGL+R    D           + +TAPE     + S K+D+
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 269 YSFGVLVLEI----ISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM-RKEGIV 323
           ++FGVL+ EI    +S     DL+             ++YE   +LE  D RM R EG  
Sbjct: 201 WAFGVLLWEIATYGMSPYPGIDLS-------------QVYE---LLE-KDYRMERPEGCP 243
Query: 324 ERDALQVINVAFICLQPHGNQRPPMSEI 351
           E+    V  +   C Q + + RP  +EI
Sbjct: 244 EK----VYELMRACWQWNPSDRPSFAEI 267

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 127/268 (47%), Gaps = 32/268 (11%)
Query: 90  LGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +G VY G     +L VAVK L  D  +    EFL E  ++  I+H NLV+LLG C
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 324
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +      ++ E+M   +L   +   + + +N      +   I+  ++YL + +    +HR
Sbjct: 325 TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 381
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           ++ A N L+ E    K+ DFGL+R    D           + +TAPE     + S K+D+
Sbjct: 382 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 441
Query: 269 YSFGVLVLEI----ISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM-RKEGIV 323
           ++FGVL+ EI    +S     DL+             ++YE   +LE  D RM R EG  
Sbjct: 442 WAFGVLLWEIATYGMSPYPGIDLS-------------QVYE---LLE-KDYRMERPEGCP 484
Query: 324 ERDALQVINVAFICLQPHGNQRPPMSEI 351
           E+    V  +   C Q + + RP  +EI
Sbjct: 485 EK----VYELMRACWQWNPSDRPSFAEI 508

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 89  LLGRGGFGPVYRG-KLADGTLV----AVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           +LG G FG VY+G  + +G  V    A+K L      +   EF+ E  ++ S+ H +LVR
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDK-----FLNWSTRFQIILGIARGLQYLH 198
           LLG C   + +L V + M +  L   ++   D       LNW  +      IA+G+ YL 
Sbjct: 82  LLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLE 134
Query: 199 EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA-YLSTNFAGTLGYTAPEYA 257
           E    R+VHRD+ A NVL+      KI DFGLAR    D+  Y +      + + A E  
Sbjct: 135 E---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 191
Query: 258 IRGELSEKADIYSFGVLVLEIIS 280
              + + ++D++S+GV + E+++
Sbjct: 192 HYRKFTHQSDVWSYGVTIWELMT 214

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 106/198 (53%), Gaps = 9/198 (4%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +  VY+G     G  VA+K++ +D  +   S  + E+ ++  ++H+N+VRL    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 149 SDGSQRLLVYEYMKN---RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
              ++  LV+E+M N   + +D    G + + L  +        + +GL + HE+   +I
Sbjct: 73  HTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KI 129
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE-LSE 264
           +HRD+K  N+L++++ Q K+GDFGLAR F       S+    TL Y AP+  +     S 
Sbjct: 130 LHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVLMGSRTYST 188
Query: 265 KADIYSFGVLVLEIISCR 282
             DI+S G ++ E+I+ +
Sbjct: 189 SIDIWSCGCILAEMITGK 206

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 127/268 (47%), Gaps = 32/268 (11%)
Query: 90  LGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +G VY G     +L VAVK L  D  +    EFL E  ++  I+H NLV+LLG C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +      ++ E+M   +L   +   + + ++      +   I+  ++YL + +    +HR
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHR 135
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+ A N L+ E    K+ DFGL+R    D           + +TAPE     + S K+D+
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 269 YSFGVLVLEI----ISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM-RKEGIV 323
           ++FGVL+ EI    +S     DL+             ++YE   +LE  D RM R EG  
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLS-------------QVYE---LLE-KDYRMERPEGCP 238
Query: 324 ERDALQVINVAFICLQPHGNQRPPMSEI 351
           E+    V  +   C Q + + RP  +EI
Sbjct: 239 EK----VYELMRACWQWNPSDRPSFAEI 262

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 106/200 (53%), Gaps = 14/200 (7%)
Query: 90  LGRGGFGPVYRGK---LAD--GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG+G FG V   +   L D  G +VAVKKL    +++   +F  E+ ++ S+QH N+V+ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 145 LGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            G C    +R   L+ EY+   SL   +   +++ ++     Q    I +G++YL     
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER-IDHIKLLQYTSQICKGMEYL---GT 135
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRG 260
            R +HRD+   N+L++ + + KIGDFGL +  P+D+        G   + + APE     
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 261 ELSEKADIYSFGVLVLEIIS 280
           + S  +D++SFGV++ E+ +
Sbjct: 196 KFSVASDVWSFGVVLYELFT 215

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 19/223 (8%)
Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           G +LG+G FG   +    +   V V K  +   ++ +  FL EV+++  ++H N+++ +G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
                 +   + EY+K  +L  +I     ++  WS R      IA G+ YLH      I+
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDSQY-PWSQRVSFAKDIASGMAYLHS---MNII 130
Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFF------PEDQAYLST-------NFAGTLGYTA 253
           HRD+ + N L+ E     + DFGLAR        PE    L            G   + A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLT-LPSEMQY 295
           PE        EK D++SFG+++ EII  R N D   LP  M +
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIG-RVNADPDYLPRTMDF 232

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 127/268 (47%), Gaps = 32/268 (11%)
Query: 90  LGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +G VY G     +L VAVK L  D  +    EFL E  ++  I+H NLV+LLG C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +      ++ E+M   +L   +   + + ++      +   I+  ++YL + +    +HR
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHR 135
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+ A N L+ E    K+ DFGL+R    D           + +TAPE     + S K+D+
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 269 YSFGVLVLEI----ISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM-RKEGIV 323
           ++FGVL+ EI    +S     DL+             ++YE   +LE  D RM R EG  
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLS-------------QVYE---LLE-KDYRMERPEGCP 238
Query: 324 ERDALQVINVAFICLQPHGNQRPPMSEI 351
           E+    V  +   C Q + + RP  +EI
Sbjct: 239 EK----VYELMRACWQWNPSDRPSFAEI 262

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 143/282 (50%), Gaps = 38/282 (13%)
Query: 90  LGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGES-------EFLSEVRMITSIQHKNL 141
           +G+GGFG V++G+L  D ++VA+K L +  S +GE+       EF  EV +++++ H N+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDS-EGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
           V+L G   +  +  +V E++    L   +  ++   + WS + +++L IA G++Y+ ++ 
Sbjct: 86  VKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYM-QNQ 141
Query: 202 HTRIVHRDIKASNVL---LDEKFQ--SKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEY 256
           +  IVHRD+++ N+    LDE     +K+ DFGL+    +   +  +   G   + APE 
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS----QQSVHSVSGLLGNFQWMAPET 197
Query: 257 --AIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD 314
             A     +EKAD YSF +++  I++     D           EY+   Y + + + ++ 
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPFD-----------EYS---YGKIKFINMIR 243
Query: 315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
               +  I E    ++ NV  +C      +RP  S IV  L+
Sbjct: 244 EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 127/268 (47%), Gaps = 32/268 (11%)
Query: 90  LGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +G VY G     +L VAVK L  D  +    EFL E  ++  I+H NLV+LLG C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +      ++ E+M   +L   +   + + ++      +   I+  ++YL + +    +HR
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHR 135
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+ A N L+ E    K+ DFGL+R    D           + +TAPE     + S K+D+
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 269 YSFGVLVLEI----ISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM-RKEGIV 323
           ++FGVL+ EI    +S     DL+             ++YE   +LE  D RM R EG  
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLS-------------QVYE---LLE-KDYRMERPEGCP 238
Query: 324 ERDALQVINVAFICLQPHGNQRPPMSEI 351
           E+    V  +   C Q + + RP  +EI
Sbjct: 239 EK----VYELMRACWQWNPSDRPSFAEI 262

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 127/268 (47%), Gaps = 32/268 (11%)
Query: 90  LGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +G VY G     +L VAVK L  D  +    EFL E  ++  I+H NLV+LLG C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +      ++ E+M   +L   +   + + ++      +   I+  ++YL + +    +HR
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHR 135
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+ A N L+ E    K+ DFGL+R    D           + +TAPE     + S K+D+
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 269 YSFGVLVLEI----ISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM-RKEGIV 323
           ++FGVL+ EI    +S     DL+             ++YE   +LE  D RM R EG  
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLS-------------QVYE---LLE-KDYRMERPEGCP 238
Query: 324 ERDALQVINVAFICLQPHGNQRPPMSEI 351
           E+    V  +   C Q + + RP  +EI
Sbjct: 239 EK----VYELMRACWQWNPSDRPSFAEI 262

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 106/200 (53%), Gaps = 14/200 (7%)
Query: 90  LGRGGFGPVYRGK---LAD--GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG+G FG V   +   L D  G +VAVKKL    +++   +F  E+ ++ S+QH N+V+ 
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 145 LGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            G C    +R   L+ EY+   SL   +    ++ ++     Q    I +G++YL     
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYL---GT 133
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRG 260
            R +HR++   N+L++ + + KIGDFGL +  P+D+ Y      G   + + APE     
Sbjct: 134 KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 193
Query: 261 ELSEKADIYSFGVLVLEIIS 280
           + S  +D++SFGV++ E+ +
Sbjct: 194 KFSVASDVWSFGVVLYELFT 213

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 22/213 (10%)
Query: 87  GNLLGRGGFGPVYRG------KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHK 139
           G  LGRG FG V         K A    VAVK L    +       +SE++++  I  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 140 NLVRLLGCCSD-GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--------- 189
           N+V LLG C+  G   +++ E+ K  +L   +  + ++F+ +   ++  L          
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSF 151
Query: 190 -IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG- 247
            +A+G+++L   +  + +HRD+ A N+LL EK   KI DFGLAR   +D  Y+    A  
Sbjct: 152 QVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 248 TLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            L + APE       + ++D++SFGVL+ EI S
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 124/264 (46%), Gaps = 24/264 (9%)
Query: 90  LGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +G VY G     +L VAVK L  D  +    EFL E  ++  I+H NLV+LLG C
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +      ++ E+M   +L   +   + + ++      +   I+  ++YL + +    +HR
Sbjct: 77  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHR 133
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+ A N L+ E    K+ DFGL+R    D           + +TAPE     + S K+D+
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 269 YSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM-RKEGIVERDA 327
           ++FGVL+ EI +   +    +       P   ++L E+       D RM R EG  E+  
Sbjct: 194 WAFGVLLWEIATYGMSPYPGID------PSQVYELLEK-------DYRMERPEGCPEK-- 238
Query: 328 LQVINVAFICLQPHGNQRPPMSEI 351
             V  +   C Q + + RP  +EI
Sbjct: 239 --VYELMRACWQWNPSDRPSFAEI 260

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 24/215 (11%)
Query: 90  LGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG G FG V+  +        D  LVAVK L  + S+    +F  E  ++T +QH+++VR
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQHIVR 78
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLD-----------LLIYGE--SDKFLNWSTRFQIILGI 190
             G C++G   L+V+EYM++  L+           LL  GE  +   L       +   +
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR-FFPEDQAYLSTNFAGTL 249
           A G+ YL   +    VHRD+   N L+ +    KIGDFG++R  +  D   +       +
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKN 284
            +  PE  +  + + ++D++SFGV++ EI +  K 
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 230

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 22/213 (10%)
Query: 87  GNLLGRGGFGPVYRG------KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHK 139
           G  LGRG FG V         K A    VAVK L    +       +SE++++  I  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 140 NLVRLLGCCSD-GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--------- 189
           N+V LLG C+  G   +++ E+ K  +L   +  + ++F+ +   ++  L          
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSF 151
Query: 190 -IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG- 247
            +A+G+++L   +  + +HRD+ A N+LL EK   KI DFGLAR   +D  Y+    A  
Sbjct: 152 QVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 248 TLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            L + APE       + ++D++SFGVL+ EI S
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 24/215 (11%)
Query: 90  LGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG G FG V+  +        D  LVAVK L  + S+    +F  E  ++T +QH+++VR
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQHIVR 84
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLD-----------LLIYGE--SDKFLNWSTRFQIILGI 190
             G C++G   L+V+EYM++  L+           LL  GE  +   L       +   +
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR-FFPEDQAYLSTNFAGTL 249
           A G+ YL   +    VHRD+   N L+ +    KIGDFG++R  +  D   +       +
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKN 284
            +  PE  +  + + ++D++SFGV++ EI +  K 
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 236

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 89/291 (30%), Positives = 127/291 (43%), Gaps = 36/291 (12%)
Query: 90  LGRGGFGPVYRGKLAD------GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG+G FG VY G   D       T VAVK +    S +   EFL+E  ++      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--------FQIILGIARGLQ 195
           LLG  S G   L+V E M +  L   +     +  N   R         Q+   IA G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YTA 253
           YL+     + VHRD+ A N ++   F  KIGDFG+ R   E  AY      G L   + A
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE-TAYYRKGGKGLLPVRWMA 200
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           PE    G  +  +D++SFGV++ EI S  +     L +E Q L     K    G  L+  
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-QVL-----KFVMDGGYLD-- 252
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
               + +   ER    V ++  +C Q +   RP   EIV +L   +    P
Sbjct: 253 ----QPDNCPER----VTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 295

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 24/215 (11%)
Query: 90  LGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG G FG V+  +        D  LVAVK L  + S+    +F  E  ++T +QH+++VR
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQHIVR 107
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLD-----------LLIYGE--SDKFLNWSTRFQIILGI 190
             G C++G   L+V+EYM++  L+           LL  GE  +   L       +   +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR-FFPEDQAYLSTNFAGTL 249
           A G+ YL   +    VHRD+   N L+ +    KIGDFG++R  +  D   +       +
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKN 284
            +  PE  +  + + ++D++SFGV++ EI +  K 
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 259

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 126/290 (43%), Gaps = 34/290 (11%)
Query: 90  LGRGGFGPVYRGKLAD------GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG+G FG VY G   D       T VAVK +    S +   EFL+E  ++      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--------FQIILGIARGLQ 195
           LLG  S G   L+V E M +  L   +     +  N   R         Q+   IA G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE-DQAYLSTNFAGTLGYTAP 254
           YL+     + VHRD+ A N ++   F  KIGDFG+ R   E D           + + AP
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 255 EYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD 314
           E    G  +  +D++SFGV++ EI S  +     L +E Q L     K    G  L+   
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-QVL-----KFVMDGGYLD--- 252
Query: 315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
              + +   ER    V ++  +C Q + N RP   EIV +L   +    P
Sbjct: 253 ---QPDNCPER----VTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFP 295

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 90  LGRGGFGPVYRGK---LAD--GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG+G FG V   +   L D  G +VAVKKL    +++   +F  E+ ++ S+QH N+V+ 
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 145 LGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            G C    +R   L+ EY+   SL   +    ++ ++     Q    I +G++YL     
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYL---GT 131
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRG 260
            R +HRD+   N+L++ + + KIGDFGL +  P+D+        G   + + APE     
Sbjct: 132 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 191
Query: 261 ELSEKADIYSFGVLVLEIIS 280
           + S  +D++SFGV++ E+ +
Sbjct: 192 KFSVASDVWSFGVVLYELFT 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 90  LGRGGFGPVYRGK---LAD--GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG+G FG V   +   L D  G +VAVKKL    +++   +F  E+ ++ S+QH N+V+ 
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 145 LGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            G C    +R   L+ EY+   SL   +    ++ ++     Q    I +G++YL     
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYL---GT 136
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRG 260
            R +HRD+   N+L++ + + KIGDFGL +  P+D+        G   + + APE     
Sbjct: 137 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 196
Query: 261 ELSEKADIYSFGVLVLEIIS 280
           + S  +D++SFGV++ E+ +
Sbjct: 197 KFSVASDVWSFGVVLYELFT 216

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 90  LGRGGFGPVYRGK---LAD--GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG+G FG V   +   L D  G +VAVKKL    +++   +F  E+ ++ S+QH N+V+ 
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 145 LGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            G C    +R   L+ EY+   SL   +    ++ ++     Q    I +G++YL     
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYL---GT 130
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRG 260
            R +HRD+   N+L++ + + KIGDFGL +  P+D+        G   + + APE     
Sbjct: 131 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 190
Query: 261 ELSEKADIYSFGVLVLEIIS 280
           + S  +D++SFGV++ E+ +
Sbjct: 191 KFSVASDVWSFGVVLYELFT 210

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 90  LGRGGFGPVYRGK---LAD--GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG+G FG V   +   L D  G +VAVKKL    +++   +F  E+ ++ S+QH N+V+ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 145 LGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            G C    +R   L+ EY+   SL   +    ++ ++     Q    I +G++YL     
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYL---GT 132
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRG 260
            R +HRD+   N+L++ + + KIGDFGL +  P+D+        G   + + APE     
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 261 ELSEKADIYSFGVLVLEIIS 280
           + S  +D++SFGV++ E+ +
Sbjct: 193 KFSVASDVWSFGVVLYELFT 212

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 27/218 (12%)
Query: 87  GNLLGRGGFGPVY--------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V         + K  +   VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWS----------TRFQII 187
           HKN++ LLG C+      ++ EY    +L   +       + +S            F+ +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 188 LG----IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE-DQAYLS 242
           +     +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR     D    +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKT 216
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           TN    + + APE       + ++D++SFGVL+ EI +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 90  LGRGGFGPVYRGK---LAD--GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG+G FG V   +   L D  G +VAVKKL    +++   +F  E+ ++ S+QH N+V+ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 145 LGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            G C    +R   L+ EY+   SL   +    ++ ++     Q    I +G++YL     
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYL---GT 135
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRG 260
            R +HRD+   N+L++ + + KIGDFGL +  P+D+        G   + + APE     
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 261 ELSEKADIYSFGVLVLEIIS 280
           + S  +D++SFGV++ E+ +
Sbjct: 196 KFSVASDVWSFGVVLYELFT 215

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 90  LGRGGFGPVYRGK---LAD--GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG+G FG V   +   L D  G +VAVKKL    +++   +F  E+ ++ S+QH N+V+ 
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 145 LGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            G C    +R   L+ EY+   SL   +    ++ ++     Q    I +G++YL     
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYL---GT 138
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRG 260
            R +HRD+   N+L++ + + KIGDFGL +  P+D+        G   + + APE     
Sbjct: 139 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 198
Query: 261 ELSEKADIYSFGVLVLEIIS 280
           + S  +D++SFGV++ E+ +
Sbjct: 199 KFSVASDVWSFGVVLYELFT 218

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 90  LGRGGFGPVYRGK---LAD--GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG+G FG V   +   L D  G +VAVKKL    +++   +F  E+ ++ S+QH N+V+ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 145 LGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            G C    +R   L+ EY+   SL   +    ++ ++     Q    I +G++YL     
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYL---GT 132
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRG 260
            R +HRD+   N+L++ + + KIGDFGL +  P+D+        G   + + APE     
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 261 ELSEKADIYSFGVLVLEIIS 280
           + S  +D++SFGV++ E+ +
Sbjct: 193 KFSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 90  LGRGGFGPVYRGK---LAD--GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG+G FG V   +   L D  G +VAVKKL    +++   +F  E+ ++ S+QH N+V+ 
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 145 LGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            G C    +R   L+ EY+   SL   +    ++ ++     Q    I +G++YL     
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYL---GT 137
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRG 260
            R +HRD+   N+L++ + + KIGDFGL +  P+D+        G   + + APE     
Sbjct: 138 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 197
Query: 261 ELSEKADIYSFGVLVLEIIS 280
           + S  +D++SFGV++ E+ +
Sbjct: 198 KFSVASDVWSFGVVLYELFT 217

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 90  LGRGGFGPVYRGK---LAD--GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG+G FG V   +   L D  G +VAVKKL    +++   +F  E+ ++ S+QH N+V+ 
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 145 LGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            G C    +R   L+ EY+   SL   +    ++ ++     Q    I +G++YL     
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYL---GT 163
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRG 260
            R +HRD+   N+L++ + + KIGDFGL +  P+D+        G   + + APE     
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 223
Query: 261 ELSEKADIYSFGVLVLEIIS 280
           + S  +D++SFGV++ E+ +
Sbjct: 224 KFSVASDVWSFGVVLYELFT 243

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 127/268 (47%), Gaps = 32/268 (11%)
Query: 90  LGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +G VY G     +L VAVK L  D  +    EFL E  ++  I+H NLV+LLG C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +      ++ E+M   +L   +   + + ++      +   I+  ++YL + +    +HR
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHR 342
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           ++ A N L+ E    K+ DFGL+R    D           + +TAPE     + S K+D+
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 269 YSFGVLVLEI----ISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM-RKEGIV 323
           ++FGVL+ EI    +S     DL+             ++YE   +LE  D RM R EG  
Sbjct: 403 WAFGVLLWEIATYGMSPYPGIDLS-------------QVYE---LLE-KDYRMERPEGCP 445
Query: 324 ERDALQVINVAFICLQPHGNQRPPMSEI 351
           E+    V  +   C Q + + RP  +EI
Sbjct: 446 EK----VYELMRACWQWNPSDRPSFAEI 469

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 18/197 (9%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+       T VAVK +           FL+E  ++ ++QH  LV+L    +
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTM--KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 80
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDK-----FLNWSTRFQIILGIARGLQYLHEDSHTR 204
                ++     K   LD L   E  K      +++S +      IA G+ ++ + ++  
Sbjct: 81  KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQRNY-- 132
Query: 205 IVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELS 263
            +HRD++A+N+L+      KI DFGLAR   ED  Y +   A   + +TAPE    G  +
Sbjct: 133 -IHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFT 190
Query: 264 EKADIYSFGVLVLEIIS 280
            K+D++SFG+L++EI++
Sbjct: 191 IKSDVWSFGILLMEIVT 207

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 90  LGRGGFGPVYRGK---LAD--GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG+G FG V   +   L D  G +VAVKKL    +++   +F  E+ ++ S+QH N+V+ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 145 LGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            G C    +R   L+ EY+   SL   +    ++ ++     Q    I +G++YL     
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYL---GT 150
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRG 260
            R +HRD+   N+L++ + + KIGDFGL +  P+D+        G   + + APE     
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 261 ELSEKADIYSFGVLVLEIIS 280
           + S  +D++SFGV++ E+ +
Sbjct: 211 KFSVASDVWSFGVVLYELFT 230

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 90  LGRGGFGPVYRGK---LAD--GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG+G FG V   +   L D  G +VAVKKL    +++   +F  E+ ++ S+QH N+V+ 
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 145 LGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            G C    +R   L+ EY+   SL   +    ++ ++     Q    I +G++YL     
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYL---GT 139
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRG 260
            R +HRD+   N+L++ + + KIGDFGL +  P+D+        G   + + APE     
Sbjct: 140 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 199
Query: 261 ELSEKADIYSFGVLVLEIIS 280
           + S  +D++SFGV++ E+ +
Sbjct: 200 KFSVASDVWSFGVVLYELFT 219

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 127/291 (43%), Gaps = 36/291 (12%)
Query: 90  LGRGGFGPVYRGKLAD------GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG+G FG VY G   D       T VAVK +    S +   EFL+E  ++      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--------FQIILGIARGLQ 195
           LLG  S G   L+V E M +  L   +     +  N   R         Q+   IA G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YTA 253
           YL+     + VHR++ A N ++   F  KIGDFG+ R   E   Y      G L   + A
Sbjct: 145 YLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWMA 200
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           PE    G  +  +D++SFGV++ EI S  +     L +E Q L     K    G  L+  
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-QVL-----KFVMDGGYLD-- 252
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
               + +   ER    V ++  +C Q + N RP   EIV +L   +    P
Sbjct: 253 ----QPDNCPER----VTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFP 295

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 27/218 (12%)
Query: 87  GNLLGRGGFGPVY--------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V         + K  +   VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGK 99
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWS----------TRFQII 187
           HKN++ LLG C+      ++ EY    +L   +       + +S            F+ +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 188 LG----IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
           +     +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR       Y  +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           TN    + + APE       + ++D++SFGVL+ EI +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 90  LGRGGFGPVYRGK---LAD--GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG+G FG V   +   L D  G +VAVKKL    +++   +F  E+ ++ S+QH N+V+ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 145 LGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            G C    +R   L+ EY+   SL   +    ++ ++     Q    I +G++YL     
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYL---GT 150
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRG 260
            R +HRD+   N+L++ + + KIGDFGL +  P+D+        G   + + APE     
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 261 ELSEKADIYSFGVLVLEIIS 280
           + S  +D++SFGV++ E+ +
Sbjct: 211 KFSVASDVWSFGVVLYELFT 230

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 127/291 (43%), Gaps = 36/291 (12%)
Query: 90  LGRGGFGPVYRGKLAD------GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG+G FG VY G   D       T VAVK +    S +   EFL+E  ++      ++VR
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--------FQIILGIARGLQ 195
           LLG  S G   L+V E M +  L   +     +  N   R         Q+   IA G+ 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YTA 253
           YL+     + VHR++ A N ++   F  KIGDFG+ R   E   Y      G L   + A
Sbjct: 146 YLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWMA 201
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           PE    G  +  +D++SFGV++ EI S  +     L +E Q L     K    G  L+  
Sbjct: 202 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-QVL-----KFVMDGGYLD-- 253
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
               + +   ER    V ++  +C Q + N RP   EIV +L   +    P
Sbjct: 254 ----QPDNCPER----VTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFP 296

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 27/218 (12%)
Query: 87  GNLLGRGGFGPVY--------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V         + K  +   VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWS----------TRFQII 187
           HKN++ LLG C+      ++ EY    +L   +       + +S            F+ +
Sbjct: 100 HKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 188 LG----IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
           +     +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR       Y  +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           TN    + + APE       + ++D++SFGVL+ EI +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 142/282 (50%), Gaps = 38/282 (13%)
Query: 90  LGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGES-------EFLSEVRMITSIQHKNL 141
           +G+GGFG V++G+L  D ++VA+K L +  S +GE+       EF  EV +++++ H N+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDS-EGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
           V+L G   +  +  +V E++    L   +  ++   + WS + +++L IA G++Y+ ++ 
Sbjct: 86  VKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYM-QNQ 141
Query: 202 HTRIVHRDIKASNVL---LDEKFQ--SKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEY 256
           +  IVHRD+++ N+    LDE     +K+ DFG +    +   +  +   G   + APE 
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS----QQSVHSVSGLLGNFQWMAPET 197
Query: 257 --AIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD 314
             A     +EKAD YSF +++  I++     D           EY+   Y + + + ++ 
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPFD-----------EYS---YGKIKFINMIR 243
Query: 315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
               +  I E    ++ NV  +C      +RP  S IV  L+
Sbjct: 244 EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 27/218 (12%)
Query: 87  GNLLGRGGFGPVY--------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V         + K  +   VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWS----------TRFQII 187
           HKN++ LLG C+      ++ EY    +L   +       + +S            F+ +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 188 LG----IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL-S 242
           +     +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR       Y  +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNT 216
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           TN    + + APE       + ++D++SFGVL+ EI +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 142/282 (50%), Gaps = 38/282 (13%)
Query: 90  LGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGES-------EFLSEVRMITSIQHKNL 141
           +G+GGFG V++G+L  D ++VA+K L +  S +GE+       EF  EV +++++ H N+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDS-EGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
           V+L G   +  +  +V E++    L   +  ++   + WS + +++L IA G++Y+ ++ 
Sbjct: 86  VKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYM-QNQ 141
Query: 202 HTRIVHRDIKASNVL---LDEKFQ--SKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEY 256
           +  IVHRD+++ N+    LDE     +K+ DF L+    +   +  +   G   + APE 
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS----QQSVHSVSGLLGNFQWMAPET 197
Query: 257 --AIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD 314
             A     +EKAD YSF +++  I++     D           EY+   Y + + + ++ 
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPFD-----------EYS---YGKIKFINMIR 243
Query: 315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
               +  I E    ++ NV  +C      +RP  S IV  L+
Sbjct: 244 EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 27/218 (12%)
Query: 87  GNLLGRGGFGPVY--------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V         + K  +   VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWS----------TRFQII 187
           HKN++ LLG C+      ++ EY    +L   +       + +S            F+ +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 188 LG----IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
           +     +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR       Y  +
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           TN    + + APE       + ++D++SFGVL+ EI +
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 126/291 (43%), Gaps = 36/291 (12%)
Query: 90  LGRGGFGPVYRGKLAD------GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG+G FG VY G   D       T VAVK +    S +   EFL+E  ++      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--------FQIILGIARGLQ 195
           LLG  S G   L+V E M +  L   +     +  N   R         Q+   IA G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YTA 253
           YL+     + VHRD+ A N ++   F  KIGDFG+ R   E   Y      G L   + A
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG-KGLLPVRWMA 200
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           PE    G  +  +D++SFGV++ EI S  +     L +E Q L     K    G  L+  
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-QVL-----KFVMDGGYLD-- 252
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
               + +   ER    V ++  +C Q +   RP   EIV +L   +    P
Sbjct: 253 ----QPDNCPER----VTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 295

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 27/218 (12%)
Query: 87  GNLLGRGGFGPVY--------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V         + K  +   VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 138 HKNLVRLLGCCS-DGSQRLLVY--------EYMKNRSLDLLIYGES-----DKFLNWSTR 183
           HKN++ LLG C+ DG   ++V         EY++ R    + Y        ++ + +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
                 +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR       Y  +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           TN    + + APE       + ++D++SFGVL+ EI +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 27/218 (12%)
Query: 87  GNLLGRGGFGPVY--------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V         + K  +   VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWS----------TRFQII 187
           HKN++ LLG C+      ++ EY    +L   +       + +S            F+ +
Sbjct: 100 HKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 188 LG----IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
           +     +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR       Y  +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           TN    + + APE       + ++D++SFGVL+ EI +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 90  LGRGGFGPVYRGK---LAD--GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG+G FG V   +   L D  G +VAVKKL    +++   +F  E+ ++ S+QH N+V+ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 145 LGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            G C    +R   L+ E++   SL   +    ++ ++     Q    I +G++YL     
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER-IDHIKLLQYTSQICKGMEYL---GT 135
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRG 260
            R +HRD+   N+L++ + + KIGDFGL +  P+D+        G   + + APE     
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 261 ELSEKADIYSFGVLVLEIIS 280
           + S  +D++SFGV++ E+ +
Sbjct: 196 KFSVASDVWSFGVVLYELFT 215

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 87  GNLLGRGGFGPVY--------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V         + K  +   VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGE--------------SDKFLNWSTR 183
           HKN++ LLG C+      ++ EY    +L   +                  ++ + +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDL 159
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE-DQAYLS 242
                 +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR     D    +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKT 216
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           TN    + + APE       + ++D++SFGVL+ EI +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 95/195 (48%), Gaps = 16/195 (8%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGE--SEFLSEVRMITSIQHKNLVRLLG 146
           +G G FG VY  + + +  +VA+KK+     Q  E   + + EVR +  ++H N ++  G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
           C        LV EY    + DLL   +  K L       +  G  +GL YLH  SH  ++
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH--SHN-MI 176
Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI---RGELS 263
           HRD+KA N+LL E    K+GDFG A          +  F GT  + APE  +    G+  
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANXFVGTPYWMAPEVILAMDEGQYD 231
Query: 264 EKADIYSFGVLVLEI 278
            K D++S G+  +E+
Sbjct: 232 GKVDVWSLGITCIEL 246

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 98/194 (50%), Gaps = 16/194 (8%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           +G+G FG V  G    G  VAVK +  D + Q    FL+E  ++T ++H NLV+LLG   
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 256
Query: 150 DGSQRL-LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +    L +V EYM   SL   +       L      +  L +   ++YL  ++    VHR
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 313
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL--GYTAPEYAIRGELSEKA 266
           D+ A NVL+ E   +K+ DFGL +         ST   G L   +TAPE     + S K+
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFSTKS 367
Query: 267 DIYSFGVLVLEIIS 280
           D++SFG+L+ EI S
Sbjct: 368 DVWSFGILLWEIYS 381

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 95/195 (48%), Gaps = 16/195 (8%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGE--SEFLSEVRMITSIQHKNLVRLLG 146
           +G G FG VY  + + +  +VA+KK+     Q  E   + + EVR +  ++H N ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
           C        LV EY    + DLL   +  K L       +  G  +GL YLH  SH  ++
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH--SHN-MI 137
Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI---RGELS 263
           HRD+KA N+LL E    K+GDFG A          +  F GT  + APE  +    G+  
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANXFVGTPYWMAPEVILAMDEGQYD 192
Query: 264 EKADIYSFGVLVLEI 278
            K D++S G+  +E+
Sbjct: 193 GKVDVWSLGITCIEL 207

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 89/291 (30%), Positives = 125/291 (42%), Gaps = 36/291 (12%)
Query: 90  LGRGGFGPVYRGKLAD------GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG+G FG VY G   D       T VAVK +    S +   EFL+E  ++      ++VR
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--------FQIILGIARGLQ 195
           LLG  S G   L+V E M +  L   +     +  N   R         Q+   IA G+ 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YTA 253
           YL+     + VHRD+ A N ++   F  KIGDFG+ R   E   Y      G L   + A
Sbjct: 144 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWMA 199
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           PE    G  +  +D++SFGV++ EI S  +     L +E Q L     K    G  L+  
Sbjct: 200 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-QVL-----KFVMDGGYLDQP 253
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
           D         ER    V ++  +C Q +   RP   EIV +L   +    P
Sbjct: 254 D------NCPER----VTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 294

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 27/218 (12%)
Query: 87  GNLLGRGGFGPVY--------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V         + K  +   VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 27  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 86
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWS----------TRFQII 187
           HKN++ LLG C+      ++ EY    +L   +       + +S            F+ +
Sbjct: 87  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 146
Query: 188 LG----IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
           +     +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR       Y  +
Sbjct: 147 VSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKT 203
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           TN    + + APE       + ++D++SFGVL+ EI +
Sbjct: 204 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 27/218 (12%)
Query: 87  GNLLGRGGFGPVY--------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V         + K  +   VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 138 HKNLVRLLGCCS-DGSQRLLV--------YEYMKNRSLDLLIYGES-----DKFLNWSTR 183
           HKN++ LLG C+ DG   ++V         EY++ R    + Y        ++ + +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
                 +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR       Y  +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           TN    + + APE       + ++D++SFGVL+ EI +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 27/218 (12%)
Query: 87  GNLLGRGGFGPVY--------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V         + K    T VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 22  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 81
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR-------------- 183
           HKN++ LLG C+      ++ EY    +L   +       L +S                
Sbjct: 82  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 141
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
                 +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR       Y  +
Sbjct: 142 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 198
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           TN    + + APE       + ++D++SFGVL+ EI +
Sbjct: 199 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 27/218 (12%)
Query: 87  GNLLGRGGFGPVY--------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V         + K    T VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR-------------- 183
           HKN++ LLG C+      ++ EY    +L   +       L +S                
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
                 +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR       Y  +
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           TN    + + APE       + ++D++SFGVL+ EI +
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 27/218 (12%)
Query: 87  GNLLGRGGFGPVY--------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V         + K  +   VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 32  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 91
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWS----------TRFQII 187
           HKN++ LLG C+      ++ EY    +L   +       + +S            F+ +
Sbjct: 92  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 151
Query: 188 LG----IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
           +     +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR       Y  +
Sbjct: 152 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 208
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           TN    + + APE       + ++D++SFGVL+ EI +
Sbjct: 209 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 98/194 (50%), Gaps = 16/194 (8%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           +G+G FG V  G    G  VAVK +  D + Q    FL+E  ++T ++H NLV+LLG   
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69
Query: 150 DGSQRL-LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +    L +V EYM   SL   +       L      +  L +   ++YL  ++    VHR
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 126
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL--GYTAPEYAIRGELSEKA 266
           D+ A NVL+ E   +K+ DFGL +         ST   G L   +TAPE     + S K+
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 267 DIYSFGVLVLEIIS 280
           D++SFG+L+ EI S
Sbjct: 181 DVWSFGILLWEIYS 194

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 95/192 (49%), Gaps = 6/192 (3%)
Query: 90  LGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +G VY G     +L VAVK L  D  +    EFL E  ++  I+H NLV+LLG C
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 97
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +      +V EYM   +L   +   + + +       +   I+  ++YL + +    +HR
Sbjct: 98  TLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKN---FIHR 154
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+ A N L+ E    K+ DFGL+R    D           + +TAPE       S K+D+
Sbjct: 155 DLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDV 214
Query: 269 YSFGVLVLEIIS 280
           ++FGVL+ EI +
Sbjct: 215 WAFGVLLWEIAT 226

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 104/197 (52%), Gaps = 16/197 (8%)
Query: 90  LGRGGFGPVYRGKLADGTL----VAVKKLCVDKSQQGES--EFLSEVRMITSIQHKNLVR 143
           LG GG   VY   LA+ T+    VA+K + +   ++ E+   F  EV   + + H+N+V 
Sbjct: 19  LGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
           ++    +     LV EY++  +L    Y ES   L+  T       I  G+++ H+    
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSE--YIESHGPLSVDTAINFTNQILDGIKHAHD---M 130
Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELS 263
           RIVHRDIK  N+L+D     KI DFG+A+   E     + +  GT+ Y +PE A +GE +
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA-KGEAT 189
Query: 264 EK-ADIYSFGVLVLEII 279
           ++  DIYS G+++ E++
Sbjct: 190 DECTDIYSIGIVLYEML 206

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 27/218 (12%)
Query: 87  GNLLGRGGFGPVY--------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V         + K    T VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 26  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 85
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR-------------- 183
           HKN++ LLG C+      ++ EY    +L   +       L +S                
Sbjct: 86  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 145
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
                 +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR       Y  +
Sbjct: 146 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 202
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           TN    + + APE       + ++D++SFGVL+ EI +
Sbjct: 203 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 27/218 (12%)
Query: 87  GNLLGRGGFGPVY--------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V         + K  +   VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWS----------TRFQII 187
           HKN++ LLG C+      ++ EY    +L   +       + +S            F+ +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 188 LG----IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
           +     +ARG++YL   +  + +HRD+ A NVL+ E    +I DFGLAR       Y  +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKT 216
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           TN    + + APE       + ++D++SFGVL+ EI +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 27/218 (12%)
Query: 87  GNLLGRGGFGPVY--------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V         + K    T VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR-------------- 183
           HKN++ LLG C+      ++ EY    +L   +       L +S                
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE-DQAYLS 242
                 +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR     D    +
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKT 209
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           TN    + + APE       + ++D++SFGVL+ EI +
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 97/194 (50%), Gaps = 16/194 (8%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           +G+G FG V  G    G  VAVK +  D + Q    FL+E  ++T ++H NLV+LLG   
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 75
Query: 150 DGSQRL-LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +    L +V EYM   SL   +       L      +  L +   ++YL  ++    VHR
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 132
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL--GYTAPEYAIRGELSEKA 266
           D+ A NVL+ E   +K+ DFGL +         ST   G L   +TAPE       S K+
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREAAFSTKS 186
Query: 267 DIYSFGVLVLEIIS 280
           D++SFG+L+ EI S
Sbjct: 187 DVWSFGILLWEIYS 200

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 27/218 (12%)
Query: 87  GNLLGRGGFGPVY--------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V         + K  +   VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 29  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 88
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWS----------TRFQII 187
           HKN++ LLG C+      ++ EY    +L   +       + +S            F+ +
Sbjct: 89  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 148
Query: 188 LG----IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
           +     +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR       Y  +
Sbjct: 149 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 205
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           TN    + + APE       + ++D++SFGVL+ EI +
Sbjct: 206 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 27/218 (12%)
Query: 87  GNLLGRGGFGPVY--------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V         + K    T VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 25  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 84
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR-------------- 183
           HKN++ LLG C+      ++ EY    +L   +       L +S                
Sbjct: 85  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 144
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
                 +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR       Y  +
Sbjct: 145 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 201
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           TN    + + APE       + ++D++SFGVL+ EI +
Sbjct: 202 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 27/218 (12%)
Query: 87  GNLLGRGGFGPVY--------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V         + K    T VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR-------------- 183
           HKN++ LLG C+      ++ EY    +L   +       L +S                
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
                 +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR       Y  +
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           TN    + + APE       + ++D++SFGVL+ EI +
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 124/290 (42%), Gaps = 34/290 (11%)
Query: 90  LGRGGFGPVYRGKLAD------GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG+G FG VY G   D       T VAVK +    S +   EFL+E  ++      ++VR
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--------FQIILGIARGLQ 195
           LLG  S G   L+V E M +  L   +     +  N   R         Q+   IA G+ 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE-DQAYLSTNFAGTLGYTAP 254
           YL+     + VHRD+ A N ++   F  KIGDFG+ R   E D           + + AP
Sbjct: 142 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 255 EYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD 314
           E    G  +  +D++SFGV++ EI S  +     L +E Q L     K    G  L+  D
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-QVL-----KFVMDGGYLDQPD 252
Query: 315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
                    ER    V ++  +C Q +   RP   EIV +L   +    P
Sbjct: 253 ------NCPER----VTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 292

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 18/197 (9%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+       T VAVK +           FL+E  ++ ++QH  LV+L    +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTM--KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDK-----FLNWSTRFQIILGIARGLQYLHEDSHTR 204
                ++     K   LD L   E  K      +++S +      IA G+ ++ + ++  
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQRNY-- 305
Query: 205 IVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELS 263
            +HRD++A+N+L+      KI DFGLAR   ED  Y +   A   + +TAPE    G  +
Sbjct: 306 -IHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFT 363
Query: 264 EKADIYSFGVLVLEIIS 280
            K+D++SFG+L++EI++
Sbjct: 364 IKSDVWSFGILLMEIVT 380

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 98/194 (50%), Gaps = 16/194 (8%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           +G+G FG V  G    G  VAVK +  D + Q    FL+E  ++T ++H NLV+LLG   
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 84
Query: 150 DGSQRL-LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
           +    L +V EYM   SL   +       L      +  L +   ++YL  ++    VHR
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 141
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL--GYTAPEYAIRGELSEKA 266
           D+ A NVL+ E   +K+ DFGL +         ST   G L   +TAPE     + S K+
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFSTKS 195
Query: 267 DIYSFGVLVLEIIS 280
           D++SFG+L+ EI S
Sbjct: 196 DVWSFGILLWEIYS 209

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 125/290 (43%), Gaps = 34/290 (11%)
Query: 90  LGRGGFGPVYRGKLAD------GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG+G FG VY G   D       T VAVK +    S +   EFL+E  ++      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--------FQIILGIARGLQ 195
           LLG  S G   L+V E M +  L   +     +  N   R         Q+   IA G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE-DQAYLSTNFAGTLGYTAP 254
           YL+     + VHRD+ A N ++   F  KIGDFG+ R   E D           + + AP
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 255 EYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD 314
           E    G  +  +D++SFGV++ EI S  +     L +E Q L     K    G  L+   
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-QVL-----KFVMDGGYLD--- 252
Query: 315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
              + +   ER    V ++  +C Q +   RP   EIV +L   +    P
Sbjct: 253 ---QPDNCPER----VTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 295

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 108/217 (49%), Gaps = 26/217 (11%)
Query: 87  GNLLGRGGFGPVYRG------KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHK 139
           G  LGRG FG V         K A    VAVK L    +       +SE++++  I  H 
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 140 NLVRLLGCCSDGSQRLLVY----------EYMKNRSLDLLIYGES--DKFLNWSTRFQII 187
           N+V LLG C+     L+V            Y++++  + + Y E+  D + ++ T   +I
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLI 153
Query: 188 ---LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN 244
                +A+G+++L   +  + +HRD+ A N+LL EK   KI DFGLAR   +D  Y+   
Sbjct: 154 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 210
Query: 245 FAG-TLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            A   L + APE       + ++D++SFGVL+ EI S
Sbjct: 211 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 24/215 (11%)
Query: 87  GNLLGRGGFGPVYRG------KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHK 139
           G  LGRG FG V         K A    VAVK L    +       +SE++++  I  H 
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 140 NLVRLLGCCSDGSQRLLVY----------EYMKNRSLDLLIYGESDKFLNWSTRFQII-- 187
           N+V LLG C+     L+V            Y++++  + + Y   D + ++ T   +I  
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXY 153
Query: 188 -LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA 246
              +A+G+++L   +  + +HRD+ A N+LL EK   KI DFGLAR   +D   +    A
Sbjct: 154 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 247 G-TLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
              L + APE       + ++D++SFGVL+ EI S
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 108/218 (49%), Gaps = 27/218 (12%)
Query: 87  GNLLGRGGFGPVY--------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V         + K    T VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 138 HKNLVRLLGCCS-DGSQRLLV--------YEYMKNRSLDLLIY-----GESDKFLNWSTR 183
           HKN++ LLG C+ DG   ++V         EY++ R    L Y        ++ L+    
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
                 +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR       Y  +
Sbjct: 138 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           TN    + + APE       + ++D++SFGVL+ EI +
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 113/241 (46%), Gaps = 34/241 (14%)
Query: 82  KNFHPGNLLGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITS 135
           KN   G  LG G FG V +         A  T VAVK L  + S     + LSE  ++  
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 136 IQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF---------------LNW 180
           + H ++++L G CS     LL+ EY K  SL   +  ES K                L+ 
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLR-ESRKVGPGYLGSGGSRNSSSLDH 141
Query: 181 STRFQIILG--------IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR 232
                + +G        I++G+QYL E    ++VHRD+ A N+L+ E  + KI DFGL+R
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 233 FFPEDQAYLSTNFAGT-LGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPS 291
              E+ +Y+  +     + + A E       + ++D++SFGVL+ EI++   N    +P 
Sbjct: 199 DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258
Query: 292 E 292
           E
Sbjct: 259 E 259

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 27/218 (12%)
Query: 87  GNLLGRGGFGPVY--------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V         + K    T VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR-------------- 183
           HKN++ LLG C+      ++ EY    +L   +       L +S                
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
                 +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR       Y  +
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           TN    + + APE       + ++D++SFGVL+ EI +
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 106/217 (48%), Gaps = 26/217 (11%)
Query: 87  GNLLGRGGFGPVYRG------KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHK 139
           G  LGRG FG V         K A    VAVK L    +       +SE++++  I  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 140 NLVRLLGCCSD-GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII----------- 187
           N+V LLG C+  G   +++ E+ K  +L   +  + ++F+ +    + +           
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 188 ---LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN 244
                +A+G+++L   +  + +HRD+ A N+LL EK   KI DFGLAR   +D  Y+   
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 245 FAG-TLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            A   L + APE       + ++D++SFGVL+ EI S
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 108/218 (49%), Gaps = 27/218 (12%)
Query: 87  GNLLGRGGFGPVY--------RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V         + K    T VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 138 HKNLVRLLGCCS-DGSQRLLV--------YEYMKNRSLDLLIY-----GESDKFLNWSTR 183
           HKN++ LLG C+ DG   ++V         EY++ R    L Y        ++ L+    
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
                 +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR       Y  +
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           TN    + + APE       + ++D++SFGVL+ EI +
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 90  LGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG G FG VY G+++          VAVK L    S+Q E +FL E  +I+ + H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWST-----RFQIILGIARGLQYLH 198
            +G       R ++ E M    L   +     +    S+        +   IA G QYL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 199 EDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAP 254
           E+     +HRDI A N LL        +KIGDFG+AR       Y     A   + +  P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 255 EYAIRGELSEKADIYSFGVLVLEIIS 280
           E  + G  + K D +SFGVL+ EI S
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 106/217 (48%), Gaps = 26/217 (11%)
Query: 87  GNLLGRGGFGPVYRG------KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHK 139
           G  LGRG FG V         K A    VAVK L    +       +SE++++  I  H 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 140 NLVRLLGCCSD-GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII----------- 187
           N+V LLG C+  G   +++ E+ K  +L   +  + ++F+ +    + +           
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 188 ---LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN 244
                +A+G+++L   +  + +HRD+ A N+LL EK   KI DFGLAR   +D  Y+   
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 245 FAG-TLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            A   L + APE       + ++D++SFGVL+ EI S
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 100/227 (44%), Gaps = 33/227 (14%)
Query: 83  NFHPGNLLGRGGFGPVYRGKL-----ADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSI 136
           N   G  LG G FG V           D  L VAVK L        +   +SE+++++ +
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 137 -QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR-------FQIIL 188
            QH+N+V LLG C+ G   L++ EY          YG+   FL   +R       F I  
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEY--------CCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 189 GIARGLQYLHEDSHT----------RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ 238
             A     LH  S              +HRD+ A NVLL     +KIGDFGLAR    D 
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 239 AYL-STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKN 284
            Y+   N    + + APE       + ++D++S+G+L+ EI S   N
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN 265

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 119/263 (45%), Gaps = 40/263 (15%)
Query: 82  KNFHPGNLLGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITS 135
           KN   G  LG G FG V +         A  T VAVK L  + S     + LSE  ++  
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 136 IQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF---------------LNW 180
           + H ++++L G CS     LL+ EY K  SL   +  ES K                L+ 
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLR-ESRKVGPGYLGSGGSRNSSSLDH 141
Query: 181 STRFQIILG--------IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR 232
                + +G        I++G+QYL E    ++VHRD+ A N+L+ E  + KI DFGL+R
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 233 -FFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPS 291
             + ED     +     + + A E       + ++D++SFGVL+ EI++   N    +P 
Sbjct: 199 DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP- 257
Query: 292 EMQYLPEYAWKLYERGRILELVD 314
                PE  + L + G  +E  D
Sbjct: 258 -----PERLFNLLKTGHRMERPD 275

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/192 (32%), Positives = 107/192 (55%), Gaps = 12/192 (6%)
Query: 90  LGRGGFGPVYRGKLADGT--LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G+G FG V++G + + T  +VA+K + +++++    +   E+ +++      + +  G 
Sbjct: 31  IGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGS 89
Query: 148 CSDGSQRLLVYEYMKNRS-LDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
              GS+  ++ EY+   S LDLL  G  D+F   +T  + IL   +GL YLH +   + +
Sbjct: 90  YLKGSKLWIIMEYLGGGSALDLLRAGPFDEF-QIATMLKEIL---KGLDYLHSE---KKI 142
Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKA 266
           HRDIKA+NVLL E+   K+ DFG+A    + Q   +T F GT  + APE   +     KA
Sbjct: 143 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIQQSAYDSKA 201
Query: 267 DIYSFGVLVLEI 278
           DI+S G+  +E+
Sbjct: 202 DIWSLGITAIEL 213

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 106/217 (48%), Gaps = 26/217 (11%)
Query: 87  GNLLGRGGFGPVYRG------KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHK 139
           G  LGRG FG V         K A    VAVK L    +       +SE++++  I  H 
Sbjct: 69  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 128
Query: 140 NLVRLLGCCSD-GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII----------- 187
           N+V LLG C+  G   +++ E+ K  +L   +  + ++F+ +    + +           
Sbjct: 129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 188
Query: 188 ---LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN 244
                +A+G+++L   +  + +HRD+ A N+LL EK   KI DFGLAR   +D  Y+   
Sbjct: 189 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 245
Query: 245 FAG-TLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            A   L + APE       + ++D++SFGVL+ EI S
Sbjct: 246 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 90  LGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG G FG VY G+++          VAVK L    S+Q E +FL E  +I+ + H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWST-----RFQIILGIARGLQYLH 198
            +G       R ++ E M    L   +     +    S+        +   IA G QYL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 199 EDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAP 254
           E+     +HRDI A N LL        +KIGDFG+AR       Y     A   + +  P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 255 EYAIRGELSEKADIYSFGVLVLEIIS 280
           E  + G  + K D +SFGVL+ EI S
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 90  LGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG G FG VY G+++          VAVK L    S+Q E +FL E  +I+   H+N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWST-----RFQIILGIARGLQYLH 198
            +G       R ++ E M    L   +     +    S+        +   IA G QYL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 199 EDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAP 254
           E+     +HRDI A N LL        +KIGDFG+AR       Y     A   + +  P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 255 EYAIRGELSEKADIYSFGVLVLEIIS 280
           E  + G  + K D +SFGVL+ EI S
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 119/263 (45%), Gaps = 40/263 (15%)
Query: 82  KNFHPGNLLGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITS 135
           KN   G  LG G FG V +         A  T VAVK L  + S     + LSE  ++  
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 136 IQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF---------------LNW 180
           + H ++++L G CS     LL+ EY K  SL   +  ES K                L+ 
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLR-ESRKVGPGYLGSGGSRNSSSLDH 141
Query: 181 STRFQIILG--------IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR 232
                + +G        I++G+QYL E S   +VHRD+ A N+L+ E  + KI DFGL+R
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 233 -FFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPS 291
             + ED     +     + + A E       + ++D++SFGVL+ EI++   N    +P 
Sbjct: 199 DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP- 257
Query: 292 EMQYLPEYAWKLYERGRILELVD 314
                PE  + L + G  +E  D
Sbjct: 258 -----PERLFNLLKTGHRMERPD 275

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 25/216 (11%)
Query: 87  GNLLGRGGFGPVYRG------KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHK 139
           G  LGRG FG V         K A    VAVK L    +       +SE++++  I  H 
Sbjct: 33  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 92
Query: 140 NLVRLLGCCSD-GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII----------- 187
           N+V LLG C+  G   +++ E+ K  +L   +  + ++F+ + T   +            
Sbjct: 93  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLIC 152
Query: 188 --LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF 245
               +A+G+++L   +  + +HRD+ A N+LL EK   KI DFGLAR   +D   +    
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 246 AG-TLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           A   L + APE       + ++D++SFGVL+ EI S
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 106/217 (48%), Gaps = 26/217 (11%)
Query: 87  GNLLGRGGFGPVYRG------KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHK 139
           G  LGRG FG V         K A    VAVK L    +       +SE++++  I  H 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 140 NLVRLLGCCSD-GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII----------- 187
           N+V LLG C+  G   +++ E+ K  +L   +  + ++F+ +    + +           
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 188 ---LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN 244
                +A+G+++L   +  + +HRD+ A N+LL EK   KI DFGLAR   +D  Y+   
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 245 FAG-TLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            A   L + APE       + ++D++SFGVL+ EI S
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 105/234 (44%), Gaps = 22/234 (9%)
Query: 62  FNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLC 115
           F G   +IS  D + + +  KN      LG G FG VY G+++          VAVK L 
Sbjct: 41  FAGKTSSIS--DLKEVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 96
Query: 116 VDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESD 175
              S+Q E +FL E  +I+   H+N+VR +G       R ++ E M    L   +     
Sbjct: 97  EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 156
Query: 176 KFLNWST-----RFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD---EKFQSKIGD 227
           +    S+        +   IA G QYL E+     +HRDI A N LL        +KIGD
Sbjct: 157 RPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 213
Query: 228 FGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           FG+AR       Y     A   + +  PE  + G  + K D +SFGVL+ EI S
Sbjct: 214 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 133/292 (45%), Gaps = 42/292 (14%)
Query: 90  LGRGGFGPVYRGKLADG-------TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           LG+G FG VY G +A G       T VA+K +    S +   EFL+E  ++      ++V
Sbjct: 33  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYG-----ESDKFL---NWSTRFQIILGIARGL 194
           RLLG  S G   L++ E M    L   +       E++  L   + S   Q+   IA G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 151
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YT 252
            YL+ +   + VHRD+ A N ++ E F  KIGDFG+ R   E   Y      G L   + 
Sbjct: 152 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWM 207
Query: 253 APEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL 312
           +PE    G  +  +D++SFGV++ EI +  +     L +E Q L     +    G +L+ 
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVL-----RFVMEGGLLDK 261
Query: 313 VD--PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESG 362
            D  P M            +  +  +C Q +   RP   EI++ +  ++E G
Sbjct: 262 PDNCPDM------------LFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 90  LGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG G FG VY G+++          VAVK L    S+Q E +FL E  +I+   H+N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWST-----RFQIILGIARGLQYLH 198
            +G       R ++ E M    L   +     +    S+        +   IA G QYL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 199 EDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAP 254
           E+     +HRDI A N LL        +KIGDFG+AR       Y     A   + +  P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 255 EYAIRGELSEKADIYSFGVLVLEIIS 280
           E  + G  + K D +SFGVL+ EI S
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 133/292 (45%), Gaps = 42/292 (14%)
Query: 90  LGRGGFGPVYRGKLADG-------TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           LG+G FG VY G +A G       T VA+K +    S +   EFL+E  ++      ++V
Sbjct: 26  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYG-----ESDKFL---NWSTRFQIILGIARGL 194
           RLLG  S G   L++ E M    L   +       E++  L   + S   Q+   IA G+
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YT 252
            YL+ +   + VHRD+ A N ++ E F  KIGDFG+ R   E   Y      G L   + 
Sbjct: 145 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWM 200
Query: 253 APEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL 312
           +PE    G  +  +D++SFGV++ EI +  +     L +E Q L     +    G +L+ 
Sbjct: 201 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVL-----RFVMEGGLLDK 254
Query: 313 VD--PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESG 362
            D  P M            +  +  +C Q +   RP   EI++ +  ++E G
Sbjct: 255 PDNCPDM------------LFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 294

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 105/234 (44%), Gaps = 22/234 (9%)
Query: 62  FNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLC 115
           F G   +IS  D + + +  KN      LG G FG VY G+++          VAVK L 
Sbjct: 31  FAGKTSSIS--DLKEVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 86
Query: 116 VDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESD 175
              S+Q E +FL E  +I+   H+N+VR +G       R ++ E M    L   +     
Sbjct: 87  EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 146
Query: 176 KFLNWST-----RFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL---DEKFQSKIGD 227
           +    S+        +   IA G QYL E+     +HRDI A N LL        +KIGD
Sbjct: 147 RPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 203
Query: 228 FGLARFFPEDQAYLSTNFAG-TLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           FG+AR       Y     A   + +  PE  + G  + K D +SFGVL+ EI S
Sbjct: 204 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 90  LGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG G FG VY G+++          VAVK L    S+Q E +FL E  +I+   H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWST-----RFQIILGIARGLQYLH 198
            +G       R ++ E M    L   +     +    S+        +   IA G QYL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 199 EDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAP 254
           E+     +HRDI A N LL        +KIGDFG+AR       Y     A   + +  P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 255 EYAIRGELSEKADIYSFGVLVLEIIS 280
           E  + G  + K D +SFGVL+ EI S
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 90  LGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG G FG VY G+++          VAVK L    S+Q E +FL E  +I+   H+N+VR
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWST-----RFQIILGIARGLQYLH 198
            +G       R ++ E M    L   +     +    S+        +   IA G QYL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 199 EDSHTRIVHRDIKASNVLLD---EKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAP 254
           E+     +HRDI A N LL        +KIGDFG+AR       Y     A   + +  P
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 255 EYAIRGELSEKADIYSFGVLVLEIIS 280
           E  + G  + K D +SFGVL+ EI S
Sbjct: 222 EAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 133/292 (45%), Gaps = 42/292 (14%)
Query: 90  LGRGGFGPVYRGKLADG-------TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           LG+G FG VY G +A G       T VA+K +    S +   EFL+E  ++      ++V
Sbjct: 24  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 82
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYG-----ESDKFL---NWSTRFQIILGIARGL 194
           RLLG  S G   L++ E M    L   +       E++  L   + S   Q+   IA G+
Sbjct: 83  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 142
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YT 252
            YL+ +   + VHRD+ A N ++ E F  KIGDFG+ R   E   Y      G L   + 
Sbjct: 143 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWM 198
Query: 253 APEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL 312
           +PE    G  +  +D++SFGV++ EI +  +     L +E Q L     +    G +L+ 
Sbjct: 199 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVL-----RFVMEGGLLDK 252
Query: 313 VD--PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESG 362
            D  P M            +  +  +C Q +   RP   EI++ +  ++E G
Sbjct: 253 PDNCPDM------------LFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 292

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 133/292 (45%), Gaps = 42/292 (14%)
Query: 90  LGRGGFGPVYRGKLADG-------TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           LG+G FG VY G +A G       T VA+K +    S +   EFL+E  ++      ++V
Sbjct: 26  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYG-----ESDKFL---NWSTRFQIILGIARGL 194
           RLLG  S G   L++ E M    L   +       E++  L   + S   Q+   IA G+
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YT 252
            YL+ +   + VHRD+ A N ++ E F  KIGDFG+ R   E   Y      G L   + 
Sbjct: 145 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWM 200
Query: 253 APEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL 312
           +PE    G  +  +D++SFGV++ EI +  +     L +E Q L     +    G +L+ 
Sbjct: 201 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVL-----RFVMEGGLLDK 254
Query: 313 VD--PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESG 362
            D  P M            +  +  +C Q +   RP   EI++ +  ++E G
Sbjct: 255 PDNCPDM------------LFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 294

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 90  LGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG G FG VY G+++          VAVK L    S+Q E +FL E  +I+   H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWST-----RFQIILGIARGLQYLH 198
            +G       R ++ E M    L   +     +    S+        +   IA G QYL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 199 EDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAP 254
           E+     +HRDI A N LL        +KIGDFG+AR       Y     A   + +  P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 255 EYAIRGELSEKADIYSFGVLVLEIIS 280
           E  + G  + K D +SFGVL+ EI S
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 90  LGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG G FG VY G+++          VAVK L    S+Q E +FL E  +I+   H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWST-----RFQIILGIARGLQYLH 198
            +G       R ++ E M    L   +     +    S+        +   IA G QYL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 199 EDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAP 254
           E+     +HRDI A N LL        +KIGDFG+AR       Y     A   + +  P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 255 EYAIRGELSEKADIYSFGVLVLEIIS 280
           E  + G  + K D +SFGVL+ EI S
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 133/292 (45%), Gaps = 42/292 (14%)
Query: 90  LGRGGFGPVYRGKLADG-------TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           LG+G FG VY G +A G       T VA+K +    S +   EFL+E  ++      ++V
Sbjct: 27  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYG-----ESDKFL---NWSTRFQIILGIARGL 194
           RLLG  S G   L++ E M    L   +       E++  L   + S   Q+   IA G+
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YT 252
            YL+ +   + VHRD+ A N ++ E F  KIGDFG+ R   E   Y      G L   + 
Sbjct: 146 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWM 201
Query: 253 APEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL 312
           +PE    G  +  +D++SFGV++ EI +  +     L +E Q L     +    G +L+ 
Sbjct: 202 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVL-----RFVMEGGLLDK 255
Query: 313 VD--PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESG 362
            D  P M            +  +  +C Q +   RP   EI++ +  ++E G
Sbjct: 256 PDNCPDM------------LFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 295

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 133/292 (45%), Gaps = 42/292 (14%)
Query: 90  LGRGGFGPVYRGKLADG-------TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           LG+G FG VY G +A G       T VA+K +    S +   EFL+E  ++      ++V
Sbjct: 20  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYG-----ESDKFL---NWSTRFQIILGIARGL 194
           RLLG  S G   L++ E M    L   +       E++  L   + S   Q+   IA G+
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YT 252
            YL+ +   + VHRD+ A N ++ E F  KIGDFG+ R   E   Y      G L   + 
Sbjct: 139 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWM 194
Query: 253 APEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL 312
           +PE    G  +  +D++SFGV++ EI +  +     L +E Q L     +    G +L+ 
Sbjct: 195 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVL-----RFVMEGGLLDK 248
Query: 313 VD--PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESG 362
            D  P M            +  +  +C Q +   RP   EI++ +  ++E G
Sbjct: 249 PDNCPDM------------LFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 288

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 129/292 (44%), Gaps = 42/292 (14%)
Query: 90  LGRGGFGPVYRGKLADG-------TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           LG+G FG VY G +A G       T VA+K +    S +   EFL+E  ++      ++V
Sbjct: 23  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 81
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLN--------WSTRFQIILGIARGL 194
           RLLG  S G   L++ E M    L   +        N         S   Q+   IA G+
Sbjct: 82  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 141
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YT 252
            YL+ +   + VHRD+ A N ++ E F  KIGDFG+ R   E   Y      G L   + 
Sbjct: 142 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWM 197
Query: 253 APEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL 312
           +PE    G  +  +D++SFGV++ EI +  +     L +E Q L     +    G +L+ 
Sbjct: 198 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVL-----RFVMEGGLLDK 251
Query: 313 VD--PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESG 362
            D  P M            +  +  +C Q +   RP   EI++ +  ++E G
Sbjct: 252 PDNCPDM------------LFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 291

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 90  LGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG G FG VY G+++          VAVK L    S+Q E +FL E  +I+   H+N+VR
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWST-----RFQIILGIARGLQYLH 198
            +G       R ++ E M    L   +     +    S+        +   IA G QYL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 199 EDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAP 254
           E+     +HRDI A N LL        +KIGDFG+AR       Y     A   + +  P
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 255 EYAIRGELSEKADIYSFGVLVLEIIS 280
           E  + G  + K D +SFGVL+ EI S
Sbjct: 207 EAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 19/218 (8%)
Query: 83  NFHPGNLLGRGGFGPVYRGKL-----ADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSI 136
           N   G  LG G FG V           D  L VAVK L        +   +SE+++++ +
Sbjct: 39  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 98
Query: 137 -QHKNLVRLLGCCSDGSQRLLVYEY--------MKNRSLDLLIYGESDKFLNWSTRFQII 187
            QH+N+V LLG C+ G   L++ EY           R  +  +  E  + L         
Sbjct: 99  GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 158
Query: 188 LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL-STNFA 246
             +A+G+ +L   +    +HRD+ A NVLL     +KIGDFGLAR    D  Y+   N  
Sbjct: 159 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 215
Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKN 284
             + + APE       + ++D++S+G+L+ EI S   N
Sbjct: 216 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN 253

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 129/292 (44%), Gaps = 42/292 (14%)
Query: 90  LGRGGFGPVYRGKLADG-------TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           LG+G FG VY G +A G       T VA+K +    S +   EFL+E  ++      ++V
Sbjct: 33  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLN--------WSTRFQIILGIARGL 194
           RLLG  S G   L++ E M    L   +        N         S   Q+   IA G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YT 252
            YL+ +   + VHRD+ A N ++ E F  KIGDFG+ R   E   Y      G L   + 
Sbjct: 152 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWM 207
Query: 253 APEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL 312
           +PE    G  +  +D++SFGV++ EI +  +     L +E Q L     +    G +L+ 
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVL-----RFVMEGGLLDK 261
Query: 313 VD--PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESG 362
            D  P M            +  +  +C Q +   RP   EI++ +  ++E G
Sbjct: 262 PDNCPDM------------LFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 19/218 (8%)
Query: 83  NFHPGNLLGRGGFGPVYR------GKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI 136
           N   G  LG G FG V        GK      VAVK L        +   +SE+++++ +
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 137 -QHKNLVRLLGCCSDGSQRLLVYEY--------MKNRSLDLLIYGESDKFLNWSTRFQII 187
            QH+N+V LLG C+ G   L++ EY           R  +  +  E  + L         
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 166
Query: 188 LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL-STNFA 246
             +A+G+ +L   +    +HRD+ A NVLL     +KIGDFGLAR    D  Y+   N  
Sbjct: 167 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 223
Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKN 284
             + + APE       + ++D++S+G+L+ EI S   N
Sbjct: 224 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN 261

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 18/209 (8%)
Query: 87  GNLLGRGGFGPVYRGKLA--DGTL--VAVKKLCVDKSQQGE-SEFLSEVRMITSIQHKNL 141
           G +LG G FG V  G L   DGT   VAVK + +D S Q E  EFLSE   +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 142 VRLLGCCSDGSQR-----LLVYEYMKNRSLD-LLIYGESD---KFLNWSTRFQIILGIAR 192
           +RLLG C + S +     +++  +MK   L   L+Y   +   K +   T  + ++ IA 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT-LGY 251
           G++YL   S+   +HRD+ A N +L +     + DFGL++       Y     A   + +
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 252 TAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            A E       + K+D+++FGV + EI +
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 105/222 (47%), Gaps = 23/222 (10%)
Query: 83  NFHPGNLLGRGGFGPVYRGKL-----ADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSI 136
           N   G  LG G FG V           D  L VAVK L        +   +SE+++++ +
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 137 -QHKNLVRLLGCCSDGSQRLLVYEYM-----------KNRSLDL-LIYGESDKFLNWSTR 183
            QH+N+V LLG C+ G   L++ EY            K+R L+    +  ++  L+    
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDL 166
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL-S 242
                 +A+G+ +L   +    +HRD+ A NVLL     +KIGDFGLAR    D  Y+  
Sbjct: 167 LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 223
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKN 284
            N    + + APE       + ++D++S+G+L+ EI S   N
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN 265

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 133/292 (45%), Gaps = 42/292 (14%)
Query: 90  LGRGGFGPVYRGKLADG-------TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           LG+G FG VY G +A G       T VA+K +    S +   EFL+E  ++      ++V
Sbjct: 55  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 113
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYG-----ESDKFL---NWSTRFQIILGIARGL 194
           RLLG  S G   L++ E M    L   +       E++  L   + S   Q+   IA G+
Sbjct: 114 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 173
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YT 252
            YL+ +   + VHRD+ A N ++ E F  KIGDFG+ R   E   Y      G L   + 
Sbjct: 174 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWM 229
Query: 253 APEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL 312
           +PE    G  +  +D++SFGV++ EI +  +     L +E Q L     +    G +L+ 
Sbjct: 230 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVL-----RFVMEGGLLDK 283
Query: 313 VD--PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESG 362
            D  P M            +  +  +C Q +   RP   EI++ +  ++E G
Sbjct: 284 PDNCPDM------------LFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 323

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 90  LGRGGFGPV---YRGKLADGT--LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG G FG V         DGT  +VAVK L  D   Q  S +  E+ ++ ++ H+++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 145 LGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            GCC D  ++   LV EY+   SL   +   S   +  +        I  G+ YLH   +
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHSQHY 138
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG--TLGYTAPEYAIRG 260
              +HR++ A NVLLD     KIGDFGLA+  PE   Y      G   + + APE     
Sbjct: 139 ---IHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 261 ELSEKADIYSFGVLVLEIIS 280
           +    +D++SFGV + E+++
Sbjct: 196 KFYYASDVWSFGVTLYELLT 215

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 133/291 (45%), Gaps = 40/291 (13%)
Query: 90  LGRGGFGPVYRGKLADG-------TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           LG+G FG VY G +A G       T VA+K +    S +   EFL+E  ++      ++V
Sbjct: 18  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 76
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYG-----ESDKFL---NWSTRFQIILGIARGL 194
           RLLG  S G   L++ E M    L   +       E++  L   + S   Q+   IA G+
Sbjct: 77  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 136
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE-DQAYLSTNFAGTLGYTA 253
            YL+ +   + VHRD+ A N ++ E F  KIGDFG+ R   E D           + + +
Sbjct: 137 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMS 193
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           PE    G  +  +D++SFGV++ EI +  +     L +E Q L     +    G +L+  
Sbjct: 194 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVL-----RFVMEGGLLDKP 247
Query: 314 D--PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESG 362
           D  P M            ++ +  +C Q +   RP   EI++ +  ++E G
Sbjct: 248 DNCPDM------------LLELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 286

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 90  LGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG G FG VY G+++          VAVK L    S+Q E +FL E  +I+   H+N+VR
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWST-----RFQIILGIARGLQYLH 198
            +G       R ++ E M    L   +     +    S+        +   IA G QYL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 199 EDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAP 254
           E+     +HRDI A N LL        +KIGDFG+AR       Y     A   + +  P
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 255 EYAIRGELSEKADIYSFGVLVLEIIS 280
           E  + G  + K D +SFGVL+ EI S
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 90  LGRGGFGPV---YRGKLADGT--LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG G FG V         DGT  +VAVK L  D   Q  S +  E+ ++ ++ H+++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 145 LGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            GCC D  ++   LV EY+   SL   +   S   +  +        I  G+ YLH   +
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQHY 138
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG--TLGYTAPEYAIRG 260
              +HR++ A NVLLD     KIGDFGLA+  PE   Y      G   + + APE     
Sbjct: 139 ---IHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 261 ELSEKADIYSFGVLVLEIIS 280
           +    +D++SFGV + E+++
Sbjct: 196 KFYYASDVWSFGVTLYELLT 215

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 90  LGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG G FG VY G+++          VAVK L    S+Q E +FL E  +I+   H+N+VR
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWST-----RFQIILGIARGLQYLH 198
            +G       R ++ E M    L   +     +    S+        +   IA G QYL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 199 EDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAP 254
           E+     +HRDI A N LL        +KIGDFG+AR       Y     A   + +  P
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 255 EYAIRGELSEKADIYSFGVLVLEIIS 280
           E  + G  + K D +SFGVL+ EI S
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 133/292 (45%), Gaps = 42/292 (14%)
Query: 90  LGRGGFGPVYRGKLADG-------TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           LG+G FG VY G +A G       T VA+K +    S +   EFL+E  ++      ++V
Sbjct: 20  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYG-----ESDKFL---NWSTRFQIILGIARGL 194
           RLLG  S G   L++ E M    L   +       E++  L   + S   Q+   IA G+
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG--YT 252
            YL+ +   + VHRD+ A N  + E F  KIGDFG+ R   E   Y      G L   + 
Sbjct: 139 AYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWM 194
Query: 253 APEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL 312
           +PE    G  +  +D++SFGV++ EI +  +     L +E Q L     +    G +L+ 
Sbjct: 195 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVL-----RFVMEGGLLDK 248
Query: 313 VD--PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESG 362
            D  P M            ++ +  +C Q +   RP   EI++ +  ++E G
Sbjct: 249 PDNCPDM------------LLELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 288

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 11/200 (5%)
Query: 90  LGRGGFGPVYR-GKLADGTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQHKNLVRLLGC 147
           +G G +G   +  + +DG ++  K+L      + E + L SEV ++  ++H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 148 CSDGSQRLL--VYEYMKNRSLDLLIY--GESDKFLNWSTRFQIILGIARGLQYLHEDS-- 201
             D +   L  V EY +   L  +I    +  ++L+     +++  +   L+  H  S  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 202 -HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
            HT ++HRD+K +NV LD K   K+GDFGLAR    D ++  T F GT  Y +PE   R 
Sbjct: 134 GHT-VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPYYMSPEQMNRM 191
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             +EK+DI+S G L+ E+ +
Sbjct: 192 SYNEKSDIWSLGCLLYELCA 211

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 132/291 (45%), Gaps = 40/291 (13%)
Query: 90  LGRGGFGPVYRGKLADG-------TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           LG+G FG VY G +A G       T VA+K +    S +   EFL+E  ++      ++V
Sbjct: 27  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYG-----ESDKFL---NWSTRFQIILGIARGL 194
           RLLG  S G   L++ E M    L   +       E++  L   + S   Q+   IA G+
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE-DQAYLSTNFAGTLGYTA 253
            YL+ +   + VHRD+ A N ++ E F  KIGDFG+ R   E D           + + +
Sbjct: 146 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMS 202
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           PE    G  +  +D++SFGV++ EI +  +     L +E Q L     +    G +L+  
Sbjct: 203 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVL-----RFVMEGGLLDKP 256
Query: 314 D--PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESG 362
           D  P M            +  +  +C Q +   RP   EI++ +  ++E G
Sbjct: 257 DNCPDM------------LFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 295

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 129/291 (44%), Gaps = 35/291 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 122
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI DFG +   P  +    T+  GTL Y  P
Sbjct: 123 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPP 176
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           E  I G +  EK D++S GVL  E +  +       P E     E     Y+R   +E  
Sbjct: 177 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISRVEFT 225
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
            P    EG   RD +  +      L+ + +QRP + E++        S  P
Sbjct: 226 FPDFVTEGA--RDLISRL------LKHNPSQRPMLREVLEHPWITANSSKP 268

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 107/229 (46%), Gaps = 50/229 (21%)
Query: 90  LGRGGFGPVYRGKLADG-------TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           +G G FG V++ + A G       T+VAVK L  + S   +++F  E  ++    + N+V
Sbjct: 55  IGEGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFL--------------NWSTRFQII- 187
           +LLG C+ G    L++EYM         YG+ ++FL              + STR ++  
Sbjct: 114 KLLGVCAVGKPMCLLFEYMA--------YGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 188 -----------LGIAR----GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR 232
                      L IAR    G+ YL E    + VHRD+   N L+ E    KI DFGL+R
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSR 222
Query: 233 -FFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
             +  D      N A  + +  PE       + ++D++++GV++ EI S
Sbjct: 223 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 85/295 (28%), Positives = 128/295 (43%), Gaps = 43/295 (14%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ------IILGI 190
           +H N++RL G   D ++  L+ EY           GE  K L   ++F        I  +
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPR--------GEVYKELQKLSKFDEQRTATYITEL 122
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
           A  L Y H     R++HRDIK  N+LL    + KI DFG +   P  +    T   GTL 
Sbjct: 123 ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLD 176
Query: 251 YTAPEYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRI 309
           Y  PE  I G +  EK D++S GVL  E +  +       P E     E     Y+R   
Sbjct: 177 YLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISR 225
Query: 310 LELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
           +E   P    EG   RD +  +      L+ + +QRP + E++        S  P
Sbjct: 226 VEFTFPDFVTEGA--RDLISRL------LKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 129/291 (44%), Gaps = 35/291 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 122
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI DFG +   P  +    T  +GTL Y  P
Sbjct: 123 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSR---RTTLSGTLDYLPP 176
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           E  I G +  EK D++S GVL  E +  +       P E     E     Y+R   +E  
Sbjct: 177 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISRVEFT 225
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
            P    EG   RD +  +      L+ + +QRP + E++        S  P
Sbjct: 226 FPDFVTEGA--RDLISRL------LKHNPSQRPMLREVLEHPWITANSSKP 268

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 129/291 (44%), Gaps = 35/291 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 126
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI DFG +   P  +    T+  GTL Y  P
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPP 180
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           E  I G +  EK D++S GVL  E +  +       P E     E     Y+R   +E  
Sbjct: 181 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISRVEFT 229
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
            P    EG   RD +  +      L+ + +QRP + E++        S  P
Sbjct: 230 FPDFVTEGA--RDLISRL------LKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 129/291 (44%), Gaps = 35/291 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 121
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI DFG +   P  +    T+  GTL Y  P
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPP 175
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           E  I G +  EK D++S GVL  E +  +       P E     E     Y+R   +E  
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISRVEFT 224
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
            P    EG   RD +  +      L+ + +QRP + E++        S  P
Sbjct: 225 FPDFVTEGA--RDLISRL------LKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 129/291 (44%), Gaps = 35/291 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 121
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI DFG +   P  +    T+  GTL Y  P
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPP 175
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           E  I G +  EK D++S GVL  E +  +       P E     E     Y+R   +E  
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISRVEFT 224
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
            P    EG   RD +  +      L+ + +QRP + E++        S  P
Sbjct: 225 FPDFVTEGA--RDLISRL------LKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 128/291 (43%), Gaps = 35/291 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 138
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI DFG +   P  +    T   GTL Y  P
Sbjct: 139 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPP 192
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           E  I G +  EK D++S GVL  E +  +       P E     E     Y+R   +E  
Sbjct: 193 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISRVEFT 241
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
            P    EG   RD +  +      L+ + +QRP + E++        S  P
Sbjct: 242 FPDFVTEGA--RDLISRL------LKHNPSQRPMLREVLEHPWITANSSKP 284

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 99/206 (48%), Gaps = 17/206 (8%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 147
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI DFG +   P  +    T   GTL Y  P
Sbjct: 148 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPP 201
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEII 279
           E  I G +  EK D++S GVL  E +
Sbjct: 202 E-MIEGRMHDEKVDLWSLGVLCYEFL 226

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 26/217 (11%)
Query: 87  GNLLGRGGFGPVYRG------KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHK 139
           G  LGRG FG V         K A    VAVK L    +       +SE++++  I  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 140 NLVRLLGCCSD-GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII----------- 187
           N+V LLG C+  G   +++ E+ K  +L   +  + ++F+ +    + +           
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 188 ---LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN 244
                +A+G+++L   +  + +HRD+ A N+LL EK   KI DFGLAR   +D   +   
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 245 FAG-TLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            A   L + APE       + ++D++SFGVL+ EI S
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 89  LLGRGGFGPVYRGK-LADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           +LG G FG VY+G  + DG      VA+K L  + S +   E L E  ++  +    + R
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSR 83
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGE----SDKFLNWSTRFQIILGIARGLQYLHE 199
           LLG C   + +L+         LD +        S   LNW  +      IA+G+ YL +
Sbjct: 84  LLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQ------IAKGMSYLED 137
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA-YLSTNFAGTLGYTAPEYAI 258
               R+VHRD+ A NVL+      KI DFGLAR    D+  Y +      + + A E  +
Sbjct: 138 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 194
Query: 259 RGELSEKADIYSFGVLVLEIIS 280
           R   + ++D++S+GV V E+++
Sbjct: 195 RRRFTHQSDVWSYGVTVWELMT 216

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 128/291 (43%), Gaps = 35/291 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 124
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI DFG +   P  +    T   GTL Y  P
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPP 178
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           E  I G +  EK D++S GVL  E +  +       P E     E     Y+R   +E  
Sbjct: 179 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISRVEFT 227
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
            P    EG   RD +  +      L+ + +QRP + E++        S  P
Sbjct: 228 FPDFVTEGA--RDLISRL------LKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 90  LGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG G FG VY G+++          VAVK L    S+Q E +FL E  +I+   H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWST-----RFQIILGIARGLQYLH 198
            +G       R ++ E M    L   +     +    S+        +   IA G QYL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 199 EDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPEDQAYLSTNFAG-TLGYTAP 254
           E+     +HRDI A N LL        +KIGDFG+A+       Y     A   + +  P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 255 EYAIRGELSEKADIYSFGVLVLEIIS 280
           E  + G  + K D +SFGVL+ EI S
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 115/234 (49%), Gaps = 29/234 (12%)
Query: 61  FFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLC 115
           +F G+    +    + LK+    F    +LG G FG VY+G  + +G      VA+K+L 
Sbjct: 21  YFQGSGEAPNQALLRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR 78
Query: 116 VDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL--------VYEYMKNRSLD 167
              S +   E L E  ++ S+ + ++ RLLG C   + +L+        + +Y++    +
Sbjct: 79  EATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN 138
Query: 168 LLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGD 227
           +     S   LNW  +      IA+G+ YL +    R+VHRD+ A NVL+      KI D
Sbjct: 139 I----GSQYLLNWCVQ------IAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITD 185
Query: 228 FGLARFF-PEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           FGLA+    E++ Y +      + + A E  +    + ++D++S+GV V E+++
Sbjct: 186 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +LG G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 139 KNLVRLLGCCSDGSQRLL--------VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L+        + +Y++    ++     S   LNW  +      I
Sbjct: 87  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------I 136
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFGLA+    E++ Y +      +
Sbjct: 137 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 193
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 194 KWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 85  HPGNLLGRGGFGPVYRGKLADGTL----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           H   ++G+G FG VY G+  D        A+K L      Q    FL E  ++  + H N
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII-------LGIARG 193
           ++ L+G        +L  E + +  L  + +G+  +F+    R   +       L +ARG
Sbjct: 84  VLALIGI-------MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARG 136
Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT---LG 250
           ++YL E    + VHRD+ A N +LDE F  K+ DFGLAR   + + Y           + 
Sbjct: 137 MEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK 193
Query: 251 YTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           +TA E       + K+D++SFGVL+ E+++
Sbjct: 194 WTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 103/199 (51%), Gaps = 12/199 (6%)
Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           G  +G G FG VY+GK      V +  +     QQ ++ F +EV ++   +H N++  +G
Sbjct: 17  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMG 75
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
             S   Q  +V ++ +  SL   ++    KF        I    ARG+ YLH  S   I+
Sbjct: 76  Y-STKPQLAIVTQWCEGSSLYHHLHASETKF-EMKKLIDIARQTARGMDYLHAKS---II 130
Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPE-DQAYLSTNFAGTLGYTAPEYAIRGELSE- 264
           HRD+K++N+ L E    KIGDFGLA        ++     +G++ + APE  IR + S  
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDSNP 189
Query: 265 ---KADIYSFGVLVLEIIS 280
              ++D+Y+FG+++ E+++
Sbjct: 190 YSFQSDVYAFGIVLYELMT 208

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 26/217 (11%)
Query: 87  GNLLGRGGFGPVYRG------KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHK 139
           G  LGRG FG V         K A    VAVK L    +       +SE++++  I  H 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 140 NLVRLLGCCSD-GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII----------- 187
           N+V LLG C+  G   +++ E+ K  +L   +  + ++F+ +    + +           
Sbjct: 83  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 188 ---LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN 244
                +A+G+++L   +  + +HRD+ A N+LL EK   KI DFGLAR   +D   +   
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 245 FAG-TLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            A   L + APE       + ++D++SFGVL+ EI S
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 128/291 (43%), Gaps = 35/291 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 121
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI DFG +   P  +    T   GTL Y  P
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPP 175
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           E  I G +  EK D++S GVL  E +  +       P E     E     Y+R   +E  
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISRVEFT 224
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
            P    EG   RD +  +      L+ + +QRP + E++        S  P
Sbjct: 225 FPDFVTEGA--RDLISRL------LKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +LG G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 139 KNLVRLLGCCSDGSQRLL--------VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L+        + +Y++    ++     S   LNW  +      I
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------I 120
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFGLA+    E++ Y +      +
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 90  LGRGGFGPVY---RGKLADGT--LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG G FG V         DGT  +VAVK L  D   Q  S +  E+ ++ ++ H+++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 145 LGCCSD-GSQRL-LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            GCC D G+  L LV EY+   SL   +   S   +  +        I  G+ YLH   +
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQHY 155
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG--TLGYTAPEYAIRG 260
              +HRD+ A NVLLD     KIGDFGLA+  PE          G   + + APE     
Sbjct: 156 ---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEY 212
Query: 261 ELSEKADIYSFGVLVLEIIS 280
           +    +D++SFGV + E+++
Sbjct: 213 KFYYASDVWSFGVTLYELLT 232

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 105/202 (51%), Gaps = 18/202 (8%)
Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           G  +G G FG VY+GK      V +  +     QQ ++ F +EV ++   +H N++  +G
Sbjct: 29  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMG 87
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
             S   Q  +V ++ +  SL   ++    KF        I    ARG+ YLH  S   I+
Sbjct: 88  Y-STAPQLAIVTQWCEGSSLYHHLHASETKF-EMKKLIDIARQTARGMDYLHAKS---II 142
Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN----FAGTLGYTAPEYAIRGEL 262
           HRD+K++N+ L E    KIGDFGLA    E   +  ++     +G++ + APE  IR + 
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLA---TEKSRWSGSHQFEQLSGSILWMAPE-VIRMQD 198
Query: 263 SE----KADIYSFGVLVLEIIS 280
           S     ++D+Y+FG+++ E+++
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMT 220

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 128/291 (43%), Gaps = 35/291 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 126
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI DFG +   P  +    T   GTL Y  P
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPP 180
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           E  I G +  EK D++S GVL  E +  +       P E     E     Y+R   +E  
Sbjct: 181 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISRVEFT 229
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
            P    EG   RD +  +      L+ + +QRP + E++        S  P
Sbjct: 230 FPDFVTEGA--RDLISRL------LKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 128/291 (43%), Gaps = 35/291 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 120
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI DFG +   P  +    T   GTL Y  P
Sbjct: 121 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPP 174
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           E  I G +  EK D++S GVL  E +  +       P E     E     Y+R   +E  
Sbjct: 175 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISRVEFT 223
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
            P    EG   RD +  +      L+ + +QRP + E++        S  P
Sbjct: 224 FPDFVTEGA--RDLISRL------LKHNPSQRPMLREVLEHPWITANSSKP 266

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 26/217 (11%)
Query: 87  GNLLGRGGFGPVYRG------KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHK 139
           G  LGRG FG V         K A    VAVK L    +       +SE++++  I  H 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 140 NLVRLLGCCSD-GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII----------- 187
           N+V LLG C+  G   +++ E+ K  +L   +  + ++F+ +    + +           
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 188 ---LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN 244
                +A+G+++L   +  + +HRD+ A N+LL EK   KI DFGLAR   +D   +   
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 245 FAG-TLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            A   L + APE       + ++D++SFGVL+ EI S
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +LG G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 139 KNLVRLLGCCSDGSQRLL--------VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L+        + +Y++    ++     S   LNW  +      I
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------I 126
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFGLA+    E++ Y +      +
Sbjct: 127 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +LG G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 139 KNLVRLLGCCSDGSQRLLV--------YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L++         +Y++    ++     S   LNW  +      I
Sbjct: 78  PHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNI----GSQYLLNWCVQ------I 127
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFGLA+    E++ Y +      +
Sbjct: 128 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 125/290 (43%), Gaps = 33/290 (11%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 126
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI DFG +   P  +    T   GTL Y  P
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPP 180
Query: 255 EYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD 314
           E        EK D++S GVL  E +  +       P E     E     Y+R   +E   
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISRVEFTF 230
Query: 315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
           P    EG   RD +  +      L+ + +QRP + E++        S  P
Sbjct: 231 PDFVTEGA--RDLISRL------LKHNPSQRPXLREVLEHPWITANSSKP 272

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +LG G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 139 KNLVRLLGCCSDGSQRLLV--------YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L++         +Y++    ++     S   LNW  +      I
Sbjct: 77  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------I 126
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFGLA+    E++ Y +      +
Sbjct: 127 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +LG G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 139 KNLVRLLGCCSDGSQRLL--------VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L+        + +Y++    ++     S   LNW  +      I
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDNI----GSQYLLNWCVQ------I 126
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFGLA+    E++ Y +      +
Sbjct: 127 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +LG G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 139 KNLVRLLGCCSDGSQRLL--------VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L+        + +Y++    ++     S   LNW  +      I
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------I 126
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFGLA+    E++ Y +      +
Sbjct: 127 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +LG G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 139 KNLVRLLGCCSDGSQRLL--------VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L+        + +Y++    ++     S   LNW  +      I
Sbjct: 80  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------I 129
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFGLA+    E++ Y +      +
Sbjct: 130 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +LG G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 139 KNLVRLLGCCSDGSQRLLV--------YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L++         +Y++    ++     S   LNW  +      I
Sbjct: 79  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------I 128
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFGLA+    E++ Y +      +
Sbjct: 129 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +LG G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 139 KNLVRLLGCCSDGSQRLLV--------YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L++         +Y++    ++     S   LNW  +      I
Sbjct: 78  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------I 127
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFGLA+    E++ Y +      +
Sbjct: 128 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 128/291 (43%), Gaps = 35/291 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 125
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI DFG +   P  +    T   GTL Y  P
Sbjct: 126 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPP 179
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           E  I G +  EK D++S GVL  E +  +       P E     E     Y+R   +E  
Sbjct: 180 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISRVEFT 228
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
            P    EG   RD +  +      L+ + +QRP + E++        S  P
Sbjct: 229 FPDFVTEGA--RDLISRL------LKHNPSQRPMLREVLEHPWITANSSKP 271

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +LG G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 139 KNLVRLLGCCSDGSQRLL--------VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L+        + +Y++    ++     S   LNW  +      I
Sbjct: 80  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------I 129
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFGLA+    E++ Y +      +
Sbjct: 130 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +LG G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 139 KNLVRLLGCCSDGSQRLL--------VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L+        + +Y++    ++     S   LNW  +      I
Sbjct: 83  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------I 132
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFGLA+    E++ Y +      +
Sbjct: 133 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 189
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 190 KWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +LG G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 139 KNLVRLLGCCSDGSQRLLV--------YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L++         +Y++    ++     S   LNW  +      I
Sbjct: 81  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------I 130
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFGLA+    E++ Y +      +
Sbjct: 131 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 187
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 128/291 (43%), Gaps = 35/291 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 121
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI DFG +   P  +    T   GTL Y  P
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTELCGTLDYLPP 175
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           E  I G +  EK D++S GVL  E +  +       P E     E     Y+R   +E  
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISRVEFT 224
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
            P    EG   RD +  +      L+ + +QRP + E++        S  P
Sbjct: 225 FPDFVTEGA--RDLISRL------LKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +LG G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 139 KNLVRLLGCCSDGSQRLL--------VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L+        + +Y++    ++     S   LNW  +      I
Sbjct: 79  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------I 128
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFGLA+    E++ Y +      +
Sbjct: 129 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +LG G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 139 KNLVRLLGCCSDGSQRLL--------VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L+        + +Y++    ++     S   LNW  +      I
Sbjct: 80  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------I 129
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFGLA+    E++ Y +      +
Sbjct: 130 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 11/200 (5%)
Query: 90  LGRGGFGPVYR-GKLADGTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQHKNLVRLLGC 147
           +G G +G   +  + +DG ++  K+L      + E + L SEV ++  ++H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 148 CSDGSQRLL--VYEYMKNRSLDLLIY--GESDKFLNWSTRFQIILGIARGLQYLHEDS-- 201
             D +   L  V EY +   L  +I    +  ++L+     +++  +   L+  H  S  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 202 -HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
            HT ++HRD+K +NV LD K   K+GDFGLAR    D+ + +  F GT  Y +PE   R 
Sbjct: 134 GHT-VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDF-AKEFVGTPYYMSPEQMNRM 191
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             +EK+DI+S G L+ E+ +
Sbjct: 192 SYNEKSDIWSLGCLLYELCA 211

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +LG G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 139 KNLVRLLGCCSDGSQRLLV--------YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L++         +Y++    ++     S   LNW  +      I
Sbjct: 80  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------I 129
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFGLA+    E++ Y +      +
Sbjct: 130 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 132/308 (42%), Gaps = 49/308 (15%)
Query: 82  KNFHPGNLLGRGGFGPVYRG------KLADGTLVAVKKLCVDKSQQGESE-FLSEVRMIT 134
           +N   G +LG G FG V         K      VAVK L  +K+   E E  +SE++M+T
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALMSELKMMT 103
Query: 135 SI-QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF---------------- 177
            +  H+N+V LLG C+      L++EY     L   +  + +KF                
Sbjct: 104 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 178 -----LNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR 232
                L +         +A+G+++L   S    VHRD+ A NVL+      KI DFGLAR
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLAR 220
Query: 233 FFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPS 291
               D  Y +  N    + + APE    G  + K+D++S+G+L+ EI S   N    +P 
Sbjct: 221 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280
Query: 292 EMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEI 351
           +  +     +KL + G   ++  P    E        ++  +   C      +RP    +
Sbjct: 281 DANF-----YKLIQNG--FKMDQPFYATE--------EIYIIMQSCWAFDSRKRPSFPNL 325
Query: 352 VAMLTCKV 359
            + L C++
Sbjct: 326 TSFLGCQL 333

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 26/217 (11%)
Query: 87  GNLLGRGGFGPVYRG------KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHK 139
           G  LGRG FG V         K A    VAVK L    +       +SE++++  I  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 140 NLVRLLGCCSD-GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII----------- 187
           N+V LLG C+  G   +++ E+ K  +L   +  + ++F+ +    + +           
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 188 ---LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN 244
                +A+G+++L   +  + +HRD+ A N+LL EK   KI DFGLAR   +D   +   
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKG 208
Query: 245 FAG-TLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            A   L + APE       + ++D++SFGVL+ EI S
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 126/279 (45%), Gaps = 35/279 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 124
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI DFG +   P  +    T   GTL Y  P
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPP 178
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           E  I G +  EK D++S GVL  E +  +       P E     E     Y+R   +E  
Sbjct: 179 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISRVEFT 227
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIV 352
            P    EG   RD +  +      L+ + +QRP + E++
Sbjct: 228 FPDFVTEGA--RDLISRL------LKHNPSQRPMLREVL 258

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +LG G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 139 KNLVRLLGCCSDGSQRLL--------VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L+        + +Y++    ++     S   LNW  +      I
Sbjct: 84  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------I 133
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFGLA+    E++ Y +      +
Sbjct: 134 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 11/200 (5%)
Query: 90  LGRGGFGPVYR-GKLADGTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQHKNLVRLLGC 147
           +G G +G   +  + +DG ++  K+L      + E + L SEV ++  ++H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 148 CSDGSQRLL--VYEYMKNRSLDLLIY--GESDKFLNWSTRFQIILGIARGLQYLHEDS-- 201
             D +   L  V EY +   L  +I    +  ++L+     +++  +   L+  H  S  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 202 -HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
            HT ++HRD+K +NV LD K   K+GDFGLAR    D ++ +  F GT  Y +PE   R 
Sbjct: 134 GHT-VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKAFVGTPYYMSPEQMNRM 191
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             +EK+DI+S G L+ E+ +
Sbjct: 192 SYNEKSDIWSLGCLLYELCA 211

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 128/291 (43%), Gaps = 35/291 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 121
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI DFG +   P  +    T   GTL Y  P
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTXLCGTLDYLPP 175
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           E  I G +  EK D++S GVL  E +  +       P E     E     Y+R   +E  
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISRVEFT 224
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
            P    EG   RD +  +      L+ + +QRP + E++        S  P
Sbjct: 225 FPDFVTEGA--RDLISRL------LKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 126/279 (45%), Gaps = 35/279 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 118
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI DFG +   P  +    T   GTL Y  P
Sbjct: 119 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPP 172
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           E  I G +  EK D++S GVL  E +  +       P E     E     Y+R   +E  
Sbjct: 173 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISRVEFT 221
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIV 352
            P    EG   RD +  +      L+ + +QRP + E++
Sbjct: 222 FPDFVTEGA--RDLISRL------LKHNPSQRPMLREVL 252

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 18/202 (8%)
Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           G  +G G FG VY+GK      V +  +     QQ ++ F +EV ++   +H N++  +G
Sbjct: 29  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMG 87
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
             S   Q  +V ++ +  SL   ++    KF        I    ARG+ YLH  S   I+
Sbjct: 88  Y-STKPQLAIVTQWCEGSSLYHHLHASETKF-EMKKLIDIARQTARGMDYLHAKS---II 142
Query: 207 HRDIKASNVLLDEKFQSKIGDFGLA----RFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
           HRD+K++N+ L E    KIGDFGLA    R+    Q       +G++ + APE  IR + 
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF---EQLSGSILWMAPE-VIRMQD 198
Query: 263 SE----KADIYSFGVLVLEIIS 280
           S     ++D+Y+FG+++ E+++
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMT 220

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 105/212 (49%), Gaps = 27/212 (12%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQ 137
            F    +LG G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 138 HKNLVRLLGCCSDGSQRLL--------VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG 189
           + ++ RLLG C   + +L+        + +Y++    ++     S   LNW  +      
Sbjct: 73  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------ 122
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGT 248
           IA G+ YL +    R+VHRD+ A NVL+      KI DFGLA+    E++ Y +      
Sbjct: 123 IAEGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 179
Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           + + A E  +    + ++D++S+GV V E+++
Sbjct: 180 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 17/206 (8%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 147
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI DFG +   P  +     +  GTL Y  P
Sbjct: 148 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RDDLCGTLDYLPP 201
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEII 279
           E  I G +  EK D++S GVL  E +
Sbjct: 202 E-MIEGRMHDEKVDLWSLGVLCYEFL 226

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 128/291 (43%), Gaps = 35/291 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 123
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI +FG +   P  +    T   GTL Y  P
Sbjct: 124 SYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR---RTTLCGTLDYLPP 177
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           E  I G +  EK D++S GVL  E +  +       P E     E     Y+R   +E  
Sbjct: 178 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISRVEFT 226
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
            P    EG   RD +  +      L+ + +QRP + E++        S  P
Sbjct: 227 FPDFVTEGA--RDLISRL------LKHNPSQRPMLREVLEHPWITANSSKP 269

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 101/214 (47%), Gaps = 40/214 (18%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG GGFG V R    D G  VA+K+   + S +    +  E++++  + H N+V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV- 80
Query: 149 SDGSQRL-------LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARG-------- 193
            DG Q+L       L  EY +         G+  K+LN   +F+   G+  G        
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEG--------GDLRKYLN---QFENCCGLKEGPIRTLLSD 129
Query: 194 ----LQYLHEDSHTRIVHRDIKASNVLLD---EKFQSKIGDFGLARFFPEDQAYLSTNFA 246
               L+YLHE+   RI+HRD+K  N++L    ++   KI D G A+    DQ  L T F 
Sbjct: 130 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFV 184
Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           GTL Y APE   + + +   D +SFG L  E I+
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 32/199 (16%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+       T VAVK +           FL+E  ++ ++QH  LV+L    +
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTM--KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 247
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDK-----FLNWSTRFQIILGIARGLQYLHEDSHTR 204
                ++     K   LD L   E  K      +++S +      IA G+ ++ + ++  
Sbjct: 248 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQRNY-- 299
Query: 205 IVHRDIKASNVLLDEKFQSKIGDFGLARF---FPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
            +HRD++A+N+L+      KI DFGLAR    FP             + +TAPE    G 
Sbjct: 300 -IHRDLRAANILVSASLVCKIADFGLARVGAKFP-------------IKWTAPEAINFGS 345
Query: 262 LSEKADIYSFGVLVLEIIS 280
            + K+D++SFG+L++EI++
Sbjct: 346 FTIKSDVWSFGILLMEIVT 364

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 101/214 (47%), Gaps = 40/214 (18%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG GGFG V R    D G  VA+K+   + S +    +  E++++  + H N+V      
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV- 81
Query: 149 SDGSQRL-------LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARG-------- 193
            DG Q+L       L  EY +         G+  K+LN   +F+   G+  G        
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEG--------GDLRKYLN---QFENCCGLKEGPIRTLLSD 130
Query: 194 ----LQYLHEDSHTRIVHRDIKASNVLLD---EKFQSKIGDFGLARFFPEDQAYLSTNFA 246
               L+YLHE+   RI+HRD+K  N++L    ++   KI D G A+    DQ  L T F 
Sbjct: 131 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFV 185
Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           GTL Y APE   + + +   D +SFG L  E I+
Sbjct: 186 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 219

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 128/291 (43%), Gaps = 35/291 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 124
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI +FG +   P  +    T   GTL Y  P
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR---RTTLCGTLDYLPP 178
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           E  I G +  EK D++S GVL  E +  +       P E     E     Y+R   +E  
Sbjct: 179 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISRVEFT 227
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
            P    EG   RD +  +      L+ + +QRP + E++        S  P
Sbjct: 228 FPDFVTEGA--RDLISRL------LKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 127/295 (43%), Gaps = 43/295 (14%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ------IILGI 190
           +H N++RL G   D ++  L+ EY           GE  K L   ++F        I  +
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPR--------GEVYKELQKLSKFDEQRTATYITEL 122
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
           A  L Y H     R++HRDIK  N+LL    + KI DFG +   P  +        GTL 
Sbjct: 123 ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLXGTLD 176
Query: 251 YTAPEYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRI 309
           Y  PE  I G +  EK D++S GVL  E +  +       P E     E     Y+R   
Sbjct: 177 YLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISR 225
Query: 310 LELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
           +E   P    EG   RD +  +      L+ + +QRP + E++        S  P
Sbjct: 226 VEFTFPDFVTEGA--RDLISRL------LKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 27/212 (12%)
Query: 83  NFHPGNLLGRGGFGPVYRGK-LADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQ 137
            F    +LG G FG VY+G  + +G      VA+ +L    S +   E L E  ++ S+ 
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 138 HKNLVRLLGCCSDGSQRLL--------VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG 189
           + ++ RLLG C   + +L+        + +Y++    ++     S   LNW  +      
Sbjct: 110 NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------ 159
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGT 248
           IA+G+ YL +    R+VHRD+ A NVL+      KI DFGLA+    E++ Y +      
Sbjct: 160 IAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 216
Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           + + A E  +    + ++D++S+GV V E+++
Sbjct: 217 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 129/277 (46%), Gaps = 29/277 (10%)
Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHK 139
           NF     +GRG F  VYR   L DG  VA+KK+ +      +  ++ + E+ ++  + H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 140 NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLI--YGESDKFLNWSTRFQIILGIARGLQYL 197
           N+++      + ++  +V E      L  +I  + +  + +   T ++  + +   L+++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYA 257
           H     R++HRDIK +NV +      K+GD GL RFF   +   + +  GT  Y +PE  
Sbjct: 153 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPERI 208
Query: 258 IRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWK--LYERGRILELVD- 314
                + K+DI+S G L+ E+ + +              P Y  K  LY   + +E  D 
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQS-------------PFYGDKMNLYSLCKKIEQCDY 255
Query: 315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEI 351
           P +  +   E +  Q++N   +C+ P   +RP ++ +
Sbjct: 256 PPLPSDHYSE-ELRQLVN---MCINPDPEKRPDVTYV 288

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 106/226 (46%), Gaps = 37/226 (16%)
Query: 83  NFHPGNLLGRGGFGPVYR------GKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI 136
           N   G  LG G FG V        GK      VAVK L        +   +SE+++++ +
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 137 -QHKNLVRLLGCCSDGSQRLLVYEY---------MKNRSLDLLIYG-----------ESD 175
            QH+N+V LLG C+ G   L++ EY         ++ +    L Y             S 
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSR 166
Query: 176 KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP 235
             L++S++      +A+G+ +L   +    +HRD+ A NVLL     +KIGDFGLAR   
Sbjct: 167 DLLHFSSQ------VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 217
Query: 236 EDQAYL-STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            D  Y+   N    + + APE       + ++D++S+G+L+ EI S
Sbjct: 218 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 128/291 (43%), Gaps = 35/291 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 124
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI DFG +   P  +     +  GTL Y  P
Sbjct: 125 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RDDLCGTLDYLPP 178
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           E  I G +  EK D++S GVL  E +  +       P E     E     Y+R   +E  
Sbjct: 179 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISRVEFT 227
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
            P    EG   RD +  +      L+ + +QRP + E++        S  P
Sbjct: 228 FPDFVTEGA--RDLISRL------LKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 109/215 (50%), Gaps = 21/215 (9%)
Query: 77  LKKATKNFHPGNLLGRGGFGPVYRGK--LADGTLVAVKKLCVDKSQQGES----EFLSEV 130
           L +A + +     +G G +G V++ +     G  VA+K++ V   ++G        ++ +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 131 RMITSIQHKNLVRLLGCCS----DGSQRL-LVYEYMKNRSLDLLIYGES--DKFLNWSTR 183
           R + + +H N+VRL   C+    D   +L LV+E++     DL  Y +   +  +   T 
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVPTETI 122
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST 243
             ++  + RGL +LH  SH R+VHRD+K  N+L+    Q K+ DFGLAR +    A   T
Sbjct: 123 KDMMFQLLRGLDFLH--SH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--T 177
Query: 244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEI 278
           +   TL Y APE  ++   +   D++S G +  E+
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSI 136
           + +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR---- 192
            H N+V+LL      ++  LV+E++   S+DL       KF++ S    I L + +    
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL---SMDL------KKFMDASALTGIPLPLIKSYLF 113
Query: 193 ----GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT 248
               GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F             T
Sbjct: 114 QLLQGLAFCH--SH-RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 169
Query: 249 LGYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           L Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 127/291 (43%), Gaps = 35/291 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 122
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI DFG +   P  +        GTL Y  P
Sbjct: 123 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RDTLCGTLDYLPP 176
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           E  I G +  EK D++S GVL  E +  +       P E     E     Y+R   +E  
Sbjct: 177 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISRVEFT 225
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
            P    EG   RD +  +      L+ + +QRP + E++        S  P
Sbjct: 226 FPDFVTEGA--RDLISRL------LKHNPSQRPMLREVLEHPWITANSSKP 268

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 88  NLLGRGGFGPVYRGK-LADGTLVAVK---KLCVDKS-QQGESEFLSEVRMITSIQHKNLV 142
            +LG G FG V++G  + +G  + +    K+  DKS +Q        +  I S+ H ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF-----LNWSTRFQIILGIARGLQYL 197
           RLLG C  GS   LV +Y+   SL   +            LNW  +      IA+G+ YL
Sbjct: 97  RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMYYL 149
Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT-LGYTAPEY 256
            E     +VHR++ A NVLL    Q ++ DFG+A   P D   L  + A T + + A E 
Sbjct: 150 EEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 206
Query: 257 AIRGELSEKADIYSFGVLVLEIIS 280
              G+ + ++D++S+GV V E+++
Sbjct: 207 IHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 127/284 (44%), Gaps = 35/284 (12%)
Query: 90  LGRGGFGPV---YRGKLADGT--LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG G FG V         DGT  +VAVK L      Q  S +  E+ ++ ++ H+++V+ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 145 LGCCSDGSQR--LLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
            GCC D  ++   LV EY+   SL D L        +  +        I  G+ YLH   
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLHAQH 132
Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIR 259
           +   +HR + A NVLLD     KIGDFGLA+  PE   Y      G   + + APE    
Sbjct: 133 Y---IHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 189
Query: 260 GELSEKADIYSFGVLVLEIIS-CRKN-------TDLTLPSEMQYLPEYAWKLYERGRILE 311
            +    +D++SFGV + E+++ C  N       T+L   ++ Q       +L ERG  L 
Sbjct: 190 CKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERL- 248
Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
              PR       +R   ++ ++   C +   + RP    +V +L
Sbjct: 249 ---PR------PDRCPCEIYHLMKNCWETEASFRPTFQNLVPIL 283

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSI 136
           + +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR---- 192
            H N+V+LL      ++  LV+E++   S+DL       KF++ S    I L + +    
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL---SMDL------KKFMDASALTGIPLPLIKSYLF 111
Query: 193 ----GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT 248
               GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F             T
Sbjct: 112 QLLQGLAFCH--SH-RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 167
Query: 249 LGYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           L Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 127/291 (43%), Gaps = 35/291 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 123
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI DFG +   P  +        GTL Y  P
Sbjct: 124 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLCGTLDYLPP 177
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           E  I G +  EK D++S GVL  E +  +       P E     E     Y+R   +E  
Sbjct: 178 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISRVEFT 226
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
            P    EG   RD +  +      L+ + +QRP + E++        S  P
Sbjct: 227 FPDFVTEGA--RDLISRL------LKHNPSQRPMLREVLEHPWITANSSKP 269

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 127/284 (44%), Gaps = 35/284 (12%)
Query: 90  LGRGGFGPV---YRGKLADGT--LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG G FG V         DGT  +VAVK L      Q  S +  E+ ++ ++ H+++V+ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 145 LGCCSDGSQR--LLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
            GCC D  ++   LV EY+   SL D L        +  +        I  G+ YLH   
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLHAQH 131
Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIR 259
           +   +HR + A NVLLD     KIGDFGLA+  PE   Y      G   + + APE    
Sbjct: 132 Y---IHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 188
Query: 260 GELSEKADIYSFGVLVLEIIS-CRKN-------TDLTLPSEMQYLPEYAWKLYERGRILE 311
            +    +D++SFGV + E+++ C  N       T+L   ++ Q       +L ERG  L 
Sbjct: 189 CKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERL- 247
Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
              PR       +R   ++ ++   C +   + RP    +V +L
Sbjct: 248 ---PR------PDRCPCEIYHLMKNCWETEASFRPTFQNLVPIL 282

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 88  NLLGRGGFGPVYRGK-LADGTLVAVK---KLCVDKS-QQGESEFLSEVRMITSIQHKNLV 142
            +LG G FG V++G  + +G  + +    K+  DKS +Q        +  I S+ H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF-----LNWSTRFQIILGIARGLQYL 197
           RLLG C  GS   LV +Y+   SL   +            LNW  +      IA+G+ YL
Sbjct: 79  RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMYYL 131
Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT-LGYTAPEY 256
            E     +VHR++ A NVLL    Q ++ DFG+A   P D   L  + A T + + A E 
Sbjct: 132 EEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 257 AIRGELSEKADIYSFGVLVLEIIS 280
              G+ + ++D++S+GV V E+++
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 127/291 (43%), Gaps = 35/291 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 121
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI DFG +   P  +        GTL Y  P
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTLDYLPP 175
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           E  I G +  EK D++S GVL  E +  +       P E     E     Y+R   +E  
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISRVEFT 224
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
            P    EG   RD +  +      L+ + +QRP + E++        S  P
Sbjct: 225 FPDFVTEGA--RDLISRL------LKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +LG G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 139 KNLVRLLGCCSDGSQRLLV--------YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L++         +Y++    ++     S   LNW  +      I
Sbjct: 81  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------I 130
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFG A+    E++ Y +      +
Sbjct: 131 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 187
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 26/213 (12%)
Query: 82  KNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQH 138
           +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR------ 192
            N+V+LL      ++  LV+E++         + +  KF++ S    I L + +      
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 193 --GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
             GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F        T+   TL 
Sbjct: 113 LQGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLW 168
Query: 251 YTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 169 YRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +L  G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 139 KNLVRLLGCCSDGSQRLL--------VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L+        + +Y++    ++     S   LNW  +      I
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------I 126
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFGLA+    E++ Y +      +
Sbjct: 127 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 82  KNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSIQH 138
           ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + ++H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGLQY 196
            N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L Y
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSRFDEQRTATYITELANALSY 127
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEY 256
            H     R++HRDIK  N+LL    + KI DFG +   P  +    T   GTL Y  PE 
Sbjct: 128 CHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPE- 180
Query: 257 AIRGEL-SEKADIYSFGVLVLEII 279
            I G +  EK D++S GVL  E +
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFL 204

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 109/215 (50%), Gaps = 21/215 (9%)
Query: 77  LKKATKNFHPGNLLGRGGFGPVYRGK--LADGTLVAVKKLCVDKSQQGES----EFLSEV 130
           L +A + +     +G G +G V++ +     G  VA+K++ V   ++G        ++ +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 131 RMITSIQHKNLVRLLGCCS----DGSQRL-LVYEYMKNRSLDLLIYGES--DKFLNWSTR 183
           R + + +H N+VRL   C+    D   +L LV+E++     DL  Y +   +  +   T 
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVPTETI 122
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST 243
             ++  + RGL +LH  SH R+VHRD+K  N+L+    Q K+ DFGLAR +    A   T
Sbjct: 123 KDMMFQLLRGLDFLH--SH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--T 177
Query: 244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEI 278
           +   TL Y APE  ++   +   D++S G +  E+
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 26/213 (12%)
Query: 82  KNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQH 138
           +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR------ 192
            N+V+LL      ++  LV+E++         + +  KF++ S    I L + +      
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 193 --GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
             GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F        T+   TL 
Sbjct: 113 LQGLSFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLW 168
Query: 251 YTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +L  G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 139 KNLVRLLGCCSDGSQRLL--------VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L+        + +Y++    ++     S   LNW  +      I
Sbjct: 84  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------I 133
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFGLA+    E++ Y +      +
Sbjct: 134 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 26/213 (12%)
Query: 82  KNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQH 138
           +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  + H
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR------ 192
            N+V+LL      ++  LV+E++         + +  KF++ S    I L + +      
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLFQL 116
Query: 193 --GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
             GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F        T+   TL 
Sbjct: 117 LQGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLW 172
Query: 251 YTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 173 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 90  LGRGGFGPVYRGKLADGT--LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G+G FG VY+G + + T  +VA+K + +++++    +   E+ +++      + R  G 
Sbjct: 27  IGKGSFGEVYKG-IDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGS 85
Query: 148 CSDGSQRLLVYEYMKNRS-LDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
               ++  ++ EY+   S LDLL  G     L  +    I+  I +GL YLH +   R +
Sbjct: 86  YLKSTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLHSE---RKI 138
Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKA 266
           HRDIKA+NVLL E+   K+ DFG+A    + Q      F GT  + APE   +     KA
Sbjct: 139 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-RNXFVGTPFWMAPEVIKQSAYDFKA 197
Query: 267 DIYSFGVLVLEIISCR-KNTDL 287
           DI+S G+  +E+      N+DL
Sbjct: 198 DIWSLGITAIELAKGEPPNSDL 219

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +LG G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 139 KNLVRLLGCCSDGSQRLL--------VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L+        + +Y++    ++     S   LNW  +      I
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------I 126
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFG A+    E++ Y +      +
Sbjct: 127 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 183
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 123/264 (46%), Gaps = 40/264 (15%)
Query: 109 VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRS-LD 167
           VA+K++ ++K Q    E L E++ ++   H N+V          +  LV + +   S LD
Sbjct: 38  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 97
Query: 168 LLIY----GESDK-FLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ 222
           ++ +    GE     L+ ST   I+  +  GL+YLH++     +HRD+KA N+LL E   
Sbjct: 98  IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGS 154
Query: 223 SKIGDFGLARFFPE----DQAYLSTNFAGTLGYTAPEYA--IRGELSEKADIYSFGVLVL 276
            +I DFG++ F        +  +   F GT  + APE    +RG    KADI+SFG+  +
Sbjct: 155 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG-YDFKADIWSFGITAI 213
Query: 277 EIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV---DPRMRKEGIVERDALQVINV 333
           E+ +                    +  Y   ++L L    DP   + G+ +++ L+    
Sbjct: 214 ELATGAA----------------PYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGK 257
Query: 334 AF-----ICLQPHGNQRPPMSEIV 352
           +F     +CLQ    +RP  +E++
Sbjct: 258 SFRKMISLCLQKDPEKRPTAAELL 281

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 105/230 (45%), Gaps = 44/230 (19%)
Query: 83  NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQH--- 138
           +F    +LG+G FG V + + A D    A+KK  +  +++  S  LSEV ++ S+ H   
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKK--IRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 139 ----------KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGES-----DKFLNWSTR 183
                     +N V+ +      S   +  EY +NR+L  LI+ E+     D++  W   
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEY--WRLF 122
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS- 242
            QI+      L Y+H      I+HRD+K  N+ +DE    KIGDFGLA+        L  
Sbjct: 123 RQIL----EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 243 ------------TNFAGTLGYTAPEYAI-RGELSEKADIYSFGVLVLEII 279
                       T+  GT  Y A E     G  +EK D+YS G++  E+I
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 26/213 (12%)
Query: 82  KNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQH 138
           +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  + H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR------ 192
            N+V+LL      ++  LV+E++         + +  KF++ S    I L + +      
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLFQL 119
Query: 193 --GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
             GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F        T+   TL 
Sbjct: 120 LQGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLW 175
Query: 251 YTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 176 YRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 109/215 (50%), Gaps = 21/215 (9%)
Query: 77  LKKATKNFHPGNLLGRGGFGPVYRGK--LADGTLVAVKKLCVDKSQQGES----EFLSEV 130
           L +A + +     +G G +G V++ +     G  VA+K++ V   ++G        ++ +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 131 RMITSIQHKNLVRLLGCCS----DGSQRL-LVYEYMKNRSLDLLIYGES--DKFLNWSTR 183
           R + + +H N+VRL   C+    D   +L LV+E++     DL  Y +   +  +   T 
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVPTETI 122
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST 243
             ++  + RGL +LH  SH R+VHRD+K  N+L+    Q K+ DFGLAR +    A   T
Sbjct: 123 KDMMFQLLRGLDFLH--SH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--T 177
Query: 244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEI 278
           +   TL Y APE  ++   +   D++S G +  E+
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +L  G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 139 KNLVRLLGCCSDGSQRLLV--------YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L++         +Y++    ++     S   LNW  +      I
Sbjct: 84  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------I 133
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFGLA+    E++ Y +      +
Sbjct: 134 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 106/197 (53%), Gaps = 12/197 (6%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G VY+ K + G +VA+K++ +D   +G  S  + E+ ++  + H N+V L+   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIIL-GIARGLQYLHEDSHTRIVH 207
                  LV+E+M+    DL    + +K     ++ +I L  + RG+ + H+    RI+H
Sbjct: 89  HSERCLTLVFEFMEK---DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILH 142
Query: 208 RDIKASNVLLDEKFQSKIGDFGLARFFP-EDQAYLSTNFAGTLGYTAPEYAI-RGELSEK 265
           RD+K  N+L++     K+ DFGLAR F    ++Y  T+   TL Y AP+  +   + S  
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSKKYSTS 200
Query: 266 ADIYSFGVLVLEIISCR 282
            DI+S G +  E+I+ +
Sbjct: 201 VDIWSIGCIFAEMITGK 217

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 111/213 (52%), Gaps = 22/213 (10%)
Query: 80  ATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSI 136
           + +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF------LNWSTRFQIILGI 190
            H N+V+LL      ++  LV+E++   S+DL  + ++         L  S  FQ++   
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLL--- 116
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
            +GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F             TL 
Sbjct: 117 -QGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 171
Query: 251 YTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +LG G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 139 KNLVRLLGCCSDGSQRLLV--------YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L++         +Y++    ++     S   LNW  +      I
Sbjct: 79  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------I 128
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFG A+    E++ Y +      +
Sbjct: 129 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 111/213 (52%), Gaps = 22/213 (10%)
Query: 80  ATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSI 136
           + +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF------LNWSTRFQIILGI 190
            H N+V+LL      ++  LV+E++   S+DL  + ++         L  S  FQ++   
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLL--- 115
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
            +GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F             TL 
Sbjct: 116 -QGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 170
Query: 251 YTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 127/291 (43%), Gaps = 35/291 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 124
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI DFG +   P  +        GTL Y  P
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTLDYLPP 178
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           E  I G +  EK D++S GVL  E +  +       P E     E     Y+R   +E  
Sbjct: 179 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISRVEFT 227
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
            P    EG   RD +  +      L+ + +QRP + E++        S  P
Sbjct: 228 FPDFVTEGA--RDLISRL------LKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +LG G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 139 KNLVRLLGCCSDGSQRLL--------VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L+        + +Y++    ++     S   LNW  +      I
Sbjct: 79  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------I 128
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFG A+    E++ Y +      +
Sbjct: 129 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 106/197 (53%), Gaps = 12/197 (6%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G VY+ K + G +VA+K++ +D   +G  S  + E+ ++  + H N+V L+   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIIL-GIARGLQYLHEDSHTRIVH 207
                  LV+E+M+    DL    + +K     ++ +I L  + RG+ + H+    RI+H
Sbjct: 89  HSERCLTLVFEFMEK---DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILH 142
Query: 208 RDIKASNVLLDEKFQSKIGDFGLARFFP-EDQAYLSTNFAGTLGYTAPEYAI-RGELSEK 265
           RD+K  N+L++     K+ DFGLAR F    ++Y  T+   TL Y AP+  +   + S  
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSKKYSTS 200
Query: 266 ADIYSFGVLVLEIISCR 282
            DI+S G +  E+I+ +
Sbjct: 201 VDIWSIGCIFAEMITGK 217

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 26/213 (12%)
Query: 82  KNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQH 138
           +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR------ 192
            N+V+LL      ++  LV+E++         + +  KF++ S    I L + +      
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 193 --GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
             GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F        T+   TL 
Sbjct: 113 LQGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLW 168
Query: 251 YTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 26/213 (12%)
Query: 82  KNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQH 138
           +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR------ 192
            N+V+LL      ++  LV+E++         + +  KF++ S    I L + +      
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 193 --GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
             GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F        T+   TL 
Sbjct: 112 LQGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLW 167
Query: 251 YTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 127/291 (43%), Gaps = 35/291 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 121
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI DFG +   P  +        GTL Y  P
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLCGTLDYLPP 175
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           E  I G +  EK D++S GVL  E +  +       P E     E     Y+R   +E  
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQE----TYKRISRVEFT 224
Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
            P    EG   RD +  +      L+ + +QRP + E++        S  P
Sbjct: 225 FPDFVTEGA--RDLISRL------LKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 123/264 (46%), Gaps = 40/264 (15%)
Query: 109 VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRS-LD 167
           VA+K++ ++K Q    E L E++ ++   H N+V          +  LV + +   S LD
Sbjct: 43  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 102
Query: 168 LLIY----GESDK-FLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ 222
           ++ +    GE     L+ ST   I+  +  GL+YLH++     +HRD+KA N+LL E   
Sbjct: 103 IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGS 159
Query: 223 SKIGDFGLARFFPE----DQAYLSTNFAGTLGYTAPEYA--IRGELSEKADIYSFGVLVL 276
            +I DFG++ F        +  +   F GT  + APE    +RG    KADI+SFG+  +
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG-YDFKADIWSFGITAI 218
Query: 277 EIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV---DPRMRKEGIVERDALQVINV 333
           E+ +                    +  Y   ++L L    DP   + G+ +++ L+    
Sbjct: 219 ELATGAA----------------PYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGK 262
Query: 334 AF-----ICLQPHGNQRPPMSEIV 352
           +F     +CLQ    +RP  +E++
Sbjct: 263 SFRKMISLCLQKDPEKRPTAAELL 286

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 26/213 (12%)
Query: 82  KNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQH 138
           +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR------ 192
            N+V+LL      ++  LV+E++         + +  KF++ S    I L + +      
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 193 --GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
             GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F        T+   TL 
Sbjct: 112 LQGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLW 167
Query: 251 YTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +LG G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 139 KNLVRLLGCCSDGSQRLLV--------YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L++         +Y++    ++     S   LNW  +      I
Sbjct: 79  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------I 128
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFG A+    E++ Y +      +
Sbjct: 129 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 27/211 (12%)
Query: 84  FHPGNLLGRGGFGPVYRG-KLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +LG G FG VY+G  + +G      VA+K+L    S +   E L E  ++ S+ +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 139 KNLVRLLGCCSDGSQRLL--------VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGI 190
            ++ RLLG C   + +L+        + +Y++    ++     S   LNW  +      I
Sbjct: 84  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQ------I 133
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
           A+G+ YL +    R+VHRD+ A NVL+      KI DFG A+    E++ Y +      +
Sbjct: 134 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 190
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            + A E  +    + ++D++S+GV V E+++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSI 136
           + +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR---- 192
            H N+V+LL      ++  LV+E++         + +  KF++ S    I L + +    
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLF 111
Query: 193 ----GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT 248
               GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F        T+   T
Sbjct: 112 QLLQGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVT 167
Query: 249 LGYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           L Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 124
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     R++HRDIK  N+LL    + KI DFG +   P  +        GTL Y  P
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLCGTLDYLPP 178
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEII 279
           E  I G +  EK D++S GVL  E +
Sbjct: 179 E-MIEGRMHDEKVDLWSLGVLCYEFL 203

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 105/231 (45%), Gaps = 32/231 (13%)
Query: 83  NFHPGNLLGRGGFGPVYRGKL-----ADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSI 136
           N   G  LG G FG V           D  L VAVK L        +   +SE+++++ +
Sbjct: 32  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 91
Query: 137 -QHKNLVRLLGCCSDGSQRLLVYEY---------MKNRSLDLL------------IYGES 174
            QH+N+V LLG C+ G   L++ EY         ++ ++  +L            +  E 
Sbjct: 92  GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKED 151
Query: 175 DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF 234
            + L           +A+G+ +L   +    +HRD+ A NVLL     +KIGDFGLAR  
Sbjct: 152 GRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 208
Query: 235 PEDQAYL-STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKN 284
             D  Y+   N    + + APE       + ++D++S+G+L+ EI S   N
Sbjct: 209 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN 259

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 26/213 (12%)
Query: 82  KNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQH 138
           +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR------ 192
            N+V+LL      ++  LV+E++         + +  KF++ S    I L + +      
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 193 --GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
             GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F        T+   TL 
Sbjct: 113 LQGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLW 168
Query: 251 YTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 105/193 (54%), Gaps = 14/193 (7%)
Query: 90  LGRGGFGPVYRGKLADGT--LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G+G FG V++G + + T  +VA+K + +++++    +   E+ +++      + +  G 
Sbjct: 15  IGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 73
Query: 148 CSDGSQRLLVYEYMKNRS-LDLLIYGESDKFLNWSTRFQIIL-GIARGLQYLHEDSHTRI 205
               ++  ++ EY+   S LDLL  G  D+     T+   IL  I +GL YLH +   + 
Sbjct: 74  YLKDTKLWIIMEYLGGGSALDLLEPGPLDE-----TQIATILREILKGLDYLHSE---KK 125
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEK 265
           +HRDIKA+NVLL E  + K+ DFG+A    + Q   +T F GT  + APE   +     K
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSAYDSK 184
Query: 266 ADIYSFGVLVLEI 278
           ADI+S G+  +E+
Sbjct: 185 ADIWSLGITAIEL 197

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 26/213 (12%)
Query: 82  KNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQH 138
           +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  + H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR------ 192
            N+V+LL      ++  LV+E++         + +  KF++ S    I L + +      
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLFQL 119
Query: 193 --GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
             GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F        T+   TL 
Sbjct: 120 LQGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLW 175
Query: 251 YTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 176 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 90  LGRGGFGPVYRGKL----ADGTLVAVKKLCVDKSQQGES--EFLSEVRMITSIQHKNLVR 143
           LG G FG V RG+          VAVK L  D   Q E+  +F+ EV  + S+ H+NL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
           L G       +++         LD L   +    L   +R+ +   +A G+ YL      
Sbjct: 76  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES---K 130
Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE--DQAYLSTNFAGTLGYTAPEYAIRGE 261
           R +HRD+ A N+LL  +   KIGDFGL R  P+  D   +  +      + APE      
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRT 190
Query: 262 LSEKADIYSFGVLVLEIIS 280
            S  +D + FGV + E+ +
Sbjct: 191 FSHASDTWMFGVTLWEMFT 209

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 109/203 (53%), Gaps = 26/203 (12%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           +G G FG VY+GK      V + K+ VD + +    F +EV ++   +H N++  +G  +
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKV-VDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR----GLQYLHEDSHTRI 205
             +   +V ++ +  SL   ++ +  KF      FQ+I  IAR    G+ YLH  +   I
Sbjct: 103 KDN-LAIVTQWCEGSSLYKHLHVQETKF----QMFQLI-DIARQTAQGMDYLHAKN---I 153
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLA----RFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
           +HRD+K++N+ L E    KIGDFGLA    R+    Q    T   G++ + APE  IR +
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT---GSVLWMAPE-VIRMQ 209
Query: 262 ----LSEKADIYSFGVLVLEIIS 280
                S ++D+YS+G+++ E+++
Sbjct: 210 DNNPFSFQSDVYSYGIVLYELMT 232

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 12/199 (6%)
Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           G  +G G FG VY+GK      V +  +     QQ ++ F +EV ++   +H N++  +G
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMG 71
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
             S   Q  +V ++ +  SL   ++    KF        I    A+G+ YLH  S   I+
Sbjct: 72  Y-STAPQLAIVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLHAKS---II 126
Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPE-DQAYLSTNFAGTLGYTAPEYAIRGE---- 261
           HRD+K++N+ L E    KIGDFGLA        ++     +G++ + APE  IR +    
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKNP 185
Query: 262 LSEKADIYSFGVLVLEIIS 280
            S ++D+Y+FG+++ E+++
Sbjct: 186 YSFQSDVYAFGIVLYELMT 204

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 22/211 (10%)
Query: 82  KNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQH 138
           +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF------LNWSTRFQIILGIAR 192
            N+V+LL      ++  LV+E++     DL  + ++         L  S  FQ++    +
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQ---DLKTFMDASALTGIPLPLIKSYLFQLL----Q 113
Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
           GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F        T+   TL Y 
Sbjct: 114 GLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYR 169
Query: 253 APEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           APE  +  +  S   DI+S G +  E+++ R
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 17/206 (8%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSI 136
           A ++F  G  LG+G FG VY  +  +   + A+K L   + ++   E +   EV + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGL 194
           +H N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 121
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            Y H     +++HRDIK  N+LL    + KI DFG +   P  +        GTL Y  P
Sbjct: 122 SYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTLDYLPP 175
Query: 255 EYAIRGEL-SEKADIYSFGVLVLEII 279
           E  I G +  EK D++S GVL  E +
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFL 200

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 90  LGRGGFGPVYRGKL----ADGTLVAVKKLCVDKSQQGES--EFLSEVRMITSIQHKNLVR 143
           LG G FG V RG+          VAVK L  D   Q E+  +F+ EV  + S+ H+NL+R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
           L G       +++         LD L   +    L   +R+ +   +A G+ YL      
Sbjct: 86  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES---K 140
Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE--DQAYLSTNFAGTLGYTAPEYAIRGE 261
           R +HRD+ A N+LL  +   KIGDFGL R  P+  D   +  +      + APE      
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRT 200
Query: 262 LSEKADIYSFGVLVLEIIS 280
            S  +D + FGV + E+ +
Sbjct: 201 FSHASDTWMFGVTLWEMFT 219

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 16/208 (7%)
Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFL----SEVRMITSI 136
           ++F  GNLLG+G F  VYR + +  G  VA+K   +DK    ++  +    +EV++   +
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIK--MIDKKAMYKAGMVQRVQNEVKIHCQL 68
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
           +H +++ L     D +   LV E   N  ++  +      F     R   +  I  G+ Y
Sbjct: 69  KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGMLY 127
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF--PEDQAYLSTNFAGTLGYTAP 254
           LH  SH  I+HRD+  SN+LL      KI DFGLA     P ++ Y      GT  Y +P
Sbjct: 128 LH--SHG-ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY---TLCGTPNYISP 181
Query: 255 EYAIRGELSEKADIYSFGVLVLEIISCR 282
           E A R     ++D++S G +   ++  R
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 105/193 (54%), Gaps = 14/193 (7%)
Query: 90  LGRGGFGPVYRGKLADGT--LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G+G FG V++G + + T  +VA+K + +++++    +   E+ +++      + +  G 
Sbjct: 35  IGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 93
Query: 148 CSDGSQRLLVYEYMKNRS-LDLLIYGESDKFLNWSTRFQIIL-GIARGLQYLHEDSHTRI 205
               ++  ++ EY+   S LDLL  G  D+     T+   IL  I +GL YLH +   + 
Sbjct: 94  YLKDTKLWIIMEYLGGGSALDLLEPGPLDE-----TQIATILREILKGLDYLHSE---KK 145
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEK 265
           +HRDIKA+NVLL E  + K+ DFG+A    + Q   +T F GT  + APE   +     K
Sbjct: 146 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSAYDSK 204
Query: 266 ADIYSFGVLVLEI 278
           ADI+S G+  +E+
Sbjct: 205 ADIWSLGITAIEL 217

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 90  LGRGGFGPVYRGKL----ADGTLVAVKKLCVDKSQQGES--EFLSEVRMITSIQHKNLVR 143
           LG G FG V RG+          VAVK L  D   Q E+  +F+ EV  + S+ H+NL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
           L G       +++         LD L   +    L   +R+ +   +A G+ YL      
Sbjct: 76  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES---K 130
Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFP--EDQAYLSTNFAGTLGYTAPEYAIRGE 261
           R +HRD+ A N+LL  +   KIGDFGL R  P  +D   +  +      + APE      
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 262 LSEKADIYSFGVLVLEIIS 280
            S  +D + FGV + E+ +
Sbjct: 191 FSHASDTWMFGVTLWEMFT 209

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 12/201 (5%)
Query: 84  FHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNLV 142
           +H    +G G +G VY+ +   G   A+KK+ ++K  +G  S  + E+ ++  ++H N+V
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
           +L        + +LV+E++      LL   E    L   T    +L +  G+ Y H+   
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHD--- 118
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFF--PEDQAYLSTNFAGTLGYTAPEYAI-R 259
            R++HRD+K  N+L++ + + KI DFGLAR F  P  +    T+   TL Y AP+  +  
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY---THEVVTLWYRAPDVLMGS 175
Query: 260 GELSEKADIYSFGVLVLEIIS 280
            + S   DI+S G +  E+++
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVN 196

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 90  LGRGGFGPVYRGKL----ADGTLVAVKKLCVDKSQQGES--EFLSEVRMITSIQHKNLVR 143
           LG G FG V RG+          VAVK L  D   Q E+  +F+ EV  + S+ H+NL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
           L G       +++         LD L   +    L   +R+ +   +A G+ YL      
Sbjct: 80  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES---K 134
Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE--DQAYLSTNFAGTLGYTAPEYAIRGE 261
           R +HRD+ A N+LL  +   KIGDFGL R  P+  D   +  +      + APE      
Sbjct: 135 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 194
Query: 262 LSEKADIYSFGVLVLEIIS 280
            S  +D + FGV + E+ +
Sbjct: 195 FSHASDTWMFGVTLWEMFT 213

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 14/207 (6%)
Query: 78  KKATKNFHPGNLLGRGGFGPVY----RGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMI 133
           K + ++F     LG G FG V+    R       +  +KK  V + +Q E     E  M+
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-NDERLML 60
Query: 134 TSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARG 193
           + + H  ++R+ G   D  Q  ++ +Y++   L  L+  +S +F N   +F     +   
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL-RKSQRFPNPVAKF-YAAEVCLA 118
Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           L+YLH      I++RD+K  N+LLD+    KI DFG A++ P+    ++    GT  Y A
Sbjct: 119 LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYXLCGTPDYIA 171
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIIS 280
           PE       ++  D +SFG+L+ E+++
Sbjct: 172 PEVVSTKPYNKSIDWWSFGILIYEMLA 198

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 12/201 (5%)
Query: 84  FHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNLV 142
           +H    +G G +G VY+ +   G   A+KK+ ++K  +G  S  + E+ ++  ++H N+V
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
           +L        + +LV+E++      LL   E    L   T    +L +  G+ Y H+   
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHD--- 118
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFF--PEDQAYLSTNFAGTLGYTAPEYAI-R 259
            R++HRD+K  N+L++ + + KI DFGLAR F  P  +    T+   TL Y AP+  +  
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK---YTHEVVTLWYRAPDVLMGS 175
Query: 260 GELSEKADIYSFGVLVLEIIS 280
            + S   DI+S G +  E+++
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVN 196

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 12/199 (6%)
Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           G  +G G FG VY+GK      V +  +     QQ ++ F +EV ++   +H N++  +G
Sbjct: 15  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMG 73
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
             S   Q  +V ++ +  SL   ++    KF        I    A+G+ YLH  S   I+
Sbjct: 74  Y-STKPQLAIVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLHAKS---II 128
Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPE-DQAYLSTNFAGTLGYTAPEYAIRGE---- 261
           HRD+K++N+ L E    KIGDFGLA        ++     +G++ + APE  IR +    
Sbjct: 129 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKNP 187
Query: 262 LSEKADIYSFGVLVLEIIS 280
            S ++D+Y+FG+++ E+++
Sbjct: 188 YSFQSDVYAFGIVLYELMT 206

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 90  LGRGGFGPVYRGKL----ADGTLVAVKKLCVDKSQQGES--EFLSEVRMITSIQHKNLVR 143
           LG G FG V RG+          VAVK L  D   Q E+  +F+ EV  + S+ H+NL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
           L G       +++         LD L   +    L   +R+ +   +A G+ YL      
Sbjct: 76  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES---K 130
Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE--DQAYLSTNFAGTLGYTAPEYAIRGE 261
           R +HRD+ A N+LL  +   KIGDFGL R  P+  D   +  +      + APE      
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 262 LSEKADIYSFGVLVLEIIS 280
            S  +D + FGV + E+ +
Sbjct: 191 FSHASDTWMFGVTLWEMFT 209

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 12/199 (6%)
Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           G  +G G FG VY+GK      V +  +     QQ ++ F +EV ++   +H N++  +G
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMG 71
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
             S   Q  +V ++ +  SL   ++    KF        I    A+G+ YLH  S   I+
Sbjct: 72  Y-STKPQLAIVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLHAKS---II 126
Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPE-DQAYLSTNFAGTLGYTAPEYAIRGE---- 261
           HRD+K++N+ L E    KIGDFGLA        ++     +G++ + APE  IR +    
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKNP 185
Query: 262 LSEKADIYSFGVLVLEIIS 280
            S ++D+Y+FG+++ E+++
Sbjct: 186 YSFQSDVYAFGIVLYELMT 204

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 90  LGRGGFGPVYRGKL----ADGTLVAVKKLCVDKSQQGES--EFLSEVRMITSIQHKNLVR 143
           LG G FG V RG+          VAVK L  D   Q E+  +F+ EV  + S+ H+NL+R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
           L G       +++         LD L   +    L   +R+ +   +A G+ YL      
Sbjct: 86  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES---K 140
Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE--DQAYLSTNFAGTLGYTAPEYAIRGE 261
           R +HRD+ A N+LL  +   KIGDFGL R  P+  D   +  +      + APE      
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200
Query: 262 LSEKADIYSFGVLVLEIIS 280
            S  +D + FGV + E+ +
Sbjct: 201 FSHASDTWMFGVTLWEMFT 219

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 12/199 (6%)
Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           G  +G G FG VY+GK      V +  +     QQ ++ F +EV ++   +H N++  +G
Sbjct: 18  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMG 76
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
             S   Q  +V ++ +  SL   ++    KF        I    A+G+ YLH  S   I+
Sbjct: 77  Y-STKPQLAIVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLHAKS---II 131
Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPE-DQAYLSTNFAGTLGYTAPEYAIRGE---- 261
           HRD+K++N+ L E    KIGDFGLA        ++     +G++ + APE  IR +    
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKNP 190
Query: 262 LSEKADIYSFGVLVLEIIS 280
            S ++D+Y+FG+++ E+++
Sbjct: 191 YSFQSDVYAFGIVLYELMT 209

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 90  LGRGGFGPVYRGKL----ADGTLVAVKKLCVDKSQQGES--EFLSEVRMITSIQHKNLVR 143
           LG G FG V RG+          VAVK L  D   Q E+  +F+ EV  + S+ H+NL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
           L G       +++         LD L   +    L   +R+ +   +A G+ YL      
Sbjct: 80  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES---K 134
Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE--DQAYLSTNFAGTLGYTAPEYAIRGE 261
           R +HRD+ A N+LL  +   KIGDFGL R  P+  D   +  +      + APE      
Sbjct: 135 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 194
Query: 262 LSEKADIYSFGVLVLEIIS 280
            S  +D + FGV + E+ +
Sbjct: 195 FSHASDTWMFGVTLWEMFT 213

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 12/199 (6%)
Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           G  +G G FG VY+GK      V +  +     QQ ++ F +EV ++   +H N++  +G
Sbjct: 18  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMG 76
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
             S   Q  +V ++ +  SL   ++    KF        I    A+G+ YLH  S   I+
Sbjct: 77  Y-STKPQLAIVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLHAKS---II 131
Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPE-DQAYLSTNFAGTLGYTAPEYAIRGE---- 261
           HRD+K++N+ L E    KIGDFGLA        ++     +G++ + APE  IR +    
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKNP 190
Query: 262 LSEKADIYSFGVLVLEIIS 280
            S ++D+Y+FG+++ E+++
Sbjct: 191 YSFQSDVYAFGIVLYELMT 209

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 12/201 (5%)
Query: 84  FHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNLV 142
           +H    +G G +G VY+ +   G   A+KK+ ++K  +G  S  + E+ ++  ++H N+V
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
           +L        + +LV+E++      LL   E    L   T    +L +  G+ Y H+   
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHD--- 118
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFF--PEDQAYLSTNFAGTLGYTAPEYAI-R 259
            R++HRD+K  N+L++ + + KI DFGLAR F  P  +    T+   TL Y AP+  +  
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY---THEIVTLWYRAPDVLMGS 175
Query: 260 GELSEKADIYSFGVLVLEIIS 280
            + S   DI+S G +  E+++
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVN 196

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 12/199 (6%)
Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           G  +G G FG VY+GK      V +  +     QQ ++ F +EV ++   +H N++  +G
Sbjct: 40  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMG 98
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
             S   Q  +V ++ +  SL   ++    KF        I    A+G+ YLH  S   I+
Sbjct: 99  Y-STKPQLAIVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLHAKS---II 153
Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPE-DQAYLSTNFAGTLGYTAPEYAIRGE---- 261
           HRD+K++N+ L E    KIGDFGLA        ++     +G++ + APE  IR +    
Sbjct: 154 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKNP 212
Query: 262 LSEKADIYSFGVLVLEIIS 280
            S ++D+Y+FG+++ E+++
Sbjct: 213 YSFQSDVYAFGIVLYELMT 231

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 102/196 (52%), Gaps = 10/196 (5%)
Query: 90  LGRGGFGPVYRG--KLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           LG G FG V +G  ++    + VA+K L     +    E + E +++  + +  +VRL+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
            C      +LV E      L   + G+ ++ +  S   +++  ++ G++YL E +    V
Sbjct: 78  VCQ-AEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKN---FV 132
Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRGELSE 264
           HRD+ A NVLL  +  +KI DFGL++    D +Y +   AG   L + APE     + S 
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 265 KADIYSFGVLVLEIIS 280
           ++D++S+GV + E +S
Sbjct: 193 RSDVWSYGVTMWEALS 208

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 22/213 (10%)
Query: 80  ATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSI 136
           + +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF------LNWSTRFQIILGI 190
            H N+V+LL      ++  LV+E++     DL  + ++         L  S  FQ++   
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQ---DLKTFMDASALTGIPLPLIKSYLFQLL--- 116
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
            +GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F             TL 
Sbjct: 117 -QGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 171
Query: 251 YTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSI 136
           + +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR---- 192
            H N+V+LL      ++  LV+E++         + +  KF++ S    I L + +    
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLF 110
Query: 193 ----GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT 248
               GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F             T
Sbjct: 111 QLLQGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 166
Query: 249 LGYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           L Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 12/199 (6%)
Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           G  +G G FG VY+GK      V +  +     QQ ++ F +EV ++   +H N++  +G
Sbjct: 41  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMG 99
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
             S   Q  +V ++ +  SL   ++    KF        I    A+G+ YLH  S   I+
Sbjct: 100 Y-STKPQLAIVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLHAKS---II 154
Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPE-DQAYLSTNFAGTLGYTAPEYAIRGE---- 261
           HRD+K++N+ L E    KIGDFGLA        ++     +G++ + APE  IR +    
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKNP 213
Query: 262 LSEKADIYSFGVLVLEIIS 280
            S ++D+Y+FG+++ E+++
Sbjct: 214 YSFQSDVYAFGIVLYELMT 232

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSI 136
           + +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR---- 192
            H N+V+LL      ++  LV+E++         + +  KF++ S    I L + +    
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLF 112
Query: 193 ----GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT 248
               GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F             T
Sbjct: 113 QLLQGLAFCH--SH-RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 168
Query: 249 LGYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           L Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSI 136
           + +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR---- 192
            H N+V+LL      ++  LV+E++         + +  KF++ S    I L + +    
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLF 112
Query: 193 ----GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT 248
               GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F             T
Sbjct: 113 QLLQGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 168
Query: 249 LGYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           L Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSI 136
           + +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR---- 192
            H N+V+LL      ++  LV+E++         + +  KF++ S    I L + +    
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLF 113
Query: 193 ----GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT 248
               GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F             T
Sbjct: 114 QLLQGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 169
Query: 249 LGYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           L Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSI 136
           + +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR---- 192
            H N+V+LL      ++  LV+E++         + +  KF++ S    I L + +    
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLF 112
Query: 193 ----GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT 248
               GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F             T
Sbjct: 113 QLLQGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 168
Query: 249 LGYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           L Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSI 136
           + +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR---- 192
            H N+V+LL      ++  LV+E++         + +  KF++ S    I L + +    
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLF 110
Query: 193 ----GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT 248
               GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F             T
Sbjct: 111 QLLQGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 166
Query: 249 LGYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           L Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSI 136
           + +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR---- 192
            H N+V+LL      ++  LV+E++         + +  KF++ S    I L + +    
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLF 113
Query: 193 ----GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT 248
               GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F             T
Sbjct: 114 QLLQGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 169
Query: 249 LGYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           L Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 103/193 (53%), Gaps = 14/193 (7%)
Query: 90  LGRGGFGPVYRGKLADGT--LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G+G FG V++G + + T  +VA+K + +++++    +   E+ +++      + +  G 
Sbjct: 30  IGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 148 CSDGSQRLLVYEYMKNRS-LDLLIYGESDKFLNWSTRFQIIL-GIARGLQYLHEDSHTRI 205
               ++  ++ EY+   S LDLL  G  D+     T+   IL  I +GL YLH +   + 
Sbjct: 89  YLKDTKLWIIMEYLGGGSALDLLEPGPLDE-----TQIATILREILKGLDYLHSE---KK 140
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEK 265
           +HRDIKA+NVLL E  + K+ DFG+A    + Q      F GT  + APE   +     K
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNXFVGTPFWMAPEVIKQSAYDSK 199
Query: 266 ADIYSFGVLVLEI 278
           ADI+S G+  +E+
Sbjct: 200 ADIWSLGITAIEL 212

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSI 136
           + +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR---- 192
            H N+V+LL      ++  LV+E++         + +  KF++ S    I L + +    
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLF 111
Query: 193 ----GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT 248
               GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F             T
Sbjct: 112 QLLQGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 167
Query: 249 LGYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           L Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSI 136
           + +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR---- 192
            H N+V+LL      ++  LV+E++         + +  KF++ S    I L + +    
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLF 110
Query: 193 ----GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT 248
               GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F             T
Sbjct: 111 QLLQGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 166
Query: 249 LGYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           L Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 18/211 (8%)
Query: 80  ATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSI 136
           + +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLL----IYGESDKFLNWSTRFQIILGIAR 192
            H N+V+LL      ++  LV+E++     D +    + G     +  S  FQ++    +
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIK-SYLFQLL----Q 114
Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
           GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F             TL Y 
Sbjct: 115 GLAFCH--SH-RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 170
Query: 253 APEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           APE  +  +  S   DI+S G +  E+++ R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 18/202 (8%)
Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           G  +G G FG VY+GK      V +  +     QQ ++ F +EV ++   +H N++  +G
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMG 71
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
             S   Q  +V ++ +  SL   ++    KF        I    A+G+ YLH  S   I+
Sbjct: 72  Y-STKPQLAIVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLHAKS---II 126
Query: 207 HRDIKASNVLLDEKFQSKIGDFGLA----RFFPEDQAYLSTNFAGTLGYTAPEYAIRGE- 261
           HRD+K++N+ L E    KIGDFGLA    R+    Q       +G++ + APE  IR + 
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQF---EQLSGSILWMAPE-VIRMQD 182
Query: 262 ---LSEKADIYSFGVLVLEIIS 280
               S ++D+Y+FG+++ E+++
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMT 204

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSI 136
           + +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR---- 192
            H N+V+LL      ++  LV+E++         + +  KF++ S    I L + +    
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLF 111
Query: 193 ----GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT 248
               GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F             T
Sbjct: 112 QLLQGLAFCH--SH-RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 167
Query: 249 LGYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           L Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 107/213 (50%), Gaps = 26/213 (12%)
Query: 82  KNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQH 138
           +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR------ 192
            N+V+LL      ++  LV+E++         + +  KF++ S    I L + +      
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 193 --GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
             GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F             TL 
Sbjct: 112 LQGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 167
Query: 251 YTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 107/213 (50%), Gaps = 26/213 (12%)
Query: 82  KNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQH 138
           +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR------ 192
            N+V+LL      ++  LV+E++         + +  KF++ S    I L + +      
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 193 --GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
             GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F             TL 
Sbjct: 112 LQGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 167
Query: 251 YTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 18/202 (8%)
Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           G  +G G FG VY+GK      V +  +     QQ ++ F +EV ++   +H N++  +G
Sbjct: 33  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMG 91
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
             S   Q  +V ++ +  SL   ++    KF        I    A+G+ YLH  S   I+
Sbjct: 92  Y-STKPQLAIVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLHAKS---II 146
Query: 207 HRDIKASNVLLDEKFQSKIGDFGLA----RFFPEDQAYLSTNFAGTLGYTAPEYAIRGE- 261
           HRD+K++N+ L E    KIGDFGLA    R+    Q       +G++ + APE  IR + 
Sbjct: 147 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQF---EQLSGSILWMAPE-VIRMQD 202
Query: 262 ---LSEKADIYSFGVLVLEIIS 280
               S ++D+Y+FG+++ E+++
Sbjct: 203 KNPYSFQSDVYAFGIVLYELMT 224

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSI 136
           + +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR---- 192
            H N+V+LL      ++  LV+E++         + +  KF++ S    I L + +    
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLF 110
Query: 193 ----GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT 248
               GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F             T
Sbjct: 111 QLLQGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 166
Query: 249 LGYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           L Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 97/204 (47%), Gaps = 17/204 (8%)
Query: 82  KNFHPGNLLGRGGFGPVYRGKLADGTLV-AVKKLCVDKSQQG--ESEFLSEVRMITSIQH 138
           ++F  G  LG+G FG VY  +      + A+K L   + ++   E +   EV + + ++H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIARGLQY 196
            N++RL G   D ++  L+ EY    +    +Y E  K   +  +     I  +A  L Y
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSRFDEQRTATYITELANALSY 127
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEY 256
            H     R++HRDIK  N+LL    + KI DFG +   P  +        GTL Y  PE 
Sbjct: 128 CHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR---RDTLCGTLDYLPPE- 180
Query: 257 AIRGEL-SEKADIYSFGVLVLEII 279
            I G +  EK D++S GVL  E +
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFL 204

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSI 136
           + +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  +
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR---- 192
            H N+V+LL      ++  LV+E++         + +  KF++ S    I L + +    
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLF 114
Query: 193 ----GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT 248
               GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F             T
Sbjct: 115 QLLQGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 170
Query: 249 LGYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           L Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 103/193 (53%), Gaps = 14/193 (7%)
Query: 90  LGRGGFGPVYRGKLADGT--LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G+G FG V++G + + T  +VA+K + +++++    +   E+ +++      + +  G 
Sbjct: 15  IGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 73
Query: 148 CSDGSQRLLVYEYMKNRS-LDLLIYGESDKFLNWSTRFQIIL-GIARGLQYLHEDSHTRI 205
               ++  ++ EY+   S LDLL  G  D+     T+   IL  I +GL YLH +   + 
Sbjct: 74  YLKDTKLWIIMEYLGGGSALDLLEPGPLDE-----TQIATILREILKGLDYLHSE---KK 125
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEK 265
           +HRDIKA+NVLL E  + K+ DFG+A    + Q      F GT  + APE   +     K
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNXFVGTPFWMAPEVIKQSAYDSK 184
Query: 266 ADIYSFGVLVLEI 278
           ADI+S G+  +E+
Sbjct: 185 ADIWSLGITAIEL 197

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 107/213 (50%), Gaps = 26/213 (12%)
Query: 82  KNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQH 138
           +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  + H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR------ 192
            N+V+LL      ++  LV+E++         + +  KF++ S    I L + +      
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLFQL 113
Query: 193 --GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
             GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F             TL 
Sbjct: 114 LQGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 169
Query: 251 YTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 26/213 (12%)
Query: 82  KNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQH 138
           +NF     +G G +G VY  R KL  G +VA+ K+ +D   +G  S  + E+ ++  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALXKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR------ 192
            N+V+LL      ++  LV+E++         + +  KF++ S    I L + +      
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 193 --GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
             GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F        T+   TL 
Sbjct: 113 LQGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLW 168
Query: 251 YTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 26/213 (12%)
Query: 82  KNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQH 138
           +NF     +G G +G VY  R KL  G +VA+ K+ +D   +G  S  + E+ ++  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALXKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR------ 192
            N+V+LL      ++  LV+E++         + +  KF++ S    I L + +      
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL---------HQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 193 --GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
             GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F        T+   TL 
Sbjct: 112 LQGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLW 167
Query: 251 YTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 18/202 (8%)
Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           G  +G G FG VY+GK      V +  +     QQ ++ F +EV ++   +H N++  +G
Sbjct: 41  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMG 99
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
             S   Q  +V ++ +  SL   ++    KF        I    A+G+ YLH  S   I+
Sbjct: 100 Y-STKPQLAIVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLHAKS---II 154
Query: 207 HRDIKASNVLLDEKFQSKIGDFGLA----RFFPEDQAYLSTNFAGTLGYTAPEYAIRGE- 261
           HRD+K++N+ L E    KIGDFGLA    R+    Q       +G++ + APE  IR + 
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQF---EQLSGSILWMAPE-VIRMQD 210
Query: 262 ---LSEKADIYSFGVLVLEIIS 280
               S ++D+Y+FG+++ E+++
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMT 232

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 102/196 (52%), Gaps = 14/196 (7%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG VY+ K  +   +A  K+   KS++   +++ E+ ++ +  H  +V+LLG   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIIL-GIARGLQYLHEDSHTRIVHR 208
              +  ++ E+    ++D ++  E D+ L    + Q++   +   L +LH     RI+HR
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIML-ELDRGLT-EPQIQVVCRQMLEALNFLHS---KRIIHR 133
Query: 209 DIKASNVLLDEKFQSKIGDFGL-ARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSE--- 264
           D+KA NVL+  +   ++ DFG+ A+     Q     +F GT  + APE  +   + +   
Sbjct: 134 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK--RDSFIGTPYWMAPEVVMCETMKDTPY 191
Query: 265 --KADIYSFGVLVLEI 278
             KADI+S G+ ++E+
Sbjct: 192 DYKADIWSLGITLIEM 207

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG----ESEFLSEVRMIT 134
           AT  + P   +G G +G VY+ +    G  VA+K + V   ++G        ++ +R + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 135 SIQHKNLVRLLGCCSDGS-----QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG 189
           + +H N+VRL+  C+        +  LV+E++ ++ L   +       L   T   ++  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
             RGL +LH +    IVHRD+K  N+L+      K+ DFGLAR +    A        TL
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPV--VVTL 175
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEI 278
            Y APE  ++   +   D++S G +  E+
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 102/196 (52%), Gaps = 14/196 (7%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG VY+ K  +   +A  K+   KS++   +++ E+ ++ +  H  +V+LLG   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIIL-GIARGLQYLHEDSHTRIVHR 208
              +  ++ E+    ++D ++  E D+ L    + Q++   +   L +LH     RI+HR
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIML-ELDRGLT-EPQIQVVCRQMLEALNFLHS---KRIIHR 141
Query: 209 DIKASNVLLDEKFQSKIGDFGL-ARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSE--- 264
           D+KA NVL+  +   ++ DFG+ A+     Q     +F GT  + APE  +   + +   
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK--RDSFIGTPYWMAPEVVMCETMKDTPY 199
Query: 265 --KADIYSFGVLVLEI 278
             KADI+S G+ ++E+
Sbjct: 200 DYKADIWSLGITLIEM 215

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 16/199 (8%)
Query: 90  LGRGGFGPVYRG------KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG G FG V +G      K  D   VA+K L     +    E + E +++  + +  +VR
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQID---VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
           L+G C      +LV E      L   + G+ ++ +  S   +++  ++ G++YL E +  
Sbjct: 401 LIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKN-- 456
Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG--TLGYTAPEYAIRGE 261
             VHR++ A NVLL  +  +KI DFGL++    D +Y +   AG   L + APE     +
Sbjct: 457 -FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 262 LSEKADIYSFGVLVLEIIS 280
            S ++D++S+GV + E +S
Sbjct: 516 FSSRSDVWSYGVTMWEALS 534

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 112/220 (50%), Gaps = 21/220 (9%)
Query: 74  FQTLKK---ATKNFHPGNL------LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGES 124
           FQ++K+    T++ +P +       LG G FG VY+ +  + +++A  K+   KS++   
Sbjct: 20  FQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE 79
Query: 125 EFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF 184
           +++ E+ ++ S  H N+V+LL      +   ++ E+    ++D ++  E ++ L  S   
Sbjct: 80  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML-ELERPLTESQIQ 138
Query: 185 QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN 244
            +       L YLH++   +I+HRD+KA N+L       K+ DFG++            +
Sbjct: 139 VVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR-XIQRRDS 194
Query: 245 FAGTLGYTAPEYAIRGELSE------KADIYSFGVLVLEI 278
           F GT  + APE  +  E S+      KAD++S G+ ++E+
Sbjct: 195 FIGTPYWMAPE-VVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 103/200 (51%), Gaps = 13/200 (6%)
Query: 90  LGRGGFGPVYRGKL-----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG G FG V   +        G  VAVK L  +      ++   E+ ++ ++ H+N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 145 LGCCSD--GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            G C++  G+   L+ E++ + SL   +    +K +N   + +  + I +G+ YL     
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYL---GS 144
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST--NFAGTLGYTAPEYAIRG 260
            + VHRD+ A NVL++ + Q KIGDFGL +    D+   +   +    + + APE  ++ 
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 204
Query: 261 ELSEKADIYSFGVLVLEIIS 280
           +    +D++SFGV + E+++
Sbjct: 205 KFYIASDVWSFGVTLHELLT 224

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 112/220 (50%), Gaps = 21/220 (9%)
Query: 74  FQTLKK---ATKNFHPGNL------LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGES 124
           FQ++K+    T++ +P +       LG G FG VY+ +  + +++A  K+   KS++   
Sbjct: 20  FQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE 79
Query: 125 EFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF 184
           +++ E+ ++ S  H N+V+LL      +   ++ E+    ++D ++  E ++ L  S   
Sbjct: 80  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML-ELERPLTESQIQ 138
Query: 185 QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN 244
            +       L YLH++   +I+HRD+KA N+L       K+ DFG++            +
Sbjct: 139 VVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR-TIQRRDS 194
Query: 245 FAGTLGYTAPEYAIRGELSE------KADIYSFGVLVLEI 278
           F GT  + APE  +  E S+      KAD++S G+ ++E+
Sbjct: 195 FIGTPYWMAPE-VVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 80  ATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSI 136
           + +NF     +G G +G VY  R KL  G +VA+KK+ +D   +G  S  + E+ ++  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR---- 192
            H N+V+LL      ++  LV+E++           +  KF++ S    I L + +    
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHVDQ---------DLKKFMDASALTGIPLPLIKSYLF 113
Query: 193 ----GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT 248
               GL + H  SH R++HRD+K  N+L++ +   K+ DFGLAR F             T
Sbjct: 114 QLLQGLAFCH--SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-T 169
Query: 249 LGYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR 282
           L Y APE  +  +  S   DI+S G +  E+++ R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 103/200 (51%), Gaps = 13/200 (6%)
Query: 90  LGRGGFGPVYRGKL-----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG G FG V   +        G  VAVK L  +      ++   E+ ++ ++ H+N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 145 LGCCSD--GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            G C++  G+   L+ E++ + SL   +    +K +N   + +  + I +G+ YL     
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYL---GS 132
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST--NFAGTLGYTAPEYAIRG 260
            + VHRD+ A NVL++ + Q KIGDFGL +    D+   +   +    + + APE  ++ 
Sbjct: 133 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 192
Query: 261 ELSEKADIYSFGVLVLEIIS 280
           +    +D++SFGV + E+++
Sbjct: 193 KFYIASDVWSFGVTLHELLT 212

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG----ESEFLSEVRMIT 134
           AT  + P   +G G +G VY+ +    G  VA+K + V   ++G        ++ +R + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 135 SIQHKNLVRLLGCCSDGS-----QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG 189
           + +H N+VRL+  C+        +  LV+E++ ++ L   +       L   T   ++  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
             RGL +LH +    IVHRD+K  N+L+      K+ DFGLAR +    A        TL
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV--TL 175
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEI 278
            Y APE  ++   +   D++S G +  E+
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 104/230 (45%), Gaps = 44/230 (19%)
Query: 83  NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQH--- 138
           +F    +LG+G FG V + + A D    A+KK  +  +++  S  LSEV ++ S+ H   
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKK--IRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 139 ----------KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGES-----DKFLNWSTR 183
                     +N V+ +      S   +  EY +N +L  LI+ E+     D++  W   
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY--WRLF 122
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS- 242
            QI+      L Y+H      I+HRD+K  N+ +DE    KIGDFGLA+        L  
Sbjct: 123 RQIL----EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 243 ------------TNFAGTLGYTAPEYAI-RGELSEKADIYSFGVLVLEII 279
                       T+  GT  Y A E     G  +EK D+YS G++  E+I
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGE----SEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V +G      +V    + + K++  +     E L+E  ++  + +  +VR++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G C +    +LV E  +   L+   Y + ++ +      +++  ++ G++YL E   +  
Sbjct: 95  GIC-EAESWMLVMEMAELGPLNK--YLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 148
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRGELS 263
           VHRD+ A NVLL  +  +KI DFGL++    D+ Y      G   + + APE     + S
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 208
Query: 264 EKADIYSFGVLVLEIIS 280
            K+D++SFGVL+ E  S
Sbjct: 209 SKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGE----SEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V +G      +V    + + K++  +     E L+E  ++  + +  +VR++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G C +    +LV E  +   L+   Y + ++ +      +++  ++ G++YL E   +  
Sbjct: 95  GIC-EAESWMLVMEMAELGPLNK--YLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 148
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRGELS 263
           VHRD+ A NVLL  +  +KI DFGL++    D+ Y      G   + + APE     + S
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 208
Query: 264 EKADIYSFGVLVLEIIS 280
            K+D++SFGVL+ E  S
Sbjct: 209 SKSDVWSFGVLMWEAFS 225

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 126/293 (43%), Gaps = 42/293 (14%)
Query: 87  GNLLGRGGFGPVYRGKL-----ADGTLVAVKKLCVDKSQQGESE-FLSEVRMITSI-QHK 139
           G  LG G FG V          +D  +    K+    +   E E  +SE+++++ +  H 
Sbjct: 51  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 110
Query: 140 NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG---------- 189
           N+V LLG C+ G   L++ EY     L   +  + D F+   T   I+            
Sbjct: 111 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 190 ------IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
                 +A+G+ +L   +    +HRD+ A N+LL     +KI DFGLAR    D  Y + 
Sbjct: 171 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVK 227
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWK 302
            N    + + APE       + ++D++S+G+ + E+ S   +    +P + ++     +K
Sbjct: 228 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF-----YK 282
Query: 303 LYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
           + + G    ++ P        E    ++ ++   C      +RP   +IV ++
Sbjct: 283 MIKEG--FRMLSP--------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 325

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 111/220 (50%), Gaps = 21/220 (9%)
Query: 74  FQTLKK---ATKNFHPGNL------LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGES 124
           FQ++K+    T++ +P +       LG G FG VY+ +  + +++A  K+   KS++   
Sbjct: 20  FQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE 79
Query: 125 EFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF 184
           +++ E+ ++ S  H N+V+LL      +   ++ E+    ++D ++  E ++ L  S   
Sbjct: 80  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML-ELERPLTESQIQ 138
Query: 185 QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN 244
            +       L YLH++   +I+HRD+KA N+L       K+ DFG++             
Sbjct: 139 VVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR-XIQRRDX 194
Query: 245 FAGTLGYTAPEYAIRGELSE------KADIYSFGVLVLEI 278
           F GT  + APE  +  E S+      KAD++S G+ ++E+
Sbjct: 195 FIGTPYWMAPE-VVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGE----SEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V +G      +V    + + K++  +     E L+E  ++  + +  +VR++
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G C +    +LV E  +   L+   Y + ++ +      +++  ++ G++YL E   +  
Sbjct: 93  GIC-EAESWMLVMEMAELGPLN--KYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 146
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRGELS 263
           VHRD+ A NVLL  +  +KI DFGL++    D+ Y      G   + + APE     + S
Sbjct: 147 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 206
Query: 264 EKADIYSFGVLVLEIIS 280
            K+D++SFGVL+ E  S
Sbjct: 207 SKSDVWSFGVLMWEAFS 223

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/227 (31%), Positives = 110/227 (48%), Gaps = 34/227 (14%)
Query: 83  NFHPGNLLGRGGFGPVYRGKLA----DGTLVAVK----KLCVDKSQQGESEFLSEVRMIT 134
           N+     LG G FG V   KLA     G  VA+K    K+      QG  E   E+  + 
Sbjct: 14  NYQIVKTLGEGSFGKV---KLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLR 68
Query: 135 SIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIAR 192
            ++H ++++L        + ++V EY  N   D ++  + DK      R  FQ I+    
Sbjct: 69  LLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV--QRDKMSEQEARRFFQQIIS--- 123
Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
            ++Y H     +IVHRD+K  N+LLDE    KI DFGL+     D  +L T+  G+  Y 
Sbjct: 124 AVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTS-CGSPNYA 178
Query: 253 APEYAIRGEL--SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLP 297
           APE  I G+L    + D++S GV +L ++ CR+     LP + + +P
Sbjct: 179 APE-VISGKLYAGPEVDVWSCGV-ILYVMLCRR-----LPFDDESIP 218

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/227 (31%), Positives = 110/227 (48%), Gaps = 34/227 (14%)
Query: 83  NFHPGNLLGRGGFGPVYRGKLA----DGTLVAVK----KLCVDKSQQGESEFLSEVRMIT 134
           N+     LG G FG V   KLA     G  VA+K    K+      QG  E   E+  + 
Sbjct: 5   NYQIVKTLGEGSFGKV---KLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLR 59
Query: 135 SIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIAR 192
            ++H ++++L        + ++V EY  N   D ++  + DK      R  FQ I+    
Sbjct: 60  LLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV--QRDKMSEQEARRFFQQIIS--- 114
Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
            ++Y H     +IVHRD+K  N+LLDE    KI DFGL+     D  +L T+  G+  Y 
Sbjct: 115 AVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTS-CGSPNYA 169
Query: 253 APEYAIRGEL--SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLP 297
           APE  I G+L    + D++S GV +L ++ CR+     LP + + +P
Sbjct: 170 APE-VISGKLYAGPEVDVWSCGV-ILYVMLCRR-----LPFDDESIP 209

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG----ESEFLSEVRMIT 134
           AT  + P   +G G +G VY+ +    G  VA+K + V   ++G        ++ +R + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 135 SIQHKNLVRLLGCCSDGS-----QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG 189
           + +H N+VRL+  C+        +  LV+E++ ++ L   +       L   T   ++  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
             RGL +LH +    IVHRD+K  N+L+      K+ DFGLAR +    A        TL
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--DPVVVTL 175
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEI 278
            Y APE  ++   +   D++S G +  E+
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/227 (31%), Positives = 110/227 (48%), Gaps = 34/227 (14%)
Query: 83  NFHPGNLLGRGGFGPVYRGKLA----DGTLVAVK----KLCVDKSQQGESEFLSEVRMIT 134
           N+     LG G FG V   KLA     G  VA+K    K+      QG  E   E+  + 
Sbjct: 15  NYQIVKTLGEGSFGKV---KLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLR 69
Query: 135 SIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIAR 192
            ++H ++++L        + ++V EY  N   D ++  + DK      R  FQ I+    
Sbjct: 70  LLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV--QRDKMSEQEARRFFQQIIS--- 124
Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
            ++Y H     +IVHRD+K  N+LLDE    KI DFGL+     D  +L T+  G+  Y 
Sbjct: 125 AVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTS-CGSPNYA 179
Query: 253 APEYAIRGEL--SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLP 297
           APE  I G+L    + D++S GV +L ++ CR+     LP + + +P
Sbjct: 180 APE-VISGKLYAGPEVDVWSCGV-ILYVMLCRR-----LPFDDESIP 219

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGE----SEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V +G      +V    + + K++  +     E L+E  ++  + +  +VR++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G C +    +LV E  +   L+   Y + ++ +      +++  ++ G++YL E   +  
Sbjct: 79  GIC-EAESWMLVMEMAELGPLN--KYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 132
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRGELS 263
           VHRD+ A NVLL  +  +KI DFGL++    D+ Y      G   + + APE     + S
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 192
Query: 264 EKADIYSFGVLVLEIIS 280
            K+D++SFGVL+ E  S
Sbjct: 193 SKSDVWSFGVLMWEAFS 209

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 109/211 (51%), Gaps = 25/211 (11%)
Query: 90  LGRGGFGPVYRGK---LAD--GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG+G FG V   +   L D  G LVAVK+L      Q + +F  E++++ ++    +V+ 
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFIVKY 76
Query: 145 LGCC-SDGSQRL-LVYEYMKNRSL-DLLIYG----ESDKFLNWSTRFQIILGIARGLQYL 197
            G     G Q L LV EY+ +  L D L       ++ + L +S++      I +G++YL
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ------ICKGMEYL 130
Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG--TLGYTAPE 255
                 R VHRD+ A N+L++ +   KI DFGLA+  P D+ Y      G   + + APE
Sbjct: 131 ---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 187
Query: 256 YAIRGELSEKADIYSFGVLVLEIIS-CRKNT 285
                  S ++D++SFGV++ E+ + C K+ 
Sbjct: 188 SLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 218

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGE----SEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V +G      +V    + + K++  +     E L+E  ++  + +  +VR++
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G C +    +LV E  +   L+   Y + ++ +      +++  ++ G++YL E   +  
Sbjct: 438 GIC-EAESWMLVMEMAELGPLNK--YLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 491
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRGELS 263
           VHRD+ A NVLL  +  +KI DFGL++    D+ Y      G   + + APE     + S
Sbjct: 492 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 551
Query: 264 EKADIYSFGVLVLEIIS 280
            K+D++SFGVL+ E  S
Sbjct: 552 SKSDVWSFGVLMWEAFS 568

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGE----SEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V +G      +V    + + K++  +     E L+E  ++  + +  +VR++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G C +    +LV E  +   L+   Y + ++ +      +++  ++ G++YL E   +  
Sbjct: 85  GIC-EAESWMLVMEMAELGPLN--KYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 138
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRGELS 263
           VHRD+ A NVLL  +  +KI DFGL++    D+ Y      G   + + APE     + S
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 264 EKADIYSFGVLVLEIIS 280
            K+D++SFGVL+ E  S
Sbjct: 199 SKSDVWSFGVLMWEAFS 215

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/227 (31%), Positives = 110/227 (48%), Gaps = 34/227 (14%)
Query: 83  NFHPGNLLGRGGFGPVYRGKLA----DGTLVAVK----KLCVDKSQQGESEFLSEVRMIT 134
           N+     LG G FG V   KLA     G  VA+K    K+      QG  E   E+  + 
Sbjct: 9   NYQIVKTLGEGSFGKV---KLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLR 63
Query: 135 SIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGIAR 192
            ++H ++++L        + ++V EY  N   D ++  + DK      R  FQ I+    
Sbjct: 64  LLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV--QRDKMSEQEARRFFQQIIS--- 118
Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
            ++Y H     +IVHRD+K  N+LLDE    KI DFGL+     D  +L T+  G+  Y 
Sbjct: 119 AVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTS-CGSPNYA 173
Query: 253 APEYAIRGEL--SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLP 297
           APE  I G+L    + D++S GV +L ++ CR+     LP + + +P
Sbjct: 174 APE-VISGKLYAGPEVDVWSCGV-ILYVMLCRR-----LPFDDESIP 213

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGE----SEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V +G      +V    + + K++  +     E L+E  ++  + +  +VR++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G C +    +LV E  +   L+   Y + ++ +      +++  ++ G++YL E   +  
Sbjct: 75  GIC-EAESWMLVMEMAELGPLN--KYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 128
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRGELS 263
           VHRD+ A NVLL  +  +KI DFGL++    D+ Y      G   + + APE     + S
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 264 EKADIYSFGVLVLEIIS 280
            K+D++SFGVL+ E  S
Sbjct: 189 SKSDVWSFGVLMWEAFS 205

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGE----SEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V +G      +V    + + K++  +     E L+E  ++  + +  +VR++
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G C +    +LV E  +   L+   Y + ++ +      +++  ++ G++YL E   +  
Sbjct: 437 GIC-EAESWMLVMEMAELGPLNK--YLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 490
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRGELS 263
           VHRD+ A NVLL  +  +KI DFGL++    D+ Y      G   + + APE     + S
Sbjct: 491 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 550
Query: 264 EKADIYSFGVLVLEIIS 280
            K+D++SFGVL+ E  S
Sbjct: 551 SKSDVWSFGVLMWEAFS 567

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 106/226 (46%), Gaps = 25/226 (11%)
Query: 89  LLGRGGFGPVYRGKLADGTLVAVKKLCVDKS---QQGESEFLS-EVRMITSIQHKNLVRL 144
            LG+GGF   +    AD   V   K+ V KS   +  + E +S E+ +  S+ H+++V  
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKI-VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 86
Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QIILGIARGLQYLHEDS 201
            G   D     +V E  + RSL L ++           R+   QI+LG     QYLH + 
Sbjct: 87  HGFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLRQIVLGC----QYLHRN- 140
Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
             R++HRD+K  N+ L+E  + KIGDFGLA     D     T   GT  Y APE   +  
Sbjct: 141 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKG 197
Query: 262 LSEKADIYSFGVLVLEII--------SCRKNTDLTLPSEMQYLPEY 299
            S + D++S G ++  ++        SC K T L +      +P++
Sbjct: 198 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 243

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 109/211 (51%), Gaps = 25/211 (11%)
Query: 90  LGRGGFGPVYRGK---LAD--GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG+G FG V   +   L D  G LVAVK+L      Q + +F  E++++ ++    +V+ 
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFIVKY 77
Query: 145 LGCC-SDGSQRL-LVYEYMKNRSL-DLLIYG----ESDKFLNWSTRFQIILGIARGLQYL 197
            G     G Q L LV EY+ +  L D L       ++ + L +S++      I +G++YL
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ------ICKGMEYL 131
Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG--TLGYTAPE 255
                 R VHRD+ A N+L++ +   KI DFGLA+  P D+ Y      G   + + APE
Sbjct: 132 ---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 188
Query: 256 YAIRGELSEKADIYSFGVLVLEIIS-CRKNT 285
                  S ++D++SFGV++ E+ + C K+ 
Sbjct: 189 SLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 219

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 109/211 (51%), Gaps = 25/211 (11%)
Query: 90  LGRGGFGPVYRGK---LAD--GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG+G FG V   +   L D  G LVAVK+L      Q + +F  E++++ ++    +V+ 
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFIVKY 89
Query: 145 LGCC-SDGSQRL-LVYEYMKNRSL-DLLIYG----ESDKFLNWSTRFQIILGIARGLQYL 197
            G     G Q L LV EY+ +  L D L       ++ + L +S++      I +G++YL
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ------ICKGMEYL 143
Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG--TLGYTAPE 255
                 R VHRD+ A N+L++ +   KI DFGLA+  P D+ Y      G   + + APE
Sbjct: 144 ---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 200
Query: 256 YAIRGELSEKADIYSFGVLVLEIIS-CRKNT 285
                  S ++D++SFGV++ E+ + C K+ 
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 231

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 106/226 (46%), Gaps = 25/226 (11%)
Query: 89  LLGRGGFGPVYRGKLADGTLVAVKKLCVDKS---QQGESEFLS-EVRMITSIQHKNLVRL 144
            LG+GGF   +    AD   V   K+ V KS   +  + E +S E+ +  S+ H+++V  
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKI-VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QIILGIARGLQYLHEDS 201
            G   D     +V E  + RSL L ++           R+   QI+LG     QYLH + 
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLRQIVLGC----QYLHRN- 136
Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
             R++HRD+K  N+ L+E  + KIGDFGLA     D     T   GT  Y APE   +  
Sbjct: 137 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKG 193
Query: 262 LSEKADIYSFGVLVLEII--------SCRKNTDLTLPSEMQYLPEY 299
            S + D++S G ++  ++        SC K T L +      +P++
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 239

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 106/226 (46%), Gaps = 25/226 (11%)
Query: 89  LLGRGGFGPVYRGKLADGTLVAVKKLCVDKS---QQGESEFLS-EVRMITSIQHKNLVRL 144
            LG+GGF   +    AD   V   K+ V KS   +  + E +S E+ +  S+ H+++V  
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKI-VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QIILGIARGLQYLHEDS 201
            G   D     +V E  + RSL L ++           R+   QI+LG     QYLH + 
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLRQIVLGC----QYLHRN- 136
Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
             R++HRD+K  N+ L+E  + KIGDFGLA     D     T   GT  Y APE   +  
Sbjct: 137 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKG 193
Query: 262 LSEKADIYSFGVLVLEII--------SCRKNTDLTLPSEMQYLPEY 299
            S + D++S G ++  ++        SC K T L +      +P++
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 239

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGE----SEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V +G      +V    + + K++  +     E L+E  ++  + +  +VR++
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G C +    +LV E  +   L+   Y + ++ +      +++  ++ G++YL E   +  
Sbjct: 73  GIC-EAESWMLVMEMAELGPLN--KYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 126
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRGELS 263
           VHRD+ A NVLL  +  +KI DFGL++    D+ Y      G   + + APE     + S
Sbjct: 127 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 186
Query: 264 EKADIYSFGVLVLEIIS 280
            K+D++SFGVL+ E  S
Sbjct: 187 SKSDVWSFGVLMWEAFS 203

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 101/225 (44%), Gaps = 19/225 (8%)
Query: 67  RTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESE 125
           R++   D   L+     F    L+G G +G VY+G+ +  G L A+K   +D +   E E
Sbjct: 9   RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIK--VMDVTGDEEEE 66
Query: 126 FLSEVRMITSI-QHKNLVRLLGCCSDGS------QRLLVYEYMKNRSLDLLIYGESDKFL 178
              E+ M+     H+N+    G     +      Q  LV E+    S+  LI       L
Sbjct: 67  IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL 126
Query: 179 NWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ 238
                  I   I RGL +LH+    +++HRDIK  NVLL E  + K+ DFG++       
Sbjct: 127 KEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 183
Query: 239 AYLSTNFAGTLGYTAPEYAIRGELSE-----KADIYSFGVLVLEI 278
              +T F GT  + APE     E  +     K+D++S G+  +E+
Sbjct: 184 GRRNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 126/293 (43%), Gaps = 42/293 (14%)
Query: 87  GNLLGRGGFGPVYRGKL-----ADGTLVAVKKLCVDKSQQGESE-FLSEVRMITSI-QHK 139
           G  LG G FG V          +D  +    K+    +   E E  +SE+++++ +  H 
Sbjct: 51  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 110
Query: 140 NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG---------- 189
           N+V LLG C+ G   L++ EY     L   +  + D F+   T   I+            
Sbjct: 111 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 190 ------IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
                 +A+G+ +L   +    +HRD+ A N+LL     +KI DFGLAR    D  Y + 
Sbjct: 171 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 227
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWK 302
            N    + + APE       + ++D++S+G+ + E+ S   +    +P + ++     +K
Sbjct: 228 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF-----YK 282
Query: 303 LYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
           + + G    ++ P        E    ++ ++   C      +RP   +IV ++
Sbjct: 283 MIKEG--FRMLSP--------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 325

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 126/293 (43%), Gaps = 42/293 (14%)
Query: 87  GNLLGRGGFGPVYRGKL-----ADGTLVAVKKLCVDKSQQGESE-FLSEVRMITSI-QHK 139
           G  LG G FG V          +D  +    K+    +   E E  +SE+++++ +  H 
Sbjct: 46  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 105
Query: 140 NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG---------- 189
           N+V LLG C+ G   L++ EY     L   +  + D F+   T   I+            
Sbjct: 106 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 165
Query: 190 ------IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
                 +A+G+ +L   +    +HRD+ A N+LL     +KI DFGLAR    D  Y + 
Sbjct: 166 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 222
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWK 302
            N    + + APE       + ++D++S+G+ + E+ S   +    +P + ++     +K
Sbjct: 223 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF-----YK 277
Query: 303 LYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
           + + G    ++ P        E    ++ ++   C      +RP   +IV ++
Sbjct: 278 MIKEG--FRMLSP--------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 320

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 126/293 (43%), Gaps = 42/293 (14%)
Query: 87  GNLLGRGGFGPVYRGKL-----ADGTLVAVKKLCVDKSQQGESE-FLSEVRMITSI-QHK 139
           G  LG G FG V          +D  +    K+    +   E E  +SE+++++ +  H 
Sbjct: 44  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 103
Query: 140 NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG---------- 189
           N+V LLG C+ G   L++ EY     L   +  + D F+   T   I+            
Sbjct: 104 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 163
Query: 190 ------IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
                 +A+G+ +L   +    +HRD+ A N+LL     +KI DFGLAR    D  Y + 
Sbjct: 164 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 220
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWK 302
            N    + + APE       + ++D++S+G+ + E+ S   +    +P + ++     +K
Sbjct: 221 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF-----YK 275
Query: 303 LYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
           + + G    ++ P        E    ++ ++   C      +RP   +IV ++
Sbjct: 276 MIKEG--FRMLSP--------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 318

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 126/293 (43%), Gaps = 42/293 (14%)
Query: 87  GNLLGRGGFGPVYRGKL-----ADGTLVAVKKLCVDKSQQGESE-FLSEVRMITSI-QHK 139
           G  LG G FG V          +D  +    K+    +   E E  +SE+++++ +  H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 140 NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG---------- 189
           N+V LLG C+ G   L++ EY     L   +  + D F+   T   I+            
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 190 ------IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LS 242
                 +A+G+ +L   +    +HRD+ A N+LL     +KI DFGLAR    D  Y + 
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWK 302
            N    + + APE       + ++D++S+G+ + E+ S   +    +P + ++     +K
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF-----YK 259
Query: 303 LYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
           + + G    ++ P        E    ++ ++   C      +RP   +IV ++
Sbjct: 260 MIKEG--FRMLSP--------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 102/230 (44%), Gaps = 44/230 (19%)
Query: 83  NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQH--- 138
           +F    +LG+G FG V + + A D    A+KK  +  +++  S  LSEV ++ S+ H   
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKK--IRHTEEKLSTILSEVXLLASLNHQYV 64
Query: 139 ----------KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGES-----DKFLNWSTR 183
                     +N V+        S   +  EY +NR+L  LI+ E+     D++  W   
Sbjct: 65  VRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEY--WRLF 122
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS- 242
            QI+      L Y+H      I+HR++K  N+ +DE    KIGDFGLA+        L  
Sbjct: 123 RQIL----EALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 243 ------------TNFAGTLGYTAPEYAI-RGELSEKADIYSFGVLVLEII 279
                       T+  GT  Y A E     G  +EK D YS G++  E I
Sbjct: 176 DSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 13/208 (6%)
Query: 74  FQTLKKATKNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKK-LCVDKSQQGESEFLSEVR 131
           FQ+++K    +    L+G G +G V + +  D G +VA+KK L  D  +  +   + E++
Sbjct: 21  FQSMEK----YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIK 76
Query: 132 MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIA 191
           ++  ++H+NLV LL  C    +  LV+E++ +  LD L    +   L++    + +  I 
Sbjct: 77  LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--LDYQVVQKYLFQII 134
Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY 251
            G+ + H  SH  I+HRDIK  N+L+ +    K+ DFG AR             A T  Y
Sbjct: 135 NGIGFCH--SHN-IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWY 190
Query: 252 TAPEYAIRGELSEKA-DIYSFGVLVLEI 278
            APE  +      KA D+++ G LV E+
Sbjct: 191 RAPELLVGDVKYGKAVDVWAIGCLVTEM 218

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 90  LGRGGFGPVYRGKL---ADG---TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG   FG VY+G L   A G     VA+K L          EF  E  +   +QH N+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIY--------GESD------KFLNWSTRFQIILG 189
           LLG  +      +++ Y  +  L   +         G +D        L       ++  
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR-FFPEDQAYLSTNFAGT 248
           IA G++YL   S   +VH+D+   NVL+ +K   KI D GL R  +  D   L  N    
Sbjct: 154 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           + + APE  + G+ S  +DI+S+GV++ E+ S
Sbjct: 211 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 91  GRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSD 150
            RG FG V++ +L +   VAVK   +   Q  +SE   E+     ++H+NL++ +     
Sbjct: 24  ARGRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQSE--REIFSTPGMKHENLLQFIAAEKR 80
Query: 151 GS----QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED------ 200
           GS    +  L+  +    SL   + G     + W+    +   ++RGL YLHED      
Sbjct: 81  GSNLEVELWLITAFHDKGSLTDYLKG---NIITWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 201 --SHTRIVHRDIKASNVLLDEKFQSKIGDFGLA-RFFPEDQAYLSTNFAGTLGYTAPEYA 257
                 I HRD K+ NVLL     + + DFGLA RF P      +    GT  Y APE  
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE-V 196
Query: 258 IRGELS------EKADIYSFGVLVLEIISCRKNTD 286
           + G ++       + D+Y+ G+++ E++S  K  D
Sbjct: 197 LEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 25/208 (12%)
Query: 91  GRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSD 150
            RG FG V++ +L +   VAVK   +   Q  ++E+  EV  +  ++H+N+++ +G    
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGAEKR 89
Query: 151 GS----QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED------ 200
           G+       L+  + +  SL   +       ++W+    I   +ARGL YLHED      
Sbjct: 90  GTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKD 146
Query: 201 -SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF-AGTLGYTAPEYAI 258
                I HRDIK+ NVLL     + I DFGLA  F   ++   T+   GT  Y APE  +
Sbjct: 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE-VL 205
Query: 259 RGELS------EKADIYSFGVLVLEIIS 280
            G ++       + D+Y+ G+++ E+ S
Sbjct: 206 EGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 80  ATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEF-------LSEVR 131
           AT  + P   +G G +G VY+ +    G  VA+K + V     G           ++ +R
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 132 MITSIQHKNLVRLLGCCSDGS-----QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQI 186
            + + +H N+VRL+  C+        +  LV+E++ ++ L   +       L   T   +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDL 125
Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA 246
           +    RGL +LH +    IVHRD+K  N+L+      K+ DFGLAR +    A   T   
Sbjct: 126 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--TPVV 180
Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEI 278
            TL Y APE  ++   +   D++S G +  E+
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 111/248 (44%), Gaps = 14/248 (5%)
Query: 42  AKELVRLALRTTKEGVSKDFFNGNLRTISYFDFQTLK-----KATKN-FHPGNLLGRGGF 95
            K+L +   R T E +S   F   L +I +  F   K       TKN F    +LG+GGF
Sbjct: 138 CKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGF 197
Query: 96  GPVYRGKL-ADGTLVAVKKLCVDKSQQ--GESEFLSEVRMITSIQHKNLVRLLGCCSDGS 152
           G V   ++ A G + A KKL   + ++  GE+  L+E +++  +  + +V L        
Sbjct: 198 GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 257
Query: 153 QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKA 212
              LV   M    L   IY         +        I  GL+ LH +   RIV+RD+K 
Sbjct: 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKP 314
Query: 213 SNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFG 272
            N+LLD+    +I D GLA   PE Q        GT+GY APE       +   D ++ G
Sbjct: 315 ENILLDDHGHIRISDLGLAVHVPEGQTI--KGRVGTVGYMAPEVVKNERYTFSPDWWALG 372
Query: 273 VLVLEIIS 280
            L+ E+I+
Sbjct: 373 CLLYEMIA 380

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 89  LLGRGGFGPVYRGKLADGTLVAVKKLCVDKS---QQGESEFLS-EVRMITSIQHKNLVRL 144
            LG+GGF   +    AD   V   K+ V KS   +  + E +S E+ +  S+ H+++V  
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKI-VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QIILGIARGLQYLHEDS 201
            G   D     +V E  + RSL L ++           R+   QI+LG     QYLH + 
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLRQIVLGC----QYLHRN- 160
Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
             R++HRD+K  N+ L+E  + KIGDFGLA     D         GT  Y APE   +  
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKG 217
Query: 262 LSEKADIYSFGVLVLEII--------SCRKNTDLTLPSEMQYLPEY 299
            S + D++S G ++  ++        SC K T L +      +P++
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 263

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 89  LLGRGGFGPVYRGKLADGTLVAVKKLCVDKS---QQGESEFLS-EVRMITSIQHKNLVRL 144
            LG+GGF   +    AD   V   K+ V KS   +  + E +S E+ +  S+ H+++V  
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKI-VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 104
Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QIILGIARGLQYLHEDS 201
            G   D     +V E  + RSL L ++           R+   QI+LG     QYLH + 
Sbjct: 105 HGFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLRQIVLGC----QYLHRN- 158
Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
             R++HRD+K  N+ L+E  + KIGDFGLA     D         GT  Y APE   +  
Sbjct: 159 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKG 215
Query: 262 LSEKADIYSFGVLVLEII--------SCRKNTDLTLPSEMQYLPEY 299
            S + D++S G ++  ++        SC K T L +      +P++
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 261

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 90  LGRGGFGPVYRGKL---ADG---TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG   FG VY+G L   A G     VA+K L          EF  E  +   +QH N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIY--------GESD------KFLNWSTRFQIILG 189
           LLG  +      +++ Y  +  L   +         G +D        L       ++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR-FFPEDQAYLSTNFAGT 248
           IA G++YL   S   +VH+D+   NVL+ +K   KI D GL R  +  D   L  N    
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           + + APE  + G+ S  +DI+S+GV++ E+ S
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 111/248 (44%), Gaps = 14/248 (5%)
Query: 42  AKELVRLALRTTKEGVSKDFFNGNLRTISYFDFQTLK-----KATKN-FHPGNLLGRGGF 95
            K+L +   R T E +S   F   L +I +  F   K       TKN F    +LG+GGF
Sbjct: 138 CKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGF 197
Query: 96  GPVYRGKL-ADGTLVAVKKLCVDKSQQ--GESEFLSEVRMITSIQHKNLVRLLGCCSDGS 152
           G V   ++ A G + A KKL   + ++  GE+  L+E +++  +  + +V L        
Sbjct: 198 GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 257
Query: 153 QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKA 212
              LV   M    L   IY         +        I  GL+ LH +   RIV+RD+K 
Sbjct: 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKP 314
Query: 213 SNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFG 272
            N+LLD+    +I D GLA   PE Q        GT+GY APE       +   D ++ G
Sbjct: 315 ENILLDDHGHIRISDLGLAVHVPEGQTI--KGRVGTVGYMAPEVVKNERYTFSPDWWALG 372
Query: 273 VLVLEIIS 280
            L+ E+I+
Sbjct: 373 CLLYEMIA 380

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 36/226 (15%)
Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
           +F P   LGRGGFG V+  K   D    A+K++ +   +    + + EV+ +  ++H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGE-----SDKFLNW------------STRF 184
           VR      + +      E ++  S  + +Y +      +   +W            S   
Sbjct: 66  VRYFNAWLEKN----TTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 185 QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ------ 238
            I L IA  +++LH      ++HRD+K SN+        K+GDFGL     +D+      
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 239 ----AYL-STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
               AY   T   GT  Y +PE       S K DI+S G+++ E++
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 108/204 (52%), Gaps = 20/204 (9%)
Query: 89  LLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +LG+G +G VY G+ L++   +A+K++    S+  +     E+ +   ++HKN+V+ LG 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-LHEEIALHKHLKHKNIVQYLGS 87
Query: 148 CSDGSQRLLVYEYMKNRSLDLLI---YG---ESDKFLNWSTRFQIILGIARGLQYLHEDS 201
            S+     +  E +   SL  L+   +G   ++++ + + T+      I  GL+YLH++ 
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-----QILEGLKYLHDN- 141
Query: 202 HTRIVHRDIKASNVLLDEKFQS-KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
             +IVHRDIK  NVL++      KI DFG ++          T F GTL Y APE   +G
Sbjct: 142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKG 198
Query: 261 E--LSEKADIYSFGVLVLEIISCR 282
                + ADI+S G  ++E+ + +
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGK 222

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 89  LLGRGGFGPVYRGKLADGTLVAVKKLCVDKS---QQGESEFLS-EVRMITSIQHKNLVRL 144
            LG+GGF   +    AD   V   K+ V KS   +  + E +S E+ +  S+ H+++V  
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKI-VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QIILGIARGLQYLHEDS 201
            G   D     +V E  + RSL L ++           R+   QI+LG     QYLH + 
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLRQIVLGC----QYLHRN- 134
Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
             R++HRD+K  N+ L+E  + KIGDFGLA     D         GT  Y APE   +  
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKG 191
Query: 262 LSEKADIYSFGVLVLEII--------SCRKNTDLTLPSEMQYLPEY 299
            S + D++S G ++  ++        SC K T L +      +P++
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 237

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 108/204 (52%), Gaps = 20/204 (9%)
Query: 89  LLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +LG+G +G VY G+ L++   +A+K++    S+  +     E+ +   ++HKN+V+ LG 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-LHEEIALHKHLKHKNIVQYLGS 73
Query: 148 CSDGSQRLLVYEYMKNRSLDLLI---YG---ESDKFLNWSTRFQIILGIARGLQYLHEDS 201
            S+     +  E +   SL  L+   +G   ++++ + + T+      I  GL+YLH++ 
Sbjct: 74  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-----QILEGLKYLHDN- 127
Query: 202 HTRIVHRDIKASNVLLDEKFQS-KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
             +IVHRDIK  NVL++      KI DFG ++          T F GTL Y APE   +G
Sbjct: 128 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKG 184
Query: 261 E--LSEKADIYSFGVLVLEIISCR 282
                + ADI+S G  ++E+ + +
Sbjct: 185 PRGYGKAADIWSLGCTIIEMATGK 208

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGE----SEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V +G      +V    + + K++  +     E L+E  ++  + +  +VR++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G C +    +LV E  +   L+   Y + ++ +      +++  ++ G++YL E   +  
Sbjct: 79  GIC-EAESWMLVMEMAELGPLN--KYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 132
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT--LGYTAPEYAIRGELS 263
           VHRD+ A NVLL  +  +KI DFGL++    D+        G   + + APE     + S
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFS 192
Query: 264 EKADIYSFGVLVLEIIS 280
            K+D++SFGVL+ E  S
Sbjct: 193 SKSDVWSFGVLMWEAFS 209

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 88  NLLGRGGFGPVYRGKLADGTL---VAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVR 143
           +++G G FG V + ++    L    A+K++    S+    +F  E+ ++  +  H N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 144 LLGCCSDGSQRLLVYEYM----------KNRSLD----LLIYGESDKFLNWSTRFQIILG 189
           LLG C       L  EY           K+R L+      I   +   L+          
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT- 248
           +ARG+ YL   S  + +HRD+ A N+L+ E + +KI DFGL+R     + Y+        
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 204
Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           + + A E       +  +D++S+GVL+ EI+S
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 16/211 (7%)
Query: 77  LKKATKNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEF----LSEVR 131
           +K   K +   + LG G F  VY+ +  +   +VA+KK+ +    + +       L E++
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 132 MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDL-LIYGESDKFLNWSTRFQIILGI 190
           ++  + H N++ LL      S   LV+++M+    DL +I  ++   L  S     +L  
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDFMET---DLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
            +GL+YLH+     I+HRD+K +N+LLDE    K+ DFGLA+ F   ++AY       T 
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQ--VVTR 176
Query: 250 GYTAPEYAIRGEL-SEKADIYSFGVLVLEII 279
            Y APE      +     D+++ G ++ E++
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 93/190 (48%), Gaps = 9/190 (4%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G +G VY+    + G +VA+K++ V+   Q   E + E+ ++      ++V+  G  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ---EIIKEISIMQQCDSPHVVKYYGSY 93
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
              +   +V EY    S+  +I    +K L       I+    +GL+YLH     R +HR
Sbjct: 94  FKNTDLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLH---FMRKIHR 149
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           DIKA N+LL+ +  +K+ DFG+A    +  A       GT  + APE       +  ADI
Sbjct: 150 DIKAGNILLNTEGHAKLADFGVAGQLTDXMAK-RNXVIGTPFWMAPEVIQEIGYNCVADI 208
Query: 269 YSFGVLVLEI 278
           +S G+  +E+
Sbjct: 209 WSLGITAIEM 218

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 88  NLLGRGGFGPVYRGKLADGTL---VAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVR 143
           +++G G FG V + ++    L    A+K++    S+    +F  E+ ++  +  H N++ 
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 80
Query: 144 LLGCCSDGSQRLLVYEYM----------KNRSLD----LLIYGESDKFLNWSTRFQIILG 189
           LLG C       L  EY           K+R L+      I   +   L+          
Sbjct: 81  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 140
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT- 248
           +ARG+ YL   S  + +HRD+ A N+L+ E + +KI DFGL+R     + Y+        
Sbjct: 141 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 194
Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           + + A E       +  +D++S+GVL+ EI+S
Sbjct: 195 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
           +F    L+G GGFG V++ K   DG    +K++   K    ++E   EV+ +  + H N+
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAE--REVKALAKLDHVNI 66
Query: 142 VRLLGC----------CSDGSQR------LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ 185
           V   GC           S  S R       +  E+    +L+  I     + L+     +
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 186 IILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF 245
           +   I +G+ Y+H     ++++RD+K SN+ L +  Q KIGDFGL      D     +  
Sbjct: 127 LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSK- 182
Query: 246 AGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
            GTL Y +PE     +  ++ D+Y+ G+++ E++
Sbjct: 183 -GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 98/192 (51%), Gaps = 11/192 (5%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQHKNLVRLLGC 147
           +G+G  G VY    +A G  VA++++  +  QQ + E + +E+ ++   ++ N+V  L  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVH 207
              G +  +V EY+   SL  ++   ++  ++      +     + L++LH +   +++H
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 208 RDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKAD 267
           RDIK+ N+LL      K+ DFG       +Q+  ST   GT  + APE   R     K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVD 198
Query: 268 IYSFGVLVLEII 279
           I+S G++ +E+I
Sbjct: 199 IWSLGIMAIEMI 210

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 25/208 (12%)
Query: 90  LGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGES---------EFLSEVRMITSI 136
           LG G +G V   K  +G     +  +KK   DK +  +          E  +E+ ++ S+
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
            H N+++L     D     LV E+ +   L   I     KF +      I+  I  G+ Y
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KF-DECDAANIMKQILSGICY 161
Query: 197 LHEDSHTRIVHRDIKASNVLLDEK---FQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           LH+ +   IVHRDIK  N+LL+ K      KI DFGL+ FF +D  Y   +  GT  Y A
Sbjct: 162 LHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKLRDRLGTAYYIA 216
Query: 254 PEYAIRGELSEKADIYSFGVLVLEIISC 281
           PE  ++ + +EK D++S GV ++ I+ C
Sbjct: 217 PE-VLKKKYNEKCDVWSCGV-IMYILLC 242

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/241 (31%), Positives = 114/241 (47%), Gaps = 46/241 (19%)
Query: 89  LLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSE--VRMITSIQHKNLVRLL- 145
           L+GRG +G VY+G L D   VAVK       Q     F++E  +  +  ++H N+ R + 
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN----FINEKNIYRVPLMEHDNIARFIV 74
Query: 146 ---GCCSDGS-QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED- 200
                 +DG  + LLV EY  N SL   +   +    +W +  ++   + RGL YLH + 
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS---DWVSSCRLAHSVTRGLAYLHTEL 131
Query: 201 ---SHTR--IVHRDIKASNVLLDEKFQSKIGDFGLA---------RFFPEDQAYLSTNFA 246
               H +  I HRD+ + NVL+       I DFGL+         R   ED A +S    
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE--V 189
Query: 247 GTLGYTAPEYAIRGELS--------EKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPE 298
           GT+ Y APE  + G ++        ++ D+Y+ G++  EI    + TDL  P E   +PE
Sbjct: 190 GTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIFM--RCTDL-FPGES--VPE 243
Query: 299 Y 299
           Y
Sbjct: 244 Y 244

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 104/233 (44%), Gaps = 19/233 (8%)
Query: 79  KATKNFHPGNLLGRGGFGPVYRGKLADGTLV----AVKKLCVDKSQQGESEFLSEVRMIT 134
           +  K +  G  LG+GGF   Y     D   V     V K  + K  Q E +  +E+ +  
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE-KMSTEIAIHK 97
Query: 135 SIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           S+ + ++V   G   D     +V E  + RSL L ++           R+ +   I +G+
Sbjct: 98  SLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTI-QGV 155
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           QYLH +   R++HRD+K  N+ L++    KIGDFGLA     D     T   GT  Y AP
Sbjct: 156 QYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTPNYIAP 211
Query: 255 EYAIRGELSEKADIYSFGVLVLEII--------SCRKNTDLTLPSEMQYLPEY 299
           E   +   S + DI+S G ++  ++        SC K T + +      +P +
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH 264

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 104/233 (44%), Gaps = 19/233 (8%)
Query: 79  KATKNFHPGNLLGRGGFGPVYRGKLADGTLV----AVKKLCVDKSQQGESEFLSEVRMIT 134
           +  K +  G  LG+GGF   Y     D   V     V K  + K  Q E +  +E+ +  
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE-KMSTEIAIHK 97
Query: 135 SIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           S+ + ++V   G   D     +V E  + RSL L ++           R+ +   I +G+
Sbjct: 98  SLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTI-QGV 155
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           QYLH +   R++HRD+K  N+ L++    KIGDFGLA    E       +  GT  Y AP
Sbjct: 156 QYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKDLCGTPNYIAP 211
Query: 255 EYAIRGELSEKADIYSFGVLVLEII--------SCRKNTDLTLPSEMQYLPEY 299
           E   +   S + DI+S G ++  ++        SC K T + +      +P +
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH 264

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 94/191 (49%), Gaps = 9/191 (4%)
Query: 90  LGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G  G V    + + G LVAVKK+ + K Q+ E  F +EV ++   QH+N+V +    
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 217
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
             G +  +V E+++  +L  ++   +   +N      + L + + L  LH      ++HR
Sbjct: 218 LVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQG---VIHR 271
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           DIK+ ++LL    + K+ DFG        +        GT  + APE   R     + DI
Sbjct: 272 DIKSDSILLTHDGRVKLSDFGFCAQV-SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDI 330
Query: 269 YSFGVLVLEII 279
           +S G++V+E++
Sbjct: 331 WSLGIMVIEMV 341

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 104/233 (44%), Gaps = 19/233 (8%)
Query: 79  KATKNFHPGNLLGRGGFGPVYRGKLADGTLV----AVKKLCVDKSQQGESEFLSEVRMIT 134
           +  K +  G  LG+GGF   Y     D   V     V K  + K  Q E +  +E+ +  
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE-KMSTEIAIHK 81
Query: 135 SIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           S+ + ++V   G   D     +V E  + RSL L ++           R+ +   I +G+
Sbjct: 82  SLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTI-QGV 139
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           QYLH +   R++HRD+K  N+ L++    KIGDFGLA    E       +  GT  Y AP
Sbjct: 140 QYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKDLCGTPNYIAP 195
Query: 255 EYAIRGELSEKADIYSFGVLVLEII--------SCRKNTDLTLPSEMQYLPEY 299
           E   +   S + DI+S G ++  ++        SC K T + +      +P +
Sbjct: 196 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH 248

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 95/191 (49%), Gaps = 9/191 (4%)
Query: 90  LGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G  G V    + + G LVAVKK+ + K Q+ E  F +EV ++   QH+N+V +    
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 95
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
             G +  +V E+++  +L  ++   +   +N      + L + + L  LH      ++HR
Sbjct: 96  LVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQG---VIHR 149
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           DIK+ ++LL    + K+ DFG      ++         GT  + APE   R     + DI
Sbjct: 150 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPEVDI 208
Query: 269 YSFGVLVLEII 279
           +S G++V+E++
Sbjct: 209 WSLGIMVIEMV 219

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 29/211 (13%)
Query: 83  NFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKS----QQGESEFLSEVRMITSIQ 137
           +F    ++GRGGFG VY  + AD G + A+K  C+DK     +QGE+  L+E R++ S+ 
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK--CLDKKRIKMKQGETLALNE-RIMLSLV 246
Query: 138 HKNLVRLLGCCSDG----SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QIILGI 190
                  + C S       +   + + M    L   +  +   F     RF   +IILG+
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGL 305
Query: 191 ARGLQYLHEDSHTR-IVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
                   E  H R +V+RD+K +N+LLDE    +I D GLA  F + + + S    GT 
Sbjct: 306 --------EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTH 354
Query: 250 GYTAPEYAIRG-ELSEKADIYSFGVLVLEII 279
           GY APE   +G      AD +S G ++ +++
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 29/211 (13%)
Query: 83  NFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKS----QQGESEFLSEVRMITSIQ 137
           +F    ++GRGGFG VY  + AD G + A+K  C+DK     +QGE+  L+E R++ S+ 
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK--CLDKKRIKMKQGETLALNE-RIMLSLV 246
Query: 138 HKNLVRLLGCCSDG----SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QIILGI 190
                  + C S       +   + + M    L   +  +   F     RF   +IILG+
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGL 305
Query: 191 ARGLQYLHEDSHTR-IVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
                   E  H R +V+RD+K +N+LLDE    +I D GLA  F + + + S    GT 
Sbjct: 306 --------EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTH 354
Query: 250 GYTAPEYAIRG-ELSEKADIYSFGVLVLEII 279
           GY APE   +G      AD +S G ++ +++
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 29/211 (13%)
Query: 83  NFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKS----QQGESEFLSEVRMITSIQ 137
           +F    ++GRGGFG VY  + AD G + A+K  C+DK     +QGE+  L+E R++ S+ 
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK--CLDKKRIKMKQGETLALNE-RIMLSLV 246
Query: 138 HKNLVRLLGCCSDG----SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QIILGI 190
                  + C S       +   + + M    L   +  +   F     RF   +IILG+
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGL 305
Query: 191 ARGLQYLHEDSHTR-IVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
                   E  H R +V+RD+K +N+LLDE    +I D GLA  F + + + S    GT 
Sbjct: 306 --------EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTH 354
Query: 250 GYTAPEYAIRG-ELSEKADIYSFGVLVLEII 279
           GY APE   +G      AD +S G ++ +++
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 90  LGRGGFGPVYRGK--LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           LG G +  VY+GK  L D  LVA+K++ ++  +      + EV ++  ++H N+V L   
Sbjct: 10  LGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 148 CSDGSQRLLVYEYMKNRSLDLLIY-GESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
                   LV+EY+     DL  Y  +    +N       +  + RGL Y H     +++
Sbjct: 69  IHTEKSLTLVFEYLDK---DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVL 122
Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARF--FPEDQAYLSTNFAGTLGYTAPEYAI-RGELS 263
           HRD+K  N+L++E+ + K+ DFGLAR    P  + Y   N   TL Y  P+  +   + S
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLARAKSIPT-KTY--DNEVVTLWYRPPDILLGSTDYS 179
Query: 264 EKADIYSFGVLVLEIISCR 282
            + D++  G +  E+ + R
Sbjct: 180 TQIDMWGVGCIFYEMATGR 198

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 29/211 (13%)
Query: 83  NFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKS----QQGESEFLSEVRMITSIQ 137
           +F    ++GRGGFG VY  + AD G + A+K  C+DK     +QGE+  L+E R++ S+ 
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK--CLDKKRIKMKQGETLALNE-RIMLSLV 245
Query: 138 HKNLVRLLGCCSDG----SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QIILGI 190
                  + C S       +   + + M    L   +  +   F     RF   +IILG+
Sbjct: 246 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGL 304
Query: 191 ARGLQYLHEDSHTR-IVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
                   E  H R +V+RD+K +N+LLDE    +I D GLA  F + + + S    GT 
Sbjct: 305 --------EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTH 353
Query: 250 GYTAPEYAIRG-ELSEKADIYSFGVLVLEII 279
           GY APE   +G      AD +S G ++ +++
Sbjct: 354 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 384

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 95/191 (49%), Gaps = 9/191 (4%)
Query: 90  LGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G  G V    + + G LVAVKK+ + K Q+ E  F +EV ++   QH+N+V +    
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 97
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
             G +  +V E+++  +L  ++   +   +N      + L + + L  LH      ++HR
Sbjct: 98  LVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQG---VIHR 151
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           DIK+ ++LL    + K+ DFG      ++         GT  + APE   R     + DI
Sbjct: 152 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPEVDI 210
Query: 269 YSFGVLVLEII 279
           +S G++V+E++
Sbjct: 211 WSLGIMVIEMV 221

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 94/191 (49%), Gaps = 9/191 (4%)
Query: 90  LGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G  G V    + + G LVAVKK+ + K Q+ E  F +EV ++   QH+N+V +    
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 140
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
             G +  +V E+++  +L  ++   +   +N      + L + + L  LH      ++HR
Sbjct: 141 LVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQG---VIHR 194
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           DIK+ ++LL    + K+ DFG        +        GT  + APE   R     + DI
Sbjct: 195 DIKSDSILLTHDGRVKLSDFGFCAQV-SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDI 253
Query: 269 YSFGVLVLEII 279
           +S G++V+E++
Sbjct: 254 WSLGIMVIEMV 264

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 126/269 (46%), Gaps = 43/269 (15%)
Query: 90  LGRGGFGPVYRGKLADG-TLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G +G V++ K  +   +VA+K++ +D   +G  S  L E+ ++  ++HKN+VRL   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 148 CSDGSQRLLVYEYMKNRSLDLLIY-----GESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
                +  LV+E+      DL  Y     G+ D  +  S  FQ++    +GL + H  + 
Sbjct: 70  LHSDKKLTLVFEFCDQ---DLKKYFDSCNGDLDPEIVKSFLFQLL----KGLGFCHSRN- 121
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
             ++HRD+K  N+L++   + K+ DFGLAR F       S     TL Y  P+     +L
Sbjct: 122 --VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKL 178
Query: 263 -SEKADIYSFGVLVLEIISCRK------NTD---------LTLPSEMQY-----LPEY-A 300
            S   D++S G +  E+ +  +      + D         L  P+E Q+     LP+Y  
Sbjct: 179 YSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 301 WKLYERGRILELVDPRMRKEGIVERDALQ 329
           + +Y     L  V P++   G   RD LQ
Sbjct: 239 YPMYPATTSLVNVVPKLNATG---RDLLQ 264

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 103/233 (44%), Gaps = 19/233 (8%)
Query: 79  KATKNFHPGNLLGRGGFGPVYRGKLADGTLV----AVKKLCVDKSQQGESEFLSEVRMIT 134
           +  K +  G  LG+GGF   Y     D   V     V K  + K  Q E +  +E+ +  
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE-KMSTEIAIHK 97
Query: 135 SIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           S+ + ++V   G   D     +V E  + RSL L ++           R+ +   I +G+
Sbjct: 98  SLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTI-QGV 155
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           QYLH +   R++HRD+K  N+ L++    KIGDFGLA    E          GT  Y AP
Sbjct: 156 QYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKXLCGTPNYIAP 211
Query: 255 EYAIRGELSEKADIYSFGVLVLEII--------SCRKNTDLTLPSEMQYLPEY 299
           E   +   S + DI+S G ++  ++        SC K T + +      +P +
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH 264

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 88  NLLGRGGFGPVYRGKLADGTL---VAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVR 143
           +++G G FG V + ++    L    A+K++    S+    +F  E+ ++  +  H N++ 
Sbjct: 28  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 87
Query: 144 LLGCCSDGSQRLLVYEYM----------KNRSLD----LLIYGESDKFLNWSTRFQIILG 189
           LLG C       L  EY           K+R L+      I   +   L+          
Sbjct: 88  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 147
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT- 248
           +ARG+ YL   S  + +HR++ A N+L+ E + +KI DFGL+R     + Y+        
Sbjct: 148 VARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 201
Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           + + A E       +  +D++S+GVL+ EI+S
Sbjct: 202 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 95/191 (49%), Gaps = 9/191 (4%)
Query: 90  LGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G  G V    + + G LVAVKK+ + K Q+ E  F +EV ++   QH+N+V +    
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 86
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
             G +  +V E+++  +L  ++   +   +N      + L + + L  LH      ++HR
Sbjct: 87  LVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQG---VIHR 140
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           DIK+ ++LL    + K+ DFG      ++         GT  + APE   R     + DI
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPEVDI 199
Query: 269 YSFGVLVLEII 279
           +S G++V+E++
Sbjct: 200 WSLGIMVIEMV 210

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 98/193 (50%), Gaps = 13/193 (6%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQHKNLVRLLGC 147
           +G+G  G VY    +A G  VA++++  +  QQ + E + +E+ ++   ++ N+V  L  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVH 207
              G +  +V EY+   SL  ++   ++  ++      +     + L++LH +   +++H
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 208 RDIKASNVLLDEKFQSKIGDFGL-ARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKA 266
           RDIK+ N+LL      K+ DFG  A+  PE      +   GT  + APE   R     K 
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSEMVGTPYWMAPEVVTRKAYGPKV 197
Query: 267 DIYSFGVLVLEII 279
           DI+S G++ +E+I
Sbjct: 198 DIWSLGIMAIEMI 210

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 89  LLGRGGFGPVYRGKL----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           +LG G FG VY G       +   VAVK    D +   + +F+SE  ++ ++ H ++V+L
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWS-------TRFQIILGIARGLQYL 197
           +G   +    ++         ++L  YGE   +L  +       T     L I + + YL
Sbjct: 75  IGIIEEEPTWII---------MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 125
Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYA 257
                   VHRDI   N+L+      K+GDFGL+R+  ++  Y ++     + + +PE  
Sbjct: 126 ES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI 182
Query: 258 IRGELSEKADIYSFGVLVLEIIS 280
                +  +D++ F V + EI+S
Sbjct: 183 NFRRFTTASDVWMFAVCMWEILS 205

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 108/212 (50%), Gaps = 27/212 (12%)
Query: 90  LGRGGFGPVYRGK---LAD--GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           LG+G FG V   +   L D  G LVAVK+L      Q + +F  E++++ ++    +V+ 
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFIVKY 73
Query: 145 LGCCSDGSQR---LLVYEYMKNRSL-DLLIYG----ESDKFLNWSTRFQIILGIARGLQY 196
            G  S G  R    LV EY+ +  L D L       ++ + L +S++      I +G++Y
Sbjct: 74  RGV-SYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ------ICKGMEY 126
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG--TLGYTAP 254
           L      R VHRD+ A N+L++ +   KI DFGLA+  P D+        G   + + AP
Sbjct: 127 L---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAP 183
Query: 255 EYAIRGELSEKADIYSFGVLVLEIIS-CRKNT 285
           E       S ++D++SFGV++ E+ + C K+ 
Sbjct: 184 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 215

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 95/191 (49%), Gaps = 9/191 (4%)
Query: 90  LGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G  G V    + + G LVAVKK+ + K Q+ E  F +EV ++   QH+N+V +    
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 90
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
             G +  +V E+++  +L  ++   +   +N      + L + + L  LH      ++HR
Sbjct: 91  LVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQG---VIHR 144
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           DIK+ ++LL    + K+ DFG      ++         GT  + APE   R     + DI
Sbjct: 145 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPEVDI 203
Query: 269 YSFGVLVLEII 279
           +S G++V+E++
Sbjct: 204 WSLGIMVIEMV 214

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 89  LLGRGGFGPVYRGKLADGT-------LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
           +LG+GG+G V++ +   G        +  +KK  + ++ +  +   +E  ++  ++H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
           V L+     G +  L+ EY+     +L +  E +      T    +  I+  L +LH+  
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGG--ELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
              I++RD+K  N++L+ +   K+ DFGL +    D     T F GT+ Y APE  +R  
Sbjct: 142 ---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYMAPEILMRSG 197
Query: 262 LSEKADIYSFGVLVLEIIS 280
            +   D +S G L+ ++++
Sbjct: 198 HNRAVDWWSLGALMYDMLT 216

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 85  HPGNL-----LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGES---EFLSEVRMITS 135
           H GN      +G+G F  V   + +  G  VA+K   +DK+Q   +   +   EVR++  
Sbjct: 10  HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIK--IIDKTQLNPTSLQKLFREVRIMKI 67
Query: 136 IQHKNLVRLLGCCSDGSQRLLVYEYMKN-RSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           + H N+V+L           L+ EY       D L+     K     ++F+ I+     +
Sbjct: 68  LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS---AV 124
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           QY H+    RIVHRD+KA N+LLD     KI DFG +  F      L T F G+  Y AP
Sbjct: 125 QYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDT-FCGSPPYAAP 179
Query: 255 E-YAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPE 298
           E +  +     + D++S GV++  ++S       +LP + Q L E
Sbjct: 180 ELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 218

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 40/227 (17%)
Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
           +F    L+G GGFG V++ K   DG    ++++   K    ++E   EV+ +  + H N+
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRV---KYNNEKAE--REVKALAKLDHVNI 67
Query: 142 VRLLGCC-----------------------SDGSQR------LLVYEYMKNRSLDLLIYG 172
           V   GC                        S  S R       +  E+    +L+  I  
Sbjct: 68  VHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 127
Query: 173 ESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR 232
              + L+     ++   I +G+ Y+H     +++HRD+K SN+ L +  Q KIGDFGL  
Sbjct: 128 RRGEKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVT 184
Query: 233 FFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
               D     T   GTL Y +PE     +  ++ D+Y+ G+++ E++
Sbjct: 185 SLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 98/193 (50%), Gaps = 13/193 (6%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQHKNLVRLLGC 147
           +G+G  G VY    +A G  VA++++  +  QQ + E + +E+ ++   ++ N+V  L  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVH 207
              G +  +V EY+   SL  ++   ++  ++      +     + L++LH +   +++H
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN---QVIH 140
Query: 208 RDIKASNVLLDEKFQSKIGDFGL-ARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKA 266
           RDIK+ N+LL      K+ DFG  A+  PE      +   GT  + APE   R     K 
Sbjct: 141 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRKAYGPKV 198
Query: 267 DIYSFGVLVLEII 279
           DI+S G++ +E+I
Sbjct: 199 DIWSLGIMAIEMI 211

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 98/192 (51%), Gaps = 11/192 (5%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQHKNLVRLLGC 147
           +G+G  G VY    +A G  VA++++  +  QQ + E + +E+ ++   ++ N+V  L  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVH 207
              G +  +V EY+   SL  ++   ++  ++      +     + L++LH +   +++H
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN---QVIH 140
Query: 208 RDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKAD 267
           R+IK+ N+LL      K+ DFG       +Q+  ST   GT  + APE   R     K D
Sbjct: 141 RNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVD 199
Query: 268 IYSFGVLVLEII 279
           I+S G++ +E+I
Sbjct: 200 IWSLGIMAIEMI 211

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 89  LLGRGGFGPVYRGKL----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           +LG G FG VY G       +   VAVK    D +   + +F+SE  ++ ++ H ++V+L
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWS-------TRFQIILGIARGLQYL 197
           +G   +    ++         ++L  YGE   +L  +       T     L I + + YL
Sbjct: 91  IGIIEEEPTWII---------MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 141
Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYA 257
                   VHRDI   N+L+      K+GDFGL+R+  ++  Y ++     + + +PE  
Sbjct: 142 ES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI 198
Query: 258 IRGELSEKADIYSFGVLVLEIIS 280
                +  +D++ F V + EI+S
Sbjct: 199 NFRRFTTASDVWMFAVCMWEILS 221

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 98/193 (50%), Gaps = 13/193 (6%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQHKNLVRLLGC 147
           +G+G  G VY    +A G  VA++++  +  QQ + E + +E+ ++   ++ N+V  L  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVH 207
              G +  +V EY+   SL  ++   ++  ++      +     + L++LH +   +++H
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 208 RDIKASNVLLDEKFQSKIGDFGL-ARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKA 266
           RDIK+ N+LL      K+ DFG  A+  PE      +   GT  + APE   R     K 
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRKAYGPKV 197
Query: 267 DIYSFGVLVLEII 279
           DI+S G++ +E+I
Sbjct: 198 DIWSLGIMAIEMI 210

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 26/210 (12%)
Query: 82  KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQ-GESEFLSEVRMITSIQHK 139
           K F    +LG G F  V+  K    G L A+K  C+ KS    +S   +E+ ++  I+H+
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALK--CIKKSPAFRDSSLENEIAVLKKIKHE 66
Query: 140 NLVRLLGCCSDGSQRLLVYEYMK-----NRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N+V L       +   LV + +      +R L+  +Y E D  L       +I  +   +
Sbjct: 67  NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL-------VIQQVLSAV 119
Query: 195 QYLHEDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY 251
           +YLHE+    IVHRD+K  N+L    +E  +  I DFGL++   E    +ST   GT GY
Sbjct: 120 KYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTA-CGTPGY 173
Query: 252 TAPEYAIRGELSEKADIYSFGVLVLEIISC 281
            APE   +   S+  D +S GV+   I+ C
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITY-ILLC 202

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 90  LGRGGFGPVYRGKLADGTL----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G +G V   +LA   +    VAVK + + ++         E+ +   + H+N+V+  
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G   +G+ + L  EY     L   I  E D  +      +    +  G+ YLH      I
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 125
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFP-EDQAYLSTNFAGTLGYTAPEYAIRGEL-S 263
            HRDIK  N+LLDE+   KI DFGLA  F   ++  L     GTL Y APE   R E  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 264 EKADIYSFGVLVLEIIS 280
           E  D++S G+++  +++
Sbjct: 186 EPVDVWSCGIVLTAMLA 202

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 89  LLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGE-SEFLSEVRMITSIQHKNLVRLLG 146
           +LG+G FG V + K        AVK +    ++  + S  L EV ++  + H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 147 CCSDGSQRLLVYE-YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
              D S   +V E Y      D +I     K  +     +II  +  G+ Y+H+ +   I
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 206 VHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
           VHRD+K  N+LL+ K +    KI DFGL+  F ++      +  GT  Y APE  +RG  
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPE-VLRGTY 199
Query: 263 SEKADIYSFGVLVLEIIS 280
            EK D++S GV++  ++S
Sbjct: 200 DEKCDVWSAGVILYILLS 217

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 89  LLGRGGFGPVYRGKL----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           +LG G FG VY G       +   VAVK    D +   + +F+SE  ++ ++ H ++V+L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWS-------TRFQIILGIARGLQYL 197
           +G   +    ++         ++L  YGE   +L  +       T     L I + + YL
Sbjct: 79  IGIIEEEPTWII---------MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 129
Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYA 257
                   VHRDI   N+L+      K+GDFGL+R+  ++  Y ++     + + +PE  
Sbjct: 130 ES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI 186
Query: 258 IRGELSEKADIYSFGVLVLEIIS 280
                +  +D++ F V + EI+S
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILS 209

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 103/225 (45%), Gaps = 27/225 (12%)
Query: 85  HPGNL-----LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGES---EFLSEVRMITS 135
           H GN      +G+G F  V   + +  G  VAVK   +DK+Q   S   +   EVR++  
Sbjct: 12  HIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVK--IIDKTQLNSSSLQKLFREVRIMKV 69
Query: 136 IQHKNLVRLLGCCSDGSQRLLVYEYMKN-RSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           + H N+V+L           LV EY       D L+     K      +F+ I+     +
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS---AV 126
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           QY H+     IVHRD+KA N+LLD     KI DFG +  F      L T F G+  Y AP
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDT-FCGSPPYAAP 181
Query: 255 E-YAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPE 298
           E +  +     + D++S GV++  ++S       +LP + Q L E
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 220

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 83  NFHPGNL-----LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGES---EFLSEVRMI 133
           + H GN      +G+G F  V   + +  G  VAVK   +DK+Q   S   +   EVR++
Sbjct: 3   DLHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVK--IIDKTQLNSSSLQKLFREVRIM 60
Query: 134 TSIQHKNLVRLLGCCSDGSQRLLVYEYMKN-RSLDLLIYGESDKFLNWSTRFQIILGIAR 192
             + H N+V+L           LV EY       D L+     K      +F+    I  
Sbjct: 61  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR---QIVS 117
Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
            +QY H+     IVHRD+KA N+LLD     KI DFG +  F      L T F G+  Y 
Sbjct: 118 AVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDT-FCGSPPYA 172
Query: 253 APE-YAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPE 298
           APE +  +     + D++S GV++  ++S       +LP + Q L E
Sbjct: 173 APELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 213

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 103/225 (45%), Gaps = 27/225 (12%)
Query: 85  HPGNL-----LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGES---EFLSEVRMITS 135
           H GN      +G+G F  V   + +  G  VAVK   +DK+Q   S   +   EVR++  
Sbjct: 12  HIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVK--IIDKTQLNSSSLQKLFREVRIMKV 69
Query: 136 IQHKNLVRLLGCCSDGSQRLLVYEYMKN-RSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           + H N+V+L           LV EY       D L+     K      +F+ I+     +
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS---AV 126
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           QY H+     IVHRD+KA N+LLD     KI DFG +  F      L T F G+  Y AP
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDT-FCGSPPYAAP 181
Query: 255 E-YAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPE 298
           E +  +     + D++S GV++  ++S       +LP + Q L E
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 220

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 90  LGRGGFGPVYRGKLADGTL----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G +G V   +LA   +    VAVK + + ++         E+ +   + H+N+V+  
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 71
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G   +G+ + L  EY     L   I  E D  +      +    +  G+ YLH      I
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 126
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFP-EDQAYLSTNFAGTLGYTAPEYAIRGEL-S 263
            HRDIK  N+LLDE+   KI DFGLA  F   ++  L     GTL Y APE   R E  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 186
Query: 264 EKADIYSFGVLVLEIIS 280
           E  D++S G+++  +++
Sbjct: 187 EPVDVWSCGIVLTAMLA 203

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 90  LGRGGFGPVYRGKLADGTL----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G +G V   +LA   +    VAVK + + ++         E+ +   + H+N+V+  
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G   +G+ + L  EY     L   I  E D  +      +    +  G+ YLH      I
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 125
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFP-EDQAYLSTNFAGTLGYTAPEYAIRGEL-S 263
            HRDIK  N+LLDE+   KI DFGLA  F   ++  L     GTL Y APE   R E  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 264 EKADIYSFGVLVLEIIS 280
           E  D++S G+++  +++
Sbjct: 186 EPVDVWSCGIVLTAMLA 202

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 13/212 (6%)
Query: 75  QTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKS---QQGESEFLSEV 130
           Q  KK  ++F  G +LG G F  V   + LA     A+K L  +K    ++ +  +++  
Sbjct: 3   QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRE 60
Query: 131 RMITS-IQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG 189
           R + S + H   V+L     D  +      Y KN  L L    +   F    TRF     
Sbjct: 61  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTA-E 118
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGT 248
           I   L+YLH      I+HRD+K  N+LL+E    +I DFG A+   PE +   +  F GT
Sbjct: 119 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175
Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
             Y +PE        + +D+++ G ++ ++++
Sbjct: 176 AQYVSPELLTEKSACKSSDLWALGCIIYQLVA 207

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 87  GNLLGRGGFGPVYRGKLAD----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           G  +G G FG V++G           VA+K      S     +FL E   +    H ++V
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--------IARGL 194
           +L+G  ++    ++         ++L   GE   FL    +F + L         ++  L
Sbjct: 75  KLIGVITENPVWII---------MELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTAL 124
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            YL      R VHRDI A NVL+      K+GDFGL+R+  +   Y ++     + + AP
Sbjct: 125 AYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 181
Query: 255 EYAIRGELSEKADIYSFGVLVLEII 279
           E       +  +D++ FGV + EI+
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 89  LLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGE-SEFLSEVRMITSIQHKNLVRLLG 146
           +LG+G FG V + K        AVK +    ++  + S  L EV ++  + H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 147 CCSDGSQRLLVYE-YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
              D S   +V E Y      D +I     K  +     +II  +  G+ Y+H+ +   I
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 206 VHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
           VHRD+K  N+LL+ K +    KI DFGL+  F ++      +  GT  Y APE  +RG  
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPE-VLRGTY 199
Query: 263 SEKADIYSFGVLVLEIIS 280
            EK D++S GV++  ++S
Sbjct: 200 DEKCDVWSAGVILYILLS 217

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 89  LLGRGGFGPVYRGKLADGT-------LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
           +LG+GG+G V++ +   G        +  +KK  + ++ +  +   +E  ++  ++H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
           V L+     G +  L+ EY+     +L +  E +      T    +  I+  L +LH+  
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGG--ELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
              I++RD+K  N++L+ +   K+ DFGL +    D   ++  F GT+ Y APE  +R  
Sbjct: 142 ---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD-GTVTHXFCGTIEYMAPEILMRSG 197
Query: 262 LSEKADIYSFGVLVLEIIS 280
            +   D +S G L+ ++++
Sbjct: 198 HNRAVDWWSLGALMYDMLT 216

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 13/205 (6%)
Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKS---QQGESEFLSEVRMITS-I 136
           ++F  G +LG G F  V   + LA     A+K L  +K    ++ +  +++  R + S +
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 94
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
            H   V+L  C  D  +      Y KN  L L    +   F    TRF     I   L+Y
Sbjct: 95  DHPFFVKLYFCFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTA-EIVSALEY 152
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPE 255
           LH      I+HRD+K  N+LL+E    +I DFG A+   PE +   +  F GT  Y +PE
Sbjct: 153 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 209
Query: 256 YAIRGELSEKADIYSFGVLVLEIIS 280
                   + +D+++ G ++ ++++
Sbjct: 210 LLTEKSACKSSDLWALGCIIYQLVA 234

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 96/192 (50%), Gaps = 12/192 (6%)
Query: 90  LGRGGFGPVYR-GKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G FG V+   + + G    +K +  D+SQ    +  +E+ ++ S+ H N++++    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 149 SDGSQRLLVYEYMKNRS-LDLLIYGES-DKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
            D     +V E  +    L+ ++  ++  K L+     +++  +   L Y H      +V
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVV 146
Query: 207 HRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELS 263
           H+D+K  N+L  +       KI DFGLA  F  D+   STN AGT  Y APE   + +++
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYMAPE-VFKRDVT 203
Query: 264 EKADIYSFGVLV 275
            K DI+S GV++
Sbjct: 204 FKCDIWSAGVVM 215

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 13/212 (6%)
Query: 75  QTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKS---QQGESEFLSEV 130
           Q  KK  ++F  G +LG G F  V   + LA     A+K L  +K    ++ +  +++  
Sbjct: 2   QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRE 59
Query: 131 RMITS-IQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG 189
           R + S + H   V+L     D  +      Y KN  L L    +   F    TRF     
Sbjct: 60  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTA-E 117
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGT 248
           I   L+YLH      I+HRD+K  N+LL+E    +I DFG A+   PE +   +  F GT
Sbjct: 118 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174
Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
             Y +PE        + +D+++ G ++ ++++
Sbjct: 175 AQYVSPELLTEKSACKSSDLWALGCIIYQLVA 206

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 89  LLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGE-SEFLSEVRMITSIQHKNLVRLLG 146
           +LG+G FG V + K        AVK +    ++  + S  L EV ++  + H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 147 CCSDGSQRLLVYE-YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
              D S   +V E Y      D +I     K  +     +II  +  G+ Y+H+ +   I
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 206 VHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
           VHRD+K  N+LL+ K +    KI DFGL+  F ++      +  GT  Y APE  +RG  
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPE-VLRGTY 199
Query: 263 SEKADIYSFGVLVLEIIS 280
            EK D++S GV++  ++S
Sbjct: 200 DEKCDVWSAGVILYILLS 217

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 90  LGRGGFGPVYRGKLADGTL----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G +G V   +LA   +    VAVK + + ++         E+ +   + H+N+V+  
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFY 71
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G   +G+ + L  EY     L   I  E D  +      +    +  G+ YLH      I
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 126
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFP-EDQAYLSTNFAGTLGYTAPEYAIRGEL-S 263
            HRDIK  N+LLDE+   KI DFGLA  F   ++  L     GTL Y APE   R E  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 264 EKADIYSFGVLVLEIIS 280
           E  D++S G+++  +++
Sbjct: 187 EPVDVWSCGIVLTAMLA 203

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 90  LGRGGFGPVYRGKLADGTL----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G +G V   +LA   +    VAVK + + ++         E+ +   + H+N+V+  
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G   +G+ + L  EY     L   I  E D  +      +    +  G+ YLH      I
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 125
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFP-EDQAYLSTNFAGTLGYTAPEYAIRGEL-S 263
            HRDIK  N+LLDE+   KI DFGLA  F   ++  L     GTL Y APE   R E  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 264 EKADIYSFGVLVLEIIS 280
           E  D++S G+++  +++
Sbjct: 186 EPVDVWSCGIVLTAMLA 202

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 90  LGRGGFGPVYRGKLADGTL----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G +G V   +LA   +    VAVK + + ++         E+ +   + H+N+V+  
Sbjct: 13  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G   +G+ + L  EY     L   I  E D  +      +    +  G+ YLH      I
Sbjct: 70  GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 124
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFP-EDQAYLSTNFAGTLGYTAPEYAIRGEL-S 263
            HRDIK  N+LLDE+   KI DFGLA  F   ++  L     GTL Y APE   R E  +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 264 EKADIYSFGVLVLEIIS 280
           E  D++S G+++  +++
Sbjct: 185 EPVDVWSCGIVLTAMLA 201

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 90  LGRGGFGPVYRGKLADGTL----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G +G V   +LA   +    VAVK + + ++         E+ +   + H+N+V+  
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G   +G+ + L  EY     L   I  E D  +      +    +  G+ YLH      I
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 126
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFP-EDQAYLSTNFAGTLGYTAPEYAIRGEL-S 263
            HRDIK  N+LLDE+   KI DFGLA  F   ++  L     GTL Y APE   R E  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 264 EKADIYSFGVLVLEIIS 280
           E  D++S G+++  +++
Sbjct: 187 EPVDVWSCGIVLTAMLA 203

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 90  LGRGGFGPVYRGKLADGTL----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G +G V   +LA   +    VAVK + + ++         E+ +   + H+N+V+  
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G   +G+ + L  EY     L   I  E D  +      +    +  G+ YLH      I
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 126
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFP-EDQAYLSTNFAGTLGYTAPEYAIRGEL-S 263
            HRDIK  N+LLDE+   KI DFGLA  F   ++  L     GTL Y APE   R E  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 264 EKADIYSFGVLVLEIIS 280
           E  D++S G+++  +++
Sbjct: 187 EPVDVWSCGIVLTAMLA 203

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 90  LGRGGFGPVYRGKLADGTL----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G +G V   +LA   +    VAVK + + ++         E+ +   + H+N+V+  
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G   +G+ + L  EY     L   I  E D  +      +    +  G+ YLH      I
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 126
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFP-EDQAYLSTNFAGTLGYTAPEYAIRGEL-S 263
            HRDIK  N+LLDE+   KI DFGLA  F   ++  L     GTL Y APE   R E  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 264 EKADIYSFGVLVLEIIS 280
           E  D++S G+++  +++
Sbjct: 187 EPVDVWSCGIVLTAMLA 203

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 90  LGRGGFGPVYRGKLADGTL----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G +G V   +LA   +    VAVK + + ++         E+ +   + H+N+V+  
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G   +G+ + L  EY     L   I  E D  +      +    +  G+ YLH      I
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 126
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFP-EDQAYLSTNFAGTLGYTAPEYAIRGEL-S 263
            HRDIK  N+LLDE+   KI DFGLA  F   ++  L     GTL Y APE   R E  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 264 EKADIYSFGVLVLEIIS 280
           E  D++S G+++  +++
Sbjct: 187 EPVDVWSCGIVLTAMLA 203

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 14/212 (6%)
Query: 90  LGRGGFGPVYRGKLADGTL----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G +G V   +LA   +    VAVK + + ++         E+ +   + H+N+V+  
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G   +G+ + L  EY     L   I  E D  +      +    +  G+ YLH      I
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 125
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFP-EDQAYLSTNFAGTLGYTAPEYAIRGEL-S 263
            HRDIK  N+LLDE+   KI DFGLA  F   ++  L     GTL Y APE   R E  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 264 EKADIYSFGVLVLEIISCRKNTDLTLPSEMQY 295
           E  D++S G+++  +++     D    S  +Y
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSXQEY 217

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 13/212 (6%)
Query: 75  QTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKS---QQGESEFLSEV 130
           Q  KK  ++F  G +LG G F  V   + LA     A+K L  +K    ++ +  +++  
Sbjct: 1   QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRE 58
Query: 131 RMITS-IQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG 189
           R + S + H   V+L     D  +      Y KN  L L    +   F    TRF     
Sbjct: 59  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTA-E 116
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGT 248
           I   L+YLH      I+HRD+K  N+LL+E    +I DFG A+   PE +   +  F GT
Sbjct: 117 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173
Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
             Y +PE        + +D+++ G ++ ++++
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVA 205

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 90  LGRGGFGPVYRGKLADGTL----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G +G V   +LA   +    VAVK + + ++         E+ +   + H+N+V+  
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G   +G+ + L  EY     L   I  E D  +      +    +  G+ YLH      I
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 126
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFP-EDQAYLSTNFAGTLGYTAPEYAIRGEL-S 263
            HRDIK  N+LLDE+   KI DFGLA  F   ++  L     GTL Y APE   R E  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 264 EKADIYSFGVLVLEIIS 280
           E  D++S G+++  +++
Sbjct: 187 EPVDVWSCGIVLTAMLA 203

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 87  GNLLGRGGFGPVYRGKLAD----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           G  +G G FG V++G           VA+K      S     +FL E   +    H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--------IARGL 194
           +L+G  ++    ++         ++L   GE   FL    +F + L         ++  L
Sbjct: 455 KLIGVITENPVWII---------MELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTAL 504
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            YL      R VHRDI A NVL+      K+GDFGL+R+  +   Y ++     + + AP
Sbjct: 505 AYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561
Query: 255 EYAIRGELSEKADIYSFGVLVLEII 279
           E       +  +D++ FGV + EI+
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 90  LGRGGFGPVYRGKLADGTL----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G +G V   +LA   +    VAVK + + ++         E+ +   + H+N+V+  
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G   +G+ + L  EY     L   I  E D  +      +    +  G+ YLH      I
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 125
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFP-EDQAYLSTNFAGTLGYTAPEYAIRGEL-S 263
            HRDIK  N+LLDE+   KI DFGLA  F   ++  L     GTL Y APE   R E  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 264 EKADIYSFGVLVLEIIS 280
           E  D++S G+++  +++
Sbjct: 186 EPVDVWSCGIVLTAMLA 202

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 90  LGRGGFGPVYRGKLADGTL----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G +G V   +LA   +    VAVK + + ++         E+ +   + H+N+V+  
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G   +G+ + L  EY     L   I  E D  +      +    +  G+ YLH      I
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 125
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFP-EDQAYLSTNFAGTLGYTAPEYAIRGEL-S 263
            HRDIK  N+LLDE+   KI DFGLA  F   ++  L     GTL Y APE   R E  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 264 EKADIYSFGVLVLEIIS 280
           E  D++S G+++  +++
Sbjct: 186 EPVDVWSCGIVLTAMLA 202

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 90  LGRGGFGPVYRGKLADGTL----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G +G V   +LA   +    VAVK + + ++         E+ +   + H+N+V+  
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G   +G+ + L  EY     L   I  E D  +      +    +  G+ YLH      I
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 125
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFP-EDQAYLSTNFAGTLGYTAPEYAIRGEL-S 263
            HRDIK  N+LLDE+   KI DFGLA  F   ++  L     GTL Y APE   R E  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 264 EKADIYSFGVLVLEIIS 280
           E  D++S G+++  +++
Sbjct: 186 EPVDVWSCGIVLTAMLA 202

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 90  LGRGGFGPVYRGKLADGTL----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G +G V   +LA   +    VAVK + + ++         E+ +   + H+N+V+  
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G   +G+ + L  EY     L   I  E D  +      +    +  G+ YLH      I
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 126
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFP-EDQAYLSTNFAGTLGYTAPEYAIRGEL-S 263
            HRDIK  N+LLDE+   KI DFGLA  F   ++  L     GTL Y APE   R E  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 264 EKADIYSFGVLVLEIIS 280
           E  D++S G+++  +++
Sbjct: 187 EPVDVWSCGIVLTAMLA 203

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 90  LGRGGFGPVYRGKLADGTL----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G +G V   +LA   +    VAVK + + ++         E+ +   + H+N+V+  
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G   +G+ + L  EY     L   I  E D  +      +    +  G+ YLH      I
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 125
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFP-EDQAYLSTNFAGTLGYTAPEYAIRGEL-S 263
            HRDIK  N+LLDE+   KI DFGLA  F   ++  L     GTL Y APE   R E  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 264 EKADIYSFGVLVLEIIS 280
           E  D++S G+++  +++
Sbjct: 186 EPVDVWSCGIVLTAMLA 202

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 90  LGRGGFGPVYRGKLADGTL----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G +G V   +LA   +    VAVK + + ++         E+ +   + H+N+V+  
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G   +G+ + L  EY     L   I  E D  +      +    +  G+ YLH      I
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 125
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFP-EDQAYLSTNFAGTLGYTAPEYAIRGEL-S 263
            HRDIK  N+LLDE+   KI DFGLA  F   ++  L     GTL Y APE   R E  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 264 EKADIYSFGVLVLEIIS 280
           E  D++S G+++  +++
Sbjct: 186 EPVDVWSCGIVLTAMLA 202

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 90  LGRGGFGPVYRGKLADGTL----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G +G V   +LA   +    VAVK + + ++         E+ +   + H+N+V+  
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G   +G+ + L  EY     L   I  E D  +      +    +  G+ YLH      I
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 125
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFP-EDQAYLSTNFAGTLGYTAPEYAIRGEL-S 263
            HRDIK  N+LLDE+   KI DFGLA  F   ++  L     GTL Y APE   R E  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 264 EKADIYSFGVLVLEIIS 280
           E  D++S G+++  +++
Sbjct: 186 EPVDVWSCGIVLTAMLA 202

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 103/225 (45%), Gaps = 27/225 (12%)
Query: 85  HPGNL-----LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGES---EFLSEVRMITS 135
           H GN      +G+G F  V   + +  G  VAV+   +DK+Q   S   +   EVR++  
Sbjct: 12  HIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVR--IIDKTQLNSSSLQKLFREVRIMKV 69
Query: 136 IQHKNLVRLLGCCSDGSQRLLVYEYMKN-RSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           + H N+V+L           LV EY       D L+     K      +F+ I+     +
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS---AV 126
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           QY H+     IVHRD+KA N+LLD     KI DFG +  F      L T F G+  Y AP
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDT-FCGSPPYAAP 181
Query: 255 E-YAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPE 298
           E +  +     + D++S GV++  ++S       +LP + Q L E
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 220

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 27/225 (12%)
Query: 85  HPGNL-----LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGES---EFLSEVRMITS 135
           H GN      +G+G F  V   + +  G  VA+K   +DK+Q   +   +   EVR++  
Sbjct: 13  HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIK--IIDKTQLNPTSLQKLFREVRIMKI 70
Query: 136 IQHKNLVRLLGCCSDGSQRLLVYEYMKN-RSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           + H N+V+L           L+ EY       D L+     K     ++F+ I+     +
Sbjct: 71  LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS---AV 127
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           QY H+    RIVHRD+KA N+LLD     KI DFG +  F          F G   Y AP
Sbjct: 128 QYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAFCGAPPYAAP 182
Query: 255 E-YAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPE 298
           E +  +     + D++S GV++  ++S       +LP + Q L E
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 221

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 87  GNLLGRGGFGPVYRGKLAD----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           G  +G G FG V++G           VA+K      S     +FL E   +    H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--------IARGL 194
           +L+G  ++    ++         ++L   GE   FL    +F + L         ++  L
Sbjct: 455 KLIGVITENPVWII---------MELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTAL 504
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            YL      R VHRDI A NVL+      K+GDFGL+R+  +   Y ++     + + AP
Sbjct: 505 AYLES---KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561
Query: 255 EYAIRGELSEKADIYSFGVLVLEII 279
           E       +  +D++ FGV + EI+
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 87  GNLLGRGGFGPVYRGKLAD----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           G  +G G FG V++G           VA+K      S     +FL E   +    H ++V
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--------IARGL 194
           +L+G  ++    ++         ++L   GE   FL    ++ + L         ++  L
Sbjct: 75  KLIGVITENPVWII---------MELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTAL 124
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            YL      R VHRDI A NVL+      K+GDFGL+R+  +   Y ++     + + AP
Sbjct: 125 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 181
Query: 255 EYAIRGELSEKADIYSFGVLVLEII 279
           E       +  +D++ FGV + EI+
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 13/209 (6%)
Query: 78  KKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKS---QQGESEFLSEVRMI 133
           KK  ++F  G +LG G F  V   + LA     A+K L  +K    ++ +  +++  R +
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDV 60
Query: 134 TS-IQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR 192
            S + H   V+L     D  +      Y KN  L L    +   F    TRF     I  
Sbjct: 61  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTA-EIVS 118
Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGY 251
            L+YLH      I+HRD+K  N+LL+E    +I DFG A+   PE +   +  F GT  Y
Sbjct: 119 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 175
Query: 252 TAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            +PE        + +D+++ G ++ ++++
Sbjct: 176 VSPELLTEKSACKSSDLWALGCIIYQLVA 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 90  LGRGGFGPVYRGKLADGTL----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G +G V   +LA   +    VAVK + + ++         E+ +   + H+N+V+  
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G   +G+ + L  EY     L   I  E D  +      +    +  G+ YLH      I
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 125
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFP-EDQAYLSTNFAGTLGYTAPEYAIRGEL-S 263
            HRDIK  N+LLDE+   KI DFGLA  F   ++  L     GTL Y APE   R E  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 264 EKADIYSFGVLVLEIIS 280
           E  D++S G+++  +++
Sbjct: 186 EPVDVWSCGIVLTAMLA 202

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 100/225 (44%), Gaps = 27/225 (12%)
Query: 85  HPGNL-----LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGES---EFLSEVRMITS 135
           H GN      +G+G F  V   + +  G  VAVK   +DK+Q   S   +   EVR++  
Sbjct: 12  HIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVK--IIDKTQLNSSSLQKLFREVRIMKV 69
Query: 136 IQHKNLVRLLGCCSDGSQRLLVYEYMKN-RSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           + H N+V+L           LV EY       D L+     K      +F+ I+     +
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS---AV 126
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           QY H+     IVHRD+KA N+LLD     KI DFG +  F          F G   Y AP
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL--DAFCGAPPYAAP 181
Query: 255 E-YAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPE 298
           E +  +     + D++S GV++  ++S       +LP + Q L E
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 220

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 10/207 (4%)
Query: 77  LKKATKNFHPGNLLGRGGFGPVYRGKLADGT----LVAVKKLCVDKSQQGESEFLSEVRM 132
           +K   ++F    +LG+G FG V+  +         + A+KK  V      E   + +  +
Sbjct: 13  IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 72
Query: 133 ITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR 192
             + +H  L  +            V EY+     DL+ + +S    + S        I  
Sbjct: 73  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGG--DLMYHIQSCHKFDLSRATFYAAEIIL 130
Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
           GLQ+LH      IV+RD+K  N+LLD+    KI DFG+ +      A  +  F GT  Y 
Sbjct: 131 GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNEFCGTPDYI 186
Query: 253 APEYAIRGELSEKADIYSFGVLVLEII 279
           APE  +  + +   D +SFGVL+ E++
Sbjct: 187 APEILLGQKYNHSVDWWSFGVLLYEML 213

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 102/222 (45%), Gaps = 22/222 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGES---EFLSEVRMITSIQH 138
           N+     +G+G F  V   + +  G  VAVK   +DK+Q   +   +   EVR++  + H
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVK--IIDKTQLNPTSLQKLFREVRIMKILNH 73
Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKN-RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYL 197
            N+V+L           LV EY       D L+     K      +F+ I+     +QY 
Sbjct: 74  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS---AVQYC 130
Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE-Y 256
           H+     IVHRD+KA N+LLD     KI DFG +  F      L T F G+  Y APE +
Sbjct: 131 HQ---KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK-LDT-FCGSPPYAAPELF 185
Query: 257 AIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPE 298
             +     + D++S GV++  ++S       +LP + Q L E
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 221

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 90  LGRGGFGPVYRGKL-ADGTLVAVKKL--CVDKSQQGESEFLSEVRMITSIQHKNLVRL-- 144
           +G G +G V   +    G  VA+KK+    D     +   L E++++   +H N++ +  
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRT-LRELKILKHFKHDNIIAIKD 121
Query: 145 -LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
            L       +   VY  +     DL     S + L        +  + RGL+Y+H     
Sbjct: 122 ILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHS---A 178
Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFF---PEDQAYLSTNFAGTLGYTAPEYAIR- 259
           +++HRD+K SN+L++E  + KIGDFG+AR     P +  Y  T +  T  Y APE  +  
Sbjct: 179 QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSL 238
Query: 260 GELSEKADIYSFGVLVLEIISCRK 283
            E ++  D++S G +  E+++ R+
Sbjct: 239 HEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 23/204 (11%)
Query: 87  GNLLGRGGFGPVYRGKLAD----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           G  +G G FG V++G           VA+K      S     +FL E   +    H ++V
Sbjct: 43  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 102
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFL-------NWSTRFQIILGIARGLQ 195
           +L+G  ++    ++         ++L   GE   FL       + ++       ++  L 
Sbjct: 103 KLIGVITENPVWII---------MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 153
Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE 255
           YL      R VHRDI A NVL+      K+GDFGL+R+  +   Y ++     + + APE
Sbjct: 154 YLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 210
Query: 256 YAIRGELSEKADIYSFGVLVLEII 279
                  +  +D++ FGV + EI+
Sbjct: 211 SINFRRFTSASDVWMFGVCMWEIL 234

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 101/225 (44%), Gaps = 27/225 (12%)
Query: 85  HPGNL-----LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGES---EFLSEVRMITS 135
           H GN      +G+G F  V   + +  G  VAV+   +DK+Q   S   +   EVR++  
Sbjct: 12  HIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVR--IIDKTQLNSSSLQKLFREVRIMKV 69
Query: 136 IQHKNLVRLLGCCSDGSQRLLVYEYMKN-RSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           + H N+V+L           LV EY       D L+     K      +F+ I+     +
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS---AV 126
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           QY H+     IVHRD+KA N+LLD     KI DFG +  F          F G+  Y AP
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL--DEFCGSPPYAAP 181
Query: 255 E-YAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPE 298
           E +  +     + D++S GV++  ++S       +LP + Q L E
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 220

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 87  GNLLGRGGFGPVYRGKLAD----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           G  +G G FG V++G           VA+K      S     +FL E   +    H ++V
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--------IARGL 194
           +L+G  ++    ++         ++L   GE   FL    ++ + L         ++  L
Sbjct: 75  KLIGVITENPVWII---------MELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTAL 124
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            YL      R VHRDI A NVL+      K+GDFGL+R+  +   Y ++     + + AP
Sbjct: 125 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 181
Query: 255 EYAIRGELSEKADIYSFGVLVLEII 279
           E       +  +D++ FGV + EI+
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 19/216 (8%)
Query: 87  GNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGE--SEFLSEVRMITSIQHKNLVR 143
           G+ LG G FG V  GK    G  VAVK L   K +  +   +   E++ +   +H ++++
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
           L    S  S   +V EY+     +L  Y   +  L+     ++   I  G+ Y H     
Sbjct: 81  LYQVISTPSDIFMVMEYVSGG--ELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM-- 136
Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL- 262
            +VHRD+K  NVLLD    +KI DFGL+     D  +L  +  G+  Y APE  I G L 
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRXS-CGSPNYAAPE-VISGRLY 192
Query: 263 -SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLP 297
              + DI+S GV++  ++        TLP +  ++P
Sbjct: 193 AGPEVDIWSSGVILYALLCG------TLPFDDDHVP 222

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 87  GNLLGRGGFGPVYRGKLAD----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           G  +G G FG V++G           VA+K      S     +FL E   +    H ++V
Sbjct: 17  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 76
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--------IARGL 194
           +L+G  ++    ++         ++L   GE   FL    ++ + L         ++  L
Sbjct: 77  KLIGVITENPVWII---------MELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTAL 126
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            YL      R VHRDI A NVL+      K+GDFGL+R+  +   Y ++     + + AP
Sbjct: 127 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 183
Query: 255 EYAIRGELSEKADIYSFGVLVLEII 279
           E       +  +D++ FGV + EI+
Sbjct: 184 ESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 87  GNLLGRGGFGPVYRGKLAD----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           G  +G G FG V++G           VA+K      S     +FL E   +    H ++V
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--------IARGL 194
           +L+G  ++    ++         ++L   GE   FL    ++ + L         ++  L
Sbjct: 72  KLIGVITENPVWII---------MELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTAL 121
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            YL      R VHRDI A NVL+      K+GDFGL+R+  +   Y ++     + + AP
Sbjct: 122 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 255 EYAIRGELSEKADIYSFGVLVLEII 279
           E       +  +D++ FGV + EI+
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 90  LGRGGFGPVYRGKL-ADGTLVAVKKL--CVDKSQQGESEFLSEVRMITSIQHKNLVRL-- 144
           +G G +G V   +    G  VA+KK+    D     +   L E++++   +H N++ +  
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRT-LRELKILKHFKHDNIIAIKD 120
Query: 145 -LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
            L       +   VY  +     DL     S + L        +  + RGL+Y+H     
Sbjct: 121 ILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHS---A 177
Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFF---PEDQAYLSTNFAGTLGYTAPEYAIR- 259
           +++HRD+K SN+L++E  + KIGDFG+AR     P +  Y  T +  T  Y APE  +  
Sbjct: 178 QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSL 237
Query: 260 GELSEKADIYSFGVLVLEIISCRK 283
            E ++  D++S G +  E+++ R+
Sbjct: 238 HEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 126/269 (46%), Gaps = 43/269 (15%)
Query: 90  LGRGGFGPVYRGKLADG-TLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G +G V++ K  +   +VA+K++ +D   +G  S  L E+ ++  ++HKN+VRL   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 148 CSDGSQRLLVYEYMKNRSLDLLIY-----GESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
                +  LV+E+      DL  Y     G+ D  +  S  FQ++    +GL + H  + 
Sbjct: 70  LHSDKKLTLVFEFCDQ---DLKKYFDSCNGDLDPEIVKSFLFQLL----KGLGFCHSRN- 121
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
             ++HRD+K  N+L++   + K+ +FGLAR F       S     TL Y  P+     +L
Sbjct: 122 --VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKL 178
Query: 263 -SEKADIYSFGVLVLEIISCRK------NTD---------LTLPSEMQY-----LPEY-A 300
            S   D++S G +  E+ +  +      + D         L  P+E Q+     LP+Y  
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 301 WKLYERGRILELVDPRMRKEGIVERDALQ 329
           + +Y     L  V P++   G   RD LQ
Sbjct: 239 YPMYPATTSLVNVVPKLNATG---RDLLQ 264

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 87  GNLLGRGGFGPVYRGKLAD----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           G  +G G FG V++G           VA+K      S     +FL E   +    H ++V
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--------IARGL 194
           +L+G  ++    ++         ++L   GE   FL    ++ + L         ++  L
Sbjct: 80  KLIGVITENPVWII---------MELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTAL 129
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            YL      R VHRDI A NVL+      K+GDFGL+R+  +   Y ++     + + AP
Sbjct: 130 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 186
Query: 255 EYAIRGELSEKADIYSFGVLVLEII 279
           E       +  +D++ FGV + EI+
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 87  GNLLGRGGFGPVYRGKLAD----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           G  +G G FG V++G           VA+K      S     +FL E   +    H ++V
Sbjct: 18  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 77
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--------IARGL 194
           +L+G  ++    ++         ++L   GE   FL    ++ + L         ++  L
Sbjct: 78  KLIGVITENPVWII---------MELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTAL 127
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            YL      R VHRDI A NVL+      K+GDFGL+R+  +   Y ++     + + AP
Sbjct: 128 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 184
Query: 255 EYAIRGELSEKADIYSFGVLVLEII 279
           E       +  +D++ FGV + EI+
Sbjct: 185 ESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 98/221 (44%), Gaps = 32/221 (14%)
Query: 70  SYFDFQTLKKATKNFHPGNLLGRGGFGPVYR------GKLADGTLVAVKKLCVDKSQQGE 123
           S F      K + N+     LG+G F  V R      G      ++  KKL     Q+ E
Sbjct: 17  SEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE 76
Query: 124 SEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGE------SDKF 177
            E     R+   +QH N+VRL     + S   LV+        DL+  GE      + +F
Sbjct: 77  RE----ARICRKLQHPNIVRLHDSIQEESFHYLVF--------DLVTGGELFEDIVAREF 124
Query: 178 LNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS---KIGDFGLARFF 234
            + +     I  I   + Y H +    IVHR++K  N+LL  K +    K+ DFGLA   
Sbjct: 125 YSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181
Query: 235 PEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLV 275
            + +A+    FAGT GY +PE   +   S+  DI++ GV++
Sbjct: 182 NDSEAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 25/207 (12%)
Query: 83  NFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQ---QG-ESEFLSEVRMITSIQH 138
           +F  G  LG+G FG VY  +      +   K+   KSQ   +G E +   E+ + + ++H
Sbjct: 16  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF-KSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ------IILGIAR 192
            N++R+     D  +  L+ E+           GE  K L    RF        +  +A 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPR--------GELYKELQKHGRFDEQRSATFMEELAD 126
Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
            L Y HE    +++HRDIK  N+L+  K + KI DFG +   P   +       GTL Y 
Sbjct: 127 ALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP---SLRRRXMCGTLDYL 180
Query: 253 APEYAIRGELSEKADIYSFGVLVLEII 279
            PE        EK D++  GVL  E +
Sbjct: 181 PPEMIEGKTHDEKVDLWCAGVLCYEFL 207

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 91/178 (51%), Gaps = 16/178 (8%)
Query: 106 GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRS 165
           G  VAVKK+ + K Q+ E  F +EV ++    H N+V +      G +  +V E+++  +
Sbjct: 70  GKQVAVKKMDLRKQQRRELLF-NEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGA 128
Query: 166 LDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKI 225
           L  ++   +   +N      + L + R L YLH      ++HRDIK+ ++LL    + K+
Sbjct: 129 LTDIV---THTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKL 182
Query: 226 GDFG----LARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
            DFG    +++  P+ +  + T +     + APE   R     + DI+S G++V+E+I
Sbjct: 183 SDFGFCAQVSKEVPKRKXLVGTPY-----WMAPEVISRLPYGTEVDIWSLGIMVIEMI 235

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 13/205 (6%)
Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKS---QQGESEFLSEVRMITS-I 136
           ++F  G +LG G F  V   + LA     A+K L  +K    ++ +  +++  R + S +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 89
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
            H   V+L     D  +      Y KN  L L    +   F    TRF     I   L+Y
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGCL-LKYIRKIGSFDETCTRFYTA-EIVSALEY 147
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPE 255
           LH      I+HRD+K  N+LL+E    +I DFG A+   PE +   + +F GT  Y +PE
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 204
Query: 256 YAIRGELSEKADIYSFGVLVLEIIS 280
                  S+ +D+++ G ++ ++++
Sbjct: 205 LLTEKSASKSSDLWALGCIIYQLVA 229

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 100/225 (44%), Gaps = 27/225 (12%)
Query: 85  HPGNL-----LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGES---EFLSEVRMITS 135
           H GN      +G+G F  V   + +  G  VAVK   +DK+Q   S   +   EVR+   
Sbjct: 12  HIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVK--IIDKTQLNSSSLQKLFREVRIXKV 69
Query: 136 IQHKNLVRLLGCCSDGSQRLLVYEYMKN-RSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           + H N+V+L           LV EY       D L+     K      +F+ I+     +
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVS---AV 126
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           QY H+     IVHRD+KA N+LLD     KI DFG +  F       +  F G   Y AP
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA--FCGAPPYAAP 181
Query: 255 E-YAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPE 298
           E +  +     + D++S GV++  ++S       +LP + Q L E
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 220

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 10/207 (4%)
Query: 77  LKKATKNFHPGNLLGRGGFGPVYRGKLADGT----LVAVKKLCVDKSQQGESEFLSEVRM 132
           +K   ++F    +LG+G FG V+  +         + A+KK  V      E   + +  +
Sbjct: 12  IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 71
Query: 133 ITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR 192
             + +H  L  +            V EY+     DL+ + +S    + S        I  
Sbjct: 72  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGG--DLMYHIQSCHKFDLSRATFYAAEIIL 129
Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
           GLQ+LH      IV+RD+K  N+LLD+    KI DFG+ +      A  +  F GT  Y 
Sbjct: 130 GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNXFCGTPDYI 185
Query: 253 APEYAIRGELSEKADIYSFGVLVLEII 279
           APE  +  + +   D +SFGVL+ E++
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEML 212

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/230 (31%), Positives = 114/230 (49%), Gaps = 22/230 (9%)
Query: 61  FFNGNLRTISYFDFQTLKKA--TKNFHPGNLLGRGGFGPVY--RGKL--ADGTLVAVKKL 114
           +F G+L+      F T KK   ++ +     LG G +G V   R K+   +  +  ++K 
Sbjct: 15  YFQGDLQATPGM-FITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKT 73
Query: 115 CVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGE 173
            V  S    S+ L EV ++  + H N+++L     D     LV E  K   L D +I+  
Sbjct: 74  SV--STSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH-- 129
Query: 174 SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS---KIGDFGL 230
             KF N      II  +  G+ YLH+ +   IVHRD+K  N+LL+ K +    KI DFGL
Sbjct: 130 RMKF-NEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGL 185
Query: 231 ARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           +  F E+Q  +     GT  Y APE  +R +  EK D++S GV++  +++
Sbjct: 186 SAVF-ENQKKMKERL-GTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLA 232

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 25/205 (12%)
Query: 87  GNLLGRGGFGPVYRGKLAD----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           G  +G G FG V++G           VA+K      S     +FL E   +    H ++V
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--------IARGL 194
           +L+G  ++    ++         ++L   GE   FL    +F + L         ++  L
Sbjct: 75  KLIGVITENPVWII---------MELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTAL 124
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            YL      R VHRDI A NVL+      K+GDFGL+R+  +     ++     + + AP
Sbjct: 125 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAP 181
Query: 255 EYAIRGELSEKADIYSFGVLVLEII 279
           E       +  +D++ FGV + EI+
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 93/197 (47%), Gaps = 14/197 (7%)
Query: 90  LGRGGFGPVYRGKLADGTL----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G  G V   +LA   +    VAVK + + ++         E+ +   + H+N+V+  
Sbjct: 14  LGEGAAGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G   +G+ + L  EY     L   I  E D  +      +    +  G+ YLH      I
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 125
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFP-EDQAYLSTNFAGTLGYTAPEYAIRGEL-S 263
            HRDIK  N+LLDE+   KI DFGLA  F   ++  L     GTL Y APE   R E  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 264 EKADIYSFGVLVLEIIS 280
           E  D++S G+++  +++
Sbjct: 186 EPVDVWSCGIVLTAMLA 202

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 79  KATKNFHPGNLLGRGGFGPVYR------GKLADGTLVAVKKLCVDKSQQGESEFLSEVRM 132
           K + N+     LG+G F  V R      G      ++  KKL     Q+ E E     R+
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE----ARI 57
Query: 133 ITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRFQIILGI 190
              +QH N+VRL     + S   LV++ +    L  D++    + +F + +     I  I
Sbjct: 58  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQI 113
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAG 247
              + Y H +    IVHR++K  N+LL  K +    K+ DFGLA    + +A+    FAG
Sbjct: 114 LESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAG 168
Query: 248 TLGYTAPEYAIRGELSEKADIYSFGVLV 275
           T GY +PE   +   S+  DI++ GV++
Sbjct: 169 TPGYLSPEVLKKDPYSKPVDIWACGVIL 196

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 79  KATKNFHPGNLLGRGGFGPVYR------GKLADGTLVAVKKLCVDKSQQGESEFLSEVRM 132
           K + N+     LG+G F  V R      G      ++  KKL     Q+ E E     R+
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE----ARI 58
Query: 133 ITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRFQIILGI 190
              +QH N+VRL     + S   LV++ +    L  D++    + +F + +     I  I
Sbjct: 59  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQI 114
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAG 247
              + Y H +    IVHR++K  N+LL  K +    K+ DFGLA    + +A+    FAG
Sbjct: 115 LESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAG 169
Query: 248 TLGYTAPEYAIRGELSEKADIYSFGVLV 275
           T GY +PE   +   S+  DI++ GV++
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 79  KATKNFHPGNLLGRGGFGPVYR------GKLADGTLVAVKKLCVDKSQQGESEFLSEVRM 132
           K + N+     LG+G F  V R      G      ++  KKL     Q+ E E     R+
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE----ARI 58
Query: 133 ITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRFQIILGI 190
              +QH N+VRL     + S   LV++ +    L  D++    + +F + +     I  I
Sbjct: 59  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQI 114
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAG 247
              + Y H +    IVHR++K  N+LL  K +    K+ DFGLA    + +A+    FAG
Sbjct: 115 LESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAG 169
Query: 248 TLGYTAPEYAIRGELSEKADIYSFGVLV 275
           T GY +PE   +   S+  DI++ GV++
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G +G V        G  VAVKKL    +S         E+R++  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 148 CSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            +    R L     VY        DL    +  K  +   +F +I  I RGL+Y+H    
Sbjct: 90  FTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS--- 143
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-E 261
             I+HRD+K SN+ ++E  + KI DFGLAR   ++ A     F  T  Y APE  +    
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA----GFVATRWYRAPEIMLNWMH 199
Query: 262 LSEKADIYSFGVLVLEIISCR 282
            ++  DI+S G ++ E+++ R
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G +G V        G  VAVKKL    +S         E+R++  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 148 CSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            +    R L     VY        DL    +  K  +   +F +I  I RGL+Y+H    
Sbjct: 90  FTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS--- 143
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-E 261
             I+HRD+K SN+ ++E  + KI DFGLAR   ++ A     F  T  Y APE  +    
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA----GFVATRWYRAPEIMLNWMH 199
Query: 262 LSEKADIYSFGVLVLEIISCR 282
            ++  DI+S G ++ E+++ R
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 25  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 82  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 138
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 139 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 191
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 192 EIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 28/206 (13%)
Query: 88  NLLGRGGFGPVYRGKLADGT----LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           ++LG G F  V    LA+      LVA+K +  +  +  E    +E+ ++  I+H N+V 
Sbjct: 24  DVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 144 LLGCCSDGSQRLLVYEYMK-----NRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLH 198
           L      G    L+ + +      +R ++   Y E D     ++R  +I  +   ++YLH
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERD-----ASR--LIFQVLDAVKYLH 133
Query: 199 EDSHTRIVHRDIKASNVL---LDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE 255
           +     IVHRD+K  N+L   LDE  +  I DFGL++   ED   + +   GT GY APE
Sbjct: 134 D---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPE 188
Query: 256 YAIRGELSEKADIYSFGVLVLEIISC 281
              +   S+  D +S GV+   I+ C
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAY-ILLC 213

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 16/199 (8%)
Query: 89  LLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQ--GESEFLSEVRMITSIQHKNLVRLL 145
           +LG+G FG V   K    G   AVK +   + +Q   +   L EV+++  + H N+++L 
Sbjct: 39  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 98
Query: 146 GCCSDGSQRLLVYE-YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTR 204
               D     LV E Y      D +I   S K  +     +II  +  G+ Y+H++   +
Sbjct: 99  EFFEDKGYFYLVGEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKN---K 152
Query: 205 IVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
           IVHRD+K  N+LL+ K +    +I DFGL+  F   +     +  GT  Y APE  + G 
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTAYYIAPE-VLHGT 209
Query: 262 LSEKADIYSFGVLVLEIIS 280
             EK D++S GV++  ++S
Sbjct: 210 YDEKCDVWSTGVILYILLS 228

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G +G V        G  VAVKKL    +S         E+R++  ++H+N++ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 148 CSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            +    R L     VY        DL    +  K  +   +F +I  I RGL+Y+H    
Sbjct: 86  FTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS--- 139
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-E 261
             I+HRD+K SN+ ++E  + KI DFGLAR   ++ A     F  T  Y APE  +    
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA----GFVATRWYRAPEIMLNWMH 195
Query: 262 LSEKADIYSFGVLVLEIISCR 282
            ++  DI+S G ++ E+++ R
Sbjct: 196 YNQTVDIWSVGCIMAELLTGR 216

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 28/206 (13%)
Query: 88  NLLGRGGFGPVYRGKLADGT----LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           ++LG G F  V    LA+      LVA+K +  +  +  E    +E+ ++  I+H N+V 
Sbjct: 24  DVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 144 LLGCCSDGSQRLLVYEYMK-----NRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLH 198
           L      G    L+ + +      +R ++   Y E D     ++R  +I  +   ++YLH
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERD-----ASR--LIFQVLDAVKYLH 133
Query: 199 EDSHTRIVHRDIKASNVL---LDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE 255
           +     IVHRD+K  N+L   LDE  +  I DFGL++   ED   + +   GT GY APE
Sbjct: 134 D---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPE 188
Query: 256 YAIRGELSEKADIYSFGVLVLEIISC 281
              +   S+  D +S GV+   I+ C
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAY-ILLC 213

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 18/200 (9%)
Query: 89  LLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQ--GESEFLSEVRMITSIQHKNLVRL 144
           +LG+G FG V   + K+  G   AVK +   + +Q   +   L EV+++  + H N+++L
Sbjct: 33  VLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 145 LGCCSDGSQRLLVYE-YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
                D     LV E Y      D +I   S K  +     +II  +  G+ Y+H++   
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKN--- 145
Query: 204 RIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
           +IVHRD+K  N+LL+ K +    +I DFGL+  F   +     +  GT  Y APE  + G
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTAYYIAPE-VLHG 202
Query: 261 ELSEKADIYSFGVLVLEIIS 280
              EK D++S GV++  ++S
Sbjct: 203 TYDEKCDVWSTGVILYILLS 222

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 30  QNLSP---IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 87  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 143
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 144 KYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM----TGYVATRWYRAP 196
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 25  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 82  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF-LIYQILRGL 138
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 139 KYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM----TGYVATRWYRAP 191
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 32  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 89  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 145
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 146 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM----TGYVATRWYRAP 198
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 32  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 89  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 145
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 146 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM----TGYVATRWYRAP 198
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 30  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 87  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 143
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 144 KYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM----TGYVATRWYRAP 196
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 13/205 (6%)
Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKS---QQGESEFLSEVRMITS-I 136
           ++F  G +LG G F  V   + LA     A+K L  +K    ++ +  +++  R + S +
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 90
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
            H   V+L     D  +      Y KN  L L    +   F    TRF     I   L+Y
Sbjct: 91  DHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTA-EIVSALEY 148
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPE 255
           LH      I+HRD+K  N+LL+E    +I DFG A+   PE +   + +F GT  Y +PE
Sbjct: 149 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 205
Query: 256 YAIRGELSEKADIYSFGVLVLEIIS 280
                   + +D+++ G ++ ++++
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVA 230

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 18/200 (9%)
Query: 89  LLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQ--GESEFLSEVRMITSIQHKNLVRL 144
           +LG+G FG V   + K+  G   AVK +   + +Q   +   L EV+++  + H N+++L
Sbjct: 56  VLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 114
Query: 145 LGCCSDGSQRLLVYE-YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
                D     LV E Y      D +I   S K  +     +II  +  G+ Y+H++   
Sbjct: 115 YEFFEDKGYFYLVGEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKN--- 168
Query: 204 RIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
           +IVHRD+K  N+LL+ K +    +I DFGL+  F   +     +  GT  Y APE  + G
Sbjct: 169 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTAYYIAPE-VLHG 225
Query: 261 ELSEKADIYSFGVLVLEIIS 280
              EK D++S GV++  ++S
Sbjct: 226 TYDEKCDVWSTGVILYILLS 245

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 13/205 (6%)
Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKS---QQGESEFLSEVRMITS-I 136
           ++F  G +LG G F  V   + LA     A+K L  +K    ++ +  +++  R + S +
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 86
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
            H   V+L     D  +      Y KN  L L    +   F    TRF     I   L+Y
Sbjct: 87  DHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTA-EIVSALEY 144
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPE 255
           LH      I+HRD+K  N+LL+E    +I DFG A+   PE +   + +F GT  Y +PE
Sbjct: 145 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 201
Query: 256 YAIRGELSEKADIYSFGVLVLEIIS 280
                   + +D+++ G ++ ++++
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVA 226

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 32  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 89  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 145
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 146 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM----TGYVATRWYRAP 198
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 25  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 82  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 138
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 139 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 191
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 25  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 82  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 138
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 139 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 191
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 28/206 (13%)
Query: 88  NLLGRGGFGPVYRGKLADGT----LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           ++LG G F  V    LA+      LVA+K +  +  +  E    +E+ ++  I+H N+V 
Sbjct: 24  DVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 144 LLGCCSDGSQRLLVYEYMK-----NRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLH 198
           L      G    L+ + +      +R ++   Y E D     ++R  +I  +   ++YLH
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERD-----ASR--LIFQVLDAVKYLH 133
Query: 199 EDSHTRIVHRDIKASNVL---LDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE 255
           +     IVHRD+K  N+L   LDE  +  I DFGL++   ED   + +   GT GY APE
Sbjct: 134 D---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPE 188
Query: 256 YAIRGELSEKADIYSFGVLVLEIISC 281
              +   S+  D +S GV+   I+ C
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAY-ILLC 213

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 25  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 82  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 138
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 139 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 191
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G +G V        G  VAVKKL    +S         E+R++  ++H+N++ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 148 CSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            +    R L     VY        DL    +  K  +   +F +I  I RGL+Y+H    
Sbjct: 96  FTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS--- 149
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-E 261
             I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y APE  +    
Sbjct: 150 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMH 205
Query: 262 LSEKADIYSFGVLVLEIISCR 282
            ++  DI+S G ++ E+++ R
Sbjct: 206 YNQTVDIWSVGCIMAELLTGR 226

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 88/200 (44%), Gaps = 25/200 (12%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQ---QG-ESEFLSEVRMITSIQHKNLVRLL 145
           LG+G FG VY  +      +   K+   KSQ   +G E +   E+ + + ++H N++R+ 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLF-KSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ------IILGIARGLQYLHE 199
               D  +  L+ E+           GE  K L    RF        +  +A  L Y HE
Sbjct: 81  NYFHDRKRIYLMLEFAPR--------GELYKELQKHGRFDEQRSATFMEELADALHYCHE 132
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
               +++HRDIK  N+L+  K + KI DFG +   P   +       GTL Y  PE    
Sbjct: 133 ---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP---SLRRRXMCGTLDYLPPEMIEG 186
Query: 260 GELSEKADIYSFGVLVLEII 279
               EK D++  GVL  E +
Sbjct: 187 KTHDEKVDLWCAGVLCYEFL 206

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 104/214 (48%), Gaps = 14/214 (6%)
Query: 75  QTLKKATKNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRM 132
           +T+ +  + +   + +G G +G V     +  G  +AVKKL    +S         E+R+
Sbjct: 44  KTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRL 103
Query: 133 ITSIQHKNLVRLLGCCSDGS---QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG 189
           +  ++H+N++ LL   +  +   +   VY        DL    +  K  +   +F +I  
Sbjct: 104 LKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQ 162
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
           I RGL+Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T 
Sbjct: 163 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATR 215
Query: 250 GYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCR 282
            Y APE  +     +   DI+S G ++ E+++ R
Sbjct: 216 WYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 25  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 82  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF-LIYQILRGL 138
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 139 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 191
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 30  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 87  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 143
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 144 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 196
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 24  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 80
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 81  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 137
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 138 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 190
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 191 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 36  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 93  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 149
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 150 KYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM----TGYVATRWYRAP 202
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 18/200 (9%)
Query: 89  LLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQ--GESEFLSEVRMITSIQHKNLVRL 144
           +LG+G FG V   + K+  G   AVK +   + +Q   +   L EV+++  + H N+++L
Sbjct: 57  VLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 115
Query: 145 LGCCSDGSQRLLVYE-YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
                D     LV E Y      D +I   S K  +     +II  +  G+ Y+H++   
Sbjct: 116 YEFFEDKGYFYLVGEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKN--- 169
Query: 204 RIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
           +IVHRD+K  N+LL+ K +    +I DFGL+  F   +     +  GT  Y APE  + G
Sbjct: 170 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTAYYIAPE-VLHG 226
Query: 261 ELSEKADIYSFGVLVLEIIS 280
              EK D++S GV++  ++S
Sbjct: 227 TYDEKCDVWSTGVILYILLS 246

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 27  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 84  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 140
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 141 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 193
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 37  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 94  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 150
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 151 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 203
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 19/200 (9%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNLVRLLGC 147
           LG G +G VY+         VA+K++ ++  ++G     + EV ++  +QH+N++ L   
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVH 207
                +  L++EY +N   DL  Y + +  ++       +  +  G+ + H     R +H
Sbjct: 102 IHHNHRLHLIFEYAEN---DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS---RRCLH 155
Query: 208 RDIKASNVLLDEKFQS-----KIGDFGLARFF--PEDQAYLSTNFAGTLGYTAPEYAIRG 260
           RD+K  N+LL     S     KIGDFGLAR F  P  Q    T+   TL Y  PE  +  
Sbjct: 156 RDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF---THEIITLWYRPPEILLGS 212
Query: 261 -ELSEKADIYSFGVLVLEII 279
              S   DI+S   +  E++
Sbjct: 213 RHYSTSVDIWSIACIWAEML 232

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 25  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 82  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 138
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 139 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 191
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 25  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +S K  +   +F +I  I RGL
Sbjct: 82  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQF-LIYQILRGL 138
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGL R   ++     T +  T  Y AP
Sbjct: 139 KYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEM----TGYVATRWYRAP 191
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G +G V        G  VAVKKL    +S         E+R++  ++H+N++ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 148 CSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            +    R L     VY        DL    +  K  +   +F +I  I RGL+Y+H    
Sbjct: 96  FTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS--- 149
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-E 261
             I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y APE  +    
Sbjct: 150 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMH 205
Query: 262 LSEKADIYSFGVLVLEIISCR 282
            ++  DI+S G ++ E+++ R
Sbjct: 206 YNQTVDIWSVGCIMAELLTGR 226

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 32  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 89  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 145
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 146 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 198
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G +G V        G  VAVKKL    +S         E+R++  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 148 CSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            +    R L     VY        DL    +  K  +   +F +I  I RGL+Y+H    
Sbjct: 90  FTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS--- 143
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-E 261
             I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y APE  +    
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMH 199
Query: 262 LSEKADIYSFGVLVLEIISCR 282
            ++  DI+S G ++ E+++ R
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 25  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 82  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 138
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 139 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 191
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 27  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 84  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 140
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 141 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 193
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 27  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 84  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 140
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 141 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 193
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 13/205 (6%)
Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKS---QQGESEFLSEVRMITS-I 136
           ++F  G +LG G F  V   + LA     A+K L  +K    ++ +  +++  R + S +
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 87
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
            H   V+L     D  +      Y KN  L L    +   F    TRF     I   L+Y
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTA-EIVSALEY 145
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPE 255
           LH      I+HRD+K  N+LL+E    +I DFG A+   PE +   +  F GT  Y +PE
Sbjct: 146 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 256 YAIRGELSEKADIYSFGVLVLEIIS 280
                   + +D+++ G ++ ++++
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 28/206 (13%)
Query: 88  NLLGRGGFGPVYRGKLADGT----LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           ++LG G F  V    LA+      LVA+K +     +  E    +E+ ++  I+H N+V 
Sbjct: 24  DVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 144 LLGCCSDGSQRLLVYEYMK-----NRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLH 198
           L      G    L+ + +      +R ++   Y E D     ++R  +I  +   ++YLH
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERD-----ASR--LIFQVLDAVKYLH 133
Query: 199 EDSHTRIVHRDIKASNVL---LDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE 255
           +     IVHRD+K  N+L   LDE  +  I DFGL++   ED   + +   GT GY APE
Sbjct: 134 D---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPE 188
Query: 256 YAIRGELSEKADIYSFGVLVLEIISC 281
              +   S+  D +S GV+   I+ C
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAY-ILLC 213

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 13/205 (6%)
Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKS---QQGESEFLSEVRMITS-I 136
           ++F  G +LG G F  V   + LA     A+K L  +K    ++ +  +++  R + S +
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 87
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
            H   V+L     D  +      Y KN  L L    +   F    TRF     I   L+Y
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTA-EIVSALEY 145
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPE 255
           LH      I+HRD+K  N+LL+E    +I DFG A+   PE +   +  F GT  Y +PE
Sbjct: 146 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 256 YAIRGELSEKADIYSFGVLVLEIIS 280
                   + +D+++ G ++ ++++
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 37  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 94  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 150
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 151 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 203
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 37  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 94  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 150
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 151 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 203
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 22  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 79  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 135
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 136 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 188
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 9/199 (4%)
Query: 89  LLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQ--GESEFLSEVRMITSIQHKNLVRLL 145
           +LGRGGFG V+  ++ A G L A KKL   + ++  G    + E +++  +  + +V L 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--IARGLQYLHEDSHT 203
                 +   LV   M    +   IY   +    +     I     I  GL++LH+ +  
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELS 263
            I++RD+K  NVLLD+    +I D GLA      Q   +  +AGT G+ APE  +  E  
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEYD 367
Query: 264 EKADIYSFGVLVLEIISCR 282
              D ++ GV + E+I+ R
Sbjct: 368 FSVDYFALGVTLYEMIAAR 386

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 27  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 84  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 140
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 141 KYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM----TGYVATRWYRAP 193
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 9/199 (4%)
Query: 89  LLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQ--GESEFLSEVRMITSIQHKNLVRLL 145
           +LGRGGFG V+  ++ A G L A KKL   + ++  G    + E +++  +  + +V L 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--IARGLQYLHEDSHT 203
                 +   LV   M    +   IY   +    +     I     I  GL++LH+ +  
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELS 263
            I++RD+K  NVLLD+    +I D GLA      Q   +  +AGT G+ APE  +  E  
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEYD 367
Query: 264 EKADIYSFGVLVLEIISCR 282
              D ++ GV + E+I+ R
Sbjct: 368 FSVDYFALGVTLYEMIAAR 386

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 25  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 82  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 138
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 139 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 191
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 31  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 88  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 144
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 145 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 197
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 9/199 (4%)
Query: 89  LLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQ--GESEFLSEVRMITSIQHKNLVRLL 145
           +LGRGGFG V+  ++ A G L A KKL   + ++  G    + E +++  +  + +V L 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--IARGLQYLHEDSHT 203
                 +   LV   M    +   IY   +    +     I     I  GL++LH+ +  
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELS 263
            I++RD+K  NVLLD+    +I D GLA      Q   +  +AGT G+ APE  +  E  
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEYD 367
Query: 264 EKADIYSFGVLVLEIISCR 282
              D ++ GV + E+I+ R
Sbjct: 368 FSVDYFALGVTLYEMIAAR 386

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 25  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 82  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 138
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 139 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 191
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 9/199 (4%)
Query: 89  LLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQ--GESEFLSEVRMITSIQHKNLVRLL 145
           +LGRGGFG V+  ++ A G L A KKL   + ++  G    + E +++  +  + +V L 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG--IARGLQYLHEDSHT 203
                 +   LV   M    +   IY   +    +     I     I  GL++LH+ +  
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELS 263
            I++RD+K  NVLLD+    +I D GLA      Q   +  +AGT G+ APE  +  E  
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEYD 367
Query: 264 EKADIYSFGVLVLEIISCR 282
              D ++ GV + E+I+ R
Sbjct: 368 FSVDYFALGVTLYEMIAAR 386

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G +G V        G  VAVKKL    +S         E+R++  ++H+N++ LL  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 148 CSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            +    R L     VY        DL    +  K  +   +F +I  I RGL+Y+H    
Sbjct: 87  FTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS--- 140
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-E 261
             I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y APE  +    
Sbjct: 141 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMH 196
Query: 262 LSEKADIYSFGVLVLEIISCR 282
            ++  DI+S G ++ E+++ R
Sbjct: 197 YNQTVDIWSVGCIMAELLTGR 217

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 13/205 (6%)
Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKS---QQGESEFLSEVRMITS-I 136
           ++F  G +LG G F  V   + LA     A+K L  +K    ++ +  +++  R + S +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 89
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
            H   V+L     D  +      Y KN  L L    +   F    TRF     I   L+Y
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTA-EIVSALEY 147
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPE 255
           LH      I+HRD+K  N+LL+E    +I DFG A+   PE +   +  F GT  Y +PE
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 256 YAIRGELSEKADIYSFGVLVLEIIS 280
                   + +D+++ G ++ ++++
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVA 229

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G +G V        G  VAVKKL    +S         E+R++  ++H+N++ LL  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 148 CSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            +    R L     VY        DL    +  K  +   +F +I  I RGL+Y+H    
Sbjct: 100 FTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS--- 153
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-E 261
             I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y APE  +    
Sbjct: 154 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMH 209
Query: 262 LSEKADIYSFGVLVLEIISCR 282
            ++  DI+S G ++ E+++ R
Sbjct: 210 YNQTVDIWSVGCIMAELLTGR 230

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G +G V        G  VAVKKL    +S         E+R++  ++H+N++ LL  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 148 CSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            +    R L     VY        DL    +  K  +   +F +I  I RGL+Y+H    
Sbjct: 88  FTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS--- 141
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-E 261
             I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y APE  +    
Sbjct: 142 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMH 197
Query: 262 LSEKADIYSFGVLVLEIISCR 282
            ++  DI+S G ++ E+++ R
Sbjct: 198 YNQTVDIWSVGCIMAELLTGR 218

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G +G V        G  VAVKKL    +S         E+R++  ++H+N++ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 148 CSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            +    R L     VY        DL    +  K  +   +F +I  I RGL+Y+H    
Sbjct: 86  FTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS--- 139
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-E 261
             I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y APE  +    
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMH 195
Query: 262 LSEKADIYSFGVLVLEIISCR 282
            ++  DI+S G ++ E+++ R
Sbjct: 196 YNQTVDIWSVGCIMAELLTGR 216

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 24/206 (11%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G V       +   VA+KK+   + Q      L E++++ + +H+N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI---- 88
Query: 149 SDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF-------QIILGIARGLQYLHE 199
            +   R    E MK+  +  DL+   E+D +    T+          +  I RGL+Y+H 
Sbjct: 89  -NDIIRAPTIEQMKDVYIVQDLM---ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPEYA 257
                ++HRD+K SN+LL+     KI DFGLAR    D  +    T +  T  Y APE  
Sbjct: 145 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 258 IRGE-LSEKADIYSFGVLVLEIISCR 282
           +  +  ++  DI+S G ++ E++S R
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 30  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 87  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 143
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 144 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 196
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 87  GNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGE--SEFLSEVRMITSIQHKNLVR 143
           G +LG GG   V+  + L D   VAVK L  D ++       F  E +   ++ H  +V 
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 144 LLGC----CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
           +          G    +V EY+   +L  +++ E    +      ++I    + L + H+
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ 134
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA--GTLGYTAPEYA 257
           +    I+HRD+K +N+++      K+ DFG+AR   +    ++   A  GT  Y +PE A
Sbjct: 135 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 258 IRGELSEKADIYSFGVLVLEIIS 280
               +  ++D+YS G ++ E+++
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLT 214

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 36  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 93  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 149
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 150 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 202
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 13/205 (6%)
Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKS---QQGESEFLSEVRMITS-I 136
           ++F  G +LG G F  V   + LA     A+K L  +K    ++ +  +++  R + S +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 89
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
            H   V+L     D  +      Y KN  L L    +   F    TRF     I   L+Y
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTA-EIVSALEY 147
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPE 255
           LH      I+HRD+K  N+LL+E    +I DFG A+   PE +   +  F GT  Y +PE
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 256 YAIRGELSEKADIYSFGVLVLEIIS 280
                   + +D+++ G ++ ++++
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVA 229

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 31  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 88  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 144
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 145 KYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM----TGYVATRWYRAP 197
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G +G V        G  VAVKKL    +S         E+R++  ++H+N++ LL  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 148 CSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            +    R L     VY        DL    +  K  +   +F +I  I RGL+Y+H    
Sbjct: 110 FTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS--- 163
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-E 261
             I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y APE  +    
Sbjct: 164 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMH 219
Query: 262 LSEKADIYSFGVLVLEIISCR 282
            ++  DI+S G ++ E+++ R
Sbjct: 220 YNQTVDIWSVGCIMAELLTGR 240

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 13/205 (6%)
Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKS---QQGESEFLSEVRMITS-I 136
           ++F  G +LG G F  V   + LA     A+K L  +K    ++ +  +++  R + S +
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 71
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
            H   V+L     D  +      Y KN  L L    +   F    TRF     I   L+Y
Sbjct: 72  DHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTA-EIVSALEY 129
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPE 255
           LH      I+HRD+K  N+LL+E    +I DFG A+   PE +   +  F GT  Y +PE
Sbjct: 130 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 186
Query: 256 YAIRGELSEKADIYSFGVLVLEIIS 280
                   + +D+++ G ++ ++++
Sbjct: 187 LLTEKSACKSSDLWALGCIIYQLVA 211

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 48  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 105 NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 161
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 162 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 214
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 87  GNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGE--SEFLSEVRMITSIQHKNLVR 143
           G +LG GG   V+  + L D   VAVK L  D ++       F  E +   ++ H  +V 
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 144 LLGC----CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
           +          G    +V EY+   +L  +++ E    +      ++I    + L + H+
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ 134
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA--GTLGYTAPEYA 257
           +    I+HRD+K +N+++      K+ DFG+AR   +    ++   A  GT  Y +PE A
Sbjct: 135 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 258 IRGELSEKADIYSFGVLVLEIIS 280
               +  ++D+YS G ++ E+++
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLT 214

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 13/205 (6%)
Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKS---QQGESEFLSEVRMITS-I 136
           ++F  G +LG G F  V   + LA     A+K L  +K    ++ +  +++  R + S +
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 87
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
            H   V+L     D  +      Y KN  L L    +   F    TRF     I   L+Y
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTA-EIVSALEY 145
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPE 255
           LH      I+HRD+K  N+LL+E    +I DFG A+   PE +   +  F GT  Y +PE
Sbjct: 146 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPE 202
Query: 256 YAIRGELSEKADIYSFGVLVLEIIS 280
                   + +D+++ G ++ ++++
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 44  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 101 NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 157
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 158 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 210
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 45  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 102 NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 158
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y AP
Sbjct: 159 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAP 211
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G +G V        G  VAVKKL    +S         E+R++  ++H+N++ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 148 CSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            +    R L     VY        DL    +  K  +   +F +I  I RGL+Y+H    
Sbjct: 86  FTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS--- 139
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-E 261
             I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y APE  +    
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMH 195
Query: 262 LSEKADIYSFGVLVLEIISCR 282
            ++  DI+S G ++ E+++ R
Sbjct: 196 YNQTVDIWSVGCIMAELLTGR 216

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G +G V        G  VAVKKL    +S         E+R++  ++H+N++ LL  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 148 CSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            +    R L     VY        DL    +  K  +   +F +I  I RGL+Y+H    
Sbjct: 109 FTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS--- 162
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-E 261
             I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y APE  +    
Sbjct: 163 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMH 218
Query: 262 LSEKADIYSFGVLVLEIISCR 282
            ++  DI+S G ++ E+++ R
Sbjct: 219 YNQTVDIWSVGCIMAELLTGR 239

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 13/205 (6%)
Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKS---QQGESEFLSEVRMITS-I 136
           ++F  G +LG G F  V   + LA     A+K L  +K    ++ +  +++  R + S +
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 90
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
            H   V+L     D  +      Y KN  L L    +   F    TRF     I   L+Y
Sbjct: 91  DHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTA-EIVSALEY 148
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPE 255
           LH      I+HRD+K  N+LL+E    +I DFG A+   PE +   +  F GT  Y +PE
Sbjct: 149 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 205
Query: 256 YAIRGELSEKADIYSFGVLVLEIIS 280
                   + +D+++ G ++ ++++
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVA 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 13/205 (6%)
Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKS---QQGESEFLSEVRMITS-I 136
           ++F  G +LG G F  V   + LA     A+K L  +K    ++ +  +++  R + S +
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 92
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
            H   V+L     D  +      Y KN  L L    +   F    TRF     I   L+Y
Sbjct: 93  DHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTA-EIVSALEY 150
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPE 255
           LH      I+HRD+K  N+LL+E    +I DFG A+   PE +   +  F GT  Y +PE
Sbjct: 151 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 207
Query: 256 YAIRGELSEKADIYSFGVLVLEIIS 280
                   + +D+++ G ++ ++++
Sbjct: 208 LLTEKSACKSSDLWALGCIIYQLVA 232

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 13/205 (6%)
Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKS---QQGESEFLSEVRMITS-I 136
           ++F  G +LG G F  V   + LA     A+K L  +K    ++ +  +++  R + S +
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 86
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
            H   V+L     D  +      Y KN  L L    +   F    TRF     I   L+Y
Sbjct: 87  DHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTA-EIVSALEY 144
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPE 255
           LH      I+HRD+K  N+LL+E    +I DFG A+   PE +   +  F GT  Y +PE
Sbjct: 145 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 201
Query: 256 YAIRGELSEKADIYSFGVLVLEIIS 280
                   + +D+++ G ++ ++++
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVA 226

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 97/195 (49%), Gaps = 12/195 (6%)
Query: 90  LGRGGFGPVYR-GKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G FG V+R  + A G   A K +        E+    E++ ++ ++H  LV L    
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET-VRKEIQTMSVLRHPTLVNLHDAF 117
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
            D ++ +++YE+M    L   +  E +K ++     + +  + +GL ++HE+++   VH 
Sbjct: 118 EDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENNY---VHL 173
Query: 209 DIKASNVLLDEKFQS--KIGDFGL-ARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEK 265
           D+K  N++   K  +  K+ DFGL A   P+    ++T   GT  + APE A    +   
Sbjct: 174 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYY 230
Query: 266 ADIYSFGVLVLEIIS 280
            D++S GVL   ++S
Sbjct: 231 TDMWSVGVLSYILLS 245

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 13/205 (6%)
Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKS---QQGESEFLSEVRMITS-I 136
           ++F  G +LG G F  V   + LA     A+K L  +K    ++ +  +++  R + S +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 89
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
            H   V+L     D  +      Y KN  L L    +   F    TRF     I   L+Y
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTA-EIVSALEY 147
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPE 255
           LH      I+HRD+K  N+LL+E    +I DFG A+   PE +   +  F GT  Y +PE
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 256 YAIRGELSEKADIYSFGVLVLEIIS 280
                   + +D+++ G ++ ++++
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVA 229

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 24/206 (11%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G V       +   VA+KK+   + Q      L E++++ + +H+N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI---- 88
Query: 149 SDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF-------QIILGIARGLQYLHE 199
            +   R    E MK+  +  DL+   E+D +    T+          +  I RGL+Y+H 
Sbjct: 89  -NDIIRAPTIEQMKDVYIVQDLM---ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPEYA 257
                ++HRD+K SN+LL+     KI DFGLAR    D  +    T +  T  Y APE  
Sbjct: 145 ---ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 258 IRGE-LSEKADIYSFGVLVLEIISCR 282
           +  +  ++  DI+S G ++ E++S R
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G V       +   VA+KK+   + Q      L E++++   +H+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGI---- 90
Query: 149 SDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF-------QIILGIARGLQYLHE 199
            +   R    E MK+  +  DL+   E+D +    T+          +  I RGL+Y+H 
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLM---ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPEYA 257
                ++HRD+K SN+LL+     KI DFGLAR    D  +    T +  T  Y APE  
Sbjct: 147 ---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 258 IRGE-LSEKADIYSFGVLVLEIISCR 282
           +  +  ++  DI+S G ++ E++S R
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 87  GNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGE--SEFLSEVRMITSIQHKNLVR 143
           G +LG GG   V+  + L D   VAVK L  D ++       F  E +   ++ H  +V 
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 144 LLGC----CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
           +          G    +V EY+   +L  +++ E    +      ++I    + L + H+
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ 134
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA--GTLGYTAPEYA 257
           +    I+HRD+K +N+L+      K+ DFG+AR   +    +    A  GT  Y +PE A
Sbjct: 135 NG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQA 191
Query: 258 IRGELSEKADIYSFGVLVLEIIS 280
               +  ++D+YS G ++ E+++
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLT 214

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 10/201 (4%)
Query: 83  NFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESE--FLSEVRMITSIQHK 139
           NF    +LG+G FG V   ++ + G L AVK L  D   Q +     ++E R+++  ++ 
Sbjct: 24  NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83
Query: 140 NLVRLLGCCSDGSQRLL-VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLH 198
             +  L CC     RL  V E++    L   I  +S +F     RF     I   L +LH
Sbjct: 84  PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFDEARARFYAA-EIISALMFLH 141
Query: 199 EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI 258
           +     I++RD+K  NVLLD +   K+ DFG+ +    +    +T F GT  Y APE   
Sbjct: 142 DKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIAPEILQ 197
Query: 259 RGELSEKADIYSFGVLVLEII 279
                   D ++ GVL+ E++
Sbjct: 198 EMLYGPAVDWWAMGVLLYEML 218

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 88  NLLGRGGFGPVYRGKLADGT-------LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
            +LG+G FG V+  K   G+       +  +KK  +    +  ++   E  ++  + H  
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM--ERDILVEVNHPF 87
Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
           +V+L        +  L+ ++++   L   +  E   F     +F +   +A  L +LH  
Sbjct: 88  IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLA-ELALALDHLHS- 144
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR--FFPEDQAYLSTNFAGTLGYTAPEYAI 258
               I++RD+K  N+LLDE+   K+ DFGL++     E +AY   +F GT+ Y APE   
Sbjct: 145 --LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVN 199
Query: 259 RGELSEKADIYSFGVLVLEIIS 280
           R   ++ AD +SFGVL+ E+++
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLT 221

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 13/205 (6%)
Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKS---QQGESEFLSEVRMITS-I 136
           ++F  G +LG G F  V   + LA     A+K L  +K    ++ +  +++  R + S +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 89
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
            H   V+L     D  +      Y KN  L L    +   F    TRF     I   L+Y
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTA-EIVSALEY 147
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPE 255
           LH      I+HRD+K  N+LL+E    +I DFG A+   PE +   +  F GT  Y +PE
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 256 YAIRGELSEKADIYSFGVLVLEIIS 280
                   + +D+++ G ++ ++++
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVA 229

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 97/195 (49%), Gaps = 12/195 (6%)
Query: 90  LGRGGFGPVYR-GKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G FG V+R  + A G   A K +        E+    E++ ++ ++H  LV L    
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET-VRKEIQTMSVLRHPTLVNLHDAF 223
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
            D ++ +++YE+M    L   +  E +K ++     + +  + +GL ++HE+++   VH 
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENNY---VHL 279
Query: 209 DIKASNVLLDEKFQS--KIGDFGL-ARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEK 265
           D+K  N++   K  +  K+ DFGL A   P+    ++T   GT  + APE A    +   
Sbjct: 280 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYY 336
Query: 266 ADIYSFGVLVLEIIS 280
            D++S GVL   ++S
Sbjct: 337 TDMWSVGVLSYILLS 351

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G +G V        G  VAVKKL    +S         E+R++  ++H+N++ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 148 CSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            +    R L     VY        DL    +  K  +   +F +I  I RGL+Y+H    
Sbjct: 86  FTPA--RSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQF-LIYQILRGLKYIHS--- 139
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-E 261
             I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  Y APE  +    
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMH 195
Query: 262 LSEKADIYSFGVLVLEIISCR 282
            ++  DI+S G ++ E+++ R
Sbjct: 196 YNQTVDIWSVGCIMAELLTGR 216

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G V       +   VA+KK+   + Q      L E++++   +H+N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 149 SDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF-------QIILGIARGLQYLHE 199
            +   R    E MK+  +  DL+   E+D +    T+          +  I RGL+Y+H 
Sbjct: 87  -NDIIRAPTIEQMKDVYIVQDLM---ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPEYA 257
                ++HRD+K SN+LL+     KI DFGLAR    D  +    T +  T  Y APE  
Sbjct: 143 ---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 258 IRGE-LSEKADIYSFGVLVLEIISCR 282
           +  +  ++  DI+S G ++ E++S R
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G V       +   VA+KK+   + Q      L E++++   +H+N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 149 SDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF-------QIILGIARGLQYLHE 199
            +   R    E MK+  +  DL+   E+D +    T+          +  I RGL+Y+H 
Sbjct: 87  -NDIIRAPTIEQMKDVYIVQDLM---ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPEYA 257
                ++HRD+K SN+LL+     KI DFGLAR    D  +    T +  T  Y APE  
Sbjct: 143 ---ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 258 IRGE-LSEKADIYSFGVLVLEIISCR 282
           +  +  ++  DI+S G ++ E++S R
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 13/205 (6%)
Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKS---QQGESEFLSEVRMITS-I 136
           ++F  G +LG G F  V   + LA     A+K L  +K    ++ +  +++  R + S +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 89
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
            H   V+L     D  +      Y KN  L L    +   F    TRF     I   L+Y
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTA-EIVSALEY 147
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPE 255
           LH      I+HRD+K  N+LL+E    +I DFG A+   PE +   +  F GT  Y +PE
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 256 YAIRGELSEKADIYSFGVLVLEIIS 280
                   + +D+++ G ++ ++++
Sbjct: 205 LLTEKSAXKSSDLWALGCIIYQLVA 229

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G V       +   VA+KK+   + Q      L E++++   +H+N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 149 SDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF-------QIILGIARGLQYLHE 199
            +   R    E MK+  +  DL+   E+D +    T+          +  I RGL+Y+H 
Sbjct: 87  -NDIIRAPTIEQMKDVYIVQDLM---ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPEYA 257
                ++HRD+K SN+LL+     KI DFGLAR    D  +    T +  T  Y APE  
Sbjct: 143 ---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 258 IRGE-LSEKADIYSFGVLVLEIISCR 282
           +  +  ++  DI+S G ++ E++S R
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G V       +   VA+KK+   + Q      L E++++   +H+N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 149 SDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF-------QIILGIARGLQYLHE 199
            +   R    E MK+  +  DL+   E+D +    T+          +  I RGL+Y+H 
Sbjct: 87  -NDIIRAPTIEQMKDVYIVQDLM---ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPEYA 257
                ++HRD+K SN+LL+     KI DFGLAR    D  +    T +  T  Y APE  
Sbjct: 143 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 258 IRGE-LSEKADIYSFGVLVLEIISCR 282
           +  +  ++  DI+S G ++ E++S R
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G V       +   VA+KK+   + Q      L E++++   +H+N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 106
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGES------DKFLNWSTRFQIILGIARGLQYLHEDSH 202
            +   R    E MK+  L   + G         + L+       +  I RGL+Y+H    
Sbjct: 107 -NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS--- 162
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPEYAIRG 260
             ++HRD+K SN+LL+     KI DFGLAR    D  +    T +  T  Y APE  +  
Sbjct: 163 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 222
Query: 261 E-LSEKADIYSFGVLVLEIISCR 282
           +  ++  DI+S G ++ E++S R
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G V       +   VA+KK+   + Q      L E++++   +H+N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 94
Query: 149 SDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF-------QIILGIARGLQYLHE 199
            +   R    E MK+  +  DL+   E+D +    T+          +  I RGL+Y+H 
Sbjct: 95  -NDIIRAPTIEQMKDVYIVQDLM---ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 150
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPEYA 257
                ++HRD+K SN+LL+     KI DFGLAR    D  +    T +  T  Y APE  
Sbjct: 151 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 207
Query: 258 IRGE-LSEKADIYSFGVLVLEIISCR 282
           +  +  ++  DI+S G ++ E++S R
Sbjct: 208 LNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G V       +   VA+KK+   + Q      L E++++   +H+N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 149 SDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF-------QIILGIARGLQYLHE 199
            +   R    E MK+  +  DL+   E+D +    T+          +  I RGL+Y+H 
Sbjct: 87  -NDIIRAPTIEQMKDVYIVQDLM---ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPEYA 257
                ++HRD+K SN+LL+     KI DFGLAR    D  +    T +  T  Y APE  
Sbjct: 143 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 258 IRGE-LSEKADIYSFGVLVLEIISCR 282
           +  +  ++  DI+S G ++ E++S R
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G V       +   VA+KK+   + Q      L E++++   +H+N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 106
Query: 149 SDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF-------QIILGIARGLQYLHE 199
            +   R    E MK+  +  DL+   E+D +    T+          +  I RGL+Y+H 
Sbjct: 107 -NDIIRAPTIEQMKDVYIVQDLM---ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 162
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPEYA 257
                ++HRD+K SN+LL+     KI DFGLAR    D  +    T +  T  Y APE  
Sbjct: 163 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 219
Query: 258 IRGE-LSEKADIYSFGVLVLEIISCR 282
           +  +  ++  DI+S G ++ E++S R
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G V       +   VA+KK+   + Q      L E++++   +H+N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 88
Query: 149 SDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF-------QIILGIARGLQYLHE 199
            +   R    E MK+  +  DL+   E+D +    T+          +  I RGL+Y+H 
Sbjct: 89  -NDIIRAPTIEQMKDVYIVQDLM---ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPEYA 257
                ++HRD+K SN+LL+     KI DFGLAR    D  +    T +  T  Y APE  
Sbjct: 145 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 258 IRGE-LSEKADIYSFGVLVLEIISCR 282
           +  +  ++  DI+S G ++ E++S R
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 25  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 82  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 138
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI D+GLAR   ++     T +  T  Y AP
Sbjct: 139 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEM----TGYVATRWYRAP 191
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 23/217 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRGKLA--DGTLV--AVKKLCVDKSQQGE-SEFLSEVRMITSI 136
           + F  G +LG+G FG V   +L   DG+ V  AVK L  D     +  EFL E   +   
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 137 QHKNLVRLLGCC--SDGSQRL----LVYEYMKNRSLDLLIY----GESDKFLNWSTRFQI 186
            H ++ +L+G    S    RL    ++  +MK+  L   +     GE+   L   T  + 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR-FFPEDQAYLSTNF 245
           ++ IA G++YL   S    +HRD+ A N +L E     + DFGL+R  +  D  Y     
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD--YYRQGC 197
Query: 246 AGTL--GYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           A  L   + A E       +  +D+++FGV + EI++
Sbjct: 198 ASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 88  NLLGRGGFGPVYRGKLADGT-------LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
            +LG+G FG V+  K   G+       +  +KK  +    +  ++   E  ++  + H  
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM--ERDILVEVNHPF 88
Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
           +V+L        +  L+ ++++   L   +  E   F     +F +   +A  L +LH  
Sbjct: 89  IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLA-ELALALDHLHS- 145
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR--FFPEDQAYLSTNFAGTLGYTAPEYAI 258
               I++RD+K  N+LLDE+   K+ DFGL++     E +AY   +F GT+ Y APE   
Sbjct: 146 --LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVN 200
Query: 259 RGELSEKADIYSFGVLVLEIIS 280
           R   ++ AD +SFGVL+ E+++
Sbjct: 201 RRGHTQSADWWSFGVLMFEMLT 222

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 88  NLLGRGGFGPVYRGKLADGT-------LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
            +LG+G FG V+  K   G+       +  +KK  +    +  ++   E  ++  + H  
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM--ERDILVEVNHPF 87
Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
           +V+L        +  L+ ++++   L   +  E   F     +F +   +A  L +LH  
Sbjct: 88  IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLA-ELALALDHLHS- 144
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR--FFPEDQAYLSTNFAGTLGYTAPEYAI 258
               I++RD+K  N+LLDE+   K+ DFGL++     E +AY   +F GT+ Y APE   
Sbjct: 145 --LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVN 199
Query: 259 RGELSEKADIYSFGVLVLEIIS 280
           R   ++ AD +SFGVL+ E+++
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLT 221

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 114/250 (45%), Gaps = 23/250 (9%)
Query: 87  GNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVR 143
           G+ LG G FG V  G+    G  VAVK L   K  S     +   E++ +   +H ++++
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 144 LLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
           L    S  +   +V EY+    L D +      + +     FQ IL     + Y H    
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS---AVDYCHRHM- 131
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
             +VHRD+K  NVLLD    +KI DFGL+     D  +L T+  G+  Y APE  I G L
Sbjct: 132 --VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTS-CGSPNYAAPE-VISGRL 186
Query: 263 --SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE 320
               + DI+S GV++  ++        TLP + +++P    K+  RG +  + +   R  
Sbjct: 187 YAGPEVDIWSCGVILYALLCG------TLPFDDEHVPTLFKKI--RGGVFYIPEYLNRSV 238
Query: 321 GIVERDALQV 330
             +    LQV
Sbjct: 239 ATLLMHMLQV 248

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G V       +   VA+KK+   + Q      L E++++   +H+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 149 SDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF-------QIILGIARGLQYLHE 199
            +   R    E MK+  +  DL+   E+D +    T+          +  I RGL+Y+H 
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLM---ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPEYA 257
                ++HRD+K SN+LL+     KI DFGLAR    D  +    T +  T  Y APE  
Sbjct: 147 ---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 258 IRGE-LSEKADIYSFGVLVLEIISCR 282
           +  +  ++  DI+S G ++ E++S R
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 13/205 (6%)
Query: 82  KNFHPGNLLGRGGFGP-VYRGKLADGTLVAVKKLCVDKS---QQGESEFLSEVRMITS-I 136
           ++F  G +LG G F   V   +LA     A+K L  +K    ++ +  +++  R + S +
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 87
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
            H   V+L     D  +      Y KN  L L    +   F    TRF     I   L+Y
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTA-EIVSALEY 145
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPE 255
           LH      I+HRD+K  N+LL+E    +I DFG A+   PE +   +  F GT  Y +PE
Sbjct: 146 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 256 YAIRGELSEKADIYSFGVLVLEIIS 280
                   + +D+++ G ++ ++++
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 37/218 (16%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKL--CVDKSQQGESEFLSEVRMITSIQ-HKNLVRLL 145
           LG+G +G V++      G +VAVKK+      S   +  F  E+ ++T +  H+N+V LL
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHENIVNLL 75
Query: 146 GCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
                 + R   LV++YM+   L  +I       L    +  ++  + + ++YLH     
Sbjct: 76  NVLRADNDRDVYLVFDYMET-DLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGG-- 129
Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARF---------------------FPEDQAYLS 242
            ++HRD+K SN+LL+ +   K+ DFGL+R                      F +DQ  L 
Sbjct: 130 -LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL- 187
Query: 243 TNFAGTLGYTAPEYAI-RGELSEKADIYSFGVLVLEII 279
           T++  T  Y APE  +   + ++  D++S G ++ EI+
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 18/200 (9%)
Query: 89  LLGRGGFGPVY--RGKLADGTLVAVKKLCVDKSQQ--GESEFLSEVRMITSIQHKNLVRL 144
           +LG+G FG V   + K+  G   AVK +   + +Q   +   L EV+++  + H N+ +L
Sbjct: 33  VLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 145 LGCCSDGSQRLLVYE-YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
                D     LV E Y      D +I   S K  +     +II  +  G+ Y H++   
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYXHKN--- 145
Query: 204 RIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
           +IVHRD+K  N+LL+ K +    +I DFGL+  F   +     +  GT  Y APE  + G
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--XKDKIGTAYYIAPE-VLHG 202
Query: 261 ELSEKADIYSFGVLVLEIIS 280
              EK D++S GV++  ++S
Sbjct: 203 TYDEKCDVWSTGVILYILLS 222

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G V       +   VA+KK+   + Q      L E++++   +H+N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 84
Query: 149 SDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF-------QIILGIARGLQYLHE 199
            +   R    E MK+  +  DL+   E+D +    T+          +  I RGL+Y+H 
Sbjct: 85  -NDIIRAPTIEQMKDVYIVQDLM---ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPEYA 257
                ++HRD+K SN+LL+     KI DFGLAR    D  +    T +  T  Y APE  
Sbjct: 141 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 197
Query: 258 IRGE-LSEKADIYSFGVLVLEIISCR 282
           +  +  ++  DI+S G ++ E++S R
Sbjct: 198 LNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G V       +   VA+KK+   + Q      L E++++   +H+N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 91
Query: 149 SDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF-------QIILGIARGLQYLHE 199
            +   R    E MK+  +  DL+   E+D +    T+          +  I RGL+Y+H 
Sbjct: 92  -NDIIRAPTIEQMKDVYIVQDLM---ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPEYA 257
                ++HRD+K SN+LL+     KI DFGLAR    D  +    T +  T  Y APE  
Sbjct: 148 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 204
Query: 258 IRGE-LSEKADIYSFGVLVLEIISCR 282
           +  +  ++  DI+S G ++ E++S R
Sbjct: 205 LNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G V       +   VA+KK+   + Q      L E++++   +H+N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 92
Query: 149 SDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF-------QIILGIARGLQYLHE 199
            +   R    E MK+  +  DL+   E+D +    T+          +  I RGL+Y+H 
Sbjct: 93  -NDIIRAPTIEQMKDVYIVQDLM---ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 148
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPEYA 257
                ++HRD+K SN+LL+     KI DFGLAR    D  +    T +  T  Y APE  
Sbjct: 149 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 205
Query: 258 IRGE-LSEKADIYSFGVLVLEIISCR 282
           +  +  ++  DI+S G ++ E++S R
Sbjct: 206 LNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G V       +   VA+KK+   + Q      L E++++   +H+N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 83
Query: 149 SDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF-------QIILGIARGLQYLHE 199
            +   R    E MK+  +  DL+   E+D +    T+          +  I RGL+Y+H 
Sbjct: 84  -NDIIRAPTIEQMKDVYIVQDLM---ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 139
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPEYA 257
                ++HRD+K SN+LL+     KI DFGLAR    D  +    T +  T  Y APE  
Sbjct: 140 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 196
Query: 258 IRGE-LSEKADIYSFGVLVLEIISCR 282
           +  +  ++  DI+S G ++ E++S R
Sbjct: 197 LNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G V       +   VA+KK+   + Q      L E++++   +H+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 149 SDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF-------QIILGIARGLQYLHE 199
            +   R    E MK+  +  DL+   E+D +    T+          +  I RGL+Y+H 
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLM---ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPEYA 257
                ++HRD+K SN+LL+     KI DFGLAR    D  +    T +  T  Y APE  
Sbjct: 147 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 258 IRGE-LSEKADIYSFGVLVLEIISCR 282
           +  +  ++  DI+S G ++ E++S R
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G V       +   VA+KK+   + Q      L E++++   +H+N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 84
Query: 149 SDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF-------QIILGIARGLQYLHE 199
            +   R    E MK+  +  DL+   E+D +    T+          +  I RGL+Y+H 
Sbjct: 85  -NDIIRAPTIEQMKDVYIVQDLM---ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPEYA 257
                ++HRD+K SN+LL+     KI DFGLAR    D  +    T +  T  Y APE  
Sbjct: 141 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 197
Query: 258 IRGE-LSEKADIYSFGVLVLEIISCR 282
           +  +  ++  DI+S G ++ E++S R
Sbjct: 198 LNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQ---QG-ESEFLS 128
           D  T      +F  G  LG+G FG VY  +      +   K+   KSQ   +G E +   
Sbjct: 14  DILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLF-KSQIEKEGVEHQLRR 72
Query: 129 EVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ--- 185
           E+ +   + H N++RL     D  +  L+ EY           GE  K L  S  F    
Sbjct: 73  EIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPR--------GELYKELQKSCTFDEQR 124
Query: 186 ---IILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS 242
              I+  +A  L Y H     +++HRDIK  N+LL  K + KI DFG +   P   +   
Sbjct: 125 TATIMEELADALMYCHG---KKVIHRDIKPENLLLGLKGELKIADFGWSVHAP---SLRR 178
Query: 243 TNFAGTLGYTAPEYAIRGEL-SEKADIYSFGVLVLEII 279
               GTL Y  PE  I G + +EK D++  GVL  E++
Sbjct: 179 KTMCGTLDYLPPE-MIEGRMHNEKVDLWCIGVLCYELL 215

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 25  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 82  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 138
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T    T  Y AP
Sbjct: 139 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGXVATRWYRAP 191
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 130/289 (44%), Gaps = 34/289 (11%)
Query: 75  QTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRM- 132
           Q  +    +  P   LGRG +G V + + +  G ++AVK++    + Q +   L ++ + 
Sbjct: 44  QNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS 103
Query: 133 ITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF--QIILGI 190
           + ++     V   G         +  E M + SLD       DK          +I + I
Sbjct: 104 MRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSI 162
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
            + L++LH  S   ++HRD+K SNVL++   Q K+ DFG++ +  +  A   T  AG   
Sbjct: 163 VKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVA--KTIDAGCKP 218
Query: 251 YTAPEYAIRGELSE-----KADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAW--KL 303
           Y APE  I  EL++     K+DI+S G+ ++E+   R              P  +W    
Sbjct: 219 YMAPE-RINPELNQKGYSVKSDIWSLGITMIELAILR-------------FPYDSWGTPF 264
Query: 304 YERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIV 352
            +  +++E   P++      ++ + + ++    CL+ +  +RP   E++
Sbjct: 265 QQLKQVVEEPSPQLP----ADKFSAEFVDFTSQCLKKNSKERPTYPELM 309

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 89  LLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +LG G FG V++ +     L    K+   +  + + E  +E+ ++  + H NL++L    
Sbjct: 96  ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
              +  +LV EY+    L   I  ES       T    +  I  G++++H+     I+H 
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT-ILFMKQICEGIRHMHQ---MYILHL 211
Query: 209 DIKASNVLL---DEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPEYAIRGELSE 264
           D+K  N+L    D K Q KI DFGLAR + P ++  L  NF GT  + APE      +S 
Sbjct: 212 DLKPENILCVNRDAK-QIKIIDFGLARRYKPREK--LKVNF-GTPEFLAPEVVNYDFVSF 267
Query: 265 KADIYSFGVLVLEIIS 280
             D++S GV+   ++S
Sbjct: 268 PTDMWSVGVIAYMLLS 283

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 92/191 (48%), Gaps = 9/191 (4%)
Query: 90  LGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G  G V   +    G  VAVK + + K Q+ E  F +EV ++   QH N+V +    
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF-NEVVIMRDYQHFNVVEMYKSY 111
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
             G +  ++ E+++  +L  ++   S   LN      +   + + L YLH      ++HR
Sbjct: 112 LVGEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLHAQG---VIHR 165
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           DIK+ ++LL    + K+ DFG      +D         GT  + APE   R   + + DI
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKXLVGTPYWMAPEVISRSLYATEVDI 224
Query: 269 YSFGVLVLEII 279
           +S G++V+E++
Sbjct: 225 WSLGIMVIEMV 235

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 29/208 (13%)
Query: 90  LGRGGFGPVYRGKLADGT-LVAVKKL----CVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           +G+G FG V   +  D   + A+K +    CV++++        E++++  ++H  LV L
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEV--RNVFKELQIMQGLEHPFLVNL 80
Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ------IILGIARGLQYLH 198
                D     +V        +DLL+ G+    L  +  F+       I  +   L YL 
Sbjct: 81  WYSFQDEEDMFMV--------VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ 132
Query: 199 EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE-YA 257
              + RI+HRD+K  N+LLDE     I DF +A   P +     T  AGT  Y APE ++
Sbjct: 133 ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI--TTMAGTKPYMAPEMFS 187
Query: 258 IR--GELSEKADIYSFGVLVLEIISCRK 283
            R     S   D +S GV   E++  R+
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 10/199 (5%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G V         T VA+KK+   + Q      L E++++   +H+N++ +    
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 149 SDGSQRLL--VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
              +   +  VY        DL    +S +  N    +  +  I RGL+Y+H      ++
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICY-FLYQILRGLKYIHS---ANVL 166
Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFF-PE-DQAYLSTNFAGTLGYTAPEYAIRGE-LS 263
           HRD+K SN+L++     KI DFGLAR   PE D     T    T  Y APE  +  +  +
Sbjct: 167 HRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYT 226
Query: 264 EKADIYSFGVLVLEIISCR 282
           +  DI+S G ++ E++S R
Sbjct: 227 KSIDIWSVGCILAEMLSNR 245

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/258 (27%), Positives = 127/258 (49%), Gaps = 36/258 (13%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNLVRLLGC 147
           +G+G FG V++ +    G  VA+KK+ ++  ++G     L E++++  ++H+N+V L+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 148 CSDGSQRL--------LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
           C   +           LV+++ ++  L  L+     KF   S   +++  +  GL Y+H 
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKF-TLSEIKRVMQMLLNGLYYIHR 143
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP---EDQAYLSTNFAGTLGYTAPEY 256
           +   +I+HRD+KA+NVL+      K+ DFGLAR F      Q     N   TL Y  PE 
Sbjct: 144 N---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPEL 200
Query: 257 AI-RGELSEKADIYSFGVLVLEIIS----CRKNTD---LTLPSEM--QYLPEY-----AW 301
            +   +     D++  G ++ E+ +     + NT+   L L S++     PE       +
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 260
Query: 302 KLYERGRILELVDPRMRK 319
           +LYE+   LELV  + RK
Sbjct: 261 ELYEK---LELVKGQKRK 275

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 25/205 (12%)
Query: 88  NLLGRGGFGPVYRGKLA----DGTLVAVKKLCVDKSQQGESEFLSEVR------MITSIQ 137
            +LG+G FG V+  +       G L A+K L     ++   +    VR      ++  + 
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVL-----KKATLKVRDRVRTKMERDILADVN 88
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYL 197
           H  +V+L        +  L+ ++++   L   +  E   F     +F +   +A GL +L
Sbjct: 89  HPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLA-ELALGLDHL 146
Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR--FFPEDQAYLSTNFAGTLGYTAPE 255
           H      I++RD+K  N+LLDE+   K+ DFGL++     E +AY   +F GT+ Y APE
Sbjct: 147 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAY---SFCGTVEYMAPE 200
Query: 256 YAIRGELSEKADIYSFGVLVLEIIS 280
              R   S  AD +S+GVL+ E+++
Sbjct: 201 VVNRQGHSHSADWWSYGVLMFEMLT 225

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G V       +   VA+KK+   + Q      L E++++   +H+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 149 SDGSQRLLVYEYMKNRSL--DLLIYGESDKF-------LNWSTRFQIILGIARGLQYLHE 199
            +   R    E MK+  +  DL+   E+D +       L+       +  I RGL+Y+H 
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLM---ETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHS 146
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPEYA 257
                ++HRD+K SN+LL+     KI DFGLAR    D  +    T +  T  Y APE  
Sbjct: 147 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 258 IRGE-LSEKADIYSFGVLVLEIISCR 282
           +  +  ++  DI+S G ++ E++S R
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 48  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 105 NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 161
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++       +  T  Y AP
Sbjct: 162 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----XGYVATRWYRAP 214
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 24/204 (11%)
Query: 90  LGRGGFGPV---YRGKLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLL 145
           +G G +G V   Y  +L     VAVKKL    +S         E+R++  ++H+N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 146 GCCS------DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
              +      D S+  LV   M     DL    +S    +   +F ++  + RGL+Y+H 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLM---GADLNNIVKSQALSDEHVQF-LVYQLLRGLKYIHS 149
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
                I+HRD+K SNV ++E  + +I DFGLAR   E+     T +  T  Y APE  + 
Sbjct: 150 AG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEM----TGYVATRWYRAPEIMLN 202
Query: 260 G-ELSEKADIYSFGVLVLEIISCR 282
               ++  DI+S G ++ E++  +
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G V       +   VA++K+   + Q      L E++++   +H+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 149 SDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF-------QIILGIARGLQYLHE 199
            +   R    E MK+  +  DL+   E+D +    T+          +  I RGL+Y+H 
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLM---ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPEYA 257
                ++HRD+K SN+LL+     KI DFGLAR    D  +    T +  T  Y APE  
Sbjct: 147 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 258 IRGE-LSEKADIYSFGVLVLEIISCR 282
           +  +  ++  DI+S G ++ E++S R
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNLVRLLGC 147
           +G+G FG V++ +    G  VA+KK+ ++  ++G     L E++++  ++H+N+V L+  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 148 CSDGSQRL--------LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
           C   +           LV+++ ++  L  L+     KF   S   +++  +  GL Y+H 
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKF-TLSEIKRVMQMLLNGLYYIHR 142
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP---EDQAYLSTNFAGTLGYTAPEY 256
           +   +I+HRD+KA+NVL+      K+ DFGLAR F      Q     N   TL Y  PE 
Sbjct: 143 N---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPEL 199
Query: 257 AI-RGELSEKADIYSFGVLVLEI 278
            +   +     D++  G ++ E+
Sbjct: 200 LLGERDYGPPIDLWGAGCIMAEM 222

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 131/288 (45%), Gaps = 34/288 (11%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRM-I 133
           +++    +  P   LGRG +G V + + +  G ++AVK++    + Q +   L ++ + +
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 134 TSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF--QIILGIA 191
            ++     V   G         +  E M + SLD       DK          +I + I 
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY 251
           + L++LH  S   ++HRD+K SNVL++   Q K+ DFG++ +  +D A      AG   Y
Sbjct: 120 KALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA--KDIDAGCKPY 175
Query: 252 TAPEYAIRGELSE-----KADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAW--KLY 304
            APE  I  EL++     K+DI+S G+ ++E+   R              P  +W     
Sbjct: 176 MAPE-RINPELNQKGYSVKSDIWSLGITMIELAILR-------------FPYDSWGTPFQ 221
Query: 305 ERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIV 352
           +  +++E   P++      ++ + + ++    CL+ +  +RP   E++
Sbjct: 222 QLKQVVEEPSPQLP----ADKFSAEFVDFTSQCLKKNSKERPTYPELM 265

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNLVRLLGC 147
           +G+G FG V++ +    G  VA+KK+ ++  ++G     L E++++  ++H+N+V L+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 148 CSDGSQRL--------LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
           C   +           LV+++ ++  L  L+     KF   S   +++  +  GL Y+H 
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKF-TLSEIKRVMQMLLNGLYYIHR 143
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP---EDQAYLSTNFAGTLGYTAPEY 256
           +   +I+HRD+KA+NVL+      K+ DFGLAR F      Q     N   TL Y  PE 
Sbjct: 144 N---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPEL 200
Query: 257 AI-RGELSEKADIYSFGVLVLEI 278
            +   +     D++  G ++ E+
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEM 223

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G FG     K   DG    +K++ + + S +   E   EV ++ +++H N+V+    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGES------DKFLNWSTRFQIILGIARGLQYLHEDS 201
             +     +V +Y +   L   I  +       D+ L+W       + I   L+++H+  
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLALKHVHD-- 143
Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
             +I+HRDIK+ N+ L +    ++GDFG+AR        L+    GT  Y +PE      
Sbjct: 144 -RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACIGTPYYLSPEICENKP 201
Query: 262 LSEKADIYSFGVLVLEIISCR 282
            + K+DI++ G ++ E+ + +
Sbjct: 202 YNNKSDIWALGCVLYELCTLK 222

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNLVRLLGC 147
           +G+G FG V++ +    G  VA+KK+ ++  ++G     L E++++  ++H+N+V L+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 148 CSDGSQRL--------LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
           C   +           LV+++ ++  L  L+     KF   S   +++  +  GL Y+H 
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKF-TLSEIKRVMQMLLNGLYYIHR 143
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP---EDQAYLSTNFAGTLGYTAPEY 256
           +   +I+HRD+KA+NVL+      K+ DFGLAR F      Q     N   TL Y  PE 
Sbjct: 144 N---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPEL 200
Query: 257 AI-RGELSEKADIYSFGVLVLEI 278
            +   +     D++  G ++ E+
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 25  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 82  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 138
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI D GLAR   ++     T +  T  Y AP
Sbjct: 139 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEM----TGYVATRWYRAP 191
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 25  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 82  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 138
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI  FGLAR   ++     T +  T  Y AP
Sbjct: 139 KYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEM----TGYVATRWYRAP 191
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 88/194 (45%), Gaps = 9/194 (4%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEF-LSEVRMITSIQHKNLVRLLGC 147
           +G G +G V++ +  D G +VA+KK    +      +  L E+RM+  ++H NLV LL  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVH 207
                +  LV+EY      D  +  E D++        +     + LQ ++       +H
Sbjct: 71  FRRKRRLHLVFEYC-----DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIH 125
Query: 208 RDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI-RGELSEKA 266
           RD+K  N+L+ +    K+ DFG AR       Y     A T  Y +PE  +   +     
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDTQYGPPV 184
Query: 267 DIYSFGVLVLEIIS 280
           D+++ G +  E++S
Sbjct: 185 DVWAIGCVFAELLS 198

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G +G V        G  VAVKKL    +S         E+R++  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 148 CSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            +    R L     VY        DL    +  K  +   +F +I  I RGL+Y+H    
Sbjct: 90  FTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS--- 143
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-E 261
             I+HRD+K SN+ ++E  + KI DF LAR   ++     T +  T  Y APE  +    
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEM----TGYVATRWYRAPEIMLNWMH 199
Query: 262 LSEKADIYSFGVLVLEIISCR 282
            ++  DI+S G ++ E+++ R
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 25  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 82  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 138
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI D GLAR   ++     T +  T  Y AP
Sbjct: 139 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEM----TGYVATRWYRAP 191
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 99/221 (44%), Gaps = 32/221 (14%)
Query: 71  YFD-FQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGT------LVAVKKLCVDKSQQGE 123
           YF    T  + T ++     LG+G F  V R      T      ++  KKL     Q+ E
Sbjct: 19  YFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLE 78
Query: 124 SEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL--DLLI---YGESDKFL 178
            E     R+   ++H N+VRL    S+     LV++ +    L  D++    Y E+D   
Sbjct: 79  RE----ARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS- 133
Query: 179 NWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS---KIGDFGLA-RFF 234
                   I  I   + ++H+     IVHRD+K  N+LL  K +    K+ DFGLA    
Sbjct: 134 ------HCIHQILESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ 184
Query: 235 PEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLV 275
            E QA+    FAGT GY +PE   +    +  DI++ GV++
Sbjct: 185 GEQQAWF--GFAGTPGYLSPEVLRKDPYGKPVDIWACGVIL 223

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQH 138
           K F     LG G F  V   +  A G L AVK  C+ K   +  ES   +E+ ++  I+H
Sbjct: 22  KIFEFKETLGTGAFSEVVLAEEKATGKLFAVK--CIPKKALKGKESSIENEIAVLRKIKH 79
Query: 139 KNLVRLLGCCSDGSQRLLVYEYMK-----NRSLDLLIYGESDKFLNWSTRFQIILGIARG 193
           +N+V L       +   LV + +      +R ++   Y E D     ST  + +L     
Sbjct: 80  ENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDA----STLIRQVLD---A 132
Query: 194 LQYLHEDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
           + YLH      IVHRD+K  N+L    DE+ +  I DFGL++   E +  + +   GT G
Sbjct: 133 VYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKGDVMSTACGTPG 187
Query: 251 YTAPEYAIRGELSEKADIYSFGVLVLEIISC 281
           Y APE   +   S+  D +S GV+   I+ C
Sbjct: 188 YVAPEVLAQKPYSKAVDCWSIGVIAY-ILLC 217

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 87  GNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGE--SEFLSEVRMITSIQHKNLVR 143
           G +LG GG   V+  + L     VAVK L  D ++       F  E +   ++ H  +V 
Sbjct: 17  GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 144 LLGC----CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
           +          G    +V EY+   +L  +++ E    +      ++I    + L + H+
Sbjct: 77  VYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ 134
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA--GTLGYTAPEYA 257
           +    I+HRD+K +N+++      K+ DFG+AR   +    ++   A  GT  Y +PE A
Sbjct: 135 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 258 IRGELSEKADIYSFGVLVLEIIS 280
               +  ++D+YS G ++ E+++
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLT 214

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHK 139
           +N  P   +G G +G V        G  VAVKKL    +S         E+R++  ++H+
Sbjct: 25  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 140 NLVRLLGCCSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
           N++ LL   +    R L     VY        DL    +  K  +   +F +I  I RGL
Sbjct: 82  NVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 138
Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y+H      I+HRD+K SN+ ++E  + KI D GLAR   ++     T +  T  Y AP
Sbjct: 139 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEM----TGYVATRWYRAP 191
Query: 255 EYAIRG-ELSEKADIYSFGVLVLEIISCR 282
           E  +     ++  DI+S G ++ E+++ R
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 24/201 (11%)
Query: 90  LGRGGFGPV---YRGKLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLL 145
           +G G +G V   Y  +L     VAVKKL    +S         E+R++  ++H+N++ LL
Sbjct: 28  VGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 146 GCCS------DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
              +      D S+  LV   M     DL    +     +   +F ++  + RGL+Y+H 
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLM---GADLNNIVKCQALSDEHVQF-LVYQLLRGLKYIHS 141
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
                I+HRD+K SNV ++E  + +I DFGLAR   E+     T +  T  Y APE  + 
Sbjct: 142 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEM----TGYVATRWYRAPEIMLN 194
Query: 260 G-ELSEKADIYSFGVLVLEII 279
               ++  DI+S G ++ E++
Sbjct: 195 WMHYNQTVDIWSVGCIMAELL 215

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 113/250 (45%), Gaps = 23/250 (9%)
Query: 87  GNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVR 143
           G+ LG G FG V  G+    G  VAVK L   K  S     +   E++ +   +H ++++
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 144 LLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
           L    S  +   +V EY+    L D +      + +     FQ IL     + Y H    
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS---AVDYCHRHM- 131
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
             +VHRD+K  NVLLD    +KI DFGL+     D  +L  +  G+  Y APE  I G L
Sbjct: 132 --VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRDS-CGSPNYAAPE-VISGRL 186
Query: 263 --SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE 320
               + DI+S GV++  ++        TLP + +++P    K+  RG +  + +   R  
Sbjct: 187 YAGPEVDIWSCGVILYALLCG------TLPFDDEHVPTLFKKI--RGGVFYIPEYLNRSV 238
Query: 321 GIVERDALQV 330
             +    LQV
Sbjct: 239 ATLLMHMLQV 248

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 14/202 (6%)
Query: 89  LLGRGGFGPVYRG-KLADGTLVAVKKLCVDK--SQQGES--EFLSEVRMITSIQHKNLVR 143
           ++G+G F  V R      G   AVK + V K  S  G S  +   E  +   ++H ++V 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF--QIILGIARGLQYLHEDS 201
           LL   S      +V+E+M    L   I   +D    +S       +  I   L+Y H+++
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 150
Query: 202 HTRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI 258
              I+HRD+K  NVLL  K  S   K+GDFG+A    E    ++    GT  + APE   
Sbjct: 151 ---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGE-SGLVAGGRVGTPHFMAPEVVK 206
Query: 259 RGELSEKADIYSFGVLVLEIIS 280
           R    +  D++  GV++  ++S
Sbjct: 207 REPYGKPVDVWGCGVILFILLS 228

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 95/194 (48%), Gaps = 8/194 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLC-VDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G  G V + +     L+  +KL  ++      ++ + E++++       +V   G  
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 83
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
               +  +  E+M   SLD ++  +  K +      ++ + + RGL YL E    +I+HR
Sbjct: 84  YSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHR 139
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+K SN+L++ + + K+ DFG++    +  A    +F GT  Y APE       S ++DI
Sbjct: 140 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMAPERLQGTHYSVQSDI 196
Query: 269 YSFGVLVLEIISCR 282
           +S G+ ++E+   R
Sbjct: 197 WSMGLSLVELAVGR 210

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G +G V        G  VAVKKL    +S         E+R++  ++H+N++ LL  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 148 CSDGSQRLL-----VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            +    R L     VY        DL    +  K  +   +F +I  I RGL+Y+H    
Sbjct: 110 FTPA--RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS--- 163
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-E 261
             I+HRD+K SN+ ++E  + KI DFGLAR   ++          T  Y APE  +    
Sbjct: 164 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----XGXVATRWYRAPEIMLNWMH 219
Query: 262 LSEKADIYSFGVLVLEIISCR 282
            ++  DI+S G ++ E+++ R
Sbjct: 220 YNQTVDIWSVGCIMAELLTGR 240

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 24/204 (11%)
Query: 90  LGRGGFGPV---YRGKLADGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLL 145
           +G G +G V   Y  +L     VAVKKL    +S         E+R++  ++H+N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 146 GCCS------DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
              +      D S+  LV   M     DL    +     +   +F ++  + RGL+Y+H 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLM---GADLNNIVKCQALSDEHVQF-LVYQLLRGLKYIHS 149
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
                I+HRD+K SNV ++E  + +I DFGLAR   E+     T +  T  Y APE  + 
Sbjct: 150 AG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEM----TGYVATRWYRAPEIMLN 202
Query: 260 G-ELSEKADIYSFGVLVLEIISCR 282
               ++  DI+S G ++ E++  +
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 21  TVLKRYQNLKP---IGSGAQGIVVAA--YDAILERNVAIKKLSRPFQNQTHAKRAYRELV 75
Query: 132 MITSIQHKNLVRLLGCCS-----DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQI 186
           ++  + HKN++ LL   +     +  Q + +   + + +L  +I  E D        +Q+
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA 246
           ++GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T + 
Sbjct: 136 LVGI----KHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYV 186
Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
            T  Y APE  +     E  DI+S GV++ E+I
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGVIMGEMI 219

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 87  GNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGE--SEFLSEVRMITSIQHKNLVR 143
           G +LG GG   V+  + L     VAVK L  D ++       F  E +   ++ H  +V 
Sbjct: 17  GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 144 LLGC----CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
           +          G    +V EY+   +L  +++ E    +      ++I    + L + H+
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ 134
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA--GTLGYTAPEYA 257
           +    I+HRD+K +N+++      K+ DFG+AR   +    ++   A  GT  Y +PE A
Sbjct: 135 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 258 IRGELSEKADIYSFGVLVLEIIS 280
               +  ++D+YS G ++ E+++
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLT 214

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 31/201 (15%)
Query: 90  LGRGGFGPVYR------GKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LG+G F  V R      G+     ++  KKL     Q+ E E     R+   ++H N+VR
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLERE----ARICRLLKHPNIVR 85
Query: 144 LLGCCSDGSQRLLVYEYMKNRSL--DLLI---YGESDKFLNWSTRFQIILGIARGLQYLH 198
           L    S+     L+++ +    L  D++    Y E+D           I  I   + + H
Sbjct: 86  LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILEAVLHCH 138
Query: 199 EDSHTRIVHRDIKASNVLLDEKFQS---KIGDFGLA-RFFPEDQAYLSTNFAGTLGYTAP 254
           +     +VHRD+K  N+LL  K +    K+ DFGLA     E QA+    FAGT GY +P
Sbjct: 139 Q---MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF--GFAGTPGYLSP 193
Query: 255 EYAIRGELSEKADIYSFGVLV 275
           E   +    +  D+++ GV++
Sbjct: 194 EVLRKDPYGKPVDLWACGVIL 214

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 31/215 (14%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYR------GKLADGTLVAVKKLCVDKSQQGESEFLSE 129
           T  + T+ +     LG+G F  V R      G+     ++  KKL     Q+ E E    
Sbjct: 5   TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE---- 60
Query: 130 VRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL--DLLI---YGESDKFLNWSTRF 184
            R+   ++H N+VRL    S+     L+++ +    L  D++    Y E+D         
Sbjct: 61  ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS------- 113
Query: 185 QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS---KIGDFGLA-RFFPEDQAY 240
             I  I   + + H+     +VHR++K  N+LL  K +    K+ DFGLA     E QA+
Sbjct: 114 HCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170
Query: 241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLV 275
               FAGT GY +PE   +    +  D+++ GV++
Sbjct: 171 F--GFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 21  TVLKRYQNLKP---IGSGAQGIVCAA--YDAILERNVAIKKLSRPFQNQTHAKRAYRELV 75
Query: 132 MITSIQHKNLVRLLGCCS-----DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQI 186
           ++  + HKN++ LL   +     +  Q + +   + + +L  +I  E D        +Q+
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA 246
           ++GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T + 
Sbjct: 136 LVGI----KHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYV 186
Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
            T  Y APE  +     E  DI+S GV++ E+I
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGVIMGEMI 219

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 87  GNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGE--SEFLSEVRMITSIQHKNLVR 143
           G +LG GG   V+  + L     VAVK L  D ++       F  E +   ++ H  +V 
Sbjct: 34  GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 93
Query: 144 LLGC----CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
           +          G    +V EY+   +L  +++ E    +      ++I    + L + H+
Sbjct: 94  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ 151
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA--GTLGYTAPEYA 257
           +    I+HRD+K +N+++      K+ DFG+AR   +    ++   A  GT  Y +PE A
Sbjct: 152 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 208
Query: 258 IRGELSEKADIYSFGVLVLEIIS 280
               +  ++D+YS G ++ E+++
Sbjct: 209 RGDSVDARSDVYSLGCVLYEVLT 231

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G V       +   VA+KK+   + Q      L E++++   +H+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 149 SDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF-------QIILGIARGLQYLHE 199
            +   R    E MK+  +  DL+   E+D +    T+          +  I RGL+Y+H 
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLM---ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPEYA 257
                ++HRD+K SN+LL+     KI DFGLAR    D  +         T  Y APE  
Sbjct: 147 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM 203
Query: 258 IRGE-LSEKADIYSFGVLVLEIISCR 282
           +  +  ++  DI+S G ++ E++S R
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G +G V       +   VA+KK+   + Q      L E++++   +H+N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 91
Query: 149 SDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF-------QIILGIARGLQYLHE 199
            +   R    E MK+  +  DL+   E+D +    T+          +  I RGL+Y+H 
Sbjct: 92  -NDIIRAPTIEQMKDVYIVQDLM---ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPEYA 257
                ++HRD+K SN+LL+     KI DFGLAR    D  +         T  Y APE  
Sbjct: 148 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM 204
Query: 258 IRGE-LSEKADIYSFGVLVLEIISCR 282
           +  +  ++  DI+S G ++ E++S R
Sbjct: 205 LNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 23/197 (11%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G+G F  V R  KL  G   A K +   K S +   +   E R+   ++H N+VRL   
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 148 CSDGSQRLLVYEYMKNRSL--DLLI---YGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            S+     LV++ +    L  D++    Y E+D           I  I   + + H+   
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILEAVLHCHQ--- 121
Query: 203 TRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQ-AYLSTNFAGTLGYTAPEYAI 258
             +VHRD+K  N+LL  K +    K+ DFGLA     DQ A+    FAGT GY +PE   
Sbjct: 122 MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWF--GFAGTPGYLSPEVLR 179
Query: 259 RGELSEKADIYSFGVLV 275
           +    +  DI++ GV++
Sbjct: 180 KEAYGKPVDIWACGVIL 196

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 23/197 (11%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           LG+G F  V R  K+  G   A K +   K S +   +   E R+   ++H N+VRL   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 148 CSDGSQRLLVYEYMKNRSL--DLLI---YGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            S+     LV++ +    L  D++    Y E+D           I  I   + + H +  
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILESVNHCHLNG- 123
Query: 203 TRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQ-AYLSTNFAGTLGYTAPEYAI 258
             IVHRD+K  N+LL  K +    K+ DFGLA     DQ A+    FAGT GY +PE   
Sbjct: 124 --IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWF--GFAGTPGYLSPEVLR 179
Query: 259 RGELSEKADIYSFGVLV 275
           +    +  D+++ GV++
Sbjct: 180 KDPYGKPVDMWACGVIL 196

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 78  KKATKNFHPGNLLGRGGFGPVYRGKLADG-------TLVAVKKLCVDKSQQGESEFLSEV 130
           K   +NF    +LG G +G V+  +   G        +  +KK  + +  +      +E 
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 131 RMITSI-QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF----- 184
           +++  I Q   LV L       ++  L+ +Y+          GE    L+   RF     
Sbjct: 110 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYING--------GELFTHLSQRERFTEHEV 161
Query: 185 QIILG-IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST 243
           QI +G I   L++LH+     I++RDIK  N+LLD      + DFGL++ F  D+   + 
Sbjct: 162 QIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 218
Query: 244 NFAGTLGYTAPEYAIRGELS---EKADIYSFGVLVLEIIS 280
           +F GT+ Y AP+  +RG  S   +  D +S GVL+ E+++
Sbjct: 219 DFCGTIEYMAPD-IVRGGDSGHDKAVDWWSLGVLMYELLT 257

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 89  LLGRGGFGPVYRGK-LADGTLVAVK----KLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LLG+G FG V   K  A G   A+K    ++ V K +   +  L+E R++ + +H  L  
Sbjct: 158 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--LTENRVLQNSRHPFLTA 215
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
           L        +   V EY     L   +  E   F     RF     I   L YLH  S  
Sbjct: 216 LKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARF-YGAEIVSALDYLH--SEK 271
Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELS 263
            +V+RD+K  N++LD+    KI DFGL +   +D A + T F GT  Y APE     +  
Sbjct: 272 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYG 330
Query: 264 EKADIYSFGVLVLEIISCR 282
              D +  GV++ E++  R
Sbjct: 331 RAVDWWGLGVVMYEMMCGR 349

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 108/229 (47%), Gaps = 38/229 (16%)
Query: 90  LGRGGFGP-VYRGKLADGTLVAVKKLCVDKSQQGES-EFLS---------------EVRM 132
           + +   GP + R  L +G+   VK     K+QQ  + +F+S               E+  
Sbjct: 3   ISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISY 62
Query: 133 ITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR--FQIILGI 190
           +  ++H ++++L    +  +  ++V EY      D ++  E  +      R  FQ I+  
Sbjct: 63  LKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIV--EKKRMTEDEGRRFFQQIIC- 119
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
              ++Y H     +IVHRD+K  N+LLD+    KI DFGL+     D  +L T+  G+  
Sbjct: 120 --AIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTS-CGSPN 172
Query: 251 YTAPEYAIRGEL--SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLP 297
           Y APE  I G+L    + D++S G+++  ++  R      LP + +++P
Sbjct: 173 YAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGR------LPFDDEFIP 214

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 23/197 (11%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           LG+G F  V R  K+  G   A K +   K S +   +   E R+   ++H N+VRL   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 148 CSDGSQRLLVYEYMKNRSL--DLLI---YGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            S+     LV++ +    L  D++    Y E+D           I  I   + + H +  
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILESVNHCHLNG- 123
Query: 203 TRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQ-AYLSTNFAGTLGYTAPEYAI 258
             IVHRD+K  N+LL  K +    K+ DFGLA     DQ A+    FAGT GY +PE   
Sbjct: 124 --IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWF--GFAGTPGYLSPEVLR 179
Query: 259 RGELSEKADIYSFGVLV 275
           +    +  D+++ GV++
Sbjct: 180 KDPYGKPVDMWACGVIL 196

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 124/305 (40%), Gaps = 45/305 (14%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKL--CVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           +GRG +G V +      G ++AVK++   VD+ +Q +     +V M +S     +V+  G
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS-DCPYIVQFYG 88
Query: 147 CCSDGSQRLLVYEYMKNRSLDLL---IYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
                    +  E M   S D     +Y   D  +      +I L   + L +L E  + 
Sbjct: 89  ALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NL 145
Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE----YAIR 259
           +I+HRDIK SN+LLD     K+ DFG++    +  A   T  AG   Y APE     A R
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPSASR 203
Query: 260 GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWK-LYERGRILELVDPRMR 318
                ++D++S G+ + E+ + R              P   W  ++++   +   DP   
Sbjct: 204 QGYDVRSDVWSLGITLYELATGR-------------FPYPKWNSVFDQLTQVVKGDPPQL 250
Query: 319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEI---------------VAMLTCKVESGI 363
                   +   IN   +CL    ++RP   E+               VA   CK+   +
Sbjct: 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQM 310
Query: 364 PVRPA 368
           P  P+
Sbjct: 311 PATPS 315

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 89  LLGRGGFGPVYRGK-LADGTLVAVK----KLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LLG+G FG V   K  A G   A+K    ++ V K +   +  L+E R++ + +H  L  
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--LTENRVLQNSRHPFLTA 212
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
           L        +   V EY     L   +  E   F     RF     I   L YLH  S  
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARF-YGAEIVSALDYLH--SEK 268
Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELS 263
            +V+RD+K  N++LD+    KI DFGL +   +D A + T F GT  Y APE     +  
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYG 327
Query: 264 EKADIYSFGVLVLEIISCR 282
              D +  GV++ E++  R
Sbjct: 328 RAVDWWGLGVVMYEMMCGR 346

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 26/225 (11%)
Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVR 131
           D+   K+  + + P +++GRG    V R    A G   AVK + V  +++   E L EVR
Sbjct: 85  DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEV-TAERLSPEQLEEVR 143
Query: 132 MITSIQ---------HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWST 182
             T  +         H +++ L+      S   LV++ M  R  +L  Y      L+   
Sbjct: 144 EATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLM--RKGELFDYLTEKVALSEKE 201
Query: 183 RFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS 242
              I+  +   + +LH ++   IVHRD+K  N+LLD+  Q ++ DFG +      +    
Sbjct: 202 TRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL-- 256
Query: 243 TNFAGTLGYTAPEYAIRGELSE-------KADIYSFGVLVLEIIS 280
               GT GY APE  ++  + E       + D+++ GV++  +++
Sbjct: 257 RELCGTPGYLAPEI-LKCSMDETHPGYGKEVDLWACGVILFTLLA 300

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 94/194 (48%), Gaps = 8/194 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLC-VDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G  G V++       LV  +KL  ++      ++ + E++++       +V   G  
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 135
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
               +  +  E+M   SLD ++  +    +      ++ + + +GL YL E    +I+HR
Sbjct: 136 YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 191
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+K SN+L++ + + K+ DFG++    +  A    +F GT  Y +PE       S ++DI
Sbjct: 192 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHYSVQSDI 248
Query: 269 YSFGVLVLEIISCR 282
           +S G+ ++E+   R
Sbjct: 249 WSMGLSLVEMAVGR 262

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 94/194 (48%), Gaps = 8/194 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLC-VDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G  G V++       LV  +KL  ++      ++ + E++++       +V   G  
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
               +  +  E+M   SLD ++  +    +      ++ + + +GL YL E    +I+HR
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 129
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+K SN+L++ + + K+ DFG++    +  A    +F GT  Y +PE       S ++DI
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHYSVQSDI 186
Query: 269 YSFGVLVLEIISCR 282
           +S G+ ++E+   R
Sbjct: 187 WSMGLSLVEMAVGR 200

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 89/194 (45%), Gaps = 10/194 (5%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           LG G FG V+R        V V K         +    +E+ ++  + H  L+ L     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD 209
           D  + +L+ E++    L   I  E  K ++ +     +     GL+++HE S   IVH D
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHEHS---IVHLD 174
Query: 210 IKASNVLLDEKFQS--KIGDFGLA-RFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKA 266
           IK  N++ + K  S  KI DFGLA +  P++   ++T    T  + APE   R  +    
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVGFYT 231
Query: 267 DIYSFGVLVLEIIS 280
           D+++ GVL   ++S
Sbjct: 232 DMWAIGVLGYVLLS 245

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 94/194 (48%), Gaps = 8/194 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLC-VDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G  G V++       LV  +KL  ++      ++ + E++++       +V   G  
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 76
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
               +  +  E+M   SLD ++  +    +      ++ + + +GL YL E    +I+HR
Sbjct: 77  YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 132
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+K SN+L++ + + K+ DFG++    ++ A     F GT  Y +PE       S ++DI
Sbjct: 133 DVKPSNILVNSRGEIKLCDFGVSGQLIDEMA---NEFVGTRSYMSPERLQGTHYSVQSDI 189
Query: 269 YSFGVLVLEIISCR 282
           +S G+ ++E+   R
Sbjct: 190 WSMGLSLVEMAVGR 203

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 85/176 (48%), Gaps = 16/176 (9%)
Query: 110 AVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDL 168
           AVK   +DKS++  SE   E+ ++    QH N++ L     DG    LV E M  R  +L
Sbjct: 56  AVK--VIDKSKRDPSE---EIEILLRYGQHPNIITLKDVYDDGKHVYLVTELM--RGGEL 108
Query: 169 LIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVL-LDEKFQS---K 224
           L      KF +      ++  I + ++YLH      +VHRD+K SN+L +DE       +
Sbjct: 109 LDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLR 165
Query: 225 IGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           I DFG A+    +   L T    T  + APE   R    E  DI+S G+L+  +++
Sbjct: 166 ICDFGFAKQLRAENGLLMTP-CYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLA 220

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 123/280 (43%), Gaps = 34/280 (12%)
Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRM-ITSIQHKN 140
           +  P   LGRG +G V + + +  G + AVK++    + Q +   L ++ +   ++    
Sbjct: 35  DLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPF 94
Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF--QIILGIARGLQYLH 198
            V   G         +  E + + SLD       DK          +I + I + L++LH
Sbjct: 95  TVTFYGALFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 153
Query: 199 EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI 258
             S   ++HRD+K SNVL++   Q K  DFG++ +  +D A      AG   Y APE  I
Sbjct: 154 --SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVA--KDIDAGCKPYXAPE-RI 208
Query: 259 RGELSE-----KADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAW--KLYERGRILE 311
             EL++     K+DI+S G+  +E+   R              P  +W     +  +++E
Sbjct: 209 NPELNQKGYSVKSDIWSLGITXIELAILR-------------FPYDSWGTPFQQLKQVVE 255
Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEI 351
              P++      ++ + + ++    CL+ +  +RP   E+
Sbjct: 256 EPSPQLP----ADKFSAEFVDFTSQCLKKNSKERPTYPEL 291

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI--QHKNLVRLLGC 147
           +G+G +G V+RG L  G  VAVK      S + E  +  E  +  ++  +H N++  +  
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIF----SSRDEQSWFRETEIYNTVLLRHDNILGFIAS 70
Query: 148 C----SDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHED-- 200
                +  +Q  L+  Y ++ SL D L     +  L      ++ +  A GL +LH +  
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLA----LRLAVSAACGLAHLHVEIF 126
Query: 201 ---SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF---AGTLGYTAP 254
                  I HRD K+ NVL+    Q  I D GLA    +   YL        GT  Y AP
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAP 186
Query: 255 EY---AIRGELSEK---ADIYSFGVLVLEI 278
           E     IR +  E     DI++FG+++ EI
Sbjct: 187 EVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 15/211 (7%)
Query: 78  KKATKNFHPGNLLGRGGFGPV--YRGKLADGTLVAVK----KLCVDKSQQGESEFLSEVR 131
           K    +F    LLG+G FG V   R K A G   A+K    ++ + K +   +  ++E R
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHT--VTESR 60
Query: 132 MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIA 191
           ++ + +H  L  L        +   V EY     L   +  E   F     RF     I 
Sbjct: 61  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGA-EIV 118
Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY 251
             L+YLH      +V+RDIK  N++LD+    KI DFGL +    D A + T F GT  Y
Sbjct: 119 SALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEY 174
Query: 252 TAPEYAIRGELSEKADIYSFGVLVLEIISCR 282
            APE     +     D +  GV++ E++  R
Sbjct: 175 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 25/215 (11%)
Query: 81  TKNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHK 139
           + +F   +LLG G +G V        G +VA+KK+            L E++++   +H+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 140 NLVRLLGCCSDGS----QRLLVYEYMKNRSLDLLIYGE--SDKFLNWSTRFQIILGIARG 193
           N++ +       S      + + + +    L  +I  +  SD  + +      I    R 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-----FIYQTLRA 124
Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS---------TN 244
           ++ LH    + ++HRD+K SN+L++     K+ DFGLAR   E  A  S         T 
Sbjct: 125 VKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 245 FAGTLGYTAPEYAI-RGELSEKADIYSFGVLVLEI 278
           +  T  Y APE  +   + S   D++S G ++ E+
Sbjct: 182 YVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 94/194 (48%), Gaps = 8/194 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLC-VDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G  G V++       LV  +KL  ++      ++ + E++++       +V   G  
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
               +  +  E+M   SLD ++  +    +      ++ + + +GL YL E    +I+HR
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 129
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+K SN+L++ + + K+ DFG++    +  A    +F GT  Y +PE       S ++DI
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHYSVQSDI 186
Query: 269 YSFGVLVLEIISCR 282
           +S G+ ++E+   R
Sbjct: 187 WSMGLSLVEMAVGR 200

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 15/211 (7%)
Query: 78  KKATKNFHPGNLLGRGGFGPV--YRGKLADGTLVAVK----KLCVDKSQQGESEFLSEVR 131
           K    +F    LLG+G FG V   R K A G   A+K    ++ + K +   +  ++E R
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHT--VTESR 57
Query: 132 MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIA 191
           ++ + +H  L  L        +   V EY     L   +  E   F     RF     I 
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGA-EIV 115
Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY 251
             L+YLH      +V+RDIK  N++LD+    KI DFGL +    D A + T F GT  Y
Sbjct: 116 SALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEY 171
Query: 252 TAPEYAIRGELSEKADIYSFGVLVLEIISCR 282
            APE     +     D +  GV++ E++  R
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-T 248
           +A+G+++L   +  + +HRD+ A N+LL EK   KI DFGLAR   +D  Y+    A   
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           L + APE       + ++D++SFGVL+ EI S
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 94/194 (48%), Gaps = 8/194 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLC-VDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G  G V++       LV  +KL  ++      ++ + E++++       +V   G  
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
               +  +  E+M   SLD ++  +    +      ++ + + +GL YL E    +I+HR
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 129
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+K SN+L++ + + K+ DFG++    +  A    +F GT  Y +PE       S ++DI
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHYSVQSDI 186
Query: 269 YSFGVLVLEIISCR 282
           +S G+ ++E+   R
Sbjct: 187 WSMGLSLVEMAVGR 200

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 21  TVLKRYQNLKP---IGSGAQGIVCAA--YDAILERNVAIKKLSRPFQNQTHAKRAYRELV 75
Query: 132 MITSIQHKNLVRLLGCCS-----DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQI 186
           ++  + HKN++ LL   +     +  Q + +   + + +L  +I  E D        +Q+
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA 246
           ++GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T + 
Sbjct: 136 LVGI----KHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYV 186
Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
            T  Y APE  +     E  DI+S G ++ E+I
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 15/211 (7%)
Query: 78  KKATKNFHPGNLLGRGGFGPV--YRGKLADGTLVAVK----KLCVDKSQQGESEFLSEVR 131
           K    +F    LLG+G FG V   R K A G   A+K    ++ + K +   +  ++E R
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHT--VTESR 57
Query: 132 MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIA 191
           ++ + +H  L  L        +   V EY     L   +  E   F     RF     I 
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGA-EIV 115
Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY 251
             L+YLH      +V+RDIK  N++LD+    KI DFGL +    D A + T F GT  Y
Sbjct: 116 SALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEY 171
Query: 252 TAPEYAIRGELSEKADIYSFGVLVLEIISCR 282
            APE     +     D +  GV++ E++  R
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 21  TVLKRYQNLKP---IGSGAQGIVCAA--YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 75
Query: 132 MITSIQHKNLVRLLGCCS------DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ 185
           ++  + HKN++ LL   +      +     LV E M + +L  +I  E D        +Q
Sbjct: 76  LMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYLLYQ 134
Query: 186 IILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF 245
           ++ GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T +
Sbjct: 135 MLXGI----KHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPY 185
Query: 246 AGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
             T  Y APE  +     E  DI+S G ++ E++
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 21  TVLKRYQNLKP---IGSGAQGIVCAA--YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 75
Query: 132 MITSIQHKNLVRLLGCCS------DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ 185
           ++  + HKN++ LL   +      +     LV E M + +L  +I  E D        +Q
Sbjct: 76  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYLLYQ 134
Query: 186 IILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF 245
           ++ GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T +
Sbjct: 135 MLXGI----KHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPY 185
Query: 246 AGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
             T  Y APE  +     E  DI+S G ++ E++
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 14  TVLKRYQNLKP---IGSGAQGIVCAA--YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 68
Query: 132 MITSIQHKNLVRLLGCCS------DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ 185
           ++  + HKN++ LL   +      +     LV E M + +L  +I  E D        +Q
Sbjct: 69  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYLLYQ 127
Query: 186 IILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF 245
           ++ GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T +
Sbjct: 128 MLXGI----KHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPY 178
Query: 246 AGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
             T  Y APE  +     E  DI+S G ++ E++
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-T 248
           +A+G+++L   +  + +HRD+ A N+LL EK   KI DFGLAR   +D  Y+    A   
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           L + APE       + ++D++SFGVL+ EI S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-T 248
           +A+G+++L   +  + +HRD+ A N+LL EK   KI DFGLAR   +D  Y+    A   
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           L + APE       + ++D++SFGVL+ EI S
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 94/194 (48%), Gaps = 8/194 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLC-VDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G  G V++       LV  +KL  ++      ++ + E++++       +V   G  
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
               +  +  E+M   SLD ++  +    +      ++ + + +GL YL E    +I+HR
Sbjct: 101 YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 156
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+K SN+L++ + + K+ DFG++    +  A    +F GT  Y +PE       S ++DI
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHYSVQSDI 213
Query: 269 YSFGVLVLEIISCR 282
           +S G+ ++E+   R
Sbjct: 214 WSMGLSLVEMAVGR 227

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 85/176 (48%), Gaps = 16/176 (9%)
Query: 110 AVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDL 168
           AVK   +DKS++  SE   E+ ++    QH N++ L     DG    LV E M  R  +L
Sbjct: 56  AVK--VIDKSKRDPSE---EIEILLRYGQHPNIITLKDVYDDGKHVYLVTELM--RGGEL 108
Query: 169 LIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVL-LDEKFQS---K 224
           L      KF +      ++  I + ++YLH      +VHRD+K SN+L +DE       +
Sbjct: 109 LDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLR 165
Query: 225 IGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           I DFG A+    +   L T    T  + APE   R    E  DI+S G+L+  +++
Sbjct: 166 ICDFGFAKQLRAENGLLMTP-CYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLA 220

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 100/206 (48%), Gaps = 29/206 (14%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLS-----EVRMITSIQHKNLVR 143
           +G G +G V        G  VA+KKL    S+  +SE  +     E+ ++  +QH+N++ 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKL----SRPFQSEIFAKRAYRELLLLKHMQHENVIG 87
Query: 144 LLGCCSDGSQR------LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYL 197
           LL   +  S         LV  +M+     ++    S++ + +     ++  + +GL+Y+
Sbjct: 88  LLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY-----LVYQMLKGLKYI 142
Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYA 257
           H      +VHRD+K  N+ ++E  + KI DFGLAR    +     T +  T  Y APE  
Sbjct: 143 HSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TGYVVTRWYRAPEVI 195
Query: 258 IRG-ELSEKADIYSFGVLVLEIISCR 282
           +     ++  DI+S G ++ E+++ +
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG-T 248
           +A+G+++L   +  + +HRD+ A N+LL EK   KI DFGLAR   +D  Y+    A   
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           L + APE       + ++D++SFGVL+ EI S
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 21  TVLKRYQNLKP---IGSGAQGIVCAA--YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 75
Query: 132 MITSIQHKNLVRLLGCCS------DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ 185
           ++  + HKN++ LL   +      +     LV E M + +L  +I  E D        +Q
Sbjct: 76  LMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYLLYQ 134
Query: 186 IILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF 245
           ++ GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T +
Sbjct: 135 MLCGI----KHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPY 185
Query: 246 AGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
             T  Y APE  +     E  DI+S G ++ E++
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 12/202 (5%)
Query: 83  NFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKL---CVDKSQQGESEFLSEVR-MITSIQ 137
           +FH   ++G+G FG V   +  A+    AVK L    + K ++ E   +SE   ++ +++
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKE-EKHIMSERNVLLKNVK 97
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYL 197
           H  LV L        +   V +Y+    L   +  E   FL    RF     IA  L YL
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAA-EIASALGYL 155
Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYA 257
           H      IV+RD+K  N+LLD +    + DFGL +   E  +  ST F GT  Y APE  
Sbjct: 156 HS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYLAPEVL 211
Query: 258 IRGELSEKADIYSFGVLVLEII 279
            +       D +  G ++ E++
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEML 233

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 94/194 (48%), Gaps = 8/194 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLC-VDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G  G V++       LV  +KL  ++      ++ + E++++       +V   G  
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
               +  +  E+M   SLD ++  +    +      ++ + + +GL YL E    +I+HR
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 129
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+K SN+L++ + + K+ DFG++    +  A    +F GT  Y +PE       S ++DI
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHYSVQSDI 186
Query: 269 YSFGVLVLEIISCR 282
           +S G+ ++E+   R
Sbjct: 187 WSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 94/194 (48%), Gaps = 8/194 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLC-VDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G  G V++       LV  +KL  ++      ++ + E++++       +V   G  
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
               +  +  E+M   SLD ++  +    +      ++ + + +GL YL E    +I+HR
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 129
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+K SN+L++ + + K+ DFG++    +  A    +F GT  Y +PE       S ++DI
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHYSVQSDI 186
Query: 269 YSFGVLVLEIISCR 282
           +S G+ ++E+   R
Sbjct: 187 WSMGLSLVEMAVGR 200

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 94/215 (43%), Gaps = 25/215 (11%)
Query: 81  TKNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHK 139
           + +F   +LLG G +G V        G +VA+KK+            L E++++   +H+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 140 NLVRLLGCCSDGS----QRLLVYEYMKNRSLDLLIYGE--SDKFLNWSTRFQIILGIARG 193
           N++ +       S      + + + +    L  +I  +  SD  + +      I    R 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-----FIYQTLRA 124
Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS---------TN 244
           ++ LH    + ++HRD+K SN+L++     K+ DFGLAR   E  A  S           
Sbjct: 125 VKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 245 FAGTLGYTAPEYAI-RGELSEKADIYSFGVLVLEI 278
           F  T  Y APE  +   + S   D++S G ++ E+
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 89  LLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-----QHKNLVR 143
           ++GRG +  V   +L     +   K+ V K    + E +  V+    +      H  LV 
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKV-VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
           L  C    S+   V EY+     DL+ + +  + L           I+  L YLHE    
Sbjct: 75  LHSCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG-- 130
Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLAR--FFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
            I++RD+K  NVLLD +   K+ D+G+ +    P D    ++ F GT  Y APE  +RGE
Sbjct: 131 -IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSXFCGTPNYIAPE-ILRGE 185
Query: 262 -LSEKADIYSFGVLVLEIISCRKNTDLTLPSE 292
                 D ++ GVL+ E+++ R   D+   S+
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 18/219 (8%)
Query: 82  KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI----- 136
           ++F    ++GRG +  V   +L     +   K+ V K    + E +  V+    +     
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKV-VKKELVNDDEDIDWVQTEKHVFEQAS 78
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
            H  LV L  C    S+   V EY+     DL+ + +  + L           I+  L Y
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAEISLALNY 136
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR--FFPEDQAYLSTNFAGTLGYTAP 254
           LHE     I++RD+K  NVLLD +   K+ D+G+ +    P D    ++ F GT  Y AP
Sbjct: 137 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSXFCGTPNYIAP 190
Query: 255 EYAIRGE-LSEKADIYSFGVLVLEIISCRKNTDLTLPSE 292
           E  +RGE      D ++ GVL+ E+++ R   D+   S+
Sbjct: 191 E-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 228

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 97/200 (48%), Gaps = 19/200 (9%)
Query: 90  LGRGGFGPVY--RGKL--ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G +G V   + KL  A+  +  +KK  V  +    +  L EV ++  + H N+++L 
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGA-LLDEVAVLKQLDHPNIMKLY 87
Query: 146 GCCSDGSQRLLVYE-YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTR 204
               D     LV E Y      D +I  +    ++ +   + +L    G  YLH+ +   
Sbjct: 88  EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS---GTTYLHKHN--- 141
Query: 205 IVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
           IVHRD+K  N+LL+ K +    KI DFGL+  F E    +     GT  Y APE  +R +
Sbjct: 142 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF-EVGGKMKERL-GTAYYIAPE-VLRKK 198
Query: 262 LSEKADIYSFGVLVLEIISC 281
             EK D++S GV +L I+ C
Sbjct: 199 YDEKCDVWSCGV-ILYILLC 217

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 41/223 (18%)
Query: 89  LLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMIT-SIQHKNLVRLLGC 147
           +LG G  G V       G  VAVK++ +D         L E++++T S  H N++R    
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA----LMEIKLLTESDDHPNVIRYY-- 75
Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ-------IILGIARGLQYLHED 200
           CS+ + R L Y  ++  +L+L    ES    + + + Q       ++  IA G+ +LH  
Sbjct: 76  CSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 133
Query: 201 SHTRIVHRDIKASNVLLD-------------EKFQSKIGDFGLARFFPEDQAYLSTNF-- 245
              +I+HRD+K  N+L+              E  +  I DFGL +     Q+   TN   
Sbjct: 134 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 246 -AGTLGYTAPE-------YAIRGELSEKADIYSFGVLVLEIIS 280
            +GT G+ APE          +  L+   DI+S G +   I+S
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 18/219 (8%)
Query: 82  KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI----- 136
           ++F    ++GRG +  V   +L     +   K+ V K    + E +  V+    +     
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKV-VKKELVNDDEDIDWVQTEKHVFEQAS 63
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
            H  LV L  C    S+   V EY+     DL+ + +  + L           I+  L Y
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAEISLALNY 121
Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR--FFPEDQAYLSTNFAGTLGYTAP 254
           LHE     I++RD+K  NVLLD +   K+ D+G+ +    P D    ++ F GT  Y AP
Sbjct: 122 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSXFCGTPNYIAP 175
Query: 255 EYAIRGE-LSEKADIYSFGVLVLEIISCRKNTDLTLPSE 292
           E  +RGE      D ++ GVL+ E+++ R   D+   S+
Sbjct: 176 E-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 213

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 100/206 (48%), Gaps = 29/206 (14%)
Query: 90  LGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLS-----EVRMITSIQHKNLVR 143
           +G G +G V        G  VA+KKL    S+  +SE  +     E+ ++  +QH+N++ 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKL----SRPFQSEIFAKRAYRELLLLKHMQHENVIG 105
Query: 144 LLGCCSDGSQR------LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYL 197
           LL   +  S         LV  +M+     ++    S++ + +     ++  + +GL+Y+
Sbjct: 106 LLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQY-----LVYQMLKGLKYI 160
Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYA 257
           H      +VHRD+K  N+ ++E  + KI DFGLAR    +     T +  T  Y APE  
Sbjct: 161 HSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TGYVVTRWYRAPEVI 213
Query: 258 IRG-ELSEKADIYSFGVLVLEIISCR 282
           +     ++  DI+S G ++ E+++ +
Sbjct: 214 LSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 21  TVLKRYQNLKP---IGSGAQGIVCAA--YDAILERNVAIKKLSRPFQNQTHAKRAYRELV 75
Query: 132 MITSIQHKNLVRLLGCCS-----DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQI 186
           ++  + HKN++ LL   +     +  Q + +   + + +L  +I  E D        +Q+
Sbjct: 76  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA 246
           + GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T + 
Sbjct: 136 LCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYV 186
Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
            T  Y APE  +     E  DI+S G ++ E+I
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 88/181 (48%), Gaps = 17/181 (9%)
Query: 106 GTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLLGCCS------DGSQRLLVY 158
           G  VAVKKL    ++Q        E+ ++  + HKN++ LL   +      +     LV 
Sbjct: 47  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 106
Query: 159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD 218
           E M + +L  +I+ E D        +Q++ GI    ++LH      I+HRD+K SN+++ 
Sbjct: 107 ELM-DANLCQVIHMELDHERMSYLLYQMLCGI----KHLHSAG---IIHRDLKPSNIVVK 158
Query: 219 EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEI 278
                KI DFGLAR    +  ++ T +  T  Y APE  +     E  DI+S G ++ E+
Sbjct: 159 SDCTLKILDFGLARTASTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 216
Query: 279 I 279
           +
Sbjct: 217 V 217

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 21  TVLKRYQNLKP---IGSGAQGIVCAA--YDAILERNVAIKKLSRPFQNQTHAKRAYRELV 75
Query: 132 MITSIQHKNLVRLLGCCS-----DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQI 186
           ++  + HKN++ LL   +     +  Q + +   + + +L  +I  E D        +Q+
Sbjct: 76  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA 246
           + GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T + 
Sbjct: 136 LCGI----KHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYV 186
Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
            T  Y APE  +     E  DI+S G ++ E+I
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 15  TVLKRYQNLKP---IGSGAQGIVCAA--YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 69
Query: 132 MITSIQHKNLVRLLGCCS------DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ 185
           ++  + HKN++ LL   +      +     LV E M + +L  +I  E D        +Q
Sbjct: 70  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQ 128
Query: 186 IILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF 245
           ++ GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T +
Sbjct: 129 MLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPY 179
Query: 246 AGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
             T  Y APE  +     E  DI+S G ++ E++
Sbjct: 180 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 32/237 (13%)
Query: 61  FFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPV-YRGKLADGTLVAVKKLCVDKS 119
           +F G++  I    +  ++K          LG GGF  V     L DG   A+K++   + 
Sbjct: 18  YFQGHMVIIDNKHYLFIQK----------LGEGGFSYVDLVEGLHDGHFYALKRILCHE- 66
Query: 120 QQGESEFLSEVRMITSIQHKNLVRLLGCC----SDGSQRLLVYEYMKNRSLDLLIYGESD 175
           QQ   E   E  M     H N++RL+  C        +  L+  + K  +L   I    D
Sbjct: 67  QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKD 126
Query: 176 K--FLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFG---- 229
           K  FL       ++LGI RGL+ +H   +    HRD+K +N+LL ++ Q  + D G    
Sbjct: 127 KGNFLTEDQILWLLLGICRGLEAIHAKGYA---HRDLKPTNILLGDEGQPVLMDLGSMNQ 183
Query: 230 -LARFFPEDQAYLSTNFAG---TLGYTAPE-YAIRGE--LSEKADIYSFGVLVLEII 279
                    QA    ++A    T+ Y APE ++++    + E+ D++S G ++  ++
Sbjct: 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 34/212 (16%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI--QHKNLVRLLGC 147
           +G+G +G V+RG    G  VAVK      S + E  +  E  +  ++  +H+N++  +  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIF----SSRDEKSWFRETELYNTVMLRHENILGFIA- 69
Query: 148 CSD------GSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLH-- 198
            SD       +Q  L+  Y +  SL D L     D      +  +I+L IA GL +LH  
Sbjct: 70  -SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTV----SCLRIVLSIASGLAHLHIE 124
Query: 199 ---EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF---AGTLGYT 252
                    I HRD+K+ N+L+ +  Q  I D GLA    +    L        GT  Y 
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 253 APEY---AIRGELSE---KADIYSFGVLVLEI 278
           APE     I+ +  +   + DI++FG+++ E+
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 4/92 (4%)
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL-STNFAGT 248
           +ARG+++L   S  + +HRD+ A N+LL E    KI DFGLAR   ++  Y+   +    
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           L + APE       S K+D++S+GVL+ EI S
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 89  LLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMIT-SIQHKNLVRLLGC 147
           +LG G  G V       G  VAVK++ +D         L E++++T S  H N++R    
Sbjct: 40  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA----LMEIKLLTESDDHPNVIRYY-- 93
Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ-------IILGIARGLQYLHED 200
           CS+ + R L Y  ++  +L+L    ES    + + + Q       ++  IA G+ +LH  
Sbjct: 94  CSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 151
Query: 201 SHTRIVHRDIKASNVLLD-------------EKFQSKIGDFGLARFFPEDQAYLSTNF-- 245
              +I+HRD+K  N+L+              E  +  I DFGL +     Q     N   
Sbjct: 152 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 246 -AGTLGYTAPEY---AIRGELSEKADIYSFGVLVLEIIS 280
            +GT G+ APE    + +  L+   DI+S G +   I+S
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 89  LLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMIT-SIQHKNLVRLLGC 147
           +LG G  G V       G  VAVK++ +D         L E++++T S  H N++R    
Sbjct: 40  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA----LMEIKLLTESDDHPNVIRYY-- 93
Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ-------IILGIARGLQYLHED 200
           CS+ + R L Y  ++  +L+L    ES    + + + Q       ++  IA G+ +LH  
Sbjct: 94  CSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 151
Query: 201 SHTRIVHRDIKASNVLLD-------------EKFQSKIGDFGLARFFPEDQAYLSTNF-- 245
              +I+HRD+K  N+L+              E  +  I DFGL +     Q     N   
Sbjct: 152 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 246 -AGTLGYTAPEY---AIRGELSEKADIYSFGVLVLEIIS 280
            +GT G+ APE    + +  L+   DI+S G +   I+S
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 34/212 (16%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI--QHKNLVRLLGC 147
           +G+G +G V+RG    G  VAVK      S + E  +  E  +  ++  +H+N++  +  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIF----SSRDEKSWFRETELYNTVMLRHENILGFIA- 69
Query: 148 CSD------GSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLH-- 198
            SD       +Q  L+  Y +  SL D L     D      +  +I+L IA GL +LH  
Sbjct: 70  -SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTV----SCLRIVLSIASGLAHLHIE 124
Query: 199 ---EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF---AGTLGYT 252
                    I HRD+K+ N+L+ +  Q  I D GLA    +    L        GT  Y 
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 253 APEY---AIRGELSE---KADIYSFGVLVLEI 278
           APE     I+ +  +   + DI++FG+++ E+
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 15  TVLKRYQNLKP---IGSGAQGIVCAA--YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 69
Query: 132 MITSIQHKNLVRLLGCCS------DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ 185
           ++  + HKN++ LL   +      +     LV E M + +L  +I  E D        +Q
Sbjct: 70  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQ 128
Query: 186 IILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF 245
           ++ GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T +
Sbjct: 129 MLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPY 179
Query: 246 AGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
             T  Y APE  +     E  DI+S G ++ E++
Sbjct: 180 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 14  TVLKRYQNLKP---IGSGAQGIVCAA--YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 68
Query: 132 MITSIQHKNLVRLLGCCS------DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ 185
           ++  + HKN++ LL   +      +     LV E M + +L  +I  E D        +Q
Sbjct: 69  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQ 127
Query: 186 IILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF 245
           ++ GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T +
Sbjct: 128 MLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPY 178
Query: 246 AGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
             T  Y APE  +     E  DI+S G ++ E++
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 22  TVLKRYQNLKP---IGSGAQGIVCAA--YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 76
Query: 132 MITSIQHKNLVRLLGCCS------DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ 185
           ++  + HKN++ LL   +      +     LV E M + +L  +I  E D        +Q
Sbjct: 77  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQ 135
Query: 186 IILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF 245
           ++ GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T +
Sbjct: 136 MLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPY 186
Query: 246 AGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
             T  Y APE  +     E  DI+S G ++ E++
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 21  TVLKRYQNLKP---IGSGAQGIVCAA--YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 75
Query: 132 MITSIQHKNLVRLLGCCS------DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ 185
           ++  + HKN++ LL   +      +     LV E M + +L  +I  E D        +Q
Sbjct: 76  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQ 134
Query: 186 IILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF 245
           ++ GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T +
Sbjct: 135 MLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPY 185
Query: 246 AGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
             T  Y APE  +     E  DI+S G ++ E++
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 21  TVLKRYQNLKP---IGSGAQGIVCAA--YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 75
Query: 132 MITSIQHKNLVRLLGCCS------DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ 185
           ++  + HKN++ LL   +      +     LV E M + +L  +I  E D        +Q
Sbjct: 76  LMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQ 134
Query: 186 IILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF 245
           ++ GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T +
Sbjct: 135 MLCGI----KHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPY 185
Query: 246 AGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
             T  Y APE  +     E  DI+S G ++ E++
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 20  TVLKRYQNLKP---IGSGAQGIVCAA--YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 74
Query: 132 MITSIQHKNLVRLLGCCS------DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ 185
           ++  + HKN++ LL   +      +     LV E M + +L  +I  E D        +Q
Sbjct: 75  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQ 133
Query: 186 IILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF 245
           ++ GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T +
Sbjct: 134 MLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPY 184
Query: 246 AGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
             T  Y APE  +     E  DI+S G ++ E++
Sbjct: 185 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 21  TVLKRYQNLKP---IGSGAQGIVCAA--YDAILERNVAIKKLSRPFQNQTHAKRAYRELV 75
Query: 132 MITSIQHKNLVRLLGCCS-----DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQI 186
           ++  + HKN++ LL   +     +  Q + +   + + +L  +I  E D        +Q+
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA 246
           + GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T + 
Sbjct: 136 LCGI----KHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYV 186
Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
            T  Y APE  +     E  DI+S G ++ E+I
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL-LG 146
           ++G G FG VY+ KL D G LVA+KK+  DK  +       E++++  + H N+VRL   
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 81
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII------LGIARGLQYLHED 200
             S G ++ +VY  +    +   +Y  +  +        +I        + R L Y+H  
Sbjct: 82  FYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 201 SHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
               I HRDIK  N+LLD +    K+ DFG A+     +  +S     +  Y APE    
Sbjct: 142 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAPELIFG 196
Query: 260 G-ELSEKADIYSFGVLVLEII 279
             + +   D++S G ++ E++
Sbjct: 197 ATDYTSSIDVWSAGCVLAELL 217

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 21  TVLKRYQNLKP---IGSGAQGIVCAA--YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 75
Query: 132 MITSIQHKNLVRLLGCCS------DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ 185
           ++  + HKN++ LL   +      +     LV E M + +L  +I  E D        +Q
Sbjct: 76  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQ 134
Query: 186 IILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF 245
           ++ GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T +
Sbjct: 135 MLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPY 185
Query: 246 AGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
             T  Y APE  +     E  DI+S G ++ E++
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 94/194 (48%), Gaps = 8/194 (4%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLC-VDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G  G V++       LV  +KL  ++      ++ + E++++       +V   G  
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 92
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
               +  +  E+M   SLD ++  +    +      ++ + + +GL YL E    +I+HR
Sbjct: 93  YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 148
Query: 209 DIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
           D+K SN+L++ + + K+ DFG++    +  A    +F GT  Y +PE       S ++DI
Sbjct: 149 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHYSVQSDI 205
Query: 269 YSFGVLVLEIISCR 282
           +S G+ ++E+   R
Sbjct: 206 WSMGLSLVEMAVGR 219

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 59  TVLKRYQNLKP---IGSGAQGIVCAA--YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 113
Query: 132 MITSIQHKNLVRLLGCCS------DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ 185
           ++  + HKN++ LL   +      +     LV E M + +L  +I  E D        +Q
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQ 172
Query: 186 IILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF 245
           ++ GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T +
Sbjct: 173 MLCGI----KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPY 223
Query: 246 AGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
             T  Y APE  +     E  DI+S G ++ E++
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL-LG 146
           ++G G FG VY+ KL D G LVA+KK+  DK  +       E++++  + H N+VRL   
Sbjct: 40  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 94
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII------LGIARGLQYLHED 200
             S G ++  VY  +    +   +Y  +  +        +I        + R L Y+H  
Sbjct: 95  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 154
Query: 201 SHTRIVHRDIKASNVLLDEKFQS-KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
               I HRDIK  N+LLD      K+ DFG A+     +  +S  +  +  Y APE    
Sbjct: 155 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRAPELIFG 209
Query: 260 G-ELSEKADIYSFGVLVLEII 279
             + +   D++S G ++ E++
Sbjct: 210 ATDYTSSIDVWSAGCVLAELL 230

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 34/212 (16%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI--QHKNLVRLLGC 147
           +G+G +G V+RG    G  VAVK      S + E  +  E  +  ++  +H+N++  +  
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIF----SSRDEKSWFRETELYNTVMLRHENILGFIA- 98
Query: 148 CSD------GSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLH-- 198
            SD       +Q  L+  Y +  SL D L     D      +  +I+L IA GL +LH  
Sbjct: 99  -SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTV----SCLRIVLSIASGLAHLHIE 153
Query: 199 ---EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF---AGTLGYT 252
                    I HRD+K+ N+L+ +  Q  I D GLA    +    L        GT  Y 
Sbjct: 154 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 213
Query: 253 APEY---AIRGELSE---KADIYSFGVLVLEI 278
           APE     I+ +  +   + DI++FG+++ E+
Sbjct: 214 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 22  TVLKRYQNLKP---IGSGAQGIVCAA--YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 76
Query: 132 MITSIQHKNLVRLLGCCS------DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ 185
           ++  + HKN++ LL   +      +     LV E M + +L  +I  E D        +Q
Sbjct: 77  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQ 135
Query: 186 IILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF 245
           ++ GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T +
Sbjct: 136 MLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPY 186
Query: 246 AGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
             T  Y APE  +     E  DI+S G ++ E++
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 16/218 (7%)
Query: 82  KNFHPGNLLGRGGFGPVYRGKLADGTLV----AVKKLCVDKSQQGESEFLSEVRMITSIQ 137
           ++F    ++GRG +  V   +L     +     VKK  V+  +  +     +     +  
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYL 197
           H  LV L  C    S+   V EY+     DL+ + +  + L           I+  L YL
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR--FFPEDQAYLSTNFAGTLGYTAPE 255
           HE     I++RD+K  NVLLD +   K+ D+G+ +    P D    ++ F GT  Y APE
Sbjct: 170 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPE 223
Query: 256 YAIRGE-LSEKADIYSFGVLVLEIISCRKNTDLTLPSE 292
             +RGE      D ++ GVL+ E+++ R   D+   S+
Sbjct: 224 -ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL-LG 146
           ++G G FG VY+ KL D G LVA+KK+  DK  +       E++++  + H N+VRL   
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 115
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII------LGIARGLQYLHED 200
             S G ++  VY  +    +   +Y  +  +        +I        + R L Y+H  
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 175
Query: 201 SHTRIVHRDIKASNVLLDEKFQS-KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
               I HRDIK  N+LLD      K+ DFG A+     +  +S  +  +  Y APE    
Sbjct: 176 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRAPELIFG 230
Query: 260 G-ELSEKADIYSFGVLVLEII 279
             + +   D++S G ++ E++
Sbjct: 231 ATDYTSSIDVWSAGCVLAELL 251

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL-LG 146
           ++G G FG VY+ KL D G LVA+KK+  DK  +       E++++  + H N+VRL   
Sbjct: 63  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 117
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII------LGIARGLQYLHED 200
             S G ++  VY  +    +   +Y  +  +        +I        + R L Y+H  
Sbjct: 118 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 177
Query: 201 SHTRIVHRDIKASNVLLDEKFQS-KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
               I HRDIK  N+LLD      K+ DFG A+     +  +S  +  +  Y APE    
Sbjct: 178 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRAPELIFG 232
Query: 260 G-ELSEKADIYSFGVLVLEII 279
             + +   D++S G ++ E++
Sbjct: 233 ATDYTSSIDVWSAGCVLAELL 253

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 127/287 (44%), Gaps = 45/287 (15%)
Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGE-SEFLSEVRMITSIQHKNLVRLL 145
           G L+G+G FG VY G+      VA++ + +++  + +   F  EV      +H+N+V  +
Sbjct: 38  GELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G C       ++    K R+L  ++  ++   L+ +   QI   I +G+ YLH      I
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVR-DAKIVLDVNKTRQIAQEIVKGMGYLHAKG---I 151
Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFP-------EDQAYLSTNFAGTLGYTAPEYAI 258
           +H+D+K+ NV  D   +  I DFGL            ED+  +     G L + APE  I
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQN---GWLCHLAPEI-I 206
Query: 259 RG----------ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGR 308
           R             S+ +D+++ G +  E +  R+    T P+E          +++ G 
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYE-LHAREWPFKTQPAEA--------IIWQMGT 257
Query: 309 ILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
            ++   P + + G+      ++ ++   C      +RP  ++++ ML
Sbjct: 258 GMK---PNLSQIGM----GKEISDILLFCWAFEQEERPTFTKLMDML 297

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL-LG 146
           ++G G FG VY+ KL D G LVA+KK+  DK  +       E++++  + H N+VRL   
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 81
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII------LGIARGLQYLHED 200
             S G ++  VY  +    +   +Y  +  +        +I        + R L Y+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 201 SHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
               I HRDIK  N+LLD +    K+ DFG A+     +  +S  +  +  Y APE    
Sbjct: 142 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRAPELIFG 196
Query: 260 G-ELSEKADIYSFGVLVLEII 279
             + +   D++S G ++ E++
Sbjct: 197 ATDYTSSIDVWSAGCVLAELL 217

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 97/200 (48%), Gaps = 19/200 (9%)
Query: 90  LGRGGFGPVY--RGKL--ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G +G V   + KL  A+  +  +KK  V  +    +  L EV ++  + H N+++L 
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGA-LLDEVAVLKQLDHPNIMKLY 70
Query: 146 GCCSDGSQRLLVYE-YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTR 204
               D     LV E Y      D +I  +    ++ +    I+  +  G  YLH+ +   
Sbjct: 71  EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV---IMKQVLSGTTYLHKHN--- 124
Query: 205 IVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
           IVHRD+K  N+LL+ K +    KI DFGL+  F E    +     GT  Y APE  +R +
Sbjct: 125 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF-EVGGKMKERL-GTAYYIAPE-VLRKK 181
Query: 262 LSEKADIYSFGVLVLEIISC 281
             EK D++S GV +L I+ C
Sbjct: 182 YDEKCDVWSCGV-ILYILLC 200

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 59  TVLKRYQNLKP---IGSGAQGIVCAA--YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 113
Query: 132 MITSIQHKNLVRLLGCCS------DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ 185
           ++  + HKN++ LL   +      +     LV E M + +L  +I  E D        +Q
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQ 172
Query: 186 IILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF 245
           ++ GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T +
Sbjct: 173 MLCGI----KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPY 223
Query: 246 AGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
             T  Y APE  +     E  DI+S G ++ E++
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL-LG 146
           ++G G FG VY+ KL D G LVA+KK+  DK  +       E++++  + H N+VRL   
Sbjct: 55  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 109
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII------LGIARGLQYLHED 200
             S G ++  VY  +    +   +Y  +  +        +I        + R L Y+H  
Sbjct: 110 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 169
Query: 201 SHTRIVHRDIKASNVLLDEKFQS-KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
               I HRDIK  N+LLD      K+ DFG A+     +  +S  +  +  Y APE    
Sbjct: 170 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRAPELIFG 224
Query: 260 G-ELSEKADIYSFGVLVLEII 279
             + +   D++S G ++ E++
Sbjct: 225 ATDYTSSIDVWSAGCVLAELL 245

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL-LG 146
           ++G G FG VY+ KL D G LVA+KK+  DK  +       E++++  + H N+VRL   
Sbjct: 65  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 119
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII------LGIARGLQYLHED 200
             S G ++  VY  +    +   +Y  +  +        +I        + R L Y+H  
Sbjct: 120 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 179
Query: 201 SHTRIVHRDIKASNVLLDEKFQS-KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
               I HRDIK  N+LLD      K+ DFG A+     +  +S  +  +  Y APE    
Sbjct: 180 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRAPELIFG 234
Query: 260 G-ELSEKADIYSFGVLVLEII 279
             + +   D++S G ++ E++
Sbjct: 235 ATDYTSSIDVWSAGCVLAELL 255

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 89  LLGRGGFGPVYRGKLAD--GT--LVAVKKLCVDKSQQGESE--FLSEVRMITSIQHKNLV 142
           +LG+G FG V    LAD  GT  L A+K L  D   Q +     + E R++  +     +
Sbjct: 26  VLGKGSFGKVM---LADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFL 82
Query: 143 RLLGCCSDGSQRL-LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
             L  C     RL  V EY+    L   I  +  KF      F     I+ GL +LH+  
Sbjct: 83  TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ-QVGKFKEPQAVF-YAAEISIGLFFLHKRG 140
Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
              I++RD+K  NV+LD +   KI DFG+ +    D    +  F GT  Y APE      
Sbjct: 141 ---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMD-GVTTREFCGTPDYIAPEIIAYQP 196
Query: 262 LSEKADIYSFGVLVLEIISCRKNTD 286
             +  D +++GVL+ E+++ +   D
Sbjct: 197 YGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 21  TVLKRYQNLKP---IGSGAQGIVCAA--YDAILERNVAIKKLSRPFQNQTHAKRAYRELV 75
Query: 132 MITSIQHKNLVRLLGCCS-----DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQI 186
           ++  + HKN++ LL   +     +  Q + +   + + +L  +I  E D        +Q+
Sbjct: 76  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA 246
           + GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T + 
Sbjct: 136 LCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYV 186
Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
            T  Y APE  +     E  DI+S G ++ E+I
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 21  TVLKRYQNLKP---IGSGAQGIVCAA--YDAILERNVAIKKLSRPFQNQTHAKRAYRELV 75
Query: 132 MITSIQHKNLVRLLGCCS-----DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQI 186
           ++  + HKN++ LL   +     +  Q + +   + + +L  +I  E D        +Q+
Sbjct: 76  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA 246
           + GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T + 
Sbjct: 136 LCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYV 186
Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
            T  Y APE  +     E  DI+S G ++ E+I
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 22  TVLKRYQNLKP---IGSGAQGIVCAA--YDAILERNVAIKKLSRPFQNQTHAKRAYRELV 76
Query: 132 MITSIQHKNLVRLLGCCS-----DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQI 186
           ++  + HKN++ LL   +     +  Q + +   + + +L  +I  E D        +Q+
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 136
Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA 246
           + GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T + 
Sbjct: 137 LCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYV 187
Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
            T  Y APE  +     E  DI+S G ++ E+I
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 220

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL-LG 146
           ++G G FG VY+ KL D G LVA+KK+  DK  +       E++++  + H N+VRL   
Sbjct: 32  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 86
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII------LGIARGLQYLHED 200
             S G ++  VY  +    +   +Y  +  +        +I        + R L Y+H  
Sbjct: 87  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 146
Query: 201 SHTRIVHRDIKASNVLLDEKFQS-KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
               I HRDIK  N+LLD      K+ DFG A+     +  +S  +  +  Y APE    
Sbjct: 147 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRAPELIFG 201
Query: 260 G-ELSEKADIYSFGVLVLEII 279
             + +   D++S G ++ E++
Sbjct: 202 ATDYTSSIDVWSAGCVLAELL 222

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 94/215 (43%), Gaps = 25/215 (11%)
Query: 81  TKNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHK 139
           + +F   +LLG G +G V        G +VA+KK+            L E++++   +H+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 140 NLVRLLGCCSDGS----QRLLVYEYMKNRSLDLLIYGE--SDKFLNWSTRFQIILGIARG 193
           N++ +       S      + + + +    L  +I  +  SD  + +      I    R 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-----FIYQTLRA 124
Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS---------TN 244
           ++ LH    + ++HRD+K SN+L++     K+ DFGLAR   E  A  S         T 
Sbjct: 125 VKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 245 FAGTLGYTAPEYAI-RGELSEKADIYSFGVLVLEI 278
              T  Y APE  +   + S   D++S G ++ E+
Sbjct: 182 XVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 89  LLGRGGFGPVYRGK-LADGTLVAVK----KLCVDKSQQGESEFLSEVRMITSIQHKNLVR 143
           LLG+G FG V   K  A G   A+K    ++ V K +   +  L+E R++ + +H  L  
Sbjct: 17  LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--LTENRVLQNSRHPFLTA 74
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
           L        +   V EY     L   +  E   F     RF     I   L YLH  S  
Sbjct: 75  LKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARF-YGAEIVSALDYLH--SEK 130
Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELS 263
            +V+RD+K  N++LD+    KI DFGL +   +D A +   F GT  Y APE     +  
Sbjct: 131 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-FCGTPEYLAPEVLEDNDYG 189
Query: 264 EKADIYSFGVLVLEIISCR 282
              D +  GV++ E++  R
Sbjct: 190 RAVDWWGLGVVMYEMMCGR 208

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 76  TLKKATKN-FHPGNLLGRGGFGPVYRGK-LADGTLVAVK----KLCVDKSQQGESEFLSE 129
            + + T N F    LLG+G FG V   K  A G   A+K    ++ V K +   +  L+E
Sbjct: 2   AMARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--LTE 59
Query: 130 VRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG 189
            R++ + +H  L  L        +   V EY     L   +  E   F     RF     
Sbjct: 60  NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARF-YGAE 117
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
           I   L YLH  S   +V+RD+K  N++LD+    KI DFGL +   +D A +   F GT 
Sbjct: 118 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-FCGTP 174
Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIISCR 282
            Y APE     +     D +  GV++ E++  R
Sbjct: 175 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL-LG 146
           ++G G FG VY+ KL D G LVA+KK+  DK  +       E++++  + H N+VRL   
Sbjct: 106 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 160
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII------LGIARGLQYLHED 200
             S G ++  VY  +    +   +Y  +  +        +I        + R L Y+H  
Sbjct: 161 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 220
Query: 201 SHTRIVHRDIKASNVLLDEKFQS-KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
               I HRDIK  N+LLD      K+ DFG A+     +  +S  +  +  Y APE    
Sbjct: 221 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRAPELIFG 275
Query: 260 G-ELSEKADIYSFGVLVLEII 279
             + +   D++S G ++ E++
Sbjct: 276 ATDYTSSIDVWSAGCVLAELL 296

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 86/193 (44%), Gaps = 10/193 (5%)
Query: 90  LGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESE-FLSEVRMITSIQHKNLVRLLGC 147
           +GRG F  VY+G   + T+ VA  +L   K  + E + F  E   +  +QH N+VR    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 148 --CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
              +   ++ +V       S  L  Y +  K             I +GLQ+LH  +   I
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPP-I 152
Query: 206 VHRDIKASNVLLDEKFQS-KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSE 264
           +HRD+K  N+ +     S KIGD GLA      +A  +    GT  + APE     +  E
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFXAPE-XYEEKYDE 208
Query: 265 KADIYSFGVLVLE 277
             D+Y+FG   LE
Sbjct: 209 SVDVYAFGXCXLE 221

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 78  KKATKNFHPGNLLGRGGFGPV--YRGKLADGTLVAVK----KLCVDKSQQGESEFLSEVR 131
           K    +F    LLG+G FG V   R K A G   A+K    ++ + K +   +  ++E R
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHT--VTESR 62
Query: 132 MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIA 191
           ++ + +H  L  L        +   V EY     L   +  E   F     RF     I 
Sbjct: 63  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGA-EIV 120
Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY 251
             L+YLH      +V+RDIK  N++LD+    KI DFGL +    D A +   F GT  Y
Sbjct: 121 SALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-FCGTPEY 176
Query: 252 TAPEYAIRGELSEKADIYSFGVLVLEIISCR 282
            APE     +     D +  GV++ E++  R
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 89/200 (44%), Gaps = 12/200 (6%)
Query: 88  NLLGRGGFGPVYRGK-LADGTLVAVK----KLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
            LLG+G FG V   K  A G   A+K    ++ V K +   +  L+E R++ + +H  L 
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--LTENRVLQNSRHPFLT 71
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            L        +   V EY     L   +  E   F     RF     I   L YLH  S 
Sbjct: 72  ALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARF-YGAEIVSALDYLH--SE 127
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
             +V+RD+K  N++LD+    KI DFGL +   +D A +   F GT  Y APE     + 
Sbjct: 128 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-FCGTPEYLAPEVLEDNDY 186
Query: 263 SEKADIYSFGVLVLEIISCR 282
               D +  GV++ E++  R
Sbjct: 187 GRAVDWWGLGVVMYEMMCGR 206

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 78  KKATKNFHPGNLLGRGGFGPV--YRGKLADGTLVAVK----KLCVDKSQQGESEFLSEVR 131
           K    +F    LLG+G FG V   R K A G   A+K    ++ + K +   +  ++E R
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHT--VTESR 57
Query: 132 MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIA 191
           ++ + +H  L  L        +   V EY     L   +  E   F     RF     I 
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGA-EIV 115
Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY 251
             L+YLH      +V+RDIK  N++LD+    KI DFGL +    D A +   F GT  Y
Sbjct: 116 SALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-FCGTPEY 171
Query: 252 TAPEYAIRGELSEKADIYSFGVLVLEIISCR 282
            APE     +     D +  GV++ E++  R
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 24/217 (11%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 26  TVLKRYQNLKP---IGSGAQGIVCAA--YDAILERNVAIKKLSRPFQNQTHAKRAYRELV 80
Query: 132 MITSIQHKNLVRLLGCCS-----DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQI 186
           ++  + HKN++ LL   +     +  Q + +   + + +L  +I  E D        +Q+
Sbjct: 81  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 140
Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA 246
           + GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T + 
Sbjct: 141 LCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYV 191
Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRK 283
            T  Y APE  +     E  D++S G ++ E++ C K
Sbjct: 192 VTRYYRAPEVILGMGYKENVDLWSVGCIMGEMV-CHK 227

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 78  KKATKNFHPGNLLGRGGFGPV--YRGKLADGTLVAVK----KLCVDKSQQGESEFLSEVR 131
           K    +F    LLG+G FG V   R K A G   A+K    ++ + K +   +  ++E R
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHT--VTESR 57
Query: 132 MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIA 191
           ++ + +H  L  L        +   V EY     L   +  E   F     RF     I 
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGA-EIV 115
Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY 251
             L+YLH      +V+RDIK  N++LD+    KI DFGL +    D A +   F GT  Y
Sbjct: 116 SALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-FCGTPEY 171
Query: 252 TAPEYAIRGELSEKADIYSFGVLVLEIISCR 282
            APE     +     D +  GV++ E++  R
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 23  TVLKRYQNLKP---IGSGAQGIVCAA--YDAILERNVAIKKLSRPFQNQTHAKRAYRELV 77
Query: 132 MITSIQHKNLVRLLGCCS-----DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQI 186
           ++  + HKN++ LL   +     +  Q + +   + + +L  +I  E D        +Q+
Sbjct: 78  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 137
Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA 246
           + GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++   F 
Sbjct: 138 LCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMVPFV 188
Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
            T  Y APE  +     E  DI+S G ++ E+I
Sbjct: 189 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 221

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 86/192 (44%), Gaps = 20/192 (10%)
Query: 103 LADGTLVAVKKLCVDKSQQGESEFLSEVRM-------ITSIQ----HKNLVRLLGCCSDG 151
           L +G+    +K    KS Q  +  +   RM       IT+++    H N+V+L     D 
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78
Query: 152 SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIK 211
               LV E +    L   I  +  K  + +    I+  +   + ++H+     +VHRD+K
Sbjct: 79  LHTFLVMELLNGGELFERI--KKKKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLK 133
Query: 212 ASNVLL---DEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADI 268
             N+L    ++  + KI DFG AR  P D   L T    TL Y APE   +    E  D+
Sbjct: 134 PENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP-CFTLHYAAPELLNQNGYDESCDL 192
Query: 269 YSFGVLVLEIIS 280
           +S GV++  ++S
Sbjct: 193 WSLGVILYTMLS 204

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 78  KKATKNFHPGNLLGRGGFGPV--YRGKLADGTLVAVK----KLCVDKSQQGESEFLSEVR 131
           K    +F    LLG+G FG V   R K A G   A+K    ++ + K +   +  ++E R
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHT--VTESR 57
Query: 132 MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIA 191
           ++ + +H  L  L        +   V EY     L   +  E   F     RF     I 
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGA-EIV 115
Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY 251
             L+YLH      +V+RDIK  N++LD+    KI DFGL +    D A +   F GT  Y
Sbjct: 116 SALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-FCGTPEY 171
Query: 252 TAPEYAIRGELSEKADIYSFGVLVLEIISCR 282
            APE     +     D +  GV++ E++  R
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 24/217 (11%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 15  TVLKRYQNLKP---IGSGAQGIVCAA--YDAILERNVAIKKLSRPFQNQTHAKRAYRELV 69
Query: 132 MITSIQHKNLVRLLGCCS-----DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQI 186
           ++  + HKN++ LL   +     +  Q + +   + + +L  +I  E D        +Q+
Sbjct: 70  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 129
Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA 246
           + GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T + 
Sbjct: 130 LCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYV 180
Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRK 283
            T  Y APE  +     E  D++S G ++ E++ C K
Sbjct: 181 VTRYYRAPEVILGMGYKENVDLWSVGCIMGEMV-CHK 216

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 19/209 (9%)
Query: 83  NFHPGNLLGRGGFGPVYR------GKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI 136
           ++  G  LG G F  V +      GK      +  ++L   +      E   EV ++  I
Sbjct: 13  HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 72
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQ 195
           +H N++ L     + +  +L+ E +    L D L   ES   L      Q +  I  G+ 
Sbjct: 73  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGVH 129
Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKF----QSKIGDFGLARFFPEDQAYLSTNFAGTLGY 251
           YLH     RI H D+K  N++L +K     + K+ DFG+A        +   N  GT  +
Sbjct: 130 YLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEF 184
Query: 252 TAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            APE      L  +AD++S GV+   ++S
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 88  NLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           ++LG+G    V+RG+    G L A+K        +     + E  ++  + HKN+V+L  
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 147 CCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIIL-GIARGLQYLHEDSHT 203
              + + R  +L+ E+    SL  ++   S+ +    + F I+L  +  G+ +L E+   
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 204 RIVHRDIKASNVL--LDEKFQS--KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
            IVHR+IK  N++  + E  QS  K+ DFG AR   +D+ ++S    GT  Y  P+   R
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYER 189
Query: 260 GELSE--------KADIYSFGV 273
             L +          D++S GV
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGV 211

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 29/213 (13%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL---- 144
           LG GG G V+     D    VA+KK+ +   Q  +   L E+++I  + H N+V++    
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA-LREIKIIRRLDHDNIVKVFEIL 77
Query: 145 ----------LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                     +G  ++ +   +V EYM+    ++L   E    L    R   +  + RGL
Sbjct: 78  GPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL---EQGPLLEEHARL-FMYQLLRGL 133
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFP---EDQAYLSTNFAGTLG 250
           +Y+H      ++HRD+K +N+ ++ E    KIGDFGLAR        + +LS     T  
Sbjct: 134 KYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKW 189
Query: 251 YTAPEYAIRGELSEKA-DIYSFGVLVLEIISCR 282
           Y +P   +      KA D+++ G +  E+++ +
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL-LG 146
           ++G G FG VY+ KL D G LVA+KK+      QG++    E++++  + H N+VRL   
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVL-----QGKAFKNRELQIMRKLDHCNIVRLRYF 81
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII------LGIARGLQYLHED 200
             S G ++  VY  +    +   +Y  +  +        +I        + R L Y+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 201 SHTRIVHRDIKASNVLLDEKFQS-KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
               I HRDIK  N+LLD      K+ DFG A+     +  +S  +  +  Y APE    
Sbjct: 142 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRAPELIFG 196
Query: 260 G-ELSEKADIYSFGVLVLEII 279
             + +   D++S G ++ E++
Sbjct: 197 ATDYTSSIDVWSAGCVLAELL 217

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 19/209 (9%)
Query: 83  NFHPGNLLGRGGFGPVYR------GKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI 136
           ++  G  LG G F  V +      GK      +  ++L   +      E   EV ++  I
Sbjct: 6   HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQ 195
           +H N++ L     + +  +L+ E +    L D L   ES   L      Q +  I  G+ 
Sbjct: 66  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGVH 122
Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKF----QSKIGDFGLARFFPEDQAYLSTNFAGTLGY 251
           YLH     RI H D+K  N++L +K     + K+ DFG+A        +   N  GT  +
Sbjct: 123 YLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEF 177
Query: 252 TAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            APE      L  +AD++S GV+   ++S
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLS 206

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 20/201 (9%)
Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL-LG 146
           ++G G FG VY+ KL D G LVA+KK+  DK  +       E++++  + H N+VRL   
Sbjct: 46  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 100
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII------LGIARGLQYLHED 200
             S G ++  VY  +    +   +Y  +  +        +I        + R L Y+H  
Sbjct: 101 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 160
Query: 201 SHTRIVHRDIKASNVLLDEKFQS-KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
               I HRDIK  N+LLD      K+ DFG A+     +  +S     +  Y APE    
Sbjct: 161 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAPELIFG 215
Query: 260 G-ELSEKADIYSFGVLVLEII 279
             + +   D++S G ++ E++
Sbjct: 216 ATDYTSSIDVWSAGCVLAELL 236

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 120/278 (43%), Gaps = 43/278 (15%)
Query: 87  GNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK----SQQGESEFLS-EVRMITSIQ--- 137
           G LLG+GGFG V+ G +L D   VA+K +  ++    S   +S     EV ++  +    
Sbjct: 36  GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95
Query: 138 -HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
            H  ++RLL         +LV E     + DL  Y      L           +   +Q+
Sbjct: 96  GHPGVIRLLDWFETQEGFMLVLE-RPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQH 154
Query: 197 LHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE 255
            H      +VHRDIK  N+L+D  +  +K+ DFG       D+ Y  T+F GT  Y+ PE
Sbjct: 155 CHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPY--TDFDGTRVYSPPE 208
Query: 256 YAIRGELSE-KADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD 314
           +  R +     A ++S G+L+ +++      D+                +ER +  E+++
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVC----GDIP---------------FERDQ--EILE 247
Query: 315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIV 352
             +     V  D   +I     CL P  + RP + EI+
Sbjct: 248 AELHFPAHVSPDCCALIRR---CLAPKPSSRPSLEEIL 282

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 20/201 (9%)
Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL-LG 146
           ++G G FG VY+ KL D G LVA+KK+      QG++    E++++  + H N+VRL   
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVL-----QGKAFKNRELQIMRKLDHCNIVRLRYF 81
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII------LGIARGLQYLHED 200
             S G ++  VY  +    +   +Y  +  +        +I        + R L Y+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 201 SHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
               I HRDIK  N+LLD +    K+ DFG A+     +  +S  +  +  Y APE    
Sbjct: 142 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRAPELIFG 196
Query: 260 G-ELSEKADIYSFGVLVLEII 279
             + +   D++S G ++ E++
Sbjct: 197 ATDYTSSIDVWSAGCVLAELL 217

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 20/201 (9%)
Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL-LG 146
           ++G G FG VY+ KL D G LVA+KK+  DK  +       E++++  + H N+VRL   
Sbjct: 35  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 89
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII------LGIARGLQYLHED 200
             S G ++  VY  +    +   +Y  +  +        +I        + R L Y+H  
Sbjct: 90  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 149
Query: 201 SHTRIVHRDIKASNVLLDEKFQS-KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
               I HRDIK  N+LLD      K+ DFG A+     +  +S     +  Y APE    
Sbjct: 150 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAPELIFG 204
Query: 260 G-ELSEKADIYSFGVLVLEII 279
             + +   D++S G ++ E++
Sbjct: 205 ATDYTSSIDVWSAGCVLAELL 225

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 17/181 (9%)
Query: 106 GTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLLGCCS------DGSQRLLVY 158
           G  VAVKKL    ++Q        E+ ++  + HKN++ LL   +      +     LV 
Sbjct: 49  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 108
Query: 159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD 218
           E M + +L  +I+ E D        +Q++ GI    ++LH      I+HRD+K SN+++ 
Sbjct: 109 ELM-DANLCQVIHMELDHERMSYLLYQMLCGI----KHLHSAG---IIHRDLKPSNIVVK 160
Query: 219 EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEI 278
                KI DFGLAR    +  ++ T +  T  Y APE  +    +   DI+S G ++ E+
Sbjct: 161 SDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGEL 218
Query: 279 I 279
           +
Sbjct: 219 V 219

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 74  FQTLKKATKNFHPGNLLGRGGFGPVYR------GKLADGTLVAVKKLCVDKSQQGESEFL 127
           FQ++     ++  G  LG G F  V +      GK      +  ++L   +      E  
Sbjct: 20  FQSM--VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIE 77
Query: 128 SEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQI 186
            EV ++  I+H N++ L     + +  +L+ E +    L D L   ES   L      Q 
Sbjct: 78  REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQF 134
Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF----QSKIGDFGLARFFPEDQAYLS 242
           +  I  G+ YLH     RI H D+K  N++L +K     + K+ DFG+A        +  
Sbjct: 135 LKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF-- 189
Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            N  GT  + APE      L  +AD++S GV+   ++S
Sbjct: 190 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 227

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 20/201 (9%)
Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL-LG 146
           ++G G FG VY+ KL D G LVA+KK+  DK  +       E++++  + H N+VRL   
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 81
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII------LGIARGLQYLHED 200
             S G ++  VY  +    +   +Y  +  +        +I        + R L Y+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 201 SHTRIVHRDIKASNVLLDEKFQS-KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
               I HRDIK  N+LLD      K+ DFG A+     +  +S     +  Y APE    
Sbjct: 142 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAPELIFG 196
Query: 260 G-ELSEKADIYSFGVLVLEII 279
             + +   D++S G ++ E++
Sbjct: 197 ATDYTSSIDVWSAGCVLAELL 217

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 20/201 (9%)
Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL-LG 146
           ++G G FG VY+ KL D G LVA+KK+  DK  +       E++++  + H N+VRL   
Sbjct: 39  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 93
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII------LGIARGLQYLHED 200
             S G ++  VY  +    +   +Y  +  +        +I        + R L Y+H  
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 153
Query: 201 SHTRIVHRDIKASNVLLDEKFQS-KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
               I HRDIK  N+LLD      K+ DFG A+     +  +S     +  Y APE    
Sbjct: 154 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAPELIFG 208
Query: 260 G-ELSEKADIYSFGVLVLEII 279
             + +   D++S G ++ E++
Sbjct: 209 ATDYTSSIDVWSAGCVLAELL 229

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 82/171 (47%), Gaps = 16/171 (9%)
Query: 116 VDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGE 173
           +DKS++  +E   E+ ++    QH N++ L     DG    +V E MK   L D ++   
Sbjct: 55  IDKSKRDPTE---EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL--- 108
Query: 174 SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVL-LDEKFQS---KIGDFG 229
             KF +      ++  I + ++YLH      +VHRD+K SN+L +DE       +I DFG
Sbjct: 109 RQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFG 165
Query: 230 LARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            A+    +   L T    T  + APE   R       DI+S GVL+  +++
Sbjct: 166 FAKQLRAENGLLMTP-CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLT 215

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL-LG 146
           ++G G FG VY+ KL D G LVA+KK+  DK  +       E++++  + H N+VRL   
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 81
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII------LGIARGLQYLHED 200
             S G ++  VY  +    +   +Y  +  +        +I        + R L Y+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 201 SHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
               I HRDIK  N+LLD +    K+ DFG A+     +  +S     +  Y APE    
Sbjct: 142 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAPELIFG 196
Query: 260 G-ELSEKADIYSFGVLVLEII 279
             + +   D++S G ++ E++
Sbjct: 197 ATDYTSSIDVWSAGCVLAELL 217

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 20/201 (9%)
Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL-LG 146
           ++G G FG VY+ KL D G LVA+KK+  DK  +       E++++  + H N+VRL   
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 115
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII------LGIARGLQYLHED 200
             S G ++  VY  +    +   +Y  +  +        +I        + R L Y+H  
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 175
Query: 201 SHTRIVHRDIKASNVLLDEKFQS-KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
               I HRDIK  N+LLD      K+ DFG A+     +  +S     +  Y APE    
Sbjct: 176 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAPELIFG 230
Query: 260 G-ELSEKADIYSFGVLVLEII 279
             + +   D++S G ++ E++
Sbjct: 231 ATDYTSSIDVWSAGCVLAELL 251

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 77/150 (51%), Gaps = 12/150 (8%)
Query: 129 EVRMITSIQHKNLVRLLGCCSDGSQRLL--VYEYMKNRSLDLLIYGESDKFLNWSTRFQI 186
           E+ ++  + H N+V+L+    D ++  L  V+E +    +   +   + K L+       
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSEDQARFY 142
Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA 246
              + +G++YLH   + +I+HRDIK SN+L+ E    KI DFG++  F    A LS N  
Sbjct: 143 FQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLS-NTV 198
Query: 247 GTLGYTAPE--YAIRGELSEKA-DIYSFGV 273
           GT  + APE     R   S KA D+++ GV
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGV 228

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 57/101 (56%), Gaps = 9/101 (8%)
Query: 185 QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN 244
           ++ + I + L YL E     ++HRD+K SN+LLDE+ Q K+ DFG++    +D+A     
Sbjct: 128 KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA--KDR 183
Query: 245 FAGTLGYTAPEY-----AIRGELSEKADIYSFGVLVLEIIS 280
            AG   Y APE        + +   +AD++S G+ ++E+ +
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT 224

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL-LG 146
           ++G G FG VY+ KL D G LVA+KK+  DK  +       E++++  + H N+VRL   
Sbjct: 28  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 82
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII------LGIARGLQYLHED 200
             S G ++  VY  +    +   +Y  +  +        +I        + R L Y+H  
Sbjct: 83  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 142
Query: 201 SHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
               I HRDIK  N+LLD +    K+ DFG A+     +  +S     +  Y APE    
Sbjct: 143 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAPELIFG 197
Query: 260 G-ELSEKADIYSFGVLVLEII 279
             + +   D++S G ++ E++
Sbjct: 198 ATDYTSSIDVWSAGCVLAELL 218

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 20/201 (9%)
Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL-LG 146
           ++G G FG VY+ KL D G LVA+KK+  DK  +       E++++  + H N+VRL   
Sbjct: 39  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 93
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII------LGIARGLQYLHED 200
             S G ++  VY  +    +   +Y  +  +        +I        + R L Y+H  
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 153
Query: 201 SHTRIVHRDIKASNVLLDEKFQS-KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
               I HRDIK  N+LLD      K+ DFG A+     +  +S     +  Y APE    
Sbjct: 154 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAPELIFG 208
Query: 260 G-ELSEKADIYSFGVLVLEII 279
             + +   D++S G ++ E++
Sbjct: 209 ATDYTSSIDVWSAGCVLAELL 229

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL-LG 146
           ++G G FG VY+ KL D G LVA+KK+  DK  +       E++++  + H N+VRL   
Sbjct: 31  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 85
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII------LGIARGLQYLHED 200
             S G ++  VY  +    +   +Y  +  +        +I        + R L Y+H  
Sbjct: 86  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 145
Query: 201 SHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
               I HRDIK  N+LLD +    K+ DFG A+     +  +S     +  Y APE    
Sbjct: 146 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAPELIFG 200
Query: 260 G-ELSEKADIYSFGVLVLEII 279
             + +   D++S G ++ E++
Sbjct: 201 ATDYTSSIDVWSAGCVLAELL 221

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 41/223 (18%)
Query: 89  LLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMIT-SIQHKNLVRLLGC 147
           +LG G  G V       G  VAVK++ +D         L E++++T S  H N++R    
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA----LMEIKLLTESDDHPNVIRYY-- 75
Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ-------IILGIARGLQYLHED 200
           CS+ + R L Y  ++  +L+L    ES    + + + Q       ++  IA G+ +LH  
Sbjct: 76  CSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 133
Query: 201 SHTRIVHRDIKASNVLLD-------------EKFQSKIGDFGLARFFPEDQAYLSTNF-- 245
              +I+HRD+K  N+L+              E  +  I DFGL +     Q     N   
Sbjct: 134 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 191
Query: 246 -AGTLGYTAPE-------YAIRGELSEKADIYSFGVLVLEIIS 280
            +GT G+ APE          +  L+   DI+S G +   I+S
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL-LG 146
           ++G G FG VY+ KL D G LVA+KK+      QG++    E++++  + H N+VRL   
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVL-----QGKAFKNRELQIMRKLDHCNIVRLRYF 81
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII------LGIARGLQYLHED 200
             S G ++  VY  +    +   +Y  +  +        +I        + R L Y+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 201 SHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
               I HRDIK  N+LLD +    K+ DFG A+     +  +S     +  Y APE    
Sbjct: 142 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAPELIFG 196
Query: 260 G-ELSEKADIYSFGVLVLEII 279
             + +   D++S G ++ E++
Sbjct: 197 ATDYTSSIDVWSAGCVLAELL 217

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 83/160 (51%), Gaps = 19/160 (11%)
Query: 125 EFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGES----DKFLNW 180
           +F +E+++IT I+++  +   G  ++  +  ++YEYM+N S+  L + E     DK    
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSI--LKFDEYFFVLDKNYTC 146
Query: 181 STRFQIILGIARGL----QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE 236
               Q+I  I + +     Y+H + +  I HRD+K SN+L+D+  + K+ DFG + +  +
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204
Query: 237 DQAYLSTNFAGTLGYTAPEYAIRGELS---EKADIYSFGV 273
            +   S    GT  +  PE+    E S    K DI+S G+
Sbjct: 205 KKIKGS---RGTYEFMPPEF-FSNESSYNGAKVDIWSLGI 240

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 103/249 (41%), Gaps = 22/249 (8%)
Query: 38  KFNKAK--ELVRLALRTTKEGVSKDFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGF 95
           KF +AK  +  +     T   +SK   NGN   +   DF  L           +LG+G F
Sbjct: 305 KFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLM----------VLGKGSF 354
Query: 96  GPVYRG-KLADGTLVAVKKLCVDKSQQGESE--FLSEVRMITSIQHKNLVRLLGCCSDGS 152
           G V    +     L AVK L  D   Q +     + E R++        +  L  C    
Sbjct: 355 GKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414
Query: 153 QRL-LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIK 211
            RL  V EY+    L   I  +  +F      F     IA GL +L       I++RD+K
Sbjct: 415 DRLYFVMEYVNGGDLMYHIQ-QVGRFKEPHAVF-YAAEIAIGLFFLQSKG---IIYRDLK 469
Query: 212 ASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSF 271
             NV+LD +   KI DFG+ +    D    +  F GT  Y APE        +  D ++F
Sbjct: 470 LDNVMLDSEGHIKIADFGMCKENIWD-GVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAF 528
Query: 272 GVLVLEIIS 280
           GVL+ E+++
Sbjct: 529 GVLLYEMLA 537

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 91/202 (45%), Gaps = 14/202 (6%)
Query: 89  LLGRGGFGPVYRG-KLADGTLVAVKKLCVDK--SQQGES--EFLSEVRMITSIQHKNLVR 143
           ++G+G F  V R      G   AVK + V K  S  G S  +   E  +   ++H ++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF--QIILGIARGLQYLHEDS 201
           LL   S      +V+E+M    L   I   +D    +S       +  I   L+Y H+++
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 150
Query: 202 HTRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI 258
              I+HRD+K   VLL  K  S   K+G FG+A    E    ++    GT  + APE   
Sbjct: 151 ---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-SGLVAGGRVGTPHFMAPEVVK 206
Query: 259 RGELSEKADIYSFGVLVLEIIS 280
           R    +  D++  GV++  ++S
Sbjct: 207 REPYGKPVDVWGCGVILFILLS 228

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 21  TVLKRYQNLKP---IGSGAQGIVCAA--YDAILERNVAIKKLSRPFQNQTHAKRAYRELV 75
Query: 132 MITSIQHKNLVRLLGCCS-----DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQI 186
           ++  + HKN++ LL   +     +  Q + +   + + +L  +I  E D        +Q+
Sbjct: 76  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA 246
           + GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++ T   
Sbjct: 136 LCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPEV 186
Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
            T  Y APE  +     E  DI+S G ++ E+I
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 91/202 (45%), Gaps = 14/202 (6%)
Query: 89  LLGRGGFGPVYRG-KLADGTLVAVKKLCVDK--SQQGES--EFLSEVRMITSIQHKNLVR 143
           ++G+G F  V R      G   AVK + V K  S  G S  +   E  +   ++H ++V 
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF--QIILGIARGLQYLHEDS 201
           LL   S      +V+E+M    L   I   +D    +S       +  I   L+Y H+++
Sbjct: 93  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 152
Query: 202 HTRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI 258
              I+HRD+K   VLL  K  S   K+G FG+A    E    ++    GT  + APE   
Sbjct: 153 ---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-SGLVAGGRVGTPHFMAPEVVK 208
Query: 259 RGELSEKADIYSFGVLVLEIIS 280
           R    +  D++  GV++  ++S
Sbjct: 209 REPYGKPVDVWGCGVILFILLS 230

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 40/215 (18%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQHKNLVRLLGCC 148
           +G+G FG V+RGK   G  VAVK   +  S++  S F  +E+     ++H+N++  +   
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 149 SDG----SQRLLVYEYMKNRSLDLLIYGESDKFLNWST-----RFQIILGIARGLQYLHE 199
           +      +Q  LV +Y ++ SL          +LN  T       ++ L  A GL +LH 
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLF--------DYLNRYTVTVEGMIKLALSTASGLAHLHM 119
Query: 200 D-----SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA-----GTL 249
           +         I HRD+K+ N+L+ +     I D GLA     D A  + + A     GT 
Sbjct: 120 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTK 177
Query: 250 GYTAPEYAIRG------ELSEKADIYSFGVLVLEI 278
            Y APE           E  ++ADIY+ G++  EI
Sbjct: 178 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 40/215 (18%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQHKNLVRLLGCC 148
           +G+G FG V+RGK   G  VAVK   +  S++  S F  +E+     ++H+N++  +   
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 149 SDG----SQRLLVYEYMKNRSLDLLIYGESDKFLNWST-----RFQIILGIARGLQYLHE 199
           +      +Q  LV +Y ++ SL          +LN  T       ++ L  A GL +LH 
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLF--------DYLNRYTVTVEGMIKLALSTASGLAHLHM 118
Query: 200 D-----SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA-----GTL 249
           +         I HRD+K+ N+L+ +     I D GLA     D A  + + A     GT 
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTK 176
Query: 250 GYTAPEYAIRG------ELSEKADIYSFGVLVLEI 278
            Y APE           E  ++ADIY+ G++  EI
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 40/215 (18%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQHKNLVRLLGCC 148
           +G+G FG V+RGK   G  VAVK   +  S++  S F  +E+     ++H+N++  +   
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 149 SDG----SQRLLVYEYMKNRSLDLLIYGESDKFLNWST-----RFQIILGIARGLQYLHE 199
           +      +Q  LV +Y ++ SL          +LN  T       ++ L  A GL +LH 
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLF--------DYLNRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 200 D-----SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA-----GTL 249
           +         I HRD+K+ N+L+ +     I D GLA     D A  + + A     GT 
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTK 215
Query: 250 GYTAPEYAIRG------ELSEKADIYSFGVLVLEI 278
            Y APE           E  ++ADIY+ G++  EI
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 40/215 (18%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQHKNLVRLLGCC 148
           +G+G FG V+RGK   G  VAVK   +  S++  S F  +E+     ++H+N++  +   
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 149 SDG----SQRLLVYEYMKNRSLDLLIYGESDKFLNWST-----RFQIILGIARGLQYLHE 199
           +      +Q  LV +Y ++ SL          +LN  T       ++ L  A GL +LH 
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLF--------DYLNRYTVTVEGMIKLALSTASGLAHLHM 124
Query: 200 D-----SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA-----GTL 249
           +         I HRD+K+ N+L+ +     I D GLA     D A  + + A     GT 
Sbjct: 125 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTK 182
Query: 250 GYTAPEYAIRG------ELSEKADIYSFGVLVLEI 278
            Y APE           E  ++ADIY+ G++  EI
Sbjct: 183 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 40/215 (18%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQHKNLVRLLGCC 148
           +G+G FG V+RGK   G  VAVK   +  S++  S F  +E+     ++H+N++  +   
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 149 SDG----SQRLLVYEYMKNRSLDLLIYGESDKFLNWST-----RFQIILGIARGLQYLHE 199
           +      +Q  LV +Y ++ SL          +LN  T       ++ L  A GL +LH 
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLF--------DYLNRYTVTVEGMIKLALSTASGLAHLHM 121
Query: 200 D-----SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA-----GTL 249
           +         I HRD+K+ N+L+ +     I D GLA     D A  + + A     GT 
Sbjct: 122 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTK 179
Query: 250 GYTAPEYAIRG------ELSEKADIYSFGVLVLEI 278
            Y APE           E  ++ADIY+ G++  EI
Sbjct: 180 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E M+    DL  +      L           +   +
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERMEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 127
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H   +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 128 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 181
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 182 PEW-IRYHRYHGRSAAVWSLGILLYDMV 208

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 40/215 (18%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQHKNLVRLLGCC 148
           +G+G FG V+RGK   G  VAVK   +  S++  S F  +E+     ++H+N++  +   
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 149 SDG----SQRLLVYEYMKNRSLDLLIYGESDKFLNWST-----RFQIILGIARGLQYLHE 199
           +      +Q  LV +Y ++ SL          +LN  T       ++ L  A GL +LH 
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLF--------DYLNRYTVTVEGMIKLALSTASGLAHLHM 144
Query: 200 D-----SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA-----GTL 249
           +         I HRD+K+ N+L+ +     I D GLA     D A  + + A     GT 
Sbjct: 145 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTK 202
Query: 250 GYTAPEYAIRG------ELSEKADIYSFGVLVLEI 278
            Y APE           E  ++ADIY+ G++  EI
Sbjct: 203 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 88  NLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           ++LG+G    V+RG+    G L A+K        +     + E  ++  + HKN+V+L  
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 147 CCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIIL-GIARGLQYLHEDSHT 203
              + + R  +L+ E+    SL  ++   S+ +    + F I+L  +  G+ +L E+   
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 204 RIVHRDIKASNVL--LDEKFQS--KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
            IVHR+IK  N++  + E  QS  K+ DFG AR   +D+ ++     GT  Y  P+   R
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVX--LYGTEEYLHPDMYER 189
Query: 260 GELSEK--------ADIYSFGV 273
             L +          D++S GV
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGV 211

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 90  LGRGGFGPVYRGKLA-DGTLVAVKKLCVD-KSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G +G V        G  VA+KKL    +S+        E+R++  ++H+N++ LL  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 148 CS------DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
            +      D +   LV  +M     DL    + +K      +F ++  + +GL+Y+H   
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGT---DLGKLMKHEKLGEDRIQF-LVYQMLKGLRYIHAAG 148
Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG---TLGYTAPEYAI 258
              I+HRD+K  N+ ++E  + KI DFGLAR     QA   +   G   T  Y APE  +
Sbjct: 149 ---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QA--DSEMXGXVVTRWYRAPEVIL 198
Query: 259 RG-ELSEKADIYSFGVLVLEIISCR 282
                ++  DI+S G ++ E+I+ +
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           +G G FG V   K +  G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EYM    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   K+ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           +G G FG V   K +  G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EYM    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   K+ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 96/232 (41%), Gaps = 20/232 (8%)
Query: 53  TKEGVSKDFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRG-KLADGTLVAV 111
           T   VSK   NGN   +   DF  L           +LG+G FG V    +     L AV
Sbjct: 1   TTNTVSKFDNNGNRDRMKLTDFNFLM----------VLGKGSFGKVMLSERKGTDELYAV 50
Query: 112 KKLCVDKSQQGESE--FLSEVRMITSIQHKNLVRLLGCCSDGSQRL-LVYEYMKNRSLDL 168
           K L  D   Q +     + E R++        +  L  C     RL  V EY+    L  
Sbjct: 51  KILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY 110
Query: 169 LIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDF 228
            I  +  +F      F     IA GL +L       I++RD+K  NV+LD +   KI DF
Sbjct: 111 HIQ-QVGRFKEPHAVF-YAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADF 165
Query: 229 GLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           G+ +    D    +  F GT  Y APE        +  D ++FGVL+ E+++
Sbjct: 166 GMCKENIWD-GVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 216

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 89  LLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           ++G G FG V++ KL +   VA+KK+  DK  +       E++++  ++H N+V L    
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR-----ELQIMRIVKHPNVVDLKAFF 101
Query: 149 -SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIIL------GIARGLQYLHEDS 201
            S+G ++  V+  +    +   +Y  S  +        ++L       + R L Y+H   
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-- 159
Query: 202 HTRIVHRDIKASNVLLDEKFQS-KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
              I HRDIK  N+LLD      K+ DFG A+     +  +S     +  Y APE     
Sbjct: 160 -IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX--ICSRYYRAPELIFGA 216
Query: 261 -ELSEKADIYSFGVLVLEII 279
              +   DI+S G ++ E++
Sbjct: 217 TNYTTNIDIWSTGCVMAELM 236

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 12/175 (6%)
Query: 67  RTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESE 125
           R  S F  QT++          +L  GGF  VY  + +  G   A+K+L  ++ ++  + 
Sbjct: 13  RDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRA- 71
Query: 126 FLSEVRMITSIQ-HKNLVRLLGCCSDGSQR--------LLVYEYMKNRSLDLLIYGESDK 176
            + EV  +  +  H N+V+     S G +         LL+ E  K + ++ L   ES  
Sbjct: 72  IIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG 131
Query: 177 FLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLA 231
            L+  T  +I     R +Q++H      I+HRD+K  N+LL  +   K+ DFG A
Sbjct: 132 PLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 84  FHPGNLLGRGGFGPVYRGKLADGTLVA----VKKLCVDKSQQGES--EFLSEVRMITSIQ 137
           +  G  LG G F  V + +     L      +KK     S++G S  +   EV ++  IQ
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQY 196
           H N++ L     + +  +L+ E +    L D L   ES   L      + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYY 129
Query: 197 LHEDSHTRIVHRDIKASNVLLDE----KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
           LH     +I H D+K  N++L +    K + KI DFGLA        +   N  GT  + 
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPAFV 184
Query: 253 APEYAIRGELSEKADIYSFGVLVLEIIS 280
           APE      L  +AD++S GV+   ++S
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 21  TVLKRYQNLKP---IGSGAQGIVCAA--YDAILERNVAIKKLSRPFQNQTHAKRAYRELV 75
Query: 132 MITSIQHKNLVRLLGCCS-----DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQI 186
           ++  + HKN++ LL   +     +  Q + +   + + +L  +I  E D        +Q+
Sbjct: 76  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA 246
           + GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++     
Sbjct: 136 LCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMEPEV 186
Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRK 283
            T  Y APE  +     E  DI+S G ++ E++ C K
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-CHK 222

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 16/166 (9%)
Query: 116 VDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGE 173
           +DKS++  +E   E+ ++    QH N++ L     DG    +V E  K   L D ++   
Sbjct: 55  IDKSKRDPTE---EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKIL--- 108
Query: 174 SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVL-LDEKFQS---KIGDFG 229
             KF +      ++  I + ++YLH      +VHRD+K SN+L +DE       +I DFG
Sbjct: 109 RQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFG 165
Query: 230 LARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLV 275
            A+    +   L T    T  + APE   R       DI+S GVL+
Sbjct: 166 FAKQLRAENGLLXTP-CYTANFVAPEVLERQGYDAACDIWSLGVLL 210

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 18/209 (8%)
Query: 82  KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESE---FLSEVRMITSIQH 138
           ++F    ++GRG FG V   KL +   V   K+         +E   F  E  ++ +   
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QIILGIARGLQ 195
           K +  L     D +   LV +Y     L  L+    D+      RF   ++++ I   + 
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAI-DSVH 192
Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE 255
            LH       VHRDIK  N+L+D     ++ DFG      ED    S+   GT  Y +PE
Sbjct: 193 QLH------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246
Query: 256 Y-----AIRGELSEKADIYSFGVLVLEII 279
                   +G    + D +S GV + E++
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEML 275

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 84  FHPGNLLGRGGFGPVYRGKLADGTLVA----VKKLCVDKSQQGES--EFLSEVRMITSIQ 137
           +  G  LG G F  V + +     L      +KK     S++G S  +   EV ++  IQ
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQY 196
           H N++ L     + +  +L+ E +    L D L   ES   L      + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYY 129
Query: 197 LHEDSHTRIVHRDIKASNVLLDE----KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
           LH     +I H D+K  N++L +    K + KI DFGLA        +   N  GT  + 
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFV 184
Query: 253 APEYAIRGELSEKADIYSFGVLVLEIIS 280
           APE      L  +AD++S GV+   ++S
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 84  FHPGNLLGRGGFGPVYRGKLADGTLVA----VKKLCVDKSQQGES--EFLSEVRMITSIQ 137
           +  G  LG G F  V + +     L      +KK     S++G S  +   EV ++  IQ
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQY 196
           H N++ L     + +  +L+ E +    L D L   ES   L      + +  I  G+ Y
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYY 128
Query: 197 LHEDSHTRIVHRDIKASNVLLDE----KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
           LH     +I H D+K  N++L +    K + KI DFGLA     D      N  GT  + 
Sbjct: 129 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFV 183
Query: 253 APEYAIRGELSEKADIYSFGVLVLEIIS 280
           APE      L  +AD++S GV+   ++S
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLS 211

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 84  FHPGNLLGRGGFGPVYRGKLADGTLVA----VKKLCVDKSQQGES--EFLSEVRMITSIQ 137
           +  G  LG G F  V + +     L      +KK     S++G S  +   EV ++  IQ
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQY 196
           H N++ L     + +  +L+ E +    L D L   ES   L      + +  I  G+ Y
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYY 128
Query: 197 LHEDSHTRIVHRDIKASNVLLDE----KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
           LH     +I H D+K  N++L +    K + KI DFGLA        +   N  GT  + 
Sbjct: 129 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFV 183
Query: 253 APEYAIRGELSEKADIYSFGVLVLEIIS 280
           APE      L  +AD++S GV+   ++S
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLS 211

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 84  FHPGNLLGRGGFGPVYRGKLADGTLVA----VKKLCVDKSQQGES--EFLSEVRMITSIQ 137
           +  G  LG G F  V + +     L      +KK     S++G S  +   EV ++  IQ
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQY 196
           H N++ L     + +  +L+ E +    L D L   ES   L      + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYY 129
Query: 197 LHEDSHTRIVHRDIKASNVLLDE----KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
           LH     +I H D+K  N++L +    K + KI DFGLA        +   N  GT  + 
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFV 184
Query: 253 APEYAIRGELSEKADIYSFGVLVLEIIS 280
           APE      L  +AD++S GV+   ++S
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 84  FHPGNLLGRGGFGPVYRGKLADGTLVA----VKKLCVDKSQQGES--EFLSEVRMITSIQ 137
           +  G  LG G F  V + +     L      +KK     S++G S  +   EV ++  IQ
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQY 196
           H N++ L     + +  +L+ E +    L D L   ES   L      + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYY 129
Query: 197 LHEDSHTRIVHRDIKASNVLLDE----KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
           LH     +I H D+K  N++L +    K + KI DFGLA        +   N  GT  + 
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFV 184
Query: 253 APEYAIRGELSEKADIYSFGVLVLEIIS 280
           APE      L  +AD++S GV+   ++S
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 28/209 (13%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS 149
           +G+G +G V+ GK   G  VAVK     +      E  +E+     ++H+N++  +    
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFIAADI 101
Query: 150 DGS----QRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTR 204
            G+    Q  L+ +Y +N SL D L        L+  +  ++      GL +LH +  + 
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 205 -----IVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS---TNFAGTLGYTAPEY 256
                I HRD+K+ N+L+ +     I D GLA  F  D   +        GT  Y  PE 
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE- 216
Query: 257 AIRGELSEK-------ADIYSFGVLVLEI 278
            +   L+         AD+YSFG+++ E+
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 103/233 (44%), Gaps = 26/233 (11%)
Query: 55  EGVSKDFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKK 113
           EGV        L+ + Y   + +  AT        LGRG FG V+R +    G   AVKK
Sbjct: 73  EGV---LLTEKLKPVDYEYREEVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKK 125
Query: 114 LCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGE 173
           + ++  +        E+     +    +V L G   +G    +  E ++  SL  L+   
Sbjct: 126 VRLEVFRA------EELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV--- 176
Query: 174 SDKFLNWSTRFQIILGIA-RGLQYLHEDSHTRIVHRDIKASNVLL-DEKFQSKIGDFGLA 231
            ++      R    LG A  GL+YLH     RI+H D+KA NVLL  +   + + DFG A
Sbjct: 177 KEQGCLPEDRALYYLGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHA 233
Query: 232 RFFPED---QAYLSTNF-AGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
                D   ++ L+ ++  GT  + APE  +      K D++S   ++L +++
Sbjct: 234 VCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLN 286

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E  +    DL  +      L           +   +
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 142
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H   +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 143 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 196
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 197 PEW-IRYHRYHGRSAAVWSLGILLYDMV 223

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVD-KSQQGESEFLSEVR 131
           T+ K  +N  P   +G G  G V      D  L   VA+KKL    ++Q        E+ 
Sbjct: 21  TVLKRYQNLKP---IGSGAQGIVCAA--YDAILERNVAIKKLSRPFQNQTHAKRAYRELV 75
Query: 132 MITSIQHKNLVRLLGCCS-----DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQI 186
           ++  + HKN++ LL   +     +  Q + +   + + +L  +I  E D        +Q+
Sbjct: 76  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA 246
           + GI    ++LH      I+HRD+K SN+++      KI DFGLAR      +++     
Sbjct: 136 LCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMEPEV 186
Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRK 283
            T  Y APE  +     E  D++S G ++ E++ C K
Sbjct: 187 VTRYYRAPEVILGMGYKENVDLWSVGCIMGEMV-CHK 222

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 84  FHPGNLLGRGGFGPVYRGKLADGTLVA----VKKLCVDKSQQGES--EFLSEVRMITSIQ 137
           +  G  LG G F  V + +     L      +KK     S++G S  +   EV ++  IQ
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQY 196
           H N++ L     + +  +L+ E +    L D L   ES   L      + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYY 129
Query: 197 LHEDSHTRIVHRDIKASNVLLDE----KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
           LH     +I H D+K  N++L +    K + KI DFGLA        +   N  GT  + 
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFV 184
Query: 253 APEYAIRGELSEKADIYSFGVLVLEIIS 280
           APE      L  +AD++S GV+   ++S
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E  +    DL  +      L           +   +
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 142
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H   +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 143 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 196
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 197 PEW-IRYHRYHGRSAAVWSLGILLYDMV 223

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E  +    DL  +      L           +   +
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 155
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H   +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 156 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 209
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 210 PEW-IRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 84  FHPGNLLGRGGFGPVYRGKLADGTLVA----VKKLCVDKSQQGES--EFLSEVRMITSIQ 137
           +  G  LG G F  V + +     L      +KK     S++G S  +   EV ++  IQ
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQY 196
           H N++ L     + +  +L+ E +    L D L   ES   L      + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYY 129
Query: 197 LHEDSHTRIVHRDIKASNVLLDE----KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
           LH     +I H D+K  N++L +    K + KI DFGLA        +   N  GT  + 
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFV 184
Query: 253 APEYAIRGELSEKADIYSFGVLVLEIIS 280
           APE      L  +AD++S GV+   ++S
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E  +    DL  +      L           +   +
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 143
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H   +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 144 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 197
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 198 PEW-IRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E  +    DL  +      L           +   +
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 170
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H   +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 171 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 224
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 225 PEW-IRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E  +    DL  +      L           +   +
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 143
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H   +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 144 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 197
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 198 PEW-IRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E  +    DL  +      L           +   +
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 143
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H   +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 144 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 197
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 198 PEW-IRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 84  FHPGNLLGRGGFGPVYRGKLADGTLVA----VKKLCVDKSQQGES--EFLSEVRMITSIQ 137
           +  G  LG G F  V + +     L      +KK     S++G S  +   EV ++  IQ
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQY 196
           H N++ L     + +  +L+ E +    L D L   ES   L      + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYY 129
Query: 197 LHEDSHTRIVHRDIKASNVLLDE----KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
           LH     +I H D+K  N++L +    K + KI DFGLA        +   N  GT  + 
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFV 184
Query: 253 APEYAIRGELSEKADIYSFGVLVLEIIS 280
           APE      L  +AD++S GV+   ++S
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 84  FHPGNLLGRGGFGPVYRGKLADGTLVA----VKKLCVDKSQQGES--EFLSEVRMITSIQ 137
           +  G  LG G F  V + +     L      +KK     S++G S  +   EV ++  IQ
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQY 196
           H N++ L     + +  +L+ E +    L D L   ES   L      + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYY 129
Query: 197 LHEDSHTRIVHRDIKASNVLLDE----KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
           LH     +I H D+K  N++L +    K + KI DFGLA        +   N  GT  + 
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFV 184
Query: 253 APEYAIRGELSEKADIYSFGVLVLEIIS 280
           APE      L  +AD++S GV+   ++S
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E  +    DL  +      L           +   +
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 127
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H   +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 128 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 181
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 182 PEW-IRYHRYHGRSAAVWSLGILLYDMV 208

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E  +    DL  +      L           +   +
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 155
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H   +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 156 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 209
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 210 PEW-IRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E  +    DL  +      L           +   +
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 128
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H   +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 129 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 182
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 183 PEW-IRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E  +    DL  +      L           +   +
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 156
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H   +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 157 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 210
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 211 PEW-IRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 84  FHPGNLLGRGGFGPVYRGKLADGTLVA----VKKLCVDKSQQGES--EFLSEVRMITSIQ 137
           +  G  LG G F  V + +     L      +KK     S++G S  +   EV ++  IQ
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQY 196
           H N++ L     + +  +L+ E +    L D L   ES   L      + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYY 129
Query: 197 LHEDSHTRIVHRDIKASNVLLDE----KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
           LH     +I H D+K  N++L +    K + KI DFGLA        +   N  GT  + 
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFV 184
Query: 253 APEYAIRGELSEKADIYSFGVLVLEIIS 280
           APE      L  +AD++S GV+   ++S
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E  +    DL  +      L           +   +
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 155
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H   +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 156 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 209
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 210 PEW-IRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E  +    DL  +      L           +   +
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 156
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H   +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 157 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 210
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 211 PEW-IRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 77/145 (53%), Gaps = 11/145 (7%)
Query: 90  LGRGGFGPVYRG---KLAD-GTLVAVKKL--CVDKSQQGESE-FLSEVRMITSIQHKNLV 142
           LG+G F  +++G   ++ D G L   + L   +DK+ +  SE F     M++ + HK+LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
              G C  G + +LV E++K  SLD  +  ++   +N   + ++   +A  + +L E++ 
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFLEENT- 133
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGD 227
             ++H ++ A N+LL  +   K G+
Sbjct: 134 --LIHGNVCAKNILLIREEDRKTGN 156

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 84  FHPGNLLGRGGFGPVYRGKLADGTLVA----VKKLCVDKSQQGES--EFLSEVRMITSIQ 137
           +  G  LG G F  V + +     L      +KK     S++G S  +   EV ++  IQ
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQY 196
           H N++ L     + +  +L+ E +    L D L   ES   L      + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYY 129
Query: 197 LHEDSHTRIVHRDIKASNVLLDE----KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
           LH     +I H D+K  N++L +    K + KI DFGLA        +   N  GT  + 
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFV 184
Query: 253 APEYAIRGELSEKADIYSFGVLVLEIIS 280
           APE      L  +AD++S GV+   ++S
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L    AGT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----AGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 87  GNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK----- 139
           G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K     
Sbjct: 48  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107
Query: 140 -NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLH 198
             ++RLL         +L+ E  +    DL  +      L           +   +++ H
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCH 166
Query: 199 EDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYA 257
              +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ PE+ 
Sbjct: 167 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSPPEW- 219
Query: 258 IRGE--LSEKADIYSFGVLVLEII 279
           IR        A ++S G+L+ +++
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMV 243

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E  +    DL  +      L           +   +
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 128
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H   +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 129 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 182
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 183 PEW-IRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E  +    DL  +      L           +   +
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 156
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H   +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 157 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 210
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 211 PEW-IRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E  +    DL  +      L           +   +
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 156
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H   +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 157 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 210
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 211 PEW-IRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E  +    DL  +      L           +   +
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 155
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H   +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 156 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 209
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 210 PEW-IRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 77  LKKATKNFHPGNLLGRGGFGPV--YRGKLADGTLVAVKKLC-VDKSQQGESEFLSEVRMI 133
           L+   +++    ++GRG FG V   R K A   + A+K L   +  ++ +S F  E R I
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHK-ASQKVYAMKLLSKFEMIKRSDSAFFWEERDI 128
Query: 134 TSIQHKNLVRLLGCC-SDGSQRLLVYEYMKNRSLDLLI--YGESDKFLNWSTRFQIILGI 190
            +  +   V  L C   D     +V EYM    L  L+  Y   +K+  + T  +++L  
Sbjct: 129 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTA-EVVLA- 186
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
              L  +H      ++HRD+K  N+LLD+    K+ DFG      E          GT  
Sbjct: 187 ---LDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPD 240
Query: 251 YTAPEY----AIRGELSEKADIYSFGVLVLEII 279
           Y +PE        G    + D +S GV + E++
Sbjct: 241 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 273

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E  +    DL  +      L           +   +
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 170
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H   +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 171 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 224
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 225 PEW-IRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E  +    DL  +      L           +   +
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 128
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H   +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 129 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 182
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 183 PEW-IRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           +G G FG V   K +  G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   K+ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 57  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 116
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E  +    DL  +      L           +   +
Sbjct: 117 SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 175
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H   +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 176 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 229
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 230 PEW-IRYHRYHGRSAAVWSLGILLYDMV 256

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 19/198 (9%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LGRG FG V+R K    G   AVKK+ ++  +      + E+     +    +V L G  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAV 133
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIA-RGLQYLHEDSHTRIVH 207
            +G    +  E ++  SL  LI            R    LG A  GL+YLH     RI+H
Sbjct: 134 REGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHT---RRILH 187
Query: 208 RDIKASNVLL-DEKFQSKIGDFGLARFFPED---QAYLSTNF-AGTLGYTAPEYAIRGEL 262
            D+KA NVLL  +  ++ + DFG A     D   ++ L+ ++  GT  + APE  +    
Sbjct: 188 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 247
Query: 263 SEKADIYSFGVLVLEIIS 280
             K DI+S   ++L +++
Sbjct: 248 DAKVDIWSSCCMMLHMLN 265

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 84  FHPGNLLGRGGFGPVYRGKLADGTLVA----VKKLCVDKSQQGES--EFLSEVRMITSIQ 137
           +  G  LG G F  V + +     L      +KK     S++G S  +   EV ++  IQ
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQY 196
           H N++ L     + +  +L+ E +    L D L   ES   L      + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYY 129
Query: 197 LHEDSHTRIVHRDIKASNVLLDE----KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
           LH     +I H D+K  N++L +    K + KI DFGLA     D      N  GT  + 
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFV 184
Query: 253 APEYAIRGELSEKADIYSFGVLVLEIIS 280
           APE      L  +AD++S GV+   ++S
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 32  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 91
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E  +    DL  +      L           +   +
Sbjct: 92  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 150
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H   +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 151 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 204
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 205 PEW-IRYHRYHGRSAAVWSLGILLYDMV 231

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 84  FHPGNLLGRGGFGPVYRGKLADGTLVA----VKKLCVDKSQQGES--EFLSEVRMITSIQ 137
           +  G  LG G F  V + +     L      +KK     S++G S  +   EV ++  IQ
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQY 196
           H N++ L     + +  +L+ E +    L D L   ES   L      + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYY 129
Query: 197 LHEDSHTRIVHRDIKASNVLLDE----KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
           LH     +I H D+K  N++L +    K + KI DFGLA        +   N  GT  + 
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFV 184
Query: 253 APEYAIRGELSEKADIYSFGVLVLEIIS 280
           APE      L  +AD++S GV+   ++S
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 86/197 (43%), Gaps = 30/197 (15%)
Query: 90  LGRGGFGPVYRGKLADGT----LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LGRG    VYR K   GT     + V K  VDK         +E+ ++  + H N+++L 
Sbjct: 61  LGRGATSIVYRCK-QKGTQKPYALKVLKKTVDKKI-----VRTEIGVLLRLSHPNIIKLK 114
Query: 146 GCCSDGSQRLLVYEYMK-----NRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
                 ++  LV E +      +R ++   Y E D           +  I   + YLHE+
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA-------DAVKQILEAVAYLHEN 167
Query: 201 SHTRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYA 257
               IVHRD+K  N+L          KI DFGL++   E Q  + T   GT GY APE  
Sbjct: 168 G---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV-EHQVLMKT-VCGTPGYCAPEIL 222
Query: 258 IRGELSEKADIYSFGVL 274
                  + D++S G++
Sbjct: 223 RGCAYGPEVDMWSVGII 239

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E  +    DL  +      L           +   +
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 123
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H      ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 124 RHCHNXG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 177
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 178 PEW-IRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 8   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 67
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E  +    DL  +      L           +   +
Sbjct: 68  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 126
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H   +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 127 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 180
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 181 PEW-IRYHRYHGRSAAVWSLGILLYDMV 207

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E  +    DL  +      L           +   +
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 123
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H   +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 124 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 177
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 178 PEW-IRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 77/145 (53%), Gaps = 11/145 (7%)
Query: 90  LGRGGFGPVYRG---KLAD-GTLVAVKKL--CVDKSQQGESE-FLSEVRMITSIQHKNLV 142
           LG+G F  +++G   ++ D G L   + L   +DK+ +  SE F     M++ + HK+LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
              G C  G + +LV E++K  SLD  +  ++   +N   + ++   +A  + +L E++ 
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAWAMHFLEENT- 133
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGD 227
             ++H ++ A N+LL  +   K G+
Sbjct: 134 --LIHGNVCAKNILLIREEDRKTGN 156

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 94
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 95  FSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 146
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+DE+   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 147 --LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 200
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 201 GYNKAVDWWALGVLIYEMAA 220

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K +  G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 108
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFXEPHARFYAAQIVLT----FEYLHS- 160
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 161 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 214
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 215 GYNKAVDWWALGVLIYEMAA 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K +  G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFXEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K +  G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY     +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIG---RFXEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+++D++   K+ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 102/233 (43%), Gaps = 26/233 (11%)
Query: 55  EGVSKDFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKK 113
           EGV        L+ + Y   + +  AT        LGRG FG V+R +    G   AVKK
Sbjct: 54  EGV---LLTEKLKPVDYEYREEVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKK 106
Query: 114 LCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGE 173
           + ++  +        E+     +    +V L G   +G    +  E ++  SL  L+   
Sbjct: 107 VRLEVFRA------EELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV--- 157
Query: 174 SDKFLNWSTRFQIILGIA-RGLQYLHEDSHTRIVHRDIKASNVLL-DEKFQSKIGDFGLA 231
            ++      R    LG A  GL+YLH     RI+H D+KA NVLL  +   + + DFG A
Sbjct: 158 KEQGCLPEDRALYYLGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHA 214
Query: 232 RFFPED---QAYLSTNF-AGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
                D   +  L+ ++  GT  + APE  +      K D++S   ++L +++
Sbjct: 215 VCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLN 267

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K +  G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFXEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 83  NFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK- 139
            +  G LLG GGFG VY G +++D   VA+K +  D+ S  GE    + V M   +  K 
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 140 -----NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
                 ++RLL         +L+ E  +    DL  +      L           +   +
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAV 123
Query: 195 QYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           ++ H   +  ++HRDIK  N+L+D  + + K+ DFG      +D  Y  T+F GT  Y+ 
Sbjct: 124 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--TDFDGTRVYSP 177
Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEII 279
           PE+ IR        A ++S G+L+ +++
Sbjct: 178 PEW-IRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 19/198 (9%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +GRG FG V+R K    G   AVKK+ ++  +      + E+     +    +V L G  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAV 135
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIA-RGLQYLHEDSHTRIVH 207
            +G    +  E ++  SL  LI            R    LG A  GL+YLH     RI+H
Sbjct: 136 REGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHT---RRILH 189
Query: 208 RDIKASNVLL-DEKFQSKIGDFGLARFFPED---QAYLSTNF-AGTLGYTAPEYAIRGEL 262
            D+KA NVLL  +  ++ + DFG A     D   ++ L+ ++  GT  + APE  +    
Sbjct: 190 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 249
Query: 263 SEKADIYSFGVLVLEIIS 280
             K DI+S   ++L +++
Sbjct: 250 DAKVDIWSSCCMMLHMLN 267

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 28/213 (13%)
Query: 83  NFHPGNLLGRGGFGP-VYRGKLADGTLVAVKKL---CVDKSQQGESEFLSEVRMITSIQH 138
           +F P ++LG G  G  VYRG + D   VAVK++   C   + + E + L E     S +H
Sbjct: 25  SFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILPECFSFADR-EVQLLRE-----SDEH 77
Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR-FQIILGIARGLQYL 197
            N++R    C++   R   Y  ++  +  L  Y E   F +       ++     GL +L
Sbjct: 78  PNVIRYF--CTE-KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 198 HEDSHTRIVHRDIKASNVLLDE-----KFQSKIGDFGLARFFPEDQAYLS--TNFAGTLG 250
           H      IVHRD+K  N+L+       K ++ I DFGL +     +   S  +   GT G
Sbjct: 135 HS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 251 YTAPEYA---IRGELSEKADIYSFGVLVLEIIS 280
           + APE      +   +   DI+S G +   +IS
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 129 EVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIIL 188
           E+ +++ ++H N++++L    +     LV E      LDL  + +    L+      I  
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVME-KHGSGLDLFAFIDRHPRLDEPLASYIFR 137
Query: 189 GIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT 248
            +   + YL       I+HRDIK  N+++ E F  K+ DFG A +   ++  L   F GT
Sbjct: 138 QLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYTFCGT 192
Query: 249 LGYTAPEYAI----RGELSEKADIYSFGVLVLEII 279
           + Y APE  +    RG    + +++S GV +  ++
Sbjct: 193 IEYCAPEVLMGNPYRG---PELEMWSLGVTLYTLV 224

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 19/198 (9%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +GRG FG V+R K    G   AVKK+ ++  +      + E+     +    +V L G  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAV 119
Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIA-RGLQYLHEDSHTRIVH 207
            +G    +  E ++  SL  LI            R    LG A  GL+YLH     RI+H
Sbjct: 120 REGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHT---RRILH 173
Query: 208 RDIKASNVLL-DEKFQSKIGDFGLARFFPED---QAYLSTNF-AGTLGYTAPEYAIRGEL 262
            D+KA NVLL  +  ++ + DFG A     D   ++ L+ ++  GT  + APE  +    
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 263 SEKADIYSFGVLVLEIIS 280
             K DI+S   ++L +++
Sbjct: 234 DAKVDIWSSCCMMLHMLN 251

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 100
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 101 FSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFXEPHARFYAAQIVLT----FEYLHS- 152
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 153 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 206
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 207 GYNKAVDWWALGVLIYEMAA 226

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K +  G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 108
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 160
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 161 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 214
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 215 GYNKAVDWWALGVLIYEMAA 234

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K +  G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY     +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+++D++   K+ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K +  G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K +  G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 102
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 103 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFXEPHARFYAAQIVLT----FEYLHS- 154
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 155 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 208
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 209 GYNKAVDWWALGVLIYEMAA 228

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K +  G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 20/198 (10%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K +  G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 93
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QIILGIARGLQYLHEDSH 202
               D S   +V EY+    +         +F     RF   QI+L      +YLH    
Sbjct: 94  FSFKDNSNLYMVMEYVPGGEM-FSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS--- 145
Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
             +++RD+K  N+L+D++   ++ DFG A+         +    GT  Y APE  +    
Sbjct: 146 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEYLAPEIILSKGY 201
Query: 263 SEKADIYSFGVLVLEIIS 280
           ++  D ++ GVL+ E+ +
Sbjct: 202 NKAVDWWALGVLIYEMAA 219

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 51/107 (47%), Gaps = 14/107 (13%)
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ----- 238
             I + IA  +++LH      ++HRD+K SN+        K+GDFGL     +D+     
Sbjct: 167 LHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 239 -----AYLS-TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
                AY +     GT  Y +PE       S K DI+S G+++ E++
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K +  G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFXEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K +  G   A+K   K  V K ++ E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY     +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+++D++   K+ DFGLA+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K +  G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 108
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 160
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+         +    GT  Y APE  +  
Sbjct: 161 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEYLAPEIILSK 214
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 215 GYNKAVDWWALGVLIYEMAA 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFXEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFXEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFAEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 128
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 129 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFXEPHARFYAAQIVLT----FEYLHS- 180
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 181 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 234
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 235 GYNKAVDWWALGVLIYEMAA 254

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+++D++   ++ DFG A+        L     GT  Y APE  I  
Sbjct: 160 --LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIIISK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 36/215 (16%)
Query: 128 SEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR---- 183
           +E+ ++  + H  ++++     D     +V E M+   L   + G  +K L  +T     
Sbjct: 70  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYF 126
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPEDQAY 240
           +Q++L +    QYLHE+    I+HRD+K  NVLL   +E    KI DFG ++   E    
Sbjct: 127 YQMLLAV----QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-- 177
Query: 241 LSTNFAGTLGYTAPEYAIR---GELSEKADIYSFGVLVLEIIS-----CRKNTDLTLPSE 292
           L     GT  Y APE  +       +   D +S GV++   +S         T ++L  +
Sbjct: 178 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 237
Query: 293 M-----QYLPEYAWKLYERG----RILELVDPRMR 318
           +      ++PE   ++ E+     + L +VDP+ R
Sbjct: 238 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 272

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 19/214 (8%)
Query: 78  KKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDK----SQQGES--EFLSEVR 131
           +K    +  G  LG G F  V + +     L    K    +    S++G S  E   EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 132 MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGI 190
           ++  + H N++ L     + +  +L+ E +    L D L   ES   L+       I  I
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQI 124
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKF----QSKIGDFGLARFFPEDQAYLSTNFA 246
             G+ YLH     +I H D+K  N++L +K       K+ DFGLA    +   +   N  
Sbjct: 125 LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIF 179
Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           GT  + APE      L  +AD++S GV+   ++S
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 106/256 (41%), Gaps = 55/256 (21%)
Query: 71  YFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGT--LVAVKKLCVDKSQQGESEFL- 127
           YF   +L +  K +H    +G+G +G V R  + + T  + A+K +  +K +Q   + + 
Sbjct: 15  YFQGGSLLELQKKYHLKGAIGQGSYG-VVRVAIENQTRAIRAIKIMNKNKIRQINPKDVE 73
Query: 128 ---SEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNR-----------------SLD 167
              +EVR++  + H N+ RL     D     LV E                      ++D
Sbjct: 74  RIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMD 133
Query: 168 LL--------------IYGESDKF---LNWSTRFQIILGIAR----GLQYLHEDSHTRIV 206
           ++              I G    F   L++  R ++I  I R     L YLH      I 
Sbjct: 134 VVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---IC 190
Query: 207 HRDIKASNVLL--DEKFQSKIGDFGLARFF---PEDQAYLSTNFAGTLGYTAPEY--AIR 259
           HRDIK  N L   ++ F+ K+ DFGL++ F      + Y  T  AGT  + APE      
Sbjct: 191 HRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN 250
Query: 260 GELSEKADIYSFGVLV 275
                K D +S GVL+
Sbjct: 251 ESYGPKCDAWSAGVLL 266

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 36/215 (16%)
Query: 128 SEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWST----R 183
           +E+ ++  + H  ++++     D     +V E M+   L   + G  +K L  +T     
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYF 120
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPEDQAY 240
           +Q++L +    QYLHE+    I+HRD+K  NVLL   +E    KI DFG ++   E    
Sbjct: 121 YQMLLAV----QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-- 171
Query: 241 LSTNFAGTLGYTAPEYAIR---GELSEKADIYSFGVLVLEIIS-----CRKNTDLTLPSE 292
           L     GT  Y APE  +       +   D +S GV++   +S         T ++L  +
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 231
Query: 293 M-----QYLPEYAWKLYERG----RILELVDPRMR 318
           +      ++PE   ++ E+     + L +VDP+ R
Sbjct: 232 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 266

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 36/215 (16%)
Query: 128 SEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWST----R 183
           +E+ ++  + H  ++++     D     +V E M+   L   + G  +K L  +T     
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYF 120
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPEDQAY 240
           +Q++L +    QYLHE+    I+HRD+K  NVLL   +E    KI DFG ++   E    
Sbjct: 121 YQMLLAV----QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-- 171
Query: 241 LSTNFAGTLGYTAPEYAIR---GELSEKADIYSFGVLVLEIIS-----CRKNTDLTLPSE 292
           L     GT  Y APE  +       +   D +S GV++   +S         T ++L  +
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 231
Query: 293 M-----QYLPEYAWKLYERG----RILELVDPRMR 318
           +      ++PE   ++ E+     + L +VDP+ R
Sbjct: 232 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 266

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 19/214 (8%)
Query: 78  KKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDK----SQQGES--EFLSEVR 131
           +K    +  G  LG G F  V + +     L    K    +    S++G S  E   EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 132 MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGI 190
           ++  + H N++ L     + +  +L+ E +    L D L   ES   L+       I  I
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQI 124
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKF----QSKIGDFGLARFFPEDQAYLSTNFA 246
             G+ YLH     +I H D+K  N++L +K       K+ DFGLA    +   +   N  
Sbjct: 125 LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIF 179
Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           GT  + APE      L  +AD++S GV+   ++S
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 36/215 (16%)
Query: 128 SEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR---- 183
           +E+ ++  + H  ++++     D     +V E M+   L   + G  +K L  +T     
Sbjct: 63  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYF 119
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPEDQAY 240
           +Q++L +    QYLHE+    I+HRD+K  NVLL   +E    KI DFG ++   E    
Sbjct: 120 YQMLLAV----QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-- 170
Query: 241 LSTNFAGTLGYTAPEYAIR---GELSEKADIYSFGVLVLEIIS-----CRKNTDLTLPSE 292
           L     GT  Y APE  +       +   D +S GV++   +S         T ++L  +
Sbjct: 171 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 230
Query: 293 M-----QYLPEYAWKLYERG----RILELVDPRMR 318
           +      ++PE   ++ E+     + L +VDP+ R
Sbjct: 231 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 265

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 100
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 101 FSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 152
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 153 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 206
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 207 GYNKAVDWWALGVLIYEMAA 226

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 36/215 (16%)
Query: 128 SEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWST----R 183
           +E+ ++  + H  ++++     D     +V E M+   L   + G  +K L  +T     
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYF 120
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPEDQAY 240
           +Q++L +    QYLHE+    I+HRD+K  NVLL   +E    KI DFG ++   E    
Sbjct: 121 YQMLLAV----QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-- 171
Query: 241 LSTNFAGTLGYTAPEYAIR---GELSEKADIYSFGVLVLEIIS-----CRKNTDLTLPSE 292
           L     GT  Y APE  +       +   D +S GV++   +S         T ++L  +
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 231
Query: 293 M-----QYLPEYAWKLYERG----RILELVDPRMR 318
           +      ++PE   ++ E+     + L +VDP+ R
Sbjct: 232 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 266

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX----GTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 19/214 (8%)
Query: 78  KKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDK----SQQGES--EFLSEVR 131
           +K    +  G  LG G F  V + +     L    K    +    S++G S  E   EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 132 MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGI 190
           ++  + H N++ L     + +  +L+ E +    L D L   ES   L+       I  I
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQI 124
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKF----QSKIGDFGLARFFPEDQAYLSTNFA 246
             G+ YLH     +I H D+K  N++L +K       K+ DFGLA    +   +   N  
Sbjct: 125 LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIF 179
Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           GT  + APE      L  +AD++S GV+   ++S
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 128
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 129 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 180
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+         +    GT  Y APE  +  
Sbjct: 181 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----ATWTLCGTPEYLAPEIILSK 234
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 235 GYNKAVDWWALGVLIYEMAA 254

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 108
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY     +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 160
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+++D++   K+ DFG A+        L     GT  Y APE  +  
Sbjct: 161 --LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 214
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 215 GYNKAVDWWALGVLIYEMAA 234

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 19/214 (8%)
Query: 78  KKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDK----SQQGES--EFLSEVR 131
           +K    +  G  LG G F  V + +     L    K    +    S++G S  E   EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 132 MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGI 190
           ++  + H N++ L     + +  +L+ E +    L D L   ES   L+       I  I
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQI 124
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKF----QSKIGDFGLARFFPEDQAYLSTNFA 246
             G+ YLH     +I H D+K  N++L +K       K+ DFGLA    +   +   N  
Sbjct: 125 LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIF 179
Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           GT  + APE      L  +AD++S GV+   ++S
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 108
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 160
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 161 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 214
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 215 GYNKAVDWWALGVLIYEMAA 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 108
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 160
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 161 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 214
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 215 GYNKAVDWWALGVLIYEMAA 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 108
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 109 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 160
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 161 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 214
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 215 GYNKAVDWWALGVLIYEMAA 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 108
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 160
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 161 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 214
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 215 GYNKAVDWWALGVLIYEMAA 234

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 128
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 129 FSFKDNSNLYMVMEYVPGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 180
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 181 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 234
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 235 GYNKAVDWWALGVLIYEMAA 254

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 21/215 (9%)
Query: 78  KKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGES-------EFLSEV 130
           +K    +  G  LG G F  V + +     L    K  + K Q   S       E   EV
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKF-IKKRQSRASRRGVCREEIEREV 66
Query: 131 RMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILG 189
            ++  + H N++ L     + +  +L+ E +    L D L   ES   L+       I  
Sbjct: 67  SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQ 123
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKF----QSKIGDFGLARFFPEDQAYLSTNF 245
           I  G+ YLH     +I H D+K  N++L +K       K+ DFGLA    +   +   N 
Sbjct: 124 ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNI 178
Query: 246 AGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            GT  + APE      L  +AD++S GV+   ++S
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 19/214 (8%)
Query: 78  KKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDK----SQQGES--EFLSEVR 131
           +K    +  G  LG G F  V + +     L    K    +    S++G S  E   EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 132 MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGI 190
           ++  + H N++ L     + +  +L+ E +    L D L   ES   L+       I  I
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQI 124
Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKF----QSKIGDFGLARFFPEDQAYLSTNFA 246
             G+ YLH     +I H D+K  N++L +K       K+ DFGLA    +   +   N  
Sbjct: 125 LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIF 179
Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           GT  + APE      L  +AD++S GV+   ++S
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K +  G   A+K   K  V K +Q E   L+E R++ ++    L +L 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLTKLE 108
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY     +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIG---RFXEPHARFYAAQIVLT----FEYLHS- 160
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+++D++   K+ DFG A+        L     GT  Y APE  +  
Sbjct: 161 --LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 214
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 215 GYNKAVDWWALGVLIYEMAA 234

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 28/211 (13%)
Query: 128 SEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII 187
           +E+ ++  + H  ++++     D     +V E M+   L   + G  +K L  +T     
Sbjct: 189 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYF 245
Query: 188 LGIARGLQYLHEDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPEDQAYLSTN 244
             +   +QYLHE+    I+HRD+K  NVLL   +E    KI DFG ++   E    L   
Sbjct: 246 YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRT 300
Query: 245 FAGTLGYTAPEYAIR---GELSEKADIYSFGVLVLEIIS-----CRKNTDLTLPSEM--- 293
             GT  Y APE  +       +   D +S GV++   +S         T ++L  ++   
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 360
Query: 294 --QYLPEYAWKLYERG----RILELVDPRMR 318
              ++PE   ++ E+     + L +VDP+ R
Sbjct: 361 KYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 391

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R+  ++    LV+L 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-LNEKRIQQAVNFPFLVKLE 108
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY     +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 109 FSFKDNSNLYMVLEYAPGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 160
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   K+ DFG A+        L     GT  Y APE  +  
Sbjct: 161 --LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 214
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 215 GYNKAVDWWALGVLIYEMAA 234

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 105/245 (42%), Gaps = 36/245 (14%)
Query: 71  YFDFQTLK--KATKNFHPGNLLGRGGFGPVYRG--KLADGTLVAVKKLC-VDKSQQGESE 125
           YF    +K  K   N+   +L+GRG +G VY    K A+   VA+KK+  + +       
Sbjct: 15  YFQGAIIKNVKVPDNYEIKHLIGRGSYGYVYLAYDKNANKN-VAIKKVNRMFEDLIDCKR 73
Query: 126 FLSEVRMITSIQHKNLVRL--LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR 183
            L E+ ++  ++   ++RL  L    D  +   +Y  ++    DL    ++  FL     
Sbjct: 74  ILREITILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHV 133
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST 243
             I+  +  G +++HE   + I+HRD+K +N LL++    KI DFGLAR    D+     
Sbjct: 134 KTILYNLLLGEKFIHE---SGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIV 190
Query: 244 N------------------------FAGTLGYTAPEYAIRGE-LSEKADIYSFGVLVLEI 278
           N                           T  Y APE  +  E  +   DI+S G +  E+
Sbjct: 191 NDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAEL 250
Query: 279 ISCRK 283
           ++  K
Sbjct: 251 LNMMK 255

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 28/211 (13%)
Query: 128 SEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII 187
           +E+ ++  + H  ++++     D     +V E M+   L   + G  +K L  +T     
Sbjct: 203 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYF 259
Query: 188 LGIARGLQYLHEDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPEDQAYLSTN 244
             +   +QYLHE+    I+HRD+K  NVLL   +E    KI DFG ++   E    L   
Sbjct: 260 YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRT 314
Query: 245 FAGTLGYTAPEYAIR---GELSEKADIYSFGVLVLEIIS-----CRKNTDLTLPSEM--- 293
             GT  Y APE  +       +   D +S GV++   +S         T ++L  ++   
Sbjct: 315 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 374
Query: 294 --QYLPEYAWKLYERG----RILELVDPRMR 318
              ++PE   ++ E+     + L +VDP+ R
Sbjct: 375 KYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 405

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K +  G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY     +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+++D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 31/222 (13%)
Query: 70  SYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCV-DKSQQGESEFLS 128
           S  DF+ L   TK       L     G +++G+   G  + VK L V D S +   +F  
Sbjct: 5   SGIDFKQLNFLTK-------LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNE 56
Query: 129 EVRMITSIQHKNLVRLLGCCSD--GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQI 186
           E   +    H N++ +LG C         L+  +M   SL  +++  ++  ++ S   + 
Sbjct: 57  ECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKF 116
Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA 246
            L +ARG+ +LH      I    + + +V++DE   ++I             A +  +F 
Sbjct: 117 ALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARIS-----------MADVKFSFQ 164
Query: 247 GTLGYTAPEYAIRGELSEK--------ADIYSFGVLVLEIIS 280
                 AP +     L +K        AD++SF VL+ E+++
Sbjct: 165 SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT 206

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K +  G   A+K   K  V K ++ E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY     +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+++D++   ++ DFGLA+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 83/189 (43%), Gaps = 15/189 (7%)
Query: 90  LGRGGFGP--VYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G FG   + R KL    LVAVK   +++    +     E+    S++H N+VR    
Sbjct: 28  IGSGNFGVARLMRDKLT-KELVAVKY--IERGAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVH 207
               +   ++ EY     L   I   + +F     RF     +  G+ Y H     +I H
Sbjct: 85  ILTPTHLAIIMEYASGGELYERICN-AGRFSEDEARF-FFQQLLSGVSYCHS---MQICH 139
Query: 208 RDIKASNVLLD--EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEK 265
           RD+K  N LLD     + KI DFG ++         ST   GT  Y APE  +R E   K
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRQEYDGK 197
Query: 266 -ADIYSFGV 273
            AD++S GV
Sbjct: 198 IADVWSCGV 206

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K +  G   A+K   K  V K +Q E   L+E R++ ++    L +L 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLTKLE 108
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY     +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 160
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+++D++   K+ DFG A+        L     GT  Y APE  +  
Sbjct: 161 --LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 214
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 215 GYNKAVDWWALGVLIYEMAA 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGK-LADGTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K +  G   A+K   K  V K +Q E   L+E R++ ++    L +L 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLTKLE 108
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY     +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 160
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+++D++   K+ DFG A+        L     GT  Y APE  +  
Sbjct: 161 --LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 214
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 215 GYNKAVDWWALGVLIYEMAA 234

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 91/195 (46%), Gaps = 27/195 (13%)
Query: 90  LGRGGFGP--VYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G FG   + R K A+  LVAVK   +++ ++ +     E+    S++H N+VR    
Sbjct: 27  IGAGNFGVARLMRDKQAN-ELVAVK--YIERGEKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QIILGIARGLQYLHEDSHTR 204
               +   +V EY     L   I   + +F     RF   Q+I G++    Y H     +
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVS----YAHA---MQ 135
Query: 205 IVHRDIKASNVLLD--EKFQSKIGDFGLARFFPEDQAYLST---NFAGTLGYTAPEYAIR 259
           + HRD+K  N LLD     + KI DFG ++      + L +   +  GT  Y APE  ++
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSK-----ASVLHSQPKSAVGTPAYIAPEVLLK 190
Query: 260 GELSEK-ADIYSFGV 273
            E   K AD++S GV
Sbjct: 191 KEYDGKVADVWSCGV 205

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y APE  +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ ++ +
Sbjct: 214 GYNKAVDWWALGVLIYQMAA 233

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 18/209 (8%)
Query: 82  KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESE---FLSEVRMITSIQH 138
           ++F    ++GRG FG V   K+ +   +   K+         +E   F  E  ++ +   
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QIILGIARGLQ 195
           + +  L     D +   LV +Y     L  L+    DK      RF   +++L I   + 
Sbjct: 134 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAI-DSIH 192
Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE 255
            LH       VHRDIK  NVLLD     ++ DFG      +D    S+   GT  Y +PE
Sbjct: 193 QLH------YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPE 246
Query: 256 Y--AIR---GELSEKADIYSFGVLVLEII 279
              A+    G+   + D +S GV + E++
Sbjct: 247 ILQAMEDGMGKYGPECDWWSLGVCMYEML 275

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 17/214 (7%)
Query: 75  QTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLC--VDKSQQGESEFLSEVRM 132
           + L+   +++    ++GRG FG V   +      V   KL    +  ++ +S F  E R 
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 126
Query: 133 ITSIQHKN-LVRLLGCCSDGSQRLLVYEYMKNRSLDLLI--YGESDKFLNWSTRFQIILG 189
           I +  +   +V+L     D     +V EYM    L  L+  Y   +K+  + T  +++L 
Sbjct: 127 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA-EVVLA 185
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
               L  +H       +HRD+K  N+LLD+    K+ DFG      ++         GT 
Sbjct: 186 ----LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 238
Query: 250 GYTAPEY----AIRGELSEKADIYSFGVLVLEII 279
            Y +PE        G    + D +S GV + E++
Sbjct: 239 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 272

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 18/209 (8%)
Query: 82  KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESE---FLSEVRMITSIQH 138
           ++F    ++GRG FG V   K+ +   +   K+         +E   F  E  ++ +   
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QIILGIARGLQ 195
           + +  L     D +   LV +Y     L  L+    DK      RF   +++L I   + 
Sbjct: 150 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAI-DSIH 208
Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE 255
            LH       VHRDIK  NVLLD     ++ DFG      +D    S+   GT  Y +PE
Sbjct: 209 QLH------YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPE 262
Query: 256 Y--AIR---GELSEKADIYSFGVLVLEII 279
              A+    G+   + D +S GV + E++
Sbjct: 263 ILQAMEDGMGKYGPECDWWSLGVCMYEML 291

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 17/214 (7%)
Query: 75  QTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLC--VDKSQQGESEFLSEVRM 132
           + L+   +++    ++GRG FG V   +      V   KL    +  ++ +S F  E R 
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121
Query: 133 ITSIQHKN-LVRLLGCCSDGSQRLLVYEYMKNRSLDLLI--YGESDKFLNWSTRFQIILG 189
           I +  +   +V+L     D     +V EYM    L  L+  Y   +K+  + T  +++L 
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA-EVVLA 180
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
               L  +H       +HRD+K  N+LLD+    K+ DFG      ++         GT 
Sbjct: 181 ----LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 233
Query: 250 GYTAPEY----AIRGELSEKADIYSFGVLVLEII 279
            Y +PE        G    + D +S GV + E++
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 17/214 (7%)
Query: 75  QTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLC--VDKSQQGESEFLSEVRM 132
           + L+   +++    ++GRG FG V   +      V   KL    +  ++ +S F  E R 
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 126
Query: 133 ITSIQHKN-LVRLLGCCSDGSQRLLVYEYMKNRSLDLLI--YGESDKFLNWSTRFQIILG 189
           I +  +   +V+L     D     +V EYM    L  L+  Y   +K+  + T  +++L 
Sbjct: 127 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA-EVVLA 185
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
               L  +H       +HRD+K  N+LLD+    K+ DFG      ++         GT 
Sbjct: 186 ----LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 238
Query: 250 GYTAPEY----AIRGELSEKADIYSFGVLVLEII 279
            Y +PE        G    + D +S GV + E++
Sbjct: 239 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 272

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLS---EVRMITSIQHKNLVR 143
           G  +GRG +G VY+ K  DG       L   K  +G    +S   E+ ++  ++H N++ 
Sbjct: 26  GCKVGRGTYGHVYKAKRKDGKDDKDYAL---KQIEGTGISMSACREIALLRELKHPNVIS 82
Query: 144 LLGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRF------QIILGIARGLQ 195
           L       + R   L+++Y ++    ++ +  + K      +        ++  I  G+ 
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 196 YLHEDSHTRIVHRDIKASNVLL----DEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTL 249
           YLH +    ++HRD+K +N+L+     E+ + KI D G AR F      L+       T 
Sbjct: 143 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199
Query: 250 GYTAPEYAIRGELSEKA-DIYSFGVLVLEIIS 280
            Y APE  +      KA DI++ G +  E+++
Sbjct: 200 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 231

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 90  LGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGE---SEFLSEVRMITSIQH-KNLVRLL 145
           LGRG F  V R  ++  T        + K ++G+   +E L E+ ++   +    ++ L 
Sbjct: 37  LGRGKFA-VVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
               + S+ +L+ EY     +  L   E  + ++ +   ++I  I  G+ YLH+++   I
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---I 152
Query: 206 VHRDIKASNVLLDEKF---QSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
           VH D+K  N+LL   +     KI DFG++R      A       GT  Y APE      +
Sbjct: 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREIMGTPEYLAPEILNYDPI 210
Query: 263 SEKADIYSFGVLVLEIIS 280
           +   D+++ G++   +++
Sbjct: 211 TTATDMWNIGIIAYMLLT 228

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 27/200 (13%)
Query: 90  LGRGGFGPVYRGKLA-DGTLVAVKK-LCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLG 146
           LG G +G V++ +   DG L AVK+ +   +  +  +  L+EV     + QH   VRL  
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 147 CCSDGSQRLLVYEYMKNRSLD--LLIYGES-DKFLNWSTRFQIILGIARGLQYLHEDSHT 203
              +G    L  E +   SL      +G S  +   W      +L +A    +LH     
Sbjct: 125 AWEEGGILYLQTE-LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA----HLHSQG-- 177
Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG-----YTAPEYAI 258
            +VH D+K +N+ L  + + K+GDFGL          L T  AG +      Y APE  +
Sbjct: 178 -LVHLDVKPANIFLGPRGRCKLGDFGLL-------VELGTAGAGEVQEGDPRYMAPEL-L 228
Query: 259 RGELSEKADIYSFGVLVLEI 278
           +G     AD++S G+ +LE+
Sbjct: 229 QGSYGTAADVFSLGLTILEV 248

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT  Y AP   +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEYLAPAIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 86/189 (45%), Gaps = 15/189 (7%)
Query: 90  LGRGGFGP--VYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G FG   + R K ++  LVAVK   +++ ++ +     E+    S++H N+VR    
Sbjct: 26  IGSGNFGVARLMRDKQSN-ELVAVKY--IERGEKIDENVKREIINHRSLRHPNIVRFKEV 82
Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVH 207
               +   +V EY     L   I   + +F     RF     +  G+ Y H     ++ H
Sbjct: 83  ILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARF-FFQQLISGVSYCHA---MQVCH 137
Query: 208 RDIKASNVLLD--EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEK 265
           RD+K  N LLD     + KI DFG ++         ST   GT  Y APE  ++ E   K
Sbjct: 138 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGK 195
Query: 266 -ADIYSFGV 273
            AD++S GV
Sbjct: 196 VADVWSCGV 204

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 86/189 (45%), Gaps = 15/189 (7%)
Query: 90  LGRGGFGP--VYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGC 147
           +G G FG   + R K ++  LVAVK   +++ ++  +    E+    S++H N+VR    
Sbjct: 27  IGSGNFGVARLMRDKQSN-ELVAVKY--IERGEKIAANVKREIINHRSLRHPNIVRFKEV 83
Query: 148 CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVH 207
               +   +V EY     L   I   + +F     RF     +  G+ Y H     ++ H
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARF-FFQQLISGVSYCHA---MQVCH 138
Query: 208 RDIKASNVLLD--EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEK 265
           RD+K  N LLD     + KI DFG ++         ST   GT  Y APE  ++ E   K
Sbjct: 139 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGK 196
Query: 266 -ADIYSFGV 273
            AD++S GV
Sbjct: 197 VADVWSCGV 205

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 81  TKNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQG---ESEFLSEVRMITSI 136
           T  FH    +G G FG V++  K  DG + A+K+    K   G   E   L EV     +
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR--SKKPLAGSVDEQNALREVYAHAVL 65
Query: 137 -QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQI---ILGIAR 192
            QH ++VR     ++    L+  EY    SL   I  E+ + +++    ++   +L + R
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVGR 124
Query: 193 GLQYLHEDSHTRIVHRDIKASNVLL 217
           GL+Y+H  S   +VH DIK SN+ +
Sbjct: 125 GLRYIHSMS---LVHMDIKPSNIFI 146

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 81  TKNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQG---ESEFLSEVRMITSI 136
           T  FH    +G G FG V++  K  DG + A+K+    K   G   E   L EV     +
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR--SKKPLAGSVDEQNALREVYAHAVL 65
Query: 137 -QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQI---ILGIAR 192
            QH ++VR     ++    L+  EY    SL   I  E+ + +++    ++   +L + R
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVGR 124
Query: 193 GLQYLHEDSHTRIVHRDIKASNVLL 217
           GL+Y+H  S   +VH DIK SN+ +
Sbjct: 125 GLRYIHSMS---LVHMDIKPSNIFI 146

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 81  TKNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQG---ESEFLSEVRMITSI 136
           T  FH    +G G FG V++  K  DG + A+K+    K   G   E   L EV     +
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR--SKKPLAGSVDEQNALREVYAHAVL 63
Query: 137 -QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQI---ILGIAR 192
            QH ++VR     ++    L+  EY    SL   I  E+ + +++    ++   +L + R
Sbjct: 64  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVGR 122
Query: 193 GLQYLHEDSHTRIVHRDIKASNVLL 217
           GL+Y+H  S   +VH DIK SN+ +
Sbjct: 123 GLRYIHSMS---LVHMDIKPSNIFI 144

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 29/218 (13%)
Query: 82  KNFHPGNLLGRGGFGPV-----------YRGKLADGTLVAVKKLCVDKSQQGESEFLSEV 130
           +N+ P  +LGRG    V           Y  K+ D T         ++ Q+     L EV
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVT--GGGSFSAEEVQELREATLKEV 74
Query: 131 RMITSIQ-HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG 189
            ++  +  H N+++L       +   LV++ MK    +L  Y      L+     +I+  
Sbjct: 75  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG--ELFDYLTEKVTLSEKETRKIMRA 132
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
           +   +  LH+     IVHRD+K  N+LLD+    K+ DFG +      +   S    GT 
Sbjct: 133 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSV--CGTP 187
Query: 250 GYTAPEYAIRGELSE-------KADIYSFGVLVLEIIS 280
            Y APE  I   +++       + D++S GV++  +++
Sbjct: 188 SYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 81  TKNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQG---ESEFLSEVRMITSI 136
           T  FH    +G G FG V++  K  DG + A+K+    K   G   E   L EV     +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR--SKKPLAGSVDEQNALREVYAHAVL 67
Query: 137 -QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQI---ILGIAR 192
            QH ++VR     ++    L+  EY    SL   I  E+ + +++    ++   +L + R
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVGR 126
Query: 193 GLQYLHEDSHTRIVHRDIKASNVLL 217
           GL+Y+H  S   +VH DIK SN+ +
Sbjct: 127 GLRYIHSMS---LVHMDIKPSNIFI 148

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 89  LLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLS----------EVRMITSIQH 138
            +  G +G V  G  ++G  VA+K++    S       LS          E+R++    H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 139 KNLVRL----LGCCSDGSQRL-LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIIL-GIAR 192
            N++ L    +        +L LV E M+    DL       + +      Q  +  I  
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRT---DLAQVIHDQRIVISPQHIQYFMYHILL 145
Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS-TNFAGTLGY 251
           GL  LHE     +VHRD+   N+LL +     I DF LAR   ED A  + T++     Y
Sbjct: 146 GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRWY 199
Query: 252 TAPEYAIRGE-LSEKADIYSFGVLVLEIIS 280
            APE  ++ +  ++  D++S G ++ E+ +
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 24/200 (12%)
Query: 90  LGRGGFGPVYRGKLAD-GTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V   K  + G   A+K   K  V K +Q E   L+E R++ ++    LV+L 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE 107
Query: 146 GCCSDGSQRLLVYEYMKNRSL--DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHED 200
               D S   +V EY+    +   L   G   +F     RF   QI+L      +YLH  
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLT----FEYLHS- 159
Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
               +++RD+K  N+L+D++   ++ DFG A+        L     GT    APE  +  
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL----CGTPEALAPEIILSK 213
Query: 261 ELSEKADIYSFGVLVLEIIS 280
             ++  D ++ GVL+ E+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAA 233

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 71  YFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLV--AVKKLCVDKSQQGESEFLS 128
           YF   T     + +   N +GRG +G V +  +  GT +  A KK+      +    F  
Sbjct: 15  YFQGSTKGDINQYYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIP-KYFVEDVDRFKQ 72
Query: 129 EVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY-----MKNRSLDLLIYGESDKFLNWSTR 183
           E+ ++ S+ H N++RL     D +   LV E      +  R +   ++ ESD        
Sbjct: 73  EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDA------- 125
Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVL-LDEKFQS--KIGDFGL-ARFFPEDQA 239
            +I+  +   + Y H+     + HRD+K  N L L +   S  K+ DFGL ARF P    
Sbjct: 126 ARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP---G 179
Query: 240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLV 275
            +     GT  Y +P+  + G    + D +S GV++
Sbjct: 180 KMMRTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMM 214

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 89  LLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLS----------EVRMITSIQH 138
            +  G +G V  G  ++G  VA+K++    S       LS          E+R++    H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 139 KNLVRL----LGCCSDGSQRL-LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIIL-GIAR 192
            N++ L    +        +L LV E M+    DL       + +      Q  +  I  
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRT---DLAQVIHDQRIVISPQHIQYFMYHILL 145
Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS-TNFAGTLGY 251
           GL  LHE     +VHRD+   N+LL +     I DF LAR   ED A  + T++     Y
Sbjct: 146 GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRWY 199
Query: 252 TAPEYAIRGE-LSEKADIYSFGVLVLEIIS 280
            APE  ++ +  ++  D++S G ++ E+ +
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 89  LLGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-HKNLVRLLG 146
           LLG G +  V     L +G   AVK +   ++    S    EV  +   Q +KN++ L+ 
Sbjct: 20  LLGEGAYAKVQGAVSLQNGKEYAVK-IIEKQAGHSRSRVFREVETLYQCQGNKNILELIE 78
Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
              D ++  LV+E ++  S+  L + +  K  N     +++  +A  L +LH      I 
Sbjct: 79  FFEDDTRFYLVFEKLQGGSI--LAHIQKQKHFNEREASRVVRDVAAALDFLHTKG---IA 133
Query: 207 HRDIKASNVLLD--EKFQS-KIGDFGLARFFPEDQAYLS------TNFAGTLGYTAPE-- 255
           HRD+K  N+L +  EK    KI DF L      + +         T   G+  Y APE  
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVV 193
Query: 256 --YAIRGELSEK-ADIYSFGVLVLEIIS 280
             +  +    +K  D++S GV++  ++S
Sbjct: 194 EVFTDQATFYDKRCDLWSLGVVLYIMLS 221

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVR 131
           D+Q ++K          LGRG +  V+    + +   V VK L   K    +++   E++
Sbjct: 38  DYQLVRK----------LGRGKYSEVFEAINITNNEKVVVKILKPVK----KNKIKREIK 83
Query: 132 MITSIQH-KNLVRLLGCCSDGSQRL--LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIIL 188
           ++ +++   N++ L     D   R   LV+E++ N     L    +D    +  RF  + 
Sbjct: 84  ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTD----YDIRF-YMY 138
Query: 189 GIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS-KIGDFGLARFFPEDQAYLSTNFAG 247
            I + L Y H      I+HRD+K  NV++D + +  ++ D+GLA F+   Q Y       
Sbjct: 139 EILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR--VA 193
Query: 248 TLGYTAPEYAIRGELSEKA-DIYSFGVLVLEII 279
           +  +  PE  +  ++ + + D++S G ++  +I
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 29/218 (13%)
Query: 82  KNFHPGNLLGRGGFGPV-----------YRGKLADGTLVAVKKLCVDKSQQGESEFLSEV 130
           +N+ P  +LGRG    V           Y  K+ D T         ++ Q+     L EV
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVT--GGGSFSAEEVQELREATLKEV 61
Query: 131 RMITSIQ-HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG 189
            ++  +  H N+++L       +   LV++ MK    +L  Y      L+     +I+  
Sbjct: 62  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG--ELFDYLTEKVTLSEKETRKIMRA 119
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
           +   +  LH+     IVHRD+K  N+LLD+    K+ DFG +     D         GT 
Sbjct: 120 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTP 174
Query: 250 GYTAPEYAIRGELSE-------KADIYSFGVLVLEIIS 280
            Y APE  I   +++       + D++S GV++  +++
Sbjct: 175 SYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 211

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 29/218 (13%)
Query: 82  KNFHPGNLLGRGGFGPV-----------YRGKLADGTLVAVKKLCVDKSQQGESEFLSEV 130
           +N+ P  +LGRG    V           Y  K+ D T         ++ Q+     L EV
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVT--GGGSFSAEEVQELREATLKEV 74
Query: 131 RMITSIQ-HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG 189
            ++  +  H N+++L       +   LV++ MK    +L  Y      L+     +I+  
Sbjct: 75  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG--ELFDYLTEKVTLSEKETRKIMRA 132
Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
           +   +  LH+     IVHRD+K  N+LLD+    K+ DFG +     D         GT 
Sbjct: 133 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTP 187
Query: 250 GYTAPEYAIRGELSE-------KADIYSFGVLVLEIIS 280
            Y APE  I   +++       + D++S GV++  +++
Sbjct: 188 SYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 27/199 (13%)
Query: 88  NLLGRGGFGPVYRGKLADGTLV--AVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           N +GRG +G V +  +  GT +  A KK+      +    F  E+ ++ S+ H N++RL 
Sbjct: 15  NTIGRGSWGEV-KIAVQKGTRIRRAAKKIP-KYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72
Query: 146 GCCSDGSQRLLVYEY-----MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
               D +   LV E      +  R +   ++ ESD         +I+  +   + Y H+ 
Sbjct: 73  ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDA-------ARIMKDVLSAVAYCHK- 124
Query: 201 SHTRIVHRDIKASNVL-LDEKFQS--KIGDFGL-ARFFPEDQAYLSTNFAGTLGYTAPEY 256
               + HRD+K  N L L +   S  K+ DFGL ARF P     +     GT  Y +P+ 
Sbjct: 125 --LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP---GKMMRTKVGTPYYVSPQ- 178
Query: 257 AIRGELSEKADIYSFGVLV 275
            + G    + D +S GV++
Sbjct: 179 VLEGLYGPECDEWSAGVMM 197
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	407
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-163
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-143
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-140
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-84
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-66
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-66
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-65
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-63
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-61
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-60
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-60
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-58
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-57
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-54
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-54
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-53
3q4u_A	301	Activin receptor type-1; structural genomics conso	7e-53
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-52
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-46
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-46
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-46
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-45
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-43
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-43
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-43
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-43
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-43
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-43
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-43
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-43
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-42
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-42
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-42
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-42
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-42
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-42
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-42
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-42
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-42
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-42
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-42
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-41
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-41
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-41
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-41
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-41
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-41
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-41
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-41
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-41
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-41
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	8e-41
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-41
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	9e-41
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-40
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-40
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-40
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-40
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-40
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-40
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-40
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-40
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-40
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-39
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-39
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-39
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-39
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-39
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-39
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-38
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-38
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-38
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-38
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-37
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-36
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-35
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-35
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-35
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-35
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-34
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-34
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-34
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-34
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-33
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-33
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-32
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-32
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	9e-32
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-31
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-31
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-31
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	9e-31
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-30
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-30
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-30
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-30
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-30
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-30
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-29
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-29
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-29
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-29
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-29
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-29
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-29
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-29
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-29
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-29
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-29
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-29
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	7e-29
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-29
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	9e-29
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-28
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-28
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-28
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-28
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-28
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-28
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-28
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-28
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-28
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-28
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-27
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-27
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-27
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-27
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-27
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-27
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-27
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-27
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	9e-27
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-26
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-26
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-26
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-26
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-26
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-26
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-26
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-26
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-26
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-26
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-26
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-26
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	6e-26
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-26
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-25
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-25
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-25
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-25
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-25
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-25
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-25
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-24
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-24
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-24
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-24
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	9e-24
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-23
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-23
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-23
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-23
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-08
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-23
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-23
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-23
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-23
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-22
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-22
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-22
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-22
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-22
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-22
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-21
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-21
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-21
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-21
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-21
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-20
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	9e-20
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-18
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-17
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-17
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-11
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	8e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-14
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-13
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  460 bits (1186), Expect = e-163
 Identities = 126/297 (42%), Positives = 188/297 (63%), Gaps = 8/297 (2%)

Query: 64  GNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGE 123
           G L+  S  +   L+ A+ NF   N+LGRGGFG VY+G+LADGTLVAVK+L  +++Q GE
Sbjct: 15  GQLKRFSLRE---LQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGE 71

Query: 124 SEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLD--LLIYGESDKFLNWS 181
            +F +EV MI+   H+NL+RL G C   ++RLLVY YM N S+   L    ES   L+W 
Sbjct: 72  LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWP 131

Query: 182 TRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL 241
            R +I LG ARGL YLH+    +I+HRD+KA+N+LLDE+F++ +GDFGLA+       ++
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 191

Query: 242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPS--EMQYLPEY 299
           +T   GT+G+ APEY   G+ SEK D++ +GV++LE+I+ ++  DL   +  +   L ++
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251

Query: 300 AWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
              L +  ++  LVD  ++     + +  Q+I VA +C Q    +RP MSE+V ML 
Sbjct: 252 VKGLLKEKKLEALVDVDLQGNY-KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  408 bits (1052), Expect = e-143
 Identities = 114/319 (35%), Positives = 166/319 (52%), Gaps = 24/319 (7%)

Query: 55  EGVSKDFFNGNLRTISYFDFQTLKKATKNFHP------GNLLGRGGFGPVYRGKLADGTL 108
           E  S +  +    +   F F  LK  T NF        GN +G GGFG VY+G + + T 
Sbjct: 1   ENKSLEVSDTRFHS---FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTT 56

Query: 109 VAVKKL---CVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRS 165
           VAVKKL       +++ + +F  E++++   QH+NLV LLG  SDG    LVY YM N S
Sbjct: 57  VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGS 116

Query: 166 LDLLIYGESDKF-LNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSK 224
           L   +        L+W  R +I  G A G+ +LHE+     +HRDIK++N+LLDE F +K
Sbjct: 117 LLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAK 173

Query: 225 IGDFGLARFFPE-DQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRK 283
           I DFGLAR   +  Q  +++   GT  Y APE  +RGE++ K+DIYSFGV++LEII+   
Sbjct: 174 ISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLP 232

Query: 284 NTDLTLPSEMQYLPEYAWKLY-ERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHG 342
             D       Q L +   ++  E   I + +D +M            + +VA  CL    
Sbjct: 233 AVDEHREP--QLLLDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKK 288

Query: 343 NQRPPMSEIVAMLTCKVES 361
           N+RP + ++  +L     S
Sbjct: 289 NKRPDIKKVQQLLQEMTAS 307

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  401 bits (1034), Expect = e-140
 Identities = 112/288 (38%), Positives = 171/288 (59%), Gaps = 8/288 (2%)

Query: 71  YFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEV 130
                 L++AT NF    L+G G FG VY+G L DG  VA+K+   + S QG  EF +E+
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEFETEI 86

Query: 131 RMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF--LNWSTRFQIIL 188
             ++  +H +LV L+G C + ++ +L+Y+YM+N +L   +YG       ++W  R +I +
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146

Query: 189 GIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE-DQAYLSTNFAG 247
           G ARGL YLH  +   I+HRD+K+ N+LLDE F  KI DFG+++   E DQ +LST   G
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKG 203

Query: 248 TLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERG 307
           TLGY  PEY I+G L+EK+D+YSFGV++ E++  R     +LP EM  L E+A + +  G
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263

Query: 308 RILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
           ++ ++VDP +  + I      +  + A  CL      RP M +++  L
Sbjct: 264 QLEQIVDPNLADK-IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  259 bits (663), Expect = 3e-84
 Identities = 71/306 (23%), Positives = 120/306 (39%), Gaps = 28/306 (9%)

Query: 72  FDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVR 131
              + L   +       +  RG FG V++ +L     VAVK   +   Q  ++E+  EV 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEY--EVY 70

Query: 132 MITSIQHKNLVRLLGCCSDGS----QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII 187
            +  ++H+N+++ +G    G+       L+  + +  SL   +       ++W+    I 
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIA 127

Query: 188 LGIARGLQYLHEDSHT-------RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY 240
             +ARGL YLHED           I HRDIK+ NVLL     + I DFGLA  F   ++ 
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 241 LSTNF-AGTLGYTAPEYA-----IRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQ 294
             T+   GT  Y APE        + +   + D+Y+ G+++ E+ S     D  +   M 
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

Query: 295 YLPEYAWKLYERGRILELV-----DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMS 349
              E   +      + E+V      P +R           +      C       R    
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307

Query: 350 EIVAML 355
            +   +
Sbjct: 308 CVGERI 313

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  213 bits (545), Expect = 1e-66
 Identities = 82/285 (28%), Positives = 143/285 (50%), Gaps = 31/285 (10%)

Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKL-CVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
              +G G FG V+R +   G+ VAVK L   D   +  +EFL EV ++  ++H N+V  +
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100

Query: 146 GCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTR 204
           G  +      +V EY+   SL  LL    + + L+   R  +   +A+G+ YLH   +  
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159

Query: 205 IVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL-S 263
           IVHR++K+ N+L+D+K+  K+ DFGL+R         S + AGT  + APE  +R E  +
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLK-ASTFLSSKSAAGTPEWMAPE-VLRDEPSN 217

Query: 264 EKADIYSFGVLVLEIISCRKNTDLTLP-SEMQYLPEYAWKLYERGRILEL---VDPRMRK 319
           EK+D+YSFGV++ E+ + +       P   +    +    +  + + LE+   ++P++  
Sbjct: 218 EKSDVYSFGVILWELATLQ------QPWGNLNPA-QVVAAVGFKCKRLEIPRNLNPQVAA 270

Query: 320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP 364
             I+E            C      +RP  + I+ +L   ++S +P
Sbjct: 271 --IIEG-----------CWTNEPWKRPSFATIMDLLRPLIKSAVP 302

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  214 bits (547), Expect = 1e-66
 Identities = 68/321 (21%), Positives = 119/321 (37%), Gaps = 47/321 (14%)

Query: 72  FDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSE-- 129
                      N     L+GRG +G VY+G L D   VAVK      S      F++E  
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF----SFANRQNFINEKN 57

Query: 130 VRMITSIQHKNLVRLLGCCSDGS-----QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF 184
           +  +  ++H N+ R +      +     + LLV EY  N SL   +   +    +W +  
Sbjct: 58  IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSC 114

Query: 185 QIILGIARGLQYLHEDSHTR------IVHRDIKASNVLLDEKFQSKIGDFGLARFF---- 234
           ++   + RGL YLH +          I HRD+ + NVL+       I DFGL+       
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 235 ---PEDQAYLSTNFAGTLGYTAPEYAIRGELS--------EKADIYSFGVLVLEIISCRK 283
              P ++   + +  GT+ Y APE  + G ++        ++ D+Y+ G++  EI   R 
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFM-RC 232

Query: 284 NTDLTLPSEMQYLPEYAWKLYERGRILELVD--------PRMRKEGIVERDALQVI-NVA 334
                  S  +Y   +  ++       ++          P+  +       A++ +    
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292

Query: 335 FICLQPHGNQRPPMSEIVAML 355
             C       R         +
Sbjct: 293 EDCWDQDAEARLTAQXAEERM 313

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  209 bits (535), Expect = 3e-65
 Identities = 78/277 (28%), Positives = 129/277 (46%), Gaps = 37/277 (13%)

Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
             ++GRG FG V + K      VA+K++   +S+     F+ E+R ++ + H N+V+L G
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIKQI---ESESERKAFIVELRQLSRVNHPNIVKLYG 68

Query: 147 CCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
            C +     LV EY +  SL ++L   E   +   +      L  ++G+ YLH      +
Sbjct: 69  ACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126

Query: 206 VHRDIKASNVLLDEKFQS-KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL-S 263
           +HRD+K  N+LL       KI DFG A     D     TN  G+  + APE    G   S
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPE-VFEGSNYS 181

Query: 264 EKADIYSFGVLVLEIISCRKNTDLTLP-SEMQYLP-EYAWKLYERGR--ILELVDPRMRK 319
           EK D++S+G+++ E+I+ RK      P  E+        W ++   R  +++ +   +  
Sbjct: 182 EKCDVFSWGIILWEVITRRK------PFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 235

Query: 320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
             ++ R           C     +QRP M EIV ++T
Sbjct: 236 --LMTR-----------CWSKDPSQRPSMEEIVKIMT 259

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  202 bits (517), Expect = 5e-63
 Identities = 77/286 (26%), Positives = 126/286 (44%), Gaps = 46/286 (16%)

Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGES---EFLSEVRMITSIQHKNLVR 143
             ++G GGFG VYR     G  VAVK    D  +           E ++   ++H N++ 
Sbjct: 12  EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 144 LLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
           L G C       LV E+ +   L  +L    S K +         + IARG+ YLH+++ 
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 203 TRIVHRDIKASNVLLDEKFQS--------KIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
             I+HRD+K+SN+L+ +K ++        KI DFGLAR +         + AG   + AP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAP 183

Query: 255 EYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLP-SEMQYLPEYAWKLYERGRILEL 312
           E  IR  + S+ +D++S+GVL+ E+++        +P   +  L   A+ +      L +
Sbjct: 184 E-VIRASMFSKGSDVWSYGVLLWELLTGE------VPFRGIDGL-AVAYGVAMNKLALPI 235

Query: 313 ---VDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
                    K  ++E            C  P  + RP  + I+  L
Sbjct: 236 PSTCPEPFAK--LMED-----------CWNPDPHSRPSFTNILDQL 268

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  199 bits (507), Expect = 2e-61
 Identities = 76/290 (26%), Positives = 137/290 (47%), Gaps = 48/290 (16%)

Query: 87  GNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGES------EFLSEVRMITSIQHK 139
              +G+GGFG V++G+ + D ++VA+K L +  S+          EF  EV +++++ H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 140 NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
           N+V+L G   +     +V E++    L   +  ++   + WS + +++L IA G++Y+  
Sbjct: 84  NIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQ- 139

Query: 200 DSHTRIVHRDIKASNVLLDEKFQS-----KIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           + +  IVHRD+++ N+ L    ++     K+ DFGL++       +  +   G   + AP
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMAP 195

Query: 255 EYAIRGEL---SEKADIYSFGVLVLEIISCRKNTDLTLP-SEMQYLP-EYAWKLYERGR- 308
           E  I  E    +EKAD YSF +++  I++         P  E  Y   ++   + E G  
Sbjct: 196 E-TIGAEEESYTEKADTYSFAMILYTILTGE------GPFDEYSYGKIKFINMIREEGLR 248

Query: 309 --ILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
             I E   PR+R   ++E            C      +RP  S IV  L+
Sbjct: 249 PTIPEDCPPRLRN--VIEL-----------CWSGDPKKRPHFSYIVKELS 285

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  196 bits (500), Expect = 2e-60
 Identities = 57/280 (20%), Positives = 114/280 (40%), Gaps = 40/280 (14%)

Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCV-DKSQQGESEFLSEVRMITSIQHKNLVRLL 145
              L     G +++G+   G  + VK L V D S +   +F  E   +    H N++ +L
Sbjct: 15  LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73

Query: 146 GCCSDGSQRLL--VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
           G C          +  +M   SL  +++  ++  ++ S   +  L +ARG+ +LH     
Sbjct: 74  GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEP 132

Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE-- 261
            I    + + +V++DE   ++I    +   F       S        + APE A++ +  
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPE-ALQKKPE 185

Query: 262 --LSEKADIYSFGVLVLEIISCRKNTDLTLP-SEMQYLPEYAWKLYERGRILEL---VDP 315
                 AD++SF VL+ E+++        +P +++  + E   K+   G    +   + P
Sbjct: 186 DTNRRSADMWSFAVLLWELVTRE------VPFADLSNM-EIGMKVALEGLRPTIPPGISP 238

Query: 316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
            + K  +++            C+     +RP    IV +L
Sbjct: 239 HVSK--LMKI-----------CMNEDPAKRPKFDMIVPIL 265

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  196 bits (500), Expect = 5e-60
 Identities = 69/300 (23%), Positives = 114/300 (38%), Gaps = 41/300 (13%)

Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           G +LG+G FG   +    +   V V K  +   ++ +  FL EV+++  ++H N+++ +G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
                 +   + EY+K  +L  +I    D    WS R      IA G+ YLH  +   I+
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIK-SMDSQYPWSQRVSFAKDIASGMAYLHSMN---II 130

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPED-------------QAYLSTNFAGTLGYTA 253
           HRD+ + N L+ E     + DFGLAR   ++                      G   + A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 254 PEYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL 312
           PE  I G    EK D++SFG+++ EII         LP  M +                 
Sbjct: 191 PE-MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG-----LNVRGFLDRYC 244

Query: 313 VD--PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML---TCKVESGIPVRP 367
               P                 +   C      +RP   ++   L      +   +P+ P
Sbjct: 245 PPNCPP------------SFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGP 292

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  187 bits (477), Expect = 7e-57
 Identities = 75/282 (26%), Positives = 131/282 (46%), Gaps = 40/282 (14%)

Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLL 145
           G  +G G FG VY+GK   G  VAVK L V   + Q    F +EV ++   +H N++  +
Sbjct: 29  GQRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86

Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G  +   Q  +V ++ +  SL   ++    K         I    ARG+ YLH  S   I
Sbjct: 87  GYSTAP-QLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHAKS---I 141

Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ-AYLSTNFAGTLGYTAPEYAIRGEL-- 262
           +HRD+K++N+ L E    KIGDFGLA        ++     +G++ + APE  IR +   
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDSN 200

Query: 263 --SEKADIYSFGVLVLEIISCRKNTDLTLP-SEMQYLPEYAWKL---YERGRILEL---V 313
             S ++D+Y+FG+++ E+++ +      LP S +    +    +        + ++    
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC 254

Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
             RM++  ++             CL+   ++RP    I+A +
Sbjct: 255 PKRMKR--LMAE-----------CLKKKRDERPSFPRILAEI 283

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  182 bits (464), Expect = 1e-54
 Identities = 63/284 (22%), Positives = 115/284 (40%), Gaps = 39/284 (13%)

Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLL 145
           G L+G+G FG VY G+   G  VA++ + +++ ++     F  EV      +H+N+V  +
Sbjct: 38  GELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G C       ++    K R+L  ++       L+ +   QI   I +G+ YLH      I
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVKGMGYLHAKG---I 151

Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARF----FPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
           +H+D+K+ NV  D   +  I DFGL           +        G L + APE  IR  
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI-IRQL 209

Query: 262 L----------SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILE 311
                      S+ +D+++ G +  E+ +         P          +K      I+ 
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHARE------WP----------FKTQPAEAIIW 253

Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
            +   M+          ++ ++   C      +RP  ++++ ML
Sbjct: 254 QMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  178 bits (454), Expect = 5e-53
 Identities = 63/295 (21%), Positives = 111/295 (37%), Gaps = 36/295 (12%)

Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSE--VRMITSIQHKNLVRL 144
              +G+G +G V+ GK   G  VAVK          E+ +  E  +     ++H+N++  
Sbjct: 42  VKQIGKGRYGEVWMGKW-RGEKVAVKVF----FTTEEASWFRETEIYQTVLMRHENILGF 96

Query: 145 LGCCSDGS----QRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
           +     G+    Q  L+ +Y +N SL D L        L+  +  ++      GL +LH 
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHT 152

Query: 200 DSHTR-----IVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL---STNFAGTLGY 251
           +  +      I HRD+K+ N+L+ +     I D GLA  F  D   +        GT  Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212

Query: 252 TAPE------YAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYE 305
             PE           +    AD+YSFG+++ E+     +  +    ++ Y  +       
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY-HDLVPSDPS 271

Query: 306 RGRILELVD-----PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
              + E+V      P        +    Q+  +   C   +   R     +   L
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  177 bits (451), Expect = 7e-53
 Identities = 63/296 (21%), Positives = 111/296 (37%), Gaps = 38/296 (12%)

Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSE--VRMITSIQHKNLVRL 144
              +G+G +G V+RG    G  VAVK      S + E  +  E  +     ++H+N++  
Sbjct: 13  LECVGKGRYGEVWRGSW-QGENVAVKIF----SSRDEKSWFRETELYNTVMLRHENILGF 67

Query: 145 LGCCSDGS----QRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
           +           Q  L+  Y +  SL D L        L+  +  +I+L IA GL +LH 
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHI 123

Query: 200 DSHTR-----IVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL---STNFAGTLGY 251
           +         I HRD+K+ N+L+ +  Q  I D GLA    +    L   +    GT  Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 252 TAPEYAIRGEL-------SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLY 304
            APE  +   +        ++ DI++FG+++ E+     +  +    +  +         
Sbjct: 184 MAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242

Query: 305 ERGRILELVDPRMR---KEGIVERDALQVINVAFI--CLQPHGNQRPPMSEIVAML 355
                  +   + R            L  +    +  C   + + R     I   L
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSL-AKLMKECWYQNPSARLTALRIKKTL 297

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  177 bits (450), Expect = 2e-52
 Identities = 67/296 (22%), Positives = 116/296 (39%), Gaps = 38/296 (12%)

Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSE--VRMITSIQHKNLVRL 144
              +G+G FG V+RGK   G  VAVK      S + E  +  E  +     ++H+N++  
Sbjct: 47  QESIGKGRFGEVWRGKW-RGEEVAVKIF----SSREERSWFREAEIYQTVMLRHENILGF 101

Query: 145 LGCCSDGS----QRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
           +   +  +    Q  LV +Y ++ SL D L    +   +      ++ L  A GL +LH 
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHM 157

Query: 200 DSHTR-----IVHRDIKASNVLLDEKFQSKIGDFGLARFF---PEDQAYLSTNFAGTLGY 251
           +         I HRD+K+ N+L+ +     I D GLA       +       +  GT  Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

Query: 252 TAPEYAIRGEL-------SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLY 304
            APE  +   +        ++ADIY+ G++  EI        +    ++ Y         
Sbjct: 218 MAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276

Query: 305 ERGRILELVDPRMR---KEGIVERDALQVINVAFI--CLQPHGNQRPPMSEIVAML 355
                  + + ++R          +AL+V+    +  C   +G  R     I   L
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVM-AKIMRECWYANGAARLTALRIKKTL 331

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  160 bits (408), Expect = 3e-46
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 25/207 (12%)

Query: 87  GNLLGRGGFGPVYRGKLADG-----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
             +LG G FG VY+G            VA+K+L    S +   E L E  ++ S+ + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF-----LNWSTRFQIILGIARGLQY 196
            RLLG C   S   L+ + M    L   +    D       LNW         IA+G+ Y
Sbjct: 80  CRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNY 132

Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT---LGYTA 253
           L +    R+VHRD+ A NVL+      KI DFGLA+    ++        G    + + A
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMA 187

Query: 254 PEYAIRGELSEKADIYSFGVLVLEIIS 280
            E  +    + ++D++S+GV V E+++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  160 bits (406), Expect = 3e-46
 Identities = 59/242 (24%), Positives = 109/242 (45%), Gaps = 21/242 (8%)

Query: 87  GNLLGRGGFGPVYRGKLA-----DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
              LG G FG V   +        G  VAVK L  +      ++   E+ ++ ++ H+N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 142 VRLLGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
           V+  G C++       L+ E++ + SL   +    +K +N   + +  + I +G+ YL  
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYLGS 144

Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL--GYTAPEYA 257
               + VHRD+ A NVL++ + Q KIGDFGL +    D+ Y +          + APE  
Sbjct: 145 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201

Query: 258 IRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAW-------KLYERGRI 309
           ++ +    +D++SFGV + E+++ C  ++           P +            + G+ 
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKR 261

Query: 310 LE 311
           L 
Sbjct: 262 LP 263

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  162 bits (411), Expect = 4e-46
 Identities = 66/197 (33%), Positives = 101/197 (51%), Gaps = 8/197 (4%)

Query: 87  GNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           G  +GRG FG V+ G+L AD TLVAVK          +++FL E R++    H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178

Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G C+      +V E ++       +  E  + L   T  Q++   A G++YL        
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLES---KCC 234

Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY--TAPEYAIRGELS 263
           +HRD+ A N L+ EK   KI DFG++R   +   Y ++     +    TAPE    G  S
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGV-YAASGGLRQVPVKWTAPEALNYGRYS 293

Query: 264 EKADIYSFGVLVLEIIS 280
            ++D++SFG+L+ E  S
Sbjct: 294 SESDVWSFGILLWETFS 310

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  157 bits (399), Expect = 4e-45
 Identities = 64/223 (28%), Positives = 93/223 (41%), Gaps = 16/223 (7%)

Query: 87  GNLLGRGGFGPVYRGKL-----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
              LG G FG V            G +VAVK L  D   Q  S +  E+ ++ ++ H+++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 142 VRLLGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
           ++  GCC D       LV EY+   S  L  Y      +  +        I  G+ YLH 
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGS--LRDYLPRHS-IGLAQLLLFAQQICEGMAYLHA 152

Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL--GYTAPEYA 257
                 +HRD+ A NVLLD     KIGDFGLA+  PE   Y      G     + APE  
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209

Query: 258 IRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEY 299
              +    +D++SFGV + E+++ C  +               
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 252

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  154 bits (390), Expect = 1e-43
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 21/205 (10%)

Query: 87  GNLLGRGGFGPVYRGKLADG-----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
             +LG G FG VY+G            VA+K+L    S +   E L E  ++ S+ + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF-----LNWSTRFQIILGIARGLQY 196
            RLLG C   S   L+ + M    L   +    D       LNW         IA+G+ Y
Sbjct: 80  CRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNY 132

Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT-LGYTAPE 255
           L +    R+VHRD+ A NVL+      KI DFGLA+    ++           + + A E
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189

Query: 256 YAIRGELSEKADIYSFGVLVLEIIS 280
             +    + ++D++S+GV V E+++
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT 214

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  157 bits (399), Expect = 1e-43
 Identities = 58/195 (29%), Positives = 95/195 (48%), Gaps = 6/195 (3%)

Query: 87  GNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
            + LG G +G VY G        VAVK L  D  +    EFL E  ++  I+H NLV+LL
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLL 282

Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G C+      ++ E+M   +L   +   + + ++      +   I+  ++YL +      
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNF 339

Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEK 265
           +HR++ A N L+ E    K+ DFGL+R    D           + +TAPE     + S K
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399

Query: 266 ADIYSFGVLVLEIIS 280
           +D+++FGVL+ EI +
Sbjct: 400 SDVWAFGVLLWEIAT 414

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  152 bits (386), Expect = 1e-43
 Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 10/196 (5%)

Query: 90  LGRGGFGPVYRGKLADG---TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           LG G FG V +G          VA+K L     +    E + E +++  + +  +VRL+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
            C      +LV E      L   + G+ ++ +  S   +++  ++ G++YL        V
Sbjct: 78  VCQ-AEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYL---EEKNFV 132

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL--GYTAPEYAIRGELSE 264
           HRD+ A NVLL  +  +KI DFGL++    D +Y +   AG     + APE     + S 
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192

Query: 265 KADIYSFGVLVLEIIS 280
           ++D++S+GV + E +S
Sbjct: 193 RSDVWSYGVTMWEALS 208

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  152 bits (387), Expect = 3e-43
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 25/207 (12%)

Query: 87  GNLLGRGGFGPVYRGKLADG-----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
             +LG G FG V++G            V +K +     +Q        +  I S+ H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF-----LNWSTRFQIILGIARGLQY 196
           VRLLG C  GS   LV +Y+   SL   +            LNW         IA+G+ Y
Sbjct: 78  VRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIAKGMYY 130

Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT---LGYTA 253
           L E     +VHR++ A NVLL    Q ++ DFG+A   P D   L    +     + + A
Sbjct: 131 LEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMA 185

Query: 254 PEYAIRGELSEKADIYSFGVLVLEIIS 280
            E    G+ + ++D++S+GV V E+++
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMT 212

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  156 bits (395), Expect = 3e-43
 Identities = 62/194 (31%), Positives = 100/194 (51%), Gaps = 6/194 (3%)

Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
              LG+G FG V+ G     T VA+K L           FL E +++  ++H+ LV+L  
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYA 246

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
             S+     +V EYM   SL   + GE+ K+L       +   IA G+ Y+        V
Sbjct: 247 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYV 302

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKA 266
           HRD++A+N+L+ E    K+ DFGLAR   +++          + +TAPE A+ G  + K+
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362

Query: 267 DIYSFGVLVLEIIS 280
           D++SFG+L+ E+ +
Sbjct: 363 DVWSFGILLTELTT 376

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  151 bits (383), Expect = 3e-43
 Identities = 62/198 (31%), Positives = 92/198 (46%), Gaps = 14/198 (7%)

Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
              LG G FG V  GK      VAVK +        E EF  E + +  + H  LV+  G
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 147 CCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
            CS      +V EY+ N  L + L      K L  S   ++   +  G+ +L E      
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL-ESHQ--F 125

Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL---GYTAPEYAIRGEL 262
           +HRD+ A N L+D     K+ DFG+ R+  +DQ   S    GT     ++APE     + 
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV---GTKFPVKWSAPEVFHYFKY 182

Query: 263 SEKADIYSFGVLVLEIIS 280
           S K+D+++FG+L+ E+ S
Sbjct: 183 SSKSDVWAFGILMWEVFS 200

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  150 bits (382), Expect = 7e-43
 Identities = 68/202 (33%), Positives = 99/202 (49%), Gaps = 12/202 (5%)

Query: 87  GNLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
             ++GRG FG VY G L D        AVK L         S+FL+E  ++    H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 143 RLLGCCSDG-SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
            LLG C       L+V  YMK+  L   I  E+             L +A+G++YL    
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKYLAS-- 146

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL---GYTAPEYAI 258
             + VHRD+ A N +LDEKF  K+ DFGLAR   + + Y   N  G      + A E   
Sbjct: 147 -KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205

Query: 259 RGELSEKADIYSFGVLVLEIIS 280
             + + K+D++SFGVL+ E+++
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMT 227

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  156 bits (396), Expect = 8e-43
 Identities = 62/194 (31%), Positives = 100/194 (51%), Gaps = 6/194 (3%)

Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
              LG+G FG V+ G     T VA+K L           FL E +++  ++H+ LV+L  
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYA 329

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
             S+     +V EYM   SL   + GE+ K+L       +   IA G+ Y+        V
Sbjct: 330 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYV 385

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKA 266
           HRD++A+N+L+ E    K+ DFGLAR   +++          + +TAPE A+ G  + K+
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445

Query: 267 DIYSFGVLVLEIIS 280
           D++SFG+L+ E+ +
Sbjct: 446 DVWSFGILLTELTT 459

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  150 bits (380), Expect = 1e-42
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 12/197 (6%)

Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
              LG G FG V  GK      VA+K +        E EF+ E +++ ++ H+ LV+L G
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYG 86

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
            C+      ++ EYM N  L   +     +        ++   +   ++YL E      +
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYL-ESKQ--FL 142

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL---GYTAPEYAIRGELS 263
           HRD+ A N L++++   K+ DFGL+R+  +D+   S    G+     ++ PE  +  + S
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV---GSKFPVRWSPPEVLMYSKFS 199

Query: 264 EKADIYSFGVLVLEIIS 280
            K+DI++FGVL+ EI S
Sbjct: 200 SKSDIWAFGVLMWEIYS 216

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  149 bits (379), Expect = 1e-42
 Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 14/198 (7%)

Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
              +G G FG V+ G   +   VA+K +        E +F+ E  ++  + H  LV+L G
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 147 CCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
            C + +   LV E+M++  L D L            T   + L +  G+ YL E++   +
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL-EEAC--V 125

Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL---GYTAPEYAIRGEL 262
           +HRD+ A N L+ E    K+ DFG+ RF  +DQ   ST   GT     + +PE       
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST---GTKFPVKWASPEVFSFSRY 182

Query: 263 SEKADIYSFGVLVLEIIS 280
           S K+D++SFGVL+ E+ S
Sbjct: 183 SSKSDVWSFGVLMWEVFS 200

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  150 bits (380), Expect = 2e-42
 Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 14/205 (6%)

Query: 85  HPGNLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           H   ++G+G FG VY G+  D        A+K L      Q    FL E  ++  + H N
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83

Query: 141 LVRLLGCCSDGS-QRLLVYEYMKNRSLDLLIY-GESDKFLNWSTRFQIILGIARGLQYLH 198
           ++ L+G          ++  YM +   DLL +     +           L +ARG++YL 
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHG--DLLQFIRSPQRNPTVKDLISFGLQVARGMEYL- 140

Query: 199 EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL---GYTAPE 255
             +  + VHRD+ A N +LDE F  K+ DFGLAR   + + Y             +TA E
Sbjct: 141 --AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198

Query: 256 YAIRGELSEKADIYSFGVLVLEIIS 280
                  + K+D++SFGVL+ E+++
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLT 223

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  149 bits (379), Expect = 2e-42
 Identities = 63/198 (31%), Positives = 99/198 (50%), Gaps = 12/198 (6%)

Query: 87  GNLLGRGGFGPVYRGKLADGTL-VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
            + LG G +G VY G     +L VAVK L  D  +    EFL E  ++  I+H NLV+LL
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLL 75

Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G C+      ++ E+M   +L   +   + + ++      +   I+  ++YL        
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNF 132

Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL---GYTAPEYAIRGEL 262
           +HRD+ A N L+ E    K+ DFGL+R    D  Y +   AG      +TAPE     + 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAH--AGAKFPIKWTAPESLAYNKF 189

Query: 263 SEKADIYSFGVLVLEIIS 280
           S K+D+++FGVL+ EI +
Sbjct: 190 SIKSDVWAFGVLLWEIAT 207

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  149 bits (378), Expect = 3e-42
 Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 16/204 (7%)

Query: 87  GNLLGRGGFGPVYRGKL-----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
              LG+G FG V   +        G +VAVKKL     +    +F  E+ ++ S+QH N+
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNI 73

Query: 142 VRLLGCCSDGSQR--LLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLH 198
           V+  G C    +R   L+ EY+   SL D L   +  + ++     Q    I +G++YL 
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLG 131

Query: 199 EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL--GYTAPEY 256
                R +HRD+   N+L++ + + KIGDFGL +  P+D+ +      G     + APE 
Sbjct: 132 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188

Query: 257 AIRGELSEKADIYSFGVLVLEIIS 280
               + S  +D++SFGV++ E+ +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  148 bits (377), Expect = 3e-42
 Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 10/196 (5%)

Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
              LG G FG V+ G     T VAVK L           FL+E  ++  +QH+ LVRL  
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYA 75

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
             +      ++ EYM+N SL   +   S   L  +    +   IA G+ ++        +
Sbjct: 76  VVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY--TAPEYAIRGELSE 264
           HRD++A+N+L+ +    KI DFGLAR   +++               TAPE    G  + 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG--AKFPIKWTAPEAINYGTFTI 189

Query: 265 KADIYSFGVLVLEIIS 280
           K+D++SFG+L+ EI++
Sbjct: 190 KSDVWSFGILLTEIVT 205

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  150 bits (380), Expect = 3e-42
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 16/204 (7%)

Query: 87  GNLLGRGGFGPVYRGKL-----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
              LG+G FG V   +        G +VAVKKL     +    +F  E+ ++ S+QH N+
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNI 104

Query: 142 VRLLGCCSDGSQR--LLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLH 198
           V+  G C    +R   L+ EY+   SL D L   +  + ++     Q    I +G++YL 
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLG 162

Query: 199 EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL--GYTAPEY 256
                R +HRD+   N+L++ + + KIGDFGL +  P+D+ Y      G     + APE 
Sbjct: 163 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219

Query: 257 AIRGELSEKADIYSFGVLVLEIIS 280
               + S  +D++SFGV++ E+ +
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFT 243

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  149 bits (379), Expect = 4e-42
 Identities = 66/215 (30%), Positives = 97/215 (45%), Gaps = 30/215 (13%)

Query: 87  GNLLGRGGFGPVYRGKLADG------TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
              LG+G FG VY G           T VA+K +    S +   EFL+E  ++      +
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIY-------GESDKFLNWSTRFQII---LGI 190
           +VRLLG  S G   L++ E M     DL  Y         ++  L   +  ++I     I
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRG--DLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147

Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
           A G+ YL+     + VHRD+ A N ++ E F  KIGDFG+ R   E   Y      G  G
Sbjct: 148 ADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR----KGGKG 200

Query: 251 Y-----TAPEYAIRGELSEKADIYSFGVLVLEIIS 280
                  +PE    G  +  +D++SFGV++ EI +
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  148 bits (376), Expect = 5e-42
 Identities = 57/219 (26%), Positives = 85/219 (38%), Gaps = 32/219 (14%)

Query: 87  GNLLGRGGFGPVYRGKLADG------TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
              LG   FG VY+G L           VA+K L          EF  E  +   +QH N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLD--------------LLIYGESDKFLNWSTRFQI 186
           +V LLG  +      +++ Y  +  L                         L       +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA 246
           +  IA G++YL   S   +VH+D+   NVL+ +K   KI D GL R       Y      
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK----L 186

Query: 247 GTLG-----YTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
                    + APE  + G+ S  +DI+S+GV++ E+ S
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  149 bits (378), Expect = 5e-42
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 10/200 (5%)

Query: 87  GNLLGRGGFGPVYRGKL----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
             ++G G  G V  G+L         VA+K L    +++   +FLSE  ++    H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
           RL G  + G   ++V EYM+N SLD  +     +         ++ G+  G++YL   S 
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYL---SD 169

Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY--TAPEYAIRG 260
              VHRD+ A NVL+D     K+ DFGL+R   +D     T   G +    TAPE     
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229

Query: 261 ELSEKADIYSFGVLVLEIIS 280
             S  +D++SFGV++ E+++
Sbjct: 230 TFSSASDVWSFGVVMWEVLA 249

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  149 bits (378), Expect = 6e-42
 Identities = 68/215 (31%), Positives = 88/215 (40%), Gaps = 30/215 (13%)

Query: 87  GNLLGRGGFGPVYRGKLADG------TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
              LG G FG VY G+++          VAVK L    S+Q E +FL E  +I+   H+N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIY-------GESDKFLNWSTRFQIILGIARG 193
           +VR +G       R ++ E M     DL  +             L       +   IA G
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGG--DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152

Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAGTLG 250
            QYL        +HRDI A N LL         KIGDFG+AR       Y      G   
Sbjct: 153 CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK----GGCA 205

Query: 251 Y-----TAPEYAIRGELSEKADIYSFGVLVLEIIS 280
                   PE  + G  + K D +SFGVL+ EI S
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  151 bits (384), Expect = 1e-41
 Identities = 53/194 (27%), Positives = 90/194 (46%), Gaps = 6/194 (3%)

Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
              LG G FG V+       T VAVK +           FL+E  ++ ++QH  LV+L  
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV--EAFLAEANVMKTLQHDKLVKLHA 250

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
             +      ++ E+M   SL   +  +                IA G+ ++        +
Sbjct: 251 VVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYI 306

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKA 266
           HRD++A+N+L+      KI DFGLAR   +++          + +TAPE    G  + K+
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 366

Query: 267 DIYSFGVLVLEIIS 280
           D++SFG+L++EI++
Sbjct: 367 DVWSFGILLMEIVT 380

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  147 bits (374), Expect = 1e-41
 Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 12/197 (6%)

Query: 90  LGRGGFGPVYRGKL---ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLL 145
           LG G FG V +G          VAVK L  +      + E L+E  ++  + +  +VR++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G C      +LV E  +   L    Y + ++ +      +++  ++ G++YL     +  
Sbjct: 85  GICE-AESWMLVMEMAELGPL--NKYLQQNRHVKDKNIIELVHQVSMGMKYL---EESNF 138

Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL--GYTAPEYAIRGELS 263
           VHRD+ A NVLL  +  +KI DFGL++    D+ Y      G     + APE     + S
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198

Query: 264 EKADIYSFGVLVLEIIS 280
            K+D++SFGVL+ E  S
Sbjct: 199 SKSDVWSFGVLMWEAFS 215

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  148 bits (376), Expect = 1e-41
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 24/208 (11%)

Query: 87  GNLLGRGGFGPVYRGKL-----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
            + LG+G FG V   +        G LVAVK+L      Q + +F  E++++ ++    +
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFI 86

Query: 142 VRLLGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKF-----LNWSTRFQIILGIARGL 194
           V+  G      ++   LV EY+ +  L   +     +      L +S+       I +G+
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS------QICKGM 140

Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL--GYT 252
           +YL      R VHRD+ A N+L++ +   KI DFGLA+  P D+ Y      G     + 
Sbjct: 141 EYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197

Query: 253 APEYAIRGELSEKADIYSFGVLVLEIIS 280
           APE       S ++D++SFGV++ E+ +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFT 225

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  149 bits (378), Expect = 2e-41
 Identities = 66/202 (32%), Positives = 99/202 (49%), Gaps = 12/202 (5%)

Query: 87  GNLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
             ++GRG FG VY G L D        AVK L         S+FL+E  ++    H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 143 RLLGCCSDG-SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
            LLG C       L+V  YMK+  L   I  E+             L +A+G+++L   +
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKFL---A 209

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL---GYTAPEYAI 258
             + VHRD+ A N +LDEKF  K+ DFGLAR   + +     N  G      + A E   
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269

Query: 259 RGELSEKADIYSFGVLVLEIIS 280
             + + K+D++SFGVL+ E+++
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMT 291

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  148 bits (375), Expect = 2e-41
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 32/218 (14%)

Query: 87  GNLLGRGGFGPVYRGKLADG------TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
              LG G FG V+  +  +        LVAVK L  + S+    +F  E  ++T +QH++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQH 104

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLD-------------LLIYGESDKFLNWSTRFQII 187
           +VR  G C++G   L+V+EYM++  L+                   +   L       + 
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 188 LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG 247
             +A G+ YL   +    VHRD+   N L+ +    KIGDFG++R       Y      G
Sbjct: 165 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR----VG 217

Query: 248 TLG-----YTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
                   +  PE  +  + + ++D++SFGV++ EI +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  146 bits (372), Expect = 2e-41
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 33/219 (15%)

Query: 87  GNLLGRGGFGPVYRGKLADG------TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
              LG G FG V+  +  +        LVAVK L  D +     +F  E  ++T++QH++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAELLTNLQHEH 78

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSL--------------DLLIYGESDKFLNWSTRFQI 186
           +V+  G C DG   ++V+EYMK+  L                    ++   L  S    I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA 246
              IA G+ YL   +    VHRD+   N L+      KIGDFG++R       Y      
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR----V 191

Query: 247 GTLG-----YTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           G        +  PE  +  + + ++D++SFGV++ EI +
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  146 bits (371), Expect = 2e-41
 Identities = 64/197 (32%), Positives = 94/197 (47%), Gaps = 16/197 (8%)

Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
              +G+G FG V  G    G  VAVK +   K+      FL+E  ++T ++H NLV+LLG
Sbjct: 26  LQTIGKGEFGDVMLGD-YRGNKVAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQLLG 81

Query: 147 CCSDGSQRL-LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
              +    L +V EYM   SL   +       L      +  L +   ++YL        
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 138

Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY--TAPEYAIRGELS 263
           VHRD+ A NVL+ E   +K+ DFGL +    + +       G L    TAPE     + S
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDT--GKLPVKWTAPEALREKKFS 192

Query: 264 EKADIYSFGVLVLEIIS 280
            K+D++SFG+L+ EI S
Sbjct: 193 TKSDVWSFGILLWEIYS 209

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  147 bits (374), Expect = 6e-41
 Identities = 68/215 (31%), Positives = 87/215 (40%), Gaps = 30/215 (13%)

Query: 87  GNLLGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
              LG G FG VY G++           VAVK L    S+Q E +FL E  +I+   H+N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIY-------GESDKFLNWSTRFQIILGIARG 193
           +VR +G       R ++ E M     DL  +             L       +   IA G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGG--DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAGTLG 250
            QYL        +HRDI A N LL         KIGDFG+AR       Y      G   
Sbjct: 194 CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK----GGCA 246

Query: 251 Y-----TAPEYAIRGELSEKADIYSFGVLVLEIIS 280
                   PE  + G  + K D +SFGVL+ EI S
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  149 bits (378), Expect = 7e-41
 Identities = 63/195 (32%), Positives = 95/195 (48%), Gaps = 12/195 (6%)

Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
              +G+G FG V  G    G  VAVK +  D + Q    FL+E  ++T ++H NLV+LLG
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLG 253

Query: 147 CCSDGSQRL-LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
              +    L +V EYM   SL   +       L      +  L +   ++YL        
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNF 310

Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEK 265
           VHRD+ A NVL+ E   +K+ DFGL +    + +         + +TAPE     + S K
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTK 366

Query: 266 ADIYSFGVLVLEIIS 280
           +D++SFG+L+ EI S
Sbjct: 367 SDVWSFGILLWEIYS 381

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  145 bits (367), Expect = 8e-41
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 15/201 (7%)

Query: 87  GNLLGRGGFGPVYRGKL----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
             +LG G FG VY G       +   VAVK    D +   + +F+SE  ++ ++ H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
           +L+G         ++ E      L   +    +  L   T     L I + + YL     
Sbjct: 77  KLIGIIE-EEPTWIIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYL---ES 131

Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL---GYTAPEYAIR 259
              VHRDI   N+L+      K+GDFGL+R+  ++  Y ++    T     + +PE    
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS---VTRLPIKWMSPESINF 188

Query: 260 GELSEKADIYSFGVLVLEIIS 280
              +  +D++ F V + EI+S
Sbjct: 189 RRFTTASDVWMFAVCMWEILS 209

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  147 bits (373), Expect = 8e-41
 Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 10/197 (5%)

Query: 90  LGRGGFGPVYRGKL----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
           +G G FG V  G+L         VA+K L V  +++   +FL E  ++    H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 146 GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           G  +     ++V EYM+N SLD  +     +         ++ GIA G++YL   S    
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL---SDMGY 168

Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY--TAPEYAIRGELS 263
           VHRD+ A N+L++     K+ DFGL R   +D     T   G +    T+PE     + +
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228

Query: 264 EKADIYSFGVLVLEIIS 280
             +D++S+G+++ E++S
Sbjct: 229 SASDVWSYGIVLWEVMS 245

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  146 bits (370), Expect = 9e-41
 Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 31/216 (14%)

Query: 87  GNLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGE-SEFLSEVRMITSIQHKNL 141
           G +LG+G FG V   +L         VAVK L  D     +  EFL E   +    H ++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 142 VRLLGCCSDGSQR------LLVYEYMKNRSLDLLIY------GESDKFLNWSTRFQIILG 189
            +L+G       +      +++  +MK+   DL  +      GE+   L   T  + ++ 
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHG--DLHAFLLASRIGENPFNLPLQTLVRFMVD 145

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
           IA G++YL   S    +HRD+ A N +L E     + DFGL+R       Y      G  
Sbjct: 146 IACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR----QGCA 198

Query: 250 G-----YTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
                 + A E       +  +D+++FGV + EI++
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  151 bits (383), Expect = 9e-41
 Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 10/196 (5%)

Query: 90  LGRGGFGPVYRGKLADG---TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           LG G FG V +G          VA+K L     +    E + E +++  + +  +VRL+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
            C      +LV E      L   + G+ ++ +  S   +++  ++ G++YL        V
Sbjct: 404 VCQ-AEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYL---EEKNFV 458

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY--TAPEYAIRGELSE 264
           HR++ A NVLL  +  +KI DFGL++    D +Y +   AG       APE     + S 
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518

Query: 265 KADIYSFGVLVLEIIS 280
           ++D++S+GV + E +S
Sbjct: 519 RSDVWSYGVTMWEALS 534

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  146 bits (370), Expect = 1e-40
 Identities = 64/222 (28%), Positives = 99/222 (44%), Gaps = 35/222 (15%)

Query: 87  GNLLGRGGFGPVYRGKLAD--------GTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V   +              VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSL--------------DLLIYGESDKFLNWSTR 183
           HKN++ LLG C+      ++ EY    +L                 I    ++ + +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST 243
                 +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR       Y   
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK-- 214

Query: 244 NFAGTLG-----YTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
               T G     + APE       + ++D++SFGVL+ EI +
Sbjct: 215 --KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  146 bits (370), Expect = 1e-40
 Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 31/218 (14%)

Query: 87  GNLLGRGGFGPVYRGKLAD------GTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHK 139
           G  LG G FG V                VAVK L        +   +SE+++++ + QH+
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 140 NLVRLLGCCSDGSQRLLVYEYMKNRSL------------DLLIYGESDKFLNWSTRFQII 187
           N+V LLG C+ G   L++ EY     L                +  ++   +        
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 188 LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG 247
             +A+G+ +L   +    +HRD+ A NVLL     +KIGDFGLAR    D  Y+      
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI----VK 223

Query: 248 TLG-----YTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
                   + APE       + ++D++S+G+L+ EI S
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  145 bits (367), Expect = 2e-40
 Identities = 64/215 (29%), Positives = 99/215 (46%), Gaps = 30/215 (13%)

Query: 87  GNLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGE-SEFLSEVRMITSIQHKNL 141
           G +LG G FG V  G L         VAVK + +D S Q E  EFLSE   +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 142 VRLLGCCSDGSQR-----LLVYEYMKNRSLDLLIY------GESDKFLNWSTRFQIILGI 190
           +RLLG C + S +     +++  +MK    DL  Y          K +   T  + ++ I
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYG--DLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156

Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
           A G++YL   S+   +HRD+ A N +L +     + DFGL++       Y      G + 
Sbjct: 157 ALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR----QGRIA 209

Query: 251 -----YTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
                + A E       + K+D+++FGV + EI +
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  143 bits (364), Expect = 2e-40
 Identities = 52/199 (26%), Positives = 87/199 (43%), Gaps = 11/199 (5%)

Query: 87  GNLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           G  +G G FG V++G           VA+K      S     +FL E   +    H ++V
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 143 RLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
           +L+G  +  +   ++ E      L   L   +    L+ ++       ++  L YL    
Sbjct: 80  KLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYL---E 133

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
             R VHRDI A NVL+      K+GDFGL+R+  +   Y ++     + + APE      
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 193

Query: 262 LSEKADIYSFGVLVLEIIS 280
            +  +D++ FGV + EI+ 
Sbjct: 194 FTSASDVWMFGVCMWEILM 212

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  145 bits (367), Expect = 2e-40
 Identities = 58/198 (29%), Positives = 103/198 (52%), Gaps = 11/198 (5%)

Query: 90  LGRGGFGPVYRGKL-----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRL 144
           +G G FG VY+G L          VA+K L    +++   +FL E  ++    H N++RL
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTR 204
            G  S     +++ EYM+N +LD  +  +  +  +      ++ GIA G++YL   ++  
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYL---ANMN 167

Query: 205 IVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY--TAPEYAIRGEL 262
            VHRD+ A N+L++     K+ DFGL+R   +D     T   G +    TAPE     + 
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227

Query: 263 SEKADIYSFGVLVLEIIS 280
           +  +D++SFG+++ E+++
Sbjct: 228 TSASDVWSFGIVMWEVMT 245

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  144 bits (366), Expect = 3e-40
 Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 33/217 (15%)

Query: 87  GNLLGRGGFGPVYRGKLADG---TLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLV 142
            +++G G FG V + ++         A+K++    S+    +F  E+ ++  +  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLD--------------LLIYGESDKFLNWSTRFQIIL 188
            LLG C       L  EY  + +L                 I   +   L+         
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 189 GIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT 248
            +ARG+ YL   S  + +HRD+ A N+L+ E + +KI DFGL+R     + Y+      T
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK----T 199

Query: 249 LG-----YTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           +G     + A E       +  +D++S+GVL+ EI+S
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  145 bits (367), Expect = 3e-40
 Identities = 57/227 (25%), Positives = 93/227 (40%), Gaps = 40/227 (17%)

Query: 87  GNLLGRGGFGPVYRGKLADG------TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
              +G G FG V++ +          T+VAVK L  + S   +++F  E  ++    + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSL----------------------DLLIYGESDKFL 178
           +V+LLG C+ G    L++EYM    L                         +       L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 179 NWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ 238
           + + +  I   +A G+ YL   S  + VHRD+   N L+ E    KI DFGL+R      
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 239 AYLSTNFAGTLGY-----TAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            Y     A            PE       + ++D++++GV++ EI S
Sbjct: 229 YYK----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  143 bits (362), Expect = 5e-40
 Identities = 61/207 (29%), Positives = 89/207 (42%), Gaps = 23/207 (11%)

Query: 87  GNLLGRGGFGPVYRGKL----ADGTLVAVKKLCVDKSQQGES--EFLSEVRMITSIQHKN 140
              LG G FG V RG+          VAVK L  D   Q E+  +F+ EV  + S+ H+N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF-----LNWSTRFQIILGIARGLQ 195
           L+RL G         +V E     SL   +      F       ++        +A G+ 
Sbjct: 83  LIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV------QVAEGMG 135

Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY--TA 253
           YL      R +HRD+ A N+LL  +   KIGDFGL R  P++  +        + +   A
Sbjct: 136 YLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 192

Query: 254 PEYAIRGELSEKADIYSFGVLVLEIIS 280
           PE       S  +D + FGV + E+ +
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFT 219

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  143 bits (363), Expect = 6e-40
 Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 40/227 (17%)

Query: 87  GNLLGRGGFGPVYRGKLADG------TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           G  LG G FG V +            T VAVK L  + S     + LSE  ++  + H +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSL----------------------DLLIYGESDKFL 178
           +++L G CS     LL+ EY K  SL                         +    ++ L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 179 NWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ 238
                      I++G+QYL   +  ++VHRD+ A N+L+ E  + KI DFGL+R   E+ 
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 239 AYLSTNFAGTLG-----YTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
           +Y+      + G     + A E       + ++D++SFGVL+ EI++
Sbjct: 205 SYV----KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  142 bits (359), Expect = 2e-39
 Identities = 56/222 (25%), Positives = 90/222 (40%), Gaps = 35/222 (15%)

Query: 87  GNLLGRGGFGPVYRGKLAD------GTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHK 139
           G  LG G FG V                VAVK L            +SE+++++ +  H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 140 NLVRLLGCCSDGSQRLLVYEYMKNRSL----------------DLLIYGESDKFLNWSTR 183
           N+V LLG C+ G   L++ EY     L                   I  + +  L+    
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST 243
                 +A+G+ +L   +    +HRD+ A N+LL     +KI DFGLAR    D  Y+  
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV-- 202

Query: 244 NFAGTLG-----YTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
                       + APE       + ++D++S+G+ + E+ S
Sbjct: 203 --VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  141 bits (357), Expect = 2e-39
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 14/203 (6%)

Query: 87  GNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRL 144
              +GRG F  VY+G        VA  +L   K ++     F  E  M+  +QH N+VR 
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 145 LGCCSDGSQ---RLLVY-EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
                   +    +++  E M + +L   +  +  K +           I +GLQ+LH  
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHT- 147

Query: 201 SHTRIVHRDIKASNVLLDEKF-QSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
               I+HRD+K  N+ +       KIGD GLA       A       GT  + APE    
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEM-YE 203

Query: 260 GELSEKADIYSFGVLVLEIISCR 282
            +  E  D+Y+FG+ +LE+ +  
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSE 226

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  143 bits (362), Expect = 4e-39
 Identities = 64/222 (28%), Positives = 99/222 (44%), Gaps = 35/222 (15%)

Query: 87  GNLLGRGGFGPVYRGKLAD--------GTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V   +              VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSL--------------DLLIYGESDKFLNWSTR 183
           HKN++ LLG C+      ++ EY    +L                 I    ++ + +   
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST 243
                 +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR       Y   
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK-- 260

Query: 244 NFAGTLG-----YTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
               T G     + APE       + ++D++SFGVL+ EI +
Sbjct: 261 --KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  141 bits (357), Expect = 5e-39
 Identities = 63/221 (28%), Positives = 96/221 (43%), Gaps = 34/221 (15%)

Query: 87  GNLLGRGGFGPVYRGKLAD------GTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHK 139
           G  LGRG FG V                VAVK L    +       +SE++++  I  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 140 NLVRLLGCCSD-GSQRLLVYEYMKNRSL--------------DLLIYGESDKFLNWSTRF 184
           N+V LLG C+  G   +++ E+ K  +L               +        FL      
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 185 QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN 244
                +A+G+++L   +  + +HRD+ A N+LL EK   KI DFGLAR   +D  Y+   
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV--- 205

Query: 245 FAGTLG-----YTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
                      + APE       + ++D++SFGVL+ EI S
Sbjct: 206 -RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  147 bits (372), Expect = 5e-39
 Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 9/198 (4%)

Query: 87  GNLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           G  +G G FG V++G           VA+K      S     +FL E   +    H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
           +L+G  ++ +   ++ E      L   +       L+ ++       ++  L YL     
Sbjct: 455 KLIGVITE-NPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLES--- 509

Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
            R VHRDI A NVL+      K+GDFGL+R+  +   Y ++     + + APE       
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569

Query: 263 SEKADIYSFGVLVLEIIS 280
           +  +D++ FGV + EI+ 
Sbjct: 570 TSASDVWMFGVCMWEILM 587

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  142 bits (360), Expect = 8e-39
 Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 35/222 (15%)

Query: 87  GNLLGRGGFGPVYRGKLAD--------GTLVAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
           G  LG G FG V   +            T VAVK L  D +++  S+ +SE+ M+  I +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSL--------------DLLIYGESDKFLNWSTR 183
           HKN++ LLG C+      ++ EY    +L                      ++ L+    
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST 243
                 +ARG++YL   +  + +HRD+ A NVL+ E    KI DFGLAR       Y   
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK-- 248

Query: 244 NFAGTLG-----YTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
               T G     + APE       + ++D++SFGVL+ EI +
Sbjct: 249 --KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  139 bits (352), Expect = 1e-38
 Identities = 65/291 (22%), Positives = 117/291 (40%), Gaps = 49/291 (16%)

Query: 78  KKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI 136
           K+   +F    L+G GGFG V++ K   DG    +K+  V  + +   +   EV+ +  +
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR--VKYNNE---KAEREVKALAKL 61

Query: 137 QHKNLVRLLGCCSDGSQRL----------------LVYEYMKNRSLDLLIYGESDKFLNW 180
            H N+V   GC                        +  E+    +L+  I     + L+ 
Sbjct: 62  DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121

Query: 181 STRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY 240
               ++   I +G+ Y+H     ++++RD+K SN+ L +  Q KIGDFGL      D   
Sbjct: 122 VLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178

Query: 241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYA 300
             T   GTL Y +PE     +  ++ D+Y+ G+++ E++            E        
Sbjct: 179 --TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKF---- 227

Query: 301 WKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEI 351
           +     G I ++ D + +   ++++            L      RP  SEI
Sbjct: 228 FTDLRDGIISDIFDKKEKT--LLQK-----------LLSKKPEDRPNTSEI 265

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  138 bits (351), Expect = 2e-38
 Identities = 48/218 (22%), Positives = 85/218 (38%), Gaps = 41/218 (18%)

Query: 87  GNLLGRGGFGPVYRGKL--------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
              LG+G F  +++G             T V +K L     +     F     M++ + H
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSH 71

Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLH 198
           K+LV   G C  G + +LV E++K  SLD  +    +  +N   + ++   +A  + +L 
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-INILWKLEVAKQLAAAMHFL- 129

Query: 199 EDSHTRIVHRDIKASNVLLDEKFQS--------KIGDFGLARFFPEDQAYLSTNFAGTLG 250
           E++   ++H ++ A N+LL  +           K+ D G++                   
Sbjct: 130 EENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------I 176

Query: 251 Y------TAPEYAI--RGELSEKADIYSFGVLVLEIIS 280
                    PE  I     L+   D +SFG  + EI S
Sbjct: 177 LQERIPWVPPE-CIENPKNLNLATDKWSFGTTLWEICS 213

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  139 bits (352), Expect = 5e-38
 Identities = 63/227 (27%), Positives = 91/227 (40%), Gaps = 40/227 (17%)

Query: 87  GNLLGRGGFGPVYRGKLADG------TLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHK 139
           G +LG G FG V                VAVK L            +SE++M+T +  H+
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 140 NLVRLLGCCSDGSQRLLVYEYMKNRSL---------------------DLLIYGESDKFL 178
           N+V LLG C+      L++EY     L                       L   E    L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 179 NWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ 238
            +         +A+G+++L        VHRD+ A NVL+      KI DFGLAR    D 
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226

Query: 239 AYLSTNFAGTLG-----YTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            Y+              + APE    G  + K+D++S+G+L+ EI S
Sbjct: 227 NYV----VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  137 bits (348), Expect = 7e-38
 Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 28/223 (12%)

Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
            +F P   LGRGGFG V+  K   D    A+K++ +   +    + + EV+ +  ++H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 141 LVRLLGCCSDG---------SQRLLVY---EYMKNRSL-DLLIYGESDKFLNWSTRFQII 187
           +VR      +          S ++ +Y   +  +  +L D +    + +    S    I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 188 LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA- 246
           L IA  +++LH      ++HRD+K SN+        K+GDFGL     +D+   +     
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 247 ----------GTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
                     GT  Y +PE       S K DI+S G+++ E++
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  137 bits (347), Expect = 1e-37
 Identities = 55/207 (26%), Positives = 100/207 (48%), Gaps = 11/207 (5%)

Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQH 138
            NF     +GRG F  VYR   L DG  VA+KK+ +      +  ++ + E+ ++  + H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLI--YGESDKFLNWSTRFQIILGIARGLQY 196
            N+++      + ++  +V E      L  +I  + +  + +   T ++  + +   L++
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEY 256
           +H     R++HRDIK +NV +      K+GD GL RFF        +   GT  Y +PE 
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPE- 206

Query: 257 AIRGEL-SEKADIYSFGVLVLEIISCR 282
            I     + K+DI+S G L+ E+ + +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQ 233

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  137 bits (348), Expect = 2e-37
 Identities = 46/206 (22%), Positives = 90/206 (43%), Gaps = 12/206 (5%)

Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESE---FLSEVRMITSIQ 137
           + +     +G G FG     K   DG    +K+  ++ S+    E      EV ++ +++
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKE--INISRMSSKEREESRREVAVLANMK 81

Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYL 197
           H N+V+      +     +V +Y +   L   I  +              + I   L+++
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141

Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYA 257
           H+    +I+HRDIK+ N+ L +    ++GDFG+AR              GT  Y +PE  
Sbjct: 142 HDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLSPE-I 196

Query: 258 IRGEL-SEKADIYSFGVLVLEIISCR 282
              +  + K+DI++ G ++ E+ + +
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLK 222

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  135 bits (341), Expect = 9e-37
 Identities = 66/320 (20%), Positives = 118/320 (36%), Gaps = 46/320 (14%)

Query: 70  SYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLS 128
            YF    +    K++     LG GGF  V   + L DG   A+K++     QQ   E   
Sbjct: 17  LYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC-HEQQDREEAQR 75

Query: 129 EVRMITSIQHKNLVRLLGCCSDGSQR----LLVYEYMKNRSLDLLIYGESDKFLNWSTRF 184
           E  M     H N++RL+  C           L+  + K  +L   I    ++  +     
Sbjct: 76  EADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI----ERLKDKGNFL 131

Query: 185 ------QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ 238
                  ++LGI RGL+ +H        HRD+K +N+LL ++ Q  + D G         
Sbjct: 132 TEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188

Query: 239 AYLST--------NFAGTLGYTAPE---YAIRGELSEKADIYSFGVLVLEIISCRKNTDL 287
                            T+ Y APE         + E+ D++S G ++  ++        
Sbjct: 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMF------G 242

Query: 288 TLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPP 347
             P +M +    +  L  + ++     PR            Q++N     +    +QRP 
Sbjct: 243 EGPYDMVFQKGDSVALAVQNQLSIPQSPRHSS------ALWQLLN---SMMTVDPHQRPH 293

Query: 348 MSEIVAMLTCKVESGIPVRP 367
           +  +++ L   ++   P + 
Sbjct: 294 IPLLLSQL-EALQPPAPGQH 312

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  132 bits (335), Expect = 3e-36
 Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 9/207 (4%)

Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHK 139
           +++     +G G +G   + +  +DG ++  K+L     ++  +   +SEV ++  ++H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 140 NLVRLLGCCSDGSQRLL--VYEYMKNRSLDLLI--YGESDKFLNWSTRFQIILGIARGLQ 195
           N+VR      D +   L  V EY +   L  +I    +  ++L+     +++  +   L+
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 196 YLHE--DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
             H   D    ++HRD+K +NV LD K   K+GDFGLAR    D ++  T F GT  Y +
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPYYMS 184

Query: 254 PEYAIRGELSEKADIYSFGVLVLEIIS 280
           PE   R   +EK+DI+S G L+ E+ +
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCA 211

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  132 bits (333), Expect = 1e-35
 Identities = 62/231 (26%), Positives = 98/231 (42%), Gaps = 46/231 (19%)

Query: 81  TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHK 139
             +F    +LG+G FG V + +   D    A+K   +  +++  S  LSEV ++ S+ H+
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIK--KIRHTEEKLSTILSEVMLLASLNHQ 62

Query: 140 NLVRLLGCCSDGSQRL-------------LVYEYMKNRSL-DLLI----YGESDKFLNWS 181
            +VR      +    +             +  EY +N +L DL+       + D++    
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL- 121

Query: 182 TRF-QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY 240
             F QI+      L Y+H      I+HRD+K  N+ +DE    KIGDFGLA+        
Sbjct: 122 --FRQILEA----LSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172

Query: 241 LSTN-------------FAGTLGYTAPE-YAIRGELSEKADIYSFGVLVLE 277
           L  +               GT  Y A E     G  +EK D+YS G++  E
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  131 bits (332), Expect = 1e-35
 Identities = 61/198 (30%), Positives = 97/198 (48%), Gaps = 14/198 (7%)

Query: 87  GNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQHKNLVRL 144
             +LG+G +G VY G+ L++   +A+K+  + +     S+ L  E+ +   ++HKN+V+ 
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKE--IPERDSRYSQPLHEEIALHKHLKHKNIVQY 84

Query: 145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG-IARGLQYLHEDSHT 203
           LG  S+     +  E +   SL  L+  +     +           I  GL+YLH++   
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN--- 141

Query: 204 RIVHRDIKASNVLLDEKF-QSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
           +IVHRDIK  NVL++      KI DFG ++          T F GTL Y APE  I    
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPE-IIDKGP 199

Query: 263 ---SEKADIYSFGVLVLE 277
               + ADI+S G  ++E
Sbjct: 200 RGYGKAADIWSLGCTIIE 217

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  131 bits (332), Expect = 2e-35
 Identities = 66/278 (23%), Positives = 108/278 (38%), Gaps = 34/278 (12%)

Query: 82  KNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESE---FLSEVRMITSI- 136
           ++F   + LG G +G V++     DG L AVK+       +G  +    L+EV     + 
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR--SMSPFRGPKDRARKLAEVGSHEKVG 114

Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
           QH   VRL     +G    L  E     SL           L  +  +  +      L +
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCE-AWGASLPEAQVWGYLRDTLLALAH 172

Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEY 256
           LH      +VH D+K +N+ L  + + K+GDFGL        A       G   Y APE 
Sbjct: 173 LHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPE- 226

Query: 257 AIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR 316
            ++G     AD++S G+ +LE+       ++ LP   +      W+   +G +       
Sbjct: 227 LLQGSYGTAADVFSLGLTILEVA-----CNMELPHGGE-----GWQQLRQGYLPPEFTAG 276

Query: 317 MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAM 354
           +  E    R  L +       L+P    R     ++A+
Sbjct: 277 LSSEL---RSVLVM------MLEPDPKLRATAEALLAL 305

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  133 bits (336), Expect = 5e-35
 Identities = 51/209 (24%), Positives = 86/209 (41%), Gaps = 20/209 (9%)

Query: 83  NFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVR-MITSIQHKNL 141
           +F P ++LG G  G +    + D   VAVK   +       ++   EV+ +  S +H N+
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVK--RILPECFSFAD--REVQLLRESDEHPNV 80

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
           +R      D   + +  E     +L   +  +    L       ++     GL +LH   
Sbjct: 81  IRYFCTEKDRQFQYIAIELCAA-TLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLHS-- 136

Query: 202 HTRIVHRDIKASNVLLDEK-----FQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAP 254
              IVHRD+K  N+L+         ++ I DFGL +     +   S  +   GT G+ AP
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 255 EY---AIRGELSEKADIYSFGVLVLEIIS 280
           E      +   +   DI+S G +   +IS
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  129 bits (326), Expect = 1e-34
 Identities = 43/221 (19%), Positives = 87/221 (39%), Gaps = 26/221 (11%)

Query: 74  FQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESE---FLSEV 130
           FQ++    + +     +G GG   V++       + A+K   V+  +        + +E+
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIK--YVNLEEADNQTLDSYRNEI 77

Query: 131 RMITSIQHKNL--VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIIL 188
             +  +Q  +   +RL           +V E       DL  + +  K ++   R     
Sbjct: 78  AYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI---DLNSWLKKKKSIDPWERKSYWK 134

Query: 189 GIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA-YLSTNFAG 247
            +   +  +H+     IVH D+K +N L+ +    K+ DFG+A     D    +  +  G
Sbjct: 135 NMLEAVHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 190

Query: 248 TLGYTAPE-----------YAIRGELSEKADIYSFGVLVLE 277
           T+ Y  PE              + ++S K+D++S G ++  
Sbjct: 191 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  127 bits (321), Expect = 4e-34
 Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 12/203 (5%)

Query: 77  LKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQ----QGESEFLSEVR 131
           + +  ++F  GNLLG+G F  VYR + +  G  VA+K   +DK             +EV+
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIK--MIDKKAMYKAGMVQRVQNEVK 63

Query: 132 MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIA 191
           +   ++H +++ L     D +   LV E   N  ++  +      F     R   +  I 
Sbjct: 64  IHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH-FMHQII 122

Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY 251
            G+ YLH  SH  I+HRD+  SN+LL      KI DFGLA           T   GT  Y
Sbjct: 123 TGMLYLH--SH-GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNY 178

Query: 252 TAPEYAIRGELSEKADIYSFGVL 274
            +PE A R     ++D++S G +
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCM 201

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  128 bits (324), Expect = 4e-34
 Identities = 72/281 (25%), Positives = 115/281 (40%), Gaps = 33/281 (11%)

Query: 78  KKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQ----QGESEFLSEVRM 132
            ++ + +  G  LG+GGF   +         + A K   V KS         +   E+ +
Sbjct: 37  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGK--IVPKSLLLKPHQREKMSMEISI 94

Query: 133 ITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIA 191
             S+ H+++V   G   D     +V E  + RSL +L              R+  +  I 
Sbjct: 95  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK--RRKALTEPEARY-YLRQIV 151

Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY 251
            G QYLH   + R++HRD+K  N+ L+E  + KIGDFGLA     D         GT  Y
Sbjct: 152 LGCQYLH--RN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNY 207

Query: 252 TAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILE 311
            APE   +   S + D++S G ++  ++  +       P E   L E     Y R +  E
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETSCLKE----TYLRIKKNE 257

Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIV 352
              P+      +   A  +I      LQ     RP ++E++
Sbjct: 258 YSIPKH-----INPVAASLIQK---MLQTDPTARPTINELL 290

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  128 bits (323), Expect = 6e-34
 Identities = 57/210 (27%), Positives = 87/210 (41%), Gaps = 25/210 (11%)

Query: 78  KKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI 136
           ++          +GRG FG V+R K    G   AVKK+ ++  +  E    +       +
Sbjct: 54  REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAG------L 107

Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLI--YG-ESDKFLNWSTRFQIILGIARG 193
               +V L G   +G    +  E ++  SL  LI   G   +    +    Q +     G
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG-QAL----EG 162

Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEK-FQSKIGDFGLARFFPEDQAYLSTN----FAGT 248
           L+YLH     RI+H D+KA NVLL     ++ + DFG A     D    S        GT
Sbjct: 163 LEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219

Query: 249 LGYTAPEYAIRGE-LSEKADIYSFGVLVLE 277
             + APE  + G+    K DI+S   ++L 
Sbjct: 220 ETHMAPE-VVMGKPCDAKVDIWSSCCMMLH 248

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  126 bits (318), Expect = 1e-33
 Identities = 72/281 (25%), Positives = 115/281 (40%), Gaps = 33/281 (11%)

Query: 78  KKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESE----FLSEVRM 132
            ++ + +  G  LG+GGF   +         + A K   V KS   +         E+ +
Sbjct: 11  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGK--IVPKSLLLKPHQREKMSMEISI 68

Query: 133 ITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIA 191
             S+ H+++V   G   D     +V E  + RSL +L              R+  +  I 
Sbjct: 69  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK--RRKALTEPEARY-YLRQIV 125

Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY 251
            G QYLH   + R++HRD+K  N+ L+E  + KIGDFGLA     D         GT  Y
Sbjct: 126 LGCQYLH--RN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNY 181

Query: 252 TAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILE 311
            APE   +   S + D++S G ++  ++  +       P E   L E     Y R +  E
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETSCLKE----TYLRIKKNE 231

Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIV 352
              P+      +   A  +I      LQ     RP ++E++
Sbjct: 232 YSIPKH-----INPVAASLIQK---MLQTDPTARPTINELL 264

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  128 bits (323), Expect = 2e-33
 Identities = 43/249 (17%), Positives = 91/249 (36%), Gaps = 26/249 (10%)

Query: 51  RTTKEGVSKDFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVA 110
              +   S D    +    S    + +    + +     +G GG   V++       + A
Sbjct: 25  FERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYA 84

Query: 111 VKKLCVDKSQQGESE---FLSEVRMITSIQHKNL--VRLLGCCSDGSQRLLVYEYMKNRS 165
           +K   V+  +        + +E+  +  +Q  +   +RL           +V E      
Sbjct: 85  IK--YVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI-- 140

Query: 166 LDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKI 225
            DL  + +  K ++   R      +   +  +H+     IVH D+K +N L+ +    K+
Sbjct: 141 -DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKL 195

Query: 226 GDFGLARFFPEDQA-YLSTNFAGTLGYTAPE-----------YAIRGELSEKADIYSFGV 273
            DFG+A     D    +  +  G + Y  PE              + ++S K+D++S G 
Sbjct: 196 IDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 255

Query: 274 LVLEIISCR 282
           ++  +   +
Sbjct: 256 ILYYMTYGK 264

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  127 bits (320), Expect = 2e-33
 Identities = 41/215 (19%), Positives = 84/215 (39%), Gaps = 26/215 (12%)

Query: 82  KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESE---FLSEVRMITSIQH 138
           + +     +G GG   V++       + A+K   V+  +        + +E+  +  +Q 
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIK--YVNLEEADNQTLDSYRNEIAYLNKLQQ 66

Query: 139 KNL--VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
            +   +RL           +V E       DL  + +  K ++   R      +   +  
Sbjct: 67  HSDKIIRLYDYEITDQYIYMVMECGNI---DLNSWLKKKKSIDPWERKSYWKNMLEAVHT 123

Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA-YLSTNFAGTLGYTAPE 255
           +H+     IVH D+K +N L+ +    K+ DFG+A     D    +  +  GT+ Y  PE
Sbjct: 124 IHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179

Query: 256 -----------YAIRGELSEKADIYSFGVLVLEII 279
                         + ++S K+D++S G ++  + 
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 214

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  123 bits (311), Expect = 2e-32
 Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 21/219 (9%)

Query: 78  KKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI 136
             +   +   ++LG+G    V+RG+    G L A+K        +     + E  ++  +
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 137 QHKNLVRLLGCCSDGSQRL--LVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARG 193
            HKN+V+L     + + R   L+ E+    SL  +L    +   L  S    ++  +  G
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 194 LQYLHEDSHTRIVHRDIKASNVLL----DEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
           + +L E+    IVHR+IK  N++     D +   K+ DFG AR   +D+    +   GT 
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS-LYGTE 179

Query: 250 GYTAPEYAIRGEL--------SEKADIYSFGVLVLEIIS 280
            Y  P+   R  L            D++S GV      +
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  122 bits (308), Expect = 3e-32
 Identities = 67/299 (22%), Positives = 111/299 (37%), Gaps = 59/299 (19%)

Query: 81  TKNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESE---FLSEVRMITSI 136
           T  FH    +G G FG V++  K  DG + A+K+    K   G  +    L EV     +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR--SKKPLAGSVDEQNALREVYAHAVL 67

Query: 137 -QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLI--YGESDKFLNWSTRFQIILGIARG 193
            QH ++VR     ++    L+  EY    SL   I        +   +    ++L + RG
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDE-------------------KFQSKIGDFGLARFF 234
           L+Y+H      +VH DIK SN+ +                     K   KIGD G     
Sbjct: 128 LRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184

Query: 235 PEDQAYLSTNFAGTLGYTAPEYAIRGELS--EKADIYSFGVLVLEIISCRKNTDLTLPSE 292
              Q        G   + A E  ++   +   KADI++  + V+            LP  
Sbjct: 185 SSPQV-----EEGDSRFLANE-VLQENYTHLPKADIFALALTVVCAA-----GAEPLPRN 233

Query: 293 MQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEI 351
                   W    +GR+     PR+    ++ ++  +++ V    + P   +RP    +
Sbjct: 234 GD-----QWHEIRQGRL-----PRI--PQVLSQEFTELLKV---MIHPDPERRPSAMAL 277

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  124 bits (313), Expect = 6e-32
 Identities = 55/228 (24%), Positives = 88/228 (38%), Gaps = 37/228 (16%)

Query: 82  KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVR-MITSIQHKN 140
                  +LG G  G V       G  VAVK++ +D         L E++ +  S  H N
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPN 70

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLI-----YGESDKFLNWSTRFQIILGIARGLQ 195
           ++R     +      +  E     +L  L+       E+ K         ++  IA G+ 
Sbjct: 71  VIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQS-------------KIGDFGLARFFPEDQAYLS 242
           +LH     +I+HRD+K  N+L+    +               I DFGL +     Q+   
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 243 TN---FAGTLGYTAPE-------YAIRGELSEKADIYSFGVLVLEIIS 280
           TN    +GT G+ APE          +  L+   DI+S G +   I+S
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  121 bits (305), Expect = 9e-32
 Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 16/195 (8%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G+G FG V++G       +VA+K + +++++    +   E+ +++      + +  G  
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89

Query: 149 SDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQI--IL-GIARGLQYLHEDSHTR 204
              ++  ++ EY+   S  DLL   E           QI  IL  I +GL YLH +   +
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLL---EPGPL----DETQIATILREILKGLDYLHSE---K 139

Query: 205 IVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSE 264
            +HRDIKA+NVLL E  + K+ DFG+A    + Q   +T F GT  + APE   +     
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSAYDS 198

Query: 265 KADIYSFGVLVLEII 279
           KADI+S G+  +E+ 
Sbjct: 199 KADIWSLGITAIELA 213

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  121 bits (305), Expect = 2e-31
 Identities = 48/220 (21%), Positives = 90/220 (40%), Gaps = 38/220 (17%)

Query: 83  NFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLS-------------- 128
           ++     L +G F  +   +  D    A+KK   +KS   +    +              
Sbjct: 32  DYRIIRTLNQGKFNKIILCE-KDNKFYALKKY--EKSLLEKKRDFTKSNNDKISIKSKYD 88

Query: 129 ----EVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKN-------RSLDLLIYGESDKF 177
               E+++IT I+++  +   G  ++  +  ++YEYM+N           +L    +   
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148

Query: 178 LNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED 237
                +  II  +     Y+H  +   I HRD+K SN+L+D+  + K+ DFG + +  + 
Sbjct: 149 PIQVIKC-IIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205

Query: 238 QAYLSTNFAGTLGYTAPEYAIRGELS---EKADIYSFGVL 274
           +  +     GT  +  PE     E S    K DI+S G+ 
Sbjct: 206 K--IKG-SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGIC 241

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  122 bits (307), Expect = 2e-31
 Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 21/210 (10%)

Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
             +   ++LG+G    V+RG+    G L A+K        +     + E  ++  + HKN
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 141 LVRLLGCCSDGSQRL--LVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYL 197
           +V+L     + + R   L+ E+    SL  +L    +   L  S    ++  +  G+ +L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 198 HEDSHTRIVHRDIKASNVLL----DEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
            E+    IVHR+IK  N++     D +   K+ DFG AR   +D+    +   GT  Y  
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS-LYGTEEYLH 183

Query: 254 PEYAIRGEL--------SEKADIYSFGVLV 275
           P+   R  L            D++S GV  
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTF 213

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  124 bits (313), Expect = 4e-31
 Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 18/215 (8%)

Query: 78  KKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI 136
            +    +     LG GGFG V R      G  VA+K+   + S +    +  E++++  +
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69

Query: 137 QHKNLVRLL------GCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILG 189
            H N+V            +     LL  EY +   L   L   E+   L       ++  
Sbjct: 70  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFA 246
           I+  L+YLHE    RI+HRD+K  N++L    Q    KI D G A+   + +   +  F 
Sbjct: 130 ISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTE-FV 184

Query: 247 GTLGYTAPEYAIRGEL-SEKADIYSFGVLVLEIIS 280
           GTL Y APE  +  +  +   D +SFG L  E I+
Sbjct: 185 GTLQYLAPE-LLEQKKYTVTVDYWSFGTLAFECIT 218

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  118 bits (298), Expect = 9e-31
 Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 15/202 (7%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G    V           VA+K++ ++K Q    E L E++ ++   H N+V      
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82

Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ------IILGIARGLQYLHEDSH 202
               +  LV + +   S+  +I     K  + S          I+  +  GL+YLH++  
Sbjct: 83  VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-- 140

Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN----FAGTLGYTAPEYAI 258
              +HRD+KA N+LL E    +I DFG++ F               F GT  + APE   
Sbjct: 141 -GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199

Query: 259 RGEL-SEKADIYSFGVLVLEII 279
           +      KADI+SFG+  +E+ 
Sbjct: 200 QVRGYDFKADIWSFGITAIELA 221

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  119 bits (301), Expect = 1e-30
 Identities = 57/213 (26%), Positives = 86/213 (40%), Gaps = 32/213 (15%)

Query: 81  TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLS------EVRMI 133
              +    ++G+G F  V R      G   AVK   VD ++   S  LS      E  + 
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVK--IVDVAKFTSSPGLSTEDLKREASIC 80

Query: 134 TSIQHKNLVRLLGCCSDGSQRLLVYEYMK---------NRSLDLLIYGESDKFLNWSTRF 184
             ++H ++V LL   S      +V+E+M           R+    +Y E+      S   
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA----SHYM 136

Query: 185 QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYL 241
           + IL     L+Y H+     I+HRD+K   VLL  K  S   K+G FG+A    E     
Sbjct: 137 RQILE---ALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA 190

Query: 242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVL 274
                GT  + APE   R    +  D++  GV+
Sbjct: 191 GG-RVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  118 bits (297), Expect = 1e-30
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 27/223 (12%)

Query: 63  NGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQ 121
           + +  +    +        + ++   +LG+G FG V + K        AVK   ++K+  
Sbjct: 3   HHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVK--VINKASA 60

Query: 122 GESE---FLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMK-----NRSLDLLIYGE 173
              +    L EV ++  + H N+++L     D S   +V E        +  +    + E
Sbjct: 61  KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE 120

Query: 174 SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGL 230
            D     +   + +     G+ Y+H+ +   IVHRD+K  N+LL   ++    KI DFGL
Sbjct: 121 HDA----ARIIKQVFS---GITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL 170

Query: 231 ARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGV 273
           +  F ++      +  GT  Y APE  +RG   EK D++S GV
Sbjct: 171 STCFQQNTKM--KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGV 210

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  117 bits (296), Expect = 1e-30
 Identities = 65/204 (31%), Positives = 97/204 (47%), Gaps = 17/204 (8%)

Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQ----QGESEFLSEVRMITSI 136
           ++F  G  LG+G FG VY  +      ++A+K L   K+Q      E +   EV + + +
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHL 66

Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQ 195
           +H N++RL G   D ++  L+ EY    ++   L   +  KF    T    I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTAT-YITELANALS 123

Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE 255
           Y H  S  R++HRDIK  N+LL    + KI DFG +   P  +   +    GTL Y  PE
Sbjct: 124 YCH--SK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--RTD-LCGTLDYLPPE 177

Query: 256 YAIRGELSEKADIYSFGVLVLEII 279
                   EK D++S GVL  E +
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFL 201

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  119 bits (300), Expect = 2e-30
 Identities = 41/203 (20%), Positives = 71/203 (34%), Gaps = 21/203 (10%)

Query: 91  GRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLS-EVRMITSIQHKNLVRLLGCC 148
           G      V   +    G  V V+++ ++        FL  E+ +     H N+V      
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 149 SDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQI--IL-GIARGLQYLHEDSHTR 204
              ++  +V  +M   S  DL+     D          I  IL G+ + L Y+H   +  
Sbjct: 96  IADNELWVVTSFMAYGSAKDLICTHFMDGM----NELAIAYILQGVLKALDYIHHMGY-- 149

Query: 205 IVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA------YLSTNFAGTLGYTAPEYAI 258
            VHR +KAS++L+    +  +                             L + +PE   
Sbjct: 150 -VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQ 208

Query: 259 RGEL--SEKADIYSFGVLVLEII 279
           +       K+DIYS G+   E+ 
Sbjct: 209 QNLQGYDAKSDIYSVGITACELA 231

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  116 bits (294), Expect = 3e-30
 Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 12/207 (5%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVR 131
           +          F     LG G FG V+  +  + G    +K +  D+SQ    +  +E+ 
Sbjct: 13  NLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIE 72

Query: 132 MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF--QIILG 189
           ++ S+ H N++++     D     +V E  +   L   I     +    S  +  +++  
Sbjct: 73  VLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ 132

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPEDQAYLSTNFA 246
           +   L Y H      +VH+D+K  N+L          KI DFGLA  F  D+    TN A
Sbjct: 133 MMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAA 187

Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGV 273
           GT  Y APE   + +++ K DI+S GV
Sbjct: 188 GTALYMAPE-VFKRDVTFKCDIWSAGV 213

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  115 bits (291), Expect = 8e-30
 Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 21/197 (10%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G+G  G VY    +A G  VA++++ + + Q  +   ++E+ ++   ++ N+V  L   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ------IILGIARGLQYLHEDSH 202
             G +  +V EY+   SL  ++           T         +     + L++LH +  
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVV---------TETCMDEGQIAAVCRECLQALEFLHSN-- 135

Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
            +++HRDIK+ N+LL      K+ DFG       +Q+  ST   GT  + APE   R   
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAY 193

Query: 263 SEKADIYSFGVLVLEII 279
             K DI+S G++ +E+I
Sbjct: 194 GPKVDIWSLGIMAIEMI 210

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  115 bits (290), Expect = 1e-29
 Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 26/205 (12%)

Query: 81  TKNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESE---FLSEVRMITSI 136
           + N+     LG+G F  V R      G   A K   ++  +    +      E R+   +
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK--IINTKKLSARDFQKLEREARICRKL 62

Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLI----YGESDKFLNWSTRFQIILGIA 191
           QH N+VRL     + S   LV++ +    L + ++    Y E+D     S   Q IL   
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA----SHCIQQILE-- 116

Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAGT 248
             + Y H      IVHR++K  N+LL  K +    K+ DFGLA    + +A+    FAGT
Sbjct: 117 -SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGT 170

Query: 249 LGYTAPEYAIRGELSEKADIYSFGV 273
            GY +PE   +   S+  DI++ GV
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGV 195

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  116 bits (292), Expect = 1e-29
 Identities = 55/235 (23%), Positives = 94/235 (40%), Gaps = 38/235 (16%)

Query: 60  DFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDK 118
                     +  D + L +          +GRG +G V +      G ++AVK++    
Sbjct: 10  KISPEQHWDFTAEDLKDLGE----------IGRGAYGSVNKMVHKPSGQIMAVKRIRSTV 59

Query: 119 SQQGESEFLSEVRMI-TSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF 177
            ++ + + L ++ ++  S     +V+  G         +  E M + S D   Y      
Sbjct: 60  DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDK-FYKYVYSV 117

Query: 178 LNWSTRFQIILGIAR----GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF 233
           L+     +I+  I       L +L E+    I+HRDIK SN+LLD     K+ DFG++  
Sbjct: 118 LDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGIS-- 173

Query: 234 FPEDQAYLS-----TNFAGTLGYTAPEYAIRGELSE-----KADIYSFGVLVLEI 278
                  L      T  AG   Y APE  I    S      ++D++S G+ + E+
Sbjct: 174 -----GQLVDSIAKTRDAGCRPYMAPE-RIDPSASRQGYDVRSDVWSLGITLYEL 222

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  116 bits (293), Expect = 1e-29
 Identities = 51/227 (22%), Positives = 103/227 (45%), Gaps = 32/227 (14%)

Query: 60  DFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK 118
                 +  +   DF+ + +          LG G  G V++      G ++A K + ++ 
Sbjct: 21  LTQKQKVGELKDDDFEKISE----------LGAGNGGVVFKVSHKPSGLVMARKLIHLEI 70

Query: 119 SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFL 178
                ++ + E++++       +V   G      +  +  E+M   SLD        + L
Sbjct: 71  KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD--------QVL 122

Query: 179 NWSTRF------QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR 232
             + R       ++ + + +GL YL E     I+HRD+K SN+L++ + + K+ DFG++ 
Sbjct: 123 KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG 180

Query: 233 FFPEDQAYLSTNFAGTLGYTAPEYAIRGEL-SEKADIYSFGVLVLEI 278
              +  A    +F GT  Y +PE  ++G   S ++DI+S G+ ++E+
Sbjct: 181 QLIDSMA---NSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEM 223

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  115 bits (290), Expect = 2e-29
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 15/203 (7%)

Query: 81  TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHK 139
            + F     LG G +G VY+      G +VA+K++ V+       E + E+ ++      
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE---SDLQEIIKEISIMQQCDSP 84

Query: 140 NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQI---ILGIARGLQY 196
           ++V+  G     +   +V EY    S+  +I   +       T  +I   +    +GL+Y
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL----TEDEIATILQSTLKGLEY 140

Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEY 256
           LH     R +HRDIKA N+LL+ +  +K+ DFG+A    +  A  +T   GT  + APE 
Sbjct: 141 LHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-VIGTPFWMAPEV 196

Query: 257 AIRGELSEKADIYSFGVLVLEII 279
                 +  ADI+S G+  +E+ 
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMA 219

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  115 bits (289), Expect = 3e-29
 Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 21/197 (10%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           +G G  G V   +    G  VAVK + + K QQ      +EV ++   QH N+V +    
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHFNVVEMYKSY 111

Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ------IILGIARGLQYLHEDSH 202
             G +  ++ E+++  +L  ++            R        +   + + L YLH    
Sbjct: 112 LVGEELWVLMEFLQGGALTDIV---------SQVRLNEEQIATVCEAVLQALAYLHAQ-- 160

Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
             ++HRDIK+ ++LL    + K+ DFG      +D     +   GT  + APE   R   
Sbjct: 161 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-LVGTPYWMAPEVISRSLY 218

Query: 263 SEKADIYSFGVLVLEII 279
           + + DI+S G++V+E++
Sbjct: 219 ATEVDIWSLGIMVIEMV 235

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  114 bits (287), Expect = 3e-29
 Identities = 63/199 (31%), Positives = 94/199 (47%), Gaps = 18/199 (9%)

Query: 89  LLGRGGFGPVYRGKLADGTL---VAVKKLCVDKSQQGESE-----FLSEVRMITSIQHKN 140
            LG GG   VY  +  D  L   VA+K +        E E     F  EV   + + H+N
Sbjct: 18  KLGGGGMSTVYLAE--DTILNIKVAIKAI---FIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
           +V ++    +     LV EY++  +L   I  ES   L+  T       I  G+++ H+ 
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHD- 129

Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
              RIVHRDIK  N+L+D     KI DFG+A+   E     + +  GT+ Y +PE A   
Sbjct: 130 --MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187

Query: 261 ELSEKADIYSFGVLVLEII 279
              E  DIYS G+++ E++
Sbjct: 188 ATDECTDIYSIGIVLYEML 206

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  113 bits (286), Expect = 3e-29
 Identities = 49/203 (24%), Positives = 80/203 (39%), Gaps = 25/203 (12%)

Query: 81  TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQ-QGESEFLSEVRMITSIQH 138
            + +   N +GRG +G V            A K   + K   +    F  E+ ++ S+ H
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAK--KIPKYFVEDVDRFKQEIEIMKSLDH 65

Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLI----YGESDKFLNWSTRFQIILGIARG 193
            N++RL     D +   LV E      L + ++    + ESD     +   + +L     
Sbjct: 66  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDA----ARIMKDVLS---A 118

Query: 194 LQYLHEDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
           + Y H+     + HRD+K  N L          K+ DFGLA  F   +        GT  
Sbjct: 119 VAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPY 173

Query: 251 YTAPEYAIRGELSEKADIYSFGV 273
           Y +P+  + G    + D +S GV
Sbjct: 174 YVSPQ-VLEGLYGPECDEWSAGV 195

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  115 bits (289), Expect = 3e-29
 Identities = 56/224 (25%), Positives = 88/224 (39%), Gaps = 26/224 (11%)

Query: 75  QTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVR-M 132
           QT++          +L  GGF  VY  + +  G   A+K+L     ++     + EV  M
Sbjct: 21  QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS-NEEEKNRAIIQEVCFM 79

Query: 133 ITSIQHKNLVRLLGCCSDGSQR--------LLVYEYMKNRSLDLLIYGESDKFLNWSTRF 184
                H N+V+     S G +         LL+ E  K + ++ L   ES   L+  T  
Sbjct: 80  KKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL 139

Query: 185 QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST- 243
           +I     R +Q++H      I+HRD+K  N+LL  +   K+ DFG A        Y  + 
Sbjct: 140 KIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198

Query: 244 ----------NFAGTLGYTAPE---YAIRGELSEKADIYSFGVL 274
                         T  Y  PE         + EK DI++ G +
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI 242

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  115 bits (289), Expect = 4e-29
 Identities = 65/225 (28%), Positives = 102/225 (45%), Gaps = 20/225 (8%)

Query: 63  NGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQ 121
            G+L+     +        K F     +G G FG VY  + + +  +VA+KK+     Q 
Sbjct: 35  AGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS 94

Query: 122 GE--SEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLN 179
            E   + + EVR +  ++H N ++  GC        LV EY    + DLL   +  K L 
Sbjct: 95  NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQ 152

Query: 180 WSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA 239
                 +  G  +GL YLH      ++HRD+KA N+LL E    K+GDFG A       +
Sbjct: 153 EVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA-------S 202

Query: 240 YLS--TNFAGTLGYTAPE---YAIRGELSEKADIYSFGVLVLEII 279
            ++   +F GT  + APE       G+   K D++S G+  +E+ 
Sbjct: 203 IMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  117 bits (295), Expect = 4e-29
 Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 27/206 (13%)

Query: 81  TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESE---FLSEVRMITSI 136
           ++ +     LG G +G V   +        A+K   + K+    S     L EV ++  +
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIK--IIRKTSVSTSSNSKLLEEVAVLKLL 93

Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLI----YGESDKFLNWSTRFQIILGIA 191
            H N+++L     D     LV E  K   L D +I    + E D          II  + 
Sbjct: 94  DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA-------AVIIKQVL 146

Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPEDQAYLSTNFAGT 248
            G+ YLH+ +   IVHRD+K  N+LL   ++    KI DFGL+  F   +        GT
Sbjct: 147 SGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERLGT 201

Query: 249 LGYTAPEYAIRGELSEKADIYSFGVL 274
             Y APE  +R +  EK D++S GV+
Sbjct: 202 AYYIAPE-VLRKKYDEKCDVWSIGVI 226

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  114 bits (287), Expect = 4e-29
 Identities = 53/199 (26%), Positives = 96/199 (48%), Gaps = 18/199 (9%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           LG G FG VY+ K    G L A K +    S++   +++ E+ ++ +  H  +V+LLG  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYIVEIEILATCDHPYIVKLLGAY 85

Query: 149 SDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQI--IL-GIARGLQYLHEDSHTRI 205
               +  ++ E+    ++D ++           T  QI  +   +   L +LH     RI
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRGL----TEPQIQVVCRQMLEALNFLHSK---RI 138

Query: 206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSE- 264
           +HRD+KA NVL+  +   ++ DFG++    +      + F GT  + APE  +   + + 
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCETMKDT 197

Query: 265 ----KADIYSFGVLVLEII 279
               KADI+S G+ ++E+ 
Sbjct: 198 PYDYKADIWSLGITLIEMA 216

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  114 bits (288), Expect = 4e-29
 Identities = 65/226 (28%), Positives = 100/226 (44%), Gaps = 19/226 (8%)

Query: 67  RTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESE 125
           R++   D   L+     F    L+G G +G VY+G+ +  G L A+K   +D +   E E
Sbjct: 9   RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKV--MDVTGDEEEE 66

Query: 126 FLSEVRMITSI-QHKNLVRLLGC------CSDGSQRLLVYEYMKNRSLDLLIYGESDKFL 178
              E+ M+     H+N+    G            Q  LV E+    S+  LI       L
Sbjct: 67  IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL 126

Query: 179 NWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ 238
                  I   I RGL +LH+    +++HRDIK  NVLL E  + K+ DFG++       
Sbjct: 127 KEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 183

Query: 239 AYLSTNFAGTLGYTAPEYAIRGELSE-----KADIYSFGVLVLEII 279
              +T F GT  + APE     E  +     K+D++S G+  +E+ 
Sbjct: 184 GRRNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  117 bits (294), Expect = 5e-29
 Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 27/219 (12%)

Query: 67  RTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESE 125
            +    +        + ++   +LG+G FG V + K        AVK   ++K+     +
Sbjct: 7   HSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVK--VINKASAKNKD 64

Query: 126 ---FLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLI----YGESDKF 177
               L EV ++  + H N+++L     D S   +V E      L D +I    + E D  
Sbjct: 65  TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA 124

Query: 178 LNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFF 234
                  +II  +  G+ Y+H+     IVHRD+K  N+LL   ++    KI DFGL+  F
Sbjct: 125 -------RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174

Query: 235 PEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGV 273
            ++      +  GT  Y APE  +RG   EK D++S GV
Sbjct: 175 QQNTKM--KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGV 210

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  113 bits (285), Expect = 6e-29
 Identities = 55/224 (24%), Positives = 99/224 (44%), Gaps = 43/224 (19%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVR 131
           D + + +          LGRG +G V + + +  G ++AVK++    + Q +   L ++ 
Sbjct: 8   DLEPIME----------LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD 57

Query: 132 MI-TSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF------ 184
           +   ++     V   G         +  E M + SLD        + ++           
Sbjct: 58  ISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFY----KQVIDKGQTIPEDILG 112

Query: 185 QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS-- 242
           +I + I + L++LH      ++HRD+K SNVL++   Q K+ DFG++        YL   
Sbjct: 113 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGIS-------GYLVDD 163

Query: 243 ---TNFAGTLGYTAPEYAIRGELSE-----KADIYSFGVLVLEI 278
                 AG   Y APE  I  EL++     K+DI+S G+ ++E+
Sbjct: 164 VAKDIDAGCKPYMAPE-RINPELNQKGYSVKSDIWSLGITMIEL 206

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  115 bits (288), Expect = 7e-29
 Identities = 27/313 (8%), Positives = 61/313 (19%), Gaps = 51/313 (16%)

Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESE--FLSEVRM 132
            L +  +       L  G    V+  + +      A+K   +                  
Sbjct: 56  LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115

Query: 133 ITSIQHKNLVRLLGCC--------------------------SDGSQRLLVYEYMKNRSL 166
              +  ++                                     +  LL+         
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLE 175

Query: 167 DLL----IYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ 222
            L                     +   + R    L       +VH      N+ +    +
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGR 232

Query: 223 SKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL--SEKADIYSFGVLVLEIIS 280
             +GD                  +  + Y   E+        +   + +  G+ +  +  
Sbjct: 233 LMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW- 287

Query: 281 CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQP 340
           C       LP  +              R+             +      +I      L  
Sbjct: 288 CLF-----LPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGR---FLNF 339

Query: 341 HGNQRPPMSEIVA 353
              +R    E + 
Sbjct: 340 DRRRRLLPLEAME 352

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  114 bits (288), Expect = 8e-29
 Identities = 56/242 (23%), Positives = 97/242 (40%), Gaps = 32/242 (13%)

Query: 52  TTKEGVSKDFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVA 110
              +G    +F          D+   K+  + + P +++GRG    V R    A G   A
Sbjct: 64  AQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFA 123

Query: 111 VK-------KLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVYEYMK 162
           VK       +L  ++ ++       E  ++  +  H +++ L+      S   LV++ M+
Sbjct: 124 VKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMR 183

Query: 163 NRSL-DLLI----YGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL 217
              L D L       E +      TR  I+  +   + +LH      IVHRD+K  N+LL
Sbjct: 184 KGELFDYLTEKVALSEKE------TR-SIMRSLLEAVSFLHA---NNIVHRDLKPENILL 233

Query: 218 DEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE------YAIRGELSEKADIYSF 271
           D+  Q ++ DFG +      +        GT GY APE              ++ D+++ 
Sbjct: 234 DDNMQIRLSDFGFSCHLEPGEKL--RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWAC 291

Query: 272 GV 273
           GV
Sbjct: 292 GV 293

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  116 bits (292), Expect = 9e-29
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 32/215 (14%)

Query: 77  LKKATKNFHP----GNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESE----FL 127
           ++ +T  F        +LG+G FG V   K    G   AVK   + K Q  +       L
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVK--VISKRQVKQKTDKESLL 74

Query: 128 SEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLI----YGESDKFLNWST 182
            EV+++  + H N+++L     D     LV E      L D +I    + E D       
Sbjct: 75  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA------ 128

Query: 183 RFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPEDQA 239
             +II  +  G+ Y+H++    IVHRD+K  N+LL    +    +I DFGL+  F   + 
Sbjct: 129 -ARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184

Query: 240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVL 274
               +  GT  Y APE  + G   EK D++S GV+
Sbjct: 185 M--KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVI 216

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  113 bits (285), Expect = 1e-28
 Identities = 50/233 (21%), Positives = 93/233 (39%), Gaps = 33/233 (14%)

Query: 58  SKDFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCV 116
                 G        D + L +          +G G  G V++ +    G ++AVK++  
Sbjct: 11  GYLTIGGQRYQAEINDLENLGE----------MGSGTCGQVWKMRFRKTGHVIAVKQMRR 60

Query: 117 DKSQQGESEFLSEVR-MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESD 175
             +++     L ++  ++ S     +V+  G     +   +  E M     + L      
Sbjct: 61  SGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQG 119

Query: 176 KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP 235
                    ++ + I + L YL E     ++HRD+K SN+LLDE+ Q K+ DFG++    
Sbjct: 120 PIPERILG-KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGIS---- 172

Query: 236 EDQAYLS-----TNFAGTLGYTAPE-----YAIRGELSEKADIYSFGVLVLEI 278
                L         AG   Y APE        + +   +AD++S G+ ++E+
Sbjct: 173 ---GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  112 bits (282), Expect = 1e-28
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 23/204 (11%)

Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQ----QGESEFLSEVRMITSIQ 137
           +F  G  LG+G FG VY  +   +  ++A+K L   KSQ      E +   E+ + + ++
Sbjct: 15  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVL--FKSQLEKEGVEHQLRREIEIQSHLR 72

Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRF---QIILGIARG 193
           H N++R+     D  +  L+ E+     L   L   +  +F    +     ++       
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ--KHGRFDEQRSATFMEELADA---- 126

Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           L Y HE    +++HRDIK  N+L+  K + KI DFG +   P  +    T   GTL Y  
Sbjct: 127 LHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR--RRT-MCGTLDYLP 180

Query: 254 PEYAIRGELSEKADIYSFGVLVLE 277
           PE        EK D++  GVL  E
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYE 204

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  114 bits (286), Expect = 1e-28
 Identities = 40/250 (16%), Positives = 79/250 (31%), Gaps = 53/250 (21%)

Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESE--------- 125
            L +  +    G +LG+              G    V      +     +          
Sbjct: 67  ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLR 126

Query: 126 ------------------FLSEVRMITSIQHKNLVRLLGCCSDGS--QRLLVYEYMKNRS 165
                             F+    ++   Q K ++R+     D     R  +Y  M++  
Sbjct: 127 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 186

Query: 166 LD----LLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF 221
                 LL +  + K L    R Q+ L + R L  LH   H  +VH  ++  +++LD++ 
Sbjct: 187 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRG 243

Query: 222 QSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI-----------RGELSEKADIYS 270
              +  F        D A +    + + G+  PE              R  ++   D ++
Sbjct: 244 GVFLTGFEHLV---RDGARVV--SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298

Query: 271 FGVLVLEIIS 280
            G+++  I  
Sbjct: 299 LGLVIYWIWC 308

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  112 bits (283), Expect = 1e-28
 Identities = 56/216 (25%), Positives = 86/216 (39%), Gaps = 37/216 (17%)

Query: 81  TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG----------ESEFLSE 129
            +N+ P  +LGRG    V R          AVK   +D +  G              L E
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVK--IIDVTGGGSFSAEEVQELREATLKE 73

Query: 130 VRMITSI-QHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLI----YGESDKFLNWSTR 183
           V ++  +  H N+++L       +   LV++ MK   L D L       E +      TR
Sbjct: 74  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE------TR 127

Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST 243
            +I+  +   +  LH+     IVHRD+K  N+LLD+    K+ DFG +      +     
Sbjct: 128 -KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--R 181

Query: 244 NFAGTLGYTAPE------YAIRGELSEKADIYSFGV 273
              GT  Y APE              ++ D++S GV
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  115 bits (289), Expect = 2e-28
 Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 21/203 (10%)

Query: 81  TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQH 138
           T+ +     LG+G F  V R   +  G   A   +   K    + + L  E R+   ++H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 139 KNLVRLLGCCSDGSQRLLVYEYMK-----NRSLDLLIYGESDKFLNWSTRFQIILGIARG 193
            N+VRL    S+     L+++ +         +    Y E+D     S   Q IL     
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADA----SHCIQQILE---A 122

Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAGTLG 250
           + + H+     +VHR++K  N+LL  K +    K+ DFGLA     +Q      FAGT G
Sbjct: 123 VLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-FAGTPG 178

Query: 251 YTAPEYAIRGELSEKADIYSFGV 273
           Y +PE   +    +  D+++ GV
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGV 201

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  112 bits (282), Expect = 2e-28
 Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 25/203 (12%)

Query: 81  TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQH 138
            K F    +LG G F  V+  K    G L A+K  C+ KS    +S   +E+ ++  I+H
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALK--CIKKSPAFRDSSLENEIAVLKKIKH 65

Query: 139 KNLVRLLGCCSDGSQRLLVYEYMK-----NRSLDLLIYGESDKFLNWSTRFQIILGIARG 193
           +N+V L       +   LV + +      +R L+  +Y E D          +I  +   
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKD------AS-LVIQQVLSA 118

Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAGTLG 250
           ++YLHE     IVHRD+K  N+L     ++    I DFGL++        +ST   GT G
Sbjct: 119 VKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MST-ACGTPG 172

Query: 251 YTAPEYAIRGELSEKADIYSFGV 273
           Y APE   +   S+  D +S GV
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGV 195

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  115 bits (290), Expect = 2e-28
 Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 38/244 (15%)

Query: 54  KEGVSKDFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVK 112
             G    +F G       +  +   K  +++     LG G +G V   K     +  A+K
Sbjct: 8   SSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIK 67

Query: 113 KLCVDKSQ--------------QGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY 158
              + KSQ              +   E  +E+ ++ S+ H N+++L     D     LV 
Sbjct: 68  --VIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVT 125

Query: 159 EYMKNRSL-DLLI----YGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKAS 213
           E+ +   L + +I    + E D          I+  I  G+ YLH+     IVHRDIK  
Sbjct: 126 EFYEGGELFEQIINRHKFDECDA-------ANIMKQILSGICYLHK---HNIVHRDIKPE 175

Query: 214 NVLL---DEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYS 270
           N+LL   +     KI DFGL+ FF +D      +  GT  Y APE  ++ + +EK D++S
Sbjct: 176 NILLENKNSLLNIKIVDFGLSSFFSKDYKL--RDRLGTAYYIAPE-VLKKKYNEKCDVWS 232

Query: 271 FGVL 274
            GV+
Sbjct: 233 CGVI 236

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  113 bits (285), Expect = 2e-28
 Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 22/203 (10%)

Query: 81  TKNFHPGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQH 138
           + N+     LG+G F  V R      G   A K +   K    + + L  E R+   +QH
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLI----YGESDKFLNWSTRFQIILGIARG 193
            N+VRL     + S   LV++ +    L + ++    Y E+D     S   Q IL     
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA----SHCIQQILE---S 140

Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAGTLG 250
           + Y H +    IVHR++K  N+LL  K +    K+ DFGLA    + +A+    FAGT G
Sbjct: 141 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPG 195

Query: 251 YTAPEYAIRGELSEKADIYSFGV 273
           Y +PE   +   S+  DI++ GV
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGV 218

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  112 bits (283), Expect = 3e-28
 Identities = 58/216 (26%), Positives = 92/216 (42%), Gaps = 31/216 (14%)

Query: 74  FQTLKKATKNFH----PGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLS 128
            Q L + +  F         +G G +    R    A     AVK   +DKS++  +E   
Sbjct: 10  VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK--IIDKSKRDPTE--- 64

Query: 129 EVR-MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLI----YGESDKFLNWST 182
           E+  ++   QH N++ L     DG    +V E MK   L D ++    + E +       
Sbjct: 65  EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSERE------A 118

Query: 183 RFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS----KIGDFGLARFFPEDQ 238
              ++  I + ++YLH      +VHRD+K SN+L  ++  +    +I DFG A+    + 
Sbjct: 119 S-AVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174

Query: 239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVL 274
             L T    T  + APE   R       DI+S GVL
Sbjct: 175 GLLMT-PCYTANFVAPEVLERQGYDAACDIWSLGVL 209

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  111 bits (280), Expect = 5e-28
 Identities = 58/193 (30%), Positives = 88/193 (45%), Gaps = 23/193 (11%)

Query: 78  KKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEF----LSEV-- 130
             AT  + P   +G G +G VY+ +    G  VA+K + V     G        + EV  
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 131 -RMITSIQHKNLVRLL----GCCSDGSQRL-LVYEYMKNRSLDL--LIYGESDKFLNWST 182
            R + + +H N+VRL+       +D   ++ LV+E++     DL   +       L   T
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAET 121

Query: 183 RFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS 242
              ++    RGL +LH  ++  IVHRD+K  N+L+      K+ DFGLAR +    A   
Sbjct: 122 IKDLMRQFLRGLDFLH--AN-CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-- 176

Query: 243 TNFAGTLGYTAPE 255
           T    TL Y APE
Sbjct: 177 TPVVVTLWYRAPE 189

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  110 bits (278), Expect = 1e-27
 Identities = 42/206 (20%), Positives = 79/206 (38%), Gaps = 23/206 (11%)

Query: 78  KKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI 136
           K+  + +     LGRG FG V+R    +       K   V      +     E+ ++   
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK--FVKVKGTDQVLVKKEISILNIA 58

Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLI-----YGESDKFLNWSTRFQIILGI 190
           +H+N++ L        + ++++E++    + + +        E +           +  +
Sbjct: 59  RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREI-------VSYVHQV 111

Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS--KIGDFGLARFFPEDQAYLSTNFAGT 248
              LQ+LH  +   I H DI+  N++   +  S  KI +FG AR       +        
Sbjct: 112 CEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTA 166

Query: 249 LGYTAPEYAIRGELSEKADIYSFGVL 274
             Y APE      +S   D++S G L
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTL 192

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  113 bits (285), Expect = 1e-27
 Identities = 45/198 (22%), Positives = 80/198 (40%), Gaps = 21/198 (10%)

Query: 89  LLGRGGFGPVYRGK--LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL- 145
            +  GG G +Y       +G  V +K L      + ++  ++E + +  + H ++V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 146 -GCCSDGSQRLLVY---EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
               +D     + Y   EY+  +SL      +    L  +     +L I   L YLH   
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLHSI- 201

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
              +V+ D+K  N++L E+ Q K+ D G                 GT G+ APE   R  
Sbjct: 202 --GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLY-----GTPGFQAPEIV-RTG 252

Query: 262 LSEKADIYSFGVLVLEII 279
            +   DIY+ G  +  + 
Sbjct: 253 PTVATDIYTVGRTLAALT 270

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  108 bits (273), Expect = 3e-27
 Identities = 67/273 (24%), Positives = 118/273 (43%), Gaps = 46/273 (16%)

Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHK 139
           + +     +G G +G V++ K      +VA+K++ +D   +G  S  L E+ ++  ++HK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 140 NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF-LNWSTRFQIILGIARGLQYLH 198
           N+VRL        +  LV+E+      DL  Y +S    L+       +  + +GL + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 199 EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPE-- 255
                 ++HRD+K  N+L++   + K+ +FGLAR F    + Y  +    TL Y  P+  
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVL 173

Query: 256 -----YAIRGELSEKADIYSFGVLVLEIISCRK-----NTD----------LTLPSE--- 292
                Y      S   D++S G +  E+ +  +     N            L  P+E   
Sbjct: 174 FGAKLY------STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227

Query: 293 --MQYLPEY-AWKLYERGRILELVDPRMRKEGI 322
             M  LP+Y  + +Y     L  V P++   G 
Sbjct: 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGR 260

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  109 bits (274), Expect = 3e-27
 Identities = 49/206 (23%), Positives = 91/206 (44%), Gaps = 22/206 (10%)

Query: 87  GNLLGRGGFGPVYRGKLADGTL---VAVKKLCVDKSQQGESEFLS----EVRMITSIQHK 139
           G +LG GG   V+  +  D      VAVK L        +  F      E +   ++ H 
Sbjct: 17  GEILGFGGMSEVHLAR--DLRDHRDVAVKVL--RADLARDPSFYLRFRREAQNAAALNHP 72

Query: 140 NLVRLL--GCCSDGSQRL--LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQ 195
            +V +   G     +  L  +V EY+   +L  ++   ++  +      ++I    + L 
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALN 130

Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL-STNFA-GTLGYTA 253
           + H+     I+HRD+K +N+++      K+ DFG+AR   +    +  T    GT  Y +
Sbjct: 131 FSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187

Query: 254 PEYAIRGELSEKADIYSFGVLVLEII 279
           PE A    +  ++D+YS G ++ E++
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVL 213

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  108 bits (273), Expect = 3e-27
 Identities = 52/179 (29%), Positives = 91/179 (50%), Gaps = 13/179 (7%)

Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHK 139
           +NF     +G G +G VY+ +    G +VA+KK+ +D   +G  S  + E+ ++  + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62

Query: 140 NLVRLLGCCSDGSQRLLVYEYMKNRSLDL--LIYGESDKFLNWSTRFQIILGIARGLQYL 197
           N+V+LL      ++  LV+E++     DL   +   +   +        +  + +GL + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL---HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119

Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPE 255
           H     R++HRD+K  N+L++ +   K+ DFGLAR F    + Y  T+   TL Y APE
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPE 173

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  108 bits (272), Expect = 6e-27
 Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 12/177 (6%)

Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKN 140
            +     +G G +G V++ +    G +VA+KK    +     +   L E+RM+  ++H N
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGES-DKFLNWSTRFQIILGIARGLQYLHE 199
           LV LL       +  LV+EY       +L   +   + +       I     + + + H 
Sbjct: 64  LVNLLEVFRRKRRLHLVFEYC---DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH- 119

Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP-EDQAYLSTNFAGTLGYTAPE 255
             H   +HRD+K  N+L+ +    K+ DFG AR        Y   +   T  Y +PE
Sbjct: 120 -KH-NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRWYRSPE 172

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  108 bits (271), Expect = 7e-27
 Identities = 47/197 (23%), Positives = 76/197 (38%), Gaps = 18/197 (9%)

Query: 89  LLGRGGFGPVYRGKLADGTL---VAVKKLCVDKSQQGESEFLS----EVRMITSIQHKNL 141
           L+GRGG G VY  +  D      VA+K +   ++   +  F +    E R    +Q  ++
Sbjct: 41  LVGRGGMGDVYEAE--DTVRERIVALKLM--SETLSSDPVFRTRMQREARTAGRLQEPHV 96

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
           V +        Q  +    +    L  ++       L       I+  I   L   H   
Sbjct: 97  VPIHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAHAA- 153

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFA-GTLGYTAPEYAIRG 260
                HRD+K  N+L+     + + DFG+A     D+         GTL Y APE     
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGNTVGTLYYMAPERFSES 210

Query: 261 ELSEKADIYSFGVLVLE 277
             + +ADIY+   ++ E
Sbjct: 211 HATYRADIYALTCVLYE 227

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  108 bits (272), Expect = 7e-27
 Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 12/177 (6%)

Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKN 140
            +    L+G G +G V + +    G +VA+KK       +  +   + E++++  ++H+N
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGES-DKFLNWSTRFQIILGIARGLQYLHE 199
           LV LL  C    +  LV+E++      +L   E     L++    + +  I  G+ + H 
Sbjct: 86  LVNLLEVCKKKKRWYLVFEFV---DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH- 141

Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPE 255
            SH  I+HRDIK  N+L+ +    K+ DFG AR      + Y   +   T  Y APE
Sbjct: 142 -SH-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDEVATRWYRAPE 194

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  108 bits (272), Expect = 9e-27
 Identities = 57/261 (21%), Positives = 88/261 (33%), Gaps = 61/261 (23%)

Query: 67  RTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESE 125
           R   YF   +L +  K +H    +G+G +G V          + A+K   ++K++  +  
Sbjct: 11  RENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIK--IMNKNKIRQIN 68

Query: 126 ------FLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL------------- 166
                   +EVR++  + H N+ RL     D     LV E      L             
Sbjct: 69  PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTG 128

Query: 167 -------------------DLLIYGESDKFLNWSTRF------QIILGIARGLQYLHEDS 201
                              + +         +            I+  I   L YLH   
Sbjct: 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN-- 186

Query: 202 HTRIVHRDIKASNVLLDEKFQS--KIGDFGLARFF----PEDQAYLSTNFAGTLGYTAPE 255
              I HRDIK  N L         K+ DFGL++ F      +   ++T  AGT  + APE
Sbjct: 187 -QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT-KAGTPYFVAPE 244

Query: 256 YAIRGEL---SEKADIYSFGV 273
             +         K D +S GV
Sbjct: 245 -VLNTTNESYGPKCDAWSAGV 264

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  109 bits (275), Expect = 1e-26
 Identities = 53/232 (22%), Positives = 91/232 (39%), Gaps = 41/232 (17%)

Query: 72  FDFQTLKKATKNFHPGNL---------LGRGGFGPVYRGK-LADGTLVAVK-----KLCV 116
           F F  L    ++ +P  L         LG G  G V           VA++     K  +
Sbjct: 116 FVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAI 175

Query: 117 DKSQQGESE--FLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLI--- 170
             +++ +      +E+ ++  + H  ++++     D     +V E M+   L D ++   
Sbjct: 176 GSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNK 234

Query: 171 -YGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS---KIG 226
              E+        +      +   +QYLHE     I+HRD+K  NVLL  + +    KI 
Sbjct: 235 RLKEAT------CKL-YFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKIT 284

Query: 227 DFGLARFFPEDQAYLSTNFAGTLGYTAPE---YAIRGELSEKADIYSFGVLV 275
           DFG ++   E    + T   GT  Y APE          +   D +S GV++
Sbjct: 285 DFGHSKILGETS-LMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  107 bits (269), Expect = 1e-26
 Identities = 51/209 (24%), Positives = 85/209 (40%), Gaps = 27/209 (12%)

Query: 81  TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVK-----KLCVDKSQQGESEFLSEVRMIT 134
             ++  G  LG G F  V + +    G   A K     +L   +      E   EV ++ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 135 SIQHKNLVRLLGCCSDGSQRLLVYEYMK-----NRSLDLLIYGESDKFLNWSTRFQIILG 189
            I+H N++ L     + +  +L+ E +      +   +     E +     +   + IL 
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA----TQFLKQILD 119

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS----KIGDFGLARFFPEDQAYLSTNF 245
              G+ YLH     RI H D+K  N++L +K       K+ DFG+A        +   N 
Sbjct: 120 ---GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNI 171

Query: 246 AGTLGYTAPEYAIRGELSEKADIYSFGVL 274
            GT  + APE      L  +AD++S GV+
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVI 200

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  107 bits (270), Expect = 1e-26
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 31/210 (14%)

Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLS-------EVRMI 133
             +  G LLG GGFG VY G  ++D   VA+K   V+K +  +   L        EV ++
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK--HVEKDRISDWGELPNGTRVPMEVVLL 100

Query: 134 TSIQHK--NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWST--RF--QII 187
             +      ++RLL         +L+ E  +    DL  +      L       F  Q++
Sbjct: 101 KKVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVL 159

Query: 188 LGIARGLQYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFA 246
             +    ++ H  +   ++HRDIK  N+L+D  + + K+ DFG      +     +  F 
Sbjct: 160 EAV----RHCH--NC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTD-FD 209

Query: 247 GTLGYTAPEYAIRGEL--SEKADIYSFGVL 274
           GT  Y+ PE+ IR        A ++S G+L
Sbjct: 210 GTRVYSPPEW-IRYHRYHGRSAAVWSLGIL 238

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  110 bits (277), Expect = 1e-26
 Identities = 56/252 (22%), Positives = 102/252 (40%), Gaps = 28/252 (11%)

Query: 38  KFNKAKELVRLALRTTKEGVSKDFFNGNLRTISYFDFQTLKKATKNFHP----GNLLGRG 93
           +        +  +   K  VS ++ N        +  Q ++    +          LG G
Sbjct: 109 RRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTG 168

Query: 94  GFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFL-SEVRMITSIQHKNLVRLLGCCSDG 151
            FG V+R    A G   A K   V    + + E +  E++ ++ ++H  LV L     D 
Sbjct: 169 AFGVVHRVTERATGNNFAAK--FVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226

Query: 152 SQRLLVYEYMKNRSL-DLLI-----YGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI 205
           ++ +++YE+M    L + +        E +         + +  + +GL ++HE++    
Sbjct: 227 NEMVMIYEFMSGGELFEKVADEHNKMSEDEA-------VEYMRQVCKGLCHMHENN---Y 276

Query: 206 VHRDIKASNVLLDEKFQS--KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELS 263
           VH D+K  N++   K  +  K+ DFGL       Q+       GT  + APE A    + 
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTAEFAAPEVAEGKPVG 334

Query: 264 EKADIYSFGVLV 275
              D++S GVL 
Sbjct: 335 YYTDMWSVGVLS 346

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  107 bits (269), Expect = 2e-26
 Identities = 60/202 (29%), Positives = 90/202 (44%), Gaps = 32/202 (15%)

Query: 87  GNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEF---LSEVRMITSIQHKNLV 142
              +G+G F  V   + +  G  VA+K +  DK+Q   +       EVR++  + H N+V
Sbjct: 20  LKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHPNIV 77

Query: 143 RLLGCCSDGSQRLLVYEYMKNRSL-DLLIY------GESDKFLNWSTRF-QIILGIARGL 194
           +L           L+ EY     + D L+        E+         F QI+  +    
Sbjct: 78  KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK------FRQIVSAV---- 127

Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           QY H+    RIVHRD+KA N+LLD     KI DFG +  F      L   F G   Y AP
Sbjct: 128 QYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDA-FCGAPPYAAP 182

Query: 255 EYAIRGELSE--KADIYSFGVL 274
           E   +G+  +  + D++S GV+
Sbjct: 183 E-LFQGKKYDGPEVDVWSLGVI 203

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  107 bits (269), Expect = 2e-26
 Identities = 53/181 (29%), Positives = 91/181 (50%), Gaps = 11/181 (6%)

Query: 78  KKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSI 136
           +   + +     +G G +G VY+ K + G +VA+K++ +D   +G  S  + E+ ++  +
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76

Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF-LNWSTRFQIILGIARGLQ 195
            H N+V L+          LV+E+M     DL    + +K  L  S     +  + RG+ 
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFM---EKDLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133

Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAP 254
           + H     RI+HRD+K  N+L++     K+ DFGLAR F    ++Y  T+   TL Y AP
Sbjct: 134 HCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAP 188

Query: 255 E 255
           +
Sbjct: 189 D 189

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  107 bits (268), Expect = 2e-26
 Identities = 60/212 (28%), Positives = 90/212 (42%), Gaps = 33/212 (15%)

Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMI------- 133
             +  G LLG+GGFG V+ G  L D   VA+K   + +++      LS+           
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIK--VIPRNRVLGWSPLSDSVTCPLEVALL 88

Query: 134 ----TSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWST--RF--Q 185
                   H  ++RLL         +LV E     + DL  Y      L       F  Q
Sbjct: 89  WKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLP-AQDLFDYITEKGPLGEGPSRCFFGQ 147

Query: 186 IILGIARGLQYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTN 244
           ++  I    Q+ H      +VHRDIK  N+L+D  +  +K+ DFG       D+ Y  T+
Sbjct: 148 VVAAI----QHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPY--TD 197

Query: 245 FAGTLGYTAPEYAIRGEL--SEKADIYSFGVL 274
           F GT  Y+ PE+ I      +  A ++S G+L
Sbjct: 198 FDGTRVYSPPEW-ISRHQYHALPATVWSLGIL 228

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  106 bits (268), Expect = 2e-26
 Identities = 51/199 (25%), Positives = 79/199 (39%), Gaps = 25/199 (12%)

Query: 86  PGNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-HKNLVR 143
               LG G F    +          AVK   + K    E+    E+  +   + H N+V+
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVK--IISKRM--EANTQKEITALKLCEGHPNIVK 70

Query: 144 LLGCCSDGSQRLLVYEYMK-----NRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLH 198
           L     D     LV E +       R      + E++          I+  +   + ++H
Sbjct: 71  LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS-------YIMRKLVSAVSHMH 123

Query: 199 EDSHTRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE 255
           +     +VHRD+K  N+L  ++  +   KI DFG AR  P D   L T    TL Y APE
Sbjct: 124 DVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPE 179

Query: 256 YAIRGELSEKADIYSFGVL 274
              +    E  D++S GV+
Sbjct: 180 LLNQNGYDESCDLWSLGVI 198

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  107 bits (269), Expect = 2e-26
 Identities = 53/202 (26%), Positives = 82/202 (40%), Gaps = 24/202 (11%)

Query: 81  TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHK 139
           +  F   + LGRG    VYR K        A+K   + K+   +    +E+ ++  + H 
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALK--VLKKTVD-KKIVRTEIGVLLRLSHP 108

Query: 140 NLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLI----YGESDKFLNWSTRFQIILGIARGL 194
           N+++L       ++  LV E +    L D ++    Y E D           +  I   +
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERD------AA-DAVKQILEAV 161

Query: 195 QYLHEDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY 251
            YLHE     IVHRD+K  N+L          KI DFGL++              GT GY
Sbjct: 162 AYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGY 216

Query: 252 TAPEYAIRGELSEKADIYSFGV 273
            APE         + D++S G+
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGI 238

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  107 bits (269), Expect = 3e-26
 Identities = 54/217 (24%), Positives = 86/217 (39%), Gaps = 29/217 (13%)

Query: 75  QTLKKA--TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVK-----KLCVDKSQQGESEF 126
           +T K+      +  G  LG G F  V + +  + G   A K     +    +      E 
Sbjct: 3   ETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEI 62

Query: 127 LSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLI----YGESDKFLNWS 181
             EV ++  + H N++ L     + +  +L+ E +    L D L       E +      
Sbjct: 63  EREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA----- 117

Query: 182 TRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS----KIGDFGLARFFPED 237
                I  I  G+ YLH      I H D+K  N++L +K       K+ DFGLA    + 
Sbjct: 118 --TSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172

Query: 238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVL 274
             +   N  GT  + APE      L  +AD++S GV+
Sbjct: 173 VEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  107 bits (269), Expect = 3e-26
 Identities = 35/246 (14%), Positives = 75/246 (30%), Gaps = 31/246 (12%)

Query: 58  SKDFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGK------LADGTLVAV 111
             + F    +  +       +  +K  +  +LLG G F  VY           +     +
Sbjct: 41  YPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVL 100

Query: 112 KKLCVDKSQQGESEFL-SEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLL 169
           K      +   E       +  +        ++        +  +LV E     +L + +
Sbjct: 101 K--VQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAI 158

Query: 170 --IYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS---- 223
                  +K +         + +   ++ +H+     I+H DIK  N +L   F      
Sbjct: 159 NLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDE 215

Query: 224 -------KIGDFGLA---RFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGV 273
                   + D G +   + FP+   +  T    T G+   E       + + D +    
Sbjct: 216 DDLSAGLALIDLGQSIDMKLFPKGTIF--TAKCETSGFQCVEMLSNKPWNYQIDYFGVAA 273

Query: 274 LVLEII 279
            V  ++
Sbjct: 274 TVYCML 279

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  107 bits (269), Expect = 4e-26
 Identities = 50/204 (24%), Positives = 83/204 (40%), Gaps = 24/204 (11%)

Query: 81  TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESE-FLSEVRMITSIQH 138
              +     LG G FG V+R    A G +   K   ++     +     +E+ ++  + H
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAK--FINTPYPLDKYTVKNEISIMNQLHH 107

Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLI-----YGESDKFLNWSTRFQIILGIAR 192
             L+ L     D  + +L+ E++    L D +        E++           +     
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV-------INYMRQACE 160

Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQS--KIGDFGLARFFPEDQAYLSTNFAGTLG 250
           GL+++HE     IVH DIK  N++ + K  S  KI DFGLA     D+         T  
Sbjct: 161 GLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAE 215

Query: 251 YTAPEYAIRGELSEKADIYSFGVL 274
           + APE   R  +    D+++ GVL
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVL 239

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  105 bits (265), Expect = 6e-26
 Identities = 52/209 (24%), Positives = 82/209 (39%), Gaps = 27/209 (12%)

Query: 81  TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVK-----KLCVDKSQQGESEFLSEVRMIT 134
              +  G  LG G F  V + +  + G   A K     +    +      E   EV ++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 135 SIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLI----YGESDKFLNWSTRFQIILG 189
            + H N++ L     + +  +L+ E +    L D L       E +           I  
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA-------TSFIKQ 123

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS----KIGDFGLARFFPEDQAYLSTNF 245
           I  G+ YLH      I H D+K  N++L +K       K+ DFGLA    +   +   N 
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNI 178

Query: 246 AGTLGYTAPEYAIRGELSEKADIYSFGVL 274
            GT  + APE      L  +AD++S GV+
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  106 bits (267), Expect = 6e-26
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 24/202 (11%)

Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQ-QGESEFLSEVRMITSIQHKN 140
                 +LG G FG V++ +  A G  +A K   +     + + E  +E+ ++  + H N
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAK--IIKTRGMKDKEEVKNEISVMNQLDHAN 147

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSL-DLLI-----YGESDKFLNWSTRFQIILGIARGL 194
           L++L       +  +LV EY+    L D +I       E D      T    +  I  G+
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD------TI-LFMKQICEGI 200

Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQS--KIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
           +++H+     I+H D+K  N+L   +     KI DFGLAR +   +  L  NF GT  + 
Sbjct: 201 RHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-LKVNF-GTPEFL 255

Query: 253 APEYAIRGELSEKADIYSFGVL 274
           APE      +S   D++S GV+
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVI 277

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  105 bits (265), Expect = 7e-26
 Identities = 49/181 (27%), Positives = 83/181 (45%), Gaps = 16/181 (8%)

Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKN 140
            +     LG G +G VY+         VA+K++ ++  ++G     + EV ++  +QH+N
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRN 94

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
           ++ L        +  L++EY      DL  Y + +  ++       +  +  G+ + H  
Sbjct: 95  IIELKSVIHHNHRLHLIFEYA---ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH-- 149

Query: 201 SHTRIVHRDIKASNVLLDEKFQS-----KIGDFGLARFF-PEDQAYLSTNFAGTLGYTAP 254
              R +HRD+K  N+LL     S     KIGDFGLAR F    + +  T+   TL Y  P
Sbjct: 150 -SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--THEIITLWYRPP 206

Query: 255 E 255
           E
Sbjct: 207 E 207

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  105 bits (265), Expect = 7e-26
 Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 29/213 (13%)

Query: 78  KKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLS-------- 128
            + ++ +   + LG G FG V+          V VK   + K +  E  ++         
Sbjct: 20  GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVK--FIKKEKVLEDCWIEDPKLGKVT 77

Query: 129 -EVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWST--RF- 184
            E+ +++ ++H N++++L    +     LV E   +  LDL  + +    L+        
Sbjct: 78  LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPLASYIF 136

Query: 185 -QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST 243
            Q++  +     YL       I+HRDIK  N+++ E F  K+ DFG A +    +    T
Sbjct: 137 RQLVSAV----GYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYT 188

Query: 244 NFAGTLGYTAPEYAIRGELSE--KADIYSFGVL 274
            F GT+ Y APE  + G      + +++S GV 
Sbjct: 189 -FCGTIEYCAPE-VLMGNPYRGPELEMWSLGVT 219

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  106 bits (266), Expect = 1e-25
 Identities = 35/231 (15%), Positives = 67/231 (29%), Gaps = 42/231 (18%)

Query: 87  GNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGES--------------------- 124
           G +LG+              G    V      +     +                     
Sbjct: 83  GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 142

Query: 125 ------EFLSEVRMITSIQHKNLVRLLGCCSDGS--QRLLVYEYMKNRSLD----LLIYG 172
                  F+    ++   Q K ++R+     D     R  +Y  M++        LL + 
Sbjct: 143 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 202

Query: 173 ESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR 232
            + K L    R Q+ L + R L  LH   H  +VH  ++  +++LD++    +  F    
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 233 FFPEDQAYLSTNFAGTLGYTAPEYAI-----RGELSEKADIYSFGVLVLEI 278
                              TA             ++   D ++ G+ +  I
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  105 bits (265), Expect = 1e-25
 Identities = 58/186 (31%), Positives = 93/186 (50%), Gaps = 15/186 (8%)

Query: 77  LKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEF----LSEVR 131
           +K   K +   + LG G F  VY+ +      +VA+KK+ +    + +       L E++
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64

Query: 132 MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGES-DKFLNWSTRFQIILGI 190
           ++  + H N++ LL      S   LV+++M     DL +  +     L  S     +L  
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDFM---ETDLEVIIKDNSLVLTPSHIKAYMLMT 121

Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTL 249
            +GL+YLH   H  I+HRD+K +N+LLDE    K+ DFGLA+ F   ++AY  T+   T 
Sbjct: 122 LQGLEYLH--QH-WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTR 176

Query: 250 GYTAPE 255
            Y APE
Sbjct: 177 WYRAPE 182

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  104 bits (262), Expect = 1e-25
 Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 11/177 (6%)

Query: 82  KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKN 140
           + +H    +G G +G VY+ +   G   A+KK+ ++K  +G  S  + E+ ++  ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF-LNWSTRFQIILGIARGLQYLHE 199
           +V+L        + +LV+E++     DL    +  +  L   T    +L +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHL---DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH- 117

Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPE 255
               R++HRD+K  N+L++ + + KI DFGLAR F    + Y  T+   TL Y AP+
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPD 170

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  104 bits (263), Expect = 1e-25
 Identities = 58/194 (29%), Positives = 94/194 (48%), Gaps = 27/194 (13%)

Query: 78  KKATKNFHPGNLLGRGGFGPVYRGK--LADGTLVAVKKLCVDKSQQG-------ESEFLS 128
            +A + +     +G G +G V++ +     G  VA+K++ V   ++G       E   L 
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL- 65

Query: 129 EVRMITSIQHKNLVRLL----GCCSDGSQRL-LVYEYMKNRSLDL--LIYGESDKFLNWS 181
             R + + +H N+VRL        +D   +L LV+E++     DL   +    +  +   
Sbjct: 66  --RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV---DQDLTTYLDKVPEPGVPTE 120

Query: 182 TRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL 241
           T   ++  + RGL +LH  SH R+VHRD+K  N+L+    Q K+ DFGLAR +    A  
Sbjct: 121 TIKDMMFQLLRGLDFLH--SH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL- 176

Query: 242 STNFAGTLGYTAPE 255
            T+   TL Y APE
Sbjct: 177 -TSVVVTLWYRAPE 189

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  104 bits (262), Expect = 2e-25
 Identities = 50/209 (23%), Positives = 83/209 (39%), Gaps = 27/209 (12%)

Query: 81  TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVK-----KLCVDKSQQGESEFLSEVRMIT 134
              +  G  LG G F  V + +  + G   A K     +    +      +   EV ++ 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 135 SIQHKNLVRLLGCCSDGSQRLLVYEYMK-----NRSLDLLIYGESDKFLNWSTRFQIILG 189
            IQH N++ L     + +  +L+ E +      +   +     E +     +   + IL 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA----TEFLKQILN 125

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS----KIGDFGLARFFPEDQAYLSTNF 245
              G+ YLH      I H D+K  N++L ++       KI DFGLA        +   N 
Sbjct: 126 ---GVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNI 177

Query: 246 AGTLGYTAPEYAIRGELSEKADIYSFGVL 274
            GT  + APE      L  +AD++S GV+
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  104 bits (261), Expect = 2e-25
 Identities = 50/177 (28%), Positives = 85/177 (48%), Gaps = 11/177 (6%)

Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           + +   + LG G +  VY+GK      LVA+K++ ++  +      + EV ++  ++H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGES-DKFLNWSTRFQIILGIARGLQYLHE 199
           +V L           LV+EY+     DL  Y +     +N       +  + RGL Y H 
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYL---DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH- 117

Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPE 255
               +++HRD+K  N+L++E+ + K+ DFGLAR      + Y   N   TL Y  P+
Sbjct: 118 --RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVTLWYRPPD 170

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  102 bits (256), Expect = 8e-25
 Identities = 52/222 (23%), Positives = 86/222 (38%), Gaps = 46/222 (20%)

Query: 87  GNLLGRGGFGPVYRGK-LADGTLVAVK---------------KLCVDKSQQGESEFLSEV 130
            + +G+G +G V       D T  A+K               +     ++      +   
Sbjct: 18  KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77

Query: 131 RMITSIQ----------HKNLVRLLGCCSDGSQRLL--VYEYMKNRSLDLLIYGESDKFL 178
             I  +           H N+V+L+    D ++  L  V+E +      ++         
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG--PVMEVPTLKPLS 135

Query: 179 NWSTRF---QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP 235
               RF    +I GI    +YLH   + +I+HRDIK SN+L+ E    KI DFG++  F 
Sbjct: 136 EDQARFYFQDLIKGI----EYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

Query: 236 EDQAYLSTNFAGTLGYTAPEYAIRGELSE----KADIYSFGV 273
              A LS    GT  + APE ++            D+++ GV
Sbjct: 189 GSDALLSN-TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGV 228

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  102 bits (257), Expect = 9e-25
 Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 34/218 (15%)

Query: 77  LKKATKNFH-----PGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGES---EFL 127
             ++ +NF+         LGRG F  V +    + G   A K   + K ++G+    E L
Sbjct: 19  YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAK--FLKKRRRGQDCRAEIL 76

Query: 128 SEVRMITSIQH-KNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLI------YGESDKFLN 179
            E+ ++   +    ++ L     + S+ +L+ EY     +  L +        E+D    
Sbjct: 77  HEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND---- 132

Query: 180 WSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPE 236
                ++I  I  G+ YLH+     IVH D+K  N+LL         KI DFG++R    
Sbjct: 133 --VI-RLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186

Query: 237 DQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVL 274
                     GT  Y APE      ++   D+++ G++
Sbjct: 187 ACEL--REIMGTPEYLAPEILNYDPITTATDMWNIGII 222

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  102 bits (256), Expect = 1e-24
 Identities = 52/215 (24%), Positives = 84/215 (39%), Gaps = 32/215 (14%)

Query: 78  KKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVK-----KLCVDKSQQGESE--FLSE 129
           K     +     LG G  G V           VA+K     K  +  +++ +      +E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65

Query: 130 VRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLI----YGESDKFLNWSTRF 184
           + ++  + H  ++++     D     +V E M+   L D ++      E+         F
Sbjct: 66  IEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATC----KLYF 120

Query: 185 QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYL 241
             +L     +QYLHE     I+HRD+K  NVLL  + +    KI DFG ++   E    +
Sbjct: 121 YQMLL---AVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LM 173

Query: 242 STNFAGTLGYTAPE---YAIRGELSEKADIYSFGV 273
            T   GT  Y APE          +   D +S GV
Sbjct: 174 RT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  101 bits (255), Expect = 1e-24
 Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 23/201 (11%)

Query: 87  GNLLGRGGFGPVYRGK-LADGTLVAVK---KLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           G+LLG G +G V            AVK   K  + +   GE+    E++++  ++HKN++
Sbjct: 10  GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69

Query: 143 RLLGCCSDGSQR--LLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QIILGIARGLQYL 197
           +L+    +  ++   +V EY      ++L      +F          Q+I G+    +YL
Sbjct: 70  QLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGL----EYL 125

Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE--DQAYLSTNFAGTLGYTAPE 255
           H  S   IVH+DIK  N+LL      KI   G+A             T   G+  +  PE
Sbjct: 126 H--SQ-GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAFQPPE 181

Query: 256 YAIRGELS---EKADIYSFGV 273
               G  +    K DI+S GV
Sbjct: 182 -IANGLDTFSGFKVDIWSAGV 201

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  101 bits (255), Expect = 1e-24
 Identities = 53/181 (29%), Positives = 90/181 (49%), Gaps = 16/181 (8%)

Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
            F     LG G +  VY+G     G  VA+K++ +D  +   S  + E+ ++  ++H+N+
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENI 65

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQ------IILGIARGLQ 195
           VRL       ++  LV+E+M     DL  Y +S    N     +          + +GL 
Sbjct: 66  VRLYDVIHTENKLTLVFEFM---DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122

Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAP 254
           + H     +I+HRD+K  N+L++++ Q K+GDFGLAR F      +  ++   TL Y AP
Sbjct: 123 FCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVTLWYRAP 177

Query: 255 E 255
           +
Sbjct: 178 D 178

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  104 bits (262), Expect = 2e-24
 Identities = 68/261 (26%), Positives = 115/261 (44%), Gaps = 28/261 (10%)

Query: 36  LWKFNKAKELVRLALRTTKEGVSKDFFNGNLRTISYFDFQTLKKATKNFHPG-------N 88
           L K     +L +  +    + +  D F   + +  +  F   K    N H          
Sbjct: 136 LVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHR 195

Query: 89  LLGRGGFGPVYRGKLAD-GTLVAVKKLCVD--KSQQGESEFLSEVRM---ITSIQHKNLV 142
           ++GRGGFG VY  + AD G + A+K L     K +QGE+  L+E  M   +++     +V
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255

Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QIILGIARGLQYLHE 199
            +        +   + + M    L   +      F     RF   +IILG    L+++H 
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILG----LEHMHN 310

Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
                +V+RD+K +N+LLDE    +I D GLA  F + + +      GT GY APE   +
Sbjct: 311 ---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQK 364

Query: 260 GELSEKA-DIYSFGVLVLEII 279
           G   + + D +S G ++ +++
Sbjct: 365 GVAYDSSADWFSLGCMLFKLL 385

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =   99 bits (250), Expect = 6e-24
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 21/216 (9%)

Query: 75  QTLKKATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKS---QQGESEF-LSE 129
           Q  KK  ++F  G +LG G F  V   +  A     A+K L  +K    ++ +  +   E
Sbjct: 23  QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRE 80

Query: 130 VRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF---QI 186
             +++ + H   V+L     D  +      Y KN  L   I      F    TRF   +I
Sbjct: 81  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEI 139

Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN-F 245
           +      L+YLH      I+HRD+K  N+LL+E    +I DFG A+    +      N F
Sbjct: 140 VSA----LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192

Query: 246 AGTLGYTAPEYAIRGELSEKA-DIYSFGVLVLEIIS 280
            GT  Y +PE  +  + + K+ D+++ G ++ ++++
Sbjct: 193 VGTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVA 227

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  100 bits (252), Expect = 7e-24
 Identities = 57/189 (30%), Positives = 93/189 (49%), Gaps = 38/189 (20%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEF----LSEVRMITSIQHKNLVRL 144
           +G+G FG V++ +    G  VA+KK+ ++  ++G   F    L E++++  ++H+N+V L
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLLKHENVVNL 81

Query: 145 LGCCSDGSQRL--------LVYEYMKNRSLDL--LIYGESDKFLNWSTRFQI---ILGIA 191
           +  C   +           LV+++      DL  L+     KF    T  +I   +  + 
Sbjct: 82  IEICRTKASPYNRCKGSIYLVFDFC---EHDLAGLLSNVLVKF----TLSEIKRVMQMLL 134

Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-----PEDQAYLSTNFA 246
            GL Y+H     +I+HRD+KA+NVL+      K+ DFGLAR F      +   Y  TN  
Sbjct: 135 NGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY--TNRV 189

Query: 247 GTLGYTAPE 255
            TL Y  PE
Sbjct: 190 VTLWYRPPE 198

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 99.7 bits (249), Expect = 9e-24
 Identities = 49/208 (23%), Positives = 80/208 (38%), Gaps = 34/208 (16%)

Query: 89  LLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQ-QGESEFLSEVRMITSIQ-HKNLVRLL 145
           +LG G    V     L      AVK   ++K      S    EV M+   Q H+N++ L+
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVK--IIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 146 GCCSDGSQRLLVYEYMKNRSL-DLLI----YGESDKFLNWSTRFQIILGIARGLQYLHED 200
               +  +  LV+E M+  S+   +     + E +          ++  +A  L +LH  
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS-------VVVQDVASALDFLHN- 129

Query: 201 SHTRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTN------FAGTLGY 251
               I HRD+K  N+L +   Q    KI DF L      +      +        G+  Y
Sbjct: 130 --KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187

Query: 252 TAPE-----YAIRGELSEKADIYSFGVL 274
            APE             ++ D++S GV+
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVI 215

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  101 bits (254), Expect = 2e-23
 Identities = 74/253 (29%), Positives = 109/253 (43%), Gaps = 22/253 (8%)

Query: 40  NKAKELVRLALRTTKEGVSKDFFNGNLRTISYFDFQTLKKATKN------FHPGNLLGRG 93
              K+L +   R T E +S   F   L +I +  F   K   +       F    +LG+G
Sbjct: 136 GPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKG 195

Query: 94  GFGPVYRGKLAD-GTLVAVKKLCVD--KSQQGESEFLSEVRMITSIQHKNLVRLLGCCSD 150
           GFG V   ++   G + A KKL     K ++GE+  L+E +++  +  + +V L      
Sbjct: 196 GFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 255

Query: 151 GSQRLLVYEYMKNRSLDLLIYGE-SDKFLNWSTRF---QIILGIARGLQYLHEDSHTRIV 206
                LV   M    L   IY      F      F   +I  G    L+ LH +   RIV
Sbjct: 256 KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG----LEDLHRE---RIV 308

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKA 266
           +RD+K  N+LLD+    +I D GLA   PE Q        GT+GY APE       +   
Sbjct: 309 YRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSP 366

Query: 267 DIYSFGVLVLEII 279
           D ++ G L+ E+I
Sbjct: 367 DWWALGCLLYEMI 379

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 47/204 (23%), Positives = 78/204 (38%), Gaps = 34/204 (16%)

Query: 87  GNLLGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVR-MITSIQHKNLVRL 144
             +LG G  G V +          A+K   +        +   EV     + Q  ++VR+
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCP----KARREVELHWRASQCPHIVRI 120

Query: 145 LGCCSDGSQR----LLVYEYMKNRSL-------DLLIYGESDKFLNWSTRFQIILGIARG 193
           +    +        L+V E +    L           + E +         +I+  I   
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA-------SEIMKSIGEA 173

Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAGTLG 250
           +QYLH  +   I HRD+K  N+L   K  +   K+ DFG A+      + L+T    T  
Sbjct: 174 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTT-PCYTPY 228

Query: 251 YTAPEYAIRGELSEKADIYSFGVL 274
           Y APE     +  +  D++S GV+
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVI 252

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 97.7 bits (244), Expect = 2e-23
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 33/203 (16%)

Query: 87  GNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLS----EVRMITSIQHKNL 141
           G+ LG G FG V  G+    G  VAVK L  ++ +    + +     E++ +   +H ++
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKIL--NRQKIRSLDVVGKIKREIQNLKLFRHPHI 73

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSL-DLLIY------GESDKFLNWSTRF-QIILGIARG 193
           ++L    S  +   +V EY+    L D +         E+ +       F QI+  +   
Sbjct: 74  IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRL------FQQILSAV--- 124

Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
             Y H      +VHRD+K  NVLLD    +KI DFGL+    + + +L T   G+  Y A
Sbjct: 125 -DYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRT-SCGSPNYAA 178

Query: 254 PEYAIRGELSE--KADIYSFGVL 274
           PE  I G L    + DI+S GV+
Sbjct: 179 PE-VISGRLYAGPEVDIWSCGVI 200

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 98.4 bits (245), Expect = 4e-23
 Identities = 41/177 (23%), Positives = 66/177 (37%), Gaps = 15/177 (8%)

Query: 115 CVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGE 173
               S         ++R +     KN V  L   S      +  +  +  +L D +    
Sbjct: 97  WPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC 156

Query: 174 SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR- 232
           S +         I + IA  +++LH      ++HRD+K SN+        K+GDFGL   
Sbjct: 157 SLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213

Query: 233 ----------FFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
                       P       T   GT  Y +PE       S K DI+S G+++ E++
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 21/107 (19%), Positives = 38/107 (35%), Gaps = 1/107 (0%)

Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
            +F P   +GRGGFG V+  K   D    A+K++ +   +    + + EV+ +  ++H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII 187
           +VR      +        E  +    D                   I
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKI 112

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 99.9 bits (249), Expect = 5e-23
 Identities = 68/257 (26%), Positives = 108/257 (42%), Gaps = 23/257 (8%)

Query: 38  KFNKAKELVRLALRTTKEGVSKDFFNGNLRTISYFDFQTLKKATKN------FHPGNLLG 91
           +      L +  LR     + +  F   L ++ +  F   K           F    +LG
Sbjct: 135 RAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLG 194

Query: 92  RGGFGPVYRGKLAD-GTLVAVKKLCVD--KSQQGESEFLSEVRMITSIQHKNLVRLLGCC 148
           RGGFG V+  ++   G L A KKL     K ++G    + E +++  +  + +V L    
Sbjct: 195 RGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF 254

Query: 149 SDGSQRLLVYEYMKNRSLDLLIYG---ESDKFLNWSTRF---QIILGIARGLQYLHEDSH 202
              +   LV   M    +   IY    ++  F      F   QI+ G    L++LH+   
Sbjct: 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLHQR-- 308

Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
             I++RD+K  NVLLD+    +I D GLA      Q      +AGT G+ APE  +  E 
Sbjct: 309 -NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTPGFMAPELLLGEEY 366

Query: 263 SEKADIYSFGVLVLEII 279
               D ++ GV + E+I
Sbjct: 367 DFSVDYFALGVTLYEMI 383

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 98.6 bits (246), Expect = 6e-23
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 28/205 (13%)

Query: 64  GNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGE 123
             +  +   D +T ++    +    ++G G FG V++ KL +   VA+KK+  DK  +  
Sbjct: 22  NKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR 81

Query: 124 SEFLSEVRMITSIQHKNLVRLLGC-CSDGSQRL-----LVYEYMKNRSLDLLIYGESDKF 177
                E++++  ++H N+V L     S+G ++      LV EY+      +  Y  S  +
Sbjct: 82  -----ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV---PETV--YRASRHY 131

Query: 178 LNWSTRFQIILG------IARGLQYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGL 230
                   ++L       + R L Y+H  S   I HRDIK  N+LLD      K+ DFG 
Sbjct: 132 AKLKQTMPMLLIKLYMYQLLRSLAYIH--SI-GICHRDIKPQNLLLDPPSGVLKLIDFGS 188

Query: 231 ARFFPEDQAYLSTNFAGTLGYTAPE 255
           A+     +     ++  +  Y APE
Sbjct: 189 AKILIAGEPN--VSYICSRYYRAPE 211

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 98.1 bits (245), Expect = 7e-23
 Identities = 56/235 (23%), Positives = 89/235 (37%), Gaps = 46/235 (19%)

Query: 74  FQTLKKATKNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEF----LS 128
            +  +K    F    + G+G FG V  GK    G  VA+KK+  D        F    L 
Sbjct: 15  DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR------FRNRELQ 68

Query: 129 EVRMITSIQHKNLVRLLGC-CSDGSQRL------LVYEYMKNRSLDLLIYGESDKFLNWS 181
            ++ +  + H N+V+L     + G +        +V EY+      L  +     +    
Sbjct: 69  IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV---PDTL--HRCCRNYYRRQ 123

Query: 182 TRFQIILG------IARGLQYLHEDSHTRIVHRDIKASNVLLDEK-FQSKIGDFGLARFF 234
                IL       + R +  LH  S   + HRDIK  NVL++E     K+ DFG A+  
Sbjct: 124 VAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

Query: 235 PEDQAYLSTNFAGTLGYTAPE-------YAIRGELSEKADIYSFGVLVLEIISCR 282
              +      +  +  Y APE       Y      +   DI+S G +  E++   
Sbjct: 183 SPSEPN--VAYICSRYYRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 48/198 (24%), Positives = 78/198 (39%), Gaps = 27/198 (13%)

Query: 89  LLGRGGFGPVYRG-KLADGTLVAVKKLCVDKSQQGESEFLSEVR-MITSIQHKNLVRLLG 146
           +LG G  G V        G   A+K   +  S     +   EV     +    ++V +L 
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALK--LLYDSP----KARQEVDHHWQASGGPHIVCILD 89

Query: 147 CCSDGSQR----LLVYEYMKNRSL-DLLIYGESDKFLNWSTRF--QIILGIARGLQYLHE 199
              +        L++ E M+   L   +       F   + R   +I+  I   +Q+LH 
Sbjct: 90  VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF---TEREAAEIMRDIGTAIQFLHS 146

Query: 200 DSHTRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEY 256
                I HRD+K  N+L   K +    K+ DFG A+   ++   L T    T  Y APE 
Sbjct: 147 ---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQT-PCYTPYYVAPEV 200

Query: 257 AIRGELSEKADIYSFGVL 274
               +  +  D++S GV+
Sbjct: 201 LGPEKYDKSCDMWSLGVI 218

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 97.0 bits (242), Expect = 1e-22
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 32/202 (15%)

Query: 87  GNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLS----EVRMITSIQHKNL 141
              LG G FG V           VA+K   + +    +S+       E+  +  ++H ++
Sbjct: 14  RETLGEGSFGKVKLATHYKTQQKVALK--FISRQLLKKSDMHMRVEREISYLKLLRHPHI 71

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIY------GESDKFLNWSTRF-QIILGIARGL 194
           ++L    +  +  ++V EY      D ++        E  +F      F QII  I    
Sbjct: 72  IKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRF------FQQIICAI---- 121

Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           +Y H     +IVHRD+K  N+LLD+    KI DFGL+    +   +L T   G+  Y AP
Sbjct: 122 EYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKT-SCGSPNYAAP 176

Query: 255 EYAIRGELSE--KADIYSFGVL 274
           E  I G+L    + D++S G++
Sbjct: 177 E-VINGKLYAGPEVDVWSCGIV 197

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 95.3 bits (238), Expect = 1e-22
 Identities = 58/198 (29%), Positives = 85/198 (42%), Gaps = 24/198 (12%)

Query: 87  GNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESE--FLSEVRMITSIQHKNLVR 143
              LG G +G V           VAVK   VD  +  +       E+ +   + H+N+V+
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVK 69

Query: 144 LLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHE 199
             G   +G+ + L  EY     L D +             +    Q++ G+     YLH 
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGV----VYLH- 122

Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA--YLSTNFAGTLGYTAPEYA 257
                I HRDIK  N+LLDE+   KI DFGLA  F  +     L+    GTL Y APE  
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPE-L 178

Query: 258 IRGEL--SEKADIYSFGV 273
           ++     +E  D++S G+
Sbjct: 179 LKRREFHAEPVDVWSCGI 196

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 53/247 (21%), Positives = 106/247 (42%), Gaps = 48/247 (19%)

Query: 56  GVSKDFFNGNL-RTISYFDFQTLKKA---TKNFHPGNLLGRGGFGPVYRGK-LADGTLVA 110
             ++ + + N  R   Y+D+++         ++     LGRG +  V+    + +   V 
Sbjct: 6   SRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVV 65

Query: 111 VKKLCVDKSQQGESEFLSEVRMITSIQ-HKNLVRLLGCCSDGSQR--LLVYEYMKNRSLD 167
           VK L   K    + +   E++++ +++   N++ L     D   R   LV+E++ N    
Sbjct: 66  VKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFK 121

Query: 168 LLIYGESDK----FLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD-EKFQ 222
            L    +D     ++     ++I+    + L Y H  S   I+HRD+K  NV++D E  +
Sbjct: 122 QLYQTLTDYDIRFYM-----YEIL----KALDYCH--SM-GIMHRDVKPHNVMIDHEHRK 169

Query: 223 SKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE---------YAIRGELSEKADIYSFGV 273
            ++ D+GLA F+   Q Y       +  +  PE         Y++        D++S G 
Sbjct: 170 LRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMYDYSL--------DMWSLGC 219

Query: 274 LVLEIIS 280
           ++  +I 
Sbjct: 220 MLASMIF 226

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 95.8 bits (239), Expect = 3e-22
 Identities = 58/198 (29%), Positives = 85/198 (42%), Gaps = 24/198 (12%)

Query: 87  GNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESE--FLSEVRMITSIQHKNLVR 143
              LG G +G V           VAVK   VD  +  +       E+ +   + H+N+V+
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVK 69

Query: 144 LLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHE 199
             G   +G+ + L  EY     L D +             +    Q++ G+     YLH 
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGV----VYLH- 122

Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA--YLSTNFAGTLGYTAPEYA 257
                I HRDIK  N+LLDE+   KI DFGLA  F  +     L+    GTL Y APE  
Sbjct: 123 -GI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPE-L 178

Query: 258 IRGEL--SEKADIYSFGV 273
           ++     +E  D++S G+
Sbjct: 179 LKRREFHAEPVDVWSCGI 196

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 96.0 bits (239), Expect = 8e-22
 Identities = 64/203 (31%), Positives = 95/203 (46%), Gaps = 33/203 (16%)

Query: 87  GNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLS----EVRMITSIQHKNL 141
           G+ LG G FG V  GK    G  VAVK L  ++ +    + +     E++ +   +H ++
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKIL--NRQKIRSLDVVGKIRREIQNLKLFRHPHI 78

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSL-DLLIY------GESDKFLNWSTRF-QIILGIARG 193
           ++L    S  S   +V EY+    L D +         ES +       F QI+ G+   
Sbjct: 79  IKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRL------FQQILSGV--- 129

Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
             Y H      +VHRD+K  NVLLD    +KI DFGL+    + + +L T   G+  Y A
Sbjct: 130 -DYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRT-SCGSPNYAA 183

Query: 254 PEYAIRGELSE--KADIYSFGVL 274
           PE  I G L    + DI+S GV+
Sbjct: 184 PE-VISGRLYAGPEVDIWSSGVI 205

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 95.2 bits (237), Expect = 1e-21
 Identities = 55/195 (28%), Positives = 87/195 (44%), Gaps = 31/195 (15%)

Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEF-LSEVRMI 133
             +    ++    ++G G FG VY+ KL D G LVA+KK+  DK       F   E++++
Sbjct: 48  PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIM 101

Query: 134 TSIQHKNLVRLLGC-CSDGSQRL-----LVYEYMKNRSLDLLIYGESDKFLNWSTRFQII 187
             + H N+VRL     S G ++      LV +Y+      +  Y  +  +        +I
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV---PETV--YRVARHYSRAKQTLPVI 156

Query: 188 LG------IARGLQYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAY 240
                   + R L Y+H  S   I HRDIK  N+LLD +    K+ DFG A+     +  
Sbjct: 157 YVKLYMYQLFRSLAYIH--SF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213

Query: 241 LSTNFAGTLGYTAPE 255
              ++  +  Y APE
Sbjct: 214 --VSYICSRYYRAPE 226

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 33/224 (14%)

Query: 67  RTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKL----CVDKSQQ 121
             +++  F+ L+           +G+G FG V   +  D   + A+K +    CV++++ 
Sbjct: 10  EDVNFDHFEILR----------AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEV 59

Query: 122 GESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWS 181
                  E++++  ++H  LV L     D     +V + +    L   +  ++  F   +
Sbjct: 60  RNV--FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ-QNVHFKEET 116

Query: 182 TRF---QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ 238
            +    ++++     L YL      RI+HRD+K  N+LLDE     I DF +A   P + 
Sbjct: 117 VKLFICELVMA----LDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169

Query: 239 AYLSTNFAGTLGYTAPEYAIRGEL---SEKADIYSFGVLVLEII 279
               T  AGT  Y APE     +    S   D +S GV   E++
Sbjct: 170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL 211

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 94.1 bits (234), Expect = 2e-21
 Identities = 45/191 (23%), Positives = 77/191 (40%), Gaps = 39/191 (20%)

Query: 90  LGRGGFGPVYRGK---LADGTLVAVKKLC---VDKSQQGESEFLSEVRMITSIQHKNLVR 143
           +GRG +G VY+ K     D    A+K++    +  S   E   L E      ++H N++ 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRE------LKHPNVIS 82

Query: 144 LLGCCSDGSQRL--LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILG---------IAR 192
           L       + R   L+++Y      DL    +  +    + +   +           I  
Sbjct: 83  LQKVFLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139

Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQS----KIGDFGLARFF-PEDQAYLSTNFAG 247
           G+ YLH  ++  ++HRD+K +N+L+  +       KI D G AR F    +     +   
Sbjct: 140 GIHYLH--AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL--ADLDP 194

Query: 248 ---TLGYTAPE 255
              T  Y APE
Sbjct: 195 VVVTFWYRAPE 205

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 93.7 bits (233), Expect = 4e-21
 Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 34/219 (15%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKS---QQGESE-F 126
           DF+ LK          ++GRG FG V   + K     + A+K L  +K    ++ E+  F
Sbjct: 75  DFEILK----------VIGRGAFGEVAVVKLK-NADKVFAMKIL--NKWEMLKRAETACF 121

Query: 127 LSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF-- 184
             E  ++ +   K +  L     D +   LV +Y     L  L+    D+      RF  
Sbjct: 122 REERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYL 181

Query: 185 -QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST 243
            ++++     +  +H+      VHRDIK  N+L+D     ++ DFG      ED    S+
Sbjct: 182 AEMVIA----IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 234

Query: 244 NFAGTLGYTAPE-----YAIRGELSEKADIYSFGVLVLE 277
              GT  Y +PE        +G    + D +S GV + E
Sbjct: 235 VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 92.8 bits (231), Expect = 5e-21
 Identities = 51/200 (25%), Positives = 80/200 (40%), Gaps = 31/200 (15%)

Query: 87  GNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL 145
              +G G FG     +      LVAVK   +++    +     E+    S++H N+VR  
Sbjct: 25  VKDIGSGNFGVARLMRDKLTKELVAVK--YIERGAAIDENVQREIINHRSLRHPNIVRFK 82

Query: 146 GCCSDGSQRLLVYEYMKNRSL-DLLIY------GESDKFLNWSTRF-QIILGIARGLQYL 197
                 +   ++ EY     L + +         E+  F      F Q++ G+     Y 
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFF------FQQLLSGV----SYC 132

Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQS--KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE 255
           H  S  +I HRD+K  N LLD       KI DFG ++          +   GT  Y APE
Sbjct: 133 H--SM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS-TVGTPAYIAPE 187

Query: 256 YAIRGEL--SEKADIYSFGV 273
             +  +    + AD++S GV
Sbjct: 188 -VLLRQEYDGKIADVWSCGV 206

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 90.1 bits (224), Expect = 3e-20
 Identities = 50/218 (22%), Positives = 87/218 (39%), Gaps = 23/218 (10%)

Query: 81  TKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESE-F---------LSEV 130
              +     +  G +G V  G  ++G  VA+K++    S                 L E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 131 RMITSIQHKNLVRLLGCCSDGSQRL-----LVYEYMKNRSLDLLIYGESDKFLNWSTRFQ 185
           R++    H N++ L        +       LV E M+   L  +I+ +         ++ 
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQY- 138

Query: 186 IILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNF 245
            +  I  GL  LHE     +VHRD+   N+LL +     I DF LAR    D     T++
Sbjct: 139 FMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN--KTHY 193

Query: 246 AGTLGYTAPEYAI-RGELSEKADIYSFGVLVLEIISCR 282
                Y APE  +     ++  D++S G ++ E+ + +
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 90.0 bits (224), Expect = 4e-20
 Identities = 68/252 (26%), Positives = 102/252 (40%), Gaps = 50/252 (19%)

Query: 43  KELVRLALRTTKEGVSKDFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGK 102
           +E V+  L   KE   K +   +  T     F  +K           LG G FG V   K
Sbjct: 12  QESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIK----------TLGTGSFGRVMLVK 61

Query: 103 LAD-GTLVAVKKL----CVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV 157
             + G   A+K L     V   Q   +  L+E R++ ++    LV+L     D S   +V
Sbjct: 62  HKESGNHYAMKILDKQKVVKLKQIEHT--LNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119

Query: 158 YEYMKNRSLDLLIYGE-------SDKFLNWSTRF---QIILGIARGLQYLHEDSHTRIVH 207
            EY+          GE         +F     RF   QI+L      +YLH      +++
Sbjct: 120 MEYVAG--------GEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHSLD---LIY 164

Query: 208 RDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN-FAGTLGYTAPEYAIRGELSEKA 266
           RD+K  N+L+D++   ++ DFG A+          T    GT    APE  I  +   KA
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPE-IILSKGYNKA 218

Query: 267 -DIYSFGVLVLE 277
            D ++ GVL+ E
Sbjct: 219 VDWWALGVLIYE 230

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 89.4 bits (222), Expect = 9e-20
 Identities = 53/219 (24%), Positives = 89/219 (40%), Gaps = 37/219 (16%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKS---QQGESE-F 126
           D++ +K          ++GRG FG V   R K +   + A+K L   K    ++ +S  F
Sbjct: 70  DYEVVK----------VIGRGAFGEVQLVRHK-STRKVYAMKLL--SKFEMIKRSDSAFF 116

Query: 127 LSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF-- 184
             E  ++       +V+L     D     +V EYM     DL+    +        RF  
Sbjct: 117 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG--DLVNLMSNYDVPEKWARFYT 174

Query: 185 -QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST 243
            +++L     L  +H       +HRD+K  N+LLD+    K+ DFG      ++      
Sbjct: 175 AEVVLA----LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 227

Query: 244 NFAGTLGYTAPEYAIRGELSEKA-----DIYSFGVLVLE 277
              GT  Y +PE  ++ +  +       D +S GV + E
Sbjct: 228 TAVGTPDYISPE-VLKSQGGDGYYGRECDWWSVGVFLYE 265

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 54/221 (24%), Positives = 84/221 (38%), Gaps = 36/221 (16%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKLCVDKS---QQGESE-F 126
           DF+ LK          ++GRG F  V   + K   G + A+K +  +K    ++GE   F
Sbjct: 62  DFEILK----------VIGRGAFSEVAVVKMK-QTGQVYAMKIM--NKWDMLKRGEVSCF 108

Query: 127 LSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF-- 184
             E  ++ +   + + +L     D +   LV EY     L  L+    ++      RF  
Sbjct: 109 REERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYL 168

Query: 185 -QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST 243
            +I++     +  +H       VHRDIK  N+LLD     ++ DFG       D    S 
Sbjct: 169 AEIVMA----IDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL 221

Query: 244 NFAGTLGYTAPEYAIRGELSEKADIY-------SFGVLVLE 277
              GT  Y +PE             Y       + GV   E
Sbjct: 222 VAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 82.5 bits (204), Expect = 6e-18
 Identities = 34/277 (12%), Positives = 70/277 (25%), Gaps = 64/277 (23%)

Query: 89  LLGRGGFGPVYRGKLADGTL---VAVKKLCVDKSQQGE--SEFLSEVRMITSIQHKNLVR 143
             G       ++    D  L   VA+  +        +   E LS    ++ I    + R
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
           +L      +  L+V E+++  SL  +         +     + +  +A      H     
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHR---A 148

Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELS 263
            +       S V +       +           +                          
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPATMP--DANPQ------------------------ 182

Query: 264 EKADIYSFGVLVLEIISCR-----KNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR 318
              DI   G  +  ++  R           L    +                + ++P   
Sbjct: 183 --DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAG------------QPIEPADI 228

Query: 319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
              I      Q+  VA   +Q  G  R   S ++ ++
Sbjct: 229 DRDI----PFQISAVAARSVQGDGGIRSA-STLLNLM 260

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 83.2 bits (206), Expect = 8e-18
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 20/211 (9%)

Query: 81  TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLC-VDKSQQGESEFLSEVRMITSIQH 138
            K +     +G G  G V           VA+KKL    ++Q        E+ ++  + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 139 KNLVRLL------GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIIL-GIA 191
           KN++ LL          +     +V E M + +L  +I  E D       R   +L  + 
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDH-----ERMSYLLYQML 137

Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY 251
            G+++LH      I+HRD+K SN+++      KI DFGLAR      +++ T +  T  Y
Sbjct: 138 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 192

Query: 252 TAPEYAIRGELSEKADIYSFGVLVLEIISCR 282
            APE  +     E  DI+S G ++ E+I   
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 65/218 (29%), Positives = 95/218 (43%), Gaps = 28/218 (12%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKL----CVDKSQQGESEFL 127
           +F+ LK          LLG+G FG V   K    G   A+K L     V K +   +  L
Sbjct: 149 EFEYLK----------LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--L 196

Query: 128 SEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF--- 184
           +E R++ + +H  L  L        +   V EY     L   +  E   F     RF   
Sbjct: 197 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGA 255

Query: 185 QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN 244
           +I+      L YLH  S   +V+RD+K  N++LD+    KI DFGL +   +D A + T 
Sbjct: 256 EIVSA----LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT- 308

Query: 245 FAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCR 282
           F GT  Y APE     +     D +  GV++ E++  R
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 81.4 bits (202), Expect = 2e-17
 Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 52/223 (23%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKL----CVDKSQQGESEF 126
           DFQ L+           LG G FG V+  R +  +G   A+K L     V   Q   +  
Sbjct: 7   DFQILR----------TLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIVVRLKQVEHT-- 53

Query: 127 LSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGE-------SDKFLN 179
             E  M++ + H  ++R+ G   D  Q  ++ +Y++         GE       S +F N
Sbjct: 54  NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG--------GELFSLLRKSQRFPN 105

Query: 180 WSTRF---QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE 236
              +F   ++ L     L+YLH      I++RD+K  N+LLD+    KI DFG A++ P+
Sbjct: 106 PVAKFYAAEVCLA----LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158

Query: 237 DQAYLSTN-FAGTLGYTAPEYAIRGELSEKA-DIYSFGVLVLE 277
                 T    GT  Y APE  +  +   K+ D +SFG+L+ E
Sbjct: 159 -----VTYTLCGTPDYIAPE-VVSTKPYNKSIDWWSFGILIYE 195

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 80.9 bits (200), Expect = 5e-17
 Identities = 49/250 (19%), Positives = 93/250 (37%), Gaps = 64/250 (25%)

Query: 81  TKNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHK 139
           +K +  G  LG G FG V      + G   A+KK+  D   +       E+ ++  + H 
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-----NRELDIMKVLDHV 60

Query: 140 NLVRLLGC--------------CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNW----- 180
           N+++L+                  D ++       + N    +++    +K+LN      
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 181 -STRFQIILG-------------------IARGLQYLHEDSHTRIVHRDIKASNVLLD-E 219
             T  +++                     + R + ++H  S   I HRDIK  N+L++ +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH--SL-GICHRDIKPQNLLVNSK 177

Query: 220 KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE-------YAIRGELSEKADIYSFG 272
               K+ DFG A+     +      +  +  Y APE       Y      +   D++S G
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPS--VAYICSRFYRAPELMLGATEY------TPSIDLWSIG 229

Query: 273 VLVLEIISCR 282
            +  E+I  +
Sbjct: 230 CVFGELILGK 239

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 81.4 bits (201), Expect = 5e-17
 Identities = 42/208 (20%), Positives = 80/208 (38%), Gaps = 19/208 (9%)

Query: 68  TISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESE- 125
           T S     +  +    +   +L+G G +G V       +  +VA+KK+        + + 
Sbjct: 39  TASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKR 98

Query: 126 FLSEVRMITSIQHKNLVRLLGCCSDGSQRL-----LVYEYMKNRSLDL--LIYGESDKFL 178
            L E+ ++  + H ++V++L               +V E       D   L    +  +L
Sbjct: 99  ILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA---DSDFKKLFR--TPVYL 153

Query: 179 NWSTRFQIIL-GIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED 237
                 + +L  +  G++Y+H  S   I+HRD+K +N L+++    K+ DFGLAR     
Sbjct: 154 T-ELHIKTLLYNLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209

Query: 238 QAYLSTNFAGTLGYTAPEYAIRGELSEK 265
           +   S                    + K
Sbjct: 210 ENGNSQLPISPREDDMNLVTFPHTKNLK 237

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 81.4 bits (201), Expect = 6e-17
 Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 24/213 (11%)

Query: 81  TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLC-VDKSQQGESEFLSEVRMITSIQH 138
            K +     +G G  G V           VA+KKL    ++Q        E+ ++  + H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120

Query: 139 KNLVRLL------GCCSDGSQRLLVYEYMK---NRSLDLLIYGESDKFLNWSTRFQIILG 189
           KN++ LL          +     LV E M     + + + +  E   +L     +Q++  
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL----LYQML-- 174

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
              G+++LH      I+HRD+K SN+++      KI DFGLAR          T +  T 
Sbjct: 175 --CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTR 227

Query: 250 GYTAPEYAIRGELSEKADIYSFGVLVLEIISCR 282
            Y APE  +     E  DI+S G ++ E++  +
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 51/191 (26%), Positives = 85/191 (44%), Gaps = 31/191 (16%)

Query: 81  TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHK 139
              +   + +G G +G V       +   VA+KK+   + Q      L E++++   +H+
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85

Query: 140 NLVRLLGCCSDGSQRL-----LVYEYMKNRSLDL--LIYGE--SDK----FLNWSTRFQI 186
           N++ +       +        +V + M+    DL  L+  +  S+     FL     +QI
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSNDHICYFL-----YQI 137

Query: 187 ILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR--FFPEDQAYLSTN 244
           +    RGL+Y+H      ++HRD+K SN+LL+     KI DFGLAR      D     T 
Sbjct: 138 L----RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190

Query: 245 FAGTLGYTAPE 255
           +  T  Y APE
Sbjct: 191 YVATRWYRAPE 201

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 49/227 (21%), Positives = 85/227 (37%), Gaps = 36/227 (15%)

Query: 57  VSKDFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLC 115
           +     + + R   YF          N+   +L+GRG +G VY          VA+KK+ 
Sbjct: 1   MHHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV- 59

Query: 116 VDKSQQGESEF---------LSEVRMITSIQHKNLVRLLGCCSDGSQRL-----LVYEYM 161
                     F         L E+ ++  ++   ++RL                +V E  
Sbjct: 60  -------NRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA 112

Query: 162 KNRSLDL--LIYGESDKFLNWSTRFQIILG-IARGLQYLHEDSHTRIVHRDIKASNVLLD 218
            +   DL  L    +  FL      + IL  +  G  ++HE   + I+HRD+K +N LL+
Sbjct: 113 DS---DLKKLFK--TPIFLT-EEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLN 163

Query: 219 EKFQSKIGDFGLAR-FFPEDQAYLSTNFAGTLGYTAPEYAIRGELSE 264
           +    K+ DFGLAR    E    +  +             ++ +L+ 
Sbjct: 164 QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 62/241 (25%), Positives = 106/241 (43%), Gaps = 35/241 (14%)

Query: 52  TTKEGVSKDFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVY----RGKLADGT 107
           T K  +      G+   +   +F+ LK          +LG G +G V+          G 
Sbjct: 34  TVKHELRTANLTGHAEKVGIENFELLK----------VLGTGAYGKVFLVRKISGHDTGK 83

Query: 108 LVAVKKL----CVDKSQQGESEFLSEVRMITSIQHKN-LVRLLGCCSDGSQRLLVYEYMK 162
           L A+K L     V K++  E    +E +++  I+    LV L       ++  L+ +Y+ 
Sbjct: 84  LYAMKVLKKATIVQKAKTTEHT-RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYIN 142

Query: 163 NRSLDLLIYGESDKFLNWSTRF---QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE 219
              L   +     +F     +    +I+L     L++LH+     I++RDIK  N+LLD 
Sbjct: 143 GGELFTHLSQRE-RFTEHEVQIYVGEIVLA----LEHLHKLG---IIYRDIKLENILLDS 194

Query: 220 KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL---SEKADIYSFGVLVL 276
                + DFGL++ F  D+   + +F GT+ Y AP+  +RG      +  D +S GVL+ 
Sbjct: 195 NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD-IVRGGDSGHDKAVDWWSLGVLMY 253

Query: 277 E 277
           E
Sbjct: 254 E 254

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 78.7 bits (195), Expect = 2e-16
 Identities = 58/234 (24%), Positives = 102/234 (43%), Gaps = 33/234 (14%)

Query: 56  GVSKDFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVY----RGKLADGTLVAV 111
           G S+   N     I    F+ L+          +LG+GG+G V+          G + A+
Sbjct: 1   GSSETSVNRGPEKIRPECFELLR----------VLGKGGYGKVFQVRKVTGANTGKIFAM 50

Query: 112 KKL----CVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRL-LVYEYMKNRSL 166
           K L     V  ++       +E  ++  ++H  +V L+        +L L+ EY+    L
Sbjct: 51  KVLKKAMIVRNAKDTAHT-KAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL 108

Query: 167 DLLIYGESDKFLNWSTRF---QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS 223
            + +  E   F+  +  F   +I +     L +LH+     I++RD+K  N++L+ +   
Sbjct: 109 FMQLERE-GIFMEDTACFYLAEISMA----LGHLHQKG---IIYRDLKPENIMLNHQGHV 160

Query: 224 KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLE 277
           K+ DFGL +    D     T F GT+ Y APE  +R   +   D +S G L+ +
Sbjct: 161 KLTDFGLCKESIHDGTVTHT-FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYD 213

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 27/214 (12%)

Query: 81  TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLC-VDKSQQGESEFLSEVRMITSIQH 138
            K +     +G G +G V        G  VA+KKL    +S+        E+ ++  +QH
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 139 KNLVRLL------GCCSDGSQRLLVYEYMK---NRSLDLLIYGESDKFLNWSTRFQIILG 189
           +N++ LL          +     LV  +M+    + + L    E  ++L +    Q++  
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVY----QML-- 136

Query: 190 IARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTL 249
             +GL+Y+H      +VHRD+K  N+ ++E  + KI DFGLAR    +     T +  T 
Sbjct: 137 --KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TGYVVTR 187

Query: 250 GYTAPEYAI-RGELSEKADIYSFGVLVLEIISCR 282
            Y APE  +     ++  DI+S G ++ E+++ +
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 78.0 bits (192), Expect = 4e-16
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 4/157 (2%)

Query: 125 EFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF 184
           +    V  I     + L  +    S  S   +  + + +   +         FL      
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLI 196

Query: 185 QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN 244
                +A+G+++L   +  + +HRD+ A N+LL EK   KI DFGLAR   +D  Y+   
Sbjct: 197 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253

Query: 245 FAGT-LGYTAPEYAIRGELSEKADIYSFGVLVLEIIS 280
            A   L + APE       + ++D++SFGVL+ EI S
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 37/158 (23%), Positives = 59/158 (37%), Gaps = 17/158 (10%)

Query: 83  NFHPGNLLGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI 136
               G  LGRG FG V           A    VAVK L    +       +SE++++  I
Sbjct: 23  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 82

Query: 137 -QHKNLVRLLGCCSDGSQRLLV-YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGL 194
             H N+V LLG C+     L+V  E+ K        +G    +L  S R + +    +G 
Sbjct: 83  GHHLNVVNLLGACTKPGGPLMVIVEFCK--------FGNLSTYL-RSKRNEFVPYKTKGA 133

Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR 232
           ++     +   +  D+K     +     S    F   +
Sbjct: 134 RFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 77.6 bits (192), Expect = 5e-16
 Identities = 66/219 (30%), Positives = 95/219 (43%), Gaps = 31/219 (14%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKL----CVDKSQQGESEFL 127
           DF  LK          LLG+G FG V   +  A G   A+K L     + K +   +  +
Sbjct: 6   DFDYLK----------LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT--V 53

Query: 128 SEVRMITSIQHKNLVRLLGCCSDGSQRL-LVYEYMKNRSLDLLIYGESDKFLNWSTRF-- 184
           +E R++ + +H  L  L         RL  V EY     L   +  E   F     RF  
Sbjct: 54  TESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYG 111

Query: 185 -QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST 243
            +I+      L+YLH      +V+RDIK  N++LD+    KI DFGL +    D A + T
Sbjct: 112 AEIVSA----LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164

Query: 244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCR 282
            F GT  Y APE     +     D +  GV++ E++  R
Sbjct: 165 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 78.9 bits (194), Expect = 6e-16
 Identities = 68/240 (28%), Positives = 98/240 (40%), Gaps = 30/240 (12%)

Query: 52  TTKEGVSKDFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLAD-GTLVA 110
            T   +SK   NGN   +   DF  L           +LG+G FG V   +      L A
Sbjct: 321 KTANTISKFDNNGNRDRMKLTDFNFLM----------VLGKGSFGKVMLSERKGTDELYA 370

Query: 111 VK---KLCVDKSQQGESEFLSEVR-MITSIQHKNLVRLLGCCSDGSQRL-LVYEYMKNRS 165
           VK   K  V +    E   + E R +    +   L +L   C     RL  V EY+    
Sbjct: 371 VKILKKDVVIQDDDVECT-MVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGD 428

Query: 166 LDLLIYGESDKFLNWSTRF---QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ 222
           L   I     +F      F   +I +G    L +L       I++RD+K  NV+LD +  
Sbjct: 429 LMYHIQQV-GRFKEPHAVFYAAEIAIG----LFFLQSKG---IIYRDLKLDNVMLDSEGH 480

Query: 223 SKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCR 282
            KI DFG+ +    D     T F GT  Y APE        +  D ++FGVL+ E+++ +
Sbjct: 481 IKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 20/211 (9%)

Query: 81  TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLC-VDKSQQGESEFLSEVRMITSIQH 138
              +     +G G +G V        G  VA+KKL    +S+        E+R++  ++H
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83

Query: 139 KNLVRLL------GCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR 192
           +N++ LL          D +   LV  +M     DL    + +K      +F ++  + +
Sbjct: 84  ENVIGLLDVFTPDETLDDFTDFYLVMPFMGT---DLGKLMKHEKLGEDRIQF-LVYQMLK 139

Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
           GL+Y+H      I+HRD+K  N+ ++E  + KI DFGLAR    +     T +  T  Y 
Sbjct: 140 GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM----TGYVVTRWYR 192

Query: 253 APEYAI-RGELSEKADIYSFGVLVLEIISCR 282
           APE  +     ++  DI+S G ++ E+I+ +
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 75.7 bits (187), Expect = 3e-15
 Identities = 56/243 (23%), Positives = 93/243 (38%), Gaps = 61/243 (25%)

Query: 75  QTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMI 133
           + +   + +F   +LLG G +G V        G +VA+KK+            L E++++
Sbjct: 4   RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKIL 63

Query: 134 TSIQHKNLVRLLGCCSDGSQRL-----LVYEYM--------KNRSLD-----LLIYGESD 175
              +H+N++ +       S        ++ E M          + L        IY    
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY---- 119

Query: 176 KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP 235
                    Q +    R ++ LH    + ++HRD+K SN+L++     K+ DFGLAR   
Sbjct: 120 ---------QTL----RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163

Query: 236 EDQAYLS---------TNFAGTLGYTAPE-------YAIRGELSEKADIYSFGVLVLEII 279
           E  A  S           F  T  Y APE       Y      S   D++S G ++ E+ 
Sbjct: 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY------SRAMDVWSCGCILAELF 217

Query: 280 SCR 282
             R
Sbjct: 218 LRR 220

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 75.3 bits (186), Expect = 3e-15
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVY----RGKLADGTLVAVKKLCVDKS---QQGESE 125
            F+ LK          +LG+G FG V+            L A+K L   K+    +    
Sbjct: 25  QFELLK----------VLGQGSFGKVFLVKKISGSDARQLYAMKVL--KKATLKVRDRVR 72

Query: 126 FLSEVRMITSIQHKNLVRLLGCCSDGSQRL-LVYEYMKNRSLDLLIYGESDKFLNWSTRF 184
              E  ++  + H  +V+L         +L L+ ++++   L   +  E   F     +F
Sbjct: 73  TKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKF 130

Query: 185 ---QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL 241
              ++ L     L +LH      I++RD+K  N+LLDE+   K+ DFGL++   + +   
Sbjct: 131 YLAELALA----LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 183

Query: 242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLE 277
            + F GT+ Y APE   R   ++ AD +SFGVL+ E
Sbjct: 184 YS-FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFE 218

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 75.3 bits (186), Expect = 3e-15
 Identities = 67/238 (28%), Positives = 91/238 (38%), Gaps = 38/238 (15%)

Query: 53  TKEGVSKDFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLAD-GTLVAV 111
           T   VSK   NGN   +   DF  L           +LG+G FG V   +      L AV
Sbjct: 1   TTNTVSKFDNNGNRDRMKLTDFNFLM----------VLGKGSFGKVMLSERKGTDELYAV 50

Query: 112 KKL----CVDKSQ----QGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRL-LVYEYMK 162
           K L     +          E   L+        +   L +L   C     RL  V EY+ 
Sbjct: 51  KILKKDVVIQDDDVECTMVEKRVLALPG-----KPPFLTQLH-SCFQTMDRLYFVMEYVN 104

Query: 163 NRSLDLLIYGESDKFLNWSTRF---QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE 219
              L   I     +F      F   +I +G    L +L       I++RD+K  NV+LD 
Sbjct: 105 GGDLMYHIQQV-GRFKEPHAVFYAAEIAIG----LFFLQS---KGIIYRDLKLDNVMLDS 156

Query: 220 KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLE 277
           +   KI DFG+ +    D     T F GT  Y APE        +  D ++FGVL+ E
Sbjct: 157 EGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 213

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 75.3 bits (186), Expect = 3e-15
 Identities = 65/233 (27%), Positives = 96/233 (41%), Gaps = 40/233 (17%)

Query: 64  GNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKL----CVDK 118
           G +  +   DF  L+          ++GRG +  V   +L     + A+K +      D 
Sbjct: 1   GAMDPLGLQDFDLLR----------VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD 50

Query: 119 SQ----QGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRL-LVYEYMKNRSLDLLIYGE 173
                 Q E     +        H  LV L   C     RL  V EY+    L   +  +
Sbjct: 51  EDIDWVQTEKHVFEQAS-----NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQ 104

Query: 174 SDKFLNWSTRF---QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGL 230
             K      RF   +I L     L YLHE     I++RD+K  NVLLD +   K+ D+G+
Sbjct: 105 -RKLPEEHARFYSAEISLA----LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM 156

Query: 231 ARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKA-DIYSFGVLVLEIISCR 282
            +         ST F GT  Y APE  +RGE    + D ++ GVL+ E+++ R
Sbjct: 157 CKEGLRPGDTTST-FCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 207

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 74.6 bits (184), Expect = 5e-15
 Identities = 66/217 (30%), Positives = 93/217 (42%), Gaps = 36/217 (16%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKL----CVDKSQQGESEF 126
           DF   K          +LG+G FG V+    K       A+K L     +       +  
Sbjct: 18  DFILHK----------MLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVVLMDDDVECT-- 64

Query: 127 LSEVRM-ITSIQHKNLVRLLGCCSDGSQRL-LVYEYMKNRSLDLLIYGESDKFLNWSTRF 184
           + E R+   + +H  L  +  C     + L  V EY+    L   I     KF      F
Sbjct: 65  MVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATF 122

Query: 185 ---QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL 241
              +IILG    LQ+LH      IV+RD+K  N+LLD+    KI DFG+ +      A  
Sbjct: 123 YAAEIILG----LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 175

Query: 242 STNFAGTLGYTAPEYAIRGELSEKA-DIYSFGVLVLE 277
           +T F GT  Y APE  + G+    + D +SFGVL+ E
Sbjct: 176 NT-FCGTPDYIAPE-ILLGQKYNHSVDWWSFGVLLYE 210

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 73.8 bits (182), Expect = 8e-15
 Identities = 54/242 (22%), Positives = 99/242 (40%), Gaps = 47/242 (19%)

Query: 68  TISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEF 126
           +++   F    +    +     LG GG G V+          VA+KK+ +   Q  +   
Sbjct: 1   SMNIHGFDLGSR----YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA- 55

Query: 127 LSEVRMITSIQHKNLVRLLGCCSDGSQRL--------------LVYEYMKNRSLDL--LI 170
           L E+++I  + H N+V++         +L              +V EYM+    DL  ++
Sbjct: 56  LREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET---DLANVL 112

Query: 171 YGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFG 229
                  L    R   +  + RGL+Y+H      ++HRD+K +N+ ++ E    KIGDFG
Sbjct: 113 E--QGPLLEEHARL-FMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFG 166

Query: 230 LARFF--PEDQAYLSTNFAGTLGYTAPE-------YAIRGELSEKADIYSFGVLVLEIIS 280
           LAR            +    T  Y +P        Y      ++  D+++ G +  E+++
Sbjct: 167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNY------TKAIDMWAAGCIFAEMLT 220

Query: 281 CR 282
            +
Sbjct: 221 GK 222

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 42/207 (20%), Positives = 71/207 (34%), Gaps = 61/207 (29%)

Query: 87  GNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVR-MITSIQHKNLVRL 144
             +LG G  G V +          A+K   +        +   EV     + Q  ++VR+
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCP----KARREVELHWRASQCPHIVRI 76

Query: 145 LGCCSDGSQR----LLVYEYMKNRSLDLLIYGE-SDKFLNWSTRF-------QIILGIAR 192
           +    +        L+V E +          GE   +  +   +        +I+  I  
Sbjct: 77  VDVYENLYAGRKCLLIVMECLDG--------GELFSRIQDRGDQAFTEREASEIMKSIGE 128

Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPE--DQAYLSTNFAG 247
            +QYLH  +   I HRD+K  N+L   K  +   K+ DFG A    E   + Y       
Sbjct: 129 AIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTGEKY------- 175

Query: 248 TLGYTAPEYAIRGELSEKADIYSFGVL 274
                           +  D++S GV+
Sbjct: 176 ---------------DKSCDMWSLGVI 187

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 24/213 (11%)

Query: 81  TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLC-VDKSQQGESEFLSEVRMITSIQH 138
            + +   + +G G +G V        G  VAVKKL    +S         E+R++  ++H
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87

Query: 139 KNLVRLL------GCCSDGSQRLLVYEYMKNRSLDLLIYGE--SDKFLNWSTRFQIILGI 190
           +N++ LL          + +   LV   M    L+ ++  +  +D  + +   +QI+   
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI-YQIL--- 142

Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLG 250
            RGL+Y+H      I+HRD+K SN+ ++E  + KI DFGLAR   ++     T +  T  
Sbjct: 143 -RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM----TGYVATRW 194

Query: 251 YTAPEYAI-RGELSEKADIYSFGVLVLEIISCR 282
           Y APE  +     ++  DI+S G ++ E+++ R
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 63/224 (28%), Positives = 94/224 (41%), Gaps = 40/224 (17%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVY--RGKLADGTLVAVKKL----CVDKSQ----QG 122
           +F+ ++          +LG+G FG V   R K   G L AVK L     +          
Sbjct: 24  NFEFIR----------VLGKGSFGKVMLARVK-ETGDLYAVKVLKKDVILQDDDVECTMT 72

Query: 123 ESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWST 182
           E   LS  R      H  L +L  C     +   V E++    L   I     +F     
Sbjct: 73  EKRILSLAR-----NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARA 126

Query: 183 RF---QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA 239
           RF   +II      L +LH+     I++RD+K  NVLLD +   K+ DFG+ +    +  
Sbjct: 127 RFYAAEIISA----LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV 179

Query: 240 YLSTNFAGTLGYTAPEYAIRGELSEKA-DIYSFGVLVLEIISCR 282
             +T F GT  Y APE  ++  L   A D ++ GVL+ E++   
Sbjct: 180 TTAT-FCGTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 34/216 (15%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVK----KLCVDKSQQGESEFL 127
           DF  LK          ++G+G FG V   +  A+    AVK    K  + K ++     +
Sbjct: 39  DFHFLK----------VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHI--M 86

Query: 128 SEVR-MITSIQHKNLVRLLGCCSDGSQRL-LVYEYMKNRSLDLLIYGESDKFLNWSTRF- 184
           SE   ++ +++H  LV L       + +L  V +Y+    L   +  E   FL    RF 
Sbjct: 87  SERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARFY 144

Query: 185 --QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS 242
             +I       L YLH  +   IV+RD+K  N+LLD +    + DFGL +   E  +  S
Sbjct: 145 AAEIASA----LGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS 197

Query: 243 TNFAGTLGYTAPEYAIRGELSEKA-DIYSFGVLVLE 277
           T F GT  Y APE  +  +  ++  D +  G ++ E
Sbjct: 198 T-FCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYE 231

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 72.0 bits (177), Expect = 5e-14
 Identities = 63/224 (28%), Positives = 93/224 (41%), Gaps = 40/224 (17%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKL----CVDKSQ----QGE 123
           DF  L+          ++GRG +  V   +L     + A++ +      D       Q E
Sbjct: 53  DFDLLR----------VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTE 102

Query: 124 SEFLSEVRMITSIQHKNLVRLLGCCSDGSQRL-LVYEYMKNRSLDLLIYGESDKFLNWST 182
                +        H  LV L   C     RL  V EY+    L   +  +  K      
Sbjct: 103 KHVFEQAS-----NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHA 155

Query: 183 RF---QIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA 239
           RF   +I L     L YLHE     I++RD+K  NVLLD +   K+ D+G+ +       
Sbjct: 156 RFYSAEISLA----LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208

Query: 240 YLSTNFAGTLGYTAPEYAIRGELSEKA-DIYSFGVLVLEIISCR 282
             ST F GT  Y APE  +RGE    + D ++ GVL+ E+++ R
Sbjct: 209 TTST-FCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 250

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 49/205 (23%), Positives = 89/205 (43%), Gaps = 44/205 (21%)

Query: 81  TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEF---------LSEV 130
            + +     LG+G +G V++      G +VAVKK+           F           E+
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF--------DAFQNSTDAQRTFREI 59

Query: 131 RMITSIQ-HKNLVRLLGCC-SDGSQRL-LVYEYMKNRSLDL--LIYGE--SDK----FLN 179
            ++T +  H+N+V LL    +D  + + LV++YM+    DL  +I             + 
Sbjct: 60  MILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET---DLHAVIRANILEPVHKQYVV- 115

Query: 180 WSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA 239
               +Q+I    + ++YLH      ++HRD+K SN+LL+ +   K+ DFGL+R F   + 
Sbjct: 116 ----YQLI----KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164

Query: 240 YLSTNFAGTLGYTAPEYAIRGELSE 264
             +         T      +  L++
Sbjct: 165 VTNNIPLSINENTENFDDDQPILTD 189

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 70.3 bits (171), Expect = 2e-13
 Identities = 41/251 (16%), Positives = 69/251 (27%), Gaps = 65/251 (25%)

Query: 80  ATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVD-------KSQQGESEFLSEV-- 130
            T+       +G G FG V++   AD T VA+K + ++         Q+   E L E+  
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 131 -------RMITSIQHKNLVRLLGCC------------------------------SDGSQ 153
                        + +  + L                                      Q
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 154 RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKAS 213
             +V E+     +DL       K  + +T   I+  +   L            HRD+   
Sbjct: 137 LFIVLEFE-FGGIDLEQM--RTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWG 191

Query: 214 NVLLDEKFQSKIGDFGLARFF----------PEDQAYLSTNFAGTLGYT---APEYAIRG 260
           NVLL +    K+      +              D         G + +      E    G
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251

Query: 261 ELSEKADIYSF 271
           +   + DIY  
Sbjct: 252 DGDYQFDIYRL 262

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 44/207 (21%), Positives = 76/207 (36%), Gaps = 52/207 (25%)

Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG----ESEF---LSEVRMI 133
             +  G  +G GGFG +Y           A   + V+  + G    E +F   +++   I
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96

Query: 134 TSIQHKNLVRLLG----------CCSDGSQRLLVYEYMKNRSLDLLIYGES-DKFLNWST 182
                +  +  LG               S R +V        ++ L  G    K    + 
Sbjct: 97  KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMV--------MERL--GIDLQKISGQNG 146

Query: 183 RFQI--ILGIA----RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKI--GDFGLARFF 234
            F+   +L +       L+Y+HE+     VH DIKA+N+LL  K   ++   D+GL+  +
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203

Query: 235 ---------PEDQAYLSTNFAGTLGYT 252
                     E+         GT+ +T
Sbjct: 204 CPNGNHKQYQENPR---KGHNGTIEFT 227

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 65.1 bits (159), Expect = 8e-12
 Identities = 51/218 (23%), Positives = 89/218 (40%), Gaps = 35/218 (16%)

Query: 89  LLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESE-FLSEVRMITSIQ--------- 137
            LG G F  V+  K + + T VA+K   + +  +  +E    E++++  +          
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMK---IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82

Query: 138 --HKNLVRLLGC----CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIA 191
               ++++LL        +G   ++V+E +    L L+   E         + QI   + 
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK-QISKQLL 141

Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS------KIGDFGLARFFPEDQ-AYLSTN 244
            GL Y+H      I+H DIK  NVL++           KI D G A ++ E     + T 
Sbjct: 142 LGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199

Query: 245 FAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCR 282
                 Y +PE  +       ADI+S   L+ E+I+  
Sbjct: 200 E-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 30/176 (17%), Positives = 58/176 (32%), Gaps = 29/176 (16%)

Query: 82  KNFHPGNLLGRGGFGPVYRGK---------LADGTLVAVKKLCVDKSQQGESEFLSEVRM 132
           + +   +   R   G +Y                   ++K     K  +  +E     R 
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK--LDAKDGRLFNEQNFFQRA 99

Query: 133 ITSIQHKNLVRLLGC------------CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNW 180
              +Q     +L                     R LV   +  RSL   +       L+ 
Sbjct: 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSE 158

Query: 181 STRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKI--GDFGLARFF 234
            +  Q+   +   L++LHE+     VH ++ A N+ +D + QS++    +G A  +
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 47/202 (23%), Positives = 78/202 (38%), Gaps = 39/202 (19%)

Query: 82  KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKK---LCVDKSQQG----ESEF---LSEVR 131
             +  G  +G+GGFG +Y   +     V       + V+ S  G    E +F    ++  
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94

Query: 132 MITSIQHKNLVRLLG----------CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWS 181
            I        ++ LG            +  S R ++ +      L  +    + +F +  
Sbjct: 95  QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRF-SRK 152

Query: 182 TRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKI--GDFGLARFF----- 234
           T  Q+ L I   L+Y+HE      VH DIKASN+LL+ K   ++   D+GLA  +     
Sbjct: 153 TVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209

Query: 235 ----PEDQAYLSTNFAGTLGYT 252
                 D         GT+ +T
Sbjct: 210 HKAYAADPKR---CHDGTIEFT 228

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 66/356 (18%), Positives = 118/356 (33%), Gaps = 103/356 (28%)

Query: 90  LGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLS-EVRMITSIQ--------HK 139
           LG G F  V+    +     VA+K   V KS +  +E    E+R++ S++         +
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMK---VVKSAEHYTETALDEIRLLKSVRNSDPNDPNRE 101

Query: 140 NLVRLLGC----CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQ 195
            +V+LL        +G+   +V+E + +  L  +I            + +II  + +GL 
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVK-KIIQQVLQGLD 160

Query: 196 YLHEDSHTRIVHRDIKASNVLL-------------------------------------- 217
           YLH  +  RI+H DIK  N+LL                                      
Sbjct: 161 YLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218

Query: 218 -----------DEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKA 266
                       EK + KI D G A +  +           T  Y + E  I    +  A
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNTPA 274

Query: 267 DIYSFGVLVLEII------SCRKNTDLT---------------LPSEM----QYLPEY-- 299
           DI+S   +  E+             + T               +P ++    +Y  E+  
Sbjct: 275 DIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFT 334

Query: 300 ---AWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIV 352
                K   + +   L +  + K    + +A    +     L+    +R   +E +
Sbjct: 335 KKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 48/211 (22%), Positives = 94/211 (44%), Gaps = 43/211 (20%)

Query: 89  LLGRGGFGPVYRGK-LADGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHK------ 139
           ++G+G FG V +         VA+K +  +K   +Q       E+R++  ++ +      
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTM 159

Query: 140 NLVRLLGC-------CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF--QIILGI 190
           N++ +L         C       + +E +   S++L    + +KF  +S     +    I
Sbjct: 160 NVIHMLENFTFRNHIC-------MTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSI 209

Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS--KIGDFGLARFFPEDQ-AYLSTNFAG 247
            + L  LH+    RI+H D+K  N+LL ++ +S  K+ DFG + +  +    Y+ + F  
Sbjct: 210 LQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-- 264

Query: 248 TLGYTAPEYAIRGELSEKADIYSFGVLVLEI 278
              Y APE  +        D++S G ++ E+
Sbjct: 265 ---YRAPEVILGARYGMPIDMWSLGCILAEL 292

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 40/167 (23%), Positives = 66/167 (39%), Gaps = 31/167 (18%)

Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQH-KN 140
           NF  G  +G G FG +  GK L     VA+K   ++  +    +   E R    +     
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK---LEPMKSRAPQLHLEYRFYKQLGSGDG 66

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGES--DKFLNWSTRFQI--ILGIA----R 192
           + ++      G    +V        L+LL  G S  D F      F +  +L IA     
Sbjct: 67  IPQVYYFGPCGKYNAMV--------LELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLIS 116

Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSK-----IGDFGLARFF 234
            ++Y+H  +   +++RD+K  N L+            I DF LA+ +
Sbjct: 117 RMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 28/209 (13%)

Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
            +  G  +G G FG +Y G  +A G  VA+K    +  +    +   E ++   +Q    
Sbjct: 10  RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMMQGGVG 66

Query: 142 V-RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
           +  +  C ++G   ++V E +   SL+ L    S KF +  T   +   +   ++Y+H  
Sbjct: 67  IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKF-SLKTVLLLADQMISRIEYIHS- 123

Query: 201 SHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFF---------PEDQAYLSTNFAGT 248
                +HRD+K  N L+    +     I DFGLA+ +         P  +     N  GT
Sbjct: 124 --KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK---NLTGT 178

Query: 249 LGYTAPEYAIRG-ELSEKADIYSFG-VLV 275
             Y A      G E S + D+ S G VL+
Sbjct: 179 ARY-ASINTHLGIEQSRRDDLESLGYVLM 206

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 28/209 (13%)

Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
            F  G  +G G FG +Y G  +     VA+K    +  +    + L E ++   +Q    
Sbjct: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKIYRILQGGTG 64

Query: 142 V-RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
           +  +     +G   +LV + +   SL+ L    S K  +  T   +   +   ++++H  
Sbjct: 65  IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKL-SLKTVLMLADQMINRVEFVHSK 122

Query: 201 SHTRIVHRDIKASNVLLDEKFQSK---IGDFGLARFF---------PEDQAYLSTNFAGT 248
           S    +HRDIK  N L+    ++    I DFGLA+ +         P  +     N  GT
Sbjct: 123 S---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK---NLTGT 176

Query: 249 LGYTAPEYAIRG-ELSEKADIYSFG-VLV 275
             Y A      G E S + D+ S G VL+
Sbjct: 177 ARY-ASVNTHLGIEQSRRDDLESLGYVLM 204

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 55.4 bits (134), Expect = 8e-09
 Identities = 36/160 (22%), Positives = 65/160 (40%), Gaps = 17/160 (10%)

Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
           ++  G  +G G FG ++ G  L +   VA+K    +  +    +   E R    +     
Sbjct: 11  HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAPQLRDEYRTYKLLAGCTG 67

Query: 142 V-RLLGCCSDGSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
           +  +     +G   +LV + +   SL DLL      +  +  T       +   +Q +HE
Sbjct: 68  IPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE 124

Query: 200 DSHTRIVHRDIKASNVLLDEKFQSK-----IGDFGLARFF 234
            S   +V+RDIK  N L+            + DFG+ +F+
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 47/210 (22%), Positives = 81/210 (38%), Gaps = 39/210 (18%)

Query: 88  NLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKS-----QQGESE--FLSEVRMITSIQHK 139
           +L+G+G FG V +     +   VA+K   + K+      Q + E   L  +    +    
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIK---IIKNKKAFLNQAQIEVRLLELMNKHDTEMKY 116

Query: 140 NLVRLLGC-------CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRF--QIILGI 190
            +V L          C       LV+E +   S +L     +  F   S     +    +
Sbjct: 117 YIVHLKRHFMFRNHLC-------LVFEML---SYNLYDLLRNTNFRGVSLNLTRKFAQQM 166

Query: 191 ARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS--KIGDFGLARFFPEDQ-AYLSTNFAG 247
              L +L       I+H D+K  N+LL    +S  KI DFG +    +    Y+ + F  
Sbjct: 167 CTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-- 223

Query: 248 TLGYTAPEYAIRGELSEKADIYSFGVLVLE 277
              Y +PE  +        D++S G +++E
Sbjct: 224 ---YRSPEVLLGMPYDLAIDMWSLGCILVE 250

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.6 bits (107), Expect = 3e-05
 Identities = 50/348 (14%), Positives = 100/348 (28%), Gaps = 109/348 (31%)

Query: 117 DKSQQGESEFLSEVR------MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLI 170
            K ++   +F+ EV       +++ I+ +            S    +Y   ++R     +
Sbjct: 73  SKQEEMVQKFVEEVLRINYKFLMSPIKTE--------QRQPSMMTRMYIEQRDR-----L 119

Query: 171 YGESDKFLNWS-TRFQIILGIARGLQYLHEDSHTRI-VHRDI---K---ASNVLLDEKFQ 222
           Y ++  F  ++ +R Q  L + + L  L       + +   +   K   A +V L  K Q
Sbjct: 120 YNDNQVFAKYNVSRLQPYLKLRQALLEL--RPAKNVLIDGVLGSGKTWVALDVCLSYKVQ 177

Query: 223 SKIGD------FG---------------LARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
            K+                         L +  P   +    +    L   + +  +R  
Sbjct: 178 CKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL 237

Query: 262 LSEKADIYSFGVLVL------EII-----SCR--------KNTDLTLPSEMQYLP-EYAW 301
           L  K   Y   +LVL      +       SC+        + TD    +   ++  ++  
Sbjct: 238 LKSKP--YENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHS 295

Query: 302 KLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPM--SEIVAMLTCKV 359
                  +  L+              L+ ++     L        P   S I   +    
Sbjct: 296 MTLTPDEVKSLL--------------LKYLDCRPQDLPREVLTTNPRRLSIIAESI---- 337

Query: 360 ESGIPVRPAYLERRRKRDETLSWDTISEP-FPSLTQSESPALPHQQPS 406
                           RD   +WD         LT     +L   +P+
Sbjct: 338 ----------------RDGLATWDNWKHVNCDKLTTIIESSLNVLEPA 369

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.2 bits (106), Expect = 3e-05
 Identities = 59/393 (15%), Positives = 109/393 (27%), Gaps = 125/393 (31%)

Query: 18  FFLGVLSVSVILIILIIILWKFNKAKELVRL--ALRTTKEGVSKDFFNGNLRT------- 68
               +LS   I  I++      +     +RL   L + +E + + F    LR        
Sbjct: 41  MPKSILSKEEIDHIIM----SKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMS 96

Query: 69  ----------------ISYFD-------------------FQTLKKATKNFHPGNLL--- 90
                           I   D                   +  L++A     P   +   
Sbjct: 97  PIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLID 156

Query: 91  GRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSD 150
           G  G      GK     +     +C+    Q + +F  ++  +           L  C+ 
Sbjct: 157 GVLGS-----GK---TWVAL--DVCLSYKVQCKMDF--KIFWLN----------LKNCNS 194

Query: 151 GSQRLLVYEYMKN--RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHR 208
               L   E ++     +D      SD   N   R   I    R L       +  +V  
Sbjct: 195 PETVL---EMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL 251

Query: 209 DIKASNVLLDEKF--QSKI----GDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
           +++ +       F    KI        +  F         +    ++  T  E       
Sbjct: 252 NVQNAKAW--NAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE------- 302

Query: 263 SEKADIYSFGVLVLEIISCRKNTDLTLPSEM-QYLPEYAWKLYERGRILELVDPRMRKEG 321
            +         L+L+ + CR      LP E+    P          R L ++     ++G
Sbjct: 303 VKS--------LLLKYLDCRPQ---DLPREVLTTNP----------RRLSII-AESIRDG 340

Query: 322 I--------VERDAL-QVINVAFICLQPHGNQR 345
           +        V  D L  +I  +   L+P   ++
Sbjct: 341 LATWDNWKHVNCDKLTTIIESSLNVLEPAEYRK 373

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 43/251 (17%), Positives = 81/251 (32%), Gaps = 103/251 (41%)

Query: 89  LLGRGGFGPVYRGK-LADGTLVAVKKLCVDKS-----QQGESE-----FLSE-------- 129
            +G G FG V   + + +    AVK   V ++     +  + E      +          
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVK---VVRNIKKYTRSAKIEADILKKIQNDDINNNNI 98

Query: 130 VRMITSIQHKN---LV-RLLGCCSDGSQRLLVYEYMKNR-----SLDLLIYGESDKFLNW 180
           V+      + +   L+   LG          +YE +         ++ +           
Sbjct: 99  VKYHGKFMYYDHMCLIFEPLGPS--------LYEIITRNNYNGFHIEDI----------K 140

Query: 181 STRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS----------------- 223
               +I+    + L YL +     + H D+K  N+LLD+ +                   
Sbjct: 141 LYCIEIL----KALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193

Query: 224 --------KIGDFGLARFFPEDQ---AYLSTNFAGTLGYTAPE------YAIRGELSEKA 266
                   K+ DFG A F  +     + ++T       Y APE      +         +
Sbjct: 194 YRTKSTGIKLIDFGCATF--KSDYHGSIINTRQ-----YRAPEVILNLGW------DVSS 240

Query: 267 DIYSFGVLVLE 277
           D++SFG ++ E
Sbjct: 241 DMWSFGCVLAE 251

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 43/236 (18%), Positives = 72/236 (30%), Gaps = 77/236 (32%)

Query: 89  LLGRGGFGPVYRG--KLADGTLVAVKKLCVDKS--QQGESE-----FLSE---------V 130
            LG G FG V          + VA+K +       +    E      + E         V
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCV 85

Query: 131 RMITSIQHKN---LV-RLLGCCSDGSQRLLVYEYMKNR-----SLDLLIYGESDKFLNWS 181
            M           +   LLG           +E++K        L  +            
Sbjct: 86  LMSDWFNFHGHMCIAFELLGKN--------TFEFLKENNFQPYPLPHV----------RH 127

Query: 182 TRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS------------------ 223
             +Q+       L++LHE    ++ H D+K  N+L                         
Sbjct: 128 MAYQLC----HALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180

Query: 224 -KIGDFGLARFFPEDQ-AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLE 277
            ++ DFG A F  E     ++T       Y  PE  +    ++  D++S G ++ E
Sbjct: 181 IRVADFGSATFDHEHHTTIVATRH-----YRPPEVILELGWAQPCDVWSIGCILFE 231

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	407
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.27
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.24
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.03
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.8
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.63
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.6
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.6
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.43
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.4
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.16
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.15
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.13
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.85
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.8
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.59
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.56
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.53
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.44
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.42
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.42
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.26
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.16
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.11
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.8
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.57
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.26
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	96.1
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	95.57
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	94.4
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	93.05
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	89.53
2knc_B	79	Integrin beta-3; transmembrane signaling, protein	88.84
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	87.6
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	86.55
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	82.84
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	81.96

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.6e-59  Score=432.79  Aligned_cols=255  Identities=25%  Similarity=0.356  Sum_probs=211.1

Q ss_pred             CCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           84 FHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      +++.+.||+|+||.||+|.+.      +++.||||++.........++|.+|+.+|++++|||||+++|+|.+.+..++|
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV  107 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI  107 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence            445678999999999999862      46789999997655555667899999999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccC--------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCce
Q 040557          158 YEYMKNRSLDLLIYGES--------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS  223 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~  223 (407)
                      ||||++|+|.+++....              ...++|..+.+++.|||.||+|||+.+   |+||||||+||||++++.+
T Consensus       108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~  184 (308)
T 4gt4_A          108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNV  184 (308)
T ss_dssp             EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred             EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCE
Confidence            99999999999996432              245899999999999999999999998   9999999999999999999


Q ss_pred             EEecccCccccCCCCc-ccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHH
Q 040557          224 KIGDFGLARFFPEDQA-YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAW  301 (407)
Q Consensus       224 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~  301 (407)
                      ||+|||+++....... .......||+.|||||++.++.|+.++|||||||+||||+| |+.||......       .+.
T Consensus       185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~-------~~~  257 (308)
T 4gt4_A          185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-------DVV  257 (308)
T ss_dssp             EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH-------HHH
T ss_pred             EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH-------HHH
Confidence            9999999987654332 23345679999999999999999999999999999999999 88898653321       122


Q ss_pred             HHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          302 KLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       302 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ..+..+....          .+..++..+.+|+.+||+.||++||||.||+++|+..
T Consensus       258 ~~i~~~~~~~----------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          258 EMIRNRQVLP----------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHHcCCCCC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            2333332211          2233456789999999999999999999999999753

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.7e-59  Score=435.67  Aligned_cols=258  Identities=20%  Similarity=0.341  Sum_probs=211.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++.... .....+.+.+|+++|++++|||||++++++.+.+..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            6789999999999999999986 469999999997544 34456789999999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      ||+||+|.+++.......+++..+..++.||+.||.|||+++   |+||||||+||||++++.+||+|||+|+.+.....
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence            999999999998766667899999999999999999999998   99999999999999999999999999997654322


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                       .....+||+.|||||++.+..|+.++|||||||++|||+||+.||.....      ......... +...     .   
T Consensus       181 -~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~-~~~~-----~---  244 (350)
T 4b9d_A          181 -LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVLKIIS-GSFP-----P---  244 (350)
T ss_dssp             -HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHH-TCCC-----C---
T ss_pred             -cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHc-CCCC-----C---
Confidence             23456899999999999999999999999999999999999999975422      222222222 2211     1   


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                        .....+.++.+|+.+||+.||++|||+.|+++|-|....
T Consensus       245 --~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          245 --VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             --CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence              112234568899999999999999999999998776443

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.5e-59  Score=428.78  Aligned_cols=257  Identities=27%  Similarity=0.448  Sum_probs=211.8

Q ss_pred             cCCCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRL  155 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  155 (407)
                      ++|.+.+.||+|+||.||+|++.      ++..||||++.. ......++|.+|+++|++++|||||+++|+|.+++..+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC-CChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            45677789999999999999863      478899999964 34555678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhHHHhccC-----------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceE
Q 040557          156 LVYEYMKNRSLDLLIYGES-----------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSK  224 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k  224 (407)
                      +|||||++|+|.++++...           ...++|..+..++.||+.||.|||+++   |+||||||+||||++++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence            9999999999999997532           356999999999999999999999988   99999999999999999999


Q ss_pred             EecccCccccCCCCccc-ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHH
Q 040557          225 IGDFGLARFFPEDQAYL-STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWK  302 (407)
Q Consensus       225 l~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~  302 (407)
                      |+|||+|+......... .....||+.|||||.+.+..|+.++|||||||++|||+| |+.||......       .+..
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~-------~~~~  241 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------EVIE  241 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHH
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHH
Confidence            99999998765443332 234569999999999999999999999999999999999 89998753321       1222


Q ss_pred             HHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          303 LYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       303 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .+..+....          .+..++.++.+|+.+||+.||++|||+.+|++.|+...
T Consensus       242 ~i~~~~~~~----------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          242 CITQGRVLQ----------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             HHHHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHcCCCCC----------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            333332211          12234567899999999999999999999999987543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.7e-58  Score=429.93  Aligned_cols=259  Identities=27%  Similarity=0.446  Sum_probs=206.6

Q ss_pred             cCCCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRL  155 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  155 (407)
                      ++|.+.+.||+|+||.||+|++.      +++.||||++.. ......++|.+|+++|++++|||||+++|+|.+.+..+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC-CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            45666788999999999999864      478899999964 34556678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhHHHhccC-------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCc
Q 040557          156 LVYEYMKNRSLDLLIYGES-------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ  222 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~  222 (407)
                      +|||||++|+|.++++...             ...++|..+..++.||+.||.|||+.+   |+||||||+||||++++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence            9999999999999997532             246999999999999999999999988   999999999999999999


Q ss_pred             eEEecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHH
Q 040557          223 SKIGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYA  300 (407)
Q Consensus       223 ~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~  300 (407)
                      +||+|||+++........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||......      + +
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~------~-~  269 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT------E-A  269 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH------H-H
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH------H-H
Confidence            999999999876544322 3345679999999999999999999999999999999999 89998653221      1 2


Q ss_pred             HHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          301 WKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       301 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                      ...+..+...          ..+..++.++.+|+.+||+.||++||||.||+++|+.+.+.
T Consensus       270 ~~~i~~g~~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          270 IDCITQGREL----------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHHHHTCCC----------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHcCCCC----------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            2223333211          12223456789999999999999999999999999876543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.3e-58  Score=421.68  Aligned_cols=259  Identities=24%  Similarity=0.378  Sum_probs=205.3

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      +++++.+.||+|+||+||+|++.  ..||||+++... .....+.|.+|+++|++++|||||+++|++.+ +..++||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            56777889999999999999874  359999986443 44556789999999999999999999999865 568999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC-c
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ-A  239 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~-~  239 (407)
                      |+||+|.++++... ..++|..+..|+.|||.||+|||+.+   |+||||||+||||++++.+||+|||+|+...... .
T Consensus       113 ~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          113 CEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             CSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            99999999997543 45999999999999999999999988   9999999999999999999999999998765432 2


Q ss_pred             ccccccccCccccCcccccc---CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          240 YLSTNFAGTLGYTAPEYAIR---GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                      ......+||+.|||||++.+   +.|+.++|||||||+||||+||+.||......      .........+..    .+.
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~~~----~p~  258 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRGYA----SPD  258 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTTCC----CCC
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCC----CCC
Confidence            23345689999999999864   46899999999999999999999999753321      122222332211    111


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      +.  .....++..+.+|+.+||+.||++||||.||+++|+.+.
T Consensus       259 ~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          259 LS--KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             ST--TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             cc--cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            11  122334567899999999999999999999999997553

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-56  Score=409.08  Aligned_cols=252  Identities=24%  Similarity=0.351  Sum_probs=202.7

Q ss_pred             CCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeec----CCeeEEEE
Q 040557           85 HPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSD----GSQRLLVY  158 (407)
Q Consensus        85 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  158 (407)
                      +..+.||+|+||.||+|.+. ++..||+|.+.... .....+.|.+|+++|++++|||||++++++.+    ...+|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            34467999999999999864 68999999986543 34456789999999999999999999999864    34679999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc-CCCceEEecccCccccCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+||+|.+++..  ...+++..+..++.||+.||+|||+++ ++|+||||||+||||+ .++.+||+|||+|+.....
T Consensus       109 Ey~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~  185 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  185 (290)
T ss_dssp             ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             eCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence            99999999999964  346999999999999999999999875 4599999999999998 4789999999999865443


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      .   ....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.....      .......+..+.....++   
T Consensus       186 ~---~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~------~~~~~~~i~~~~~~~~~~---  252 (290)
T 3fpq_A          186 F---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVKPASFD---  252 (290)
T ss_dssp             S---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHHHHTTTCCCGGGG---
T ss_pred             c---cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc------HHHHHHHHHcCCCCCCCC---
Confidence            2   345789999999998764 699999999999999999999999964322      112222232222111111   


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                            ...+.++.+|+.+||+.||++|||+.|+++|-|..
T Consensus       253 ------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~  287 (290)
T 3fpq_A          253 ------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  287 (290)
T ss_dssp             ------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             ------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence                  11234588999999999999999999999998764

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.5e-57  Score=423.24  Aligned_cols=255  Identities=24%  Similarity=0.340  Sum_probs=212.8

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      +.|+..+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+++|+.++|||||++++++.+.+.+|+||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            46888899999999999999864 699999999965432 2345688999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      |+||+|.+++..   ..+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.+..... 
T Consensus       153 ~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-  225 (346)
T 4fih_A          153 LEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  225 (346)
T ss_dssp             CTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred             CCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence            999999999864   34999999999999999999999998   99999999999999999999999999998765433 


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                      .....+||+.|||||++.+..|+.++|||||||++|||++|+.||......      . ....+..+.     .+.+.  
T Consensus       226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~-~~~~i~~~~-----~~~~~--  291 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------K-AMKMIRDNL-----PPRLK--  291 (346)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------H-HHHHHHHSS-----CCCCS--
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------H-HHHHHHcCC-----CCCCC--
Confidence            234578999999999999999999999999999999999999999753221      1 112222221     11111  


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                       .....+.++.+|+.+||+.||++|||+.|+++|-|...
T Consensus       292 -~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~  329 (346)
T 4fih_A          292 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK  329 (346)
T ss_dssp             -CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence             11223456889999999999999999999999988754

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.2e-57  Score=424.71  Aligned_cols=269  Identities=28%  Similarity=0.426  Sum_probs=221.1

Q ss_pred             cCHHHHHHHhcCCCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCC-Cceeee
Q 040557           72 FDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQH-KNLVRL  144 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l  144 (407)
                      ++...++...++|++++.||+|+||.||+|.+.      .++.||||++.........+.|.+|+++|.+++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            455556666788999999999999999999753      2368999999766666667789999999999965 999999


Q ss_pred             eeeeec-CCeeEEEEEeccCCChhHHHhccC--------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeec
Q 040557          145 LGCCSD-GSQRLLVYEYMKNRSLDLLIYGES--------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD  209 (407)
Q Consensus       145 ~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~d  209 (407)
                      +|+|.+ ++..++|||||++|+|.++++...              ...+++..+..++.|||.||+|||+++   |+|||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence            999865 457899999999999999997532              245899999999999999999999998   99999


Q ss_pred             cccccEEEcCCCceEEecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCC
Q 040557          210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDL  287 (407)
Q Consensus       210 lk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~  287 (407)
                      |||+|||+++++.+||+|||+|+.+..+... ......||+.|||||.+.+..|+.++|||||||+||||+| |+.||..
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999977554433 3345679999999999999999999999999999999998 8999865


Q ss_pred             CCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          288 TLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ....      ..+...+..+....          .+..++.++.+++.+||+.||++|||+.||+++|....
T Consensus       291 ~~~~------~~~~~~i~~g~~~~----------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll  346 (353)
T 4ase_A          291 VKID------EEFCRRLKEGTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  346 (353)
T ss_dssp             CCCS------HHHHHHHHHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCHH------HHHHHHHHcCCCCC----------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            4322      22333333332211          12234557889999999999999999999999997654

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.2e-57  Score=414.93  Aligned_cols=250  Identities=21%  Similarity=0.285  Sum_probs=208.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++....  .......+.+|+++|++++|||||++++++.+.+..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5688999999999999999986 469999999996432  2234567899999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||++||+|.+++...  +.+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+.+....
T Consensus       112 Ey~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          112 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            999999999999643  45999999999999999999999998   9999999999999999999999999999876433


Q ss_pred             c-ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          239 A-YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       239 ~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      . ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.....      ...... +..+..      . 
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~-i~~~~~------~-  252 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFAK-IIKLEY------D-  252 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH-HHHTCC------C-
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-HHcCCC------C-
Confidence            2 234567899999999999999999999999999999999999999975322      122222 222221      1 


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAM  354 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  354 (407)
                          .+...+.++.+|+.+||+.||++|||++|++.+
T Consensus       253 ----~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          253 ----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             ----CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             ----CCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence                112234568899999999999999999986443

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7.4e-57  Score=415.81  Aligned_cols=268  Identities=24%  Similarity=0.292  Sum_probs=201.3

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC----eeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS----QRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv  157 (407)
                      ++|.+.+.||+|+||+||+|++ +|+.||||++....  .....+..|+..+.+++|||||+++|+|.+.+    .++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            4566778999999999999998 58999999985322  22223344566667889999999999997653    57999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccC-----CCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS-----HTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                      ||||++|+|.++++..   .++|..+.+++.|++.||+|||++.     .++|+||||||+||||++++.+||+|||+|+
T Consensus        80 ~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            9999999999999643   4899999999999999999999872     3359999999999999999999999999998


Q ss_pred             ccCCCCcc---cccccccCccccCccccccC------CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCc--------
Q 040557          233 FFPEDQAY---LSTNFAGTLGYTAPEYAIRG------ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQY--------  295 (407)
Q Consensus       233 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~--------  295 (407)
                      ........   .....+||+.|||||++.+.      .++.++|||||||+||||+||++|+.........+        
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            76544322   22346799999999998764      46789999999999999999998875432211110        


Q ss_pred             hhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          296 LPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ...........    ..+++.+.......+.+..+.+|+.+||+.||++||||.||++.|+.+.
T Consensus       237 ~~~~~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~  296 (303)
T 3hmm_A          237 SVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             CHHHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hHHHHHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            11112222211    1222333222223345677899999999999999999999999997654

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=8.1e-57  Score=417.13  Aligned_cols=251  Identities=24%  Similarity=0.258  Sum_probs=204.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      +.|+..+.||+|+||.||+|++. +|+.||||++.....      ..+|+.+|+.++|||||++++++.+++..|+||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            45677788999999999999864 699999999965432      24799999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC-ceEEecccCccccCCCCc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF-QSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~~  239 (407)
                      |+||+|.+++...  ..+++..+..++.||+.||+|||+++   |+||||||+||||+.++ .+||+|||+|+.+..+..
T Consensus       132 ~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          132 LEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             CTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            9999999999643  45999999999999999999999998   99999999999999887 699999999998754332


Q ss_pred             c----cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          240 Y----LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       240 ~----~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                      .    .....+||+.|||||++.+..|+.++|||||||++|||+||+.||........      .........       
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~i~~~~~-------  273 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL------CLKIASEPP-------  273 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC------HHHHHHSCC-------
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHHcCCC-------
Confidence            1    12346799999999999999999999999999999999999999976543321      111122111       


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ...  ..+...+..+.+++.+||+.||++|||+.|++++|...
T Consensus       274 ~~~--~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          274 PIR--EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             GGG--GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             Cch--hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            010  11223455688999999999999999999999998654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.6e-56  Score=402.53  Aligned_cols=252  Identities=23%  Similarity=0.312  Sum_probs=196.2

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++....  .......+.+|+++|++++||||+++++++.+.+..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            6799999999999999999986 469999999996543  2234567899999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+ +|+|.+++..  ...+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+......
T Consensus        93 Ey~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             ECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             eCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            999 6799888854  346999999999999999999999998   9999999999999999999999999998765433


Q ss_pred             cccccccccCccccCccccccCCC-CccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      .  ....+||+.|||||++.+..+ +.++||||+||++|||+||+.||.....      .. .......+..      . 
T Consensus       167 ~--~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~-~~~~i~~~~~------~-  230 (275)
T 3hyh_A          167 F--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PV-LFKNISNGVY------T-  230 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHHTCC------C-
T ss_pred             c--cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HH-HHHHHHcCCC------C-
Confidence            2  245789999999999998876 5799999999999999999999975321      11 2222222221      1 


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                          .+...+.++.+++.+||+.||++|||++|+++|-|...
T Consensus       231 ----~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          231 ----LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             ----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             ----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                11123456889999999999999999999999988754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3e-56  Score=424.41  Aligned_cols=255  Identities=24%  Similarity=0.343  Sum_probs=212.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      +.|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.+.+.+||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT-CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            56889999999999999999864 69999999996543 23345688999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      |+||+|.+++..   ..+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.+..... 
T Consensus       230 ~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-  302 (423)
T 4fie_A          230 LEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  302 (423)
T ss_dssp             CTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-
T ss_pred             CCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc-
Confidence            999999999854   34999999999999999999999998   99999999999999999999999999998765433 


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                      .....+||+.|||||++.+..|+.++|||||||++|||++|+.||......      . ....+..+.     .+.+.  
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~-~~~~i~~~~-----~~~~~--  368 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------K-AMKMIRDNL-----PPRLK--  368 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------H-HHHHHHHSC-----CCCCS--
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------H-HHHHHHcCC-----CCCCc--
Confidence            234578999999999999999999999999999999999999999753221      1 112222221     11111  


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                       .....+..+.+|+.+||+.||++|||+.|+++|-|...
T Consensus       369 -~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~  406 (423)
T 4fie_A          369 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK  406 (423)
T ss_dssp             -CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence             11123456889999999999999999999999988754

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.8e-56  Score=410.00  Aligned_cols=252  Identities=23%  Similarity=0.288  Sum_probs=201.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEec----CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA----DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      ++|++.+.||+|+||.||+|+..    +++.||||++.... .......+.+|+++|++++|||||++++++.+.+..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            56888999999999999999752    47899999996543 12233467899999999999999999999999999999


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      |||||+||+|.+++...  ..+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+....
T Consensus       104 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            99999999999999643  46999999999999999999999998   99999999999999999999999999986544


Q ss_pred             CCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          237 DQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                      ... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||......      +..... ..+..      .
T Consensus       179 ~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i-~~~~~------~  244 (304)
T 3ubd_A          179 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK------ETMTMI-LKAKL------G  244 (304)
T ss_dssp             --C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH-HHCCC------C
T ss_pred             CCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH------HHHHHH-HcCCC------C
Confidence            332 234578999999999999999999999999999999999999999754321      222222 22211      1


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhhc
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRPP-----MSEIVAMLTC  357 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~l~~  357 (407)
                           .+...+.++.+|+.+||+.||++|||     ++|+++|-|+
T Consensus       245 -----~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f  285 (304)
T 3ubd_A          245 -----MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF  285 (304)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGG
T ss_pred             -----CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccc
Confidence                 12223456889999999999999998     5899998875

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.5e-54  Score=396.14  Aligned_cols=261  Identities=23%  Similarity=0.379  Sum_probs=194.6

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC--------
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS--------  152 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------  152 (407)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++.........+.+.+|+++|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            45888899999999999999864 699999999976666666678999999999999999999999986543        


Q ss_pred             ----eeEEEEEeccCCChhHHHhccCC-CCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEec
Q 040557          153 ----QRLLVYEYMKNRSLDLLIYGESD-KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGD  227 (407)
Q Consensus       153 ----~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~D  227 (407)
                          ..|+|||||++|+|.+++..... ...++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999975432 34567788999999999999999998   99999999999999999999999


Q ss_pred             ccCccccCCCCcc-----------cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCch
Q 040557          228 FGLARFFPEDQAY-----------LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYL  296 (407)
Q Consensus       228 fgla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~  296 (407)
                      ||+|+.+......           ..+..+||+.|||||++.+..|+.++|||||||++|||++   ||....    .  
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----~--  232 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----E--  232 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----H--
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----H--
Confidence            9999877543221           1234579999999999999999999999999999999996   553210    0  


Q ss_pred             hHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccCCCCC
Q 040557          297 PEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPV  365 (407)
Q Consensus       297 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~~~~~  365 (407)
                      ..............     .     ........+.+++.+||+.||++|||+.|+++|-+.. +.+.|.
T Consensus       233 ~~~~~~~~~~~~~p-----~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~-~~~~p~  290 (299)
T 4g31_A          233 RVRTLTDVRNLKFP-----P-----LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE-DLDFPG  290 (299)
T ss_dssp             HHHHHHHHHTTCCC-----H-----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGC-CC----
T ss_pred             HHHHHHHHhcCCCC-----C-----CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhC-CCCCCC
Confidence            00011111111110     0     1122334567899999999999999999999987753 334443

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-51  Score=389.99  Aligned_cols=266  Identities=22%  Similarity=0.304  Sum_probs=205.2

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeec------CCe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSD------GSQ  153 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~  153 (407)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++.... .......+.+|+++|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5688899999999999999986 479999999996543 33445678899999999999999999998753      357


Q ss_pred             eEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          154 RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      .|+|||||+ |+|.+++.  ..+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+.
T Consensus       134 ~~ivmE~~~-g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             EEEEEECCS-EEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEeCCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeee
Confidence            899999996 67988885  3456999999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCC---cccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHH-hCc
Q 040557          234 FPEDQ---AYLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYE-RGR  308 (407)
Q Consensus       234 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~  308 (407)
                      +....   .......+||+.|||||++.+. .++.++||||+||++|||++|+.||......+      ....... .+.
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~------~l~~I~~~~g~  281 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH------QLQLIMMVLGT  281 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH------HHHHHHHHHCC
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH------HHHHHHHhcCC
Confidence            64332   2223457899999999998875 56999999999999999999999997543211      1111111 000


Q ss_pred             cccccCc------------cc-ccCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          309 ILELVDP------------RM-RKEGIV-----ERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       309 ~~~~~d~------------~~-~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .......            .+ .....+     ...+.++.+|+.+||+.||++|||+.|+++|-|...
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~  350 (398)
T 4b99_A          282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK  350 (398)
T ss_dssp             CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred             CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence            0000000            00 000000     112356889999999999999999999999998753

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.3e-51  Score=386.29  Aligned_cols=269  Identities=22%  Similarity=0.277  Sum_probs=202.7

Q ss_pred             HHHhcCCCCCCeeeccCCccEEEEEec----CCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCC
Q 040557           78 KKATKNFHPGNLLGRGGFGPVYRGKLA----DGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGS  152 (407)
Q Consensus        78 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  152 (407)
                      ....++|++.+.||+|+||+||+|+.+    +++.||+|.+....   ...++.+|+++|..+ +||||+++++++.+.+
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            345678999999999999999999753    47889999985433   334678999999998 6999999999999999


Q ss_pred             eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCC-CceEEecccCc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEK-FQSKIGDFGLA  231 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfgla  231 (407)
                      ..|+||||+++|+|.+++.     .+++..+..++.|++.||+|||+++   |+||||||+|||++.+ +.+||+|||+|
T Consensus        94 ~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            9999999999999999982     3899999999999999999999998   9999999999999876 79999999999


Q ss_pred             cccCCCCc---------------------------ccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCC
Q 040557          232 RFFPEDQA---------------------------YLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRK  283 (407)
Q Consensus       232 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~  283 (407)
                      +.......                           ......+||+.|||||++.+. .|+.++||||+||++|||+||+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            86543221                           112345799999999998875 58999999999999999999999


Q ss_pred             CCCCCCCcccCchhHHHH------------------------------HHHHhCccccccCccccc--------CCCCHH
Q 040557          284 NTDLTLPSEMQYLPEYAW------------------------------KLYERGRILELVDPRMRK--------EGIVER  325 (407)
Q Consensus       284 p~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~d~~~~~--------~~~~~~  325 (407)
                      ||........ .+.....                              .............+....        ......
T Consensus       246 Pf~~~~~~~~-~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  324 (361)
T 4f9c_A          246 PFYKASDDLT-ALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE  324 (361)
T ss_dssp             SSSCCSSHHH-HHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred             CCCCCCCHHH-HHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence            9965432211 0000000                              000000000000000000        000011


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          326 DALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       326 ~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .+.++.+|+.+||+.||++|||++|+++|-|+.
T Consensus       325 is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~  357 (361)
T 4f9c_A          325 VPDEAYDLLDKLLDLNPASRITAEEALLHPFFK  357 (361)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGT
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence            235678999999999999999999999998864

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1e-50  Score=380.01  Aligned_cols=289  Identities=42%  Similarity=0.731  Sum_probs=240.2

Q ss_pred             ccccCHHHHHHHhcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeee
Q 040557           69 ISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC  148 (407)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  148 (407)
                      ...|++.++....++|++.+.||+|+||.||+|+..+|+.||||++...........+.+|+++++.++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            45689999999999999999999999999999998889999999997554444444689999999999999999999999


Q ss_pred             ecCCeeEEEEEeccCCChhHHHhccC--CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEe
Q 040557          149 SDGSQRLLVYEYMKNRSLDLLIYGES--DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIG  226 (407)
Q Consensus       149 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~  226 (407)
                      .+.+..++||||+++|+|.+++....  ...+++..+..++.|++.||.|||+...++++||||||+|||+++++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999997543  3459999999999999999999999822239999999999999999999999


Q ss_pred             cccCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCC--CcccCchhHHHHHHH
Q 040557          227 DFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTL--PSEMQYLPEYAWKLY  304 (407)
Q Consensus       227 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~--~~~~~~~~~~~~~~~  304 (407)
                      |||++...............||+.|+|||.+.+..++.++||||||+++|||++|+.||....  .........+.....
T Consensus       177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  256 (326)
T 3uim_A          177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL  256 (326)
T ss_dssp             CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred             cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence            999999876655555556679999999999999999999999999999999999999996321  111222333444444


Q ss_pred             HhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          305 ERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       305 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .........+..... ......+..+.+++.+||+.||++|||+.+|+++|+..
T Consensus       257 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          257 KEKKLEALVDVDLQG-NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             SSCCSTTSSCTTCTT-SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             hchhhhhhcChhhcc-ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            444555555555543 35677888999999999999999999999999999864

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.5e-50  Score=374.33  Aligned_cols=283  Identities=39%  Similarity=0.694  Sum_probs=241.5

Q ss_pred             cCHHHHHHHhcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC
Q 040557           72 FDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG  151 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  151 (407)
                      +.+.++...+++|+..+.||+|+||.||+|.+.+|+.||||++... .......+.+|+++++.++||||+++++++.+.
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC-CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            4455566678999999999999999999999888999999988644 334566789999999999999999999999999


Q ss_pred             CeeEEEEEeccCCChhHHHhccC--CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEeccc
Q 040557          152 SQRLLVYEYMKNRSLDLLIYGES--DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFG  229 (407)
Q Consensus       152 ~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  229 (407)
                      +..++||||+++|+|.+++....  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence            99999999999999999986543  235899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCc-ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCc
Q 040557          230 LARFFPEDQA-YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGR  308 (407)
Q Consensus       230 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      ++........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....+.+......+.......+.
T Consensus       185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred             cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence            9986543222 222345689999999999999999999999999999999999999987777666656666666666667


Q ss_pred             cccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          309 ILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       309 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      +...+++..... .....+..+.+++.+||+.||++|||+.|++++|+...
T Consensus       265 ~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l  314 (321)
T 2qkw_B          265 LEQIVDPNLADK-IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL  314 (321)
T ss_dssp             CCSSSSSSCTTC-SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhcChhhccc-cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            777777666543 56678889999999999999999999999999998654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.8e-50  Score=398.46  Aligned_cols=254  Identities=22%  Similarity=0.297  Sum_probs=205.2

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHH---HHHHHHHcCCCCceeeeeeeeecCCeeE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFL---SEVRMITSIQHKNLVRLLGCCSDGSQRL  155 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~~  155 (407)
                      ++|++.++||+|+||.||+|+.. +|+.||+|++.+...  ......+.   .++.+++.++|||||++++++.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            57899999999999999999864 699999999964321  11222333   3466777789999999999999999999


Q ss_pred             EEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccC
Q 040557          156 LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP  235 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~  235 (407)
                      +||||++||+|..++...  ..+++..+..++.||+.||+|||+++   |+||||||+||||+.+|.+||+|||+|+.+.
T Consensus       269 lVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            999999999999999643  45999999999999999999999998   9999999999999999999999999999775


Q ss_pred             CCCcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          236 EDQAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       236 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      ....   ...+||+.|||||++.+ ..|+.++|||||||++|||++|+.||........   .. ..........     
T Consensus       344 ~~~~---~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~~-i~~~i~~~~~-----  411 (689)
T 3v5w_A          344 KKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HE-IDRMTLTMAV-----  411 (689)
T ss_dssp             SCCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---HH-HHHHHHHCCC-----
T ss_pred             CCCC---CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HH-HHHhhcCCCC-----
Confidence            5432   35789999999999975 5799999999999999999999999975432211   11 1111111111     


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhhcc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPP-----MSEIVAMLTCK  358 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~l~~~  358 (407)
                            ..+...+.++.+|+.+||+.||++|++     +.||++|-|+.
T Consensus       412 ------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~  454 (689)
T 3v5w_A          412 ------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR  454 (689)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGT
T ss_pred             ------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcccc
Confidence                  112223456889999999999999998     79999998864

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.2e-49  Score=394.32  Aligned_cols=258  Identities=21%  Similarity=0.254  Sum_probs=212.5

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+... .....+.+.+|+++|+.++|||||++++++.+.+.+|+|||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc-chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            367899999999999999999864 6999999998643 34455678899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCC--CceEEecccCccccCCC
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEK--FQSKIGDFGLARFFPED  237 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~--~~~kl~Dfgla~~~~~~  237 (407)
                      ||+||+|.+++... ...+++..+..++.||+.||.|||+++   |+||||||+|||++.+  +.+||+|||+++.+...
T Consensus       235 ~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          235 FMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             ecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            99999999988543 345899999999999999999999998   9999999999999854  89999999999987655


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      ...  ...+||+.|||||++.+..|+.++|||||||++|||++|+.||......      .... .+..+...  ++...
T Consensus       311 ~~~--~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~------~~~~-~i~~~~~~--~~~~~  379 (573)
T 3uto_A          311 QSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLR-NVKSCDWN--MDDSA  379 (573)
T ss_dssp             SEE--EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHH-HHHTTCCC--CCSGG
T ss_pred             Cce--eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHH-HHHhCCCC--CCccc
Confidence            432  3568999999999999999999999999999999999999999754321      1111 12211110  01111


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                           ....+..+.+|+.+||+.||++|||+.|+++|-|...
T Consensus       380 -----~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~  416 (573)
T 3uto_A          380 -----FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP  416 (573)
T ss_dssp             -----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSC
T ss_pred             -----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCC
Confidence                 1112456789999999999999999999999988653

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8.8e-48  Score=355.39  Aligned_cols=259  Identities=22%  Similarity=0.345  Sum_probs=214.2

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            36899999999999999999985 579999999986443 2335678899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++|+|.+++...   .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++........
T Consensus        98 ~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           98 YLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            99999999998643   4899999999999999999999998   99999999999999999999999999987654433


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                      . .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......      .........+..      ..  
T Consensus       172 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~------~~--  236 (297)
T 3fxz_A          172 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP------EL--  236 (297)
T ss_dssp             C-BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC------CC--
T ss_pred             c-cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC------CC--
Confidence            2 34467999999999999999999999999999999999999999643221      111222221111      01  


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccCC
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESG  362 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~~  362 (407)
                       ..+...+..+.+++.+||+.||++|||+.|+++|.+......
T Consensus       237 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          237 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             -SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             -CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence             112223456889999999999999999999999998765544

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5.4e-48  Score=360.94  Aligned_cols=260  Identities=24%  Similarity=0.316  Sum_probs=208.2

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|++.+.||+|+||.||+|... +++.||+|++.........+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            367888999999999999999865 7899999998655544445678899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++|+|.+++.  ....+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++..+.....
T Consensus        86 ~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           86 YCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             CCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            999999999984  3445999999999999999999999998   99999999999999999999999999986643222


Q ss_pred             -ccccccccCccccCccccccCCC-CccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          240 -YLSTNFAGTLGYTAPEYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       240 -~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                       .......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||........     .. ..+.....  ...   
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----~~-~~~~~~~~--~~~---  229 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-----EY-SDWKEKKT--YLN---  229 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-----HH-HHHHTTCT--TST---
T ss_pred             ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-----HH-HHHhcccc--cCC---
Confidence             22235679999999999988775 7899999999999999999999975433211     11 11111110  000   


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                          .....+..+.+++.+||+.||++|||+.|++++.|....
T Consensus       230 ----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  268 (323)
T 3tki_A          230 ----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (323)
T ss_dssp             ----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             ----ccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence                011234567899999999999999999999999987543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.9e-47  Score=357.66  Aligned_cols=254  Identities=24%  Similarity=0.312  Sum_probs=212.1

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      .++|++.+.||+|+||.||+|.+ .+|+.||||++.... .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            36788889999999999999986 579999999986543 3445667889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.......
T Consensus        94 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           94 EYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             CCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             ECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            999999999998543  45899999999999999999999998   9999999999999999999999999998765443


Q ss_pred             cccccccccCccccCccccccCCCC-ccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELS-EKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~-~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      .  ....+||+.|+|||.+.+..++ .++|||||||++|||++|+.||.....      ... ......+...       
T Consensus       169 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~-~~~i~~~~~~-------  232 (328)
T 3fe3_A          169 K--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KEL-RERVLRGKYR-------  232 (328)
T ss_dssp             G--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHH-HHHHHHCCCC-------
T ss_pred             c--cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HHH-HHHHHhCCCC-------
Confidence            2  3456899999999999888775 799999999999999999999975432      111 2222222110       


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                          .+...+..+.+++.+||+.||++|||+.|+++|.|...
T Consensus       233 ----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~  270 (328)
T 3fe3_A          233 ----IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINA  270 (328)
T ss_dssp             ----CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred             ----CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence                11123456889999999999999999999999988654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.9e-48  Score=358.46  Aligned_cols=269  Identities=28%  Similarity=0.426  Sum_probs=205.8

Q ss_pred             HHhcCCCCCCeeeccCCccEEEEEecCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           79 KATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ...++|++.+.||+|+||.||+|+. +|+.||||++.... .......+.+|++++++++||||+++++++.+....++|
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV  112 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence            3456788889999999999999987 68899999986544 344456789999999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccC-CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          158 YEYMKNRSLDLLIYGES-DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      |||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++++||||||+|||++.++.+||+|||+++....
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            99999999999996433 234899999999999999999999875 4599999999999999999999999999986543


Q ss_pred             CCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          237 DQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                      ... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......      ............       
T Consensus       192 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~------~~~~~~~~~~~~-------  257 (309)
T 3p86_A          192 TFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA------QVVAAVGFKCKR-------  257 (309)
T ss_dssp             -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHHSCCC-------
T ss_pred             ccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCCC-------
Confidence            322 223467999999999999999999999999999999999999998753321      111111111110       


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccCCCCCC
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVR  366 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~~~~~~  366 (407)
                         ...+...+..+.+++.+||+.||++|||+.++++.|+.......|+.
T Consensus       258 ---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~  304 (309)
T 3p86_A          258 ---LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP  304 (309)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred             ---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence               01222334568899999999999999999999999988776655543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.5e-47  Score=362.01  Aligned_cols=258  Identities=28%  Similarity=0.435  Sum_probs=212.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEec--------CCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCC
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA--------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGS  152 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  152 (407)
                      ++|++.+.||+|+||.||+|...        ++..||||++...........+.+|++++..+ +||||+++++++.+.+
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            67888899999999999999752        35679999997665566677899999999999 8999999999999999


Q ss_pred             eeEEEEEeccCCChhHHHhccC--------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGES--------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD  218 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~  218 (407)
                      ..++||||+++|+|.+++....              ...+++..+..++.|++.||.|||+.+   ++||||||+|||++
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~  237 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVT  237 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEEC
Confidence            9999999999999999997543              235899999999999999999999998   99999999999999


Q ss_pred             CCCceEEecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCch
Q 040557          219 EKFQSKIGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYL  296 (407)
Q Consensus       219 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~  296 (407)
                      .++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+    
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~----  313 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----  313 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----
T ss_pred             CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH----
Confidence            9999999999999876543322 2234567889999999999999999999999999999999 898886533211    


Q ss_pred             hHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          297 PEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       297 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                         .......+...          ..+..++..+.+++.+||+.||++|||+.|++++|+.+.
T Consensus       314 ---~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          314 ---LFKLLKEGHRM----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             ---HHHHHHTTCCC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHHHhcCCCC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence               12222222111          112223456889999999999999999999999998654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.6e-47  Score=352.74  Aligned_cols=259  Identities=25%  Similarity=0.442  Sum_probs=210.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+.. ........+.+|++++++++||||+++++++.+.+..++||||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            56778899999999999999864 689999998843 3456667899999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++|+|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.........
T Consensus        89 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           89 IKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             CTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             cCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            9999999999753 345899999999999999999999998   999999999999999999999999999876543322


Q ss_pred             c-------------ccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhC
Q 040557          241 L-------------STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERG  307 (407)
Q Consensus       241 ~-------------~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      .             .....||+.|+|||.+.+..++.++||||||+++|||++|..|+....+......... ...... 
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-~~~~~~-  242 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-RGFLDR-  242 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-HHHHHH-
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-hccccc-
Confidence            1             1145799999999999999999999999999999999999998875544332211110 111110 


Q ss_pred             ccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          308 RILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       308 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                              .     .+...+..+.+++.+||+.||++|||+.++++.|+....
T Consensus       243 --------~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          243 --------Y-----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             --------T-----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------c-----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                    0     111123458899999999999999999999999986643

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.5e-47  Score=357.89  Aligned_cols=265  Identities=25%  Similarity=0.357  Sum_probs=207.0

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC----eeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS----QRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv  157 (407)
                      ++|++.+.||+|+||.||+|+.. ++.||||++...  ......+..|+.++++++||||+++++++....    ..++|
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC-CCEEEEEEeecC--chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            67888899999999999999885 899999998533  233445667999999999999999999997744    46999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhcccccc----------CCCceeeeccccccEEEcCCCceEEec
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED----------SHTRIVHRDIKASNVLLDEKFQSKIGD  227 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------~~~~i~H~dlk~~Nill~~~~~~kl~D  227 (407)
                      |||+++|+|.+++...   .+++..+..++.|++.||.|||+.          +   ++||||||+|||++.++.+||+|
T Consensus       101 ~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A          101 TAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECC
T ss_pred             EecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEcc
Confidence            9999999999999643   489999999999999999999998          6   99999999999999999999999


Q ss_pred             ccCccccCCCCcc-cccccccCccccCccccccC-----CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhH---
Q 040557          228 FGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRG-----ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPE---  298 (407)
Q Consensus       228 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~---  298 (407)
                      ||+++.+...... ......||+.|+|||.+.+.     .++.++|||||||++|||+||+.||.............   
T Consensus       175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  254 (322)
T 3soc_A          175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG  254 (322)
T ss_dssp             CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred             CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence            9999876544332 22346799999999998763     55678999999999999999999997654332211111   


Q ss_pred             ------HHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          299 ------YAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       299 ------~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                            ...........    .+.+.........+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       255 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~  317 (322)
T 3soc_A          255 QHPSLEDMQEVVVHKKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ  317 (322)
T ss_dssp             SSCCHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCchhhhhhhhhcccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                  11111111111    1111111112345667999999999999999999999999998653

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=8.6e-46  Score=343.60  Aligned_cols=281  Identities=37%  Similarity=0.580  Sum_probs=228.6

Q ss_pred             cccCHHHHHHHhcCCCCC------CeeeccCCccEEEEEecCCcEEEEEEecccc---ChhhHHHHHHHHHHHHcCCCCc
Q 040557           70 SYFDFQTLKKATKNFHPG------NLLGRGGFGPVYRGKLADGTLVAVKKLCVDK---SQQGESEFLSEVRMITSIQHKN  140 (407)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~n  140 (407)
                      ..|++.++..++++|...      +.||+|+||.||+|.. +++.||+|++....   .......+.+|+.+++.++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            458999999999998877      8999999999999987 68899999986432   2344577899999999999999


Q ss_pred             eeeeeeeeecCCeeEEEEEeccCCChhHHHhccC-CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC
Q 040557          141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGES-DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE  219 (407)
Q Consensus       141 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~  219 (407)
                      |+++++++.+.+..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||++++
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~  168 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDE  168 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECT
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcC
Confidence            9999999999999999999999999999986432 456999999999999999999999998   999999999999999


Q ss_pred             CCceEEecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhH
Q 040557          220 KFQSKIGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPE  298 (407)
Q Consensus       220 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~  298 (407)
                      ++.+||+|||++......... ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.......  ....
T Consensus       169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~  245 (307)
T 2nru_A          169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LLLD  245 (307)
T ss_dssp             TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--BTTH
T ss_pred             CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--HHHH
Confidence            999999999999876543222 2334579999999997754 58999999999999999999999997644322  1122


Q ss_pred             HHHHHHHh-CccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          299 YAWKLYER-GRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       299 ~~~~~~~~-~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      +....... ..+.+.++..+.  ......+..+.+++.+||+.||++|||+.+++++|+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          246 IKEEIEDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHHHTTSCCHHHHSCSSCS--CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHHhhhhhhhhhhhcccccc--ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            22221111 122333444432  245667888999999999999999999999999998654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6.9e-47  Score=353.22  Aligned_cols=267  Identities=22%  Similarity=0.313  Sum_probs=217.7

Q ss_pred             cccCHHHHHHHhcC----------CCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCC
Q 040557           70 SYFDFQTLKKATKN----------FHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQH  138 (407)
Q Consensus        70 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h  138 (407)
                      ..+++++++.+++.          |+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++|
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCC
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCC
Confidence            34788888877764          556678999999999999875 79999999986433 3445678899999999999


Q ss_pred             CceeeeeeeeecCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc
Q 040557          139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD  218 (407)
Q Consensus       139 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~  218 (407)
                      +||+++++++...+..++||||+++|+|.+++..   ..+++..+..++.|++.||.|||+.+   ++||||||+|||++
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~  175 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT  175 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence            9999999999999999999999999999999853   35899999999999999999999998   99999999999999


Q ss_pred             CCCceEEecccCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhH
Q 040557          219 EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPE  298 (407)
Q Consensus       219 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~  298 (407)
                      .++.+||+|||++......... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......      .
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~------~  248 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV------Q  248 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------H
T ss_pred             CCCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H
Confidence            9999999999999876544322 23467999999999999999999999999999999999999998643221      1


Q ss_pred             HHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          299 YAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       299 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                       ....+.....     +.+.   .....+..+.+++.+||+.||++|||+.+++++.+...
T Consensus       249 -~~~~~~~~~~-----~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~  300 (321)
T 2c30_A          249 -AMKRLRDSPP-----PKLK---NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ  300 (321)
T ss_dssp             -HHHHHHHSSC-----CCCT---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred             -HHHHHhcCCC-----CCcC---ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence             1111221111     1111   11123456889999999999999999999999988754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=6.3e-47  Score=354.09  Aligned_cols=259  Identities=28%  Similarity=0.442  Sum_probs=210.3

Q ss_pred             cCCCCCCeeeccCCccEEEEEec----CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA----DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ++|++.+.||+|+||.||+|.+.    .+..||||.+...........+.+|+++++.++||||+++++++.+.+..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            56778899999999999999874    35569999997665666677899999999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.....
T Consensus       129 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             eeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            99999999999986443 45999999999999999999999998   999999999999999999999999999877543


Q ss_pred             Ccc--cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          238 QAY--LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       238 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      ...  ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......       ........+...    
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-------~~~~~~~~~~~~----  273 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-------DVISSVEEGYRL----  273 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-------HHHHHHHTTCCC----
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHHcCCCC----
Confidence            322  2223456788999999999999999999999999999999 99998643221       111222221110    


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                            ..+...+..+.+++.+||+.||++|||+.+|++.|+.....
T Consensus       274 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          274 ------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence                  01122345688999999999999999999999999876544

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5e-47  Score=345.23  Aligned_cols=257  Identities=27%  Similarity=0.408  Sum_probs=212.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      ++|++.+.||+|+||.||+|...+++.||+|++....  ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            5677788999999999999998889999999986433  23457899999999999999999999999999999999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      ++++|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..........
T Consensus        88 ~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  163 (269)
T 4hcu_A           88 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  163 (269)
T ss_dssp             TTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             CCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence            9999999986433 45899999999999999999999998   9999999999999999999999999998776554433


Q ss_pred             ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                      .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......      . .......+..     ..    
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~-~~~~~~~~~~-----~~----  227 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------E-VVEDISTGFR-----LY----  227 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------H-HHHHHHTTCC-----CC----
T ss_pred             ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------H-HHHHHhcCcc-----CC----
Confidence            445567889999999999999999999999999999999 89888643221      1 1111221110     00    


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                       .+...+..+.+++.+||+.||++|||+.+++++|+...+.
T Consensus       228 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          228 -KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence             1111245688999999999999999999999999876543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.3e-46  Score=342.30  Aligned_cols=257  Identities=27%  Similarity=0.413  Sum_probs=212.7

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      .++|++.+.||+|+||.||+|...++..||+|.+....  .....+.+|++++.+++||||+++++++.+....++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT--BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC--CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            35678889999999999999999888899999986433  2345789999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++++|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.........
T Consensus        85 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           85 ISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             CTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             cCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            9999999998654 345899999999999999999999998   999999999999999999999999999877665544


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                      ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......      ..... ...+..  ..      
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~-~~~~~~--~~------  225 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLK-VSQGHR--LY------  225 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHH-HHTTCC--CC------
T ss_pred             cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHHH-HHcCCC--CC------
Confidence            4445567788999999999899999999999999999999 99998643221      11111 111110  00      


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                        .+...+..+.+++.+||+.||++|||+.+++++|+...+
T Consensus       226 --~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          226 --RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             --CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             --CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence              111123468899999999999999999999999987643

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.5e-47  Score=361.50  Aligned_cols=258  Identities=26%  Similarity=0.444  Sum_probs=200.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEec----CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA----DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ++|++.+.||+|+||.||+|++.    ++..||||.+...........|.+|+.++.+++||||+++++++.+.+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57999999999999999999864    57789999997655566677899999999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++|+|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.....
T Consensus       125 ~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          125 TEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            9999999999999643 345899999999999999999999998   999999999999999999999999999877544


Q ss_pred             Cccc--ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          238 QAYL--STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       238 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      ....  .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......       ........+..     
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-------~~~~~i~~~~~-----  268 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-------DVIKAVDEGYR-----  268 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-------HHHHHHHTTEE-----
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCC-----
Confidence            3221  122345778999999999999999999999999999998 99998643211       11122222110     


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                          . ..+...+..+.+++.+||+.||++||++.+|++.|+....
T Consensus       269 ----~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          269 ----L-PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             ----C-CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----C-CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence                0 0112234568999999999999999999999999987654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=344.96  Aligned_cols=270  Identities=20%  Similarity=0.266  Sum_probs=215.4

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC--eeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS--QRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  158 (407)
                      ++|.+.+.||+|+||.||+|... +|+.||||++...........+.+|++++++++||||+++++++....  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            56888899999999999999865 589999999975554455677889999999999999999999987655  779999


Q ss_pred             EeccCCChhHHHhccCC-CCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEE----cCCCceEEecccCccc
Q 040557          159 EYMKNRSLDLLIYGESD-KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL----DEKFQSKIGDFGLARF  233 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfgla~~  233 (407)
                      ||+++|+|.+++..... ..+++..+..++.|++.||.|||+.+   ++||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999975432 34999999999999999999999998   9999999999999    7888899999999987


Q ss_pred             cCCCCcccccccccCccccCccccc--------cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHH
Q 040557          234 FPEDQAYLSTNFAGTLGYTAPEYAI--------RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYE  305 (407)
Q Consensus       234 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  305 (407)
                      .......  ....||+.|+|||.+.        +..++.++|||||||++|||++|+.||........  ..........
T Consensus       166 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~  241 (319)
T 4euu_A          166 LEDDEQF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIIT  241 (319)
T ss_dssp             CCTTCCB--CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHHHHHHH
T ss_pred             cCCCCce--eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHHHhc
Confidence            7654432  3457999999999886        57889999999999999999999999965433221  1222333332


Q ss_pred             hCccc---cc---cC------ccc-ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          306 RGRIL---EL---VD------PRM-RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       306 ~~~~~---~~---~d------~~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .....   ..   ..      ..+ ............+.+++.+||+.||++|||++|++++....
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            21100   00   00      011 11234567788899999999999999999999999998753

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7.3e-47  Score=360.85  Aligned_cols=257  Identities=30%  Similarity=0.421  Sum_probs=210.4

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|.+.+.||+|+||.||+|... +++.||||.+...........|.+|+++|++++||||+++++++.+.+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            356778899999999999999975 7899999998755445555678999999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++|+|.+++... ...+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+++.......
T Consensus       193 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          193 LVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             CCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            99999999998643 335899999999999999999999998   99999999999999999999999999986544322


Q ss_pred             ccc-cccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          240 YLS-TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       240 ~~~-~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      ... ....++..|+|||.+.+..++.++|||||||++|||+| |..|+.....       .........+...       
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~-------  334 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-------QQTREFVEKGGRL-------  334 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-------HHHHHHHHTTCCC-------
T ss_pred             eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCC-------
Confidence            211 12235778999999999999999999999999999998 8888864321       1122222222111       


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                         ..+..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       335 ---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          335 ---PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence               11222345688999999999999999999999999754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.9e-46  Score=349.76  Aligned_cols=253  Identities=24%  Similarity=0.261  Sum_probs=209.2

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++....  .......+.+|++++..++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            56888899999999999999865 69999999996432  2234567889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|..++...  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        85 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           85 EYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             ECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            999999999988543  45899999999999999999999998   9999999999999999999999999998643322


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                      . .....+||+.|+|||.+.+..++.++|||||||++|||++|+.||......      ..... +..+..      .  
T Consensus       160 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~-i~~~~~------~--  223 (337)
T 1o6l_A          160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFEL-ILMEEI------R--  223 (337)
T ss_dssp             C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHHCCC------C--
T ss_pred             C-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------HHHHH-HHcCCC------C--
Confidence            2 234567999999999999999999999999999999999999999643211      11111 211111      0  


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhcc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRP-----PMSEIVAMLTCK  358 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~l~~~  358 (407)
                         .+...+..+.+++.+||+.||++||     ++.|+++|.++.
T Consensus       224 ---~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~  265 (337)
T 1o6l_A          224 ---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL  265 (337)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             ---CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcC
Confidence               1122345688999999999999999     999999998764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6e-47  Score=359.13  Aligned_cols=269  Identities=28%  Similarity=0.415  Sum_probs=217.9

Q ss_pred             cCHHHHHHHhcCCCCCCeeeccCCccEEEEEe------cCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeee
Q 040557           72 FDFQTLKKATKNFHPGNLLGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRL  144 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l  144 (407)
                      ++...++...++|++.+.||+|+||.||+|++      .+++.||||++...........+.+|++++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            55566666778999999999999999999973      246889999997665666677899999999999 79999999


Q ss_pred             eeeeecCC-eeEEEEEeccCCChhHHHhccCC------------------------------------------------
Q 040557          145 LGCCSDGS-QRLLVYEYMKNRSLDLLIYGESD------------------------------------------------  175 (407)
Q Consensus       145 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------  175 (407)
                      ++++.+.+ ..++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99987755 48999999999999999975432                                                


Q ss_pred             ----------------CCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          176 ----------------KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       176 ----------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                                      ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++........
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                            12899999999999999999999998   99999999999999999999999999987644332


Q ss_pred             -ccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          240 -YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       240 -~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                       .......||+.|+|||.+.+..++.++||||||+++|||+| |+.||......      .........+....      
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~~~~~~~~~~------  316 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRRLKEGTRMR------  316 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS------HHHHHHHHHTCCCC------
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh------HHHHHHHHcCCCCC------
Confidence             22344668999999999999999999999999999999998 99998654322      12222222222111      


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                          .+...+..+.+++.+||+.||++|||+.|++++|+...
T Consensus       317 ----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          317 ----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence                11123456889999999999999999999999998654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.1e-45  Score=349.84  Aligned_cols=257  Identities=22%  Similarity=0.243  Sum_probs=210.6

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChh-----hHHHHHHHHHHHHcCCCCceeeeeeeeecCCee
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQ-----GESEFLSEVRMITSIQHKNLVRLLGCCSDGSQR  154 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  154 (407)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+.......     ....+.+|+.+|..++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467888899999999999999865 68999999997544221     356789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC----ceEEecccC
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF----QSKIGDFGL  230 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfgl  230 (407)
                      ++||||+++|+|.+++..  ...+++..+..++.|++.||.|||+.+   ++||||||+|||+++++    .+||+|||+
T Consensus        91 ~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            999999999999999853  456999999999999999999999998   99999999999998877    799999999


Q ss_pred             ccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccc
Q 040557          231 ARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRIL  310 (407)
Q Consensus       231 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      +........  .....||+.|+|||.+.+..++.++|||||||++|+|++|..||......      ... ..+..+...
T Consensus       166 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~------~~~-~~i~~~~~~  236 (361)
T 2yab_A          166 AHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETL-ANITAVSYD  236 (361)
T ss_dssp             CEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHH-HHHHTTCCC
T ss_pred             ceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHH-HHHHhcCCC
Confidence            987765432  23467999999999999999999999999999999999999999753221      111 112111110


Q ss_pred             cccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          311 ELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       311 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                        +++...     ...+..+.+++.+||+.||++|||+.|+++|.|..
T Consensus       237 --~~~~~~-----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  277 (361)
T 2yab_A          237 --FDEEFF-----SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT  277 (361)
T ss_dssp             --CCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred             --CCchhc-----cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence              011100     11234688999999999999999999999998864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4e-47  Score=367.63  Aligned_cols=268  Identities=20%  Similarity=0.230  Sum_probs=214.7

Q ss_pred             HHHHHHHhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeec
Q 040557           74 FQTLKKATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSD  150 (407)
Q Consensus        74 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  150 (407)
                      +.+++...++|++.+.||+|+||.||+|+.. +++.||+|++.....  ......+.+|..++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            4445555688999999999999999999875 478999999864221  1122347899999999999999999999999


Q ss_pred             CCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccC
Q 040557          151 GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGL  230 (407)
Q Consensus       151 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgl  230 (407)
                      .+..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhh
Confidence            99999999999999999999643 345999999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccCccccCccccc-----cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHH
Q 040557          231 ARFFPEDQAYLSTNFAGTLGYTAPEYAI-----RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYE  305 (407)
Q Consensus       231 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  305 (407)
                      ++.............+||+.|+|||++.     ...++.++|||||||++|||++|+.||......      ........
T Consensus       222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~------~~~~~i~~  295 (437)
T 4aw2_A          222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMN  295 (437)
T ss_dssp             CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHT
T ss_pred             hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh------HHHHhhhh
Confidence            9877665554455578999999999987     567899999999999999999999999754321      11222211


Q ss_pred             hCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHhhcc
Q 040557          306 RGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQ--RPPMSEIVAMLTCK  358 (407)
Q Consensus       306 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~~l~~~  358 (407)
                      ...... + +.     .....+..+.+++.+||+.+|++  ||+++|+++|.++.
T Consensus       296 ~~~~~~-~-p~-----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~  343 (437)
T 4aw2_A          296 HKERFQ-F-PT-----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFS  343 (437)
T ss_dssp             HHHHCC-C-CS-----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGT
T ss_pred             cccccc-C-Cc-----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccC
Confidence            100000 0 10     00113456889999999998888  99999999998874

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.2e-46  Score=367.85  Aligned_cols=260  Identities=25%  Similarity=0.397  Sum_probs=213.7

Q ss_pred             HHHhcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           78 KKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        78 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      +...++|++.+.||+|+||.||+|.+.++..||||++....  ...+.|.+|+++|++++||||+++++++. ....++|
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv  260 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII  260 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence            33456788888999999999999999888999999986433  34668999999999999999999999986 5678999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++|+|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.....
T Consensus       261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred             EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence            99999999999997554446899999999999999999999998   999999999999999999999999999977654


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                      .........++..|+|||.+....++.++|||||||++|||+| |+.||......      + ....+..+..       
T Consensus       338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~------~-~~~~i~~~~~-------  403 (454)
T 1qcf_A          338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP------E-VIRALERGYR-------  403 (454)
T ss_dssp             HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------H-HHHHHHHTCC-------
T ss_pred             ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCC-------
Confidence            3333334557889999999999999999999999999999999 99998643221      1 1222222211       


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                      +   ..+..++..+.+++.+||+.||++|||+.+|++.|+....
T Consensus       404 ~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          404 M---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             C---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence            0   0122345678999999999999999999999999986543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.4e-46  Score=345.15  Aligned_cols=260  Identities=24%  Similarity=0.363  Sum_probs=201.6

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHc--CCCCceeeeeeeeec----CCee
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITS--IQHKNLVRLLGCCSD----GSQR  154 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~----~~~~  154 (407)
                      .++|++.+.||+|+||.||+|+. +|+.||||++..    .....+.+|.+++..  ++||||+++++++..    ....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc----ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            46788899999999999999988 689999999853    233455667777666  799999999998644    3468


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhcccc--------ccCCCceeeeccccccEEEcCCCceEEe
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLH--------EDSHTRIVHRDIKASNVLLDEKFQSKIG  226 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~dlk~~Nill~~~~~~kl~  226 (407)
                      ++||||+++|+|.+++..   ..+++..+..++.|++.||.|||        +.+   ++||||||+|||++.++.+||+
T Consensus        82 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred             EEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence            999999999999999943   35899999999999999999999        766   9999999999999999999999


Q ss_pred             cccCccccCCCCccc---ccccccCccccCccccccC------CCCccccEEehhHHHHHHHhc----------CCCCCC
Q 040557          227 DFGLARFFPEDQAYL---STNFAGTLGYTAPEYAIRG------ELSEKADIYSFGVLVLEIISC----------RKNTDL  287 (407)
Q Consensus       227 Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~k~Dv~s~G~vl~el~tg----------~~p~~~  287 (407)
                      |||+++.........   .....||+.|+|||.+.+.      .++.++|||||||++|||+||          +.||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            999998665433321   2334799999999998876      456799999999999999999          667654


Q ss_pred             CCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          288 TLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      ..+....  ............    ..+...........+..+.+++.+||+.||++|||+.+|++.|+.
T Consensus       236 ~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          236 VVPNDPS--FEDMRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             TSCSSCC--HHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCCCcc--hhhhhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            4333221  111111111111    111111111233467789999999999999999999999999975

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.1e-46  Score=371.74  Aligned_cols=257  Identities=27%  Similarity=0.395  Sum_probs=214.6

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecC-CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      ..+|++.+.||+|+||.||+|.+.. +..||||.+....  ...+.|.+|+++|++++||||++++++|.+....++|||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            4567778899999999999998764 8899999986433  345679999999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++|+|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.......
T Consensus       297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred             ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence            999999999998766667999999999999999999999998   99999999999999999999999999998765544


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                      .......++..|+|||.+.+..++.++|||||||++|||+| |+.||.......       ....+..+..       + 
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~-------~-  438 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYR-------M-  438 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHHHHHTTCC-------C-
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC-------C-
Confidence            33344567789999999999999999999999999999999 888886533211       1222222211       1 


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                        ..+..++..+.+|+.+||+.||++|||+.+|++.|+...
T Consensus       439 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          439 --ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             --CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence              112234567889999999999999999999999998654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=9e-46  Score=341.45  Aligned_cols=263  Identities=24%  Similarity=0.338  Sum_probs=207.0

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      .++|++.+.||+|+||.||+|... +++.||+|.+....  .......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            367888899999999999999864 68999999985433  334457889999999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        90 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            9999999999998643  45899999999999999999999998   999999999999999999999999999877655


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      .........||+.|+|||.+.+..++.++||||||+++|||++|+.||......      ......... ..... ... 
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~-~~~~~-~~~-  235 (294)
T 4eqm_A          165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQD-SVPNV-TTD-  235 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSS-CCCCH-HHH-
T ss_pred             cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhc-cCCCc-chh-
Confidence            444444567999999999999999999999999999999999999999754321      111111111 11100 000 


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhccccC
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRP-PMSEIVAMLTCKVES  361 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~ev~~~l~~~~~~  361 (407)
                          .....+..+.+++.+||+.||++|| ++.++.+.|......
T Consensus       236 ----~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          236 ----VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             ----SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             ----cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence                1112345688999999999999999 899999998765433

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.7e-46  Score=353.77  Aligned_cols=262  Identities=29%  Similarity=0.401  Sum_probs=215.9

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec--------CCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecC
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA--------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDG  151 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  151 (407)
                      .++|.+.+.||+|+||.||+|...        ++..||||++...........+.+|++++.++ +||||+++++++.+.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            467888899999999999999852        24579999997666666678899999999999 999999999999999


Q ss_pred             CeeEEEEEeccCCChhHHHhccC--------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEE
Q 040557          152 SQRLLVYEYMKNRSLDLLIYGES--------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL  217 (407)
Q Consensus       152 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill  217 (407)
                      +..++||||+++|+|.+++....              ...+++..+..++.|++.||.|||+.+   ++||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence            99999999999999999997543              245899999999999999999999998   9999999999999


Q ss_pred             cCCCceEEecccCccccCCCCc-ccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCc
Q 040557          218 DEKFQSKIGDFGLARFFPEDQA-YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQY  295 (407)
Q Consensus       218 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~  295 (407)
                      ++++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.....     
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-----  299 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  299 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence            9999999999999987654332 22234567889999999999999999999999999999999 8988864321     


Q ss_pred             hhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccCC
Q 040557          296 LPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESG  362 (407)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~~  362 (407)
                        ......+..+....          .+...+..+.+++.+||+.||++|||+.|++++|+......
T Consensus       300 --~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  354 (382)
T 3tt0_A          300 --EELFKLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  354 (382)
T ss_dssp             --HHHHHHHHTTCCCC----------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             --HHHHHHHHcCCCCC----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence              11222222222111          11123456889999999999999999999999998776543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-46  Score=350.75  Aligned_cols=261  Identities=28%  Similarity=0.418  Sum_probs=214.3

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCe
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQ  153 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  153 (407)
                      ..++|++.+.||+|+||.||+|+..      +++.||+|.+...........+.+|+.++++++||||+++++++.+.+.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            4578999999999999999999864      3488999999766566667789999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhHHHhccC----------------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccc
Q 040557          154 RLLVYEYMKNRSLDLLIYGES----------------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIK  211 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk  211 (407)
                      .++||||+++|+|.+++....                      ...+++..++.++.|++.||.|||+.+   ++|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence            999999999999999997532                      156899999999999999999999998   9999999


Q ss_pred             cccEEEcCCCceEEecccCccccCCCCc-ccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCC
Q 040557          212 ASNVLLDEKFQSKIGDFGLARFFPEDQA-YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTL  289 (407)
Q Consensus       212 ~~Nill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~  289 (407)
                      |+|||++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            9999999999999999999986643322 12234568899999999999999999999999999999999 998886432


Q ss_pred             CcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          290 PSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                      .       .........+....          .+...+..+.+++.+||+.||++|||+.+++++|+...+
T Consensus       282 ~-------~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          282 H-------EEVIYYVRDGNILA----------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             H-------HHHHHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             h-------HHHHHHHhCCCcCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            1       11222222222211          112234568899999999999999999999999987543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.4e-46  Score=352.48  Aligned_cols=253  Identities=21%  Similarity=0.274  Sum_probs=207.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|.+.+.||+|+||.||+|.. .+|+.||+|++.....  ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            6788889999999999999986 5789999999864321  122357889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+ +|+|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||++.......
T Consensus        89 E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           89 EYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             CCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             ECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            999 67888887543  45999999999999999999999998   9999999999999999999999999998765543


Q ss_pred             cccccccccCccccCccccccCCC-CccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      .  ....+||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||.........                ..+....
T Consensus       163 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i~~~~  224 (336)
T 3h4j_B          163 F--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKVNSCV  224 (336)
T ss_dssp             T--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCCCSSC
T ss_pred             c--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHHHcCC
Confidence            2  234679999999999988776 78999999999999999999999754322110                0000000


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                        ...+...+..+.+++.+||+.||.+|||+.|++++.|....
T Consensus       225 --~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          225 --YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             --CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             --CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence              01122234568899999999999999999999999987643

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.1e-46  Score=347.33  Aligned_cols=268  Identities=23%  Similarity=0.322  Sum_probs=205.6

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccCh-hhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQ-QGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|++.+.||+|+||+||+|+..+|+.||+|++...... .....+.+|++++++++||||+++++++.+....++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            3678888999999999999999988999999998654322 234678899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++ +|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.......
T Consensus       100 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A          100 FMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR  174 (311)
T ss_dssp             CCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred             CCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence            9985 777777543 345899999999999999999999998   99999999999999999999999999987653322


Q ss_pred             ccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcc---------
Q 040557          240 YLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRI---------  309 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------  309 (407)
                      . .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.   .............         
T Consensus       175 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          175 S-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGGGTTS
T ss_pred             c-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhhhhcc
Confidence            2 234578999999998876 5689999999999999999999999975443221   1111111110000         


Q ss_pred             -------ccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          310 -------LELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       310 -------~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                             ....+..... ......+.++.+++.+||+.||++|||+.|+++|.|+.
T Consensus       251 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  305 (311)
T 3niz_A          251 PLWKQRTFQVFEKKPWS-SIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK  305 (311)
T ss_dssp             HHHHSCCCCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             chhhhcccccccCCcHH-HhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence                   0000000000 00011235688999999999999999999999998764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=357.41  Aligned_cols=259  Identities=29%  Similarity=0.375  Sum_probs=210.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRL  155 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  155 (407)
                      ++|++.+.||+|+||.||+|...      ++..||||++...........+.+|+.++++++||||+++++++.+....+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            67888899999999999999842      467899999976556667778999999999999999999999999999999


Q ss_pred             EEEEeccCCChhHHHhccC-----CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC---ceEEec
Q 040557          156 LVYEYMKNRSLDLLIYGES-----DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF---QSKIGD  227 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~kl~D  227 (407)
                      +||||+++|+|.+++....     ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECC
Confidence            9999999999999997543     245899999999999999999999998   99999999999999554   599999


Q ss_pred             ccCccccCCCCc-ccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHH
Q 040557          228 FGLARFFPEDQA-YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYE  305 (407)
Q Consensus       228 fgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  305 (407)
                      ||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++ |..||......       .......
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~-------~~~~~i~  300 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVT  300 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHHHHH
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHH
Confidence            999985532211 12234568999999999999999999999999999999998 88888653221       1222222


Q ss_pred             hCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          306 RGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       306 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                      .+...          ..+...+..+.+++.+||+.||++|||+.+|+++|+....
T Consensus       301 ~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          301 SGGRM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             TTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCC----------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            22111          0112234568899999999999999999999999987643

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7.2e-46  Score=354.35  Aligned_cols=261  Identities=23%  Similarity=0.321  Sum_probs=208.7

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  156 (407)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.....  ......+.+|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            367888899999999999999865 588999999975432  22334578899999887 89999999999999999999


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ||||+++|+|..++...  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       131 V~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            99999999999988643  45999999999999999999999998   99999999999999999999999999986432


Q ss_pred             CCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCccc--CchhHHHHHHHHhCccccccC
Q 040557          237 DQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEM--QYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      ... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........  .............+..     
T Consensus       206 ~~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-----  279 (396)
T 4dc2_A          206 PGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-----  279 (396)
T ss_dssp             TTC-CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-----
T ss_pred             CCC-ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-----
Confidence            222 23457899999999999999999999999999999999999999975432211  1111222222222211     


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHhhcc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPM------SEIVAMLTCK  358 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~------~ev~~~l~~~  358 (407)
                            ..+...+..+.+++.+||+.||++||++      .|+++|.++.
T Consensus       280 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~  323 (396)
T 4dc2_A          280 ------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR  323 (396)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTT
T ss_pred             ------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcccc
Confidence                  1122234568899999999999999984      7999998864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.5e-45  Score=345.52  Aligned_cols=258  Identities=18%  Similarity=0.222  Sum_probs=206.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      ++|++.+.||+|+||.||+|.. .+|+.||||.+.....   ...+.+|+++++.+ +|+||+++++++...+..++|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            5788889999999999999985 5789999999864432   23578999999999 99999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCc-----eEEecccCcccc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ-----SKIGDFGLARFF  234 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~-----~kl~Dfgla~~~  234 (407)
                      |+ +++|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.     +||+|||+++.+
T Consensus        86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           86 LL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             eC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            99 99999998754 356999999999999999999999998   999999999999998887     999999999876


Q ss_pred             CCCCcc------cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCc
Q 040557          235 PEDQAY------LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGR  308 (407)
Q Consensus       235 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      ......      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........   ......... ..
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~---~~~~~~i~~-~~  236 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL---KERYQKIGD-TK  236 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH---HHHHHHHHH-HH
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH---HHHHHHHHh-hh
Confidence            443321      12356799999999999999999999999999999999999999976543321   111111111 00


Q ss_pred             cccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          309 ILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       309 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ...  ......    ...+ .+.+++..||+.||.+||++.+|++.|...
T Consensus       237 ~~~--~~~~~~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          237 RAT--PIEVLC----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             HHS--CHHHHT----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             ccC--CHHHHh----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence            000  000000    0123 789999999999999999999999999754

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.2e-46  Score=342.46  Aligned_cols=256  Identities=24%  Similarity=0.387  Sum_probs=208.8

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      .++|++.+.||+|+||.||+|...++..||+|++....  .....+.+|++++..++|+||+++++++.+.+..++||||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC--CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            46788889999999999999999888899999996433  2345789999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++|+|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.........
T Consensus       101 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  176 (283)
T 3gen_A          101 MANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  176 (283)
T ss_dssp             CTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred             cCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence            9999999999653 345999999999999999999999998   999999999999999999999999999877654433


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                      ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......       ........+..     .    
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~~~~~~-----~----  240 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-------ETAEHIAQGLR-----L----  240 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHHHHTTCC-----C----
T ss_pred             cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-------HHHHHHhcccC-----C----
Confidence            3344567889999999999999999999999999999998 99998643221       11111221110     0    


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                       ..+...+..+.+++.+||+.||++|||+.+++++|+...
T Consensus       241 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          241 -YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             -CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence             011122356889999999999999999999999998654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=8.5e-46  Score=352.67  Aligned_cols=255  Identities=23%  Similarity=0.348  Sum_probs=208.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|... +|+.||+|.+....  .......+.+|+++|..++||||+++++++.+....++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56888899999999999999864 58899999986432  2234567889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+.+|+|..++..  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        95 e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             CCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             ecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence            99999999999854  445999999999999999999999998   9999999999999999999999999998775443


Q ss_pred             cccccccccCccccCcccccc---CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIR---GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                      .  ....+||+.|+|||++.+   ..++.++|||||||++|||++|+.||........   ... .........      
T Consensus       170 ~--~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~---~~~-~~~~~~~~~------  237 (384)
T 4fr4_A          170 Q--ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS---KEI-VHTFETTVV------  237 (384)
T ss_dssp             C--BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH---HHH-HHHHHHCCC------
T ss_pred             c--eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH---HHH-HHHHhhccc------
Confidence            2  345689999999999874   4589999999999999999999999975443321   111 111111110      


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHhhcc
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPP-MSEIVAMLTCK  358 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~ev~~~l~~~  358 (407)
                           ..+...+..+.+++.+||+.||++||+ +.++++|.++.
T Consensus       238 -----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~  276 (384)
T 4fr4_A          238 -----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN  276 (384)
T ss_dssp             -----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGT
T ss_pred             -----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhh
Confidence                 112223456889999999999999998 89998877653

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4e-47  Score=350.62  Aligned_cols=263  Identities=24%  Similarity=0.404  Sum_probs=203.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-----cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeec--CCee
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSD--GSQR  154 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  154 (407)
                      ++|++.+.||+|+||.||+|++     .+++.||||++.. ........+.+|++++++++||||+++++++..  ....
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            6678889999999999999984     3688999999863 344556789999999999999999999999854  3568


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcccc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF  234 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~  234 (407)
                      ++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++...
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             EEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            99999999999999996543 34899999999999999999999998   999999999999999999999999999877


Q ss_pred             CCCCcc--cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCc---------ccCchhHHHHHH
Q 040557          235 PEDQAY--LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPS---------EMQYLPEYAWKL  303 (407)
Q Consensus       235 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~---------~~~~~~~~~~~~  303 (407)
                      ......  ......++..|+|||.+.+..++.++||||||+++|||+||..|+......         ............
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (295)
T 3ugc_A          165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  244 (295)
T ss_dssp             -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence            544322  223345778899999999999999999999999999999999887542110         000000011111


Q ss_pred             HHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          304 YERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       304 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ...+..          ...+...+..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus       245 ~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~  290 (295)
T 3ugc_A          245 LKNNGR----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  290 (295)
T ss_dssp             HHTTCC----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhccCc----------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            111110          0112234567899999999999999999999999997653

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.2e-46  Score=364.62  Aligned_cols=259  Identities=28%  Similarity=0.443  Sum_probs=206.2

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      ..++|++.+.||+|+||.||+|.+.++..||||++....  ...+.|.+|+++|++++||||+++++++.+ +..++|||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e  258 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  258 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence            346677888999999999999999878889999986433  234678999999999999999999999976 67899999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++|+|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++.......
T Consensus       259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            999999999997554556999999999999999999999998   99999999999999999999999999987765443


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......       .....+..+..       + 
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-------~~~~~i~~~~~-------~-  400 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERGYR-------M-  400 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCC-------C-
T ss_pred             ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCC-------C-
Confidence            33344567889999999999999999999999999999999 89888643221       12222222211       0 


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                        ..+..++..+.+++.+||+.||++|||+.++++.|+.....
T Consensus       401 --~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          401 --PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             --CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence              11223456788999999999999999999999999866443

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.4e-45  Score=350.94  Aligned_cols=269  Identities=19%  Similarity=0.225  Sum_probs=210.1

Q ss_pred             hcCCCCCCeeecc--CCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           81 TKNFHPGNLLGRG--GFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        81 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      .++|++.+.||+|  +||.||+|+.. +|+.||||++.... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3678888999999  99999999875 69999999996554 33445678899999999999999999999999999999


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ||||+++|+|.+++.......+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            999999999999997766667999999999999999999999998   99999999999999999999999999875432


Q ss_pred             CCc------ccccccccCccccCcccccc--CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCc
Q 040557          237 DQA------YLSTNFAGTLGYTAPEYAIR--GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGR  308 (407)
Q Consensus       237 ~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      ...      .......||+.|+|||.+.+  ..++.++|||||||++|||++|+.||........  ......     +.
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~-----~~  253 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLN-----GT  253 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC---------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhc-----CC
Confidence            111      11123478999999999987  5789999999999999999999999975432211  000000     00


Q ss_pred             cccccCc-----------------------------------ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040557          309 ILELVDP-----------------------------------RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVA  353 (407)
Q Consensus       309 ~~~~~d~-----------------------------------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  353 (407)
                      ....++.                                   ...........+..+.+|+.+||+.||++|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            0000000                                   00000112223456899999999999999999999999


Q ss_pred             Hhhccc
Q 040557          354 MLTCKV  359 (407)
Q Consensus       354 ~l~~~~  359 (407)
                      |.+...
T Consensus       334 hp~f~~  339 (389)
T 3gni_B          334 HSFFKQ  339 (389)
T ss_dssp             SGGGGG
T ss_pred             CHHHHH
Confidence            987653

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.3e-45  Score=345.87  Aligned_cols=255  Identities=22%  Similarity=0.353  Sum_probs=202.8

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC-------
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS-------  152 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------  152 (407)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++.........+.+.+|++++++++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            467888899999999999999875 799999999976555556678999999999999999999999885543       


Q ss_pred             --------------------------------------------------eeEEEEEeccCCChhHHHhccC-CCCCCHH
Q 040557          153 --------------------------------------------------QRLLVYEYMKNRSLDLLIYGES-DKFLNWS  181 (407)
Q Consensus       153 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~  181 (407)
                                                                        ..++||||+++|+|.+++.... ....++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              3799999999999999997543 2346777


Q ss_pred             HHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc-----------ccccccccCcc
Q 040557          182 TRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA-----------YLSTNFAGTLG  250 (407)
Q Consensus       182 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-----------~~~~~~~gt~~  250 (407)
                      .+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.......           .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            88999999999999999998   99999999999999999999999999987765421           12234579999


Q ss_pred             ccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHH
Q 040557          251 YTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQV  330 (407)
Q Consensus       251 y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l  330 (407)
                      |+|||.+.+..++.++||||||+++|||++|..|+..         ..............          .........+
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---------~~~~~~~~~~~~~~----------~~~~~~~~~~  302 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---------RVRIITDVRNLKFP----------LLFTQKYPQE  302 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---------HHHHHHHHHTTCCC----------HHHHHHCHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---------HHHHHHHhhccCCC----------cccccCChhH
Confidence            9999999999999999999999999999998654310         00111111111100          0112334567


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          331 INVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       331 ~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      .+++.+||+.||++|||+.|++++.+.
T Consensus       303 ~~li~~~l~~~p~~Rps~~~~l~~~~f  329 (332)
T 3qd2_B          303 HMMVQDMLSPSPTERPEATDIIENAIF  329 (332)
T ss_dssp             HHHHHHHHCSSGGGSCCHHHHHHSTTC
T ss_pred             HHHHHHHccCCCCcCCCHHHHhhchhh
Confidence            899999999999999999999998765

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=7.9e-46  Score=344.80  Aligned_cols=259  Identities=29%  Similarity=0.438  Sum_probs=214.1

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe------cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCee
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQR  154 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  154 (407)
                      .++|.+.+.||+|+||.||+|..      .++..||+|.+...........+.+|+++++.++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            46788889999999999999975      245889999997665666677899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhHHHhccCC----------------------CCCCHHHHHHHHHHHHHHhccccccCCCceeeecccc
Q 040557          155 LLVYEYMKNRSLDLLIYGESD----------------------KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKA  212 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~  212 (407)
                      ++||||+++|+|.+++.....                      ..+++..+..++.|++.||.|||+.+   ++||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence            999999999999999975432                      34899999999999999999999998   99999999


Q ss_pred             ccEEEcCCCceEEecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCC
Q 040557          213 SNVLLDEKFQSKIGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLP  290 (407)
Q Consensus       213 ~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~  290 (407)
                      +||++++++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999877544332 2234467889999999999999999999999999999999 9999865433


Q ss_pred             cccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          291 SEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ..       .......+...          ..+...+..+.+++.+||+.||++|||+.+++++|+...
T Consensus       259 ~~-------~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          259 ER-------LFNLLKTGHRM----------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             GG-------HHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HH-------HHHHhhcCCcC----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            21       22222222111          111223456889999999999999999999999997653

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-45  Score=344.48  Aligned_cols=257  Identities=19%  Similarity=0.221  Sum_probs=210.4

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+...  ......+.+|+.++..++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            467888999999999999999865 5889999998533  3445678899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC--CCceEEecccCccccCCC
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE--KFQSKIGDFGLARFFPED  237 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~--~~~~kl~Dfgla~~~~~~  237 (407)
                      |+++|+|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.  ++.+||+|||++..+...
T Consensus        82 ~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           82 FISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             eCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            99999999998543 345899999999999999999999998   999999999999997  789999999999887654


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      ..  .....||+.|+|||.+.+..++.++|||||||++|+|++|..||......      ........ +...  .+...
T Consensus       158 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~-~~~~--~~~~~  226 (321)
T 1tki_A          158 DN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMN-AEYT--FDEEA  226 (321)
T ss_dssp             CE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHH-TCCC--CCHHH
T ss_pred             Cc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHc-CCCC--CChhh
Confidence            32  23457999999999999988999999999999999999999999653221      11222221 1110  00000


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .     ...+..+.+++.+||+.||++|||+.|+++|.|...
T Consensus       227 ~-----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  263 (321)
T 1tki_A          227 F-----KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             H-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             h-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence            0     012456889999999999999999999999998654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6e-46  Score=340.32  Aligned_cols=257  Identities=23%  Similarity=0.348  Sum_probs=197.7

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecC----CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLAD----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      .++|++.+.||+|+||.||+|....    +..||+|.+.........+.+.+|+.++++++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            3678888999999999999998642    45799999876555566678999999999999999999999985 457899


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.....
T Consensus        93 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCc
Confidence            99999999999998644 345899999999999999999999998   99999999999999999999999999987765


Q ss_pred             CCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          237 DQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                      ..........+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+      .. ..+..+...     
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~------~~-~~i~~~~~~-----  236 (281)
T 1mp8_A          169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VI-GRIENGERL-----  236 (281)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HH-HHHHTTCCC-----
T ss_pred             ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH------HH-HHHHcCCCC-----
Confidence            44433344567889999999999999999999999999999997 888886543221      11 112221111     


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                           ..+...+..+.+++.+||+.||++|||+.+++++|+...
T Consensus       237 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          237 -----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                 112223456889999999999999999999999997643

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.6e-46  Score=353.19  Aligned_cols=254  Identities=22%  Similarity=0.290  Sum_probs=205.6

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  156 (407)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++....  .......+.+|.+++..+ +||||+++++++.+.+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            478889999999999999999864 68999999986432  223456688999999988 79999999999999999999


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ||||+++|+|..++...  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       102 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            99999999999998643  45999999999999999999999998   99999999999999999999999999986433


Q ss_pred             CCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          237 DQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                      ... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......      ..... +..+..       
T Consensus       177 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~-i~~~~~-------  241 (353)
T 3txo_A          177 NGV-TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------DLFEA-ILNDEV-------  241 (353)
T ss_dssp             ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHHCCC-------
T ss_pred             CCc-cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------HHHHH-HHcCCC-------
Confidence            222 234568999999999999999999999999999999999999999754321      11222 222211       


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHhhcc
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRPPM------SEIVAMLTCK  358 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~------~ev~~~l~~~  358 (407)
                          ..+......+.+++.+||+.||++||++      .++++|.++.
T Consensus       242 ----~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~  285 (353)
T 3txo_A          242 ----VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK  285 (353)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGT
T ss_pred             ----CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCccc
Confidence                0112234568899999999999999998      8999998864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-45  Score=343.65  Aligned_cols=257  Identities=21%  Similarity=0.246  Sum_probs=209.5

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccCh-----hhHHHHHHHHHHHHcCCCCceeeeeeeeecCCee
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQ-----QGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQR  154 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  154 (407)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+......     .....+.+|+.+++.++||||+++++++.+....
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            356888899999999999999865 6899999998654322     2356789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC----ceEEecccC
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF----QSKIGDFGL  230 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfgl  230 (407)
                      ++||||+++|+|.+++..  ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++    .+||+|||+
T Consensus        90 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            999999999999999853  456999999999999999999999998   99999999999999887    899999999


Q ss_pred             ccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccc
Q 040557          231 ARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRIL  310 (407)
Q Consensus       231 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      +........  .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......      ..... .......
T Consensus       165 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~-~~~~~~~  235 (326)
T 2y0a_A          165 AHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLAN-VSAVNYE  235 (326)
T ss_dssp             CEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHH-HHHTCCC
T ss_pred             CeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH------HHHHH-HHhcCCC
Confidence            987754332  23467999999999999999999999999999999999999998643221      11111 1111100


Q ss_pred             cccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          311 ELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       311 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                        ......     ...+..+.+++.+||+.||++|||+.|+++|.+..
T Consensus       236 --~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  276 (326)
T 2y0a_A          236 --FEDEYF-----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK  276 (326)
T ss_dssp             --CCHHHH-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTS
T ss_pred             --cCcccc-----ccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCcc
Confidence              000000     11235688999999999999999999999998864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.1e-45  Score=346.22  Aligned_cols=260  Identities=23%  Similarity=0.325  Sum_probs=209.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++....  .......+.+|..++.++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            56788899999999999999865 58999999997543  334456788999999988 899999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++|+|..++...  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        89 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            9999999999998643  45899999999999999999999998   999999999999999999999999999864332


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCccc--CchhHHHHHHHHhCccccccCc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEM--QYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                      .. .....+||+.|+|||.+.+..++.++|||||||++|||++|+.||........  .............+...     
T Consensus       164 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-----  237 (345)
T 3a8x_A          164 GD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-----  237 (345)
T ss_dssp             TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC-----
T ss_pred             CC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC-----
Confidence            22 23456899999999999999999999999999999999999999965322111  11112222222222111     


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHhhcc
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPM------SEIVAMLTCK  358 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~------~ev~~~l~~~  358 (407)
                            .+...+..+.+++.+||+.||++||++      .++++|-++.
T Consensus       238 ------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~  280 (345)
T 3a8x_A          238 ------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR  280 (345)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGT
T ss_pred             ------CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccC
Confidence                  112234568899999999999999994      8999988764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.3e-45  Score=348.34  Aligned_cols=259  Identities=25%  Similarity=0.307  Sum_probs=211.3

Q ss_pred             HHhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           79 KATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      ...++|++.+.||+|+||.||+|... +|+.||+|.+.... .......+.+|+++++.++||||+++++++.+.+..++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34577999999999999999999864 68999999996543 33455678999999999999999999999999999999


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCC---CceEEecccCccc
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEK---FQSKIGDFGLARF  233 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfgla~~  233 (407)
                      ||||+++|+|.+++..  ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.+   +.+||+|||++..
T Consensus       106 v~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             EECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            9999999999998853  356899999999999999999999998   9999999999999865   4599999999987


Q ss_pred             cCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccccc
Q 040557          234 FPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV  313 (407)
Q Consensus       234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ......  .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||.....       ......+..+... ..
T Consensus       181 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-------~~~~~~i~~~~~~-~~  250 (362)
T 2bdw_A          181 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYAQIKAGAYD-YP  250 (362)
T ss_dssp             CTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCC-CC
T ss_pred             ecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCCCC-CC
Confidence            764332  2346799999999999999999999999999999999999999864321       1122222222211 00


Q ss_pred             CcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       314 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .+.      ....+..+.+++.+||+.||++|||+.++++|.|..
T Consensus       251 ~~~------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  289 (362)
T 2bdw_A          251 SPE------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC  289 (362)
T ss_dssp             TTG------GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHH
T ss_pred             ccc------ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccC
Confidence            000      012345688999999999999999999999998764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.8e-45  Score=359.02  Aligned_cols=252  Identities=29%  Similarity=0.401  Sum_probs=207.3

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC-eeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS-QRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  159 (407)
                      .++|++.+.||+|+||.||+|... |+.||||+++...   ..+.|.+|+++|++++||||+++++++.... ..++|||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            356788899999999999999984 7899999996433   3457899999999999999999999987655 7899999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++|+|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++...... 
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  343 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  343 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence            999999999998766566899999999999999999999998   9999999999999999999999999998654322 


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                         ....++..|+|||.+.+..++.++|||||||++|||+| |+.||......+       ....+..+...        
T Consensus       344 ---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~~--------  405 (450)
T 1k9a_A          344 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKM--------  405 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-------HHHHHHTTCCC--------
T ss_pred             ---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC--------
Confidence               22357889999999999999999999999999999998 999986543321       11222222111        


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                        ..+..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       406 --~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          406 --DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence              1122345678999999999999999999999999976543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.9e-45  Score=336.80  Aligned_cols=266  Identities=21%  Similarity=0.305  Sum_probs=205.4

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      ++|++.+.||+|+||+||+|... +|+.||+|++..... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46888899999999999999864 689999999975443 3345678899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++ ++...+.. ....+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  156 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             CCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred             cCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence            9986 55555433 2345999999999999999999999998   99999999999999999999999999987654332


Q ss_pred             ccccccccCccccCccccccCC-CCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh-Cccc-------
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER-GRIL-------  310 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~-------  310 (407)
                       ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.|+......     .......... +...       
T Consensus       157 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~-----~~~~~~i~~~~~~~~~~~~~~~  230 (292)
T 3o0g_A          157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-----DDQLKRIFRLLGTPTEEQWPSM  230 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-----HHHHHHHHHHHCCCCTTTCTTG
T ss_pred             -cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH-----HHHHHHHHHHhCCCChhhhhhh
Confidence             223457899999999988765 799999999999999999999886433221     1111111110 0000       


Q ss_pred             -cccCc--------ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          311 -ELVDP--------RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       311 -~~~d~--------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                       ...+.        ...........+..+.+++.+||+.||++|||++|+++|-|+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  287 (292)
T 3o0g_A          231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS  287 (292)
T ss_dssp             GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccc
Confidence             00000        0000011122345688999999999999999999999998864

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-45  Score=343.25  Aligned_cols=250  Identities=23%  Similarity=0.312  Sum_probs=208.8

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++....  .......+.+|..+++.++||||+++++++.+....++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            56788899999999999999864 69999999986432  1234567789999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++......
T Consensus        86 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~  160 (318)
T 1fot_A           86 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT  160 (318)
T ss_dssp             CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred             eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCcc
Confidence            999999999999643  45899999999999999999999998   9999999999999999999999999998765432


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                          ...+||+.|+|||.+.+..++.++|||||||++|||++|+.||.....      ......... +..      .  
T Consensus       161 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~-~~~------~--  221 (318)
T 1fot_A          161 ----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILN-AEL------R--  221 (318)
T ss_dssp             ----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHH-CCC------C--
T ss_pred             ----ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHh-CCC------C--
Confidence                346799999999999999999999999999999999999999965321      112222222 111      0  


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhcc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRP-----PMSEIVAMLTCK  358 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~l~~~  358 (407)
                         .+...+..+.+++.+||+.||++||     +++++++|-++.
T Consensus       222 ---~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~  263 (318)
T 1fot_A          222 ---FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK  263 (318)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred             ---CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcccc
Confidence               1122345688999999999999999     999999998864

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=340.41  Aligned_cols=251  Identities=24%  Similarity=0.341  Sum_probs=198.8

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  157 (407)
                      .++|+..+.||+|+||+||+|... +|+.||||++.... .......+..|+..+..+ +|+||+++++++.+++..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            367888999999999999999875 79999999985432 334445566677666665 899999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+ +++|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++......
T Consensus       136 ~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             EECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             Eecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            9999 678988876543 45999999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      ..  .....||+.|+|||++.+ .++.++|||||||++|||++|..++...          ..+..+..+...    +..
T Consensus       211 ~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~~~~~~~~~----~~~  273 (311)
T 3p1a_A          211 GA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQQLRQGYLP----PEF  273 (311)
T ss_dssp             ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHHHHTTTCCC----HHH
T ss_pred             CC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHHHHhccCCC----ccc
Confidence            32  234569999999998775 7999999999999999999997765421          111122222111    111


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .     ...+..+.+++.+||+.||++|||+.|++++.|..
T Consensus       274 ~-----~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~  309 (311)
T 3p1a_A          274 T-----AGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR  309 (311)
T ss_dssp             H-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGS
T ss_pred             c-----cCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcccc
Confidence            1     11245688999999999999999999999988753

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.2e-45  Score=337.59  Aligned_cols=253  Identities=22%  Similarity=0.275  Sum_probs=199.4

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccCh-------------------------hhHHHHHHHHHHHHc
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQ-------------------------QGESEFLSEVRMITS  135 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------------------------~~~~~~~~e~~~l~~  135 (407)
                      ++|++.+.||+|+||.||+|... +|+.||||++......                         ...+.+.+|++++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            67888899999999999999864 6899999998654311                         123568899999999


Q ss_pred             CCCCceeeeeeeeec--CCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccc
Q 040557          136 IQHKNLVRLLGCCSD--GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKAS  213 (407)
Q Consensus       136 l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~  213 (407)
                      ++||||+++++++.+  ....++||||+++++|.+++   ....+++..+..++.|++.||.|||+.+   ++||||||+
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~  166 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPS  166 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH
Confidence            999999999999986  56789999999999998865   3346999999999999999999999998   999999999


Q ss_pred             cEEEcCCCceEEecccCccccCCCCcccccccccCccccCccccccCC---CCccccEEehhHHHHHHHhcCCCCCCCCC
Q 040557          214 NVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE---LSEKADIYSFGVLVLEIISCRKNTDLTLP  290 (407)
Q Consensus       214 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~Dv~s~G~vl~el~tg~~p~~~~~~  290 (407)
                      |||++.++.+||+|||++......... .....||+.|+|||.+.+..   ++.++|||||||++|||++|+.||.....
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             HEEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            999999999999999999877544322 23467999999999987755   47889999999999999999999864321


Q ss_pred             cccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          291 SEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                            .. ........... .  +.      ....+..+.+++.+||+.||++|||+.|+++|.|.
T Consensus       246 ------~~-~~~~~~~~~~~-~--~~------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~  296 (298)
T 2zv2_A          246 ------MC-LHSKIKSQALE-F--PD------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV  296 (298)
T ss_dssp             ------HH-HHHHHHHCCCC-C--CS------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHH
T ss_pred             ------HH-HHHHHhcccCC-C--CC------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccc
Confidence                  11 11112211111 0  00      01123568899999999999999999999988764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.1e-45  Score=345.97  Aligned_cols=256  Identities=26%  Similarity=0.413  Sum_probs=201.0

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCc----EEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGT----LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      ++|+..+.||+|+||.||+|.+. +|+    .||+|.+...........+.+|+.++++++||||+++++++.++. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            56778899999999999999853 444    368888765555556678999999999999999999999998765 788


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      |+||+.+|+|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++....
T Consensus        94 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            999999999999987543 45899999999999999999999998   99999999999999999999999999987754


Q ss_pred             CCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          237 DQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       237 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      .... ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.......       .......+...    
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~~~----  238 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERL----  238 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTCCC----
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-------HHHHHHcCCCC----
Confidence            4322 2234457889999999999999999999999999999999 999987543321       12222222111    


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                            ..+...+..+.+++.+||+.||++|||+.+++++|+...
T Consensus       239 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~  277 (327)
T 3poz_A          239 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             ------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred             ------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                  011223456889999999999999999999999997653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.3e-45  Score=356.56  Aligned_cols=261  Identities=21%  Similarity=0.259  Sum_probs=211.2

Q ss_pred             HHhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           79 KATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      ...++|++.+.||+|+||.||+|.. .+|+.||+|.+..... ......+.+|+++++.++||||+++++++.+.+..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            3457788999999999999999975 4789999999875543 3345678999999999999999999999999999999


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc---CCCceEEecccCccc
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD---EKFQSKIGDFGLARF  233 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfgla~~  233 (407)
                      ||||+++|+|.+.+...  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++   +++.+||+|||++..
T Consensus        88 v~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           88 IFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             EECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            99999999999988643  45999999999999999999999998   99999999999998   567899999999987


Q ss_pred             cCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccccc
Q 040557          234 FPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV  313 (407)
Q Consensus       234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ....... .....||+.|+|||.+.+..++.++|||||||++|+|++|..||.....       ......+..+... ..
T Consensus       163 ~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~-~~  233 (444)
T 3soa_A          163 VEGEQQA-WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-------HRLYQQIKAGAYD-FP  233 (444)
T ss_dssp             CCTTCCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHTCCC-CC
T ss_pred             ecCCCce-eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHHhCCCC-CC
Confidence            6554322 2346799999999999999999999999999999999999999864321       1122222222211 00


Q ss_pred             CcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       314 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .+.      ....+..+.+++.+||+.||++|||+.|+++|.|...
T Consensus       234 ~~~------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          234 SPE------WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             TTT------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             ccc------cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence            010      0123456889999999999999999999999988643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.2e-45  Score=348.28  Aligned_cols=250  Identities=22%  Similarity=0.242  Sum_probs=209.6

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++....  .......+.+|++++..++||||+++++++.+....++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            56788899999999999999865 69999999986432  1234567889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       121 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~  195 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT  195 (350)
T ss_dssp             ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred             cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCCc
Confidence            999999999998643  35899999999999999999999998   9999999999999999999999999998765432


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                          ...+||+.|+|||.+.+..++.++|||||||++|||++|+.||.....      .. ....+..+...        
T Consensus       196 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~-~~~~i~~~~~~--------  256 (350)
T 1rdq_E          196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQ-IYEKIVSGKVR--------  256 (350)
T ss_dssp             ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHHCCCC--------
T ss_pred             ----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HH-HHHHHHcCCCC--------
Confidence                346799999999999999999999999999999999999999975322      11 22222222211        


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhhcc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPP-----MSEIVAMLTCK  358 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~l~~~  358 (407)
                         .+...+..+.+++.+||+.||++||+     +.++++|.++.
T Consensus       257 ---~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~  298 (350)
T 1rdq_E          257 ---FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA  298 (350)
T ss_dssp             ---CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred             ---CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcC
Confidence               11223456889999999999999998     99999998864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.8e-45  Score=341.97  Aligned_cols=261  Identities=23%  Similarity=0.248  Sum_probs=188.1

Q ss_pred             CCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCC-CCceeeeeeeeecCCeeEEEEEeccCC
Q 040557           87 GNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-HKNLVRLLGCCSDGSQRLLVYEYMKNR  164 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g  164 (407)
                      .+.||+|+||.||+|... +|+.||||++..    .....+.+|+.++..+. ||||+++++++.+....++||||+++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEG----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEECh----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence            478999999999999864 689999999853    23456779999999996 999999999999999999999999999


Q ss_pred             ChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC---ceEEecccCccccCCCCccc
Q 040557          165 SLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF---QSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       165 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfgla~~~~~~~~~~  241 (407)
                      +|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++   .+||+|||+++........ 
T Consensus        92 ~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-  165 (325)
T 3kn6_A           92 ELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-  165 (325)
T ss_dssp             BHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-
Confidence            999999653  46999999999999999999999998   99999999999998665   8999999999876544322 


Q ss_pred             ccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCC
Q 040557          242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEG  321 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  321 (407)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..................+..+...  ....     
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~--~~~~-----  238 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS--FEGE-----  238 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC--CCSH-----
T ss_pred             ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC--CCcc-----
Confidence            234578999999999999999999999999999999999999997644322211112222222222110  0000     


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccCCCC
Q 040557          322 IVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIP  364 (407)
Q Consensus       322 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~~~~  364 (407)
                      .....+..+.+++.+||+.||++|||+.|+++|.|.......+
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~  281 (325)
T 3kn6_A          239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS  281 (325)
T ss_dssp             HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCC
T ss_pred             cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCC
Confidence            0012345688999999999999999999999999876554433

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6.7e-46  Score=356.41  Aligned_cols=264  Identities=20%  Similarity=0.223  Sum_probs=212.7

Q ss_pred             HHHHHhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC
Q 040557           76 TLKKATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS  152 (407)
Q Consensus        76 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  152 (407)
                      +++...++|++.+.||+|+||.||+|+.. +++.||+|++.....  ......+.+|..++..++||||+++++++.+..
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            44445678999999999999999999865 589999999854221  112235789999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                      ..|+||||++||+|.+++...   .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeE
Confidence            999999999999999998643   4899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcccccccccCccccCccccccCC----CCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCc
Q 040557          233 FFPEDQAYLSTNFAGTLGYTAPEYAIRGE----LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGR  308 (407)
Q Consensus       233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      .............+||+.|+|||++.+..    ++.++|||||||++|||++|+.||......      ...........
T Consensus       217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~  290 (410)
T 3v8s_A          217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKN  290 (410)
T ss_dssp             ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTHHH
T ss_pred             eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------hHHHHHHhccc
Confidence            87665544445678999999999998765    889999999999999999999999753321      11222211100


Q ss_pred             cccccCcccccCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHhhccc
Q 040557          309 ILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQ--RPPMSEIVAMLTCKV  359 (407)
Q Consensus       309 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~~l~~~~  359 (407)
                      ..     ....   ....+..+.+++.+||+.+|.+  ||++.||++|.++..
T Consensus       291 ~~-----~~p~---~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~  335 (410)
T 3v8s_A          291 SL-----TFPD---DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  335 (410)
T ss_dssp             HC-----CCCT---TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred             cc-----cCCC---cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence            00     0000   0112356889999999999988  999999999998753

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.7e-46  Score=350.42  Aligned_cols=262  Identities=27%  Similarity=0.437  Sum_probs=209.8

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEe------cCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCC
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGS  152 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  152 (407)
                      ..++|++.+.||+|+||.||+|..      .++..||+|.+...........+.+|+.++.++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            447888899999999999999985      246689999997554444557889999999999 8999999999999999


Q ss_pred             eeEEEEEeccCCChhHHHhccCC---------------------CCCCHHHHHHHHHHHHHHhccccccCCCceeeeccc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGESD---------------------KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIK  211 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk  211 (407)
                      ..++||||+++|+|.+++.....                     ..+++..+..++.|++.||.|||+.+   ++|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence            99999999999999999975432                     24799999999999999999999998   9999999


Q ss_pred             cccEEEcCCCceEEecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCC
Q 040557          212 ASNVLLDEKFQSKIGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTL  289 (407)
Q Consensus       212 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~  289 (407)
                      |+|||++.++.+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||+| |..||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            99999999999999999999866443322 2234567889999999999999999999999999999998 999986543


Q ss_pred             CcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          290 PSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                      ..      .........+...          ..+...+..+.+++.+||+.||++|||+.+++++|+....
T Consensus       280 ~~------~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          280 VD------ANFYKLIQNGFKM----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             CS------HHHHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             cH------HHHHHHHhcCCCC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            22      1122222222111          0112234568899999999999999999999999986543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-45  Score=335.35  Aligned_cols=256  Identities=27%  Similarity=0.405  Sum_probs=211.1

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      ++|++.+.||+|+||.||+|...++..||+|.+....  ...+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            5677788999999999999998888999999996433  23467899999999999999999999999999999999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      ++++|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++..........
T Consensus        86 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  161 (267)
T 3t9t_A           86 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  161 (267)
T ss_dssp             TTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             CCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence            9999999986543 45899999999999999999999998   9999999999999999999999999998765443333


Q ss_pred             ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......      ... .....+...          
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~-~~i~~~~~~----------  224 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVV-EDISTGFRL----------  224 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHH-HHHHTTCCC----------
T ss_pred             cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------HHH-HHHhcCCcC----------
Confidence            334567889999999998999999999999999999999 88888643221      111 112221100          


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                      ..+...+..+.+++.+||+.||++|||+.+++++|....+
T Consensus       225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            0111234568899999999999999999999999987654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=8.7e-46  Score=344.38  Aligned_cols=260  Identities=25%  Similarity=0.412  Sum_probs=214.0

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe------cCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCe
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQ  153 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  153 (407)
                      .++|++.+.||+|+||.||+|..      .+++.||+|.+.........+.+.+|+.++.++ +||||+++++++.+.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            36788889999999999999974      357889999997665556667899999999999 99999999999999999


Q ss_pred             eEEEEEeccCCChhHHHhccCC----------------CCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEE
Q 040557          154 RLLVYEYMKNRSLDLLIYGESD----------------KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL  217 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill  217 (407)
                      .++||||+++|+|.+++.....                ..+++..+..++.|++.||.|||+.+   ++||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence            9999999999999999975442                24899999999999999999999998   9999999999999


Q ss_pred             cCCCceEEecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCc
Q 040557          218 DEKFQSKIGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQY  295 (407)
Q Consensus       218 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~  295 (407)
                      +.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......    
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----  254 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD----  254 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS----
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch----
Confidence            99999999999999877654332 2234557889999999999999999999999999999999 99888654322    


Q ss_pred             hhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          296 LPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                        .........+...     .     .+...+..+.+++.+||+.||++|||+.+++++|+...
T Consensus       255 --~~~~~~~~~~~~~-----~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          255 --SKFYKMIKEGFRM-----L-----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             --HHHHHHHHHTCCC-----C-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --hHHHHHhccCCCC-----C-----CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence              1122222222110     0     11123456889999999999999999999999998654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.4e-45  Score=356.87  Aligned_cols=253  Identities=26%  Similarity=0.329  Sum_probs=209.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|.+.+.||+|+||.||+|+.. +|+.||||++.....  ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56888899999999999999865 799999999864321  123467889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|.+++.  ....+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.......
T Consensus        96 E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           96 EYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             ECCSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             eCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            9999999999985  3456999999999999999999999998   9999999999999999999999999998775543


Q ss_pred             cccccccccCccccCccccccCCC-CccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      .  ....+||+.|+|||.+.+..+ +.++|||||||++|||++|+.||......      .... .+..+...       
T Consensus       171 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~~-~i~~~~~~-------  234 (476)
T 2y94_A          171 F--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------TLFK-KICDGIFY-------  234 (476)
T ss_dssp             C--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------HHHH-HHHTTCCC-------
T ss_pred             c--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------HHHH-HHhcCCcC-------
Confidence            2  234679999999999988766 78999999999999999999999753321      1122 22222110       


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                          .+...+..+.+++.+||+.||++|||+.|+++|.|...
T Consensus       235 ----~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          235 ----TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             ----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             ----CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence                11112346889999999999999999999999887654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.7e-45  Score=340.95  Aligned_cols=267  Identities=25%  Similarity=0.360  Sum_probs=195.0

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+...........+.+|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467889999999999999999864 6899999999765544445678899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccC----CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccC
Q 040557          160 YMKNRSLDLLIYGES----DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP  235 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~  235 (407)
                      |++ |+|.+++....    ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 59988875432    245899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh-Ccccc--
Q 040557          236 EDQAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER-GRILE--  311 (407)
Q Consensus       236 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~--  311 (407)
                      ..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+      ........ +...+  
T Consensus       160 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~~~~~~~~~  232 (317)
T 2pmi_A          160 IPVNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE------QLKLIFDIMGTPNESL  232 (317)
T ss_dssp             SCCCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHHHCSCCTTT
T ss_pred             CCccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHHHhCCCChhH
Confidence            33221 234578999999999876 468999999999999999999999997543211      11111110 00000  


Q ss_pred             --------ccCccccc-----------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          312 --------LVDPRMRK-----------EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       312 --------~~d~~~~~-----------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                              ...+....           .......+..+.+++.+||+.||++|||+.|+++|-|..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~  298 (317)
T 2pmi_A          233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA  298 (317)
T ss_dssp             CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred             hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhh
Confidence                    00000000           000011235688999999999999999999999998764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.8e-45  Score=349.18  Aligned_cols=277  Identities=21%  Similarity=0.222  Sum_probs=213.4

Q ss_pred             ccCHHHHHHHhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCC-----CCceeee
Q 040557           71 YFDFQTLKKATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-----HKNLVRL  144 (407)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l  144 (407)
                      .|++.......++|++.+.||+|+||.||+|+. .+++.||||++..  .......+..|++++..+.     |+||+++
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN--IKKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc--chhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            355555556678999999999999999999986 4689999999852  3444566788999999886     9999999


Q ss_pred             eeeeecCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC-----
Q 040557          145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE-----  219 (407)
Q Consensus       145 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-----  219 (407)
                      ++++...+..++||||+ +++|.+++.......+++..+..++.|++.||.|||+.+   |+||||||+|||++.     
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~  177 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEK  177 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCE
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccc
Confidence            99999999999999999 899999998766667999999999999999999999998   999999999999975     


Q ss_pred             --------------------CCceEEecccCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHH
Q 040557          220 --------------------KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII  279 (407)
Q Consensus       220 --------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~  279 (407)
                                          ++.+||+|||++.......    ....||+.|+|||.+.+..++.++|||||||++|||+
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  253 (360)
T 3llt_A          178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY  253 (360)
T ss_dssp             EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred             cccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence                                7899999999998654432    3467899999999999999999999999999999999


Q ss_pred             hcCCCCCCCCCcccCc--------hhHHHHHHHHhCccccccCcc-c----ccCCCCH---------------HHHHHHH
Q 040557          280 SCRKNTDLTLPSEMQY--------LPEYAWKLYERGRILELVDPR-M----RKEGIVE---------------RDALQVI  331 (407)
Q Consensus       280 tg~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~d~~-~----~~~~~~~---------------~~~~~l~  331 (407)
                      +|+.||......+...        .+...............++.. .    .......               .....+.
T Consensus       254 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  333 (360)
T 3llt_A          254 TGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC  333 (360)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHH
T ss_pred             HCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHH
Confidence            9999997543211000        000000000000000000000 0    0000000               0114677


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          332 NVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       332 ~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      +++.+||+.||++|||+.|+++|.|.
T Consensus       334 ~li~~~L~~dP~~Rpta~elL~hp~f  359 (360)
T 3llt_A          334 DFLYSILQIDPTLRPSPAELLKHKFL  359 (360)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred             HHHHHHhcCChhhCCCHHHHhcCccc
Confidence            99999999999999999999998764

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=7.1e-46  Score=341.11  Aligned_cols=265  Identities=25%  Similarity=0.361  Sum_probs=203.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccCh-hhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQ-QGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      ++|++.+.||+|+||.||+|+..+|+.||+|++...... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            467888999999999999999888999999998654322 2236788999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++ +|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++........ 
T Consensus        82 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-  155 (288)
T ss_dssp             CSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             cCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence            986 888888643 345899999999999999999999998   99999999999999999999999999987653322 


Q ss_pred             cccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh-Ccc---------
Q 040557          241 LSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER-GRI---------  309 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~---------  309 (407)
                      ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......      ......... +..         
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA------DQLMRIFRILGTPNSKNWPNVT  229 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHCCCCTTTSTTGG
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHHCCCChhhchhhh
Confidence            1234568999999999876 45899999999999999999999998653221      111111110 000         


Q ss_pred             -ccccCccccc------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          310 -LELVDPRMRK------EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       310 -~~~~d~~~~~------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                       ....++....      .......+..+.+++.+||+.||++|||+.|+++|.|..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~  285 (288)
T 1ob3_A          230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK  285 (288)
T ss_dssp             GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred             cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence             0001111100      001112345688999999999999999999999998764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.4e-46  Score=342.29  Aligned_cols=257  Identities=27%  Similarity=0.392  Sum_probs=215.1

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ..++|++.+.||+|+||.||+|... ++..||+|.+...  ....+.+.+|++++++++||||+++++++.+....++||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC--STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            3467888899999999999999875 4889999998543  334567899999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++++|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......
T Consensus        89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            9999999999998766677999999999999999999999998   9999999999999999999999999999877655


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      ........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.......       ...........       
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-------~~~~~~~~~~~-------  231 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRM-------  231 (288)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHHHHHTTCCC-------
T ss_pred             cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhccCCC-------
Confidence            444455667889999999999999999999999999999999 888886543221       11112211100       


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                         ..+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus       232 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          232 ---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence               11122345688999999999999999999999998754

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.1e-46  Score=356.49  Aligned_cols=267  Identities=21%  Similarity=0.199  Sum_probs=212.6

Q ss_pred             HHHHHHHhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeec
Q 040557           74 FQTLKKATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSD  150 (407)
Q Consensus        74 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  150 (407)
                      ..+++...++|++.+.||+|+||.||+|+.. +|+.||+|++....  .......+.+|..++..++|+||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3444455688999999999999999999874 69999999986432  11223457899999999999999999999999


Q ss_pred             CCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccC
Q 040557          151 GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGL  230 (407)
Q Consensus       151 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgl  230 (407)
                      .+..|+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGl  208 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGS  208 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechh
Confidence            999999999999999999996432 35899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccCccccCccccc-------cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHH
Q 040557          231 ARFFPEDQAYLSTNFAGTLGYTAPEYAI-------RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKL  303 (407)
Q Consensus       231 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~  303 (407)
                      ++.............+||+.|+|||++.       ...++.++|||||||++|||++|+.||......      ......
T Consensus       209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i  282 (412)
T 2vd5_A          209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA------ETYGKI  282 (412)
T ss_dssp             CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHH
T ss_pred             heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH------HHHHHH
Confidence            9887665544444568999999999987       357899999999999999999999999754321      111111


Q ss_pred             HHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHHhhcc
Q 040557          304 YERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQR---PPMSEIVAMLTCK  358 (407)
Q Consensus       304 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---Ps~~ev~~~l~~~  358 (407)
                      ........  -+.     .....+..+.+++.+||+ +|++|   |+++|+++|-++.
T Consensus       283 ~~~~~~~~--~p~-----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~  332 (412)
T 2vd5_A          283 VHYKEHLS--LPL-----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF  332 (412)
T ss_dssp             HTHHHHCC--CC---------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGT
T ss_pred             HhcccCcC--CCc-----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcC
Confidence            11100000  010     111234568899999999 99998   6999999998864

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.2e-45  Score=347.28  Aligned_cols=259  Identities=23%  Similarity=0.303  Sum_probs=208.6

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc----ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK----SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRL  155 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  155 (407)
                      .++|++.+.||+|+||.||+|... +|+.||||++....    .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            357888999999999999999864 68999999985432    1123567899999999999999999999999999999


Q ss_pred             EEEEeccCCChhHHHhcc--CCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCc---eEEecccC
Q 040557          156 LVYEYMKNRSLDLLIYGE--SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ---SKIGDFGL  230 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfgl  230 (407)
                      +||||+++|+|.+.+...  ....+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999998877543  2345899999999999999999999998   999999999999986654   99999999


Q ss_pred             ccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccc
Q 040557          231 ARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRIL  310 (407)
Q Consensus       231 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      +........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....        .........+...
T Consensus       180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~i~~~~~~  250 (351)
T 3c0i_A          180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--------ERLFEGIIKGKYK  250 (351)
T ss_dssp             CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--------HHHHHHHHHTCCC
T ss_pred             eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--------HHHHHHHHcCCCC
Confidence            987765432 2334679999999999999999999999999999999999999997521        1111122222111


Q ss_pred             cccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          311 ELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       311 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                        .++...     ...+..+.+++.+||+.||++|||+.++++|.|..
T Consensus       251 --~~~~~~-----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~  291 (351)
T 3c0i_A          251 --MNPRQW-----SHISESAKDLVRRMLMLDPAERITVYEALNHPWLK  291 (351)
T ss_dssp             --CCHHHH-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             --CCcccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhc
Confidence              000000     01235688999999999999999999999988764

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.2e-45  Score=339.99  Aligned_cols=263  Identities=23%  Similarity=0.394  Sum_probs=206.4

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-----cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC--Cee
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG--SQR  154 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  154 (407)
                      +.|++.+.||+|+||.||+|++     .+++.||+|++...........+.+|+++++.++|+||+++++++.+.  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4577788999999999999983     468999999997655555567899999999999999999999999876  668


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcccc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF  234 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~  234 (407)
                      ++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++...
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccc
Confidence            99999999999999986443 45899999999999999999999998   999999999999999999999999999877


Q ss_pred             CCCCcc--cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCC--------CcccCchhHHHHHHH
Q 040557          235 PEDQAY--LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTL--------PSEMQYLPEYAWKLY  304 (407)
Q Consensus       235 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~--------~~~~~~~~~~~~~~~  304 (407)
                      ......  ......||..|+|||.+.+..++.++||||||+++|||++|+.|+....        +..............
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL  256 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence            654432  2334568889999999999999999999999999999999998754221        000000111111111


Q ss_pred             HhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          305 ERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       305 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ..+..          ...+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus       257 ~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          257 KEGKR----------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HTTCC----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hccCC----------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            11110          011223446789999999999999999999999999754

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9e-46  Score=348.25  Aligned_cols=255  Identities=24%  Similarity=0.322  Sum_probs=208.7

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRL  155 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  155 (407)
                      ..++|.+.+.||+|+||.||+|+.. +|+.||+|++....  .......+..|.+++..+ +||||+++++++.+.+..+
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            4578888999999999999999875 68999999996432  123345678899999877 9999999999999999999


Q ss_pred             EEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccC
Q 040557          156 LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP  235 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~  235 (407)
                      +||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++...
T Consensus        95 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            999999999999998643  45899999999999999999999998   9999999999999999999999999998653


Q ss_pred             CCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          236 EDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       236 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                      .... .....+||+.|+|||.+.+..++.++|||||||++|||++|+.||......      . ....+..+.      +
T Consensus       170 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~-~~~~i~~~~------~  235 (345)
T 1xjd_A          170 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------E-LFHSIRMDN------P  235 (345)
T ss_dssp             CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCC------C
T ss_pred             cCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH------H-HHHHHHhCC------C
Confidence            3222 234568999999999999999999999999999999999999999753221      1 112222111      1


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHHhhcc
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMS-EIVAMLTCK  358 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-ev~~~l~~~  358 (407)
                      .     .+...+..+.+++.+||+.||++||++. ++++|.++.
T Consensus       236 ~-----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~  274 (345)
T 1xjd_A          236 F-----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR  274 (345)
T ss_dssp             C-----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGT
T ss_pred             C-----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCcccc
Confidence            1     1112345688999999999999999998 898887764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.4e-45  Score=361.89  Aligned_cols=258  Identities=26%  Similarity=0.338  Sum_probs=214.1

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|++....  .......+.+|+++|..++||||+++++++.+.+..++||
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  263 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL  263 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence            56888899999999999999864 69999999986432  2233567889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||++||+|.+++.......+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            9999999999997665566999999999999999999999998   9999999999999999999999999998775543


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                      .  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||........   .............         
T Consensus       341 ~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~---~~~i~~~i~~~~~---------  406 (576)
T 2acx_A          341 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK---REEVERLVKEVPE---------  406 (576)
T ss_dssp             C--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC---HHHHHHHHHHCCC---------
T ss_pred             c--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh---HHHHHHHhhcccc---------
Confidence            2  2345899999999999999999999999999999999999999975432211   1122222221110         


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhcc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRP-----PMSEIVAMLTCK  358 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~l~~~  358 (407)
                        ..+...+..+.+++.+||+.||++||     ++.|+++|-++.
T Consensus       407 --~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~  449 (576)
T 2acx_A          407 --EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK  449 (576)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGT
T ss_pred             --cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhc
Confidence              11122345688999999999999999     899999998865

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6.1e-45  Score=345.38  Aligned_cols=259  Identities=21%  Similarity=0.215  Sum_probs=197.8

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|++.+.||+|+||.||+++.. +|+.||+|++....  .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            367888899999999999999875 78999999986432  223567899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCc--eEEecccCccccCCC
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ--SKIGDFGLARFFPED  237 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~--~kl~Dfgla~~~~~~  237 (407)
                      |+++|+|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.  +||+|||+++.....
T Consensus        97 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           97 YASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             eCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            99999999998543  35999999999999999999999998   999999999999987765  999999999854322


Q ss_pred             CcccccccccCccccCccccccCCCCcc-ccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEK-ADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k-~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                      ..  .....||+.|+|||.+.+..++.+ +|||||||++|||++|+.||.......  ............ ..      .
T Consensus       172 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~-~~------~  240 (361)
T 3uc3_A          172 SQ--PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILSV-KY------S  240 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHTT-CC------C
T ss_pred             CC--CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhcC-CC------C
Confidence            21  234579999999999988887665 899999999999999999997543321  111112211111 00      0


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                      ...   ....+..+.+++.+||+.||++|||+.|+++|.|....
T Consensus       241 ~~~---~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          241 IPD---DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             CCT---TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             CCC---cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            000   00123568899999999999999999999999887543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1e-45  Score=345.46  Aligned_cols=269  Identities=27%  Similarity=0.409  Sum_probs=217.3

Q ss_pred             cCHHHHHHHhcCCCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeee
Q 040557           72 FDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLL  145 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~  145 (407)
                      +..++++...++|++.+.||+|+||.||+|...      +++.||+|.+...........+.+|+++++.++|+||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            344445556688999999999999999999753      37889999997655556667899999999999999999999


Q ss_pred             eeeecCCeeEEEEEeccCCChhHHHhccC--------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEE
Q 040557          146 GCCSDGSQRLLVYEYMKNRSLDLLIYGES--------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL  217 (407)
Q Consensus       146 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill  217 (407)
                      +++.+.+..++||||+++|+|.+++....        ...+++..+..++.|++.||.|||+.+   ++||||||+||++
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence            99999999999999999999999986432        245799999999999999999999998   9999999999999


Q ss_pred             cCCCceEEecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCc
Q 040557          218 DEKFQSKIGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQY  295 (407)
Q Consensus       218 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~  295 (407)
                      +.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....     
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----  246 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----  246 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-----
Confidence            99999999999999866443322 2233457889999999999999999999999999999999 7888764321     


Q ss_pred             hhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          296 LPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                        .........+....          .+...+..+.+++.+||+.||++|||+.+++++|+....
T Consensus       247 --~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          247 --EQVLRFVMEGGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             --HHHHHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             --HHHHHHHHcCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence              11222222222111          112234568899999999999999999999999987643

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.8e-45  Score=341.30  Aligned_cols=260  Identities=28%  Similarity=0.425  Sum_probs=212.6

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec--------CCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecC
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA--------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDG  151 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  151 (407)
                      .++|++.+.||+|+||.||+|...        ++..||+|++...........+.+|++++.++ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            367888899999999999999863        46789999997665666677899999999999 899999999999999


Q ss_pred             CeeEEEEEeccCCChhHHHhccCC--------------CCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEE
Q 040557          152 SQRLLVYEYMKNRSLDLLIYGESD--------------KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL  217 (407)
Q Consensus       152 ~~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill  217 (407)
                      +..++||||+++|+|.+++.....              ..+++..+..++.|++.||.|||+.+   ++||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence            999999999999999999975432              34899999999999999999999998   9999999999999


Q ss_pred             cCCCceEEecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCc
Q 040557          218 DEKFQSKIGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQY  295 (407)
Q Consensus       218 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~  295 (407)
                      +.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......    
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----  266 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----  266 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH----
Confidence            99999999999999877654332 2233457889999999999999999999999999999999 99888643211    


Q ss_pred             hhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          296 LPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                         .....+..+....          .+...+..+.+++.+||+.||++|||+.+++++|+....
T Consensus       267 ---~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          267 ---ELFKLLKEGHRMD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             ---HHHHHHHHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHHHHhcCCCCC----------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence               1222222221110          112234568899999999999999999999999987643

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-44  Score=340.33  Aligned_cols=274  Identities=23%  Similarity=0.331  Sum_probs=205.3

Q ss_pred             HHHHHHHhcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcC--CCCceeeeeeeeecC
Q 040557           74 FQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI--QHKNLVRLLGCCSDG  151 (407)
Q Consensus        74 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~  151 (407)
                      ........++|++.+.||+|+||.||+|+.. |+.||||++...    ....+..|.+++...  +|+||+++++++...
T Consensus        29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            3334455678999999999999999999985 899999998532    233455666666654  899999999999877


Q ss_pred             ----CeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccC-----CCceeeeccccccEEEcCCCc
Q 040557          152 ----SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS-----HTRIVHRDIKASNVLLDEKFQ  222 (407)
Q Consensus       152 ----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~dlk~~Nill~~~~~  222 (407)
                          ...++||||+++|+|.+++...   .+++..+..++.|++.||.|||+..     .++++||||||+|||++.++.
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~  180 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT  180 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence                6789999999999999999543   4899999999999999999999881     112999999999999999999


Q ss_pred             eEEecccCccccCCCCccc---ccccccCccccCccccccCCCCcc------ccEEehhHHHHHHHhcC----------C
Q 040557          223 SKIGDFGLARFFPEDQAYL---STNFAGTLGYTAPEYAIRGELSEK------ADIYSFGVLVLEIISCR----------K  283 (407)
Q Consensus       223 ~kl~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k------~Dv~s~G~vl~el~tg~----------~  283 (407)
                      +||+|||++..+.......   .....||+.|+|||.+.+..++.+      +|||||||++|||+||.          .
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~  260 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL  260 (337)
T ss_dssp             EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence            9999999998765433221   124579999999999988766655      99999999999999994          4


Q ss_pred             CCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          284 NTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       284 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                      |+....+....  .............    .+..........++..+.+++.+||+.||++|||+.+++++|+...+.
T Consensus       261 p~~~~~~~~~~--~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          261 PYHDLVPSDPS--YEDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             TTTTTSCSSCC--HHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cHhhhcCCCCc--hhhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence            44432222211  1111111111111    111111111235678899999999999999999999999999876543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.4e-44  Score=329.13  Aligned_cols=254  Identities=22%  Similarity=0.322  Sum_probs=207.4

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC--CeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG--SQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|+.. |+.||||.+.... .......+.+|+.++++++||||+++++++.+.  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            56788899999999999999984 8999999997544 344557799999999999999999999999877  7889999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|.+++.......+++..+..++.|++.||.|||+.+ ++++||||||+||+++.++.++|+|||++.....  
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~--  165 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS--  165 (271)
T ss_dssp             ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--
T ss_pred             cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc--
Confidence            9999999999998666557999999999999999999999864 4599999999999999999999999998865332  


Q ss_pred             cccccccccCccccCccccccCCCCc---cccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSE---KADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~---k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                          ....||+.|+|||.+.+..++.   ++||||||+++|||++|+.||......      .........+..     +
T Consensus       166 ----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~-----~  230 (271)
T 3kmu_A          166 ----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALEGLR-----P  230 (271)
T ss_dssp             ----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHHHSCCC-----C
T ss_pred             ----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHHhcCCC-----C
Confidence                2346899999999998765544   799999999999999999998643221      111222221111     1


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .     .+...+..+.+++.+||+.||++|||+.++++.|....
T Consensus       231 ~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          231 T-----IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             C-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             C-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            1     11223456889999999999999999999999997653

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.3e-44  Score=347.64  Aligned_cols=264  Identities=21%  Similarity=0.203  Sum_probs=199.8

Q ss_pred             cCCCCC-CeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHc-CCCCceeeeeeeeec----CCee
Q 040557           82 KNFHPG-NLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITS-IQHKNLVRLLGCCSD----GSQR  154 (407)
Q Consensus        82 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~~  154 (407)
                      ++|.+. +.||+|+||.||+|... +|+.||||++...      ..+.+|++++.+ .+|+||+++++++..    ....
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            455554 68999999999999864 6899999998521      245688888754 489999999998865    5678


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC---CCceEEecccCc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE---KFQSKIGDFGLA  231 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfgla  231 (407)
                      ++||||+++|+|.+++.......+++..+..++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence            99999999999999997665567999999999999999999999998   999999999999997   789999999999


Q ss_pred             cccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccc
Q 040557          232 RFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILE  311 (407)
Q Consensus       232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      +.......  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||..........  . ....+..+... 
T Consensus       212 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~-~~~~i~~~~~~-  285 (400)
T 1nxk_A          212 KETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--G-MKTRIRMGQYE-  285 (400)
T ss_dssp             EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC--S-HHHHHHHTCCC-
T ss_pred             cccCCCCc--cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH--H-HHHHHHcCccc-
Confidence            87654332  235678999999999999999999999999999999999999997654332111  0 11111212111 


Q ss_pred             ccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccCCCCCC
Q 040557          312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVR  366 (407)
Q Consensus       312 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~~~~~~  366 (407)
                      ...+      .....+..+.+++.+||+.||++|||+.|+++|.|.......+..
T Consensus       286 ~~~~------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~  334 (400)
T 1nxk_A          286 FPNP------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT  334 (400)
T ss_dssp             CCTT------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTSCCC
T ss_pred             CCCc------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCCCCC
Confidence            0000      011234568899999999999999999999999987655544433

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=9.4e-45  Score=330.45  Aligned_cols=253  Identities=28%  Similarity=0.431  Sum_probs=195.8

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccC---hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKS---QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|... |+.||||++.....   ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            56788899999999999999984 89999999865432   223467889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC--------CCceEEecccC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE--------KFQSKIGDFGL  230 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~--------~~~~kl~Dfgl  230 (407)
                      ||+++++|.+++.   ...+++..+..++.|++.||.|||+.+..+++||||||+||+++.        ++.+||+|||+
T Consensus        86 e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~  162 (271)
T 3dtc_A           86 EFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL  162 (271)
T ss_dssp             ECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred             EcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence            9999999999984   346899999999999999999999987556899999999999986        67899999999


Q ss_pred             ccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccc
Q 040557          231 ARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRIL  310 (407)
Q Consensus       231 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      +........   ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......      ...... ..+...
T Consensus       163 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~-~~~~~~  232 (271)
T 3dtc_A          163 AREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AVAYGV-AMNKLA  232 (271)
T ss_dssp             ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHH-HTSCCC
T ss_pred             ccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHhh-hcCCCC
Confidence            986654332   2457899999999999999999999999999999999999998643211      111111 111111


Q ss_pred             cccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          311 ELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       311 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                          .     ..+...+..+.+++.+||+.||++|||+.|++++|+.
T Consensus       233 ----~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          233 ----L-----PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             ----C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             ----C-----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence                0     1122234568899999999999999999999999964

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.7e-45  Score=366.44  Aligned_cols=259  Identities=28%  Similarity=0.442  Sum_probs=212.5

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      ..++|++.+.||+|+||.||+|.+.++..||||++....  ...+.|.+|+++|++++|+||+++++++.+ ...++|||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence            345677788999999999999999888889999996433  234679999999999999999999999976 67899999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++|+|.+++.......+++..+..++.|++.||.|||+++   ++||||||+|||+++++.+||+|||+++.......
T Consensus       342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred             hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence            999999999997554556999999999999999999999998   99999999999999999999999999987764433


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                      .......++..|+|||.+.+..++.++|||||||++|||++ |+.||.....       ......+..+...        
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-------~~~~~~i~~~~~~--------  483 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGYRM--------  483 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-------HHHHHHHHTTCCC--------
T ss_pred             ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCC--------
Confidence            23334557889999999999999999999999999999999 8888864321       1122222222111        


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                        ..+..++..+.+|+.+||+.||++|||+.+|++.|+.....
T Consensus       484 --~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          484 --PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             --CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence              01223445688999999999999999999999999876543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=348.20  Aligned_cols=257  Identities=19%  Similarity=0.295  Sum_probs=201.2

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCC--CceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQH--KNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||++...+++.||||++.... .......+.+|+.+|..++|  +||+++++++.+....++||
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~   88 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM   88 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence            5688889999999999999998889999999986543 34455778999999999976  99999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      | +.+|+|.+++..  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++ ++.+||+|||+++.+....
T Consensus        89 e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           89 E-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             C-CCSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             e-CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            9 568899999964  346899999999999999999999998   99999999999997 5689999999998775443


Q ss_pred             cc-cccccccCccccCcccccc-----------CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh
Q 040557          239 AY-LSTNFAGTLGYTAPEYAIR-----------GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER  306 (407)
Q Consensus       239 ~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      .. ......||+.|+|||.+.+           ..++.++|||||||++|||++|+.||......     ......... 
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~~-  235 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIID-  235 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHC-
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHHHHHhc-
Confidence            22 2335679999999999865           67899999999999999999999999643221     111111111 


Q ss_pred             CccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          307 GRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       307 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                              +.... ..+......+.+++.+||+.||++|||+.|+++|.|....
T Consensus       236 --------~~~~~-~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          236 --------PNHEI-EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             --------TTSCC-CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             --------CCccc-CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence                    11110 0111123468899999999999999999999999987643

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.4e-45  Score=334.88  Aligned_cols=256  Identities=27%  Similarity=0.425  Sum_probs=209.8

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      .++|++.+.||+|+||.||+|...++..||+|.+....  .....+.+|+++++.++||||+++++++.+ +..++||||
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   88 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence            36788889999999999999998888899999986433  335678999999999999999999999864 468999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++++|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++.........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence            99999999986544446999999999999999999999998   999999999999999999999999999987655444


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......      .. ......+...         
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~-~~~~~~~~~~---------  229 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EV-IQNLERGYRM---------  229 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HH-HHHHHTTCCC---------
T ss_pred             cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH------HH-HHHHhcccCC---------
Confidence            3444567889999999998999999999999999999999 88888643221      11 1122221100         


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                       ..+...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus       230 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  268 (279)
T 1qpc_A          230 -VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (279)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence             011223456889999999999999999999999997653

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-45  Score=340.24  Aligned_cols=269  Identities=24%  Similarity=0.350  Sum_probs=203.7

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccC----hhhHHHHHHHHHHHHcC---CCCceeeeeeeeecC
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKS----QQGESEFLSEVRMITSI---QHKNLVRLLGCCSDG  151 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~  151 (407)
                      ..++|++.+.||+|+||+||+|+. .+|+.||+|++.....    ......+.+|+++++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            357899999999999999999985 4689999999864331    11123556777777666   499999999999765


Q ss_pred             C-----eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEe
Q 040557          152 S-----QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIG  226 (407)
Q Consensus       152 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~  226 (407)
                      .     ..++||||+. |+|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEe
Confidence            5     5799999997 59999997766666999999999999999999999998   9999999999999999999999


Q ss_pred             cccCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh
Q 040557          227 DFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER  306 (407)
Q Consensus       227 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      |||++........  .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......      .........
T Consensus       163 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~------~~~~~i~~~  234 (308)
T 3g33_A          163 DFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA------DQLGKIFDL  234 (308)
T ss_dssp             SCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH------HHHHHHHHH
T ss_pred             eCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHH
Confidence            9999987654332  24567899999999999999999999999999999999999999654321      111111110


Q ss_pred             -Cccc--cc---c---CcccccC-C-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          307 -GRIL--EL---V---DPRMRKE-G-----IVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       307 -~~~~--~~---~---d~~~~~~-~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                       +...  ..   .   ....... .     .....+..+.+++.+||+.||++|||+.|+++|-|....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence             0000  00   0   0000000 0     001123568899999999999999999999999886543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.8e-45  Score=345.06  Aligned_cols=254  Identities=24%  Similarity=0.288  Sum_probs=208.6

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  156 (407)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++....  .......+..|.+++..+ +||||+++++++.+.+..|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            467888899999999999999875 48899999986432  123456788999999988 89999999999999999999


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        99 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            99999999999998643  35899999999999999999999998   99999999999999999999999999986433


Q ss_pred             CCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          237 DQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                      ... .....+||+.|+|||.+.+..++.++|||||||++|||++|+.||.....      ......... +..       
T Consensus       174 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~-~~~-------  238 (353)
T 2i0e_A          174 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIME-HNV-------  238 (353)
T ss_dssp             TTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-CCC-------
T ss_pred             CCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHHHHHHHh-CCC-------
Confidence            222 23456899999999999999999999999999999999999999975322      112222222 111       


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhhcc
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRPP-----MSEIVAMLTCK  358 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~l~~~  358 (407)
                          ..+...+..+.+++.+||+.||++||+     +.++++|.++.
T Consensus       239 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~  281 (353)
T 2i0e_A          239 ----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR  281 (353)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGT
T ss_pred             ----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcccc
Confidence                011223456889999999999999994     69999988764

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.2e-45  Score=342.83  Aligned_cols=253  Identities=22%  Similarity=0.337  Sum_probs=199.0

Q ss_pred             cCCCCCCeeeccCCccEEEEEe----cCCcEEEEEEecccc---ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCee
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL----ADGTLVAVKKLCVDK---SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQR  154 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  154 (407)
                      ++|++.+.||+|+||.||+++.    .+|+.||+|++....   .......+.+|+++++.++||||+++++++.+.+..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            5788889999999999999986    478999999996543   123345678999999999999999999999999999


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcccc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF  234 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~  234 (407)
                      ++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++..
T Consensus        97 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           97 YLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            9999999999999998543  45899999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          235 PEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       235 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      ..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......      ........ ...     
T Consensus       172 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~-~~~-----  238 (327)
T 3a62_A          172 IHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKILK-CKL-----  238 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHH-TCC-----
T ss_pred             ccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHh-CCC-----
Confidence            43322 223467999999999999999999999999999999999999999753221      11222221 111     


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhcc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRP-----PMSEIVAMLTCK  358 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~l~~~  358 (407)
                       .     .+...+..+.+++.+||+.||++||     ++.++++|.++.
T Consensus       239 -~-----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~  281 (327)
T 3a62_A          239 -N-----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR  281 (327)
T ss_dssp             -C-----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGS
T ss_pred             -C-----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCccc
Confidence             0     1122345688999999999999999     889999998864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-44  Score=345.33  Aligned_cols=259  Identities=22%  Similarity=0.236  Sum_probs=210.7

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+... .......+.+|+++|..++||||+++++++.+....++|||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc-chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            467889999999999999999864 6899999998643 33445678999999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC--CCceEEecccCccccCCC
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE--KFQSKIGDFGLARFFPED  237 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~--~~~~kl~Dfgla~~~~~~  237 (407)
                      |+++|+|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.  ++.+||+|||++......
T Consensus       129 ~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          129 FLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             cCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            99999999988543 335899999999999999999999998   999999999999974  577999999999977654


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      ...  ....||+.|+|||.+.+..++.++|||||||++|||++|+.||......      ..... +......  .+.. 
T Consensus       205 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~-i~~~~~~--~~~~-  272 (387)
T 1kob_A          205 EIV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQN-VKRCDWE--FDED-  272 (387)
T ss_dssp             SCE--EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHH-HHHCCCC--CCSS-
T ss_pred             cce--eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH------HHHHH-HHhCCCC--CCcc-
Confidence            322  3457999999999999999999999999999999999999999753211      11111 1111110  1111 


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                          .....+..+.+++.+||+.||++|||+.|+++|.|....
T Consensus       273 ----~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          273 ----AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             ----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             ----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence                111234568899999999999999999999999886543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=7.1e-45  Score=333.15  Aligned_cols=256  Identities=23%  Similarity=0.364  Sum_probs=204.9

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecC----CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLAD----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      .++|.+.+.||+|+||.||+|...+    +..||+|.+...........+.+|+.+++.++||||+++++++.++ ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            3678888999999999999998542    3469999987665566678899999999999999999999998754 5689


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        90 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             EEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             EEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            999999999999986533 45899999999999999999999998   99999999999999999999999999987765


Q ss_pred             CCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          237 DQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                      ..........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......       .......+....    
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-------~~~~~~~~~~~~----  234 (281)
T 3cc6_A          166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-------VIGVLEKGDRLP----  234 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-------HHHHHHHTCCCC----
T ss_pred             ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-------HHHHHhcCCCCC----
Confidence            54433444567889999999998999999999999999999998 999986433221       111122221110    


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                            .+...+..+.+++.+||+.||++|||+.+++++|+..
T Consensus       235 ------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          235 ------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence                  1112345688999999999999999999999999764

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.4e-45  Score=333.60  Aligned_cols=254  Identities=26%  Similarity=0.379  Sum_probs=205.2

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      .++|++.+.||+|+||.||+|... ++..||+|++.....  ......+.+|+.+++.++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            367888899999999999999864 577999999854321  22346788999999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......
T Consensus        88 ~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            9999999999998543  45899999999999999999999998   999999999999999999999999998755433


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      .   .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||......      . ..........      . 
T Consensus       163 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~~~~~~~~~~------~-  225 (279)
T 3fdn_A          163 R---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------E-TYKRISRVEF------T-  225 (279)
T ss_dssp             --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHHTCC------C-
T ss_pred             c---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH------H-HHHHHHhCCC------C-
Confidence            2   23457899999999999999999999999999999999999998643211      1 1111111110      0 


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                          .+...+..+.+++.+||+.||++|||+.|+++|.|....
T Consensus       226 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~  264 (279)
T 3fdn_A          226 ----FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN  264 (279)
T ss_dssp             ----CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             ----CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence                112234568899999999999999999999999886543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.1e-45  Score=341.12  Aligned_cols=269  Identities=28%  Similarity=0.426  Sum_probs=216.8

Q ss_pred             cCHHHHHHHhcCCCCCCeeeccCCccEEEEEe------cCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeee
Q 040557           72 FDFQTLKKATKNFHPGNLLGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRL  144 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l  144 (407)
                      ++........++|++.+.||+|+||.||+|..      .+++.||||.+...........+.+|+.++.++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            44555555668899999999999999999974      356899999997665666667899999999999 79999999


Q ss_pred             eeeeecCC-eeEEEEEeccCCChhHHHhccCC--------------CCCCHHHHHHHHHHHHHHhccccccCCCceeeec
Q 040557          145 LGCCSDGS-QRLLVYEYMKNRSLDLLIYGESD--------------KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRD  209 (407)
Q Consensus       145 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~d  209 (407)
                      ++++...+ ..++||||+++|+|.+++.....              ..+++..+..++.|++.||.|||+.+   ++|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence            99987654 58999999999999999975442              22889999999999999999999998   99999


Q ss_pred             cccccEEEcCCCceEEecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCC
Q 040557          210 IKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDL  287 (407)
Q Consensus       210 lk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~  287 (407)
                      |||+||+++.++.+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            9999999999999999999999876543322 2334567889999999999999999999999999999998 9999865


Q ss_pred             CCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          288 TLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ....      .........+....          .+...+..+.+++.+||+.||++|||+.+++++|+...
T Consensus       254 ~~~~------~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          254 VKID------EEFCRRLKEGTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             CCCS------HHHHHHHHHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cchh------HHHHHHhccCccCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            4322      11222222221111          11123456889999999999999999999999998653

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6e-45  Score=332.56  Aligned_cols=258  Identities=24%  Similarity=0.333  Sum_probs=210.4

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+...........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467888899999999999999865 6899999999765555566788999999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++++|.+++.  ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........
T Consensus        86 ~~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           86 YCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             CCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             ecCCCcHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            999999999884  3456899999999999999999999998   99999999999999999999999999986643221


Q ss_pred             -ccccccccCccccCccccccCCC-CccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          240 -YLSTNFAGTLGYTAPEYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       240 -~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                       .......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||........      ....+......  ..   
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~--~~---  229 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWKEKKTY--LN---  229 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH------HHHHHHTTCTT--ST---
T ss_pred             hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH------HHHHhhhcccc--cC---
Confidence             12234678999999999987765 7899999999999999999999975433211      11111111100  00   


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                          .....+..+.+++.+||+.||++|||+.|++++.+..
T Consensus       230 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~  266 (276)
T 2yex_A          230 ----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN  266 (276)
T ss_dssp             ----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred             ----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcccc
Confidence                0112345688999999999999999999999988754

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.2e-44  Score=332.54  Aligned_cols=261  Identities=16%  Similarity=0.200  Sum_probs=208.0

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++.....   ...+.+|++++..+ +|+|++++++++.+....++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            35788889999999999999985 5799999999854332   23577899999999 7999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCc-----eEEecccCccc
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ-----SKIGDFGLARF  233 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~-----~kl~Dfgla~~  233 (407)
                      ||+ +++|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.     +||+|||++..
T Consensus        86 e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           86 DLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             Eec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            999 99999999654 345999999999999999999999998   999999999999987766     99999999987


Q ss_pred             cCCCCcc------cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhC
Q 040557          234 FPEDQAY------LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERG  307 (407)
Q Consensus       234 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      .......      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......................
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            6543321      2234679999999999999999999999999999999999999997644322211111111110000


Q ss_pred             ccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          308 RILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       308 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ...     ..     ....+..+.+++.+||+.||++|||+.+|++.|+...
T Consensus       241 ~~~-----~~-----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~  282 (298)
T 1csn_A          241 PLR-----EL-----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  282 (298)
T ss_dssp             CHH-----HH-----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             cHH-----HH-----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence            000     00     0112456889999999999999999999999998654

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7.2e-46  Score=345.97  Aligned_cols=268  Identities=26%  Similarity=0.410  Sum_probs=207.0

Q ss_pred             CCCCCeeeccCCccEEEEEe-----cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeec--CCeeEE
Q 040557           84 FHPGNLLGRGGFGPVYRGKL-----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSD--GSQRLL  156 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l  156 (407)
                      |++.+.||+|+||.||++.+     .+|+.||||++...........+.+|++++++++||||+++++++.+  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            37788999999999998864     26889999999766666667789999999999999999999999987  467899


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ||||+++|+|.+++...   .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus       113 v~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             EECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             EEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            99999999999998543   3899999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCcc--cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          237 DQAY--LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       237 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      ....  ......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.......... ..+...........+.++
T Consensus       187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL-IGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-HCSCCHHHHHHHHHHHHH
T ss_pred             cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhh-hcccccchhHHHHHHHHh
Confidence            4332  2234568889999999999999999999999999999999999876321110000 000000000000111111


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .... ...+...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus       266 ~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          266 RGER-LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             TTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccC-CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            1111 1122234567899999999999999999999999997654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=8.5e-45  Score=342.89  Aligned_cols=257  Identities=21%  Similarity=0.268  Sum_probs=194.5

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++....   ..+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            4567888999999999999999875 58899999986432   3456789999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC---CCceEEecccCccccC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE---KFQSKIGDFGLARFFP  235 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfgla~~~~  235 (407)
                      ||+++|+|.+++..  ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.   ++.+||+|||+++...
T Consensus       128 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          128 ELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             EeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            99999999999853  345899999999999999999999998   999999999999975   8899999999998765


Q ss_pred             CCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          236 EDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       236 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                      ....  .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......      ......+...... ...+
T Consensus       203 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~i~~~~~~-~~~~  273 (349)
T 2w4o_A          203 HQVL--MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD------QFMFRRILNCEYY-FISP  273 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH------HHHHHHHHTTCCC-CCTT
T ss_pred             cccc--cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc------HHHHHHHHhCCCc-cCCc
Confidence            4322  23467999999999999999999999999999999999999998654322      1111122211110 0001


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                            .....+..+.+++.+||+.||++|||+.|+++|.+...
T Consensus       274 ------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  311 (349)
T 2w4o_A          274 ------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG  311 (349)
T ss_dssp             ------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             ------hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence                  11123456889999999999999999999999988653

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.2e-44  Score=328.38  Aligned_cols=254  Identities=28%  Similarity=0.488  Sum_probs=202.4

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhh------HHHHHHHHHHHHcCCCCceeeeeeeeecCCee
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQG------ESEFLSEVRMITSIQHKNLVRLLGCCSDGSQR  154 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  154 (407)
                      ++|++.+.||+|+||.||+|+. .+++.||+|++........      ...+.+|++++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            6788889999999999999986 4789999999865432211      167899999999999999999999987655  


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCc-----eEEeccc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ-----SKIGDFG  229 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~-----~kl~Dfg  229 (407)
                      ++||||+++|+|.+.+... ...+++..+..++.|++.||.|||+.+ .+++||||||+|||++.++.     +||+|||
T Consensus        97 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg  174 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG  174 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred             eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence            7999999999998888643 346999999999999999999999875 34999999999999988776     9999999


Q ss_pred             CccccCCCCcccccccccCccccCccccc--cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhC
Q 040557          230 LARFFPEDQAYLSTNFAGTLGYTAPEYAI--RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERG  307 (407)
Q Consensus       230 la~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      +++.....    .....||+.|+|||.+.  ...++.++||||||+++|||++|+.||........    .... .....
T Consensus       175 ~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~-~~~~~  245 (287)
T 4f0f_A          175 LSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KFIN-MIREE  245 (287)
T ss_dssp             TCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HHHH-HHHHS
T ss_pred             cccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HHHH-HHhcc
Confidence            99854432    23467999999999884  45678999999999999999999999975443321    1111 11111


Q ss_pred             ccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          308 RILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       308 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      ...    +.     .+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus       246 ~~~----~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          246 GLR----PT-----IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             CCC----CC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             CCC----CC-----CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            111    11     122234568999999999999999999999999864

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=335.70  Aligned_cols=272  Identities=20%  Similarity=0.309  Sum_probs=203.8

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      ++|++.+.||+|+||.||+|... +|+.||+|++..... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57888899999999999999875 589999999865443 3345678899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++++|..++..  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........
T Consensus        83 ~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           83 YCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             CCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             eCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence            9999999988753  345899999999999999999999998   99999999999999999999999999987654332


Q ss_pred             ccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchh--------HHHHHHHHhCccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLP--------EYAWKLYERGRIL  310 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~  310 (407)
                      . .....||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+.....        ......+......
T Consensus       158 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          158 Y-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             c-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence            2 234578999999999876 67899999999999999999999999754332110000        0000011111100


Q ss_pred             c---ccCcccccC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          311 E---LVDPRMRKE--GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       311 ~---~~d~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .   ..++.....  ......+..+.+++.+||+.||++|||++|+++|.|...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  290 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN  290 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTT
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHh
Confidence            0   000000000  000123456889999999999999999999999988653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.3e-45  Score=350.73  Aligned_cols=256  Identities=19%  Similarity=0.296  Sum_probs=202.0

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCC--CCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQ--HKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|...+++.||||++.... .......+.+|+.+|..++  |+||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4588889999999999999998889999999986543 3445678999999999996  599999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      | +.+++|.+++...  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||+++.+....
T Consensus       136 E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             E-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             e-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            9 5688999998654  36899999999999999999999998   99999999999996 5799999999998775433


Q ss_pred             cc-cccccccCccccCcccccc-----------CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh
Q 040557          239 AY-LSTNFAGTLGYTAPEYAIR-----------GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER  306 (407)
Q Consensus       239 ~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      .. ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||......     ......... 
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~~~~~-  282 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIID-  282 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHHHHC-
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHHHHHhC-
Confidence            22 2345679999999998865           46899999999999999999999999643221     111111111 


Q ss_pred             CccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          307 GRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       307 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                              +..... .+...+..+.+++.+||+.||++|||+.|+++|.|...
T Consensus       283 --------~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~  326 (390)
T 2zmd_A          283 --------PNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  326 (390)
T ss_dssp             --------TTSCCC-CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             --------ccccCC-CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence                    111100 11111346889999999999999999999999988754

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-44  Score=331.56  Aligned_cols=257  Identities=25%  Similarity=0.288  Sum_probs=203.4

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|.+.+.||+|+||.||++... +|..||+|.+...........+.+|++++++++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            356888899999999999999864 6899999999766555566789999999999999999999999999999999999


Q ss_pred             eccCCChhHHHhcc--CCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEE---cCCCceEEecccCcccc
Q 040557          160 YMKNRSLDLLIYGE--SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFF  234 (407)
Q Consensus       160 ~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfgla~~~  234 (407)
                      |+++|+|.+++...  ....+++..+..++.|++.||.|||+.+   ++||||||+||++   +.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999888543  2456999999999999999999999998   9999999999999   45678999999999876


Q ss_pred             CCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          235 PEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       235 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      .....  .....||+.|+|||.+. ..++.++||||||+++|||++|+.||......      .... ........    
T Consensus       178 ~~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------~~~~-~~~~~~~~----  243 (285)
T 3is5_A          178 KSDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------EVQQ-KATYKEPN----  243 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH-HHHHCCCC----
T ss_pred             CCccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH------HHHh-hhccCCcc----
Confidence            54332  23467999999999875 57899999999999999999999998753221      1111 11111110    


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .......    .+..+.+++.+||+.||++|||+.|++++-+..
T Consensus       244 ~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~  283 (285)
T 3is5_A          244 YAVECRP----LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK  283 (285)
T ss_dssp             CCC--CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGG
T ss_pred             cccccCc----CCHHHHHHHHHHccCChhhCcCHHHHhcCHHhh
Confidence            0000011    234688999999999999999999999987753

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.2e-45  Score=343.01  Aligned_cols=249  Identities=21%  Similarity=0.293  Sum_probs=206.3

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccCh-------hhHHHHHHHHHHHHcCCCCceeeeeeeeecC
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQ-------QGESEFLSEVRMITSIQHKNLVRLLGCCSDG  151 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  151 (407)
                      ..++|++.+.||+|+||.||+|.. .+|+.||||.+......       .....+.+|++++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            457899999999999999999985 46899999998654311       1233567899999999999999999999999


Q ss_pred             CeeEEEEEeccCC-ChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccC
Q 040557          152 SQRLLVYEYMKNR-SLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGL  230 (407)
Q Consensus       152 ~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgl  230 (407)
                      +..++||||+.+| +|..++..  ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeeccc
Confidence            9999999999777 99998853  345999999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccCccccCccccccCCC-CccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcc
Q 040557          231 ARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRI  309 (407)
Q Consensus       231 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      +........  .....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||.....                   
T Consensus       177 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------------  235 (335)
T 3dls_A          177 AAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------------------  235 (335)
T ss_dssp             CEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------------------
T ss_pred             ceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------------------
Confidence            987765433  234679999999999988877 8899999999999999999999863110                   


Q ss_pred             ccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          310 LELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       310 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                        .......   .+...+..+.+++.+||+.||++|||+.+++++.|...
T Consensus       236 --~~~~~~~---~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~  280 (335)
T 3dls_A          236 --TVEAAIH---PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ  280 (335)
T ss_dssp             --GTTTCCC---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred             --HHhhccC---CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence              0001111   11112456889999999999999999999999988653

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.9e-44  Score=331.81  Aligned_cols=259  Identities=26%  Similarity=0.415  Sum_probs=197.4

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|++.+.||+|+||.||+|+..  ..||+|.+.... .......+.+|++++++++|+||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            367888899999999999999864  359999986544 344567899999999999999999999976 4556899999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC-
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ-  238 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~-  238 (407)
                      |+++++|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....... 
T Consensus       100 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A          100 WCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             ecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccc
Confidence            99999999998643 345899999999999999999999998   9999999999999999999999999998654322 


Q ss_pred             cccccccccCccccCccccc---cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          239 AYLSTNFAGTLGYTAPEYAI---RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                      ........||+.|+|||.+.   +..++.++||||||+++|||++|+.||......      .........+.....+..
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~  249 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIEMVGRGSLSPDLSK  249 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH------HHHHHHHHHTSCCCCTTS
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH------HHHHHHhcccccCcchhh
Confidence            22223457999999999886   567899999999999999999999999653321      222333333322211111


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                            .....+..+.+++.+||+.||++|||+.++++.|+..
T Consensus       250 ------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l  286 (289)
T 3og7_A          250 ------VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL  286 (289)
T ss_dssp             ------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             ------ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence                  1122346789999999999999999999999999764

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-44  Score=332.56  Aligned_cols=256  Identities=25%  Similarity=0.398  Sum_probs=208.7

Q ss_pred             cCCCCCC-eeeccCCccEEEEEec---CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           82 KNFHPGN-LLGRGGFGPVYRGKLA---DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        82 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ++|.+.+ .||+|+||.||+|...   ++..||+|.+...........+.+|++++..++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            3444445 8999999999999753   57889999997665666678899999999999999999999999 45568999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++++|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......
T Consensus        88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            9999999999998643 345899999999999999999999998   999999999999999999999999999877544


Q ss_pred             Cccc--ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          238 QAYL--STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       238 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      ....  .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+       .......+...    
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~i~~~~~~----  232 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRM----  232 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCC----
T ss_pred             cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHhcCCcC----
Confidence            3322  223456889999999998899999999999999999998 999986543221       11222222111    


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                            ..+...+..+.+++.+||+.||++||++.+++++|+...
T Consensus       233 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  271 (287)
T 1u59_A          233 ------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  271 (287)
T ss_dssp             ------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                  112234557899999999999999999999999998654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=5.6e-45  Score=346.34  Aligned_cols=267  Identities=19%  Similarity=0.234  Sum_probs=204.0

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecC------CcEEEEEEeccccChh----------hHHHHHHHHHHHHcCCCCceeee
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLAD------GTLVAVKKLCVDKSQQ----------GESEFLSEVRMITSIQHKNLVRL  144 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~l  144 (407)
                      .++|++.+.||+|+||.||+|.+.+      ++.||||.+.......          ....+..|+..+..++|+||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4578889999999999999998754      4789999986443110          01224456667778899999999


Q ss_pred             eeeeecC----CeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc--
Q 040557          145 LGCCSDG----SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD--  218 (407)
Q Consensus       145 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~--  218 (407)
                      ++++...    ...++||||+ +++|.+++... ...+++..+..++.|++.||.|||+.+   |+||||||+|||++  
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESS
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecC
Confidence            9998664    4579999999 99999998653 356999999999999999999999998   99999999999999  


Q ss_pred             CCCceEEecccCccccCCCCcc------cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcc
Q 040557          219 EKFQSKIGDFGLARFFPEDQAY------LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSE  292 (407)
Q Consensus       219 ~~~~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~  292 (407)
                      .++.+||+|||+++.+......      ......||+.|+|||.+.+..++.++|||||||++|||+||+.||.......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            8899999999999876533221      1133459999999999999999999999999999999999999997533221


Q ss_pred             cCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          293 MQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .  ........ ....+.+.+++.+....    .+..+.+++..||+.||++||++.+|++.|....
T Consensus       269 ~--~~~~~~~~-~~~~~~~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~  328 (364)
T 3op5_A          269 K--YVRDSKIR-YRENIASLMDKCFPAAN----APGEIAKYMETVKLLDYTEKPLYENLRDILLQGL  328 (364)
T ss_dssp             H--HHHHHHHH-HHHCHHHHHHHHSCTTC----CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             H--HHHHHHHH-hhhhHHHHHHHhccccc----CHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence            1  01111111 11223333333332222    2356889999999999999999999999997654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.6e-45  Score=342.60  Aligned_cols=262  Identities=22%  Similarity=0.341  Sum_probs=200.9

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCe----
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQ----  153 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  153 (407)
                      .++|++.+.||+|+||.||+|+. .+++.||||++....  .......+.+|++++.+++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            36788899999999999999986 578999999996543  33445678999999999999999999999876543    


Q ss_pred             eEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          154 RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      .++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++..
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             cEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence            49999999999999998643  45899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcc--cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccc
Q 040557          234 FPEDQAY--LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILE  311 (407)
Q Consensus       234 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      .......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......      ............. 
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~-  238 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIP-  238 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCC-
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCCC-
Confidence            6543221  223456899999999999999999999999999999999999999654321      2222222221111 


Q ss_pred             ccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       312 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                         +....    ...+..+.+++.+||+.||++||+..+++.+.+.....
T Consensus       239 ---~~~~~----~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          239 ---PSARH----EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             ---HHHHS----TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             ---ccccc----CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence               11111    11245688999999999999999888888776654433

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.7e-45  Score=356.76  Aligned_cols=254  Identities=25%  Similarity=0.265  Sum_probs=199.5

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++....  .......+.+|++++..++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            36788899999999999999986 468999999986432  333445678999999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccc-cCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE-DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      |||+++|+|..++...  ..+++..+..++.|++.||.|||+ .+   |+||||||+|||++.++.+||+|||+++....
T Consensus       227 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          227 MEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             ECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            9999999999988543  468999999999999999999998 77   99999999999999999999999999986543


Q ss_pred             CCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          237 DQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                      ... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......      ..... ......      .
T Consensus       302 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~-i~~~~~------~  367 (446)
T 4ejn_A          302 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFEL-ILMEEI------R  367 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHHCCC------C
T ss_pred             CCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHH-HHhCCC------C
Confidence            322 234568999999999999999999999999999999999999999643221      11111 111111      0


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhcc
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRP-----PMSEIVAMLTCK  358 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~l~~~  358 (407)
                           .+...+..+.+++.+||+.||++||     ++.|+++|.++.
T Consensus       368 -----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~  409 (446)
T 4ejn_A          368 -----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA  409 (446)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             -----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcccc
Confidence                 1122345688999999999999999     999999998864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=347.01  Aligned_cols=271  Identities=21%  Similarity=0.266  Sum_probs=215.4

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC--eeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS--QRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  158 (407)
                      ++|.+.+.||+|+||.||+|... +|+.||||++...........+.+|++++++++||||+++++++....  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            56888899999999999999875 589999999975554455677889999999999999999999987655  779999


Q ss_pred             EeccCCChhHHHhccC-CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEE----cCCCceEEecccCccc
Q 040557          159 EYMKNRSLDLLIYGES-DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL----DEKFQSKIGDFGLARF  233 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfgla~~  233 (407)
                      ||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            9999999999986543 233999999999999999999999998   9999999999999    7788899999999987


Q ss_pred             cCCCCcccccccccCccccCcccccc--------CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHH
Q 040557          234 FPEDQAYLSTNFAGTLGYTAPEYAIR--------GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYE  305 (407)
Q Consensus       234 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  305 (407)
                      ......  .....||+.|+|||.+.+        ..++.++|||||||++|||++|+.||........  ..........
T Consensus       166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~--~~~~~~~~~~  241 (396)
T 4eut_A          166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIIT  241 (396)
T ss_dssp             CCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT--CHHHHHHHHH
T ss_pred             ccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc--hHHHHHHHhc
Confidence            755432  234679999999998865        5678899999999999999999999965433221  1222333332


Q ss_pred             hCcccccc-------C------ccc-ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          306 RGRILELV-------D------PRM-RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       306 ~~~~~~~~-------d------~~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                      ... ...+       +      ..+ ............+.+++.+||+.||++||++.++++.+..+..
T Consensus       242 ~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          242 GKP-SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             SCC-TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             CCC-cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            211 1100       0      000 1113446678889999999999999999999999999876554

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=8.1e-45  Score=339.53  Aligned_cols=261  Identities=24%  Similarity=0.389  Sum_probs=194.4

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecC-C---cEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCee-
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLAD-G---TLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQR-  154 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-  154 (407)
                      .++|++.+.||+|+||.||+|.... +   ..||||.+.... .......+.+|++++++++||||+++++++...... 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            4678899999999999999998653 3   279999986543 334567899999999999999999999999877655 


Q ss_pred             -----EEEEEeccCCChhHHHhccC----CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEE
Q 040557          155 -----LLVYEYMKNRSLDLLIYGES----DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKI  225 (407)
Q Consensus       155 -----~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl  225 (407)
                           ++||||+++|+|.+++....    ...+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence                 99999999999999986432    225899999999999999999999998   999999999999999999999


Q ss_pred             ecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHH
Q 040557          226 GDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKL  303 (407)
Q Consensus       226 ~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~  303 (407)
                      +|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.......       ....
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~  251 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-------IYNY  251 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHH
T ss_pred             eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-------HHHH
Confidence            999999876543322 2223457889999999999999999999999999999999 888886543221       1111


Q ss_pred             HHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          304 YERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       304 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                      ...+...          ..+...+..+.+++.+||+.||++|||+.++++.|+.....
T Consensus       252 ~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          252 LIGGNRL----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             HHTTCCC----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HhcCCCC----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            1111111          01122345688999999999999999999999998866543

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-44  Score=338.66  Aligned_cols=257  Identities=26%  Similarity=0.440  Sum_probs=202.4

Q ss_pred             cCCCCCCeeeccCCccEEEEEecC-----CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLAD-----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      ++|+..+.||+|+||.||+|....     +..||+|.+...........+.+|+++++.++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            456667899999999999997642     235999999765555666789999999999999999999999999999999


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus       124 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          124 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            99999999999998653 345899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcc--cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCcccccc
Q 040557          237 DQAY--LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELV  313 (407)
Q Consensus       237 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ....  ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......       .....+..+...   
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------~~~~~~~~~~~~---  269 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-------EVMKAINDGFRL---  269 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTTCCC---
T ss_pred             ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHHCCCcC---
Confidence            3221  1223446789999999999999999999999999999999 99998643211       112222222110   


Q ss_pred             CcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       314 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                             ..+...+..+.+++.+||+.||++||++.+++++|+...
T Consensus       270 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  308 (333)
T 1mqb_A          270 -------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  308 (333)
T ss_dssp             -------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                   011223456889999999999999999999999998654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=331.41  Aligned_cols=254  Identities=24%  Similarity=0.367  Sum_probs=187.3

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|.. .+|+.||+|.+.....  ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            5688889999999999999986 4799999999854321  122467889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++++|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        91 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           91 EMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             ECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             ecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            999999999998643 346899999999999999999999998   9999999999999999999999999998765332


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                      .. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........          ..     ....... 
T Consensus       167 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------~~-----~~~~~~~-  229 (278)
T 3cok_A          167 EK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT----------LN-----KVVLADY-  229 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSCC-
T ss_pred             Cc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------HH-----HHhhccc-
Confidence            21 2245689999999999998999999999999999999999999875432211          00     0000001 


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                        ..+...+..+.+++.+||+.||++|||+.+++++.+..
T Consensus       230 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~  267 (278)
T 3cok_A          230 --EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS  267 (278)
T ss_dssp             --CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC
T ss_pred             --CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCcccc
Confidence              11122345688999999999999999999999987754

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.6e-45  Score=342.44  Aligned_cols=270  Identities=23%  Similarity=0.243  Sum_probs=208.4

Q ss_pred             cCHHHHHHHhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc----ChhhHHHHHHHHHHHHcCCCCceeeeee
Q 040557           72 FDFQTLKKATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK----SQQGESEFLSEVRMITSIQHKNLVRLLG  146 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~  146 (407)
                      .+-.++....++|++.+.||+|+||.||+|.. .+++.||+|++....    .......+.+|++++++++||||+++++
T Consensus        16 ~q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~   95 (345)
T 3hko_A           16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE   95 (345)
T ss_dssp             CCCBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccCchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeeh
Confidence            33345667778999999999999999999986 468899999986432    2344568899999999999999999999


Q ss_pred             eeecCCeeEEEEEeccCCChhHHHhccC--------------------------------------CCCCCHHHHHHHHH
Q 040557          147 CCSDGSQRLLVYEYMKNRSLDLLIYGES--------------------------------------DKFLNWSTRFQIIL  188 (407)
Q Consensus       147 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------~~~l~~~~~~~i~~  188 (407)
                      ++.+.+..++||||+++|+|.+++....                                      ...+++..+..++.
T Consensus        96 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  175 (345)
T 3hko_A           96 VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR  175 (345)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred             hhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence            9999999999999999999999884210                                      11235777889999


Q ss_pred             HHHHHhccccccCCCceeeeccccccEEEcCCC--ceEEecccCccccCC---CCcccccccccCccccCcccccc--CC
Q 040557          189 GIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF--QSKIGDFGLARFFPE---DQAYLSTNFAGTLGYTAPEYAIR--GE  261 (407)
Q Consensus       189 ~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~--~~kl~Dfgla~~~~~---~~~~~~~~~~gt~~y~aPE~~~~--~~  261 (407)
                      |++.||.|||+.+   ++||||||+|||++.++  .+||+|||++..+..   ..........||+.|+|||.+.+  ..
T Consensus       176 qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  252 (345)
T 3hko_A          176 QIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES  252 (345)
T ss_dssp             HHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSC
T ss_pred             HHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCC
Confidence            9999999999998   99999999999998776  899999999986533   22222345679999999999875  67


Q ss_pred             CCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCC
Q 040557          262 LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPH  341 (407)
Q Consensus       262 ~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~  341 (407)
                      ++.++||||||+++|||++|+.||......      .............  ..+..      ...+..+.+++.+||+.|
T Consensus       253 ~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~--~~~~~------~~~~~~~~~li~~~l~~~  318 (345)
T 3hko_A          253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLCF--ENPNY------NVLSPLARDLLSNLLNRN  318 (345)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCT--TSGGG------GGSCHHHHHHHHHHSCSC
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhccccc--CCccc------ccCCHHHHHHHHHHcCCC
Confidence            899999999999999999999998643321      1222222211100  00110      112456889999999999


Q ss_pred             CCCCCCHHHHHHHhhcc
Q 040557          342 GNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       342 p~~RPs~~ev~~~l~~~  358 (407)
                      |++|||+.+++++.+..
T Consensus       319 p~~Rps~~~~l~hp~~~  335 (345)
T 3hko_A          319 VDERFDAMRALQHPWIS  335 (345)
T ss_dssp             TTTSCCHHHHHHSHHHH
T ss_pred             hhHCCCHHHHhcChhhc
Confidence            99999999999998754

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=334.74  Aligned_cols=254  Identities=29%  Similarity=0.462  Sum_probs=197.0

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      ++|++.+.||+|+||.||+|+.. ++.||+|.+..   ......+.+|++++++++||||+++++++.+  ..++||||+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~   81 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA   81 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS---TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC---hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence            56777889999999999999984 78999999852   3345678999999999999999999999874  479999999


Q ss_pred             cCCChhHHHhccCC-CCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCc-eEEecccCccccCCCCc
Q 040557          162 KNRSLDLLIYGESD-KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ-SKIGDFGLARFFPEDQA  239 (407)
Q Consensus       162 ~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~-~kl~Dfgla~~~~~~~~  239 (407)
                      ++|+|.+++..... ..+++..++.++.|++.||.|||+.+..+++||||||+||+++.++. +||+|||++....... 
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-  160 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-  160 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-
Confidence            99999999975432 34789999999999999999999932223999999999999998886 7999999998654322 


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                         ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......    ....+. ...+...     .   
T Consensus       161 ---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~-~~~~~~~-----~---  224 (307)
T 2eva_A          161 ---TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWA-VHNGTRP-----P---  224 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHH-HHTTCCC-----C---
T ss_pred             ---ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHH-HhcCCCC-----C---
Confidence               23468999999999999999999999999999999999999986433221    111111 1111111     1   


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                        .....+..+.+++.+||+.||++|||+.+++++|+....
T Consensus       225 --~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          225 --LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             --CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             --cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence              111234568899999999999999999999999987543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2e-44  Score=339.95  Aligned_cols=253  Identities=27%  Similarity=0.403  Sum_probs=205.6

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      +.|+..+.||+|+||.||+|+. .+|+.||||++.....  ......+.+|++++++++||||+++++++.+.+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4578888999999999999985 5789999999865432  233467899999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+. |+|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||++...... 
T Consensus       134 e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  207 (348)
T ss_dssp             ECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             ecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence            9997 5787777533 345899999999999999999999998   999999999999999999999999999876543 


Q ss_pred             cccccccccCccccCccccc---cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          239 AYLSTNFAGTLGYTAPEYAI---RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                          ....||+.|+|||.+.   ...++.++|||||||++|||++|+.||.....      ......... +..     +
T Consensus       208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~-~~~-----~  271 (348)
T 1u5q_A          208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQ-NES-----P  271 (348)
T ss_dssp             ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHH-SCC-----C
T ss_pred             ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHh-cCC-----C
Confidence                2357999999999884   56789999999999999999999999864321      112222222 111     1


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                      ....    ...+..+.+++.+||+.||++|||+.+++++.+....
T Consensus       272 ~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          272 ALQS----GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             CCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             CCCC----CCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence            1111    1224468899999999999999999999999887543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=9e-45  Score=339.57  Aligned_cols=256  Identities=28%  Similarity=0.396  Sum_probs=202.6

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcE----EEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTL----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      ++|++.+.||+|+||.||+|.+. +++.    ||+|.+...........+.+|+.++.+++||||+++++++. ....++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            56777889999999999999854 4443    78888754443344456778999999999999999999986 456889


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ||||+.+|+|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++....
T Consensus        92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            99999999999998644 345899999999999999999999998   99999999999999999999999999998755


Q ss_pred             CCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          237 DQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       237 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      .... ......+|..|+|||.+.+..++.++||||||+++|||+| |+.||.......       .......+....   
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~---  237 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-------VPDLLEKGERLA---  237 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-------HHHHHHTTCBCC---
T ss_pred             ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCCCCC---
Confidence            4332 2334567889999999999999999999999999999999 999987543321       122222221110   


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                             .+...+..+.+++.+||+.||++|||+.+++++|....
T Consensus       238 -------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          238 -------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             -------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             -------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                   11112234778999999999999999999999998653

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.5e-44  Score=337.77  Aligned_cols=272  Identities=24%  Similarity=0.330  Sum_probs=211.6

Q ss_pred             cCHHHHHHHhcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHc--CCCCceeeeeeeee
Q 040557           72 FDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITS--IQHKNLVRLLGCCS  149 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~  149 (407)
                      ..........++|++.+.||+|+||.||+|+. +|+.||||.+..    .....+.+|.+++..  ++||||+++++++.
T Consensus        32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            44444556678999999999999999999998 589999999843    234567889998887  68999999999998


Q ss_pred             cCC----eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhcccc--------ccCCCceeeeccccccEEE
Q 040557          150 DGS----QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLH--------EDSHTRIVHRDIKASNVLL  217 (407)
Q Consensus       150 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~dlk~~Nill  217 (407)
                      ...    ..++||||+++|+|.+++...   .+++..++.++.|++.||.|||        +.+   ++||||||+|||+
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll  180 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILV  180 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEE
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEE
Confidence            776    789999999999999999643   4899999999999999999999        666   9999999999999


Q ss_pred             cCCCceEEecccCccccCCCCcc---cccccccCccccCccccccC------CCCccccEEehhHHHHHHHhc-------
Q 040557          218 DEKFQSKIGDFGLARFFPEDQAY---LSTNFAGTLGYTAPEYAIRG------ELSEKADIYSFGVLVLEIISC-------  281 (407)
Q Consensus       218 ~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~k~Dv~s~G~vl~el~tg-------  281 (407)
                      +.++.+||+|||++.........   ......||+.|+|||.+.+.      .++.++||||||+++|||+||       
T Consensus       181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~  260 (342)
T 1b6c_B          181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  260 (342)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence            99999999999999876544322   22345799999999998765      334789999999999999999       


Q ss_pred             ---CCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          282 ---RKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       282 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                         ..||.........  .............    .+.+............+.+++.+||+.||++|||+.+|+++|+.+
T Consensus       261 ~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          261 EDYQLPYYDLVPSDPS--VEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             CCCCCTTTTTSCSSCC--HHHHHHHHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccCccccCcCccc--HHHHHHHHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence               5566543322211  1112222221111    122211112235667899999999999999999999999999865


Q ss_pred             cc
Q 040557          359 VE  360 (407)
Q Consensus       359 ~~  360 (407)
                      .+
T Consensus       335 ~~  336 (342)
T 1b6c_B          335 SQ  336 (342)
T ss_dssp             HH
T ss_pred             HH
Confidence            43

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.1e-44  Score=330.60  Aligned_cols=253  Identities=24%  Similarity=0.332  Sum_probs=208.0

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|... ++..||+|.+.....  ......+.+|+++++.++|+||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            56888899999999999999865 578999999854321  223467889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......
T Consensus        94 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (284)
T 2vgo_A           94 EFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR  168 (284)
T ss_dssp             CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred             EeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence            999999999998643  35899999999999999999999998   9999999999999999999999999997654432


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                         .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......      ..... .....      ..  
T Consensus       169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~-~~~~~------~~--  230 (284)
T 2vgo_A          169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETHRR-IVNVD------LK--  230 (284)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHH-HHTTC------CC--
T ss_pred             ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHHHH-Hhccc------cC--
Confidence               23457899999999999999999999999999999999999998643211      11111 11111      11  


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                         .+...+..+.+++.+||+.||++|||+.++++|.+....
T Consensus       231 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          231 ---FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             ---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             ---CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence               112234568899999999999999999999998876543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.8e-44  Score=355.17  Aligned_cols=259  Identities=24%  Similarity=0.337  Sum_probs=211.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|...+.||+|+||.||+|+.. +|+.||+|++.....  ......+.+|++++.+++||||+++++++.+....|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            56788889999999999999875 699999999964331  233467889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccC--CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          159 EYMKNRSLDLLIYGES--DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ||++||+|..++....  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999999986543  456999999999999999999999998   99999999999999999999999999987754


Q ss_pred             CCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          237 DQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                      .... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ........... ...       
T Consensus       342 ~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~~-~~~-------  410 (543)
T 3c4z_A          342 GQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVLE-QAV-------  410 (543)
T ss_dssp             TCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHHH-CCC-------
T ss_pred             CCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHhh-ccc-------
Confidence            4322 234589999999999999999999999999999999999999997643221  11111222111 111       


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHhhcc
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRPPM-----SEIVAMLTCK  358 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~ev~~~l~~~  358 (407)
                          ..+...+..+.+++.+||+.||++||++     .++++|.++.
T Consensus       411 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~  453 (543)
T 3c4z_A          411 ----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR  453 (543)
T ss_dssp             ----CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGT
T ss_pred             ----CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCcccc
Confidence                1122234568899999999999999965     7899887764

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.9e-44  Score=332.86  Aligned_cols=262  Identities=19%  Similarity=0.217  Sum_probs=200.0

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      ..++|++.+.||+|+||.||+|... +++.||+|.+....  .......+.+|+.++.+++||||+++++++...+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3478999999999999999999865 68899999986543  23335778999999999999999999999999999999


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus       112 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            99999999999998643  45899999999999999999999998   99999999999999999999999999987665


Q ss_pred             CCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          237 DQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                      ..........|++.|+|||.+.+..++.++||||||+++|||++|+.||.....       ........... .   .+.
T Consensus       187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~-~---~~~  255 (309)
T 2h34_A          187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------SVMGAHINQAI-P---RPS  255 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------HHHHHHHHSCC-C---CGG
T ss_pred             cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------HHHHHHhccCC-C---Ccc
Confidence            443333456799999999999999999999999999999999999999864321       11112222111 0   010


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhccccC
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRP-PMSEIVAMLTCKVES  361 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~ev~~~l~~~~~~  361 (407)
                      .    .....+..+.+++.+||+.||++|| ++.++++.|+.....
T Consensus       256 ~----~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          256 T----VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             G----TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             c----cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence            0    1112334688999999999999999 999999999865443

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.2e-44  Score=335.28  Aligned_cols=257  Identities=22%  Similarity=0.245  Sum_probs=209.6

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccCh-----hhHHHHHHHHHHHHcCCCCceeeeeeeeecCCee
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQ-----QGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQR  154 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  154 (407)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+......     .....+.+|+.++..++||||+++++++.+....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            456888899999999999999865 6899999998654322     1356789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC----ceEEecccC
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF----QSKIGDFGL  230 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfgl  230 (407)
                      ++||||+++++|.+++..  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++    .+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            999999999999999954  346899999999999999999999998   99999999999999887    799999999


Q ss_pred             ccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccc
Q 040557          231 ARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRIL  310 (407)
Q Consensus       231 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      +........  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......      ..... +..... 
T Consensus       166 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~-i~~~~~-  235 (321)
T 2a2a_A          166 AHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLAN-ITSVSY-  235 (321)
T ss_dssp             CEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHH-HHTTCC-
T ss_pred             ceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HHHHH-HHhccc-
Confidence            987755432  23457999999999999999999999999999999999999998643221      11111 111110 


Q ss_pred             cccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          311 ELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       311 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                       ..++...     ...+..+.+++.+||+.||++|||+.|+++|.+..
T Consensus       236 -~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~  277 (321)
T 2a2a_A          236 -DFDEEFF-----SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT  277 (321)
T ss_dssp             -CCCHHHH-----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTS
T ss_pred             -ccChhhh-----cccCHHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence             0011110     01234688999999999999999999999998764

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=7e-44  Score=326.94  Aligned_cols=257  Identities=25%  Similarity=0.311  Sum_probs=209.7

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      .++|++.+.||+|+||.||+|... +|+.||+|++.... .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            477888999999999999999864 58999999986544 3445577889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCc---eEEecccCccccC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ---SKIGDFGLARFFP  235 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfgla~~~~  235 (407)
                      ||+++++|.+.+...  ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.   +||+|||++....
T Consensus        85 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            999999998888543  45899999999999999999999998   999999999999986655   9999999998765


Q ss_pred             CCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          236 EDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       236 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                      ....  .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......       ........+... ...+
T Consensus       160 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~-~~~~  229 (284)
T 3kk8_A          160 DSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYAQIKAGAYD-YPSP  229 (284)
T ss_dssp             SSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCC-CCTT
T ss_pred             cCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-------HHHHHHHhcccc-CCch
Confidence            4432  23467999999999999999999999999999999999999998643211       111222222111 0000


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .      ....+..+.+++.+||+.||++|||+.|+++|.+..
T Consensus       230 ~------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~  266 (284)
T 3kk8_A          230 E------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC  266 (284)
T ss_dssp             T------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHH
T ss_pred             h------hcccCHHHHHHHHHHcccChhhCCCHHHHhcCcccc
Confidence            0      112345688999999999999999999999987754

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.7e-44  Score=332.67  Aligned_cols=264  Identities=20%  Similarity=0.252  Sum_probs=201.8

Q ss_pred             cCCCCC-CeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPG-NLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      +.|.+. +.||+|+||.||+|.. .+|+.||||++.... ......+.+|++++.++ +||||+++++++.+.+..++||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            567764 7899999999999985 479999999986443 33456788999999985 7999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCc---eEEecccCccccC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ---SKIGDFGLARFFP  235 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfgla~~~~  235 (407)
                      ||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.   +||+|||++....
T Consensus        91 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           91 EKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             EcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            999999999998653  45899999999999999999999998   999999999999998766   9999999998654


Q ss_pred             CCCc------ccccccccCccccCcccccc-----CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCch--------
Q 040557          236 EDQA------YLSTNFAGTLGYTAPEYAIR-----GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYL--------  296 (407)
Q Consensus       236 ~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~--------  296 (407)
                      ....      .......||+.|+|||.+.+     ..++.++|||||||++|||++|+.||.........+.        
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  245 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC  245 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence            2211      11123469999999999875     5688999999999999999999999976554332111        


Q ss_pred             hHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          297 PEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       297 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ..........+... .  +....    ...+..+.+++.+||+.||++|||+.|+++|.|..
T Consensus       246 ~~~~~~~i~~~~~~-~--~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~  300 (316)
T 2ac3_A          246 QNMLFESIQEGKYE-F--PDKDW----AHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ  300 (316)
T ss_dssp             HHHHHHHHHHCCCC-C--CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred             HHHHHHHHhccCcc-c--Cchhc----ccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence            01111222222110 0  00000    01235688999999999999999999999998864

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=363.43  Aligned_cols=248  Identities=25%  Similarity=0.403  Sum_probs=200.4

Q ss_pred             eeeccCCccEEEEEec---CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCC
Q 040557           89 LLGRGGFGPVYRGKLA---DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRS  165 (407)
Q Consensus        89 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  165 (407)
                      .||+|+||.||+|.+.   ++..||||+++........+.|.+|+++|++++||||+++++++.+ +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            6999999999999763   4667999999765555567789999999999999999999999976 56899999999999


Q ss_pred             hhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcccc--c
Q 040557          166 LDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--T  243 (407)
Q Consensus       166 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~--~  243 (407)
                      |.+++... ...+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++..........  .
T Consensus       422 L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  497 (613)
T 2ozo_A          422 LHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS  497 (613)
T ss_dssp             HHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred             HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence            99998643 445999999999999999999999998   99999999999999999999999999987754332211  2


Q ss_pred             ccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCC
Q 040557          244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGI  322 (407)
Q Consensus       244 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  322 (407)
                      ...+++.|+|||++.+..++.++|||||||++|||++ |+.||......+       ....+..+...          ..
T Consensus       498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~----------~~  560 (613)
T 2ozo_A          498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRM----------EC  560 (613)
T ss_dssp             ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-------HHHHHHTTCCC----------CC
T ss_pred             CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCC----------CC
Confidence            2345689999999999999999999999999999998 999987543321       22223322211          12


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          323 VERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       323 ~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      +..++..+.+++.+||+.||++||++.+|++.|+..
T Consensus       561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            223456789999999999999999999999998754

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-44  Score=344.98  Aligned_cols=258  Identities=31%  Similarity=0.450  Sum_probs=195.4

Q ss_pred             CCCCCCeeeccCCccEEEEEec--CC--cEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeec-CCeeEEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA--DG--TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSD-GSQRLLV  157 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv  157 (407)
                      .|++.+.||+|+||.||+|...  ++  ..||+|.+...........|.+|+.++++++||||+++++++.. .+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            3556678999999999999853  22  36899998755555667789999999999999999999998754 5678999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++|+|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++.....
T Consensus       170 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             EECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccc
Confidence            9999999999999643 345899999999999999999999998   999999999999999999999999999866443


Q ss_pred             Ccc---cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCcccccc
Q 040557          238 QAY---LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELV  313 (407)
Q Consensus       238 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ...   ......+|+.|+|||.+.+..++.++||||||+++|||+| |.+||......+      .. .....+...  .
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~------~~-~~~~~~~~~--~  316 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------IT-VYLLQGRRL--L  316 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC------HH-HHHHTTCCC--C
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH------HH-HHHHcCCCC--C
Confidence            221   1233457889999999999999999999999999999999 566665432221      11 111222110  0


Q ss_pred             CcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       314 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                              .+...+..+.+++.+||+.||++|||+.+++++|+.....
T Consensus       317 --------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~  356 (373)
T 3c1x_A          317 --------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  356 (373)
T ss_dssp             --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                    1122345688999999999999999999999999876543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2e-44  Score=337.48  Aligned_cols=266  Identities=21%  Similarity=0.263  Sum_probs=210.2

Q ss_pred             HHHHHHHhcCCCCC-CeeeccCCccEEEEEec-CCcEEEEEEeccccC-hhhHHHHHHHHHHHHcC-CCCceeeeeeeee
Q 040557           74 FQTLKKATKNFHPG-NLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS-QQGESEFLSEVRMITSI-QHKNLVRLLGCCS  149 (407)
Q Consensus        74 ~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  149 (407)
                      +...+...+.|.+. +.||+|+||.||+|... +|+.||+|++..... ......+.+|+.++..+ +||||+++++++.
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~   99 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE   99 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            33445556677776 78999999999999865 699999999865432 33456789999999999 5799999999999


Q ss_pred             cCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC---CCceEEe
Q 040557          150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE---KFQSKIG  226 (407)
Q Consensus       150 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~  226 (407)
                      +....++||||+++|+|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+|||++.   ++.+||+
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~  176 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV  176 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEEC
T ss_pred             eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEe
Confidence            9999999999999999999986655677999999999999999999999998   999999999999997   7899999


Q ss_pred             cccCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh
Q 040557          227 DFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER  306 (407)
Q Consensus       227 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  306 (407)
                      |||++........  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......      ..... ...
T Consensus       177 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~-i~~  247 (327)
T 3lm5_A          177 DFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ------ETYLN-ISQ  247 (327)
T ss_dssp             CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHH
T ss_pred             eCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch------HHHHH-HHh
Confidence            9999987654332  23457999999999999999999999999999999999999998653221      11111 111


Q ss_pred             CccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          307 GRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       307 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ....      ... ......+..+.+++.+||+.||++|||+.++++|.|..
T Consensus       248 ~~~~------~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~  292 (327)
T 3lm5_A          248 VNVD------YSE-ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQ  292 (327)
T ss_dssp             TCCC------CCT-TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGC
T ss_pred             cccc------cCc-hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhc
Confidence            1100      000 01112345688999999999999999999999998864

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.1e-44  Score=340.10  Aligned_cols=261  Identities=27%  Similarity=0.421  Sum_probs=211.8

Q ss_pred             HHhcCCCCCCeeeccCCccEEEEEecC------CcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecC
Q 040557           79 KATKNFHPGNLLGRGGFGPVYRGKLAD------GTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDG  151 (407)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  151 (407)
                      ...++|++.+.||+|+||.||+|....      +..||+|.+...........+.+|+.++..+ +||||+++++++.+.
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            345788889999999999999998642      2479999997665556677899999999999 899999999999999


Q ss_pred             CeeEEEEEeccCCChhHHHhccC------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC
Q 040557          152 SQRLLVYEYMKNRSLDLLIYGES------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE  219 (407)
Q Consensus       152 ~~~~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~  219 (407)
                      +..++||||+++|+|.+++....            ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN  199 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence            99999999999999999986432            345899999999999999999999998   999999999999999


Q ss_pred             CCceEEecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchh
Q 040557          220 KFQSKIGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLP  297 (407)
Q Consensus       220 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~  297 (407)
                      ++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||......      
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------  273 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN------  273 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS------
T ss_pred             CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh------
Confidence            999999999999866433222 2234557889999999999999999999999999999999 88888654322      


Q ss_pred             HHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          298 EYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       298 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .........+...     .     .+...+..+.+++.+||+.||++|||+.+++++|+..
T Consensus       274 ~~~~~~~~~~~~~-----~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          274 SKFYKLVKDGYQM-----A-----QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             HHHHHHHHHTCCC-----C-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCC-----C-----CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence            1122222222110     0     1111245688999999999999999999999999754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=9e-45  Score=344.40  Aligned_cols=270  Identities=21%  Similarity=0.304  Sum_probs=208.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      ++|++.+.||+|+||.||+|... +|..||+|++...........+.+|+.++..++||||+++++++.+.+..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            56888899999999999999865 68999999997665666677899999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhcccccc-CCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED-SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      +++|+|.+++...  ..+++..+..++.|++.||.|||+. +   ++||||||+|||++.++.++|+|||++....... 
T Consensus       113 ~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  186 (360)
T 3eqc_A          113 MDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  186 (360)
T ss_dssp             CTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC-
T ss_pred             CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccccc-
Confidence            9999999999643  3589999999999999999999985 7   9999999999999999999999999997553221 


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhH---------HH----------
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPE---------YA----------  300 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~---------~~----------  300 (407)
                        .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.............         ..          
T Consensus       187 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (360)
T 3eqc_A          187 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  264 (360)
T ss_dssp             ------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred             --ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence              234579999999999999999999999999999999999999997543211100000         00          


Q ss_pred             ----HHHHHhCccccccCccc---ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          301 ----WKLYERGRILELVDPRM---RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       301 ----~~~~~~~~~~~~~d~~~---~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                          ..........+.++...   .........+..+.+++.+||+.||++|||+.|+++|.|...
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  330 (360)
T 3eqc_A          265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  330 (360)
T ss_dssp             ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred             cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence                00000000000000000   000011113456889999999999999999999999988643

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-45  Score=345.69  Aligned_cols=258  Identities=23%  Similarity=0.295  Sum_probs=207.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEe----cCCcEEEEEEecccc---ChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL----ADGTLVAVKKLCVDK---SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQ  153 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  153 (407)
                      ++|++.+.||+|+||.||+|+.    .+|+.||||++....   .......+.+|++++..+ +|+||+++++++.....
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            6788899999999999999986    368999999986432   112334567899999999 69999999999999999


Q ss_pred             eEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          154 RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      .++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             EEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            99999999999999998643  35899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcccccccccCccccCcccccc--CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccc
Q 040557          234 FPEDQAYLSTNFAGTLGYTAPEYAIR--GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILE  311 (407)
Q Consensus       234 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      +............||+.|+|||.+.+  ..++.++|||||||++|||++|+.||.......  ............ .   
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~-~---  282 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKS-E---  282 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHC-C---
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--hHHHHHHHHhcc-C---
Confidence            76544444455689999999999886  357899999999999999999999997543221  111122221111 0   


Q ss_pred             ccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhcc
Q 040557          312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRP-----PMSEIVAMLTCK  358 (407)
Q Consensus       312 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~l~~~  358 (407)
                         +     ..+...+..+.+++.+||+.||++||     ++.|++++.+..
T Consensus       283 ---~-----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~  326 (355)
T 1vzo_A          283 ---P-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ  326 (355)
T ss_dssp             ---C-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred             ---C-----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence               1     11222345688999999999999999     999999998864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2e-44  Score=331.36  Aligned_cols=252  Identities=23%  Similarity=0.383  Sum_probs=201.4

Q ss_pred             cCCCCCCeeeccCCccEEEEEecC-C-------cEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLAD-G-------TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQ  153 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  153 (407)
                      ++|.+.+.||+|+||.||+|.... +       ..||+|.+... .....+.+.+|++++++++||||+++++++.+.+.
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            567788999999999999997542 3       47999998543 34455779999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCc--------eEE
Q 040557          154 RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ--------SKI  225 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~--------~kl  225 (407)
                      .++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.        +||
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence            999999999999999996543 34899999999999999999999998   999999999999998887        999


Q ss_pred             ecccCccccCCCCcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHH
Q 040557          226 GDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLY  304 (407)
Q Consensus       226 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~  304 (407)
                      +|||++......     ....||+.|+|||.+.+ ..++.++||||||+++|||++|..|+.......      ......
T Consensus       163 ~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~------~~~~~~  231 (289)
T 4fvq_A          163 SDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ------RKLQFY  231 (289)
T ss_dssp             CCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHH
T ss_pred             ccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH------HHHHHh
Confidence            999999755432     23457889999999987 778999999999999999999765554322211      111111


Q ss_pred             HhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          305 ERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       305 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                      ....   .+...         .+..+.+++.+||+.||++|||+.+++++|+.....
T Consensus       232 ~~~~---~~~~~---------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          232 EDRH---QLPAP---------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             HTTC---CCCCC---------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             hccC---CCCCC---------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            1110   00011         123478999999999999999999999999876654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5.8e-44  Score=339.93  Aligned_cols=251  Identities=24%  Similarity=0.263  Sum_probs=199.8

Q ss_pred             CCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccCCC
Q 040557           87 GNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRS  165 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  165 (407)
                      .+.||+|+||.||+|.. .+|+.||+|++... .......+.+|++++.+++||||+++++++.+.+..++||||+++|+
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTR-GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccc-ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            45799999999999986 46899999998643 33456689999999999999999999999999999999999999999


Q ss_pred             hhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEE--cCCCceEEecccCccccCCCCccccc
Q 040557          166 LDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL--DEKFQSKIGDFGLARFFPEDQAYLST  243 (407)
Q Consensus       166 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill--~~~~~~kl~Dfgla~~~~~~~~~~~~  243 (407)
                      |.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+|||+  +.++.+||+|||+++........  .
T Consensus       173 L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~--~  246 (373)
T 2x4f_A          173 LFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--K  246 (373)
T ss_dssp             EHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC--C
T ss_pred             HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc--c
Confidence            99888643 345899999999999999999999998   9999999999999  56789999999999977654332  3


Q ss_pred             ccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCC
Q 040557          244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIV  323 (407)
Q Consensus       244 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  323 (407)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||......      ...........  ...+...      
T Consensus       247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~--~~~~~~~------  312 (373)
T 2x4f_A          247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACRW--DLEDEEF------  312 (373)
T ss_dssp             CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCC--CSCSGGG------
T ss_pred             cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccC--CCChhhh------
Confidence            456999999999999999999999999999999999999999654321      12222222111  0000000      


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          324 ERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       324 ~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ...+..+.+++.+||+.||++|||+.|+++|.+..
T Consensus       313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~  347 (373)
T 2x4f_A          313 QDISEEAKEFISKLLIKEKSWRISASEALKHPWLS  347 (373)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcC
Confidence            11245688999999999999999999999998764

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3e-44  Score=328.23  Aligned_cols=257  Identities=21%  Similarity=0.230  Sum_probs=207.3

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ..++|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|++++++++||||+++++++.+....++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            3467888899999999999999865 57799999986443 234567899999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEE---cCCCceEEecccCccccC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFP  235 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfgla~~~~  235 (407)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+||++   +.++.++|+|||++....
T Consensus        86 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           86 ELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             ECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             eccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            999999999988543  45899999999999999999999998   9999999999999   788999999999998765


Q ss_pred             CCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          236 EDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       236 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                      ....  .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||......      . .......+....   +
T Consensus       161 ~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~~---~  227 (277)
T 3f3z_A          161 PGKM--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS------E-VMLKIREGTFTF---P  227 (277)
T ss_dssp             TTSC--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCCC---C
T ss_pred             Cccc--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH------H-HHHHHHhCCCCC---C
Confidence            4432  234579999999998765 4899999999999999999999998653221      1 111122221100   0


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ....    ...+..+.+++.+||+.||++|||+.++++|.+...
T Consensus       228 ~~~~----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  267 (277)
T 3f3z_A          228 EKDW----LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK  267 (277)
T ss_dssp             HHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred             chhh----hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence            0000    012456889999999999999999999999877643

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.4e-44  Score=331.44  Aligned_cols=258  Identities=31%  Similarity=0.453  Sum_probs=204.1

Q ss_pred             cCCCCCCeeeccCCccEEEEEecC----CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeee-ecCCeeEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLAD----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC-SDGSQRLL  156 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~l  156 (407)
                      .+|++.+.||+|+||.||+|...+    +..||+|.+...........+.+|+.++++++||||+++++++ ...+..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            457778899999999999998542    2368999987666666677899999999999999999999986 45567899


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++.....
T Consensus       105 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccc
Confidence            99999999999999643 345899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcc---cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCC-CCCCCCCcccCchhHHHHHHHHhCccccc
Q 040557          237 DQAY---LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRK-NTDLTLPSEMQYLPEYAWKLYERGRILEL  312 (407)
Q Consensus       237 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ....   ......+|+.|+|||.+.+..++.++||||||+++|||++|+. |+.......      .... ...+...  
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~------~~~~-~~~~~~~--  251 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVY-LLQGRRL--  251 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT------HHHH-HHTTCCC--
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH------HHHH-HhcCCCC--
Confidence            3321   1234567889999999999999999999999999999999554 443322211      1111 1111110  


Q ss_pred             cCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          313 VDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       313 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                          .    .+...+..+.+++.+||+.||++|||+.++++.|+....
T Consensus       252 ----~----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          252 ----L----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             ----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----C----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                0    111224568899999999999999999999999987543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2e-44  Score=330.35  Aligned_cols=248  Identities=25%  Similarity=0.424  Sum_probs=205.1

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeec--------
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSD--------  150 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  150 (407)
                      ..++|++.+.||+|+||.||+|... +|+.||+|.+....     ..+.+|++++.+++||||+++++++..        
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            4467888899999999999999875 79999999986433     246789999999999999999998854        


Q ss_pred             --------CCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCc
Q 040557          151 --------GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ  222 (407)
Q Consensus       151 --------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~  222 (407)
                              ....++||||+++|+|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+||++++++.
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence                    445799999999999999997665667999999999999999999999998   999999999999999999


Q ss_pred             eEEecccCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHH
Q 040557          223 SKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWK  302 (407)
Q Consensus       223 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~  302 (407)
                      +||+|||++........  .....||+.|+|||.+.+..++.++||||||+++|||++|..|+..         ......
T Consensus       161 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---------~~~~~~  229 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---------TSKFFT  229 (284)
T ss_dssp             EEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---------HHHHHH
T ss_pred             EEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---------HHHHHH
Confidence            99999999987755432  2345699999999999999999999999999999999999877531         011111


Q ss_pred             HHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          303 LYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       303 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ....+.+             ....+..+.+++.+||+.||++|||+.|++++|+...
T Consensus       230 ~~~~~~~-------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          230 DLRDGII-------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             HHHTTCC-------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             Hhhcccc-------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            1221111             1112345789999999999999999999999998654

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=338.70  Aligned_cols=265  Identities=25%  Similarity=0.353  Sum_probs=196.1

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHH--HHcCCCCceeeeeeeee-----cCCee
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRM--ITSIQHKNLVRLLGCCS-----DGSQR  154 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~-----~~~~~  154 (407)
                      ++|++.+.||+|+||.||+|+. +++.||||++....    ...+..|.++  +..++|+||+++++++.     .....
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            6788889999999999999987 68999999985322    2334445444  44579999999998543     23467


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhcccccc---------CCCceeeeccccccEEEcCCCceEE
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED---------SHTRIVHRDIKASNVLLDEKFQSKI  225 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------~~~~i~H~dlk~~Nill~~~~~~kl  225 (407)
                      ++||||+++|+|.+++....   .++..+..++.|++.||.|||+.         +   ++||||||+|||++.++.+||
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEE
T ss_pred             EEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEE
Confidence            89999999999999995433   58999999999999999999998         6   999999999999999999999


Q ss_pred             ecccCccccCCCCc-------ccccccccCccccCcccccc-------CCCCccccEEehhHHHHHHHhcCCCCCCCCCc
Q 040557          226 GDFGLARFFPEDQA-------YLSTNFAGTLGYTAPEYAIR-------GELSEKADIYSFGVLVLEIISCRKNTDLTLPS  291 (407)
Q Consensus       226 ~Dfgla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~  291 (407)
                      +|||++..+.....       .......||+.|+|||.+.+       ..++.++|||||||++|||++|+.|+......
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            99999987654321       11224579999999999876       45678999999999999999998776543221


Q ss_pred             -ccCchh----------HHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          292 -EMQYLP----------EYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       292 -~~~~~~----------~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                       ......          ...............+....   ......+..+.+++.+||+.||++|||+.|+++.|+....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW---KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC---CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc---ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence             111100          00111111111111111111   1123456779999999999999999999999999987653

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.2e-45  Score=340.05  Aligned_cols=270  Identities=23%  Similarity=0.359  Sum_probs=198.8

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      ++|++.+.||+|+||.||+|... +|+.||+|++...........+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            46888899999999999999875 68999999986544333223456899999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      ++ |+|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.........
T Consensus        82 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  156 (324)
T 3mtl_A           82 LD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  156 (324)
T ss_dssp             CS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence            97 4888887644 345899999999999999999999998   999999999999999999999999999865433222


Q ss_pred             cccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCc---cccccC--
Q 040557          241 LSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGR---ILELVD--  314 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d--  314 (407)
                       .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.   ............   ......  
T Consensus       157 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~  232 (324)
T 3mtl_A          157 -YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILSNE  232 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGCH
T ss_pred             -cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHhchhhhcch
Confidence             234578999999998876 5689999999999999999999999975432210   011111110000   000000  


Q ss_pred             -------cccccCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          315 -------PRMRKEG---IVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       315 -------~~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                             +......   ........+.+++.+||+.||++|||+.|+++|.|+...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence                   0000000   001123567899999999999999999999999987543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-44  Score=330.26  Aligned_cols=258  Identities=27%  Similarity=0.375  Sum_probs=205.7

Q ss_pred             CCCCCCeeeccCCccEEEEEec-C---CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCee-EEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-D---GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQR-LLV  157 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv  157 (407)
                      .|...+.||+|+||.||+|.+. +   +..||+|.+.........+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            3455688999999999999753 2   2379999997656666678899999999999999999999999776655 999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+.+|+|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.....
T Consensus       102 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             ECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             EecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            9999999999999653 455899999999999999999999998   999999999999999999999999999866543


Q ss_pred             Ccc---cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          238 QAY---LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       238 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      ...   ......+|+.|+|||.+.+..++.++||||||+++|||++|+.|+.......      ........+...    
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~------~~~~~~~~~~~~----  247 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF------DLTHFLAQGRRL----  247 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG------GHHHHHHTTCCC----
T ss_pred             cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH------HHHHHhhcCCCC----
Confidence            221   1234567889999999999999999999999999999999766654322211      111122222110    


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                            ..+...+..+.+++.+||+.||++|||+.++++.|+....
T Consensus       248 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          248 ------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                  0112234568899999999999999999999999987643

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=9.3e-44  Score=343.85  Aligned_cols=260  Identities=21%  Similarity=0.262  Sum_probs=197.5

Q ss_pred             HHHhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC-------hhhHHHHHHHHHHHHcCCCCceeeeeeeee
Q 040557           78 KKATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS-------QQGESEFLSEVRMITSIQHKNLVRLLGCCS  149 (407)
Q Consensus        78 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  149 (407)
                      ....++|.+.+.||+|+||.||+|... +++.||||++.....       ......+.+|+++|++++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            345688999999999999999999864 689999999865321       112235789999999999999999999986


Q ss_pred             cCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCC---CceEEe
Q 040557          150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEK---FQSKIG  226 (407)
Q Consensus       150 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~---~~~kl~  226 (407)
                      . ...++||||+++|+|.+++.  ....+++..+..++.|++.||.|||+.+   ++||||||+|||++.+   +.+||+
T Consensus       211 ~-~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          211 A-EDYYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             S-SEEEEEEECCTTCBGGGGTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             c-CceEEEEEcCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence            4 45799999999999998884  3456999999999999999999999998   9999999999999754   459999


Q ss_pred             cccCccccCCCCcccccccccCccccCcccccc---CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHH
Q 040557          227 DFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR---GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKL  303 (407)
Q Consensus       227 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~  303 (407)
                      |||+++.......  .....||+.|+|||++.+   ..++.++|||||||++|||++|+.||........      ....
T Consensus       285 DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~------~~~~  356 (419)
T 3i6u_A          285 DFGHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS------LKDQ  356 (419)
T ss_dssp             CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC------HHHH
T ss_pred             ecccceecCCCcc--ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH------HHHH
Confidence            9999987654332  234679999999998863   6788999999999999999999999975332211      1111


Q ss_pred             HHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          304 YERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       304 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ...+.... . +...     ...+..+.+++.+||+.||++|||+.|+++|.|..
T Consensus       357 i~~~~~~~-~-~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~  404 (419)
T 3i6u_A          357 ITSGKYNF-I-PEVW-----AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ  404 (419)
T ss_dssp             HHTTCCCC-C-HHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             HhcCCCCC-C-chhh-----cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccC
Confidence            22221110 0 0000     01245688999999999999999999999998863

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.5e-44  Score=343.04  Aligned_cols=267  Identities=22%  Similarity=0.356  Sum_probs=195.1

Q ss_pred             HHhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCC-CCceeeeeeeeecCC--e
Q 040557           79 KATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQ-HKNLVRLLGCCSDGS--Q  153 (407)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~  153 (407)
                      ...++|++.+.||+|+||.||+|.. .+|+.||||++.... .......+.+|+.++..+. |+||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3457899999999999999999986 468999999985432 3445667889999999996 999999999997544  6


Q ss_pred             eEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          154 RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      .|+||||++ |+|..++..   ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            899999997 589888854   35899999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCC--------------------cccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcc
Q 040557          234 FPEDQ--------------------AYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSE  292 (407)
Q Consensus       234 ~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~  292 (407)
                      +....                    .......+||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            54211                    112234679999999999876 678999999999999999999999997543211


Q ss_pred             cCchhHHHHHHHHhCccc--ccc----C-----------------cccccC------------CCCHHHHHHHHHHHHHc
Q 040557          293 MQYLPEYAWKLYERGRIL--ELV----D-----------------PRMRKE------------GIVERDALQVINVAFIC  337 (407)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~--~~~----d-----------------~~~~~~------------~~~~~~~~~l~~l~~~c  337 (407)
                            ............  +.+    .                 ......            ......+..+.+|+.+|
T Consensus       239 ------~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~  312 (388)
T 3oz6_A          239 ------QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKL  312 (388)
T ss_dssp             ------HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHH
T ss_pred             ------HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHh
Confidence                  111111000000  000    0                 000000            00001235688999999


Q ss_pred             cCCCCCCCCCHHHHHHHhhcc
Q 040557          338 LQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       338 l~~~p~~RPs~~ev~~~l~~~  358 (407)
                      |+.||++|||+.|+++|.+..
T Consensus       313 L~~dP~~R~t~~e~l~Hp~~~  333 (388)
T 3oz6_A          313 LQFNPNKRISANDALKHPFVS  333 (388)
T ss_dssp             CCSSGGGSCCHHHHTTSTTTT
T ss_pred             hccCcccCCCHHHHhCCHHHH
Confidence            999999999999999997753

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.7e-44  Score=350.59  Aligned_cols=269  Identities=23%  Similarity=0.242  Sum_probs=199.4

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC------C
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG------S  152 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  152 (407)
                      .++|++.+.||+|+||.||+|... +|+.||||++.... .......+.+|+.+|+.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            478899999999999999999854 68999999996432 344567788999999999999999999998654      3


Q ss_pred             eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                      ..|+||||++++ |...+.    ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       141 ~~~lv~E~~~~~-l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             eEEEEEeCCCCC-HHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            569999999865 555553    23899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCccc----------------Cch
Q 040557          233 FFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEM----------------QYL  296 (407)
Q Consensus       233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~----------------~~~  296 (407)
                      ......  .....+||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.                ..+
T Consensus       213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          213 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             ----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred             ecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence            765432  23456899999999999999999999999999999999999999975431110                000


Q ss_pred             hHHHHHHHHhCcc------ccccCcccccC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          297 PEYAWKLYERGRI------LELVDPRMRKE--GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       297 ~~~~~~~~~~~~~------~~~~d~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .............      ...+...+...  .........+.+|+.+||+.||++|||++|+++|.|...
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  361 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence            0000000000000      00000000000  001122567899999999999999999999999998753

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.1e-43  Score=329.78  Aligned_cols=263  Identities=22%  Similarity=0.375  Sum_probs=200.3

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++....  .......+.+|+.++++++|+||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            35788899999999999999986 479999999986432  344567789999999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhcc--CCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccC
Q 040557          158 YEYMKNRSLDLLIYGE--SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP  235 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~  235 (407)
                      |||+++|+|.+++...  ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999988642  3456899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          236 EDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       236 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                      ..... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||.......    .. ............    
T Consensus       188 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~-~~~~~~~~~~~~----  257 (310)
T 2wqm_A          188 SKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YS-LCKKIEQCDYPP----  257 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH----HH-HHHHHHTTCSCC----
T ss_pred             CCCcc-ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH----HH-HHHHhhcccCCC----
Confidence            43321 234568999999999999999999999999999999999999986432211    11 111222221111    


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                       ..    ....+..+.+++.+||+.||++|||+.+++++|+.....
T Consensus       258 -~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          258 -LP----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             -CC----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -Cc----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence             11    112345688999999999999999999999999876433

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.4e-44  Score=340.05  Aligned_cols=257  Identities=23%  Similarity=0.287  Sum_probs=205.5

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ..++|++.+.||+|+||.||++... +|+.||+|.+.....     ...+|++++.++ +||||+++++++.+....++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence            3467888999999999999999865 689999999964432     234688888887 799999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCC----CceEEecccCccc
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEK----FQSKIGDFGLARF  233 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~----~~~kl~Dfgla~~  233 (407)
                      |||+++|+|.+++..  ...+++..+..++.|++.||.|||+.+   ++||||||+|||+.++    +.+||+|||++..
T Consensus        95 ~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           95 TELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             ECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            999999999998854  346999999999999999999999998   9999999999998543    3599999999987


Q ss_pred             cCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccccc
Q 040557          234 FPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV  313 (407)
Q Consensus       234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ....... ....+||+.|+|||.+.+..++.++|||||||++|||++|+.||.......    .......+..+...   
T Consensus       170 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~~~~i~~~~~~---  241 (342)
T 2qr7_A          170 LRAENGL-LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT----PEEILARIGSGKFS---  241 (342)
T ss_dssp             CBCTTCC-BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC----HHHHHHHHHHCCCC---
T ss_pred             CcCCCCc-eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC----HHHHHHHHccCCcc---
Confidence            6544322 234678999999999988889999999999999999999999997532211    12222223333221   


Q ss_pred             CcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       314 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                         ... ......+..+.+++.+||+.||++|||+.++++|.|..
T Consensus       242 ---~~~-~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  282 (342)
T 2qr7_A          242 ---LSG-GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV  282 (342)
T ss_dssp             ---CCS-TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred             ---cCc-cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence               000 01112345688999999999999999999999998864

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.4e-44  Score=337.01  Aligned_cols=260  Identities=29%  Similarity=0.379  Sum_probs=207.1

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe------cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCee
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQR  154 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  154 (407)
                      .++|++.+.||+|+||.||+|+.      .++..||||.+...........+.+|+.++++++||||+++++++.+....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46788899999999999999973      357789999997555666677899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhHHHhccCC-----CCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC---CCceEEe
Q 040557          155 LLVYEYMKNRSLDLLIYGESD-----KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE---KFQSKIG  226 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~  226 (407)
                      ++||||+++|+|.+++.....     ..+++..++.++.|++.||.|||+.+   ++||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999975432     45899999999999999999999998   999999999999994   4569999


Q ss_pred             cccCccccCCCCc-ccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHH
Q 040557          227 DFGLARFFPEDQA-YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLY  304 (407)
Q Consensus       227 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  304 (407)
                      |||++........ .......||+.|+|||.+.+..++.++||||||+++|||+| |+.||......       ......
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~~  258 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFV  258 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHHHH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-------HHHHHH
Confidence            9999975533222 12234567899999999999999999999999999999998 88888643211       112222


Q ss_pred             HhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          305 ERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       305 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                      ..+....          .+...+..+.+++.+||+.||++|||+.+++++|+....
T Consensus       259 ~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          259 TSGGRMD----------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             HTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcCCCCC----------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            2221110          112234568899999999999999999999999987643

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-44  Score=336.56  Aligned_cols=256  Identities=26%  Similarity=0.409  Sum_probs=200.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcE----EEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTL----VAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      ++|++.+.||+|+||.||+|.+. +++.    ||+|.+...........+.+|+.+++.++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            56888899999999999999853 4443    57887765555556778999999999999999999999998765 789


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      |+||+.+|+|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++....
T Consensus        94 v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            999999999999987543 45899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          237 DQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       237 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      .... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.......       .......+...    
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~~~~~~----  238 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERL----  238 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTCCC----
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCC----
Confidence            3322 2233457889999999999999999999999999999999 999987543322       11222222111    


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                            ..+...+..+.+++.+||+.||++|||+.|+++.|....
T Consensus       239 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  277 (327)
T 3lzb_A          239 ------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             ------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                  011223456889999999999999999999999998664

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.6e-43  Score=346.52  Aligned_cols=261  Identities=20%  Similarity=0.278  Sum_probs=205.0

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCC-CceeeeeeeeecCCeeEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQH-KNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  158 (407)
                      .++|++.+.||+|+||.||+|.. .+++.||||++......   ..+.+|++++..++| +++..+..++......++||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            46799999999999999999986 56999999987644332   247789999999976 56666667777888899999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEE---cCCCceEEecccCccccC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFP  235 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfgla~~~~  235 (407)
                      ||+ +++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+||||   +.++.+||+|||+++.+.
T Consensus        83 e~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             ECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            999 999999986433 45999999999999999999999998   9999999999999   688999999999998775


Q ss_pred             CCCcc------cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcc
Q 040557          236 EDQAY------LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRI  309 (407)
Q Consensus       236 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      .....      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........   ... +.....
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~---~~~-i~~~~~  233 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK---YEK-ISEKKV  233 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHH---HHH-HHHHHH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHH---HHH-Hhhccc
Confidence            44321      12256799999999999999999999999999999999999999976443321111   111 111111


Q ss_pred             ccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          310 LELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       310 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ...+.. +.     ...+..+.+++..||+.||++||++.+|++.|+...
T Consensus       234 ~~~~~~-l~-----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~  277 (483)
T 3sv0_A          234 ATSIEA-LC-----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF  277 (483)
T ss_dssp             HSCHHH-HH-----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             cccHHH-Hh-----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            111100 00     012356899999999999999999999999988653

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=341.86  Aligned_cols=264  Identities=19%  Similarity=0.233  Sum_probs=198.1

Q ss_pred             cCCCCCCeeeccCCccEEEEEec----CCcEEEEEEeccccChh----------hHHHHHHHHHHHHcCCCCceeeeeee
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA----DGTLVAVKKLCVDKSQQ----------GESEFLSEVRMITSIQHKNLVRLLGC  147 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~l~~~  147 (407)
                      ++|.+.+.||+|+||.||+|...    ++..+|+|.+.......          ....+.+|+..+..++|+||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            57888899999999999999875    57889999986543221          11346678889999999999999999


Q ss_pred             eec----CCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC--
Q 040557          148 CSD----GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF--  221 (407)
Q Consensus       148 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~--  221 (407)
                      +..    ....++||||+ +++|.+++....  .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++  
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTT
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCC
Confidence            877    77899999999 999999985433  6999999999999999999999998   99999999999999877  


Q ss_pred             ceEEecccCccccCCCCcc------cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCc
Q 040557          222 QSKIGDFGLARFFPEDQAY------LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQY  295 (407)
Q Consensus       222 ~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~  295 (407)
                      .+||+|||+++.+......      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... 
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~-  269 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA-  269 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH-
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH-
Confidence            9999999999876432211      123457999999999999999999999999999999999999999643222110 


Q ss_pred             hhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          296 LPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      . ......... .+...+......    ...+..+.+++.+||+.||++|||+.+|++.|+..
T Consensus       270 ~-~~~~~~~~~-~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          270 V-QTAKTNLLD-ELPQSVLKWAPS----GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             H-HHHHHHHHH-TTTHHHHHHSCT----TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             H-HHHHHhhcc-cccHHHHhhccc----cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            0 001111110 111111000000    02345689999999999999999999999999754

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.8e-44  Score=337.77  Aligned_cols=264  Identities=25%  Similarity=0.389  Sum_probs=208.4

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-----cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeee--cCCee
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS--DGSQR  154 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~  154 (407)
                      ++|++.+.||+|+||.||+|++     .+++.||||++... .......+.+|++++++++|+||+++++++.  +....
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            5678889999999999999983     46889999998643 4455567899999999999999999999886  45678


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcccc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF  234 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~  234 (407)
                      ++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++...
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence            99999999999999986533 35899999999999999999999998   999999999999999999999999999977


Q ss_pred             CCCCcc--cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCccc--------CchhHHHHHHH
Q 040557          235 PEDQAY--LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEM--------QYLPEYAWKLY  304 (407)
Q Consensus       235 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~--------~~~~~~~~~~~  304 (407)
                      ......  ......||..|+|||.+.+..++.++||||||+++|+|++|+.|+........        ...........
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL  257 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence            544322  22345688899999999999999999999999999999999998753221100        00000111111


Q ss_pred             HhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          305 ERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       305 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                      ..+.         . ...+...+..+.+++.+||+.||++|||+.+++++|+....
T Consensus       258 ~~~~---------~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          258 EEGQ---------R-LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             HTTC---------C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             hccc---------C-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            1111         0 01122345678999999999999999999999999986543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.8e-44  Score=351.86  Aligned_cols=273  Identities=20%  Similarity=0.279  Sum_probs=188.9

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeec-----CCe
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSD-----GSQ  153 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~  153 (407)
                      .++|++.+.||+|+||.||+|... +|+.||||++.... .......+.+|+++|+.++|+||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            367999999999999999999854 68999999985432 34456788999999999999999999999843     357


Q ss_pred             eEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          154 RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      .|+||||+ +|+|..++..  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       132 ~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence            89999998 4689888853  456999999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCc--------------------------ccccccccCccccCcccc-ccCCCCccccEEehhHHHHHHHh------
Q 040557          234 FPEDQA--------------------------YLSTNFAGTLGYTAPEYA-IRGELSEKADIYSFGVLVLEIIS------  280 (407)
Q Consensus       234 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~Dv~s~G~vl~el~t------  280 (407)
                      ......                          ......+||+.|+|||++ ....++.++|||||||++|||++      
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~  285 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV  285 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence            643211                          122345789999999976 46679999999999999999999      


Q ss_pred             -----cCCCCCCCCCcccC-------ch-------hHHH---HHHHHhCc--------------cccccCcccc--cCCC
Q 040557          281 -----CRKNTDLTLPSEMQ-------YL-------PEYA---WKLYERGR--------------ILELVDPRMR--KEGI  322 (407)
Q Consensus       281 -----g~~p~~~~~~~~~~-------~~-------~~~~---~~~~~~~~--------------~~~~~d~~~~--~~~~  322 (407)
                           |+++|.+.......       ..       ....   ...+....              ....+.....  ....
T Consensus       286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (458)
T 3rp9_A          286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER  365 (458)
T ss_dssp             SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred             cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence                 44444332210000       00       0000   00000000              0000000000  0000


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          323 VERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       323 ~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .......+.+|+.+||+.||++|||++|+++|-++..
T Consensus       366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~  402 (458)
T 3rp9_A          366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE  402 (458)
T ss_dssp             STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhh
Confidence            1122456889999999999999999999999988753

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.3e-44  Score=336.63  Aligned_cols=272  Identities=24%  Similarity=0.399  Sum_probs=204.4

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++..... ......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            57888899999999999999875 589999999865433 3345668899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++++|..+...  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........
T Consensus       105 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  179 (331)
T 4aaa_A          105 FVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  179 (331)
T ss_dssp             CCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             cCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence            9999999888643  345999999999999999999999998   99999999999999999999999999987654332


Q ss_pred             ccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCc--------hhHHHHHHHHhCccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQY--------LPEYAWKLYERGRIL  310 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~~  310 (407)
                       ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+...        ........+......
T Consensus       180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (331)
T 4aaa_A          180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF  258 (331)
T ss_dssp             -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred             -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence             22345789999999998875 78999999999999999999999987543221100        000001111111110


Q ss_pred             -cccCcccccCCC----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          311 -ELVDPRMRKEGI----VERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       311 -~~~d~~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                       ....+.......    ....+..+.+++.+||+.||++|||+.|+++|-+...
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence             011111111100    0123467899999999999999999999999987643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=326.20  Aligned_cols=257  Identities=22%  Similarity=0.263  Sum_probs=204.7

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc---ChhhHHHHHHHHHHHHcCCCCceeeeeeee--ecCCee
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK---SQQGESEFLSEVRMITSIQHKNLVRLLGCC--SDGSQR  154 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~--~~~~~~  154 (407)
                      .++|++.+.||+|+||.||+|... +++.||+|.+....   .......+.+|+++++.++|+||+++++++  .+....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            478999999999999999999864 68899999986432   123456789999999999999999999998  445678


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcccc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF  234 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~  234 (407)
                      ++||||++++ |.+++.......+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999876 777776655667999999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCC-cccccccccCccccCccccccCC--CCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccc
Q 040557          235 PEDQ-AYLSTNFAGTLGYTAPEYAIRGE--LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILE  311 (407)
Q Consensus       235 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      .... ........||+.|+|||.+.+..  ++.++||||||+++|||++|+.||.....      .. ....+..+..  
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~-~~~~i~~~~~--  230 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YK-LFENIGKGSY--  230 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HH-HHHHHHHCCC--
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HH-HHHHHhcCCC--
Confidence            5322 12223456899999999887644  47899999999999999999999874321      11 1222222211  


Q ss_pred             ccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       312 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                          .     .+...+..+.+++.+||+.||++|||+.+++++.+...
T Consensus       231 ----~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  269 (305)
T 2wtk_C          231 ----A-----IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK  269 (305)
T ss_dssp             ----C-----CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred             ----C-----CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence                0     11123456889999999999999999999999987653

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.9e-43  Score=325.15  Aligned_cols=254  Identities=24%  Similarity=0.349  Sum_probs=202.6

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeec----CCeeEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSD----GSQRLL  156 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~l  156 (407)
                      .|.+.+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.+++.++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            3566678999999999999864 68899999986543 34456778999999999999999999998864    456899


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc-CCCceEEecccCccccC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFP  235 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfgla~~~~  235 (407)
                      ||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+ ++++||||||+||+++ +++.+||+|||++....
T Consensus       107 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            99999999999999643  45899999999999999999999875 4599999999999998 78999999999997654


Q ss_pred             CCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          236 EDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       236 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                      ....   ....||+.|+|||.+. +.++.++||||||+++|+|++|+.||......      .........+......+ 
T Consensus       184 ~~~~---~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~-  252 (290)
T 1t4h_A          184 ASFA---KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASFD-  252 (290)
T ss_dssp             TTSB---EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGGG-
T ss_pred             cccc---ccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------HHHHHHHhccCCccccC-
Confidence            4332   3457999999999776 45899999999999999999999998643221      11122222221111111 


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                              ...+..+.+++.+||+.||++|||+.++++|.+..
T Consensus       253 --------~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~  287 (290)
T 1t4h_A          253 --------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  287 (290)
T ss_dssp             --------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             --------CCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccc
Confidence                    11124588999999999999999999999998764

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6.3e-44  Score=342.78  Aligned_cols=267  Identities=23%  Similarity=0.272  Sum_probs=208.6

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCC--------CCceeeeeeeee--
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ--------HKNLVRLLGCCS--  149 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~--  149 (407)
                      .++|++.+.||+|+||.||+|+. .+++.||||++..  .......+.+|+++++.++        |+||+++++++.  
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS--AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec--CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            47899999999999999999985 4688999999853  3445567889999999885        788999999987  


Q ss_pred             --cCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhcccccc-CCCceeeeccccccEEEcCCC-----
Q 040557          150 --DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED-SHTRIVHRDIKASNVLLDEKF-----  221 (407)
Q Consensus       150 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~~~~-----  221 (407)
                        +....++||||+ +++|.+.+.......+++..+..++.|++.||.|||++ +   |+||||||+|||++.++     
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence              566889999999 56666666555556799999999999999999999998 7   99999999999999775     


Q ss_pred             --------------------------------------------ceEEecccCccccCCCCcccccccccCccccCcccc
Q 040557          222 --------------------------------------------QSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYA  257 (407)
Q Consensus       222 --------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~  257 (407)
                                                                  .+||+|||++.......    ....||+.|+|||.+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----TEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----CSCCSCGGGCCHHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----ccCCCCCcccCChhh
Confidence                                                        79999999998765432    345789999999999


Q ss_pred             ccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHH-----------hCccc-cccCcc---------
Q 040557          258 IRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYE-----------RGRIL-ELVDPR---------  316 (407)
Q Consensus       258 ~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~~~-~~~d~~---------  316 (407)
                      .+..++.++|||||||++|||++|+.||....................           .+... +.....         
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            999999999999999999999999999976554432211111111111           01000 000000         


Q ss_pred             ---------cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          317 ---------MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       317 ---------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                               .............+.+|+.+||+.||++|||+.|+++|-|.
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~  395 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL  395 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGG
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccc
Confidence                     00112345667889999999999999999999999998775

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.9e-43  Score=325.79  Aligned_cols=262  Identities=20%  Similarity=0.279  Sum_probs=202.2

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeee-ecCCeeEEE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC-SDGSQRLLV  157 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv  157 (407)
                      ..++|++.+.||+|+||.||+|.. .+++.||||.+......   ..+.+|++++..++|++++..++++ ...+..++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            457899999999999999999986 57899999987543322   3477899999999888777666655 667788999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEE---cCCCceEEecccCcccc
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFF  234 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfgla~~~  234 (407)
                      |||+ +++|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||||+|||+   ++++.+||+|||++...
T Consensus        84 ~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            9999 999999986433 45999999999999999999999998   9999999999999   78899999999999876


Q ss_pred             CCCCcc------cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCc
Q 040557          235 PEDQAY------LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGR  308 (407)
Q Consensus       235 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      ......      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......................
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            544321      22346799999999999999999999999999999999999999976544333222111111110000


Q ss_pred             cccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          309 ILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       309 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .     +...     ...+..+.+++.+||+.||++|||+.++++.|....
T Consensus       239 ~-----~~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~  279 (296)
T 4hgt_A          239 I-----EVLC-----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             H-----HHHT-----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             h-----hhhh-----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence            0     0000     112356889999999999999999999999997653

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3e-44  Score=332.63  Aligned_cols=255  Identities=24%  Similarity=0.376  Sum_probs=211.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      +.|+..+.||+|+||.||+|.. .+++.||+|.+...........+.+|+.++..++|+||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            5678889999999999999985 468999999997665555667899999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++++|.+++..   ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........ 
T Consensus       102 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  174 (303)
T 3a7i_A          102 LGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  174 (303)
T ss_dssp             CTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred             CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence            999999999843   45899999999999999999999998   99999999999999999999999999987654332 


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                      ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+......      . .......+..     +.+   
T Consensus       175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~~~~~~~~~~-----~~~---  239 (303)
T 3a7i_A          175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------K-VLFLIPKNNP-----PTL---  239 (303)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------H-HHHHHHHSCC-----CCC---
T ss_pred             ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH------H-HHHHhhcCCC-----CCC---
Confidence            223457899999999999999999999999999999999999998643221      1 1111222211     111   


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                        ....+..+.+++.+||+.||++|||+.+++++.+....
T Consensus       240 --~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          240 --EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             --CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             --ccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence              11223468899999999999999999999999876543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.2e-44  Score=328.75  Aligned_cols=251  Identities=25%  Similarity=0.362  Sum_probs=204.5

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  156 (407)
                      ..++|++.+.||+|+||.||+|... +++.||+|.+.... .......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3467888899999999999999875 79999999986543 334566788999999999 99999999999999999999


Q ss_pred             EEEeccCCChhHHHhccC--CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC---------------
Q 040557          157 VYEYMKNRSLDLLIYGES--DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE---------------  219 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---------------  219 (407)
                      ||||+++|+|.+++....  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.               
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999986542  256899999999999999999999998   999999999999984               


Q ss_pred             ----CCceEEecccCccccCCCCcccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccC
Q 040557          220 ----KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQ  294 (407)
Q Consensus       220 ----~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~  294 (407)
                          ...++|+|||++.......     ...||+.|+|||.+.+. .++.++||||||+++|||++|.+++...      
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------  234 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------  234 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS------
T ss_pred             ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch------
Confidence                4479999999998765433     24589999999998776 6678999999999999999998765321      


Q ss_pred             chhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          295 YLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                          ........+....          .+...+..+.+++.+||+.||++|||+.++++|.+..
T Consensus       235 ----~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  284 (289)
T 1x8b_A          235 ----DQWHEIRQGRLPR----------IPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL  284 (289)
T ss_dssp             ----HHHHHHHTTCCCC----------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred             ----hHHHHHHcCCCCC----------CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence                0111222222211          1112345688999999999999999999999998754

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=9.5e-45  Score=335.70  Aligned_cols=268  Identities=23%  Similarity=0.366  Sum_probs=190.4

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ..++|++.+.||+|+||.||+|.. .+++.||||.+...........+.+|+.++.+++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            347889999999999999999985 4689999999865544455667889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhc------cCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          159 EYMKNRSLDLLIYG------ESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       159 e~~~~g~L~~~l~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                      ||+++++|.+++..      .....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            99999999998863      12456899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCc----ccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhC
Q 040557          233 FFPEDQA----YLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERG  307 (407)
Q Consensus       233 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      .......    .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......      ....... +
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~-~  242 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK------VLMLTLQ-N  242 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHHHT-S
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh------HHHHHhc-c
Confidence            7653321    11234568999999998876 568999999999999999999999987543221      1111111 1


Q ss_pred             ccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          308 RILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       308 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .... ..............+..+.+++.+||+.||++|||+.+++++.+..
T Consensus       243 ~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  292 (303)
T 2vwi_A          243 DPPS-LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ  292 (303)
T ss_dssp             SCCC-TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-
T ss_pred             CCCc-cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhh
Confidence            1110 0000100011112345688999999999999999999999987653

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.4e-44  Score=327.86  Aligned_cols=253  Identities=25%  Similarity=0.341  Sum_probs=209.0

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+....  .......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            56788899999999999999875 58899999986543  3345677899999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        95 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           95 ELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             ECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            999999999988543  45899999999999999999999998   9999999999999999999999999998765332


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                      . ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......      .... ....+..      .  
T Consensus       170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~-~~~~~~~------~--  233 (294)
T 2rku_A          170 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYL-RIKKNEY------S--  233 (294)
T ss_dssp             C-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHH-HHHTTCC------C--
T ss_pred             c-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHH-HHhhccC------C--
Confidence            2 123457899999999999989999999999999999999999998643221      1111 1111110      0  


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                         .+...+..+.+++.+||+.||++|||+.+++++.+..
T Consensus       234 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~  270 (294)
T 2rku_A          234 ---IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFT  270 (294)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred             ---CccccCHHHHHHHHHHcccChhhCcCHHHHhhChhee
Confidence               1112335688999999999999999999999987764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.3e-44  Score=342.05  Aligned_cols=253  Identities=23%  Similarity=0.284  Sum_probs=197.1

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHH-HHcCCCCceeeeeeeeecCCeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRM-ITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++.....  ......+.+|..+ ++.++||||+++++++.+.+..|+|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            57888899999999999999865 588999999965432  2334556677776 4668999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++|+|..++...  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       118 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          118 LDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            9999999999998643  45899999999999999999999998   999999999999999999999999999864322


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      .. .....+||+.|+|||.+.+..++.++|||||||++|||++|+.||.....      ......... +..      . 
T Consensus       193 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~-~~~------~-  257 (373)
T 2r5t_A          193 NS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILN-KPL------Q-  257 (373)
T ss_dssp             CC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHH-SCC------C-
T ss_pred             CC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHh-ccc------C-
Confidence            21 23456899999999999999999999999999999999999999964321      112222222 111      0 


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHHhhcc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPM----SEIVAMLTCK  358 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~----~ev~~~l~~~  358 (407)
                          .+...+..+.+++.+||+.||++||++    .++.+|.++.
T Consensus       258 ----~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~  298 (373)
T 2r5t_A          258 ----LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS  298 (373)
T ss_dssp             ----CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGT
T ss_pred             ----CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCcccc
Confidence                111234568899999999999999997    5777776653

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.1e-43  Score=333.60  Aligned_cols=255  Identities=24%  Similarity=0.343  Sum_probs=210.1

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      .++|.+.+.||+|+||.||++... +++.||+|.+....  .......+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            367888899999999999999865 58899999986543  334567789999999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++......
T Consensus       120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            9999999999988543  45899999999999999999999998   999999999999999999999999999876533


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      .. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......      ..... ...+..      . 
T Consensus       195 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~-~~~~~~------~-  259 (335)
T 2owb_A          195 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLR-IKKNEY------S-  259 (335)
T ss_dssp             TC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHH-HHHTCC------C-
T ss_pred             cc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HHHHH-HhcCCC------C-
Confidence            22 123457999999999999999999999999999999999999998643211      11111 111111      0 


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                          .+......+.+++.+||+.||++|||+.|++++.+...
T Consensus       260 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~  297 (335)
T 2owb_A          260 ----IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS  297 (335)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             ----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                11122346889999999999999999999999887643

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.7e-44  Score=328.85  Aligned_cols=260  Identities=25%  Similarity=0.384  Sum_probs=207.0

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeee--cCCeeEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCS--DGSQRLL  156 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~l  156 (407)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+.... .......+.+|++++++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            367888899999999999999865 68999999996543 3445677899999999999999999999874  4568899


Q ss_pred             EEEeccCCChhHHHhccC--CCCCCHHHHHHHHHHHHHHhccccccC--CCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          157 VYEYMKNRSLDLLIYGES--DKFLNWSTRFQIILGIARGLQYLHEDS--HTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                      ||||+++|+|.+++....  ...+++..++.++.|++.||.|||+.+  ..+++||||||+||+++.++.+||+|||++.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999986432  345899999999999999999999976  2349999999999999999999999999998


Q ss_pred             ccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccc
Q 040557          233 FFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL  312 (407)
Q Consensus       233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ........ .....|++.|+|||.+.+..++.++||||||+++|||++|+.||.....       ......+..+.... 
T Consensus       165 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~i~~~~~~~-  235 (279)
T 2w5a_A          165 ILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELAGKIREGKFRR-  235 (279)
T ss_dssp             HC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCC-
T ss_pred             eecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-------HHHHHHHhhccccc-
Confidence            76544321 2235689999999999999999999999999999999999999875321       11222222232211 


Q ss_pred             cCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          313 VDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       313 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                               .+...+..+.+++.+||+.||++|||+.|++++++..
T Consensus       236 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          236 ---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             ---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred             ---------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence                     1122345688999999999999999999999998754

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.1e-43  Score=341.61  Aligned_cols=200  Identities=26%  Similarity=0.393  Sum_probs=167.3

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC-----Ce
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG-----SQ  153 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  153 (407)
                      .++|++.+.||+|+||.||+|... +|+.||||++.... .......+.+|+++|+.++|+||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468888999999999999999864 58899999996432 344567889999999999999999999998765     57


Q ss_pred             eEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          154 RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      .|+||||+. |+|.+++..  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       105 ~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            899999986 599998853  456999999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcc---------------------cccccccCccccCcccc-ccCCCCccccEEehhHHHHHHHhcCCCCC
Q 040557          234 FPEDQAY---------------------LSTNFAGTLGYTAPEYA-IRGELSEKADIYSFGVLVLEIISCRKNTD  286 (407)
Q Consensus       234 ~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~k~Dv~s~G~vl~el~tg~~p~~  286 (407)
                      .......                     .....+||+.|+|||.+ ....++.++|||||||++|||++|..|+.
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            6543211                     12456899999999986 55679999999999999999998655543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=7.2e-44  Score=325.49  Aligned_cols=253  Identities=26%  Similarity=0.348  Sum_probs=199.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|... +|+.||+|.+....  .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            57888899999999999999875 79999999986432  1233467889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        91 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           91 EYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             ECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             eccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            999999999998643  35899999999999999999999998   9999999999999999999999999998765433


Q ss_pred             cccccccccCccccCccccccCCC-CccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      .  .....|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.....      .. .......+...       
T Consensus       166 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~-~~~~~~~~~~~-------  229 (276)
T 2h6d_A          166 F--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV------PT-LFKKIRGGVFY-------  229 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHHCCCC-------
T ss_pred             c--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HH-HHHHhhcCccc-------
Confidence            2  234568999999999987765 6899999999999999999999864321      11 12222222110       


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                          .+...+..+.+++.+||+.||++|||+.++++|.+...
T Consensus       230 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~  267 (276)
T 2h6d_A          230 ----IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ  267 (276)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred             ----CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence                11122356889999999999999999999999987643

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.5e-44  Score=332.44  Aligned_cols=260  Identities=23%  Similarity=0.302  Sum_probs=202.9

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeee----cCCeeE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS----DGSQRL  155 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~  155 (407)
                      .++|++.+.||+|+||.||++.. .+|+.||||++.. ........+.+|+++++.++||||+++++++.    .....+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC-HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE-SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec-CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            46788899999999999999986 5799999999854 34455678899999999999999999999986    345789


Q ss_pred             EEEEeccCCChhHHHhcc--CCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          156 LVYEYMKNRSLDLLIYGE--SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      +||||+++|+|.+++...  ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            999999999999988642  3456999999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCcc--------cccccccCccccCccccccCC---CCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHH
Q 040557          234 FPEDQAY--------LSTNFAGTLGYTAPEYAIRGE---LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWK  302 (407)
Q Consensus       234 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~  302 (407)
                      .......        ......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||........ .    ...
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~----~~~  258 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-S----VAL  258 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-C----HHH
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-h----hhH
Confidence            5422111        012345799999999887654   68999999999999999999999852111000 0    001


Q ss_pred             HHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          303 LYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       303 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .... ..      ..   ......+..+.+++.+||+.||++|||+.+++++|+...
T Consensus       259 ~~~~-~~------~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          259 AVQN-QL------SI---PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             HHHC-C--------C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             Hhhc-cC------CC---CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            1111 00      00   011123456889999999999999999999999998654

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.4e-43  Score=324.25  Aligned_cols=261  Identities=20%  Similarity=0.281  Sum_probs=205.0

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeee-ecCCeeEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCC-SDGSQRLLVY  158 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~  158 (407)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++......   ..+.+|+.++..++|++++..++++ ......++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            46788899999999999999986 57999999998644322   3578999999999888866666555 6677889999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEE---cCCCceEEecccCccccC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFP  235 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfgla~~~~  235 (407)
                      ||+ +++|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+|||+   ++++.+||+|||++....
T Consensus        85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             Eec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            999 89999998643 345999999999999999999999998   9999999999999   488899999999998765


Q ss_pred             CCCcc------cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcc
Q 040557          236 EDQAY------LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRI  309 (407)
Q Consensus       236 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      .....      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........................
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence            44321      123467999999999999999999999999999999999999999865433322221111111100000


Q ss_pred             ccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          310 LELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       310 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                           +.+     ....+..+.+++.+||+.||++|||+.++++.|....
T Consensus       240 -----~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  279 (296)
T 3uzp_A          240 -----EVL-----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             -----HHH-----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             -----HHH-----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence                 000     0112356889999999999999999999999997654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=9.9e-44  Score=330.67  Aligned_cols=260  Identities=26%  Similarity=0.407  Sum_probs=197.7

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec----CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC--
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA----DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS--  152 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--  152 (407)
                      ..++|.+.+.||+|+||.||+|...    ++..||+|.+.... .......+.+|+.++++++||||+++++++.+..  
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            3467888899999999999999753    34589999986543 3445577899999999999999999999997655  


Q ss_pred             ---eeEEEEEeccCCChhHHHhcc----CCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEE
Q 040557          153 ---QRLLVYEYMKNRSLDLLIYGE----SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKI  225 (407)
Q Consensus       153 ---~~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl  225 (407)
                         ..++||||+++|+|.+++...    ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence               349999999999999998532    3456999999999999999999999998   999999999999999999999


Q ss_pred             ecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHH
Q 040557          226 GDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKL  303 (407)
Q Consensus       226 ~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~  303 (407)
                      +|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.......      .. ..
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~-~~  261 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE------MY-DY  261 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG------HH-HH
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HH-HH
Confidence            999999876543322 1233457889999999999999999999999999999999 888876433221      11 11


Q ss_pred             HHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          304 YERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       304 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ...+...          ..+...+..+.+++.+||+.||++|||+.+++++|+...
T Consensus       262 ~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          262 LLHGHRL----------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             HHTTCCC----------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHcCCCC----------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1211111          111223456889999999999999999999999998654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.3e-43  Score=343.70  Aligned_cols=269  Identities=18%  Similarity=0.235  Sum_probs=205.7

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcC------CCCceeeeeeeeecCCe
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSI------QHKNLVRLLGCCSDGSQ  153 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~  153 (407)
                      ..+|++.+.||+|+||.||+|... +++.||||++..  .......+.+|++++..+      +|+||+++++++.....
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN--EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC--ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            356888999999999999999764 589999999853  334445677888888776      57799999999999999


Q ss_pred             eEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCc--eEEecccCc
Q 040557          154 RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ--SKIGDFGLA  231 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~--~kl~Dfgla  231 (407)
                      .++||||+. ++|.+++.......+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.  +||+|||++
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            999999996 68999987766667999999999999999999999998   999999999999999887  999999999


Q ss_pred             cccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHH-------HHH
Q 040557          232 RFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAW-------KLY  304 (407)
Q Consensus       232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~-------~~~  304 (407)
                      .......    ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.  +.....       ..+
T Consensus       250 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~--l~~i~~~~~~p~~~~~  323 (429)
T 3kvw_A          250 CYEHQRV----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ--LACMIELLGMPSQKLL  323 (429)
T ss_dssp             EETTCCC----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHH
T ss_pred             eecCCcc----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHcCCCCHHHH
Confidence            8654432    346789999999999999999999999999999999999999875432110  000000       000


Q ss_pred             HhC-ccccccCc---------------------------ccccC--C------CCHHHHHHHHHHHHHccCCCCCCCCCH
Q 040557          305 ERG-RILELVDP---------------------------RMRKE--G------IVERDALQVINVAFICLQPHGNQRPPM  348 (407)
Q Consensus       305 ~~~-~~~~~~d~---------------------------~~~~~--~------~~~~~~~~l~~l~~~cl~~~p~~RPs~  348 (407)
                      ... .....++.                           .....  .      ........+.+|+.+||+.||++|||+
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta  403 (429)
T 3kvw_A          324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP  403 (429)
T ss_dssp             HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence            000 00000000                           00000  0      000113568899999999999999999


Q ss_pred             HHHHHHhhccccC
Q 040557          349 SEIVAMLTCKVES  361 (407)
Q Consensus       349 ~ev~~~l~~~~~~  361 (407)
                      .|+++|.|.....
T Consensus       404 ~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          404 GQALRHPWLRRRL  416 (429)
T ss_dssp             HHHHTSTTTC---
T ss_pred             HHHhCChhhccCC
Confidence            9999999876443

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=341.56  Aligned_cols=261  Identities=17%  Similarity=0.223  Sum_probs=203.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEecC---------CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceee---------
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLAD---------GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVR---------  143 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~---------  143 (407)
                      ++|++.+.||+|+||.||+|....         ++.||+|.+...      ..+.+|++++.+++||||++         
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            678888999999999999998753         789999998633      35779999999999999987         


Q ss_pred             ------eeeeeec-CCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEE
Q 040557          144 ------LLGCCSD-GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVL  216 (407)
Q Consensus       144 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil  216 (407)
                            +++++.. ....++||||+ +++|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+|||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence                  5666665 67889999999 999999997654567999999999999999999999998   999999999999


Q ss_pred             EcCCC--ceEEecccCccccCCCCcc------cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCC
Q 040557          217 LDEKF--QSKIGDFGLARFFPEDQAY------LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLT  288 (407)
Q Consensus       217 l~~~~--~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~  288 (407)
                      ++.++  .+||+|||+++.+......      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  9999999999876533221      113357999999999999999999999999999999999999999754


Q ss_pred             CCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          289 LPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ...... ....... +. .......+......    ..+..+.+++.+||+.||++|||+.++++.|+...
T Consensus       272 ~~~~~~-~~~~~~~-~~-~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  335 (352)
T 2jii_A          272 LPNTED-IMKQKQK-FV-DKPGPFVGPCGHWI----RPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL  335 (352)
T ss_dssp             TTCHHH-HHHHHHH-HH-HSCCCEECTTSCEE----CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             CcCHHH-HHHHHHh-cc-CChhhhhhhccccC----CCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence            322111 1111111 11 11111221111111    12356889999999999999999999999998654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.7e-43  Score=348.81  Aligned_cols=260  Identities=25%  Similarity=0.312  Sum_probs=208.5

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ..++|++.+.||+|+||+||+|... +|+.||||++.... .......+.+|++++++++||||+++++++.+....++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3467888999999999999999864 68999999985432 223456789999999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc---CCCceEEecccCcccc
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD---EKFQSKIGDFGLARFF  234 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfgla~~~  234 (407)
                      |||+.+|+|.+.+...  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++   .++.+||+|||++..+
T Consensus       100 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          100 GELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            9999999998888543  45899999999999999999999998   99999999999995   4567999999999876


Q ss_pred             CCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          235 PEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       235 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      .....  .....||+.|+|||.+.+ .++.++|||||||++|+|++|+.||......      . ....+..+...... 
T Consensus       175 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~-~~~~i~~~~~~~~~-  243 (486)
T 3mwu_A          175 QQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------D-ILKRVETGKYAFDL-  243 (486)
T ss_dssp             CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHTCCCSCS-
T ss_pred             CCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCCCCCCC-
Confidence            54432  234679999999998865 5999999999999999999999999653221      1 12222222211100 


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                      +..      ...+..+.+++.+||+.||++|||+.++++|.|.....
T Consensus       244 ~~~------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          244 PQW------RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             GGG------GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             ccc------CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            110      12245688999999999999999999999998876443

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-43  Score=334.26  Aligned_cols=269  Identities=24%  Similarity=0.345  Sum_probs=201.6

Q ss_pred             HHhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChh----hHHHHHHHHHHHHcCCCCceeeeeeeeecCCe
Q 040557           79 KATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQ----GESEFLSEVRMITSIQHKNLVRLLGCCSDGSQ  153 (407)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  153 (407)
                      ...++|++.+.||+|+||.||+|... +|+.||||.+.......    ....+.+|+++++.++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999864 58999999986433211    12467899999999999999999999999999


Q ss_pred             eEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          154 RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      .++||||+++ +|..++... ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             eEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            9999999986 888887543 345889999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh-Cccc-
Q 040557          234 FPEDQAYLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER-GRIL-  310 (407)
Q Consensus       234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~-  310 (407)
                      +..... ......||+.|+|||.+.+. .++.++|||||||++|||++|.+||......      ......... +... 
T Consensus       162 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~------~~~~~i~~~~~~~~~  234 (346)
T 1ua2_A          162 FGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL------DQLTRIFETLGTPTE  234 (346)
T ss_dssp             TTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCCCCT
T ss_pred             ccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHHHcCCCCh
Confidence            654332 22346789999999998764 5899999999999999999999988654321      111111111 1000 


Q ss_pred             -ccc------Cccc-c-cCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          311 -ELV------DPRM-R-KEGIV-----ERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       311 -~~~------d~~~-~-~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                       ...      +... . ....+     ...+..+.+++.+||+.||++|||+.|+++|.+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~  297 (346)
T 1ua2_A          235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  297 (346)
T ss_dssp             TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence             000      0000 0 00001     122457899999999999999999999999998754

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.8e-44  Score=336.55  Aligned_cols=258  Identities=24%  Similarity=0.372  Sum_probs=204.4

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcE--EEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTL--VAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ++|++.+.||+|+||.||+|+.. +|..  +|+|.+...........+.+|++++.++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57888899999999999999864 5664  4999986544455566789999999999 899999999999999999999


Q ss_pred             EEeccCCChhHHHhccC--------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCce
Q 040557          158 YEYMKNRSLDLLIYGES--------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS  223 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~  223 (407)
                      |||+++|+|.+++....              ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999986532              346899999999999999999999998   9999999999999999999


Q ss_pred             EEecccCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHH
Q 040557          224 KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWK  302 (407)
Q Consensus       224 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~  302 (407)
                      ||+|||+++......  ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......       ....
T Consensus       182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------~~~~  252 (327)
T 1fvr_A          182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELYE  252 (327)
T ss_dssp             EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHH
T ss_pred             EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-------HHHH
Confidence            999999997443221  1223457889999999998899999999999999999998 99998653221       1111


Q ss_pred             HHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          303 LYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       303 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                      ....+..     .     ..+...+..+.+++.+||+.||++|||+.+++++|......
T Consensus       253 ~~~~~~~-----~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          253 KLPQGYR-----L-----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             HGGGTCC-----C-----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HhhcCCC-----C-----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            1221110     0     01122345688999999999999999999999999876543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.2e-43  Score=325.14  Aligned_cols=255  Identities=22%  Similarity=0.256  Sum_probs=204.2

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccCh-----hhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQ-----QGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRL  155 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  155 (407)
                      ++|++.+.||+|+||.||+|... +|+.||+|.+......     .....+.+|+.++++++||||+++++++.+....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            56888899999999999999875 6899999998654322     23567899999999999999999999999999999


Q ss_pred             EEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC----ceEEecccCc
Q 040557          156 LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF----QSKIGDFGLA  231 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfgla  231 (407)
                      +||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++    .++|+|||++
T Consensus        85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            999999999999998543  45899999999999999999999998   99999999999999877    8999999999


Q ss_pred             cccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccc
Q 040557          232 RFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILE  311 (407)
Q Consensus       232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      ........  .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||......      . ........... 
T Consensus       160 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~-  229 (283)
T 3bhy_A          160 HKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ------E-TLTNISAVNYD-  229 (283)
T ss_dssp             EECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHTTCCC-
T ss_pred             eeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH------H-HHHHhHhcccC-
Confidence            87654332  23456899999999999999999999999999999999999998653221      1 11111111100 


Q ss_pred             ccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       312 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                       .+....     ...+..+.+++.+||+.||++|||+.+++++.+.
T Consensus       230 -~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~  269 (283)
T 3bhy_A          230 -FDEEYF-----SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWI  269 (283)
T ss_dssp             -CCHHHH-----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHH
T ss_pred             -Ccchhc-----ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHH
Confidence             000000     1123468899999999999999999999998654

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=7.9e-44  Score=336.23  Aligned_cols=265  Identities=20%  Similarity=0.281  Sum_probs=210.1

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChh----------------hHHHHHHHHHHHHcCCCCceeee
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQ----------------GESEFLSEVRMITSIQHKNLVRL  144 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~e~~~l~~l~h~niv~l  144 (407)
                      .++|++.+.||+|+||.||+|.. +|+.||+|.+.......                ....+.+|+.++.+++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            36788899999999999999999 89999999986432111                11678999999999999999999


Q ss_pred             eeeeecCCeeEEEEEeccCCChhHH------HhccCCCCCCHHHHHHHHHHHHHHhccccc-cCCCceeeeccccccEEE
Q 040557          145 LGCCSDGSQRLLVYEYMKNRSLDLL------IYGESDKFLNWSTRFQIILGIARGLQYLHE-DSHTRIVHRDIKASNVLL  217 (407)
Q Consensus       145 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill  217 (407)
                      ++++.+.+..++||||+++|+|.++      +.......+++..+..++.|++.||.|||+ .+   ++||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence            9999999999999999999999998      654446779999999999999999999998 87   9999999999999


Q ss_pred             cCCCceEEecccCccccCCCCcccccccccCccccCccccccC-CCCc-cccEEehhHHHHHHHhcCCCCCCCCCcccCc
Q 040557          218 DEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-ELSE-KADIYSFGVLVLEIISCRKNTDLTLPSEMQY  295 (407)
Q Consensus       218 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~  295 (407)
                      +.++.++|+|||++......   ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||......    
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----  258 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL----  258 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred             cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence            99999999999999876443   22446799999999999887 6766 999999999999999999999754331    


Q ss_pred             hhHHHHHHHHhCccccccCc-----ccc---cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          296 LPEYAWKLYERGRILELVDP-----RMR---KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~d~-----~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                        ......+..+......+.     ...   ........+..+.+++.+||+.||++|||+.|+++|.+..
T Consensus       259 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~  327 (348)
T 2pml_X          259 --VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA  327 (348)
T ss_dssp             --HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGT
T ss_pred             --HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence              111222222211100000     000   0000122346789999999999999999999999998764

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-43  Score=336.67  Aligned_cols=260  Identities=25%  Similarity=0.336  Sum_probs=199.8

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC------
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS------  152 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  152 (407)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++.... .......+.+|+++++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46788889999999999999986 469999999985433 3344567899999999999999999999997653      


Q ss_pred             eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                      ..++||||+ +++|.+++..   ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            469999999 7899999864   35899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHH-hCcc-
Q 040557          233 FFPEDQAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYE-RGRI-  309 (407)
Q Consensus       233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~-  309 (407)
                      ......    ....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......      ........ .+.. 
T Consensus       177 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~l~~i~~~~g~~~  246 (367)
T 1cm8_A          177 QADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL------DQLKEIMKVTGTPP  246 (367)
T ss_dssp             ECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCCCC
T ss_pred             cccccc----CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHhcCCCC
Confidence            765432    34678999999999887 68999999999999999999999999754321      11111110 0000 


Q ss_pred             -------------------ccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          310 -------------------LELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       310 -------------------~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                                         .......+.  ......+..+.+++.+||+.||++|||+.|+++|.+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~  313 (367)
T 1cm8_A          247 AEFVQRLQSDEAKNYMKGLPELEKKDFA--SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES  313 (367)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGG--GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             HHHHHHhhhHHHHHHHHhCCCCCCCCHH--HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHh
Confidence                               000000000  011123456889999999999999999999999988653

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-44  Score=334.82  Aligned_cols=265  Identities=27%  Similarity=0.405  Sum_probs=204.8

Q ss_pred             cCHHHHHHHhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeee
Q 040557           72 FDFQTLKKATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCS  149 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  149 (407)
                      +++..+....++|++.+.||+|+||.||+|+. .+|+.||+|++....  .....+.+|+.++.++ +||||+++++++.
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            44455555678899999999999999999986 468999999986433  2345788999999998 8999999999997


Q ss_pred             c------CCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCce
Q 040557          150 D------GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS  223 (407)
Q Consensus       150 ~------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~  223 (407)
                      .      ....++||||+++|+|.+++.......+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence            6      467899999999999999997665567999999999999999999999998   9999999999999999999


Q ss_pred             EEecccCccccCCCCcccccccccCccccCccccc-----cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhH
Q 040557          224 KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI-----RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPE  298 (407)
Q Consensus       224 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~  298 (407)
                      ||+|||++........ ......||+.|+|||.+.     +..++.++||||||+++|||++|+.||......      .
T Consensus       169 kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~  241 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------R  241 (326)
T ss_dssp             EECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------H
T ss_pred             EEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------H
Confidence            9999999987653322 123457899999999887     567899999999999999999999998643221      1


Q ss_pred             HHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          299 YAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       299 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .... ...+..     +.....    ..+..+.+++.+||+.||++|||+.++++|.+..
T Consensus       242 ~~~~-~~~~~~-----~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~  291 (326)
T 2x7f_A          242 ALFL-IPRNPA-----PRLKSK----KWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR  291 (326)
T ss_dssp             HHHH-HHHSCC-----CCCSCS----CSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred             HHHH-hhcCcc-----ccCCcc----ccCHHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence            1111 111111     111111    1234688999999999999999999999987764

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.5e-44  Score=338.62  Aligned_cols=267  Identities=22%  Similarity=0.301  Sum_probs=197.4

Q ss_pred             HHhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccCh-hhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           79 KATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQ-QGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      ...++|++.+.||+|+||.||+|.. .+|+.||||++...... .....+.+|++++++++||||+++++++.+.+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            3457899999999999999999985 46899999998654322 234567899999999999999999999999999999


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc-----CCCceEEecccCc
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD-----EKFQSKIGDFGLA  231 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-----~~~~~kl~Dfgla  231 (407)
                      ||||+++ +|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++     +++.+||+|||++
T Consensus       111 v~e~~~~-~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EEECCSE-EHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EEecCCC-CHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            9999985 999988543  35899999999999999999999998   99999999999994     5556999999999


Q ss_pred             cccCCCCcccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh-Ccc
Q 040557          232 RFFPEDQAYLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER-GRI  309 (407)
Q Consensus       232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~  309 (407)
                      ......... .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||......      ......... +..
T Consensus       185 ~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~~  257 (329)
T 3gbz_A          185 RAFGIPIRQ-FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI------DQLFKIFEVLGLP  257 (329)
T ss_dssp             HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCCC
T ss_pred             cccCCcccc-cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH------HHHHHHHHHhCCC
Confidence            876533222 2345689999999998874 5899999999999999999999998653321      111111111 000


Q ss_pred             ccc-------------cCcccccCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          310 LEL-------------VDPRMRKEG----IVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       310 ~~~-------------~d~~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ...             ..+......    ........+.+++.+||+.||++|||+.|+++|-|+.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  323 (329)
T 3gbz_A          258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS  323 (329)
T ss_dssp             CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccC
Confidence            000             000000000    0001235678999999999999999999999998865

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=7.8e-44  Score=336.79  Aligned_cols=267  Identities=23%  Similarity=0.321  Sum_probs=202.6

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeec--------C
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSD--------G  151 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~  151 (407)
                      ++|++.+.||+|+||.||+|+. .+|+.||+|++..... ......+.+|+++++.++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            6788889999999999999987 5789999999865432 2234567899999999999999999999876        4


Q ss_pred             CeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCc
Q 040557          152 SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLA  231 (407)
Q Consensus       152 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla  231 (407)
                      +..++||||+++ +|...+... ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            468999999986 676666433 345999999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCc---ccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhC
Q 040557          232 RFFPEDQA---YLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERG  307 (407)
Q Consensus       232 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      +.+.....   .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........   ........  +
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~--~  246 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLC--G  246 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHH--C
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHh--C
Confidence            87653221   12234678999999998876 5689999999999999999999999875432211   00111100  1


Q ss_pred             ccccccCccc------------ccCCCC-HH------HHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          308 RILELVDPRM------------RKEGIV-ER------DALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       308 ~~~~~~d~~~------------~~~~~~-~~------~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ......-+..            ...... ..      ....+.+++.+||+.||++|||+.|+++|-|..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  316 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW  316 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcC
Confidence            1100000000            000000 00      134578999999999999999999999999875

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.1e-43  Score=335.35  Aligned_cols=263  Identities=21%  Similarity=0.322  Sum_probs=210.5

Q ss_pred             HHHHHHHhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccCh-------hhHHHHHHHHHHHHcC-CCCceeee
Q 040557           74 FQTLKKATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQ-------QGESEFLSEVRMITSI-QHKNLVRL  144 (407)
Q Consensus        74 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l-~h~niv~l  144 (407)
                      +.......++|++.+.||+|+||.||+|.+. +|+.||||++......       .....+.+|+.++.++ +||||+++
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            3344556678999999999999999999875 7999999998654311       1245678999999999 89999999


Q ss_pred             eeeeecCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceE
Q 040557          145 LGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSK  224 (407)
Q Consensus       145 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k  224 (407)
                      ++++......++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik  240 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR  240 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence            99999999999999999999999998643  45899999999999999999999998   99999999999999999999


Q ss_pred             EecccCccccCCCCcccccccccCccccCcccccc------CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhH
Q 040557          225 IGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR------GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPE  298 (407)
Q Consensus       225 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~  298 (407)
                      |+|||++..+.....  .....||+.|+|||++.+      ..++.++|||||||++|||++|+.||......      .
T Consensus       241 l~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~------~  312 (365)
T 2y7j_A          241 LSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI------L  312 (365)
T ss_dssp             ECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------H
T ss_pred             EEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH------H
Confidence            999999987765432  234679999999998863      35889999999999999999999998643211      1


Q ss_pred             HHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          299 YAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       299 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                       .......+.... ..+..  .    ..+..+.+++.+||+.||++|||+.++++|.|+
T Consensus       313 -~~~~i~~~~~~~-~~~~~--~----~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f  363 (365)
T 2y7j_A          313 -MLRMIMEGQYQF-SSPEW--D----DRSSTVKDLISRLLQVDPEARLTAEQALQHPFF  363 (365)
T ss_dssp             -HHHHHHHTCCCC-CHHHH--S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             -HHHHHHhCCCCC-CCccc--c----cCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence             111122221110 00000  0    123458899999999999999999999999875

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.7e-45  Score=339.84  Aligned_cols=262  Identities=24%  Similarity=0.412  Sum_probs=206.2

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-----cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC--ee
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-----ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS--QR  154 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~  154 (407)
                      ++|++.+.||+|+||.||+|+.     .+|+.||+|++... .......+.+|++++++++|+||+++++++...+  ..
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            5688889999999999999983     36899999998643 3445568999999999999999999999986544  78


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcccc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF  234 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~  234 (407)
                      ++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            99999999999999996543 45899999999999999999999998   999999999999999999999999999887


Q ss_pred             CCCCccc--ccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCc---------ccCchhHHHHHH
Q 040557          235 PEDQAYL--STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPS---------EMQYLPEYAWKL  303 (407)
Q Consensus       235 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~---------~~~~~~~~~~~~  303 (407)
                      .......  .....++..|+|||.+.+..++.++||||||+++|||+||..|+......         ............
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  275 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence            6543321  22345778899999999989999999999999999999999887532100         000000011111


Q ss_pred             HHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          304 YERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       304 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ...+..          ...+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus       276 ~~~~~~----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          276 LKNNGR----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHTTCC----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhcCCC----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111110          011223456789999999999999999999999999764

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8e-44  Score=338.52  Aligned_cols=254  Identities=15%  Similarity=0.129  Sum_probs=203.1

Q ss_pred             HhcCCCCCCeeeccCCccEEEEE------ecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCC---CCceeeeeeeeec
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGK------LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ---HKNLVRLLGCCSD  150 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~  150 (407)
                      ..++|.+.+.||+|+||.||+|.      ..+++.||+|++...    ....+..|++++..++   |+||+++++++..
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            44678888999999999999993      456899999998533    2345778888888876   9999999999999


Q ss_pred             CCeeEEEEEeccCCChhHHHhcc---CCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC--------
Q 040557          151 GSQRLLVYEYMKNRSLDLLIYGE---SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE--------  219 (407)
Q Consensus       151 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~--------  219 (407)
                      .+..++||||+++|+|.+++...   ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.        
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence            99999999999999999999642   3456999999999999999999999998   999999999999998        


Q ss_pred             ---CCceEEecccCccccCC-CCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCc
Q 040557          220 ---KFQSKIGDFGLARFFPE-DQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQY  295 (407)
Q Consensus       220 ---~~~~kl~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~  295 (407)
                         ++.+||+|||+++.+.. .........+||+.|+|||++.+..++.++|||||||++|||+||+.||........  
T Consensus       216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--  293 (365)
T 3e7e_A          216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--  293 (365)
T ss_dssp             ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--
T ss_pred             ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce--
Confidence               89999999999976532 122233456799999999999999999999999999999999999999853322110  


Q ss_pred             hhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHhhccccCC
Q 040557          296 LPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQR-PPMSEIVAMLTCKVESG  362 (407)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R-Ps~~ev~~~l~~~~~~~  362 (407)
                                      .+...+... .   ....+.+++..|++.+|.+| |++.++.+.|+......
T Consensus       294 ----------------~~~~~~~~~-~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          294 ----------------KPEGLFRRL-P---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             ----------------EECSCCTTC-S---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ----------------eechhcccc-C---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence                            011111111 1   23457788999999999998 57888888877655443

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.7e-43  Score=325.36  Aligned_cols=258  Identities=24%  Similarity=0.361  Sum_probs=191.5

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHH-HHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEF-LSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~-~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++...........+ .++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            36788889999999999999986 47899999999755444444444 44445577789999999999999999999999


Q ss_pred             EeccCCChhHHHhc--cCCCCCCHHHHHHHHHHHHHHhcccccc-CCCceeeeccccccEEEcCCCceEEecccCccccC
Q 040557          159 EYMKNRSLDLLIYG--ESDKFLNWSTRFQIILGIARGLQYLHED-SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP  235 (407)
Q Consensus       159 e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~  235 (407)
                      ||+++ +|.+++..  .....+++..+..++.|++.||.|||+. +   ++||||||+||+++.++.+||+|||++....
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99975 88777643  2345699999999999999999999998 8   9999999999999999999999999998765


Q ss_pred             CCCcccccccccCccccCcccc----ccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccc
Q 040557          236 EDQAYLSTNFAGTLGYTAPEYA----IRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILE  311 (407)
Q Consensus       236 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      ....  .....||+.|+|||.+    .+..++.++||||||+++|||++|+.||......     ............   
T Consensus       162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~---  231 (290)
T 3fme_A          162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVVEEPS---  231 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHHHSCC---
T ss_pred             cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHhccCC---
Confidence            4432  2334699999999986    5667899999999999999999999998643221     111222222111   


Q ss_pred             ccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       312 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                         +...    ....+..+.+++.+||+.||++|||+.|+++|.+...
T Consensus       232 ---~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          232 ---PQLP----ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             ---CCCC----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             ---CCcc----cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence               1111    1123456889999999999999999999999887653

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.6e-44  Score=328.84  Aligned_cols=251  Identities=29%  Similarity=0.394  Sum_probs=198.2

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC-CeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG-SQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e  159 (407)
                      .++|++.+.||+|+||.||+|.. +|+.||+|.+....   ..+.+.+|++++++++||||+++++++... +..++|||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            36788889999999999999988 48999999986432   445788999999999999999999987544 57899999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++|+|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++....... 
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  171 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  171 (278)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence            999999999997554445899999999999999999999998   9999999999999999999999999998654332 


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                         ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......       .......+..     .   
T Consensus       172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~-----~---  233 (278)
T 1byg_A          172 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYK-----M---  233 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-------HHHHHTTTCC-----C---
T ss_pred             ---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcCCC-----C---
Confidence               23457889999999999999999999999999999998 999886432211       1111221110     0   


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                        ..+...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus       234 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          234 --DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence              112223456889999999999999999999999997654

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=9.1e-44  Score=327.50  Aligned_cols=254  Identities=27%  Similarity=0.405  Sum_probs=203.2

Q ss_pred             cCCCCCC-eeeccCCccEEEEEe---cCCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           82 KNFHPGN-LLGRGGFGPVYRGKL---ADGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        82 ~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      ++|.+.+ .||+|+||.||+|.+   .+++.||||.+..... ......+.+|+++++.++||||+++++++ ..+..++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            4566666 899999999999954   2478899999865432 23356799999999999999999999999 5567899


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        95 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             EEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            99999999999999643  45899999999999999999999998   99999999999999999999999999987765


Q ss_pred             CCcccc--cccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCcccccc
Q 040557          237 DQAYLS--TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELV  313 (407)
Q Consensus       237 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ......  ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......       ........+...   
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~---  239 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERM---  239 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCC---
T ss_pred             CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCCC---
Confidence            443221  23446789999999998899999999999999999999 99998653321       122222222211   


Q ss_pred             CcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       314 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                             ..+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus       240 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          240 -------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             -------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                   11222345689999999999999999999999999754

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=6.4e-44  Score=338.78  Aligned_cols=275  Identities=21%  Similarity=0.272  Sum_probs=204.2

Q ss_pred             cCHHHHHHHhcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccC----------hhhHHHHHHHHHHHHcCCCCce
Q 040557           72 FDFQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKS----------QQGESEFLSEVRMITSIQHKNL  141 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~e~~~l~~l~h~ni  141 (407)
                      ....++....++|++.+.||+|+||.||+|...+|+.||||++.....          ......+.+|++++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            345677788899999999999999999999988899999999854322          1223678999999999999999


Q ss_pred             eeeeeeeec-----CCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEE
Q 040557          142 VRLLGCCSD-----GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVL  216 (407)
Q Consensus       142 v~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil  216 (407)
                      +++++++..     ....++||||+. |+|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+|||
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  166 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL  166 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence            999999843     346799999998 5887777633 346999999999999999999999998   999999999999


Q ss_pred             EcCCCceEEecccCccccCCCCcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCc
Q 040557          217 LDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQY  295 (407)
Q Consensus       217 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~  295 (407)
                      ++.++.+||+|||++........  .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||......    
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----  240 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY----  240 (362)
T ss_dssp             ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----
T ss_pred             EcCCCCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH----
Confidence            99999999999999985543332  234578999999998877 67899999999999999999999999754321    


Q ss_pred             hhHHHHHHHHh---Ccc-----------ccccCcccccC------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040557          296 LPEYAWKLYER---GRI-----------LELVDPRMRKE------GIVERDALQVINVAFICLQPHGNQRPPMSEIVAML  355 (407)
Q Consensus       296 ~~~~~~~~~~~---~~~-----------~~~~d~~~~~~------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l  355 (407)
                        .........   ...           .+.+.......      ......+..+.+++.+||+.||++|||+.|+++|.
T Consensus       241 --~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  318 (362)
T 3pg1_A          241 --NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP  318 (362)
T ss_dssp             --HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             --HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc
Confidence              111111110   000           00000000000      00111245688999999999999999999999998


Q ss_pred             hccc
Q 040557          356 TCKV  359 (407)
Q Consensus       356 ~~~~  359 (407)
                      +...
T Consensus       319 ~f~~  322 (362)
T 3pg1_A          319 YFES  322 (362)
T ss_dssp             GGTT
T ss_pred             hhhh
Confidence            8643

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=9e-44  Score=350.70  Aligned_cols=257  Identities=25%  Similarity=0.329  Sum_probs=209.9

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      .++|++.+.||+|+||.||+|... +|+.||||++....  .......+.+|++++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467888899999999999999865 78999999986543  234467789999999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEE---cCCCceEEecccCcccc
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFF  234 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfgla~~~  234 (407)
                      |||+.+|+|.+++..  ...+++..+..++.|++.||.|||+.+   ++||||||+|||+   +.++.+||+|||++..+
T Consensus       105 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          105 GEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             ECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             EecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            999999999998854  345999999999999999999999998   9999999999999   56789999999999877


Q ss_pred             CCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          235 PEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       235 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      .....  .....||+.|+|||.+.+ .++.++|||||||++|+|++|+.||......      . ....+..+...... 
T Consensus       180 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~-~~~~i~~~~~~~~~-  248 (484)
T 3nyv_A          180 EASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY------D-ILKKVEKGKYTFEL-  248 (484)
T ss_dssp             CCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCCCCS-
T ss_pred             ccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH------H-HHHHHHcCCCCCCC-
Confidence            55432  234579999999998865 6999999999999999999999999753221      1 22222222211100 


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      +..      ...+..+.+++.+||+.||++|||+.|+++|.|...
T Consensus       249 ~~~------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~  287 (484)
T 3nyv_A          249 PQW------KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT  287 (484)
T ss_dssp             GGG------GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred             ccc------ccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence            000      123456889999999999999999999999988653

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.6e-43  Score=325.58  Aligned_cols=258  Identities=23%  Similarity=0.293  Sum_probs=207.6

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|.+.+.||+|+||.||+|+.. +|+.||+|.+.... ......+.+|+.++..++||||+++++++.+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            467888899999999999999864 69999999986433 2334568899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEE---cCCCceEEecccCccccCC
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL---DEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfgla~~~~~  236 (407)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+||++   ++++.++|+|||++.....
T Consensus        87 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           87 LVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             cCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            99999999988543  45899999999999999999999998   9999999999999   7889999999999976543


Q ss_pred             CCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          237 DQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                      ..   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......       .....+..+...  ... 
T Consensus       162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~~~--~~~-  228 (304)
T 2jam_A          162 GI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES-------KLFEKIKEGYYE--FES-  228 (304)
T ss_dssp             BT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHCCCC--CCT-
T ss_pred             Cc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHcCCCC--CCc-
Confidence            32   23356899999999999999999999999999999999999998643221       112222222111  000 


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                          ......+..+.+++.+||+.||++|||+.+++++.+.....
T Consensus       229 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          229 ----PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             ----TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             ----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence                01122345688999999999999999999999998875443

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5.6e-45  Score=347.91  Aligned_cols=246  Identities=15%  Similarity=0.149  Sum_probs=191.9

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHH---HHHHcCCCCceeeee-------ee
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEV---RMITSIQHKNLVRLL-------GC  147 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~  147 (407)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++....  .....+.+.+|+   +.+++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            35678889999999999999985 569999999986432  334557788999   455566899999998       55


Q ss_pred             eecCC-----------------eeEEEEEeccCCChhHHHhccC-----CCCCCHHHHHHHHHHHHHHhccccccCCCce
Q 040557          148 CSDGS-----------------QRLLVYEYMKNRSLDLLIYGES-----DKFLNWSTRFQIILGIARGLQYLHEDSHTRI  205 (407)
Q Consensus       148 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  205 (407)
                      +.+.+                 ..++||||+ +|+|.+++....     ...+++..+..++.|++.||.|||+.+   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            55443                 278999999 689999986432     122446888899999999999999998   9


Q ss_pred             eeeccccccEEEcCCCceEEecccCccccCCCCcccccccccCccccCccccccC-----------CCCccccEEehhHH
Q 040557          206 VHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-----------ELSEKADIYSFGVL  274 (407)
Q Consensus       206 ~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~k~Dv~s~G~v  274 (407)
                      +||||||+|||++.++.+||+|||+++....    ......| +.|+|||.+.+.           .++.++|||||||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999986433    2234567 999999999887           89999999999999


Q ss_pred             HHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040557          275 VLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAM  354 (407)
Q Consensus       275 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  354 (407)
                      +|||++|+.||.........               .... ...  .    ..+..+.+++.+||+.||++|||+.+++++
T Consensus       303 l~elltg~~Pf~~~~~~~~~---------------~~~~-~~~--~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGGS---------------EWIF-RSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             HHHHHHSSCCC------CCS---------------GGGG-SSC--C----CCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             HHHHHHCCCCCcccccccch---------------hhhh-hhc--c----CCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            99999999998643322110               0000 000  1    123568899999999999999999999998


Q ss_pred             hhc
Q 040557          355 LTC  357 (407)
Q Consensus       355 l~~  357 (407)
                      .+.
T Consensus       361 p~f  363 (377)
T 3byv_A          361 PEY  363 (377)
T ss_dssp             HHH
T ss_pred             hHH
Confidence            664

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.8e-43  Score=348.70  Aligned_cols=260  Identities=26%  Similarity=0.320  Sum_probs=207.3

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccCh------------hhHHHHHHHHHHHHcCCCCceeeeee
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQ------------QGESEFLSEVRMITSIQHKNLVRLLG  146 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~e~~~l~~l~h~niv~l~~  146 (407)
                      ..++|.+.+.||+|+||+||+|... +++.||+|++......            .....+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999865 5889999998654321            23567899999999999999999999


Q ss_pred             eeecCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC---ce
Q 040557          147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF---QS  223 (407)
Q Consensus       147 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~  223 (407)
                      ++.+....++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++   .+
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence            999999999999999999999888543  45999999999999999999999998   99999999999999775   69


Q ss_pred             EEecccCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHH
Q 040557          224 KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKL  303 (407)
Q Consensus       224 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~  303 (407)
                      ||+|||++........  .....||+.|+|||.+. +.++.++|||||||++|+|++|+.||......      . ....
T Consensus       189 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~-~~~~  258 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ------D-IIKK  258 (504)
T ss_dssp             EECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHH
T ss_pred             EEEECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHH
Confidence            9999999987765432  23467999999999876 56999999999999999999999999754321      1 2222


Q ss_pred             HHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          304 YERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       304 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                      +..+....  +....     ...+..+.+++.+||+.||++|||+.|+++|.|.....
T Consensus       259 i~~~~~~~--~~~~~-----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          259 VEKGKYYF--DFNDW-----KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             HHHCCCCC--CHHHH-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             HHcCCCCC--Ccccc-----CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            22222110  00000     01235688999999999999999999999998875433

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4e-43  Score=338.32  Aligned_cols=270  Identities=20%  Similarity=0.276  Sum_probs=185.7

Q ss_pred             CCCC-CCeeeccCCccEEEEEec---CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeee--cCCeeEE
Q 040557           83 NFHP-GNLLGRGGFGPVYRGKLA---DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS--DGSQRLL  156 (407)
Q Consensus        83 ~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~l  156 (407)
                      .|.+ +++||+|+||.||+|+..   +++.||+|++.....   ...+.+|+++|+.++||||+++++++.  .....++
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            3444 568999999999999865   578999999864332   235789999999999999999999994  4678999


Q ss_pred             EEEeccCCChhHHHhcc-------CCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEE----cCCCceEE
Q 040557          157 VYEYMKNRSLDLLIYGE-------SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL----DEKFQSKI  225 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill----~~~~~~kl  225 (407)
                      ||||+.+ +|.+++...       ....+++..+..++.|++.||.|||+.+   |+||||||+|||+    +.++.+||
T Consensus        98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence            9999975 777666421       1234899999999999999999999998   9999999999999    77889999


Q ss_pred             ecccCccccCCCCc--ccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCccc---CchhHH
Q 040557          226 GDFGLARFFPEDQA--YLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEM---QYLPEY  299 (407)
Q Consensus       226 ~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~---~~~~~~  299 (407)
                      +|||+++.+.....  .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........   ......
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            99999987754322  12234679999999999887 4589999999999999999999999975443211   000111


Q ss_pred             HHHHHHh-CccccccCccc-------------cc---CCCC---------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040557          300 AWKLYER-GRILELVDPRM-------------RK---EGIV---------ERDALQVINVAFICLQPHGNQRPPMSEIVA  353 (407)
Q Consensus       300 ~~~~~~~-~~~~~~~d~~~-------------~~---~~~~---------~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  353 (407)
                      ....... +......-..+             ..   ....         ......+.+|+.+||+.||++|||+.|+++
T Consensus       254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            1111110 00000000000             00   0000         001345789999999999999999999999


Q ss_pred             Hhhccc
Q 040557          354 MLTCKV  359 (407)
Q Consensus       354 ~l~~~~  359 (407)
                      |-|+..
T Consensus       334 hp~f~~  339 (405)
T 3rgf_A          334 DPYFLE  339 (405)
T ss_dssp             SGGGTS
T ss_pred             Chhhcc
Confidence            999864

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.6e-43  Score=358.05  Aligned_cols=248  Identities=27%  Similarity=0.410  Sum_probs=198.6

Q ss_pred             CeeeccCCccEEEEEec---CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccC
Q 040557           88 NLLGRGGFGPVYRGKLA---DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKN  163 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  163 (407)
                      +.||+|+||.||+|.+.   +++.||||+++... .......+.+|+++|.+++||||+++++++.+ +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            36999999999999642   46789999996543 23446789999999999999999999999975 457899999999


Q ss_pred             CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc--c
Q 040557          164 RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY--L  241 (407)
Q Consensus       164 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--~  241 (407)
                      |+|.+++..  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+......  .
T Consensus       454 g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          454 GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             CCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            999999954  345899999999999999999999998   999999999999999999999999999877544322  2


Q ss_pred             ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                      .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......       .....+..+...          
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~~~~~i~~~~~~----------  591 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERM----------  591 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCC----------
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCC----------
Confidence            233457889999999999999999999999999999998 99998654321       122233332211          


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ..+..++..+.+++.+||+.||++|||+.+|++.|...
T Consensus       592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11223456789999999999999999999999999753

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.3e-43  Score=335.13  Aligned_cols=269  Identities=23%  Similarity=0.264  Sum_probs=206.8

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCC-----------CCceeeeeeeee
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-----------HKNLVRLLGCCS  149 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~  149 (407)
                      ++|++.+.||+|+||.||+|.. .+|+.||||++..  .......+.+|+.++.+++           |+||+++++++.
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC--CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            6788889999999999999986 4689999999853  3344567889999998876           899999999987


Q ss_pred             cCC----eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhcccccc-CCCceeeeccccccEEEc------
Q 040557          150 DGS----QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED-SHTRIVHRDIKASNVLLD------  218 (407)
Q Consensus       150 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~------  218 (407)
                      ..+    ..++||||+ +++|.+++.......+++..+..++.|++.||.|||++ +   ++||||||+|||++      
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence            544    789999999 88999999776666799999999999999999999998 8   99999999999994      


Q ss_pred             CCCceEEecccCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhH
Q 040557          219 EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPE  298 (407)
Q Consensus       219 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~  298 (407)
                      ..+.+||+|||++.......    ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.............
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence            44589999999998765432    34578999999999999999999999999999999999999997654332211111


Q ss_pred             HHHHHHH-hCccc--------------------cccCc---------ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 040557          299 YAWKLYE-RGRIL--------------------ELVDP---------RMRKEGIVERDALQVINVAFICLQPHGNQRPPM  348 (407)
Q Consensus       299 ~~~~~~~-~~~~~--------------------~~~d~---------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  348 (407)
                      ....... .+...                    ..+..         .......+...+..+.+++.+||+.||++|||+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence            1111111 00000                    00000         000112456677889999999999999999999


Q ss_pred             HHHHHHhhcccc
Q 040557          349 SEIVAMLTCKVE  360 (407)
Q Consensus       349 ~ev~~~l~~~~~  360 (407)
                      .|+++|.+....
T Consensus       329 ~ell~hp~f~~~  340 (373)
T 1q8y_A          329 GGLVNHPWLKDT  340 (373)
T ss_dssp             HHHHTCGGGTTC
T ss_pred             HHHhhChhhhcc
Confidence            999999887543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1e-43  Score=337.69  Aligned_cols=269  Identities=22%  Similarity=0.287  Sum_probs=206.5

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC-----Cee
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG-----SQR  154 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  154 (407)
                      .++|++.+.||+|+||.||+|... +++.||||++...........+.+|++++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            357888999999999999999864 68899999997555555667899999999999999999999998654     368


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcccc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF  234 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~  234 (407)
                      ++||||+. |+|.+++..   ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++...
T Consensus       106 ~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            99999997 489888854   34899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCccc--ccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcc--
Q 040557          235 PEDQAYL--STNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRI--  309 (407)
Q Consensus       235 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  309 (407)
                      .......  .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.  + ............  
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~-~~i~~~~~~~~~~~  255 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--L-NHILGILGSPSQED  255 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH--H-HHHHHHHCSCCHHH
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH--H-HHHHHHhCCCCHHH
Confidence            5433221  234579999999998654 5589999999999999999999999975433211  0 000000000000  


Q ss_pred             -ccc--------cCcccccCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          310 -LEL--------VDPRMRKEGIV-----ERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       310 -~~~--------~d~~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                       ...        ...........     ...+..+.+++.+||+.||++|||+.|+++|.+...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  319 (364)
T 3qyz_A          256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ  319 (364)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred             HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhh
Confidence             000        00000000000     112356889999999999999999999999988754

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.1e-43  Score=331.75  Aligned_cols=265  Identities=19%  Similarity=0.228  Sum_probs=207.7

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe--cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCC------ceeeeeeeeecCC
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL--ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHK------NLVRLLGCCSDGS  152 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~~~~  152 (407)
                      .++|++.+.||+|+||.||+|..  .+|+.||||++..  .......+.+|++++..++|+      +++++++++.+.+
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN--VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS--SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec--CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            36788889999999999999986  3688999999853  334456788999999988765      4999999999999


Q ss_pred             eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC-------------
Q 040557          153 QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE-------------  219 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-------------  219 (407)
                      ..++||||+ +++|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+|||++.             
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence            999999999 889999997666667899999999999999999999998   999999999999987             


Q ss_pred             ------CCceEEecccCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCccc
Q 040557          220 ------KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEM  293 (407)
Q Consensus       220 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~  293 (407)
                            ++.+||+|||++.......    ....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             ccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                  6789999999998754332    345789999999999999999999999999999999999999975432211


Q ss_pred             CchhHHHHHHH--------HhCccccc---------------------cCcccccCCCCHHHHHHHHHHHHHccCCCCCC
Q 040557          294 QYLPEYAWKLY--------ERGRILEL---------------------VDPRMRKEGIVERDALQVINVAFICLQPHGNQ  344 (407)
Q Consensus       294 ~~~~~~~~~~~--------~~~~~~~~---------------------~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~  344 (407)
                         ........        ........                     ..+...........+..+.+++.+||+.||++
T Consensus       243 ---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          243 ---LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             ---HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             ---HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence               00000000        00000000                     00000001122345678999999999999999


Q ss_pred             CCCHHHHHHHhhcc
Q 040557          345 RPPMSEIVAMLTCK  358 (407)
Q Consensus       345 RPs~~ev~~~l~~~  358 (407)
                      |||+.|+++|-+..
T Consensus       320 Rpt~~ell~hp~f~  333 (339)
T 1z57_A          320 RITLREALKHPFFD  333 (339)
T ss_dssp             SCCHHHHTTSGGGG
T ss_pred             ccCHHHHhcCHHHH
Confidence            99999999987754

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.5e-43  Score=348.13  Aligned_cols=257  Identities=26%  Similarity=0.326  Sum_probs=202.9

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ..++|++.+.||+|+||.||+|+.. ++..||+|++.... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3457888999999999999999865 68999999986543 223356788999999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCC---CceEEecccCcccc
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEK---FQSKIGDFGLARFF  234 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfgla~~~  234 (407)
                      |||+++|+|.+.+...  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.+   +.+||+|||++...
T Consensus       115 ~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          115 MECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            9999999998888543  45899999999999999999999998   9999999999999764   45999999999877


Q ss_pred             CCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          235 PEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       235 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      .....  .....||+.|+|||.+. ..++.++|||||||++|+|++|+.||......      . ....+..+... ...
T Consensus       190 ~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~-~~~~i~~~~~~-~~~  258 (494)
T 3lij_A          190 ENQKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ------E-ILRKVEKGKYT-FDS  258 (494)
T ss_dssp             BTTBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHTCCC-CCS
T ss_pred             CCCcc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCCCC-CCc
Confidence            54432  23467999999999875 56999999999999999999999999754321      1 22222222211 000


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      +..      ...+..+.+++.+||+.||++|||+.++++|.|..
T Consensus       259 ~~~------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  296 (494)
T 3lij_A          259 PEW------KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK  296 (494)
T ss_dssp             GGG------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred             hhc------ccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccc
Confidence            111      11235688999999999999999999999987754

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.5e-43  Score=360.67  Aligned_cols=254  Identities=23%  Similarity=0.280  Sum_probs=209.7

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  156 (407)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....  .......+..|.+++..+ +|+||+++++++.+.+..|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            467888899999999999999864 68899999986432  223345678999999988 79999999999999999999


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ||||+++|+|..++...  ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++....
T Consensus       420 V~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            99999999999999644  35999999999999999999999998   99999999999999999999999999986443


Q ss_pred             CCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          237 DQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                      ... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......      ..... +..+..       
T Consensus       495 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~~~~~-i~~~~~-------  559 (674)
T 3pfq_A          495 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQS-IMEHNV-------  559 (674)
T ss_dssp             TTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHSSCC-------
T ss_pred             CCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------HHHHH-HHhCCC-------
Confidence            322 234578999999999999999999999999999999999999999753221      12222 221111       


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHhhcc
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRPPM-----SEIVAMLTCK  358 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~ev~~~l~~~  358 (407)
                          .++...+.++.+|+.+||+.||++||++     +||++|.++.
T Consensus       560 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~  602 (674)
T 3pfq_A          560 ----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR  602 (674)
T ss_dssp             ----CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGS
T ss_pred             ----CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcccc
Confidence                1122334568899999999999999997     8999887764

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.6e-43  Score=330.26  Aligned_cols=262  Identities=19%  Similarity=0.264  Sum_probs=203.0

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCC-CCceeeeeeeeec--CCeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-HKNLVRLLGCCSD--GSQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv  157 (407)
                      ++|++.+.||+|+||.||+|.. .+++.||+|++...    ....+.+|++++..++ |+||+++++++.+  ....++|
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            6788899999999999999985 57899999998532    2456889999999996 9999999999987  5678999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC-ceEEecccCccccCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF-QSKIGDFGLARFFPE  236 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfgla~~~~~  236 (407)
                      |||+.+++|.+++.     .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++ .+||+|||+++....
T Consensus       112 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             EECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             EeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            99999999999873     3889999999999999999999998   99999999999999766 899999999987654


Q ss_pred             CCcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHH--------HHHHHHhC
Q 040557          237 DQAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEY--------AWKLYERG  307 (407)
Q Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~--------~~~~~~~~  307 (407)
                      ...  .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||......... +...        ........
T Consensus       184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHHHT
T ss_pred             CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhhHHHHh
Confidence            433  234578999999999877 67899999999999999999999998643322110 0000        00111111


Q ss_pred             ccc------cccC-------cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          308 RIL------ELVD-------PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       308 ~~~------~~~d-------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ...      +.+.       ............+..+.+++.+||+.||++|||+.|+++|.|+.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~  324 (330)
T 3nsz_A          261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY  324 (330)
T ss_dssp             TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGT
T ss_pred             ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHh
Confidence            000      0000       00000111112356789999999999999999999999998764

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-43  Score=337.55  Aligned_cols=264  Identities=22%  Similarity=0.292  Sum_probs=198.9

Q ss_pred             HHHhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeec------
Q 040557           78 KKATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSD------  150 (407)
Q Consensus        78 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------  150 (407)
                      +...++|++.+.||+|+||.||+|.. .+|+.||||++......     ..+|+++++.++|+||+++++++..      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            34567899999999999999999986 57999999998643321     2379999999999999999999843      


Q ss_pred             --------------------------------CCeeEEEEEeccCCChhHHHhc--cCCCCCCHHHHHHHHHHHHHHhcc
Q 040557          151 --------------------------------GSQRLLVYEYMKNRSLDLLIYG--ESDKFLNWSTRFQIILGIARGLQY  196 (407)
Q Consensus       151 --------------------------------~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~  196 (407)
                                                      ....++||||+++ +|.+.+..  .....+++..+..++.|++.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            3347899999984 77776643  345669999999999999999999


Q ss_pred             ccccCCCceeeeccccccEEEc-CCCceEEecccCccccCCCCcccccccccCccccCccccccC-CCCccccEEehhHH
Q 040557          197 LHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVL  274 (407)
Q Consensus       197 LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~v  274 (407)
                      ||+.+   ++||||||+|||++ .++.+||+|||+++.......  .....||+.|+|||.+.+. .++.++|||||||+
T Consensus       157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            99998   99999999999998 688999999999987654432  2345789999999988775 58999999999999


Q ss_pred             HHHHHhcCCCCCCCCCcccCchhHHHHHHHHh-C------------ccccccCcccccC----CCCHHHHHHHHHHHHHc
Q 040557          275 VLEIISCRKNTDLTLPSEMQYLPEYAWKLYER-G------------RILELVDPRMRKE----GIVERDALQVINVAFIC  337 (407)
Q Consensus       275 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~------------~~~~~~d~~~~~~----~~~~~~~~~l~~l~~~c  337 (407)
                      +|||++|+.||......+      ........ +            ...+..-+.....    ..+...+..+.+++.+|
T Consensus       232 l~ell~g~~pf~~~~~~~------~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  305 (383)
T 3eb0_A          232 FGELILGKPLFSGETSID------QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQI  305 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHH------HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred             HHHHHhCCCCCCCCChHH------HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHH
Confidence            999999999997543211      11111110 0            0000000000000    01112345688999999


Q ss_pred             cCCCCCCCCCHHHHHHHhhcc
Q 040557          338 LQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       338 l~~~p~~RPs~~ev~~~l~~~  358 (407)
                      |+.||++|||+.|+++|-++.
T Consensus       306 L~~dP~~R~t~~e~l~hp~f~  326 (383)
T 3eb0_A          306 LRYEPDLRINPYEAMAHPFFD  326 (383)
T ss_dssp             CCSSGGGSCCHHHHHTSGGGH
T ss_pred             ccCChhhCCCHHHHhcCHHHH
Confidence            999999999999999998764

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.1e-43  Score=357.35  Aligned_cols=257  Identities=23%  Similarity=0.348  Sum_probs=205.6

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec----CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA----DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRL  155 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  155 (407)
                      ..++|++.+.||+|+||.||+|.+.    .+..||+|.+.........+.+.+|+.++++++||||+++++++.+ +..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence            3467888899999999999999863    2567999998655555566789999999999999999999999854 5689


Q ss_pred             EEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccC
Q 040557          156 LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP  235 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~  235 (407)
                      +||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++...
T Consensus       467 lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             EEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            999999999999999644 335899999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          236 EDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       236 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      ...........+|+.|+|||.+.+..++.++||||||+++|||++ |..||......      ... ..+..+...    
T Consensus       543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~------~~~-~~i~~~~~~----  611 (656)
T 2j0j_A          543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVI-GRIENGERL----  611 (656)
T ss_dssp             C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHH-HHHHHTCCC----
T ss_pred             CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH------HHH-HHHHcCCCC----
Confidence            554444444567889999999999999999999999999999997 88888643221      111 122222111    


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                            ..+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus       612 ------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          612 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                  01222345688999999999999999999999999764

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.6e-44  Score=342.57  Aligned_cols=259  Identities=11%  Similarity=0.032  Sum_probs=186.0

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHHHcC--CCCceeeee-------eeee
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMITSI--QHKNLVRLL-------GCCS  149 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~~  149 (407)
                      .+|...+.||+|+||.||+|.+. +|+.||||++.....  ......+.+|+.++..+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45778899999999999999864 789999999976542  23455677885444444  699988754       3333


Q ss_pred             cC-----------------CeeEEEEEeccCCChhHHHhccCCCCCCHHHH------HHHHHHHHHHhccccccCCCcee
Q 040557          150 DG-----------------SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTR------FQIILGIARGLQYLHEDSHTRIV  206 (407)
Q Consensus       150 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~~i~  206 (407)
                      ..                 ...++||||++ |+|.+++.... ..+.+..+      ..++.|++.||.|||+.+   |+
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---iv  216 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKG---LV  216 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Cc
Confidence            22                 34799999998 89999997542 23455666      788899999999999998   99


Q ss_pred             eeccccccEEEcCCCceEEecccCccccCCCCcccccccccCccccCcccccc--CCCCccccEEehhHHHHHHHhcCCC
Q 040557          207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR--GELSEKADIYSFGVLVLEIISCRKN  284 (407)
Q Consensus       207 H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~s~G~vl~el~tg~~p  284 (407)
                      ||||||+|||++.++.+||+|||+++......    ....+|+.|+|||.+.+  ..++.++|||||||++|||++|+.|
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P  292 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP  292 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999998764332    13456799999999987  6899999999999999999999999


Q ss_pred             CCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          285 TDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      |....+.......        ............... .....+..+.+++.+||+.||++|||+.++++|.|..
T Consensus       293 f~~~~~~~~~~~~--------~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~  357 (371)
T 3q60_A          293 FGLVTPGIKGSWK--------RPSLRVPGTDSLAFG-SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL  357 (371)
T ss_dssp             TTBCCTTCTTCCC--------BCCTTSCCCCSCCCT-TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred             CCCcCcccccchh--------hhhhhhccccccchh-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence            9765443221100        000000000111100 1112345788999999999999999999999987653

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.3e-43  Score=321.50  Aligned_cols=257  Identities=27%  Similarity=0.377  Sum_probs=201.9

Q ss_pred             CCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           83 NFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      +|.....||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            344456899999999999986 468899999986443 344567899999999999999999999999999999999999


Q ss_pred             cCCChhHHHhccC-CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC-CCceEEecccCccccCCCCc
Q 040557          162 KNRSLDLLIYGES-DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE-KFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       162 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~~~  239 (407)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++. ++.+||+|||++........
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence            9999999987543 335678999999999999999999998   999999999999987 89999999999987654322


Q ss_pred             ccccccccCccccCccccccCC--CCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGE--LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                       ......|++.|+|||.+.+..  ++.++||||||+++|||++|+.||.......     ..........     ..+. 
T Consensus       179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~-----~~~~-  246 (295)
T 2clq_A          179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-----AAMFKVGMFK-----VHPE-  246 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-----HHHHHHHHHC-----CCCC-
T ss_pred             -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-----HHHHhhcccc-----cccc-
Confidence             123457899999999987653  8899999999999999999999985322111     1111110100     0111 


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                          .+...+..+.+++.+||+.||++|||+.+++++-+...
T Consensus       247 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~  284 (295)
T 2clq_A          247 ----IPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV  284 (295)
T ss_dssp             ----CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC
T ss_pred             ----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhh
Confidence                12223456889999999999999999999999887643

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=9.2e-43  Score=325.51  Aligned_cols=258  Identities=21%  Similarity=0.251  Sum_probs=201.2

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC-------hhhHHHHHHHHHHHHcCCCCceeeeeeeeecC
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS-------QQGESEFLSEVRMITSIQHKNLVRLLGCCSDG  151 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  151 (407)
                      ..++|.+.+.||+|+||.||+|... +|+.||||.+.....       ......+.+|++++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3467888999999999999999864 588999999864321       12234578999999999999999999999766


Q ss_pred             CeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCc---eEEecc
Q 040557          152 SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ---SKIGDF  228 (407)
Q Consensus       152 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~---~kl~Df  228 (407)
                      . .++||||+++|+|.+++.  ....+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.   +||+||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             c-eEEEEecCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence            5 899999999999999884  3456899999999999999999999998   999999999999987654   999999


Q ss_pred             cCccccCCCCcccccccccCccccCccccc---cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHH
Q 040557          229 GLARFFPEDQAYLSTNFAGTLGYTAPEYAI---RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYE  305 (407)
Q Consensus       229 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  305 (407)
                      |++........  .....||+.|+|||.+.   ...++.++|||||||++|||++|+.||........      ......
T Consensus       162 g~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~  233 (322)
T 2ycf_A          162 GHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS------LKDQIT  233 (322)
T ss_dssp             TTCEECCCCHH--HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC------HHHHHH
T ss_pred             ccceecccccc--cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH------HHHHHH
Confidence            99987654322  23456899999999874   56789999999999999999999999975433211      111122


Q ss_pred             hCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          306 RGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       306 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .+....  .+...     ...+..+.+++.+||+.||++|||+.++++|.+..
T Consensus       234 ~~~~~~--~~~~~-----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~  279 (322)
T 2ycf_A          234 SGKYNF--IPEVW-----AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ  279 (322)
T ss_dssp             HTCCCC--CHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGC
T ss_pred             hCcccc--Cchhh-----hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcC
Confidence            221110  00000     01245688999999999999999999999988754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.4e-43  Score=328.14  Aligned_cols=257  Identities=24%  Similarity=0.343  Sum_probs=204.3

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ..++|++.+.||+|+||.||+|... +|+.||+|.+....   ....+.+|+.++..++||||+++++++...+..++||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            4467888999999999999999865 58999999986433   3356889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++++|.+++... ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus       104 e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          104 EYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             ECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             ecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            999999999998633 345899999999999999999999998   9999999999999999999999999998765432


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                      . ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......      .... ....+...     ...
T Consensus       180 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~-~~~~~~~~-----~~~  246 (314)
T 3com_A          180 A-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIF-MIPTNPPP-----TFR  246 (314)
T ss_dssp             S-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHH-HHHHSCCC-----CCS
T ss_pred             c-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHH-HHhcCCCc-----ccC
Confidence            2 123457899999999999999999999999999999999999998643211      1111 11111111     110


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                         .+...+..+.+++.+||+.||++|||+.+++++.+...
T Consensus       247 ---~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~  284 (314)
T 3com_A          247 ---KPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS  284 (314)
T ss_dssp             ---SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred             ---CcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhc
Confidence               11223456889999999999999999999999887653

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=331.55  Aligned_cols=258  Identities=23%  Similarity=0.306  Sum_probs=187.7

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCC-CCceeeeeeeee--------c
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-HKNLVRLLGCCS--------D  150 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~--------~  150 (407)
                      ..+|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|+.++.++. ||||+++++++.        .
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            357888899999999999999864 6899999998533 4455667899999999995 999999999983        3


Q ss_pred             CCeeEEEEEeccCCChhHHHhc-cCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEeccc
Q 040557          151 GSQRLLVYEYMKNRSLDLLIYG-ESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFG  229 (407)
Q Consensus       151 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  229 (407)
                      ....++||||+. |+|.+++.. .....+++..+..++.|++.||.|||+.+ ++++||||||+|||++.++.+||+|||
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence            445799999996 688888754 23456999999999999999999999874 359999999999999999999999999


Q ss_pred             CccccCCCCccc-----------ccccccCccccCcccc---ccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCc
Q 040557          230 LARFFPEDQAYL-----------STNFAGTLGYTAPEYA---IRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQY  295 (407)
Q Consensus       230 la~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~  295 (407)
                      ++..........           .....||+.|+|||.+   .+..++.++||||||+++|||++|+.||.......   
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---  260 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---  260 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH---
Confidence            998765432211           1134689999999988   56678999999999999999999999986432110   


Q ss_pred             hhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          296 LPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                             ... +...    ...     .......+.+++.+||+.||++|||+.|++++|+.....
T Consensus       261 -------~~~-~~~~----~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          261 -------IVN-GKYS----IPP-----HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             -------------CC----CCT-----TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------hhc-Cccc----CCc-----ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                   000 0000    000     011123477899999999999999999999999876543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=7.6e-44  Score=329.64  Aligned_cols=257  Identities=23%  Similarity=0.362  Sum_probs=201.8

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+... .......+.+|++++..++||||+++++++.+.+..++|||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC-CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            467888899999999999999875 5899999998543 33445678999999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++++|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....... 
T Consensus        97 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  171 (302)
T 2j7t_A           97 FCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-  171 (302)
T ss_dssp             CCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred             eCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence            99999999988643 345899999999999999999999998   9999999999999999999999999986432111 


Q ss_pred             ccccccccCccccCccccc-----cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          240 YLSTNFAGTLGYTAPEYAI-----RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      .......||+.|+|||.+.     +..++.++||||||+++|||++|+.|+......      ........ ....... 
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~~~-  243 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAK-SDPPTLL-  243 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHH-SCCCCCS-
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHhc-cCCcccC-
Confidence            1112356899999999883     667899999999999999999999998643221      11111111 1111110 


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                             .+...+..+.+++.+||+.||++|||+.++++|.+..
T Consensus       244 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  280 (302)
T 2j7t_A          244 -------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVS  280 (302)
T ss_dssp             -------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTT
T ss_pred             -------CccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHh
Confidence                   1122345688999999999999999999999987754

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.3e-42  Score=330.87  Aligned_cols=268  Identities=24%  Similarity=0.240  Sum_probs=196.1

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC------
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS------  152 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  152 (407)
                      .++|++.+.||+|+||.||+|... +|+.||||++.... .......+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            367888999999999999999864 68999999986533 3445567889999999999999999999997654      


Q ss_pred             eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                      ..++||||+++ +|.+.+.    ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             ceEEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            67999999975 7777774    23899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCccc----------------Cch
Q 040557          233 FFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEM----------------QYL  296 (407)
Q Consensus       233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~----------------~~~  296 (407)
                      ......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........                ..+
T Consensus       176 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  253 (371)
T 2xrw_A          176 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  253 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred             cccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            665432  22346799999999999999999999999999999999999999975432100                000


Q ss_pred             hHHHHHHHHhCcc------ccccCcccccC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          297 PEYAWKLYERGRI------LELVDPRMRKE--GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       297 ~~~~~~~~~~~~~------~~~~d~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .............      ...+.......  .........+.+++.+||+.||++|||+.|+++|.+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  323 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN  323 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence            0000000000000      00000000000  00122356789999999999999999999999998864

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.8e-42  Score=326.26  Aligned_cols=269  Identities=22%  Similarity=0.313  Sum_probs=204.0

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC-----Cee
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG-----SQR  154 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  154 (407)
                      .++|++.+.||+|+||.||+|... +|+.||||.+...........+.+|+++++.++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467888899999999999999865 68999999996555555667888999999999999999999987654     678


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcccc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF  234 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~  234 (407)
                      ++||||+. |+|.+++..   ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++...
T Consensus        90 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            99999997 589888854   35899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcc---------cccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHH
Q 040557          235 PEDQAY---------LSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLY  304 (407)
Q Consensus       235 ~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~  304 (407)
                      ......         ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........   ........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~  239 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ---LLLIFGII  239 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHH
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHh
Confidence            533211         1123578999999998765 7789999999999999999999999975431100   00000000


Q ss_pred             HhCc----cc--------cccC--cccccC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          305 ERGR----IL--------ELVD--PRMRKE---GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       305 ~~~~----~~--------~~~d--~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ....    ..        +.+.  +.....   ......+..+.+++.+||+.||++|||+.|+++|.+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  311 (353)
T 2b9h_A          240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT  311 (353)
T ss_dssp             CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence            0000    00        0000  000000   000123456889999999999999999999999988643

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.3e-43  Score=326.22  Aligned_cols=257  Identities=27%  Similarity=0.374  Sum_probs=196.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEec--CCc--EEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA--DGT--LVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRL  155 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  155 (407)
                      ++|++.+.||+|+||.||+|.+.  +++  .||+|++....  .......+.+|++++.+++||||+++++++.... .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            57888899999999999999853  333  68999986543  2345578899999999999999999999998765 88


Q ss_pred             EEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccC
Q 040557          156 LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP  235 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~  235 (407)
                      +||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        97 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccccc
Confidence            9999999999999986543 45899999999999999999999998   9999999999999999999999999998775


Q ss_pred             CCCcc--cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccc
Q 040557          236 EDQAY--LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILEL  312 (407)
Q Consensus       236 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      .....  ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......      .........+..   
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~---  243 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGER---  243 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCC---
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHccCCC---
Confidence            44322  1233457889999999999899999999999999999999 99998643221      112221111110   


Q ss_pred             cCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          313 VDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       313 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                          .   ......+..+.+++.+||+.||++|||+.+++++|....
T Consensus       244 ----~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          244 ----L---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             ----C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             ----C---CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence                0   011223456899999999999999999999999997654

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3e-43  Score=329.23  Aligned_cols=267  Identities=23%  Similarity=0.357  Sum_probs=205.0

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEe--cCCcEEEEEEeccccCh-hhHHHHHHHHHHHHcC---CCCceeeeeeeee----
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKL--ADGTLVAVKKLCVDKSQ-QGESEFLSEVRMITSI---QHKNLVRLLGCCS----  149 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l---~h~niv~l~~~~~----  149 (407)
                      ..++|++.+.||+|+||.||+|..  .+|+.||+|++...... .....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            447888999999999999999987  46889999998654322 1123456777776665   8999999999987    


Q ss_pred             -cCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecc
Q 040557          150 -DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDF  228 (407)
Q Consensus       150 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  228 (407)
                       .....++||||+. |+|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecC
Confidence             5567899999998 69999997766666999999999999999999999998   999999999999999999999999


Q ss_pred             cCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh-C
Q 040557          229 GLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER-G  307 (407)
Q Consensus       229 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~  307 (407)
                      |++.......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......      ......... +
T Consensus       165 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~~  236 (326)
T 1blx_A          165 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV------DQLGKILDVIG  236 (326)
T ss_dssp             CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHC
T ss_pred             cccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHHHcC
Confidence            9998765332  223467899999999999999999999999999999999999998754321      111111110 0


Q ss_pred             c--ccc----------ccCccc--ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          308 R--ILE----------LVDPRM--RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       308 ~--~~~----------~~d~~~--~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .  ...          ......  .........+..+.+++.+||+.||++|||+.|+++|-+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  301 (326)
T 1blx_A          237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ  301 (326)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred             CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccc
Confidence            0  000          000000  00001122345688999999999999999999999987753

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=9e-43  Score=326.24  Aligned_cols=259  Identities=23%  Similarity=0.326  Sum_probs=184.0

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHH-HHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVR-MITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      ++|+..+.||+|+||.||+|... +|+.||||++...........+..|+. +++.++||||+++++++.+.+..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            67888999999999999999874 689999999976555555566667776 6677799999999999999999999999


Q ss_pred             eccCCChhHHHhc---cCCCCCCHHHHHHHHHHHHHHhcccccc-CCCceeeeccccccEEEcCCCceEEecccCccccC
Q 040557          160 YMKNRSLDLLIYG---ESDKFLNWSTRFQIILGIARGLQYLHED-SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP  235 (407)
Q Consensus       160 ~~~~g~L~~~l~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~  235 (407)
                      |+++ +|.+++..   .....+++..+..++.|++.||.|||+. +   ++||||||+||+++.++.+||+|||++....
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            9986 77766642   2356689999999999999999999998 8   9999999999999999999999999998765


Q ss_pred             CCCcccccccccCccccCcccc----ccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccc
Q 040557          236 EDQAYLSTNFAGTLGYTAPEYA----IRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILE  311 (407)
Q Consensus       236 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      ....  .....||+.|+|||.+    .+..++.++||||||+++|||++|+.||........         ..  .....
T Consensus       178 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------~~--~~~~~  244 (327)
T 3aln_A          178 DSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---------QL--TQVVK  244 (327)
T ss_dssp             ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCCCC
T ss_pred             cccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---------HH--HHHhc
Confidence            4332  2234689999999998    456789999999999999999999999864321100         00  00000


Q ss_pred             ccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       312 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ...+.+.. ......+..+.+++.+||+.||++|||+.+++++.+..
T Consensus       245 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~  290 (327)
T 3aln_A          245 GDPPQLSN-SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL  290 (327)
T ss_dssp             SCCCCCCC-CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             CCCCCCCC-cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHH
Confidence            00011111 01112345688999999999999999999999987754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=8.8e-43  Score=331.06  Aligned_cols=262  Identities=24%  Similarity=0.323  Sum_probs=187.3

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC------C
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG------S  152 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  152 (407)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++.... .......+.+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            37888899999999999999985 468999999986432 344567788999999999999999999998654      5


Q ss_pred             eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                      ..++|+|++ +++|.+++..   ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            679999999 6899888753   45999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh-Ccc-
Q 040557          233 FFPEDQAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER-GRI-  309 (407)
Q Consensus       233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~-  309 (407)
                      .....    .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......      ......... +.. 
T Consensus       181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~l~~i~~~~g~p~  250 (367)
T 2fst_X          181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI------DQLKLILRLVGTPG  250 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHCSCC
T ss_pred             ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCCCC
Confidence            65433    234679999999999877 68899999999999999999999999654321      111111100 000 


Q ss_pred             cc------------ccCcccccCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          310 LE------------LVDPRMRKEGIV-----ERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       310 ~~------------~~d~~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .+            .+..........     ......+.+|+.+||+.||++|||+.|+++|.+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~  317 (367)
T 2fst_X          251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  317 (367)
T ss_dssp             HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhh
Confidence            00            000000000000     012356889999999999999999999999988653

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.4e-43  Score=328.95  Aligned_cols=265  Identities=18%  Similarity=0.195  Sum_probs=180.6

Q ss_pred             hcCCCCC-CeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeec----CCee
Q 040557           81 TKNFHPG-NLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSD----GSQR  154 (407)
Q Consensus        81 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~  154 (407)
                      .++|.+. +.||+|+||.||+|... +|+.||||++...  ....   .+....+..+.|+||+++++++..    ....
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            4677774 46999999999999875 6999999998532  2221   122233556799999999999875    4558


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC---CCceEEecccCc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE---KFQSKIGDFGLA  231 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfgla  231 (407)
                      ++||||+++|+|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+|||++.   ++.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            99999999999999998766667999999999999999999999998   999999999999986   455999999999


Q ss_pred             cccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccc
Q 040557          232 RFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILE  311 (407)
Q Consensus       232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      .......   .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..........   ........+.   
T Consensus       179 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~---  249 (336)
T 3fhr_A          179 KETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLGQ---  249 (336)
T ss_dssp             EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred             eeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhccc---
Confidence            8665332   234568999999999988899999999999999999999999996543322100   0000000000   


Q ss_pred             ccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccCCCCCC
Q 040557          312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVR  366 (407)
Q Consensus       312 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~~~~~~  366 (407)
                         ..... ......+..+.+++.+||+.||++|||+.|+++|.|.......+..
T Consensus       250 ---~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~  300 (336)
T 3fhr_A          250 ---YGFPN-PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQT  300 (336)
T ss_dssp             ----CCCT-TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCCC
T ss_pred             ---cccCc-hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCCC
Confidence               00000 0111234568899999999999999999999999987655444433

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.9e-42  Score=317.50  Aligned_cols=258  Identities=23%  Similarity=0.277  Sum_probs=208.1

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC--------hhhHHHHHHHHHHHHcCC-CCceeeeeeeee
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--------QQGESEFLSEVRMITSIQ-HKNLVRLLGCCS  149 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~  149 (407)
                      ..++|++.+.||+|+||.||+|... +|+.||||.+.....        ......+.+|++++.++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3478888999999999999999875 689999999864431        123456889999999995 999999999999


Q ss_pred             cCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEeccc
Q 040557          150 DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFG  229 (407)
Q Consensus       150 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  229 (407)
                      +....++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence            999999999999999999998643  45899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCcccccccccCccccCccccc------cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHH
Q 040557          230 LARFFPEDQAYLSTNFAGTLGYTAPEYAI------RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKL  303 (407)
Q Consensus       230 la~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~  303 (407)
                      ++........  .....|++.|+|||.+.      ...++.++||||||+++|||++|+.||......      . ....
T Consensus       170 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~  240 (298)
T 1phk_A          170 FSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------L-MLRM  240 (298)
T ss_dssp             TCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHH
T ss_pred             chhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH------H-HHHH
Confidence            9987654432  23457899999999875      456889999999999999999999998643211      1 1122


Q ss_pred             HHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          304 YERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       304 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ...+... ...+      .....+..+.+++.+||+.||++|||+.++++|-+..
T Consensus       241 ~~~~~~~-~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (298)
T 1phk_A          241 IMSGNYQ-FGSP------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ  288 (298)
T ss_dssp             HHHTCCC-CCTT------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HhcCCcc-cCcc------cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhh
Confidence            2222111 0000      1112345688999999999999999999999987754

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.7e-43  Score=337.00  Aligned_cols=264  Identities=23%  Similarity=0.282  Sum_probs=197.6

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC------eeE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS------QRL  155 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~  155 (407)
                      .+|++.+.||+|+||.||+|+..++..||+|++......     ..+|+++++.++||||+++++++....      ..+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            568888999999999999999877777999988543321     237999999999999999999985433      378


Q ss_pred             EEEEeccCCChhHHHh-ccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc-CCCceEEecccCccc
Q 040557          156 LVYEYMKNRSLDLLIY-GESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARF  233 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfgla~~  233 (407)
                      +||||++++.+..... ......+++..+..++.|++.||.|||+.+   |+||||||+|||++ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            9999998765544432 223456999999999999999999999998   99999999999999 799999999999987


Q ss_pred             cCCCCcccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHH----------H
Q 040557          234 FPEDQAYLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAW----------K  302 (407)
Q Consensus       234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~----------~  302 (407)
                      ......  .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+  .+.....          .
T Consensus       192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHH
T ss_pred             ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHH
Confidence            654332  2345789999999988765 58999999999999999999999997543211  0111100          0


Q ss_pred             HHHhCccccccCcccccC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          303 LYERGRILELVDPRMRKE----GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       303 ~~~~~~~~~~~d~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ..........+ +.....    ......+..+.+++.+||+.||++|||+.|+++|-++.
T Consensus       268 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  326 (394)
T 4e7w_A          268 TMNPNYMEHKF-PQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD  326 (394)
T ss_dssp             HHCGGGSSSCC-CCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGS
T ss_pred             hhChhhhhhcc-ccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhh
Confidence            00000000000 000000    01111345789999999999999999999999998865

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=7.5e-42  Score=326.88  Aligned_cols=266  Identities=20%  Similarity=0.215  Sum_probs=205.9

Q ss_pred             HHhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCC-CC-----ceeeeeeeeecC
Q 040557           79 KATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-HK-----NLVRLLGCCSDG  151 (407)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~  151 (407)
                      ...++|++.+.||+|+||.||+|... +++.||||++..  .......+..|++++..++ |+     +++++++++...
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN--KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS--SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec--cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            34578999999999999999999865 688999999853  3344566778888888874 55     499999999999


Q ss_pred             CeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc--CCCceEEeccc
Q 040557          152 SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD--EKFQSKIGDFG  229 (407)
Q Consensus       152 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~--~~~~~kl~Dfg  229 (407)
                      +..++||||+. |+|.+++.......+++..+..++.|++.||.|||++ ..+|+||||||+|||++  .++.+||+|||
T Consensus       129 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG  206 (382)
T 2vx3_A          129 NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG  206 (382)
T ss_dssp             TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred             CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence            99999999996 5999999776656799999999999999999999953 12399999999999995  47789999999


Q ss_pred             CccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh-Cc
Q 040557          230 LARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER-GR  308 (407)
Q Consensus       230 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~  308 (407)
                      +++......    ....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+      ........ +.
T Consensus       207 ~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~------~~~~i~~~~~~  276 (382)
T 2vx3_A          207 SSCQLGQRI----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD------QMNKIVEVLGI  276 (382)
T ss_dssp             TCEETTCCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHHHCS
T ss_pred             Cceeccccc----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHHhCC
Confidence            998775432    34678999999999999999999999999999999999999997543211      11111100 00


Q ss_pred             c---------------ccccCcc------------------------------------cccCCCCHHHHHHHHHHHHHc
Q 040557          309 I---------------LELVDPR------------------------------------MRKEGIVERDALQVINVAFIC  337 (407)
Q Consensus       309 ~---------------~~~~d~~------------------------------------~~~~~~~~~~~~~l~~l~~~c  337 (407)
                      .               ..+.+..                                    .............+.+|+.+|
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m  356 (382)
T 2vx3_A          277 PPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRM  356 (382)
T ss_dssp             CCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHh
Confidence            0               0000000                                    000011223446789999999


Q ss_pred             cCCCCCCCCCHHHHHHHhhcc
Q 040557          338 LQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       338 l~~~p~~RPs~~ev~~~l~~~  358 (407)
                      |+.||++|||+.|+++|-|..
T Consensus       357 L~~dP~~Rpta~e~L~hp~f~  377 (382)
T 2vx3_A          357 LDYDPKTRIQPYYALQHSFFK  377 (382)
T ss_dssp             TCSCTTTSCCHHHHTTSGGGC
T ss_pred             cCCChhhCCCHHHHhcCcccc
Confidence            999999999999999998864

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.5e-42  Score=327.53  Aligned_cols=275  Identities=21%  Similarity=0.255  Sum_probs=193.5

Q ss_pred             HHHHHHhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCe
Q 040557           75 QTLKKATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQ  153 (407)
Q Consensus        75 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  153 (407)
                      .......++|++.+.||+|+||.||+|... +|+.||||++....  .....+.++++.+..++||||+++++++.....
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            345566789999999999999999999874 68999999985432  222355678888899999999999999865332


Q ss_pred             -------eEEEEEeccCCChhHHHhc--cCCCCCCHHHHHHHHHHHHHHhcccc--ccCCCceeeeccccccEEEcC-CC
Q 040557          154 -------RLLVYEYMKNRSLDLLIYG--ESDKFLNWSTRFQIILGIARGLQYLH--EDSHTRIVHRDIKASNVLLDE-KF  221 (407)
Q Consensus       154 -------~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~i~H~dlk~~Nill~~-~~  221 (407)
                             .++||||+++ +|...+..  .....+++..+..++.|++.||.|||  +.+   ++||||||+|||++. ++
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTT
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCC
Confidence                   7899999987 44433321  34556899999999999999999999  777   999999999999996 89


Q ss_pred             ceEEecccCccccCCCCcccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHH
Q 040557          222 QSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYA  300 (407)
Q Consensus       222 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~  300 (407)
                      .+||+|||++........  .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||........  +....
T Consensus       170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~~~  245 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--LHEIV  245 (360)
T ss_dssp             EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH
T ss_pred             cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH--HHHHH
Confidence            999999999987764432  2345789999999988765 489999999999999999999999975432110  00000


Q ss_pred             H----------HHHHhC-ccccccCcc-cc----cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          301 W----------KLYERG-RILELVDPR-MR----KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       301 ~----------~~~~~~-~~~~~~d~~-~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .          ..+... ......+.. ..    ........+..+.+++.+||+.||++|||+.|+++|.|...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  320 (360)
T 3e3p_A          246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE  320 (360)
T ss_dssp             HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred             HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence            0          000000 000000000 00    00011123567899999999999999999999999988754

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.7e-43  Score=326.12  Aligned_cols=264  Identities=19%  Similarity=0.290  Sum_probs=203.4

Q ss_pred             HHHHHHHhcCCCCCCeeeccCCccEEEEEecCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCC--CCceeeeeeeeec
Q 040557           74 FQTLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQ--HKNLVRLLGCCSD  150 (407)
Q Consensus        74 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~  150 (407)
                      ++.+....++|++.+.||+|+||.||++...+|+.||||.+.... .......+.+|++++.+++  |+||+++++++..
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   99 (313)
T 3cek_A           20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   99 (313)
T ss_dssp             CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred             eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence            333444457788999999999999999998889999999986543 3445678899999999996  5999999999999


Q ss_pred             CCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccC
Q 040557          151 GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGL  230 (407)
Q Consensus       151 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgl  230 (407)
                      .+..++||| +.+++|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+|||+++ +.+||+|||+
T Consensus       100 ~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~  172 (313)
T 3cek_A          100 DQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGI  172 (313)
T ss_dssp             SSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred             CCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccc
Confidence            999999999 5688999998643  46899999999999999999999998   999999999999975 7999999999


Q ss_pred             ccccCCCCcc-cccccccCccccCcccccc-----------CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhH
Q 040557          231 ARFFPEDQAY-LSTNFAGTLGYTAPEYAIR-----------GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPE  298 (407)
Q Consensus       231 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~  298 (407)
                      +......... ......||+.|+|||.+.+           ..++.++||||||+++|||++|+.||......     ..
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~  247 (313)
T 3cek_A          173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----IS  247 (313)
T ss_dssp             SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HH
T ss_pred             cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HH
Confidence            9876543322 2234568999999998865           47888999999999999999999998643221     11


Q ss_pred             HHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          299 YAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       299 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .........         ... ..+...+..+.+++.+||+.||++|||+.|++++.+...
T Consensus       248 ~~~~~~~~~---------~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~  298 (313)
T 3cek_A          248 KLHAIIDPN---------HEI-EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  298 (313)
T ss_dssp             HHHHHHCTT---------SCC-CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred             HHHHHHhcc---------ccc-CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence            111111111         100 011112356889999999999999999999999988653

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.4e-42  Score=327.94  Aligned_cols=260  Identities=23%  Similarity=0.325  Sum_probs=199.6

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCee----
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQR----  154 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~----  154 (407)
                      .++|.+.+.||+|+||.||+|... +|+.||||++.... .......+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468888999999999999999864 68999999986543 334457788999999999999999999999877655    


Q ss_pred             --EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          155 --LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       155 --~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                        ++||||+. ++|.+++.    ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccc
Confidence              99999997 58877762    33899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh-Cccc
Q 040557          233 FFPEDQAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER-GRIL  310 (407)
Q Consensus       233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~  310 (407)
                      ......    ....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......      ......... +...
T Consensus       193 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~~~~  262 (371)
T 4exu_A          193 HADAEM----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL------DQLTQILKVTGVPG  262 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHCCCC
T ss_pred             ccccCc----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHHHhCCCc
Confidence            654332    34678999999999887 68899999999999999999999999754321      111111110 0000


Q ss_pred             -c---------------ccCcccccC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          311 -E---------------LVDPRMRKE--GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       311 -~---------------~~d~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                       +               .+.......  ......+..+.+++.+||+.||++|||+.|+++|.++.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  328 (371)
T 4exu_A          263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE  328 (371)
T ss_dssp             HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence             0               000000000  00011245789999999999999999999999998864

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.9e-43  Score=325.61  Aligned_cols=263  Identities=21%  Similarity=0.287  Sum_probs=195.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeee-----------
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCS-----------  149 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-----------  149 (407)
                      ++|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|++++++++||||+++++++.           
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            67888899999999999999875 4899999998643 4455678899999999999999999998873           


Q ss_pred             ---cCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc-CCCceEE
Q 040557          150 ---DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD-EKFQSKI  225 (407)
Q Consensus       150 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl  225 (407)
                         +....++||||++ |+|.+++..   ..+++..+..++.|++.||.|||+.+   ++||||||+||+++ +++.+||
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence               4467899999998 599998843   45899999999999999999999998   99999999999997 6779999


Q ss_pred             ecccCccccCCCCcc--cccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHH
Q 040557          226 GDFGLARFFPEDQAY--LSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWK  302 (407)
Q Consensus       226 ~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~  302 (407)
                      +|||++.........  ......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......      .....
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~~  236 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL------EQMQL  236 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH------HHHHH
Confidence            999999876532211  1233467899999998865 67899999999999999999999999754321      11111


Q ss_pred             HHHhCc-------------cccccCcccccCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          303 LYERGR-------------ILELVDPRMRKEGI-----VERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       303 ~~~~~~-------------~~~~~d~~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ......             +...+.........     ....+..+.+++.+||+.||++|||+.|+++|.+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  310 (320)
T 2i6l_A          237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS  310 (320)
T ss_dssp             HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHH
T ss_pred             HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccc
Confidence            111100             00000000000000     011345688999999999999999999999998764

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.5e-42  Score=335.55  Aligned_cols=264  Identities=24%  Similarity=0.300  Sum_probs=195.8

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC------Cee
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG------SQR  154 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~  154 (407)
                      .+|+..+.||+|+||.||+|++. +|+.||||++.....     .+.+|+++|+.++|+||+++++++...      ...
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            45788899999999999999875 599999999854322     234799999999999999999988431      236


Q ss_pred             EEEEEeccCCChhHHHhc--cCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCC-CceEEecccCc
Q 040557          155 LLVYEYMKNRSLDLLIYG--ESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEK-FQSKIGDFGLA  231 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfgla  231 (407)
                      ++||||+++ ++...+..  .....+++..+..++.|++.||.|||+.+   |+||||||+|||++.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence            799999986 55555432  23456999999999999999999999998   9999999999999955 67899999999


Q ss_pred             cccCCCCcccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHH-------H
Q 040557          232 RFFPEDQAYLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWK-------L  303 (407)
Q Consensus       232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~-------~  303 (407)
                      +.+.....  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+  .+......       .
T Consensus       205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHH
T ss_pred             hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHH
Confidence            87654332  2346789999999998765 78999999999999999999999997543211  11111110       0


Q ss_pred             HH--hCccccccCcccccCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          304 YE--RGRILELVDPRMRKEG----IVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       304 ~~--~~~~~~~~d~~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      +.  .....+...+.+....    +....+..+.+|+.+||+.||++|||+.|+++|.++.
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~  341 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD  341 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhc
Confidence            00  0000000001111000    1112245789999999999999999999999998874

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2e-42  Score=319.81  Aligned_cols=256  Identities=26%  Similarity=0.363  Sum_probs=195.5

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeec---------
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSD---------  150 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---------  150 (407)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|.+..  .......+.+|+.++++++||||+++++++.+         
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE--EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec--cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            467888899999999999999864 799999999853  34455778999999999999999999998754         


Q ss_pred             ----CCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEe
Q 040557          151 ----GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIG  226 (407)
Q Consensus       151 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~  226 (407)
                          ....++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence                45679999999999999999753 345788999999999999999999998   9999999999999999999999


Q ss_pred             cccCccccCCCC-------------cccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcc
Q 040557          227 DFGLARFFPEDQ-------------AYLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSE  292 (407)
Q Consensus       227 Dfgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~  292 (407)
                      |||++.......             ........||+.|+|||.+.+. .++.++||||||+++|||++   |+....   
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~---  232 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM---  232 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH---
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch---
Confidence            999998764321             1112345689999999998764 78999999999999999998   332110   


Q ss_pred             cCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          293 MQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                        . .......+....      .... .......+..+.+++.+||+.||++|||+.+++++.|..
T Consensus       233 --~-~~~~~~~~~~~~------~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (303)
T 1zy4_A          233 --E-RVNILKKLRSVS------IEFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP  288 (303)
T ss_dssp             --H-HHHHHHHHHSTT------CCCC-TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSC
T ss_pred             --h-HHHHHHhccccc------cccC-ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcC
Confidence              0 011111111111      0111 112223345688999999999999999999999998864

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.2e-42  Score=317.55  Aligned_cols=258  Identities=26%  Similarity=0.322  Sum_probs=206.7

Q ss_pred             HHhcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           79 KATKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      ...++|++.+.||+|+||.||+|... +++.||+|++.... .......+.+|++++++++||||+++++++.+.+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            44578999999999999999999875 68999999986543 23446678999999999999999999999999999999


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCC---CceEEecccCccc
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEK---FQSKIGDFGLARF  233 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfgla~~  233 (407)
                      ||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.+   +.+||+|||++..
T Consensus        99 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A           99 VGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            99999999998888543  35899999999999999999999998   9999999999999754   4799999999987


Q ss_pred             cCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccccc
Q 040557          234 FPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV  313 (407)
Q Consensus       234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      .......  ....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||......      . ....+..+......
T Consensus       174 ~~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~~~~  243 (287)
T 2wei_A          174 FQQNTKM--KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------D-ILKRVETGKYAFDL  243 (287)
T ss_dssp             BCCCSSC--SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCCCCS
T ss_pred             ecCCCcc--ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHcCCCCCCc
Confidence            6544322  23458899999998765 4899999999999999999999998653221      1 12222222211000


Q ss_pred             CcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       314 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                       +..      ...+..+.+++.+||+.||++|||+.+++++.+..
T Consensus       244 -~~~------~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~  281 (287)
T 2wei_A          244 -PQW------RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ  281 (287)
T ss_dssp             -GGG------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred             -hhh------hhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHh
Confidence             000      11235688999999999999999999999987643

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.6e-42  Score=336.71  Aligned_cols=253  Identities=23%  Similarity=0.287  Sum_probs=189.3

Q ss_pred             CCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEEEEecc
Q 040557           84 FHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVYEYMK  162 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  162 (407)
                      |...+.||+|+||+||.+...+|+.||||++...    ....+.+|+.++.++ +||||+++++++.+.+..++||||+.
T Consensus        17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            4445789999999998776668999999998532    234578999999876 89999999999999999999999995


Q ss_pred             CCChhHHHhccCCCC-----CCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCC-------------CceE
Q 040557          163 NRSLDLLIYGESDKF-----LNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEK-------------FQSK  224 (407)
Q Consensus       163 ~g~L~~~l~~~~~~~-----l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-------------~~~k  224 (407)
                       |+|.+++.......     .++..+..++.|++.||.|||+.+   |+||||||+|||++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             69999996543211     133345789999999999999998   9999999999999754             4899


Q ss_pred             EecccCccccCCCCcc---cccccccCccccCcccccc-------CCCCccccEEehhHHHHHHHh-cCCCCCCCCCccc
Q 040557          225 IGDFGLARFFPEDQAY---LSTNFAGTLGYTAPEYAIR-------GELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEM  293 (407)
Q Consensus       225 l~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~  293 (407)
                      |+|||++.........   ......||+.|+|||.+.+       ..++.++|||||||++|||+| |+.||....... 
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-  247 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-  247 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence            9999999987654322   1234579999999999865       678999999999999999999 898986433221 


Q ss_pred             CchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          294 QYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                             ..... +... .  +.. ........+..+.+++.+||+.||++|||+.++++|.+.
T Consensus       248 -------~~i~~-~~~~-~--~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f  299 (434)
T 2rio_A          248 -------SNIIR-GIFS-L--DEM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF  299 (434)
T ss_dssp             -------HHHHH-TCCC-C--CCC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             -------HHHhc-CCCC-c--ccc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCcc
Confidence                   11111 1100 0  011 111234567789999999999999999999999998775

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.6e-42  Score=325.45  Aligned_cols=265  Identities=18%  Similarity=0.220  Sum_probs=204.7

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CC-cEEEEEEeccccChhhHHHHHHHHHHHHcCCCCc------eeeeeeeeecCC
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DG-TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN------LVRLLGCCSDGS  152 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~  152 (407)
                      .++|++.+.||+|+||.||+|... ++ ..||+|++..  .......+.+|++++..++|++      ++.+.+++...+
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN--VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc--cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            368888999999999999999864 34 6899999853  3345567889999999887665      899999999999


Q ss_pred             eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEE---------------
Q 040557          153 QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL---------------  217 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill---------------  217 (407)
                      ..++||||+ ++++.+++.......+++..+..++.|++.||.|||+.+   ++||||||+|||+               
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            999999999 667777776555567999999999999999999999998   9999999999999               


Q ss_pred             ----cCCCceEEecccCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCccc
Q 040557          218 ----DEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEM  293 (407)
Q Consensus       218 ----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~  293 (407)
                          +.++.+||+|||++.......    ....||+.|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                567899999999998654332    345799999999999999999999999999999999999999975432110


Q ss_pred             CchhHHHHHHH--------HhCccccc---------------------cCcccccCCCCHHHHHHHHHHHHHccCCCCCC
Q 040557          294 QYLPEYAWKLY--------ERGRILEL---------------------VDPRMRKEGIVERDALQVINVAFICLQPHGNQ  344 (407)
Q Consensus       294 ~~~~~~~~~~~--------~~~~~~~~---------------------~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~  344 (407)
                         ........        ........                     ..+..............+.+++.+||+.||++
T Consensus       248 ---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          248 ---LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             ---HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             ---HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence               00000000        00000000                     00000000112234567899999999999999


Q ss_pred             CCCHHHHHHHhhcc
Q 040557          345 RPPMSEIVAMLTCK  358 (407)
Q Consensus       345 RPs~~ev~~~l~~~  358 (407)
                      |||+.|+++|-+..
T Consensus       325 Rpt~~e~l~hp~f~  338 (355)
T 2eu9_A          325 RITLAEALLHPFFA  338 (355)
T ss_dssp             SCCHHHHTTSGGGG
T ss_pred             CcCHHHHhcChhhc
Confidence            99999999998764

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=324.17  Aligned_cols=260  Identities=23%  Similarity=0.349  Sum_probs=199.7

Q ss_pred             HHhcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           79 KATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        79 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ...++|++.+.||+|+||.||+|...+  .+|+|.+..... ......+.+|+.++++++|+||+++++++.+....++|
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  107 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII  107 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence            345788999999999999999998753  499999865432 22334577899999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++++|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++ ++.++|+|||++......
T Consensus       108 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          108 TSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             CBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             eecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            9999999999998543 345899999999999999999999998   99999999999998 679999999998765321


Q ss_pred             C----cccccccccCccccCcccccc---------CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHH
Q 040557          238 Q----AYLSTNFAGTLGYTAPEYAIR---------GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLY  304 (407)
Q Consensus       238 ~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~  304 (407)
                      .    ........|++.|+|||.+.+         ..++.++||||||+++|||++|+.||......      ... ...
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~-~~~  255 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------AII-WQM  255 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------HHH-HHH
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHH-HHh
Confidence            1    111223468999999998864         45789999999999999999999998643221      111 122


Q ss_pred             HhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          305 ERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       305 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                      ..+........         ..+..+.+++.+||+.||++|||+.++++.|+.....
T Consensus       256 ~~~~~~~~~~~---------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          256 GTGMKPNLSQI---------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             HTTCCCCCCCS---------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             ccCCCCCCCcC---------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            22221111111         1223488999999999999999999999999876433

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.1e-42  Score=327.27  Aligned_cols=260  Identities=23%  Similarity=0.311  Sum_probs=199.5

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCe-----
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQ-----  153 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  153 (407)
                      .++|...+.||+|+||.||+|... +|+.||||.+.... .......+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            367888899999999999999864 68999999986543 33445678999999999999999999999977654     


Q ss_pred             -eEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          154 -RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       154 -~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                       .++||||+. ++|.+++.    ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             eEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence             499999997 58877763    24899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh-Cccc
Q 040557          233 FFPEDQAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER-GRIL  310 (407)
Q Consensus       233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~  310 (407)
                      ......    ....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......      ......... +...
T Consensus       175 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~~~~  244 (353)
T 3coi_A          175 HADAEM----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL------DQLTQILKVTGVPG  244 (353)
T ss_dssp             C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH------HHHHHHHHHHCBCC
T ss_pred             CCCCCc----cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCCCC
Confidence            654332    34578999999998877 67899999999999999999999999754321      111111100 0000


Q ss_pred             ----------------cccCc--ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          311 ----------------ELVDP--RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       311 ----------------~~~d~--~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                                      ..+..  ...-.......+..+.+++.+||+.||++|||+.++++|-+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~  310 (353)
T 3coi_A          245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE  310 (353)
T ss_dssp             HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence                            00000  0000011123456789999999999999999999999998864

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=317.42  Aligned_cols=257  Identities=21%  Similarity=0.303  Sum_probs=184.2

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHH-HHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEF-LSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~-~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      .++|++.+.||+|+||.||+|... +|+.||||++...........+ .++..++..++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            367788889999999999999875 6899999999765544444344 44445677889999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhcccccc-CCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED-SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      ||+ ++.+..+.. .....+++..+..++.|++.||.|||+. +   ++||||||+||+++.++.+||+|||++......
T Consensus       104 e~~-~~~~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          104 ELM-GTCAEKLKK-RMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             CCC-SEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecc-CCcHHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            999 445555543 3345689999999999999999999995 7   999999999999999999999999999866543


Q ss_pred             CcccccccccCccccCccccc-----cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAI-----RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL  312 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ..  .....||+.|+|||.+.     ...++.++||||||+++|||++|+.||......     ......... +...  
T Consensus       179 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~-~~~~--  248 (318)
T 2dyl_A          179 KA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQ-EEPP--  248 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHH-SCCC--
T ss_pred             cc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhc-cCCC--
Confidence            32  23456899999999984     557889999999999999999999998643221     112222222 1111  


Q ss_pred             cCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          313 VDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       313 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                         ....   ....+..+.+++.+||+.||++|||+.++++|.+..
T Consensus       249 ---~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (318)
T 2dyl_A          249 ---LLPG---HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK  288 (318)
T ss_dssp             ---CCCS---SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred             ---CCCc---cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHH
Confidence               1110   011235688999999999999999999999987654

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=7.1e-43  Score=325.98  Aligned_cols=251  Identities=24%  Similarity=0.382  Sum_probs=202.9

Q ss_pred             HHHHHhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccCh-----hhHHHHHHHHHHHHcCC--CCceeeeeee
Q 040557           76 TLKKATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQ-----QGESEFLSEVRMITSIQ--HKNLVRLLGC  147 (407)
Q Consensus        76 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~--h~niv~l~~~  147 (407)
                      ......++|++.+.||+|+||.||+|.. .+|+.||||.+......     .....+.+|+.++.+++  |+||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            3344557899999999999999999985 46899999998654321     12245678999999995  5999999999


Q ss_pred             eecCCeeEEEEEeccC-CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc-CCCceEE
Q 040557          148 CSDGSQRLLVYEYMKN-RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD-EKFQSKI  225 (407)
Q Consensus       148 ~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl  225 (407)
                      +...+..++|||++.+ ++|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++ +++.+||
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL  191 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL  191 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEE
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEE
Confidence            9999999999999986 8999998643  45899999999999999999999998   99999999999999 7899999


Q ss_pred             ecccCccccCCCCcccccccccCccccCccccccCCC-CccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHH
Q 040557          226 GDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLY  304 (407)
Q Consensus       226 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~  304 (407)
                      +|||++........   ....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....            ...
T Consensus       192 ~Dfg~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~~~  256 (320)
T 3a99_A          192 IDFGSGALLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EII  256 (320)
T ss_dssp             CCCTTCEECCSSCB---CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHH
T ss_pred             eeCccccccccccc---cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------hhh
Confidence            99999987754332   34579999999999887766 788999999999999999999985310            011


Q ss_pred             HhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          305 ERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       305 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                       .+..       .    .....+..+.+++.+||+.||++|||+.+++++.+..
T Consensus       257 -~~~~-------~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~  298 (320)
T 3a99_A          257 -RGQV-------F----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ  298 (320)
T ss_dssp             -HCCC-------C----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             -cccc-------c----ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhc
Confidence             1110       0    1111234688999999999999999999999998754

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-42  Score=320.89  Aligned_cols=250  Identities=24%  Similarity=0.378  Sum_probs=195.2

Q ss_pred             HHHHhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccCh-----hhHHHHHHHHHHHHcC----CCCceeeeee
Q 040557           77 LKKATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQ-----QGESEFLSEVRMITSI----QHKNLVRLLG  146 (407)
Q Consensus        77 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l----~h~niv~l~~  146 (407)
                      .+...++|++.+.||+|+||.||+|.. .+|+.||||.+......     .....+.+|+.++.++    +|+||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            344567899999999999999999986 46899999998644321     1223456799999888    8999999999


Q ss_pred             eeecCCeeEEEEEe-ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc-CCCceE
Q 040557          147 CCSDGSQRLLVYEY-MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD-EKFQSK  224 (407)
Q Consensus       147 ~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~k  224 (407)
                      ++...+..++|||+ +.+++|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+||+++ +++.+|
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence            99999999999999 7899999998643  35899999999999999999999998   99999999999999 889999


Q ss_pred             EecccCccccCCCCcccccccccCccccCccccccCCCC-ccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHH
Q 040557          225 IGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELS-EKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKL  303 (407)
Q Consensus       225 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~  303 (407)
                      |+|||++........   ....|+..|+|||.+.+..+. .++||||||+++|||++|+.||....            ..
T Consensus       181 l~dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~~  245 (312)
T 2iwi_A          181 LIDFGSGALLHDEPY---TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------EI  245 (312)
T ss_dssp             ECCCSSCEECCSSCB---CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HH
T ss_pred             EEEcchhhhcccCcc---cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------HH
Confidence            999999987765432   345689999999998877664 58999999999999999999986310            01


Q ss_pred             HHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          304 YERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       304 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .. ..        .   ..+...+..+.+++.+||+.||++|||+.|++++.+..
T Consensus       246 ~~-~~--------~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~  288 (312)
T 2iwi_A          246 LE-AE--------L---HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ  288 (312)
T ss_dssp             HH-TC--------C---CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTC
T ss_pred             hh-hc--------c---CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence            11 10        0   01122345688999999999999999999999998764

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.1e-42  Score=344.02  Aligned_cols=271  Identities=24%  Similarity=0.270  Sum_probs=202.8

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeec------CC
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSD------GS  152 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~  152 (407)
                      ..++|++.+.||+|+||.||+|.. .+|+.||||++...........+.+|++++.+++||||+++++++..      .+
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            347899999999999999999986 46899999998765566667789999999999999999999998765      67


Q ss_pred             eeEEEEEeccCCChhHHHhccC-CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCc---eEEecc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGES-DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQ---SKIGDF  228 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~---~kl~Df  228 (407)
                      ..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.   +||+||
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence            7899999999999999997543 335899999999999999999999998   999999999999997665   999999


Q ss_pred             cCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCc
Q 040557          229 GLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGR  308 (407)
Q Consensus       229 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      |++........  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ..............
T Consensus       169 G~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~-~~~~i~~~~~~~~~  245 (676)
T 3qa8_A          169 GYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ-WHGKVREKSNEHIV  245 (676)
T ss_dssp             CCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH-SSTTCC------CC
T ss_pred             ccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh-hhhhhhcccchhhh
Confidence            99987754432  2346799999999999999999999999999999999999999965321100 00000000000000


Q ss_pred             cccccC------ccc-ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          309 ILELVD------PRM-RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       309 ~~~~~d------~~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ..+...      ... .........+..+.+++.+||+.||++|||+.+++++.+
T Consensus       246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~  300 (676)
T 3qa8_A          246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC  300 (676)
T ss_dssp             SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTT
T ss_pred             hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHH
Confidence            000000      000 011233446778999999999999999999988654433

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.9e-42  Score=330.38  Aligned_cols=252  Identities=22%  Similarity=0.269  Sum_probs=188.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      .+|...+.||+|+||+||.....+|+.||||++......    .+.+|+++|+.+ +||||+++++++.+....++||||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            457777899999999976555567999999998543221    246899999999 799999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC-----CCceEEecccCccccC
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE-----KFQSKIGDFGLARFFP  235 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-----~~~~kl~Dfgla~~~~  235 (407)
                      +. |+|.+++..... ...+..+..++.|++.||.|||+.+   |+||||||+|||++.     ...+||+|||+++...
T Consensus       100 ~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A          100 CA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             CS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             CC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            96 599999865443 2444556789999999999999998   999999999999953     3368899999998775


Q ss_pred             CCCc--ccccccccCccccCccccc---cCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCcc
Q 040557          236 EDQA--YLSTNFAGTLGYTAPEYAI---RGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRI  309 (407)
Q Consensus       236 ~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (407)
                      ....  .......||+.|+|||.+.   ...++.++|||||||++|||++ |..||......       ....... ...
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~~~~~~~-~~~  246 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------QANILLG-ACS  246 (432)
T ss_dssp             -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------HHHHHTT-CCC
T ss_pred             CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------HHHHHhc-cCC
Confidence            4322  2234567999999999987   4567889999999999999999 88888533221       1111111 100


Q ss_pred             ccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          310 LELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       310 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      ..       ...........+.+++.+||+.||++|||+.++++|.++
T Consensus       247 ~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f  287 (432)
T 3p23_A          247 LD-------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF  287 (432)
T ss_dssp             CT-------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTT
T ss_pred             cc-------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccc
Confidence            00       001122345567899999999999999999999988775

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8e-41  Score=342.39  Aligned_cols=238  Identities=22%  Similarity=0.304  Sum_probs=192.8

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec--CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCe-----
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA--DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQ-----  153 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  153 (407)
                      .++|++.+.||+|+||.||+|.+.  +|+.||||.+...........+.+|++++.+++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            378999999999999999999875  6899999998655555666788999999999999999999999987655     


Q ss_pred             eEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          154 RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      .|+||||+++++|.+++..    .+++..+..++.|++.||.|||+.+   |+||||||+|||++.+ .+||+|||+++.
T Consensus       159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence            6999999999999887643    5999999999999999999999998   9999999999999986 999999999987


Q ss_pred             cCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccccc
Q 040557          234 FPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV  313 (407)
Q Consensus       234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      ....     ....||+.|+|||++.+.. +.++|||||||++|||++|..|+........                    
T Consensus       231 ~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------------------  284 (681)
T 2pzi_A          231 INSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------------------  284 (681)
T ss_dssp             TTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------------------
T ss_pred             cccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc--------------------
Confidence            6543     3457999999999887654 8999999999999999999887653211100                    


Q ss_pred             CcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCH-HHHHHHhh
Q 040557          314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPM-SEIVAMLT  356 (407)
Q Consensus       314 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-~ev~~~l~  356 (407)
                          ............+.+++.+||+.||++||+. +++...|.
T Consensus       285 ----~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          285 ----PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             ----CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             ----cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence                0000111233568899999999999999964 44544443

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.8e-40  Score=303.28  Aligned_cols=239  Identities=20%  Similarity=0.214  Sum_probs=185.8

Q ss_pred             cCCCCC-CeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHH-HcCCCCceeeeeeeeec----CCee
Q 040557           82 KNFHPG-NLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMI-TSIQHKNLVRLLGCCSD----GSQR  154 (407)
Q Consensus        82 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~  154 (407)
                      ++|.+. +.||+|+||.||+|.. .+|+.||+|++...      ..+.+|++++ +..+||||+++++++..    ....
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            456555 6799999999999986 46899999998521      2466888888 55599999999999876    6778


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC---CCceEEecccCc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE---KFQSKIGDFGLA  231 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfgla  231 (407)
                      ++||||+++|+|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+||+++.   ++.+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999999998766667999999999999999999999998   999999999999998   789999999999


Q ss_pred             cccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccc
Q 040557          232 RFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILE  311 (407)
Q Consensus       232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      ....                       +..++.++|||||||++|||++|+.||.........            .....
T Consensus       168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------------~~~~~  212 (299)
T 3m2w_A          168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------PGMKT  212 (299)
T ss_dssp             EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CCSCC
T ss_pred             cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------------HHHHH
Confidence            6432                       245678999999999999999999999654322110            00000


Q ss_pred             ccCcccccCCCC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccCCCCCC
Q 040557          312 LVDPRMRKEGIV----ERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVR  366 (407)
Q Consensus       312 ~~d~~~~~~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~~~~~~  366 (407)
                      .+..  .....+    ...+..+.+++.+||+.||++|||+.|+++|.+.......+..
T Consensus       213 ~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~  269 (299)
T 3m2w_A          213 RIRM--GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT  269 (299)
T ss_dssp             SSCT--TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCC
T ss_pred             HHhh--ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCC
Confidence            0000  000011    1134578899999999999999999999999887655444433

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=5.1e-41  Score=324.05  Aligned_cols=245  Identities=16%  Similarity=0.134  Sum_probs=182.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccCh--hhHHHHHHHHHHHHcCCC-Cceee--------------
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQ--QGESEFLSEVRMITSIQH-KNLVR--------------  143 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h-~niv~--------------  143 (407)
                      .+|...+.||+|+||.||+|.+ .+|+.||||++......  ...+.+.+|+.++..+.| .|...              
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            4466778999999999999985 46999999998643322  235678899999999977 22211              


Q ss_pred             -------eeeeeec-----CCeeEEEEEeccCCChhHHHh-----ccCCCCCCHHHHHHHHHHHHHHhccccccCCCcee
Q 040557          144 -------LLGCCSD-----GSQRLLVYEYMKNRSLDLLIY-----GESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV  206 (407)
Q Consensus       144 -------l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~-----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~  206 (407)
                             +..++..     ....+++|+++ +++|.+++.     ......+++..+..++.|++.||.|||+.+   |+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence                   1111111     22356777765 679988884     233455888999999999999999999998   99


Q ss_pred             eeccccccEEEcCCCceEEecccCccccCCCCcccccccccCccccCcccc----------ccCCCCccccEEehhHHHH
Q 040557          207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYA----------IRGELSEKADIYSFGVLVL  276 (407)
Q Consensus       207 H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~k~Dv~s~G~vl~  276 (407)
                      ||||||+|||++.++.+||+|||+++.....    .....| +.|+|||++          .+..++.++|||||||++|
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            9999999999999999999999999865443    234567 999999998          5556889999999999999


Q ss_pred             HHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          277 EIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       277 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ||++|+.||.........               ...+...   ..    .+..+.+++.+||+.||++|||+.+++++.+
T Consensus       309 elltg~~Pf~~~~~~~~~---------------~~~~~~~---~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~  366 (413)
T 3dzo_A          309 WIWCADLPNTDDAALGGS---------------EWIFRSC---KN----IPQPVRALLEGFLRYPKEDRLLPLQAMETPE  366 (413)
T ss_dssp             HHHHSSCCCCTTGGGSCS---------------GGGGSSC---CC----CCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred             HHHHCCCCCCCcchhhhH---------------HHHHhhc---cc----CCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence            999999999754322110               0011100   11    2356889999999999999999999987754


Q ss_pred             c
Q 040557          357 C  357 (407)
Q Consensus       357 ~  357 (407)
                      .
T Consensus       367 ~  367 (413)
T 3dzo_A          367 Y  367 (413)
T ss_dssp             H
T ss_pred             H
Confidence            3

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=9.3e-40  Score=299.74  Aligned_cols=232  Identities=13%  Similarity=0.032  Sum_probs=182.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|... +|+.||||.+.....  ......+.+|+..+.+++|+||+++++++.+.+..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            57888899999999999999875 489999999975433  344578999999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++++|.+++..   . .....+.+++.|++.||.|||+.+   ++||||||+|||+++++.+||+++|         
T Consensus       111 e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~---------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA---------  174 (286)
T ss_dssp             ECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred             EecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc---------
Confidence            99999999999843   2 355678899999999999999998   9999999999999999999997543         


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                                  |++       .++.++|||||||++|||+||+.||............   .     ........+ ..
T Consensus       175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~-----~~~~~~~~~-~~  226 (286)
T 3uqc_A          175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---E-----RDTAGQPIE-PA  226 (286)
T ss_dssp             ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---C-----BCTTSCBCC-HH
T ss_pred             ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---H-----HHhccCCCC-hh
Confidence                        333       3688999999999999999999999765432210000   0     000000000 00


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                        ......+..+.+++.+||+.||++| |+.|+++.|.....
T Consensus       227 --~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          227 --DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             --HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             --hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence              0011234568899999999999999 99999999986543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.1e-40  Score=309.40  Aligned_cols=247  Identities=16%  Similarity=0.136  Sum_probs=185.2

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccC-------hhhHHHHHHHHHHHHcCC---------CCceeeee
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKS-------QQGESEFLSEVRMITSIQ---------HKNLVRLL  145 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~---------h~niv~l~  145 (407)
                      ++|++.+.||+|+||.||+|+. +|+.||||++.....       ......+.+|+++++.++         |+||+++.
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            5688889999999999999998 689999999975432       223467889999988885         66666655


Q ss_pred             ee-----------------eec-------------CCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhc
Q 040557          146 GC-----------------CSD-------------GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQ  195 (407)
Q Consensus       146 ~~-----------------~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~  195 (407)
                      +.                 +.+             ....++||||+++|++.+.+..   ..+++..+..++.|++.||.
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHH
Confidence            54                 333             6789999999999976666532   45899999999999999999


Q ss_pred             ccc-ccCCCceeeeccccccEEEcCCC--------------------ceEEecccCccccCCCCcccccccccCccccCc
Q 040557          196 YLH-EDSHTRIVHRDIKASNVLLDEKF--------------------QSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP  254 (407)
Q Consensus       196 ~LH-~~~~~~i~H~dlk~~Nill~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aP  254 (407)
                      ||| +.+   |+||||||+|||++.++                    .+||+|||+++.....      ...||+.|+||
T Consensus       176 ~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aP  246 (336)
T 2vuw_A          176 VAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDE  246 (336)
T ss_dssp             HHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCS
T ss_pred             HHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccCh
Confidence            999 888   99999999999999887                    8999999999876532      34799999999


Q ss_pred             cccccCCCCccccEEehhHH-HHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHH
Q 040557          255 EYAIRGELSEKADIYSFGVL-VLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINV  333 (407)
Q Consensus       255 E~~~~~~~~~k~Dv~s~G~v-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l  333 (407)
                      |.+.+.. +.++||||+|++ .+++++|..||...     .................     ...........+..+.+|
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~s~~~~dl  315 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----LWLHYLTDKMLKQMTFK-----TKCNTPAMKQIKRKIQEF  315 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----HHHHHHHHHHHHTCCCS-----SCCCSHHHHHHHHHHHHH
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----hhhhHHHHhhhhhhccC-----cccchhhhhhcCHHHHHH
Confidence            9988766 899999998777 77788888876310     00000011111110000     000011223567889999


Q ss_pred             HHHccCCCCCCCCCHHHHH-HHhhc
Q 040557          334 AFICLQPHGNQRPPMSEIV-AMLTC  357 (407)
Q Consensus       334 ~~~cl~~~p~~RPs~~ev~-~~l~~  357 (407)
                      +.+||+.|     |+.|++ +|-+.
T Consensus       316 i~~~L~~d-----sa~e~l~~Hp~f  335 (336)
T 2vuw_A          316 HRTMLNFS-----SATDLLCQHSLF  335 (336)
T ss_dssp             HHHGGGSS-----SHHHHHHHCGGG
T ss_pred             HHHHhccC-----CHHHHHhcCCCc
Confidence            99999976     999999 88664

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=1.1e-32  Score=275.12  Aligned_cols=184  Identities=20%  Similarity=0.186  Sum_probs=130.8

Q ss_pred             eeccCCccEEEEE-ecCCcEEEEEEecccc---------ChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEEE
Q 040557           90 LGRGGFGPVYRGK-LADGTLVAVKKLCVDK---------SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        90 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---------~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      .+.|++|.+..++ .-.|+.+|+|.+....         .....++|.+|+++|+++ .|+||+++++++++....||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            5667777776664 3358899999996542         123346799999999999 7999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||++|++|.+++..  ...++..   +|+.||+.||+|||++|   |+||||||+|||+++++.+||+|||+|+....+.
T Consensus       322 Eyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          322 EKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             ECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             ecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            99999999999954  3456654   48899999999999999   9999999999999999999999999998776543


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCC
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRK  283 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~  283 (407)
                      .. ....+||+.|||||++.+ .+..++|+||+|++++++.++..
T Consensus       394 ~~-~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          394 SW-PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             CC-SHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred             cc-ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence            32 345689999999998865 46778999999999998876543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=2.7e-29  Score=249.19  Aligned_cols=185  Identities=18%  Similarity=0.204  Sum_probs=146.8

Q ss_pred             CCCCeeeccCCccEEEEEecCCcEEEEEEeccccCh-------hhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           85 HPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQ-------QGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        85 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ...+.||+|+||.||+|.. .+..+++|+.......       ...+++.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4457899999999999965 5788999987543211       1235689999999999999999766666677788999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++++|.+++..          +..++.|++.||.|||+++   |+||||||+|||+++  .+||+|||+++.....
T Consensus       418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            999999999999854          4689999999999999998   999999999999999  9999999999987654


Q ss_pred             Cccc------ccccccCccccCcccccc--CCCCccccEEehhHHHHHHHhcCCCC
Q 040557          238 QAYL------STNFAGTLGYTAPEYAIR--GELSEKADIYSFGVLVLEIISCRKNT  285 (407)
Q Consensus       238 ~~~~------~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~s~G~vl~el~tg~~p~  285 (407)
                      ....      .....||+.|||||++..  ..|+...|+|+..+-.++-+.++.++
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            3221      235679999999999987  67888999999999988888776554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=7.7e-26  Score=206.28  Aligned_cols=152  Identities=18%  Similarity=0.102  Sum_probs=120.1

Q ss_pred             HHHHhcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccCh-----------------hhHHHHHHHHHHHHcCCCC
Q 040557           77 LKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQ-----------------QGESEFLSEVRMITSIQHK  139 (407)
Q Consensus        77 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~l~h~  139 (407)
                      +......|.+++.||+|+||.||+|...+|+.||+|.+......                 .....+.+|+++|++++  
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            33344556667999999999999999877999999998643211                 13457899999999998  


Q ss_pred             ceeeeeeeeecCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC
Q 040557          140 NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE  219 (407)
Q Consensus       140 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~  219 (407)
                      | +++.+++.. +..++||||++||+|.+ +..        .....++.|++.||.|||+.+   ++||||||+|||++ 
T Consensus       163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-  227 (282)
T 1zar_A          163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-  227 (282)
T ss_dssp             T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-
T ss_pred             C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-
Confidence            5 666665543 55699999999999988 411        123469999999999999998   99999999999999 


Q ss_pred             CCceEEecccCccccCCCCcccccccccCccccCcccccc
Q 040557          220 KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR  259 (407)
Q Consensus       220 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~  259 (407)
                      ++.+||+|||+++.              +..++|||++.+
T Consensus       228 ~~~vkl~DFG~a~~--------------~~~~~a~e~l~r  253 (282)
T 1zar_A          228 EEGIWIIDFPQSVE--------------VGEEGWREILER  253 (282)
T ss_dssp             TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred             CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence            99999999999973              344678887643

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=5.2e-21  Score=172.18  Aligned_cols=138  Identities=19%  Similarity=0.186  Sum_probs=106.4

Q ss_pred             CCCCCeeeccCCccEEEEEe-cCCcE--EEEEEeccccCh-----------------------hhHHHHHHHHHHHHcCC
Q 040557           84 FHPGNLLGRGGFGPVYRGKL-ADGTL--VAVKKLCVDKSQ-----------------------QGESEFLSEVRMITSIQ  137 (407)
Q Consensus        84 ~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~  137 (407)
                      |.+.+.||+|+||.||+|.. .+|+.  ||||++......                       .....+.+|++.|..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            55678899999999999987 68989  999987543111                       11236789999999998


Q ss_pred             CCce--eeeeeeeecCCeeEEEEEeccC-C----ChhHHHhccCCCCCCHHHHHHHHHHHHHHhcccc-ccCCCceeeec
Q 040557          138 HKNL--VRLLGCCSDGSQRLLVYEYMKN-R----SLDLLIYGESDKFLNWSTRFQIILGIARGLQYLH-EDSHTRIVHRD  209 (407)
Q Consensus       138 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~i~H~d  209 (407)
                      |+++  ..++++    ...++||||+.+ |    +|.++...     .++..+..++.|++.||.||| +.+   ++|||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrD  196 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE---LVHAD  196 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC---EECSS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC---EEeCC
Confidence            7754  334432    356899999942 4    66665422     224456789999999999999 888   99999


Q ss_pred             cccccEEEcCCCceEEecccCccccC
Q 040557          210 IKASNVLLDEKFQSKIGDFGLARFFP  235 (407)
Q Consensus       210 lk~~Nill~~~~~~kl~Dfgla~~~~  235 (407)
                      |||.|||+++  .++|+|||+|....
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEETT
T ss_pred             CCHHHEEEcC--cEEEEECcccccCC
Confidence            9999999998  99999999997653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=3.6e-19  Score=166.64  Aligned_cols=149  Identities=12%  Similarity=0.176  Sum_probs=105.0

Q ss_pred             cCHHHHHHHhcC---CCCCCeeeccCCccEEEEEecCCcEEEEEEeccccC-------------hhhHHH--------HH
Q 040557           72 FDFQTLKKATKN---FHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKS-------------QQGESE--------FL  127 (407)
Q Consensus        72 ~~~~~~~~~~~~---~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------~~~~~~--------~~  127 (407)
                      ||+-.+....++   |+++..||.|+||.||+|...+|+.||||+++....             ......        ..
T Consensus        82 yD~LAL~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~  161 (397)
T 4gyi_A           82 LDYLALHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAI  161 (397)
T ss_dssp             HHHHHHHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHH
Confidence            445455555544   888999999999999999998999999998753210             000111        13


Q ss_pred             HHHHHHHcCCCCce--eeeeeeeecCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCce
Q 040557          128 SEVRMITSIQHKNL--VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRI  205 (407)
Q Consensus       128 ~e~~~l~~l~h~ni--v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  205 (407)
                      +|...|.++.+.++  ...+++    ...+|||||++|++|..+..        ......++.|++.+|.+||+.|   +
T Consensus       162 kE~~nL~rL~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~g---I  226 (397)
T 4gyi_A          162 KEFAFMKALYEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKHG---L  226 (397)
T ss_dssp             HHHHHHHHHHHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHTT---E
T ss_pred             HHHHHHHHHHhcCCCCCeeeec----cCceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHCC---C
Confidence            45556666544333  222222    12379999999988866532        1123567899999999999998   9


Q ss_pred             eeeccccccEEEcCCC----------ceEEecccCccccC
Q 040557          206 VHRDIKASNVLLDEKF----------QSKIGDFGLARFFP  235 (407)
Q Consensus       206 ~H~dlk~~Nill~~~~----------~~kl~Dfgla~~~~  235 (407)
                      +||||||.|||+++++          .+.|+||+-+....
T Consensus       227 VHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          227 IHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             ECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             cCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence            9999999999998876          38999999886543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.41  E-value=4e-13  Score=120.78  Aligned_cols=147  Identities=14%  Similarity=0.031  Sum_probs=111.5

Q ss_pred             HHHHhcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeE
Q 040557           77 LKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRL  155 (407)
Q Consensus        77 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  155 (407)
                      +......|+....++.|+.+.||++... |..+++|....... .....+.+|+++++.+ .+.++.++++++.+.+..+
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence            3444566777677888888999999864 68899999854211 1223578899999988 4677889999998888999


Q ss_pred             EEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccC----------------------------------
Q 040557          156 LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS----------------------------------  201 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------  201 (407)
                      +||||++|.+|.+...       +......++.++++++..||+..                                  
T Consensus        87 lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             EEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            9999999999877631       11223467888999999999810                                  


Q ss_pred             ----------------------CCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          202 ----------------------HTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       202 ----------------------~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                                            ...++|+|+++.||+++++..+.|+||+.+.
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                  1348999999999999876666799998775

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.27  E-value=3.6e-12  Score=114.15  Aligned_cols=128  Identities=15%  Similarity=0.121  Sum_probs=94.2

Q ss_pred             eccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCc--eeeeeeeeecCCeeEEEEEeccCCChhH
Q 040557           91 GRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN--LVRLLGCCSDGSQRLLVYEYMKNRSLDL  168 (407)
Q Consensus        91 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~  168 (407)
                      +.|..+.||++...+|..+++|.....    ....+.+|+++++.+.+.+  +.+++++...++..++||||++|.++. 
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence            355568999998777888999987532    1234678999988885434  556888888878889999999998884 


Q ss_pred             HHhccCCCCCCHHHHHHHHHHHHHHhccccccC-----------------------------------------------
Q 040557          169 LIYGESDKFLNWSTRFQIILGIARGLQYLHEDS-----------------------------------------------  201 (407)
Q Consensus       169 ~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----------------------------------------------  201 (407)
                       .. .    .+   ...++.+++..+..||+..                                               
T Consensus       104 -~~-~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (264)
T 1nd4_A          104 -SS-H----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL  174 (264)
T ss_dssp             -TS-C----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred             -cC-c----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence             21 1    11   1245666777777777642                                               


Q ss_pred             --------CCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          202 --------HTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       202 --------~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                              ...++|+|++|.||+++++..+.|+|||.+.
T Consensus       175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                    1239999999999999887667799999876

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.24  E-value=2.9e-11  Score=113.82  Aligned_cols=143  Identities=16%  Similarity=0.200  Sum_probs=105.5

Q ss_pred             CCeeeccCCccEEEEEecCCcEEEEEEec--cccChhhHHHHHHHHHHHHcCC--CCceeeeeeeeecC---CeeEEEEE
Q 040557           87 GNLLGRGGFGPVYRGKLADGTLVAVKKLC--VDKSQQGESEFLSEVRMITSIQ--HKNLVRLLGCCSDG---SQRLLVYE  159 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e  159 (407)
                      .+.|+.|.++.||+.... +..+++|+..  ..........+.+|.++++.+.  +.++.+++.++.+.   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            356899999999999875 4678888764  3222223446788999999886  45678899888776   45799999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccC--------------------------------------
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS--------------------------------------  201 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------  201 (407)
                      |++|..+.+..    ...++...+..++.+++++|..||+..                                      
T Consensus       122 ~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          122 FVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             CCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             ecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            99998774321    123678888889999999999999731                                      


Q ss_pred             -----------------CCceeeeccccccEEEcCCCc--eEEecccCcccc
Q 040557          202 -----------------HTRIVHRDIKASNVLLDEKFQ--SKIGDFGLARFF  234 (407)
Q Consensus       202 -----------------~~~i~H~dlk~~Nill~~~~~--~kl~Dfgla~~~  234 (407)
                                       ...++|+|+++.||+++.++.  +.|+||+.+...
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                             245999999999999997753  689999998753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.03  E-value=1e-10  Score=107.32  Aligned_cols=183  Identities=18%  Similarity=0.189  Sum_probs=117.8

Q ss_pred             CCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCc--eeeeeeeeecCC---eeEEEEEe
Q 040557           87 GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKN--LVRLLGCCSDGS---QRLLVYEY  160 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lv~e~  160 (407)
                      .+.++.|....||+..    ..+++|...   .......+.+|.++|+.+ .+..  +.+++.......   ..|+|||+
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~---~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPK---HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEES---SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecC---CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            3568999999999864    458888753   223456788999999887 3333  345555543333   34889999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhcccccc----------------------------------------
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED----------------------------------------  200 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------------------------------------  200 (407)
                      ++|.++.....    ..++...+..++.+++..+..||+.                                        
T Consensus        98 i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           98 IKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             cCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            99988865332    1256666667777777777777751                                        


Q ss_pred             ---------------CCCceeeeccccccEEEcC--CCceEEecccCccccCCCCcccccccccCccc---cCcccccc-
Q 040557          201 ---------------SHTRIVHRDIKASNVLLDE--KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGY---TAPEYAIR-  259 (407)
Q Consensus       201 ---------------~~~~i~H~dlk~~Nill~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y---~aPE~~~~-  259 (407)
                                     ..+.++|+|+++.||++++  +..+.|+||+.+...........     ...+   ..|+.... 
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~-----~~~~~~~~~~~~~~~~  248 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFIS-----LMEDDEEYGMEFVSKI  248 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHT-----TCCTTTSCCHHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHH-----HHhhccccCHHHHHHH
Confidence                           1235899999999999998  55678999999875433211100     0000   12221110 


Q ss_pred             ----CC---------CCccccEEehhHHHHHHHhcCCCC
Q 040557          260 ----GE---------LSEKADIYSFGVLVLEIISCRKNT  285 (407)
Q Consensus       260 ----~~---------~~~k~Dv~s~G~vl~el~tg~~p~  285 (407)
                          +.         .....+.|++|.++|.+.+|..++
T Consensus       249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                00         012258899999999999998653

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.60  E-value=4e-07  Score=83.34  Aligned_cols=136  Identities=18%  Similarity=0.150  Sum_probs=89.7

Q ss_pred             CeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCC---ceeeeeeeee-cCCeeEEEEEeccC
Q 040557           88 NLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHK---NLVRLLGCCS-DGSQRLLVYEYMKN  163 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~  163 (407)
                      +.++.|....||+.    |..+++|...   .......+.+|.++|..+.+.   .+.+++.++. ..+..++||||++|
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPK---SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEES---SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eecCCCcceeEEEE----CCEEEEEecC---CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            45788888899987    5668888742   233456788999999998642   3556666664 44567899999999


Q ss_pred             CChhHHHhccCCCCCCHHHHHHHHHHHHHHhcccccc-------------------------------------------
Q 040557          164 RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED-------------------------------------------  200 (407)
Q Consensus       164 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------------------------------------------  200 (407)
                      .++......    .++......++.+++..|..||+.                                           
T Consensus        98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            887653210    123333333344444443333332                                           


Q ss_pred             --------------CCCceeeeccccccEEEcC---CCc-eEEecccCcccc
Q 040557          201 --------------SHTRIVHRDIKASNVLLDE---KFQ-SKIGDFGLARFF  234 (407)
Q Consensus       201 --------------~~~~i~H~dlk~~Nill~~---~~~-~kl~Dfgla~~~  234 (407)
                                    ..+.++|+|+++.||+++.   ++. +.|+||+.+...
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                          2234799999999999997   455 489999988643

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.60  E-value=2.3e-07  Score=83.30  Aligned_cols=135  Identities=15%  Similarity=0.091  Sum_probs=91.0

Q ss_pred             eeeccCCc-cEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCC-CCceeeeeeeeecCCeeEEEEEeccCCC
Q 040557           89 LLGRGGFG-PVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-HKNLVRLLGCCSDGSQRLLVYEYMKNRS  165 (407)
Q Consensus        89 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  165 (407)
                      .+..|..| .||+.... ++..+++|+-..    .....+.+|...|+.+. +-.+.++++++.+.+..++|||+++|.+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            45556665 58987754 466789997632    23456788999988873 4457788999999999999999999987


Q ss_pred             hhHHHhccCCCCCCHHHHHHHHHHHHHHhcccccc---------------------------------------------
Q 040557          166 LDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED---------------------------------------------  200 (407)
Q Consensus       166 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------------------------------------------  200 (407)
                      +.+......      .....+..+++..+..||+.                                             
T Consensus       107 ~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          107 AFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             ccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            765432110      11122333333333333321                                             


Q ss_pred             ----------CCCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          201 ----------SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       201 ----------~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                                ..+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                      122389999999999999887778999988863

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.40  E-value=3.7e-07  Score=85.40  Aligned_cols=80  Identities=6%  Similarity=-0.024  Sum_probs=53.3

Q ss_pred             Cee-eccCCccEEEEEec-------CCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCC-C--CceeeeeeeeecC---
Q 040557           88 NLL-GRGGFGPVYRGKLA-------DGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQ-H--KNLVRLLGCCSDG---  151 (407)
Q Consensus        88 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~---  151 (407)
                      +.| +.|....+|+....       ++..+++|.......  ......+.+|..++..+. +  ..+.++++++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 77888899988764       267788887643220  001134667888888773 2  3567788877665   


Q ss_pred             CeeEEEEEeccCCChh
Q 040557          152 SQRLLVYEYMKNRSLD  167 (407)
Q Consensus       152 ~~~~lv~e~~~~g~L~  167 (407)
                      +..++||||++|..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3568999999986654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.16  E-value=5.6e-06  Score=78.56  Aligned_cols=75  Identities=12%  Similarity=0.061  Sum_probs=48.1

Q ss_pred             CeeeccCCccEEEEEec-CCcEEEEEEeccccC------hhhHHHHHHHHHHHHcCCC--C-ceeeeeeeeecCCeeEEE
Q 040557           88 NLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS------QQGESEFLSEVRMITSIQH--K-NLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~e~~~l~~l~h--~-niv~l~~~~~~~~~~~lv  157 (407)
                      +.||.|..+.||++... +++.++||.......      .....++..|.+++..+..  + .+.+++.+  +....++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence            46899999999999754 468899998643211      0122356778888887732  3 34455544  34456899


Q ss_pred             EEeccCC
Q 040557          158 YEYMKNR  164 (407)
Q Consensus       158 ~e~~~~g  164 (407)
                      ||++++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.15  E-value=1e-05  Score=74.98  Aligned_cols=138  Identities=19%  Similarity=0.267  Sum_probs=76.5

Q ss_pred             eeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCC--CCceeeeee------eeecCCeeEEEEEe
Q 040557           89 LLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ--HKNLVRLLG------CCSDGSQRLLVYEY  160 (407)
Q Consensus        89 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~------~~~~~~~~~lv~e~  160 (407)
                      .|+.|..+.||+....+| .+++|+...  ..   ..+..|.+++..+.  .-.+.+++.      +....+..+++|||
T Consensus        39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~--~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDSG-AVCLKRIHR--PE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             ECC----CEEEEEEETTE-EEEEEEECS--CH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eccccccCcEEEEEeCCC-CEEEEecCC--CH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            355577889999987554 589998853  22   22334455444442  112333332      12345677899999


Q ss_pred             ccCCChh--------------HHHhccCC------------CCCCHHHHH------------------------------
Q 040557          161 MKNRSLD--------------LLIYGESD------------KFLNWSTRF------------------------------  184 (407)
Q Consensus       161 ~~~g~L~--------------~~l~~~~~------------~~l~~~~~~------------------------------  184 (407)
                      ++|..+.              ..+|....            ..-.|....                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542              01111100            011232210                              


Q ss_pred             -HHHHHHHHHhccccc--------c--CCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          185 -QIILGIARGLQYLHE--------D--SHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       185 -~i~~~i~~~l~~LH~--------~--~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                       .+...+..++.+|+.        .  ....++|+|+++.||+++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence             011123345556653        1  23459999999999999888899999999775

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.13  E-value=1.4e-05  Score=73.02  Aligned_cols=136  Identities=15%  Similarity=0.119  Sum_probs=90.0

Q ss_pred             CeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCC---CCceeeeeeeeecCCeeEEEEEeccCC
Q 040557           88 NLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ---HKNLVRLLGCCSDGSQRLLVYEYMKNR  164 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g  164 (407)
                      +.|+.|....+|+... ++..+++|.....    ....+..|.+.|+.+.   ...+.++++++...+..++||||+++.
T Consensus        42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             EEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            4688999999999986 4678889986422    3456788988888873   366888888888888899999999987


Q ss_pred             ChhH-----------HHhccCC-C-------------------CCCHHHHH---HHHH----------------HHHHH-
Q 040557          165 SLDL-----------LIYGESD-K-------------------FLNWSTRF---QIIL----------------GIARG-  193 (407)
Q Consensus       165 ~L~~-----------~l~~~~~-~-------------------~l~~~~~~---~i~~----------------~i~~~-  193 (407)
                      .+..           .+|.... .                   .-+|....   ++..                .++.. 
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            6521           1222111 0                   12454322   1110                11111 


Q ss_pred             hccccc-cCCCceeeeccccccEEEcCCCceEEeccc
Q 040557          194 LQYLHE-DSHTRIVHRDIKASNVLLDEKFQSKIGDFG  229 (407)
Q Consensus       194 l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  229 (407)
                      ...|.. ...+.++|+|+.+.|++++.++ +.|.|++
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            122321 1246699999999999999887 8899973

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.85  E-value=5.2e-05  Score=68.46  Aligned_cols=75  Identities=25%  Similarity=0.239  Sum_probs=53.3

Q ss_pred             CCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCC-C--CceeeeeeeeecCCeeEEEEEeccC
Q 040557           87 GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-H--KNLVRLLGCCSDGSQRLLVYEYMKN  163 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~lv~e~~~~  163 (407)
                      .+.+|.|..+.||+....||+.|.+|+..... ......|..|.+.|+.+. .  -.+.+++++.    ..++||||+++
T Consensus        20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~   94 (288)
T 3f7w_A           20 VAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDE   94 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCC
T ss_pred             EEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecc
Confidence            45689999999999999999999999864332 222335778999888773 2  2345555542    24789999987


Q ss_pred             CCh
Q 040557          164 RSL  166 (407)
Q Consensus       164 g~L  166 (407)
                      +..
T Consensus        95 ~~~   97 (288)
T 3f7w_A           95 RPP   97 (288)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.80  E-value=7.2e-05  Score=71.47  Aligned_cols=79  Identities=13%  Similarity=0.053  Sum_probs=47.0

Q ss_pred             CceeeeccccccEEEcCCCceEEecccCccccCCCCcccccccccCccccCccccccC---CCCccccEEehhHHHHHHH
Q 040557          203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG---ELSEKADIYSFGVLVLEII  279 (407)
Q Consensus       203 ~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~Dv~s~G~vl~el~  279 (407)
                      ..++|+|++++|||++.++ ++|+||+.+..-.........-..-...|.+|+.....   .-....++.+....+|+.+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  310 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF  310 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence            3499999999999999876 99999999875432211100000011345566544311   1122345557777778777


Q ss_pred             hcC
Q 040557          280 SCR  282 (407)
Q Consensus       280 tg~  282 (407)
                      ++.
T Consensus       311 ~~~  313 (420)
T 2pyw_A          311 NKR  313 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.59  E-value=0.00022  Score=65.77  Aligned_cols=33  Identities=30%  Similarity=0.307  Sum_probs=28.0

Q ss_pred             CceeeeccccccEEEcCC----CceEEecccCccccC
Q 040557          203 TRIVHRDIKASNVLLDEK----FQSKIGDFGLARFFP  235 (407)
Q Consensus       203 ~~i~H~dlk~~Nill~~~----~~~kl~Dfgla~~~~  235 (407)
                      ..++|+|+.+.|||++.+    +.+.|+||+.+..-.
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            359999999999999874    689999999887543

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.56  E-value=0.0004  Score=63.53  Aligned_cols=157  Identities=14%  Similarity=0.120  Sum_probs=83.7

Q ss_pred             cCHHHHHHHhcCCCCCC-----eeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCc--eeee
Q 040557           72 FDFQTLKKATKNFHPGN-----LLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN--LVRL  144 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~~~-----~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l  144 (407)
                      .+.+++......|..+.     .|+.|....+|+....+| .+++|.......   ...+..|..++..+...+  +.++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCcc
Confidence            45566666666666533     356677789999987655 578898754211   123456677666653212  2333


Q ss_pred             eee------eecCCeeEEEEEeccCCChhH--------------HHhccC----CC---CC---CHHHHHHH--------
Q 040557          145 LGC------CSDGSQRLLVYEYMKNRSLDL--------------LIYGES----DK---FL---NWSTRFQI--------  186 (407)
Q Consensus       145 ~~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~----~~---~l---~~~~~~~i--------  186 (407)
                      +..      ....+..+++++|++|..+..              .+|...    ..   ..   .|.....-        
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            321      122356789999998865321              011110    00   01   12221100        


Q ss_pred             ----HHHHHHHhccccc----cCCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          187 ----ILGIARGLQYLHE----DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       187 ----~~~i~~~l~~LH~----~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                          ...+...+..++.    .....++|+|+++.||+++++..+.|+||+.+.
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                0012223333321    112359999999999999987666899998775

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.53  E-value=0.00028  Score=66.11  Aligned_cols=139  Identities=19%  Similarity=0.196  Sum_probs=81.5

Q ss_pred             CeeeccCCccEEEEEec--------CCcEEEEEEeccccChhhHHHHHHHHHHHHcCC-CCceeeeeeeeecCCeeEEEE
Q 040557           88 NLLGRGGFGPVYRGKLA--------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-HKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  158 (407)
                      +.|..|-...+|+....        +++.+++|+.-.  .......+.+|.++++.+. +.-..++++++.+    .+||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            45777888899998864        247889987522  1223445668999888774 3223567776654    2899


Q ss_pred             EeccCCChhHH-----------------HhccC---CCCCC--HHHHHHHHHHHHHH-------------------hcc-
Q 040557          159 EYMKNRSLDLL-----------------IYGES---DKFLN--WSTRFQIILGIARG-------------------LQY-  196 (407)
Q Consensus       159 e~~~~g~L~~~-----------------l~~~~---~~~l~--~~~~~~i~~~i~~~-------------------l~~-  196 (407)
                      ||++|.+|..-                 +|...   .+...  |..+.++..++...                   +.. 
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998655311                 11111   11122  44555555444221                   111 


Q ss_pred             ---cccc-CCCceeeeccccccEEEcCC----CceEEecccCcc
Q 040557          197 ---LHED-SHTRIVHRDIKASNVLLDEK----FQSKIGDFGLAR  232 (407)
Q Consensus       197 ---LH~~-~~~~i~H~dlk~~Nill~~~----~~~kl~Dfgla~  232 (407)
                         |... ....++|+|+.+.||+++.+    +.+.|+||..+.
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence               2111 12359999999999999876    789999998775

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.44  E-value=0.0003  Score=63.85  Aligned_cols=71  Identities=10%  Similarity=0.021  Sum_probs=42.6

Q ss_pred             CCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCce-eeeeeeeecCCeeEEEEEec-cCC
Q 040557           87 GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL-VRLLGCCSDGSQRLLVYEYM-KNR  164 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g  164 (407)
                      .+.|+.|....+|+.     ..+++|+......  ......+|..++..+...++ .+++++.  .+.-++++||+ ++.
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE--EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCcc--ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence            467888999999998     4578887643211  11122467777766632222 4555543  33447899999 654


Q ss_pred             Ch
Q 040557          165 SL  166 (407)
Q Consensus       165 ~L  166 (407)
                      ++
T Consensus        94 ~l   95 (301)
T 3dxq_A           94 TM   95 (301)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.42  E-value=0.00038  Score=66.55  Aligned_cols=72  Identities=21%  Similarity=0.308  Sum_probs=47.8

Q ss_pred             CeeeccCCccEEEEEecC--------CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCce-eeeeeeeecCCeeEEEE
Q 040557           88 NLLGRGGFGPVYRGKLAD--------GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL-VRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  158 (407)
                      +.|+.|....+|+....+        +..+++|+......   ...+.+|..++..+...++ .++++.+.+    .+|+
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            457778889999998753        57889998732111   1345578888887743333 566766543    3899


Q ss_pred             EeccCCCh
Q 040557          159 EYMKNRSL  166 (407)
Q Consensus       159 e~~~~g~L  166 (407)
                      ||++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986444

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.42  E-value=0.0025  Score=58.32  Aligned_cols=157  Identities=14%  Similarity=0.095  Sum_probs=86.1

Q ss_pred             cCHHHHHHHhcCCCC-----CCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCC--Cceeee
Q 040557           72 FDFQTLKKATKNFHP-----GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQH--KNLVRL  144 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l  144 (407)
                      .+.+.+......|.+     ...++ |....||+....+|+.+++|......  .....+..|..++..+..  -.+.++
T Consensus        11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~~   87 (328)
T 1zyl_A           11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAP   87 (328)
T ss_dssp             CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred             CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecce
Confidence            444555544444432     23466 77889999887778789999885321  123455667777776632  224444


Q ss_pred             eee-----eecCCeeEEEEEeccCCChh-----HH---------Hhcc-------CCCCCCHHHH---------------
Q 040557          145 LGC-----CSDGSQRLLVYEYMKNRSLD-----LL---------IYGE-------SDKFLNWSTR---------------  183 (407)
Q Consensus       145 ~~~-----~~~~~~~~lv~e~~~~g~L~-----~~---------l~~~-------~~~~l~~~~~---------------  183 (407)
                      +..     ....+..+++|+|++|..+.     ..         +|..       .....++...               
T Consensus        88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  167 (328)
T 1zyl_A           88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP  167 (328)
T ss_dssp             CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred             eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence            443     12244567899999875432     10         1110       0111222211               


Q ss_pred             -------HHHHHHHHHHhcc-ccccCCCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          184 -------FQIILGIARGLQY-LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       184 -------~~i~~~i~~~l~~-LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                             ...+..++..+.- +.......++|+|+++.||+++ + .+.|+||+.+..
T Consensus       168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                   0111111111211 1111223489999999999999 4 899999987764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.26  E-value=0.00065  Score=65.38  Aligned_cols=73  Identities=11%  Similarity=0.081  Sum_probs=45.7

Q ss_pred             CeeeccCCccEEEEEecC-CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCce-eeeeeeeecCCeeEEEEEeccCCC
Q 040557           88 NLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL-VRLLGCCSDGSQRLLVYEYMKNRS  165 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~  165 (407)
                      +.|+.|-...+|+....+ +..+++|+......  ......+|..++..+...++ .++++++..    .+||||++|.+
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~--~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~  187 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTD--EIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA  187 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CC--SCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChh--hhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence            357778888999998764 47788887632211  11112478888888864444 567776632    25999998755


Q ss_pred             h
Q 040557          166 L  166 (407)
Q Consensus       166 L  166 (407)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.16  E-value=0.00062  Score=63.67  Aligned_cols=73  Identities=14%  Similarity=0.109  Sum_probs=41.8

Q ss_pred             CeeeccCCccEEEEEecC---------CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCc-eeeeeeeeecCCeeEEE
Q 040557           88 NLLGRGGFGPVYRGKLAD---------GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN-LVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv  157 (407)
                      +.|+.|....+|+....+         +..+++|+.....  ........|.+++..+...+ +.++++..  .  -++|
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            356778888999998654         2678888764321  11112356777777764333 34566544  2  2689


Q ss_pred             EEeccCCCh
Q 040557          158 YEYMKNRSL  166 (407)
Q Consensus       158 ~e~~~~g~L  166 (407)
                      |||++|..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.11  E-value=0.0034  Score=57.90  Aligned_cols=31  Identities=29%  Similarity=0.325  Sum_probs=27.5

Q ss_pred             CceeeeccccccEEEcCCCceEEecccCccc
Q 040557          203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       203 ~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      ..++|+|+.+.||++++++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4599999999999999888899999987764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.80  E-value=0.0017  Score=55.07  Aligned_cols=103  Identities=14%  Similarity=0.115  Sum_probs=65.8

Q ss_pred             CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccccc
Q 040557          164 RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST  243 (407)
Q Consensus       164 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  243 (407)
                      -+|.++|... +.+++++++|.++.|.+.+|.-+-....+  ..+=+-|..|++..+|.|.+.+ +.+.           
T Consensus        33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-----------
Confidence            3788888644 46799999999999999998765211111  1222347899999999998764 1110           


Q ss_pred             ccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCC
Q 040557          244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKN  284 (407)
Q Consensus       244 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p  284 (407)
                        .....+.+||... ...+.+.=|||+|+++|.-+--..|
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence              1223466888653 4556788999999999999875443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.26  E-value=0.017  Score=54.76  Aligned_cols=73  Identities=5%  Similarity=0.011  Sum_probs=45.6

Q ss_pred             CeeeccCCccEEEEEecC--------CcEEEEEEeccccChhhHHHHHHHHHHHHcCC-CCceeeeeeeeecCCeeEEEE
Q 040557           88 NLLGRGGFGPVYRGKLAD--------GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-HKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  158 (407)
                      +.+..|-...+|+....+        +..+++++.....  .......+|.++++.+. +.-..++++.+.    -++||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            356667778999998753        5788998863221  11112347777777774 222345555432    27899


Q ss_pred             EeccCCCh
Q 040557          159 EYMKNRSL  166 (407)
Q Consensus       159 e~~~~g~L  166 (407)
                      ||++|..|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998664

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=96.10  E-value=0.0075  Score=35.44  Aligned_cols=30  Identities=10%  Similarity=0.113  Sum_probs=16.4

Q ss_pred             CcCcchhhhHHHHHHHHHHHHHHHHHHHHH
Q 040557            9 DRGLLAALFFFLGVLSVSVILIILIIILWK   38 (407)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~   38 (407)
                      ..+-..+..+++|+++.+++++.+++++||
T Consensus         7 ~ls~GaIAGiVvG~v~gv~li~~l~~~~~r   36 (38)
T 2k1k_A            7 GLTGGEIVAVIFGLLLGAALLLGILVFRSR   36 (38)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCceeeeehHHHHHHHHHHHHHHHHee
Confidence            334445566667766655555545444443

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=95.57  E-value=0.016  Score=35.12  Aligned_cols=28  Identities=11%  Similarity=0.138  Sum_probs=12.8

Q ss_pred             hhhhHHHHHHHHHHHHHHHHHHHHHhch
Q 040557           14 AALFFFLGVLSVSVILIILIIILWKFNK   41 (407)
Q Consensus        14 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~   41 (407)
                      .+++.++|.+++++++++++++++|+++
T Consensus        12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~   39 (44)
T 2ks1_B           12 SIATGMVGALLLLLVVALGIGLFMRRRH   39 (44)
T ss_dssp             SSTHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             eEEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence            3444444444444444444445554443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=94.40  E-value=0.068  Score=32.31  Aligned_cols=27  Identities=15%  Similarity=0.079  Sum_probs=11.6

Q ss_pred             hhhHHHHHHHHHHHHHHHHHHHHHhch
Q 040557           15 ALFFFLGVLSVSVILIILIIILWKFNK   41 (407)
Q Consensus        15 ~~~~~~~~~~~~~~l~~~~~~~~~~~~   41 (407)
                      ++..++|.++++++++++.++++|+++
T Consensus        12 IA~gVVgGv~~v~ii~~~~~~~~RRRr   38 (44)
T 2l2t_A           12 IAAGVIGGLFILVIVGLTFAVYVRRKS   38 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEeehHHHHHHHHHHHHHHHHhhhhh
Confidence            333444434444444444445554443

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=93.05  E-value=0.12  Score=31.10  Aligned_cols=25  Identities=24%  Similarity=0.279  Sum_probs=10.6

Q ss_pred             hhhHHHHHHHHHHHHHHHHHHHHHhc
Q 040557           15 ALFFFLGVLSVSVILIILIIILWKFN   40 (407)
Q Consensus        15 ~~~~~~~~~~~~~~l~~~~~~~~~~~   40 (407)
                      +++.++| +++++++.+++++++|++
T Consensus        14 Ia~~vVG-vll~vi~~l~~~~~~RRR   38 (44)
T 2jwa_A           14 IISAVVG-ILLVVVLGVVFGILIKRR   38 (44)
T ss_dssp             HHHHHHH-HHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHH-HHHHHHHHHHHHhheehh
Confidence            4444555 333333333444444443

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=89.53  E-value=2.2  Score=36.00  Aligned_cols=83  Identities=5%  Similarity=0.037  Sum_probs=61.2

Q ss_pred             CCCceeeeeeeeecCCeeEEEEEeccCC-ChhHHHhccCCCCCCHHHHHHHHHHHHHHhc-cccccCCCceeeecccccc
Q 040557          137 QHKNLVRLLGCCSDGSQRLLVYEYMKNR-SLDLLIYGESDKFLNWSTRFQIILGIARGLQ-YLHEDSHTRIVHRDIKASN  214 (407)
Q Consensus       137 ~h~niv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~i~H~dlk~~N  214 (407)
                      .||++  -..+-.+.+.+.+.++.-+++ ++...      +.++...+++++.+++.... +++.     -+|--|.|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence            57877  334446667777777765433 33322      23788999999999999888 7765     5777899999


Q ss_pred             EEEcCCCceEEecccCcc
Q 040557          215 VLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       215 ill~~~~~~kl~Dfgla~  232 (407)
                      ++++.++.+++.-.|+-.
T Consensus       115 L~f~~~~~p~i~hRGi~~  132 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKE  132 (219)
T ss_dssp             EEECTTCCEEESCCEETT
T ss_pred             EEEeCCCcEEEEEcCCcc
Confidence            999999999998777654

>2knc_B Integrin beta-3; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens}

Probab=88.84  E-value=0.73  Score=31.96  Aligned_cols=22  Identities=18%  Similarity=0.622  Sum_probs=9.8

Q ss_pred             hHHHHHHHHHHHHHHHHHHHHH
Q 040557           17 FFFLGVLSVSVILIILIIILWK   38 (407)
Q Consensus        17 ~~~~~~~~~~~~l~~~~~~~~~   38 (407)
                      .+++|++++++++.++++++|+
T Consensus        12 ~Iv~gvi~gilliGllllliwk   33 (79)
T 2knc_B           12 VVLLSVMGAILLIGLAALLIWK   33 (79)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHHHHHHHHH
Confidence            3444444444444444444443

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=87.60  E-value=1.7  Score=36.56  Aligned_cols=116  Identities=9%  Similarity=0.032  Sum_probs=75.8

Q ss_pred             CCCceeeeeeeeecCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEE
Q 040557          137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVL  216 (407)
Q Consensus       137 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil  216 (407)
                      .||+.+.. .+-.+.+.+.+.++.-+  +...+-.   -+.++...+++++.+|+....+++.     -+|--|.|+|++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~---ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN---IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG---GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH---HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEE
Confidence            68888865 45556666555555443  2222221   2347889999999999998877664     578889999999


Q ss_pred             EcCCCceEEecccCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCC
Q 040557          217 LDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTD  286 (407)
Q Consensus       217 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~  286 (407)
                      ++.++.+++.=.|+-..+.+..                       .+...=.-.+=+++..+++++..|+
T Consensus       112 f~~~~~p~i~~RGik~~l~P~~-----------------------~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNVVDPLP-----------------------VSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             ECTTSCEEESCCEETTTBSCCC-----------------------CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EcCCCCEEEEEccCccCCCCCC-----------------------CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999998776654322211                       0111112245678888888887653

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=86.55  E-value=0.079  Score=50.87  Aligned_cols=61  Identities=10%  Similarity=0.033  Sum_probs=17.3

Q ss_pred             CCCeeeccCCccEEEEEecC-CcEEEE------EEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeee
Q 040557           86 PGNLLGRGGFGPVYRGKLAD-GTLVAV------KKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCS  149 (407)
Q Consensus        86 ~~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  149 (407)
                      +.+.||   ||.||+|.+.. ...|||      |...... ..+....|.+|..++..++|+|+++..++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            345666   99999998753 357888      6654322 2233456888999999999999999887753

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=82.84  E-value=2.2  Score=25.65  Aligned_cols=30  Identities=20%  Similarity=0.275  Sum_probs=19.2

Q ss_pred             hhhhHHHHHHHHHHHHHHHHHHHHHhchhH
Q 040557           14 AALFFFLGVLSVSVILIILIIILWKFNKAK   43 (407)
Q Consensus        14 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~   43 (407)
                      ....++.|++..++++++++..+|.+.|++
T Consensus         8 ~~~aIA~gVVgGv~~v~ii~~~~~~~~RRR   37 (44)
T 2l2t_A            8 RTPLIAAGVIGGLFILVIVGLTFAVYVRRK   37 (44)
T ss_dssp             SSHHHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CcceEEEeehHHHHHHHHHHHHHHHHhhhh
Confidence            344555555555666667777777877766

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=81.96  E-value=0.76  Score=43.06  Aligned_cols=29  Identities=31%  Similarity=0.525  Sum_probs=24.7

Q ss_pred             eeeeccccccEEE------cCCCceEEecccCccc
Q 040557          205 IVHRDIKASNVLL------DEKFQSKIGDFGLARF  233 (407)
Q Consensus       205 i~H~dlk~~Nill------~~~~~~kl~Dfgla~~  233 (407)
                      ++|+|+.+.|||+      +++..+.++||-.|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      4567799999988753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	407
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-70
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-68
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-68
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-67
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-66
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-65
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-63
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-62
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-62
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-61
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-61
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-61
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-60
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-59
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-59
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-58
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-58
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-57
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-57
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-56
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-56
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-56
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-56
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-56
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-56
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-55
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-55
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-54
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-54
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-52
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-52
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-48
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-47
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-46
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-45
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-44
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-44
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-43
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-43
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-43
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-42
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-42
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-42
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-42
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-42
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-41
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-40
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-39
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	8e-38
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-37
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-34
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-33
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-33
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-31
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	9e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-29
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-26
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-25

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (560), Expect = 5e-70
 Identities = 72/274 (26%), Positives = 122/274 (44%), Gaps = 22/274 (8%)

Query: 82  KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
           +       LG G FG V+ G     T VAVK L   +       FL+E  ++  +QH+ L
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRL 70

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
           VRL    +      ++ EYM+N SL   +   S   L  +    +   IA G+ ++ E +
Sbjct: 71  VRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
               +HRD++A+N+L+ +    KI DFGLAR   +++          + +TAPE    G 
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 262 LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEG 321
            + K+D++SFG+L+ EI++  +     +P      PE    L            RM +  
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGR-----IPYPGMTNPEVIQNLER--------GYRMVRPD 233

Query: 322 IVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
               +  Q++    +C +     RP    + ++L
Sbjct: 234 NCPEELYQLMR---LCWKERPEDRPTFDYLRSVL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (545), Expect = 5e-68
 Identities = 75/281 (26%), Positives = 121/281 (43%), Gaps = 22/281 (7%)

Query: 82  KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
                   +G G FG V+ G   +   VA+K +   +    E +F+ E  ++  + H  L
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKL 62

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
           V+L G C + +   LV+E+M++  L   +  +   F    T   + L +  G+ YL E  
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGMAYLEEA- 120

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
              ++HRD+ A N L+ E    K+ DFG+ RF  +DQ   ST     + + +PE      
Sbjct: 121 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178

Query: 262 LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEG 321
            S K+D++SFGVL+ E+ S  K     +P E +   E    +        L  PR+    
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGK-----IPYENRSNSEVVEDI---STGFRLYKPRLAST- 229

Query: 322 IVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESG 362
                   V  +   C +     RP  S ++  L    ESG
Sbjct: 230 -------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG 263

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 9e-68
 Identities = 64/274 (23%), Positives = 122/274 (44%), Gaps = 22/274 (8%)

Query: 82  KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
           K+      LG G FG V  GK      VA+K +   +    E EF+ E +++ ++ H+ L
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI--KEGSMSEDEFIEEAKVMMNLSHEKL 61

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
           V+L G C+      ++ EYM N  L   +     +F       ++   +   ++YL    
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRF-QTQQLLEMCKDVCEAMEYLE--- 117

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
             + +HRD+ A N L++++   K+ DFGL+R+  +D+   S      + ++ PE  +  +
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177

Query: 262 LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEG 321
            S K+DI++FGVL+ EI S  K                 ++ +      E +   +R   
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLY- 221

Query: 322 IVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
                + +V  + + C     ++RP    +++ +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 7e-67
 Identities = 72/274 (26%), Positives = 123/274 (44%), Gaps = 22/274 (8%)

Query: 82  KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
           ++      LG+G FG V+ G     T VA+K L           FL E +++  ++H+ L
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 74

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
           V+L    S+     +V EYM   SL   + GE+ K+L       +   IA G+ Y+    
Sbjct: 75  VQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--- 130

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
               VHRD++A+N+L+ E    K+ DFGLAR   +++          + +TAPE A+ G 
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190

Query: 262 LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEG 321
            + K+D++SFG+L+ E+ +  +            +P       E   +L+ V+   R   
Sbjct: 191 FTIKSDVWSFGILLTELTTKGR------------VPYPGMVNRE---VLDQVERGYRMP- 234

Query: 322 IVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
                   + ++   C +    +RP    + A L
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 1e-66
 Identities = 72/278 (25%), Positives = 125/278 (44%), Gaps = 24/278 (8%)

Query: 83  NFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNL 141
               G  +G G FG VY+GK      VAVK L V   + Q    F +EV ++   +H N+
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
           +  +G  +   Q  +V ++ +  SL   ++    KF        I    A+G+ YLH   
Sbjct: 67  LLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLH--- 121

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYA--- 257
              I+HRD+K++N+ L E    KIGDFGLA               +G++ + APE     
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 258 IRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM 317
            +   S ++D+Y+FG+++ E+++ +      LP       +    +  RG     + P +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGY----LSPDL 231

Query: 318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
            K  +       +  +   CL+   ++RP   +I+A +
Sbjct: 232 SK--VRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  209 bits (532), Expect = 2e-65
 Identities = 69/301 (22%), Positives = 127/301 (42%), Gaps = 37/301 (12%)

Query: 72  FDFQTLKKATKNFHP---------GNLLGRGGFGPVYRGKLA----DGTLVAVKKLCVDK 118
           F F+   +A + F             ++G G FG V  G L         VA+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 119 SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFL 178
           +++   +FLSE  ++    H N++ L G  +  +  +++ E+M+N SLD  +     +F 
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 179 NWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ 238
                  ++ GIA G++YL        VHRD+ A N+L++     K+ DFGL+RF  +D 
Sbjct: 126 TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182

Query: 239 AYL----STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQ 294
           +      +      + +TAPE     + +  +D++S+G+++ E++S  +           
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE----------- 231

Query: 295 YLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAM 354
                 +       ++  ++   R           +  +   C Q   N RP   +IV  
Sbjct: 232 ----RPYWDMTNQDVINAIEQDYRLP-PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 355 L 355
           L
Sbjct: 287 L 287

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 3e-63
 Identities = 75/275 (27%), Positives = 116/275 (42%), Gaps = 28/275 (10%)

Query: 82  KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
           K       +G+G FG V  G    G  VAVK +   K+      FL+E  ++T ++H NL
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI---KNDATAQAFLAEASVMTQLRHSNL 62

Query: 142 VRLLGCCSDGSQRL-LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
           V+LLG   +    L +V EYM   SL   +       L      +  L +   ++YL  +
Sbjct: 63  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122

Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
                VHRD+ A NVL+ E   +K+ DFGL +     Q          + +TAPE     
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREK 175

Query: 261 ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE 320
           + S K+D++SFG+L+ EI S  +     +P     L +   ++ E+G  ++  D      
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVVPRV-EKGYKMDAPDGCPP-- 227

Query: 321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
                    V  V   C       RP   ++   L
Sbjct: 228 --------AVYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 4e-62
 Identities = 60/305 (19%), Positives = 123/305 (40%), Gaps = 40/305 (13%)

Query: 77  LKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITS 135
           ++    +F   + LG G  G V++      G ++A K + ++      ++ + E++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 136 IQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQ 195
                +V   G      +  +  E+M   SLD ++       +      ++ + + +GL 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLT 118

Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPE 255
           YL E    +I+HRD+K SN+L++ + + K+ DFG++    +     + +F GT  Y +PE
Sbjct: 119 YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPE 173

Query: 256 YAIRGELSEKADIYSFGVLVLEIISCR-----------------------KNTDLTLPSE 292
                  S ++DI+S G+ ++E+   R                         T     + 
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233

Query: 293 MQYLPEYAWKLYERGRILELVD------PRMRKEGIVERDALQVINVAFICLQPHGNQRP 346
            + L  Y         I EL+D      P     G+   +    +N    CL  +  +R 
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN---KCLIKNPAERA 290

Query: 347 PMSEI 351
            + ++
Sbjct: 291 DLKQL 295

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  199 bits (507), Expect = 5e-62
 Identities = 70/275 (25%), Positives = 119/275 (43%), Gaps = 22/275 (8%)

Query: 82  KNFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
            +    + LG G +G VY G        VAVK L   +      EFL E  ++  I+H N
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPN 74

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
           LV+LLG C+      ++ E+M   +L   +   + + ++      +   I+  ++YL + 
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134

Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
                +HRD+ A N L+ E    K+ DFGL+R    D           + +TAPE     
Sbjct: 135 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 191

Query: 261 ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE 320
           + S K+D+++FGVL+ EI +   +                +   +  ++ EL++   R E
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSP---------------YPGIDLSQVYELLEKDYRME 236

Query: 321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
              E    +V  +   C Q + + RP  +EI    
Sbjct: 237 -RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 3e-61
 Identities = 80/323 (24%), Positives = 126/323 (39%), Gaps = 53/323 (16%)

Query: 71  YFDFQTLKKATK------NFHPGNLLGRGGFGPVYRG------KLADGTLVAVKKLCVDK 118
           Y DF+  +   K      N   G +LG G FG V         K      VAVK L    
Sbjct: 20  YVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA 79

Query: 119 SQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF 177
                   +SE++M+T +  H+N+V LLG C+      L++EY     L   +  + +KF
Sbjct: 80  DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKF 139

Query: 178 ---------------------LNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVL 216
                                L +         +A+G+++L        VHRD+ A NVL
Sbjct: 140 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVL 196

Query: 217 LDEKFQSKIGDFGLARFFPEDQAYLS-TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLV 275
           +      KI DFGLAR    D  Y+   N    + + APE    G  + K+D++S+G+L+
Sbjct: 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 256

Query: 276 LEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAF 335
            EI S         P     +    +KL + G        +M +      +   ++    
Sbjct: 257 WEIFSLGV-----NPYPGIPVDANFYKLIQNG-------FKMDQPFYATEEIYIIMQS-- 302

Query: 336 ICLQPHGNQRPPMSEIVAMLTCK 358
            C      +RP    + + L C+
Sbjct: 303 -CWAFDSRKRPSFPNLTSFLGCQ 324

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 5e-61
 Identities = 63/302 (20%), Positives = 116/302 (38%), Gaps = 29/302 (9%)

Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
              +G+G FG V+RGK   G  VAVK       ++      +E+     ++H+N++  + 
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIF--SSREERSWFREAEIYQTVMLRHENILGFIA 64

Query: 147 CCSDG----SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED-- 200
             +      +Q  LV +Y ++ SL   +   +   +      ++ L  A GL +LH +  
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIV 121

Query: 201 ---SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS---TNFAGTLGYTAP 254
                  I HRD+K+ N+L+ +     I D GLA         +     +  GT  Y AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 255 EY------AIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQY----LPEYAWKLY 304
           E           E  ++ADIY+ G++  EI        +    ++ Y      + + +  
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 305 ERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT-CKVESGI 363
            +    + + P +            +  +   C   +G  R     I   L+    + GI
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301

Query: 364 PV 365
            +
Sbjct: 302 KM 303

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 7e-61
 Identities = 66/280 (23%), Positives = 124/280 (44%), Gaps = 27/280 (9%)

Query: 83  NFHPGNLLGRGGFGPVYRGKLADGT-----LVAVKKLCVDKSQQGESEFLSEVRMITSIQ 137
                 ++G G FG VY+G L   +      VA+K L    +++   +FL E  ++    
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYL 197
           H N++RL G  S     +++ EYM+N +       E D   +      ++ GIA G++YL
Sbjct: 68  HHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST--NFAGTLGYTAPE 255
               +   VHRD+ A N+L++     K+ DFGL+R   +D     T       + +TAPE
Sbjct: 127 A---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 256 YAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP 315
                + +  +D++SFG+++ E+++  +     L +                 +++ ++ 
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---------------EVMKAIND 228

Query: 316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
             R           +  +   C Q    +RP  ++IV++L
Sbjct: 229 GFRLP-TPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  195 bits (496), Expect = 4e-60
 Identities = 72/312 (23%), Positives = 118/312 (37%), Gaps = 48/312 (15%)

Query: 73  DFQTLKKATKNFHPGNLLGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEF 126
              +L+    N      +G G FG V++ +          T+VAVK L  + S   +++F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 127 LSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGES------------ 174
             E  ++    + N+V+LLG C+ G    L++EYM    L+  +   S            
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 175 ----------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSK 224
                        L+ + +  I   +A G+ YL      + VHRD+   N L+ E    K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVK 180

Query: 225 IGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRK 283
           I DFGL+R       Y    N A  + +  PE       + ++D++++GV++ EI S   
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 284 NTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGN 343
                         E        G IL             E   L++ N+  +C      
Sbjct: 241 ------QPYYGMAHEEVIYYVRDGNILA----------CPENCPLELYNLMRLCWSKLPA 284

Query: 344 QRPPMSEIVAML 355
            RP    I  +L
Sbjct: 285 DRPSFCSIHRIL 296

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 3e-59
 Identities = 66/297 (22%), Positives = 115/297 (38%), Gaps = 42/297 (14%)

Query: 83  NFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSI 136
               G  LG G FG V                VAVK L            +SE+++++ +
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 137 -QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF----------------LN 179
             H N+V LLG C+ G   L++ EY     L   +  + D F                L+
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 180 WSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA 239
                     +A+G+ +L        +HRD+ A N+LL     +KI DFGLAR    D  
Sbjct: 144 LEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 240 Y-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPE 298
           Y +  N    + + APE       + ++D++S+G+ + E+ S   +    +P + +    
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---- 256

Query: 299 YAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
                       +++    R     E    ++ ++   C      +RP   +IV ++
Sbjct: 257 ----------FYKMIKEGFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 4e-59
 Identities = 79/280 (28%), Positives = 120/280 (42%), Gaps = 28/280 (10%)

Query: 85  HPGNLLGRGGFGPVYRGKLAD----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           H   ++GRG FG VY G L D        AVK L         S+FL+E  ++    H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89

Query: 141 LVRLLGCCSDG-SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
           ++ LLG C       L+V  YMK+  L   I  E+             L +A+G+++L  
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLA- 147

Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL---STNFAGTLGYTAPEY 256
               + VHRD+ A N +LDEKF  K+ DFGLAR   + +       T     + + A E 
Sbjct: 148 --SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205

Query: 257 AIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR 316
               + + K+D++SFGVL+ E+++         P       +    L +  R+L      
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLLQGRRLL------ 254

Query: 317 MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
                  E     +  V   C  P    RP  SE+V+ ++
Sbjct: 255 -----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 1e-58
 Identities = 66/271 (24%), Positives = 117/271 (43%), Gaps = 26/271 (9%)

Query: 90  LGRGGFGPVYRGKLA---DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLG 146
           LG G FG V +G          VA+K L     +    E + E +++  + +  +VRL+G
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 147 CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIV 206
            C      +LV E      L   + G+ ++ +  S   +++  ++ G++YL        V
Sbjct: 77  VC-QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLE---EKNFV 131

Query: 207 HRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLS--TNFAGTLGYTAPEYAIRGELSE 264
           HRD+ A NVLL  +  +KI DFGL++    D +Y +  +     L + APE     + S 
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191

Query: 265 KADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVE 324
           ++D++S+GV + E +S  +      P +    PE    + E+G+ +E   P    E    
Sbjct: 192 RSDVWSYGVTMWEALSYGQ-----KPYKKMKGPEVMAFI-EQGKRMEC-PPECPPE---- 240

Query: 325 RDALQVINVAFICLQPHGNQRPPMSEIVAML 355
                +  +   C       RP    +   +
Sbjct: 241 -----LYALMSDCWIYKWEDRPDFLTVEQRM 266

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 4e-58
 Identities = 68/274 (24%), Positives = 116/274 (42%), Gaps = 28/274 (10%)

Query: 88  NLLGRGGFGPVYRGKLAD---GTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNLVR 143
             LG G FG V +G          VAVK L  + +    + E L+E  ++  + +  +VR
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 144 LLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHT 203
           ++G C   S  +LV E  +   L+  +    ++ +      +++  ++ G++YL     +
Sbjct: 73  MIGICEAES-WMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---ES 126

Query: 204 RIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTN--FAGTLGYTAPEYAIRGE 261
             VHRD+ A NVLL  +  +KI DFGL++    D+ Y          + + APE     +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 262 LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEG 321
            S K+D++SFGVL+ E  S  +      P       E    L +          RM    
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSEVTAMLEK--------GERMGCPA 233

Query: 322 IVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
              R+   ++N   +C       RP  + +   L
Sbjct: 234 GCPREMYDLMN---LCWTYDVENRPGFAAVELRL 264

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 3e-57
 Identities = 71/278 (25%), Positives = 121/278 (43%), Gaps = 26/278 (9%)

Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESE-FLSEVRMITSIQHKN 140
           ++     +G G +G   + +  +DG ++  K+L      + E +  +SEV ++  ++H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 141 LVRLLGCCSDGSQRLL--VYEYMKNRSLDLLI--YGESDKFLNWSTRFQIILGIARGLQY 196
           +VR      D +   L  V EY +   L  +I    +  ++L+     +++  +   L+ 
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 197 LHE--DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
            H   D    ++HRD+K +NV LD K   K+GDFGLAR    D ++    F GT  Y +P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSP 183

Query: 255 EYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD 314
           E   R   +EK+DI+S G L+ E+ +         P       E A K+ E         
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAGKIRE--------G 229

Query: 315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIV 352
              R       +  ++I      L      RP + EI+
Sbjct: 230 KFRRIPYRYSDELNEIITR---MLNLKDYHRPSVEEIL 264

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (472), Expect = 6e-57
 Identities = 66/273 (24%), Positives = 112/273 (41%), Gaps = 23/273 (8%)

Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN 140
           +++     LG G +G V           VAVK + + ++         E+ +   + H+N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
           +V+  G   +G+ + L  EY     L   I  E D  +      +    +  G+ YLH  
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 120

Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPEYAIR 259
               I HRDIK  N+LLDE+   KI DFGLA  F   ++  L     GTL Y APE   R
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179

Query: 260 GEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR 318
            E  +E  D++S G+++  +++     D    S  +Y               +     + 
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------------SDWKEKKTYLN 227

Query: 319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEI 351
               ++   L +++     L  + + R  + +I
Sbjct: 228 PWKKIDSAPLALLH---KILVENPSARITIPDI 257

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 3e-56
 Identities = 65/278 (23%), Positives = 111/278 (39%), Gaps = 27/278 (9%)

Query: 84  FHPGNLLGRGGFGPVYRGKLAD-----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
           F    +LG G FG VY+G            VA+K+L    S +   E L E  ++ S+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLH 198
            ++ RLLG C   + +L+         LD     E    +         + IA+G+ YL 
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYLE 128

Query: 199 EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLGYTAPEYA 257
                R+VHRD+ A NVL+      KI DFGLA+    E++ Y +      + + A E  
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185

Query: 258 IRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM 317
           +    + ++D++S+GV V E+++                    +       I  +++   
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGS---------------KPYDGIPASEISSILEKGE 230

Query: 318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
           R         + V  +   C     + RP   E++   
Sbjct: 231 RLP-QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  185 bits (471), Expect = 3e-56
 Identities = 73/278 (26%), Positives = 112/278 (40%), Gaps = 32/278 (11%)

Query: 81  TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGES--EFLSEVRMITSIQ 137
            K F     +G G FG VY  + + +  +VA+KK+     Q  E   + + EVR +  ++
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYL 197
           H N ++  GC        LV EY    + DLL   +  K L       +  G  +GL YL
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYL 131

Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYA 257
           H      ++HRD+KA N+LL E    K+GDFG A          + +F GT  + APE  
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVI 183

Query: 258 I---RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD 314
           +    G+   K D++S G+  +E+   +            Y             I +   
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------------HIAQNES 231

Query: 315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIV 352
           P ++     E       N    CLQ     RP    ++
Sbjct: 232 PALQSGHWSE----YFRNFVDSCLQKIPQDRPTSEVLL 265

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 5e-56
 Identities = 68/274 (24%), Positives = 112/274 (40%), Gaps = 29/274 (10%)

Query: 82  KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQH 138
           ++F  G  LG+G FG VY  +      ++A+K L   +      E +   EV + + ++H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLH 198
            N++RL G   D ++  L+ EY    ++   +  +     +       I  +A  L Y H
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCH 123

Query: 199 EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI 258
                R++HRDIK  N+LL    + KI DFG +   P  +        GTL Y  PE   
Sbjct: 124 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIE 177

Query: 259 RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR 318
                EK D++S GVL  E +  +   +     E      Y           + V    R
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-----YKRISRVEFTFPDFVTEGAR 232

Query: 319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIV 352
              ++ R            L+ + +QRP + E++
Sbjct: 233 D--LISR-----------LLKHNPSQRPMLREVL 253

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 5e-56
 Identities = 63/292 (21%), Positives = 117/292 (40%), Gaps = 39/292 (13%)

Query: 82  KNFHPGNLLGRGGFGPVYRGKLADGTL---VAVKKLCVDKSQQGESEFLSEVRMITSI-Q 137
            +    +++G G FG V + ++    L    A+K++    S+    +F  E+ ++  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYG--------------ESDKFLNWSTR 183
           H N++ LLG C       L  EY  + +L   +                 +   L+    
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 184 FQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLST 243
                 +ARG+ YL +    + +HRD+ A N+L+ E + +KI DFGL+R          T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184

Query: 244 NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKL 303
                + + A E       +  +D++S+GVL+ EI+S         P       E   KL
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTCAELYEKL 239

Query: 304 YERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
            +          R+ K    + +   ++     C +    +RP  ++I+  L
Sbjct: 240 PQ--------GYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSL 280

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 6e-56
 Identities = 63/291 (21%), Positives = 120/291 (41%), Gaps = 27/291 (9%)

Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
            +     LG G FG VY+ +      L A K +   KS++   +++ E+ ++ S  H N+
Sbjct: 13  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT-KSEEELEDYMVEIDILASCDHPNI 71

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
           V+LL      +   ++ E+    ++D ++  E ++ L  S    +       L YLH+  
Sbjct: 72  VKLLDAFYYENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQTLDALNYLHD-- 128

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI--- 258
             +I+HRD+KA N+L       K+ DFG++           + F GT  + APE  +   
Sbjct: 129 -NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMCET 186

Query: 259 --RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR 316
                   KAD++S G+ ++E+           P  +              +I +   P 
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL------------KIAKSEPPT 234

Query: 317 MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVRP 367
           + +      +    +     CL+ + + R   S+++      V+S  P+R 
Sbjct: 235 LAQPSRWSSNFKDFLKK---CLEKNVDARWTTSQLLQHPFVTVDSNKPIRE 282

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 9e-56
 Identities = 74/283 (26%), Positives = 112/283 (39%), Gaps = 28/283 (9%)

Query: 82  KNFHPGNLLGRGGFGPVYRGKL----ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITS 135
           K+      LG G FG V RG+          VAVK L  D     +   +F+ EV  + S
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 136 IQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQ 195
           + H+NL+RL G       + +V E     SL   +      FL   T  +  + +A G+ 
Sbjct: 68  LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMG 125

Query: 196 YLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY--LSTNFAGTLGYTA 253
           YL      R +HRD+ A N+LL  +   KIGDFGL R  P++  +  +  +      + A
Sbjct: 126 YLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182

Query: 254 PEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           PE       S  +D + FGV + E+ +  +      P       +   K+ + G  L   
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGERLP-- 235

Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
               R E   +     + NV   C       RP    +   L 
Sbjct: 236 ----RPEDCPQ----DIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 2e-55
 Identities = 63/273 (23%), Positives = 107/273 (39%), Gaps = 29/273 (10%)

Query: 87  GNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRL 144
              +GRG F  VY+G   +    VA  +L   K ++     F  E  M+  +QH N+VR 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 145 LGCCSDGSQR----LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
                   +     +LV E M + +L   +  +  K +           I +GLQ+LH  
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 201 SHTRIVHRDIKASNVLL-DEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
           +   I+HRD+K  N+ +       KIGD GLA          +    GT  + APE    
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEM-YE 186

Query: 260 GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK 319
            +  E  D+Y+FG+ +LE+ +         P          ++    G      D     
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSE------YPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240

Query: 320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIV 352
           E         V  +   C++ + ++R  + +++
Sbjct: 241 E---------VKEIIEGCIRQNKDERYSIKDLL 264

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 3e-55
 Identities = 61/278 (21%), Positives = 105/278 (37%), Gaps = 25/278 (8%)

Query: 83  NFHPGNLLGRGGFGPVYRGKLAD----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQH 138
               G  +G G FG V++G           VA+K      S     +FL E   +    H
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67

Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLH 198
            ++V+L+G  ++     ++ E      L   +       L+ ++       ++  L YL 
Sbjct: 68  PHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLE 125

Query: 199 EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI 258
                R VHRDI A NVL+      K+GDFGL+R+  +   Y ++     + + APE   
Sbjct: 126 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182

Query: 259 RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR 318
               +  +D++ FGV + EI+                         E G  L +  P   
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGV------KPFQGVKNNDVIGRIENGERLPM-PPNCP 235

Query: 319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT 356
                      + ++   C     ++RP  +E+ A L+
Sbjct: 236 PT---------LYSLMTKCWAYDPSRRPRFTELKAQLS 264

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 2e-54
 Identities = 74/296 (25%), Positives = 120/296 (40%), Gaps = 34/296 (11%)

Query: 82  KNFHPGNLLGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITS 135
           +       LG+G FG VY G           T VA+K +    S +   EFL+E  ++  
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 136 IQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKF--------LNWSTRFQII 187
               ++VRLLG  S G   L++ E M    L   +                + S   Q+ 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 188 LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL-STNFA 246
             IA G+ YL+ +   + VHRD+ A N ++ E F  KIGDFG+ R   E   Y       
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER 306
             + + +PE    G  +  +D++SFGV++ EI +  +              E   +    
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE------QPYQGLSNEQVLRFVME 250

Query: 307 GRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESG 362
           G +L+  D               +  +  +C Q +   RP   EI++ +  ++E G
Sbjct: 251 GGLLDKPDNCPD----------MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 8e-54
 Identities = 61/272 (22%), Positives = 112/272 (41%), Gaps = 24/272 (8%)

Query: 81  TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHK 139
            K +     +G+G  G VY    +A G  VA++++ + +  + E   ++E+ ++   ++ 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNP 77

Query: 140 NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
           N+V  L     G +  +V EY+   SL  ++    +  ++      +     + L++LH 
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHS 134

Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
               +++HRDIK+ N+LL      K+ DFG       +Q+  ST   GT  + APE   R
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTR 190

Query: 260 GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK 319
                K DI+S G++ +E+I          P    Y             I     P ++ 
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------------LIATNGTPELQN 238

Query: 320 EGIVERDALQVINVAFICLQPHGNQRPPMSEI 351
              +       +N    CL     +R    E+
Sbjct: 239 PEKLSAIFRDFLN---RCLDMDVEKRGSAKEL 267

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 5e-52
 Identities = 75/296 (25%), Positives = 117/296 (39%), Gaps = 41/296 (13%)

Query: 83  NFHPGNLLGRGGFGPVYRG------KLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI 136
               G  LGRG FG V         K A    VAVK L    +       +SE++++  I
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 137 QHKNLVRLLG--CCSDGSQRLLVYEYMKNRSLDLLIYGESDKF--------------LNW 180
            H   V  L   C   G   +++ E+ K  +L   +  + ++F              L  
Sbjct: 74  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133

Query: 181 STRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY 240
                    +A+G+++L      + +HRD+ A N+LL EK   KI DFGLAR   +D  Y
Sbjct: 134 EHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190

Query: 241 L-STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEY 299
           +   +    L + APE       + ++D++SFGVL+ EI S         P     + E 
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDEE 245

Query: 300 AWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
             +  + G  +   D              ++      C     +QRP  SE+V  L
Sbjct: 246 FCRRLKEGTRMRAPDYTTP----------EMYQTMLDCWHGEPSQRPTFSELVEHL 291

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 6e-52
 Identities = 76/297 (25%), Positives = 123/297 (41%), Gaps = 43/297 (14%)

Query: 83  NFHPGNLLGRGGFGPVYRGKL--------ADGTLVAVKKLCVDKSQQGESEFLSEVRMIT 134
               G  LG G FG V   +            T VAVK L  D +++  S+ +SE+ M+ 
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73

Query: 135 SI-QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIY--------------GESDKFLN 179
            I +HKN++ LLG C+      ++ EY    +L   +                  ++ L+
Sbjct: 74  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 180 WSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA 239
                     +ARG++YL      + +HRD+ A NVL+ E    KI DFGLAR       
Sbjct: 134 SKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190

Query: 240 YLST-NFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPE 298
           Y  T N    + + APE       + ++D++SFGVL+ EI +   +    +P       E
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------VE 244

Query: 299 YAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAML 355
             +KL + G  ++                 ++  +   C     +QRP   ++V  L
Sbjct: 245 ELFKLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 1e-48
 Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 9/212 (4%)

Query: 75  QTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDK--SQQGESEFLSEVR 131
           Q  KK  ++F  G +LG G F  V   + LA     A+K L       +        E  
Sbjct: 1   QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60

Query: 132 MITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIA 191
           +++ + H   V+L     D  +      Y KN  L   I        + +        I 
Sbjct: 61  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIV 118

Query: 192 RGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF-PEDQAYLSTNFAGTLG 250
             L+YLH      I+HRD+K  N+LL+E    +I DFG A+   PE +   + +F GT  
Sbjct: 119 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175

Query: 251 YTAPEYAIRGELSEKADIYSFGVLVLEIISCR 282
           Y +PE        + +D+++ G ++ ++++  
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 207

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  162 bits (412), Expect = 3e-47
 Identities = 62/272 (22%), Positives = 110/272 (40%), Gaps = 24/272 (8%)

Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
           ++     LG G FG V+R    A G   A K + +   +  +     E++ ++ ++H  L
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFV-MTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
           V L     D ++ +++YE+M    L   +  E +K ++     + +  + +GL ++HE+ 
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHEN- 143

Query: 202 HTRIVHRDIKASNVLLDEKFQS--KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
               VH D+K  N++   K  +  K+ DFGL       Q+   T   GT  + APE A  
Sbjct: 144 --NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEG 199

Query: 260 GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK 319
             +    D++S GVL   ++S         P    +  E   +     +  +        
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGL------SP----FGGENDDETLRNVKSCDWNMDDSAF 249

Query: 320 EGIVERDALQVINVAFICLQPHGNQRPPMSEI 351
            GI E D    I      L    N R  + + 
Sbjct: 250 SGISE-DGKDFIRK---LLLADPNTRMTIHQA 277

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  161 bits (407), Expect = 2e-46
 Identities = 65/278 (23%), Positives = 112/278 (40%), Gaps = 30/278 (10%)

Query: 83  NFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVD--KSQQGESEFLSEVRMIT---SI 136
           +F    ++GRGGFG VY  + AD G + A+K L     K +QGE+  L+E  M++   + 
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
               +V +        +   + + M    L   +        + +        I  GL++
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEH 122

Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEY 256
           +H      +V+RD+K +N+LLDE    +I D GLA  F + + +      GT GY APE 
Sbjct: 123 MHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEV 176

Query: 257 AIRGE-LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP 315
             +G      AD +S G ++ +++            +   +      L     + +   P
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--DRMTLTMAVELPDSFSP 234

Query: 316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVA 353
            +R   ++E             LQ   N+R       A
Sbjct: 235 ELRS--LLEG-----------LLQRDVNRRLGCLGRGA 259

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (393), Expect = 6e-45
 Identities = 54/279 (19%), Positives = 99/279 (35%), Gaps = 19/279 (6%)

Query: 74  FQTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRM 132
           ++  +     +   ++LG G F  V   +      LVA+K +     +  E    +E+ +
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 133 ITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR 192
           +  I+H N+V L      G    L+ + +    L   I      F       ++I  +  
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLD 118

Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
            ++YLH+        +        LDE  +  I DFGL++          +   GT GY 
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL--STACGTPGYV 176

Query: 253 APEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL 312
           APE   +   S+  D +S GV+   ++               +  E   KL+E+    E 
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGY----------PPFYDENDAKLFEQILKAEY 226

Query: 313 VDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEI 351
                  + I +  A   I      ++    +R    + 
Sbjct: 227 EFDSPYWDDISD-SAKDFIR---HLMEKDPEKRFTCEQA 261

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  153 bits (387), Expect = 2e-44
 Identities = 65/281 (23%), Positives = 117/281 (41%), Gaps = 17/281 (6%)

Query: 83  NFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHKNL 141
            +H    +G G +G VY+ +   G   A+KK+ ++K  +G  S  + E+ ++  ++H N+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
           V+L        + +LV+E++      LL   E    L   T    +L +  G+ Y H+  
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHD-- 118

Query: 202 HTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGE 261
             R++HRD+K  N+L++ + + KI DFGLAR F       +                  +
Sbjct: 119 -RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177

Query: 262 LSEKADIYSFGVLVLEIISCR-----KNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR 316
            S   DI+S G +  E+++        +    L    + L     K +     L   DP 
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237

Query: 317 M-RKEGIVERDALQVINVAFI-----CLQPHGNQRPPMSEI 351
               E +     L+ ++ + I      L+   NQR    + 
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  155 bits (393), Expect = 2e-44
 Identities = 58/272 (21%), Positives = 103/272 (37%), Gaps = 24/272 (8%)

Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
            +     LG G FG V+R    A G +   K +        +    +E+ ++  + H  L
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHHPKL 88

Query: 142 VRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
           + L     D  + +L+ E++    L   I  E  K ++ +     +     GL+++HE  
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE-- 145

Query: 202 HTRIVHRDIKASNVLLDEKFQS--KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
              IVH DIK  N++ + K  S  KI DFGLA     D+  +      T  + APE   R
Sbjct: 146 -HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDR 202

Query: 260 GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK 319
             +    D+++ GVL   ++S              +  E   +  +  +  +        
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGL----------SPFAGEDDLETLQNVKRCDWEFDEDAF 252

Query: 320 EGIVERDALQVINVAFICLQPHGNQRPPMSEI 351
             +   +A   I      LQ    +R  + + 
Sbjct: 253 SSVSP-EAKDFIKN---LLQKEPRKRLTVHDA 280

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 2e-43
 Identities = 60/292 (20%), Positives = 118/292 (40%), Gaps = 24/292 (8%)

Query: 79  KATKNFHPGNLLGRGGFGPVYRGK--LADGTLVAVKKLCVDKSQQGESE----FLSEVRM 132
           +A + +     +G G +G V++ +     G  VA+K++ V   ++G        ++ +R 
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 133 ITSIQHKNLVRLLGCCSDGSQRLLVYEYMKNRSLD----LLIYGESDKFLNWSTRFQIIL 188
           + + +H N+VRL   C+           +    +D      +    +  +   T   ++ 
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 189 GIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGT 248
            + RGL +LH     R+VHRD+K  N+L+    Q K+ DFGLAR +    A   T+   T
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVT 178

Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIISCR-----KNTDLTLPSEMQYLPEYAWKL 303
           L Y APE  ++   +   D++S G +  E+   +      +    L   +  +     + 
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 304 YERGRILELVDPRMRKEGIVERDALQVINVA--FI--CLQPHGNQRPPMSEI 351
           + R   L       +    +E+    +  +    +  CL  +  +R      
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  151 bits (382), Expect = 2e-43
 Identities = 57/313 (18%), Positives = 110/313 (35%), Gaps = 39/313 (12%)

Query: 84  FHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           +  G  +G G FG +Y G  +A G  VA+K  CV        +   E ++   +Q    +
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP---QLHIESKIYKMMQGGVGI 65

Query: 143 RLLG-CCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS 201
             +  C ++G   ++V E +     DL  +    +  +  T   +   +   ++Y+H   
Sbjct: 66  PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHS-- 121

Query: 202 HTRIVHRDIKASNVL---LDEKFQSKIGDFGLARFFPEDQAY------LSTNFAGTLGYT 252
               +HRD+K  N L     +     I DFGLA+ + + + +       + N  GT  Y 
Sbjct: 122 -KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 253 APEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILEL 312
           +    +  E S + D+ S G +++                         + YER    ++
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGS-------LPWQGLKAATKRQKYERISEKKM 233

Query: 313 VDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVRPAYLER 372
             P          +    +N    C     + +P  S +  +           R  +  +
Sbjct: 234 STPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLF----------RNLFHRQ 280

Query: 373 RRKRDETLSWDTI 385
               D    W+ +
Sbjct: 281 GFSYDYVFDWNML 293

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  149 bits (377), Expect = 6e-43
 Identities = 65/297 (21%), Positives = 121/297 (40%), Gaps = 30/297 (10%)

Query: 76  TLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGES--EFLSEVRM 132
           T    +  +  G +LG GG   V+  + L     VAVK L  D ++       F  E + 
Sbjct: 1   TPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQN 60

Query: 133 ITSIQHKNLVRLLGCCSD----GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIIL 188
             ++ H  +V +          G    +V EY+   +L  +++  ++  +      ++I 
Sbjct: 61  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIA 118

Query: 189 GIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL--STNFA 246
              + L + H+     I+HRD+K +N+++      K+ DFG+AR   +    +  +    
Sbjct: 119 DACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175

Query: 247 GTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER 306
           GT  Y +PE A    +  ++D+YS G ++ E+++         P         A++    
Sbjct: 176 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHVRE 229

Query: 307 GRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPP-MSEIVAMLTCKVESG 362
             I     P  R EG+   D   V+      L  +   R    +E+ A L  +V +G
Sbjct: 230 DPI----PPSARHEGLSA-DLDAVVLK---ALAKNPENRYQTAAEMRADLV-RVHNG 277

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (378), Expect = 8e-43
 Identities = 61/283 (21%), Positives = 113/283 (39%), Gaps = 22/283 (7%)

Query: 88  NLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESE----FLSEVRMITSIQHKNLV 142
           + LG G F  VY+ +      +VA+KK+ +    + +       L E++++  + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 143 RLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSH 202
            LL      S   LV+++M+     ++   ++   L  S     +L   +GL+YLH+   
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119

Query: 203 TRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL 262
             I+HRD+K +N+LLDE    K+ DFGLA+ F        T+   T  Y APE      +
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARM 177

Query: 263 -SEKADIYSFGVLVLEIISCR-----KNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR 316
                D+++ G ++ E++         +    L    + L     + +     L      
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237

Query: 317 MRKEGIVERDALQVINVAFI-----CLQPHGNQRPPMSEIVAM 354
               GI             +         +   R   ++ + M
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  150 bits (379), Expect = 9e-43
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 12/205 (5%)

Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQH 138
           ++F     LG G FG V+  +   +G   A+K L  +     +       E  M++ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLH 198
             ++R+ G   D  Q  ++ +Y++   L  L+          +        +   L+YLH
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF--YAAEVCLALEYLH 121

Query: 199 EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI 258
                 I++RD+K  N+LLD+    KI DFG A++ P+          GT  Y APE   
Sbjct: 122 SK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVS 174

Query: 259 RGELSEKADIYSFGVLVLEIISCRK 283
               ++  D +SFG+L+ E+++   
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYT 199

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 2e-42
 Identities = 55/289 (19%), Positives = 110/289 (38%), Gaps = 21/289 (7%)

Query: 81  TKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHK 139
              +   + +G G +G V       +   VA+KK+   + Q      L E++++   +H+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 140 NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGE-SDKFLNWSTRFQIILGIARGLQYLH 198
           N++ +       +   +   Y+    +   +Y     + L+       +  I RGL+Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 199 EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY--LSTNFAGTLGYTAPEY 256
                 ++HRD+K SN+LL+     KI DFGLAR    D  +    T +  T  Y APE 
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 257 AIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYL--------PEYAWKLYERG 307
            +  +  ++  DI+S G ++ E++S R         +             +         
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 308 RILELVDPRMRKEGIVERDALQVINVAFI-----CLQPHGNQRPPMSEI 351
           +    +     K  +         +   +      L  + ++R  + + 
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 2e-42
 Identities = 58/277 (20%), Positives = 101/277 (36%), Gaps = 25/277 (9%)

Query: 78  KKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI 136
           K+  + +     LGRG FG V+R    +       K   V      +     E+ ++   
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKF--VKVKGTDQVLVKKEISILNIA 58

Query: 137 QHKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQY 196
           +H+N++ L        + ++++E++    +   I   S   LN       +  +   LQ+
Sbjct: 59  RHRNILHLHESFESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQF 117

Query: 197 LHEDSHTRIVHRDIKASNVLLDEKFQS--KIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           LH      I H DI+  N++   +  S  KI +FG AR       +          Y AP
Sbjct: 118 LHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAP 172

Query: 255 EYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD 314
           E      +S   D++S G LV  ++S         P    +L E   ++ E     E   
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGI------NP----FLAETNQQIIENIMNAEYTF 222

Query: 315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEI 351
                + I   +A+  ++     L      R   SE 
Sbjct: 223 DEEAFKEISI-EAMDFVDR---LLVKERKSRMTASEA 255

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  148 bits (374), Expect = 3e-42
 Identities = 49/317 (15%), Positives = 99/317 (31%), Gaps = 41/317 (12%)

Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQH-K 139
            ++  G  +G G FG ++ G  L +   VA+K       +    +   E R    +    
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE---PRRSDAPQLRDEYRTYKLLAGCT 61

Query: 140 NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
            +  +     +G   +LV + +     DLL      +  +  T       +   +Q +HE
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLD--LCGRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 200 DSHTRIVHRDIKASNVLLDEKFQS-----KIGDFGLARFFPED------QAYLSTNFAGT 248
                +V+RDIK  N L+            + DFG+ +F+ +             N +GT
Sbjct: 120 ---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176

Query: 249 LGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGR 308
             Y +    +  E S + D+ + G + +  +           +          + YER  
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-------KQKYERIG 229

Query: 309 ILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVRPA 368
             +   P          +  + ++          +  P    +  +              
Sbjct: 230 EKKQSTPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLF----------SKV 276

Query: 369 YLERRRKRDETLSWDTI 385
                   DE   W+ +
Sbjct: 277 LERLNTTEDENFDWNLL 293

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 3e-42
 Identities = 56/285 (19%), Positives = 114/285 (40%), Gaps = 23/285 (8%)

Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKN 140
           NF     +G G +G VY+ +    G +VA+KK+ +D  ++   S  + E+ ++  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 141 LVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
           +V+LL      ++  LV+E++ ++ L   +   +   +        +  + +GL + H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 201 SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRG 260
              R++HRD+K  N+L++ +   K+ DFGLAR F       +                  
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178

Query: 261 ELSEKADIYSFGVLVLEIISCR--------KNTDLTLPSEMQYLPEYAWKLYERGRILEL 312
             S   DI+S G +  E+++ R         +    +   +    E  W         + 
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238

Query: 313 VDPRMRKEGI------VERDALQVINVAFICLQPHGNQRPPMSEI 351
             P+  ++        ++ D   +++     L    N+R      
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAA 280

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  147 bits (371), Expect = 6e-42
 Identities = 57/287 (19%), Positives = 103/287 (35%), Gaps = 41/287 (14%)

Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKL--------CVDKSQQGESEFLSEVRMI 133
           N+ P  +LGRG    V R          AVK +          ++ Q+     L EV ++
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 134 TSIQ-HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR 192
             +  H N+++L       +   LV++ MK   L   +       L+     +I+  +  
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLE 121

Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYT 252
            +  LH+     IVHRD+K  N+LLD+    K+ DFG +      +        GT  Y 
Sbjct: 122 VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYL 176

Query: 253 APEYAIRGEL------SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER 306
           APE              ++ D++S GV++  +++                P +  K    
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS-------------PPFWHRKQMLM 223

Query: 307 GRILELVDPRMRKEGI--VERDALQVINVAFICLQPHGNQRPPMSEI 351
            R++   + +               +++     L     +R    E 
Sbjct: 224 LRMIMSGNYQFGSPEWDDYSDTVKDLVSR---FLVVQPQKRYTAEEA 267

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 2e-41
 Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 10/204 (4%)

Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDK--SQQGESEFLSEVRMIT-SIQH 138
           +F    +LG+G FG V+  +        A+K L  D           + E R+++ + +H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLH 198
             L  +            V EY+    L   I  +S    + S        I  GLQ+LH
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 199 EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI 258
                 IV+RD+K  N+LLD+    KI DFG+ +      A  +T F GT  Y APE  +
Sbjct: 121 S---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILL 176

Query: 259 RGELSEKADIYSFGVLVLEIISCR 282
             + +   D +SFGVL+ E++  +
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQ 200

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 1e-40
 Identities = 66/314 (21%), Positives = 116/314 (36%), Gaps = 31/314 (9%)

Query: 87  GNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVR-MITSIQHKNLVRL 144
             +LG G  G V +          A+K L      Q   +   EV     + Q  ++VR+
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKML------QDCPKARREVELHWRASQCPHIVRI 70

Query: 145 LGCCSDGSQR----LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED 200
           +    +        L+V E +    L   I    D+        +I+  I   +QYLH  
Sbjct: 71  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 129

Query: 201 SHTRIVHRDIKASNVLLDEKFQS---KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYA 257
               I HRD+K  N+L   K  +   K+ DFG A+      +  +  +  T  Y APE  
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVL 185

Query: 258 IRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM 317
              +  +  D++S GV++  ++          P    +    +  +  R R+ +   P  
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGY------PPFYSNHGLAISPGMKTRIRMGQYEFPNP 239

Query: 318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVRPAYLERRRKRD 377
               + E +   +I      L+    QR  ++E +        + +P  P +  R  K D
Sbjct: 240 EWSEVSE-EVKMLIR---NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKED 295

Query: 378 ETLSWDTISEPFPS 391
           +   W+ + E   S
Sbjct: 296 KE-RWEDVKEEMTS 308

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 3e-39
 Identities = 63/290 (21%), Positives = 108/290 (37%), Gaps = 31/290 (10%)

Query: 83  NFHPGNLLGRGGFGPVYRGKLAD-GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL 141
           ++    ++G G FG VY+ KL D G LVA+KK+  DK          E++++  + H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNI 75

Query: 142 VRLLGCCSDGSQR------LLVYEYMKNRSLDLLI-YGESDKFLNWSTRFQIILGIARGL 194
           VRL        ++       LV +Y+      +   Y  + + L        +  + R L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 195 QYLHEDSHTRIVHRDIKASNVLLDEK-FQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
            Y+H      I HRDIK  N+LLD      K+ DFG A+     +  +S   +    Y A
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--YYRA 190

Query: 254 PEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYL-------PEYAWKLYE 305
           PE      + +   D++S G ++ E++  +         +           P        
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

Query: 306 RGRILELVDPRMRKEGIVERDALQVINVA--FI--CLQPHGNQRPPMSEI 351
                E   P+++     +    +    A       L+     R    E 
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 4e-39
 Identities = 55/287 (19%), Positives = 108/287 (37%), Gaps = 25/287 (8%)

Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG-ESEFLSEVRMITSIQHK 139
           + +     +G G +G V++ K      +VA+K++ +D   +G  S  L E+ ++  ++HK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 140 NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHE 199
           N+VRL        +  LV+E+          +   +  L+       +  + +GL + H 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKY--FDSCNGDLDPEIVKSFLFQLLKGLGFCH- 118

Query: 200 DSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIR 259
                ++HRD+K  N+L++   + K+ +FGLAR F       S                 
Sbjct: 119 --SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176

Query: 260 GELSEKADIYSFGVLVLEIISCR------KNTDLTL---------PSEMQYLPEYAWKLY 304
              S   D++S G +  E+ +         + D  L         P+E Q+        Y
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236

Query: 305 ERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEI 351
           +   +       +     +      ++      L+ +  QR    E 
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQN---LLKCNPVQRISAEEA 280

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 8e-38
 Identities = 57/278 (20%), Positives = 101/278 (36%), Gaps = 31/278 (11%)

Query: 84  FHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGES-----EFLSEVRMITSIQ 137
           +  G  LG G F  V + +  + G   A K +   +++         +   EV ++  IQ
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYL 197
           H N++ L     + +  +L+ E +    L    +    + L      + +  I  G+ YL
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELF--DFLAEKESLTEEEATEFLKQILNGVYYL 129

Query: 198 HEDSHTRIVHRDIKASNVLLDE----KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           H     +I H D+K  N++L +    K + KI DFGLA        +   N  GT  + A
Sbjct: 130 HSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVA 184

Query: 254 PEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           PE      L  +AD++S GV+   ++S              +L +   +       +   
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGA----------SPFLGDTKQETLANVSAVNYE 234

Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEI 351
                        A   I      L     +R  + + 
Sbjct: 235 FEDEYFSNTSA-LAKDFIRR---LLVKDPKKRMTIQDS 268

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 4e-37
 Identities = 64/297 (21%), Positives = 121/297 (40%), Gaps = 33/297 (11%)

Query: 83  NFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGES-EFLSEVRMITSIQHKN 140
            +     +G+G FG V++ +    G  VA+KK+ ++  ++G     L E++++  ++H+N
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70

Query: 141 LVRLLGCCSDGSQR--------LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIAR 192
           +V L+  C   +           LV+++ ++    LL           S   +++  +  
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLN 128

Query: 193 GLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA---YLSTNFAGTL 249
           GL Y+H +   +I+HRD+KA+NVL+      K+ DFGLAR F   +       TN   TL
Sbjct: 129 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

Query: 250 GYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYL---------PEY 299
            Y  PE  +   +     D++  G ++ E+ +               L         PE 
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245

Query: 300 AWKLYERGRILELVDPRMRKEGIVERDALQVINVAFI-----CLQPHGNQRPPMSEI 351
              +       +L   + +K  + +R    V +   +      L     QR    + 
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 4e-37
 Identities = 61/278 (21%), Positives = 106/278 (38%), Gaps = 41/278 (14%)

Query: 84  FHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGES-----EFLSEVRMITSIQ 137
           +  G LLG GGFG VY G  ++D   VA+K +  D+               EV ++  + 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 138 --HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQ 195
                ++RLL         +L+ E  +    DL  +      L           +   ++
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVR 124

Query: 196 YLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAP 254
           + H      ++HRDIK  N+L+D  + + K+ DFG      +      T+F GT  Y+ P
Sbjct: 125 HCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPP 178

Query: 255 EYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV 313
           E+          A ++S G+L+ +++                +P    +   RG++    
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------IPFEHDEEIIRGQV--FF 223

Query: 314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEI 351
             R+  E           ++   CL    + RP   EI
Sbjct: 224 RQRVSSE---------CQHLIRWCLALRPSDRPTFEEI 252

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 4e-36
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 9/204 (4%)

Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQH 138
            +F    LLG+G FG V   +  A G   A+K L  +   ++   +  ++E R++ + +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 139 KNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLH 198
             L  L        +   V EY     L   +    ++             I   L+YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLH 122

Query: 199 EDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAI 258
                 +V+RDIK  N++LD+    KI DFGL +    D A +   F GT  Y APE   
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-KTFCGTPEYLAPEVLE 178

Query: 259 RGELSEKADIYSFGVLVLEIISCR 282
             +     D +  GV++ E++  R
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGR 202

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (321), Expect = 3e-34
 Identities = 61/306 (19%), Positives = 111/306 (36%), Gaps = 37/306 (12%)

Query: 72  FDFQTLKKAT----KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESE- 125
           F  Q + K        +     +G G +G V        G  VA+KKL      +  ++ 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 126 FLSEVRMITSIQHKNLVRLLGCCSDGSQR------LLVYEYMKNRSLDLLIYGESDKFLN 179
              E+R++  ++H+N++ LL   +            LV  +M      L+ + +    L 
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK----LG 119

Query: 180 WSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA 239
                 ++  + +GL+Y+H        HRD+K  N+ ++E  + KI DFGLAR    +  
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSE-- 174

Query: 240 YLSTNFAGTLGYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR--------KNTDLTLP 290
              T +  T  Y APE  +     ++  DI+S G ++ E+I+ +         +    + 
Sbjct: 175 --MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 232

Query: 291 SEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFI-----CLQPHGNQR 345
                 P    +  +       +      E       L   +   +      L     QR
Sbjct: 233 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR 292

Query: 346 PPMSEI 351
               E 
Sbjct: 293 VTAGEA 298

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  125 bits (315), Expect = 2e-33
 Identities = 62/314 (19%), Positives = 120/314 (38%), Gaps = 43/314 (13%)

Query: 67  RTISYFDFQTLKKATKN---FHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQG 122
           R   Y+D+++      N   +     LGRG +  V+    + +   V VK L   K ++ 
Sbjct: 17  RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK- 75

Query: 123 ESEFLSEVRMITSIQ-HKNLVRLLGCCSDGSQRL--LVYEYMKNRSLDLLIYGESDKFLN 179
                 E++++ +++   N++ L     D   R   LV+E++ N     L      + L 
Sbjct: 76  ---IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLT 127

Query: 180 WSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS-KIGDFGLARFFPEDQ 238
                  +  I + L Y H      I+HRD+K  NV++D + +  ++ D+GLA F+   Q
Sbjct: 128 DYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184

Query: 239 AYLSTNFAGTLGYTAPEYAIRGEL-SEKADIYSFGVLVLEIISCRK-------------- 283
            Y       +  +  PE  +  ++     D++S G ++  +I  ++              
Sbjct: 185 EY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 242

Query: 284 -NTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFI-----C 337
               L       Y+ +Y  +L  R   +     R R E  V  +   +++   +      
Sbjct: 243 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 302

Query: 338 LQPHGNQRPPMSEI 351
           L+     R    E 
Sbjct: 303 LRYDHQSRLTAREA 316

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  125 bits (314), Expect = 4e-33
 Identities = 56/243 (23%), Positives = 95/243 (39%), Gaps = 22/243 (9%)

Query: 43  KELVRLALRTTKEGVSKDFFNGNLRTISYFDFQTLKKATKNFHPGNLLGRGGFGPVYRGK 102
           +E V+  L   KE   K +   +  T     F  +K           LG G FG V   K
Sbjct: 12  QESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVK 61

Query: 103 -LADGTLVAVKKLCVDKSQQGE--SEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE 159
               G   A+K L   K  + +     L+E R++ ++    LV+L     D S   +V E
Sbjct: 62  HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121

Query: 160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE 219
           Y+    +   +        +          I    +YLH      +++RD+K  N+L+D+
Sbjct: 122 YVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQ 176

Query: 220 KFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEII 279
           +   ++ DFG A+              GT    APE  +    ++  D ++ GVL+ E+ 
Sbjct: 177 QGYIQVTDFGFAKRVKGRT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232

Query: 280 SCR 282
           +  
Sbjct: 233 AGY 235

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 2e-31
 Identities = 59/305 (19%), Positives = 107/305 (35%), Gaps = 48/305 (15%)

Query: 82  KNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESE-FLSEVRMITSIQHK 139
           K +     +G G  G V           VA+KKL      Q  ++    E+ ++  + HK
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 140 NLVRLLGCCS------DGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARG 193
           N++ LL   +      +     LV E M      ++                ++  +  G
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQMLCG 131

Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           +++LH       +HRD+K SN+++      KI DFGLAR          T +  T  Y A
Sbjct: 132 IKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRA 186

Query: 254 PEYAIRGELSEKADIYSFGVLVLEIISCR---------------------------KNTD 286
           PE  +     E  DI+S G ++ E++  +                           K   
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246

Query: 287 LTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRP 346
            T+ + ++  P+YA   + +     L         +    A  +++     L     +R 
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK---MLVIDPAKRI 303

Query: 347 PMSEI 351
            + + 
Sbjct: 304 SVDDA 308

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 9e-31
 Identities = 61/282 (21%), Positives = 111/282 (39%), Gaps = 29/282 (10%)

Query: 82  KNFHPGNLLGRGGFGPVYRGKLA----DGTLVAVKKL---CVDKSQQGESEFLSEVRMIT 134
           +NF    +LG G +G V+  +       G L A+K L    + +  +      +E +++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 135 SIQHK-NLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARG 193
            I+    LV L       ++  L+ +Y+    L   +     +          +  I   
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS--QRERFTEHEVQIYVGEIVLA 141

Query: 194 LQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAGTLGYTA 253
           L++LH+     I++RDIK  N+LLD      + DFGL++ F  D+   + +F GT+ Y A
Sbjct: 142 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198

Query: 254 PEYAIRGE--LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILE 311
           P+    G+    +  D +S GVL+ E+++         P  +        ++  R    E
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGA------SPFTVDGEKNSQAEISRRILKSE 252

Query: 312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVA 353
              P+      +   A  +I      L     +R       A
Sbjct: 253 PPYPQE-----MSALAKDLIQR---LLMKDPKKRLGCGPRDA 286

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 2e-29
 Identities = 59/298 (19%), Positives = 119/298 (39%), Gaps = 31/298 (10%)

Query: 75  QTLKKATKNFHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESE-FLSEVRM 132
           +T+ +  + +   + +G G +G V        G  VAVKKL         ++    E+R+
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70

Query: 133 ITSIQHKNLVRLLGCCSDGS-----QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQII 187
           +  ++H+N++ LL   +          + +  ++    L+ ++     + L       +I
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLI 127

Query: 188 LGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYLSTNFAG 247
             I RGL+Y+H        HRD+K SN+ ++E  + KI DFGLAR   ++     T +  
Sbjct: 128 YQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVA 180

Query: 248 TLGYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCR-----KNTDLTLPSEMQYL---PE 298
           T  Y APE  +     ++  DI+S G ++ E+++ R      +    L   ++ +     
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240

Query: 299 YAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFI-----CLQPHGNQRPPMSEI 351
              K          +    +   +   +     N   +      L    ++R   ++ 
Sbjct: 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score =  102 bits (254), Expect = 3e-26
 Identities = 38/202 (18%), Positives = 63/202 (31%), Gaps = 26/202 (12%)

Query: 87  GNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKS---------QQGESEFLSEVRMITSIQ 137
           G L+G G    V+           VK   V  +           G+  F          +
Sbjct: 5   GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 138 HKNLVRLLGCCSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYL 197
            + L +L G          VY +  N  L  LI  +    +      +++  I   +   
Sbjct: 65  FRALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119

Query: 198 HEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFF--PEDQAYLSTNFAGTLGYTAPE 255
           +      IVH D+   NVL+ E     I DF  +        +  L  +    + Y +  
Sbjct: 120 YHR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRT 175

Query: 256 YAIRGELSEKADIYSFGVLVLE 277
           Y        + DI S    +L+
Sbjct: 176 YRT------EKDINSAIDRILQ 191

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  103 bits (257), Expect = 3e-25
 Identities = 48/220 (21%), Positives = 83/220 (37%), Gaps = 29/220 (13%)

Query: 84  FHPGNLLGRGGFGPVYRGK-LADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV 142
           +     LG G F  V+  K + + T VA+K +     +        E++++  +   +  
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV--RGDKVYTEAAEDEIKLLQRVNDADNT 72

Query: 143 RLLGCCSDGSQRLLVYEY--------------MKNRSLDLLIYGESDKFLNWSTRFQIIL 188
           +     ++   +LL +                +   +L  LI     + +      QI  
Sbjct: 73  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132

Query: 189 GIARGLQYLHEDSHTRIVHRDIKASNVLLDEK------FQSKIGDFGLARFFPEDQAYLS 242
            +  GL Y+H      I+H DIK  NVL++         Q KI D G A ++ E      
Sbjct: 133 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN-- 188

Query: 243 TNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCR 282
                T  Y +PE  +       ADI+S   L+ E+I+  
Sbjct: 189 --SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	407
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.69
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.24
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.87
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.17
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.08
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.9

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-57  Score=408.80  Aligned_cols=257  Identities=27%  Similarity=0.409  Sum_probs=200.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      ++|++.+.||+|+||+||+|++.+++.||||++...  ....++|.+|++++++++||||++++|+|.+.+..++||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC--cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            467778899999999999999988899999998643  334567999999999999999999999999999999999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      ++|+|.+++... ...+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.........
T Consensus        83 ~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          83 EHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             TTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            999999988644 345899999999999999999999998   9999999999999999999999999999876655444


Q ss_pred             ccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCC
Q 040557          242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEG  321 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  321 (407)
                      .....||+.|+|||.+.+..++.++|||||||++|||+|++.|+......     .. ....+..+...  .        
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-----~~-~~~~i~~~~~~--~--------  222 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SE-VVEDISTGFRL--Y--------  222 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-----HH-HHHHHHHTCCC--C--------
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-----HH-HHHHHHhcCCC--C--------
Confidence            45567999999999999999999999999999999999965554332211     11 22222222111  1        


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          322 IVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       322 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                      .+..++.++.+++.+||+.||++||||+||+++|+.+.+
T Consensus       223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            112234568899999999999999999999999987654

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-57  Score=406.73  Aligned_cols=257  Identities=25%  Similarity=0.326  Sum_probs=207.8

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++.........+.+.+|+++|++++||||+++++++.+++..|+||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            5688889999999999999986 469999999997655445556789999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc-
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA-  239 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-  239 (407)
                      +++|+|.+++.  ....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+|+....... 
T Consensus        85 ~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          85 CSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            99999999984  4456999999999999999999999998   99999999999999999999999999997754332 


Q ss_pred             ccccccccCccccCccccccCCC-CccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                      ......+||+.|||||++.+..+ +.++|||||||++|||+||+.||........      ............       
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~------~~~~~~~~~~~~-------  226 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWKEKKTYL-------  226 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH------HHHHHHTTCTTS-------
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH------HHHHHhcCCCCC-------
Confidence            22345789999999999988776 6789999999999999999999975433211      111111111100       


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                        ......+..+.+++.+||+.||++|||++|+++|-|..
T Consensus       227 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~  264 (271)
T d1nvra_         227 --NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN  264 (271)
T ss_dssp             --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred             --CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhC
Confidence              01112245678999999999999999999999998764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-56  Score=405.46  Aligned_cols=254  Identities=27%  Similarity=0.432  Sum_probs=210.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      ++|++.+.||+|+||.||+|.++++..||||++....  ...+.|.+|+++|++++|||||+++|++.+ +..++||||+
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            5677788999999999999999888899999986433  345679999999999999999999998865 5679999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      ++|+|.+++.......+++..+.+++.||+.||.|||+.+   |+||||||+||||++++.+||+|||+|+.........
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~  166 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA  166 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred             CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcccc
Confidence            9999999886655556999999999999999999999988   9999999999999999999999999999887665555


Q ss_pred             ccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCC
Q 040557          242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEG  321 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  321 (407)
                      .....||+.|||||.+.++.++.++|||||||++|||+||+.|+......      ......+..+...          .
T Consensus       167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~------~~~~~~i~~~~~~----------~  230 (272)
T d1qpca_         167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLERGYRM----------V  230 (272)
T ss_dssp             CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTTCCC----------C
T ss_pred             ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhcCCC----------C
Confidence            55678999999999999999999999999999999999977665432221      1122222222111          0


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          322 IVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       322 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      .+...+..+.+|+.+||+.||++||||++|++.|+.
T Consensus       231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence            112234568899999999999999999999998863

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=400.06  Aligned_cols=260  Identities=27%  Similarity=0.415  Sum_probs=205.5

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|++.+.||+|+||+||+|++.  ..||||++.... .....+.|.+|+++|++++||||++++|++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            467899999999999999999864  359999986543 34556789999999999999999999999865 56899999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++|+|.+++.... ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+.......
T Consensus        84 y~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          84 WCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             CCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             cCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            999999999986443 45999999999999999999999998   99999999999999999999999999987654332


Q ss_pred             -ccccccccCccccCcccccc---CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          240 -YLSTNFAGTLGYTAPEYAIR---GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       240 -~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                       .......||+.|||||++.+   ..|+.++|||||||++|||+||+.||......      .........+...    +
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~------~~~~~~~~~~~~~----p  229 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIFMVGRGYLS----P  229 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHHTSCC----C
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCCC----C
Confidence             23345679999999999864   45899999999999999999999999754322      1222233333211    1


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ....  ....++..+.+++.+||+.||++|||++||+++|+.+.
T Consensus       230 ~~~~--~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~  271 (276)
T d1uwha_         230 DLSK--VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA  271 (276)
T ss_dssp             CGGG--SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cchh--ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            1111  12223457889999999999999999999999998654

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.9e-57  Score=412.29  Aligned_cols=257  Identities=27%  Similarity=0.399  Sum_probs=216.4

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++....  ...++|.+|+++|++++|||||+++|+|.+++..++|||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            356788889999999999999875 58899999986433  345679999999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+++|+|.+++.......+++..+..++.|++.||.|||+++   |+||||||+||||++++.+||+|||+++....+..
T Consensus        94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            999999999998776778999999999999999999999998   99999999999999999999999999998776655


Q ss_pred             ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                      .......|++.|+|||.+.+..++.++|||||||++|||++|+.|+......      ......+..+...         
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~------~~~~~~i~~~~~~---------  235 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLEKDYRM---------  235 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHTTCCC---------
T ss_pred             eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH------HHHHHHHhcCCCC---------
Confidence            5555567899999999999999999999999999999999988776533221      1222333322111         


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                       ..+...+..+.+|+.+||+.||++|||+.||++.|+..
T Consensus       236 -~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         236 -ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             -CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             12223455789999999999999999999999998754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.9e-56  Score=406.81  Aligned_cols=258  Identities=26%  Similarity=0.437  Sum_probs=200.0

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CC---cEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DG---TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ++|++.+.||+|+||+||+|.+. +|   ..||||.+.........+.|.+|+++|++++|||||+++|++.+.+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            34566789999999999999864 23   368999987666666777899999999999999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++|+|.+++... ...+++..+..++.||+.||.|||+.+   ++||||||+||||+.++.+||+|||+++.+...
T Consensus       106 ~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             EECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence            9999999999988643 345899999999999999999999998   999999999999999999999999999877543


Q ss_pred             Cccc----ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccc
Q 040557          238 QAYL----STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILEL  312 (407)
Q Consensus       238 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      ....    .....||+.|||||.+.++.++.++|||||||++|||+| |+.||......      . ....+..+..   
T Consensus       182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~------~-~~~~i~~~~~---  251 (299)
T d1jpaa_         182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ------D-VINAIEQDYR---  251 (299)
T ss_dssp             --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------H-HHHHHHTTCC---
T ss_pred             CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCC---
Confidence            3221    123457999999999999999999999999999999998 88888643221      1 1222222211   


Q ss_pred             cCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          313 VDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       313 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                          .   ..+...+..+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus       252 ----~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         252 ----L---PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             ----C---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----C---CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                1   1122345678899999999999999999999999976543

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-55  Score=393.05  Aligned_cols=253  Identities=25%  Similarity=0.412  Sum_probs=213.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      ++|++.+.||+|+||+||+|++++++.||||+++...  ...+.|.+|+.++++++||||++++|+|.+.+..++||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc--CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            6789999999999999999999888899999986543  34467999999999999999999999999999999999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      ++|+|..++.... ..+++..+.+++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++.........
T Consensus        82 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          82 ANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             TTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             CCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            9999999876443 45899999999999999999999988   9999999999999999999999999998776655544


Q ss_pred             ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                      .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||......      + ....+..+...  .       
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~------~-~~~~i~~~~~~--~-------  221 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------E-TAEHIAQGLRL--Y-------  221 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------H-HHHHHHTTCCC--C-------
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH------H-HHHHHHhCCCC--C-------
Confidence            455679999999999999999999999999999999998 78888644321      1 22222322111  1       


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                       .+...+..+.+++.+||+.||++|||+++|+++|..
T Consensus       222 -~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         222 -RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             -CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             -CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence             112234568899999999999999999999999853

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-55  Score=398.99  Aligned_cols=257  Identities=22%  Similarity=0.341  Sum_probs=213.8

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++..... ...+.+.+|+++|++++||||+++++++.+.+..|+||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC-hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            4799999999999999999985 4699999999865432 3356789999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++|+|.+++..   ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+......
T Consensus        99 ~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~  172 (293)
T d1yhwa1          99 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (293)
T ss_dssp             CTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             cCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence            999999998754   34999999999999999999999998   999999999999999999999999999987554332


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                       ....+||+.|+|||.+.+..++.++|||||||++|||+||+.||.....      ..........+...      +   
T Consensus       173 -~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~~~~~~~~~------~---  236 (293)
T d1yhwa1         173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGTPE------L---  236 (293)
T ss_dssp             -BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCSCC------C---
T ss_pred             -ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH------HHHHHHHHhCCCCC------C---
Confidence             3456799999999999999999999999999999999999999964322      12222222222111      1   


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                      ..+...+..+.+++.+||+.||++|||+.|+++|-|.....
T Consensus       237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~  277 (293)
T d1yhwa1         237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (293)
T ss_dssp             SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence            11222345688999999999999999999999998875433

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-56  Score=399.27  Aligned_cols=250  Identities=26%  Similarity=0.385  Sum_probs=209.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++....  .......+.+|+++++.++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46888899999999999999874 68999999986432  2233567889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|.+++...  ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        86 Ey~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~  160 (263)
T d2j4za1          86 EYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  160 (263)
T ss_dssp             ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred             eecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence            999999999998643  45999999999999999999999998   9999999999999999999999999998765443


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                      .   ....||+.|||||++.+..++.++|||||||++|||++|+.||......      . .......+..      .  
T Consensus       161 ~---~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~-~~~~i~~~~~------~--  222 (263)
T d2j4za1         161 R---TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------E-TYKRISRVEF------T--  222 (263)
T ss_dssp             C---EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHTTCC------C--
T ss_pred             c---cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH------H-HHHHHHcCCC------C--
Confidence            2   3467999999999999999999999999999999999999999653221      1 2222222211      1  


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                         .+...+..+.+++.+||+.||++|||++|+++|-|.
T Consensus       223 ---~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~  258 (263)
T d2j4za1         223 ---FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI  258 (263)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHH
T ss_pred             ---CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCc
Confidence               112234568899999999999999999999998765

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-56  Score=399.41  Aligned_cols=257  Identities=25%  Similarity=0.397  Sum_probs=198.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeec--CCeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSD--GSQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv  157 (407)
                      ++|++.+.||+|+||.||+|+. .+|+.||||.+.... .....+.+.+|+++|++++||||+++++++.+  .+..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5688889999999999999986 468999999986554 34455678999999999999999999999865  4568999


Q ss_pred             EEeccCCChhHHHhcc--CCCCCCHHHHHHHHHHHHHHhccccccC--CCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          158 YEYMKNRSLDLLIYGE--SDKFLNWSTRFQIILGIARGLQYLHEDS--HTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      |||+++|+|.+++...  ....+++..++.++.|++.||.|||+.+  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998542  3467999999999999999999999865  23599999999999999999999999999998


Q ss_pred             cCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccccc
Q 040557          234 FPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELV  313 (407)
Q Consensus       234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (407)
                      +...... .....||+.|||||++.+..++.++|||||||++|||+||+.||.....       ......+..+....  
T Consensus       164 ~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-------~~~~~~i~~~~~~~--  233 (269)
T d2java1         164 LNHDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELAGKIREGKFRR--  233 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHTCCCC--
T ss_pred             cccCCCc-cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-------HHHHHHHHcCCCCC--
Confidence            7654332 3456899999999999999999999999999999999999999964322       11222233332211  


Q ss_pred             CcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          314 DPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       314 d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                              .+...+.++.+++.+||+.||++|||+.|+++|.|
T Consensus       234 --------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~  268 (269)
T d2java1         234 --------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  268 (269)
T ss_dssp             --------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             --------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence                    11223456889999999999999999999998754

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-55  Score=395.54  Aligned_cols=253  Identities=26%  Similarity=0.409  Sum_probs=207.9

Q ss_pred             CCCCCC-eeeccCCccEEEEEec---CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           83 NFHPGN-LLGRGGFGPVYRGKLA---DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        83 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      +|.+.+ .||+|+||.||+|.+.   ++..||||++.........++|.+|+++|++++|||||+++|++.+ +..++||
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm   87 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM   87 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence            444455 4999999999999753   3557999999766666677889999999999999999999999975 4679999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|.+++... ...+++..+.+++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        88 E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          88 EMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             ECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            999999999987543 345999999999999999999999998   9999999999999999999999999999876543


Q ss_pred             cc--cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          239 AY--LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       239 ~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                      ..  ......||+.|+|||.+.++.++.++|||||||++|||+| |+.||......      + +...+..+...+    
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~------~-~~~~i~~~~~~~----  232 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------E-VMAFIEQGKRME----  232 (285)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH------H-HHHHHHTTCCCC----
T ss_pred             cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCCCC----
Confidence            32  2234568999999999999999999999999999999998 89998754322      1 222333332211    


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                            .+...+.++.+|+.+||+.||++||||.+|++.|+.
T Consensus       233 ------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         233 ------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             ------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                  222345678899999999999999999999998864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-55  Score=397.91  Aligned_cols=259  Identities=27%  Similarity=0.473  Sum_probs=204.4

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCC-----cEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADG-----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      +.|+..++||+|+||.||+|.+.++     ..||||++..........+|.+|+++|++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            3466678999999999999986532     36999999766666667789999999999999999999999999999999


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ||||+.+|++.+++... ...+++..+..++.|++.||.|||+.+   |+||||||+||||+.++.+||+|||+++....
T Consensus        87 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          87 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccC
Confidence            99999999998887543 345999999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCc--ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          237 DQA--YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       237 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      ...  .......||+.|||||.+.++.++.++|||||||++|||++|+.|+......      ......+..+...    
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~------~~~~~~i~~~~~~----  232 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HEVMKAINDGFRL----  232 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTTCCC----
T ss_pred             CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH------HHHHHHHhccCCC----
Confidence            332  2223456899999999999999999999999999999999987766543221      1122233322111    


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                            ..+...+..+.+|+.+||+.||++||||.||+++|+.+..
T Consensus       233 ------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         233 ------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             ------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence                  1222345678999999999999999999999999986554

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=400.91  Aligned_cols=257  Identities=23%  Similarity=0.333  Sum_probs=209.6

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      +.|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+++|++++||||+++++++.+.+..++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            45788889999999999999864 6899999998644 334456788999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++|+|.+++... ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+....... 
T Consensus        91 ~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-  165 (288)
T d2jfla1          91 CAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-  165 (288)
T ss_dssp             CTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-
T ss_pred             CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCcc-
Confidence            9999999987543 345999999999999999999999998   99999999999999999999999999976543221 


Q ss_pred             cccccccCccccCccccc-----cCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCc
Q 040557          241 LSTNFAGTLGYTAPEYAI-----RGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDP  315 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  315 (407)
                      ......||+.|+|||++.     +..|+.++|||||||++|||+||+.||....+.+      ....... +...     
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~------~~~~i~~-~~~~-----  233 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR------VLLKIAK-SEPP-----  233 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHHHH-SCCC-----
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH------HHHHHHc-CCCC-----
Confidence            223567999999999884     4568999999999999999999999997543321      1222222 2111     


Q ss_pred             ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          316 RMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       316 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .+   ..+...+.++.+++.+||+.||++|||+.|+++|-|...
T Consensus       234 ~~---~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         234 TL---AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             CC---SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             CC---CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            11   111233456889999999999999999999999987643

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-55  Score=396.28  Aligned_cols=256  Identities=27%  Similarity=0.443  Sum_probs=204.6

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      ++|++.+.||+|+||.||+|++.++..||||++...  ....+.|.+|+.+|++++|+|||+++|++.+ +..++||||+
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc--cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            578889999999999999999988889999998543  3345679999999999999999999999855 5679999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      ++|+|..++.......++|..+..++.||+.||+|||+.+   ++||||||+||||++++.+||+|||+++.........
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~  170 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  170 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence            9999999987666667999999999999999999999998   9999999999999999999999999999876555444


Q ss_pred             ccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccCC
Q 040557          242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKEG  321 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  321 (407)
                      .....||+.|+|||.+.++.++.++|||||||++|||+||+.|+......      ......+..+...          .
T Consensus       171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~------~~~~~~i~~~~~~----------~  234 (285)
T d1fmka3         171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVERGYRM----------P  234 (285)
T ss_dssp             -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTTCCC----------C
T ss_pred             eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH------HHHHHHHHhcCCC----------C
Confidence            55567999999999999999999999999999999999987766543221      1112222222111          1


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          322 IVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       322 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .+...+..+.+++.+||+.||++|||+++|+++|+...
T Consensus       235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence            12233457889999999999999999999999987543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=408.56  Aligned_cols=270  Identities=21%  Similarity=0.317  Sum_probs=209.6

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|++.+.||+|+||+||+|+. .+|+.||+|++...........+.+|+.+|++++|||||+++++|.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            46788889999999999999986 46899999999766555556789999999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhcccccc-CCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED-SHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      |+++|+|.+++...  ..+++..+..++.|++.||.|||+. +   |+||||||+|||+++++.+||+|||+|+.+....
T Consensus        85 y~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  159 (322)
T d1s9ja_          85 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  159 (322)
T ss_dssp             CCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred             cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence            99999999999643  4599999999999999999999974 7   9999999999999999999999999998664322


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHH-HHH--------HHHhC--
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEY-AWK--------LYERG--  307 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~-~~~--------~~~~~--  307 (407)
                         ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||........+..... ...        ....+  
T Consensus       160 ---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         160 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             ---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             ---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence               2356899999999999999999999999999999999999999976443211100000 000        00000  


Q ss_pred             ------------ccccccCcccc---cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          308 ------------RILELVDPRMR---KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       308 ------------~~~~~~d~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                                  ...+..+....   ........+.++.+++.+||+.||++|||++|+++|-+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~  302 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK  302 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhC
Confidence                        00000000000   0000011235688999999999999999999999986653

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-54  Score=387.63  Aligned_cols=251  Identities=24%  Similarity=0.348  Sum_probs=201.1

Q ss_pred             CCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeec----CCeeEEEE
Q 040557           85 HPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSD----GSQRLLVY  158 (407)
Q Consensus        85 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  158 (407)
                      +..+.||+|+||+||+|.+. ++..||+|.+.... .....+.|.+|+++|++++||||+++++++.+    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            34467999999999999864 68899999986544 34456679999999999999999999999864    35679999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc-CCCceEEecccCccccCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD-EKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfgla~~~~~~  237 (407)
                      ||+++|+|.+++...  ..+++..+..++.||+.||+|||+++ ++|+||||||+|||++ +++.+||+|||+++.....
T Consensus        92 E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~  168 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  168 (270)
T ss_dssp             ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             eCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence            999999999998543  46899999999999999999999875 4599999999999997 5789999999999865443


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      .   ....+||+.|||||.+.+ .++.++|||||||++|||++|+.||......      ......+..+.....    .
T Consensus       169 ~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~~~~~~~----~  234 (270)
T d1t4ha_         169 F---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPAS----F  234 (270)
T ss_dssp             S---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGG----G
T ss_pred             c---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHHHHHHcCCCCcc----c
Confidence            3   235689999999998765 6999999999999999999999999643221      122222222221111    1


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      .     ...+.++.+++.+||+.||++|||+.|+++|-|.
T Consensus       235 ~-----~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~f  269 (270)
T d1t4ha_         235 D-----KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF  269 (270)
T ss_dssp             G-----GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             C-----ccCCHHHHHHHHHHccCCHhHCcCHHHHhCCccc
Confidence            1     1123458899999999999999999999998764

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-55  Score=398.24  Aligned_cols=252  Identities=21%  Similarity=0.284  Sum_probs=205.4

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++....  .......+.+|+++|++++||||+++++++.+.+..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5688899999999999999986 469999999986432  2234467899999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|.+++...  +.+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+|+.+....
T Consensus        88 Ey~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCC
Confidence            999999999988543  45999999999999999999999998   9999999999999999999999999999876433


Q ss_pred             c-ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          239 A-YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       239 ~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      . ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......      . .......+..      . 
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~-~~~~i~~~~~------~-  228 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY------L-IFQKIIKLEY------D-  228 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHTTCC------C-
T ss_pred             cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH------H-HHHHHHcCCC------C-
Confidence            2 2334568999999999999999999999999999999999999999753221      1 1122222211      1 


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                          .+...+.++.+|+.+||+.||++|||++|++++.+
T Consensus       229 ----~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~  263 (288)
T d1uu3a_         229 ----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP  263 (288)
T ss_dssp             ----CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred             ----CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence                11223456889999999999999999999866543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-54  Score=400.86  Aligned_cols=257  Identities=28%  Similarity=0.426  Sum_probs=207.5

Q ss_pred             hcCCCCCCeeeccCCccEEEEEecC-C-----cEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCe
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLAD-G-----TLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQ  153 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  153 (407)
                      .++|++++.||+|+||+||+|+... +     ..||+|.+...........+.+|+.+|.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3678888999999999999998642 2     369999986555555566889999999998 89999999999999999


Q ss_pred             eEEEEEeccCCChhHHHhccCC---------------------CCCCHHHHHHHHHHHHHHhccccccCCCceeeecccc
Q 040557          154 RLLVYEYMKNRSLDLLIYGESD---------------------KFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKA  212 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~  212 (407)
                      .++||||+++|+|.+++.....                     ..+++..+..++.|++.||.|||+++   |+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence            9999999999999999965432                     35899999999999999999999998   99999999


Q ss_pred             ccEEEcCCCceEEecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCC
Q 040557          213 SNVLLDEKFQSKIGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLP  290 (407)
Q Consensus       213 ~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~  290 (407)
                      +|||++.++.+||+|||+|+........ ......||+.|||||.+.++.++.++|||||||++|||+| |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999876544332 2335668999999999999999999999999999999998 8999865432


Q ss_pred             cccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          291 SEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      .      ....+....+...          ..+...+..+.+|+.+||+.||++|||++||+++|.
T Consensus       273 ~------~~~~~~~~~~~~~----------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 D------ANFYKLIQNGFKM----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             S------HHHHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             H------HHHHHHHhcCCCC----------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            2      1223333332111          112234467899999999999999999999999995

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.6e-55  Score=399.74  Aligned_cols=260  Identities=20%  Similarity=0.252  Sum_probs=196.0

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .+.|++.+.||+|+||+||+|+.. +|+.||||++...........+.+|+++|++++||||+++++++.+++..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            366888899999999999999864 6899999999765544455678899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc---CCCceEEecccCccccCC
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD---EKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfgla~~~~~  236 (407)
                      |++||+|.+++..  ...+++..+..++.|++.||.|||+.+   ++||||||+|||+.   +++.+||+|||+++....
T Consensus        88 ~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          88 LVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             CCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             ccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            9999999999954  456999999999999999999999998   99999999999995   578999999999987654


Q ss_pred             CCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          237 DQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                      ...  ....+||+.|||||++.+..|+.++|||||||++|||++|+.||......      ..... ...+...      
T Consensus       163 ~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~-i~~~~~~------  227 (307)
T d1a06a_         163 GSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA------KLFEQ-ILKAEYE------  227 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHH-HHTTCCC------
T ss_pred             CCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH------HHHHH-HhccCCC------
Confidence            432  23467999999999999999999999999999999999999999743221      11111 2211110      


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccC
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVES  361 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~  361 (407)
                      ... ......+..+.+++.+||+.||++|||+.|+++|.|.....
T Consensus       228 ~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  271 (307)
T d1a06a_         228 FDS-PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT  271 (307)
T ss_dssp             CCT-TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred             CCC-ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            000 01122345688999999999999999999999998765443

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-54  Score=387.98  Aligned_cols=246  Identities=27%  Similarity=0.416  Sum_probs=198.5

Q ss_pred             CeeeccCCccEEEEEec---CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEeccC
Q 040557           88 NLLGRGGFGPVYRGKLA---DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYMKN  163 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  163 (407)
                      +.||+|+||+||+|.+.   .++.||||++.... .....++|.+|+++|++++|||||+++|+|.++ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            46999999999999754   35689999986443 233456899999999999999999999999654 57899999999


Q ss_pred             CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc--
Q 040557          164 RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL--  241 (407)
Q Consensus       164 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~--  241 (407)
                      |+|.+++..  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.......  
T Consensus        92 g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          92 GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            999999864  345999999999999999999999998   9999999999999999999999999999775443322  


Q ss_pred             ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccccC
Q 040557          242 STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRKE  320 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  320 (407)
                      .....||+.|||||.+.+..++.++|||||||++|||+| |+.||.....       ..+...+..+...          
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-------~~~~~~i~~~~~~----------  229 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SEVTAMLEKGERM----------  229 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCC----------
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-------HHHHHHHHcCCCC----------
Confidence            234578999999999999999999999999999999998 8999864322       1222333333211          


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040557          321 GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLT  356 (407)
Q Consensus       321 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~  356 (407)
                      ..+..++..+.+|+.+||+.||++|||+++|++.|+
T Consensus       230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~  265 (277)
T d1xbba_         230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR  265 (277)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence            112234567889999999999999999999988875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-53  Score=391.70  Aligned_cols=251  Identities=26%  Similarity=0.395  Sum_probs=206.1

Q ss_pred             CCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccC--hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKS--QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .|+..+.||+|+||.||+|+. .+|+.||||++.....  ....+.+.+|+++|++++|||||++++++.+.+..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            477788999999999999985 4689999999875442  2344678999999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      ||.+|+|..++..  ...+++..+..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||++......  
T Consensus        96 ~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--  168 (309)
T d1u5ra_          96 YCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (309)
T ss_dssp             CCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             ecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence            9999999776643  346999999999999999999999998   999999999999999999999999999866443  


Q ss_pred             ccccccccCccccCcccccc---CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          240 YLSTNFAGTLGYTAPEYAIR---GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                         ....||+.|||||++.+   +.|+.++|||||||++|||++|+.||.....      ......... +...     .
T Consensus       169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~i~~-~~~~-----~  233 (309)
T d1u5ra_         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQ-NESP-----A  233 (309)
T ss_dssp             ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHH-SCCC-----C
T ss_pred             ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHh-CCCC-----C
Confidence               24579999999999864   4689999999999999999999999864321      112222222 2111     1


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ...    ...+..+.+++.+||+.||++|||+.|+++|-+...
T Consensus       234 ~~~----~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         234 LQS----GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             CSC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             CCC----CCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence            111    122456889999999999999999999999877654

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=385.52  Aligned_cols=255  Identities=24%  Similarity=0.349  Sum_probs=198.6

Q ss_pred             cCCCCCCeeeccCCccEEEEEecC----CcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLAD----GTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ++|++++.||+|+||.||+|.+..    +..||||.+...........|.+|+++|++++||||++++|++. .+..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            578888999999999999998642    45699999876566666778999999999999999999999996 4678999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++|+|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.+...
T Consensus        86 ~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          86 MELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCC
Confidence            9999999999887644 345899999999999999999999998   999999999999999999999999999987665


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCcc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPR  316 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  316 (407)
                      .........||+.|+|||.+.+..++.++|||||||++|||+| |.+|+......+       ....+..+...      
T Consensus       162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-------~~~~i~~~~~~------  228 (273)
T d1mp8a_         162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERL------  228 (273)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTCCC------
T ss_pred             cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC------
Confidence            5555556678999999999999999999999999999999998 788886543321       12222222211      


Q ss_pred             cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          317 MRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       317 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                          ..+...+..+.+|+.+||+.||++|||+.||+++|+.+
T Consensus       229 ----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         229 ----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                11223456789999999999999999999999999754

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-53  Score=390.24  Aligned_cols=260  Identities=28%  Similarity=0.430  Sum_probs=212.7

Q ss_pred             HhcCCCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCe
Q 040557           80 ATKNFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQ  153 (407)
Q Consensus        80 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  153 (407)
                      ..++|++.+.||+|+||+||+|+..      +++.||||++.........++|.+|+++|++++||||++++++|.+...
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            4567899999999999999999853      4578999999766666667789999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhHHHhccC----------------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccc
Q 040557          154 RLLVYEYMKNRSLDLLIYGES----------------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIK  211 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk  211 (407)
                      .+++|||+++|+|.+++....                      ...+++..+..++.|++.||+|||+.+   ++|||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK  167 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA  167 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence            999999999999999986422                      234889999999999999999999998   9999999


Q ss_pred             cccEEEcCCCceEEecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCC-CCCCCC
Q 040557          212 ASNVLLDEKFQSKIGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRK-NTDLTL  289 (407)
Q Consensus       212 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~-p~~~~~  289 (407)
                      |+|||++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|.. |+....
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~  247 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  247 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence            99999999999999999999876543322 2345678999999999999999999999999999999999964 554322


Q ss_pred             CcccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          290 PSEMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ..      + ....+..+....          .+...+.++.+|+.+||+.||++||||.||+++|+.+.
T Consensus       248 ~~------e-~~~~v~~~~~~~----------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         248 HE------E-VIYYVRDGNILA----------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             HH------H-HHHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HH------H-HHHHHHcCCCCC----------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            11      1 222233332211          12223456899999999999999999999999998654

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=384.28  Aligned_cols=256  Identities=21%  Similarity=0.246  Sum_probs=210.0

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccC-----hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCee
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKS-----QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQR  154 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  154 (407)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++.....     ....+.+.+|+.+|++++||||+++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            36788999999999999999986 4799999999865432     22357899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC----ceEEecccC
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF----QSKIGDFGL  230 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfgl  230 (407)
                      |+||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++    .+||+|||+
T Consensus        89 ~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence            9999999999999998643  46999999999999999999999998   99999999999998776    499999999


Q ss_pred             ccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccc
Q 040557          231 ARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRIL  310 (407)
Q Consensus       231 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      +........  .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......      ... ..+..+...
T Consensus       164 a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~-~~i~~~~~~  234 (293)
T d1jksa_         164 AHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETL-ANVSAVNYE  234 (293)
T ss_dssp             CEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHTTCCC
T ss_pred             hhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH------HHH-HHHHhcCCC
Confidence            988755433  23467999999999999999999999999999999999999999753321      111 112221110


Q ss_pred             cccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          311 ELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       311 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                        .....     ....+..+.+++.+||+.||++|||++|+++|-|.
T Consensus       235 --~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~  274 (293)
T d1jksa_         235 --FEDEY-----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI  274 (293)
T ss_dssp             --CCHHH-----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred             --CCchh-----cCCCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence              00000     01123568899999999999999999999998765

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.5e-52  Score=391.56  Aligned_cols=257  Identities=21%  Similarity=0.261  Sum_probs=211.4

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+++|++++||||+++++++.+.+..|+|||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc-chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            35788999999999999999986 46999999998643 34456788999999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc--CCCceEEecccCccccCCC
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD--EKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~--~~~~~kl~Dfgla~~~~~~  237 (407)
                      |+++|+|.+++... ...+++..+..++.||+.||.|||+++   ++||||||+|||++  .++.+||+|||+++.+...
T Consensus       104 ~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         104 FMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             cCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            99999999988543 345999999999999999999999998   99999999999996  4678999999999987654


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      ...  ....||+.|||||++.+..++.++|||||||++|||++|+.||.....      .+....... +...  .+.. 
T Consensus       180 ~~~--~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~-~~~~--~~~~-  247 (350)
T d1koaa2         180 QSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKS-CDWN--MDDS-  247 (350)
T ss_dssp             SCE--EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-TCCC--SCCG-
T ss_pred             ccc--ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHh-CCCC--CCcc-
Confidence            432  456899999999999999999999999999999999999999964322      122222221 1110  0011 


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                          .....+..+.+++.+||+.||++|||+.|+++|-|..
T Consensus       248 ----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~  284 (350)
T d1koaa2         248 ----AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT  284 (350)
T ss_dssp             ----GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTS
T ss_pred             ----cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence                1112245688999999999999999999999997754

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=9.5e-53  Score=393.23  Aligned_cols=258  Identities=22%  Similarity=0.236  Sum_probs=211.9

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+++|++++||||+++++++.+++..|+|||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            35788999999999999999986 479999999986433 3445678899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc--CCCceEEecccCccccCCC
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD--EKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~--~~~~~kl~Dfgla~~~~~~  237 (407)
                      |+++|+|.+++... ...+++..+..++.||+.||.|||+.+   |+||||||+||||+  .++.+||+|||+|..+...
T Consensus       107 ~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         107 FLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             cCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence            99999998877433 345999999999999999999999998   99999999999998  6789999999999987655


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      ..  .....||+.|+|||++.+..++.++|||||||++|||+||+.||......      ..... +..+...      .
T Consensus       183 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~-i~~~~~~------~  247 (352)
T d1koba_         183 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQN-VKRCDWE------F  247 (352)
T ss_dssp             SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHH-HHHCCCC------C
T ss_pred             Cc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHhCCCC------C
Confidence            43  24467999999999999999999999999999999999999999643221      11222 2222110      1


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      .. ......+.++.+|+.+||+.||++|||+.|+++|-|...
T Consensus       248 ~~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~  288 (352)
T d1koba_         248 DE-DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG  288 (352)
T ss_dssp             CS-STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred             Cc-ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            00 011223456889999999999999999999999977643

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=389.01  Aligned_cols=253  Identities=25%  Similarity=0.285  Sum_probs=211.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++....  .......+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5688889999999999999986 479999999996442  2234567889999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+++|+|..++...  ..+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+......
T Consensus        85 ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          85 EYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             ECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            999999999998543  45899999999999999999999998   9999999999999999999999999998765433


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                      . .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||......      . .......+..      .  
T Consensus       160 ~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~------~-~~~~i~~~~~------~--  223 (337)
T d1o6la_         160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------R-LFELILMEEI------R--  223 (337)
T ss_dssp             C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCC------C--
T ss_pred             c-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH------H-HHHHHhcCCC------C--
Confidence            2 234578999999999999999999999999999999999999999754321      1 2222222221      1  


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhhcc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPP-----MSEIVAMLTCK  358 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~l~~~  358 (407)
                         .+...+.++.+|+.+||+.||++||+     +.|+++|-++.
T Consensus       224 ---~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~  265 (337)
T d1o6la_         224 ---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL  265 (337)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             ---CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccc
Confidence               12223456889999999999999995     89999998764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-53  Score=382.22  Aligned_cols=250  Identities=29%  Similarity=0.403  Sum_probs=197.3

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeec-CCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSD-GSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~  160 (407)
                      ++|++.+.||+|+||.||+|++ .|+.||||+++.+   ...+.|.+|++++++++||||++++|+|.+ .+..++||||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            4567778999999999999998 4789999999543   234578999999999999999999999854 4668999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +++|+|.+++.......+++..+++++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+++......  
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--  157 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  157 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC--
Confidence            99999999997655556899999999999999999999988   9999999999999999999999999998654432  


Q ss_pred             cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccCccccc
Q 040557          241 LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMRK  319 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  319 (407)
                        ....+|..|+|||.+.++.++.++|||||||++|||+| |+.|+.......       ....+..+...         
T Consensus       158 --~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~-------~~~~i~~~~~~---------  219 (262)
T d1byga_         158 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKM---------  219 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-------HHHHHTTTCCC---------
T ss_pred             --ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCC---------
Confidence              23468899999999999999999999999999999998 566665432221       11122222111         


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          320 EGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       320 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                       ..+...+..+.+++.+||+.||++|||+.+++++|+.+.
T Consensus       220 -~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         220 -DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence             122233456889999999999999999999999997653

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.1e-52  Score=385.71  Aligned_cols=250  Identities=23%  Similarity=0.305  Sum_probs=209.1

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++....  .....+.+.+|+.+|+.++||||+++++++.+.+..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5688889999999999999986 469999999986432  2234567899999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||++||+|..++...  ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+......
T Consensus        84 E~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~  158 (316)
T d1fota_          84 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT  158 (316)
T ss_dssp             CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred             eecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecccc
Confidence            999999999988543  45889999999999999999999998   9999999999999999999999999999875443


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                          ...+||+.|||||++.+..|+.++|||||||++|||+||+.||......      ....... .+..         
T Consensus       159 ----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~-~~~~---------  218 (316)
T d1fota_         159 ----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKIL-NAEL---------  218 (316)
T ss_dssp             ----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHH-HCCC---------
T ss_pred             ----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------HHHHHHH-cCCC---------
Confidence                3468999999999999999999999999999999999999999753221      1222222 2211         


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhcc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRP-----PMSEIVAMLTCK  358 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~l~~~  358 (407)
                        ..+...+.++.+++.+||+.||++||     |++++++|.+..
T Consensus       219 --~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~  261 (316)
T d1fota_         219 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK  261 (316)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred             --CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccc
Confidence              01122345688999999999999996     999999997753

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-52  Score=384.84  Aligned_cols=265  Identities=28%  Similarity=0.415  Sum_probs=203.4

Q ss_pred             HHHHHhcCCCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeee
Q 040557           76 TLKKATKNFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCC  148 (407)
Q Consensus        76 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  148 (407)
                      .++...++|++.+.||+|+||.||+|...      +++.||||++...........+.+|...+.++ +|+||+.+++++
T Consensus         7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~   86 (299)
T d1ywna1           7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC   86 (299)
T ss_dssp             HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence            33333467888999999999999999753      35689999997666666677888999988887 689999999987


Q ss_pred             ecC-CeeEEEEEeccCCChhHHHhccC--------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccc
Q 040557          149 SDG-SQRLLVYEYMKNRSLDLLIYGES--------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKAS  213 (407)
Q Consensus       149 ~~~-~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~  213 (407)
                      ... ...++||||+++|+|.+++....              ...+++..+..++.||+.||.|||+++   |+||||||+
T Consensus        87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~  163 (299)
T d1ywna1          87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR  163 (299)
T ss_dssp             CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred             ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcc
Confidence            654 56899999999999999996432              235899999999999999999999998   999999999


Q ss_pred             cEEEcCCCceEEecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCC-CCCCCCCc
Q 040557          214 NVLLDEKFQSKIGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRK-NTDLTLPS  291 (407)
Q Consensus       214 Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~-p~~~~~~~  291 (407)
                      ||||++++.+||+|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||+||.. ||......
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999999876544332 3345679999999999999999999999999999999999764 55432221


Q ss_pred             ccCchhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          292 EMQYLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                            ......+..+....          .+...+.++.+++.+||+.||++|||+.||+++|+.+.
T Consensus       244 ------~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         244 ------EEFCRRLKEGTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             ------HHHHHHHHHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------HHHHHHHhcCCCCC----------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                  22233333332211          11223456889999999999999999999999998654

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-52  Score=386.47  Aligned_cols=255  Identities=26%  Similarity=0.416  Sum_probs=202.2

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCc----EEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGT----LVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLL  156 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  156 (407)
                      .+|++.+.||+|+||+||+|.+. +|+    .||+|++.........+.|.+|++++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            35788899999999999999864 444    58999886555556677899999999999999999999999875 5678


Q ss_pred             EEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCC
Q 040557          157 VYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       157 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~  236 (407)
                      ++||+.+|+|.+++... ...+++..+.+++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            89999999999887654 456999999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCccc-ccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          237 DQAYL-STNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       237 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      ..... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||......+       +...+..+...    
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-------~~~~i~~~~~~----  232 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERL----  232 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-------HHHHHHHTCCC----
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCC----
Confidence            44332 234568999999999999999999999999999999999 677776433221       22223332211    


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                            ..+..++..+.+|+.+||+.||++|||+.||+++|+..
T Consensus       233 ------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         233 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             ------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence                  11223456789999999999999999999999998754

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=380.02  Aligned_cols=254  Identities=30%  Similarity=0.449  Sum_probs=204.7

Q ss_pred             CCeeeccCCccEEEEEecCC----cEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeec-CCeeEEEEEec
Q 040557           87 GNLLGRGGFGPVYRGKLADG----TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSD-GSQRLLVYEYM  161 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  161 (407)
                      .++||+|+||+||+|++.++    ..||||++.........++|.+|+++|++++||||++++|++.. ++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            36899999999999986432    36899999765566677889999999999999999999999865 56889999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc-
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY-  240 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-  240 (407)
                      ++|+|.+++... ...+++..+.+++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++........ 
T Consensus       112 ~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         112 KHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             TTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             ecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence            999999988644 345789999999999999999999998   999999999999999999999999999876543322 


Q ss_pred             --cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          241 --LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       241 --~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                        ......||+.|+|||.+.+..++.++||||||+++|||+||+.|+.......     . ....+..+...  .     
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-----~-~~~~i~~g~~~--~-----  254 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----D-ITVYLLQGRRL--L-----  254 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHHHHHTTCCC--C-----
T ss_pred             ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-----H-HHHHHHcCCCC--C-----
Confidence              2234578999999999999999999999999999999999888876432211     1 11122222211  0     


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                         .+...+..+.+++.+||+.||++||||.||+++|+.+..
T Consensus       255 ---~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         255 ---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence               112234568899999999999999999999999987653

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-52  Score=380.87  Aligned_cols=266  Identities=23%  Similarity=0.292  Sum_probs=199.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHH--HHHHHHcCCCCceeeeeeeeecCC----eeE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLS--EVRMITSIQHKNLVRLLGCCSDGS----QRL  155 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~--e~~~l~~l~h~niv~l~~~~~~~~----~~~  155 (407)
                      .+|.+.+.||+|+||.||+|++ +|+.||||++...    ....+..  |+..+.+++||||+++++++.+.+    ..+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            3456678899999999999997 6899999998532    2233444  444556779999999999997543    579


Q ss_pred             EEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccC-----CCceeeeccccccEEEcCCCceEEecccC
Q 040557          156 LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDS-----HTRIVHRDIKASNVLLDEKFQSKIGDFGL  230 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~dlk~~Nill~~~~~~kl~Dfgl  230 (407)
                      +||||+++|+|.++++..   .++|..+++++.|++.||.|||+..     ..+|+||||||+||||+.++.+||+|||+
T Consensus        78 lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence            999999999999999643   4899999999999999999999741     23599999999999999999999999999


Q ss_pred             ccccCCCCcc---cccccccCccccCccccccCC------CCccccEEehhHHHHHHHhcCCCCCCCCCcccC-------
Q 040557          231 ARFFPEDQAY---LSTNFAGTLGYTAPEYAIRGE------LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQ-------  294 (407)
Q Consensus       231 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~-------  294 (407)
                      ++........   ......||+.|+|||++.+..      ++.++|||||||+||||+||..|+.........       
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~  234 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence            9877543322   233567999999999887643      678999999999999999999887543322111       


Q ss_pred             -chhHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          295 -YLPEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       295 -~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                       ............+    ..++.+............+.+++.+||+.||++|||+.||+++|+.+.
T Consensus       235 ~~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         235 DPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             SCCHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence             1111222222221    222222222223345667899999999999999999999999997653

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=383.21  Aligned_cols=265  Identities=20%  Similarity=0.193  Sum_probs=206.7

Q ss_pred             cCCCCC-CeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeec----CCee
Q 040557           82 KNFHPG-NLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSD----GSQR  154 (407)
Q Consensus        82 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~  154 (407)
                      ++|.+. +.||+|+||+||+|+. .+|+.||||++...      ..+.+|++++.++ +||||+++++++.+    ....
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            567765 4699999999999986 57999999998521      3467899887655 89999999999865    4568


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC---CCceEEecccCc
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE---KFQSKIGDFGLA  231 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfgla  231 (407)
                      |+|||||+||+|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+|||+++   ++.+||+|||++
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence            99999999999999997665667999999999999999999999998   999999999999985   567999999999


Q ss_pred             cccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccc
Q 040557          232 RFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILE  311 (407)
Q Consensus       232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      +.......  .....||+.|||||++.+..|+.++|||||||++|||+||+.||.........      ..... .....
T Consensus       162 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~------~~~~~-~i~~~  232 (335)
T d2ozaa1         162 KETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------PGMKT-RIRMG  232 (335)
T ss_dssp             EECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------CCCSC
T ss_pred             eeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH------HHHHH-HHhcC
Confidence            87765443  24567999999999999999999999999999999999999999754332210      00000 00000


Q ss_pred             ccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccccCCCCCCc
Q 040557          312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVESGIPVRP  367 (407)
Q Consensus       312 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~~~~~~~p  367 (407)
                      .  .... .......+.++.+|+.+||+.||++|||+.|+++|-|.......|..|
T Consensus       233 ~--~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~  285 (335)
T d2ozaa1         233 Q--YEFP-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP  285 (335)
T ss_dssp             S--SSCC-TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCCCE
T ss_pred             C--CCCC-CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCCCC
Confidence            0  0000 001123456789999999999999999999999997765555444433

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-52  Score=382.35  Aligned_cols=257  Identities=24%  Similarity=0.381  Sum_probs=204.1

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCc--EEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGT--LVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ++|++.+.||+|+||.||+|.+. +|.  .||||++.........+.|.+|+++|+++ +||||++++|+|.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            56778899999999999999865 344  47888876554555667899999999998 799999999999999999999


Q ss_pred             EEeccCCChhHHHhcc--------------CCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCce
Q 040557          158 YEYMKNRSLDLLIYGE--------------SDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQS  223 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~  223 (407)
                      |||+++|+|.++++..              ....+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999998643              2467999999999999999999999998   9999999999999999999


Q ss_pred             EEecccCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCC-CCCCCCCcccCchhHHHHH
Q 040557          224 KIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRK-NTDLTLPSEMQYLPEYAWK  302 (407)
Q Consensus       224 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~-p~~~~~~~~~~~~~~~~~~  302 (407)
                      ||+|||+++.......  .....||..|+|||.+.++.++.++|||||||++|||++|.. |+.....      .+ ...
T Consensus       167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~------~~-~~~  237 (309)
T d1fvra_         167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AE-LYE  237 (309)
T ss_dssp             EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HH-HHH
T ss_pred             EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH------HH-HHH
Confidence            9999999986543322  234568999999999999999999999999999999999875 4543221      11 122


Q ss_pred             HHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          303 LYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       303 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                      .+..+..     +     ..+...+..+.+|+.+||+.||++||||+||+++|+.+.+
T Consensus       238 ~i~~~~~-----~-----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         238 KLPQGYR-----L-----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             HGGGTCC-----C-----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhcCC-----C-----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            2222211     1     1222345678999999999999999999999999987654

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.4e-51  Score=381.88  Aligned_cols=250  Identities=22%  Similarity=0.242  Sum_probs=209.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  158 (407)
                      ++|++.+.||+|+||.||+|++ .+|+.||||++....  .....+.+.+|+++|+.++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5688889999999999999986 469999999986432  2234567899999999999999999999999999999999


Q ss_pred             EeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCC
Q 040557          159 EYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQ  238 (407)
Q Consensus       159 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  238 (407)
                      ||+.+|+|..++...  +.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+......
T Consensus       121 e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~  195 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT  195 (350)
T ss_dssp             ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred             ccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence            999999999998543  35999999999999999999999998   9999999999999999999999999999775433


Q ss_pred             cccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCcccc
Q 040557          239 AYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRMR  318 (407)
Q Consensus       239 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  318 (407)
                          ....||+.|||||++.+..++.++|||||||++|||+||+.||.....      ....... ..+...        
T Consensus       196 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i-~~~~~~--------  256 (350)
T d1rdqe_         196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKI-VSGKVR--------  256 (350)
T ss_dssp             ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH-HHCCCC--------
T ss_pred             ----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHHHHH-hcCCCC--------
Confidence                346799999999999999999999999999999999999999975321      1122222 222110        


Q ss_pred             cCCCCHHHHHHHHHHHHHccCCCCCCC-----CCHHHHHHHhhcc
Q 040557          319 KEGIVERDALQVINVAFICLQPHGNQR-----PPMSEIVAMLTCK  358 (407)
Q Consensus       319 ~~~~~~~~~~~l~~l~~~cl~~~p~~R-----Ps~~ev~~~l~~~  358 (407)
                         .+...+.++.+++.+||+.||.+|     ||++++++|-|+.
T Consensus       257 ---~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~  298 (350)
T d1rdqe_         257 ---FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA  298 (350)
T ss_dssp             ---CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred             ---CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCcccc
Confidence               112234568899999999999999     4999999998764

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-52  Score=380.91  Aligned_cols=260  Identities=27%  Similarity=0.413  Sum_probs=212.6

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec------CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCee
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA------DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQR  154 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  154 (407)
                      .++|++++.||+|+||+||+|.+.      +++.||||++...........|.+|++++++++||||++++|++...+..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            467888899999999999999753      35789999997666666667899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhHHHhccC--------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEe
Q 040557          155 LLVYEYMKNRSLDLLIYGES--------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIG  226 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~  226 (407)
                      ++||||+++|+|.+++....        ...+++..+.+++.|++.||.|||+.+   |+||||||+|||+++++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence            99999999999999886432        234799999999999999999999998   9999999999999999999999


Q ss_pred             cccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcC-CCCCCCCCcccCchhHHHHHHH
Q 040557          227 DFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCR-KNTDLTLPSEMQYLPEYAWKLY  304 (407)
Q Consensus       227 Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~-~p~~~~~~~~~~~~~~~~~~~~  304 (407)
                      |||+++........ ......||+.|+|||.+.++.++.++||||||+++|||+||+ .|+....      ..... ..+
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~------~~~~~-~~i  248 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQVL-RFV  248 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------HHHHH-HHH
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC------HHHHH-HHH
Confidence            99999876544332 233456899999999999999999999999999999999996 4443221      11222 222


Q ss_pred             HhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcccc
Q 040557          305 ERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKVE  360 (407)
Q Consensus       305 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~~  360 (407)
                      ..+....          .+...+..+.+++.+||+.||++||||.+|+++|+...+
T Consensus       249 ~~~~~~~----------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         249 MEGGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HhCCCCC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            2222211          112234569999999999999999999999999987643

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=379.72  Aligned_cols=261  Identities=25%  Similarity=0.413  Sum_probs=214.2

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe------cCCcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCCe
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL------ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGSQ  153 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  153 (407)
                      .++|++++.||+|+||.||+|++      .+++.||||++...........|.+|+.+++++ +|||||+++|+|.+...
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            36788889999999999999975      346789999997666666777899999999999 79999999999999999


Q ss_pred             eEEEEEeccCCChhHHHhccC----------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEE
Q 040557          154 RLLVYEYMKNRSLDLLIYGES----------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLL  217 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill  217 (407)
                      .++||||+++|+|.++++...                ...+++..+..++.||+.||+|||+++   ++||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence            999999999999999986533                235899999999999999999999998   9999999999999


Q ss_pred             cCCCceEEecccCccccCCCCc-ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCch
Q 040557          218 DEKFQSKIGDFGLARFFPEDQA-YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYL  296 (407)
Q Consensus       218 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~  296 (407)
                      +.++.+|++|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+|++.|+......     
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~-----  253 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-----  253 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS-----
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH-----
Confidence            9999999999999998765433 2334567999999999999999999999999999999999965554332221     


Q ss_pred             hHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          297 PEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       297 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ...+.+....+...          ..+...+..+.+|+.+||+.||++||||.+|+++|+..+
T Consensus       254 ~~~~~~~i~~~~~~----------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i  306 (311)
T d1t46a_         254 DSKFYKMIKEGFRM----------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (311)
T ss_dssp             SHHHHHHHHHTCCC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCC----------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence            12233333333211          111223456899999999999999999999999997543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.1e-51  Score=369.98  Aligned_cols=257  Identities=23%  Similarity=0.276  Sum_probs=210.1

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccCh--------hhHHHHHHHHHHHHcCC-CCceeeeeeeeec
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQ--------QGESEFLSEVRMITSIQ-HKNLVRLLGCCSD  150 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~  150 (407)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++......        ...+.+.+|+.+|++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            36788899999999999999986 47999999998654321        22346889999999996 9999999999999


Q ss_pred             CCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccC
Q 040557          151 GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGL  230 (407)
Q Consensus       151 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgl  230 (407)
                      ++..|+||||+++|+|.+++...  ..+++..+..++.||+.||+|||+.+   ++||||||+|||++.++.+||+|||+
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            99999999999999999999643  46999999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccCccccCcccccc------CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHH
Q 040557          231 ARFFPEDQAYLSTNFAGTLGYTAPEYAIR------GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLY  304 (407)
Q Consensus       231 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~  304 (407)
                      ++.+.....  .....||+.|+|||.+.+      ..++.++||||+||++|||++|+.||.....       ......+
T Consensus       157 a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-------~~~~~~i  227 (277)
T d1phka_         157 SCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-------MLMLRMI  227 (277)
T ss_dssp             CEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHH
T ss_pred             eeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH-------HHHHHHH
Confidence            998765432  245679999999998863      3568899999999999999999999975432       1122222


Q ss_pred             HhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          305 ERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       305 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ..+... ...+      .....+.++.+++.+||+.||++|||+.|+++|-|..
T Consensus       228 ~~~~~~-~~~~------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~  274 (277)
T d1phka_         228 MSGNYQ-FGSP------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ  274 (277)
T ss_dssp             HHTCCC-CCTT------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HhCCCC-CCCc------ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHH
Confidence            222211 0001      1122345788999999999999999999999987653

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.6e-51  Score=386.82  Aligned_cols=254  Identities=22%  Similarity=0.298  Sum_probs=203.6

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccC--hhhHHHHHH---HHHHHHcCCCCceeeeeeeeecCCeeE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKS--QQGESEFLS---EVRMITSIQHKNLVRLLGCCSDGSQRL  155 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~~~~~  155 (407)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++.....  ......+.+   ++.+++.++||||+++++++.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57888899999999999999864 699999999854321  122233444   467777788999999999999999999


Q ss_pred             EEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccC
Q 040557          156 LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP  235 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~  235 (407)
                      +||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+|+.+.
T Consensus        84 ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            999999999999998643  45899999999999999999999998   9999999999999999999999999999776


Q ss_pred             CCCcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccC
Q 040557          236 EDQAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVD  314 (407)
Q Consensus       236 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  314 (407)
                      ....   ....||+.|+|||++.+ ..|+.++|||||||++|||+||+.||........   .    .......     .
T Consensus       159 ~~~~---~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~----~~~~~~~-----~  223 (364)
T d1omwa3         159 KKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---H----EIDRMTL-----T  223 (364)
T ss_dssp             SSCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH---H----HHHHHSS-----S
T ss_pred             CCcc---cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH---H----HHHHhcc-----c
Confidence            5432   34679999999999875 5689999999999999999999999976443221   0    1111100     0


Q ss_pred             cccccCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhhcc
Q 040557          315 PRMRKEGIVERDALQVINVAFICLQPHGNQRPP-----MSEIVAMLTCK  358 (407)
Q Consensus       315 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~l~~~  358 (407)
                      ...   ..+...+..+.+++.+||+.||++|||     ++|+++|-|+.
T Consensus       224 ~~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~  269 (364)
T d1omwa3         224 MAV---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR  269 (364)
T ss_dssp             CCC---CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGT
T ss_pred             CCC---CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcccc
Confidence            000   111223456889999999999999999     79999998764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-52  Score=376.42  Aligned_cols=255  Identities=27%  Similarity=0.377  Sum_probs=195.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEec--CC--cEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA--DG--TLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRL  155 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  155 (407)
                      ++|++.+.||+|+||.||+|++.  ++  ..||||++....  .....++|.+|+++|++++||||++++|++.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            55778889999999999999753  22  368999986543  234456899999999999999999999999764 678


Q ss_pred             EEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccC
Q 040557          156 LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP  235 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~  235 (407)
                      +||||+++|++.+.+.... ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcc
Confidence            9999999999998876543 45999999999999999999999998   9999999999999999999999999999875


Q ss_pred             CCCcc--cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCchhHHHHHHHHhCccccc
Q 040557          236 EDQAY--LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYLPEYAWKLYERGRILEL  312 (407)
Q Consensus       236 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (407)
                      .....  ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||.....      .+........+...  
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~------~~~~~~i~~~~~~~--  234 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEGERL--  234 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSCCCC--
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH------HHHHHHHHhCCCCC--
Confidence            54332  2234568889999999999999999999999999999998 8988864322      12223322222111  


Q ss_pred             cCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          313 VDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       313 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                              ..+...+..+.+++.+||+.||++|||+.+|++.|..
T Consensus       235 --------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         235 --------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence                    1112234568899999999999999999999998864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-51  Score=376.46  Aligned_cols=258  Identities=29%  Similarity=0.424  Sum_probs=207.7

Q ss_pred             cCCCCCCeeeccCCccEEEEEecC--------CcEEEEEEeccccChhhHHHHHHHHHHHHcC-CCCceeeeeeeeecCC
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLAD--------GTLVAVKKLCVDKSQQGESEFLSEVRMITSI-QHKNLVRLLGCCSDGS  152 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  152 (407)
                      ++|++++.||+|+||.||+|+...        +..||||++...........+.+|...+.++ +||||++++++|.+.+
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            577788999999999999997532        3479999997766666778899999999888 8999999999999999


Q ss_pred             eeEEEEEeccCCChhHHHhccC--------------CCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGES--------------DKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD  218 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~  218 (407)
                      ..++||||+++|+|.+++....              ...+++..+.+++.|++.||+|||+.+   ++||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeec
Confidence            9999999999999999996443              245899999999999999999999998   99999999999999


Q ss_pred             CCCceEEecccCccccCCCCcc-cccccccCccccCccccccCCCCccccEEehhHHHHHHHh-cCCCCCCCCCcccCch
Q 040557          219 EKFQSKIGDFGLARFFPEDQAY-LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIIS-CRKNTDLTLPSEMQYL  296 (407)
Q Consensus       219 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~t-g~~p~~~~~~~~~~~~  296 (407)
                      .++.+||+|||+++........ ......||+.|+|||.+.++.|+.++|||||||++|||++ |..||.....      
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~------  243 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------  243 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH------
Confidence            9999999999999876543322 2344678999999999999999999999999999999998 5666653221      


Q ss_pred             hHHHHHHHHhCccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          297 PEYAWKLYERGRILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       297 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                       ......+..+....          .+...+..+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus       244 -~~~~~~i~~~~~~~----------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         244 -EELFKLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             -HHHHHHHHTTCCCC----------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHHHHHHcCCCCC----------CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence             22333333332111          11123456889999999999999999999999998654

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=380.58  Aligned_cols=252  Identities=23%  Similarity=0.305  Sum_probs=206.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc--ChhhHHHHHHHHHHHH-cCCCCceeeeeeeeecCCeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK--SQQGESEFLSEVRMIT-SIQHKNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv  157 (407)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++....  .......+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            56888899999999999999864 69999999996432  2233456677777765 68999999999999999999999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPED  237 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  237 (407)
                      |||+++|+|.+++...  ..+++..+..++.||+.||+|||+++   ++||||||+|||+++++.+||+|||+++.....
T Consensus        82 mEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccc
Confidence            9999999999999643  45899999999999999999999998   999999999999999999999999999876544


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      .. ......||+.|+|||++.+..++.++|||||||++|||+||+.||......       ........+..      . 
T Consensus       157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-------~~~~~i~~~~~------~-  221 (320)
T d1xjda_         157 DA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFHSIRMDNP------F-  221 (320)
T ss_dssp             TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC------C-
T ss_pred             cc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCC------C-
Confidence            33 234468999999999999999999999999999999999999999754321       12222222211      1 


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHHhhc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMS-EIVAMLTC  357 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-ev~~~l~~  357 (407)
                          .+...+..+.+|+.+||+.||++|||+. ++++|-+.
T Consensus       222 ----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff  258 (320)
T d1xjda_         222 ----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF  258 (320)
T ss_dssp             ----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred             ----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchh
Confidence                1122345688999999999999999995 79887664

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.2e-51  Score=370.65  Aligned_cols=258  Identities=23%  Similarity=0.337  Sum_probs=201.9

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc--ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC----e
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK--SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS----Q  153 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~  153 (407)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++....  .......|.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            36788899999999999999986 579999999996543  3344567999999999999999999999986543    3


Q ss_pred             eEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          154 RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      .|+||||++||+|..++...  +.+++..+..++.|++.||+|||+.+   ++||||||+|||++.++..+|+|||.+..
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhh
Confidence            78999999999999888543  45999999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCc--ccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccc
Q 040557          234 FPEDQA--YLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILE  311 (407)
Q Consensus       234 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      ......  .......||+.|+|||++.+..++.++|||||||++|||+||+.||....+      ..........+... 
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~~-  233 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP-  233 (277)
T ss_dssp             CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC-
T ss_pred             hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCCC-
Confidence            643322  223456799999999999999999999999999999999999999975332      12233333322211 


Q ss_pred             ccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhc
Q 040557          312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRP-PMSEIVAMLTC  357 (407)
Q Consensus       312 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~ev~~~l~~  357 (407)
                         +...    ....+..+.+++.+||+.||++|| |++++++.|..
T Consensus       234 ---~~~~----~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         234 ---PSAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             ---GGGT----SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ---Cchh----ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence               1111    112345688999999999999999 89999887754

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=374.69  Aligned_cols=256  Identities=20%  Similarity=0.224  Sum_probs=208.8

Q ss_pred             hcCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      .++|++.+.||+|+||+||+|... +|+.||||.+...  ......+.+|+++|+.++||||+++++++.+.+..|+|||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            467889999999999999999864 6889999999643  3344568899999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC--CCceEEecccCccccCCC
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE--KFQSKIGDFGLARFFPED  237 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~--~~~~kl~Dfgla~~~~~~  237 (407)
                      ||+||+|.+++... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.  ...+||+|||+++.....
T Consensus        82 ~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          82 FISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             cCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            99999999998543 235899999999999999999999998   999999999999985  458999999999877554


Q ss_pred             CcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccccccCccc
Q 040557          238 QAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILELVDPRM  317 (407)
Q Consensus       238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  317 (407)
                      ..  .....+|+.|+|||.+.+..++.++|||||||++|||++|+.||......      ........ +...  ++...
T Consensus       158 ~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~-~~~~--~~~~~  226 (321)
T d1tkia_         158 DN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMN-AEYT--FDEEA  226 (321)
T ss_dssp             CE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHH-TCCC--CCHHH
T ss_pred             Cc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-CCCC--CChhh
Confidence            32  23457899999999999999999999999999999999999999754321      12222222 1110  00000


Q ss_pred             ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          318 RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       318 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .     ...+.++.+++.+||+.||++|||+.|+++|-|..
T Consensus       227 ~-----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~  262 (321)
T d1tkia_         227 F-----KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK  262 (321)
T ss_dssp             H-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             c-----cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence            0     01234578999999999999999999999987764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-50  Score=370.18  Aligned_cols=260  Identities=23%  Similarity=0.341  Sum_probs=198.1

Q ss_pred             CCeeeccCCccEEEEEec-CCcEEEEEEeccccChhh----HHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEec
Q 040557           87 GNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQG----ESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEYM  161 (407)
Q Consensus        87 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  161 (407)
                      .++||+|+||+||+|+.. +|+.||||++........    ...+.+|+.+|++++||||+++++++.+.+..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            368999999999999864 699999999865432211    246889999999999999999999999999999999999


Q ss_pred             cCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCccc
Q 040557          162 KNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAYL  241 (407)
Q Consensus       162 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  241 (407)
                      .++++..+.  .....+++..+..++.||+.||+|||+++   ++||||||+|||++.++.+||+|||+++........ 
T Consensus        83 ~~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-  156 (299)
T d1ua2a_          83 ETDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-  156 (299)
T ss_dssp             SEEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-
T ss_pred             cchHHhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc-
Confidence            998777665  33456899999999999999999999998   999999999999999999999999999876554332 


Q ss_pred             ccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh-C--ccccccC---
Q 040557          242 STNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER-G--RILELVD---  314 (407)
Q Consensus       242 ~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~d---  314 (407)
                      ....+||+.|+|||.+.+. .++.++|||||||++|||+||+.||......+      ........ +  ......+   
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~------~l~~i~~~~~~~~~~~~~~~~~  230 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD------QLTRIFETLGTPTEEQWPDMCS  230 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHHHCCCCTTTSSSTTS
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH------HHHHHHHhcCCCChhhccchhc
Confidence            2346799999999988754 67999999999999999999999986543211      11111110 0  0000000   


Q ss_pred             ---c-cccc-CCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          315 ---P-RMRK-EGIV-----ERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       315 ---~-~~~~-~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                         . .... ...+     .....++.+|+.+||+.||++|||++|+++|-+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~  284 (299)
T d1ua2a_         231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS  284 (299)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred             cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhC
Confidence               0 0000 0000     11235688999999999999999999999997753

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=370.27  Aligned_cols=265  Identities=24%  Similarity=0.364  Sum_probs=203.9

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++..... ......+.+|+++|++++||||+++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5788889999999999999986 5799999999965432 2235678999999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      |+.++ +..++.......+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.......
T Consensus        82 ~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          82 FLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             CCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             ecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            99764 444554455667999999999999999999999998   99999999999999999999999999987754433


Q ss_pred             ccccccccCccccCccccccCC-CCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHH-hCccccccCcc-
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYE-RGRILELVDPR-  316 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~-  316 (407)
                      . .....||+.|+|||.+.... ++.++|||||||++|+|++|+.||......      ........ .+...+...+. 
T Consensus       158 ~-~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~------~~~~~i~~~~~~~~~~~~~~~  230 (298)
T d1gz8a_         158 T-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI------DQLFRIFRTLGTPDEVVWPGV  230 (298)
T ss_dssp             C-TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHCCCCTTTSTTG
T ss_pred             c-ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH------HHHHHHHHhcCCCchhhcccc
Confidence            2 33467999999999877765 488999999999999999999999754321      11111111 01111000000 


Q ss_pred             ------------cccCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          317 ------------MRKEG---IVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       317 ------------~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                                  .....   .....+.++.+++.+||+.||++|||+.|+++|-+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff  286 (298)
T d1gz8a_         231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF  286 (298)
T ss_dssp             GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhh
Confidence                        00000   001123568899999999999999999999999765

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=367.51  Aligned_cols=245  Identities=24%  Similarity=0.376  Sum_probs=199.3

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccCh-----hhHHHHHHHHHHHHcCC--CCceeeeeeeeecCCe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQ-----QGESEFLSEVRMITSIQ--HKNLVRLLGCCSDGSQ  153 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~  153 (407)
                      ++|++++.||+|+||+||+|+. .+|+.||||++......     ....++.+|+.+|++++  ||||+++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5788999999999999999986 47999999998643211     11234678999999986  8999999999999999


Q ss_pred             eEEEEEeccC-CChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC-CCceEEecccCc
Q 040557          154 RLLVYEYMKN-RSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE-KFQSKIGDFGLA  231 (407)
Q Consensus       154 ~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfgla  231 (407)
                      .++||||+.+ +++.+++..  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++. ++.+||+|||++
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccc
Confidence            9999999976 577777643  345999999999999999999999998   999999999999985 579999999999


Q ss_pred             cccCCCCcccccccccCccccCccccccCCC-CccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccc
Q 040557          232 RFFPEDQAYLSTNFAGTLGYTAPEYAIRGEL-SEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRIL  310 (407)
Q Consensus       232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      +......   .....||+.|+|||++.+..+ +.++|||||||++|||+||+.||....            . ...+.. 
T Consensus       159 ~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~-i~~~~~-  221 (273)
T d1xwsa_         159 ALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------E-IIRGQV-  221 (273)
T ss_dssp             EECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------H-HHHCCC-
T ss_pred             eeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------H-Hhhccc-
Confidence            8765433   245689999999999987765 677899999999999999999986310            1 111111 


Q ss_pred             cccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          311 ELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       311 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                           .     .+...+.++.+++.+||+.||++|||++|+++|-|..
T Consensus       222 -----~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~  259 (273)
T d1xwsa_         222 -----F-----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ  259 (273)
T ss_dssp             -----C-----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             -----C-----CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence                 0     1111235688999999999999999999999998753

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.6e-50  Score=366.24  Aligned_cols=264  Identities=25%  Similarity=0.364  Sum_probs=203.8

Q ss_pred             cCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEEe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYEY  160 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  160 (407)
                      ++|++.+.||+|+||+||+|++.+|+.||||++..... ......+.+|+.+|++++||||+++++++.+.+..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            57888899999999999999998999999999965432 23356789999999999999999999999999999999999


Q ss_pred             ccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCcc
Q 040557          161 MKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQAY  240 (407)
Q Consensus       161 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  240 (407)
                      +.++.+..+..  ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++........ 
T Consensus        82 ~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-  155 (286)
T d1ob3a_          82 LDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-  155 (286)
T ss_dssp             CSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             ehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence            98877766653  3456999999999999999999999998   99999999999999999999999999987654432 


Q ss_pred             cccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHH-hCcc--------c
Q 040557          241 LSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYE-RGRI--------L  310 (407)
Q Consensus       241 ~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~--------~  310 (407)
                      ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+      ...+... .+..        .
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~------~~~~i~~~~~~~~~~~~~~~~  229 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD------QLMRIFRILGTPNSKNWPNVT  229 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHHHCCCCTTTSTTGG
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH------HHHHHHHhhCCCChhhccchh
Confidence            22345689999999998764 56999999999999999999999996532211      1111110 0000        0


Q ss_pred             cc--cCcccc------cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          311 EL--VDPRMR------KEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       311 ~~--~d~~~~------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      ..  .+....      ........+..+.+++.+||+.||++|||++|+++|-+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f  284 (286)
T d1ob3a_         230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF  284 (286)
T ss_dssp             GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            00  000000      001111234568899999999999999999999998764

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-49  Score=363.22  Aligned_cols=265  Identities=23%  Similarity=0.329  Sum_probs=199.9

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cC-CcEEEEEEeccccCh-hhHHHHHHHHHHHHcC---CCCceeeeeeeeec----
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-AD-GTLVAVKKLCVDKSQ-QGESEFLSEVRMITSI---QHKNLVRLLGCCSD----  150 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~----  150 (407)
                      .++|++.+.||+|+||+||+|++ .+ ++.||||++...... .....+.+|+.+|+.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999986 34 667999998654322 2223455777776655   79999999999853    


Q ss_pred             -CCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEeccc
Q 040557          151 -GSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFG  229 (407)
Q Consensus       151 -~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  229 (407)
                       ....+++|||+.++++..... .....+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             cCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence             346799999999877655443 44556899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh-Cc
Q 040557          230 LARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER-GR  308 (407)
Q Consensus       230 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~  308 (407)
                      ++.......  ......||+.|+|||++.+..|+.++||||+||++|||++|+.||......+      ........ +.
T Consensus       162 ~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~------~~~~i~~~~~~  233 (305)
T d1blxa_         162 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD------QLGKILDVIGL  233 (305)
T ss_dssp             SCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHHHCC
T ss_pred             hhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH------HHHHHHHhhCC
Confidence            998654433  2345789999999999999999999999999999999999999997543211      11111110 00


Q ss_pred             c-----------ccccCccc---ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          309 I-----------LELVDPRM---RKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       309 ~-----------~~~~d~~~---~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                      .           ........   .........+..+.+|+.+||+.||++|||+.|+++|.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff  296 (305)
T d1blxa_         234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  296 (305)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence            0           00000000   0000111234567899999999999999999999999765

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=354.88  Aligned_cols=267  Identities=23%  Similarity=0.314  Sum_probs=199.1

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeec--------C
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSD--------G  151 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~  151 (407)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++..... .....++.+|+++|++++|+|++++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            6788889999999999999986 4799999999865433 2344678899999999999999999998754        3


Q ss_pred             CeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCc
Q 040557          152 SQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLA  231 (407)
Q Consensus       152 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla  231 (407)
                      +..++||||+.++.+....  .....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        90 ~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeeccee
Confidence            4679999999887776554  34456899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcc---cccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhC
Q 040557          232 RFFPEDQAY---LSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERG  307 (407)
Q Consensus       232 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  307 (407)
                      +.+......   .....+||+.|+|||.+.+. .++.++|||||||++|||++|+.||........   ........  +
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~---~~~i~~~~--~  239 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLC--G  239 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHH--C
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH---HHHHHHhc--C
Confidence            876543322   22345799999999998765 689999999999999999999999965332111   00011111  1


Q ss_pred             ccccccCcc------------cccCCCCH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          308 RILELVDPR------------MRKEGIVE-------RDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       308 ~~~~~~d~~------------~~~~~~~~-------~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .........            ........       .....+.+|+.+||+.||++|||++|+++|-++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~  309 (318)
T d3blha1         240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW  309 (318)
T ss_dssp             CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGS
T ss_pred             CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhc
Confidence            100000000            00000011       1134567899999999999999999999998874

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-47  Score=356.19  Aligned_cols=269  Identities=21%  Similarity=0.285  Sum_probs=200.4

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC----eeE
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS----QRL  155 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~  155 (407)
                      +.+|++.+.||+|+||+||+|.. .+|+.||||++.........+.+++|+++|+.++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            35688889999999999999985 5799999999976555566678999999999999999999999986543    234


Q ss_pred             EEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccC
Q 040557          156 LVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFP  235 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~  235 (407)
                      ++++|+.+|+|.+++...   .+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||++....
T Consensus        87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            556667799999998543   4899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcc--cccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCc----
Q 040557          236 EDQAY--LSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGR----  308 (407)
Q Consensus       236 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----  308 (407)
                      .....  .....+||+.|+|||.+.. ..++.++||||+||++|||++|+.||......+...   ..........    
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~  237 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN---HILGILGSPSQEDL  237 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCSCCHHHH
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHH---HHhhhccCCChhhh
Confidence            43322  2345679999999998854 567899999999999999999999996543211100   0000000000    


Q ss_pred             ---c----ccccCcccccCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          309 ---I----LELVDPRMRKEGIV-----ERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       309 ---~----~~~~d~~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                         .    .............+     ......+.+++.+||+.||++|||+.|+++|-+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~  299 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE  299 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence               0    00000000000000     01124688999999999999999999999997643

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=359.86  Aligned_cols=263  Identities=25%  Similarity=0.339  Sum_probs=197.1

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecCC------
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDGS------  152 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  152 (407)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++.... .....+.+.+|+++|+.++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            46788889999999999999986 469999999996543 3344567899999999999999999999997654      


Q ss_pred             eeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          153 QRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       153 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                      ..++||||+ +++|..+...   ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccccee
Confidence            569999999 5677777643   35999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHH-------HHH
Q 040557          233 FFPEDQAYLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAW-------KLY  304 (407)
Q Consensus       233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~-------~~~  304 (407)
                      ......    +...||+.|+|||.+.+. .++.++||||+||++|||++|+.||........  +.....       ..+
T Consensus       170 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         170 QADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             ECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHH
T ss_pred             ccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH--HHHHHhccCCCcHHHH
Confidence            765443    346799999999998764 568999999999999999999999965432110  000000       000


Q ss_pred             HhC----------ccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          305 ERG----------RILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       305 ~~~----------~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ...          ...+.......  .........+.+|+.+||+.||++|||+.|+++|-+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~  305 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFA--SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE  305 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGG--GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred             hhhcchhhhhhhccCCcccccchH--HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhC
Confidence            000          00000000000  01112235678999999999999999999999997764

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=358.96  Aligned_cols=263  Identities=24%  Similarity=0.293  Sum_probs=196.1

Q ss_pred             CCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCceeeeeeeeec------CCeeE
Q 040557           83 NFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLVRLLGCCSD------GSQRL  155 (407)
Q Consensus        83 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~~~  155 (407)
                      +|+..++||+|+||+||+|+.. +|+.||||++......     +.+|+++|++++|+||+++++++..      ..+.+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            4666788999999999999864 6999999999654322     2479999999999999999999843      33578


Q ss_pred             EEEEeccCCChhHHHh-ccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC-ceEEecccCccc
Q 040557          156 LVYEYMKNRSLDLLIY-GESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF-QSKIGDFGLARF  233 (407)
Q Consensus       156 lv~e~~~~g~L~~~l~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfgla~~  233 (407)
                      +||||++++.+..+.. ......+++..+..++.|++.||+|||+++   |+||||||+|||++.++ .+||+|||+++.
T Consensus        96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence            9999998765544443 234556999999999999999999999998   99999999999999765 899999999987


Q ss_pred             cCCCCcccccccccCccccCcccccc-CCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHH----------HH
Q 040557          234 FPEDQAYLSTNFAGTLGYTAPEYAIR-GELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYA----------WK  302 (407)
Q Consensus       234 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~----------~~  302 (407)
                      +......  ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+  .+....          +.
T Consensus       173 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         173 LVRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             CCTTSCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHHH
T ss_pred             ccCCccc--ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHHHhCCChHHhhh
Confidence            7554432  34679999999998775 578999999999999999999999996543211  000000          00


Q ss_pred             HHHhC----ccccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          303 LYERG----RILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       303 ~~~~~----~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      .....    ............ ......+.++.+|+.+||+.||++|||+.|+++|-++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~  307 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD  307 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGG-TSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred             hhccchhhccccccccCchhh-hcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence            00000    000000000000 01122345688999999999999999999999997764

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-48  Score=357.03  Aligned_cols=257  Identities=23%  Similarity=0.284  Sum_probs=207.3

Q ss_pred             cCCCCCCeeeccCCccEEEEEe----cCCcEEEEEEecccc---ChhhHHHHHHHHHHHHcCCC-CceeeeeeeeecCCe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL----ADGTLVAVKKLCVDK---SQQGESEFLSEVRMITSIQH-KNLVRLLGCCSDGSQ  153 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~  153 (407)
                      ++|++.+.||+|+||+||+|+.    .+|+.||||.+....   .....+.+.+|+++|++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6688899999999999999974    248899999986432   12234567899999999966 899999999999999


Q ss_pred             eEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          154 RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      .+++|||+.+|+|.+++...  ..+.+.....++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhh
Confidence            99999999999999998644  34788899999999999999999998   99999999999999999999999999988


Q ss_pred             cCCCCcccccccccCccccCccccccC--CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCcccc
Q 040557          234 FPEDQAYLSTNFAGTLGYTAPEYAIRG--ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRILE  311 (407)
Q Consensus       234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (407)
                      +............|++.|+|||.+.+.  .++.++|||||||+||||++|+.||........   ............   
T Consensus       179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~---~~~i~~~~~~~~---  252 (322)
T d1vzoa_         179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS---QAEISRRILKSE---  252 (322)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC---HHHHHHHHHHCC---
T ss_pred             hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcccCC---
Confidence            766555555567899999999998764  468899999999999999999999976543321   111111111111   


Q ss_pred             ccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhc
Q 040557          312 LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRP-----PMSEIVAMLTC  357 (407)
Q Consensus       312 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~l~~  357 (407)
                         +     ..+...+..+.+++.+||+.||++||     |++|+++|-+.
T Consensus       253 ---~-----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff  295 (322)
T d1vzoa_         253 ---P-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF  295 (322)
T ss_dssp             ---C-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred             ---C-----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhh
Confidence               0     11223456788999999999999999     58999998775

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-46  Score=345.22  Aligned_cols=265  Identities=20%  Similarity=0.298  Sum_probs=208.0

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccC-hhhHHHHHHHHHHHHcCCCCceeeeeeeeecCCeeEEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKS-QQGESEFLSEVRMITSIQHKNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  159 (407)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++.... ......+.+|+.+|+.++|+||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5788889999999999999986 4789999999965543 3446788999999999999999999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccccCCCCc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARFFPEDQA  239 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  239 (407)
                      ++.++++..++.  ..+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++.......
T Consensus        82 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          82 FCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             CCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             eccccccccccc--cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence            999999888774  3456899999999999999999999998   99999999999999999999999999987754433


Q ss_pred             ccccccccCccccCccccccCC-CCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHH-hCcc--------
Q 040557          240 YLSTNFAGTLGYTAPEYAIRGE-LSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYE-RGRI--------  309 (407)
Q Consensus       240 ~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~--------  309 (407)
                      . .....+++.|+|||.+.... ++.++|||||||++|||++|+.||.......     ........ .+..        
T Consensus       157 ~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~  230 (292)
T d1unla_         157 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-----DQLKRIFRLLGTPTEEQWPSM  230 (292)
T ss_dssp             C-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-----HHHHHHHHHHCCCCTTTCTTG
T ss_pred             c-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH-----HHHHHHHhhcCCCChhhhhhh
Confidence            2 23346788999999887665 6899999999999999999999975432211     11111111 0000        


Q ss_pred             ---cc-----ccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          310 ---LE-----LVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       310 ---~~-----~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                         .+     ..................+.+|+.+||+.||++|||++|+++|-|+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f  286 (292)
T d1unla_         231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF  286 (292)
T ss_dssp             GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred             hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhh
Confidence               00     0000001111222234568899999999999999999999999876

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.4e-46  Score=343.82  Aligned_cols=259  Identities=17%  Similarity=0.202  Sum_probs=202.8

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEeccccChhhHHHHHHHHHHHHcCCC-CceeeeeeeeecCCeeEEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQH-KNLVRLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  159 (407)
                      ++|++.+.||+|+||+||+|++. +|+.||||.+......   ..+.+|++.+..+.| +|++.+++++..+...++|||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            67889999999999999999864 6899999988543322   346788899999864 899999999999999999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcC-----CCceEEecccCcccc
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDE-----KFQSKIGDFGLARFF  234 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-----~~~~kl~Dfgla~~~  234 (407)
                      |+ +++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.     ++.+||+|||+|+.+
T Consensus        82 ~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          82 LL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             ec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            99 68998887643 345899999999999999999999998   999999999999974     578999999999876


Q ss_pred             CCCCcc------cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCc
Q 040557          235 PEDQAY------LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGR  308 (407)
Q Consensus       235 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (407)
                      ......      ......||+.|||||.+.+..++.++|||||||++|||+||+.||.......................
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  236 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence            533211      22346799999999999999999999999999999999999999975443322111111111111111


Q ss_pred             cccccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          309 ILELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       309 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ..+     +.     ...+.++.+++..|++.+|++||+++.+.+.|...
T Consensus       237 ~~~-----l~-----~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         237 LRE-----LC-----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             HHH-----HT-----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             hHH-----hc-----CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            110     10     11234688999999999999999999998887653

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-46  Score=343.57  Aligned_cols=258  Identities=20%  Similarity=0.284  Sum_probs=194.6

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCcee-eeeeeeecCCeeEEEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNLV-RLLGCCSDGSQRLLVYE  159 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e  159 (407)
                      ++|++.+.||+|+||.||+|++ .+|+.||||++......   .++..|+++++.++|+|++ .+.+++.+++..++|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            5688999999999999999986 46899999988654322   3477899999999776654 55566677888999999


Q ss_pred             eccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEc---CCCceEEecccCccccCC
Q 040557          160 YMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLD---EKFQSKIGDFGLARFFPE  236 (407)
Q Consensus       160 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfgla~~~~~  236 (407)
                      |+. +++...+.. ....+++..+..++.|++.||+|||+++   |+||||||+|||++   .+..++|+|||+|+.+..
T Consensus        84 ~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          84 LLG-PSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             CCC-CBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EcC-Cchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            994 566655543 3346999999999999999999999998   99999999999986   455799999999997754


Q ss_pred             CCcc------cccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHhCccc
Q 040557          237 DQAY------LSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYERGRIL  310 (407)
Q Consensus       237 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (407)
                      ....      ......||+.|||||.+.+..++.++|||||||++|||+||+.||........................ 
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-  237 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-  237 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH-
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh-
Confidence            3321      233567999999999999999999999999999999999999999765443222111111110000000 


Q ss_pred             cccCcccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 040557          311 ELVDPRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTC  357 (407)
Q Consensus       311 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~  357 (407)
                          +..     ....+.++.+++..||+.+|++||++.++.+.|+.
T Consensus       238 ----~~~-----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         238 ----EVL-----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             ----HHH-----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             ----hHh-----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence                000     11123568899999999999999999988877753

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.2e-46  Score=350.24  Aligned_cols=263  Identities=19%  Similarity=0.260  Sum_probs=200.8

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCC-CCceeeeeeeeecC--CeeEEE
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-HKNLVRLLGCCSDG--SQRLLV  157 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv  157 (407)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++...    ...++.+|+++|+.+. ||||+++++++...  ...++|
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            5789999999999999999986 47999999998532    2356789999999995 99999999998743  568999


Q ss_pred             EEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCC-ceEEecccCccccCC
Q 040557          158 YEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKF-QSKIGDFGLARFFPE  236 (407)
Q Consensus       158 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfgla~~~~~  236 (407)
                      |||+.+++|..+.     +.+++..+..++.||+.||.|||+++   |+||||||+|||++.++ .+||+|||+++....
T Consensus       111 ~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         111 FEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             EeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            9999999987664     35899999999999999999999998   99999999999998654 699999999987765


Q ss_pred             CCcccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchh-------HHHHHHHHhCc
Q 040557          237 DQAYLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLP-------EYAWKLYERGR  308 (407)
Q Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~-------~~~~~~~~~~~  308 (407)
                      ...  .....+|+.|+|||.+.+. .++.++||||+||+++||++|+.||............       ...........
T Consensus       183 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         183 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             CCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence            433  2456799999999998765 5799999999999999999999998754432111000       00001111100


Q ss_pred             cc------cccC-------cccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcc
Q 040557          309 IL------ELVD-------PRMRKEGIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCK  358 (407)
Q Consensus       309 ~~------~~~d-------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~  358 (407)
                      ..      ....       ............+.++.+|+.+||+.||++|||++|+++|-|+.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~  323 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY  323 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence            00      0000       00001111122345688999999999999999999999998763

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-46  Score=348.12  Aligned_cols=268  Identities=23%  Similarity=0.235  Sum_probs=195.5

Q ss_pred             cCCCCCCeeeccCCccEEEEEec-CCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeec------CCe
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKLA-DGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSD------GSQ  153 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~  153 (407)
                      ++|++.++||+|+||+||+|++. +|+.||||++.... ......++.+|+.+|++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67888999999999999999865 69999999997543 34445678999999999999999999999853      467


Q ss_pred             eEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          154 RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      .|+||||+.++.+..+ .    ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++++|||+++.
T Consensus        97 ~~iv~Ey~~~~l~~~~-~----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMDANLCQVI-Q----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCSEEHHHHH-T----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             eEEEEeccchHHHHhh-h----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhc
Confidence            8999999977655443 2    34899999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCccc----------------Cchh
Q 040557          234 FPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEM----------------QYLP  297 (407)
Q Consensus       234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~----------------~~~~  297 (407)
                      .....  ......+|+.|+|||.+.+..++.++||||+||+++||++|+.||........                ....
T Consensus       169 ~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         169 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred             ccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence            65433  23456799999999999999999999999999999999999999864421100                0000


Q ss_pred             HHHHHHHHhCcc------ccccCcccccC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          298 EYAWKLYERGRI------LELVDPRMRKE--GIVERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       298 ~~~~~~~~~~~~------~~~~d~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      ............      ...+.......  ......+..+.+|+.+||+.||++|||++|+++|-|...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~  316 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  316 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence            001111111100      00010111110  011234567899999999999999999999999988754

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-45  Score=346.89  Aligned_cols=263  Identities=23%  Similarity=0.303  Sum_probs=198.4

Q ss_pred             hcCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEecccc-ChhhHHHHHHHHHHHHcCCCCceeeeeeeeecC-----Ce
Q 040557           81 TKNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDK-SQQGESEFLSEVRMITSIQHKNLVRLLGCCSDG-----SQ  153 (407)
Q Consensus        81 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  153 (407)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++.... .......+.+|+++|+.++|+|++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46799999999999999999985 579999999996543 334556789999999999999999999998533     33


Q ss_pred             eEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEecccCccc
Q 040557          154 RLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       154 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      .+++++|+.+|+|.+++..   +.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++..
T Consensus        97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcc
Confidence            4667788889999999843   35999999999999999999999998   99999999999999999999999999976


Q ss_pred             cCCCCcccccccccCccccCccccccC-CCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHHHHHHHHh-Cccc-
Q 040557          234 FPEDQAYLSTNFAGTLGYTAPEYAIRG-ELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEYAWKLYER-GRIL-  310 (407)
Q Consensus       234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~-  310 (407)
                      ....    .....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||........      ....... +... 
T Consensus       171 ~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~------~~~i~~~~~~~~~  240 (348)
T d2gfsa1         171 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ------LKLILRLVGTPGA  240 (348)
T ss_dssp             CTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHHHCCCCH
T ss_pred             cCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH------HHHHHHhcCCCCh
Confidence            5432    2346799999999987765 468999999999999999999999965432110      0000000 0000 


Q ss_pred             c------------ccCcccccCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhccc
Q 040557          311 E------------LVDPRMRKEGIV-----ERDALQVINVAFICLQPHGNQRPPMSEIVAMLTCKV  359 (407)
Q Consensus       311 ~------------~~d~~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~l~~~~  359 (407)
                      +            ............     ......+.+|+.+||+.||++|||++|+++|-|...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~  306 (348)
T d2gfsa1         241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  306 (348)
T ss_dssp             HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence            0            000000000000     112356789999999999999999999999988653

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.6e-41  Score=315.78  Aligned_cols=268  Identities=22%  Similarity=0.226  Sum_probs=195.3

Q ss_pred             cCCCCCCeeeccCCccEEEEEe-cCCcEEEEEEeccccChhhHHHHHHHHHHHHcCC-----------CCceeeeeeeee
Q 040557           82 KNFHPGNLLGRGGFGPVYRGKL-ADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-----------HKNLVRLLGCCS  149 (407)
Q Consensus        82 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~  149 (407)
                      ++|++.++||+|+||+||+|+. .+|+.||||+++..  ....+.+.+|+.+++.++           |+||+++++++.
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            3588899999999999999986 47999999999633  333456778888888775           578999998875


Q ss_pred             c--CCeeEEEEEeccCCCh-hHHHhccCCCCCCHHHHHHHHHHHHHHhccccc-cCCCceeeeccccccEEEcCCC----
Q 040557          150 D--GSQRLLVYEYMKNRSL-DLLIYGESDKFLNWSTRFQIILGIARGLQYLHE-DSHTRIVHRDIKASNVLLDEKF----  221 (407)
Q Consensus       150 ~--~~~~~lv~e~~~~g~L-~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~----  221 (407)
                      .  ....+++++++..+.. ...........+++..+..++.|++.||.|||+ .+   |+||||||+|||++.++    
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred             eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccc
Confidence            4  3456677777655443 333444555678999999999999999999997 66   99999999999998654    


Q ss_pred             --ceEEecccCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHHHHHhcCCCCCCCCCcccCchhHH
Q 040557          222 --QSKIGDFGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVLEIISCRKNTDLTLPSEMQYLPEY  299 (407)
Q Consensus       222 --~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~el~tg~~p~~~~~~~~~~~~~~~  299 (407)
                        .++++|||.+.......    ....||+.|+|||.+....++.++||||+||+++||++|+.||..............
T Consensus       168 ~~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             cceeeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence              39999999998654332    346799999999999999999999999999999999999999875443222111111


Q ss_pred             HHHHHH-hCcc-----------ccccC---------cc---------cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 040557          300 AWKLYE-RGRI-----------LELVD---------PR---------MRKEGIVERDALQVINVAFICLQPHGNQRPPMS  349 (407)
Q Consensus       300 ~~~~~~-~~~~-----------~~~~d---------~~---------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  349 (407)
                      ...... -+..           ....+         ..         .............+.+|+.+||+.||++|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            111100 0000           00000         00         011224456778899999999999999999999


Q ss_pred             HHHHHhhcc
Q 040557          350 EIVAMLTCK  358 (407)
Q Consensus       350 ev~~~l~~~  358 (407)
                      |+++|-++.
T Consensus       324 e~L~Hp~f~  332 (362)
T d1q8ya_         324 GLVNHPWLK  332 (362)
T ss_dssp             HHHTCGGGT
T ss_pred             HHhcCcccC
Confidence            999998765

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=4.6e-26  Score=193.71  Aligned_cols=171  Identities=18%  Similarity=0.110  Sum_probs=122.0

Q ss_pred             CCCCeeeccCCccEEEEEecCCcEEEEEEeccccC-----------------hhhHHHHHHHHHHHHcCCCCceeeeeee
Q 040557           85 HPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKS-----------------QQGESEFLSEVRMITSIQHKNLVRLLGC  147 (407)
Q Consensus        85 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------------~~~~~~~~~e~~~l~~l~h~niv~l~~~  147 (407)
                      .+++.||+|+||+||+|...+|+.||||+++....                 ........+|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            35688999999999999988999999998753211                 0112345578889999999999988766


Q ss_pred             eecCCeeEEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhccccccCCCceeeeccccccEEEcCCCceEEec
Q 040557          148 CSDGSQRLLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHEDSHTRIVHRDIKASNVLLDEKFQSKIGD  227 (407)
Q Consensus       148 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~D  227 (407)
                      ..    .+++|||++++.+..         ++......++.|++.++.|||+.+   ++||||||+|||++++ .++|+|
T Consensus        83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECC
T ss_pred             cC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEE
Confidence            32    379999998865533         334445678999999999999998   9999999999999976 589999


Q ss_pred             ccCccccCCCCcccccccccCccccCccccccCCCCccccEEehhHHHH
Q 040557          228 FGLARFFPEDQAYLSTNFAGTLGYTAPEYAIRGELSEKADIYSFGVLVL  276 (407)
Q Consensus       228 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~G~vl~  276 (407)
                      ||+|.............  ..... -.+ ...+.|+.++|+||..--++
T Consensus       146 FG~a~~~~~~~~~~~l~--rd~~~-~~~-~f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         146 FPQSVEVGEEGWREILE--RDVRN-IIT-YFSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CTTCEETTSTTHHHHHH--HHHHH-HHH-HHHHHHCCCCCHHHHHHHHH
T ss_pred             CCCcccCCCCCcHHHHH--HHHHH-HHH-HHcCCCCCcccHHHHHHHHh
Confidence            99998665333210000  00000 001 12456788999999765443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.69  E-value=1.8e-08  Score=87.91  Aligned_cols=148  Identities=15%  Similarity=0.053  Sum_probs=93.1

Q ss_pred             HHHHHhcCCCCCCeeeccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCC-CCceeeeeeeeecCCee
Q 040557           76 TLKKATKNFHPGNLLGRGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ-HKNLVRLLGCCSDGSQR  154 (407)
Q Consensus        76 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~  154 (407)
                      +++.....|+..+..+.++.+.||+... ++..+.+|+..... ......+.+|...+..+. +-.+.+++.+..+++..
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~-~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRY-KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGG-TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCc-ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            4555556666544444444568998875 56677888774332 122234567888877663 44467788888888889


Q ss_pred             EEEEEeccCCChhHHHhccCCCCCCHHHHHHHHHHHHHHhcccccc----------------------------------
Q 040557          155 LLVYEYMKNRSLDLLIYGESDKFLNWSTRFQIILGIARGLQYLHED----------------------------------  200 (407)
Q Consensus       155 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------------------------------  200 (407)
                      ++||++++|.++.......    ..   ...++.+++..+..||+.                                  
T Consensus        86 ~lv~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            9999999998775433110    01   111222233333333320                                  


Q ss_pred             ----------------------CCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          201 ----------------------SHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       201 ----------------------~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                                            ....++|+|+.+.|||+++++.+-|+||+.+.
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                  11238999999999999987667799998775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.24  E-value=1e-06  Score=76.03  Aligned_cols=73  Identities=14%  Similarity=0.131  Sum_probs=51.7

Q ss_pred             eeccCC-ccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCC--CCceeeeeeeeecCCeeEEEEEeccCCCh
Q 040557           90 LGRGGF-GPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQ--HKNLVRLLGCCSDGSQRLLVYEYMKNRSL  166 (407)
Q Consensus        90 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L  166 (407)
                      +..|.. +.||+....++..+++|......    ...+..|...++.+.  .-.+.+++++..+++..++||+|++|.++
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            444544 57899988778888999764332    123567777777663  33456788888888889999999988665

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.87  E-value=1.4e-05  Score=73.40  Aligned_cols=76  Identities=13%  Similarity=0.100  Sum_probs=47.3

Q ss_pred             CeeeccCCccEEEEEecC-CcEEEEEEeccc------cChhhHHHHHHHHHHHHcC-CC--CceeeeeeeeecCCeeEEE
Q 040557           88 NLLGRGGFGPVYRGKLAD-GTLVAVKKLCVD------KSQQGESEFLSEVRMITSI-QH--KNLVRLLGCCSDGSQRLLV  157 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~------~~~~~~~~~~~e~~~l~~l-~h--~niv~l~~~~~~~~~~~lv  157 (407)
                      +.||.|....||+....+ ++.++||.-...      .......+...|.+.|+.+ .+  ..+.+++.+  +....++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            468999999999998654 678999965321      1111223445678777766 22  345556654  44556899


Q ss_pred             EEeccCCC
Q 040557          158 YEYMKNRS  165 (407)
Q Consensus       158 ~e~~~~g~  165 (407)
                      ||++.+..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.17  E-value=0.00082  Score=59.47  Aligned_cols=135  Identities=14%  Similarity=0.129  Sum_probs=76.1

Q ss_pred             CccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCce--eeeee-----eeecCCeeEEEEEeccCCChh
Q 040557           95 FGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL--VRLLG-----CCSDGSQRLLVYEYMKNRSLD  167 (407)
Q Consensus        95 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~g~L~  167 (407)
                      --.||++...+|..|++|.....  ....+++..|...+..|...++  +..+.     .+......+.+++++.|..+.
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~--~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPE--RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTT--TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             cceeEEEEcCCCCEEEEEEeCCC--CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            35899999999999999987533  2234556778887777642222  21111     223455678899998764431


Q ss_pred             -----HH---------Hhc-------cCCCCCCHH----------------------HHHHHHHHHHHHhcc-ccccCCC
Q 040557          168 -----LL---------IYG-------ESDKFLNWS----------------------TRFQIILGIARGLQY-LHEDSHT  203 (407)
Q Consensus       168 -----~~---------l~~-------~~~~~l~~~----------------------~~~~i~~~i~~~l~~-LH~~~~~  203 (407)
                           ..         +|.       ..+...++.                      .....+..+...+.- +.+....
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence                 10         010       001112211                      111222233322221 1222234


Q ss_pred             ceeeeccccccEEEcCCCceEEecccCccc
Q 040557          204 RIVHRDIKASNVLLDEKFQSKIGDFGLARF  233 (407)
Q Consensus       204 ~i~H~dlk~~Nill~~~~~~kl~Dfgla~~  233 (407)
                      .++|+|+.+.|||++++  ..++||+-+..
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhccc
Confidence            58999999999999754  45899988864

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.08  E-value=0.0046  Score=54.04  Aligned_cols=157  Identities=11%  Similarity=0.032  Sum_probs=80.8

Q ss_pred             cCHHHHHHHhcCCCCCCeee-----ccCCccEEEEEecCCcEEEEEEeccccChhhHHHHHHHHHHHHcCCCCc--eeee
Q 040557           72 FDFQTLKKATKNFHPGNLLG-----RGGFGPVYRGKLADGTLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKN--LVRL  144 (407)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lg-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l  144 (407)
                      .+.++++....+|.+++...     .|---+.|.....+|+ +++|++......   ..+..|++++..+...+  +...
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~---~~l~~~~~~l~~L~~~g~pvp~p   78 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLP   78 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCH---HHHHHHHHHHHhhhhcccccccc
Confidence            45677888888898877654     4555678999886655 888987532222   23344566666553222  1111


Q ss_pred             ee------eeecCCeeEEEEEeccCCChhH--------------HHhcc--C-----CCCCCH-----------------
Q 040557          145 LG------CCSDGSQRLLVYEYMKNRSLDL--------------LIYGE--S-----DKFLNW-----------------  180 (407)
Q Consensus       145 ~~------~~~~~~~~~lv~e~~~~g~L~~--------------~l~~~--~-----~~~l~~-----------------  180 (407)
                      +.      +.........++.+..+.....              .++..  .     ......                 
T Consensus        79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (316)
T d2ppqa1          79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  158 (316)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence            11      1122344566677665533310              00000  0     000000                 


Q ss_pred             -HHHHHHHHHHHHHhcccccc-CCCceeeeccccccEEEcCCCceEEecccCcc
Q 040557          181 -STRFQIILGIARGLQYLHED-SHTRIVHRDIKASNVLLDEKFQSKIGDFGLAR  232 (407)
Q Consensus       181 -~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~  232 (407)
                       ......+......+...+.. -..+++|+|+.++||+++.+...-|.||+.+.
T Consensus       159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence             00111122222222222211 12349999999999999998777899999885

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.90  E-value=0.0015  Score=59.41  Aligned_cols=72  Identities=21%  Similarity=0.312  Sum_probs=47.3

Q ss_pred             CeeeccCCccEEEEEecCC--------cEEEEEEeccccChhhHHHHHHHHHHHHcCCCCce-eeeeeeeecCCeeEEEE
Q 040557           88 NLLGRGGFGPVYRGKLADG--------TLVAVKKLCVDKSQQGESEFLSEVRMITSIQHKNL-VRLLGCCSDGSQRLLVY  158 (407)
Q Consensus        88 ~~lg~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  158 (407)
                      +.|+.|-.-.+|++...++        +.|.+++.- ..  .......+|..+++.+.-.++ .++++++.+    ..|+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            4677788889999986543        456666653 22  223345688888888743344 577777754    5789


Q ss_pred             EeccCCCh
Q 040557          159 EYMKNRSL  166 (407)
Q Consensus       159 e~~~~g~L  166 (407)
                      ||++|..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987554